archetype #,Feature Name,P value (Mann-Whitney),Median Difference,Mean Difference,Significant after Benjamini-Hochberg correction?,Is first bin maximal?
1,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,2.8267e-05,0.37482,0.39329,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,4.5779e-05,0.26399,0.29881,1,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.0017696,0.23345,0.1917,1,1
1,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.0172,0.16968,0.15484,1,1
1,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.045233,0.15438,0.091879,1,1
1,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.0015882,0.088582,0.13856,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.0080134,-0.11039,-0.27049,1,0
1,GO ALDEHYDE CATABOLIC PROCESS,0.046961,-0.11548,-0.12635,1,0
1,GO BASE EXCISION REPAIR AP SITE FORMATION,0.024086,-0.12846,-0.18506,1,0
1,GO HISTONE EXCHANGE,0.010572,-0.13825,-0.20609,1,0
1,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.010101,-0.14221,-0.17266,1,0
1,GO MITOCHONDRIAL TRANSCRIPTION,0.0010209,-0.14806,-0.2397,1,0
1,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.0011418,-0.16058,-0.18918,1,0
1,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,0.056456,-0.16494,-0.26488,1,0
1,GO IRON SULFUR CLUSTER ASSEMBLY,0.0172,-0.18344,-0.19913,1,0
1,GO DNA DEAMINATION,0.035953,-0.1836,-0.29326,1,0
1,GO RETINOL METABOLIC PROCESS,0.0020776,-0.18583,-0.26951,1,0
1,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,0.00051151,-0.18692,-0.18381,1,0
1,GO PEPTIDE BIOSYNTHETIC PROCESS,7.7514e-06,-0.18868,-0.24244,1,0
1,GO CENTROMERE COMPLEX ASSEMBLY,0.0038653,-0.19171,-0.27283,1,0
1,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.00081392,-0.1942,-0.22323,1,0
1,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,6.4139e-05,-0.19588,-0.28599,1,0
1,GO NEGATIVE REGULATION OF BEHAVIOR,0.0080134,-0.19612,-0.20557,1,0
1,GO SPERM EGG RECOGNITION,0.0042727,-0.20301,-0.20333,1,0
1,GO RIBOSOME BIOGENESIS,3.9936e-05,-0.20424,-0.25968,1,0
1,GO KERATINIZATION,0.052482,-0.20476,-0.17802,1,0
1,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.00012367,-0.20633,-0.30103,1,0
1,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.043559,-0.20818,-0.41448,1,0
1,GO HYPERSENSITIVITY,0.037377,-0.20957,-0.52225,1,0
1,GO RNA SURVEILLANCE,0.00017019,-0.20969,-0.30944,1,0
1,GO CELLULAR RESPONSE TO LITHIUM ION,0.0010798,-0.21001,-0.29282,1,0
1,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.0023095,-0.21379,-0.27752,1,0
1,GO T CELL MEDIATED CYTOTOXICITY,0.045233,-0.21519,-0.38974,1,0
1,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,1.2939e-05,-0.21528,-0.28707,1,0
1,GO RNA CATABOLIC PROCESS,7.7514e-06,-0.21624,-0.25133,1,0
1,GO SEQUESTERING OF METAL ION,0.026142,-0.21725,-0.22809,1,0
1,GO RESPONSE TO XENOBIOTIC STIMULUS,0.00017019,-0.2211,-0.26129,1,0
1,GO MEIOSIS I CELL CYCLE PROCESS,0.00076864,-0.22305,-0.33098,1,0
1,GO FOREBRAIN REGIONALIZATION,0.016475,-0.2238,-0.35787,1,0
1,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.02951,-0.22409,-0.41727,1,0
1,GO MALE MEIOSIS I,0.015776,-0.22698,-0.33245,1,0
1,GO RRNA METABOLIC PROCESS,1.4947e-05,-0.22735,-0.29878,1,0
1,GO KINETOCHORE ORGANIZATION,0.0027019,-0.22861,-0.33303,1,0
1,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,1.9888e-05,-0.22944,-0.29168,1,0
1,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,0.019548,-0.2312,-0.2908,1,0
1,GO TERPENOID BIOSYNTHETIC PROCESS,0.00057531,-0.23395,-0.25874,1,0
1,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.00045436,-0.2344,-0.25888,1,0
1,GO RETINAL METABOLIC PROCESS,0.033245,-0.23468,-0.30471,1,0
1,GO MEIOTIC CHROMOSOME SEGREGATION,0.00026348,-0.23491,-0.36801,1,0
1,GO SPERM AXONEME ASSEMBLY,0.008797,-0.23728,-0.22807,1,0
1,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,0.031957,-0.23778,-0.38142,1,0
1,GO AMIDE BIOSYNTHETIC PROCESS,7.1973e-06,-0.2382,-0.2857,1,0
1,GO VIRAL BUDDING,9.5377e-05,-0.23837,-0.32007,1,0
1,GO TRNA MODIFICATION,1.8524e-05,-0.23885,-0.33885,1,0
1,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,9.6689e-06,-0.24159,-0.33593,1,0
1,GO CELL REDOX HOMEOSTASIS,5.2428e-05,-0.24193,-0.3524,1,0
1,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,0.00040321,-0.24211,-0.32222,1,0
1,GO PEPTIDYL ASPARAGINE MODIFICATION,3.4805e-05,-0.24262,-0.32857,1,0
1,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.00019306,-0.24273,-0.24486,1,0
1,GO SENSORY PERCEPTION OF TASTE,0.00033648,-0.24312,-0.32251,1,0
1,GO MUCUS SECRETION,0.045233,-0.24314,-0.22892,1,0
1,GO STEROID ESTERIFICATION,0.0028457,-0.24378,-0.37076,1,0
1,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.006955,-0.2444,-0.25233,1,0
1,GO STARTLE RESPONSE,0.015104,-0.24578,-0.36679,1,0
1,GO HISTONE MRNA METABOLIC PROCESS,8.9327e-05,-0.24587,-0.29055,1,0
1,GO FUSION OF SPERM TO EGG PLASMA MEMBRANE INVOLVED IN SINGLE FERTILIZATION,0.015104,-0.24641,-0.23537,1,0
1,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.00072571,-0.24645,-0.34287,1,0
1,GO NCRNA PROCESSING,1.6059e-05,-0.24708,-0.31944,1,0
1,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,8.9327e-05,-0.24859,-0.29765,1,0
1,GO SENSORY PERCEPTION OF SMELL,0.00011593,-0.24954,-0.25177,1,0
1,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,3.0304e-05,-0.2505,-0.3056,1,0
1,GO REGULATION OF CILIUM MOVEMENT,0.0052065,-0.25115,-0.21764,1,0
1,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,8.9327e-05,-0.25142,-0.30236,1,0
1,GO URONIC ACID METABOLIC PROCESS,0.00026348,-0.25175,-0.22375,1,0
1,GO MACROMOLECULE DEPALMITOYLATION,0.0015882,-0.25502,-0.22958,1,0
1,GO NCRNA METABOLIC PROCESS,1.0403e-05,-0.25646,-0.33111,1,0
1,GO GASTRIC ACID SECRETION,0.00057531,-0.26032,-0.28085,1,0
1,GO SENSORY PERCEPTION OF BITTER TASTE,0.0023095,-0.26166,-0.32101,1,0
1,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,3.7287e-05,-0.2635,-0.34288,1,0
1,GO REGULATION OF T CELL MEDIATED IMMUNITY,0.0042727,-0.26413,-0.46607,1,0
1,GO MULTIVESICULAR BODY ORGANIZATION,2.636e-05,-0.26504,-0.34225,1,0
1,GO VIRION ASSEMBLY,9.6689e-06,-0.26624,-0.3343,1,0
1,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,0.0024341,-0.26692,-0.32621,1,0
1,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.006955,-0.26828,-0.4508,1,0
1,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.0052065,-0.26839,-0.23134,1,0
1,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,3.9422e-06,-0.2688,-0.29995,1,0
1,GO PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.00035748,-0.26965,-0.32855,1,0
1,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.0016767,-0.27023,-0.33943,1,0
1,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.00028019,-0.27045,-0.34885,1,0
1,GO POSITIVE REGULATION OF ACROSOME REACTION,0.012106,-0.27358,-0.25418,1,0
1,GO OUTER DYNEIN ARM ASSEMBLY,0.018736,-0.27473,-0.33022,1,0
1,GO AMINE CATABOLIC PROCESS,0.00091199,-0.27644,-0.37447,1,0
1,GO NEUROPEPTIDE SIGNALING PATHWAY,0.016475,-0.27706,-0.25736,1,0
1,GO AMP METABOLIC PROCESS,0.00040321,-0.27835,-0.28401,1,0
1,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,0.0028457,-0.27889,-0.38801,1,0
1,GO REGULATION OF T CELL CHEMOTAXIS,0.035953,-0.27911,-0.42201,1,0
1,GO KINETOCHORE ASSEMBLY,0.0012071,-0.27923,-0.36164,1,0
1,GO POSITIVE REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.008797,-0.27951,-0.33622,1,0
1,GO REGULATION OF LYSOSOMAL LUMEN PH,0.00045436,-0.27971,-0.37826,1,0
1,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,1.6059e-05,-0.28131,-0.32141,1,0
1,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,3.0304e-05,-0.28148,-0.31254,1,0
1,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.00054254,-0.28159,-0.35654,1,0
1,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.0031545,-0.2833,-0.41581,1,0
1,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,5.2428e-05,-0.28338,-0.35677,1,0
1,GO T CELL MEDIATED IMMUNITY,0.0029965,-0.28479,-0.46114,1,0
1,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,2.8267e-05,-0.28563,-0.2986,1,0
1,GO RESPONSE TO FOOD,0.0015882,-0.28767,-0.29393,1,0
1,GO LIPOXYGENASE PATHWAY,0.037377,-0.28809,-0.24242,1,0
1,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,3.7287e-05,-0.28822,-0.3587,1,0
1,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.016475,-0.28859,-0.43926,1,0
1,GO PROTEIN NITROSYLATION,0.00015974,-0.29027,-0.36411,1,0
1,GO MALE MEIOTIC NUCLEAR DIVISION,0.0015041,-0.29092,-0.37142,1,0
1,GO RESPONSE TO INSECTICIDE,0.0057394,-0.29186,-0.35847,1,0
1,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00014989,-0.29241,-0.31148,1,0
1,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.00014989,-0.29319,-0.36342,1,0
1,GO TOLERANCE INDUCTION,0.028348,-0.29431,-0.59652,1,0
1,GO OOCYTE DIFFERENTIATION,4.8997e-05,-0.29436,-0.38007,1,0
1,GO RETINA HOMEOSTASIS,8.9843e-06,-0.2944,-0.34083,1,0
1,GO RNA MODIFICATION,7.1973e-06,-0.29523,-0.37676,1,0
1,GO TRNA METHYLATION,1.4947e-05,-0.29579,-0.37679,1,0
1,GO PROTEIN TARGETING TO MITOCHONDRION,1.8524e-05,-0.29659,-0.32641,1,0
1,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.013834,-0.29692,-0.38915,1,0
1,GO ETHANOL METABOLIC PROCESS,0.00064645,-0.29697,-0.4246,1,0
1,GO ZINC ION HOMEOSTASIS,0.00081392,-0.29785,-0.35162,1,0
1,GO INTERLEUKIN 5 PRODUCTION,0.030713,-0.29833,-0.36032,1,0
1,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.011574,-0.29854,-0.23408,1,0
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,7.1973e-06,-0.29862,-0.32719,1,0
1,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,9.5377e-05,-0.29991,-0.33895,1,0
1,GO PHOTOTRANSDUCTION,6.2007e-06,-0.30095,-0.36511,1,0
1,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,0.00014989,-0.30105,-0.38457,1,0
1,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,1.2035e-05,-0.30132,-0.35594,1,0
1,GO RIBONUCLEOSIDE CATABOLIC PROCESS,0.008797,-0.3014,-0.32312,1,0
1,GO FEMALE MEIOTIC NUCLEAR DIVISION,0.00011593,-0.30142,-0.39458,1,0
1,GO GTP METABOLIC PROCESS,2.636e-05,-0.30158,-0.33965,1,0
1,GO REGULATION OF FEEDING BEHAVIOR,3.0304e-05,-0.30161,-0.33911,1,0
1,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,5.2428e-05,-0.30205,-0.39721,1,0
1,GO DORSAL SPINAL CORD DEVELOPMENT,0.0015041,-0.30218,-0.40673,1,0
1,GO BEHAVIORAL RESPONSE TO COCAINE,0.0066311,-0.30271,-0.42264,1,0
1,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,2.2907e-05,-0.30271,-0.37732,1,0
1,GO OOGENESIS,3.7287e-05,-0.30284,-0.37068,1,0
1,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,0.00013188,-0.3033,-0.38314,1,0
1,GO NUCLEOSOME ASSEMBLY,0.00018128,-0.30362,-0.35081,1,0
1,GO DETOXIFICATION,0.00018128,-0.30406,-0.299,1,0
1,GO DOPAMINE BIOSYNTHETIC PROCESS,0.0049572,-0.30478,-0.36307,1,0
1,GO METHIONINE BIOSYNTHETIC PROCESS,0.0015882,-0.30482,-0.31895,1,0
1,GO POSITIVE REGULATION OF CELL KILLING,0.024086,-0.30519,-0.41368,1,0
1,GO ACTIVATION OF INNATE IMMUNE RESPONSE,2.1347e-05,-0.30541,-0.39477,1,0
1,GO CELL KILLING,0.0092139,-0.30627,-0.39062,1,0
1,GO HEPATOCYTE DIFFERENTIATION,0.0016767,-0.30641,-0.32462,1,0
1,GO NUCLEOSIDE METABOLIC PROCESS,1.2939e-05,-0.3065,-0.33117,1,0
1,GO IMMUNOLOGICAL MEMORY PROCESS,0.0040644,-0.30754,-0.45607,1,0
1,GO HOMOLOGOUS RECOMBINATION,9.5377e-05,-0.30762,-0.40534,1,0
1,GO METHIONINE METABOLIC PROCESS,0.00042807,-0.30795,-0.32849,1,0
1,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,8.3461e-06,-0.30908,-0.36009,1,0
1,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,0.00051151,-0.30918,-0.35698,1,0
1,GO PYRIMIDINE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORT,0.00017019,-0.30931,-0.41428,1,0
1,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,0.0012071,-0.30958,-0.30874,1,0
1,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,4.5779e-05,-0.30969,-0.37269,1,0
1,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,7.1973e-06,-0.30993,-0.36044,1,0
1,GO OPSONIZATION,0.0029965,-0.31029,-0.47286,1,0
1,GO EMBRYONIC AXIS SPECIFICATION,1.7249e-05,-0.31032,-0.3827,1,0
1,GO NUCLEOSIDE CATABOLIC PROCESS,0.0012071,-0.3105,-0.33949,1,0
1,GO TRIPARTITE REGIONAL SUBDIVISION,7.8298e-05,-0.31152,-0.36022,1,0
1,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,7.7514e-06,-0.31162,-0.38194,1,0
1,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.0029965,-0.31193,-0.35518,1,0
1,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.00010181,-0.31229,-0.33846,1,0
1,GO PEPTIDYL METHIONINE MODIFICATION,0.00060992,-0.31247,-0.38188,1,0
1,GO PEPTIDYL ARGININE MODIFICATION,0.00015974,-0.31272,-0.3012,1,0
1,GO INTERLEUKIN 17 PRODUCTION,0.0027019,-0.31279,-0.51519,1,0
1,GO DNA REPLICATION INITIATION,0.00010181,-0.3131,-0.35462,1,0
1,GO RIBONUCLEOSIDE METABOLIC PROCESS,1.4947e-05,-0.3133,-0.33654,1,0
1,GO PHASIC SMOOTH MUSCLE CONTRACTION,0.0015041,-0.31334,-0.26736,1,0
1,GO MRNA METABOLIC PROCESS,6.6813e-06,-0.31354,-0.34804,1,0
1,GO GLYCOSIDE METABOLIC PROCESS,0.00068502,-0.31409,-0.32103,1,0
1,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.0016767,-0.31424,-0.36661,1,0
1,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,5.2428e-05,-0.31439,-0.36683,1,0
1,GO REGULATION OF MICROTUBULE BASED MOVEMENT,3.4805e-05,-0.31518,-0.30851,1,0
1,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.016475,-0.31535,-0.52249,1,0
1,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.008797,-0.31548,-0.30379,1,0
1,GO PEROXISOME ORGANIZATION,1.2035e-05,-0.31553,-0.35708,1,0
1,GO SNRNA METABOLIC PROCESS,4.5779e-05,-0.31566,-0.34187,1,0
1,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,1.8524e-05,-0.3157,-0.36675,1,0
1,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.0049572,-0.31633,-0.25561,1,0
1,GO DRUG METABOLIC PROCESS,1.2939e-05,-0.31709,-0.35625,1,0
1,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.00014989,-0.31729,-0.38656,1,0
1,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,3.0304e-05,-0.31746,-0.42058,1,0
1,GO RNA METHYLATION,6.6813e-06,-0.31775,-0.4161,1,0
1,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,1.7249e-05,-0.31781,-0.41113,1,0
1,GO INTERMEDIATE FILAMENT ORGANIZATION,0.00010181,-0.31785,-0.40056,1,0
1,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.0036751,-0.31818,-0.29522,1,0
1,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,0.0031545,-0.3183,-0.29002,1,0
1,GO RESPONSE TO INTERLEUKIN 12,2.636e-05,-0.31837,-0.38107,1,0
1,GO SALIVA SECRETION,0.0083971,-0.31843,-0.2839,1,0
1,GO FEAR RESPONSE,4.2763e-05,-0.31859,-0.38619,1,0
1,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.006955,-0.31875,-0.4838,1,0
1,GO CELL CELL RECOGNITION,0.00024771,-0.31938,-0.33087,1,0
1,GO SKELETAL MUSCLE TISSUE REGENERATION,3.7287e-05,-0.3195,-0.44435,1,0
1,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,0.010101,-0.31957,-0.42088,1,0
1,GO NEPHRON TUBULE FORMATION,0.0019699,-0.31962,-0.29391,1,0
1,GO REGULATION OF CELL CYCLE CHECKPOINT,7.8298e-05,-0.3199,-0.3935,1,0
1,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.034576,-0.32003,-0.41395,1,0
1,GO POSITIVE REGULATION OF T CELL MIGRATION,0.0096484,-0.3205,-0.49155,1,0
1,GO TONIC SMOOTH MUSCLE CONTRACTION,0.00054254,-0.32057,-0.42012,1,0
1,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,1.2035e-05,-0.32072,-0.39495,1,0
1,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,6.4139e-05,-0.32093,-0.38729,1,0
1,GO RETINOIC ACID METABOLIC PROCESS,0.0020776,-0.32127,-0.28937,1,0
1,GO RNA INTERFERENCE,8.3641e-05,-0.32127,-0.38621,1,0
1,GO REGULATION OF CELL KILLING,0.0076456,-0.32146,-0.47641,1,0
1,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.00060992,-0.32207,-0.33065,1,0
1,GO GPI ANCHOR METABOLIC PROCESS,0.0011418,-0.32238,-0.30897,1,0
1,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,0.0020776,-0.32242,-0.40124,1,0
1,GO REGULATION OF CHROMOSOME SEPARATION,4.2763e-05,-0.32247,-0.41249,1,0
1,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.00035748,-0.32258,-0.33517,1,0
1,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,8.3641e-05,-0.32269,-0.39266,1,0
1,GO NEURON FATE SPECIFICATION,0.024086,-0.32286,-0.40068,1,0
1,GO ALPHA BETA T CELL PROLIFERATION,0.011063,-0.32291,-0.53409,1,0
1,GO CELLULAR OXIDANT DETOXIFICATION,0.00013188,-0.32349,-0.31621,1,0
1,GO CYTOPLASMIC TRANSLATIONAL INITIATION,3.0304e-05,-0.32421,-0.28963,1,0
1,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,0.015104,-0.32464,-0.38542,1,0
1,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.01266,-0.32471,-0.50877,1,0
1,GO REGULATION OF SPINDLE CHECKPOINT,0.00014062,-0.32475,-0.38597,1,0
1,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,1.2035e-05,-0.32486,-0.409,1,0
1,GO INTERLEUKIN 4 PRODUCTION,0.010572,-0.32557,-0.49188,1,0
1,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,1.2035e-05,-0.32619,-0.38769,1,0
1,GO ACROSOME REACTION,0.00072571,-0.32626,-0.39221,1,0
1,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,0.00019306,-0.32648,-0.39053,1,0
1,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,0.00014062,-0.32747,-0.40255,1,0
1,GO RRNA CATABOLIC PROCESS,4.8997e-05,-0.32763,-0.42742,1,0
1,GO ESTROGEN METABOLIC PROCESS,2.4576e-05,-0.32821,-0.33307,1,0
1,GO GLYCOSYL COMPOUND METABOLIC PROCESS,1.2035e-05,-0.32884,-0.33219,1,0
1,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.034576,-0.32954,-0.41112,1,0
1,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00081392,-0.32959,-0.39104,1,0
1,GO INTRACILIARY RETROGRADE TRANSPORT,0.00042807,-0.32997,-0.43005,1,0
1,GO PROTON TRANSMEMBRANE TRANSPORT,1.7249e-05,-0.33003,-0.34675,1,0
1,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.00017019,-0.33032,-0.32475,1,0
1,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.00040321,-0.33114,-0.30785,1,0
1,GO REGULATION OF T CELL CYTOKINE PRODUCTION,0.0052065,-0.33195,-0.51967,1,0
1,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.00024771,-0.33214,-0.40754,1,0
1,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,2.8267e-05,-0.3324,-0.40502,1,0
1,GO PRIMARY ALCOHOL METABOLIC PROCESS,4.2763e-05,-0.33284,-0.37448,1,0
1,GO MITOCHONDRIAL DNA REPLICATION,9.6689e-06,-0.33313,-0.41042,1,0
1,GO RETINAL CONE CELL DIFFERENTIATION,0.00048214,-0.33387,-0.30694,1,0
1,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,6.8565e-05,-0.33389,-0.39137,1,0
1,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.006955,-0.3342,-0.4165,1,0
1,GO CELLULAR AMINO ACID METABOLIC PROCESS,7.7514e-06,-0.33445,-0.3688,1,0
1,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,1.0403e-05,-0.33485,-0.37443,1,0
1,GO REGULATION OF TOLERANCE INDUCTION,0.030713,-0.3351,-0.58081,1,0
1,GO IMMUNE RESPONSE TO TUMOR CELL,0.0042727,-0.33539,-0.45644,1,0
1,GO PROTEIN ADP RIBOSYLATION,3.248e-05,-0.33572,-0.47808,1,0
1,GO PEROXISOMAL TRANSPORT,1.7249e-05,-0.33576,-0.35407,1,0
1,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.00026348,-0.33596,-0.44702,1,0
1,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0047188,-0.33643,-0.50255,1,0
1,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,5.6086e-05,-0.33691,-0.31083,1,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,5.7533e-06,-0.33714,-0.43582,1,0
1,GO GERM CELL DEVELOPMENT,2.1347e-05,-0.33791,-0.38813,1,0
1,GO REGULATION OF LIGASE ACTIVITY,4.5779e-05,-0.33809,-0.39248,1,0
1,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,1.2939e-05,-0.3384,-0.3532,1,0
1,GO T CELL CYTOKINE PRODUCTION,0.0015041,-0.33847,-0.51844,1,0
1,GO MIDDLE EAR MORPHOGENESIS,0.00015974,-0.33896,-0.37189,1,0
1,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.012106,-0.33918,-0.38848,1,0
1,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.028348,-0.33992,-0.47895,1,0
1,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,5.9985e-05,-0.34069,-0.53388,1,0
1,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,1.0403e-05,-0.34072,-0.41273,1,0
1,GO PLASMA MEMBRANE FUSION,0.00026348,-0.34114,-0.36848,1,0
1,GO HYDROGEN PEROXIDE METABOLIC PROCESS,6.4139e-05,-0.34126,-0.33698,1,0
1,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,0.007293,-0.34132,-0.3497,1,0
1,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.016475,-0.34136,-0.34028,1,0
1,GO POSITIVE REGULATION OF FERTILIZATION,0.0015041,-0.34161,-0.33035,1,0
1,GO DETECTION OF LIGHT STIMULUS,5.337e-06,-0.34171,-0.37878,1,0
1,GO SPERMATID DIFFERENTIATION,3.4805e-05,-0.34197,-0.37131,1,0
1,GO INTERFERON GAMMA PRODUCTION,0.0052065,-0.34218,-0.51221,1,0
1,GO RESPONSE TO INTERFERON BETA,0.010101,-0.34238,-0.50761,1,0
1,GO SNRNA TRANSCRIPTION,9.6689e-06,-0.3425,-0.42411,1,0
1,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.0025648,-0.3428,-0.35355,1,0
1,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,4.2763e-05,-0.34321,-0.38954,1,0
1,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,8.3461e-06,-0.34324,-0.38469,1,0
1,GO INTERLEUKIN 13 PRODUCTION,0.013834,-0.34434,-0.45021,1,0
1,GO CELLULAR HORMONE METABOLIC PROCESS,5.9985e-05,-0.34458,-0.33778,1,0
1,GO SPERM CAPACITATION,0.0083971,-0.34514,-0.2401,1,0
1,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,0.00072571,-0.34539,-0.28989,1,0
1,GO BICARBONATE TRANSPORT,0.00015974,-0.34548,-0.37364,1,0
1,GO FEEDING BEHAVIOR,0.00018128,-0.34549,-0.3916,1,0
1,GO PREPULSE INHIBITION,0.0047188,-0.34559,-0.47726,1,0
1,GO REGULATION OF SISTER CHROMATID SEGREGATION,2.8267e-05,-0.3459,-0.43873,1,0
1,GO PHOTORECEPTOR CELL DEVELOPMENT,1.7249e-05,-0.34643,-0.40406,1,0
1,GO PEPTIDYL ARGININE METHYLATION,5.2428e-05,-0.34668,-0.39786,1,0
1,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,8.3461e-06,-0.34668,-0.36656,1,0
1,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.030713,-0.34729,-0.5568,1,0
1,GO PH REDUCTION,8.3461e-06,-0.34752,-0.41937,1,0
1,GO NODAL SIGNALING PATHWAY,0.00054254,-0.34773,-0.3031,1,0
1,GO MATURATION OF SSU RRNA,8.3461e-06,-0.34796,-0.34366,1,0
1,GO POSITIVE REGULATION OF MRNA PROCESSING,3.248e-05,-0.34827,-0.38165,1,0
1,GO ICOSANOID BIOSYNTHETIC PROCESS,0.00029789,-0.3486,-0.45063,1,0
1,GO LIPID DIGESTION,0.030713,-0.34867,-0.29197,1,0
1,GO NUCLEAR CHROMOSOME SEGREGATION,2.4576e-05,-0.3489,-0.4292,1,0
1,GO SECRETION BY TISSUE,9.5377e-05,-0.34892,-0.34119,1,0
1,GO TERPENOID METABOLIC PROCESS,5.6086e-05,-0.349,-0.36531,1,0
1,GO PROTEIN LOCALIZATION TO CHROMOSOME,1.7249e-05,-0.34982,-0.43719,1,0
1,GO DENTATE GYRUS DEVELOPMENT,5.9985e-05,-0.35001,-0.39575,1,0
1,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.0063209,-0.35021,-0.44861,1,0
1,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,0.0016767,-0.35049,-0.38697,1,0
1,GO DETECTION OF VISIBLE LIGHT,4.5891e-06,-0.35065,-0.37957,1,0
1,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.0052065,-0.35131,-0.42737,1,0
1,GO REGULATION OF BEHAVIOR,7.7514e-06,-0.35166,-0.43407,1,0
1,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,7.8298e-05,-0.35172,-0.38941,1,0
1,GO GLUTATHIONE METABOLIC PROCESS,5.2428e-05,-0.35247,-0.3332,1,0
1,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,5.6086e-05,-0.35259,-0.35656,1,0
1,GO EPOXYGENASE P450 PATHWAY,0.019548,-0.35275,-0.22756,1,0
1,GO LIPOPROTEIN CATABOLIC PROCESS,0.00017019,-0.35314,-0.43649,1,0
1,GO LYMPHOCYTE APOPTOTIC PROCESS,0.00035748,-0.3534,-0.50582,1,0
1,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.00332,-0.35344,-0.33007,1,0
1,GO HOMOCYSTEINE METABOLIC PROCESS,0.00011593,-0.35345,-0.37671,1,0
1,GO SEMINIFEROUS TUBULE DEVELOPMENT,2.636e-05,-0.35384,-0.49268,1,0
1,GO INTERLEUKIN 10 PRODUCTION,0.0076456,-0.35417,-0.52957,1,0
1,GO MUSCLE CELL FATE COMMITMENT,0.00010181,-0.35432,-0.40095,1,0
1,GO CHEMOKINE BIOSYNTHETIC PROCESS,0.0019699,-0.35478,-0.62401,1,0
1,GO ISOPRENOID METABOLIC PROCESS,5.9985e-05,-0.35519,-0.3489,1,0
1,GO INTERSTRAND CROSS LINK REPAIR,3.248e-05,-0.35519,-0.41836,1,0
1,GO NEGATIVE REGULATION OF AMINE TRANSPORT,0.00096503,-0.35578,-0.41804,1,0
1,GO ETHANOL OXIDATION,0.0057394,-0.35595,-0.45123,1,0
1,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,5.337e-06,-0.35629,-0.37022,1,0
1,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,0.00014062,-0.35649,-0.46385,1,0
1,GO MACROPHAGE APOPTOTIC PROCESS,0.012106,-0.35664,-0.3107,1,0
1,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,3.7287e-05,-0.35735,-0.39331,1,0
1,GO CHROMOSOME SEGREGATION,2.4576e-05,-0.35757,-0.42771,1,0
1,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,1.1191e-05,-0.35766,-0.40182,1,0
1,GO DEFENSE RESPONSE TO OTHER ORGANISM,0.00013188,-0.35794,-0.50076,1,0
1,GO CHROMATIN SILENCING AT TELOMERE,0.00021879,-0.35811,-0.3742,1,0
1,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,5.6086e-05,-0.35813,-0.427,1,0
1,GO DNA DOUBLE STRAND BREAK PROCESSING,1.8524e-05,-0.35835,-0.46184,1,0
1,GO CELL CYCLE G2 M PHASE TRANSITION,9.6689e-06,-0.35856,-0.43054,1,0
1,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,3.7287e-05,-0.35921,-0.40544,1,0
1,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,6.6813e-06,-0.35923,-0.39922,1,0
1,GO ZINC ION TRANSPORT,1.2939e-05,-0.35978,-0.38911,1,0
1,GO KERATINOCYTE DIFFERENTIATION,0.00024771,-0.35984,-0.35907,1,0
1,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,7.3279e-05,-0.36022,-0.4398,1,0
1,GO SLEEP,3.9936e-05,-0.36027,-0.38682,1,0
1,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00081392,-0.36036,-0.45016,1,0
1,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.00068502,-0.36041,-0.46465,1,0
1,GO GLUTAMATE METABOLIC PROCESS,0.00011593,-0.36043,-0.40294,1,0
1,GO TRANSCRIPTION BY RNA POLYMERASE III,6.2007e-06,-0.36051,-0.41663,1,0
1,GO REGULATION OF RESPONSE TO TUMOR CELL,0.0025648,-0.36112,-0.42759,1,0
1,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,0.0047188,-0.36122,-0.56955,1,0
1,GO PROSTATE GLAND GROWTH,0.00086166,-0.36147,-0.2998,1,0
1,GO NEGATIVE REGULATION OF DNA BINDING,1.2939e-05,-0.36183,-0.43581,1,0
1,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,8.3461e-06,-0.36206,-0.36797,1,0
1,GO EXPLORATION BEHAVIOR,0.00014989,-0.36227,-0.45627,1,0
1,GO ARACHIDONIC ACID METABOLIC PROCESS,9.5377e-05,-0.36291,-0.42508,1,0
1,GO REGULATION OF CELLULAR RESPIRATION,4.8997e-05,-0.36327,-0.39091,1,0
1,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.00026348,-0.36351,-0.34703,1,0
1,GO DNA PACKAGING,2.636e-05,-0.36371,-0.44455,1,0
1,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.0057394,-0.36397,-0.4751,1,0
1,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.00068502,-0.36479,-0.40255,1,0
1,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,7.7514e-06,-0.36485,-0.39618,1,0
1,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.0076456,-0.36514,-0.50503,1,0
1,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,7.8298e-05,-0.36529,-0.34224,1,0
1,GO LEUKOCYTE MEDIATED CYTOTOXICITY,0.0063209,-0.36555,-0.45748,1,0
1,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.0042727,-0.36616,-0.4624,1,0
1,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,4.5779e-05,-0.36674,-0.42267,1,0
1,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0054671,-0.36679,-0.41305,1,0
1,GO PROTEIN LOCALIZATION TO ORGANELLE,4.5891e-06,-0.36711,-0.41511,1,0
1,GO NEURAL NUCLEUS DEVELOPMENT,7.8298e-05,-0.36749,-0.476,1,0
1,GO ICOSANOID METABOLIC PROCESS,9.5377e-05,-0.36757,-0.40373,1,0
1,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.012106,-0.36768,-0.64459,1,0
1,GO T CELL CHEMOTAXIS,0.019548,-0.36802,-0.51976,1,0
1,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,0.0017696,-0.36819,-0.40656,1,0
1,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0027019,-0.36847,-0.55638,1,0
1,GO CELLULAR KETONE METABOLIC PROCESS,7.1973e-06,-0.36891,-0.39873,1,0
1,GO SPLICEOSOMAL COMPLEX ASSEMBLY,5.2428e-05,-0.36902,-0.40892,1,0
1,GO REGULATION OF T CELL APOPTOTIC PROCESS,0.012106,-0.36931,-0.47086,1,0
1,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,2.8267e-05,-0.36947,-0.39585,1,0
1,GO PROTEIN AUTOPROCESSING,0.00057531,-0.36952,-0.34206,1,0
1,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,0.013235,-0.36977,-0.45085,1,0
1,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,5.7533e-06,-0.37024,-0.41055,1,0
1,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,1.8524e-05,-0.37035,-0.41575,1,0
1,GO PHOTOTRANSDUCTION VISIBLE LIGHT,4.9495e-06,-0.37036,-0.41549,1,0
1,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,8.9843e-06,-0.37058,-0.37895,1,0
1,GO T CELL APOPTOTIC PROCESS,0.0015882,-0.37067,-0.47587,1,0
1,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,2.8267e-05,-0.37069,-0.4134,1,0
1,GO NUCLEOTIDE SALVAGE,0.00014062,-0.37075,-0.35987,1,0
1,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,9.6689e-06,-0.37105,-0.34614,1,0
1,GO INNATE IMMUNE RESPONSE,0.00019306,-0.37141,-0.50842,1,0
1,GO RESPONSE TO L GLUTAMATE,2.2907e-05,-0.3717,-0.43408,1,0
1,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0023095,-0.37193,-0.49405,1,0
1,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,5.2428e-05,-0.37194,-0.39679,1,0
1,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.010101,-0.37197,-0.49429,1,0
1,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,4.5891e-06,-0.37205,-0.45933,1,0
1,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.011063,-0.37212,-0.48671,1,0
1,GO POSITIVE REGULATION OF T CELL PROLIFERATION,0.0076456,-0.37225,-0.53061,1,0
1,GO POSITIVE REGULATION OF REGULATORY T CELL DIFFERENTIATION,0.0049572,-0.37243,-0.58166,1,0
1,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,5.9985e-05,-0.37253,-0.42162,1,0
1,GO AMINO SUGAR CATABOLIC PROCESS,0.0029965,-0.37254,-0.48824,1,0
1,GO CILIUM MOVEMENT,0.00018128,-0.37262,-0.36615,1,0
1,GO TISSUE REGENERATION,4.5779e-05,-0.37289,-0.43147,1,0
1,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,0.00020554,-0.37297,-0.40352,1,0
1,GO REGULATION OF EXIT FROM MITOSIS,0.00019306,-0.37305,-0.40004,1,0
1,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0172,-0.37334,-0.48671,1,0
1,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,4.9495e-06,-0.37346,-0.38607,1,0
1,GO SPERM MOTILITY,6.8565e-05,-0.3735,-0.35948,1,0
1,GO UNSATURATED FATTY ACID METABOLIC PROCESS,3.7287e-05,-0.37353,-0.40213,1,0
1,GO NUCLEOSOME ORGANIZATION,2.4576e-05,-0.37405,-0.415,1,0
1,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.00031664,-0.37418,-0.49875,1,0
1,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,1.7249e-05,-0.37453,-0.41025,1,0
1,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.0042727,-0.37551,-0.39797,1,0
1,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,0.00060992,-0.37568,-0.37508,1,0
1,GO ACUTE PHASE RESPONSE,0.00028019,-0.37615,-0.46752,1,0
1,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,2.1347e-05,-0.37617,-0.40299,1,0
1,GO POSITIVE REGULATION OF DEFENSE RESPONSE,7.3279e-05,-0.37617,-0.45359,1,0
1,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,1.2035e-05,-0.37645,-0.41687,1,0
1,GO REGULATION OF DNA CATABOLIC PROCESS,1.2035e-05,-0.37658,-0.40595,1,0
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,3.7287e-05,-0.37659,-0.40218,1,0
1,GO RESPONSE TO TOXIC SUBSTANCE,9.6689e-06,-0.37694,-0.39167,1,0
1,GO SISTER CHROMATID SEGREGATION,3.9936e-05,-0.37704,-0.43796,1,0
1,GO HEME METABOLIC PROCESS,1.9888e-05,-0.37743,-0.4124,1,0
1,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,3.7287e-05,-0.3776,-0.37713,1,0
1,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,8.9843e-06,-0.3776,-0.41053,1,0
1,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,4.9495e-06,-0.37788,-0.39521,1,0
1,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,6.8565e-05,-0.37803,-0.44205,1,0
1,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,5.337e-06,-0.37816,-0.42397,1,0
1,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,1.4947e-05,-0.37816,-0.44866,1,0
1,GO ETHANOL CATABOLIC PROCESS,0.00035748,-0.3783,-0.40222,1,0
1,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,3.9422e-06,-0.37844,-0.48297,1,0
1,GO SECONDARY METABOLIC PROCESS,4.8997e-05,-0.37874,-0.36691,1,0
1,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,0.0015041,-0.37883,-0.50421,1,0
1,GO MITOTIC SISTER CHROMATID SEGREGATION,4.8997e-05,-0.37897,-0.42998,1,0
1,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.00029789,-0.37912,-0.43238,1,0
1,GO HISTONE H3 K9 ACETYLATION,1.6059e-05,-0.37936,-0.44052,1,0
1,GO OXIDATIVE DEMETHYLATION,2.1347e-05,-0.38015,-0.43979,1,0
1,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,7.3279e-05,-0.38017,-0.43019,1,0
1,GO RESPONSE TO INTERFERON GAMMA,0.0027019,-0.38038,-0.55562,1,0
1,GO PROSTANOID METABOLIC PROCESS,0.00021879,-0.38049,-0.43003,1,0
1,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,0.0010798,-0.38059,-0.36809,1,0
1,GO PROTEIN CONTAINING COMPLEX REMODELING,0.00023283,-0.38063,-0.45247,1,0
1,GO DIGESTION,4.8997e-05,-0.38095,-0.34738,1,0
1,GO NEUTROPHIL MIGRATION,0.007293,-0.3811,-0.47331,1,0
1,GO NCRNA TRANSCRIPTION,8.9843e-06,-0.38155,-0.4478,1,0
1,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,0.0017696,-0.38169,-0.57069,1,0
1,GO EXTRACELLULAR VESICLE BIOGENESIS,1.4947e-05,-0.38174,-0.49031,1,0
1,GO FERTILIZATION,3.0304e-05,-0.38175,-0.36462,1,0
1,GO NON MOTILE CILIUM ASSEMBLY,9.6689e-06,-0.38216,-0.4829,1,0
1,GO PROTEIN LOCALIZATION TO MEMBRANE,4.9495e-06,-0.38234,-0.39962,1,0
1,GO DETECTION OF STIMULUS,4.9495e-06,-0.38237,-0.38647,1,0
1,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,1.1191e-05,-0.3825,-0.4812,1,0
1,GO OXIDATION REDUCTION PROCESS,7.7514e-06,-0.38258,-0.38162,1,0
1,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.0010209,-0.38267,-0.51167,1,0
1,GO RESPONSE TO MINERALOCORTICOID,2.636e-05,-0.38305,-0.47295,1,0
1,GO ALPHA AMINO ACID METABOLIC PROCESS,5.337e-06,-0.38326,-0.4097,1,0
1,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,6.6813e-06,-0.38341,-0.42705,1,0
1,GO REGULATION OF PRESYNAPSE ORGANIZATION,0.0013481,-0.38352,-0.43835,1,0
1,GO TETRAPYRROLE METABOLIC PROCESS,1.0403e-05,-0.38355,-0.41488,1,0
1,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,1.7249e-05,-0.38376,-0.41104,1,0
1,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,9.5377e-05,-0.38392,-0.46783,1,0
1,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,2.2907e-05,-0.38394,-0.35651,1,0
1,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,1.4947e-05,-0.38397,-0.46998,1,0
1,GO REGULATION OF STEM CELL DIFFERENTIATION,1.2035e-05,-0.38426,-0.40705,1,0
1,GO INSEMINATION,0.00051151,-0.38478,-0.38325,1,0
1,GO PYROPTOSIS,0.00064645,-0.38485,-0.39933,1,0
1,GO ACTIVATED T CELL PROLIFERATION,0.00019306,-0.38494,-0.51921,1,0
1,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.00068502,-0.38528,-0.53619,1,0
1,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,5.6086e-05,-0.38566,-0.41,1,0
1,GO INTRACILIARY TRANSPORT,0.00010181,-0.38621,-0.39397,1,0
1,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,8.9327e-05,-0.38623,-0.3539,1,0
1,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,0.0019699,-0.38627,-0.39303,1,0
1,GO CHEMOSENSORY BEHAVIOR,3.7287e-05,-0.38658,-0.41131,1,0
1,GO REGULATION OF MYOBLAST DIFFERENTIATION,6.4139e-05,-0.38683,-0.43214,1,0
1,GO FEMALE GAMETE GENERATION,5.7533e-06,-0.38713,-0.44649,1,0
1,GO SUBSTANTIA NIGRA DEVELOPMENT,9.6689e-06,-0.38719,-0.43126,1,0
1,GO REGULATION OF DOPAMINE SECRETION,0.0025648,-0.38725,-0.43877,1,0
1,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.00026348,-0.38742,-0.43827,1,0
1,GO APOPTOTIC DNA FRAGMENTATION,5.7533e-06,-0.38763,-0.41644,1,0
1,GO TRIGLYCERIDE METABOLIC PROCESS,9.6689e-06,-0.38781,-0.43994,1,0
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.00013188,-0.38801,-0.5323,1,0
1,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,1.8524e-05,-0.38805,-0.47096,1,0
1,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,6.2007e-06,-0.3881,-0.41967,1,0
1,GO T CELL PROLIFERATION,0.00072571,-0.38815,-0.54601,1,0
1,GO DENDRITE SELF AVOIDANCE,9.5377e-05,-0.38838,-0.481,1,0
1,GO ATP TRANSPORT,3.248e-05,-0.3884,-0.46051,1,0
1,GO PHOTORECEPTOR CELL MAINTENANCE,1.7249e-05,-0.38868,-0.37288,1,0
1,GO DEFENSE RESPONSE TO BACTERIUM,0.0016767,-0.38873,-0.40085,1,0
1,GO RESPONSE TO AMPHETAMINE,0.00068502,-0.38876,-0.3441,1,0
1,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,5.7533e-06,-0.38895,-0.44105,1,0
1,GO MYELOID DENDRITIC CELL ACTIVATION,0.023112,-0.38895,-0.4707,1,0
1,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.00026348,-0.38934,-0.56717,1,0
1,GO DNA DEPENDENT DNA REPLICATION,1.7249e-05,-0.38937,-0.44489,1,0
1,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.0012758,-0.38963,-0.51046,1,0
1,GO RESPONSE TO DIETARY EXCESS,0.00051151,-0.38972,-0.42733,1,0
1,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,5.2428e-05,-0.38973,-0.39097,1,0
1,GO HUMORAL IMMUNE RESPONSE,0.0066311,-0.38977,-0.41593,1,0
1,GO POSTSYNAPSE ASSEMBLY,0.0014241,-0.3901,-0.51484,1,0
1,GO CELLULAR AMINO ACID CATABOLIC PROCESS,5.337e-06,-0.3902,-0.40803,1,0
1,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.00072571,-0.39042,-0.53728,1,0
1,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.00068502,-0.39066,-0.62557,1,0
1,GO ATP DEPENDENT CHROMATIN REMODELING,2.8267e-05,-0.39066,-0.41721,1,0
1,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,1.4947e-05,-0.39072,-0.40525,1,0
1,GO CHROMOSOME SEPARATION,2.8267e-05,-0.39079,-0.46326,1,0
1,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,1.3909e-05,-0.39102,-0.43197,1,0
1,GO CELLULAR RESPONSE TO OXYGEN RADICAL,5.2428e-05,-0.39127,-0.39728,1,0
1,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,1.1191e-05,-0.39148,-0.42303,1,0
1,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,3.9936e-05,-0.39152,-0.42302,1,0
1,GO MRNA SPLICE SITE SELECTION,9.5377e-05,-0.39167,-0.49535,1,0
1,GO RESPONSE TO BACTERIUM,0.00010181,-0.3917,-0.48839,1,0
1,GO FUCOSE METABOLIC PROCESS,1.2035e-05,-0.39184,-0.41599,1,0
1,GO RESPONSE TO TUMOR NECROSIS FACTOR,3.4805e-05,-0.39229,-0.48248,1,0
1,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.00012367,-0.39252,-0.41041,1,0
1,GO SKELETAL MUSCLE CELL PROLIFERATION,2.636e-05,-0.39258,-0.42357,1,0
1,GO REGULATION OF MEIOTIC CELL CYCLE,8.3641e-05,-0.39296,-0.41973,1,0
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00033648,-0.39307,-0.55211,1,0
1,GO CARDIOLIPIN METABOLIC PROCESS,7.1973e-06,-0.39308,-0.42995,1,0
1,GO INTRACELLULAR PROTEIN TRANSPORT,4.9495e-06,-0.3931,-0.42879,1,0
1,GO RESPONSE TO BIOTIC STIMULUS,3.9936e-05,-0.39337,-0.5004,1,0
1,GO PHOTORECEPTOR CELL DIFFERENTIATION,2.8267e-05,-0.39351,-0.43032,1,0
1,GO INTERLEUKIN 1 PRODUCTION,0.00076864,-0.39352,-0.54078,1,0
1,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.00332,-0.39355,-0.49468,1,0
1,GO TRANSPOSITION,6.4139e-05,-0.39357,-0.42021,1,0
1,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,0.00014989,-0.39396,-0.51955,1,0
1,GO RESPONSE TO CHEMOKINE,0.01266,-0.39432,-0.45102,1,0
1,GO RESPONSE TO FUNGUS,0.00064645,-0.3944,-0.3949,1,0
1,GO REGULATION OF DNA DAMAGE CHECKPOINT,6.8565e-05,-0.39451,-0.42378,1,0
1,GO REGULATION OF T CELL MIGRATION,0.0017696,-0.39453,-0.51231,1,0
1,GO GENITALIA MORPHOGENESIS,0.00029789,-0.39488,-0.42234,1,0
1,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.00011593,-0.39529,-0.38879,1,0
1,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.0083971,-0.39562,-0.46202,1,0
1,GO REGULATION OF PROTEIN COMPLEX STABILITY,6.4139e-05,-0.39567,-0.43737,1,0
1,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.00091199,-0.39586,-0.48157,1,0
1,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00064645,-0.39598,-0.58476,1,0
1,GO GLUTAMATE SECRETION,0.00031664,-0.39599,-0.50406,1,0
1,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,5.7533e-06,-0.39613,-0.42849,1,0
1,GO REGULATION OF LEUKOCYTE PROLIFERATION,0.0013481,-0.39639,-0.54422,1,0
1,GO ESTABLISHMENT OF TISSUE POLARITY,4.9495e-06,-0.39664,-0.46133,1,0
1,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00045436,-0.3967,-0.54257,1,0
1,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.00076864,-0.39696,-0.5252,1,0
1,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,1.1191e-05,-0.39719,-0.45456,1,0
1,GO RIBONUCLEOTIDE CATABOLIC PROCESS,1.0403e-05,-0.39766,-0.42131,1,0
1,GO LIPOPROTEIN METABOLIC PROCESS,9.6689e-06,-0.39766,-0.45237,1,0
1,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.00054254,-0.39801,-0.42952,1,0
1,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,9.6689e-06,-0.39812,-0.42924,1,0
1,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.0014241,-0.39813,-0.55131,1,0
1,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00015974,-0.3992,-0.54841,1,0
1,GO REGULATION OF TRANSPOSITION,5.9985e-05,-0.39964,-0.44769,1,0
1,GO ALPHA AMINO ACID CATABOLIC PROCESS,3.9422e-06,-0.39975,-0.40919,1,0
1,GO SPERMATID NUCLEUS DIFFERENTIATION,1.7249e-05,-0.39979,-0.45686,1,0
1,GO COBALAMIN METABOLIC PROCESS,3.0304e-05,-0.40001,-0.44101,1,0
1,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,4.2763e-05,-0.40004,-0.43426,1,0
1,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.0015882,-0.40049,-0.39693,1,0
1,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,3.9422e-06,-0.40063,-0.49138,1,0
1,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,0.00014062,-0.40083,-0.40548,1,0
1,GO REGULATION OF CHROMOSOME SEGREGATION,2.4576e-05,-0.40108,-0.46456,1,0
1,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,4.8997e-05,-0.40131,-0.49371,1,0
1,GO THYROID GLAND DEVELOPMENT,8.9327e-05,-0.40151,-0.53511,1,0
1,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,1.2035e-05,-0.40152,-0.43715,1,0
1,GO ZYMOGEN INHIBITION,0.0015041,-0.40153,-0.46746,1,0
1,GO SYMBIOTIC PROCESS,4.5891e-06,-0.40154,-0.42976,1,0
1,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.00054254,-0.40169,-0.50767,1,0
1,GO CELL CYCLE DNA REPLICATION,7.3279e-05,-0.40171,-0.41448,1,0
1,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.00054254,-0.40171,-0.53283,1,0
1,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.00011593,-0.40177,-0.3437,1,0
1,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,5.6086e-05,-0.40227,-0.48549,1,0
1,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,3.9422e-06,-0.40249,-0.43435,1,0
1,GO MEIOTIC CHROMOSOME SEPARATION,0.00023283,-0.40267,-0.49168,1,0
1,GO RESPONSE TO INTERLEUKIN 1,3.0304e-05,-0.40277,-0.45259,1,0
1,GO RESPONSE TO VITAMIN A,7.7514e-06,-0.40287,-0.40551,1,0
1,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.00017019,-0.40315,-0.54079,1,0
1,GO CELLULAR RESPONSE TO ALKALOID,1.0403e-05,-0.40317,-0.43316,1,0
1,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,7.7514e-06,-0.4032,-0.47995,1,0
1,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.0013481,-0.4034,-0.4167,1,0
1,GO MYELOID LEUKOCYTE MIGRATION,0.00040321,-0.40343,-0.51978,1,0
1,GO VITAMIN METABOLIC PROCESS,7.1973e-06,-0.40368,-0.4214,1,0
1,GO NEURAL RETINA DEVELOPMENT,4.8997e-05,-0.40393,-0.45387,1,0
1,GO ADHESION OF SYMBIONT TO HOST,0.0023095,-0.40427,-0.63493,1,0
1,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0015882,-0.40428,-0.48812,1,0
1,GO GAMETE GENERATION,7.1973e-06,-0.40429,-0.4313,1,0
1,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,3.0304e-05,-0.4043,-0.55139,1,0
1,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,3.7287e-05,-0.40452,-0.56866,1,0
1,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.00020554,-0.40471,-0.43033,1,0
1,GO ETHER METABOLIC PROCESS,1.3909e-05,-0.40481,-0.46622,1,0
1,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,8.3461e-06,-0.40491,-0.44808,1,0
1,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.00086166,-0.40507,-0.56682,1,0
1,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,7.8298e-05,-0.40527,-0.56745,1,0
1,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,0.0096484,-0.40538,-0.46714,1,0
1,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.00040321,-0.40539,-0.53892,1,0
1,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.00010866,-0.40545,-0.39289,1,0
1,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,5.337e-06,-0.40549,-0.44609,1,0
1,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.00014062,-0.40554,-0.43359,1,0
1,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,9.5377e-05,-0.40556,-0.43471,1,0
1,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,8.3641e-05,-0.40574,-0.4833,1,0
1,GO MITOTIC RECOMBINATION,1.3909e-05,-0.40585,-0.48526,1,0
1,GO NECROTIC CELL DEATH,4.2763e-05,-0.40589,-0.45886,1,0
1,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,2.2907e-05,-0.40595,-0.49857,1,0
1,GO REGULATION OF CELL CYCLE PHASE TRANSITION,7.7514e-06,-0.40623,-0.45555,1,0
1,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,0.00021879,-0.40639,-0.47891,1,0
1,GO PHAGOSOME ACIDIFICATION,2.1347e-05,-0.40674,-0.43621,1,0
1,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00072571,-0.40679,-0.55982,1,0
1,GO DENDRITIC CELL MIGRATION,0.0096484,-0.4068,-0.55608,1,0
1,GO LEUKOCYTE MEDIATED IMMUNITY,2.4576e-05,-0.40712,-0.53467,1,0
1,GO ANDROGEN METABOLIC PROCESS,0.00051151,-0.40729,-0.34003,1,0
1,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,8.3641e-05,-0.40753,-0.424,1,0
1,GO FATTY ACID METABOLIC PROCESS,8.3461e-06,-0.40772,-0.42628,1,0
1,GO DEFENSE RESPONSE,3.248e-05,-0.40784,-0.52249,1,0
1,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.0020776,-0.40818,-0.40233,1,0
1,GO CELLULAR RESPONSE TO LIGHT STIMULUS,3.9422e-06,-0.40838,-0.44306,1,0
1,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.00013188,-0.40858,-0.39499,1,0
1,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,7.8298e-05,-0.40892,-0.55238,1,0
1,GO POSITIVE REGULATION OF LIPID TRANSPORT,2.4576e-05,-0.40905,-0.46091,1,0
1,GO REGULATION OF DENDRITE EXTENSION,0.00072571,-0.40929,-0.49668,1,0
1,GO REGULATION OF INNATE IMMUNE RESPONSE,8.3641e-05,-0.40935,-0.47235,1,0
1,GO LYMPHOCYTE MEDIATED IMMUNITY,0.00057531,-0.40943,-0.54602,1,0
1,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00014062,-0.40975,-0.54891,1,0
1,GO DNA RECOMBINATION,6.2007e-06,-0.40992,-0.47372,1,0
1,GO SENSORY PERCEPTION,6.2007e-06,-0.41008,-0.40693,1,0
1,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.0060238,-0.41014,-0.50312,1,0
1,GO CELLULAR RESPONSE TO INTERFERON BETA,0.0024341,-0.41018,-0.46203,1,0
1,GO PIGMENT BIOSYNTHETIC PROCESS,4.9495e-06,-0.41019,-0.44328,1,0
1,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,1.2939e-05,-0.41021,-0.47407,1,0
1,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.00040321,-0.41024,-0.54578,1,0
1,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.00057531,-0.41029,-0.51239,1,0
1,GO CELLULAR DEFENSE RESPONSE,0.012106,-0.41071,-0.4818,1,0
1,GO DNA CONFORMATION CHANGE,1.1191e-05,-0.41072,-0.48005,1,0
1,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.00068502,-0.41081,-0.38692,1,0
1,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00015974,-0.41087,-0.57431,1,0
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,1.2035e-05,-0.41088,-0.44146,1,0
1,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.0012071,-0.41124,-0.50167,1,0
1,GO NIK NF KAPPAB SIGNALING,1.9888e-05,-0.41134,-0.4674,1,0
1,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,0.00017019,-0.41137,-0.59344,1,0
1,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,5.9985e-05,-0.41156,-0.3832,1,0
1,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.00026348,-0.41174,-0.45938,1,0
1,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,0.0042727,-0.41181,-0.4654,1,0
1,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,9.5377e-05,-0.41189,-0.43726,1,0
1,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00017019,-0.41195,-0.5712,1,0
1,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,9.6689e-06,-0.41195,-0.40923,1,0
1,GO POSITIVE REGULATION OF TRANSLATION,3.9422e-06,-0.41207,-0.44604,1,0
1,GO PROTEIN FOLDING,8.3461e-06,-0.41225,-0.42729,1,0
1,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,3.4805e-05,-0.41241,-0.46499,1,0
1,GO GRANULOCYTE MIGRATION,0.0031545,-0.41255,-0.4952,1,0
1,GO HISTONE H2A UBIQUITINATION,8.9843e-06,-0.41256,-0.51194,1,0
1,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.00091199,-0.41256,-0.4443,1,0
1,GO EPITHELIAL STRUCTURE MAINTENANCE,0.00017019,-0.41266,-0.34838,1,0
1,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,2.8267e-05,-0.41276,-0.46598,1,0
1,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,5.337e-06,-0.41283,-0.44895,1,0
1,GO PROTEIN MONOUBIQUITINATION,8.3461e-06,-0.41287,-0.51087,1,0
1,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.00042807,-0.41289,-0.5235,1,0
1,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.0010209,-0.41297,-0.5223,1,0
1,GO ALPHA BETA T CELL ACTIVATION,0.00045436,-0.41306,-0.57732,1,0
1,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0012071,-0.41343,-0.58586,1,0
1,GO RESPONSE TO TUMOR CELL,0.00091199,-0.41345,-0.47349,1,0
1,GO T CELL TOLERANCE INDUCTION,0.031957,-0.41351,-0.57584,1,0
1,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.031957,-0.41366,-0.38576,1,0
1,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.00018128,-0.41401,-0.55001,1,0
1,GO AMMONIUM ION METABOLIC PROCESS,0.00042807,-0.41428,-0.42025,1,0
1,GO RESPONSE TO AMINE,0.00011593,-0.41431,-0.38598,1,0
1,GO IRON ION TRANSMEMBRANE TRANSPORT,1.7249e-05,-0.41448,-0.49319,1,0
1,GO MISMATCH REPAIR,1.0403e-05,-0.41448,-0.46808,1,0
1,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,0.01266,-0.41465,-0.6325,1,0
1,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,1.2035e-05,-0.41467,-0.43245,1,0
1,GO PHOTOPERIODISM,0.00013188,-0.4148,-0.41448,1,0
1,GO AXONEME ASSEMBLY,0.0029965,-0.41486,-0.34475,1,0
1,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,1.1191e-05,-0.41514,-0.44039,1,0
1,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,1.6059e-05,-0.41526,-0.40528,1,0
1,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,0.00035748,-0.41553,-0.4295,1,0
1,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00029789,-0.41579,-0.53703,1,0
1,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,0.00076864,-0.41584,-0.43993,1,0
1,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.0034935,-0.41596,-0.51701,1,0
1,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,8.3461e-06,-0.41614,-0.43979,1,0
1,GO GLYCEROL ETHER METABOLIC PROCESS,6.2007e-06,-0.41631,-0.48634,1,0
1,GO ORGANIC ACID CATABOLIC PROCESS,6.6813e-06,-0.41652,-0.43206,1,0
1,GO REGULATION OF T CELL ACTIVATION,0.00020554,-0.41662,-0.56118,1,0
1,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,0.050584,-0.41673,-0.29235,1,0
1,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,4.5891e-06,-0.41688,-0.44275,1,0
1,GO CYTOKINE MEDIATED SIGNALING PATHWAY,5.2428e-05,-0.41704,-0.53965,1,0
1,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00076864,-0.41742,-0.55635,1,0
1,GO PROSTANOID BIOSYNTHETIC PROCESS,0.00048214,-0.41758,-0.48003,1,0
1,GO NEURON CELL CELL ADHESION,0.011063,-0.41764,-0.39659,1,0
1,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,3.4805e-05,-0.4177,-0.54737,1,0
1,GO REGULATION OF GONAD DEVELOPMENT,1.1191e-05,-0.41771,-0.44752,1,0
1,GO INTERLEUKIN 2 PRODUCTION,0.00057531,-0.41777,-0.59648,1,0
1,GO TRANSITION METAL ION TRANSPORT,6.2007e-06,-0.41783,-0.4402,1,0
1,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,2.636e-05,-0.4179,-0.47287,1,0
1,GO SEXUAL REPRODUCTION,7.1973e-06,-0.41792,-0.42704,1,0
1,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,1.3909e-05,-0.418,-0.41232,1,0
1,GO ACUTE INFLAMMATORY RESPONSE,0.00015974,-0.41801,-0.47518,1,0
1,GO METHYLATION,4.5891e-06,-0.4181,-0.47183,1,0
1,GO T CELL SELECTION,0.0012758,-0.41876,-0.57554,1,0
1,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,1.4947e-05,-0.41917,-0.55051,1,0
1,GO PROTEIN HETEROOLIGOMERIZATION,7.7514e-06,-0.41938,-0.49111,1,0
1,GO EPIDERMAL CELL DIFFERENTIATION,4.8997e-05,-0.41944,-0.40903,1,0
1,GO ETHER BIOSYNTHETIC PROCESS,4.8997e-05,-0.41946,-0.50296,1,0
1,GO SMALL MOLECULE CATABOLIC PROCESS,6.6813e-06,-0.41946,-0.43639,1,0
1,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,6.6813e-06,-0.41947,-0.45158,1,0
1,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,5.2428e-05,-0.41969,-0.53531,1,0
1,GO RESPONSE TO ISOQUINOLINE ALKALOID,7.7514e-06,-0.4197,-0.43391,1,0
1,GO HISTONE H2A ACETYLATION,8.3461e-06,-0.41975,-0.46858,1,0
1,GO RESPONSE TO PROTOZOAN,0.0063209,-0.41976,-0.53624,1,0
1,GO TRANSITION METAL ION HOMEOSTASIS,1.0403e-05,-0.41984,-0.43125,1,0
1,GO RECOMBINATIONAL REPAIR,1.4947e-05,-0.41986,-0.50844,1,0
1,GO REGULATION OF HISTONE UBIQUITINATION,5.7533e-06,-0.4199,-0.50019,1,0
1,GO DENDRITIC CELL CHEMOTAXIS,0.012106,-0.41998,-0.54692,1,0
1,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,2.4576e-05,-0.42012,-0.43074,1,0
1,GO REGULATION OF IMMUNE EFFECTOR PROCESS,0.00010866,-0.42056,-0.57935,1,0
1,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,2.4576e-05,-0.4207,-0.50153,1,0
1,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,5.7533e-06,-0.42134,-0.4444,1,0
1,GO EPIDERMIS DEVELOPMENT,1.7249e-05,-0.42138,-0.45401,1,0
1,GO POSITIVE REGULATION OF MEMBRANE DEPOLARIZATION,0.00015974,-0.42141,-0.42047,1,0
1,GO SYNAPTIC TRANSMISSION CHOLINERGIC,4.5779e-05,-0.42161,-0.40166,1,0
1,GO CELLULAR RESPONSE TO ANTIBIOTIC,1.2035e-05,-0.42168,-0.46606,1,0
1,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,7.8298e-05,-0.42181,-0.44884,1,0
1,GO MYELOID LEUKOCYTE ACTIVATION,1.9888e-05,-0.4219,-0.54177,1,0
1,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.00048214,-0.42208,-0.52683,1,0
1,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,0.0016767,-0.42221,-0.46927,1,0
1,GO LINOLEIC ACID METABOLIC PROCESS,7.8298e-05,-0.42252,-0.46842,1,0
1,GO POTASSIUM ION HOMEOSTASIS,7.1973e-06,-0.42269,-0.50196,1,0
1,GO NEUTROPHIL CHEMOTAXIS,0.0092139,-0.42274,-0.47787,1,0
1,GO REGULATION OF MRNA METABOLIC PROCESS,6.2007e-06,-0.4231,-0.46143,1,0
1,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.00013188,-0.42314,-0.45479,1,0
1,GO HORMONE METABOLIC PROCESS,5.2428e-05,-0.42335,-0.38319,1,0
1,GO THALAMUS DEVELOPMENT,0.0016767,-0.42341,-0.42306,1,0
1,GO INTERLEUKIN 1 BETA PRODUCTION,0.00048214,-0.42356,-0.57127,1,0
1,GO SYNAPTIC VESICLE TRANSPORT,8.3641e-05,-0.42371,-0.53062,1,0
1,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,3.4805e-05,-0.42395,-0.43179,1,0
1,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,7.1973e-06,-0.42417,-0.5011,1,0
1,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.00018128,-0.42431,-0.43153,1,0
1,GO REGULATION OF DEFENSE RESPONSE,1.8524e-05,-0.42437,-0.50828,1,0
1,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.00021879,-0.42438,-0.39432,1,0
1,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.0042727,-0.42446,-0.56437,1,0
1,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.00042807,-0.42452,-0.4688,1,0
1,GO DOPAMINE METABOLIC PROCESS,7.8298e-05,-0.42473,-0.47076,1,0
1,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00091199,-0.42474,-0.55289,1,0
1,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.00017019,-0.42477,-0.57082,1,0
1,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,6.2007e-06,-0.42481,-0.45398,1,0
1,GO RESPONSE TO INTERLEUKIN 18,0.00332,-0.42494,-0.58371,1,0
1,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,1.4947e-05,-0.42496,-0.4744,1,0
1,GO EMBRYONIC PATTERN SPECIFICATION,6.2007e-06,-0.42498,-0.46489,1,0
1,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00045436,-0.42498,-0.56118,1,0
1,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,2.4576e-05,-0.42502,-0.46933,1,0
1,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.00040321,-0.42518,-0.57502,1,0
1,GO REGULATION OF STEROL TRANSPORT,1.7249e-05,-0.42518,-0.50818,1,0
1,GO BRAIN MORPHOGENESIS,1.3909e-05,-0.42534,-0.51274,1,0
1,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,6.6813e-06,-0.42535,-0.46502,1,0
1,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,0.0011418,-0.4256,-0.4789,1,0
1,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.00028019,-0.4257,-0.5097,1,0
1,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,6.2007e-06,-0.42588,-0.51243,1,0
1,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,0.0012758,-0.42601,-0.44085,1,0
1,GO MYOTUBE CELL DEVELOPMENT,8.9843e-06,-0.42614,-0.43854,1,0
1,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,3.0304e-05,-0.42618,-0.45559,1,0
1,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,4.9495e-06,-0.4262,-0.47082,1,0
1,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.0024341,-0.42621,-0.56097,1,0
1,GO LEUKOCYTE PROLIFERATION,0.00033648,-0.42651,-0.56049,1,0
1,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,4.2539e-06,-0.42656,-0.4648,1,0
1,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,3.248e-05,-0.4266,-0.50898,1,0
1,GO PROTEIN REFOLDING,5.9985e-05,-0.42669,-0.43203,1,0
1,GO REGULATION OF T CELL TOLERANCE INDUCTION,0.034576,-0.42686,-0.63935,1,0
1,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.00051151,-0.42688,-0.47892,1,0
1,GO PIGMENT METABOLIC PROCESS,7.1973e-06,-0.4269,-0.43517,1,0
1,GO POSITIVE REGULATION OF HAIR CYCLE,0.00068502,-0.42699,-0.46859,1,0
1,GO GLUCOCORTICOID METABOLIC PROCESS,0.00033648,-0.42701,-0.49497,1,0
1,GO SUPEROXIDE METABOLIC PROCESS,2.2907e-05,-0.42702,-0.52172,1,0
1,GO REGULATION OF MRNA CATABOLIC PROCESS,4.5891e-06,-0.42714,-0.44969,1,0
1,GO PRESYNAPSE ORGANIZATION,7.8298e-05,-0.42735,-0.50025,1,0
1,GO DOPAMINE TRANSPORT,0.0017696,-0.42738,-0.44257,1,0
1,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,4.5891e-06,-0.4274,-0.48522,1,0
1,GO LEUKOTRIENE METABOLIC PROCESS,0.00029789,-0.42757,-0.47032,1,0
1,GO ORGANOPHOSPHATE CATABOLIC PROCESS,5.337e-06,-0.42766,-0.44951,1,0
1,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,4.9495e-06,-0.42769,-0.5095,1,0
1,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,3.9422e-06,-0.4277,-0.48841,1,0
1,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,0.0024341,-0.42771,-0.52946,1,0
1,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,1.9888e-05,-0.42775,-0.44344,1,0
1,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,5.337e-06,-0.4282,-0.44554,1,0
1,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,2.636e-05,-0.4282,-0.44709,1,0
1,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,6.6813e-06,-0.42821,-0.44247,1,0
1,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,1.0403e-05,-0.42825,-0.51403,1,0
1,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.00057531,-0.42846,-0.56813,1,0
1,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.020391,-0.4285,-0.48062,1,0
1,GO TYPE 2 IMMUNE RESPONSE,0.0018673,-0.42881,-0.53432,1,0
1,GO AMINO ACID BETAINE METABOLIC PROCESS,0.00064645,-0.42885,-0.38061,1,0
1,GO TELOMERE MAINTENANCE VIA RECOMBINATION,1.1191e-05,-0.42917,-0.49361,1,0
1,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,2.2907e-05,-0.42935,-0.40528,1,0
1,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,0.0042727,-0.42943,-0.60734,1,0
1,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,2.2907e-05,-0.42961,-0.43297,1,0
1,GO LEUKOCYTE APOPTOTIC PROCESS,0.00017019,-0.43,-0.56065,1,0
1,GO LYMPHOCYTE CHEMOTAXIS,0.020391,-0.43016,-0.48296,1,0
1,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.0015041,-0.43033,-0.53179,1,0
1,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,8.9843e-06,-0.43036,-0.45761,1,0
1,GO LIVER REGENERATION,1.2035e-05,-0.43039,-0.43731,1,0
1,GO THYMIC T CELL SELECTION,0.0047188,-0.43054,-0.54885,1,0
1,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,7.1973e-06,-0.43082,-0.55613,1,0
1,GO T CELL ACTIVATION,0.00010866,-0.43084,-0.56945,1,0
1,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,9.6689e-06,-0.4309,-0.49591,1,0
1,GO SENSORY PERCEPTION OF LIGHT STIMULUS,6.6813e-06,-0.43122,-0.41695,1,0
1,GO CELLULAR LIPID CATABOLIC PROCESS,7.1973e-06,-0.43142,-0.4823,1,0
1,GO TRIGLYCERIDE CATABOLIC PROCESS,0.00012367,-0.43144,-0.34693,1,0
1,GO EXTRACELLULAR TRANSPORT,0.00035748,-0.43151,-0.42942,1,0
1,GO REGULATION OF B CELL APOPTOTIC PROCESS,6.4139e-05,-0.43198,-0.52857,1,0
1,GO CYTOKINE PRODUCTION,2.636e-05,-0.43203,-0.55417,1,0
1,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,6.8565e-05,-0.43207,-0.46888,1,0
1,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,8.3461e-06,-0.43244,-0.46981,1,0
1,GO REGULATION OF RNA SPLICING,1.0403e-05,-0.4325,-0.47474,1,0
1,GO URETER DEVELOPMENT,8.9327e-05,-0.4325,-0.45811,1,0
1,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0054671,-0.43257,-0.53556,1,0
1,GO REGULATION OF PH,4.9495e-06,-0.43266,-0.48635,1,0
1,GO CATECHOLAMINE METABOLIC PROCESS,7.3279e-05,-0.43274,-0.45481,1,0
1,GO DNA METABOLIC PROCESS,7.1973e-06,-0.43277,-0.46482,1,0
1,GO REGULATION OF SYNAPSE ASSEMBLY,6.6813e-06,-0.43283,-0.55313,1,0
1,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.00040321,-0.43294,-0.58043,1,0
1,GO SISTER CHROMATID COHESION,1.7249e-05,-0.43299,-0.50473,1,0
1,GO CARDIAC VENTRICLE FORMATION,0.00064645,-0.43312,-0.46119,1,0
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,5.337e-06,-0.43314,-0.44329,1,0
1,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0049572,-0.43326,-0.48648,1,0
1,GO TOXIN METABOLIC PROCESS,0.00026348,-0.43349,-0.39473,1,0
1,GO DNA DEALKYLATION,3.248e-05,-0.43356,-0.42805,1,0
1,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.021265,-0.43371,-0.45557,1,0
1,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,1.1191e-05,-0.43372,-0.46745,1,0
1,GO SYNAPTIC SIGNALING,1.6059e-05,-0.43388,-0.52847,1,0
1,GO CRISTAE FORMATION,7.7514e-06,-0.434,-0.55277,1,0
1,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00332,-0.43403,-0.56809,1,0
1,GO RNA LOCALIZATION,6.6813e-06,-0.43407,-0.4681,1,0
1,GO MITOCHONDRIAL DEPOLARIZATION,0.00023283,-0.43434,-0.47943,1,0
1,GO DNA MODIFICATION,7.1973e-06,-0.4344,-0.44293,1,0
1,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,7.3279e-05,-0.43451,-0.58507,1,0
1,GO POSITIVE REGULATION OF RNA SPLICING,1.7249e-05,-0.43453,-0.47103,1,0
1,GO C21 STEROID HORMONE METABOLIC PROCESS,0.00012367,-0.43459,-0.41749,1,0
1,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,1.2035e-05,-0.4346,-0.49372,1,0
1,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,2.2907e-05,-0.43475,-0.38555,1,0
1,GO RESPONSE TO NITRIC OXIDE,4.5779e-05,-0.43509,-0.47625,1,0
1,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.00010181,-0.43515,-0.57549,1,0
1,GO PIGMENT GRANULE LOCALIZATION,1.6059e-05,-0.43522,-0.43986,1,0
1,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,6.6813e-06,-0.4353,-0.45432,1,0
1,GO POSITIVE REGULATION OF HORMONE SECRETION,3.0304e-05,-0.43546,-0.43786,1,0
1,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.0054671,-0.43576,-0.56053,1,0
1,GO ADAPTIVE IMMUNE RESPONSE,0.0015041,-0.43582,-0.58293,1,0
1,GO SERINE PHOSPHORYLATION OF STAT PROTEIN,0.00042807,-0.43585,-0.38996,1,0
1,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.00096503,-0.43585,-0.49473,1,0
1,GO VIRAL RELEASE FROM HOST CELL,1.2035e-05,-0.43586,-0.44779,1,0
1,GO MRNA 3 END PROCESSING,1.1191e-05,-0.43601,-0.46706,1,0
1,GO HISTONE UBIQUITINATION,7.7514e-06,-0.43604,-0.51552,1,0
1,GO REGULATION OF HISTONE H3 K4 METHYLATION,2.636e-05,-0.43607,-0.44796,1,0
1,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.00011593,-0.43643,-0.58557,1,0
1,GO VESICLE FUSION TO PLASMA MEMBRANE,0.00054254,-0.43647,-0.60279,1,0
1,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.00015974,-0.43661,-0.45903,1,0
1,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,4.9495e-06,-0.43667,-0.48522,1,0
1,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.00021879,-0.43684,-0.57466,1,0
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,3.9422e-06,-0.43686,-0.49041,1,0
1,GO TUMOR NECROSIS FACTOR SECRETION,7.3279e-05,-0.43694,-0.50464,1,0
1,GO INTERLEUKIN 12 PRODUCTION,0.0044907,-0.43707,-0.53204,1,0
1,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,4.8997e-05,-0.43709,-0.59441,1,0
1,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,3.4805e-05,-0.4371,-0.49303,1,0
1,GO REGULATION OF INFLAMMATORY RESPONSE,3.248e-05,-0.43715,-0.54163,1,0
1,GO RNA EXPORT FROM NUCLEUS,7.7514e-06,-0.43732,-0.47708,1,0
1,GO DENDRITIC CELL DIFFERENTIATION,0.0092139,-0.43739,-0.56444,1,0
1,GO COPPER ION TRANSPORT,3.248e-05,-0.43792,-0.45212,1,0
1,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.00014062,-0.43816,-0.41031,1,0
1,GO IMMUNE EFFECTOR PROCESS,2.2907e-05,-0.43823,-0.55017,1,0
1,GO RESPONSE TO VIRUS,0.00013188,-0.43823,-0.49668,1,0
1,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,4.2539e-06,-0.43828,-0.45488,1,0
1,GO LEARNING,8.3461e-06,-0.4383,-0.52106,1,0
1,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,1.8524e-05,-0.43841,-0.45924,1,0
1,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,4.5891e-06,-0.43871,-0.50057,1,0
1,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,7.1973e-06,-0.43892,-0.44107,1,0
1,GO INTRACELLULAR TRANSPORT,4.9495e-06,-0.43894,-0.46872,1,0
1,GO POSITIVE REGULATION OF LIPASE ACTIVITY,1.7249e-05,-0.43904,-0.49057,1,0
1,GO SENSORY PERCEPTION OF PAIN,6.6813e-06,-0.43908,-0.49028,1,0
1,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.00019306,-0.43911,-0.54416,1,0
1,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,4.9495e-06,-0.43927,-0.49288,1,0
1,GO LEUKOCYTE CELL CELL ADHESION,0.00013188,-0.43942,-0.57943,1,0
1,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.00014989,-0.43946,-0.56234,1,0
1,GO NEUROTRANSMITTER SECRETION,0.00020554,-0.43952,-0.54765,1,0
1,GO RESPONSE TO OXYGEN RADICAL,1.6059e-05,-0.43953,-0.43066,1,0
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,8.3461e-06,-0.43968,-0.49248,1,0
1,GO REGULATION OF IMMUNE RESPONSE,5.2428e-05,-0.44001,-0.55129,1,0
1,GO RRNA TRANSCRIPTION,8.9843e-06,-0.44004,-0.49547,1,0
1,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.00024771,-0.44012,-0.50181,1,0
1,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,4.2539e-06,-0.44015,-0.4929,1,0
1,GO REGULATION OF RIBOSOME BIOGENESIS,3.9422e-06,-0.44021,-0.51539,1,0
1,GO FATTY ACID BIOSYNTHETIC PROCESS,8.9843e-06,-0.44031,-0.43602,1,0
1,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,8.3461e-06,-0.44032,-0.49374,1,0
1,GO POSITIVE REGULATION OF VIRAL PROCESS,3.9422e-06,-0.44032,-0.51602,1,0
1,GO IMMUNOGLOBULIN SECRETION,0.00051151,-0.44046,-0.50548,1,0
1,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00020554,-0.44051,-0.55927,1,0
1,GO DETECTION OF BIOTIC STIMULUS,0.0012758,-0.44052,-0.53321,1,0
1,GO POSITIVE REGULATION OF LYASE ACTIVITY,4.8997e-05,-0.4407,-0.44139,1,0
1,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,8.3461e-06,-0.44079,-0.45513,1,0
1,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,0.0016767,-0.44082,-0.42742,1,0
1,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0015882,-0.44095,-0.5208,1,0
1,GO RESPONSE TO ALKALOID,6.6813e-06,-0.4413,-0.47194,1,0
1,GO CELLULAR IRON ION HOMEOSTASIS,1.3909e-05,-0.44134,-0.4404,1,0
1,GO NON CANONICAL WNT SIGNALING PATHWAY,5.337e-06,-0.44176,-0.5004,1,0
1,GO CYTOKINE METABOLIC PROCESS,5.9985e-05,-0.44236,-0.57074,1,0
1,GO CELLULAR COPPER ION HOMEOSTASIS,1.2939e-05,-0.44241,-0.51089,1,0
1,GO NEUTRAL LIPID METABOLIC PROCESS,6.6813e-06,-0.4426,-0.48351,1,0
1,GO REGULATION OF SENSORY PERCEPTION,2.2907e-05,-0.44263,-0.41349,1,0
1,GO AXIS SPECIFICATION,7.1973e-06,-0.44307,-0.45376,1,0
1,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,4.5779e-05,-0.44314,-0.40431,1,0
1,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,0.00081392,-0.44316,-0.45648,1,0
1,GO CELLULAR RESPONSE TO GAMMA RADIATION,5.7533e-06,-0.44351,-0.47248,1,0
1,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,3.7287e-05,-0.44405,-0.4292,1,0
1,GO TELOMERE ORGANIZATION,8.3461e-06,-0.44423,-0.46475,1,0
1,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,4.8997e-05,-0.4443,-0.53101,1,0
1,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,6.2007e-06,-0.4444,-0.44661,1,0
1,GO DIGESTIVE SYSTEM PROCESS,2.8267e-05,-0.44443,-0.38338,1,0
1,GO CARNITINE METABOLIC PROCESS,0.00014062,-0.44455,-0.39855,1,0
1,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,9.6689e-06,-0.4447,-0.45039,1,0
1,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.00014062,-0.44471,-0.59466,1,0
1,GO T CELL MIGRATION,0.0018673,-0.44481,-0.59239,1,0
1,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,6.4139e-05,-0.44489,-0.42933,1,0
1,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,0.0034935,-0.44495,-0.50933,1,0
1,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.00015974,-0.4451,-0.37385,1,0
1,GO CYTOKINE SECRETION,0.00010181,-0.44513,-0.5311,1,0
1,GO INTERACTION WITH SYMBIONT,2.636e-05,-0.44515,-0.45139,1,0
1,GO RENAL ABSORPTION,0.00033648,-0.44521,-0.52118,1,0
1,GO NEGATIVE REGULATION BY HOST OF VIRAL PROCESS,0.00014989,-0.44532,-0.44892,1,0
1,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.00072571,-0.44549,-0.5805,1,0
1,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,1.9888e-05,-0.4456,-0.46139,1,0
1,GO DETECTION OF OTHER ORGANISM,0.0024341,-0.44581,-0.56133,1,0
1,GO LEUKOCYTE CHEMOTAXIS,0.00033648,-0.44594,-0.52878,1,0
1,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,0.00018128,-0.44608,-0.56657,1,0
1,GO NAD BIOSYNTHETIC PROCESS,0.00024771,-0.44609,-0.47963,1,0
1,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,5.337e-06,-0.44615,-0.49262,1,0
1,GO BILE ACID BIOSYNTHETIC PROCESS,1.3909e-05,-0.44617,-0.43882,1,0
1,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,0.0066311,-0.44618,-0.53589,1,0
1,GO MICROTUBULE SEVERING,0.00010866,-0.44624,-0.4895,1,0
1,GO CELL DIFFERENTIATION IN SPINAL CORD,3.7287e-05,-0.4463,-0.48372,1,0
1,GO DNA DEMETHYLATION,2.636e-05,-0.44635,-0.4586,1,0
1,GO ORGANIC ACID METABOLIC PROCESS,5.337e-06,-0.44635,-0.44674,1,0
1,GO RESPONSE TO DEXAMETHASONE,8.9843e-06,-0.4464,-0.47623,1,0
1,GO VENTRAL SPINAL CORD DEVELOPMENT,4.5779e-05,-0.44645,-0.48265,1,0
1,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,3.9422e-06,-0.44668,-0.48394,1,0
1,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,3.9422e-06,-0.44669,-0.47134,1,0
1,GO T CELL DIFFERENTIATION,5.9985e-05,-0.44724,-0.58785,1,0
1,GO REGULATORY T CELL DIFFERENTIATION,0.00028019,-0.44729,-0.59189,1,0
1,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.00033648,-0.44738,-0.59765,1,0
1,GO REGULATION OF CYTOPLASMIC TRANSLATION,4.5891e-06,-0.44741,-0.47881,1,0
1,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,3.7287e-05,-0.44747,-0.53578,1,0
1,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,4.2539e-06,-0.4476,-0.4647,1,0
1,GO REGULATION OF HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.0016767,-0.44775,-0.52287,1,0
1,GO NEGATIVE REGULATION OF CELL KILLING,0.0080134,-0.44778,-0.63237,1,0
1,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,1.2939e-05,-0.44781,-0.56875,1,0
1,GO DIOL BIOSYNTHETIC PROCESS,0.00021879,-0.44793,-0.47262,1,0
1,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,2.8267e-05,-0.44799,-0.55561,1,0
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,6.6813e-06,-0.44801,-0.49043,1,0
1,GO PANCREATIC JUICE SECRETION,0.00024771,-0.44808,-0.46125,1,0
1,GO REGULATION OF CILIUM ASSEMBLY,1.8524e-05,-0.4481,-0.49531,1,0
1,GO REGULATION OF NEUTROPHIL MIGRATION,0.00091199,-0.44816,-0.6018,1,0
1,GO POSITIVE REGULATION OF CELL ACTIVATION,0.00013188,-0.44825,-0.58113,1,0
1,GO G0 TO G1 TRANSITION,1.3909e-05,-0.44847,-0.50798,1,0
1,GO LYMPHOCYTE MIGRATION,0.0021907,-0.44847,-0.54771,1,0
1,GO LABYRINTHINE LAYER MORPHOGENESIS,0.0003797,-0.44852,-0.51366,1,0
1,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,8.9843e-06,-0.44866,-0.47264,1,0
1,GO REGULATION OF LIPID TRANSPORT,1.4947e-05,-0.44869,-0.45451,1,0
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,3.0304e-05,-0.4487,-0.46336,1,0
1,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,4.5891e-06,-0.44878,-0.50243,1,0
1,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,5.6086e-05,-0.44887,-0.49723,1,0
1,GO SHORT TERM MEMORY,0.00029789,-0.44896,-0.48884,1,0
1,GO LIPID OXIDATION,7.7514e-06,-0.44898,-0.44661,1,0
1,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00011593,-0.44907,-0.57314,1,0
1,GO REGULATION OF CELL CYCLE PROCESS,6.6813e-06,-0.44941,-0.48903,1,0
1,GO REFLEX,0.0042727,-0.44945,-0.4488,1,0
1,GO CELLULAR RESPONSE TO OXYGEN LEVELS,4.2539e-06,-0.44949,-0.47042,1,0
1,GO POSITIVE REGULATION OF IMMUNE RESPONSE,5.2428e-05,-0.44955,-0.54431,1,0
1,GO INFLAMMATORY CELL APOPTOTIC PROCESS,0.00048214,-0.44969,-0.52027,1,0
1,GO LYMPHOCYTE ACTIVATION,3.9936e-05,-0.44974,-0.57922,1,0
1,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,0.00029789,-0.44974,-0.55789,1,0
1,GO MONOVALENT INORGANIC CATION TRANSPORT,1.2939e-05,-0.44986,-0.45507,1,0
1,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,3.9422e-06,-0.45014,-0.49105,1,0
1,GO PROGRAMMED NECROTIC CELL DEATH,6.4139e-05,-0.45016,-0.50651,1,0
1,GO WALKING BEHAVIOR,5.9985e-05,-0.4503,-0.50489,1,0
1,GO AMINE TRANSPORT,0.00042807,-0.45043,-0.435,1,0
1,GO UV DAMAGE EXCISION REPAIR,7.7514e-06,-0.45071,-0.51745,1,0
1,GO NEGATIVE REGULATION OF MACROPHAGE MIGRATION,0.00020554,-0.45073,-0.42784,1,0
1,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,7.3279e-05,-0.45082,-0.65229,1,0
1,GO T CELL LINEAGE COMMITMENT,0.00014062,-0.45087,-0.55368,1,0
1,GO DETECTION OF ABIOTIC STIMULUS,7.7514e-06,-0.45092,-0.45368,1,0
1,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,5.9985e-05,-0.45099,-0.5736,1,0
1,GO ZYMOGEN ACTIVATION,7.3279e-05,-0.45106,-0.53957,1,0
1,GO HISTONE MONOUBIQUITINATION,9.6689e-06,-0.45116,-0.52827,1,0
1,GO MESENCHYMAL TO EPITHELIAL TRANSITION,2.636e-05,-0.45119,-0.49511,1,0
1,GO REGULATION OF LYASE ACTIVITY,7.1973e-06,-0.45127,-0.46844,1,0
1,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.00014062,-0.45129,-0.58271,1,0
1,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,0.0010798,-0.45137,-0.59275,1,0
1,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,8.3641e-05,-0.45144,-0.52111,1,0
1,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,5.337e-06,-0.45151,-0.51971,1,0
1,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,3.9422e-06,-0.45178,-0.50826,1,0
1,GO RESPONSE TO CORTICOSTEROID,1.2035e-05,-0.45192,-0.49812,1,0
1,GO DNA REPLICATION,1.4947e-05,-0.4521,-0.47692,1,0
1,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,3.9422e-06,-0.45215,-0.47476,1,0
1,GO DOUBLE STRAND BREAK REPAIR,8.3461e-06,-0.45227,-0.51545,1,0
1,GO REGULATION OF CELL ACTIVATION,5.9985e-05,-0.45232,-0.58956,1,0
1,GO REGULATION OF CALCIUM MEDIATED SIGNALING,6.6813e-06,-0.45242,-0.51165,1,0
1,GO POSITIVE REGULATION OF LIPID LOCALIZATION,1.2939e-05,-0.45249,-0.52644,1,0
1,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,6.8565e-05,-0.45272,-0.53416,1,0
1,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,8.3461e-06,-0.45272,-0.51496,1,0
1,GO VACUOLAR ACIDIFICATION,1.0403e-05,-0.45272,-0.46664,1,0
1,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,8.9843e-06,-0.45277,-0.53367,1,0
1,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.0003797,-0.45282,-0.48953,1,0
1,GO STEROID METABOLIC PROCESS,1.2939e-05,-0.45292,-0.44664,1,0
1,GO REGULATION OF VIRAL TRANSCRIPTION,5.7533e-06,-0.45299,-0.48969,1,0
1,GO SULFUR COMPOUND METABOLIC PROCESS,6.6813e-06,-0.45331,-0.43624,1,0
1,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,1.1191e-05,-0.4534,-0.43191,1,0
1,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,7.8298e-05,-0.4534,-0.49427,1,0
1,GO BILE ACID METABOLIC PROCESS,1.6059e-05,-0.4534,-0.43936,1,0
1,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.00023283,-0.45342,-0.50043,1,0
1,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,5.7533e-06,-0.45361,-0.49119,1,0
1,GO NEUROTRANSMITTER TRANSPORT,7.8298e-05,-0.45429,-0.53832,1,0
1,GO BLASTOCYST FORMATION,4.5891e-06,-0.45444,-0.48792,1,0
1,GO NUCLEAR PORE ORGANIZATION,2.1347e-05,-0.45451,-0.54279,1,0
1,GO REGULATION OF CELL MATURATION,1.7249e-05,-0.45453,-0.42307,1,0
1,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,7.7514e-06,-0.45467,-0.47866,1,0
1,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,8.9843e-06,-0.45491,-0.51778,1,0
1,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,6.2007e-06,-0.45491,-0.49836,1,0
1,GO SYNAPTIC MEMBRANE ADHESION,0.00014062,-0.45493,-0.58049,1,0
1,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,2.8267e-05,-0.45497,-0.48209,1,0
1,GO RESPONSE TO INTERLEUKIN 4,3.7287e-05,-0.45508,-0.5233,1,0
1,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,0.00057531,-0.45508,-0.6246,1,0
1,GO IRON ION TRANSPORT,1.1191e-05,-0.45511,-0.47838,1,0
1,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.00013188,-0.45514,-0.50524,1,0
1,GO PROTEIN O LINKED MANNOSYLATION,2.4576e-05,-0.45516,-0.4811,1,0
1,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,0.0042727,-0.45528,-0.52503,1,0
1,GO CELLULAR MACROMOLECULE LOCALIZATION,4.9495e-06,-0.45558,-0.48736,1,0
1,GO NADH METABOLIC PROCESS,5.9985e-05,-0.45565,-0.50469,1,0
1,GO MITOTIC SISTER CHROMATID COHESION,1.9888e-05,-0.45569,-0.49545,1,0
1,GO MRNA CLEAVAGE,1.1191e-05,-0.4557,-0.50409,1,0
1,GO TROPHECTODERMAL CELL DIFFERENTIATION,6.2007e-06,-0.45572,-0.46605,1,0
1,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,3.7287e-05,-0.45576,-0.52066,1,0
1,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.037377,-0.4558,-0.43038,1,0
1,GO NEGATIVE REGULATION OF LYASE ACTIVITY,4.5779e-05,-0.45583,-0.48596,1,0
1,GO NERVOUS SYSTEM PROCESS,6.2007e-06,-0.45599,-0.47276,1,0
1,GO MULTI ORGANISM PROCESS,6.2007e-06,-0.4561,-0.45773,1,0
1,GO NEUTRAL LIPID CATABOLIC PROCESS,4.8997e-05,-0.45617,-0.39929,1,0
1,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,3.248e-05,-0.45629,-0.58972,1,0
1,GO PROTEIN TRIMERIZATION,3.4805e-05,-0.45633,-0.54341,1,0
1,GO MULTI ORGANISM LOCALIZATION,4.9495e-06,-0.45638,-0.49819,1,0
1,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,2.1347e-05,-0.45642,-0.43172,1,0
1,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,8.9327e-05,-0.45643,-0.55642,1,0
1,GO MULTICELLULAR ORGANISM REPRODUCTION,5.7533e-06,-0.45645,-0.45834,1,0
1,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,1.6059e-05,-0.45649,-0.48571,1,0
1,GO SUPEROXIDE ANION GENERATION,0.00014062,-0.45655,-0.53592,1,0
1,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.012106,-0.45657,-0.63837,1,0
1,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,6.8565e-05,-0.45679,-0.57456,1,0
1,GO MICROTUBULE BASED MOVEMENT,1.2939e-05,-0.45686,-0.48017,1,0
1,GO SARCOMERE ORGANIZATION,1.6059e-05,-0.45694,-0.43246,1,0
1,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,4.9495e-06,-0.45694,-0.50136,1,0
1,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,5.9985e-05,-0.45704,-0.45075,1,0
1,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,0.0024341,-0.45705,-0.75725,1,0
1,GO INFLAMMATORY RESPONSE,3.4805e-05,-0.45714,-0.56109,1,0
1,GO PEROXISOMAL MEMBRANE TRANSPORT,4.2539e-06,-0.45715,-0.51683,1,0
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,5.7533e-06,-0.45753,-0.59958,1,0
1,GO DIET INDUCED THERMOGENESIS,2.636e-05,-0.45784,-0.47625,1,0
1,GO ESTABLISHMENT OF RNA LOCALIZATION,5.7533e-06,-0.45808,-0.49786,1,0
1,GO MATING,2.8267e-05,-0.45808,-0.45929,1,0
1,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,1.1191e-05,-0.45815,-0.51867,1,0
1,GO REGULATION OF T CELL DIFFERENTIATION,8.3641e-05,-0.45817,-0.59086,1,0
1,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,6.2007e-06,-0.45817,-0.47429,1,0
1,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,0.00010181,-0.45837,-0.46222,1,0
1,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,1.8524e-05,-0.45849,-0.54302,1,0
1,GO MACROPHAGE MIGRATION,0.00054254,-0.45861,-0.54468,1,0
1,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,6.4139e-05,-0.45874,-0.48457,1,0
1,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,4.5891e-06,-0.45879,-0.46305,1,0
1,GO RESPONSE TO ETHANOL,1.1191e-05,-0.45883,-0.42428,1,0
1,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,2.8267e-05,-0.45883,-0.52931,1,0
1,GO FLUID TRANSPORT,0.00014062,-0.459,-0.4905,1,0
1,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,7.7514e-06,-0.45933,-0.52028,1,0
1,GO PROTEIN MATURATION,9.6689e-06,-0.45951,-0.46943,1,0
1,GO FUCOSYLATION,8.3461e-06,-0.45955,-0.51321,1,0
1,GO MONOCYTE CHEMOTAXIS,0.023112,-0.45961,-0.45653,1,0
1,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,7.1973e-06,-0.45969,-0.43698,1,0
1,GO ORGANIC ACID BIOSYNTHETIC PROCESS,4.9495e-06,-0.45975,-0.46137,1,0
1,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,4.8997e-05,-0.45976,-0.59307,1,0
1,GO PLASMINOGEN ACTIVATION,7.8298e-05,-0.45978,-0.58327,1,0
1,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,7.7514e-06,-0.45988,-0.53162,1,0
1,GO LEUKOCYTE TETHERING OR ROLLING,0.00013188,-0.45992,-0.57537,1,0
1,GO FATTY ACID CATABOLIC PROCESS,1.6059e-05,-0.45993,-0.44943,1,0
1,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,1.8524e-05,-0.46021,-0.54701,1,0
1,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.00019306,-0.46026,-0.3992,1,0
1,GO INTERMEDIATE FILAMENT BASED PROCESS,1.3909e-05,-0.46031,-0.4948,1,0
1,GO POSITIVE REGULATION OF CHEMOTAXIS,5.6086e-05,-0.46032,-0.57307,1,0
1,GO MECHANOSENSORY BEHAVIOR,0.0038653,-0.46037,-0.4639,1,0
1,GO DNA GEOMETRIC CHANGE,7.7514e-06,-0.46052,-0.50573,1,0
1,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,0.0038653,-0.46055,-0.4795,1,0
1,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.0054671,-0.46073,-0.52022,1,0
1,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,1.4947e-05,-0.46073,-0.50791,1,0
1,GO REGULATION OF LYMPHOCYTE MIGRATION,0.0010798,-0.46077,-0.54136,1,0
1,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,4.2539e-06,-0.4612,-0.49257,1,0
1,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,6.6813e-06,-0.46176,-0.47692,1,0
1,GO REGULATION OF CELL CYCLE ARREST,8.9843e-06,-0.46189,-0.48421,1,0
1,GO ACTIN NUCLEATION,6.6813e-06,-0.46193,-0.49937,1,0
1,GO KETONE BIOSYNTHETIC PROCESS,0.00013188,-0.46237,-0.44833,1,0
1,GO METENCEPHALON DEVELOPMENT,9.6689e-06,-0.46257,-0.52669,1,0
1,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,1.4947e-05,-0.46274,-0.56636,1,0
1,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,4.5779e-05,-0.46281,-0.60746,1,0
1,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,4.5891e-06,-0.46282,-0.50142,1,0
1,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.00012367,-0.46289,-0.52174,1,0
1,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,9.5377e-05,-0.46315,-0.51395,1,0
1,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,0.00018128,-0.46318,-0.56328,1,0
1,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.00020554,-0.46326,-0.48527,1,0
1,GO HYPOTHALAMUS DEVELOPMENT,9.5377e-05,-0.46332,-0.43516,1,0
1,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,1.2035e-05,-0.46337,-0.51149,1,0
1,GO COPPER ION HOMEOSTASIS,7.7514e-06,-0.46359,-0.49805,1,0
1,GO MYOBLAST PROLIFERATION,3.0304e-05,-0.46383,-0.48559,1,0
1,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,4.5779e-05,-0.4639,-0.49047,1,0
1,GO DENDRITE EXTENSION,0.00024771,-0.46405,-0.50109,1,0
1,GO AMINE BIOSYNTHETIC PROCESS,0.00076864,-0.46407,-0.37582,1,0
1,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00031664,-0.46421,-0.56265,1,0
1,GO RESPONSE TO NICOTINE,2.8267e-05,-0.46439,-0.46378,1,0
1,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.00014989,-0.46443,-0.59205,1,0
1,GO DICARBOXYLIC ACID TRANSPORT,5.6086e-05,-0.46452,-0.47652,1,0
1,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,9.6689e-06,-0.46458,-0.5033,1,0
1,GO CELLULAR RESPONSE TO VIRUS,2.1347e-05,-0.46478,-0.52459,1,0
1,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,1.1191e-05,-0.46503,-0.51866,1,0
1,GO INDUCTION OF POSITIVE CHEMOTAXIS,6.4139e-05,-0.46517,-0.48616,1,0
1,GO SYNAPTIC VESICLE EXOCYTOSIS,0.00013188,-0.46525,-0.58758,1,0
1,GO ANTIGEN PROCESSING AND PRESENTATION,4.5779e-05,-0.4653,-0.5085,1,0
1,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,0.010101,-0.46536,-0.44416,1,0
1,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,1.4947e-05,-0.46551,-0.47802,1,0
1,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,2.2907e-05,-0.46551,-0.49286,1,0
1,GO REGULATION OF POTASSIUM ION TRANSPORT,8.9843e-06,-0.46563,-0.49421,1,0
1,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,1.9888e-05,-0.46565,-0.53655,1,0
1,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,6.2007e-06,-0.4657,-0.50332,1,0
1,GO REGULATION OF HUMORAL IMMUNE RESPONSE,0.0020776,-0.46571,-0.60277,1,0
1,GO ARACHIDONIC ACID SECRETION,0.00010181,-0.46572,-0.43759,1,0
1,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,5.6086e-05,-0.46591,-0.49796,1,0
1,GO POTASSIUM ION TRANSPORT,2.2907e-05,-0.46592,-0.48946,1,0
1,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,1.6059e-05,-0.46598,-0.59643,1,0
1,GO SKIN DEVELOPMENT,1.9888e-05,-0.46601,-0.47629,1,0
1,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,2.8267e-05,-0.46605,-0.55885,1,0
1,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,2.2907e-05,-0.46614,-0.60997,1,0
1,GO REGULATION OF CELL CELL ADHESION,2.8267e-05,-0.46631,-0.59175,1,0
1,GO FEVER GENERATION,1.7249e-05,-0.46649,-0.49961,1,0
1,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,4.2539e-06,-0.46665,-0.50048,1,0
1,GO FOLIC ACID METABOLIC PROCESS,7.7514e-06,-0.46673,-0.47082,1,0
1,GO STEROID CATABOLIC PROCESS,0.00040321,-0.46675,-0.45341,1,0
1,GO DETECTION OF CALCIUM ION,0.00051151,-0.46713,-0.42168,1,0
1,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,0.00054254,-0.46736,-0.58845,1,0
1,GO CHLORIDE TRANSPORT,6.6813e-06,-0.46743,-0.48664,1,0
1,GO REGULATION OF PROTEIN ACETYLATION,5.337e-06,-0.46752,-0.50802,1,0
1,GO CHROMATIN REMODELING,9.6689e-06,-0.4677,-0.50599,1,0
1,GO MITOTIC SPINDLE ASSEMBLY,1.4947e-05,-0.46773,-0.508,1,0
1,GO CELLULAR PIGMENTATION,1.8524e-05,-0.46776,-0.42112,1,0
1,GO REGULATION OF IMMUNE SYSTEM PROCESS,1.2035e-05,-0.46789,-0.56286,1,0
1,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,6.8565e-05,-0.46793,-0.55295,1,0
1,GO RESPONSE TO AUDITORY STIMULUS,0.0014241,-0.46803,-0.47386,1,0
1,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,1.0403e-05,-0.46807,-0.44499,1,0
1,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00010181,-0.46816,-0.58463,1,0
1,GO RESPONSE TO ELECTRICAL STIMULUS,1.7249e-05,-0.46822,-0.46489,1,0
1,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,4.8997e-05,-0.46826,-0.49723,1,0
1,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,6.2007e-06,-0.46829,-0.50247,1,0
1,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,1.7249e-05,-0.46832,-0.54303,1,0
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,6.6813e-06,-0.46835,-0.45131,1,0
1,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,7.1973e-06,-0.46837,-0.55188,1,0
1,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,4.9495e-06,-0.46845,-0.45807,1,0
1,GO IMMUNOGLOBULIN PRODUCTION,1.4947e-05,-0.46852,-0.56838,1,0
1,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,4.5779e-05,-0.46862,-0.52149,1,0
1,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,1.4947e-05,-0.46864,-0.45265,1,0
1,GO REGULATION OF AMYLOID BETA CLEARANCE,4.8997e-05,-0.46877,-0.62512,1,0
1,GO POSITIVE REGULATION OF CYTOKINE SECRETION,6.4139e-05,-0.46878,-0.53883,1,0
1,GO IRON ION HOMEOSTASIS,1.2939e-05,-0.46882,-0.46679,1,0
1,GO STEROID BIOSYNTHETIC PROCESS,3.7287e-05,-0.46907,-0.42738,1,0
1,GO REGULATION OF HORMONE LEVELS,1.9888e-05,-0.46909,-0.45463,1,0
1,GO ORGANELLE ASSEMBLY,5.7533e-06,-0.46914,-0.49646,1,0
1,GO ALCOHOL METABOLIC PROCESS,6.2007e-06,-0.46948,-0.48825,1,0
1,GO ORGANELLE DISASSEMBLY,4.9495e-06,-0.46948,-0.51708,1,0
1,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.00091199,-0.46958,-0.56667,1,0
1,GO MONONUCLEAR CELL MIGRATION,0.0038653,-0.46961,-0.51594,1,0
1,GO REGULATION OF DNA REPAIR,7.7514e-06,-0.46963,-0.516,1,0
1,GO RESPONSE TO CAFFEINE,3.7287e-05,-0.46972,-0.46418,1,0
1,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,6.2007e-06,-0.46977,-0.5117,1,0
1,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.0028457,-0.46978,-0.52655,1,0
1,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.0012071,-0.4698,-0.61528,1,0
1,GO PRESYNAPTIC MEMBRANE ORGANIZATION,0.0015041,-0.46987,-0.52097,1,0
1,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,5.6086e-05,-0.46988,-0.52512,1,0
1,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.033245,-0.46992,-0.40575,1,0
1,GO ACTIVATION OF IMMUNE RESPONSE,2.8267e-05,-0.46993,-0.55826,1,0
1,GO REGULATION OF MICROTUBULE BASED PROCESS,8.9843e-06,-0.46995,-0.52998,1,0
1,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,4.9495e-06,-0.47013,-0.49888,1,0
1,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,3.7287e-05,-0.47018,-0.53507,1,0
1,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,6.2007e-06,-0.47043,-0.53902,1,0
1,GO LIPID CATABOLIC PROCESS,6.2007e-06,-0.47045,-0.48252,1,0
1,GO SINGLE STRAND BREAK REPAIR,3.7287e-05,-0.4705,-0.47035,1,0
1,GO GRANULOCYTE CHEMOTAXIS,0.00332,-0.47054,-0.49602,1,0
1,GO PROTEIN TETRAMERIZATION,4.9495e-06,-0.47061,-0.48181,1,0
1,GO CELL CYCLE CHECKPOINT,9.6689e-06,-0.47062,-0.50935,1,0
1,GO IMPORT INTO NUCLEUS,3.9422e-06,-0.47098,-0.50146,1,0
1,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,5.7533e-06,-0.47101,-0.47931,1,0
1,GO NATURAL KILLER CELL ACTIVATION,0.00015974,-0.47129,-0.57491,1,0
1,GO FEMALE GENITALIA DEVELOPMENT,9.6689e-06,-0.47133,-0.47076,1,0
1,GO HISTONE H3 K4 METHYLATION,1.2939e-05,-0.47136,-0.51863,1,0
1,GO POSITIVE REGULATION OF HEART RATE,5.9985e-05,-0.4714,-0.4547,1,0
1,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,0.00031664,-0.47158,-0.74513,1,0
1,GO REGULATION OF GLIAL CELL DIFFERENTIATION,9.6689e-06,-0.47161,-0.48872,1,0
1,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.00060992,-0.47165,-0.41324,1,0
1,GO NUCLEAR TRANSPORT,4.2539e-06,-0.47167,-0.494,1,0
1,GO ANIMAL ORGAN REGENERATION,6.2007e-06,-0.47169,-0.50375,1,0
1,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,4.5779e-05,-0.47185,-0.55712,1,0
1,GO GAMMA AMINOBUTYRIC ACID SECRETION,0.00021879,-0.47189,-0.52473,1,0
1,GO PROTEIN TRANSPORT ALONG MICROTUBULE,3.0304e-05,-0.47193,-0.49983,1,0
1,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,1.2939e-05,-0.47213,-0.47516,1,0
1,GO REGULATION OF MONOOXYGENASE ACTIVITY,3.9422e-06,-0.47221,-0.48483,1,0
1,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,2.8267e-05,-0.4723,-0.54124,1,0
1,GO HEAT GENERATION,2.2907e-05,-0.47236,-0.49165,1,0
1,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,1.9888e-05,-0.4724,-0.52979,1,0
1,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.0172,-0.47254,-0.61513,1,0
1,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,8.3641e-05,-0.47258,-0.46995,1,0
1,GO INNER DYNEIN ARM ASSEMBLY,0.00060992,-0.47273,-0.49998,1,0
1,GO TRANSPORT ALONG MICROTUBULE,8.9843e-06,-0.47277,-0.53329,1,0
1,GO CELL ACTIVATION,9.6689e-06,-0.47295,-0.56682,1,0
1,GO PROTEIN POLYUBIQUITINATION,4.5891e-06,-0.473,-0.50465,1,0
1,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,4.5779e-05,-0.47302,-0.47258,1,0
1,GO DEFENSE RESPONSE TO VIRUS,0.00020554,-0.47306,-0.52999,1,0
1,GO LIPID EXPORT FROM CELL,5.2428e-05,-0.47319,-0.41949,1,0
1,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,8.3461e-06,-0.47346,-0.52516,1,0
1,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,1.4947e-05,-0.47369,-0.47499,1,0
1,GO NADP METABOLIC PROCESS,9.6689e-06,-0.47372,-0.45806,1,0
1,GO POST TRANSLATIONAL PROTEIN MODIFICATION,4.9495e-06,-0.47401,-0.50764,1,0
1,GO PARTURITION,1.4947e-05,-0.47404,-0.47755,1,0
1,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,1.9888e-05,-0.4741,-0.50124,1,0
1,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,1.6059e-05,-0.47422,-0.53457,1,0
1,GO REGULATION OF AMINO ACID TRANSPORT,0.00021879,-0.47437,-0.49078,1,0
1,GO CELLULAR LIPID METABOLIC PROCESS,5.337e-06,-0.47457,-0.48593,1,0
1,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,4.5891e-06,-0.47467,-0.51338,1,0
1,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,1.3909e-05,-0.47467,-0.50087,1,0
1,GO LYMPHOCYTE DIFFERENTIATION,2.636e-05,-0.47493,-0.59745,1,0
1,GO SYNAPSE MATURATION,7.8298e-05,-0.47506,-0.59967,1,0
1,GO RESPONSE TO IMMOBILIZATION STRESS,0.0024341,-0.47508,-0.35961,1,0
1,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,9.6689e-06,-0.47514,-0.5058,1,0
1,GO INTERFERON ALPHA PRODUCTION,3.9936e-05,-0.47524,-0.59036,1,0
1,GO RESPONSE TO LIGHT STIMULUS,4.9495e-06,-0.4753,-0.47554,1,0
1,GO POSITIVE REGULATION OF DNA REPAIR,7.7514e-06,-0.47534,-0.53446,1,0
1,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,2.4576e-05,-0.47558,-0.501,1,0
1,GO VAGINA DEVELOPMENT,0.00015974,-0.47569,-0.50186,1,0
1,GO ADULT LOCOMOTORY BEHAVIOR,0.00010181,-0.47586,-0.51334,1,0
1,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,2.2907e-05,-0.47591,-0.49226,1,0
1,GO POSITIVE REGULATION OF TORC1 SIGNALING,1.7249e-05,-0.47601,-0.54392,1,0
1,GO DNA TEMPLATED TRANSCRIPTION INITIATION,4.2539e-06,-0.47605,-0.47611,1,0
1,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,5.337e-06,-0.47613,-0.51548,1,0
1,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,1.7249e-05,-0.47614,-0.47063,1,0
1,GO CHEMOKINE PRODUCTION,0.00010181,-0.47626,-0.54506,1,0
1,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.0018673,-0.4763,-0.55351,1,0
1,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00029789,-0.47638,-0.51793,1,0
1,GO SYNAPTIC VESICLE BUDDING,0.00023283,-0.47643,-0.52299,1,0
1,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,6.2007e-06,-0.47647,-0.49422,1,0
1,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,2.4576e-05,-0.47647,-0.62027,1,0
1,GO REGULATION OF PEPTIDASE ACTIVITY,1.0403e-05,-0.47664,-0.49388,1,0
1,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,1.4947e-05,-0.47673,-0.47385,1,0
1,GO EXECUTION PHASE OF APOPTOSIS,4.5891e-06,-0.47678,-0.49791,1,0
1,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,1.2939e-05,-0.47679,-0.48557,1,0
1,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.0057394,-0.47679,-0.4987,1,0
1,GO MIDBRAIN DEVELOPMENT,4.9495e-06,-0.47701,-0.48645,1,0
1,GO CARBOHYDRATE DERIVATIVE TRANSPORT,2.4576e-05,-0.47723,-0.46091,1,0
1,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,4.5891e-06,-0.47732,-0.51652,1,0
1,GO POLYOL BIOSYNTHETIC PROCESS,1.6059e-05,-0.47736,-0.473,1,0
1,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,8.9843e-06,-0.47745,-0.53933,1,0
1,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,3.248e-05,-0.47748,-0.51451,1,0
1,GO REPLICATION FORK PROCESSING,1.7249e-05,-0.47753,-0.5863,1,0
1,GO REGULATION OF LIPID LOCALIZATION,1.0403e-05,-0.47756,-0.49163,1,0
1,GO NEGATIVE REGULATION OF B CELL ACTIVATION,0.0003797,-0.47766,-0.61517,1,0
1,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,1.2939e-05,-0.47768,-0.51225,1,0
1,GO PIGMENT GRANULE ORGANIZATION,2.636e-05,-0.47769,-0.45715,1,0
1,GO NEGATIVE REGULATION OF CELL ACTIVATION,0.00012367,-0.4777,-0.60587,1,0
1,GO APOPTOTIC SIGNALING PATHWAY,4.5891e-06,-0.47771,-0.50819,1,0
1,GO COGNITION,6.2007e-06,-0.47773,-0.50826,1,0
1,GO POSITIVE REGULATION OF CYTOKINESIS,2.4576e-05,-0.47774,-0.4861,1,0
1,GO LIPID IMPORT INTO CELL,6.6813e-06,-0.47776,-0.5906,1,0
1,GO REGULATION OF CELLULAR PH,4.5891e-06,-0.47786,-0.50581,1,0
1,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.0027019,-0.4779,-0.57149,1,0
1,GO WATER TRANSPORT,0.00017019,-0.47799,-0.5201,1,0
1,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.00024771,-0.47802,-0.59215,1,0
1,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,5.7533e-06,-0.47802,-0.4857,1,0
1,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,3.4805e-05,-0.47825,-0.57916,1,0
1,GO EXCITATORY SYNAPSE ASSEMBLY,0.00010181,-0.47831,-0.54201,1,0
1,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,8.3641e-05,-0.47832,-0.53139,1,0
1,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,9.6689e-06,-0.47844,-0.50808,1,0
1,GO REGULATION OF NEUROTRANSMITTER LEVELS,5.2428e-05,-0.47845,-0.53816,1,0
1,GO PHOSPHATIDYLGLYCEROL BIOSYNTHETIC PROCESS,1.2035e-05,-0.47877,-0.49909,1,0
1,GO MICROTUBULE BASED PROCESS,8.9843e-06,-0.47879,-0.51163,1,0
1,GO REGULATION OF POSTSYNAPSE ORGANIZATION,8.3461e-06,-0.47882,-0.56753,1,0
1,GO T CELL HOMEOSTASIS,1.7249e-05,-0.47895,-0.49571,1,0
1,GO REGULATION OF SYMBIOTIC PROCESS,3.4805e-05,-0.47899,-0.50353,1,0
1,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,8.9843e-06,-0.47899,-0.54588,1,0
1,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,1.1191e-05,-0.47902,-0.54765,1,0
1,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,3.248e-05,-0.47912,-0.55342,1,0
1,GO SULFATION,3.4805e-05,-0.47928,-0.48959,1,0
1,GO DOPAMINERGIC NEURON DIFFERENTIATION,1.3909e-05,-0.47951,-0.46769,1,0
1,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00028019,-0.47954,-0.57702,1,0
1,GO REGULATION OF DNA REPLICATION,1.2035e-05,-0.47955,-0.48944,1,0
1,GO POSITIVE REGULATION OF HEART CONTRACTION,3.4805e-05,-0.47962,-0.49878,1,0
1,GO REGULATION OF LIPASE ACTIVITY,1.3909e-05,-0.47975,-0.50903,1,0
1,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.00014062,-0.47979,-0.53599,1,0
1,GO RESPONSE TO GAMMA RADIATION,6.6813e-06,-0.47982,-0.48804,1,0
1,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,1.2939e-05,-0.47997,-0.51475,1,0
1,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,4.9495e-06,-0.48006,-0.52774,1,0
1,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,0.00021879,-0.4803,-0.59694,1,0
1,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,4.9495e-06,-0.4803,-0.50649,1,0
1,GO HETEROTYPIC CELL CELL ADHESION,2.4576e-05,-0.48035,-0.58324,1,0
1,GO POSITIVE REGULATION OF HEMOPOIESIS,1.0403e-05,-0.48037,-0.59747,1,0
1,GO RESPONSE TO UV B,8.3641e-05,-0.48041,-0.46497,1,0
1,GO LIPID METABOLIC PROCESS,5.7533e-06,-0.48045,-0.48923,1,0
1,GO ALPHA BETA T CELL DIFFERENTIATION,0.00024771,-0.48048,-0.60098,1,0
1,GO REGULATION OF MAST CELL ACTIVATION,1.3909e-05,-0.48051,-0.62389,1,0
1,GO NUCLEOTIDE PHOSPHORYLATION,7.1973e-06,-0.48052,-0.52471,1,0
1,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00023283,-0.4808,-0.61435,1,0
1,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,0.0012758,-0.48092,-0.48367,1,0
1,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,3.7287e-05,-0.48094,-0.62976,1,0
1,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,4.5779e-05,-0.48094,-0.55805,1,0
1,GO REGULATION OF TRANS SYNAPTIC SIGNALING,1.2035e-05,-0.481,-0.57102,1,0
1,GO LONG TERM SYNAPTIC DEPRESSION,1.8524e-05,-0.48103,-0.52173,1,0
1,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.00020554,-0.48129,-0.69937,1,0
1,GO BROWN FAT CELL DIFFERENTIATION,1.2035e-05,-0.48131,-0.47574,1,0
1,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,5.337e-06,-0.48136,-0.50407,1,0
1,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,1.3909e-05,-0.48141,-0.54464,1,0
1,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0042727,-0.4816,-0.49179,1,0
1,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,1.2035e-05,-0.48168,-0.49584,1,0
1,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,3.7287e-05,-0.48175,-0.47651,1,0
1,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,2.636e-05,-0.48175,-0.46761,1,0
1,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.00024771,-0.48177,-0.5532,1,0
1,GO RESPONSE TO EXTRACELLULAR STIMULUS,5.7533e-06,-0.48192,-0.50629,1,0
1,GO NUCLEAR EXPORT,5.337e-06,-0.48208,-0.51069,1,0
1,GO POSITIVE T CELL SELECTION,0.0015882,-0.4821,-0.60536,1,0
1,GO BILE ACID AND BILE SALT TRANSPORT,1.2939e-05,-0.48212,-0.50272,1,0
1,GO CHEMOKINE SECRETION,0.00332,-0.48212,-0.55684,1,0
1,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.028348,-0.48222,-0.51263,1,0
1,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,9.5377e-05,-0.48222,-0.60531,1,0
1,GO MACROPHAGE CHEMOTAXIS,0.0011418,-0.48223,-0.52332,1,0
1,GO SYNAPSE ASSEMBLY,1.4947e-05,-0.48228,-0.57229,1,0
1,GO REGULATION OF SISTER CHROMATID COHESION,1.3909e-05,-0.48229,-0.55098,1,0
1,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,5.7533e-06,-0.48235,-0.48375,1,0
1,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,7.3279e-05,-0.48241,-0.56015,1,0
1,GO CEREBELLAR CORTEX DEVELOPMENT,8.3461e-06,-0.48242,-0.56835,1,0
1,GO METANEPHRIC MESENCHYME DEVELOPMENT,2.1347e-05,-0.48246,-0.56154,1,0
1,GO LIPID DROPLET ORGANIZATION,1.9888e-05,-0.48251,-0.4693,1,0
1,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,1.0403e-05,-0.48267,-0.51802,1,0
1,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,8.9843e-06,-0.48281,-0.52604,1,0
1,GO ALCOHOL BIOSYNTHETIC PROCESS,1.1191e-05,-0.48294,-0.49002,1,0
1,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,4.2539e-06,-0.48298,-0.49344,1,0
1,GO POSITIVE REGULATION OF INSULIN SECRETION,2.4576e-05,-0.48315,-0.45542,1,0
1,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,1.0403e-05,-0.48318,-0.55301,1,0
1,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,3.248e-05,-0.48321,-0.49919,1,0
1,GO DIOL METABOLIC PROCESS,0.00020554,-0.4833,-0.49679,1,0
1,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,1.3909e-05,-0.48331,-0.5748,1,0
1,GO RESPONSE TO WATER,0.00081392,-0.48345,-0.44749,1,0
1,GO NEUROMUSCULAR PROCESS,1.3909e-05,-0.48353,-0.55443,1,0
1,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,1.9888e-05,-0.48356,-0.55228,1,0
1,GO HYPOTONIC RESPONSE,1.3909e-05,-0.48378,-0.54779,1,0
1,GO POSITIVE REGULATION OF CHROMATIN BINDING,6.6813e-06,-0.48392,-0.58269,1,0
1,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,0.00096503,-0.48397,-0.58023,1,0
1,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,3.4805e-05,-0.48426,-0.6715,1,0
1,GO RESPONSE TO RADIATION,4.2539e-06,-0.48433,-0.48515,1,0
1,GO FC RECEPTOR SIGNALING PATHWAY,3.9422e-06,-0.48434,-0.5479,1,0
1,GO CILIUM ORGANIZATION,1.4947e-05,-0.48438,-0.49412,1,0
1,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,3.9936e-05,-0.48468,-0.6224,1,0
1,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,1.1191e-05,-0.4849,-0.52754,1,0
1,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,4.8997e-05,-0.48496,-0.50065,1,0
1,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,1.3909e-05,-0.48508,-0.50951,1,0
1,GO ARGININE METABOLIC PROCESS,3.9422e-06,-0.48512,-0.53535,1,0
1,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,4.9495e-06,-0.48536,-0.48553,1,0
1,GO REGULATION OF MEMBRANE POTENTIAL,1.7249e-05,-0.48554,-0.5076,1,0
1,GO REGULATION OF ACTIN NUCLEATION,7.7514e-06,-0.48558,-0.51186,1,0
1,GO PEPTIDE HORMONE SECRETION,2.1347e-05,-0.48568,-0.49907,1,0
1,GO MICROTUBULE CYTOSKELETON ORGANIZATION,1.0403e-05,-0.48585,-0.53298,1,0
1,GO CALCIUM MEDIATED SIGNALING,7.1973e-06,-0.48597,-0.50555,1,0
1,GO REGULATION OF SYNAPTIC PLASTICITY,1.7249e-05,-0.48623,-0.56205,1,0
1,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,4.5891e-06,-0.48644,-0.47442,1,0
1,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,1.2939e-05,-0.48645,-0.50479,1,0
1,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,6.6813e-06,-0.48652,-0.48809,1,0
1,GO PURINE NUCLEOTIDE TRANSPORT,6.8565e-05,-0.48664,-0.46516,1,0
1,GO HISTONE H4 DEACETYLATION,3.7287e-05,-0.487,-0.44225,1,0
1,GO RESPONSE TO CYTOKINE,1.0403e-05,-0.48704,-0.55775,1,0
1,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,4.5891e-06,-0.48704,-0.52546,1,0
1,GO SKELETAL MUSCLE CONTRACTION,9.6689e-06,-0.48741,-0.47965,1,0
1,GO CATECHOLAMINE SECRETION,0.00064645,-0.48743,-0.47405,1,0
1,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,6.8565e-05,-0.48749,-0.5932,1,0
1,GO INTERLEUKIN 8 PRODUCTION,0.00014062,-0.48758,-0.58914,1,0
1,GO LEUKOCYTE DIFFERENTIATION,1.3909e-05,-0.48758,-0.5967,1,0
1,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,4.9495e-06,-0.4876,-0.5013,1,0
1,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,5.7533e-06,-0.48761,-0.49285,1,0
1,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,1.0403e-05,-0.48762,-0.56886,1,0
1,GO TRNA TRANSPORT,9.6689e-06,-0.48767,-0.54131,1,0
1,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,8.3461e-06,-0.48787,-0.5388,1,0
1,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,7.7514e-06,-0.48795,-0.49406,1,0
1,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,1.7249e-05,-0.48801,-0.48294,1,0
1,GO EXOCYTIC PROCESS,1.8524e-05,-0.48809,-0.58421,1,0
1,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.00011593,-0.48813,-0.59401,1,0
1,GO REGULATION OF MITOCHONDRION ORGANIZATION,4.9495e-06,-0.48814,-0.518,1,0
1,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,2.2907e-05,-0.48819,-0.54196,1,0
1,GO APOPTOTIC PROCESS,4.5891e-06,-0.48822,-0.52276,1,0
1,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,4.5891e-06,-0.48825,-0.54006,1,0
1,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,0.00031664,-0.48842,-0.54728,1,0
1,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,4.2539e-06,-0.48848,-0.54704,1,0
1,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,2.636e-05,-0.48859,-0.55956,1,0
1,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.00015974,-0.4886,-0.50872,1,0
1,GO BEHAVIOR,7.7514e-06,-0.48864,-0.52553,1,0
1,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,5.7533e-06,-0.48865,-0.52273,1,0
1,GO NCRNA EXPORT FROM NUCLEUS,8.9843e-06,-0.48866,-0.56191,1,0
1,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,1.2035e-05,-0.48866,-0.51432,1,0
1,GO OLIGODENDROCYTE DIFFERENTIATION,1.0403e-05,-0.48878,-0.48088,1,0
1,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,2.1347e-05,-0.48897,-0.53054,1,0
1,GO CELLULAR COMPONENT DISASSEMBLY,3.9422e-06,-0.48904,-0.50692,1,0
1,GO ADULT BEHAVIOR,5.6086e-05,-0.48909,-0.51785,1,0
1,GO FATTY ACID TRANSPORT,4.5891e-06,-0.48935,-0.51603,1,0
1,GO PROTEIN AUTOUBIQUITINATION,7.1973e-06,-0.48942,-0.48877,1,0
1,GO MYELOID LEUKOCYTE DIFFERENTIATION,1.6059e-05,-0.48949,-0.60092,1,0
1,GO STEROL METABOLIC PROCESS,8.9843e-06,-0.48968,-0.4937,1,0
1,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.0017696,-0.48974,-0.40049,1,0
1,GO RESPONSE TO OXIDATIVE STRESS,4.5891e-06,-0.48975,-0.50993,1,0
1,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,2.4576e-05,-0.48976,-0.52613,1,0
1,GO RESPONSE TO HYDROPEROXIDE,0.00010866,-0.48978,-0.55011,1,0
1,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,0.00026348,-0.48979,-0.54688,1,0
1,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,4.9495e-06,-0.4901,-0.50852,1,0
1,GO TRANSMEMBRANE TRANSPORT,5.7533e-06,-0.49021,-0.47729,1,0
1,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,6.2007e-06,-0.49028,-0.47731,1,0
1,GO WATER HOMEOSTASIS,3.248e-05,-0.49033,-0.48383,1,0
1,GO PROTEIN HOMOOLIGOMERIZATION,4.9495e-06,-0.49042,-0.50826,1,0
1,GO RESPONSE TO FATTY ACID,8.9843e-06,-0.49042,-0.50532,1,0
1,GO EAR MORPHOGENESIS,1.2035e-05,-0.49056,-0.46911,1,0
1,GO CELLULAR HOMEOSTASIS,4.5891e-06,-0.49076,-0.50389,1,0
1,GO MICROTUBULE BASED TRANSPORT,1.1191e-05,-0.49082,-0.52165,1,0
1,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.00081392,-0.49083,-0.58133,1,0
1,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,2.2907e-05,-0.49088,-0.49251,1,0
1,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00040321,-0.49097,-0.60739,1,0
1,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.00012367,-0.49113,-0.50423,1,0
1,GO RIG I SIGNALING PATHWAY,1.6059e-05,-0.49119,-0.51168,1,0
1,GO MONOSACCHARIDE METABOLIC PROCESS,6.6813e-06,-0.49138,-0.51088,1,0
1,GO RESPONSE TO CORTICOSTERONE,0.0010798,-0.49148,-0.4929,1,0
1,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.025096,-0.49151,-0.51776,1,0
1,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,6.2007e-06,-0.49159,-0.50246,1,0
1,GO POSITIVE REGULATION OF PEPTIDE SECRETION,8.3461e-06,-0.49174,-0.51313,1,0
1,GO REPRODUCTION,6.2007e-06,-0.49174,-0.4828,1,0
1,GO DNA METHYLATION OR DEMETHYLATION,8.9843e-06,-0.49176,-0.48572,1,0
1,GO MODULATION BY HOST OF VIRAL PROCESS,8.9843e-06,-0.49208,-0.52666,1,0
1,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,5.337e-06,-0.49219,-0.51064,1,0
1,GO MAINTENANCE OF LOCATION IN CELL,5.337e-06,-0.49222,-0.52601,1,0
1,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,1.0403e-05,-0.49244,-0.53851,1,0
1,GO PONS DEVELOPMENT,0.023112,-0.49276,-0.44496,1,0
1,GO GLYCOSYLATION,7.7514e-06,-0.49276,-0.49409,1,0
1,GO PROTEIN COMPLEX OLIGOMERIZATION,4.9495e-06,-0.49278,-0.519,1,0
1,GO THYMOCYTE APOPTOTIC PROCESS,6.8565e-05,-0.49282,-0.55485,1,0
1,GO VITAMIN BIOSYNTHETIC PROCESS,2.2907e-05,-0.49285,-0.57638,1,0
1,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,3.248e-05,-0.49288,-0.60546,1,0
1,GO WHITE FAT CELL DIFFERENTIATION,3.9422e-06,-0.49289,-0.53954,1,0
1,GO LONG CHAIN FATTY ACID TRANSPORT,8.3461e-06,-0.49295,-0.49188,1,0
1,GO PROTEIN PROCESSING,1.0403e-05,-0.49298,-0.50683,1,0
1,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,8.9843e-06,-0.49316,-0.56216,1,0
1,GO CELL CHEMOTAXIS,9.5377e-05,-0.49316,-0.55874,1,0
1,GO COPII COATED VESICLE BUDDING,5.7533e-06,-0.4932,-0.50779,1,0
1,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,6.6813e-06,-0.4932,-0.53447,1,0
1,GO ENDOCRINE PROCESS,9.6689e-06,-0.49326,-0.51162,1,0
1,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,7.1973e-06,-0.49339,-0.48242,1,0
1,GO FATTY ACID BETA OXIDATION,1.1191e-05,-0.49354,-0.47472,1,0
1,GO HORMONE TRANSPORT,1.6059e-05,-0.49356,-0.48504,1,0
1,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,5.337e-06,-0.49379,-0.53622,1,0
1,GO REGULATION OF B CELL DIFFERENTIATION,7.3279e-05,-0.49381,-0.67011,1,0
1,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,0.00024771,-0.49395,-0.58595,1,0
1,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,4.2539e-06,-0.49403,-0.53532,1,0
1,GO REGULATION OF PROTEIN FOLDING,1.2939e-05,-0.49406,-0.49238,1,0
1,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,1.0403e-05,-0.49408,-0.49634,1,0
1,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,7.1973e-06,-0.49446,-0.52444,1,0
1,GO VESICLE BUDDING FROM MEMBRANE,6.2007e-06,-0.49488,-0.51028,1,0
1,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.0063209,-0.49489,-0.52781,1,0
1,GO REGULATION OF PEPTIDE HORMONE SECRETION,2.2907e-05,-0.49531,-0.49215,1,0
1,GO NEGATIVE REGULATION OF PROTEOLYSIS,8.9843e-06,-0.49547,-0.49843,1,0
1,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,8.9843e-06,-0.49556,-0.47916,1,0
1,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,3.0304e-05,-0.49572,-0.544,1,0
1,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00048214,-0.49574,-0.57009,1,0
1,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,1.4947e-05,-0.49578,-0.49836,1,0
1,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,5.337e-06,-0.49582,-0.48991,1,0
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,4.9495e-06,-0.4959,-0.5062,1,0
1,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,8.9843e-06,-0.4959,-0.55127,1,0
1,GO REGULATION OF PEPTIDE TRANSPORT,4.9495e-06,-0.49594,-0.53114,1,0
1,GO NEGATIVE REGULATION OF TRANSPORT,4.2539e-06,-0.49598,-0.50707,1,0
1,GO LYMPHOCYTE COSTIMULATION,0.00031664,-0.49598,-0.60166,1,0
1,GO NEURON CELLULAR HOMEOSTASIS,2.4576e-05,-0.49613,-0.55098,1,0
1,GO CELL PROLIFERATION IN HINDBRAIN,1.6059e-05,-0.49632,-0.50624,1,0
1,GO AMINO SUGAR METABOLIC PROCESS,8.3461e-06,-0.49636,-0.52617,1,0
1,GO BLASTODERM SEGMENTATION,1.1191e-05,-0.49668,-0.48924,1,0
1,GO CELL DIFFERENTIATION IN HINDBRAIN,3.0304e-05,-0.49671,-0.49973,1,0
1,GO ENDOSOME ORGANIZATION,4.9495e-06,-0.49685,-0.5133,1,0
1,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,9.6689e-06,-0.49685,-0.56091,1,0
1,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,5.7533e-06,-0.49685,-0.51884,1,0
1,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,5.6086e-05,-0.49686,-0.61241,1,0
1,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,4.5891e-06,-0.49687,-0.53147,1,0
1,GO CELL RECOGNITION,9.6689e-06,-0.49694,-0.48403,1,0
1,GO REGULATION OF LEUKOCYTE MIGRATION,0.00013188,-0.49696,-0.57699,1,0
1,GO LOCOMOTORY BEHAVIOR,1.8524e-05,-0.49697,-0.55985,1,0
1,GO REGULATION OF CATION CHANNEL ACTIVITY,6.2007e-06,-0.49702,-0.51201,1,0
1,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.00026348,-0.49706,-0.60914,1,0
1,GO REPRODUCTIVE BEHAVIOR,0.00015974,-0.49714,-0.4806,1,0
1,GO NEGATIVE REGULATION OF CELL DEATH,3.9422e-06,-0.49725,-0.51526,1,0
1,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,4.5891e-06,-0.49729,-0.51236,1,0
1,GO CATION TRANSMEMBRANE TRANSPORT,6.6813e-06,-0.49741,-0.49575,1,0
1,GO VIRAL GENOME REPLICATION,5.9985e-05,-0.49756,-0.51374,1,0
1,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,5.7533e-06,-0.49763,-0.53415,1,0
1,GO RESPONSE TO ALCOHOL,4.9495e-06,-0.49776,-0.52698,1,0
1,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,7.7514e-06,-0.49781,-0.53659,1,0
1,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,6.6813e-06,-0.4979,-0.5678,1,0
1,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,2.2907e-05,-0.4979,-0.58063,1,0
1,GO RESPONSE TO TYPE I INTERFERON,0.0028457,-0.49792,-0.59973,1,0
1,GO 2 OXOGLUTARATE METABOLIC PROCESS,2.8267e-05,-0.49811,-0.50596,1,0
1,GO NEURAL TUBE PATTERNING,2.8267e-05,-0.49813,-0.49306,1,0
1,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,8.3461e-06,-0.49823,-0.51485,1,0
1,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,5.337e-06,-0.49826,-0.5963,1,0
1,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,1.1191e-05,-0.49831,-0.5293,1,0
1,GO NEGATIVE REGULATION OF DNA REPLICATION,1.4947e-05,-0.4984,-0.49122,1,0
1,GO REGULATION OF NECROTIC CELL DEATH,0.00014062,-0.49846,-0.47396,1,0
1,GO ORGANOPHOSPHATE METABOLIC PROCESS,5.337e-06,-0.49858,-0.49664,1,0
1,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,0.00017019,-0.49859,-0.52222,1,0
1,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,2.8267e-05,-0.49876,-0.59557,1,0
1,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,1.4947e-05,-0.49882,-0.56402,1,0
1,GO MODULATION OF PROCESS OF OTHER ORGANISM,6.2007e-06,-0.49897,-0.51456,1,0
1,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,3.4805e-05,-0.49931,-0.52788,1,0
1,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.00010181,-0.49937,-0.42288,1,0
1,GO T HELPER CELL LINEAGE COMMITMENT,0.0011418,-0.49949,-0.60362,1,0
1,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.010101,-0.49952,-0.47317,1,0
1,GO RESPIRATORY BURST INVOLVED IN DEFENSE RESPONSE,6.4139e-05,-0.49952,-0.54625,1,0
1,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,6.2007e-06,-0.4996,-0.53194,1,0
1,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,0.00017019,-0.49962,-0.47647,1,0
1,GO INORGANIC ANION TRANSPORT,5.337e-06,-0.49973,-0.50212,1,0
1,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,1.3909e-05,-0.49974,-0.4554,1,0
1,GO MYOBLAST FUSION,5.2428e-05,-0.4998,-0.63673,1,0
1,GO DIENCEPHALON DEVELOPMENT,0.00020554,-0.49984,-0.46553,1,0
1,GO REGULATION OF PROTEOLYSIS,4.9495e-06,-0.49988,-0.51839,1,0
1,GO REGULATION OF RESPONSE TO STRESS,3.9422e-06,-0.49991,-0.53772,1,0
1,GO PROTEIN KINASE A SIGNALING,8.9843e-06,-0.49995,-0.48346,1,0
1,GO NUCLEAR BODY ORGANIZATION,1.7249e-05,-0.50003,-0.52082,1,0
1,GO CATION TRANSPORT,7.1973e-06,-0.5001,-0.49048,1,0
1,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,9.5377e-05,-0.50011,-0.4664,1,0
1,GO SYNCYTIUM FORMATION,3.0304e-05,-0.50013,-0.60779,1,0
1,GO REGULATION OF LEUKOCYTE DEGRANULATION,1.6059e-05,-0.50019,-0.69715,1,0
1,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,1.1191e-05,-0.50025,-0.50431,1,0
1,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,8.9843e-06,-0.50026,-0.53765,1,0
1,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.00042807,-0.50037,-0.50914,1,0
1,GO O GLYCAN PROCESSING,8.9327e-05,-0.5004,-0.46445,1,0
1,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,3.9422e-06,-0.50047,-0.57043,1,0
1,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,4.2763e-05,-0.50048,-0.55071,1,0
1,GO T CELL RECEPTOR SIGNALING PATHWAY,5.9985e-05,-0.50057,-0.52991,1,0
1,GO REGULATION OF NEUROBLAST PROLIFERATION,3.0304e-05,-0.50059,-0.49134,1,0
1,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.00028019,-0.50067,-0.60493,1,0
1,GO HORMONE MEDIATED SIGNALING PATHWAY,4.5891e-06,-0.50071,-0.51622,1,0
1,GO REGENERATION,5.337e-06,-0.50079,-0.52279,1,0
1,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,6.2007e-06,-0.50082,-0.49782,1,0
1,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,4.5779e-05,-0.50087,-0.48126,1,0
1,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,0.0013481,-0.50096,-0.60061,1,0
1,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,0.00023283,-0.50108,-0.50992,1,0
1,GO CD40 SIGNALING PATHWAY,4.5779e-05,-0.5011,-0.60949,1,0
1,GO EMBRYONIC BRAIN DEVELOPMENT,0.00013188,-0.50118,-0.44472,1,0
1,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,7.3279e-05,-0.50129,-0.46924,1,0
1,GO MODULATION BY HOST OF SYMBIONT PROCESS,7.7514e-06,-0.50134,-0.52567,1,0
1,GO ION TRANSMEMBRANE TRANSPORT,6.2007e-06,-0.50136,-0.49825,1,0
1,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,0.00010181,-0.50138,-0.56818,1,0
1,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,9.6689e-06,-0.5014,-0.58982,1,0
1,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.00031664,-0.50143,-0.42951,1,0
1,GO HINDBRAIN MORPHOGENESIS,4.5891e-06,-0.50143,-0.56597,1,0
1,GO TRANSFERRIN TRANSPORT,9.6689e-06,-0.50164,-0.48776,1,0
1,GO REGULATION OF TRANSPORTER ACTIVITY,6.2007e-06,-0.50165,-0.51315,1,0
1,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,5.7533e-06,-0.50171,-0.56484,1,0
1,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,4.9495e-06,-0.50174,-0.50323,1,0
1,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,8.3461e-06,-0.50185,-0.52455,1,0
1,GO PROTEIN HOMOTETRAMERIZATION,7.1973e-06,-0.50191,-0.48414,1,0
1,GO NEGATIVE REGULATION OF CELL CELL ADHESION,1.9888e-05,-0.50215,-0.59918,1,0
1,GO PROTEOLYSIS,4.9495e-06,-0.50221,-0.51424,1,0
1,GO RECEPTOR LOCALIZATION TO SYNAPSE,2.636e-05,-0.50257,-0.56949,1,0
1,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,4.5779e-05,-0.50285,-0.58638,1,0
1,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,1.7249e-05,-0.50292,-0.50344,1,0
1,GO HISTONE H3 K9 TRIMETHYLATION,8.3461e-06,-0.50297,-0.5704,1,0
1,GO STEROL HOMEOSTASIS,6.2007e-06,-0.503,-0.54648,1,0
1,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,0.00021879,-0.50302,-0.65772,1,0
1,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,1.1191e-05,-0.50312,-0.62147,1,0
1,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,1.6059e-05,-0.50327,-0.61572,1,0
1,GO CARBOHYDRATE HOMEOSTASIS,8.3461e-06,-0.5033,-0.51323,1,0
1,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.0031545,-0.50341,-0.54977,1,0
1,GO SOMATIC STEM CELL POPULATION MAINTENANCE,1.3909e-05,-0.50344,-0.5093,1,0
1,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,8.9843e-06,-0.50346,-0.51701,1,0
1,GO CENTRIOLE ASSEMBLY,8.9843e-06,-0.50351,-0.5813,1,0
1,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.0080134,-0.50371,-0.58901,1,0
1,GO CELLULAR PROTEIN CATABOLIC PROCESS,4.5891e-06,-0.5039,-0.53423,1,0
1,GO FATTY ACYL COA METABOLIC PROCESS,7.3279e-05,-0.50391,-0.4723,1,0
1,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.00023283,-0.504,-0.56576,1,0
1,GO GOLGI VESICLE BUDDING,6.2007e-06,-0.50403,-0.52595,1,0
1,GO GLIAL CELL PROLIFERATION,2.2907e-05,-0.50406,-0.5348,1,0
1,GO CELLULAR ION HOMEOSTASIS,5.337e-06,-0.50408,-0.50718,1,0
1,GO CARBOHYDRATE METABOLIC PROCESS,5.7533e-06,-0.5041,-0.51263,1,0
1,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.00019306,-0.50431,-0.45545,1,0
1,GO METAL ION HOMEOSTASIS,5.7533e-06,-0.50431,-0.50864,1,0
1,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,3.9422e-06,-0.50435,-0.56022,1,0
1,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,7.7514e-06,-0.5044,-0.51993,1,0
1,GO ADAPTATION OF SIGNALING PATHWAY,8.3461e-06,-0.5045,-0.55899,1,0
1,GO INTERLEUKIN 6 PRODUCTION,3.9936e-05,-0.50469,-0.59006,1,0
1,GO AMYLOID BETA FORMATION,8.3461e-06,-0.50471,-0.55612,1,0
1,GO PROTEIN LOCALIZATION TO CILIUM,1.1191e-05,-0.5049,-0.52406,1,0
1,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,5.337e-06,-0.50491,-0.52375,1,0
1,GO PROTEIN METHYLATION,7.1973e-06,-0.50499,-0.54423,1,0
1,GO REGULATION OF HEMOPOIESIS,6.2007e-06,-0.50503,-0.56026,1,0
1,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.012106,-0.50508,-0.6548,1,0
1,GO REGULATION OF CELL DEATH,4.2539e-06,-0.50512,-0.52788,1,0
1,GO CARDIAC CHAMBER FORMATION,0.00012367,-0.50514,-0.5382,1,0
1,GO RESPONSE TO NUTRIENT,6.6813e-06,-0.50527,-0.54198,1,0
1,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,6.4139e-05,-0.50528,-0.62001,1,0
1,GO CARBOHYDRATE CATABOLIC PROCESS,5.337e-06,-0.50533,-0.54575,1,0
1,GO CATECHOLAMINE UPTAKE,0.00040321,-0.50533,-0.49151,1,0
1,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,4.9495e-06,-0.50543,-0.58066,1,0
1,GO REGULATION OF CAMP MEDIATED SIGNALING,1.9888e-05,-0.50546,-0.50044,1,0
1,GO PROTEIN LOCALIZATION TO SYNAPSE,3.0304e-05,-0.50547,-0.57206,1,0
1,GO MAST CELL ACTIVATION,1.1191e-05,-0.50548,-0.61095,1,0
1,GO INSULIN SECRETION,1.6059e-05,-0.50556,-0.5078,1,0
1,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,3.0304e-05,-0.50557,-0.5633,1,0
1,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,3.4805e-05,-0.50558,-0.57545,1,0
1,GO ENDOPLASMIC RETICULUM ORGANIZATION,5.7533e-06,-0.50561,-0.54667,1,0
1,GO REGULATION OF MEMBRANE DEPOLARIZATION,3.0304e-05,-0.50562,-0.48666,1,0
1,GO CELL MATURATION,1.4947e-05,-0.50567,-0.49487,1,0
1,GO MACROPHAGE DIFFERENTIATION,3.0304e-05,-0.50571,-0.6746,1,0
1,GO CHOLESTEROL EFFLUX,7.1973e-06,-0.50572,-0.55251,1,0
1,GO DNA INTEGRITY CHECKPOINT,7.7514e-06,-0.50575,-0.52769,1,0
1,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,1.1191e-05,-0.50587,-0.48733,1,0
1,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,1.2035e-05,-0.5059,-0.59617,1,0
1,GO REGULATION OF INSULIN SECRETION,1.3909e-05,-0.50596,-0.50275,1,0
1,GO INNER EAR MORPHOGENESIS,1.7249e-05,-0.506,-0.47145,1,0
1,GO SYNAPTIC VESICLE LOCALIZATION,3.7287e-05,-0.506,-0.58099,1,0
1,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.00035748,-0.50602,-0.54147,1,0
1,GO STEROL TRANSPORT,5.337e-06,-0.50603,-0.56188,1,0
1,GO REGULATION OF HORMONE SECRETION,1.6059e-05,-0.50604,-0.47752,1,0
1,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00064645,-0.50613,-0.60811,1,0
1,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,4.9495e-06,-0.50626,-0.54861,1,0
1,GO RESPONSE TO CATECHOLAMINE,4.8997e-05,-0.50632,-0.50132,1,0
1,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,5.7533e-06,-0.50634,-0.54872,1,0
1,GO REGULATION OF VIRAL LIFE CYCLE,6.8565e-05,-0.50639,-0.51872,1,0
1,GO LIPID BIOSYNTHETIC PROCESS,6.2007e-06,-0.50646,-0.49303,1,0
1,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,5.7533e-06,-0.50655,-0.51757,1,0
1,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,3.9936e-05,-0.5067,-0.51376,1,0
1,GO NON RECOMBINATIONAL REPAIR,7.1973e-06,-0.50686,-0.51919,1,0
1,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.00332,-0.50689,-0.5033,1,0
1,GO MITOTIC G1 S TRANSITION CHECKPOINT,8.3461e-06,-0.50693,-0.50514,1,0
1,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,5.337e-06,-0.50695,-0.49621,1,0
1,GO ERAD PATHWAY,4.5891e-06,-0.50698,-0.57357,1,0
1,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00035748,-0.50741,-0.60352,1,0
1,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,5.337e-06,-0.50743,-0.54358,1,0
1,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,1.3909e-05,-0.50756,-0.50776,1,0
1,GO GLYCEROLIPID CATABOLIC PROCESS,1.3909e-05,-0.50757,-0.46251,1,0
1,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,7.1973e-06,-0.50765,-0.52549,1,0
1,GO PROGESTERONE METABOLIC PROCESS,0.00031664,-0.50789,-0.47422,1,0
1,GO REGULATION OF PROTEIN KINASE A SIGNALING,2.4576e-05,-0.5079,-0.51694,1,0
1,GO B CELL PROLIFERATION,0.00024771,-0.50797,-0.6377,1,0
1,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,3.0304e-05,-0.50813,-0.51614,1,0
1,GO MACROAUTOPHAGY,4.5891e-06,-0.50836,-0.54379,1,0
1,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,4.5779e-05,-0.50841,-0.54575,1,0
1,GO T CELL DIFFERENTIATION IN THYMUS,1.9888e-05,-0.50866,-0.59281,1,0
1,GO COPULATION,9.5377e-05,-0.50868,-0.47609,1,0
1,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,1.4947e-05,-0.50876,-0.56756,1,0
1,GO POSITIVE REGULATION OF GLIOGENESIS,9.6689e-06,-0.50877,-0.52905,1,0
1,GO NEURONAL ACTION POTENTIAL,5.9985e-05,-0.50877,-0.48192,1,0
1,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,1.3909e-05,-0.50882,-0.48923,1,0
1,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,5.6086e-05,-0.50885,-0.50395,1,0
1,GO NEGATIVE REGULATION OF ION TRANSPORT,4.9495e-06,-0.50886,-0.51804,1,0
1,GO TRANSMISSION OF NERVE IMPULSE,5.6086e-05,-0.50896,-0.49779,1,0
1,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,1.7249e-05,-0.50896,-0.51118,1,0
1,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,3.248e-05,-0.50897,-0.48557,1,0
1,GO SIGNAL RELEASE,1.0403e-05,-0.50897,-0.51634,1,0
1,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,3.4805e-05,-0.50907,-0.6273,1,0
1,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.0010209,-0.50908,-0.41853,1,0
1,GO PHOSPHOLIPID HOMEOSTASIS,1.8524e-05,-0.50913,-0.52353,1,0
1,GO RESPONSE TO IONIZING RADIATION,4.2539e-06,-0.50913,-0.52379,1,0
1,GO HOMEOSTATIC PROCESS,4.9495e-06,-0.50917,-0.5206,1,0
1,GO RECEPTOR BIOSYNTHETIC PROCESS,8.9843e-06,-0.50925,-0.55182,1,0
1,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,0.0010798,-0.50934,-0.49753,1,0
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,4.9495e-06,-0.50938,-0.51487,1,0
1,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,1.8524e-05,-0.50944,-0.58178,1,0
1,GO GLUCOSE METABOLIC PROCESS,8.3461e-06,-0.50971,-0.53836,1,0
1,GO ENGULFMENT OF APOPTOTIC CELL,9.6689e-06,-0.50974,-0.62194,1,0
1,GO LIVER MORPHOGENESIS,1.8524e-05,-0.50991,-0.57838,1,0
1,GO VESICLE TARGETING,5.7533e-06,-0.51012,-0.53103,1,0
1,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,3.7287e-05,-0.51013,-0.47972,1,0
1,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,3.248e-05,-0.51016,-0.53287,1,0
1,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.00014062,-0.51022,-0.60651,1,0
1,GO ORGANELLE LOCALIZATION,5.337e-06,-0.51049,-0.55688,1,0
1,GO POSITIVE REGULATION OF TOR SIGNALING,6.2007e-06,-0.51054,-0.54948,1,0
1,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,5.7533e-06,-0.5106,-0.59077,1,0
1,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,1.3909e-05,-0.51068,-0.53697,1,0
1,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,1.4947e-05,-0.51079,-0.52161,1,0
1,GO ACIDIC AMINO ACID TRANSPORT,3.248e-05,-0.51087,-0.52851,1,0
1,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,1.1191e-05,-0.51088,-0.52969,1,0
1,GO TYPE I INTERFERON PRODUCTION,1.3909e-05,-0.51088,-0.56712,1,0
1,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,1.9888e-05,-0.51106,-0.53532,1,0
1,GO ION HOMEOSTASIS,5.337e-06,-0.51119,-0.5106,1,0
1,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,4.5891e-06,-0.51131,-0.54833,1,0
1,GO SYNAPTIC VESICLE DOCKING,0.0017696,-0.51143,-0.64323,1,0
1,GO REGULATION OF CYCLASE ACTIVITY,6.6813e-06,-0.51153,-0.49889,1,0
1,GO MEMBRANE DOCKING,8.3461e-06,-0.51168,-0.55217,1,0
1,GO REGULATION OF VIRAL GENOME REPLICATION,0.00014989,-0.51172,-0.50889,1,0
1,GO KIDNEY MESENCHYME DEVELOPMENT,1.7249e-05,-0.51183,-0.57123,1,0
1,GO PROTEIN DEPHOSPHORYLATION,4.5891e-06,-0.51194,-0.54665,1,0
1,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,5.337e-06,-0.512,-0.53755,1,0
1,GO THYMUS DEVELOPMENT,7.7514e-06,-0.51208,-0.5082,1,0
1,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,6.4139e-05,-0.51216,-0.61606,1,0
1,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,7.8298e-05,-0.51235,-0.58951,1,0
1,GO UBIQUITIN DEPENDENT ERAD PATHWAY,4.9495e-06,-0.51245,-0.57273,1,0
1,GO RESPONSE TO DOPAMINE,7.3279e-05,-0.51251,-0.49075,1,0
1,GO POSITIVE REGULATION OF PROTEOLYSIS,4.2539e-06,-0.51251,-0.55003,1,0
1,GO REGULATION OF SYNAPTIC VESICLE CYCLE,5.9985e-05,-0.51272,-0.61424,1,0
1,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,7.7514e-06,-0.51275,-0.52031,1,0
1,GO EPITHELIAL CELL MATURATION,8.3641e-05,-0.51289,-0.50943,1,0
1,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,2.1347e-05,-0.51322,-0.61821,1,0
1,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,2.4576e-05,-0.51334,-0.57446,1,0
1,GO REGULATION OF PROTEIN LOCALIZATION,4.9495e-06,-0.51348,-0.54615,1,0
1,GO NEGATIVE REGULATION OF BINDING,4.9495e-06,-0.51363,-0.5284,1,0
1,GO LEUKOCYTE MIGRATION,3.0304e-05,-0.51372,-0.59893,1,0
1,GO REGULATION OF AMYLOID BETA FORMATION,1.0403e-05,-0.51373,-0.57278,1,0
1,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,1.9888e-05,-0.51375,-0.4413,1,0
1,GO B CELL APOPTOTIC PROCESS,3.4805e-05,-0.51389,-0.51758,1,0
1,GO RESPONSE TO DRUG,5.7533e-06,-0.51389,-0.51301,1,0
1,GO SPLEEN DEVELOPMENT,8.9843e-06,-0.5141,-0.53645,1,0
1,GO REGULATION OF MYELINATION,4.9495e-06,-0.51418,-0.53698,1,0
1,GO SPINAL CORD DEVELOPMENT,9.6689e-06,-0.51419,-0.55995,1,0
1,GO RESPONSE TO ABIOTIC STIMULUS,4.2539e-06,-0.51423,-0.51113,1,0
1,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,1.0403e-05,-0.51433,-0.5356,1,0
1,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,4.9495e-06,-0.5144,-0.54455,1,0
1,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,4.5891e-06,-0.51442,-0.53796,1,0
1,GO HISTONE H4 K16 ACETYLATION,2.1347e-05,-0.5145,-0.56622,1,0
1,GO REGULATION OF PROTEIN TARGETING,4.5891e-06,-0.51453,-0.56043,1,0
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,5.9985e-05,-0.51454,-0.51737,1,0
1,GO REGULATION OF B CELL PROLIFERATION,0.00014062,-0.51456,-0.66372,1,0
1,GO TOR SIGNALING,5.337e-06,-0.51492,-0.56824,1,0
1,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,1.4947e-05,-0.51492,-0.51734,1,0
1,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,7.7514e-06,-0.51494,-0.56246,1,0
1,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,1.4947e-05,-0.51494,-0.47261,1,0
1,GO AUTOPHAGOSOME MATURATION,4.2539e-06,-0.51497,-0.56245,1,0
1,GO NEUROINFLAMMATORY RESPONSE,0.00010181,-0.51533,-0.66609,1,0
1,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,1.2035e-05,-0.51537,-0.5937,1,0
1,GO OSTEOBLAST DEVELOPMENT,1.8524e-05,-0.51542,-0.51723,1,0
1,GO HISTONE H3 ACETYLATION,4.5891e-06,-0.51548,-0.57679,1,0
1,GO MAINTENANCE OF LOCATION,4.9495e-06,-0.51552,-0.54087,1,0
1,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,1.4947e-05,-0.51564,-0.55713,1,0
1,GO THYROID HORMONE METABOLIC PROCESS,0.00010181,-0.51566,-0.45715,1,0
1,GO MONOCARBOXYLIC ACID TRANSPORT,4.2539e-06,-0.51576,-0.52694,1,0
1,GO REGULATION OF DNA RECOMBINATION,4.2539e-06,-0.51584,-0.5727,1,0
1,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,4.5891e-06,-0.51591,-0.52674,1,0
1,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,3.4805e-05,-0.51606,-0.55658,1,0
1,GO POSITIVE REGULATION OF CENTROSOME CYCLE,3.9936e-05,-0.5161,-0.55455,1,0
1,GO FIBROBLAST APOPTOTIC PROCESS,2.4576e-05,-0.51611,-0.53573,1,0
1,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,1.9888e-05,-0.51614,-0.49451,1,0
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.00020554,-0.51622,-0.62362,1,0
1,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,1.2035e-05,-0.51637,-0.58597,1,0
1,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,3.9422e-06,-0.51645,-0.52442,1,0
1,GO SPONTANEOUS SYNAPTIC TRANSMISSION,0.0019699,-0.51651,-0.53788,1,0
1,GO RESPONSE TO INORGANIC SUBSTANCE,5.7533e-06,-0.51661,-0.49539,1,0
1,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,2.1347e-05,-0.51684,-0.53359,1,0
1,GO RESPIRATORY BURST,0.00010866,-0.51689,-0.59793,1,0
1,GO ION TRANSPORT,6.6813e-06,-0.517,-0.49409,1,0
1,GO MEMBRANE LIPID METABOLIC PROCESS,1.2939e-05,-0.51708,-0.49927,1,0
1,GO NEUTROPHIL EXTRAVASATION,6.8565e-05,-0.51713,-0.6501,1,0
1,GO DIVALENT INORGANIC CATION HOMEOSTASIS,5.337e-06,-0.51716,-0.51391,1,0
1,GO POSITIVE REGULATION OF PHAGOCYTOSIS,0.00017019,-0.51733,-0.65312,1,0
1,GO SODIUM ION TRANSPORT,1.2939e-05,-0.51747,-0.49384,1,0
1,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,1.6059e-05,-0.51748,-0.54463,1,0
1,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0027019,-0.51774,-0.58083,1,0
1,GO RESPONSE TO SALT STRESS,5.6086e-05,-0.51783,-0.45901,1,0
1,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.0010798,-0.51806,-0.61683,1,0
1,GO SECRETION,5.337e-06,-0.51808,-0.53588,1,0
1,GO HORMONE BIOSYNTHETIC PROCESS,0.00024771,-0.51814,-0.43902,1,0
1,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,0.0034935,-0.51816,-0.5714,1,0
1,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,6.6813e-06,-0.51816,-0.50778,1,0
1,GO DEPHOSPHORYLATION,4.5891e-06,-0.5182,-0.54431,1,0
1,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.00014989,-0.51821,-0.5874,1,0
1,GO MANGANESE ION TRANSPORT,4.9495e-06,-0.51838,-0.50713,1,0
1,GO MAINTENANCE OF PROTEIN LOCATION,5.7533e-06,-0.51843,-0.51348,1,0
1,GO NEGATIVE REGULATION OF VIRAL PROCESS,0.00035748,-0.51856,-0.51701,1,0
1,GO POSITIVE REGULATION OF STEROL TRANSPORT,1.7249e-05,-0.51859,-0.60247,1,0
1,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,1.4947e-05,-0.51881,-0.55508,1,0
1,GO PROTEIN POLYGLUTAMYLATION,0.00012367,-0.51894,-0.47907,1,0
1,GO VITAMIN TRANSPORT,2.636e-05,-0.51913,-0.47606,1,0
1,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,5.9985e-05,-0.5192,-0.57519,1,0
1,GO PROTEIN CATABOLIC PROCESS,4.5891e-06,-0.51922,-0.54217,1,0
1,GO POSTSYNAPSE ORGANIZATION,6.6813e-06,-0.51935,-0.58182,1,0
1,GO CHEMICAL HOMEOSTASIS,6.2007e-06,-0.51945,-0.51144,1,0
1,GO VIRAL LIFE CYCLE,6.6813e-06,-0.51955,-0.53963,1,0
1,GO POSITIVE REGULATION OF CHEMOKINE SECRETION,0.0027019,-0.5196,-0.58073,1,0
1,GO LIPOSACCHARIDE METABOLIC PROCESS,1.7249e-05,-0.51964,-0.48728,1,0
1,GO INHIBITORY POSTSYNAPTIC POTENTIAL,0.0018673,-0.51966,-0.54245,1,0
1,GO PROTEIN O LINKED GLYCOSYLATION,1.2035e-05,-0.51979,-0.50217,1,0
1,GO SECOND MESSENGER MEDIATED SIGNALING,6.6813e-06,-0.51988,-0.50857,1,0
1,GO REGULATION OF CELL POPULATION PROLIFERATION,4.5891e-06,-0.52002,-0.54477,1,0
1,GO RESPONSE TO ANTIBIOTIC,4.2539e-06,-0.52017,-0.50474,1,0
1,GO REGULATION OF COAGULATION,1.2939e-05,-0.52026,-0.61032,1,0
1,GO I KAPPAB KINASE NF KAPPAB SIGNALING,1.0403e-05,-0.52037,-0.56116,1,0
1,GO RECEPTOR SIGNALING PATHWAY VIA STAT,2.2907e-05,-0.5204,-0.57571,1,0
1,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,4.9495e-06,-0.52042,-0.55002,1,0
1,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,2.2907e-05,-0.52044,-0.56694,1,0
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,3.248e-05,-0.52052,-0.52489,1,0
1,GO RNA STABILIZATION,4.9495e-06,-0.5206,-0.52129,1,0
1,GO RETINA LAYER FORMATION,0.00068502,-0.5206,-0.51653,1,0
1,GO LONG TERM SYNAPTIC POTENTIATION,1.4947e-05,-0.52083,-0.54317,1,0
1,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,6.6813e-06,-0.5209,-0.49605,1,0
1,GO REGULATION OF PLATELET AGGREGATION,3.0304e-05,-0.52093,-0.61555,1,0
1,GO REGULATION OF PROTEIN GLYCOSYLATION,6.4139e-05,-0.52099,-0.59382,1,0
1,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,0.00081392,-0.52105,-0.64814,1,0
1,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,4.5891e-06,-0.52113,-0.55818,1,0
1,GO REGULATION OF NIK NF KAPPAB SIGNALING,1.6059e-05,-0.52113,-0.60069,1,0
1,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,5.337e-06,-0.52116,-0.52037,1,0
1,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,4.5891e-06,-0.52117,-0.53098,1,0
1,GO T HELPER 1 CELL DIFFERENTIATION,0.0021907,-0.52122,-0.60621,1,0
1,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,1.8524e-05,-0.52124,-0.51291,1,0
1,GO CEREBELLAR CORTEX MORPHOGENESIS,6.6813e-06,-0.52144,-0.5855,1,0
1,GO POSITIVE REGULATION OF TRANSPORT,5.337e-06,-0.52152,-0.54482,1,0
1,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,5.7533e-06,-0.52157,-0.54084,1,0
1,GO RESPONSE TO OSMOTIC STRESS,5.7533e-06,-0.52158,-0.52783,1,0
1,GO REGULATION OF INTRACELLULAR TRANSPORT,4.2539e-06,-0.52159,-0.55504,1,0
1,GO NEGATIVE REGULATION OF DNA RECOMBINATION,7.1973e-06,-0.52164,-0.56111,1,0
1,GO SODIUM ION TRANSMEMBRANE TRANSPORT,1.2035e-05,-0.52165,-0.50266,1,0
1,GO PROTEIN ACYLATION,6.2007e-06,-0.52167,-0.56538,1,0
1,GO MODULATION BY SYMBIONT OF HOST PROCESS,3.9422e-06,-0.52176,-0.57729,1,0
1,GO PROTEIN ACETYLATION,4.9495e-06,-0.52176,-0.57009,1,0
1,GO EAR DEVELOPMENT,7.7514e-06,-0.52176,-0.49823,1,0
1,GO MUSCLE CELL CELLULAR HOMEOSTASIS,4.9495e-06,-0.5218,-0.53884,1,0
1,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,0.00081392,-0.52181,-0.51235,1,0
1,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,4.5891e-06,-0.52186,-0.56063,1,0
1,GO CEREBRAL CORTEX CELL MIGRATION,1.3909e-05,-0.52189,-0.61552,1,0
1,GO SEROTONIN SECRETION,4.2763e-05,-0.52193,-0.51684,1,0
1,GO GRANULOCYTE DIFFERENTIATION,1.7249e-05,-0.5221,-0.63178,1,0
1,GO CELLULAR RESPONSE TO MANGANESE ION,6.6813e-06,-0.52218,-0.52932,1,0
1,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,2.2907e-05,-0.52222,-0.5601,1,0
1,GO POSITIVE REGULATION OF EXOCYTOSIS,1.2939e-05,-0.52248,-0.56008,1,0
1,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,4.9495e-06,-0.52255,-0.52735,1,0
1,GO TISSUE HOMEOSTASIS,5.337e-06,-0.52257,-0.55225,1,0
1,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,1.8524e-05,-0.52266,-0.52712,1,0
1,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,1.1191e-05,-0.52278,-0.55064,1,0
1,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,7.7514e-06,-0.52286,-0.54513,1,0
1,GO DNA METHYLATION,8.9843e-06,-0.52294,-0.51013,1,0
1,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.0024341,-0.52302,-0.51995,1,0
1,GO EXOCYTOSIS,4.5891e-06,-0.52305,-0.56398,1,0
1,GO CELL CELL SIGNALING,6.2007e-06,-0.52311,-0.52375,1,0
1,GO GLYCEROLIPID METABOLIC PROCESS,5.337e-06,-0.52312,-0.52918,1,0
1,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,5.7533e-06,-0.52322,-0.51872,1,0
1,GO RESPONSE TO GLUCAGON,3.0304e-05,-0.52323,-0.53364,1,0
1,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,1.7249e-05,-0.52323,-0.54436,1,0
1,GO REGULATION OF ORGANELLE ASSEMBLY,4.2539e-06,-0.52323,-0.56776,1,0
1,GO ENDOCRINE HORMONE SECRETION,2.8267e-05,-0.52338,-0.48151,1,0
1,GO REGULATION OF MACROPHAGE CHEMOTAXIS,9.5377e-05,-0.52351,-0.61125,1,0
1,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,9.6689e-06,-0.52354,-0.54462,1,0
1,GO POSITIVE REGULATION OF ION TRANSPORT,5.337e-06,-0.52356,-0.50537,1,0
1,GO STRIATED MUSCLE CELL PROLIFERATION,4.5891e-06,-0.52375,-0.54107,1,0
1,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,0.0010798,-0.52383,-0.44146,1,0
1,GO METAL ION TRANSPORT,6.2007e-06,-0.52388,-0.50594,1,0
1,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,8.9327e-05,-0.52389,-0.64172,1,0
1,GO REGULATION OF LEUKOCYTE TETHERING OR ROLLING,0.0016767,-0.52414,-0.54041,1,0
1,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,3.9422e-06,-0.52431,-0.5119,1,0
1,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,5.337e-06,-0.52442,-0.52157,1,0
1,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,3.9422e-06,-0.52454,-0.52443,1,0
1,GO REGULATION OF TRANSMEMBRANE TRANSPORT,5.7533e-06,-0.5246,-0.52396,1,0
1,GO RESPONSE TO THYROID HORMONE,1.6059e-05,-0.52498,-0.55855,1,0
1,GO RESPONSE TO GONADOTROPIN,1.7249e-05,-0.52511,-0.52313,1,0
1,GO CELLULAR RESPONSE TO CHEMICAL STRESS,4.5891e-06,-0.52511,-0.5198,1,0
1,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,8.9843e-06,-0.52533,-0.56166,1,0
1,GO MICROTUBULE BUNDLE FORMATION,0.00010866,-0.52544,-0.45696,1,0
1,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,6.6813e-06,-0.5255,-0.52997,1,0
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,4.2763e-05,-0.52551,-0.55258,1,0
1,GO DIVALENT INORGANIC CATION TRANSPORT,5.7533e-06,-0.52554,-0.53162,1,0
1,GO GLYCOPROTEIN METABOLIC PROCESS,4.5891e-06,-0.52571,-0.54438,1,0
1,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,1.6059e-05,-0.52575,-0.56727,1,0
1,GO ANTEROGRADE AXONAL TRANSPORT,7.7514e-06,-0.52577,-0.61335,1,0
1,GO PROTEIN LIPID COMPLEX ASSEMBLY,1.1191e-05,-0.52578,-0.54417,1,0
1,GO HIPPOCAMPUS DEVELOPMENT,8.3461e-06,-0.52586,-0.52591,1,0
1,GO RESPONSE TO STARVATION,5.7533e-06,-0.52595,-0.53585,1,0
1,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,6.6813e-06,-0.52599,-0.56545,1,0
1,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,4.5891e-06,-0.52619,-0.56218,1,0
1,GO NEGATIVE REGULATION OF SECRETION,3.9422e-06,-0.52638,-0.51223,1,0
1,GO REGULATION OF GENE EXPRESSION EPIGENETIC,6.2007e-06,-0.52659,-0.52866,1,0
1,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,5.337e-06,-0.52667,-0.56096,1,0
1,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,9.5377e-05,-0.52679,-0.60919,1,0
1,GO MITOCHONDRION LOCALIZATION,8.9843e-06,-0.52684,-0.59643,1,0
1,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.00068502,-0.52697,-0.6752,1,0
1,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.00012367,-0.52699,-0.44813,1,0
1,GO REGULATION OF B CELL ACTIVATION,5.2428e-05,-0.52703,-0.64754,1,0
1,GO HINDBRAIN DEVELOPMENT,8.9843e-06,-0.52706,-0.54089,1,0
1,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,2.8267e-05,-0.52711,-0.55848,1,0
1,GO ER NUCLEUS SIGNALING PATHWAY,7.1973e-06,-0.52713,-0.53736,1,0
1,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,1.0403e-05,-0.52725,-0.5881,1,0
1,GO REGULATION OF ION TRANSPORT,6.2007e-06,-0.52731,-0.51261,1,0
1,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,3.9936e-05,-0.52741,-0.50948,1,0
1,GO NEURON APOPTOTIC PROCESS,5.337e-06,-0.52745,-0.53335,1,0
1,GO MYOTUBE DIFFERENTIATION,1.0403e-05,-0.52747,-0.56804,1,0
1,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,5.337e-06,-0.52751,-0.56858,1,0
1,GO AMINO ACID TRANSPORT,1.3909e-05,-0.52753,-0.52933,1,0
1,GO REGULATION OF VESICLE FUSION,8.3641e-05,-0.52775,-0.6408,1,0
1,GO MULTICELLULAR ORGANISMAL SIGNALING,1.3909e-05,-0.52778,-0.52748,1,0
1,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,6.6813e-06,-0.52785,-0.5288,1,0
1,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,1.0403e-05,-0.52785,-0.56037,1,0
1,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.00019306,-0.52794,-0.66737,1,0
1,GO CELLULAR RESPONSE TO FATTY ACID,9.6689e-06,-0.528,-0.50221,1,0
1,GO CHROMATIN ORGANIZATION,6.2007e-06,-0.52813,-0.56552,1,0
1,GO NEGATIVE REGULATION OF HORMONE SECRETION,7.7514e-06,-0.52825,-0.52411,1,0
1,GO ENDODERMAL CELL FATE COMMITMENT,3.4805e-05,-0.52828,-0.50167,1,0
1,GO REGULATION OF PROTEIN IMPORT,3.9422e-06,-0.52841,-0.55394,1,0
1,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,4.5891e-06,-0.52841,-0.54201,1,0
1,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,1.1191e-05,-0.52844,-0.54577,1,0
1,GO REGULATION OF PEPTIDE SECRETION,7.7514e-06,-0.52857,-0.53211,1,0
1,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,6.6813e-06,-0.52862,-0.51659,1,0
1,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,4.8997e-05,-0.52866,-0.60461,1,0
1,GO HISTONE METHYLATION,5.337e-06,-0.52885,-0.58752,1,0
1,GO ERK1 AND ERK2 CASCADE,8.9843e-06,-0.52886,-0.60596,1,0
1,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,2.4576e-05,-0.52887,-0.55372,1,0
1,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,5.6086e-05,-0.52889,-0.55898,1,0
1,GO RESPONSE TO AMINO ACID STARVATION,5.337e-06,-0.52892,-0.56872,1,0
1,GO REGULATION OF PHOSPHATASE ACTIVITY,4.5891e-06,-0.52894,-0.57487,1,0
1,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,4.9495e-06,-0.529,-0.547,1,0
1,GO CGMP MEDIATED SIGNALING,8.3461e-06,-0.52908,-0.56134,1,0
1,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,1.1191e-05,-0.52912,-0.58971,1,0
1,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,1.0403e-05,-0.52922,-0.54475,1,0
1,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,6.2007e-06,-0.52925,-0.57332,1,0
1,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,7.7514e-06,-0.52931,-0.61562,1,0
1,GO REGULATION OF CIRCADIAN RHYTHM,1.2035e-05,-0.52948,-0.53627,1,0
1,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,4.5891e-06,-0.52959,-0.5748,1,0
1,GO ENDOCRINE SYSTEM DEVELOPMENT,4.8997e-05,-0.5296,-0.52756,1,0
1,GO ANION TRANSMEMBRANE TRANSPORT,5.7533e-06,-0.52991,-0.51621,1,0
1,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,0.00033648,-0.52995,-0.62346,1,0
1,GO POSITIVE REGULATION OF SECRETION,7.1973e-06,-0.52996,-0.51339,1,0
1,GO HEART VALVE FORMATION,7.3279e-05,-0.53011,-0.58373,1,0
1,GO PHOSPHOLIPID CATABOLIC PROCESS,1.0403e-05,-0.53014,-0.58627,1,0
1,GO RESPONSE TO OXYGEN LEVELS,4.2539e-06,-0.5305,-0.52274,1,0
1,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.00018128,-0.53052,-0.51453,1,0
1,GO PALLIUM DEVELOPMENT,6.6813e-06,-0.53052,-0.56808,1,0
1,GO RESPONSE TO REACTIVE OXYGEN SPECIES,6.2007e-06,-0.53052,-0.52923,1,0
1,GO REGULATION OF MACROPHAGE MIGRATION,0.00014989,-0.53057,-0.60429,1,0
1,GO REGULATION OF CHROMATIN BINDING,6.2007e-06,-0.53064,-0.6103,1,0
1,GO SEX DETERMINATION,9.5377e-05,-0.53066,-0.47031,1,0
1,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,3.7287e-05,-0.53069,-0.55655,1,0
1,GO MONOAMINE TRANSPORT,0.00015974,-0.53076,-0.49319,1,0
1,GO CALCINEURIN MEDIATED SIGNALING,3.9422e-06,-0.53079,-0.5773,1,0
1,GO AGING,4.2539e-06,-0.53084,-0.53748,1,0
1,GO B CELL MEDIATED IMMUNITY,0.00031664,-0.53092,-0.62001,1,0
1,GO REGULATION OF METAL ION TRANSPORT,5.337e-06,-0.53092,-0.52872,1,0
1,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,5.7533e-06,-0.53094,-0.51725,1,0
1,GO EPITHELIAL CELL DIFFERENTIATION,6.6813e-06,-0.53103,-0.51156,1,0
1,GO AMYLOID FIBRIL FORMATION,1.8524e-05,-0.53113,-0.61844,1,0
1,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,3.9422e-06,-0.53133,-0.54765,1,0
1,GO RNA POLYADENYLATION,6.2007e-06,-0.53134,-0.58513,1,0
1,GO ENTRAINMENT OF CIRCADIAN CLOCK,2.2907e-05,-0.53135,-0.5146,1,0
1,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,1.4947e-05,-0.53138,-0.67055,1,0
1,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,4.2539e-06,-0.53143,-0.54773,1,0
1,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,2.2907e-05,-0.53148,-0.56947,1,0
1,GO NOREPINEPHRINE TRANSPORT,0.00015974,-0.53153,-0.59628,1,0
1,GO MEMBRANE ORGANIZATION,4.9495e-06,-0.53161,-0.55759,1,0
1,GO CELLULAR RESPONSE TO RETINOIC ACID,1.0403e-05,-0.5318,-0.55141,1,0
1,GO REGULATION OF STEROID METABOLIC PROCESS,2.4576e-05,-0.53193,-0.50211,1,0
1,GO REGULATION OF CYTOKINESIS,1.2939e-05,-0.53196,-0.54447,1,0
1,GO REGULATION OF PHAGOCYTOSIS,6.4139e-05,-0.53202,-0.64619,1,0
1,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,7.1973e-06,-0.5322,-0.54192,1,0
1,GO REGULATION OF ASTROCYTE DIFFERENTIATION,3.4805e-05,-0.53237,-0.52023,1,0
1,GO LAYER FORMATION IN CEREBRAL CORTEX,1.2035e-05,-0.53245,-0.67608,1,0
1,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,4.8997e-05,-0.53259,-0.6088,1,0
1,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,1.4947e-05,-0.53265,-0.57243,1,0
1,GO AXONAL FASCICULATION,1.0403e-05,-0.53269,-0.64473,1,0
1,GO ASTROCYTE DIFFERENTIATION,8.3461e-06,-0.53296,-0.58097,1,0
1,GO REGULATION OF INTEGRIN ACTIVATION,0.00020554,-0.53302,-0.55544,1,0
1,GO SYNAPTIC VESICLE MATURATION,0.0012758,-0.5331,-0.58792,1,0
1,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,0.00011593,-0.5333,-0.50504,1,0
1,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,0.0044907,-0.53336,-0.51604,1,0
1,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,0.00051151,-0.53341,-0.73774,1,0
1,GO RESPONSE TO NITROGEN COMPOUND,4.5891e-06,-0.5335,-0.55159,1,0
1,GO ISOTYPE SWITCHING TO IGG ISOTYPES,3.9936e-05,-0.53383,-0.57065,1,0
1,GO PHAGOSOME MATURATION,6.6813e-06,-0.53389,-0.54373,1,0
1,GO RESPONSE TO LIPID,4.5891e-06,-0.53405,-0.54138,1,0
1,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,6.6813e-06,-0.53414,-0.52087,1,0
1,GO MUSCLE FIBER DEVELOPMENT,8.3461e-06,-0.53421,-0.54117,1,0
1,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,0.00040321,-0.53424,-0.55418,1,0
1,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,8.9843e-06,-0.53437,-0.52472,1,0
1,GO RESPONSE TO REDOX STATE,0.00029789,-0.53451,-0.4916,1,0
1,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,7.1973e-06,-0.53452,-0.54187,1,0
1,GO POSITIVE REGULATION OF CELL DEATH,4.5891e-06,-0.53452,-0.55716,1,0
1,GO POSITIVE REGULATION OF HEAT GENERATION,5.9985e-05,-0.53457,-0.50365,1,0
1,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,3.9422e-06,-0.53484,-0.58749,1,0
1,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,1.8524e-05,-0.53488,-0.6345,1,0
1,GO CERAMIDE BIOSYNTHETIC PROCESS,1.4947e-05,-0.53496,-0.54402,1,0
1,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,9.6689e-06,-0.5351,-0.5019,1,0
1,GO AXO DENDRITIC TRANSPORT,1.0403e-05,-0.5352,-0.62141,1,0
1,GO TELENCEPHALON DEVELOPMENT,4.9495e-06,-0.53534,-0.57181,1,0
1,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,4.8997e-05,-0.53539,-0.64092,1,0
1,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,1.0403e-05,-0.53547,-0.57501,1,0
1,GO B CELL RECEPTOR SIGNALING PATHWAY,0.00012367,-0.53549,-0.70202,1,0
1,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,1.1191e-05,-0.53556,-0.51881,1,0
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,6.6813e-06,-0.53563,-0.52971,1,0
1,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,6.2007e-06,-0.53572,-0.5242,1,0
1,GO SERTOLI CELL DIFFERENTIATION,6.6813e-06,-0.53578,-0.62173,1,0
1,GO MEMORY,9.6689e-06,-0.53589,-0.52935,1,0
1,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,1.8524e-05,-0.53591,-0.63094,1,0
1,GO VITAMIN D METABOLIC PROCESS,3.9936e-05,-0.53616,-0.57253,1,0
1,GO SENSORY ORGAN MORPHOGENESIS,6.6813e-06,-0.5362,-0.53257,1,0
1,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,4.2539e-06,-0.53623,-0.58224,1,0
1,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,6.2007e-06,-0.53631,-0.59778,1,0
1,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,4.2539e-06,-0.53663,-0.55218,1,0
1,GO LYMPHOCYTE HOMEOSTASIS,1.2035e-05,-0.53667,-0.57079,1,0
1,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,9.6689e-06,-0.53672,-0.56765,1,0
1,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,5.7533e-06,-0.53689,-0.57805,1,0
1,GO RESPONSE TO HYDROGEN PEROXIDE,6.2007e-06,-0.53696,-0.50939,1,0
1,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.0015882,-0.53703,-0.57664,1,0
1,GO POSITIVE REGULATION OF CELL ADHESION,1.8524e-05,-0.53708,-0.62672,1,0
1,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,3.0304e-05,-0.53709,-0.66747,1,0
1,GO MELANOCYTE DIFFERENTIATION,3.9422e-06,-0.53714,-0.55931,1,0
1,GO CELLULAR RESPONSE TO LIPID,4.5891e-06,-0.53721,-0.55373,1,0
1,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,2.636e-05,-0.53723,-0.59483,1,0
1,GO REGULATION OF GLUCONEOGENESIS,6.2007e-06,-0.53727,-0.58953,1,0
1,GO POLYOL METABOLIC PROCESS,6.2007e-06,-0.53729,-0.52407,1,0
1,GO RESPONSE TO PAIN,1.0403e-05,-0.5373,-0.5393,1,0
1,GO POSITIVE REGULATION OF TELOMERE CAPPING,4.2763e-05,-0.5373,-0.51491,1,0
1,GO LYTIC VACUOLE ORGANIZATION,4.9495e-06,-0.53739,-0.58889,1,0
1,GO AMELOGENESIS,1.2939e-05,-0.53742,-0.57667,1,0
1,GO AUTOPHAGY OF MITOCHONDRION,4.9495e-06,-0.53747,-0.55995,1,0
1,GO PHOSPHOLIPID TRANSPORT,6.2007e-06,-0.53749,-0.57571,1,0
1,GO VISUAL BEHAVIOR,7.1973e-06,-0.53752,-0.53139,1,0
1,GO REGULATION OF ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0017696,-0.53768,-0.52637,1,0
1,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.00026348,-0.5377,-0.63112,1,0
1,GO REGULATION OF NMDA RECEPTOR ACTIVITY,3.7287e-05,-0.53774,-0.50903,1,0
1,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,1.6059e-05,-0.53777,-0.54966,1,0
1,GO POSITIVE REGULATION OF SIGNALING,4.5891e-06,-0.53783,-0.55104,1,0
1,GO RESPONSE TO ESTRADIOL,6.6813e-06,-0.5379,-0.53031,1,0
1,GO REGULATION OF MONONUCLEAR CELL MIGRATION,0.0010209,-0.5379,-0.57855,1,0
1,GO POSITIVE THYMIC T CELL SELECTION,0.0083971,-0.53811,-0.60531,1,0
1,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,4.2539e-06,-0.53839,-0.54086,1,0
1,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,1.9888e-05,-0.53842,-0.59706,1,0
1,GO CELLULAR RESPONSE TO ATP,6.6813e-06,-0.53847,-0.53835,1,0
1,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,9.6689e-06,-0.53851,-0.55724,1,0
1,GO EMBRYONIC FORELIMB MORPHOGENESIS,1.6059e-05,-0.53854,-0.50401,1,0
1,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,4.2539e-06,-0.53858,-0.56541,1,0
1,GO RESPONSE TO STEROID HORMONE,4.9495e-06,-0.53877,-0.55423,1,0
1,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,8.9843e-06,-0.53878,-0.57099,1,0
1,GO RESPONSE TO PEPTIDOGLYCAN,0.00072571,-0.53891,-0.6033,1,0
1,GO REGULATION OF CELLULAR CATABOLIC PROCESS,4.5891e-06,-0.53892,-0.54099,1,0
1,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,1.3909e-05,-0.53897,-0.61187,1,0
1,GO COLLECTING DUCT DEVELOPMENT,0.00023283,-0.539,-0.53078,1,0
1,GO GLIAL CELL ACTIVATION,0.00028019,-0.53908,-0.67187,1,0
1,GO RESPONSE TO TEMPERATURE STIMULUS,4.5891e-06,-0.53911,-0.53813,1,0
1,GO FATTY ACID DERIVATIVE TRANSPORT,1.8524e-05,-0.53913,-0.51965,1,0
1,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,0.010572,-0.5392,-0.67942,1,0
1,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,6.6813e-06,-0.53921,-0.53986,1,0
1,GO ORGANELLE FUSION,6.2007e-06,-0.53934,-0.58763,1,0
1,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,2.4576e-05,-0.53937,-0.54606,1,0
1,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,3.9422e-06,-0.53938,-0.55937,1,0
1,GO PEPTIDYL LYSINE MODIFICATION,4.5891e-06,-0.5394,-0.57569,1,0
1,GO HISTONE H3 K14 ACETYLATION,8.9843e-06,-0.5394,-0.59782,1,0
1,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,6.2007e-06,-0.53952,-0.54513,1,0
1,GO REGULATION OF HEAT GENERATION,3.4805e-05,-0.53956,-0.51326,1,0
1,GO REGULATION OF TOR SIGNALING,4.9495e-06,-0.53956,-0.58963,1,0
1,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,2.636e-05,-0.53956,-0.51731,1,0
1,GO CELLULAR RESPONSE TO SALT STRESS,0.00029789,-0.53964,-0.54237,1,0
1,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,1.2035e-05,-0.53964,-0.66759,1,0
1,GO RESPONSE TO MURAMYL DIPEPTIDE,1.4947e-05,-0.53983,-0.6914,1,0
1,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,4.5891e-06,-0.53983,-0.56053,1,0
1,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,1.8524e-05,-0.53983,-0.55116,1,0
1,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.00035748,-0.53994,-0.6658,1,0
1,GO CELLULAR RESPONSE TO CAMP,4.9495e-06,-0.54017,-0.51415,1,0
1,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,5.337e-06,-0.5402,-0.56346,1,0
1,GO ANION TRANSPORT,6.2007e-06,-0.54022,-0.50802,1,0
1,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,1.0403e-05,-0.54033,-0.51432,1,0
1,GO REGULATION OF LIPID KINASE ACTIVITY,5.337e-06,-0.54045,-0.65941,1,0
1,GO GOLGI VESICLE TRANSPORT,4.2539e-06,-0.54058,-0.57154,1,0
1,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,4.9495e-06,-0.54069,-0.58554,1,0
1,GO REGULATION OF CARDIAC CONDUCTION,1.7249e-05,-0.5407,-0.49651,1,0
1,GO GLIAL CELL FATE COMMITMENT,0.00033648,-0.5409,-0.50326,1,0
1,GO BODY FLUID SECRETION,4.9495e-06,-0.54097,-0.50033,1,0
1,GO HEAD DEVELOPMENT,4.9495e-06,-0.54104,-0.57269,1,0
1,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,4.5891e-06,-0.54105,-0.54447,1,0
1,GO MEMBRANE BIOGENESIS,9.6689e-06,-0.54106,-0.57655,1,0
1,GO MUSCLE CELL APOPTOTIC PROCESS,6.2007e-06,-0.54108,-0.54767,1,0
1,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,0.00010866,-0.54112,-0.57022,1,0
1,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,3.4805e-05,-0.54121,-0.68546,1,0
1,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.0021907,-0.54126,-0.52166,1,0
1,GO RESPONSE TO VITAMIN,5.337e-06,-0.54132,-0.59169,1,0
1,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,5.7533e-06,-0.54135,-0.56462,1,0
1,GO REGULATION OF CATABOLIC PROCESS,4.5891e-06,-0.54154,-0.54081,1,0
1,GO RESPONSE TO EPINEPHRINE,2.4576e-05,-0.54171,-0.52151,1,0
1,GO SOMITE DEVELOPMENT,5.337e-06,-0.5418,-0.54899,1,0
1,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,5.337e-06,-0.54181,-0.54428,1,0
1,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,9.6689e-06,-0.54183,-0.68069,1,0
1,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,4.8997e-05,-0.54186,-0.59444,1,0
1,GO STORE OPERATED CALCIUM ENTRY,1.4947e-05,-0.54188,-0.59409,1,0
1,GO PIGMENTATION,6.2007e-06,-0.5419,-0.48096,1,0
1,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,1.6059e-05,-0.54194,-0.49861,1,0
1,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,6.6813e-06,-0.54195,-0.5064,1,0
1,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.00024771,-0.54212,-0.47515,1,0
1,GO OSTEOCLAST DIFFERENTIATION,9.6689e-06,-0.54216,-0.6321,1,0
1,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,0.00018128,-0.54219,-0.51264,1,0
1,GO MRNA METHYLATION,5.7533e-06,-0.54221,-0.59695,1,0
1,GO REGULATION OF CELLULAR LOCALIZATION,4.5891e-06,-0.54226,-0.57246,1,0
1,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,4.9495e-06,-0.54229,-0.54182,1,0
1,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,7.1973e-06,-0.54231,-0.6129,1,0
1,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,1.4947e-05,-0.54242,-0.57639,1,0
1,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,8.9843e-06,-0.54242,-0.60707,1,0
1,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.00014989,-0.54243,-0.60331,1,0
1,GO AXONAL TRANSPORT,8.9843e-06,-0.5425,-0.63922,1,0
1,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,6.2007e-06,-0.54251,-0.55322,1,0
1,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,8.9843e-06,-0.54258,-0.539,1,0
1,GO ANION HOMEOSTASIS,4.5891e-06,-0.54265,-0.567,1,0
1,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.00033648,-0.5427,-0.48114,1,0
1,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,5.7533e-06,-0.54271,-0.55671,1,0
1,GO REGULATION OF RECEPTOR BINDING,1.7249e-05,-0.54288,-0.63827,1,0
1,GO RESPONSE TO METAL ION,8.3461e-06,-0.5429,-0.48909,1,0
1,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,4.9495e-06,-0.54293,-0.53252,1,0
1,GO REGULATION OF TRANSFERASE ACTIVITY,4.5891e-06,-0.54294,-0.5601,1,0
1,GO SULFUR COMPOUND CATABOLIC PROCESS,5.337e-06,-0.54302,-0.56,1,0
1,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,4.2539e-06,-0.54303,-0.54411,1,0
1,GO REGULATION OF PROTEIN CATABOLIC PROCESS,4.2539e-06,-0.54309,-0.56477,1,0
1,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.00014989,-0.54314,-0.52909,1,0
1,GO ANATOMICAL STRUCTURE HOMEOSTASIS,4.5891e-06,-0.54316,-0.52004,1,0
1,GO SENSORY ORGAN DEVELOPMENT,5.337e-06,-0.54321,-0.55304,1,0
1,GO INTERACTION WITH HOST,4.5891e-06,-0.54324,-0.5627,1,0
1,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,4.9495e-06,-0.54327,-0.58253,1,0
1,GO MODULATION BY VIRUS OF HOST PROCESS,4.5891e-06,-0.54344,-0.56436,1,0
1,GO CEREBELLAR CORTEX FORMATION,1.2035e-05,-0.54349,-0.56521,1,0
1,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,4.5891e-06,-0.5435,-0.52719,1,0
1,GO AMYLOID BETA METABOLIC PROCESS,1.2035e-05,-0.54359,-0.55877,1,0
1,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,4.5891e-06,-0.54372,-0.55428,1,0
1,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,6.2007e-06,-0.54376,-0.52854,1,0
1,GO MOTILE CILIUM ASSEMBLY,0.00011593,-0.54382,-0.52146,1,0
1,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,5.9985e-05,-0.54383,-0.6374,1,0
1,GO MEMBRANE INVAGINATION,1.7249e-05,-0.54409,-0.67785,1,0
1,GO SEGMENTATION,3.9422e-06,-0.54417,-0.55525,1,0
1,GO LIPID LOCALIZATION,6.6813e-06,-0.5443,-0.52324,1,0
1,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,7.7514e-06,-0.54436,-0.49683,1,0
1,GO POSITIVE REGULATION OF BIOMINERALIZATION,2.2907e-05,-0.5444,-0.57821,1,0
1,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,5.2428e-05,-0.54474,-0.56214,1,0
1,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,2.636e-05,-0.54495,-0.55123,1,0
1,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,3.9936e-05,-0.54497,-0.5876,1,0
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,1.7249e-05,-0.54503,-0.46816,1,0
1,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,4.9495e-06,-0.54516,-0.5459,1,0
1,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,4.2539e-06,-0.54526,-0.57297,1,0
1,GO B CELL ACTIVATION,1.2939e-05,-0.54535,-0.61775,1,0
1,GO REGULATION OF FATTY ACID METABOLIC PROCESS,4.9495e-06,-0.5455,-0.5561,1,0
1,GO SECRETORY GRANULE ORGANIZATION,9.6689e-06,-0.54562,-0.54937,1,0
1,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,0.00011593,-0.54564,-0.57803,1,0
1,GO CLATHRIN COAT ASSEMBLY,0.00028019,-0.54565,-0.54337,1,0
1,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,3.7287e-05,-0.54581,-0.62384,1,0
1,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,1.2035e-05,-0.5459,-0.6352,1,0
1,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,3.9422e-06,-0.5459,-0.56193,1,0
1,GO REGULATION OF CHEMOTAXIS,1.3909e-05,-0.54595,-0.60082,1,0
1,GO REGULATION OF ORGANELLE ORGANIZATION,4.2539e-06,-0.54606,-0.56807,1,0
1,GO PEPTIDYL LYSINE METHYLATION,7.1973e-06,-0.54625,-0.58296,1,0
1,GO ACYLGLYCEROL HOMEOSTASIS,5.337e-06,-0.54648,-0.54198,1,0
1,GO REGULATION OF LIPID CATABOLIC PROCESS,1.7249e-05,-0.54655,-0.53761,1,0
1,GO CERAMIDE TRANSPORT,1.1191e-05,-0.54677,-0.5929,1,0
1,GO REGULATION OF PROTEIN MODIFICATION PROCESS,4.5891e-06,-0.54686,-0.55988,1,0
1,GO RESPONSE TO IRON ION,1.2035e-05,-0.54693,-0.53424,1,0
1,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,6.2007e-06,-0.54722,-0.51973,1,0
1,GO PSEUDOPODIUM ORGANIZATION,0.00024771,-0.54738,-0.57753,1,0
1,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,4.5891e-06,-0.54739,-0.55796,1,0
1,GO PEPTIDYL LYSINE ACETYLATION,5.337e-06,-0.54741,-0.58159,1,0
1,GO CELL AGGREGATION,0.00028019,-0.54751,-0.48085,1,0
1,GO MYELOID CELL APOPTOTIC PROCESS,4.5779e-05,-0.54753,-0.52852,1,0
1,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,7.1973e-06,-0.54755,-0.59335,1,0
1,GO LIPID GLYCOSYLATION,2.2907e-05,-0.54757,-0.59687,1,0
1,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,1.2939e-05,-0.54759,-0.61555,1,0
1,GO CELL PROJECTION ASSEMBLY,6.2007e-06,-0.5476,-0.55131,1,0
1,GO REGULATION OF CHOLESTEROL EFFLUX,1.0403e-05,-0.5477,-0.59725,1,0
1,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.00010181,-0.54772,-0.49616,1,0
1,GO ORGANIC ANION TRANSPORT,7.1973e-06,-0.54777,-0.50597,1,0
1,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,4.5891e-06,-0.54778,-0.55087,1,0
1,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,6.6813e-06,-0.5479,-0.60305,1,0
1,GO CALCIUM ION REGULATED EXOCYTOSIS,0.00072571,-0.54794,-0.5753,1,0
1,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,5.337e-06,-0.54798,-0.58958,1,0
1,GO REGULATION OF ANGIOTENSIN LEVELS IN BLOOD,0.00045436,-0.54799,-0.59515,1,0
1,GO T HELPER 1 TYPE IMMUNE RESPONSE,0.0040644,-0.54809,-0.57774,1,0
1,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,2.636e-05,-0.54816,-0.53571,1,0
1,GO MULTI MULTICELLULAR ORGANISM PROCESS,8.9843e-06,-0.54817,-0.55446,1,0
1,GO MACROPHAGE ACTIVATION,4.8997e-05,-0.5482,-0.66199,1,0
1,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,3.9422e-06,-0.54822,-0.55672,1,0
1,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,4.5891e-06,-0.54822,-0.56981,1,0
1,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,4.2539e-06,-0.54831,-0.55003,1,0
1,GO INOSITOL PHOSPHATE METABOLIC PROCESS,3.9422e-06,-0.54845,-0.5657,1,0
1,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,2.636e-05,-0.54847,-0.51675,1,0
1,GO LATERAL MESODERM DEVELOPMENT,3.9936e-05,-0.54851,-0.49493,1,0
1,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,4.2539e-06,-0.54853,-0.55843,1,0
1,GO NEGATIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.00028019,-0.54855,-0.57058,1,0
1,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,5.337e-06,-0.54856,-0.52912,1,0
1,GO SMOOTHENED SIGNALING PATHWAY,8.3461e-06,-0.54861,-0.55278,1,0
1,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,1.7249e-05,-0.54872,-0.58198,1,0
1,GO HISTONE H4 K5 ACETYLATION,2.636e-05,-0.5488,-0.59486,1,0
1,GO RESPONSE TO DSRNA,1.4947e-05,-0.5488,-0.54647,1,0
1,GO SEQUESTERING OF CALCIUM ION,1.2035e-05,-0.54884,-0.56981,1,0
1,GO RESPONSE TO HEAT,3.9422e-06,-0.54896,-0.54158,1,0
1,GO INOSITOL METABOLIC PROCESS,0.00013188,-0.54933,-0.55094,1,0
1,GO SYNAPSE ORGANIZATION,5.337e-06,-0.54939,-0.60587,1,0
1,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,4.2539e-06,-0.54939,-0.54875,1,0
1,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.00011593,-0.54942,-0.63045,1,0
1,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,1.0403e-05,-0.54948,-0.54216,1,0
1,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,5.7533e-06,-0.54981,-0.56405,1,0
1,GO VITAMIN D BIOSYNTHETIC PROCESS,9.5377e-05,-0.54982,-0.65345,1,0
1,GO ENSHEATHMENT OF NEURONS,4.9495e-06,-0.54984,-0.55367,1,0
1,GO AUDITORY RECEPTOR CELL DEVELOPMENT,4.8997e-05,-0.54989,-0.55962,1,0
1,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,1.0403e-05,-0.54992,-0.51485,1,0
1,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,4.5891e-06,-0.55,-0.58997,1,0
1,GO LIPID MODIFICATION,5.337e-06,-0.55006,-0.53185,1,0
1,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,4.5779e-05,-0.55014,-0.63892,1,0
1,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,0.00024771,-0.55016,-0.66046,1,0
1,GO PROTEIN SUMOYLATION,5.337e-06,-0.5502,-0.57923,1,0
1,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,1.9888e-05,-0.5503,-0.65557,1,0
1,GO POSITIVE REGULATION OF VESICLE FUSION,2.636e-05,-0.55039,-0.5584,1,0
1,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,7.8298e-05,-0.55045,-0.53054,1,0
1,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0003797,-0.55046,-0.65431,1,0
1,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.00014989,-0.55053,-0.61697,1,0
1,GO REGULATION OF TRANSPORT,5.337e-06,-0.55062,-0.53629,1,0
1,GO REGULATION OF EPIDERMIS DEVELOPMENT,1.0403e-05,-0.55063,-0.58662,1,0
1,GO CELLULAR GLUCOSE HOMEOSTASIS,7.7514e-06,-0.55082,-0.55565,1,0
1,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,7.8298e-05,-0.55083,-0.47272,1,0
1,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,0.00048214,-0.55083,-0.67505,1,0
1,GO ORGANOPHOSPHATE ESTER TRANSPORT,6.2007e-06,-0.55083,-0.54827,1,0
1,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,5.2428e-05,-0.55089,-0.64239,1,0
1,GO RESPONSE TO KETONE,4.2539e-06,-0.55097,-0.55707,1,0
1,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,3.9422e-06,-0.55101,-0.63629,1,0
1,GO NEGATIVE REGULATION OF SIGNALING,4.5891e-06,-0.55106,-0.57262,1,0
1,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,7.1973e-06,-0.55118,-0.53739,1,0
1,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,3.9422e-06,-0.55123,-0.59196,1,0
1,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,4.5891e-06,-0.55141,-0.5639,1,0
1,GO PHOSPHOLIPID METABOLIC PROCESS,5.337e-06,-0.55147,-0.54933,1,0
1,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,4.9495e-06,-0.55151,-0.58352,1,0
1,GO RESPONSE TO FORSKOLIN,8.3641e-05,-0.55158,-0.62112,1,0
1,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,4.9495e-06,-0.55169,-0.55544,1,0
1,GO REGULATION OF MACROAUTOPHAGY,4.5891e-06,-0.55173,-0.58689,1,0
1,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,6.6813e-06,-0.55179,-0.52605,1,0
1,GO OLIGODENDROCYTE DEVELOPMENT,1.9888e-05,-0.55185,-0.54773,1,0
1,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,0.0029965,-0.55188,-0.60418,1,0
1,GO ASSOCIATIVE LEARNING,8.9843e-06,-0.55188,-0.53358,1,0
1,GO CYTOSOLIC CALCIUM ION TRANSPORT,7.7514e-06,-0.55189,-0.57009,1,0
1,GO RHYTHMIC BEHAVIOR,1.4947e-05,-0.55195,-0.54806,1,0
1,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,2.1347e-05,-0.55208,-0.53608,1,0
1,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,7.7514e-06,-0.55226,-0.58028,1,0
1,GO RESPONSE TO ATP,4.5891e-06,-0.5523,-0.5513,1,0
1,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,9.6689e-06,-0.55231,-0.5703,1,0
1,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,2.636e-05,-0.55266,-0.53623,1,0
1,GO NEGATIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.00024771,-0.5527,-0.76238,1,0
1,GO POLYSACCHARIDE CATABOLIC PROCESS,4.2539e-06,-0.55274,-0.57235,1,0
1,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,3.9936e-05,-0.55277,-0.60592,1,0
1,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,8.9843e-06,-0.55297,-0.52527,1,0
1,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,8.3641e-05,-0.5531,-0.56432,1,0
1,GO REGULATION OF B CELL MEDIATED IMMUNITY,6.4139e-05,-0.55335,-0.59881,1,0
1,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,4.5779e-05,-0.55336,-0.5145,1,0
1,GO CARDIOBLAST DIFFERENTIATION,1.1191e-05,-0.55353,-0.57619,1,0
1,GO LIPID HOMEOSTASIS,5.337e-06,-0.55367,-0.53582,1,0
1,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,3.0304e-05,-0.55369,-0.61972,1,0
1,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,8.9327e-05,-0.55375,-0.64345,1,0
1,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,6.8565e-05,-0.55375,-0.50058,1,0
1,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,1.6059e-05,-0.55389,-0.63648,1,0
1,GO REGULATION OF ORGAN GROWTH,4.5891e-06,-0.55397,-0.55141,1,0
1,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,4.2539e-06,-0.55402,-0.5574,1,0
1,GO ESTABLISHMENT OF SPINDLE ORIENTATION,7.7514e-06,-0.55406,-0.55683,1,0
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,0.00018128,-0.5541,-0.57552,1,0
1,GO ACTIN MEDIATED CELL CONTRACTION,4.2539e-06,-0.55411,-0.5477,1,0
1,GO OVARIAN FOLLICLE DEVELOPMENT,2.1347e-05,-0.55416,-0.48156,1,0
1,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,4.9495e-06,-0.55429,-0.57506,1,0
1,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,8.3461e-06,-0.55431,-0.64427,1,0
1,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,3.4805e-05,-0.55437,-0.64196,1,0
1,GO GLUCOSE IMPORT,4.5891e-06,-0.55445,-0.52417,1,0
1,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,4.2539e-06,-0.55452,-0.55883,1,0
1,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,7.1973e-06,-0.55455,-0.56484,1,0
1,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,1.2035e-05,-0.55455,-0.66226,1,0
1,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,4.2539e-06,-0.55456,-0.58457,1,0
1,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.008797,-0.5546,-0.53319,1,0
1,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,5.7533e-06,-0.55474,-0.56566,1,0
1,GO MICROTUBULE DEPOLYMERIZATION,1.7249e-05,-0.55474,-0.65715,1,0
1,GO VESICLE ORGANIZATION,4.9495e-06,-0.55478,-0.5655,1,0
1,GO REGULATION OF ENDOCRINE PROCESS,1.7249e-05,-0.55479,-0.49856,1,0
1,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,1.4947e-05,-0.55481,-0.56471,1,0
1,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,0.00076864,-0.55487,-0.57161,1,0
1,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,8.3461e-06,-0.55494,-0.59295,1,0
1,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,1.6059e-05,-0.55495,-0.59167,1,0
1,GO NEGATIVE REGULATION OF LIPID TRANSPORT,4.9495e-06,-0.55499,-0.6434,1,0
1,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,6.2007e-06,-0.55519,-0.57608,1,0
1,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,6.6813e-06,-0.55522,-0.5579,1,0
1,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,6.2007e-06,-0.55532,-0.56905,1,0
1,GO IMMUNE SYSTEM DEVELOPMENT,4.5891e-06,-0.55535,-0.57203,1,0
1,GO FOREBRAIN DEVELOPMENT,6.2007e-06,-0.55551,-0.56585,1,0
1,GO REGULATION OF ERAD PATHWAY,4.9495e-06,-0.55552,-0.58966,1,0
1,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,2.4576e-05,-0.55563,-0.52535,1,0
1,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,1.6059e-05,-0.55571,-0.5521,1,0
1,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,4.5891e-06,-0.55575,-0.58247,1,0
1,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,4.5891e-06,-0.5558,-0.57607,1,0
1,GO REGULATION OF PHOSPHORYLATION,4.5891e-06,-0.55601,-0.57348,1,0
1,GO REGULATION OF DEPHOSPHORYLATION,4.5891e-06,-0.55601,-0.60112,1,0
1,GO ORGANELLE MEMBRANE FUSION,5.7533e-06,-0.55613,-0.61916,1,0
1,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,5.2428e-05,-0.55622,-0.57238,1,0
1,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,3.9422e-06,-0.55629,-0.60955,1,0
1,GO SNARE COMPLEX ASSEMBLY,1.2035e-05,-0.5563,-0.58772,1,0
1,GO ANATOMICAL STRUCTURE MATURATION,8.3461e-06,-0.55631,-0.54412,1,0
1,GO NEURON MIGRATION,9.6689e-06,-0.5564,-0.61762,1,0
1,GO REGULATION OF SECRETION,6.2007e-06,-0.55652,-0.52622,1,0
1,GO POSITIVE REGULATION OF B CELL PROLIFERATION,5.6086e-05,-0.5566,-0.65341,1,0
1,GO FOREGUT MORPHOGENESIS,3.248e-05,-0.55661,-0.57509,1,0
1,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,1.9888e-05,-0.55668,-0.67947,1,0
1,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,3.7287e-05,-0.55674,-0.53175,1,0
1,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,3.9422e-06,-0.55675,-0.58457,1,0
1,GO NEGATIVE REGULATION OF DNA REPAIR,7.7514e-06,-0.55685,-0.54478,1,0
1,GO NEURONAL ION CHANNEL CLUSTERING,0.00011593,-0.55689,-0.58221,1,0
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,1.6059e-05,-0.55706,-0.54474,1,0
1,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,4.9495e-06,-0.55708,-0.56039,1,0
1,GO TRANSEPITHELIAL TRANSPORT,8.9843e-06,-0.55715,-0.55872,1,0
1,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,8.3461e-06,-0.55716,-0.53832,1,0
1,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,6.6813e-06,-0.5572,-0.55286,1,0
1,GO CGMP METABOLIC PROCESS,0.00045436,-0.55731,-0.52388,1,0
1,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,5.337e-06,-0.55733,-0.58518,1,0
1,GO LEUKOCYTE HOMEOSTASIS,8.3461e-06,-0.55734,-0.61308,1,0
1,GO DENDRITIC CELL APOPTOTIC PROCESS,0.0080134,-0.55741,-0.78584,1,0
1,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,1.8524e-05,-0.55755,-0.62249,1,0
1,GO CIRCADIAN RHYTHM,7.1973e-06,-0.55756,-0.54923,1,0
1,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,4.8997e-05,-0.55773,-0.57763,1,0
1,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,6.2007e-06,-0.55779,-0.54782,1,0
1,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,6.6813e-06,-0.55786,-0.61441,1,0
1,GO POSITIVE REGULATION OF MYELINATION,8.9843e-06,-0.55796,-0.61442,1,0
1,GO CARTILAGE MORPHOGENESIS,6.2007e-06,-0.55806,-0.66999,1,0
1,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,6.2007e-06,-0.55812,-0.61374,1,0
1,GO REGULATION OF POSITIVE CHEMOTAXIS,1.4947e-05,-0.55814,-0.56274,1,0
1,GO REGULATION OF CALCIUM ION TRANSPORT,5.337e-06,-0.55817,-0.55369,1,0
1,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,1.8524e-05,-0.55826,-0.61177,1,0
1,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,5.337e-06,-0.55834,-0.54469,1,0
1,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,7.1973e-06,-0.55862,-0.63992,1,0
1,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,4.2539e-06,-0.55874,-0.57946,1,0
1,GO NEUROBLAST PROLIFERATION,1.8524e-05,-0.55886,-0.56848,1,0
1,GO RESPONSE TO INTERLEUKIN 7,1.6059e-05,-0.55888,-0.60745,1,0
1,GO SYNAPSE PRUNING,0.0049572,-0.55893,-0.70313,1,0
1,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,4.2539e-06,-0.55903,-0.60189,1,0
1,GO SYNAPTIC VESICLE RECYCLING,2.8267e-05,-0.55906,-0.60839,1,0
1,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,0.0018673,-0.55914,-0.58566,1,0
1,GO CELLULAR RESPONSE TO OSMOTIC STRESS,1.1191e-05,-0.5592,-0.53872,1,0
1,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,7.1973e-06,-0.55927,-0.53677,1,0
1,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,4.5891e-06,-0.55957,-0.60287,1,0
1,GO DEVELOPMENTAL PIGMENTATION,3.9422e-06,-0.55966,-0.52098,1,0
1,GO REGULATION OF STRIATED MUSCLE CONTRACTION,1.2939e-05,-0.55972,-0.5239,1,0
1,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,6.2007e-06,-0.55974,-0.60954,1,0
1,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,8.3461e-06,-0.5598,-0.55345,1,0
1,GO ADAPTIVE THERMOGENESIS,5.337e-06,-0.55987,-0.55153,1,0
1,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.00011593,-0.56009,-0.63051,1,0
1,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,5.2428e-05,-0.56013,-0.54541,1,0
1,GO POSITIVE CHEMOTAXIS,2.8267e-05,-0.56026,-0.54003,1,0
1,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,4.9495e-06,-0.56032,-0.58274,1,0
1,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,6.2007e-06,-0.56045,-0.56069,1,0
1,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,1.0403e-05,-0.56046,-0.55233,1,0
1,GO REGULATION OF NERVOUS SYSTEM PROCESS,6.6813e-06,-0.5605,-0.55308,1,0
1,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,3.7287e-05,-0.56061,-0.61795,1,0
1,GO REGULATION OF EXOCYTOSIS,9.6689e-06,-0.56061,-0.5862,1,0
1,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,3.9422e-06,-0.56077,-0.59769,1,0
1,GO RESPONSE TO ACETYLCHOLINE,8.3641e-05,-0.56077,-0.59135,1,0
1,GO NEGATIVE REGULATION OF CELL AGING,5.7533e-06,-0.56078,-0.55595,1,0
1,GO CERAMIDE METABOLIC PROCESS,1.2035e-05,-0.56082,-0.5643,1,0
1,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,9.5377e-05,-0.56087,-0.61778,1,0
1,GO SYNAPTIC TRANSMISSION GABAERGIC,5.337e-06,-0.56097,-0.55354,1,0
1,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,3.9422e-06,-0.56102,-0.57152,1,0
1,GO REGULATION OF RECEPTOR RECYCLING,3.9422e-06,-0.56104,-0.57775,1,0
1,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,5.7533e-06,-0.56115,-0.54772,1,0
1,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,5.2428e-05,-0.56119,-0.63739,1,0
1,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.0080134,-0.56124,-0.56291,1,0
1,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,4.2539e-06,-0.56124,-0.57143,1,0
1,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,4.2539e-06,-0.56125,-0.55484,1,0
1,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,4.2539e-06,-0.5615,-0.57685,1,0
1,GO VESICLE DOCKING,8.3461e-06,-0.56176,-0.60896,1,0
1,GO PROTEIN DESTABILIZATION,5.337e-06,-0.56177,-0.59532,1,0
1,GO REGULATION OF HYDROLASE ACTIVITY,4.5891e-06,-0.56185,-0.56827,1,0
1,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,4.5891e-06,-0.5619,-0.58435,1,0
1,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0012071,-0.56206,-0.55493,1,0
1,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,3.248e-05,-0.56207,-0.60018,1,0
1,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,6.6813e-06,-0.56208,-0.59314,1,0
1,GO VESICLE LOCALIZATION,4.9495e-06,-0.56218,-0.58476,1,0
1,GO MUSCLE ORGAN DEVELOPMENT,4.5891e-06,-0.5622,-0.5639,1,0
1,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,3.7287e-05,-0.56229,-0.70227,1,0
1,GO DENDRITIC SPINE MORPHOGENESIS,8.3461e-06,-0.56256,-0.61455,1,0
1,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,8.3461e-06,-0.56263,-0.6288,1,0
1,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,3.9422e-06,-0.56265,-0.62443,1,0
1,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,7.7514e-06,-0.56273,-0.54275,1,0
1,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,9.5377e-05,-0.56273,-0.58156,1,0
1,GO VESICLE CARGO LOADING,4.5891e-06,-0.56273,-0.59679,1,0
1,GO CALCIUM ION IMPORT,1.3909e-05,-0.56277,-0.54532,1,0
1,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,4.5891e-06,-0.56285,-0.57244,1,0
1,GO PROTEIN HYDROXYLATION,2.8267e-05,-0.5629,-0.56685,1,0
1,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,3.7287e-05,-0.56291,-0.53356,1,0
1,GO RESPONSE TO MONOSACCHARIDE,5.7533e-06,-0.56297,-0.54901,1,0
1,GO RESPONSE TO ORGANOPHOSPHORUS,5.7533e-06,-0.56301,-0.54129,1,0
1,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,4.9495e-06,-0.56301,-0.58128,1,0
1,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.00012367,-0.56312,-0.44525,1,0
1,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,4.2539e-06,-0.56319,-0.51939,1,0
1,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,4.5891e-06,-0.56319,-0.57289,1,0
1,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,0.00029789,-0.56337,-0.53107,1,0
1,GO IRON COORDINATION ENTITY TRANSPORT,0.00010866,-0.56342,-0.53709,1,0
1,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,9.6689e-06,-0.56346,-0.54075,1,0
1,GO CELLULAR RESPONSE TO KETONE,5.337e-06,-0.56349,-0.55934,1,0
1,GO GENETIC IMPRINTING,6.4139e-05,-0.56351,-0.52683,1,0
1,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,7.1973e-06,-0.56355,-0.53626,1,0
1,GO FOAM CELL DIFFERENTIATION,1.9888e-05,-0.56387,-0.59066,1,0
1,GO RECEPTOR RECYCLING,4.5891e-06,-0.56393,-0.57283,1,0
1,GO HEART PROCESS,6.2007e-06,-0.5641,-0.52965,1,0
1,GO NEURON DEATH,4.9495e-06,-0.56419,-0.56856,1,0
1,GO PIGMENT CELL DIFFERENTIATION,3.9422e-06,-0.56427,-0.56555,1,0
1,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,4.2539e-06,-0.5643,-0.55999,1,0
1,GO SKELETAL MUSCLE ADAPTATION,3.4805e-05,-0.56443,-0.51557,1,0
1,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.00096503,-0.56446,-0.539,1,0
1,GO UTERUS DEVELOPMENT,4.2763e-05,-0.56446,-0.5115,1,0
1,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,9.6689e-06,-0.5646,-0.57101,1,0
1,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,1.3909e-05,-0.56487,-0.5317,1,0
1,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.00035748,-0.56507,-0.62815,1,0
1,GO ECTODERM DEVELOPMENT,2.1347e-05,-0.5651,-0.46457,1,0
1,GO PEPTIDE SECRETION,7.1973e-06,-0.5651,-0.53857,1,0
1,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,3.9422e-06,-0.56518,-0.55729,1,0
1,GO CALCIUM ION IMPORT INTO CYTOSOL,5.2428e-05,-0.56519,-0.58893,1,0
1,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,5.7533e-06,-0.56522,-0.57394,1,0
1,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,5.337e-06,-0.56528,-0.54574,1,0
1,GO RHYTHMIC PROCESS,4.9495e-06,-0.56529,-0.56402,1,0
1,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,2.4576e-05,-0.56529,-0.58829,1,0
1,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,4.5891e-06,-0.56532,-0.57149,1,0
1,GO MESODERM DEVELOPMENT,4.9495e-06,-0.56551,-0.53708,1,0
1,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,6.2007e-06,-0.56559,-0.56272,1,0
1,GO REGULATION OF RESPONSE TO WOUNDING,4.9495e-06,-0.56575,-0.60646,1,0
1,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,5.337e-06,-0.56576,-0.55807,1,0
1,GO MIDGUT DEVELOPMENT,1.2035e-05,-0.56577,-0.58705,1,0
1,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,4.2539e-06,-0.5659,-0.58537,1,0
1,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,4.5891e-06,-0.56621,-0.56939,1,0
1,GO INTERMEMBRANE LIPID TRANSFER,4.2539e-06,-0.56622,-0.61304,1,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,4.5891e-06,-0.56636,-0.56363,1,0
1,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,4.9495e-06,-0.56641,-0.61225,1,0
1,GO REGULATION OF GROWTH HORMONE SECRETION,0.0038653,-0.56665,-0.5432,1,0
1,GO NEGATIVE REGULATION OF WOUND HEALING,7.7514e-06,-0.56674,-0.61121,1,0
1,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,8.9843e-06,-0.56677,-0.60244,1,0
1,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,4.2539e-06,-0.56677,-0.58899,1,0
1,GO REGULATION OF LIPID METABOLIC PROCESS,5.7533e-06,-0.56679,-0.56398,1,0
1,GO NEGATIVE REGULATION OF PROTEIN BINDING,5.337e-06,-0.56686,-0.57152,1,0
1,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,1.2035e-05,-0.56686,-0.6103,1,0
1,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,5.337e-06,-0.56695,-0.59291,1,0
1,GO NEGATIVE REGULATION OF PHOSPHORYLATION,5.7533e-06,-0.56696,-0.57784,1,0
1,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,3.9422e-06,-0.56699,-0.63751,1,0
1,GO PRESYNAPTIC ENDOCYTOSIS,2.2907e-05,-0.56702,-0.61458,1,0
1,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,7.1973e-06,-0.56707,-0.59282,1,0
1,GO PROXIMAL DISTAL PATTERN FORMATION,0.00017019,-0.56707,-0.50705,1,0
1,GO T CELL ACTIVATION VIA T CELL RECEPTOR CONTACT WITH ANTIGEN BOUND TO MHC MOLECULE ON ANTIGEN PRESENTING CELL,0.023112,-0.56708,-0.74591,1,0
1,GO REGULATION OF SYNAPSE MATURATION,2.4576e-05,-0.56717,-0.65865,1,0
1,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,4.5891e-06,-0.56741,-0.61692,1,0
1,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,4.2763e-05,-0.56768,-0.64144,1,0
1,GO PEPTIDYL SERINE DEPHOSPHORYLATION,7.7514e-06,-0.56781,-0.55242,1,0
1,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,0.00017019,-0.56802,-0.6345,1,0
1,GO ORGANIC HYDROXY COMPOUND TRANSPORT,1.3909e-05,-0.56809,-0.49313,1,0
1,GO PROTEIN POLYMERIZATION,4.2539e-06,-0.56813,-0.59658,1,0
1,GO COVALENT CHROMATIN MODIFICATION,4.5891e-06,-0.56815,-0.59267,1,0
1,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,0.00045436,-0.56815,-0.75161,1,0
1,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,3.9422e-06,-0.56819,-0.58895,1,0
1,GO GERMINAL CENTER FORMATION,8.3641e-05,-0.56827,-0.78257,1,0
1,GO NEURON DIFFERENTIATION,6.6813e-06,-0.56841,-0.59073,1,0
1,GO RESPONSE TO PROSTAGLANDIN,3.0304e-05,-0.56842,-0.56393,1,0
1,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,3.248e-05,-0.56848,-0.64843,1,0
1,GO NEGATIVE REGULATION OF EXOCYTOSIS,1.0403e-05,-0.56862,-0.60938,1,0
1,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,7.7514e-06,-0.56877,-0.57251,1,0
1,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,7.3279e-05,-0.56878,-0.53494,1,0
1,GO NATURAL KILLER CELL DIFFERENTIATION,2.636e-05,-0.56888,-0.62594,1,0
1,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.00072571,-0.56897,-0.58655,1,0
1,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.00021879,-0.569,-0.57925,1,0
1,GO REGULATION OF NEURON DIFFERENTIATION,5.7533e-06,-0.56909,-0.61721,1,0
1,GO POSITIVE REGULATION OF WOUND HEALING,4.9495e-06,-0.56911,-0.60369,1,0
1,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,2.8267e-05,-0.56915,-0.58941,1,0
1,GO RESPONSE TO MISFOLDED PROTEIN,1.2035e-05,-0.56917,-0.63787,1,0
1,GO RESPONSE TO RETINOIC ACID,8.3461e-06,-0.56917,-0.5694,1,0
1,GO CELL CELL ADHESION,5.337e-06,-0.5692,-0.58968,1,0
1,GO GLIOGENESIS,6.2007e-06,-0.56922,-0.56468,1,0
1,GO ORGANIC ACID TRANSPORT,7.7514e-06,-0.56927,-0.51331,1,0
1,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,5.7533e-06,-0.56929,-0.61333,1,0
1,GO FEMALE SEX DIFFERENTIATION,4.2539e-06,-0.56946,-0.5256,1,0
1,GO ASTROCYTE DEVELOPMENT,1.8524e-05,-0.56954,-0.64579,1,0
1,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,8.3461e-06,-0.56962,-0.61463,1,0
1,GO POSITIVE REGULATION OF HISTONE METHYLATION,7.1973e-06,-0.5699,-0.59711,1,0
1,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,4.5891e-06,-0.5699,-0.57581,1,0
1,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,2.8267e-05,-0.56995,-0.56791,1,0
1,GO MAST CELL MEDIATED IMMUNITY,4.5891e-06,-0.56996,-0.67534,1,0
1,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,5.337e-06,-0.57,-0.54034,1,0
1,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,0.00010866,-0.57014,-0.57892,1,0
1,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,9.6689e-06,-0.57028,-0.55909,1,0
1,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,4.5891e-06,-0.57029,-0.57144,1,0
1,GO SOMITOGENESIS,4.5891e-06,-0.5703,-0.57494,1,0
1,GO ERBB2 SIGNALING PATHWAY,4.2539e-06,-0.57039,-0.55807,1,0
1,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,1.4947e-05,-0.5704,-0.63386,1,0
1,GO INTESTINAL ABSORPTION,0.00012367,-0.57042,-0.53558,1,0
1,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,8.9843e-06,-0.57053,-0.61042,1,0
1,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,2.4576e-05,-0.57055,-0.64847,1,0
1,GO AUTOPHAGY OF NUCLEUS,4.2539e-06,-0.5707,-0.59588,1,0
1,GO POSITIVE REGULATION OF PROTEIN IMPORT,5.7533e-06,-0.57074,-0.59533,1,0
1,GO REGULATION OF MYELOID CELL DIFFERENTIATION,3.9422e-06,-0.57074,-0.62379,1,0
1,GO IMPORT INTO CELL,7.7514e-06,-0.57085,-0.54792,1,0
1,GO RESPONSE TO PURINE CONTAINING COMPOUND,5.337e-06,-0.57091,-0.55377,1,0
1,GO INTESTINAL LIPID ABSORPTION,0.0034935,-0.571,-0.40569,1,0
1,GO REGULATION OF MRNA POLYADENYLATION,6.2007e-06,-0.57103,-0.63283,1,0
1,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,6.6813e-06,-0.57106,-0.57487,1,0
1,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,7.8298e-05,-0.57131,-0.61814,1,0
1,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,3.9422e-06,-0.57137,-0.56616,1,0
1,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,4.5891e-06,-0.57139,-0.5962,1,0
1,GO MYELOID CELL DIFFERENTIATION,3.9422e-06,-0.57142,-0.60531,1,0
1,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,4.9495e-06,-0.57148,-0.60545,1,0
1,GO RESPONSE TO LEPTIN,1.9888e-05,-0.57151,-0.52286,1,0
1,GO TELOMERE CAPPING,7.7514e-06,-0.57157,-0.5782,1,0
1,GO TEMPERATURE HOMEOSTASIS,5.337e-06,-0.57161,-0.55315,1,0
1,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,8.9327e-05,-0.57184,-0.72464,1,0
1,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,5.337e-06,-0.57187,-0.55051,1,0
1,GO ANIMAL ORGAN MORPHOGENESIS,4.9495e-06,-0.5719,-0.58134,1,0
1,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,6.2007e-06,-0.57209,-0.56468,1,0
1,GO REGULATION OF MRNA 3 END PROCESSING,5.7533e-06,-0.57213,-0.58959,1,0
1,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,9.6689e-06,-0.57216,-0.639,1,0
1,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,4.5891e-06,-0.57222,-0.57396,1,0
1,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,4.5891e-06,-0.57238,-0.54206,1,0
1,GO REGULATION OF CELLULAR RESPONSE TO HEAT,5.337e-06,-0.57238,-0.58231,1,0
1,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,1.3909e-05,-0.57244,-0.58836,1,0
1,GO NEUROGENESIS,5.337e-06,-0.57249,-0.58666,1,0
1,GO NEGATIVE REGULATION OF KINASE ACTIVITY,7.1973e-06,-0.57279,-0.56667,1,0
1,GO REGULATION OF HISTONE MODIFICATION,4.9495e-06,-0.5729,-0.58551,1,0
1,GO REGULATION OF AUTOPHAGY,4.5891e-06,-0.57299,-0.58489,1,0
1,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,2.1347e-05,-0.573,-0.63819,1,0
1,GO CELL ADHESION MOLECULE PRODUCTION,0.00015974,-0.57303,-0.59418,1,0
1,GO RESPONSE TO AXON INJURY,1.2035e-05,-0.57306,-0.56443,1,0
1,GO OLFACTORY LOBE DEVELOPMENT,4.5779e-05,-0.57307,-0.57392,1,0
1,GO MIRNA METABOLIC PROCESS,6.2007e-06,-0.57321,-0.5987,1,0
1,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,4.2539e-06,-0.57322,-0.56896,1,0
1,GO RESPONSE TO VITAMIN D,2.1347e-05,-0.57326,-0.57355,1,0
1,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,7.1973e-06,-0.57326,-0.61598,1,0
1,GO DIACYLGLYCEROL METABOLIC PROCESS,7.7514e-06,-0.57337,-0.63588,1,0
1,GO NEGATIVE REGULATION OF ENDOCYTOSIS,4.5891e-06,-0.57338,-0.58975,1,0
1,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,3.7287e-05,-0.57348,-0.58661,1,0
1,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,4.5891e-06,-0.57353,-0.56147,1,0
1,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,3.248e-05,-0.57362,-0.66599,1,0
1,GO SEGMENT SPECIFICATION,3.248e-05,-0.5737,-0.51523,1,0
1,GO ORGANIC CATION TRANSPORT,2.636e-05,-0.57379,-0.5144,1,0
1,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,4.9495e-06,-0.57381,-0.5908,1,0
1,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,6.2007e-06,-0.57385,-0.54681,1,0
1,GO RESPONSE TO POTASSIUM ION,0.00020554,-0.57386,-0.54004,1,0
1,GO IMPORT ACROSS PLASMA MEMBRANE,7.7514e-06,-0.57412,-0.54985,1,0
1,GO REGULATION OF REGULATED SECRETORY PATHWAY,1.2035e-05,-0.57413,-0.60896,1,0
1,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,1.2035e-05,-0.57418,-0.5555,1,0
1,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,7.1973e-06,-0.57419,-0.59091,1,0
1,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,4.5891e-06,-0.57425,-0.57755,1,0
1,GO PROSTAGLANDIN SECRETION,4.5779e-05,-0.57433,-0.51696,1,0
1,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,4.2539e-06,-0.57434,-0.60079,1,0
1,GO RESPONSE TO NERVE GROWTH FACTOR,6.2007e-06,-0.57437,-0.60105,1,0
1,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,4.2539e-06,-0.57454,-0.57197,1,0
1,GO PROTEIN LOCALIZATION TO CELL JUNCTION,9.6689e-06,-0.57462,-0.6125,1,0
1,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,6.6813e-06,-0.5747,-0.58343,1,0
1,GO REGULATION OF RESPIRATORY BURST,2.636e-05,-0.57493,-0.53631,1,0
1,GO CYCLOOXYGENASE PATHWAY,0.0012071,-0.57498,-0.56109,1,0
1,GO NEURON RECOGNITION,2.1347e-05,-0.57501,-0.59693,1,0
1,GO DISTAL TUBULE DEVELOPMENT,0.00017019,-0.57513,-0.67382,1,0
1,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.00042807,-0.57515,-0.56901,1,0
1,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,1.0403e-05,-0.57542,-0.55315,1,0
1,GO ACTION POTENTIAL,8.3461e-06,-0.57556,-0.55126,1,0
1,GO RESPONSE TO HORMONE,4.5891e-06,-0.5756,-0.56177,1,0
1,GO NEUTRAL AMINO ACID TRANSPORT,7.1973e-06,-0.57569,-0.57415,1,0
1,GO INTEGRIN ACTIVATION,9.5377e-05,-0.57577,-0.69029,1,0
1,GO MEMBRANE HYPERPOLARIZATION,1.7249e-05,-0.57582,-0.55161,1,0
1,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,1.3909e-05,-0.57593,-0.52811,1,0
1,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,5.337e-06,-0.57595,-0.58917,1,0
1,GO MUSCLE TISSUE DEVELOPMENT,4.2539e-06,-0.57613,-0.56358,1,0
1,GO NEGATIVE REGULATION OF PROTEIN MATURATION,1.0403e-05,-0.57615,-0.64221,1,0
1,GO MUSCLE CELL PROLIFERATION,5.337e-06,-0.57628,-0.5991,1,0
1,GO VACUOLE ORGANIZATION,3.9422e-06,-0.57635,-0.59383,1,0
1,GO NEGATIVE REGULATION OF NEURON DEATH,6.2007e-06,-0.57636,-0.56396,1,0
1,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,2.636e-05,-0.57642,-0.62919,1,0
1,GO MUSCLE SYSTEM PROCESS,4.9495e-06,-0.57658,-0.55852,1,0
1,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,2.636e-05,-0.57662,-0.54984,1,0
1,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,9.6689e-06,-0.57665,-0.5756,1,0
1,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,4.8997e-05,-0.57669,-0.49904,1,0
1,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,0.0057394,-0.57677,-0.7163,1,0
1,GO HEART GROWTH,4.9495e-06,-0.57682,-0.55838,1,0
1,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,4.5891e-06,-0.57688,-0.63603,1,0
1,GO SPECIFICATION OF SYMMETRY,6.2007e-06,-0.57712,-0.5362,1,0
1,GO REGULATION OF MACROPHAGE ACTIVATION,4.2763e-05,-0.57713,-0.67608,1,0
1,GO RAB PROTEIN SIGNAL TRANSDUCTION,2.1347e-05,-0.57717,-0.6288,1,0
1,GO SEQUESTERING OF TRIGLYCERIDE,7.1973e-06,-0.5772,-0.57495,1,0
1,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,1.6059e-05,-0.57723,-0.64897,1,0
1,GO CARBOHYDRATE PHOSPHORYLATION,1.2035e-05,-0.57725,-0.58334,1,0
1,GO ENDOMEMBRANE SYSTEM ORGANIZATION,4.9495e-06,-0.57729,-0.60006,1,0
1,GO REGULATION OF GROWTH,4.5891e-06,-0.57751,-0.5728,1,0
1,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,4.8997e-05,-0.57753,-0.56334,1,0
1,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,7.7514e-06,-0.57755,-0.62319,1,0
1,GO ENERGY RESERVE METABOLIC PROCESS,8.9843e-06,-0.57775,-0.53303,1,0
1,GO NEGATIVE T CELL SELECTION,0.010101,-0.57776,-0.57663,1,0
1,GO GLIAL CELL DIFFERENTIATION,6.6813e-06,-0.57779,-0.56185,1,0
1,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,7.7514e-06,-0.57795,-0.57249,1,0
1,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,6.2007e-06,-0.57803,-0.60362,1,0
1,GO NEGATIVE REGULATION OF COAGULATION,4.2763e-05,-0.57811,-0.61847,1,0
1,GO SPHINGOLIPID METABOLIC PROCESS,1.4947e-05,-0.57824,-0.55052,1,0
1,GO POSITIVE REGULATION OF CELL DEVELOPMENT,4.5891e-06,-0.5783,-0.58738,1,0
1,GO EPHRIN RECEPTOR SIGNALING PATHWAY,3.9422e-06,-0.57831,-0.59017,1,0
1,GO T HELPER 17 TYPE IMMUNE RESPONSE,7.3279e-05,-0.57833,-0.62617,1,0
1,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,4.5891e-06,-0.57838,-0.59354,1,0
1,GO REGULATION OF FIBRINOLYSIS,2.4576e-05,-0.57848,-0.60703,1,0
1,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,1.1191e-05,-0.57849,-0.58399,1,0
1,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,1.3909e-05,-0.5785,-0.57358,1,0
1,GO REGULATION OF CELLULAR RESPONSE TO STRESS,4.2539e-06,-0.57876,-0.56384,1,0
1,GO REGULATION OF MUSCLE CONTRACTION,5.337e-06,-0.57885,-0.52449,1,0
1,GO EMBRYO IMPLANTATION,7.1973e-06,-0.57887,-0.6498,1,0
1,GO REGULATION OF CALCIUM ION IMPORT,1.8524e-05,-0.57891,-0.59067,1,0
1,GO REGULATION OF SYSTEM PROCESS,5.7533e-06,-0.57892,-0.53573,1,0
1,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.00018128,-0.57892,-0.56527,1,0
1,GO DENDRITE MORPHOGENESIS,7.7514e-06,-0.57909,-0.63172,1,0
1,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.00042807,-0.57913,-0.65735,1,0
1,GO POSITIVE REGULATION OF CELL GROWTH,4.9495e-06,-0.57919,-0.6022,1,0
1,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,4.5891e-06,-0.57927,-0.58746,1,0
1,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,2.4576e-05,-0.57929,-0.63359,1,0
1,GO REGULATION OF TELOMERE CAPPING,8.3461e-06,-0.57938,-0.60287,1,0
1,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,2.2907e-05,-0.57939,-0.52831,1,0
1,GO MEMBRANE FUSION,5.7533e-06,-0.57939,-0.57954,1,0
1,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,4.2539e-06,-0.57942,-0.6224,1,0
1,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,6.2007e-06,-0.57945,-0.52057,1,0
1,GO DENDRITE DEVELOPMENT,6.2007e-06,-0.5795,-0.62371,1,0
1,GO NEURON DEVELOPMENT,6.6813e-06,-0.57951,-0.60825,1,0
1,GO MITOPHAGY,5.337e-06,-0.57964,-0.64981,1,0
1,GO REGULATION OF GLUCOSE METABOLIC PROCESS,1.2939e-05,-0.58003,-0.5629,1,0
1,GO REGULATION OF PROTEIN KINASE ACTIVITY,5.337e-06,-0.5801,-0.5799,1,0
1,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,0.0003797,-0.58012,-0.51866,1,0
1,GO LIPID STORAGE,6.2007e-06,-0.58014,-0.56923,1,0
1,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,3.9422e-06,-0.58023,-0.62589,1,0
1,GO RESPONSE TO COLD,1.8524e-05,-0.58046,-0.56748,1,0
1,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,9.6689e-06,-0.58065,-0.63058,1,0
1,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,7.1973e-06,-0.58086,-0.55233,1,0
1,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.00048214,-0.58092,-0.49406,1,0
1,GO HETEROCHROMATIN ORGANIZATION,7.1973e-06,-0.58095,-0.59582,1,0
1,GO VESICLE TRANSPORT ALONG MICROTUBULE,5.7533e-06,-0.58107,-0.63401,1,0
1,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,3.9422e-06,-0.58108,-0.60424,1,0
1,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,4.9495e-06,-0.58143,-0.59061,1,0
1,GO RESPONSE TO ENDOGENOUS STIMULUS,4.5891e-06,-0.58144,-0.57154,1,0
1,GO RECEPTOR METABOLIC PROCESS,4.2539e-06,-0.58148,-0.58829,1,0
1,GO MAINTENANCE OF CELL POLARITY,4.5779e-05,-0.5816,-0.52982,1,0
1,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,1.1191e-05,-0.58166,-0.62303,1,0
1,GO REGULATION OF MICROTUBULE BINDING,3.248e-05,-0.58177,-0.68558,1,0
1,GO RESPONSE TO HYPEROXIA,4.2539e-06,-0.58183,-0.61675,1,0
1,GO REGULATION OF COLLATERAL SPROUTING,6.8565e-05,-0.58191,-0.66103,1,0
1,GO NEURAL PRECURSOR CELL PROLIFERATION,8.3461e-06,-0.58197,-0.55438,1,0
1,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.00024771,-0.58208,-0.61327,1,0
1,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,8.9843e-06,-0.58226,-0.5144,1,0
1,GO REGULATION OF MICROTUBULE POLYMERIZATION,1.7249e-05,-0.58237,-0.61738,1,0
1,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,4.5779e-05,-0.58238,-0.52036,1,0
1,GO POLYSACCHARIDE METABOLIC PROCESS,7.7514e-06,-0.58241,-0.56264,1,0
1,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,1.3909e-05,-0.58255,-0.65677,1,0
1,GO GROWTH,4.5891e-06,-0.58257,-0.5793,1,0
1,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,1.9888e-05,-0.58269,-0.56772,1,0
1,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,8.9327e-05,-0.58273,-0.54253,1,0
1,GO KERATAN SULFATE METABOLIC PROCESS,1.2939e-05,-0.58279,-0.62888,1,0
1,GO NOTCH RECEPTOR PROCESSING,0.00018128,-0.58282,-0.56014,1,0
1,GO MUSCLE CONTRACTION,5.337e-06,-0.58286,-0.54948,1,0
1,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,2.8267e-05,-0.58305,-0.64347,1,0
1,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,4.5891e-06,-0.58319,-0.59619,1,0
1,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,5.337e-06,-0.58344,-0.60084,1,0
1,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,4.2539e-06,-0.58356,-0.53789,1,0
1,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,6.2007e-06,-0.58362,-0.58354,1,0
1,GO AUTOPHAGOSOME ORGANIZATION,4.2539e-06,-0.58375,-0.60544,1,0
1,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,4.2539e-06,-0.58383,-0.59728,1,0
1,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,3.4805e-05,-0.58388,-0.56469,1,0
1,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.00015974,-0.58392,-0.58837,1,0
1,GO POSITIVE REGULATION OF COAGULATION,7.7514e-06,-0.58396,-0.61084,1,0
1,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,4.2539e-06,-0.58399,-0.60222,1,0
1,GO RESPONSE TO COCAINE,5.6086e-05,-0.58412,-0.52326,1,0
1,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,1.4947e-05,-0.58416,-0.64659,1,0
1,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,6.2007e-06,-0.58434,-0.55272,1,0
1,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,6.6813e-06,-0.58434,-0.56643,1,0
1,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,4.8997e-05,-0.58438,-0.57755,1,0
1,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,6.2007e-06,-0.58449,-0.56766,1,0
1,GO B CELL HOMEOSTASIS,5.7533e-06,-0.58451,-0.68219,1,0
1,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,8.3461e-06,-0.58457,-0.58134,1,0
1,GO LEPTIN MEDIATED SIGNALING PATHWAY,4.2763e-05,-0.58464,-0.51092,1,0
1,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,4.9495e-06,-0.58466,-0.58036,1,0
1,GO RESPONSE TO CALCIUM ION,7.1973e-06,-0.58482,-0.5362,1,0
1,GO STRIATED MUSCLE CONTRACTION,6.6813e-06,-0.58487,-0.54027,1,0
1,GO CELLULAR RESPONSE TO HORMONE STIMULUS,4.2539e-06,-0.58492,-0.57127,1,0
1,GO PEPTIDYL AMINO ACID MODIFICATION,4.2539e-06,-0.58497,-0.57798,1,0
1,GO CARDIAC CONDUCTION,1.1191e-05,-0.58501,-0.54699,1,0
1,GO REGULATION OF WOUND HEALING,5.337e-06,-0.58521,-0.60167,1,0
1,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,4.5891e-06,-0.58528,-0.63017,1,0
1,GO PEPTIDYL LYSINE DIMETHYLATION,4.9495e-06,-0.58529,-0.6018,1,0
1,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,4.2539e-06,-0.5853,-0.65535,1,0
1,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,1.0403e-05,-0.58538,-0.591,1,0
1,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,4.5891e-06,-0.58549,-0.5902,1,0
1,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,9.6689e-06,-0.58551,-0.65896,1,0
1,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,4.5779e-05,-0.58555,-0.54593,1,0
1,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,2.636e-05,-0.58577,-0.51603,1,0
1,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,6.2007e-06,-0.58581,-0.55536,1,0
1,GO MICROTUBULE POLYMERIZATION,8.3461e-06,-0.58587,-0.6259,1,0
1,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.0031545,-0.58608,-0.55092,1,0
1,GO DEVELOPMENTAL GROWTH,4.2539e-06,-0.5861,-0.59579,1,0
1,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,8.9843e-06,-0.5861,-0.57048,1,0
1,GO REGULATION OF CHROMATIN ORGANIZATION,4.9495e-06,-0.58614,-0.58109,1,0
1,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,6.6813e-06,-0.58641,-0.60749,1,0
1,GO NEGATIVE REGULATION OF GENE SILENCING,1.4947e-05,-0.58663,-0.55292,1,0
1,GO POSITIVE REGULATION OF BONE MINERALIZATION,2.636e-05,-0.58665,-0.62281,1,0
1,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,7.7514e-06,-0.58677,-0.55676,1,0
1,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,5.7533e-06,-0.58687,-0.60914,1,0
1,GO RESPONSE TO ACID CHEMICAL,4.5891e-06,-0.58688,-0.56368,1,0
1,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.00026348,-0.58697,-0.62507,1,0
1,GO REGULATION OF WNT SIGNALING PATHWAY,4.9495e-06,-0.58703,-0.56418,1,0
1,GO REGULATION OF MAPK CASCADE,4.5891e-06,-0.58708,-0.60757,1,0
1,GO HISTONE H3 K9 MODIFICATION,4.2539e-06,-0.58724,-0.62478,1,0
1,GO REGULATION OF HORMONE METABOLIC PROCESS,9.5377e-05,-0.58726,-0.63966,1,0
1,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,8.9843e-06,-0.58733,-0.57242,1,0
1,GO NEUROTRANSMITTER UPTAKE,1.8524e-05,-0.58743,-0.50557,1,0
1,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,6.6813e-06,-0.5875,-0.60032,1,0
1,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,1.6059e-05,-0.58751,-0.60686,1,0
1,GO ENTEROENDOCRINE CELL DIFFERENTIATION,7.1973e-06,-0.58756,-0.60029,1,0
1,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,6.2007e-06,-0.58763,-0.58122,1,0
1,GO RESPONSE TO CAMP,6.2007e-06,-0.58768,-0.56418,1,0
1,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,5.337e-06,-0.58783,-0.6228,1,0
1,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,4.2539e-06,-0.58794,-0.55868,1,0
1,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,3.9422e-06,-0.58803,-0.6272,1,0
1,GO BONE MINERALIZATION,8.9843e-06,-0.58805,-0.59832,1,0
1,GO REGULATION OF SODIUM ION TRANSPORT,1.0403e-05,-0.58813,-0.53412,1,0
1,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,3.9422e-06,-0.58814,-0.60585,1,0
1,GO MEMBRANE DEPOLARIZATION,4.2763e-05,-0.58815,-0.55443,1,0
1,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,2.8267e-05,-0.58824,-0.69822,1,0
1,GO INTERFERON BETA PRODUCTION,1.0403e-05,-0.58832,-0.64041,1,0
1,GO GOLGI ORGANIZATION,4.2539e-06,-0.58836,-0.63801,1,0
1,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,2.4576e-05,-0.58857,-0.6194,1,0
1,GO RESPONSE TO INCREASED OXYGEN LEVELS,4.2539e-06,-0.58863,-0.54042,1,0
1,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,3.9422e-06,-0.58869,-0.57058,1,0
1,GO NEUROTRANSMITTER REUPTAKE,2.2907e-05,-0.58871,-0.52489,1,0
1,GO METANEPHRIC EPITHELIUM DEVELOPMENT,3.248e-05,-0.58876,-0.62393,1,0
1,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,4.9495e-06,-0.58879,-0.58,1,0
1,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,6.6813e-06,-0.58881,-0.62839,1,0
1,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,2.2907e-05,-0.58883,-0.68056,1,0
1,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,4.5891e-06,-0.5889,-0.588,1,0
1,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,1.2939e-05,-0.58891,-0.5489,1,0
1,GO B CELL DIFFERENTIATION,7.7514e-06,-0.58893,-0.64365,1,0
1,GO DETERMINATION OF ADULT LIFESPAN,2.4576e-05,-0.589,-0.57114,1,0
1,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,7.1973e-06,-0.58908,-0.55578,1,0
1,GO REGULATION OF BLOOD PRESSURE,5.7533e-06,-0.58917,-0.54851,1,0
1,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,1.2035e-05,-0.58923,-0.5893,1,0
1,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,8.3641e-05,-0.58931,-0.59593,1,0
1,GO CELL PART MORPHOGENESIS,4.5891e-06,-0.58938,-0.63644,1,0
1,GO GAMMA DELTA T CELL DIFFERENTIATION,1.3909e-05,-0.58955,-0.73576,1,0
1,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,4.5779e-05,-0.5896,-0.6546,1,0
1,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,2.636e-05,-0.58967,-0.58097,1,0
1,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,4.2539e-06,-0.58981,-0.59464,1,0
1,GO REGULATION OF HISTONE METHYLATION,6.2007e-06,-0.58984,-0.63097,1,0
1,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,1.4947e-05,-0.59,-0.58597,1,0
1,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,1.0403e-05,-0.59003,-0.5587,1,0
1,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,8.9843e-06,-0.59005,-0.57022,1,0
1,GO MULTICELLULAR ORGANISMAL MOVEMENT,1.0403e-05,-0.59007,-0.58347,1,0
1,GO REGULATION OF PROTEIN MATURATION,5.337e-06,-0.59008,-0.58018,1,0
1,GO EMBRYO DEVELOPMENT,4.2539e-06,-0.59015,-0.5851,1,0
1,GO NEGATIVE REGULATION OF HEMOPOIESIS,7.1973e-06,-0.59033,-0.63411,1,0
1,GO REGULATION OF MYOBLAST FUSION,0.0010798,-0.59043,-0.61249,1,0
1,GO AMINOGLYCAN METABOLIC PROCESS,6.2007e-06,-0.59051,-0.61518,1,0
1,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,5.7533e-06,-0.59054,-0.57061,1,0
1,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,6.2007e-06,-0.59072,-0.60157,1,0
1,GO FOREBRAIN NEURON DEVELOPMENT,0.00010866,-0.59082,-0.57357,1,0
1,GO REGULATION OF GLIAL CELL MIGRATION,3.7287e-05,-0.59092,-0.7084,1,0
1,GO MOVEMENT IN HOST ENVIRONMENT,7.7514e-06,-0.59092,-0.57741,1,0
1,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,6.6813e-06,-0.59127,-0.6113,1,0
1,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,4.5891e-06,-0.59136,-0.64018,1,0
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,6.2007e-06,-0.59138,-0.57533,1,0
1,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.00010866,-0.59146,-0.58486,1,0
1,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,1.0403e-05,-0.59146,-0.63556,1,0
1,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,4.2539e-06,-0.59152,-0.59108,1,0
1,GO PARENTAL BEHAVIOR,0.0029965,-0.59153,-0.50789,1,0
1,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,5.337e-06,-0.59159,-0.60102,1,0
1,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,5.2428e-05,-0.59182,-0.50914,1,0
1,GO MATURE B CELL DIFFERENTIATION,2.4576e-05,-0.59187,-0.7405,1,0
1,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,1.0403e-05,-0.59207,-0.54185,1,0
1,GO REGULATION OF RECEPTOR INTERNALIZATION,4.5891e-06,-0.59218,-0.62078,1,0
1,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,1.6059e-05,-0.59224,-0.60305,1,0
1,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,8.3641e-05,-0.5924,-0.72215,1,0
1,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,5.7533e-06,-0.59257,-0.62662,1,0
1,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,3.248e-05,-0.59258,-0.56966,1,0
1,GO COMPLEMENT ACTIVATION,0.0020776,-0.59261,-0.62208,1,0
1,GO HOMEOSTASIS OF NUMBER OF CELLS,3.9422e-06,-0.59271,-0.59443,1,0
1,GO MACROMOLECULE DEACYLATION,5.7533e-06,-0.59273,-0.57358,1,0
1,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,6.6813e-06,-0.59274,-0.6113,1,0
1,GO NEGATIVE REGULATION OF BLOOD PRESSURE,5.6086e-05,-0.5928,-0.50416,1,0
1,GO POSITIVE REGULATION OF B CELL ACTIVATION,2.1347e-05,-0.59305,-0.65578,1,0
1,GO PRIMARY MIRNA PROCESSING,2.1347e-05,-0.59305,-0.6158,1,0
1,GO CELL GROWTH,4.2539e-06,-0.59312,-0.60465,1,0
1,GO CELLULAR RESPONSE TO DRUG,4.9495e-06,-0.5932,-0.55415,1,0
1,GO POSITIVE REGULATION OF MAPK CASCADE,4.5891e-06,-0.59325,-0.60976,1,0
1,GO REGULATION OF MUSCLE SYSTEM PROCESS,4.9495e-06,-0.59327,-0.54997,1,0
1,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,4.5891e-06,-0.59334,-0.62273,1,0
1,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,3.9422e-06,-0.59334,-0.60304,1,0
1,GO POSITIVE REGULATION OF URINE VOLUME,3.7287e-05,-0.5934,-0.56116,1,0
1,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,1.4947e-05,-0.59356,-0.64909,1,0
1,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,4.5891e-06,-0.59361,-0.60198,1,0
1,GO AXON DEVELOPMENT,4.5891e-06,-0.59374,-0.63389,1,0
1,GO POSITIVE REGULATION OF TISSUE REMODELING,3.0304e-05,-0.59385,-0.5865,1,0
1,GO PLACENTA DEVELOPMENT,4.9495e-06,-0.59393,-0.61026,1,0
1,GO CELLULAR RESPONSE TO DSRNA,3.7287e-05,-0.59396,-0.58268,1,0
1,GO DIGESTIVE SYSTEM DEVELOPMENT,7.1973e-06,-0.59401,-0.59141,1,0
1,GO REGULATION OF ACTIN FILAMENT LENGTH,4.5891e-06,-0.59403,-0.61666,1,0
1,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,6.2007e-06,-0.59408,-0.63842,1,0
1,GO FOREBRAIN NEURON DIFFERENTIATION,0.00029789,-0.59409,-0.52689,1,0
1,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,4.9495e-06,-0.5942,-0.58985,1,0
1,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,4.2539e-06,-0.59424,-0.62613,1,0
1,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,5.337e-06,-0.59429,-0.62233,1,0
1,GO REGULATION OF MYOTUBE DIFFERENTIATION,1.9888e-05,-0.59447,-0.62327,1,0
1,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,6.8565e-05,-0.59447,-0.64106,1,0
1,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,5.7533e-06,-0.5945,-0.64877,1,0
1,GO REGULATION OF CELL DEVELOPMENT,4.5891e-06,-0.59456,-0.60198,1,0
1,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,1.4947e-05,-0.59457,-0.58593,1,0
1,GO REGULATION OF BODY FLUID LEVELS,4.5891e-06,-0.59462,-0.59916,1,0
1,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.0003797,-0.5947,-0.51706,1,0
1,GO ADIPOSE TISSUE DEVELOPMENT,8.3461e-06,-0.59481,-0.59327,1,0
1,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,0.00010181,-0.59486,-0.56633,1,0
1,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,3.9422e-06,-0.59488,-0.59371,1,0
1,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,7.7514e-06,-0.59496,-0.55103,1,0
1,GO LYSOSOME LOCALIZATION,4.2539e-06,-0.59499,-0.63557,1,0
1,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,5.337e-06,-0.5955,-0.59231,1,0
1,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,4.9495e-06,-0.5955,-0.57782,1,0
1,GO AMYLOID BETA CLEARANCE,2.4576e-05,-0.59585,-0.68527,1,0
1,GO NEGATIVE REGULATION OF AUTOPHAGY,3.9422e-06,-0.59587,-0.61602,1,0
1,GO ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.00011593,-0.596,-0.5268,1,0
1,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,6.6813e-06,-0.59628,-0.61245,1,0
1,GO LONG TERM MEMORY,1.6059e-05,-0.59646,-0.57328,1,0
1,GO REGULATION OF CHROMATIN ASSEMBLY,7.1973e-06,-0.59659,-0.62973,1,0
1,GO ENTRY INTO HOST,1.0403e-05,-0.59669,-0.60854,1,0
1,GO NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY,6.6813e-06,-0.59681,-0.56435,1,0
1,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,6.6813e-06,-0.59687,-0.62672,1,0
1,GO MESENCHYME DEVELOPMENT,4.9495e-06,-0.59702,-0.59978,1,0
1,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,1.2939e-05,-0.59705,-0.60123,1,0
1,GO CELL CELL SIGNALING BY WNT,4.5891e-06,-0.59715,-0.57557,1,0
1,GO POSITIVE REGULATION OF GROWTH,4.5891e-06,-0.5972,-0.60935,1,0
1,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,8.9843e-06,-0.59724,-0.57807,1,0
1,GO REGULATION OF LIPID STORAGE,4.5891e-06,-0.59731,-0.62575,1,0
1,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,1.3909e-05,-0.59737,-0.61596,1,0
1,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,3.0304e-05,-0.59747,-0.53931,1,0
1,GO SPINDLE LOCALIZATION,8.3461e-06,-0.59749,-0.60364,1,0
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,7.1973e-06,-0.59761,-0.56189,1,0
1,GO MEGAKARYOCYTE DIFFERENTIATION,4.2539e-06,-0.59767,-0.61896,1,0
1,GO CELLULAR HYPEROSMOTIC RESPONSE,4.5779e-05,-0.59773,-0.56877,1,0
1,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,4.2539e-06,-0.59774,-0.65638,1,0
1,GO BIOMINERALIZATION,7.7514e-06,-0.59779,-0.61026,1,0
1,GO NEURAL CREST CELL DIFFERENTIATION,4.5891e-06,-0.59792,-0.58938,1,0
1,GO REGULATION OF CELL DIFFERENTIATION,4.5891e-06,-0.59797,-0.59233,1,0
1,GO RESPONSE TO WOUNDING,4.9495e-06,-0.59797,-0.62815,1,0
1,GO CELL PROLIFERATION IN FOREBRAIN,2.8267e-05,-0.59804,-0.61873,1,0
1,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,6.2007e-06,-0.59807,-0.6587,1,0
1,GO REGULATION OF CYTOSKELETON ORGANIZATION,4.2539e-06,-0.59816,-0.61756,1,0
1,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,6.6813e-06,-0.59818,-0.62872,1,0
1,GO DEVELOPMENTAL MATURATION,7.7514e-06,-0.59822,-0.55799,1,0
1,GO REGULATION OF PROTEIN BINDING,4.5891e-06,-0.59828,-0.5953,1,0
1,GO MUSCLE CELL DEVELOPMENT,4.9495e-06,-0.59853,-0.55824,1,0
1,GO NEURON MATURATION,3.0304e-05,-0.5989,-0.58301,1,0
1,GO POSITIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,5.2428e-05,-0.59892,-0.62156,1,0
1,GO CELLULAR GLUCAN METABOLIC PROCESS,9.6689e-06,-0.59896,-0.53451,1,0
1,GO REGULATION OF BIOMINERALIZATION,7.7514e-06,-0.59907,-0.63361,1,0
1,GO PANCREAS DEVELOPMENT,7.7514e-06,-0.59923,-0.5896,1,0
1,GO INFLAMMATORY RESPONSE TO WOUNDING,7.8298e-05,-0.59928,-0.74947,1,0
1,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,2.8267e-05,-0.59931,-0.70058,1,0
1,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,4.9495e-06,-0.59931,-0.61717,1,0
1,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,4.9495e-06,-0.59932,-0.61396,1,0
1,GO INTRACELLULAR STEROL TRANSPORT,4.2539e-06,-0.59933,-0.63785,1,0
1,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,4.5891e-06,-0.59934,-0.58207,1,0
1,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,5.7533e-06,-0.59941,-0.58763,1,0
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,7.8298e-05,-0.59943,-0.64505,1,0
1,GO SENSORY SYSTEM DEVELOPMENT,4.5891e-06,-0.59948,-0.59947,1,0
1,GO SYNAPTIC VESICLE PRIMING,0.00026348,-0.5995,-0.63003,1,0
1,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,7.1973e-06,-0.59962,-0.55029,1,0
1,GO STRIATED MUSCLE CELL DIFFERENTIATION,4.9495e-06,-0.59962,-0.57905,1,0
1,GO MORPHOGENESIS OF AN EPITHELIUM,4.5891e-06,-0.59962,-0.5926,1,0
1,GO BRANCHING MORPHOGENESIS OF A NERVE,0.00033648,-0.59963,-0.5794,1,0
1,GO OVULATION CYCLE PROCESS,3.9422e-06,-0.59971,-0.59869,1,0
1,GO RAC PROTEIN SIGNAL TRANSDUCTION,4.9495e-06,-0.5998,-0.63138,1,0
1,GO LENS FIBER CELL DIFFERENTIATION,1.4947e-05,-0.59982,-0.55305,1,0
1,GO MYELOID CELL HOMEOSTASIS,4.2539e-06,-0.59989,-0.60077,1,0
1,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,6.6813e-06,-0.59995,-0.67287,1,0
1,GO CIRCULATORY SYSTEM PROCESS,4.9495e-06,-0.60007,-0.56389,1,0
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,5.7533e-06,-0.60007,-0.58129,1,0
1,GO REGULATION OF BLOOD CIRCULATION,7.1973e-06,-0.6003,-0.54982,1,0
1,GO GLIAL CELL DEVELOPMENT,6.2007e-06,-0.60032,-0.58412,1,0
1,GO N ACETYLNEURAMINATE METABOLIC PROCESS,7.1973e-06,-0.60042,-0.60914,1,0
1,GO POSITIVE REGULATION OF PROTEIN MATURATION,1.0403e-05,-0.60045,-0.6256,1,0
1,GO CAMERA TYPE EYE DEVELOPMENT,4.5891e-06,-0.60054,-0.58957,1,0
1,GO HAIR CELL DIFFERENTIATION,1.0403e-05,-0.6006,-0.59048,1,0
1,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,7.1973e-06,-0.60068,-0.60088,1,0
1,GO DIVALENT METAL ION EXPORT,7.7514e-06,-0.60091,-0.62065,1,0
1,GO NEGATIVE REGULATION OF LIPID STORAGE,5.7533e-06,-0.60099,-0.62864,1,0
1,GO POSITIVE REGULATION OF VASOCONSTRICTION,9.6689e-06,-0.6012,-0.63162,1,0
1,GO CELLULAR RESPONSE TO CALCIUM ION,1.6059e-05,-0.60136,-0.55979,1,0
1,GO REGULATION OF KIDNEY DEVELOPMENT,9.6689e-06,-0.60169,-0.59793,1,0
1,GO MAINTENANCE OF CELL NUMBER,4.9495e-06,-0.60181,-0.56622,1,0
1,GO CELL PROJECTION ORGANIZATION,5.337e-06,-0.60196,-0.59017,1,0
1,GO CARDIAC MUSCLE CONTRACTION,6.6813e-06,-0.60198,-0.56555,1,0
1,GO POSITIVE REGULATION OF OSSIFICATION,1.2035e-05,-0.60202,-0.59654,1,0
1,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,4.9495e-06,-0.60216,-0.60772,1,0
1,GO SMOOTH MUSCLE CELL DIFFERENTIATION,5.7533e-06,-0.60227,-0.62282,1,0
1,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,0.00060992,-0.60237,-0.65652,1,0
1,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,4.9495e-06,-0.60246,-0.59516,1,0
1,GO REGULATION OF DENDRITE MORPHOGENESIS,4.9495e-06,-0.60247,-0.63492,1,0
1,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,8.3461e-06,-0.60282,-0.60391,1,0
1,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,3.9422e-06,-0.60285,-0.602,1,0
1,GO LIPOPROTEIN LOCALIZATION,9.6689e-06,-0.60304,-0.62574,1,0
1,GO RECEPTOR INTERNALIZATION,4.5891e-06,-0.60311,-0.59856,1,0
1,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,2.1347e-05,-0.60324,-0.59079,1,0
1,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,3.9422e-06,-0.60337,-0.59629,1,0
1,GO EPITHELIAL CELL PROLIFERATION,4.9495e-06,-0.60347,-0.60425,1,0
1,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,7.8298e-05,-0.60353,-0.57851,1,0
1,GO PHAGOCYTOSIS,8.9843e-06,-0.60354,-0.67088,1,0
1,GO PLATELET DEGRANULATION,1.4947e-05,-0.60354,-0.64131,1,0
1,GO SERTOLI CELL DEVELOPMENT,7.7514e-06,-0.60362,-0.63226,1,0
1,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.00072571,-0.60367,-0.58264,1,0
1,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,4.9495e-06,-0.60369,-0.62073,1,0
1,GO ODONTOGENESIS,6.2007e-06,-0.6037,-0.61158,1,0
1,GO REGULATION OF TUBE SIZE,7.7514e-06,-0.60372,-0.53695,1,0
1,GO VOCALIZATION BEHAVIOR,0.00029789,-0.60376,-0.52274,1,0
1,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,1.0403e-05,-0.60384,-0.64495,1,0
1,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.011063,-0.60397,-0.57249,1,0
1,GO RESPONSE TO CARBOHYDRATE,5.337e-06,-0.60407,-0.56102,1,0
1,GO RESPONSE TO INTERLEUKIN 15,0.00019306,-0.6041,-0.76376,1,0
1,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.00010866,-0.60413,-0.56808,1,0
1,GO REGULATION OF PROTEIN POLYMERIZATION,4.5891e-06,-0.60439,-0.61396,1,0
1,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,4.2539e-06,-0.6044,-0.62788,1,0
1,GO DENDRITIC SPINE DEVELOPMENT,5.337e-06,-0.60442,-0.63123,1,0
1,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,5.7533e-06,-0.60443,-0.60945,1,0
1,GO REGULATION OF METANEPHROS DEVELOPMENT,1.8524e-05,-0.60465,-0.66367,1,0
1,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,8.9327e-05,-0.60487,-0.57569,1,0
1,GO T CELL EXTRAVASATION,0.00035748,-0.60495,-0.65435,1,0
1,GO GAMMA DELTA T CELL ACTIVATION,5.6086e-05,-0.60509,-0.67546,1,0
1,GO RESPONSE TO PEPTIDE,4.5891e-06,-0.60516,-0.59193,1,0
1,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,1.8524e-05,-0.60582,-0.61288,1,0
1,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,8.9843e-06,-0.60584,-0.57477,1,0
1,GO MUSCLE STRUCTURE DEVELOPMENT,4.5891e-06,-0.60586,-0.58148,1,0
1,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,7.7514e-06,-0.60606,-0.63505,1,0
1,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,4.5891e-06,-0.60633,-0.65306,1,0
1,GO REGULATION OF VACUOLE ORGANIZATION,4.5891e-06,-0.60666,-0.61136,1,0
1,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,0.00040321,-0.60678,-0.5192,1,0
1,GO ORGAN GROWTH,4.5891e-06,-0.60688,-0.58004,1,0
1,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,4.9495e-06,-0.60693,-0.6075,1,0
1,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,8.9843e-06,-0.607,-0.61608,1,0
1,GO NEGATIVE REGULATION OF GROWTH,4.9495e-06,-0.60706,-0.58543,1,0
1,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,4.2539e-06,-0.60727,-0.68889,1,0
1,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,8.9843e-06,-0.6073,-0.64902,1,0
1,GO REGULATION OF CELL PROJECTION ASSEMBLY,4.5891e-06,-0.60748,-0.58601,1,0
1,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,4.5891e-06,-0.60755,-0.58217,1,0
1,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.00051151,-0.60755,-0.70599,1,0
1,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,1.2939e-05,-0.60759,-0.5771,1,0
1,GO CELLULAR RESPONSE TO PH,1.3909e-05,-0.6076,-0.57099,1,0
1,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,4.5891e-06,-0.60764,-0.59865,1,0
1,GO HYALURONAN CATABOLIC PROCESS,1.0403e-05,-0.60779,-0.61714,1,0
1,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,9.6689e-06,-0.60783,-0.71846,1,0
1,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,1.1191e-05,-0.60788,-0.5976,1,0
1,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,2.2907e-05,-0.60814,-0.66468,1,0
1,GO CARDIAC CELL DEVELOPMENT,4.9495e-06,-0.6082,-0.55577,1,0
1,GO CANONICAL WNT SIGNALING PATHWAY,4.9495e-06,-0.60831,-0.57443,1,0
1,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,7.1973e-06,-0.60846,-0.61361,1,0
1,GO SMOOTH MUSCLE CELL PROLIFERATION,5.337e-06,-0.60849,-0.63641,1,0
1,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,4.5891e-06,-0.60855,-0.59036,1,0
1,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,3.4805e-05,-0.60871,-0.64219,1,0
1,GO RESPONSE TO PEPTIDE HORMONE,4.5891e-06,-0.60873,-0.57605,1,0
1,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,7.3279e-05,-0.60875,-0.6694,1,0
1,GO REGULATION OF PROTEIN DEACETYLATION,7.7514e-06,-0.6088,-0.59229,1,0
1,GO REGULATION OF ENDOCYTOSIS,4.5891e-06,-0.60895,-0.63688,1,0
1,GO RESPONSE TO INSULIN,4.9495e-06,-0.60922,-0.56815,1,0
1,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,1.0403e-05,-0.60934,-0.5861,1,0
1,GO EXCRETION,1.7249e-05,-0.60947,-0.51793,1,0
1,GO BLOOD COAGULATION INTRINSIC PATHWAY,4.8997e-05,-0.60947,-0.57684,1,0
1,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,4.2539e-06,-0.60952,-0.58083,1,0
1,GO PROTEIN KINASE B SIGNALING,4.9495e-06,-0.61004,-0.59506,1,0
1,GO CELLULAR COMPONENT MORPHOGENESIS,4.2539e-06,-0.61007,-0.63348,1,0
1,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,7.8298e-05,-0.61016,-0.54351,1,0
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,6.2007e-06,-0.61018,-0.62872,1,0
1,GO BRANCHED CHAIN AMINO ACID TRANSPORT,1.4947e-05,-0.61023,-0.7072,1,0
1,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,3.0304e-05,-0.61026,-0.66042,1,0
1,GO TISSUE MORPHOGENESIS,4.2539e-06,-0.61027,-0.59577,1,0
1,GO NEGATIVE REGULATION OF CELL GROWTH,4.9495e-06,-0.61048,-0.60783,1,0
1,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.0013481,-0.61057,-0.68858,1,0
1,GO BONE RESORPTION,6.2007e-06,-0.61071,-0.67873,1,0
1,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,6.2007e-06,-0.61101,-0.55218,1,0
1,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,6.6813e-06,-0.61105,-0.66314,1,0
1,GO OSSIFICATION,4.9495e-06,-0.61146,-0.6052,1,0
1,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,4.5891e-06,-0.61152,-0.58565,1,0
1,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,4.5891e-06,-0.61155,-0.61378,1,0
1,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,9.6689e-06,-0.61163,-0.64894,1,0
1,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,4.9495e-06,-0.61165,-0.67033,1,0
1,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,0.00028019,-0.61172,-0.52774,1,0
1,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,2.8267e-05,-0.61182,-0.621,1,0
1,GO ERYTHROCYTE HOMEOSTASIS,4.2539e-06,-0.61212,-0.59427,1,0
1,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,0.00010181,-0.61214,-0.54575,1,0
1,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,2.1347e-05,-0.61216,-0.60035,1,0
1,GO DEMETHYLATION,5.337e-06,-0.61221,-0.59618,1,0
1,GO REGULATION OF DENDRITE DEVELOPMENT,5.7533e-06,-0.61224,-0.62244,1,0
1,GO DEVELOPMENTAL CELL GROWTH,4.5891e-06,-0.61227,-0.64258,1,0
1,GO COAGULATION,4.9495e-06,-0.61227,-0.63625,1,0
1,GO OVULATION,9.6689e-06,-0.61237,-0.60016,1,0
1,GO FIBRINOLYSIS,4.8997e-05,-0.61239,-0.64291,1,0
1,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,5.337e-06,-0.61242,-0.6221,1,0
1,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.00033648,-0.61255,-0.56725,1,0
1,GO AMINOGLYCAN CATABOLIC PROCESS,1.0403e-05,-0.6127,-0.63506,1,0
1,GO CELL MOTILITY,4.5891e-06,-0.61295,-0.61796,1,0
1,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.00015974,-0.6131,-0.64121,1,0
1,GO MULTI ORGANISM CELLULAR PROCESS,1.2939e-05,-0.61318,-0.69807,1,0
1,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,1.0403e-05,-0.61332,-0.63708,1,0
1,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,4.9495e-06,-0.61341,-0.61767,1,0
1,GO NEURON REMODELING,5.6086e-05,-0.61375,-0.64364,1,0
1,GO COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY,0.0036751,-0.61386,-0.67207,1,0
1,GO ENDOSOMAL TRANSPORT,4.5891e-06,-0.61405,-0.58921,1,0
1,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,0.00042807,-0.61412,-0.73901,1,0
1,GO HEPATOCYTE APOPTOTIC PROCESS,3.0304e-05,-0.61412,-0.61566,1,0
1,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,1.2939e-05,-0.61421,-0.67839,1,0
1,GO RESPONSE TO GROWTH HORMONE,7.1973e-06,-0.61422,-0.57751,1,0
1,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,9.6689e-06,-0.61425,-0.68061,1,0
1,GO VACUOLAR TRANSPORT,4.2539e-06,-0.6144,-0.62984,1,0
1,GO REGULATION OF DEVELOPMENTAL GROWTH,4.5891e-06,-0.61454,-0.59761,1,0
1,GO LEFT RIGHT PATTERN FORMATION,9.6689e-06,-0.6146,-0.5626,1,0
1,GO WOUND HEALING,4.5891e-06,-0.6146,-0.65063,1,0
1,GO RESPONSE TO MECHANICAL STIMULUS,8.3461e-06,-0.61464,-0.60813,1,0
1,GO REGULATION OF VESICLE MEDIATED TRANSPORT,4.9495e-06,-0.61497,-0.61293,1,0
1,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,1.2939e-05,-0.61526,-0.67987,1,0
1,GO MUSCLE CELL MIGRATION,5.337e-06,-0.61529,-0.67734,1,0
1,GO CELLULAR EXTRAVASATION,2.8267e-05,-0.61538,-0.68248,1,0
1,GO CRANIAL NERVE MORPHOGENESIS,1.2035e-05,-0.61548,-0.6398,1,0
1,GO GLYCOGEN BIOSYNTHETIC PROCESS,1.1191e-05,-0.61556,-0.53991,1,0
1,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,4.5891e-06,-0.6156,-0.63983,1,0
1,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.00015974,-0.61569,-0.745,1,0
1,GO I KAPPAB PHOSPHORYLATION,1.2035e-05,-0.61572,-0.68802,1,0
1,GO REGULATION OF INCLUSION BODY ASSEMBLY,4.8997e-05,-0.6158,-0.621,1,0
1,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,2.1347e-05,-0.61582,-0.67889,1,0
1,GO LYMPH NODE DEVELOPMENT,8.9843e-06,-0.61585,-0.68362,1,0
1,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,3.9422e-06,-0.61604,-0.60244,1,0
1,GO MYOFIBRIL ASSEMBLY,5.337e-06,-0.6162,-0.6182,1,0
1,GO LOCALIZATION WITHIN MEMBRANE,6.6813e-06,-0.61622,-0.63728,1,0
1,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,4.2539e-06,-0.61624,-0.64112,1,0
1,GO NEURON PROJECTION EXTENSION,4.5891e-06,-0.6165,-0.66291,1,0
1,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,5.7533e-06,-0.61656,-0.62029,1,0
1,GO POSITIVE REGULATION OF LIPID STORAGE,9.6689e-06,-0.61658,-0.69198,1,0
1,GO NEPHRIC DUCT DEVELOPMENT,0.00019306,-0.61694,-0.52927,1,0
1,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,2.8267e-05,-0.61716,-0.68166,1,0
1,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,0.00024771,-0.61721,-0.68976,1,0
1,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,3.9422e-06,-0.61725,-0.63447,1,0
1,GO CELLULAR RESPONSE TO INSULIN STIMULUS,4.9495e-06,-0.6173,-0.57413,1,0
1,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,7.1973e-06,-0.61735,-0.59698,1,0
1,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,4.9495e-06,-0.61736,-0.65317,1,0
1,GO APICAL PROTEIN LOCALIZATION,3.0304e-05,-0.61744,-0.5704,1,0
1,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,4.5891e-06,-0.61747,-0.58171,1,0
1,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,4.2539e-06,-0.61753,-0.62739,1,0
1,GO EMBRYONIC HEART TUBE DEVELOPMENT,5.337e-06,-0.61768,-0.62669,1,0
1,GO FATTY ACID TRANSMEMBRANE TRANSPORT,7.1973e-06,-0.61791,-0.63099,1,0
1,GO RESPONSE TO ESTROGEN,6.2007e-06,-0.61809,-0.58608,1,0
1,GO METANEPHROS MORPHOGENESIS,1.6059e-05,-0.61816,-0.61358,1,0
1,GO CELLULAR RESPONSE TO NUTRIENT,9.6689e-06,-0.61826,-0.63052,1,0
1,GO REGULATION OF PROTEIN POLYUBIQUITINATION,4.2539e-06,-0.6183,-0.62551,1,0
1,GO HOMOTYPIC CELL CELL ADHESION,4.5891e-06,-0.61861,-0.67365,1,0
1,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,4.9495e-06,-0.61876,-0.66146,1,0
1,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,4.5891e-06,-0.61881,-0.63654,1,0
1,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,1.1191e-05,-0.61921,-0.58224,1,0
1,GO PHOSPHATIDIC ACID METABOLIC PROCESS,6.6813e-06,-0.61952,-0.59306,1,0
1,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,3.0304e-05,-0.62004,-0.583,1,0
1,GO RESPONSE TO INTERFERON ALPHA,0.0023095,-0.62008,-0.66278,1,0
1,GO LUNG EPITHELIUM DEVELOPMENT,3.248e-05,-0.62016,-0.5578,1,0
1,GO REGULATION OF ERBB SIGNALING PATHWAY,5.337e-06,-0.62021,-0.62605,1,0
1,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,7.7514e-06,-0.62033,-0.62587,1,0
1,GO EMBRYONIC MORPHOGENESIS,4.9495e-06,-0.62034,-0.60256,1,0
1,GO JNK CASCADE,4.2539e-06,-0.62105,-0.63677,1,0
1,GO CYTOSKELETON ORGANIZATION,4.2539e-06,-0.6211,-0.60488,1,0
1,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,5.9985e-05,-0.62115,-0.7178,1,0
1,GO REGULATION OF CELL PROJECTION ORGANIZATION,4.2539e-06,-0.6212,-0.63005,1,0
1,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,4.5891e-06,-0.62143,-0.61535,1,0
1,GO PEPTIDYL SERINE MODIFICATION,4.2539e-06,-0.62149,-0.63288,1,0
1,GO 3 UTR MEDIATED MRNA STABILIZATION,6.6813e-06,-0.62152,-0.62212,1,0
1,GO REGULATION OF BONE MINERALIZATION,1.0403e-05,-0.62163,-0.63409,1,0
1,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,4.5891e-06,-0.62169,-0.61992,1,0
1,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,4.5891e-06,-0.62188,-0.62769,1,0
1,GO REGULATION OF PLATELET ACTIVATION,4.5779e-05,-0.62201,-0.68859,1,0
1,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,5.9985e-05,-0.62201,-0.57028,1,0
1,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,4.9495e-06,-0.62206,-0.60568,1,0
1,GO RESPONSE TO PROGESTERONE,7.1973e-06,-0.6221,-0.63613,1,0
1,GO REGULATION OF RUFFLE ASSEMBLY,9.6689e-06,-0.62225,-0.59424,1,0
1,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,2.2907e-05,-0.62232,-0.58452,1,0
1,GO REGULATION OF OSTEOCLAST DEVELOPMENT,1.9888e-05,-0.62237,-0.74463,1,0
1,GO HEPARIN METABOLIC PROCESS,5.337e-06,-0.62257,-0.7014,1,0
1,GO MUSCLE CELL DIFFERENTIATION,4.5891e-06,-0.62257,-0.58476,1,0
1,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,5.337e-06,-0.62264,-0.67329,1,0
1,GO REGULATION OF OSSIFICATION,8.9843e-06,-0.62279,-0.60917,1,0
1,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,6.4139e-05,-0.62295,-0.56283,1,0
1,GO LUNG MORPHOGENESIS,1.0403e-05,-0.62304,-0.6353,1,0
1,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,5.337e-06,-0.62305,-0.63859,1,0
1,GO LAMELLIPODIUM ORGANIZATION,3.9422e-06,-0.62327,-0.61759,1,0
1,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,6.6813e-06,-0.62332,-0.64735,1,0
1,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,1.2939e-05,-0.62336,-0.61419,1,0
1,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,4.2539e-06,-0.6234,-0.62986,1,0
1,GO ENDOCYTOSIS,4.9495e-06,-0.62353,-0.62543,1,0
1,GO CELLULAR RESPONSE TO PEPTIDE,4.2539e-06,-0.62365,-0.59979,1,0
1,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,0.00010866,-0.62372,-0.52289,1,0
1,GO NEGATIVE REGULATION OF HEART CONTRACTION,4.2539e-06,-0.62376,-0.6183,1,0
1,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.00086166,-0.62415,-0.57121,1,0
1,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,5.337e-06,-0.62417,-0.67359,1,0
1,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,5.7533e-06,-0.62419,-0.64082,1,0
1,GO REGULATION OF ISOTYPE SWITCHING,7.1973e-06,-0.62441,-0.65147,1,0
1,GO RESPONSE TO STEROL DEPLETION,8.9843e-06,-0.62447,-0.62917,1,0
1,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,8.9843e-06,-0.62447,-0.57658,1,0
1,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,8.3641e-05,-0.62459,-0.5711,1,0
1,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,7.1973e-06,-0.62477,-0.63363,1,0
1,GO VESICLE CYTOSKELETAL TRAFFICKING,4.9495e-06,-0.62486,-0.66777,1,0
1,GO REGULATION OF RNA EXPORT FROM NUCLEUS,3.9422e-06,-0.62487,-0.68537,1,0
1,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,0.00013188,-0.62488,-0.70663,1,0
1,GO GDP METABOLIC PROCESS,1.3909e-05,-0.62497,-0.52377,1,0
1,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,6.2007e-06,-0.62513,-0.60511,1,0
1,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,8.3461e-06,-0.62529,-0.62768,1,0
1,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,1.3909e-05,-0.62535,-0.59252,1,0
1,GO POSITIVE REGULATION OF CATABOLIC PROCESS,4.2539e-06,-0.62546,-0.615,1,0
1,GO LUNG CELL DIFFERENTIATION,0.00012367,-0.62549,-0.52191,1,0
1,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,4.9495e-06,-0.6255,-0.61708,1,0
1,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,1.7249e-05,-0.62555,-0.61982,1,0
1,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,7.7514e-06,-0.62561,-0.63864,1,0
1,GO RUFFLE ASSEMBLY,8.3461e-06,-0.62567,-0.60294,1,0
1,GO LOOP OF HENLE DEVELOPMENT,0.0003797,-0.62567,-0.61046,1,0
1,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,3.4805e-05,-0.62571,-0.60283,1,0
1,GO SULFUR COMPOUND TRANSPORT,1.2035e-05,-0.62596,-0.59785,1,0
1,GO NEGATIVE REGULATION OF TOR SIGNALING,4.2539e-06,-0.62605,-0.63396,1,0
1,GO ACTIN FILAMENT BASED MOVEMENT,4.2539e-06,-0.62612,-0.62231,1,0
1,GO PROTEIN LOCALIZATION TO CELL SURFACE,4.5891e-06,-0.62638,-0.62571,1,0
1,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,6.2007e-06,-0.627,-0.68795,1,0
1,GO LEUKOCYTE AGGREGATION,0.00031664,-0.62711,-0.73257,1,0
1,GO REGULATION OF GLOMERULUS DEVELOPMENT,1.9888e-05,-0.62715,-0.70805,1,0
1,GO CARDIAC SEPTUM MORPHOGENESIS,4.5891e-06,-0.62739,-0.65689,1,0
1,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,8.3641e-05,-0.62766,-0.67873,1,0
1,GO PROTEIN LOCALIZATION TO VACUOLE,4.9495e-06,-0.62766,-0.64,1,0
1,GO NEURON PROJECTION GUIDANCE,4.9495e-06,-0.62773,-0.67419,1,0
1,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,2.636e-05,-0.62778,-0.66852,1,0
1,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,5.7533e-06,-0.62789,-0.66413,1,0
1,GO ASTROCYTE ACTIVATION,1.8524e-05,-0.62796,-0.69302,1,0
1,GO SCHWANN CELL DEVELOPMENT,6.2007e-06,-0.62802,-0.6416,1,0
1,GO OLIGOPEPTIDE TRANSPORT,7.1973e-06,-0.62815,-0.61773,1,0
1,GO REGULATION OF MACROPHAGE DIFFERENTIATION,1.7249e-05,-0.62818,-0.71711,1,0
1,GO CELLULAR RESPONSE TO STEROL DEPLETION,1.0403e-05,-0.62829,-0.62216,1,0
1,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,4.9495e-06,-0.62832,-0.6608,1,0
1,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,0.00010866,-0.62841,-0.5731,1,0
1,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,3.9936e-05,-0.62842,-0.66145,1,0
1,GO PEPTIDYL TYROSINE MODIFICATION,4.2539e-06,-0.62843,-0.64983,1,0
1,GO CHAPERONE MEDIATED AUTOPHAGY,1.9888e-05,-0.62859,-0.53528,1,0
1,GO RECEPTOR MEDIATED ENDOCYTOSIS,4.9495e-06,-0.62864,-0.60986,1,0
1,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,5.9985e-05,-0.6288,-0.66783,1,0
1,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,4.8997e-05,-0.62883,-0.75512,1,0
1,GO REGULATION OF CELL ADHESION,6.2007e-06,-0.62884,-0.65776,1,0
1,GO OLIGOSACCHARIDE METABOLIC PROCESS,6.6813e-06,-0.62888,-0.59282,1,0
1,GO RESPONSE TO INTERLEUKIN 2,0.00011593,-0.62912,-0.69955,1,0
1,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,1.1191e-05,-0.62922,-0.56812,1,0
1,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,4.2539e-06,-0.62923,-0.59233,1,0
1,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,4.2539e-06,-0.62925,-0.64301,1,0
1,GO OPTIC NERVE DEVELOPMENT,0.00026348,-0.62936,-0.55656,1,0
1,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.0003797,-0.62948,-0.6041,1,0
1,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,4.2539e-06,-0.62954,-0.61792,1,0
1,GO SCHWANN CELL DIFFERENTIATION,6.2007e-06,-0.62955,-0.62566,1,0
1,GO CARDIOCYTE DIFFERENTIATION,4.2539e-06,-0.6296,-0.60045,1,0
1,GO TAXIS,5.7533e-06,-0.63,-0.60552,1,0
1,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,4.5891e-06,-0.6301,-0.61996,1,0
1,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,4.2539e-06,-0.63015,-0.63654,1,0
1,GO VENTRICULAR SYSTEM DEVELOPMENT,4.9495e-06,-0.63029,-0.6263,1,0
1,GO PROSTAGLANDIN TRANSPORT,1.8524e-05,-0.63051,-0.59383,1,0
1,GO PHOSPHATE ION TRANSPORT,8.3461e-06,-0.63054,-0.61422,1,0
1,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,1.6059e-05,-0.63069,-0.62274,1,0
1,GO MEMBRANE RAFT ORGANIZATION,4.2763e-05,-0.63074,-0.66948,1,0
1,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,8.3461e-06,-0.63075,-0.62112,1,0
1,GO POSITIVE REGULATION OF NEURON DEATH,4.5891e-06,-0.63097,-0.60785,1,0
1,GO BIOLOGICAL ADHESION,4.9495e-06,-0.63127,-0.63731,1,0
1,GO INTRACELLULAR LIPID TRANSPORT,4.2539e-06,-0.63178,-0.62157,1,0
1,GO RESPONSE TO MANGANESE ION,6.2007e-06,-0.63185,-0.60825,1,0
1,GO CARDIAC MUSCLE CELL DIFFERENTIATION,4.2539e-06,-0.63203,-0.58768,1,0
1,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,1.2035e-05,-0.63207,-0.60406,1,0
1,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,4.2539e-06,-0.63233,-0.64396,1,0
1,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,4.9495e-06,-0.63246,-0.6253,1,0
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,3.9422e-06,-0.63264,-0.6038,1,0
1,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,2.2907e-05,-0.63284,-0.60318,1,0
1,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.00010181,-0.63288,-0.73756,1,0
1,GO POSITIVE REGULATION OF BLOOD CIRCULATION,6.2007e-06,-0.63302,-0.55954,1,0
1,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,4.5891e-06,-0.63311,-0.58533,1,0
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,5.337e-06,-0.63348,-0.66723,1,0
1,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,8.9843e-06,-0.63349,-0.61127,1,0
1,GO ERBB SIGNALING PATHWAY,3.9422e-06,-0.63355,-0.61315,1,0
1,GO SPHINGOMYELIN METABOLIC PROCESS,4.5779e-05,-0.63367,-0.55391,1,0
1,GO MUSCLE ADAPTATION,4.5891e-06,-0.63373,-0.64224,1,0
1,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,6.6813e-06,-0.63376,-0.61556,1,0
1,GO EPITHELIAL TUBE FORMATION,4.5891e-06,-0.63411,-0.57756,1,0
1,GO REGULATION OF FATTY ACID OXIDATION,1.2939e-05,-0.63415,-0.5701,1,0
1,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,7.7514e-06,-0.63416,-0.60024,1,0
1,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,4.5891e-06,-0.63417,-0.66111,1,0
1,GO RESPONSE TO ANGIOTENSIN,5.337e-06,-0.63431,-0.67086,1,0
1,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,7.7514e-06,-0.63432,-0.64599,1,0
1,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,9.6689e-06,-0.63433,-0.55613,1,0
1,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,2.1347e-05,-0.63438,-0.68785,1,0
1,GO INOSITOL LIPID MEDIATED SIGNALING,3.9422e-06,-0.63441,-0.65359,1,0
1,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,8.9843e-06,-0.63442,-0.69508,1,0
1,GO NEURON PROJECTION ORGANIZATION,4.9495e-06,-0.63447,-0.65614,1,0
1,GO POSITIVE REGULATION OF VASCULOGENESIS,8.3641e-05,-0.63481,-0.57644,1,0
1,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,0.00081392,-0.63484,-0.63685,1,0
1,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,3.9422e-06,-0.63498,-0.63227,1,0
1,GO MAMMARY GLAND DUCT MORPHOGENESIS,1.8524e-05,-0.63498,-0.6379,1,0
1,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,0.011574,-0.635,-0.78934,1,0
1,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,3.7287e-05,-0.63516,-0.59749,1,0
1,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,5.7533e-06,-0.63524,-0.63739,1,0
1,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,4.9495e-06,-0.63526,-0.61197,1,0
1,GO RESPONSE TO INACTIVITY,6.2007e-06,-0.63546,-0.64982,1,0
1,GO EMBRYONIC HEART TUBE MORPHOGENESIS,4.9495e-06,-0.63558,-0.62768,1,0
1,GO GALACTOSE METABOLIC PROCESS,3.248e-05,-0.63569,-0.57344,1,0
1,GO FAT CELL DIFFERENTIATION,6.2007e-06,-0.63576,-0.59292,1,0
1,GO REGULATION OF AXONOGENESIS,4.5891e-06,-0.63579,-0.70263,1,0
1,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,1.2939e-05,-0.63582,-0.67521,1,0
1,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,7.1973e-06,-0.63602,-0.63773,1,0
1,GO NEGATIVE REGULATION OF JNK CASCADE,3.9422e-06,-0.63622,-0.64314,1,0
1,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,5.7533e-06,-0.63625,-0.64387,1,0
1,GO STRIATED MUSCLE ADAPTATION,7.7514e-06,-0.63627,-0.62272,1,0
1,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,4.8997e-05,-0.63641,-0.55007,1,0
1,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,3.9422e-06,-0.63646,-0.64039,1,0
1,GO MITRAL VALVE DEVELOPMENT,8.9327e-05,-0.63697,-0.6592,1,0
1,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,4.2539e-06,-0.63707,-0.64719,1,0
1,GO TYPE B PANCREATIC CELL PROLIFERATION,1.0403e-05,-0.63709,-0.64978,1,0
1,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,8.3461e-06,-0.63724,-0.68907,1,0
1,GO OVULATION CYCLE,3.9422e-06,-0.63741,-0.62089,1,0
1,GO HYALURONAN METABOLIC PROCESS,5.337e-06,-0.63748,-0.6498,1,0
1,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,4.2539e-06,-0.63758,-0.68229,1,0
1,GO VITAMIN TRANSMEMBRANE TRANSPORT,3.9936e-05,-0.63764,-0.59289,1,0
1,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,4.2539e-06,-0.63765,-0.63111,1,0
1,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,1.9888e-05,-0.63774,-0.59618,1,0
1,GO REGULATION OF CELLULAR COMPONENT SIZE,4.2539e-06,-0.63803,-0.63287,1,0
1,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,2.1347e-05,-0.63808,-0.66245,1,0
1,GO HISTONE DEACETYLATION,5.7533e-06,-0.63812,-0.60452,1,0
1,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,4.5891e-06,-0.63814,-0.64453,1,0
1,GO NEURAL CREST CELL MIGRATION,5.7533e-06,-0.63818,-0.61972,1,0
1,GO REGULATION OF ACTION POTENTIAL,4.2539e-06,-0.63824,-0.66072,1,0
1,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,3.9422e-06,-0.6383,-0.61956,1,0
1,GO REGULATION OF PROTEIN SUMOYLATION,6.2007e-06,-0.63836,-0.5996,1,0
1,GO HISTONE DEUBIQUITINATION,4.2539e-06,-0.63856,-0.7027,1,0
1,GO RESPONSE TO ACIDIC PH,2.2907e-05,-0.63866,-0.61345,1,0
1,GO RDNA HETEROCHROMATIN ASSEMBLY,1.8524e-05,-0.63904,-0.67384,1,0
1,GO LAMELLIPODIUM ASSEMBLY,3.9422e-06,-0.63906,-0.63392,1,0
1,GO ADRENAL GLAND DEVELOPMENT,9.5377e-05,-0.63911,-0.5696,1,0
1,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,1.0403e-05,-0.63926,-0.63687,1,0
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,5.337e-06,-0.63962,-0.68207,1,0
1,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,3.248e-05,-0.63974,-0.60045,1,0
1,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,1.7249e-05,-0.63978,-0.56106,1,0
1,GO CHROMATIN DISASSEMBLY,5.9985e-05,-0.63982,-0.59624,1,0
1,GO CARDIAC ATRIUM DEVELOPMENT,9.6689e-06,-0.6399,-0.67568,1,0
1,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,7.7514e-06,-0.63992,-0.71245,1,0
1,GO RUFFLE ORGANIZATION,6.2007e-06,-0.63994,-0.64227,1,0
1,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,4.9495e-06,-0.64028,-0.64767,1,0
1,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,6.6813e-06,-0.64028,-0.62214,1,0
1,GO CARDIAC VENTRICLE DEVELOPMENT,4.9495e-06,-0.64053,-0.63396,1,0
1,GO PEPTIDYL LYSINE TRIMETHYLATION,4.5891e-06,-0.64083,-0.67698,1,0
1,GO SIALYLATION,8.9327e-05,-0.64089,-0.5585,1,0
1,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,2.4576e-05,-0.641,-0.5874,1,0
1,GO CARDIAC CHAMBER MORPHOGENESIS,4.9495e-06,-0.64115,-0.64899,1,0
1,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,4.2539e-06,-0.64145,-0.66937,1,0
1,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,5.7533e-06,-0.64159,-0.63418,1,0
1,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,3.248e-05,-0.64161,-0.54954,1,0
1,GO EPITHELIAL CELL FATE COMMITMENT,2.1347e-05,-0.64183,-0.59925,1,0
1,GO CARDIAC MYOFIBRIL ASSEMBLY,5.337e-06,-0.6421,-0.68079,1,0
1,GO REGULATION OF CELLULAR EXTRAVASATION,5.9985e-05,-0.64218,-0.67924,1,0
1,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,8.3461e-06,-0.64227,-0.62846,1,0
1,GO CELL JUNCTION ORGANIZATION,4.9495e-06,-0.64265,-0.64359,1,0
1,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,4.9495e-06,-0.64276,-0.58934,1,0
1,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,7.7514e-06,-0.64279,-0.63744,1,0
1,GO REGULATION OF TORC1 SIGNALING,4.5891e-06,-0.64309,-0.66696,1,0
1,GO BRONCHUS DEVELOPMENT,7.8298e-05,-0.64315,-0.62916,1,0
1,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,4.9495e-06,-0.64357,-0.61315,1,0
1,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,5.7533e-06,-0.6436,-0.61585,1,0
1,GO ENDOCARDIUM DEVELOPMENT,1.1191e-05,-0.6437,-0.59453,1,0
1,GO COMMISSURAL NEURON AXON GUIDANCE,2.2907e-05,-0.64381,-0.66275,1,0
1,GO RESPIRATORY SYSTEM PROCESS,4.9495e-06,-0.64391,-0.66907,1,0
1,GO KERATINOCYTE PROLIFERATION,8.3461e-06,-0.64397,-0.60535,1,0
1,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,6.6813e-06,-0.64464,-0.6117,1,0
1,GO REGULATION OF MEMBRANE INVAGINATION,0.00014062,-0.64471,-0.71875,1,0
1,GO TRANSCYTOSIS,6.6813e-06,-0.64487,-0.66765,1,0
1,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.00010866,-0.64489,-0.70671,1,0
1,GO RECEPTOR CLUSTERING,7.1973e-06,-0.64498,-0.66444,1,0
1,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,4.2539e-06,-0.64512,-0.60916,1,0
1,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,4.5891e-06,-0.64516,-0.68748,1,0
1,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,7.8298e-05,-0.64517,-0.64063,1,0
1,GO ANGIOTENSIN ACTIVATED SIGNALING PATHWAY,4.9495e-06,-0.64519,-0.6421,1,0
1,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,4.2539e-06,-0.64521,-0.67147,1,0
1,GO SPINAL CORD PATTERNING,9.5377e-05,-0.64525,-0.62704,1,0
1,GO METANEPHRIC NEPHRON MORPHOGENESIS,6.2007e-06,-0.64543,-0.65732,1,0
1,GO STRESS GRANULE ASSEMBLY,6.2007e-06,-0.64547,-0.63955,1,0
1,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,4.5891e-06,-0.6456,-0.63604,1,0
1,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,6.6813e-06,-0.64563,-0.63848,1,0
1,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,3.248e-05,-0.64564,-0.62551,1,0
1,GO CHOLESTEROL STORAGE,8.9843e-06,-0.64586,-0.70884,1,0
1,GO CAMP METABOLIC PROCESS,1.3909e-05,-0.64597,-0.65106,1,0
1,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,6.2007e-06,-0.64633,-0.66022,1,0
1,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,1.9888e-05,-0.64643,-0.63438,1,0
1,GO PROTEIN TARGETING TO VACUOLE,5.7533e-06,-0.64651,-0.66387,1,0
1,GO NEUROEPITHELIAL CELL DIFFERENTIATION,5.6086e-05,-0.64672,-0.58851,1,0
1,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,3.9422e-06,-0.64682,-0.64574,1,0
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,4.2763e-05,-0.64704,-0.62674,1,0
1,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,3.248e-05,-0.64721,-0.718,1,0
1,GO MESENCHYMAL CELL DIFFERENTIATION,6.2007e-06,-0.64725,-0.62239,1,0
1,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,4.9495e-06,-0.64755,-0.64496,1,0
1,GO POSITIVE REGULATION OF JNK CASCADE,4.9495e-06,-0.64757,-0.67552,1,0
1,GO EMBRYONIC PLACENTA DEVELOPMENT,8.9843e-06,-0.64774,-0.62166,1,0
1,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,4.2539e-06,-0.6481,-0.65795,1,0
1,GO NEGATIVE REGULATION OF CELL ADHESION,6.2007e-06,-0.64819,-0.66964,1,0
1,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,7.7514e-06,-0.64822,-0.71124,1,0
1,GO ACTIN CYTOSKELETON REORGANIZATION,3.9422e-06,-0.64826,-0.69179,1,0
1,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,5.7533e-06,-0.6483,-0.67549,1,0
1,GO CELL JUNCTION ASSEMBLY,4.9495e-06,-0.6484,-0.64254,1,0
1,GO REGULATION OF EXTENT OF CELL GROWTH,4.5891e-06,-0.64841,-0.68669,1,0
1,GO TELENCEPHALON GLIAL CELL MIGRATION,1.0403e-05,-0.64843,-0.66587,1,0
1,GO EYE MORPHOGENESIS,4.5891e-06,-0.64853,-0.60777,1,0
1,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,8.9843e-06,-0.64861,-0.70809,1,0
1,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,6.6813e-06,-0.64871,-0.57012,1,0
1,GO UV PROTECTION,4.9495e-06,-0.64874,-0.61523,1,0
1,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,4.5891e-06,-0.64877,-0.65605,1,0
1,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,4.5891e-06,-0.64891,-0.64366,1,0
1,GO REGULATION OF FILOPODIUM ASSEMBLY,4.5891e-06,-0.649,-0.68683,1,0
1,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,1.9888e-05,-0.64915,-0.71866,1,0
1,GO NEGATIVE REGULATION OF AXONOGENESIS,4.9495e-06,-0.64918,-0.69765,1,0
1,GO REGULATION OF CGMP MEDIATED SIGNALING,6.4139e-05,-0.64924,-0.64919,1,0
1,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,8.3461e-06,-0.64965,-0.64319,1,0
1,GO POSITIVE REGULATION OF ERAD PATHWAY,4.2539e-06,-0.64974,-0.67402,1,0
1,GO CELL JUNCTION MAINTENANCE,3.0304e-05,-0.64994,-0.63954,1,0
1,GO NEGATIVE REGULATION OF ORGAN GROWTH,4.9495e-06,-0.64995,-0.63134,1,0
1,GO REGULATION OF T HELPER CELL DIFFERENTIATION,0.00015974,-0.65007,-0.66745,1,0
1,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,1.1191e-05,-0.65017,-0.68534,1,0
1,GO INSULIN RECEPTOR SIGNALING PATHWAY,4.9495e-06,-0.65023,-0.60502,1,0
1,GO NEGATIVE REGULATION OF ANION TRANSPORT,4.5891e-06,-0.65024,-0.61256,1,0
1,GO MESODERM MORPHOGENESIS,5.337e-06,-0.65025,-0.60471,1,0
1,GO CENTRIOLE CENTRIOLE COHESION,6.6813e-06,-0.65045,-0.7796,1,0
1,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,4.2539e-06,-0.65053,-0.63685,1,0
1,GO MORPHOGENESIS OF AN ENDOTHELIUM,7.7514e-06,-0.65053,-0.66026,1,0
1,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,4.2539e-06,-0.65064,-0.65179,1,0
1,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,6.8565e-05,-0.65142,-0.69664,1,0
1,GO PROTEOGLYCAN METABOLIC PROCESS,4.5891e-06,-0.65143,-0.66374,1,0
1,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,6.2007e-06,-0.65157,-0.62465,1,0
1,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,4.2539e-06,-0.65171,-0.66001,1,0
1,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,4.5891e-06,-0.65186,-0.65623,1,0
1,GO CHONDROITIN SULFATE CATABOLIC PROCESS,1.2939e-05,-0.65196,-0.70501,1,0
1,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,1.2035e-05,-0.65197,-0.6613,1,0
1,GO PERICARDIUM DEVELOPMENT,9.6689e-06,-0.65198,-0.68968,1,0
1,GO MAMMARY GLAND MORPHOGENESIS,1.3909e-05,-0.65238,-0.67784,1,0
1,GO RESPONSE TO LIPOTEICHOIC ACID,0.00042807,-0.65246,-0.63784,1,0
1,GO KERATINOCYTE DEVELOPMENT,5.9985e-05,-0.65246,-0.58559,1,0
1,GO RESPONSE TO PROSTAGLANDIN E,2.2907e-05,-0.65264,-0.62028,1,0
1,GO RAS PROTEIN SIGNAL TRANSDUCTION,4.2539e-06,-0.65265,-0.65934,1,0
1,GO HAIR FOLLICLE MATURATION,3.9422e-06,-0.65287,-0.65135,1,0
1,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.00045436,-0.65299,-0.59459,1,0
1,GO RNA DECAPPING,5.337e-06,-0.65335,-0.63228,1,0
1,GO REGULATION OF NOTCH SIGNALING PATHWAY,8.3461e-06,-0.6534,-0.664,1,0
1,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,1.7249e-05,-0.65349,-0.63793,1,0
1,GO REGULATION OF HISTONE H3 K9 METHYLATION,5.337e-06,-0.65349,-0.66642,1,0
1,GO SYNAPTIC VESICLE ENDOSOMAL PROCESSING,8.9843e-06,-0.65356,-0.68012,1,0
1,GO CELL MORPHOGENESIS,4.2539e-06,-0.65357,-0.65505,1,0
1,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,4.5891e-06,-0.65358,-0.62354,1,0
1,GO SECONDARY PALATE DEVELOPMENT,7.1973e-06,-0.6536,-0.70797,1,0
1,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,4.2539e-06,-0.65363,-0.64262,1,0
1,GO POSITIVE REGULATION OF DNA RECOMBINATION,3.9422e-06,-0.65366,-0.66927,1,0
1,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,6.6813e-06,-0.65367,-0.59949,1,0
1,GO AZOLE TRANSMEMBRANE TRANSPORT,2.1347e-05,-0.65386,-0.66217,1,0
1,GO MEMBRANE PROTEIN PROTEOLYSIS,4.9495e-06,-0.65418,-0.70943,1,0
1,GO PROTEIN DEMANNOSYLATION,5.7533e-06,-0.65456,-0.70808,1,0
1,GO REGULATION OF MUSCLE ADAPTATION,4.9495e-06,-0.6548,-0.6467,1,0
1,GO SELECTIVE AUTOPHAGY,5.337e-06,-0.65502,-0.61584,1,0
1,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,4.9495e-06,-0.65508,-0.62845,1,0
1,GO DISACCHARIDE METABOLIC PROCESS,4.9495e-06,-0.65511,-0.68433,1,0
1,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,3.9422e-06,-0.65515,-0.70868,1,0
1,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,1.1191e-05,-0.65529,-0.57679,1,0
1,GO REGULATION OF PROTEIN DEUBIQUITINATION,1.0403e-05,-0.65541,-0.60133,1,0
1,GO REGULATION OF MAP KINASE ACTIVITY,4.9495e-06,-0.65542,-0.64689,1,0
1,GO MUSCLE ORGAN MORPHOGENESIS,4.5891e-06,-0.65571,-0.62207,1,0
1,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,4.9495e-06,-0.65572,-0.66509,1,0
1,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,1.3909e-05,-0.65572,-0.58756,1,0
1,GO REGULATION OF TISSUE REMODELING,7.1973e-06,-0.65578,-0.70268,1,0
1,GO ENDOCRINE PANCREAS DEVELOPMENT,7.1973e-06,-0.65579,-0.59929,1,0
1,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,4.5779e-05,-0.65599,-0.72647,1,0
1,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,7.7514e-06,-0.65602,-0.63532,1,0
1,GO PLATELET AGGREGATION,3.9422e-06,-0.65626,-0.70586,1,0
1,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,4.9495e-06,-0.65645,-0.63373,1,0
1,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,6.8565e-05,-0.65653,-0.75762,1,0
1,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,2.2907e-05,-0.65654,-0.69019,1,0
1,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,4.2539e-06,-0.6566,-0.67752,1,0
1,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,4.9495e-06,-0.6567,-0.63813,1,0
1,GO MICROTUBULE ANCHORING AT CENTROSOME,7.1973e-06,-0.65678,-0.72086,1,0
1,GO CELLULAR RESPONSE TO ALCOHOL,4.2539e-06,-0.65689,-0.68104,1,0
1,GO CORTICAL CYTOSKELETON ORGANIZATION,4.2539e-06,-0.65708,-0.67059,1,0
1,GO ENTRY OF BACTERIUM INTO HOST CELL,5.337e-06,-0.6571,-0.69277,1,0
1,GO NEGATIVE REGULATION OF MAPK CASCADE,4.5891e-06,-0.6572,-0.64918,1,0
1,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,9.6689e-06,-0.65722,-0.63515,1,0
1,GO MODIFICATION OF SYNAPTIC STRUCTURE,6.6813e-06,-0.65726,-0.66985,1,0
1,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,4.5891e-06,-0.65727,-0.66541,1,0
1,GO EXPORT ACROSS PLASMA MEMBRANE,6.2007e-06,-0.65771,-0.58243,1,0
1,GO AMEBOIDAL TYPE CELL MIGRATION,4.2539e-06,-0.65774,-0.66378,1,0
1,GO DETECTION OF MECHANICAL STIMULUS,1.0403e-05,-0.65804,-0.5882,1,0
1,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,4.5891e-06,-0.65816,-0.61442,1,0
1,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,3.9422e-06,-0.65853,-0.59561,1,0
1,GO HEART DEVELOPMENT,4.2539e-06,-0.65915,-0.62705,1,0
1,GO OPIOID RECEPTOR SIGNALING PATHWAY,0.00021879,-0.65915,-0.54747,1,0
1,GO REGULATION OF EPITHELIAL CELL MIGRATION,3.9422e-06,-0.65944,-0.69063,1,0
1,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,8.3461e-06,-0.65952,-0.64805,1,0
1,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,4.5891e-06,-0.65961,-0.62821,1,0
1,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,9.6689e-06,-0.66002,-0.61216,1,0
1,GO CARDIAC MUSCLE CELL CONTRACTION,4.5891e-06,-0.66028,-0.64277,1,0
1,GO MATERNAL PLACENTA DEVELOPMENT,5.337e-06,-0.66139,-0.69909,1,0
1,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,1.0403e-05,-0.66156,-0.64043,1,0
1,GO CELL VOLUME HOMEOSTASIS,8.3461e-06,-0.66204,-0.60392,1,0
1,GO REGULATION OF EMBRYONIC DEVELOPMENT,4.2539e-06,-0.66222,-0.62386,1,0
1,GO RESPONSE TO INTERLEUKIN 6,1.8524e-05,-0.66231,-0.68739,1,0
1,GO GLIAL CELL MIGRATION,5.337e-06,-0.66258,-0.68148,1,0
1,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,4.5779e-05,-0.66264,-0.68283,1,0
1,GO CIRCULATORY SYSTEM DEVELOPMENT,4.2539e-06,-0.6627,-0.66571,1,0
1,GO NEGATIVE REGULATION OF AXON EXTENSION,4.9495e-06,-0.66291,-0.68195,1,0
1,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,1.9888e-05,-0.66295,-0.64635,1,0
1,GO MUSCLE HYPERTROPHY,4.5891e-06,-0.66296,-0.62971,1,0
1,GO RESPONSE TO GROWTH FACTOR,4.9495e-06,-0.66318,-0.63577,1,0
1,GO HISTONE H3 K9 METHYLATION,3.9422e-06,-0.66336,-0.68168,1,0
1,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,4.5891e-06,-0.6635,-0.60319,1,0
1,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,8.9843e-06,-0.66354,-0.71973,1,0
1,GO POST EMBRYONIC DEVELOPMENT,3.9422e-06,-0.66354,-0.65089,1,0
1,GO TUBE MORPHOGENESIS,4.5891e-06,-0.66421,-0.6713,1,0
1,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,1.1191e-05,-0.66439,-0.63448,1,0
1,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,6.6813e-06,-0.66458,-0.65178,1,0
1,GO TRIGEMINAL NERVE DEVELOPMENT,0.00014989,-0.66503,-0.69499,1,0
1,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,1.8524e-05,-0.66533,-0.64852,1,0
1,GO REGULATION OF PLASMINOGEN ACTIVATION,6.4139e-05,-0.66537,-0.69303,1,0
1,GO PROTEIN LOCALIZATION TO AXON,0.00028019,-0.66543,-0.64846,1,0
1,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,7.7514e-06,-0.66553,-0.67682,1,0
1,GO PINOCYTOSIS,5.337e-06,-0.66558,-0.71189,1,0
1,GO ENAMEL MINERALIZATION,1.4947e-05,-0.66562,-0.7078,1,0
1,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,5.337e-06,-0.66567,-0.64225,1,0
1,GO PROTEIN K48 LINKED DEUBIQUITINATION,4.5891e-06,-0.66606,-0.71947,1,0
1,GO POSITIVE REGULATION OF ACTIN NUCLEATION,5.337e-06,-0.66627,-0.65321,1,0
1,GO NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.00031664,-0.6663,-0.58213,1,0
1,GO CARDIAC ATRIUM MORPHOGENESIS,5.7533e-06,-0.66671,-0.71463,1,0
1,GO DENDRITIC SPINE MAINTENANCE,5.7533e-06,-0.66681,-0.69542,1,0
1,GO CAMERA TYPE EYE MORPHOGENESIS,8.3461e-06,-0.66693,-0.58298,1,0
1,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,1.4947e-05,-0.66698,-0.60691,1,0
1,GO REGULATION OF CELL MORPHOGENESIS,4.2539e-06,-0.667,-0.67462,1,0
1,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,3.9422e-06,-0.66708,-0.70235,1,0
1,GO FIBROBLAST ACTIVATION,3.9422e-06,-0.66717,-0.72057,1,0
1,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,5.7533e-06,-0.6673,-0.74345,1,0
1,GO ATRIAL SEPTUM DEVELOPMENT,5.2428e-05,-0.6674,-0.62229,1,0
1,GO TUBE DEVELOPMENT,4.9495e-06,-0.66757,-0.64929,1,0
1,GO MITOCHONDRION DISTRIBUTION,1.1191e-05,-0.66762,-0.66634,1,0
1,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,3.9422e-06,-0.66773,-0.70808,1,0
1,GO MICROTUBULE ANCHORING,5.337e-06,-0.66794,-0.68232,1,0
1,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,5.337e-06,-0.66803,-0.65631,1,0
1,GO SPHINGOID METABOLIC PROCESS,7.1973e-06,-0.66843,-0.65798,1,0
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,5.7533e-06,-0.66851,-0.65318,1,0
1,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,4.2539e-06,-0.66857,-0.67962,1,0
1,GO REGULATION OF PODOSOME ASSEMBLY,4.2539e-06,-0.6688,-0.74889,1,0
1,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,5.337e-06,-0.66882,-0.75653,1,0
1,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,1.9888e-05,-0.66889,-0.62715,1,0
1,GO PROTEIN LOCALIZATION TO LYSOSOME,5.7533e-06,-0.66903,-0.66008,1,0
1,GO RHO PROTEIN SIGNAL TRANSDUCTION,4.5891e-06,-0.66904,-0.665,1,0
1,GO NEPHRON DEVELOPMENT,5.7533e-06,-0.66924,-0.64543,1,0
1,GO APOPTOTIC CELL CLEARANCE,3.7287e-05,-0.66925,-0.72612,1,0
1,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,3.9422e-06,-0.66926,-0.64839,1,0
1,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,3.9422e-06,-0.66963,-0.68322,1,0
1,GO RETROGRADE AXONAL TRANSPORT,7.7514e-06,-0.66975,-0.73308,1,0
1,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.00064645,-0.66979,-0.63567,1,0
1,GO ENDOTHELIAL CELL MIGRATION,4.2539e-06,-0.66985,-0.6852,1,0
1,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,8.9843e-06,-0.6699,-0.7321,1,0
1,GO TORC1 SIGNALING,4.5891e-06,-0.6702,-0.69358,1,0
1,GO INCLUSION BODY ASSEMBLY,3.9936e-05,-0.67076,-0.61529,1,0
1,GO HEART MORPHOGENESIS,3.9422e-06,-0.67079,-0.63509,1,0
1,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,5.7533e-06,-0.67101,-0.65154,1,0
1,GO HISTONE H3 K9 DEMETHYLATION,7.1973e-06,-0.67121,-0.71571,1,0
1,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,2.4576e-05,-0.67137,-0.65613,1,0
1,GO ACTIN FILAMENT ORGANIZATION,4.5891e-06,-0.67147,-0.64594,1,0
1,GO GLYCOLIPID CATABOLIC PROCESS,1.2035e-05,-0.6717,-0.71764,1,0
1,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,5.7533e-06,-0.67181,-0.66117,1,0
1,GO REVERSE CHOLESTEROL TRANSPORT,5.2428e-05,-0.67181,-0.70614,1,0
1,GO PEPTIDYL THREONINE MODIFICATION,4.5891e-06,-0.67187,-0.67393,1,0
1,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,1.2035e-05,-0.67196,-0.64523,1,0
1,GO POSITIVE REGULATION OF GLIAL CELL MIGRATION,6.4139e-05,-0.6722,-0.76661,1,0
1,GO CARDIAC VENTRICLE MORPHOGENESIS,6.6813e-06,-0.6722,-0.62305,1,0
1,GO RESPONSE TO STEROL,3.9422e-06,-0.67224,-0.75918,1,0
1,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,1.2035e-05,-0.67231,-0.6654,1,0
1,GO RELAXATION OF CARDIAC MUSCLE,2.636e-05,-0.67239,-0.6396,1,0
1,GO COLLATERAL SPROUTING,7.7514e-06,-0.67249,-0.72939,1,0
1,GO ACTIVATION OF MAPK ACTIVITY,4.9495e-06,-0.67252,-0.62444,1,0
1,GO DECIDUALIZATION,8.3461e-06,-0.6726,-0.72041,1,0
1,GO PLATELET ACTIVATION,3.9422e-06,-0.67288,-0.71408,1,0
1,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,0.00024771,-0.67298,-0.71483,1,0
1,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,1.4947e-05,-0.67312,-0.63926,1,0
1,GO LIPID PHOSPHORYLATION,3.9422e-06,-0.67333,-0.67734,1,0
1,GO REGULATION OF CELL SIZE,3.9422e-06,-0.67364,-0.6763,1,0
1,GO XENOBIOTIC TRANSPORT,6.6813e-06,-0.67383,-0.65459,1,0
1,GO BONE MATURATION,6.6813e-06,-0.67384,-0.65263,1,0
1,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,0.00014062,-0.67387,-0.62966,1,0
1,GO REGULATION OF HISTONE DEACETYLATION,1.4947e-05,-0.6739,-0.58899,1,0
1,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,6.6813e-06,-0.67414,-0.62056,1,0
1,GO MULTICELLULAR ORGANISM GROWTH,4.9495e-06,-0.6749,-0.65681,1,0
1,GO LIPID TRANSLOCATION,7.7514e-06,-0.67501,-0.66081,1,0
1,GO CELLULAR RESPONSE TO ETHANOL,1.8524e-05,-0.67539,-0.73492,1,0
1,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,4.2539e-06,-0.67549,-0.64644,1,0
1,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,3.4805e-05,-0.67557,-0.66538,1,0
1,GO REGULATION OF BONE REMODELING,5.7533e-06,-0.6759,-0.70882,1,0
1,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,4.5891e-06,-0.67593,-0.68612,1,0
1,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,9.6689e-06,-0.67596,-0.65111,1,0
1,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,3.9422e-06,-0.67621,-0.63903,1,0
1,GO CELL CELL JUNCTION MAINTENANCE,1.3909e-05,-0.67651,-0.72939,1,0
1,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,3.0304e-05,-0.67652,-0.65716,1,0
1,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,1.1191e-05,-0.67657,-0.75084,1,0
1,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,5.7533e-06,-0.6766,-0.63646,1,0
1,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,1.0403e-05,-0.67666,-0.67011,1,0
1,GO FILOPODIUM ASSEMBLY,4.5891e-06,-0.67677,-0.69245,1,0
1,GO CYTOSOLIC TRANSPORT,4.9495e-06,-0.67719,-0.68737,1,0
1,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,7.1973e-06,-0.67732,-0.61383,1,0
1,GO TISSUE MIGRATION,4.2539e-06,-0.67745,-0.68698,1,0
1,GO NEGATIVE REGULATION OF BONE MINERALIZATION,7.3279e-05,-0.67772,-0.62369,1,0
1,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.00076864,-0.67781,-0.60404,1,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,3.9422e-06,-0.67795,-0.73413,1,0
1,GO DENDRITIC TRANSPORT,3.7287e-05,-0.67807,-0.75851,1,0
1,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,1.2939e-05,-0.6781,-0.68104,1,0
1,GO NEGATIVE REGULATION OF HISTONE METHYLATION,8.9843e-06,-0.67818,-0.67858,1,0
1,GO PEPTIDE CROSS LINKING,0.00015974,-0.67843,-0.6137,1,0
1,GO CELLULAR RESPONSE TO STEROL,4.5891e-06,-0.67861,-0.74026,1,0
1,GO REGULATION OF MUSCLE HYPERTROPHY,4.9495e-06,-0.67867,-0.63328,1,0
1,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,4.2539e-06,-0.67896,-0.73316,1,0
1,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,1.6059e-05,-0.67899,-0.62441,1,0
1,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,0.00042807,-0.67934,-0.59174,1,0
1,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,8.3461e-06,-0.67942,-0.67396,1,0
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,7.7514e-06,-0.68001,-0.68881,1,0
1,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,1.2939e-05,-0.68014,-0.65312,1,0
1,GO P BODY ASSEMBLY,4.2539e-06,-0.6803,-0.74793,1,0
1,GO SUPRAMOLECULAR FIBER ORGANIZATION,4.2539e-06,-0.68041,-0.66287,1,0
1,GO EPITHELIAL CELL APOPTOTIC PROCESS,4.9495e-06,-0.68062,-0.67291,1,0
1,GO MYELOID CELL DEVELOPMENT,3.9422e-06,-0.6809,-0.72584,1,0
1,GO ANIMAL ORGAN MATURATION,1.3909e-05,-0.68123,-0.60549,1,0
1,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,5.7533e-06,-0.68154,-0.68024,1,0
1,GO CARNITINE SHUTTLE,3.7287e-05,-0.6816,-0.57879,1,0
1,GO AXON EXTENSION,3.9422e-06,-0.68171,-0.70457,1,0
1,GO BEHAVIORAL RESPONSE TO PAIN,7.7514e-06,-0.68241,-0.61761,1,0
1,GO POSITIVE REGULATION OF ENDOCYTOSIS,4.9495e-06,-0.68281,-0.68836,1,0
1,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,2.1347e-05,-0.68295,-0.69296,1,0
1,GO REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.00013188,-0.68299,-0.661,1,0
1,GO RESPIRATORY SYSTEM DEVELOPMENT,4.9495e-06,-0.68357,-0.66081,1,0
1,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,4.5891e-06,-0.68365,-0.68792,1,0
1,GO POSITIVE REGULATION OF AXONOGENESIS,4.2539e-06,-0.68378,-0.73746,1,0
1,GO HEMOGLOBIN METABOLIC PROCESS,2.1347e-05,-0.68395,-0.609,1,0
1,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,1.9888e-05,-0.684,-0.7331,1,0
1,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,6.8565e-05,-0.68409,-0.57506,1,0
1,GO LYSOSOMAL TRANSPORT,4.2539e-06,-0.6841,-0.69135,1,0
1,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,7.1973e-06,-0.68421,-0.6312,1,0
1,GO NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.00035748,-0.68426,-0.70795,1,0
1,GO POSITIVE REGULATION OF AUTOPHAGY,4.2539e-06,-0.68441,-0.6553,1,0
1,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,6.2007e-06,-0.6845,-0.66529,1,0
1,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,1.2939e-05,-0.68458,-0.74656,1,0
1,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,1.3909e-05,-0.68474,-0.64857,1,0
1,GO PROTEIN DEGLYCOSYLATION,4.5891e-06,-0.68484,-0.71366,1,0
1,GO RECEPTOR CATABOLIC PROCESS,3.9422e-06,-0.68494,-0.67691,1,0
1,GO POSITIVE REGULATION OF PROTEIN BINDING,4.5891e-06,-0.68578,-0.64454,1,0
1,GO REGULATION OF GASTRULATION,4.5891e-06,-0.68596,-0.66792,1,0
1,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,1.7249e-05,-0.6863,-0.71229,1,0
1,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,8.3461e-06,-0.68649,-0.75913,1,0
1,GO REGULATION OF CELL JUNCTION ASSEMBLY,4.9495e-06,-0.68656,-0.6652,1,0
1,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,4.2539e-06,-0.68675,-0.68355,1,0
1,GO OLFACTORY BULB INTERNEURON DIFFERENTIATION,0.0027019,-0.68681,-0.50788,1,0
1,GO VASCULOGENESIS,6.6813e-06,-0.68683,-0.70185,1,0
1,GO VASCULATURE DEVELOPMENT,4.2539e-06,-0.68695,-0.71674,1,0
1,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,7.1973e-06,-0.68702,-0.67607,1,0
1,GO ACTIVATION OF MAPKK ACTIVITY,4.5891e-06,-0.68702,-0.72635,1,0
1,GO REGULATION OF BONE DEVELOPMENT,5.7533e-06,-0.68738,-0.73559,1,0
1,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,5.7533e-06,-0.68772,-0.67609,1,0
1,GO PHAGOLYSOSOME ASSEMBLY,6.6813e-06,-0.68794,-0.70668,1,0
1,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,7.7514e-06,-0.68805,-0.713,1,0
1,GO SMAD PROTEIN SIGNAL TRANSDUCTION,6.2007e-06,-0.68813,-0.64209,1,0
1,GO ALDEHYDE BIOSYNTHETIC PROCESS,4.8997e-05,-0.68824,-0.67432,1,0
1,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,6.6813e-06,-0.68862,-0.66345,1,0
1,GO SPHINGOSINE BIOSYNTHETIC PROCESS,5.7533e-06,-0.68878,-0.68036,1,0
1,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,4.5891e-06,-0.68921,-0.69674,1,0
1,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,4.2539e-06,-0.68935,-0.64339,1,0
1,GO MEMBRANE LIPID CATABOLIC PROCESS,8.3461e-06,-0.68939,-0.66945,1,0
1,GO GROWTH HORMONE SECRETION,0.00045436,-0.68982,-0.61094,1,0
1,GO REGULATION OF ENDOCYTIC RECYCLING,8.9843e-06,-0.68982,-0.70125,1,0
1,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,4.9495e-06,-0.68984,-0.72545,1,0
1,GO CARDIAC CHAMBER DEVELOPMENT,4.5891e-06,-0.69028,-0.67294,1,0
1,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,8.9843e-06,-0.69029,-0.68617,1,0
1,GO NEGATIVE REGULATION OF CHEMOTAXIS,9.6689e-06,-0.69085,-0.66872,1,0
1,GO RESPONSE TO HYDROXYUREA,1.0403e-05,-0.69092,-0.64036,1,0
1,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.00060992,-0.691,-0.56793,1,0
1,GO OSTEOCLAST DEVELOPMENT,6.6813e-06,-0.69119,-0.76316,1,0
1,GO OLIGOSACCHARIDE CATABOLIC PROCESS,6.2007e-06,-0.69136,-0.76724,1,0
1,GO T HELPER 2 CELL DIFFERENTIATION,0.00068502,-0.69141,-0.63408,1,0
1,GO EPITHELIAL CELL DEVELOPMENT,5.337e-06,-0.69175,-0.66298,1,0
1,GO MOTOR NEURON AXON GUIDANCE,8.9843e-06,-0.69193,-0.64171,1,0
1,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,2.1347e-05,-0.69228,-0.6965,1,0
1,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,4.9495e-06,-0.69245,-0.64219,1,0
1,GO DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION,0.011574,-0.69246,-0.80205,1,0
1,GO REGULATION OF FAT CELL DIFFERENTIATION,8.3461e-06,-0.69248,-0.64359,1,0
1,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,6.6813e-06,-0.69252,-0.74283,1,0
1,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,4.5891e-06,-0.69289,-0.70031,1,0
1,GO TRABECULA MORPHOGENESIS,5.7533e-06,-0.69289,-0.74317,1,0
1,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,2.636e-05,-0.69291,-0.6846,1,0
1,GO REGULATION OF MITOPHAGY,5.337e-06,-0.69324,-0.71889,1,0
1,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,1.2035e-05,-0.69325,-0.66816,1,0
1,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,4.2539e-06,-0.69326,-0.67921,1,0
1,GO REGULATION OF VASCULATURE DEVELOPMENT,5.337e-06,-0.69331,-0.70623,1,0
1,GO ACTIN FILAMENT BASED PROCESS,4.2539e-06,-0.69336,-0.6564,1,0
1,GO GROWTH PLATE CARTILAGE DEVELOPMENT,8.9843e-06,-0.69391,-0.63349,1,0
1,GO CHONDROCYTE PROLIFERATION,4.9495e-06,-0.69435,-0.73312,1,0
1,GO ERYTHROCYTE MATURATION,7.1973e-06,-0.69463,-0.65771,1,0
1,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,1.0403e-05,-0.69469,-0.64916,1,0
1,GO HISTONE H3 K4 TRIMETHYLATION,6.2007e-06,-0.69491,-0.76965,1,0
1,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,5.337e-06,-0.69507,-0.67195,1,0
1,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,4.2539e-06,-0.6955,-0.69463,1,0
1,GO POSITIVE REGULATION OF BONE RESORPTION,1.6059e-05,-0.69621,-0.66072,1,0
1,GO GASTRULATION,4.9495e-06,-0.69652,-0.68634,1,0
1,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,4.2539e-06,-0.69673,-0.68077,1,0
1,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,3.9422e-06,-0.69698,-0.71605,1,0
1,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,7.1973e-06,-0.69707,-0.68358,1,0
1,GO NEGATIVE REGULATION OF NEURON MIGRATION,5.7533e-06,-0.6971,-0.68972,1,0
1,GO RESPONSE TO PH,1.1191e-05,-0.69742,-0.63715,1,0
1,GO VENTRICULAR SEPTUM DEVELOPMENT,4.5891e-06,-0.69753,-0.66923,1,0
1,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,8.3641e-05,-0.69762,-0.71601,1,0
1,GO BONE REMODELING,5.337e-06,-0.69797,-0.71338,1,0
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,8.3461e-06,-0.69807,-0.65541,1,0
1,GO EMBRYONIC BODY MORPHOGENESIS,6.2007e-06,-0.69842,-0.6957,1,0
1,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,2.1347e-05,-0.69875,-0.70064,1,0
1,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,4.2539e-06,-0.69882,-0.72845,1,0
1,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,3.9422e-06,-0.69915,-0.73456,1,0
1,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,6.6813e-06,-0.69951,-0.68783,1,0
1,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,1.9888e-05,-0.69957,-0.67471,1,0
1,GO RESPONSE TO ISCHEMIA,4.5891e-06,-0.69973,-0.70345,1,0
1,GO REGULATION OF CELL SHAPE,3.9422e-06,-0.69974,-0.7065,1,0
1,GO BARBED END ACTIN FILAMENT CAPPING,3.9422e-06,-0.70038,-0.70986,1,0
1,GO SMOOTH MUSCLE CELL MIGRATION,5.7533e-06,-0.70045,-0.73991,1,0
1,GO BLOOD VESSEL MORPHOGENESIS,4.5891e-06,-0.70081,-0.71603,1,0
1,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,4.5891e-06,-0.70086,-0.69827,1,0
1,GO NEURAL TUBE FORMATION,4.5891e-06,-0.7009,-0.63215,1,0
1,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,1.2035e-05,-0.70124,-0.68017,1,0
1,GO ENDOCARDIAL CUSHION FORMATION,4.5891e-06,-0.70131,-0.73873,1,0
1,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,4.9495e-06,-0.70149,-0.6908,1,0
1,GO 3 UTR MEDIATED MRNA DESTABILIZATION,5.7533e-06,-0.70175,-0.75275,1,0
1,GO REGULATION OF PINOCYTOSIS,4.9495e-06,-0.70188,-0.71326,1,0
1,GO OSTEOBLAST PROLIFERATION,1.7249e-05,-0.70215,-0.67429,1,0
1,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,1.0403e-05,-0.70259,-0.69446,1,0
1,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,4.9495e-06,-0.70264,-0.65719,1,0
1,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,2.1347e-05,-0.70312,-0.62869,1,0
1,GO RESPONSE TO LEUCINE,6.6813e-06,-0.70353,-0.74156,1,0
1,GO INTRACELLULAR MRNA LOCALIZATION,4.5891e-06,-0.70367,-0.6408,1,0
1,GO CARDIAC SEPTUM DEVELOPMENT,4.5891e-06,-0.70368,-0.70807,1,0
1,GO PROTEIN KINASE C SIGNALING,1.0403e-05,-0.70386,-0.6808,1,0
1,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,6.6813e-06,-0.70395,-0.72041,1,0
1,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,3.248e-05,-0.70401,-0.73997,1,0
1,GO NEGATIVE REGULATION OF BIOMINERALIZATION,8.9843e-06,-0.70471,-0.748,1,0
1,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,4.2539e-06,-0.70487,-0.69416,1,0
1,GO BONE DEVELOPMENT,3.9422e-06,-0.70493,-0.70225,1,0
1,GO PEPTIDE CATABOLIC PROCESS,6.2007e-06,-0.70534,-0.66467,1,0
1,GO TYPE B PANCREATIC CELL DEVELOPMENT,1.2035e-05,-0.70541,-0.65982,1,0
1,GO ENERGY HOMEOSTASIS,1.2939e-05,-0.70562,-0.61554,1,0
1,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,4.9495e-06,-0.70574,-0.64793,1,0
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,5.337e-06,-0.706,-0.67007,1,0
1,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,6.6813e-06,-0.70648,-0.74062,1,0
1,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,4.9495e-06,-0.7071,-0.72732,1,0
1,GO METANEPHRIC NEPHRON DEVELOPMENT,6.2007e-06,-0.70735,-0.73248,1,0
1,GO ADHERENS JUNCTION ORGANIZATION,4.2539e-06,-0.70772,-0.73319,1,0
1,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,1.0403e-05,-0.70849,-0.67224,1,0
1,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,3.9422e-06,-0.7085,-0.70095,1,0
1,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,8.9843e-06,-0.7087,-0.67594,1,0
1,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,4.2539e-06,-0.70872,-0.69171,1,0
1,GO REGULATION OF CELL SUBSTRATE ADHESION,5.7533e-06,-0.70903,-0.74822,1,0
1,GO HEMATOPOIETIC STEM CELL PROLIFERATION,4.5891e-06,-0.70921,-0.70927,1,0
1,GO CELL SUBSTRATE ADHESION,4.5891e-06,-0.70932,-0.75762,1,0
1,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,5.7533e-06,-0.70949,-0.66856,1,0
1,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,4.2539e-06,-0.70966,-0.68315,1,0
1,GO MAMMARY GLAND DEVELOPMENT,4.5891e-06,-0.71015,-0.66335,1,0
1,GO TRACHEA MORPHOGENESIS,4.2539e-06,-0.71048,-0.74885,1,0
1,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,5.7533e-06,-0.71057,-0.67462,1,0
1,GO ESTABLISHMENT OF CELL POLARITY,4.2539e-06,-0.7108,-0.69158,1,0
1,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,5.6086e-05,-0.71126,-0.7202,1,0
1,GO HISTONE H3 K36 METHYLATION,4.2539e-06,-0.71191,-0.77003,1,0
1,GO NEGATIVE REGULATION OF TISSUE REMODELING,2.1347e-05,-0.71194,-0.80171,1,0
1,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,4.5891e-06,-0.71234,-0.68335,1,0
1,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,5.337e-06,-0.71251,-0.6805,1,0
1,GO GOLGI TO VACUOLE TRANSPORT,4.2539e-06,-0.71259,-0.75197,1,0
1,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,2.4576e-05,-0.71269,-0.64887,1,0
1,GO EMBRYONIC HEMOPOIESIS,8.3461e-06,-0.71326,-0.70202,1,0
1,GO ANATOMICAL STRUCTURE ARRANGEMENT,5.337e-06,-0.71361,-0.73266,1,0
1,GO NOREPINEPHRINE METABOLIC PROCESS,0.00010866,-0.71454,-0.61394,1,0
1,GO CELL JUNCTION DISASSEMBLY,5.2428e-05,-0.71469,-0.78748,1,0
1,GO REGULATION OF JUN KINASE ACTIVITY,4.9495e-06,-0.7149,-0.69763,1,0
1,GO ATRIAL SEPTUM MORPHOGENESIS,5.9985e-05,-0.715,-0.6425,1,0
1,GO ACTIVATION OF JUN KINASE ACTIVITY,5.337e-06,-0.71512,-0.75372,1,0
1,GO FORMATION OF PRIMARY GERM LAYER,4.9495e-06,-0.71524,-0.72217,1,0
1,GO TISSUE REMODELING,4.9495e-06,-0.71552,-0.73535,1,0
1,GO PHAGOCYTOSIS RECOGNITION,5.6086e-05,-0.71554,-0.67741,1,0
1,GO EMBRYONIC EYE MORPHOGENESIS,4.2539e-06,-0.71655,-0.73114,1,0
1,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,5.337e-06,-0.71686,-0.67147,1,0
1,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,3.9422e-06,-0.71775,-0.71278,1,0
1,GO NEGATIVE CHEMOTAXIS,4.9495e-06,-0.71874,-0.72721,1,0
1,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,1.3909e-05,-0.7192,-0.76083,1,0
1,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,4.5891e-06,-0.71923,-0.74274,1,0
1,GO INACTIVATION OF MAPK ACTIVITY,1.2939e-05,-0.71969,-0.63973,1,0
1,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,5.337e-06,-0.71996,-0.69079,1,0
1,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,8.9843e-06,-0.7203,-0.6872,1,0
1,GO ERYTHROCYTE DEVELOPMENT,3.9422e-06,-0.72058,-0.70482,1,0
1,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,4.9495e-06,-0.72101,-0.76021,1,0
1,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,8.9843e-06,-0.72123,-0.73327,1,0
1,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,4.5891e-06,-0.72129,-0.71531,1,0
1,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,6.6813e-06,-0.72229,-0.67466,1,0
1,GO ACTIN CROSSLINK FORMATION,7.1973e-06,-0.72301,-0.69556,1,0
1,GO PROTEIN LOCALIZATION TO MICROTUBULE,7.1973e-06,-0.72321,-0.69277,1,0
1,GO ENDOTHELIAL CELL PROLIFERATION,4.2539e-06,-0.72397,-0.69541,1,0
1,GO REPLACEMENT OSSIFICATION,1.0403e-05,-0.7241,-0.68915,1,0
1,GO LAMELLIPODIUM MORPHOGENESIS,1.2939e-05,-0.72493,-0.63998,1,0
1,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,6.6813e-06,-0.72503,-0.70092,1,0
1,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,4.5891e-06,-0.7254,-0.76824,1,0
1,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,3.9422e-06,-0.72574,-0.69641,1,0
1,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,5.7533e-06,-0.72579,-0.70206,1,0
1,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,4.9495e-06,-0.72585,-0.69458,1,0
1,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,7.1973e-06,-0.72639,-0.67626,1,0
1,GO ACTIVATION OF JNKK ACTIVITY,4.5891e-06,-0.72669,-0.78564,1,0
1,GO CORPUS CALLOSUM DEVELOPMENT,5.337e-06,-0.72682,-0.72843,1,0
1,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,5.337e-06,-0.72753,-0.79933,1,0
1,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,5.7533e-06,-0.72753,-0.78841,1,0
1,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,2.1347e-05,-0.72768,-0.69073,1,0
1,GO CELLULAR RESPONSE TO ACID CHEMICAL,3.9422e-06,-0.72784,-0.73743,1,0
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,4.2539e-06,-0.72795,-0.69936,1,0
1,GO PULMONARY VALVE DEVELOPMENT,4.9495e-06,-0.72831,-0.81117,1,0
1,GO INTEGRIN MEDIATED SIGNALING PATHWAY,4.5891e-06,-0.7284,-0.75633,1,0
1,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,4.9495e-06,-0.72851,-0.69724,1,0
1,GO REGULATION OF THE FORCE OF HEART CONTRACTION,1.0403e-05,-0.72914,-0.61537,1,0
1,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,2.2907e-05,-0.72949,-0.77046,1,0
1,GO CAVEOLIN MEDIATED ENDOCYTOSIS,1.9888e-05,-0.73008,-0.66567,1,0
1,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,6.4139e-05,-0.73011,-0.83712,1,0
1,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,7.1973e-06,-0.73049,-0.66148,1,0
1,GO REGULATION OF MIRNA METABOLIC PROCESS,4.5891e-06,-0.73098,-0.75594,1,0
1,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,2.2907e-05,-0.73108,-0.67829,1,0
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,6.2007e-06,-0.7311,-0.67527,1,0
1,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,1.1191e-05,-0.73118,-0.63519,1,0
1,GO REGULATION OF GTPASE ACTIVITY,4.2539e-06,-0.7313,-0.69224,1,0
1,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,3.9422e-06,-0.73222,-0.74078,1,0
1,GO GLYCOPROTEIN CATABOLIC PROCESS,5.7533e-06,-0.73233,-0.75363,1,0
1,GO PROTEIN AUTOPHOSPHORYLATION,3.9422e-06,-0.73234,-0.71547,1,0
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,6.2007e-06,-0.73248,-0.77202,1,0
1,GO GOLGI TO ENDOSOME TRANSPORT,5.337e-06,-0.73321,-0.69825,1,0
1,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,1.3909e-05,-0.73358,-0.69209,1,0
1,GO KERATAN SULFATE CATABOLIC PROCESS,8.9327e-05,-0.7343,-0.76318,1,0
1,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,3.0304e-05,-0.73437,-0.70911,1,0
1,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,4.2539e-06,-0.73468,-0.73295,1,0
1,GO P38MAPK CASCADE,4.9495e-06,-0.73485,-0.74907,1,0
1,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,4.5891e-06,-0.73491,-0.68639,1,0
1,GO PLASMA MEMBRANE ORGANIZATION,4.5891e-06,-0.73522,-0.70549,1,0
1,GO LEYDIG CELL DIFFERENTIATION,0.0010798,-0.7359,-0.55159,1,0
1,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,7.7514e-06,-0.73603,-0.66475,1,0
1,GO REGULATION OF DEACETYLASE ACTIVITY,5.337e-06,-0.73634,-0.73591,1,0
1,GO REGULATION OF CELL MATRIX ADHESION,4.2539e-06,-0.73672,-0.76605,1,0
1,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,7.1973e-06,-0.73693,-0.70195,1,0
1,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,5.7533e-06,-0.73723,-0.75347,1,0
1,GO BLEB ASSEMBLY,5.2428e-05,-0.73735,-0.72409,1,0
1,GO BONE CELL DEVELOPMENT,3.9422e-06,-0.73761,-0.77537,1,0
1,GO CELL ADHESION MEDIATED BY INTEGRIN,1.7249e-05,-0.73768,-0.80933,1,0
1,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,1.2035e-05,-0.73783,-0.79502,1,0
1,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,8.3461e-06,-0.73798,-0.70822,1,0
1,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,4.5779e-05,-0.73814,-0.6155,1,0
1,GO REGULATION OF FATTY ACID BETA OXIDATION,6.2007e-06,-0.73839,-0.70118,1,0
1,GO POSITIVE REGULATION OF GTPASE ACTIVITY,4.2539e-06,-0.73845,-0.6973,1,0
1,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,1.3909e-05,-0.73889,-0.7183,1,0
1,GO REGULATION OF COLLAGEN METABOLIC PROCESS,6.6813e-06,-0.73898,-0.7812,1,0
1,GO LUTEINIZATION,6.2007e-06,-0.73944,-0.79383,1,0
1,GO PODOSOME ASSEMBLY,3.9422e-06,-0.74193,-0.81446,1,0
1,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,3.9422e-06,-0.74199,-0.72257,1,0
1,GO ALANINE TRANSPORT,1.1191e-05,-0.74201,-0.71663,1,0
1,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,3.9422e-06,-0.74218,-0.77603,1,0
1,GO INHIBITORY SYNAPSE ASSEMBLY,6.4139e-05,-0.74249,-0.68,1,0
1,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,2.4576e-05,-0.74315,-0.72301,1,0
1,GO TUBULIN DEACETYLATION,6.6813e-06,-0.74361,-0.73484,1,0
1,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,2.4576e-05,-0.74379,-0.79252,1,0
1,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,2.4576e-05,-0.74462,-0.75083,1,0
1,GO GASTRULATION WITH MOUTH FORMING SECOND,1.1191e-05,-0.74492,-0.68728,1,0
1,GO BONE GROWTH,7.1973e-06,-0.74557,-0.68579,1,0
1,GO CELL MATRIX ADHESION,3.9422e-06,-0.74561,-0.77531,1,0
1,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,4.2539e-06,-0.7465,-0.72552,1,0
1,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,4.5891e-06,-0.74678,-0.74932,1,0
1,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,1.2035e-05,-0.7471,-0.74202,1,0
1,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,1.4947e-05,-0.74792,-0.6865,1,0
1,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,4.5779e-05,-0.74933,-0.72251,1,0
1,GO RNA DESTABILIZATION,3.9422e-06,-0.74961,-0.75487,1,0
1,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,4.9495e-06,-0.75086,-0.72335,1,0
1,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,4.9495e-06,-0.75096,-0.67666,1,0
1,GO REGULATION OF VASCULAR PERMEABILITY,8.3461e-06,-0.75136,-0.66612,1,0
1,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,4.9495e-06,-0.75153,-0.76462,1,0
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,4.2539e-06,-0.75203,-0.71148,1,0
1,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,4.5891e-06,-0.75261,-0.71165,1,0
1,GO POSITIVE REGULATION OF AXON EXTENSION,3.9422e-06,-0.75325,-0.75428,1,0
1,GO ACTIN FILAMENT BUNDLE ORGANIZATION,4.5891e-06,-0.75342,-0.70234,1,0
1,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,6.2007e-06,-0.75361,-0.76914,1,0
1,GO ANATOMICAL STRUCTURE REGRESSION,7.3279e-05,-0.75409,-0.66002,1,0
1,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,1.2035e-05,-0.75435,-0.69529,1,0
1,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,4.2539e-06,-0.7548,-0.73853,1,0
1,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,5.9985e-05,-0.7548,-0.73556,1,0
1,GO PULMONARY VALVE MORPHOGENESIS,5.7533e-06,-0.75484,-0.79176,1,0
1,GO POSITIVE REGULATION OF P38MAPK CASCADE,4.9495e-06,-0.75485,-0.75035,1,0
1,GO REGULATION OF KERATINOCYTE PROLIFERATION,8.9843e-06,-0.75627,-0.6749,1,0
1,GO COLLAGEN CATABOLIC PROCESS,3.7287e-05,-0.7565,-0.73854,1,0
1,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,3.4805e-05,-0.75677,-0.69586,1,0
1,GO AXO DENDRITIC PROTEIN TRANSPORT,1.2035e-05,-0.75709,-0.78397,1,0
1,GO KERATINOCYTE MIGRATION,4.2539e-06,-0.75737,-0.72676,1,0
1,GO EXTRACELLULAR MATRIX DISASSEMBLY,1.0403e-05,-0.75778,-0.76665,1,0
1,GO ACTOMYOSIN STRUCTURE ORGANIZATION,4.5891e-06,-0.75849,-0.69896,1,0
1,GO REGULATION OF AXON GUIDANCE,4.5891e-06,-0.75852,-0.77073,1,0
1,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,4.2539e-06,-0.75903,-0.76345,1,0
1,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,3.9422e-06,-0.75923,-0.72128,1,0
1,GO HEART VALVE DEVELOPMENT,3.9422e-06,-0.75959,-0.77856,1,0
1,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,4.5891e-06,-0.75973,-0.69873,1,0
1,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.00021879,-0.75993,-0.86572,1,0
1,GO PLATELET MORPHOGENESIS,3.9422e-06,-0.76025,-0.74533,1,0
1,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,8.3461e-06,-0.76062,-0.78489,1,0
1,GO CELLULAR RESPONSE TO CHOLESTEROL,4.5891e-06,-0.76068,-0.8051,1,0
1,GO BETA CATENIN TCF COMPLEX ASSEMBLY,4.9495e-06,-0.76091,-0.76449,1,0
1,GO STRESS FIBER ASSEMBLY,4.2539e-06,-0.76196,-0.70259,1,0
1,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,0.00096503,-0.76242,-0.59765,1,0
1,GO REGULATION OF NEURON MIGRATION,6.6813e-06,-0.76295,-0.75124,1,0
1,GO CORONARY VASCULATURE MORPHOGENESIS,5.337e-06,-0.76304,-0.79162,1,0
1,GO EPITHELIAL CELL MORPHOGENESIS,1.2939e-05,-0.76352,-0.73244,1,0
1,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,4.9495e-06,-0.76365,-0.74048,1,0
1,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,3.9422e-06,-0.76392,-0.75687,1,0
1,GO REGULATION OF STEM CELL DIVISION,1.1191e-05,-0.76428,-0.71993,1,0
1,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,4.5891e-06,-0.76487,-0.72704,1,0
1,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,4.9495e-06,-0.7657,-0.71647,1,0
1,GO COMPLEMENT RECEPTOR MEDIATED SIGNALING PATHWAY,0.00076864,-0.7661,-0.65932,1,0
1,GO CLATHRIN DEPENDENT ENDOCYTOSIS,5.337e-06,-0.76669,-0.73675,1,0
1,GO ACTIVATION OF GTPASE ACTIVITY,4.9495e-06,-0.76729,-0.73438,1,0
1,GO MEGAKARYOCYTE DEVELOPMENT,3.9422e-06,-0.76735,-0.78911,1,0
1,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,1.3909e-05,-0.76766,-0.74578,1,0
1,GO REGULATION OF NATURAL KILLER CELL DIFFERENTIATION,5.6086e-05,-0.76817,-0.65044,1,0
1,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,4.2539e-06,-0.76859,-0.74136,1,0
1,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,1.2035e-05,-0.76859,-0.82418,1,0
1,GO EPITHELIAL CELL CELL ADHESION,7.1973e-06,-0.7686,-0.78672,1,0
1,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,5.337e-06,-0.76861,-0.74735,1,0
1,GO FACIAL NERVE MORPHOGENESIS,2.2907e-05,-0.76879,-0.74192,1,0
1,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,3.9422e-06,-0.76954,-0.82527,1,0
1,GO RESPONSE TO MUSCLE STRETCH,5.6086e-05,-0.76981,-0.6962,1,0
1,GO CERAMIDE CATABOLIC PROCESS,7.7514e-06,-0.76993,-0.73572,1,0
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,2.8267e-05,-0.77038,-0.73152,1,0
1,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,5.7533e-06,-0.77066,-0.78881,1,0
1,GO GAP JUNCTION ASSEMBLY,0.00015974,-0.77271,-0.72565,1,0
1,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,9.6689e-06,-0.77297,-0.75301,1,0
1,GO REGULATION OF SPROUTING ANGIOGENESIS,4.5891e-06,-0.77311,-0.74678,1,0
1,GO GLOMERULUS DEVELOPMENT,4.5891e-06,-0.77377,-0.799,1,0
1,GO ACTIN FILAMENT BASED TRANSPORT,6.6813e-06,-0.7739,-0.76499,1,0
1,GO NEGATIVE REGULATION OF TORC1 SIGNALING,6.2007e-06,-0.77536,-0.75747,1,0
1,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,4.5891e-06,-0.77548,-0.75954,1,0
1,GO RAP PROTEIN SIGNAL TRANSDUCTION,3.9422e-06,-0.77559,-0.78598,1,0
1,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,4.2539e-06,-0.77591,-0.75418,1,0
1,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,9.6689e-06,-0.77739,-0.77762,1,0
1,GO BASEMENT MEMBRANE ORGANIZATION,5.337e-06,-0.77764,-0.78603,1,0
1,GO ENDOCYTIC RECYCLING,4.2539e-06,-0.77876,-0.72033,1,0
1,GO NEGATIVE REGULATION OF BONE REMODELING,3.9936e-05,-0.77945,-0.7818,1,0
1,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,1.3909e-05,-0.78044,-0.7742,1,0
1,GO ENDODERM DEVELOPMENT,5.337e-06,-0.78066,-0.79083,1,0
1,GO HIPPO SIGNALING,5.337e-06,-0.78114,-0.75705,1,0
1,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,5.337e-06,-0.78125,-0.75355,1,0
1,GO RESPONSE TO AMYLOID BETA,4.2539e-06,-0.78154,-0.78515,1,0
1,GO REGULATION OF PROTEIN KINASE C SIGNALING,3.248e-05,-0.7823,-0.74882,1,0
1,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,6.2007e-06,-0.78237,-0.78062,1,0
1,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,6.8565e-05,-0.78329,-0.64753,1,0
1,GO PROTEIN ACTIVATION CASCADE,7.8298e-05,-0.78342,-0.6725,1,0
1,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,2.2907e-05,-0.78364,-0.80292,1,0
1,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,4.2763e-05,-0.78371,-0.84703,1,0
1,GO ARTERY MORPHOGENESIS,5.337e-06,-0.78437,-0.75781,1,0
1,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,5.7533e-06,-0.78457,-0.7438,1,0
1,GO SYNAPTIC VESICLE CLUSTERING,5.2428e-05,-0.78495,-0.7368,1,0
1,GO ARF PROTEIN SIGNAL TRANSDUCTION,5.337e-06,-0.78531,-0.82528,1,0
1,GO GOLGI RIBBON FORMATION,5.7533e-06,-0.78554,-0.80722,1,0
1,GO LUNG ALVEOLUS DEVELOPMENT,7.7514e-06,-0.78628,-0.78088,1,0
1,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,7.1973e-06,-0.78743,-0.84469,1,0
1,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,4.9495e-06,-0.78813,-0.76458,1,0
1,GO BODY MORPHOGENESIS,4.5891e-06,-0.78847,-0.77576,1,0
1,GO REGULATION OF NEURON MATURATION,5.2428e-05,-0.78854,-0.5943,1,0
1,GO NEGATIVE REGULATION OF AXON GUIDANCE,4.2539e-06,-0.78873,-0.80726,1,0
1,GO EXTRACELLULAR STRUCTURE ORGANIZATION,6.2007e-06,-0.78951,-0.80978,1,0
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,5.337e-06,-0.78953,-0.77013,1,0
1,GO LATERAL VENTRICLE DEVELOPMENT,8.3461e-06,-0.7903,-0.79303,1,0
1,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,4.5891e-06,-0.79048,-0.77108,1,0
1,GO NEUTROPHIL HOMEOSTASIS,3.9422e-06,-0.79157,-0.85263,1,0
1,GO COLLAGEN METABOLIC PROCESS,7.7514e-06,-0.7916,-0.82487,1,0
1,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,6.6813e-06,-0.79161,-0.77254,1,0
1,GO BLOOD VESSEL REMODELING,5.7533e-06,-0.79229,-0.78265,1,0
1,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,4.9495e-06,-0.79277,-0.81876,1,0
1,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,9.5377e-05,-0.79283,-0.71392,1,0
1,GO ASTRAL MICROTUBULE ORGANIZATION,1.2939e-05,-0.79317,-0.73457,1,0
1,GO MACROPHAGE CYTOKINE PRODUCTION,1.1191e-05,-0.79379,-0.80921,1,0
1,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,4.9495e-06,-0.79407,-0.81628,1,0
1,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,4.5891e-06,-0.79421,-0.81732,1,0
1,GO MONONUCLEAR CELL DIFFERENTIATION,8.9843e-06,-0.79477,-0.77665,1,0
1,GO CELLULAR RESPONSE TO AMYLOID BETA,4.2539e-06,-0.7948,-0.77004,1,0
1,GO SOMATIC STEM CELL DIVISION,0.00020554,-0.79509,-0.66278,1,0
1,GO HEMIDESMOSOME ASSEMBLY,0.0029965,-0.79576,-0.61857,1,0
1,GO SEMI LUNAR VALVE DEVELOPMENT,3.9422e-06,-0.79617,-0.80288,1,0
1,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,4.2539e-06,-0.79731,-0.79023,1,0
1,GO MICROTUBULE NUCLEATION,7.7514e-06,-0.79751,-0.75232,1,0
1,GO REGULATION OF NEUTROPHIL ACTIVATION,5.2428e-05,-0.7977,-0.83358,1,0
1,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,3.9422e-06,-0.79945,-0.79305,1,0
1,GO FOCAL ADHESION ASSEMBLY,4.5891e-06,-0.79983,-0.80414,1,0
1,GO CORONARY VASCULATURE DEVELOPMENT,4.9495e-06,-0.80022,-0.77099,1,0
1,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,4.9495e-06,-0.80024,-0.75687,1,0
1,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,4.2539e-06,-0.80075,-0.81262,1,0
1,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,1.2035e-05,-0.80309,-0.72083,1,0
1,GO VASCULAR WOUND HEALING,1.0403e-05,-0.80452,-0.79639,1,0
1,GO ACTIN FILAMENT DEPOLYMERIZATION,4.5891e-06,-0.80482,-0.75971,1,0
1,GO ACTIVATION OF MAPKKK ACTIVITY,9.6689e-06,-0.80531,-0.74581,1,0
1,GO AORTIC VALVE DEVELOPMENT,3.9422e-06,-0.80779,-0.79801,1,0
1,GO EPIBOLY,3.9422e-06,-0.808,-0.78205,1,0
1,GO MRNA TRANSCRIPTION,4.9495e-06,-0.81072,-0.76623,1,0
1,GO SUBSTRATE DEPENDENT CELL MIGRATION,3.9422e-06,-0.81139,-0.82052,1,0
1,GO FACE DEVELOPMENT,3.9422e-06,-0.81235,-0.81281,1,0
1,GO NEURON PROJECTION ARBORIZATION,5.337e-06,-0.81343,-0.80788,1,0
1,GO LYMPHANGIOGENESIS,7.1973e-06,-0.81586,-0.75059,1,0
1,GO TOOTH MINERALIZATION,8.9843e-06,-0.81815,-0.78462,1,0
1,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,6.2007e-06,-0.8191,-0.79962,1,0
1,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,3.9422e-06,-0.81925,-0.80809,1,0
1,GO PROTEIN DEMETHYLATION,5.337e-06,-0.82492,-0.77927,1,0
1,GO DERMATAN SULFATE METABOLIC PROCESS,1.7249e-05,-0.82609,-0.78288,1,0
1,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,4.5891e-06,-0.82673,-0.78494,1,0
1,GO ARTERY DEVELOPMENT,4.2539e-06,-0.82761,-0.77903,1,0
1,GO CELL CELL ADHESION MEDIATED BY CADHERIN,1.2939e-05,-0.82837,-0.75117,1,0
1,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,8.3461e-06,-0.82895,-0.8807,1,0
1,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,4.2539e-06,-0.8295,-0.90414,1,0
1,GO AORTA MORPHOGENESIS,4.5891e-06,-0.83074,-0.83012,1,0
1,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,3.0304e-05,-0.83205,-0.81208,1,0
1,GO RESPONSE TO MAGNESIUM ION,2.636e-05,-0.83254,-0.71762,1,0
1,GO HEAD MORPHOGENESIS,4.5891e-06,-0.83643,-0.83265,1,0
1,GO POSITIVE REGULATION OF MITOPHAGY,4.5891e-06,-0.83661,-0.82286,1,0
1,GO VENOUS BLOOD VESSEL DEVELOPMENT,5.7533e-06,-0.83899,-0.80782,1,0
1,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,4.9495e-06,-0.84009,-0.77599,1,0
1,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,4.2539e-06,-0.84085,-0.84279,1,0
1,GO AORTA DEVELOPMENT,3.9422e-06,-0.8413,-0.84837,1,0
1,GO CELL SUBSTRATE JUNCTION ORGANIZATION,4.9495e-06,-0.84219,-0.81273,1,0
1,GO COLLAGEN BIOSYNTHETIC PROCESS,5.337e-06,-0.84308,-0.87921,1,0
1,GO ACTIN FILAMENT SEVERING,7.7514e-06,-0.84336,-0.75795,1,0
1,GO SECRETORY GRANULE LOCALIZATION,9.6689e-06,-0.84367,-0.83168,1,0
1,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,5.337e-06,-0.84392,-0.83597,1,0
1,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,4.9495e-06,-0.84469,-0.79187,1,0
1,GO CRANIAL NERVE STRUCTURAL ORGANIZATION,8.3461e-06,-0.84571,-0.8092,1,0
1,GO REGULATION OF KERATINOCYTE MIGRATION,3.9422e-06,-0.84584,-0.8404,1,0
1,GO RESPONSE TO FLUID SHEAR STRESS,4.2539e-06,-0.84676,-0.84496,1,0
1,GO PLACENTA BLOOD VESSEL DEVELOPMENT,8.3461e-06,-0.85048,-0.74664,1,0
1,GO LYMPH VESSEL MORPHOGENESIS,7.1973e-06,-0.85123,-0.78633,1,0
1,GO LOCOMOTOR RHYTHM,7.7514e-06,-0.85172,-0.80442,1,0
1,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,4.2539e-06,-0.85229,-0.78868,1,0
1,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,1.8524e-05,-0.85296,-0.77231,1,0
1,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,1.1191e-05,-0.85518,-0.8511,1,0
1,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,4.5891e-06,-0.85694,-0.80201,1,0
1,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,8.3461e-06,-0.85741,-0.74545,1,0
1,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,4.2539e-06,-0.859,-0.83283,1,0
1,GO ENDODERM FORMATION,6.2007e-06,-0.86165,-0.84597,1,0
1,GO NUCLEAR MIGRATION,4.9495e-06,-0.86204,-0.85039,1,0
1,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,4.9495e-06,-0.86471,-0.79302,1,0
1,GO REGULATION OF AUTOPHAGOSOME MATURATION,4.5891e-06,-0.86679,-0.80255,1,0
1,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,5.7533e-06,-0.86752,-0.8143,1,0
1,GO REGULATION OF MONOCYTE DIFFERENTIATION,3.0304e-05,-0.87039,-0.82941,1,0
1,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,3.9422e-06,-0.87519,-0.8207,1,0
1,GO EXTRACELLULAR MATRIX ASSEMBLY,6.2007e-06,-0.87593,-0.90861,1,0
1,GO DENSE CORE GRANULE TRANSPORT,7.3279e-05,-0.87745,-0.82685,1,0
1,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,8.9843e-06,-0.88187,-0.84717,1,0
1,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,4.9495e-06,-0.88511,-0.83822,1,0
1,GO PLASMA MEMBRANE TUBULATION,3.9422e-06,-0.8861,-0.8318,1,0
1,GO BASEMENT MEMBRANE ASSEMBLY,1.0403e-05,-0.88748,-0.84353,1,0
1,GO NUCLEUS LOCALIZATION,5.337e-06,-0.88833,-0.82596,1,0
1,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,4.5891e-06,-0.88962,-0.88419,1,0
1,GO MYELIN ASSEMBLY,5.7533e-06,-0.89118,-0.78658,1,0
1,GO CELL MIGRATION IN HINDBRAIN,2.4576e-05,-0.89268,-0.77661,1,0
1,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,1.2035e-05,-0.89721,-0.89054,1,0
1,GO NEGATIVE REGULATION OF HIPPO SIGNALING,6.2007e-06,-0.89995,-0.82521,1,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,3.9422e-06,-0.9042,-0.94446,1,0
1,GO METANEPHRIC GLOMERULUS DEVELOPMENT,8.3461e-06,-0.90669,-0.9124,1,0
1,GO POSITIVE REGULATION OF NEURON MIGRATION,3.9422e-06,-0.91511,-0.92234,1,0
1,GO ENDODERMAL CELL DIFFERENTIATION,5.337e-06,-0.9161,-0.93054,1,0
1,GO LYMPH VESSEL DEVELOPMENT,6.2007e-06,-0.91933,-0.83874,1,0
1,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.00010866,-0.92291,-0.99863,1,0
1,GO BONE TRABECULA MORPHOGENESIS,7.8298e-05,-0.92476,-0.85409,1,0
1,GO HYALURONAN BIOSYNTHETIC PROCESS,4.9495e-06,-0.92603,-0.89323,1,0
1,GO ADHERENS JUNCTION ASSEMBLY,5.337e-06,-0.92618,-0.87721,1,0
1,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,3.9422e-06,-0.92655,-0.92373,1,0
1,GO GLOMERULAR MESANGIUM DEVELOPMENT,7.1973e-06,-0.92879,-0.9716,1,0
1,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,5.337e-06,-0.93067,-0.87451,1,0
1,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,8.3641e-05,-0.93355,-0.89202,1,0
1,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,1.1191e-05,-0.93707,-0.84373,1,0
1,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,4.2539e-06,-0.93762,-0.87361,1,0
1,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,4.2539e-06,-0.93953,-0.9054,1,0
1,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,1.1191e-05,-0.94049,-0.97005,1,0
1,GO MACROPHAGE PROLIFERATION,5.2428e-05,-0.94062,-0.88075,1,0
1,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,6.6813e-06,-0.94111,-0.86766,1,0
1,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,5.7533e-06,-0.94297,-0.94619,1,0
1,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,3.4805e-05,-0.94764,-0.82382,1,0
1,GO PROTEIN LOCALIZATION TO PRESYNAPSE,1.4947e-05,-0.95881,-0.84176,1,0
1,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,6.4139e-05,-0.95924,-0.79733,1,0
1,GO SKIN MORPHOGENESIS,8.9843e-06,-0.96257,-0.91253,1,0
1,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,4.9495e-06,-0.97458,-0.89019,1,0
1,GO ENDOTHELIAL CELL MORPHOGENESIS,5.7533e-06,-0.97533,-0.96018,1,0
1,GO REGULATION OF NEURON PROJECTION ARBORIZATION,8.9843e-06,-0.99135,-0.8693,1,0
1,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,5.337e-06,-1.0646,-0.96008,1,0
1,GO ELASTIC FIBER ASSEMBLY,1.0403e-05,-1.0784,-1.0383,1,0
1,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,4.2539e-06,-1.1525,-1.1533,1,0
1,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.091819,0.13768,0.086126,0,1
1,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.10811,0.1185,0.079637,0,1
1,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.054439,0.14442,0.12896,0,0
1,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.18102,0.11873,0.04378,0,0
1,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.10134,0.09617,0.095433,0,0
1,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.29248,0.088266,0.029721,0,0
1,GO OXYGEN TRANSPORT,0.65188,0.086736,-0.066425,0,0
1,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.27821,0.066894,0.019169,0,0
1,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.50109,0.054832,0.0060933,0,0
1,GO TRANSLATIONAL TERMINATION,0.51122,0.050554,-0.015039,0,0
1,GO REGULATION OF APPETITE,0.62923,0.046798,-0.1192,0,0
1,GO MITOCHONDRIAL TRANSLATION,0.76963,0.032666,-0.065235,0,0
1,GO SEQUESTERING OF ACTIN MONOMERS,0.69814,0.031164,0.067921,0,0
1,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.76963,0.030923,-0.043814,0,0
1,GO OXIDATIVE PHOSPHORYLATION,0.81845,0.029227,-0.020852,0,0
1,GO TRANSLATIONAL INITIATION,0.53179,0.0023127,0.032857,0,0
1,GO PROTEASOME ASSEMBLY,0.33029,-0.0081704,-0.10382,0,0
1,GO MITOCHONDRIAL GENE EXPRESSION,0.32248,-0.012501,-0.10628,0,0
1,GO XENOBIOTIC CATABOLIC PROCESS,0.52145,-0.018781,-0.094319,0,0
1,GO TRANSLATIONAL ELONGATION,0.53179,-0.019058,-0.068676,0,0
1,GO GAS TRANSPORT,0.33821,-0.01985,-0.16505,0,0
1,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.60692,-0.020305,-0.04752,0,0
1,GO PROTEIN NEDDYLATION,0.36271,-0.024538,-0.067986,0,0
1,GO PROTEIN TARGETING TO MEMBRANE,0.89296,-0.025854,-0.007756,0,0
1,GO CYTOPLASMIC TRANSLATION,0.32248,-0.030683,-0.040193,0,0
1,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.27821,-0.03324,-0.088737,0,0
1,GO GTP BIOSYNTHETIC PROCESS,0.28529,-0.035358,-0.09055,0,0
1,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.24463,-0.04311,-0.10006,0,0
1,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.37111,-0.043679,-0.077005,0,0
1,GO CHROMATIN REMODELING AT CENTROMERE,0.08588,-0.060854,-0.15244,0,0
1,GO PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.1475,-0.061545,-0.1477,0,0
1,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,0.70989,-0.063905,-0.058636,0,0
1,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.17591,-0.067946,-0.14978,0,0
1,GO RIBOSOME ASSEMBLY,0.08881,-0.067994,-0.068351,0,0
1,GO VIRAL GENE EXPRESSION,0.098083,-0.070823,-0.055811,0,0
1,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,0.0036751,-0.072602,-0.19366,0,0
1,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.10468,-0.072707,-0.11673,0,0
1,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.33821,-0.075498,-0.037737,0,0
1,GO PIRNA METABOLIC PROCESS,0.08881,-0.075898,-0.16574,0,0
1,GO UTP METABOLIC PROCESS,0.25111,-0.076824,-0.11159,0,0
1,GO BINDING OF SPERM TO ZONA PELLUCIDA,0.069906,-0.07806,-0.13178,0,0
1,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,0.091819,-0.078448,-0.084043,0,0
1,GO RRNA 3 END PROCESSING,0.11894,-0.079117,-0.12558,0,0
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.0172,-0.086193,-0.13495,0,0
1,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.15655,-0.094099,-0.11505,0,0
1,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.023112,-0.095135,-0.18776,0,0
1,GO ELECTRON TRANSPORT CHAIN,0.054439,-0.10396,-0.11871,0,0
1,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.022172,-0.10664,-0.16038,0,0
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.062884,-0.10974,-0.070651,0,0
1,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.037377,-0.10996,-0.24695,0,0
1,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.2259,-0.11228,-0.12954,0,0
1,GO DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.0028457,-0.11549,-0.20324,0,0
1,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,0.0063209,-0.11771,-0.2043,0,0
1,GO REGULATION OF RESPONSE TO FOOD,0.12662,-0.11899,-0.19595,0,0
1,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.046961,-0.12433,-0.15651,0,0
1,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.024086,-0.12493,-0.16504,0,0
1,GO CYTOCHROME COMPLEX ASSEMBLY,0.0040644,-0.12886,-0.19795,0,0
1,GO PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS,0.013834,-0.12954,-0.21845,0,0
1,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.0052065,-0.12958,-0.19436,0,0
1,GO TRNA 5 LEADER REMOVAL,0.056456,-0.1313,-0.14005,0,0
1,GO CELLULAR RESPIRATION,0.018736,-0.1324,-0.15604,0,0
1,GO TRNA 5 END PROCESSING,0.02951,-0.13262,-0.15997,0,0
1,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.53179,-0.13838,-0.073621,0,0
1,GO DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.037377,-0.13912,-0.15963,0,0
1,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.013235,-0.14162,-0.1517,0,0
1,GO ANTIMICROBIAL HUMORAL RESPONSE,0.16602,-0.14226,-0.17803,0,0
1,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.0063209,-0.14447,-0.24924,0,0
1,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.0083971,-0.14988,-0.2194,0,0
1,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.016475,-0.15082,-0.20203,0,0
1,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.0024341,-0.15186,-0.22683,0,0
1,GO DETOXIFICATION OF INORGANIC COMPOUND,0.27126,-0.15478,-0.23521,0,0
1,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.00072571,-0.15616,-0.20479,0,0
1,GO INNATE IMMUNE RESPONSE IN MUCOSA,0.58498,-0.15709,-0.10483,0,0
1,GO ANTIBACTERIAL HUMORAL RESPONSE,0.17591,-0.15864,-0.22556,0,0
1,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.0015041,-0.15882,-0.30844,0,0
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,9.6689e-06,-0.1594,-0.2008,0,0
1,GO REGULATION OF DEOXYRIBONUCLEASE ACTIVITY,0.0042727,-0.16102,-0.22622,0,0
1,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.0028457,-0.16139,-0.25039,0,0
1,GO TELENCEPHALON REGIONALIZATION,0.11894,-0.16249,-0.28739,0,0
1,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.00072571,-0.16258,-0.22147,0,0
1,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.022172,-0.16792,-0.20414,0,0
1,GO TRNA WOBBLE URIDINE MODIFICATION,0.00029789,-0.16833,-0.29757,0,0
1,GO KILLING OF CELLS OF OTHER ORGANISM,0.072385,-0.16886,-0.18732,0,0
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.0024341,-0.17081,-0.27406,0,0
1,GO QUINONE METABOLIC PROCESS,0.0013481,-0.17235,-0.22366,0,0
1,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.0042727,-0.17253,-0.24935,0,0
1,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.014457,-0.17265,-0.20427,0,0
1,GO OTIC VESICLE DEVELOPMENT,0.035953,-0.17519,-0.21115,0,0
1,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,0.13885,-0.17875,-0.3562,0,0
1,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.00035748,-0.18511,-0.26795,0,0
1,GO PROTEIN TARGETING,6.2007e-06,-0.18841,-0.2404,0,0
1,GO MIDBODY ABSCISSION,0.00091199,-0.18982,-0.29396,0,0
1,GO DNA LIGATION,0.0034935,-0.19033,-0.25995,0,0
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,3.7287e-05,-0.1906,-0.27889,0,0
1,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.00096503,-0.19225,-0.22117,0,0
1,GO PROTEIN DENEDDYLATION,0.01266,-0.19358,-0.21396,0,0
1,GO PENTOSE METABOLIC PROCESS,0.00024771,-0.19616,-0.30071,0,0
1,GO ERROR PRONE TRANSLESION SYNTHESIS,0.0017696,-0.19732,-0.23978,0,0
1,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.0010209,-0.1982,-0.25536,0,0
1,GO REGULATION OF GLUTAMATE SECRETION,0.010101,-0.20061,-0.41694,0,0
1,GO AEROBIC RESPIRATION,0.0031545,-0.20126,-0.20496,0,0
1,GO CYTIDINE TO URIDINE EDITING,0.069906,-0.20207,-0.34947,0,0
1,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.00020554,-0.20208,-0.28408,0,0
1,GO ESCRT COMPLEX DISASSEMBLY,0.00076864,-0.2038,-0.28012,0,0
1,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.00010181,-0.2046,-0.27378,0,0
1,GO CORNIFICATION,0.10134,-0.20461,-0.18233,0,0
1,GO MITOCHONDRIAL PROTEIN PROCESSING,0.0013481,-0.2058,-0.24971,0,0
1,GO GROOMING BEHAVIOR,0.045233,-0.20633,-0.25682,0,0
1,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.00040321,-0.20787,-0.28835,0,0
1,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,7.8298e-05,-0.21036,-0.29814,0,0
1,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,0.00086166,-0.21129,-0.28229,0,0
1,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.007293,-0.21264,-0.21965,0,0
1,GO TRNA METABOLIC PROCESS,3.9936e-05,-0.21298,-0.31216,0,0
1,GO PROTEIN K11 LINKED UBIQUITINATION,5.2428e-05,-0.21638,-0.31131,0,0
1,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,2.2907e-05,-0.21943,-0.28283,0,0
1,GO TRNA PROCESSING,2.636e-05,-0.21964,-0.31231,0,0
1,GO MATURATION OF LSU RRNA,0.0016767,-0.22019,-0.21711,0,0
1,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.00031664,-0.22171,-0.28892,0,0
1,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.074935,-0.22469,-0.36229,0,0
1,GO REGULATION OF TRANSLATIONAL ELONGATION,3.9936e-05,-0.2255,-0.27582,0,0
1,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.062884,-0.22571,-0.2246,0,0
1,GO CORTICOSTEROID HORMONE SECRETION,0.034576,-0.22838,-0.24579,0,0
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,0.00010866,-0.22949,-0.27793,0,0
1,GO TRNA WOBBLE BASE MODIFICATION,5.9985e-05,-0.23007,-0.34471,0,0
1,GO NUCLEOSIDE SALVAGE,0.00018128,-0.23012,-0.27613,0,0
1,GO DEFENSE RESPONSE TO FUNGUS,0.015104,-0.23042,-0.28335,0,0
1,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.00026348,-0.23077,-0.32044,0,0
1,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,4.8997e-05,-0.2322,-0.29391,0,0
1,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.00081392,-0.23304,-0.23045,0,0
1,GO NCRNA 3 END PROCESSING,0.00015974,-0.2331,-0.27828,0,0
1,GO LATE ENDOSOME TO VACUOLE TRANSPORT,9.5377e-05,-0.23421,-0.30892,0,0
1,GO RRNA MODIFICATION,7.3279e-05,-0.23443,-0.32142,0,0
1,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,1.3909e-05,-0.23482,-0.30569,0,0
1,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,8.9327e-05,-0.23492,-0.32796,0,0
1,GO HISTONE SERINE PHOSPHORYLATION,0.00020554,-0.2352,-0.34102,0,0
1,GO MITOCHONDRIAL RNA METABOLIC PROCESS,9.5377e-05,-0.23605,-0.35128,0,0
1,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.00010866,-0.23615,-0.33941,0,0
1,GO PSEUDOURIDINE SYNTHESIS,0.0016767,-0.24034,-0.27468,0,0
1,GO RRNA METHYLATION,3.0304e-05,-0.24061,-0.33116,0,0
1,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,0.019548,-0.24069,-0.2444,0,0
1,GO MITOCHONDRIAL RNA PROCESSING,0.00054254,-0.24073,-0.39106,0,0
1,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.0012071,-0.24088,-0.22297,0,0
1,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,7.8298e-05,-0.24149,-0.28764,0,0
1,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,0.43329,-0.24241,-0.32138,0,0
1,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,0.0003797,-0.24253,-0.27605,0,0
1,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,0.0015041,-0.24268,-0.26386,0,0
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.0003797,-0.24317,-0.2509,0,0
1,GO TELOMERASE RNA LOCALIZATION,0.00020554,-0.24395,-0.26484,0,0
1,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,2.2907e-05,-0.24417,-0.30379,0,0
1,GO PEPTIDE METABOLIC PROCESS,5.7533e-06,-0.24428,-0.28078,0,0
1,GO STABILIZATION OF MEMBRANE POTENTIAL,0.041938,-0.24482,-0.35658,0,0
1,GO REGULATION OF FERTILIZATION,0.0034935,-0.24644,-0.2478,0,0
1,GO PURINE CONTAINING COMPOUND SALVAGE,0.00057531,-0.24834,-0.2363,0,0
1,GO UBIQUINONE METABOLIC PROCESS,0.0011418,-0.24836,-0.27596,0,0
1,GO LACTATE METABOLIC PROCESS,0.0010209,-0.24901,-0.27928,0,0
1,GO PROTEIN INSERTION INTO MEMBRANE,5.9985e-05,-0.2508,-0.30027,0,0
1,GO RNA CAPPING,9.6689e-06,-0.25121,-0.32135,0,0
1,GO VIRAL LATENCY,0.00076864,-0.25243,-0.30094,0,0
1,GO RNA 5 END PROCESSING,0.00014062,-0.25253,-0.28323,0,0
1,GO ERROR FREE TRANSLESION SYNTHESIS,0.00033648,-0.25388,-0.28649,0,0
1,GO MITOTIC METAPHASE PLATE CONGRESSION,0.00028019,-0.25494,-0.33762,0,0
1,GO TETRAHYDROFOLATE METABOLIC PROCESS,0.00012367,-0.25562,-0.32621,0,0
1,GO POSITIVE REGULATION OF BEHAVIOR,0.0025648,-0.25599,-0.34347,0,0
1,GO SNORNA 3 END PROCESSING,0.00086166,-0.256,-0.29412,0,0
1,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.058535,-0.25745,-0.17428,0,0
1,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,6.2007e-06,-0.2588,-0.3454,0,0
1,GO VITAMIN CATABOLIC PROCESS,0.0092139,-0.2591,-0.27575,0,0
1,GO DRUG CATABOLIC PROCESS,0.0015041,-0.26055,-0.28752,0,0
1,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,0.10811,-0.26196,-0.4118,0,0
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,4.5891e-06,-0.26236,-0.31497,0,0
1,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,3.248e-05,-0.26344,-0.39339,0,0
1,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.080256,-0.264,-0.22286,0,0
1,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.00060992,-0.26452,-0.35253,0,0
1,GO POLYAMINE BIOSYNTHETIC PROCESS,8.9327e-05,-0.26561,-0.30034,0,0
1,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.00017019,-0.26729,-0.27836,0,0
1,GO MITOTIC CYTOKINETIC PROCESS,5.9985e-05,-0.26787,-0.37037,0,0
1,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,1.4947e-05,-0.26813,-0.35289,0,0
1,GO REGULATION OF GASTRIC ACID SECRETION,0.0013481,-0.27027,-0.30923,0,0
1,GO KETONE BODY METABOLIC PROCESS,0.0042727,-0.27403,-0.21673,0,0
1,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.00029789,-0.27562,-0.37628,0,0
1,GO POSTREPLICATION REPAIR,2.1347e-05,-0.27671,-0.35523,0,0
1,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,3.9422e-06,-0.27756,-0.31173,0,0
1,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.00076864,-0.27777,-0.3447,0,0
1,GO NEGATIVE REGULATION OF RNA SPLICING,0.00086166,-0.27854,-0.2956,0,0
1,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,0.197,-0.27946,-0.41949,0,0
1,GO TRNA CATABOLIC PROCESS,0.00076864,-0.27951,-0.40048,0,0
1,GO RETINAL ROD CELL DIFFERENTIATION,0.0014241,-0.27986,-0.30265,0,0
1,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.0049572,-0.281,-0.2014,0,0
1,GO PROTEIN TRANSMEMBRANE TRANSPORT,1.9888e-05,-0.2813,-0.31949,0,0
1,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,0.00019306,-0.28324,-0.31,0,0
1,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.0024341,-0.28431,-0.34714,0,0
1,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,1.7249e-05,-0.28455,-0.32606,0,0
1,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,8.3641e-05,-0.28483,-0.38735,0,0
1,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.0003797,-0.28583,-0.32707,0,0
1,GO FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS,3.7287e-05,-0.28674,-0.34082,0,0
1,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.0034935,-0.28774,-0.28514,0,0
1,GO TETRAHYDROFOLATE INTERCONVERSION,0.00024771,-0.29011,-0.30749,0,0
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,3.248e-05,-0.29036,-0.34178,0,0
1,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.00068502,-0.29095,-0.35911,0,0
1,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.00076864,-0.29156,-0.27855,0,0
1,GO CYTOLYSIS,0.10134,-0.29287,-0.3397,0,0
1,GO TONGUE DEVELOPMENT,3.0304e-05,-0.29303,-0.39362,0,0
1,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.0013481,-0.29332,-0.36965,0,0
1,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,7.7514e-06,-0.29466,-0.39422,0,0
1,GO AMINO ACID ACTIVATION,0.00010181,-0.29467,-0.34891,0,0
1,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.00029789,-0.29469,-0.32294,0,0
1,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,0.0025648,-0.29473,-0.27221,0,0
1,GO TRANSLESION SYNTHESIS,2.636e-05,-0.2963,-0.36879,0,0
1,GO SIGNAL PEPTIDE PROCESSING,0.0027019,-0.29683,-0.28949,0,0
1,GO CELLULAR METABOLIC COMPOUND SALVAGE,6.8565e-05,-0.29787,-0.29879,0,0
1,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.00021879,-0.29919,-0.34206,0,0
1,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,5.9985e-05,-0.29954,-0.3866,0,0
1,GO V D J RECOMBINATION,0.0003797,-0.30029,-0.34628,0,0
1,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,3.248e-05,-0.30088,-0.37383,0,0
1,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.00014062,-0.30088,-0.33658,0,0
1,GO NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING,0.00013188,-0.30106,-0.31369,0,0
1,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,1.6059e-05,-0.30138,-0.32302,0,0
1,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,4.8997e-05,-0.30144,-0.32076,0,0
1,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,8.3461e-06,-0.30164,-0.35094,0,0
1,GO CARDIAC CELL FATE COMMITMENT,0.0025648,-0.30239,-0.31403,0,0
1,GO POSITIVE REGULATION OF CELL AGING,0.0010209,-0.30406,-0.26193,0,0
1,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,1.6059e-05,-0.3049,-0.41916,0,0
1,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.0034935,-0.30624,-0.2996,0,0
1,GO SNRNA PROCESSING,0.00010866,-0.30675,-0.33894,0,0
1,GO POSITIVE REGULATION OF ATPASE ACTIVITY,3.4805e-05,-0.30677,-0.32641,0,0
1,GO SNORNA METABOLIC PROCESS,7.8298e-05,-0.30682,-0.34629,0,0
1,GO CELLULAR AMIDE METABOLIC PROCESS,5.337e-06,-0.30725,-0.32705,0,0
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.00014062,-0.30787,-0.3335,0,0
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.00035748,-0.30916,-0.30325,0,0
1,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,0.012106,-0.3118,-0.49125,0,0
1,GO NUCLEOTIDE EXCISION REPAIR,1.3909e-05,-0.31241,-0.37956,0,0
1,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.00332,-0.31275,-0.30131,0,0
1,GO PROTEIN LOCALIZATION TO MITOCHONDRION,1.7249e-05,-0.31393,-0.34829,0,0
1,GO PURINE NUCLEOBASE METABOLIC PROCESS,6.8565e-05,-0.31412,-0.33839,0,0
1,GO PURINE NUCLEOSIDE METABOLIC PROCESS,1.3909e-05,-0.3156,-0.32056,0,0
1,GO MUSCLE FILAMENT SLIDING,0.00013188,-0.31606,-0.31922,0,0
1,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.00072571,-0.31646,-0.3757,0,0
1,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,7.7514e-06,-0.31715,-0.36213,0,0
1,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,1.9888e-05,-0.31819,-0.37416,0,0
1,GO POLYAMINE METABOLIC PROCESS,3.7287e-05,-0.3183,-0.34729,0,0
1,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.00091199,-0.3191,-0.37255,0,0
1,GO MEIOTIC CELL CYCLE PROCESS,5.9985e-05,-0.31915,-0.4054,0,0
1,GO RESPONSE TO NITROSATIVE STRESS,0.00017019,-0.31918,-0.28342,0,0
1,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,4.5779e-05,-0.31946,-0.36359,0,0
1,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.0015882,-0.32046,-0.28271,0,0
1,GO CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.00086166,-0.32063,-0.37379,0,0
1,GO REGULATION OF RELAXATION OF MUSCLE,0.0092139,-0.3231,-0.40706,0,0
1,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.0018673,-0.32416,-0.35429,0,0
1,GO ATP METABOLIC PROCESS,3.248e-05,-0.32418,-0.32305,0,0
1,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.0020776,-0.32514,-0.39607,0,0
1,GO EATING BEHAVIOR,0.0015882,-0.32548,-0.34368,0,0
1,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,5.9985e-05,-0.32617,-0.36978,0,0
1,GO RESPONSE TO ZINC ION,5.6086e-05,-0.32697,-0.37224,0,0
1,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,3.9936e-05,-0.32756,-0.36743,0,0
1,GO NADPH REGENERATION,2.8267e-05,-0.32784,-0.43045,0,0
1,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.00015974,-0.329,-0.38701,0,0
1,GO DNA STRAND ELONGATION,0.00014062,-0.32921,-0.37473,0,0
1,GO REGULATION OF PROTON TRANSPORT,3.248e-05,-0.32978,-0.3919,0,0
1,GO SULFUR AMINO ACID METABOLIC PROCESS,0.00013188,-0.33036,-0.36111,0,0
1,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,3.7287e-05,-0.33149,-0.37171,0,0
1,GO CIRCADIAN SLEEP WAKE CYCLE,0.00035748,-0.33166,-0.36309,0,0
1,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.0042727,-0.33241,-0.37554,0,0
1,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,4.2763e-05,-0.33385,-0.34552,0,0
1,GO REGULATION OF HELICASE ACTIVITY,0.00033648,-0.33387,-0.33573,0,0
1,GO TRICARBOXYLIC ACID CYCLE,1.7249e-05,-0.33456,-0.38528,0,0
1,GO MATURATION OF 5 8S RRNA,8.3641e-05,-0.33459,-0.33854,0,0
1,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,7.1973e-06,-0.33502,-0.42991,0,0
1,GO MITOCHONDRION ORGANIZATION,6.2007e-06,-0.3359,-0.37988,0,0
1,GO GLYCINE METABOLIC PROCESS,0.00017019,-0.3361,-0.35775,0,0
1,GO MITOCHONDRIAL TRANSPORT,2.8267e-05,-0.3365,-0.37365,0,0
1,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.00021879,-0.33729,-0.36673,0,0
1,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,2.8267e-05,-0.33739,-0.44368,0,0
1,GO REGULATION OF TRANSLATIONAL FIDELITY,3.7287e-05,-0.33852,-0.35474,0,0
1,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,1.0403e-05,-0.33944,-0.35294,0,0
1,GO PROTEIN HETEROTETRAMERIZATION,4.8997e-05,-0.33978,-0.41972,0,0
1,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.00057531,-0.33991,-0.36501,0,0
1,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,3.248e-05,-0.34,-0.37148,0,0
1,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.00068502,-0.34178,-0.39438,0,0
1,GO MEIOTIC CELL CYCLE,2.1347e-05,-0.34184,-0.43641,0,0
1,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,0.00045436,-0.34184,-0.39119,0,0
1,GO AXONAL TRANSPORT OF MITOCHONDRION,0.00045436,-0.34232,-0.4799,0,0
1,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,4.8997e-05,-0.34254,-0.35745,0,0
1,GO METAPHASE PLATE CONGRESSION,5.6086e-05,-0.34306,-0.41526,0,0
1,GO NUCLEAR ENVELOPE REASSEMBLY,6.8565e-05,-0.34367,-0.40364,0,0
1,GO RESPONSE TO UV C,2.636e-05,-0.34412,-0.48307,0,0
1,GO BASE EXCISION REPAIR,3.9936e-05,-0.34433,-0.37881,0,0
1,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,1.3909e-05,-0.34519,-0.39445,0,0
1,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,1.6059e-05,-0.34583,-0.3541,0,0
1,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,8.3641e-05,-0.34711,-0.3369,0,0
1,GO PROTEIN LOCALIZATION TO NUCLEOLUS,6.4139e-05,-0.34715,-0.3574,0,0
1,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.00035748,-0.34816,-0.36574,0,0
1,GO VIRAL TRANSLATION,3.7287e-05,-0.34827,-0.36515,0,0
1,GO MULTIVESICULAR BODY SORTING PATHWAY,2.4576e-05,-0.34863,-0.38298,0,0
1,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,1.1191e-05,-0.34888,-0.36753,0,0
1,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,1.2939e-05,-0.35063,-0.39944,0,0
1,GO APOPTOTIC MITOCHONDRIAL CHANGES,1.1191e-05,-0.35107,-0.38785,0,0
1,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,0.00029789,-0.35393,-0.39882,0,0
1,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,1.9888e-05,-0.35449,-0.39307,0,0
1,GO OOCYTE MATURATION,5.6086e-05,-0.3546,-0.40753,0,0
1,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.00042807,-0.35472,-0.46347,0,0
1,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,3.0304e-05,-0.35564,-0.41121,0,0
1,GO RNA PROCESSING,7.1973e-06,-0.35576,-0.39569,0,0
1,GO RESPONSE TO SALT,0.00013188,-0.35581,-0.36757,0,0
1,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,2.4576e-05,-0.35587,-0.39396,0,0
1,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.0034935,-0.35696,-0.39214,0,0
1,GO AMINE METABOLIC PROCESS,2.1347e-05,-0.3574,-0.34564,0,0
1,GO REGULATION OF CELL PROJECTION SIZE,0.00021879,-0.35893,-0.41322,0,0
1,GO HEART FIELD SPECIFICATION,0.00028019,-0.36004,-0.48913,0,0
1,GO ONE CARBON METABOLIC PROCESS,1.4947e-05,-0.36028,-0.37221,0,0
1,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.0038653,-0.36034,-0.33176,0,0
1,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,7.1973e-06,-0.36129,-0.42875,0,0
1,GO REGULATION OF ACROSOME REACTION,0.013235,-0.36154,-0.30387,0,0
1,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,2.8267e-05,-0.36169,-0.4324,0,0
1,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.040368,-0.36261,-0.2253,0,0
1,GO EXIT FROM MITOSIS,4.2763e-05,-0.36282,-0.44203,0,0
1,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,4.2763e-05,-0.36332,-0.35725,0,0
1,GO REGULATION OF CELL FATE COMMITMENT,0.00014989,-0.36388,-0.41586,0,0
1,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,7.1973e-06,-0.36438,-0.4328,0,0
1,GO REGULATION OF CENTROSOME DUPLICATION,1.1191e-05,-0.36508,-0.47509,0,0
1,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,2.1347e-05,-0.36607,-0.46071,0,0
1,GO REGULATION OF TRANSLATIONAL INITIATION,4.2539e-06,-0.36665,-0.45195,0,0
1,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,3.0304e-05,-0.36722,-0.4068,0,0
1,GO REGULATION OF MRNA BINDING,1.2939e-05,-0.36732,-0.40905,0,0
1,GO REGULATION OF NUCLEASE ACTIVITY,0.00076864,-0.36738,-0.37134,0,0
1,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,4.8997e-05,-0.36741,-0.41386,0,0
1,GO CHROMOSOME LOCALIZATION,2.8267e-05,-0.3681,-0.43755,0,0
1,GO CELLULAR RESPONSE TO COPPER ION,0.0047188,-0.36815,-0.37415,0,0
1,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,1.2939e-05,-0.36837,-0.37559,0,0
1,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,1.7249e-05,-0.36894,-0.53413,0,0
1,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,4.9495e-06,-0.369,-0.40758,0,0
1,GO ACID SECRETION,0.00028019,-0.36902,-0.35197,0,0
1,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.0052065,-0.36923,-0.39092,0,0
1,GO REGULATION OF RNA BINDING,9.6689e-06,-0.36951,-0.42679,0,0
1,GO RNA 3 END PROCESSING,1.1191e-05,-0.37036,-0.41044,0,0
1,GO SINGLE FERTILIZATION,4.2763e-05,-0.37039,-0.35221,0,0
1,GO MITOCHONDRION MORPHOGENESIS,9.6689e-06,-0.37353,-0.40368,0,0
1,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.00011593,-0.37421,-0.36519,0,0
1,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,1.8524e-05,-0.37466,-0.41693,0,0
1,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,6.6813e-06,-0.37498,-0.39109,0,0
1,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,0.00017019,-0.3753,-0.38818,0,0
1,GO CHRONIC INFLAMMATORY RESPONSE,0.080256,-0.37564,-0.3887,0,0
1,GO RESPONSE TO COPPER ION,0.0012758,-0.37642,-0.35765,0,0
1,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.00013188,-0.37698,-0.39517,0,0
1,GO DNA CATABOLIC PROCESS,7.1973e-06,-0.37743,-0.43146,0,0
1,GO COENZYME A METABOLIC PROCESS,8.9843e-06,-0.37781,-0.43439,0,0
1,GO EOSINOPHIL CHEMOTAXIS,0.067497,-0.37798,-0.40896,0,0
1,GO REGULATION OF ATPASE ACTIVITY,8.9843e-06,-0.37803,-0.3707,0,0
1,GO REGULATION OF OOGENESIS,7.1973e-06,-0.37819,-0.45551,0,0
1,GO COENZYME A BIOSYNTHETIC PROCESS,6.4139e-05,-0.37863,-0.41514,0,0
1,GO MALE GAMETE GENERATION,1.0403e-05,-0.37905,-0.40582,0,0
1,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.00017019,-0.37939,-0.42218,0,0
1,GO MESODERMAL CELL FATE SPECIFICATION,2.2907e-05,-0.3796,-0.43762,0,0
1,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00048214,-0.37996,-0.36543,0,0
1,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,1.3909e-05,-0.38012,-0.42362,0,0
1,GO NEGATIVE REGULATION OF ERAD PATHWAY,1.4947e-05,-0.38033,-0.45088,0,0
1,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,2.636e-05,-0.38293,-0.37951,0,0
1,GO REGULATION OF WATER LOSS VIA SKIN,0.0015041,-0.38364,-0.31579,0,0
1,GO MYOBLAST MIGRATION,0.0017696,-0.38431,-0.36448,0,0
1,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,3.4805e-05,-0.38479,-0.36549,0,0
1,GO HISTONE PHOSPHORYLATION,7.7514e-06,-0.38519,-0.49104,0,0
1,GO REGULATION OF MITOTIC SPINDLE ASSEMBLY,5.9985e-05,-0.38599,-0.39648,0,0
1,GO ALDITOL METABOLIC PROCESS,0.0034935,-0.38648,-0.31646,0,0
1,GO REGULATION OF CENTROSOME CYCLE,1.0403e-05,-0.38695,-0.46528,0,0
1,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,0.00014989,-0.38891,-0.44478,0,0
1,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.019548,-0.3892,-0.34054,0,0
1,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,1.9888e-05,-0.38933,-0.45017,0,0
1,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.00028019,-0.38939,-0.40116,0,0
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,7.1973e-06,-0.38947,-0.43485,0,0
1,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,0.00021879,-0.38967,-0.42352,0,0
1,GO PEPTIDYL PROLINE MODIFICATION,2.8267e-05,-0.38981,-0.39193,0,0
1,GO NEGATIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.00014062,-0.39005,-0.34786,0,0
1,GO NEURON FATE COMMITMENT,0.0019699,-0.39051,-0.43838,0,0
1,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,5.2428e-05,-0.39155,-0.43727,0,0
1,GO CELLULAR RESPONSE TO ZINC ION,0.0083971,-0.39272,-0.37609,0,0
1,GO REGULATION OF HISTONE H4 ACETYLATION,6.8565e-05,-0.39285,-0.45463,0,0
1,GO MANNOSYLATION,3.0304e-05,-0.39483,-0.44312,0,0
1,GO RNA SPLICING,1.6059e-05,-0.395,-0.4122,0,0
1,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,5.2428e-05,-0.3955,-0.38685,0,0
1,GO MITOTIC CELL CYCLE ARREST,6.8565e-05,-0.3956,-0.43306,0,0
1,GO REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT,0.0052065,-0.39588,-0.35882,0,0
1,GO REGULATION OF DNA BINDING,4.9495e-06,-0.39617,-0.47021,0,0
1,GO CHROMATIN SILENCING,1.3909e-05,-0.39648,-0.46315,0,0
1,GO CHROMOSOME CONDENSATION,7.3279e-05,-0.39725,-0.47892,0,0
1,GO STEROID HORMONE SECRETION,0.00068502,-0.39726,-0.3819,0,0
1,GO HISTONE H2B UBIQUITINATION,5.7533e-06,-0.39798,-0.49346,0,0
1,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.00054254,-0.39924,-0.38376,0,0
1,GO L ASCORBIC ACID METABOLIC PROCESS,0.00035748,-0.3994,-0.3785,0,0
1,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,0.00029789,-0.39967,-0.33381,0,0
1,GO RESPONSE TO CADMIUM ION,2.4576e-05,-0.40071,-0.43799,0,0
1,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,4.2763e-05,-0.40077,-0.37922,0,0
1,GO REGULATION OF MEMBRANE PERMEABILITY,1.9888e-05,-0.40145,-0.4128,0,0
1,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,6.2007e-06,-0.40189,-0.46626,0,0
1,GO HORMONE CATABOLIC PROCESS,0.00048214,-0.40324,-0.36576,0,0
1,GO NUCLEOBASE METABOLIC PROCESS,6.2007e-06,-0.40396,-0.44128,0,0
1,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.00017019,-0.40435,-0.38655,0,0
1,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,6.2007e-06,-0.40438,-0.45418,0,0
1,GO MRNA PROCESSING,1.2035e-05,-0.40478,-0.43273,0,0
1,GO DNA REPAIR,8.9843e-06,-0.40487,-0.45747,0,0
1,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,6.2007e-06,-0.40537,-0.4585,0,0
1,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,4.2539e-06,-0.4064,-0.47516,0,0
1,GO HEART INDUCTION,0.0027019,-0.40699,-0.42013,0,0
1,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,1.6059e-05,-0.40743,-0.50873,0,0
1,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,3.0304e-05,-0.40781,-0.40316,0,0
1,GO FAT CELL PROLIFERATION,0.00031664,-0.40869,-0.43542,0,0
1,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,1.6059e-05,-0.40892,-0.38473,0,0
1,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,2.4576e-05,-0.40909,-0.47114,0,0
1,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,4.5891e-06,-0.40955,-0.44951,0,0
1,GO PROTEIN MANNOSYLATION,3.9936e-05,-0.40974,-0.46109,0,0
1,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,0.00015974,-0.40976,-0.49557,0,0
1,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,5.337e-06,-0.40982,-0.44419,0,0
1,GO BLASTOCYST DEVELOPMENT,5.337e-06,-0.41082,-0.42042,0,0
1,GO CYSTEINE METABOLIC PROCESS,5.9985e-05,-0.41117,-0.43172,0,0
1,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,2.1347e-05,-0.41134,-0.52664,0,0
1,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,7.3279e-05,-0.41165,-0.41092,0,0
1,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,1.3909e-05,-0.41296,-0.42666,0,0
1,GO ORGANELLE FISSION,1.1191e-05,-0.41361,-0.46862,0,0
1,GO DNA REPLICATION CHECKPOINT,6.4139e-05,-0.41381,-0.4464,0,0
1,GO CELL CYCLE PHASE TRANSITION,7.7514e-06,-0.41524,-0.45391,0,0
1,GO REGULATION OF MULTI ORGANISM PROCESS,6.6813e-06,-0.4153,-0.42309,0,0
1,GO NEGATIVE REGULATION OF AMINO ACID TRANSPORT,0.0019699,-0.41749,-0.40672,0,0
1,GO NEGATIVE REGULATION OF GLIOGENESIS,4.5779e-05,-0.4178,-0.3935,0,0
1,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,1.3909e-05,-0.41793,-0.46454,0,0
1,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,2.8267e-05,-0.41805,-0.42407,0,0
1,GO PHARYNGEAL SYSTEM DEVELOPMENT,9.5377e-05,-0.4185,-0.45419,0,0
1,GO ORGAN INDUCTION,4.5779e-05,-0.41868,-0.3956,0,0
1,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,2.8267e-05,-0.419,-0.42829,0,0
1,GO REGULATION OF REPRODUCTIVE PROCESS,6.6813e-06,-0.42032,-0.43842,0,0
1,GO THIOESTER METABOLIC PROCESS,1.1191e-05,-0.4204,-0.41085,0,0
1,GO MONOSACCHARIDE CATABOLIC PROCESS,2.636e-05,-0.42144,-0.45308,0,0
1,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,1.3909e-05,-0.42329,-0.46912,0,0
1,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,0.0025648,-0.42368,-0.45728,0,0
1,GO INNER EAR RECEPTOR CELL DEVELOPMENT,1.9888e-05,-0.42399,-0.48787,0,0
1,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.00014989,-0.42504,-0.4235,0,0
1,GO REGULATION OF MICROVILLUS ORGANIZATION,0.00021879,-0.42594,-0.48245,0,0
1,GO TONGUE MORPHOGENESIS,0.00081392,-0.42631,-0.36498,0,0
1,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,0.0010209,-0.42631,-0.3907,0,0
1,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,0.00010181,-0.42679,-0.43581,0,0
1,GO MRNA MODIFICATION,3.4805e-05,-0.42698,-0.43874,0,0
1,GO NEGATIVE REGULATION OF MRNA PROCESSING,6.8565e-05,-0.42738,-0.46841,0,0
1,GO FRUCTOSE METABOLIC PROCESS,4.5779e-05,-0.4275,-0.50443,0,0
1,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,4.5891e-06,-0.42803,-0.45234,0,0
1,GO INDOLALKYLAMINE METABOLIC PROCESS,0.0010209,-0.4284,-0.35826,0,0
1,GO CYTOKINETIC PROCESS,1.4947e-05,-0.42845,-0.47939,0,0
1,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,1.2939e-05,-0.42889,-0.42155,0,0
1,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,3.248e-05,-0.4294,-0.44719,0,0
1,GO CYTOSKELETON DEPENDENT CYTOKINESIS,1.0403e-05,-0.4299,-0.51367,0,0
1,GO REGULATION OF MESODERM DEVELOPMENT,1.4947e-05,-0.43024,-0.41517,0,0
1,GO EOSINOPHIL MIGRATION,0.038848,-0.43032,-0.48453,0,0
1,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,6.6813e-06,-0.43097,-0.45331,0,0
1,GO REGULATION OF EXOSOMAL SECRETION,2.2907e-05,-0.43115,-0.51667,0,0
1,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,3.7287e-05,-0.43128,-0.47427,0,0
1,GO REGULATION OF MRNA PROCESSING,1.1191e-05,-0.43137,-0.49696,0,0
1,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,1.2035e-05,-0.43162,-0.48323,0,0
1,GO ACROSOME ASSEMBLY,0.00014989,-0.43167,-0.44541,0,0
1,GO REGULATION OF GTP BINDING,4.2763e-05,-0.43233,-0.47255,0,0
1,GO ACETYL COA METABOLIC PROCESS,3.9422e-06,-0.43274,-0.52368,0,0
1,GO GABAERGIC NEURON DIFFERENTIATION,0.08881,-0.43295,-0.4668,0,0
1,GO CENTROSOME SEPARATION,4.2763e-05,-0.43312,-0.47212,0,0
1,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,2.8267e-05,-0.43325,-0.41878,0,0
1,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,9.6689e-06,-0.43365,-0.44025,0,0
1,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,2.636e-05,-0.4345,-0.51965,0,0
1,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.00013188,-0.43455,-0.46186,0,0
1,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,1.0403e-05,-0.43504,-0.49689,0,0
1,GO BLASTOCYST GROWTH,4.2539e-06,-0.43527,-0.49948,0,0
1,GO SECONDARY HEART FIELD SPECIFICATION,0.00096503,-0.43539,-0.5113,0,0
1,GO MALE SEX DETERMINATION,0.00014062,-0.43561,-0.4569,0,0
1,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,4.9495e-06,-0.43575,-0.4552,0,0
1,GO ECTODERMAL PLACODE DEVELOPMENT,3.248e-05,-0.43706,-0.42415,0,0
1,GO PROTEIN OXIDATION,0.00018128,-0.43791,-0.41928,0,0
1,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,7.1973e-06,-0.43826,-0.48349,0,0
1,GO GMP METABOLIC PROCESS,4.5891e-06,-0.43826,-0.45534,0,0
1,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,1.1191e-05,-0.43828,-0.42605,0,0
1,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,0.0017696,-0.43867,-0.44438,0,0
1,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,7.1973e-06,-0.43898,-0.46815,0,0
1,GO PROTEIN N LINKED GLYCOSYLATION,9.6689e-06,-0.43901,-0.43834,0,0
1,GO NEGATIVE REGULATION OF PROTEIN IMPORT,5.2428e-05,-0.44063,-0.45719,0,0
1,GO CELL FATE SPECIFICATION,1.7249e-05,-0.44102,-0.48203,0,0
1,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00010866,-0.44116,-0.45961,0,0
1,GO REGULATION OF TRANSLATIONAL TERMINATION,1.3909e-05,-0.44205,-0.46809,0,0
1,GO NEGATIVE REGULATION OF CELL CYCLE,5.337e-06,-0.44235,-0.48927,0,0
1,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,1.2035e-05,-0.44296,-0.44493,0,0
1,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,1.9888e-05,-0.44327,-0.46977,0,0
1,GO REGULATION OF PROSTAGLANDIN SECRETION,0.00045436,-0.44344,-0.44714,0,0
1,GO POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION,4.2763e-05,-0.44409,-0.48805,0,0
1,GO PEPTIDYL CYSTEINE MODIFICATION,2.2907e-05,-0.4441,-0.454,0,0
1,GO PROTEIN K48 LINKED UBIQUITINATION,4.9495e-06,-0.4442,-0.49448,0,0
1,GO CELLULAR RESPONSE TO UV,4.9495e-06,-0.44423,-0.47769,0,0
1,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,4.9495e-06,-0.44441,-0.48953,0,0
1,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,8.3461e-06,-0.4447,-0.42419,0,0
1,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,0.00024771,-0.44523,-0.40319,0,0
1,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,3.9422e-06,-0.44553,-0.48665,0,0
1,GO CENTROSOME DUPLICATION,1.3909e-05,-0.44653,-0.53798,0,0
1,GO RESPONSE TO LEAD ION,9.6689e-06,-0.44654,-0.51579,0,0
1,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,9.6689e-06,-0.44663,-0.49448,0,0
1,GO PARAXIAL MESODERM MORPHOGENESIS,0.00068502,-0.44666,-0.44057,0,0
1,GO REGULATION OF NUCLEAR DIVISION,1.0403e-05,-0.44681,-0.46884,0,0
1,GO NUCLEOBASE BIOSYNTHETIC PROCESS,4.8997e-05,-0.44695,-0.43114,0,0
1,GO DORSAL VENTRAL PATTERN FORMATION,4.8997e-05,-0.44754,-0.46446,0,0
1,GO MYOBLAST DIFFERENTIATION,1.2035e-05,-0.44806,-0.49596,0,0
1,GO DICARBOXYLIC ACID METABOLIC PROCESS,1.1191e-05,-0.44813,-0.41104,0,0
1,GO REGULATION OF MITOTIC CELL CYCLE,6.6813e-06,-0.44846,-0.48835,0,0
1,GO CELLULAR RESPONSE TO IRON ION,0.0003797,-0.44885,-0.49143,0,0
1,GO RIBOSE PHOSPHATE METABOLIC PROCESS,5.7533e-06,-0.44888,-0.47291,0,0
1,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,6.2007e-06,-0.44933,-0.49127,0,0
1,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,4.5891e-06,-0.44982,-0.52075,0,0
1,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,9.6689e-06,-0.4507,-0.45366,0,0
1,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,0.00018128,-0.45081,-0.47098,0,0
1,GO MACROMOLECULE CATABOLIC PROCESS,4.2539e-06,-0.45086,-0.4755,0,0
1,GO STEROL BIOSYNTHETIC PROCESS,5.6086e-05,-0.45144,-0.4343,0,0
1,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,4.5891e-06,-0.4519,-0.49093,0,0
1,GO POSITIVE REGULATION OF DNA BINDING,8.9843e-06,-0.45202,-0.47256,0,0
1,GO COCHLEA DEVELOPMENT,2.1347e-05,-0.45271,-0.49876,0,0
1,GO CELL CYCLE PROCESS,7.7514e-06,-0.45289,-0.49337,0,0
1,GO CELL DIVISION,8.9843e-06,-0.45299,-0.48643,0,0
1,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.00014062,-0.45323,-0.43305,0,0
1,GO HISTAMINE SECRETION,0.00332,-0.45325,-0.38177,0,0
1,GO MITOTIC CELL CYCLE,7.7514e-06,-0.4534,-0.48966,0,0
1,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,4.8997e-05,-0.45411,-0.41456,0,0
1,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,1.1191e-05,-0.45491,-0.39927,0,0
1,GO GLYCOLIPID BIOSYNTHETIC PROCESS,3.9936e-05,-0.45528,-0.43748,0,0
1,GO REGULATION OF CELL AGING,7.7514e-06,-0.45534,-0.46509,0,0
1,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,5.337e-06,-0.45548,-0.47991,0,0
1,GO IMP BIOSYNTHETIC PROCESS,0.00023283,-0.45576,-0.43348,0,0
1,GO WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,5.2428e-05,-0.45596,-0.46295,0,0
1,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,5.337e-06,-0.45613,-0.48974,0,0
1,GO CELLULAR RESPONSE TO CADMIUM ION,0.00010866,-0.4564,-0.50347,0,0
1,GO MRNA EXPORT FROM NUCLEUS,9.6689e-06,-0.4568,-0.49867,0,0
1,GO POSITIVE REGULATION OF NUCLEAR DIVISION,7.7514e-06,-0.45727,-0.48874,0,0
1,GO TRANSCRIPTION BY RNA POLYMERASE I,5.337e-06,-0.45771,-0.49824,0,0
1,GO REGULATION OF CENTRIOLE REPLICATION,1.4947e-05,-0.458,-0.52417,0,0
1,GO NUCLEUS ORGANIZATION,6.6813e-06,-0.45859,-0.50329,0,0
1,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,5.337e-06,-0.4586,-0.48634,0,0
1,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,4.2539e-06,-0.45929,-0.49153,0,0
1,GO RESPONSE TO PARATHYROID HORMONE,4.2763e-05,-0.46008,-0.47888,0,0
1,GO HEXOSE CATABOLIC PROCESS,1.9888e-05,-0.46022,-0.4987,0,0
1,GO IMP METABOLIC PROCESS,0.00015974,-0.46032,-0.43585,0,0
1,GO REGULATION OF NEUROTRANSMITTER UPTAKE,2.1347e-05,-0.46055,-0.49776,0,0
1,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,4.5891e-06,-0.46121,-0.4825,0,0
1,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,8.3461e-06,-0.46132,-0.47543,0,0
1,GO RESPONSE TO LITHIUM ION,0.00010866,-0.46181,-0.44857,0,0
1,GO POSITIVE REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,3.248e-05,-0.46189,-0.45548,0,0
1,GO MITOTIC NUCLEAR DIVISION,1.2035e-05,-0.46241,-0.49289,0,0
1,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,5.7533e-06,-0.4626,-0.4866,0,0
1,GO POSITIVE REGULATION OF AMINE TRANSPORT,0.0012071,-0.46288,-0.507,0,0
1,GO HEART FORMATION,3.0304e-05,-0.46306,-0.49525,0,0
1,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,4.5891e-06,-0.46343,-0.46602,0,0
1,GO DE NOVO PROTEIN FOLDING,2.4576e-05,-0.46472,-0.46652,0,0
1,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,1.2035e-05,-0.46475,-0.54663,0,0
1,GO COCHLEA MORPHOGENESIS,1.3909e-05,-0.46512,-0.46762,0,0
1,GO CELL CYCLE,6.2007e-06,-0.46569,-0.4974,0,0
1,GO CELLULAR RESPONSE TO RADIATION,4.2539e-06,-0.4659,-0.46424,0,0
1,GO NCRNA CATABOLIC PROCESS,8.3461e-06,-0.4661,-0.4733,0,0
1,GO ANIMAL ORGAN FORMATION,8.9843e-06,-0.46627,-0.50784,0,0
1,GO RETINAL GANGLION CELL AXON GUIDANCE,7.8298e-05,-0.46637,-0.5657,0,0
1,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,8.3461e-06,-0.46664,-0.49415,0,0
1,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,0.00014062,-0.46683,-0.3977,0,0
1,GO RESPONSE TO UV,5.337e-06,-0.46716,-0.5002,0,0
1,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,1.2939e-05,-0.46737,-0.46018,0,0
1,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,8.3641e-05,-0.46741,-0.42264,0,0
1,GO POSITIVE REGULATION OF CELL CYCLE,7.1973e-06,-0.46746,-0.51318,0,0
1,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,4.9495e-06,-0.46777,-0.52677,0,0
1,GO ALCOHOL CATABOLIC PROCESS,2.1347e-05,-0.46781,-0.46215,0,0
1,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,5.7533e-06,-0.46788,-0.50424,0,0
1,GO GLUTAMINE METABOLIC PROCESS,4.5891e-06,-0.46811,-0.52103,0,0
1,GO MITOTIC CYTOKINESIS,8.9843e-06,-0.46867,-0.5201,0,0
1,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,7.7514e-06,-0.46938,-0.53283,0,0
1,GO C4 DICARBOXYLATE TRANSPORT,3.4805e-05,-0.4697,-0.45881,0,0
1,GO LYSINE METABOLIC PROCESS,0.00010866,-0.46973,-0.41362,0,0
1,GO RESPONSE TO X RAY,7.7514e-06,-0.47,-0.54744,0,0
1,GO MRNA TRANSPORT,6.6813e-06,-0.47004,-0.51206,0,0
1,GO PENILE ERECTION,0.00026348,-0.4708,-0.5345,0,0
1,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,7.7514e-06,-0.47108,-0.47789,0,0
1,GO MITOCHONDRIAL FUSION,7.7514e-06,-0.47117,-0.5253,0,0
1,GO VIRAL RNA GENOME REPLICATION,1.0403e-05,-0.47123,-0.52011,0,0
1,GO PITUITARY GLAND DEVELOPMENT,0.00332,-0.4713,-0.41789,0,0
1,GO SUCKLING BEHAVIOR,0.00020554,-0.47146,-0.56311,0,0
1,GO DEVELOPMENTAL INDUCTION,3.7287e-05,-0.47299,-0.46613,0,0
1,GO LENS FIBER CELL DEVELOPMENT,3.0304e-05,-0.47353,-0.51867,0,0
1,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,4.9495e-06,-0.47356,-0.45794,0,0
1,GO REGULATION OF CELL CYCLE,5.337e-06,-0.47369,-0.5064,0,0
1,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,6.6813e-06,-0.47436,-0.48992,0,0
1,GO DNA BIOSYNTHETIC PROCESS,4.9495e-06,-0.47438,-0.48231,0,0
1,GO CELLULAR RESPONSE TO IONIZING RADIATION,5.7533e-06,-0.47493,-0.4951,0,0
1,GO NAD METABOLIC PROCESS,1.2939e-05,-0.47539,-0.54159,0,0
1,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,3.9936e-05,-0.47595,-0.50582,0,0
1,GO EMBRYONIC PLACENTA MORPHOGENESIS,0.00012367,-0.47598,-0.56001,0,0
1,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,5.7533e-06,-0.47671,-0.49004,0,0
1,GO NOTOCHORD DEVELOPMENT,0.00029789,-0.47675,-0.49849,0,0
1,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,6.8565e-05,-0.47721,-0.57028,0,0
1,GO INNER CELL MASS CELL PROLIFERATION,7.7514e-06,-0.47728,-0.56269,0,0
1,GO PROTEIN K63 LINKED UBIQUITINATION,4.9495e-06,-0.4785,-0.51553,0,0
1,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,8.3461e-06,-0.47898,-0.49305,0,0
1,GO MECHANORECEPTOR DIFFERENTIATION,1.0403e-05,-0.4793,-0.49909,0,0
1,GO REGULATION OF ANIMAL ORGAN FORMATION,2.2907e-05,-0.47936,-0.46544,0,0
1,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,3.9422e-06,-0.47942,-0.57297,0,0
1,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,2.1347e-05,-0.47974,-0.46851,0,0
1,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,1.2035e-05,-0.48034,-0.59796,0,0
1,GO PORE COMPLEX ASSEMBLY,4.9495e-06,-0.48084,-0.53597,0,0
1,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,7.1973e-06,-0.48086,-0.45894,0,0
1,GO MESODERMAL CELL FATE COMMITMENT,1.9888e-05,-0.48089,-0.45225,0,0
1,GO CHROMOSOME ORGANIZATION,7.7514e-06,-0.48103,-0.51645,0,0
1,GO BRANCH ELONGATION OF AN EPITHELIUM,4.2763e-05,-0.4811,-0.45216,0,0
1,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,6.6813e-06,-0.4816,-0.46877,0,0
1,GO RESPONSE TO ETHER,6.8565e-05,-0.48161,-0.43807,0,0
1,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,6.2007e-06,-0.48186,-0.50634,0,0
1,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.00028019,-0.48263,-0.48688,0,0
1,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,7.7514e-06,-0.48293,-0.50854,0,0
1,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,1.3909e-05,-0.48316,-0.50888,0,0
1,GO ASYMMETRIC CELL DIVISION,4.2539e-06,-0.4832,-0.54574,0,0
1,GO MITOTIC SPINDLE ORGANIZATION,1.9888e-05,-0.48368,-0.50389,0,0
1,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,4.5891e-06,-0.48394,-0.5023,0,0
1,GO HEART TRABECULA FORMATION,0.00014062,-0.48507,-0.48914,0,0
1,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.00026348,-0.48531,-0.39481,0,0
1,GO RESPONSE TO MUSCLE ACTIVITY,1.4947e-05,-0.48543,-0.47618,0,0
1,GO DICARBOXYLIC ACID CATABOLIC PROCESS,7.3279e-05,-0.48642,-0.388,0,0
1,GO REGULATION OF HEART MORPHOGENESIS,1.2035e-05,-0.4868,-0.58684,0,0
1,GO HISTONE H2A MONOUBIQUITINATION,3.248e-05,-0.48682,-0.52058,0,0
1,GO CELL CYCLE G1 S PHASE TRANSITION,5.7533e-06,-0.48734,-0.49016,0,0
1,GO SPINDLE MIDZONE ASSEMBLY,2.8267e-05,-0.48755,-0.62583,0,0
1,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,7.1973e-06,-0.4884,-0.54339,0,0
1,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,1.6059e-05,-0.48857,-0.51762,0,0
1,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,6.2007e-06,-0.48875,-0.50039,0,0
1,GO PROTEIN LOCALIZATION TO CHROMATIN,1.6059e-05,-0.48914,-0.51799,0,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,1.8524e-05,-0.48934,-0.47908,0,0
1,GO VASODILATION,2.2907e-05,-0.48999,-0.44444,0,0
1,GO PARAXIAL MESODERM DEVELOPMENT,3.4805e-05,-0.49022,-0.48353,0,0
1,GO STEM CELL DIFFERENTIATION,3.9422e-06,-0.4906,-0.49866,0,0
1,GO POSITIVE REGULATION OF GLUCONEOGENESIS,1.3909e-05,-0.49105,-0.50212,0,0
1,GO POLYOL TRANSPORT,0.00013188,-0.49169,-0.50158,0,0
1,GO REGULATION OF DNA METABOLIC PROCESS,4.5891e-06,-0.49185,-0.51841,0,0
1,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,4.5779e-05,-0.49207,-0.46624,0,0
1,GO PROTEIN IMPORT,3.9422e-06,-0.49212,-0.49802,0,0
1,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,4.9495e-06,-0.49248,-0.53484,0,0
1,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,6.2007e-06,-0.49266,-0.50949,0,0
1,GO FATTY ACID HOMEOSTASIS,1.7249e-05,-0.49269,-0.5157,0,0
1,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,5.337e-06,-0.49298,-0.50379,0,0
1,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,1.0403e-05,-0.49302,-0.5384,0,0
1,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,1.0403e-05,-0.49362,-0.59726,0,0
1,GO NUCLEAR ENVELOPE ORGANIZATION,8.3461e-06,-0.49396,-0.54661,0,0
1,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,5.337e-06,-0.49456,-0.53087,0,0
1,GO SPINDLE ASSEMBLY,9.6689e-06,-0.49466,-0.52131,0,0
1,GO HISTAMINE TRANSPORT,0.0003797,-0.49495,-0.45126,0,0
1,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,2.8267e-05,-0.49581,-0.52104,0,0
1,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,6.6813e-06,-0.49585,-0.57464,0,0
1,GO REGULATION OF CELL FATE SPECIFICATION,6.4139e-05,-0.49597,-0.52917,0,0
1,GO BIOLOGICAL PHASE,0.00024771,-0.49617,-0.46638,0,0
1,GO CELLULAR SENESCENCE,5.337e-06,-0.49632,-0.4841,0,0
1,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,6.6813e-06,-0.49653,-0.5226,0,0
1,GO GANGLION DEVELOPMENT,0.00091199,-0.49705,-0.51646,0,0
1,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,6.8565e-05,-0.49736,-0.45132,0,0
1,GO POSITIVE REGULATION OF ORGAN GROWTH,5.337e-06,-0.49744,-0.54952,0,0
1,GO FOREBRAIN NEURON FATE COMMITMENT,0.17091,-0.49779,-0.40738,0,0
1,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.00010866,-0.49801,-0.51469,0,0
1,GO MITOTIC CELL CYCLE CHECKPOINT,8.9843e-06,-0.49845,-0.51473,0,0
1,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,7.1973e-06,-0.49864,-0.47947,0,0
1,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,8.3461e-06,-0.49876,-0.59841,0,0
1,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,2.8267e-05,-0.49947,-0.49895,0,0
1,GO MATING BEHAVIOR,0.00040321,-0.49952,-0.45603,0,0
1,GO INTRA S DNA DAMAGE CHECKPOINT,1.3909e-05,-0.49955,-0.61977,0,0
1,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,0.00096503,-0.49974,-0.46549,0,0
1,GO PROSTATE GLAND DEVELOPMENT,1.4947e-05,-0.49981,-0.51916,0,0
1,GO REGULATION OF STEM CELL PROLIFERATION,8.3461e-06,-0.50024,-0.52686,0,0
1,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,1.6059e-05,-0.50057,-0.53058,0,0
1,GO PEPTIDYL PROLINE HYDROXYLATION,0.00035748,-0.50128,-0.44541,0,0
1,GO RELAXATION OF MUSCLE,1.3909e-05,-0.50161,-0.52193,0,0
1,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,4.9495e-06,-0.50165,-0.55668,0,0
1,GO SKELETAL MUSCLE CELL DIFFERENTIATION,5.337e-06,-0.50196,-0.51031,0,0
1,GO REGULATION OF GLIOGENESIS,5.7533e-06,-0.5021,-0.50982,0,0
1,GO NUCLEOTIDE TRANSPORT,1.2035e-05,-0.50212,-0.48951,0,0
1,GO DETECTION OF TEMPERATURE STIMULUS,3.4805e-05,-0.50216,-0.54685,0,0
1,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,6.2007e-06,-0.50247,-0.51573,0,0
1,GO POSITIVE REGULATION OF BINDING,4.5891e-06,-0.50249,-0.53529,0,0
1,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.00031664,-0.5026,-0.46977,0,0
1,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,4.5891e-06,-0.50279,-0.52776,0,0
1,GO NEPHRIC DUCT MORPHOGENESIS,0.00018128,-0.50295,-0.46065,0,0
1,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,9.6689e-06,-0.50322,-0.52837,0,0
1,GO AUTOPHAGIC CELL DEATH,2.2907e-05,-0.50332,-0.48212,0,0
1,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.00051151,-0.50374,-0.47857,0,0
1,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,6.2007e-06,-0.50396,-0.50082,0,0
1,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,0.00015974,-0.50422,-0.53185,0,0
1,GO CYTOKINESIS,8.9843e-06,-0.50481,-0.52804,0,0
1,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,3.9422e-06,-0.50483,-0.55638,0,0
1,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,5.337e-06,-0.50512,-0.52641,0,0
1,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,1.2035e-05,-0.50516,-0.51508,0,0
1,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,3.9422e-06,-0.5053,-0.51585,0,0
1,GO SPINDLE ORGANIZATION,1.4947e-05,-0.50531,-0.52541,0,0
1,GO CELL CYCLE ARREST,4.5891e-06,-0.50603,-0.51996,0,0
1,GO RESPONSE TO ACTIVITY,6.2007e-06,-0.50605,-0.47584,0,0
1,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,2.636e-05,-0.50678,-0.53006,0,0
1,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,5.337e-06,-0.50689,-0.52139,0,0
1,GO GONADOTROPIN SECRETION,1.1191e-05,-0.50704,-0.50215,0,0
1,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,1.0403e-05,-0.50734,-0.47279,0,0
1,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,4.2539e-06,-0.50793,-0.57562,0,0
1,GO POSITIVE REGULATION OF ANION TRANSPORT,7.3279e-05,-0.50807,-0.43409,0,0
1,GO PROTEIN STABILIZATION,4.2539e-06,-0.50828,-0.50285,0,0
1,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,6.2007e-06,-0.50832,-0.52269,0,0
1,GO PIGMENT ACCUMULATION,4.2763e-05,-0.50844,-0.60973,0,0
1,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,0.00023283,-0.50861,-0.44884,0,0
1,GO ACETYL COA BIOSYNTHETIC PROCESS,6.2007e-06,-0.50863,-0.53125,0,0
1,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,4.2539e-06,-0.50957,-0.50107,0,0
1,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,3.248e-05,-0.50979,-0.56307,0,0
1,GO REGULATION OF ATP METABOLIC PROCESS,4.2539e-06,-0.50981,-0.52063,0,0
1,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,6.6813e-06,-0.50994,-0.53986,0,0
1,GO POSITIVE REGULATION OF CELL CYCLE ARREST,9.6689e-06,-0.51068,-0.51303,0,0
1,GO FOREBRAIN CELL MIGRATION,4.9495e-06,-0.51073,-0.58926,0,0
1,GO REGULATION OF PROTEIN STABILITY,4.5891e-06,-0.5108,-0.50669,0,0
1,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,2.1347e-05,-0.51082,-0.56225,0,0
1,GO GENE SILENCING,5.7533e-06,-0.51091,-0.52588,0,0
1,GO SODIUM ION HOMEOSTASIS,3.0304e-05,-0.5111,-0.4746,0,0
1,GO MULTICELLULAR ORGANISM AGING,1.6059e-05,-0.51118,-0.48249,0,0
1,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,1.4947e-05,-0.51124,-0.50979,0,0
1,GO REGULATION OF GLUCOSE IMPORT,6.2007e-06,-0.51126,-0.50413,0,0
1,GO REGULATION OF HEART RATE,1.8524e-05,-0.51153,-0.5096,0,0
1,GO GLUCOSE CATABOLIC PROCESS,5.2428e-05,-0.51206,-0.54776,0,0
1,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,2.8267e-05,-0.51255,-0.48119,0,0
1,GO REGULATION OF BINDING,4.5891e-06,-0.51304,-0.53768,0,0
1,GO REGULATION OF CHROMOSOME ORGANIZATION,8.3461e-06,-0.51321,-0.5287,0,0
1,GO ATP BIOSYNTHETIC PROCESS,4.2763e-05,-0.51394,-0.46768,0,0
1,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,5.337e-06,-0.51404,-0.55224,0,0
1,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,4.9495e-06,-0.51405,-0.5592,0,0
1,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,4.2539e-06,-0.51424,-0.50231,0,0
1,GO CELLULAR RESPONSE TO NITRIC OXIDE,4.9495e-06,-0.51589,-0.55389,0,0
1,GO L GLUTAMATE IMPORT,4.2763e-05,-0.51615,-0.4349,0,0
1,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,1.0403e-05,-0.51652,-0.54903,0,0
1,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,3.9422e-06,-0.51669,-0.56436,0,0
1,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,4.2539e-06,-0.51835,-0.55629,0,0
1,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,4.2539e-06,-0.51849,-0.55586,0,0
1,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,4.9495e-06,-0.51853,-0.50033,0,0
1,GO EPIDERMIS MORPHOGENESIS,0.00023283,-0.51872,-0.51454,0,0
1,GO CELLULAR RESPONSE TO X RAY,3.248e-05,-0.51888,-0.59049,0,0
1,GO CELLULAR SODIUM ION HOMEOSTASIS,6.4139e-05,-0.51895,-0.50076,0,0
1,GO THIOESTER BIOSYNTHETIC PROCESS,2.636e-05,-0.5192,-0.50707,0,0
1,GO GLIAL CELL APOPTOTIC PROCESS,1.2035e-05,-0.51931,-0.59165,0,0
1,GO LIMBIC SYSTEM DEVELOPMENT,5.337e-06,-0.51931,-0.5233,0,0
1,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,9.6689e-06,-0.51992,-0.58186,0,0
1,GO MALE GENITALIA DEVELOPMENT,8.9327e-05,-0.51996,-0.49064,0,0
1,GO CELLULAR POTASSIUM ION HOMEOSTASIS,4.5779e-05,-0.52025,-0.50076,0,0
1,GO REGULATION OF CELL DIVISION,4.2539e-06,-0.52038,-0.54822,0,0
1,GO REGIONALIZATION,1.0403e-05,-0.52041,-0.51637,0,0
1,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,7.7514e-06,-0.52059,-0.52409,0,0
1,GO GENITALIA DEVELOPMENT,6.2007e-06,-0.52061,-0.52454,0,0
1,GO TOXIN TRANSPORT,3.9422e-06,-0.52073,-0.57547,0,0
1,GO PATTERN SPECIFICATION PROCESS,6.2007e-06,-0.52161,-0.53077,0,0
1,GO L SERINE METABOLIC PROCESS,3.4805e-05,-0.52171,-0.50078,0,0
1,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,9.6689e-06,-0.5219,-0.51677,0,0
1,GO MITOTIC CHROMOSOME CONDENSATION,4.8997e-05,-0.52235,-0.59296,0,0
1,GO CEREBRAL CORTEX DEVELOPMENT,6.2007e-06,-0.52362,-0.61873,0,0
1,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,6.2007e-06,-0.52406,-0.5723,0,0
1,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,1.0403e-05,-0.52511,-0.49107,0,0
1,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,8.9843e-06,-0.52527,-0.49379,0,0
1,GO GOLGI LOCALIZATION,6.6813e-06,-0.52612,-0.49219,0,0
1,GO G2 DNA DAMAGE CHECKPOINT,9.6689e-06,-0.52632,-0.57393,0,0
1,GO REGULATION OF GLIAL CELL PROLIFERATION,5.2428e-05,-0.52655,-0.48984,0,0
1,GO CRANIAL NERVE DEVELOPMENT,2.8267e-05,-0.52672,-0.57265,0,0
1,GO MITOTIC DNA REPLICATION,0.00010181,-0.52678,-0.47971,0,0
1,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,7.7514e-06,-0.5268,-0.49244,0,0
1,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,4.5891e-06,-0.52682,-0.5511,0,0
1,GO REGULATION OF EXCRETION,6.4139e-05,-0.52726,-0.48928,0,0
1,GO PYRUVATE METABOLIC PROCESS,6.6813e-06,-0.52726,-0.54809,0,0
1,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.00048214,-0.52752,-0.49803,0,0
1,GO REGULATION OF SPINDLE ORGANIZATION,1.3909e-05,-0.52818,-0.52056,0,0
1,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,1.9888e-05,-0.52863,-0.45646,0,0
1,GO SEX DIFFERENTIATION,4.9495e-06,-0.52868,-0.50667,0,0
1,GO PROTEIN K63 LINKED DEUBIQUITINATION,4.9495e-06,-0.52872,-0.60021,0,0
1,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,8.9843e-06,-0.52909,-0.62033,0,0
1,GO REGULATION OF GENE SILENCING,5.337e-06,-0.52985,-0.54259,0,0
1,GO CHAPERONE MEDIATED PROTEIN FOLDING,7.7514e-06,-0.53052,-0.50398,0,0
1,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,6.2007e-06,-0.53058,-0.5527,0,0
1,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,7.7514e-06,-0.53078,-0.54282,0,0
1,GO SUBPALLIUM DEVELOPMENT,0.00015974,-0.5308,-0.5502,0,0
1,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,4.8997e-05,-0.53117,-0.51116,0,0
1,GO MITOTIC G2 M TRANSITION CHECKPOINT,9.6689e-06,-0.53174,-0.56423,0,0
1,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,4.5891e-06,-0.53176,-0.61217,0,0
1,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,7.3279e-05,-0.53182,-0.52046,0,0
1,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,1.8524e-05,-0.53195,-0.53755,0,0
1,GO RENAL SODIUM EXCRETION,6.4139e-05,-0.53237,-0.50331,0,0
1,GO REGULATION OF HISTONE PHOSPHORYLATION,9.6689e-06,-0.53278,-0.54847,0,0
1,GO NERVE DEVELOPMENT,2.2907e-05,-0.53318,-0.59902,0,0
1,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,2.4576e-05,-0.53328,-0.49867,0,0
1,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,5.337e-06,-0.53348,-0.49977,0,0
1,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,1.0403e-05,-0.53368,-0.60669,0,0
1,GO POSITIVE REGULATION OF DNA REPLICATION,1.3909e-05,-0.53396,-0.50973,0,0
1,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,2.8267e-05,-0.53429,-0.53121,0,0
1,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.00064645,-0.53429,-0.45388,0,0
1,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.00091199,-0.53451,-0.45551,0,0
1,GO SULFATE TRANSPORT,0.00045436,-0.5346,-0.45149,0,0
1,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,7.1973e-06,-0.53502,-0.52363,0,0
1,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,3.9422e-06,-0.53525,-0.59611,0,0
1,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,5.337e-06,-0.53542,-0.51328,0,0
1,GO HYPEROSMOTIC SALINITY RESPONSE,0.00057531,-0.53549,-0.46473,0,0
1,GO LABYRINTHINE LAYER DEVELOPMENT,8.3461e-06,-0.53578,-0.59084,0,0
1,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,3.4805e-05,-0.53579,-0.50802,0,0
1,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,7.7514e-06,-0.53632,-0.5037,0,0
1,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,1.2939e-05,-0.5365,-0.55307,0,0
1,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,4.9495e-06,-0.53653,-0.52214,0,0
1,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,5.7533e-06,-0.53807,-0.62122,0,0
1,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,7.1973e-06,-0.53836,-0.62457,0,0
1,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,1.2035e-05,-0.53865,-0.61067,0,0
1,GO EMBRYONIC HINDLIMB MORPHOGENESIS,9.6689e-06,-0.53908,-0.56186,0,0
1,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,1.3909e-05,-0.53965,-0.66958,0,0
1,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,3.7287e-05,-0.53992,-0.53905,0,0
1,GO NEUROTRANSMITTER METABOLIC PROCESS,0.00014989,-0.54015,-0.46351,0,0
1,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,2.1347e-05,-0.54055,-0.58599,0,0
1,GO EMBRYONIC ORGAN MORPHOGENESIS,4.9495e-06,-0.54084,-0.56787,0,0
1,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,1.2939e-05,-0.54095,-0.53784,0,0
1,GO AMINO SUGAR BIOSYNTHETIC PROCESS,7.7514e-06,-0.54133,-0.58009,0,0
1,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,2.636e-05,-0.54137,-0.5509,0,0
1,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,1.4947e-05,-0.54153,-0.536,0,0
1,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,1.8524e-05,-0.54164,-0.51079,0,0
1,GO REGULATION OF ODONTOGENESIS,5.7533e-06,-0.54178,-0.56581,0,0
1,GO CELL AGING,5.337e-06,-0.54179,-0.5011,0,0
1,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,4.9495e-06,-0.54183,-0.53963,0,0
1,GO REGULATION OF HEART GROWTH,4.9495e-06,-0.54242,-0.53163,0,0
1,GO MESONEPHROS DEVELOPMENT,2.1347e-05,-0.54244,-0.49993,0,0
1,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,4.2763e-05,-0.5434,-0.50375,0,0
1,GO MICROVILLUS ORGANIZATION,1.1191e-05,-0.54341,-0.54428,0,0
1,GO FIBROBLAST PROLIFERATION,6.6813e-06,-0.54382,-0.56852,0,0
1,GO POSITIVE REGULATION OF CELL DIVISION,6.2007e-06,-0.54383,-0.52266,0,0
1,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,5.9985e-05,-0.54453,-0.54984,0,0
1,GO MITOTIC DNA INTEGRITY CHECKPOINT,7.7514e-06,-0.54528,-0.5406,0,0
1,GO RENAL TUBULE DEVELOPMENT,1.0403e-05,-0.54585,-0.55299,0,0
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,4.2539e-06,-0.54587,-0.56465,0,0
1,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,8.9843e-06,-0.54611,-0.57037,0,0
1,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.00033648,-0.54794,-0.60397,0,0
1,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,7.1973e-06,-0.54797,-0.56105,0,0
1,GO CELL FATE COMMITMENT,7.1973e-06,-0.548,-0.52514,0,0
1,GO SEROTONIN TRANSPORT,1.9888e-05,-0.54811,-0.56292,0,0
1,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,8.3461e-06,-0.54939,-0.61196,0,0
1,GO PROTEIN AUTO ADP RIBOSYLATION,9.6689e-06,-0.54995,-0.64034,0,0
1,GO HISTONE H4 ACETYLATION,6.2007e-06,-0.55018,-0.60445,0,0
1,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,0.00028019,-0.55028,-0.51563,0,0
1,GO MESONEPHRIC TUBULE MORPHOGENESIS,1.3909e-05,-0.55035,-0.50023,0,0
1,GO LEFT RIGHT AXIS SPECIFICATION,2.1347e-05,-0.55067,-0.58686,0,0
1,GO FORELIMB MORPHOGENESIS,1.6059e-05,-0.55107,-0.53629,0,0
1,GO REGULATION OF MITOCHONDRIAL FISSION,5.7533e-06,-0.55131,-0.58837,0,0
1,GO REGULATION OF TELOMERASE ACTIVITY,8.3461e-06,-0.55136,-0.51429,0,0
1,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.00019306,-0.55163,-0.47747,0,0
1,GO REGULATION OF HAIR CYCLE,1.8524e-05,-0.55168,-0.54732,0,0
1,GO ORGANELLE INHERITANCE,7.1973e-06,-0.55174,-0.53651,0,0
1,GO RENAL VESICLE DEVELOPMENT,1.0403e-05,-0.55209,-0.59411,0,0
1,GO REGULATION OF SPINDLE ASSEMBLY,1.6059e-05,-0.55212,-0.48621,0,0
1,GO MAINTENANCE OF SYNAPSE STRUCTURE,0.00054254,-0.55253,-0.62587,0,0
1,GO MEMBRANE DISASSEMBLY,7.1973e-06,-0.55288,-0.63488,0,0
1,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,4.5891e-06,-0.55329,-0.54329,0,0
1,GO NOREPINEPHRINE SECRETION,0.00020554,-0.55403,-0.55469,0,0
1,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,1.9888e-05,-0.55478,-0.57127,0,0
1,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,3.9422e-06,-0.55509,-0.55983,0,0
1,GO REGULATION OF ICOSANOID SECRETION,0.00014062,-0.55526,-0.4311,0,0
1,GO EPITHELIUM DEVELOPMENT,4.5891e-06,-0.55577,-0.54091,0,0
1,GO MALE SEX DIFFERENTIATION,6.2007e-06,-0.55621,-0.54601,0,0
1,GO AMINO ACID TRANSMEMBRANE TRANSPORT,8.9843e-06,-0.55622,-0.51072,0,0
1,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,6.6813e-06,-0.55623,-0.56897,0,0
1,GO POSITIVE REGULATION OF HEART GROWTH,7.7514e-06,-0.5567,-0.52894,0,0
1,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,6.2007e-06,-0.55694,-0.58732,0,0
1,GO NATURAL KILLER CELL CHEMOTAXIS,0.19156,-0.55703,-0.40866,0,0
1,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,5.7533e-06,-0.5574,-0.5338,0,0
1,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,4.5891e-06,-0.55751,-0.59593,0,0
1,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,4.8997e-05,-0.55758,-0.48964,0,0
1,GO REGULATION OF EPITHELIAL TUBE FORMATION,1.8524e-05,-0.55823,-0.61517,0,0
1,GO MEMBRANE FISSION,4.8997e-05,-0.55844,-0.60611,0,0
1,GO POLYOL CATABOLIC PROCESS,3.9936e-05,-0.55854,-0.50138,0,0
1,GO ER OVERLOAD RESPONSE,2.4576e-05,-0.55888,-0.49278,0,0
1,GO REGULATION OF TELOMERE MAINTENANCE,6.2007e-06,-0.55914,-0.54865,0,0
1,GO DOSAGE COMPENSATION,1.2035e-05,-0.55972,-0.61984,0,0
1,GO FOREBRAIN GENERATION OF NEURONS,6.8565e-05,-0.56038,-0.52269,0,0
1,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,5.337e-06,-0.56109,-0.60955,0,0
1,GO NEGATIVE REGULATION OF CELL DIVISION,1.7249e-05,-0.56175,-0.61542,0,0
1,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,1.4947e-05,-0.56219,-0.61551,0,0
1,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,7.1973e-06,-0.56222,-0.53712,0,0
1,GO MITOCHONDRIAL FISSION,7.1973e-06,-0.5624,-0.58544,0,0
1,GO PROTEIN LOCALIZATION TO NUCLEUS,3.9422e-06,-0.56275,-0.55801,0,0
1,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,5.7533e-06,-0.56296,-0.60132,0,0
1,GO NEPHRON MORPHOGENESIS,1.3909e-05,-0.56305,-0.53563,0,0
1,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,5.337e-06,-0.56319,-0.58007,0,0
1,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,4.5891e-06,-0.56513,-0.57793,0,0
1,GO PROTEIN PALMITOYLATION,4.8997e-05,-0.56658,-0.53715,0,0
1,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,3.9422e-06,-0.56667,-0.60152,0,0
1,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,4.2539e-06,-0.56679,-0.59254,0,0
1,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,4.2539e-06,-0.56699,-0.58293,0,0
1,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,3.9936e-05,-0.5671,-0.62713,0,0
1,GO MOLTING CYCLE,1.1191e-05,-0.56744,-0.54402,0,0
1,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,6.6813e-06,-0.56773,-0.55869,0,0
1,GO CELLULAR RESPONSE TO HEAT,4.2539e-06,-0.56921,-0.55352,0,0
1,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,1.3909e-05,-0.56921,-0.53421,0,0
1,GO LIMB BUD FORMATION,0.00024771,-0.56936,-0.55866,0,0
1,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,4.9495e-06,-0.5696,-0.5739,0,0
1,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,1.4947e-05,-0.56965,-0.56742,0,0
1,GO KIDNEY MORPHOGENESIS,1.6059e-05,-0.5697,-0.54139,0,0
1,GO CARDIAC MUSCLE CELL PROLIFERATION,5.337e-06,-0.56978,-0.57678,0,0
1,GO CELLULAR RESPONSE TO STARVATION,5.7533e-06,-0.57131,-0.55853,0,0
1,GO REGULATION OF FATTY ACID TRANSPORT,2.1347e-05,-0.57177,-0.51468,0,0
1,GO DIGESTIVE TRACT MORPHOGENESIS,1.8524e-05,-0.57187,-0.53685,0,0
1,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,4.2539e-06,-0.57265,-0.57724,0,0
1,GO EMBRYONIC ORGAN DEVELOPMENT,4.9495e-06,-0.57276,-0.58129,0,0
1,GO PROTEIN DNA COMPLEX DISASSEMBLY,8.3641e-05,-0.57306,-0.53229,0,0
1,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,7.1973e-06,-0.57331,-0.61063,0,0
1,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,1.9888e-05,-0.57401,-0.60644,0,0
1,GO ENDOCARDIAL CUSHION DEVELOPMENT,3.9422e-06,-0.5741,-0.66826,0,0
1,GO MODIFIED AMINO ACID TRANSPORT,1.4947e-05,-0.57434,-0.51723,0,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,4.8997e-05,-0.57478,-0.52608,0,0
1,GO HYPEROSMOTIC RESPONSE,1.2035e-05,-0.575,-0.56623,0,0
1,GO CARBOHYDRATE TRANSPORT,5.337e-06,-0.57587,-0.55123,0,0
1,GO METANEPHROS DEVELOPMENT,8.9843e-06,-0.57604,-0.57995,0,0
1,GO POSITIVE REGULATION OF CELL MATURATION,3.7287e-05,-0.57662,-0.52183,0,0
1,GO CHLORIDE ION HOMEOSTASIS,1.2939e-05,-0.57764,-0.57428,0,0
1,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,4.5891e-06,-0.57867,-0.58245,0,0
1,GO MAGNESIUM ION TRANSPORT,9.6689e-06,-0.57924,-0.59928,0,0
1,GO NEPHRON EPITHELIUM DEVELOPMENT,8.9843e-06,-0.57954,-0.56537,0,0
1,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,3.9422e-06,-0.57991,-0.58372,0,0
1,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,6.6813e-06,-0.58036,-0.64287,0,0
1,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,0.00010866,-0.58056,-0.63042,0,0
1,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,4.5779e-05,-0.58133,-0.66903,0,0
1,GO LATERAL SPROUTING FROM AN EPITHELIUM,4.5779e-05,-0.58139,-0.6051,0,0
1,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,0.00096503,-0.58207,-0.4586,0,0
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,5.7533e-06,-0.58232,-0.54176,0,0
1,GO REGULATION OF DNA METHYLATION,1.1191e-05,-0.5825,-0.56469,0,0
1,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,7.1973e-06,-0.58286,-0.59371,0,0
1,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,8.9843e-06,-0.58309,-0.59993,0,0
1,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,4.2539e-06,-0.58576,-0.62212,0,0
1,GO MAGNESIUM ION HOMEOSTASIS,3.248e-05,-0.58585,-0.54957,0,0
1,GO REPRODUCTIVE SYSTEM DEVELOPMENT,4.2539e-06,-0.58599,-0.54622,0,0
1,GO HINDLIMB MORPHOGENESIS,8.3461e-06,-0.58612,-0.57541,0,0
1,GO ENDOSOME TO LYSOSOME TRANSPORT,4.5891e-06,-0.58645,-0.61963,0,0
1,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,1.7249e-05,-0.58709,-0.52415,0,0
1,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,4.5891e-06,-0.58726,-0.63247,0,0
1,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,7.1973e-06,-0.58745,-0.58443,0,0
1,GO MITOCHONDRIAL GENOME MAINTENANCE,7.7514e-06,-0.58809,-0.58001,0,0
1,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,8.9843e-06,-0.58819,-0.60457,0,0
1,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,1.2035e-05,-0.58991,-0.56721,0,0
1,GO HISTONE H3 K27 METHYLATION,4.5779e-05,-0.58994,-0.62922,0,0
1,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,4.5891e-06,-0.59005,-0.55673,0,0
1,GO REGULATION OF URINE VOLUME,1.6059e-05,-0.59006,-0.5472,0,0
1,GO CELL FATE DETERMINATION,2.2907e-05,-0.59017,-0.53281,0,0
1,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,4.2539e-06,-0.59074,-0.61795,0,0
1,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.00076864,-0.5908,-0.52574,0,0
1,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,4.2763e-05,-0.5913,-0.60163,0,0
1,GO REGULATION OF TUBULIN DEACETYLATION,7.7514e-06,-0.5924,-0.64195,0,0
1,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,8.9843e-06,-0.59246,-0.65945,0,0
1,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.00031664,-0.59248,-0.50461,0,0
1,GO L AMINO ACID TRANSPORT,6.6813e-06,-0.59339,-0.54034,0,0
1,GO IN UTERO EMBRYONIC DEVELOPMENT,4.2539e-06,-0.5939,-0.57292,0,0
1,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,7.1973e-06,-0.59516,-0.53523,0,0
1,GO PHOSPHOLIPID DEPHOSPHORYLATION,5.7533e-06,-0.59552,-0.61626,0,0
1,GO RESPONSE TO TESTOSTERONE,4.5891e-06,-0.59684,-0.5275,0,0
1,GO GLAND DEVELOPMENT,5.337e-06,-0.59788,-0.58071,0,0
1,GO REPLICATIVE SENESCENCE,3.9936e-05,-0.59799,-0.48024,0,0
1,GO MAINTENANCE OF ORGANELLE LOCATION,7.7514e-06,-0.59814,-0.62293,0,0
1,GO DORSAL VENTRAL AXIS SPECIFICATION,0.0011418,-0.59838,-0.48658,0,0
1,GO KIDNEY EPITHELIUM DEVELOPMENT,8.9843e-06,-0.59877,-0.5711,0,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,7.1973e-06,-0.6005,-0.63926,0,0
1,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,4.9495e-06,-0.60128,-0.65444,0,0
1,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,1.9888e-05,-0.60181,-0.57034,0,0
1,GO PROSTATIC BUD FORMATION,5.2428e-05,-0.60195,-0.58845,0,0
1,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,1.2035e-05,-0.60221,-0.57479,0,0
1,GO OSTEOBLAST DIFFERENTIATION,4.5891e-06,-0.60239,-0.59567,0,0
1,GO MEIOTIC SPINDLE ORGANIZATION,2.2907e-05,-0.60277,-0.63923,0,0
1,GO AXIS ELONGATION,1.4947e-05,-0.6031,-0.54725,0,0
1,GO INNERVATION,0.00024771,-0.60331,-0.71012,0,0
1,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,8.9843e-06,-0.60362,-0.61287,0,0
1,GO NOTCH SIGNALING PATHWAY,7.7514e-06,-0.60392,-0.60278,0,0
1,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.00021879,-0.60504,-0.56791,0,0
1,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,2.1347e-05,-0.60523,-0.56998,0,0
1,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.0011418,-0.6053,-0.5188,0,0
1,GO REGULATION OF SECONDARY METABOLIC PROCESS,7.1973e-06,-0.60649,-0.61982,0,0
1,GO SPHINGOLIPID MEDIATED SIGNALING PATHWAY,1.3909e-05,-0.6078,-0.66347,0,0
1,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,0.00029789,-0.60914,-0.56825,0,0
1,GO CRANIOFACIAL SUTURE MORPHOGENESIS,6.2007e-06,-0.60941,-0.65475,0,0
1,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,6.6813e-06,-0.61005,-0.5575,0,0
1,GO EMBRYONIC DIGIT MORPHOGENESIS,5.7533e-06,-0.61008,-0.5862,0,0
1,GO RADIAL GLIAL CELL DIFFERENTIATION,9.6689e-06,-0.61017,-0.61284,0,0
1,GO GLYCINE TRANSPORT,0.00040321,-0.61061,-0.56627,0,0
1,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,4.9495e-06,-0.61072,-0.64696,0,0
1,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,8.9843e-06,-0.61075,-0.59927,0,0
1,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.00021879,-0.61079,-0.57184,0,0
1,GO NEURAL CREST FORMATION,0.0017696,-0.6109,-0.44106,0,0
1,GO ENDOCARDIAL CUSHION MORPHOGENESIS,3.9422e-06,-0.61163,-0.69641,0,0
1,GO SMAD PROTEIN COMPLEX ASSEMBLY,7.7514e-06,-0.61259,-0.57402,0,0
1,GO MITOCHONDRIAL DNA METABOLIC PROCESS,1.9888e-05,-0.61315,-0.59267,0,0
1,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,1.1191e-05,-0.61332,-0.61248,0,0
1,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,2.1347e-05,-0.61404,-0.56523,0,0
1,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,5.7533e-06,-0.61421,-0.63445,0,0
1,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,5.9985e-05,-0.61482,-0.53786,0,0
1,GO NEUROTROPHIN SIGNALING PATHWAY,6.2007e-06,-0.61552,-0.58767,0,0
1,GO HISTONE H3 DEACETYLATION,1.2939e-05,-0.61569,-0.54939,0,0
1,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,1.1191e-05,-0.61611,-0.64459,0,0
1,GO SKIN EPIDERMIS DEVELOPMENT,1.1191e-05,-0.61637,-0.56857,0,0
1,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,7.1973e-06,-0.61659,-0.62264,0,0
1,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,6.2007e-06,-0.61685,-0.65913,0,0
1,GO SPHINGOSINE 1 PHOSPHATE RECEPTOR SIGNALING PATHWAY,1.1191e-05,-0.61703,-0.65007,0,0
1,GO STEM CELL PROLIFERATION,5.337e-06,-0.61704,-0.60153,0,0
1,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,5.337e-06,-0.61735,-0.60344,0,0
1,GO REGULATION OF ANION TRANSPORT,8.9843e-06,-0.61754,-0.54191,0,0
1,GO MAST CELL MIGRATION,1.9888e-05,-0.61771,-0.64982,0,0
1,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,8.9843e-06,-0.61811,-0.58131,0,0
1,GO NEURON PROJECTION REGENERATION,6.6813e-06,-0.61884,-0.63626,0,0
1,GO UROGENITAL SYSTEM DEVELOPMENT,5.7533e-06,-0.61927,-0.58976,0,0
1,GO REGULATION OF RECEPTOR CLUSTERING,0.00031664,-0.61934,-0.59637,0,0
1,GO TRACHEA DEVELOPMENT,4.2539e-06,-0.61961,-0.68114,0,0
1,GO PROSTATE GLAND MORPHOGENESIS,5.6086e-05,-0.61963,-0.56905,0,0
1,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,5.7533e-06,-0.61984,-0.63226,0,0
1,GO CYTOPLASM ORGANIZATION,1.2939e-05,-0.62118,-0.66168,0,0
1,GO GLAND MORPHOGENESIS,7.1973e-06,-0.62187,-0.66516,0,0
1,GO REGULATION OF GOLGI ORGANIZATION,5.337e-06,-0.62324,-0.66771,0,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,8.3461e-06,-0.62354,-0.61153,0,0
1,GO STRIATUM DEVELOPMENT,8.9843e-06,-0.62354,-0.59583,0,0
1,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,2.4576e-05,-0.625,-0.57443,0,0
1,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,3.4805e-05,-0.62545,-0.60775,0,0
1,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,1.2035e-05,-0.62665,-0.5938,0,0
1,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,4.5891e-06,-0.62716,-0.63511,0,0
1,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,1.4947e-05,-0.62746,-0.62584,0,0
1,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,1.7249e-05,-0.62761,-0.7472,0,0
1,GO REGULATION OF ORGANIC ACID TRANSPORT,2.636e-05,-0.62767,-0.51088,0,0
1,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,1.9888e-05,-0.62773,-0.67151,0,0
1,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,1.9888e-05,-0.62813,-0.59912,0,0
1,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,4.9495e-06,-0.62857,-0.63157,0,0
1,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,2.8267e-05,-0.6287,-0.66763,0,0
1,GO MESENCHYMAL CELL PROLIFERATION,1.4947e-05,-0.62904,-0.64377,0,0
1,GO TRABECULA FORMATION,9.6689e-06,-0.6295,-0.64095,0,0
1,GO AMINO ACID IMPORT,9.6689e-06,-0.63019,-0.56199,0,0
1,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,7.1973e-06,-0.63069,-0.59889,0,0
1,GO TUBE FORMATION,4.2539e-06,-0.63109,-0.58095,0,0
1,GO MESENCHYME MORPHOGENESIS,5.7533e-06,-0.63112,-0.67015,0,0
1,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,4.2539e-06,-0.63129,-0.58908,0,0
1,GO APPENDAGE DEVELOPMENT,4.5891e-06,-0.63331,-0.61719,0,0
1,GO POST ANAL TAIL MORPHOGENESIS,4.2539e-06,-0.63583,-0.66487,0,0
1,GO MEMBRANE REPOLARIZATION,1.0403e-05,-0.63648,-0.60653,0,0
1,GO CELLULAR COMPONENT MAINTENANCE,4.9495e-06,-0.63654,-0.64784,0,0
1,GO NOSE DEVELOPMENT,0.00023283,-0.63668,-0.61958,0,0
1,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,7.1973e-06,-0.63759,-0.63315,0,0
1,GO APPENDAGE MORPHOGENESIS,5.7533e-06,-0.63821,-0.63198,0,0
1,GO COPII COATED VESICLE CARGO LOADING,4.9495e-06,-0.63903,-0.67179,0,0
1,GO LACTATION,3.9422e-06,-0.64031,-0.64569,0,0
1,GO SMOOTH MUSCLE CONTRACTION,5.337e-06,-0.64098,-0.57724,0,0
1,GO REGULATION OF SULFUR METABOLIC PROCESS,2.8267e-05,-0.6414,-0.64515,0,0
1,GO PROTEIN LOCALIZATION TO CYTOSKELETON,5.337e-06,-0.64149,-0.66163,0,0
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,1.3909e-05,-0.64206,-0.56549,0,0
1,GO CELLULAR RESPONSE TO VITAMIN D,7.3279e-05,-0.64245,-0.52207,0,0
1,GO EXOCRINE SYSTEM DEVELOPMENT,6.2007e-06,-0.64266,-0.67538,0,0
1,GO NEUROBLAST DIVISION,4.2539e-06,-0.64392,-0.67729,0,0
1,GO REGULATION OF NEURON PROJECTION REGENERATION,6.2007e-06,-0.64411,-0.66728,0,0
1,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,5.2428e-05,-0.64412,-0.60037,0,0
1,GO NEGATIVE REGULATION OF OSSIFICATION,7.1973e-06,-0.64434,-0.62762,0,0
1,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,1.9888e-05,-0.6451,-0.69288,0,0
1,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,1.1191e-05,-0.64641,-0.6763,0,0
1,GO REGULATION OF VASCULOGENESIS,7.3279e-05,-0.64664,-0.58836,0,0
1,GO REGULATION OF VASOCONSTRICTION,1.1191e-05,-0.6469,-0.63281,0,0
1,GO EPITHELIAL TUBE MORPHOGENESIS,4.9495e-06,-0.64702,-0.60848,0,0
1,GO EMBRYONIC APPENDAGE MORPHOGENESIS,5.7533e-06,-0.64718,-0.6356,0,0
1,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,1.3909e-05,-0.64731,-0.61427,0,0
1,GO PRO B CELL DIFFERENTIATION,1.0403e-05,-0.64901,-0.68067,0,0
1,GO REGULATION OF MEMBRANE REPOLARIZATION,9.6689e-06,-0.64951,-0.65905,0,0
1,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.00091199,-0.65021,-0.48007,0,0
1,GO ESTROUS CYCLE,1.9888e-05,-0.65054,-0.63126,0,0
1,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,3.4805e-05,-0.65191,-0.55201,0,0
1,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,6.4139e-05,-0.65302,-0.56593,0,0
1,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,4.9495e-06,-0.65302,-0.62633,0,0
1,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,6.2007e-06,-0.65331,-0.61823,0,0
1,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,6.2007e-06,-0.65364,-0.66444,0,0
1,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,6.2007e-06,-0.65377,-0.63725,0,0
1,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,2.636e-05,-0.65403,-0.66278,0,0
1,GO RENAL SYSTEM PROCESS,6.2007e-06,-0.65438,-0.62167,0,0
1,GO SKELETAL SYSTEM MORPHOGENESIS,4.5891e-06,-0.65462,-0.64685,0,0
1,GO BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS,5.6086e-05,-0.65587,-0.61197,0,0
1,GO RENAL WATER HOMEOSTASIS,1.3909e-05,-0.65632,-0.63161,0,0
1,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,4.5891e-06,-0.65706,-0.6446,0,0
1,GO TRICARBOXYLIC ACID METABOLIC PROCESS,5.337e-06,-0.6572,-0.61011,0,0
1,GO NEGATIVE REGULATION OF MAST CELL ACTIVATION,0.00013188,-0.65826,-0.65765,0,0
1,GO MICROVILLUS ASSEMBLY,4.5891e-06,-0.65844,-0.63219,0,0
1,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.00091199,-0.6586,-0.67252,0,0
1,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,1.8524e-05,-0.65875,-0.71538,0,0
1,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,2.2907e-05,-0.65935,-0.54416,0,0
1,GO REGULATION OF MITOCHONDRIAL FUSION,5.7533e-06,-0.66007,-0.6333,0,0
1,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,4.5891e-06,-0.66018,-0.64318,0,0
1,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,3.0304e-05,-0.66036,-0.60791,0,0
1,GO PROTEIN DEPOLYMERIZATION,4.5891e-06,-0.66065,-0.7048,0,0
1,GO NEURONAL STEM CELL POPULATION MAINTENANCE,8.3461e-06,-0.66078,-0.65934,0,0
1,GO ROOF OF MOUTH DEVELOPMENT,4.5891e-06,-0.66101,-0.65997,0,0
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,1.6059e-05,-0.66121,-0.62816,0,0
1,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,4.2763e-05,-0.66258,-0.62641,0,0
1,GO POST GOLGI VESICLE MEDIATED TRANSPORT,3.9422e-06,-0.66272,-0.65533,0,0
1,GO VENTRICULAR SEPTUM MORPHOGENESIS,6.6813e-06,-0.66406,-0.64445,0,0
1,GO SKELETAL SYSTEM DEVELOPMENT,4.5891e-06,-0.66428,-0.64436,0,0
1,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,8.3461e-06,-0.66632,-0.70319,0,0
1,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,2.636e-05,-0.66701,-0.65301,0,0
1,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,9.6689e-06,-0.66733,-0.64657,0,0
1,GO STEM CELL DIVISION,5.337e-06,-0.66985,-0.67945,0,0
1,GO MESODERMAL CELL DIFFERENTIATION,4.9495e-06,-0.67242,-0.65128,0,0
1,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,3.9422e-06,-0.67374,-0.68874,0,0
1,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,9.6689e-06,-0.67643,-0.68436,0,0
1,GO TROPHOBLAST CELL MIGRATION,3.9422e-06,-0.67742,-0.68474,0,0
1,GO CARTILAGE DEVELOPMENT,4.9495e-06,-0.6782,-0.66438,0,0
1,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,6.6813e-06,-0.67894,-0.63591,0,0
1,GO NEURAL TUBE DEVELOPMENT,5.337e-06,-0.67917,-0.62477,0,0
1,GO REGULATION OF RENAL SYSTEM PROCESS,1.2035e-05,-0.68051,-0.58554,0,0
1,GO CELLULAR RESPONSE TO VITAMIN,1.6059e-05,-0.68075,-0.6261,0,0
1,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,5.337e-06,-0.68234,-0.69753,0,0
1,GO POSITIVE REGULATION OF FILOPODIUM ASSEMBLY,4.2539e-06,-0.6826,-0.71875,0,0
1,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,4.5891e-06,-0.68411,-0.66719,0,0
1,GO REGULATION OF PROTEIN DEPOLYMERIZATION,4.2539e-06,-0.68539,-0.70846,0,0
1,GO POSITIVE REGULATION OF MACROAUTOPHAGY,4.9495e-06,-0.68605,-0.69976,0,0
1,GO EPITHELIAL TO MESENCHYMAL TRANSITION,7.1973e-06,-0.68733,-0.64205,0,0
1,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,9.6689e-06,-0.68782,-0.71871,0,0
1,GO BONE MORPHOGENESIS,4.5891e-06,-0.68793,-0.691,0,0
1,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,4.2539e-06,-0.68824,-0.65923,0,0
1,GO HEART TRABECULA MORPHOGENESIS,4.5891e-06,-0.68871,-0.70777,0,0
1,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,7.3279e-05,-0.68875,-0.61373,0,0
1,GO GANGLIOSIDE METABOLIC PROCESS,2.4576e-05,-0.68884,-0.62048,0,0
1,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,6.2007e-06,-0.69266,-0.62499,0,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,8.9843e-06,-0.69409,-0.62534,0,0
1,GO SALIVARY GLAND DEVELOPMENT,4.2539e-06,-0.69834,-0.74065,0,0
1,GO BASIC AMINO ACID TRANSPORT,5.6086e-05,-0.69834,-0.64574,0,0
1,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,9.6689e-06,-0.69869,-0.68174,0,0
1,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,5.7533e-06,-0.69874,-0.66805,0,0
1,GO CONNECTIVE TISSUE DEVELOPMENT,4.9495e-06,-0.69881,-0.66785,0,0
1,GO ACTIN FILAMENT NETWORK FORMATION,1.6059e-05,-0.6992,-0.66929,0,0
1,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,4.2539e-06,-0.7002,-0.68267,0,0
1,GO OUTFLOW TRACT MORPHOGENESIS,4.5891e-06,-0.70107,-0.67179,0,0
1,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,4.5891e-06,-0.70221,-0.71946,0,0
1,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,3.7287e-05,-0.70336,-0.60326,0,0
1,GO ENDOCHONDRAL BONE MORPHOGENESIS,4.9495e-06,-0.70367,-0.67522,0,0
1,GO CONVERGENT EXTENSION,1.4947e-05,-0.70526,-0.64463,0,0
1,GO AROMATIC AMINO ACID TRANSPORT,9.6689e-06,-0.70592,-0.74527,0,0
1,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,6.6813e-06,-0.70597,-0.68265,0,0
1,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,4.5891e-06,-0.70597,-0.66108,0,0
1,GO REGULATION OF GLOMERULAR FILTRATION,1.9888e-05,-0.70791,-0.74819,0,0
1,GO CELL CELL JUNCTION ORGANIZATION,5.337e-06,-0.70865,-0.64695,0,0
1,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,1.3909e-05,-0.70913,-0.64788,0,0
1,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,1.6059e-05,-0.71008,-0.7016,0,0
1,GO CELL CELL JUNCTION ASSEMBLY,5.7533e-06,-0.71023,-0.61317,0,0
1,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,2.1347e-05,-0.71286,-0.63727,0,0
1,GO GLOMERULAR EPITHELIUM DEVELOPMENT,8.3461e-06,-0.71306,-0.66464,0,0
1,GO N GLYCAN PROCESSING,1.3909e-05,-0.71337,-0.68641,0,0
1,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,3.9422e-06,-0.71352,-0.74029,0,0
1,GO PROTEIN TARGETING TO LYSOSOME,7.7514e-06,-0.71368,-0.6659,0,0
1,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,5.7533e-06,-0.71392,-0.69159,0,0
1,GO CIRCADIAN REGULATION OF GENE EXPRESSION,8.3461e-06,-0.71551,-0.6883,0,0
1,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,4.5891e-06,-0.71836,-0.73663,0,0
1,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,5.7533e-06,-0.71862,-0.74333,0,0
1,GO REGULATION OF HIPPO SIGNALING,1.2035e-05,-0.71893,-0.6813,0,0
1,GO RESPONSE TO BMP,5.7533e-06,-0.71925,-0.66969,0,0
1,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,7.7514e-06,-0.71973,-0.76268,0,0
1,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,1.6059e-05,-0.71992,-0.71878,0,0
1,GO ENDOTHELIAL CELL CHEMOTAXIS,1.2035e-05,-0.72102,-0.66922,0,0
1,GO CHONDROCYTE DIFFERENTIATION,4.9495e-06,-0.72163,-0.73198,0,0
1,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,7.7514e-06,-0.7242,-0.7724,0,0
1,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,1.2939e-05,-0.72997,-0.6765,0,0
1,GO REGULATION OF FIBROBLAST MIGRATION,4.2539e-06,-0.73053,-0.69465,0,0
1,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,4.5891e-06,-0.73106,-0.77453,0,0
1,GO FIBROBLAST MIGRATION,3.9422e-06,-0.73518,-0.69067,0,0
1,GO REGULATION OF BMP SIGNALING PATHWAY,5.337e-06,-0.73675,-0.70292,0,0
1,GO ANOIKIS,8.9843e-06,-0.73805,-0.69679,0,0
1,GO MAINTENANCE OF BLOOD BRAIN BARRIER,7.7514e-06,-0.73841,-0.67514,0,0
1,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,4.5891e-06,-0.73858,-0.70923,0,0
1,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,7.7514e-06,-0.73941,-0.75537,0,0
1,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,1.2035e-05,-0.74054,-0.73017,0,0
1,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,3.9422e-06,-0.74125,-0.76095,0,0
1,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,4.9495e-06,-0.74426,-0.80644,0,0
1,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,5.337e-06,-0.74432,-0.66649,0,0
1,GO APICAL JUNCTION ASSEMBLY,1.4947e-05,-0.74463,-0.57971,0,0
1,GO EMBRYONIC CAMERA TYPE EYE FORMATION,8.9843e-06,-0.74614,-0.76185,0,0
1,GO NK T CELL DIFFERENTIATION,4.2763e-05,-0.75051,-0.72753,0,0
1,GO NEGATIVE REGULATION OF ANOIKIS,3.7287e-05,-0.75152,-0.75199,0,0
1,GO ENDOTHELIUM DEVELOPMENT,4.9495e-06,-0.75273,-0.73264,0,0
1,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,8.3461e-06,-0.75577,-0.70188,0,0
1,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,4.9495e-06,-0.75662,-0.72616,0,0
1,GO REGULATION OF CARTILAGE DEVELOPMENT,4.9495e-06,-0.75729,-0.70142,0,0
1,GO SPROUTING ANGIOGENESIS,4.2539e-06,-0.75733,-0.7491,0,0
1,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,8.9327e-05,-0.75944,-0.66961,0,0
1,GO REGULATION OF ANOIKIS,1.3909e-05,-0.76024,-0.71521,0,0
1,GO CHONDROCYTE DEVELOPMENT,6.6813e-06,-0.76081,-0.77722,0,0
1,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,3.4805e-05,-0.76294,-0.67312,0,0
1,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,5.337e-06,-0.76888,-0.79872,0,0
1,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,7.1973e-06,-0.76956,-0.71335,0,0
1,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS,2.1347e-05,-0.77132,-0.73682,0,0
1,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,5.7533e-06,-0.77319,-0.73964,0,0
1,GO MYELIN MAINTENANCE,6.6813e-06,-0.77577,-0.69431,0,0
1,GO REGULATION OF CYTOPLASMIC TRANSPORT,4.9495e-06,-0.77772,-0.71955,0,0
1,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,6.2007e-06,-0.7833,-0.79255,0,0
1,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,3.9422e-06,-0.78818,-0.77223,0,0
1,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,4.5891e-06,-0.79856,-0.77856,0,0
1,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,4.9495e-06,-0.80165,-0.7599,0,0
1,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,4.5891e-06,-0.80959,-0.7836,0,0
1,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,4.9495e-06,-0.82102,-0.8462,0,0
1,GO DEFINITIVE HEMOPOIESIS,5.7533e-06,-0.82161,-0.79034,0,0
1,GO RENAL FILTRATION,8.3461e-06,-0.82191,-0.87135,0,0
1,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,5.337e-06,-0.82381,-0.7953,0,0
1,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,5.7533e-06,-0.82521,-0.86157,0,0
1,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,5.337e-06,-0.83214,-0.78747,0,0
1,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,3.9422e-06,-0.86213,-0.78574,0,0
1,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,7.7514e-06,-0.86345,-0.75923,0,0
1,GO ENDOTHELIAL CELL DEVELOPMENT,4.5891e-06,-0.87074,-0.8192,0,0
1,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,5.337e-06,-0.89113,-0.82292,0,0
1,GO COLLAGEN FIBRIL ORGANIZATION,6.6813e-06,-0.89278,-0.96117,0,0
1,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,6.2007e-06,-0.89294,-0.82067,0,0
1,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,5.7533e-06,-0.91214,-0.86549,0,0
1,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,1.7249e-05,-0.92506,-0.95161,0,0
1,GO DORSAL AORTA DEVELOPMENT,7.1973e-06,-0.94338,-0.84503,0,0
1,GO PROTEIN LOCALIZATION TO ENDOSOME,6.2007e-06,-0.95664,-0.85341,0,0
1,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,6.2007e-06,-0.9843,-0.87976,0,0
1,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,5.337e-06,-1.0288,-1.0412,0,0
1,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,4.5891e-06,-1.0297,-0.91087,0,0
1,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,5.337e-06,-1.0302,-1.0591,0,0
1,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,7.7514e-06,-1.0345,-0.93999,0,0
2,GO DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION,4.5779e-05,1.3473,1.2283,1,1
2,GO T CELL ACTIVATION VIA T CELL RECEPTOR CONTACT WITH ANTIGEN BOUND TO MHC MOLECULE ON ANTIGEN PRESENTING CELL,2.8267e-05,1.3162,1.2983,1,1
2,GO NATURAL KILLER CELL CHEMOTAXIS,0.00010181,1.2871,1.1126,1,1
2,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,2.8267e-05,1.2695,1.2171,1,1
2,GO DENDRITIC CELL APOPTOTIC PROCESS,4.5779e-05,1.2502,1.1888,1,1
2,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,1.6059e-05,1.1976,1.1257,1,1
2,GO CHRONIC INFLAMMATORY RESPONSE,1.2035e-05,1.166,1.0039,1,1
2,GO TOLERANCE INDUCTION,8.3641e-05,1.0921,0.9378,1,1
2,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,1.1191e-05,1.0774,1.0385,1,1
2,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,5.6086e-05,1.0762,0.93325,1,1
2,GO HYPERSENSITIVITY,3.248e-05,1.075,1.0001,1,1
2,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,9.6689e-06,1.0566,1.023,1,1
2,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,1.4947e-05,1.0462,1.0267,1,1
2,GO REGULATION OF T CELL TOLERANCE INDUCTION,0.00015974,1.0434,1.0145,1,1
2,GO IMMUNOLOGICAL SYNAPSE FORMATION,7.3279e-05,1.0397,0.9764,1,1
2,GO T CELL TOLERANCE INDUCTION,0.00012367,1.0309,0.94207,1,1
2,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,8.9843e-06,1.0303,1.0168,1,1
2,GO REGULATION OF TOLERANCE INDUCTION,0.00020554,1.0295,0.86245,1,1
2,GO T HELPER 17 CELL LINEAGE COMMITMENT,6.8565e-05,1.0293,0.91249,1,1
2,GO NEGATIVE T CELL SELECTION,4.5779e-05,1.0182,0.97037,1,1
2,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,1.9888e-05,0.99862,0.94811,1,1
2,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,4.8997e-05,0.99143,0.95855,1,1
2,GO POSITIVE REGULATION OF REGULATORY T CELL DIFFERENTIATION,0.00017019,0.99107,0.77769,1,1
2,GO CHEMOKINE BIOSYNTHETIC PROCESS,5.7533e-06,0.98813,0.99596,1,1
2,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,1.1191e-05,0.98527,0.95856,1,1
2,GO DENDRITIC CELL MIGRATION,3.4805e-05,0.97983,0.86374,1,1
2,GO DENDRITIC CELL CHEMOTAXIS,3.7287e-05,0.97669,0.89033,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,4.5779e-05,0.9764,0.89471,1,1
2,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,3.0304e-05,0.9754,0.94601,1,1
2,GO T HELPER 1 TYPE IMMUNE RESPONSE,1.2939e-05,0.96391,0.87601,1,1
2,GO LYMPHOCYTE CHEMOTAXIS,1.0403e-05,0.94512,0.87876,1,1
2,GO SYNAPSE PRUNING,3.4805e-05,0.94434,1.0171,1,1
2,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,1.8524e-05,0.93451,0.90261,1,1
2,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,2.2907e-05,0.9336,0.80445,1,1
2,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,4.8997e-05,0.93239,0.84768,1,1
2,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,3.0304e-05,0.93037,0.89165,1,1
2,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,3.9936e-05,0.92589,0.81245,1,1
2,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,1.6059e-05,0.92497,0.85597,1,1
2,GO COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY,0.00013188,0.92431,0.967,1,1
2,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,3.7287e-05,0.92033,0.84674,1,1
2,GO T CELL CHEMOTAXIS,3.0304e-05,0.91746,0.82836,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,2.4576e-05,0.91309,0.81386,1,1
2,GO RESPONSE TO PROTOZOAN,2.2907e-05,0.91174,0.80392,1,1
2,GO T HELPER 1 CELL DIFFERENTIATION,1.3909e-05,0.91136,0.85793,1,1
2,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,4.8997e-05,0.9095,0.86753,1,1
2,GO REGULATION OF MONOCYTE CHEMOTAXIS,2.8267e-05,0.90882,0.85178,1,1
2,GO DENDRITIC CELL DIFFERENTIATION,3.7287e-05,0.90857,0.81405,1,1
2,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,3.7287e-05,0.90013,0.83762,1,1
2,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,8.9327e-05,0.89968,0.83641,1,1
2,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,1.2939e-05,0.89764,0.80491,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,2.636e-05,0.89692,0.83488,1,1
2,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,1.1191e-05,0.88948,0.88765,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,3.9936e-05,0.8884,0.89315,1,1
2,GO DETECTION OF OTHER ORGANISM,2.2907e-05,0.88355,0.81017,1,1
2,GO INTERLEUKIN 10 PRODUCTION,1.6059e-05,0.88275,0.76367,1,1
2,GO POSITIVE T CELL SELECTION,5.9985e-05,0.88118,0.77332,1,1
2,GO T HELPER CELL LINEAGE COMMITMENT,4.5779e-05,0.87903,0.79836,1,1
2,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,1.2939e-05,0.87738,0.80534,1,1
2,GO REGULATION OF MICROGLIAL CELL ACTIVATION,2.1347e-05,0.87504,0.81521,1,1
2,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,2.4576e-05,0.87226,0.84793,1,1
2,GO POSITIVE REGULATION OF GLIAL CELL MIGRATION,3.7287e-05,0.87117,0.76319,1,1
2,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,1.9888e-05,0.86576,0.81785,1,1
2,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,2.1347e-05,0.8647,0.81937,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,4.8997e-05,0.8626,0.7323,1,1
2,GO B CELL RECEPTOR SIGNALING PATHWAY,4.8997e-05,0.86101,0.80064,1,1
2,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,2.1347e-05,0.8599,0.82795,1,1
2,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,1.2939e-05,0.85721,0.83104,1,1
2,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,4.2763e-05,0.85506,0.78494,1,1
2,GO POSITIVE THYMIC T CELL SELECTION,0.00010866,0.85384,0.8319,1,1
2,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,2.636e-05,0.85309,0.84855,1,1
2,GO LEUKOCYTE AGGREGATION,3.248e-05,0.8515,0.88935,1,1
2,GO RESPONSE TO PEPTIDOGLYCAN,6.6813e-06,0.84808,0.84406,1,1
2,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,6.8565e-05,0.84441,0.82511,1,1
2,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,5.2428e-05,0.84301,0.73001,1,1
2,GO REGULATION OF T CELL APOPTOTIC PROCESS,3.248e-05,0.84084,0.71004,1,1
2,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,1.2939e-05,0.83957,0.78879,1,1
2,GO CYTOLYSIS,3.7287e-05,0.83877,0.87952,1,1
2,GO T CELL MEDIATED CYTOTOXICITY,1.2939e-05,0.83775,0.81036,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,2.4576e-05,0.83633,0.73997,1,1
2,GO T HELPER 2 CELL DIFFERENTIATION,1.2035e-05,0.83629,0.82087,1,1
2,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,0.0010209,0.83371,0.71117,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,1.7249e-05,0.83206,0.72692,1,1
2,GO RESPONSE TO CHEMOKINE,7.7514e-06,0.83105,0.80893,1,1
2,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,2.2907e-05,0.8309,0.74977,1,1
2,GO NEGATIVE REGULATION OF CELL KILLING,5.6086e-05,0.83075,0.8456,1,1
2,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,3.9936e-05,0.82915,0.75125,1,1
2,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,2.8267e-05,0.82835,0.81143,1,1
2,GO POSITIVE REGULATION OF CHEMOKINE SECRETION,2.636e-05,0.8282,0.86888,1,1
2,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,1.8524e-05,0.82699,0.80281,1,1
2,GO POSITIVE REGULATION OF T CELL MIGRATION,3.0304e-05,0.82687,0.73068,1,1
2,GO COMPLEMENT RECEPTOR MEDIATED SIGNALING PATHWAY,4.5779e-05,0.8252,0.83529,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,1.7249e-05,0.82352,0.76222,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,1.8524e-05,0.82258,0.80996,1,1
2,GO MONOCYTE CHEMOTAXIS,8.3461e-06,0.82228,0.85929,1,1
2,GO ADAPTIVE IMMUNE RESPONSE,3.248e-05,0.82211,0.73301,1,1
2,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,2.8267e-05,0.82057,0.76082,1,1
2,GO CYCLOOXYGENASE PATHWAY,1.3909e-05,0.81668,0.85515,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,1.2939e-05,0.81658,0.82124,1,1
2,GO REGULATION OF HUMORAL IMMUNE RESPONSE,3.248e-05,0.81415,0.83447,1,1
2,GO CELLULAR DEFENSE RESPONSE,3.248e-05,0.81281,0.77619,1,1
2,GO REGULATION OF GLIAL CELL MIGRATION,2.4576e-05,0.81242,0.70661,1,1
2,GO B CELL PROLIFERATION,4.2763e-05,0.81081,0.74896,1,1
2,GO T CELL SELECTION,6.8565e-05,0.81056,0.72635,1,1
2,GO TYPE 2 IMMUNE RESPONSE,1.1191e-05,0.80958,0.77421,1,1
2,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,3.9936e-05,0.80914,0.72671,1,1
2,GO DETECTION OF BIOTIC STIMULUS,1.6059e-05,0.80884,0.71302,1,1
2,GO LYMPHOCYTE MIGRATION,3.248e-05,0.80883,0.74924,1,1
2,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,2.8267e-05,0.80765,0.80169,1,1
2,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,2.636e-05,0.80703,0.72476,1,1
2,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,1.2939e-05,0.80686,0.7535,1,1
2,GO T CELL MIGRATION,3.248e-05,0.80663,0.76849,1,1
2,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,4.5779e-05,0.80654,0.72615,1,1
2,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,1.4947e-05,0.80527,0.77117,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,3.9936e-05,0.80454,0.79313,1,1
2,GO COMPLEMENT ACTIVATION,2.4576e-05,0.80439,0.83768,1,1
2,GO MYELOID DENDRITIC CELL ACTIVATION,4.8997e-05,0.80309,0.7659,1,1
2,GO INFLAMMATORY RESPONSE TO WOUNDING,1.1191e-05,0.80302,0.75255,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE DEGRANULATION,8.9327e-05,0.80283,0.79908,1,1
2,GO INTERLEUKIN 2 PRODUCTION,1.0403e-05,0.80167,0.7572,1,1
2,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,2.636e-05,0.80104,0.72416,1,1
2,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,2.4576e-05,0.79816,0.79601,1,1
2,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.00010181,0.79672,0.68776,1,1
2,GO REGULATION OF NEUTROPHIL ACTIVATION,0.00015974,0.79581,0.71695,1,1
2,GO T CELL EXTRAVASATION,1.6059e-05,0.79425,0.71614,1,1
2,GO THYMIC T CELL SELECTION,8.3641e-05,0.79367,0.7488,1,1
2,GO INTERLEUKIN 4 PRODUCTION,2.2907e-05,0.79312,0.75416,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,1.3909e-05,0.79266,0.81239,1,1
2,GO RESPONSE TO INTERLEUKIN 18,7.8298e-05,0.79218,0.70904,1,1
2,GO REGULATION OF T CELL CYTOKINE PRODUCTION,2.4576e-05,0.79089,0.757,1,1
2,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,2.8267e-05,0.79083,0.73372,1,1
2,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,1.9888e-05,0.78892,0.74893,1,1
2,GO NEUTROPHIL MIGRATION,1.6059e-05,0.78851,0.71299,1,1
2,GO POSITIVE REGULATION OF T CELL PROLIFERATION,2.636e-05,0.78812,0.7516,1,1
2,GO REGULATION OF T CELL CHEMOTAXIS,3.7287e-05,0.78783,0.71936,1,1
2,GO NEUTROPHIL CHEMOTAXIS,2.636e-05,0.78756,0.74537,1,1
2,GO INTERLEUKIN 1 BETA PRODUCTION,1.3909e-05,0.78715,0.72733,1,1
2,GO IMMUNOGLOBULIN SECRETION,3.248e-05,0.78338,0.65095,1,1
2,GO INTERLEUKIN 13 PRODUCTION,1.1191e-05,0.77998,0.80081,1,1
2,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,2.2907e-05,0.77742,0.6935,1,1
2,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,3.9936e-05,0.77586,0.72395,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,4.8997e-05,0.77577,0.71094,1,1
2,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,3.248e-05,0.77505,0.68889,1,1
2,GO REGULATION OF HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.00013188,0.77393,0.71105,1,1
2,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.00011593,0.77306,0.70804,1,1
2,GO GLIAL CELL ACTIVATION,2.636e-05,0.77237,0.75713,1,1
2,GO NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE,3.9936e-05,0.77101,0.80299,1,1
2,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,8.3461e-06,0.77099,0.77697,1,1
2,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,1.9888e-05,0.76966,0.73984,1,1
2,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,3.7287e-05,0.76926,0.75334,1,1
2,GO CHEMOKINE SECRETION,2.1347e-05,0.76716,0.81212,1,1
2,GO POSITIVE REGULATION OF PHAGOCYTOSIS,1.8524e-05,0.76553,0.72215,1,1
2,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,3.248e-05,0.76467,0.75596,1,1
2,GO REGULATION OF T HELPER CELL DIFFERENTIATION,3.7287e-05,0.76426,0.71544,1,1
2,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,1.8524e-05,0.76364,0.76986,1,1
2,GO T CELL CYTOKINE PRODUCTION,1.9888e-05,0.76265,0.70028,1,1
2,GO REGULATION OF T CELL MEDIATED IMMUNITY,1.7249e-05,0.76081,0.69732,1,1
2,GO RESPONSE TO INTERLEUKIN 15,1.6059e-05,0.75858,0.78503,1,1
2,GO AMINO SUGAR CATABOLIC PROCESS,1.6059e-05,0.75836,0.75628,1,1
2,GO REGULATION OF LEUKOCYTE TETHERING OR ROLLING,3.4805e-05,0.75796,0.79923,1,1
2,GO OPSONIZATION,0.00045436,0.75704,0.64349,1,1
2,GO INTERLEUKIN 12 PRODUCTION,7.8298e-05,0.75702,0.70856,1,1
2,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,5.2428e-05,0.75689,0.76227,1,1
2,GO VITAMIN D BIOSYNTHETIC PROCESS,0.00010866,0.75646,0.65538,1,1
2,GO REGULATION OF B CELL PROLIFERATION,3.7287e-05,0.75617,0.71515,1,1
2,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,0.00031664,0.75557,0.65015,1,1
2,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,1.0403e-05,0.75529,0.71717,1,1
2,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,2.636e-05,0.75471,0.80441,1,1
2,GO T CELL MEDIATED IMMUNITY,1.8524e-05,0.75431,0.67381,1,1
2,GO MYELOID DENDRITIC CELL DIFFERENTIATION,5.9985e-05,0.75408,0.68168,1,1
2,GO MONONUCLEAR CELL MIGRATION,6.2007e-06,0.75404,0.77834,1,1
2,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,3.7287e-05,0.75377,0.65896,1,1
2,GO REGULATION OF OSTEOCLAST DEVELOPMENT,8.3641e-05,0.75364,0.70354,1,1
2,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.00010866,0.75347,0.66921,1,1
2,GO ALPHA BETA T CELL PROLIFERATION,0.00010866,0.75338,0.67269,1,1
2,GO NEGATIVE REGULATION OF B CELL ACTIVATION,9.5377e-05,0.74968,0.6358,1,1
2,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,4.8997e-05,0.74944,0.66551,1,1
2,GO LYMPHOCYTE COSTIMULATION,0.00012367,0.74888,0.63003,1,1
2,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,2.1347e-05,0.74778,0.68556,1,1
2,GO REGULATION OF CELL KILLING,2.636e-05,0.74758,0.6975,1,1
2,GO GRANULOCYTE MIGRATION,1.6059e-05,0.74623,0.67435,1,1
2,GO REGULATORY T CELL DIFFERENTIATION,0.00033648,0.7449,0.59968,1,1
2,GO RESPONSE TO INTERFERON GAMMA,1.9888e-05,0.74021,0.69987,1,1
2,GO POSITIVE REGULATION OF CELL KILLING,3.7287e-05,0.73976,0.69275,1,1
2,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,4.2763e-05,0.73953,0.7064,1,1
2,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,2.8267e-05,0.73918,0.65364,1,1
2,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,2.2907e-05,0.73834,0.70131,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,3.0304e-05,0.7376,0.66721,1,1
2,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,3.7287e-05,0.73717,0.84769,1,1
2,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,1.2939e-05,0.73693,0.75417,1,1
2,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,5.337e-06,0.73651,0.71558,1,1
2,GO INTERFERON GAMMA PRODUCTION,3.248e-05,0.7357,0.71789,1,1
2,GO INTERLEUKIN 1 PRODUCTION,9.6689e-06,0.73515,0.71667,1,1
2,GO MATURE B CELL DIFFERENTIATION,2.4576e-05,0.73315,0.7216,1,1
2,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,5.2428e-05,0.73235,0.70215,1,1
2,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,8.3641e-05,0.73203,0.71705,1,1
2,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,1.7249e-05,0.73193,0.68311,1,1
2,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,3.7287e-05,0.73075,0.63989,1,1
2,GO GRANULOCYTE CHEMOTAXIS,1.8524e-05,0.73075,0.6961,1,1
2,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,1.3909e-05,0.73064,0.67259,1,1
2,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,2.2907e-05,0.73027,0.64984,1,1
2,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,3.248e-05,0.72959,0.68593,1,1
2,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,9.5377e-05,0.72753,0.64353,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,2.8267e-05,0.72707,0.66325,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.00011593,0.72702,0.68119,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,3.9936e-05,0.72583,0.64883,1,1
2,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00013188,0.72461,0.69886,1,1
2,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,3.0304e-05,0.72417,0.67494,1,1
2,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,2.2907e-05,0.72409,0.66144,1,1
2,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,3.248e-05,0.72384,0.68501,1,1
2,GO LEUKOCYTE TETHERING OR ROLLING,0.00011593,0.72341,0.63273,1,1
2,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,3.9422e-06,0.72219,0.83473,1,1
2,GO ALPHA BETA T CELL ACTIVATION,4.2763e-05,0.722,0.6646,1,1
2,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,8.3641e-05,0.72172,0.64935,1,1
2,GO LEUKOCYTE MEDIATED CYTOTOXICITY,3.0304e-05,0.71912,0.67409,1,1
2,GO REGULATION OF MONONUCLEAR CELL MIGRATION,9.6689e-06,0.71875,0.73589,1,1
2,GO GERMINAL CENTER FORMATION,9.5377e-05,0.71872,0.76418,1,1
2,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,7.3279e-05,0.71844,0.75009,1,1
2,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,1.1191e-05,0.7175,0.75615,1,1
2,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,1.0403e-05,0.71699,0.75208,1,1
2,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,3.0304e-05,0.71633,0.68165,1,1
2,GO NEUROINFLAMMATORY RESPONSE,4.5779e-05,0.71617,0.68949,1,1
2,GO ETHANOL OXIDATION,1.4947e-05,0.71519,0.88788,1,1
2,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,4.5779e-05,0.71507,0.71252,1,1
2,GO NEGATIVE REGULATION OF BONE REMODELING,9.5377e-05,0.71436,0.67209,1,1
2,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,4.5779e-05,0.71199,0.63512,1,1
2,GO ALPHA BETA T CELL DIFFERENTIATION,4.5779e-05,0.71159,0.6646,1,1
2,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,0.00020554,0.71148,0.62274,1,1
2,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.00024771,0.71118,0.616,1,1
2,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,4.2763e-05,0.70961,0.63487,1,1
2,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,1.7249e-05,0.70949,0.67183,1,1
2,GO INTERLEUKIN 17 PRODUCTION,2.2907e-05,0.7081,0.69287,1,1
2,GO B CELL MEDIATED IMMUNITY,2.4576e-05,0.70792,0.68193,1,1
2,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,3.0304e-05,0.70764,0.66184,1,1
2,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,3.0304e-05,0.70764,0.63855,1,1
2,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,2.8267e-05,0.70648,0.69172,1,1
2,GO INTERLEUKIN 8 PRODUCTION,7.7514e-06,0.70617,0.66196,1,1
2,GO LYMPHOCYTE MEDIATED IMMUNITY,3.0304e-05,0.70563,0.64369,1,1
2,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,2.1347e-05,0.70397,0.65827,1,1
2,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,2.1347e-05,0.7031,0.68256,1,1
2,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,2.8267e-05,0.70186,0.62624,1,1
2,GO REGULATION OF LYMPHOCYTE MIGRATION,4.2763e-05,0.70117,0.63466,1,1
2,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,2.4576e-05,0.70092,0.68583,1,1
2,GO REGULATION OF MYOBLAST FUSION,9.5377e-05,0.69786,0.67848,1,1
2,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,5.2428e-05,0.69762,0.69722,1,1
2,GO REGULATION OF LEUKOCYTE PROLIFERATION,4.2763e-05,0.69066,0.63472,1,1
2,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,9.5377e-05,0.68752,0.70044,1,1
2,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,3.0304e-05,0.68695,0.61404,1,1
2,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,3.248e-05,0.68497,0.64268,1,1
2,GO REGULATION OF B CELL DIFFERENTIATION,6.4139e-05,0.68431,0.64906,1,1
2,GO REGULATION OF ANGIOTENSIN LEVELS IN BLOOD,0.00014989,0.68287,0.70225,1,1
2,GO REGULATION OF NEUTROPHIL MIGRATION,7.3279e-05,0.68248,0.64424,1,1
2,GO RESPONSE TO INTERFERON BETA,7.8298e-05,0.68045,0.59917,1,1
2,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,5.6086e-05,0.68044,0.59768,1,1
2,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,5.6086e-05,0.67956,0.65142,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,3.9936e-05,0.6788,0.6033,1,1
2,GO LEUKOCYTE CELL CELL ADHESION,3.7287e-05,0.67761,0.61084,1,1
2,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,8.3641e-05,0.6765,0.60404,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,3.248e-05,0.67622,0.62949,1,1
2,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,3.4805e-05,0.67518,0.61479,1,1
2,GO GAMMA DELTA T CELL ACTIVATION,0.00018128,0.67389,0.62311,1,1
2,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,7.1973e-06,0.67352,0.69965,1,1
2,GO ADHESION OF SYMBIONT TO HOST,0.0017696,0.6724,0.56066,1,1
2,GO MACROPHAGE MIGRATION,1.0403e-05,0.67221,0.65438,1,1
2,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.00010866,0.67177,0.66531,1,1
2,GO REGULATION OF T CELL MIGRATION,5.2428e-05,0.67168,0.62863,1,1
2,GO CELLULAR EXTRAVASATION,4.5779e-05,0.67092,0.62752,1,1
2,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,7.3279e-05,0.66864,0.73163,1,1
2,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,3.9936e-05,0.66683,0.60472,1,1
2,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00042807,0.66612,0.64876,1,1
2,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,6.8565e-05,0.66463,0.73663,1,1
2,GO REGULATION OF PHAGOCYTOSIS,2.4576e-05,0.66416,0.63299,1,1
2,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,2.636e-05,0.66366,0.63577,1,1
2,GO NEGATIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,1.3909e-05,0.66318,0.66096,1,1
2,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,2.1347e-05,0.66198,0.60946,1,1
2,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,3.9936e-05,0.66066,0.57802,1,1
2,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,4.2763e-05,0.66043,0.59934,1,1
2,GO POSITIVE REGULATION OF CELL CELL ADHESION,3.7287e-05,0.66021,0.60971,1,1
2,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,9.5377e-05,0.65941,0.63805,1,1
2,GO INTERLEUKIN 5 PRODUCTION,0.00024771,0.65937,0.62274,1,1
2,GO CELLULAR RESPONSE TO ETHANOL,0.00012367,0.6588,0.56426,1,1
2,GO NATURAL KILLER CELL MEDIATED IMMUNITY,7.3279e-05,0.6587,0.61988,1,1
2,GO ANTIBACTERIAL HUMORAL RESPONSE,0.00045436,0.65848,0.58212,1,1
2,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,2.8267e-05,0.65759,0.64415,1,1
2,GO REGULATION OF T CELL DIFFERENTIATION,5.9985e-05,0.65699,0.57445,1,1
2,GO MACROPHAGE PROLIFERATION,0.00010181,0.65682,0.7491,1,1
2,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,2.4576e-05,0.65652,0.58519,1,1
2,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,3.0304e-05,0.65573,0.70362,1,1
2,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.00013188,0.65519,0.55971,1,1
2,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,4.8997e-05,0.65423,0.60948,1,1
2,GO APOPTOTIC CELL CLEARANCE,4.5779e-05,0.65404,0.62467,1,1
2,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,2.4576e-05,0.65264,0.59716,1,1
2,GO CYTOKINE METABOLIC PROCESS,1.0403e-05,0.65137,0.64236,1,1
2,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00010866,0.6512,0.6616,1,1
2,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,5.9985e-05,0.64989,0.56002,1,1
2,GO REGULATION OF MACROPHAGE MIGRATION,1.2035e-05,0.64975,0.63884,1,1
2,GO RESPONSE TO LIPOTEICHOIC ACID,1.4947e-05,0.64947,0.70589,1,1
2,GO LEUKOCYTE PROLIFERATION,4.8997e-05,0.64868,0.6048,1,1
2,GO REGULATION OF MACROPHAGE ACTIVATION,1.7249e-05,0.64742,0.66419,1,1
2,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,6.4139e-05,0.64733,0.65464,1,1
2,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.00076864,0.64651,0.54466,1,1
2,GO REGULATION OF B CELL ACTIVATION,6.4139e-05,0.64634,0.61517,1,1
2,GO MYELOID LEUKOCYTE MIGRATION,2.2907e-05,0.64531,0.59818,1,1
2,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,4.2763e-05,0.64514,0.61362,1,1
2,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,1.4947e-05,0.64507,0.62117,1,1
2,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,2.4576e-05,0.64507,0.64636,1,1
2,GO POSITIVE REGULATION OF B CELL PROLIFERATION,4.8997e-05,0.64424,0.59552,1,1
2,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,3.248e-05,0.64337,0.57819,1,1
2,GO CELL KILLING,2.4576e-05,0.64267,0.59131,1,1
2,GO POSITIVE REGULATION OF CELL ACTIVATION,3.7287e-05,0.64237,0.60292,1,1
2,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,2.4576e-05,0.64236,0.59116,1,1
2,GO REGULATION OF IMMUNE EFFECTOR PROCESS,3.0304e-05,0.64214,0.57907,1,1
2,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00019306,0.64131,0.58758,1,1
2,GO LEUKOCYTE APOPTOTIC PROCESS,3.248e-05,0.64066,0.58617,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,2.636e-05,0.64033,0.60829,1,1
2,GO RESPONSE TO INTERFERON ALPHA,0.00014989,0.63892,0.64357,1,1
2,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,3.7287e-05,0.63831,0.59545,1,1
2,GO T CELL DIFFERENTIATION,7.3279e-05,0.63685,0.55968,1,1
2,GO FIBRINOLYSIS,3.248e-05,0.63618,0.65434,1,1
2,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,0.00021879,0.63616,0.59402,1,1
2,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,2.8267e-05,0.63443,0.69973,1,1
2,GO INTEGRIN ACTIVATION,5.6086e-05,0.63386,0.64811,1,1
2,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,3.4805e-05,0.63376,0.59177,1,1
2,GO PHAGOCYTOSIS RECOGNITION,2.4576e-05,0.63362,0.65388,1,1
2,GO ASTROCYTE ACTIVATION,2.4576e-05,0.6335,0.58124,1,1
2,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,3.0304e-05,0.63333,0.66519,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,2.2907e-05,0.63321,0.58376,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,2.2907e-05,0.63239,0.57729,1,1
2,GO NEGATIVE REGULATION OF TISSUE REMODELING,0.00019306,0.63232,0.62451,1,1
2,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.00014989,0.63208,0.52656,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,2.2907e-05,0.63149,0.59317,1,1
2,GO NEUTROPHIL EXTRAVASATION,8.9327e-05,0.63109,0.62741,1,1
2,GO RESPONSE TO TYPE I INTERFERON,0.00015974,0.63089,0.57172,1,1
2,GO REGULATION OF T CELL ACTIVATION,5.9985e-05,0.63023,0.58345,1,1
2,GO HUMORAL IMMUNE RESPONSE,2.8267e-05,0.63002,0.64573,1,1
2,GO LEUKOCYTE CHEMOTAXIS,2.4576e-05,0.62995,0.61602,1,1
2,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.00024771,0.62969,0.54539,1,1
2,GO T CELL PROLIFERATION,3.9936e-05,0.62849,0.6119,1,1
2,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,2.1347e-05,0.62826,0.58326,1,1
2,GO MACROPHAGE ACTIVATION,2.4576e-05,0.62825,0.66339,1,1
2,GO REGULATION OF PLATELET ACTIVATION,0.00020554,0.62786,0.58465,1,1
2,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,1.6059e-05,0.62769,0.58924,1,1
2,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,4.2763e-05,0.62699,0.58142,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,2.1347e-05,0.62692,0.59663,1,1
2,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,4.8997e-05,0.62679,0.57455,1,1
2,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,4.8997e-05,0.62652,0.5948,1,1
2,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,2.636e-05,0.62558,0.6036,1,1
2,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,6.4139e-05,0.6253,0.58564,1,1
2,GO REGULATION OF CELLULAR EXTRAVASATION,1.8524e-05,0.62503,0.67913,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,8.3461e-06,0.62417,0.67401,1,1
2,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,2.1347e-05,0.62331,0.66909,1,1
2,GO REGULATION OF BONE DEVELOPMENT,4.8997e-05,0.6231,0.60402,1,1
2,GO NATURAL KILLER CELL ACTIVATION,6.8565e-05,0.62307,0.55228,1,1
2,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,6.4139e-05,0.62301,0.55609,1,1
2,GO CD40 SIGNALING PATHWAY,3.4805e-05,0.62102,0.562,1,1
2,GO T HELPER 17 TYPE IMMUNE RESPONSE,4.2763e-05,0.62092,0.62074,1,1
2,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,0.00012367,0.61864,0.59619,1,1
2,GO T CELL APOPTOTIC PROCESS,2.8267e-05,0.61848,0.58317,1,1
2,GO PLASMINOGEN ACTIVATION,0.00011593,0.61677,0.57251,1,1
2,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.00031664,0.61619,0.56108,1,1
2,GO MACROPHAGE CHEMOTAXIS,1.2035e-05,0.61536,0.61972,1,1
2,GO NEGATIVE REGULATION OF CELL ACTIVATION,5.2428e-05,0.61532,0.55551,1,1
2,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,1.9888e-05,0.61334,0.58018,1,1
2,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,5.9985e-05,0.61318,0.56982,1,1
2,GO REGULATION OF MEMBRANE INVAGINATION,0.00011593,0.61282,0.66037,1,1
2,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,3.7287e-05,0.61266,0.61071,1,1
2,GO REGULATION OF PLASMINOGEN ACTIVATION,0.00033648,0.61219,0.56887,1,1
2,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,4.8997e-05,0.611,0.54737,1,1
2,GO REGULATION OF LYMPHOCYTE ACTIVATION,5.9985e-05,0.61076,0.55634,1,1
2,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.00015974,0.60961,0.55391,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,5.2428e-05,0.6096,0.54213,1,1
2,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.00011593,0.60959,0.60708,1,1
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,2.8267e-05,0.60948,0.63809,1,1
2,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,5.337e-06,0.60911,0.67395,1,1
2,GO PROTEIN ACTIVATION CASCADE,6.4139e-05,0.6089,0.64773,1,1
2,GO MHC CLASS II BIOSYNTHETIC PROCESS,6.8565e-05,0.60883,0.56265,1,1
2,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,5.6086e-05,0.60871,0.53802,1,1
2,GO ETHANOL METABOLIC PROCESS,3.7287e-05,0.6083,0.67563,1,1
2,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.00011593,0.60829,0.57189,1,1
2,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,2.1347e-05,0.60823,0.63377,1,1
2,GO RESPIRATORY BURST INVOLVED IN DEFENSE RESPONSE,0.00029789,0.60811,0.53622,1,1
2,GO AMYLOID BETA CLEARANCE,5.9985e-05,0.608,0.57513,1,1
2,GO T CELL ACTIVATION,5.2428e-05,0.60757,0.56083,1,1
2,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,5.9985e-05,0.60722,0.62094,1,1
2,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,1.6059e-05,0.60645,0.59759,1,1
2,GO REGULATION OF MACROPHAGE CHEMOTAXIS,2.1347e-05,0.60638,0.57897,1,1
2,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,3.4805e-05,0.60589,0.58218,1,1
2,GO INTERLEUKIN 6 PRODUCTION,3.4805e-05,0.60544,0.55368,1,1
2,GO I KAPPAB PHOSPHORYLATION,3.248e-05,0.60299,0.57211,1,1
2,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.00020554,0.60298,0.56876,1,1
2,GO REGULATION OF CELL ACTIVATION,4.8997e-05,0.60224,0.54448,1,1
2,GO INFLAMMATORY CELL APOPTOTIC PROCESS,2.636e-05,0.60138,0.60424,1,1
2,GO INNATE IMMUNE RESPONSE IN MUCOSA,0.0054671,0.60137,0.48391,1,1
2,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.0003797,0.59959,0.5357,1,1
2,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,3.9936e-05,0.59809,0.62867,1,1
2,GO CYTOKINE SECRETION,2.8267e-05,0.59783,0.54156,1,1
2,GO ACUTE PHASE RESPONSE,1.9888e-05,0.59743,0.56648,1,1
2,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,1.9888e-05,0.597,0.58972,1,1
2,GO NEUTROPHIL HOMEOSTASIS,1.3909e-05,0.59535,0.60654,1,1
2,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,3.7287e-05,0.59507,0.52201,1,1
2,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,1.8524e-05,0.59481,0.57773,1,1
2,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00010866,0.59479,0.55538,1,1
2,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,3.0304e-05,0.59439,0.6054,1,1
2,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,1.9888e-05,0.59437,0.65703,1,1
2,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,3.9936e-05,0.59165,0.63099,1,1
2,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,6.4139e-05,0.59157,0.54716,1,1
2,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,1.9888e-05,0.59156,0.58749,1,1
2,GO LYMPHOCYTE APOPTOTIC PROCESS,3.0304e-05,0.59059,0.53944,1,1
2,GO ACUTE INFLAMMATORY RESPONSE,1.7249e-05,0.58896,0.54794,1,1
2,GO LYMPHOCYTE DIFFERENTIATION,6.8565e-05,0.58857,0.53294,1,1
2,GO IMMUNE RESPONSE TO TUMOR CELL,1.8524e-05,0.58815,0.58737,1,1
2,GO REGULATION OF LEUKOCYTE MIGRATION,1.8524e-05,0.58618,0.59086,1,1
2,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,5.2428e-05,0.58501,0.55198,1,1
2,GO T CELL LINEAGE COMMITMENT,0.00013188,0.58392,0.53572,1,1
2,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,4.5779e-05,0.58386,0.53937,1,1
2,GO CELL ADHESION MEDIATED BY INTEGRIN,0.00019306,0.58336,0.58057,1,1
2,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.00029789,0.58276,0.55044,1,1
2,GO BLEB ASSEMBLY,0.00045436,0.58221,0.56816,1,1
2,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,7.8298e-05,0.58098,0.56617,1,1
2,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,5.6086e-05,0.58077,0.60076,1,1
2,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,2.2907e-05,0.57871,0.59244,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,4.5779e-05,0.57643,0.53995,1,1
2,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,3.248e-05,0.57587,0.58797,1,1
2,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,6.4139e-05,0.57557,0.5097,1,1
2,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,2.4576e-05,0.57441,0.56233,1,1
2,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,1.2939e-05,0.57399,0.63602,1,1
2,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,4.8997e-05,0.57364,0.50677,1,1
2,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.00010866,0.57351,0.5385,1,1
2,GO PROSTANOID BIOSYNTHETIC PROCESS,8.9843e-06,0.57303,0.61535,1,1
2,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.00024771,0.57242,0.53645,1,1
2,GO REGULATION OF MONOCYTE DIFFERENTIATION,3.248e-05,0.57206,0.6513,1,1
2,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,8.9327e-05,0.57144,0.51595,1,1
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,0.00010866,0.571,0.6585,1,1
2,GO MACROPHAGE DIFFERENTIATION,4.2763e-05,0.57069,0.55584,1,1
2,GO POSITIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,2.8267e-05,0.57045,0.61298,1,1
2,GO RESPONSE TO MURAMYL DIPEPTIDE,4.8997e-05,0.57023,0.547,1,1
2,GO RESPONSE TO INTERLEUKIN 2,0.00072571,0.56997,0.54797,1,1
2,GO OSTEOCLAST DEVELOPMENT,8.3641e-05,0.56948,0.60491,1,1
2,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,5.2428e-05,0.56937,0.58923,1,1
2,GO INTERFERON ALPHA PRODUCTION,9.5377e-05,0.56887,0.50604,1,1
2,GO DEFENSE RESPONSE TO BACTERIUM,2.2907e-05,0.56619,0.53571,1,1
2,GO RESPIRATORY BURST,0.00010866,0.56573,0.56145,1,1
2,GO REGULATION OF IMMUNE RESPONSE,3.7287e-05,0.56336,0.50675,1,1
2,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00045436,0.56285,0.5528,1,1
2,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,0.00018128,0.56218,0.50159,1,1
2,GO POSITIVE REGULATION OF CYTOKINE SECRETION,5.6086e-05,0.5604,0.52112,1,1
2,GO LYMPHOCYTE ACTIVATION,6.4139e-05,0.56029,0.51623,1,1
2,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.00012367,0.55914,0.55253,1,1
2,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,1.1191e-05,0.55708,0.63956,1,1
2,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.00024771,0.55706,0.57975,1,1
2,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,2.1347e-05,0.55698,0.54351,1,1
2,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,5.6086e-05,0.55611,0.50812,1,1
2,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,3.7287e-05,0.55541,0.5329,1,1
2,GO REGULATION OF B CELL MEDIATED IMMUNITY,6.4139e-05,0.55486,0.53859,1,1
2,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.00035748,0.55466,0.48041,1,1
2,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.00033648,0.55465,0.47865,1,1
2,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,0.00042807,0.55437,0.53658,1,1
2,GO PHAGOCYTOSIS,3.248e-05,0.55287,0.53318,1,1
2,GO POSITIVE REGULATION OF B CELL ACTIVATION,5.2428e-05,0.55263,0.55701,1,1
2,GO BONE TRABECULA MORPHOGENESIS,0.0063209,0.55227,0.44507,1,1
2,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,0.00014989,0.55176,0.51257,1,1
2,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,3.7287e-05,0.5511,0.52551,1,1
2,GO CELL JUNCTION DISASSEMBLY,0.00010866,0.55089,0.65717,1,1
2,GO LEUKOCYTE HOMEOSTASIS,8.9327e-05,0.55036,0.49484,1,1
2,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,1.9888e-05,0.5499,0.6582,1,1
2,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,8.3641e-05,0.54956,0.50555,1,1
2,GO LYMPH NODE DEVELOPMENT,0.00033648,0.54951,0.53371,1,1
2,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,3.0304e-05,0.54816,0.51436,1,1
2,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,2.8267e-05,0.54793,0.53692,1,1
2,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,1.9888e-05,0.54791,0.53644,1,1
2,GO ZYMOGEN INHIBITION,3.248e-05,0.54752,0.5746,1,1
2,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,4.5779e-05,0.54516,0.50092,1,1
2,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,1.8524e-05,0.54511,0.54365,1,1
2,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.00014989,0.54401,0.53361,1,1
2,GO NAD BIOSYNTHETIC PROCESS,1.4947e-05,0.54313,0.51579,1,1
2,GO REGULATION OF AMYLOID BETA CLEARANCE,6.4139e-05,0.54272,0.54439,1,1
2,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,9.5377e-05,0.5424,0.4713,1,1
2,GO CHEMOKINE PRODUCTION,1.1191e-05,0.54219,0.56471,1,1
2,GO B CELL HOMEOSTASIS,0.00026348,0.542,0.47315,1,1
2,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,9.6689e-06,0.54156,0.57814,1,1
2,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,2.1347e-05,0.5415,0.52839,1,1
2,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,3.248e-05,0.54133,0.52863,1,1
2,GO CYTIDINE TO URIDINE EDITING,7.8298e-05,0.54114,0.57808,1,1
2,GO CELL CHEMOTAXIS,3.7287e-05,0.54109,0.54591,1,1
2,GO MACROPHAGE CYTOKINE PRODUCTION,0.00024771,0.54108,0.58595,1,1
2,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,5.6086e-05,0.5397,0.49699,1,1
2,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,2.2907e-05,0.53873,0.54753,1,1
2,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,1.6059e-05,0.53743,0.61079,1,1
2,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,3.7287e-05,0.53583,0.65821,1,1
2,GO REGULATION OF CELL CELL ADHESION,5.6086e-05,0.53525,0.50452,1,1
2,GO LEUKOCYTE DIFFERENTIATION,4.8997e-05,0.53514,0.50324,1,1
2,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,7.3279e-05,0.53478,0.45948,1,1
2,GO LYMPHOCYTE HOMEOSTASIS,0.00013188,0.53394,0.47185,1,1
2,GO INFLAMMATORY RESPONSE,3.0304e-05,0.53273,0.51498,1,1
2,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,0.00010866,0.53193,0.49252,1,1
2,GO CELLULAR RESPONSE TO INTERFERON BETA,0.00013188,0.5319,0.45725,1,1
2,GO B CELL ACTIVATION,7.3279e-05,0.53161,0.52375,1,1
2,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,2.8267e-05,0.5309,0.60446,1,1
2,GO ACTIVATION OF IMMUNE RESPONSE,3.9936e-05,0.53061,0.48792,1,1
2,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,3.7287e-05,0.5306,0.46415,1,1
2,GO INNATE IMMUNE RESPONSE,2.4576e-05,0.53059,0.50048,1,1
2,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,3.4805e-05,0.5291,0.4897,1,1
2,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,3.7287e-05,0.52857,0.48186,1,1
2,GO NEGATIVE REGULATION OF PROTEIN MATURATION,5.6086e-05,0.52857,0.50973,1,1
2,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,7.8298e-05,0.52843,0.57684,1,1
2,GO LEUKOCYTE MIGRATION,4.5779e-05,0.52827,0.52824,1,1
2,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,8.3641e-05,0.52814,0.52969,1,1
2,GO POSITIVE REGULATION OF IMMUNE RESPONSE,3.7287e-05,0.52669,0.49015,1,1
2,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,1.6059e-05,0.5265,0.54687,1,1
2,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,3.0304e-05,0.52575,0.49656,1,1
2,GO MYELOID LEUKOCYTE DIFFERENTIATION,3.0304e-05,0.52428,0.47679,1,1
2,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.00020554,0.5236,0.5211,1,1
2,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00010181,0.52291,0.49847,1,1
2,GO IMMUNOGLOBULIN PRODUCTION,4.2763e-05,0.52276,0.51178,1,1
2,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,3.248e-05,0.52195,0.53712,1,1
2,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,1.9888e-05,0.52151,0.59126,1,1
2,GO MEMBRANE RAFT ORGANIZATION,0.00013188,0.52139,0.54146,1,1
2,GO ICOSANOID BIOSYNTHETIC PROCESS,1.6059e-05,0.52046,0.55191,1,1
2,GO VITAMIN D METABOLIC PROCESS,0.00010866,0.52021,0.49008,1,1
2,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,6.8565e-05,0.51935,0.50516,1,1
2,GO DEFENSE RESPONSE TO OTHER ORGANISM,2.8267e-05,0.51909,0.47829,1,1
2,GO HEMIDESMOSOME ASSEMBLY,0.025096,0.51853,0.4636,1,1
2,GO REGULATION OF MAST CELL ACTIVATION,0.00020554,0.51803,0.48462,1,1
2,GO RESPONSE TO HYDROPEROXIDE,0.00023283,0.51676,0.50702,1,1
2,GO CYTOKINE MEDIATED SIGNALING PATHWAY,3.248e-05,0.5157,0.46958,1,1
2,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,3.0304e-05,0.51569,0.47744,1,1
2,GO REGULATION OF INTEGRIN ACTIVATION,0.00023283,0.51522,0.49913,1,1
2,GO RESPONSE TO BACTERIUM,3.0304e-05,0.51498,0.51207,1,1
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,9.5377e-05,0.51457,0.60263,1,1
2,GO PEPTIDE CROSS LINKING,0.00017019,0.51417,0.52923,1,1
2,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,5.9985e-05,0.51303,0.47798,1,1
2,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,1.0403e-05,0.51163,0.53197,1,1
2,GO POSITIVE REGULATION OF CELL ADHESION,4.5779e-05,0.5114,0.51216,1,1
2,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,0.0011418,0.51129,0.49503,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,2.4576e-05,0.5088,0.50547,1,1
2,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,5.6086e-05,0.50873,0.51732,1,1
2,GO REGULATION OF RESPONSE TO TUMOR CELL,0.00010181,0.50872,0.49725,1,1
2,GO SUPEROXIDE ANION GENERATION,8.3641e-05,0.50857,0.48325,1,1
2,GO NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.00029789,0.50816,0.48153,1,1
2,GO VITAMIN BIOSYNTHETIC PROCESS,0.00010181,0.50758,0.47548,1,1
2,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.00035748,0.50604,0.4735,1,1
2,GO LEUKOCYTE MEDIATED IMMUNITY,2.636e-05,0.50514,0.47225,1,1
2,GO T HELPER 2 CELL CYTOKINE PRODUCTION,4.2763e-05,0.5049,0.58574,1,1
2,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.00015974,0.50483,0.52554,1,1
2,GO GAMMA DELTA T CELL DIFFERENTIATION,0.00045436,0.50288,0.50441,1,1
2,GO REGULATION OF INFLAMMATORY RESPONSE,3.0304e-05,0.50145,0.49056,1,1
2,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,5.9985e-05,0.50118,0.49589,1,1
2,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,3.4805e-05,0.50056,0.52049,1,1
2,GO CYTOKINE PRODUCTION,3.4805e-05,0.49999,0.47201,1,1
2,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,0.00014989,0.49906,0.49225,1,1
2,GO REGULATION OF FIBRINOLYSIS,3.7287e-05,0.49864,0.60673,1,1
2,GO MYOBLAST FUSION,9.5377e-05,0.49827,0.4944,1,1
2,GO REGULATION OF NIK NF KAPPAB SIGNALING,3.0304e-05,0.49686,0.49937,1,1
2,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,8.3641e-05,0.49643,0.45298,1,1
2,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.0063209,0.49638,0.38045,1,1
2,GO RESPONSE TO TUMOR CELL,9.5377e-05,0.4963,0.48504,1,1
2,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,3.7287e-05,0.49596,0.4867,1,1
2,GO REGULATION OF IMMUNE SYSTEM PROCESS,4.5779e-05,0.49569,0.44616,1,1
2,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.00018128,0.4952,0.45723,1,1
2,GO T CELL DIFFERENTIATION IN THYMUS,0.00014062,0.49444,0.47779,1,1
2,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,0.0017696,0.49403,0.47776,1,1
2,GO IMMUNE EFFECTOR PROCESS,3.248e-05,0.4922,0.46035,1,1
2,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,2.8267e-05,0.49112,0.46195,1,1
2,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.00014989,0.49108,0.56386,1,1
2,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,3.248e-05,0.49008,0.48596,1,1
2,GO MAST CELL ACTIVATION,0.00076864,0.4898,0.43703,1,1
2,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,7.8298e-05,0.48953,0.42857,1,1
2,GO MULTI ORGANISM CELLULAR PROCESS,6.4139e-05,0.48904,0.55183,1,1
2,GO REGULATION OF MACROPHAGE DIFFERENTIATION,3.248e-05,0.48838,0.50366,1,1
2,GO IMMUNOLOGICAL MEMORY PROCESS,0.00054254,0.48837,0.51522,1,1
2,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.0012071,0.48831,0.42745,1,1
2,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00040321,0.48773,0.47555,1,1
2,GO MAST CELL MEDIATED IMMUNITY,0.00081392,0.48616,0.4243,1,1
2,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.00014989,0.48582,0.49622,1,1
2,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.00040321,0.48529,0.46756,1,1
2,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.00010866,0.48488,0.49952,1,1
2,GO TUMOR NECROSIS FACTOR SECRETION,2.636e-05,0.48379,0.48654,1,1
2,GO REGULATION OF STEM CELL DIVISION,0.00081392,0.48368,0.48866,1,1
2,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,3.9936e-05,0.48285,0.57414,1,1
2,GO OSTEOCLAST DIFFERENTIATION,7.8298e-05,0.48228,0.44798,1,1
2,GO MACROPHAGE APOPTOTIC PROCESS,0.00096503,0.48226,0.44079,1,1
2,GO POSITIVE REGULATION OF CHEMOTAXIS,0.00010181,0.48193,0.47228,1,1
2,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.00013188,0.4819,0.47982,1,1
2,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.00014989,0.48174,0.53699,1,1
2,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,2.1347e-05,0.48164,0.53693,1,1
2,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,2.2907e-05,0.48154,0.48605,1,1
2,GO SEROTONIN SECRETION,0.00096503,0.48105,0.43873,1,1
2,GO MYELOID LEUKOCYTE ACTIVATION,3.4805e-05,0.48047,0.4638,1,1
2,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,1.7249e-05,0.48021,0.56977,1,1
2,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,6.4139e-05,0.48006,0.7158,1,1
2,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.00021879,0.47943,0.51382,1,1
2,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.00086166,0.47888,0.43904,1,1
2,GO DEFENSE RESPONSE TO VIRUS,0.00014989,0.4774,0.43259,1,1
2,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,0.00024771,0.47696,0.51866,1,1
2,GO T CELL RECEPTOR SIGNALING PATHWAY,6.4139e-05,0.47679,0.43046,1,1
2,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,0.0013481,0.47659,0.47204,1,1
2,GO FLUID TRANSPORT,0.00048214,0.47543,0.46087,1,1
2,GO POSITIVE REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.00057531,0.47522,0.41342,1,1
2,GO NEGATIVE REGULATION OF VIRAL PROCESS,7.3279e-05,0.47516,0.46404,1,1
2,GO DEFENSE RESPONSE,3.4805e-05,0.47446,0.44326,1,1
2,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.00017019,0.47442,0.47669,1,1
2,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.00081392,0.47409,0.40082,1,1
2,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.00060992,0.47366,0.50421,1,1
2,GO NEGATIVE REGULATION OF CELL CELL ADHESION,3.7287e-05,0.47361,0.47335,1,1
2,GO IRON ION TRANSMEMBRANE TRANSPORT,8.3641e-05,0.47238,0.43887,1,1
2,GO RESPONSE TO PROSTAGLANDIN,0.00035748,0.47232,0.42937,1,1
2,GO OLIGOSACCHARIDE CATABOLIC PROCESS,3.7287e-05,0.47196,0.50241,1,1
2,GO REVERSE CHOLESTEROL TRANSPORT,0.00057531,0.47156,0.47113,1,1
2,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.00013188,0.47097,0.5539,1,1
2,GO RESPONSE TO BIOTIC STIMULUS,3.0304e-05,0.47083,0.4372,1,1
2,GO ELASTIC FIBER ASSEMBLY,0.0011418,0.47059,0.71244,1,1
2,GO MONONUCLEAR CELL DIFFERENTIATION,2.4576e-05,0.47043,0.56401,1,1
2,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,1.7249e-05,0.4703,0.53471,1,1
2,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,6.8565e-05,0.47019,0.58748,1,1
2,GO ASTROCYTE DEVELOPMENT,0.00010181,0.46927,0.46586,1,1
2,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,4.8997e-05,0.46849,0.53012,1,1
2,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,0.00026348,0.46792,0.49154,1,1
2,GO NEGATIVE REGULATION OF MACROPHAGE MIGRATION,0.00031664,0.46747,0.42678,1,1
2,GO REGULATION OF LIPID KINASE ACTIVITY,0.00042807,0.46713,0.40861,1,1
2,GO POSITIVE REGULATION OF HEMOPOIESIS,2.8267e-05,0.46645,0.47636,1,1
2,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,0.00012367,0.4662,0.65655,1,1
2,GO FOAM CELL DIFFERENTIATION,8.9327e-05,0.46611,0.47587,1,1
2,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,3.0304e-05,0.46413,0.53923,1,1
2,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,0.00048214,0.46401,0.47551,1,1
2,GO BONE RESORPTION,0.00017019,0.46383,0.45217,1,1
2,GO RESPONSE TO VIRUS,9.5377e-05,0.46369,0.41607,1,1
2,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.00024771,0.46333,0.4547,1,1
2,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.00015974,0.46224,0.47291,1,1
2,GO ACTIVATED T CELL PROLIFERATION,0.00048214,0.46164,0.40864,1,1
2,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,4.2763e-05,0.46155,0.45582,1,1
2,GO T CELL HOMEOSTASIS,0.00031664,0.46128,0.37867,1,1
2,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,4.8997e-05,0.46098,0.57882,1,1
2,GO B CELL DIFFERENTIATION,8.9327e-05,0.46088,0.5043,1,1
2,GO CELL ACTIVATION,5.2428e-05,0.4602,0.43512,1,1
2,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.00020554,0.46011,0.45794,1,1
2,GO MEMBRANE INVAGINATION,0.00012367,0.45862,0.47625,1,1
2,GO RESPONSE TO PROSTAGLANDIN E,0.0016767,0.45683,0.39525,1,1
2,GO SYNCYTIUM FORMATION,5.6086e-05,0.45674,0.47059,1,1
2,GO MYELOID CELL APOPTOTIC PROCESS,1.2939e-05,0.45658,0.46506,1,1
2,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,7.3279e-05,0.45608,0.41132,1,1
2,GO LEUKOTRIENE METABOLIC PROCESS,4.8997e-05,0.45583,0.50689,1,1
2,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,9.5377e-05,0.45579,0.47011,1,1
2,GO INTEGRIN MEDIATED SIGNALING PATHWAY,0.00021879,0.45535,0.47787,1,1
2,GO ANTIMICROBIAL HUMORAL RESPONSE,0.00023283,0.45503,0.47201,1,1
2,GO PROTEIN CONTAINING COMPLEX REMODELING,9.5377e-05,0.45342,0.44711,1,1
2,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,4.2763e-05,0.4519,0.50232,1,1
2,GO FEVER GENERATION,4.8997e-05,0.45184,0.46227,1,1
2,GO WATER TRANSPORT,0.00086166,0.45183,0.49776,1,1
2,GO MITRAL VALVE DEVELOPMENT,0.0042727,0.45166,0.36565,1,1
2,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.00023283,0.45042,0.50416,1,1
2,GO STORE OPERATED CALCIUM ENTRY,0.00020554,0.44999,0.40098,1,1
2,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.00014989,0.44938,0.53801,1,1
2,GO LIPOPROTEIN LOCALIZATION,0.0003797,0.44937,0.39995,1,1
2,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,5.9985e-05,0.44839,0.48746,1,1
2,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,3.7287e-05,0.44791,0.423,1,1
2,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,1.3909e-05,0.4476,0.44721,1,1
2,GO HETEROTYPIC CELL CELL ADHESION,3.9936e-05,0.44626,0.4721,1,1
2,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.00028019,0.44595,0.40846,1,1
2,GO AMINE CATABOLIC PROCESS,0.00010866,0.44578,0.40322,1,1
2,GO REGULATION OF B CELL APOPTOTIC PROCESS,0.00013188,0.44559,0.42335,1,1
2,GO ZYMOGEN ACTIVATION,5.9985e-05,0.44555,0.46886,1,1
2,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,1.8524e-05,0.44524,0.48846,1,1
2,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,8.9327e-05,0.44521,0.42849,1,1
2,GO RESPONSE TO FUNGUS,0.00054254,0.44512,0.43821,1,1
2,GO GAS TRANSPORT,0.0047188,0.44507,0.40175,1,1
2,GO REGULATION OF INNATE IMMUNE RESPONSE,0.00020554,0.44451,0.37176,1,1
2,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,3.7287e-05,0.44395,0.4765,1,1
2,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.0015041,0.44346,0.39612,1,1
2,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,7.3279e-05,0.44232,0.42028,1,1
2,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,2.1347e-05,0.44166,0.45446,1,1
2,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.00054254,0.44103,0.44536,1,1
2,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.00042807,0.4406,0.44712,1,1
2,GO POSITIVE REGULATION OF STEROL TRANSPORT,0.00026348,0.4404,0.44212,1,1
2,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.00012367,0.43965,0.44685,1,1
2,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,3.4805e-05,0.43948,0.45918,1,1
2,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,0.00011593,0.43751,0.48274,1,1
2,GO GRANULOCYTE DIFFERENTIATION,2.2907e-05,0.43724,0.50416,1,1
2,GO POSITIVE REGULATION OF DEFENSE RESPONSE,3.0304e-05,0.43409,0.40023,1,1
2,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.00014989,0.43392,0.43094,1,1
2,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,3.248e-05,0.43337,0.48752,1,1
2,GO THYMOCYTE APOPTOTIC PROCESS,0.00018128,0.43284,0.42296,1,1
2,GO GLOMERULAR MESANGIUM DEVELOPMENT,0.00031664,0.43275,0.60902,1,1
2,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.00060992,0.43254,0.43959,1,1
2,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,0.00024771,0.43174,0.41076,1,1
2,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.00026348,0.43156,0.42036,1,1
2,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,8.9327e-05,0.43077,0.52889,1,1
2,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.00033648,0.43045,0.52092,1,1
2,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,2.4576e-05,0.43021,0.52029,1,1
2,GO PYROPTOSIS,0.00054254,0.42978,0.4244,1,1
2,GO COLLAGEN CATABOLIC PROCESS,0.00012367,0.42972,0.50646,1,1
2,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,0.00010181,0.42909,0.45752,1,1
2,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,1.6059e-05,0.42901,0.47218,1,1
2,GO ACTIN FILAMENT SEVERING,0.00012367,0.42772,0.48839,1,1
2,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.0018673,0.42767,0.40958,1,1
2,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,3.7287e-05,0.42732,0.41532,1,1
2,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,0.00035748,0.42695,0.42284,1,1
2,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,8.9327e-05,0.42692,0.46679,1,1
2,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,0.00012367,0.42641,0.4579,1,1
2,GO CHOLESTEROL STORAGE,0.00014062,0.42593,0.47662,1,1
2,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.00057531,0.4254,0.41427,1,1
2,GO POSITIVE REGULATION OF COAGULATION,2.8267e-05,0.42487,0.49125,1,1
2,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,2.1347e-05,0.42395,0.41974,1,1
2,GO REGULATION OF DEFENSE RESPONSE,3.9936e-05,0.42366,0.40207,1,1
2,GO BONE CELL DEVELOPMENT,0.00019306,0.4236,0.4434,1,1
2,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,1.1191e-05,0.42302,0.44379,1,1
2,GO ENTRY INTO HOST,5.2428e-05,0.42232,0.43798,1,1
2,GO PROSTANOID METABOLIC PROCESS,1.8524e-05,0.42193,0.45561,1,1
2,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.00023283,0.42137,0.43142,1,1
2,GO RESPONSE TO INTERLEUKIN 1,1.4947e-05,0.42127,0.39844,1,1
2,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.00026348,0.42085,0.40546,1,1
2,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.00018128,0.42084,0.40535,1,1
2,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00013188,0.42061,0.37633,1,1
2,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,0.00060992,0.41928,0.38858,1,1
2,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,3.7287e-05,0.41893,0.40863,1,1
2,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,1.3909e-05,0.41869,0.46964,1,1
2,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.0021907,0.41803,0.37609,1,1
2,GO PSEUDOPODIUM ORGANIZATION,0.00096503,0.41793,0.36681,1,1
2,GO REGULATION OF CHEMOTAXIS,7.3279e-05,0.41756,0.42905,1,1
2,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.00019306,0.41745,0.46832,1,1
2,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.00014989,0.41714,0.44372,1,1
2,GO RESPONSE TO INTERLEUKIN 4,5.6086e-05,0.41708,0.43033,1,1
2,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,4.8997e-05,0.41704,0.39548,1,1
2,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.00021879,0.41633,0.46514,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,0.00018128,0.41585,0.37368,1,1
2,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0012071,0.41579,0.36245,1,1
2,GO SOMATIC STEM CELL DIVISION,0.0049572,0.41521,0.40119,1,1
2,GO ERK1 AND ERK2 CASCADE,3.9936e-05,0.41451,0.42944,1,1
2,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,5.2428e-05,0.4145,0.40318,1,1
2,GO DNA DEAMINATION,0.00068502,0.4142,0.3932,1,1
2,GO NEGATIVE REGULATION BY HOST OF VIRAL PROCESS,0.00035748,0.41369,0.35744,1,1
2,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.00091199,0.41347,0.40178,1,1
2,GO CELL ADHESION MOLECULE PRODUCTION,0.00020554,0.41347,0.49609,1,1
2,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,4.5779e-05,0.41089,0.44497,1,1
2,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,0.00018128,0.41079,0.47231,1,1
2,GO RESPONSE TO INTERLEUKIN 6,0.0003797,0.41071,0.41745,1,1
2,GO NEGATIVE REGULATION OF CHEMOTAXIS,0.00013188,0.41066,0.4412,1,1
2,GO RETINOL METABOLIC PROCESS,2.2907e-05,0.41023,0.40895,1,1
2,GO PROGRAMMED NECROTIC CELL DEATH,6.8565e-05,0.40941,0.40826,1,1
2,GO HYALURONAN CATABOLIC PROCESS,4.8997e-05,0.40868,0.49562,1,1
2,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,3.4805e-05,0.40768,0.37936,1,1
2,GO RESPONSE TO CYTOKINE,4.2763e-05,0.40741,0.39594,1,1
2,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,3.0304e-05,0.40689,0.42028,1,1
2,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.00019306,0.40656,0.41033,1,1
2,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.00064645,0.40645,0.42883,1,1
2,GO MUCUS SECRETION,5.2428e-05,0.40541,0.46475,1,1
2,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.00057531,0.40496,0.36708,1,1
2,GO OXYGEN TRANSPORT,0.058535,0.40474,0.26083,1,1
2,GO RESPONSE TO TUMOR NECROSIS FACTOR,2.636e-05,0.4045,0.39682,1,1
2,GO TRANSCYTOSIS,0.0021907,0.40449,0.40308,1,1
2,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.00096503,0.40385,0.42519,1,1
2,GO PINOCYTOSIS,0.00031664,0.40306,0.40551,1,1
2,GO LIPOXYGENASE PATHWAY,0.0023095,0.40304,0.42043,1,1
2,GO GLYCOLIPID CATABOLIC PROCESS,0.00031664,0.403,0.45278,1,1
2,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,1.7249e-05,0.40294,0.45891,1,1
2,GO NEGATIVE REGULATION OF LIPID STORAGE,0.00014989,0.40281,0.42228,1,1
2,GO KERATAN SULFATE CATABOLIC PROCESS,0.00064645,0.40257,0.56703,1,1
2,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.00013188,0.40165,0.46604,1,1
2,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.00086166,0.40078,0.46263,1,1
2,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.00042807,0.39956,0.43074,1,1
2,GO GAP JUNCTION ASSEMBLY,0.0010209,0.39927,0.49937,1,1
2,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.00021879,0.39882,0.44881,1,1
2,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.00024771,0.39776,0.40649,1,1
2,GO REGULATION OF NATURAL KILLER CELL DIFFERENTIATION,0.00057531,0.39768,0.4487,1,1
2,GO SKIN MORPHOGENESIS,0.006955,0.39753,0.37316,1,1
2,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,4.5779e-05,0.39741,0.453,1,1
2,GO NATURAL KILLER CELL DIFFERENTIATION,0.00068502,0.39521,0.39044,1,1
2,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,0.00023283,0.39477,0.40549,1,1
2,GO DIET INDUCED THERMOGENESIS,0.0018673,0.39475,0.34895,1,1
2,GO EXTRACELLULAR MATRIX DISASSEMBLY,4.5779e-05,0.39417,0.50116,1,1
2,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,7.3279e-05,0.39414,0.3911,1,1
2,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,7.3279e-05,0.39357,0.38018,1,1
2,GO CELLULAR RESPONSE TO LITHIUM ION,0.00014989,0.39323,0.32253,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,0.00012367,0.39281,0.37871,1,1
2,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,8.3641e-05,0.39258,0.41383,1,1
2,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,0.00060992,0.3921,0.40072,1,1
2,GO PROTEIN TRIMERIZATION,0.00011593,0.3914,0.47523,1,1
2,GO REGULATION OF STEROL TRANSPORT,0.00010866,0.38989,0.39555,1,1
2,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.00012367,0.38985,0.54124,1,1
2,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,2.4576e-05,0.3891,0.41073,1,1
2,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,5.9985e-05,0.38845,0.45302,1,1
2,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.00076864,0.38827,0.3759,1,1
2,GO AMYLOID FIBRIL FORMATION,0.00026348,0.38768,0.39591,1,1
2,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,7.7514e-06,0.38766,0.48411,1,1
2,GO LIVER MORPHOGENESIS,8.9327e-05,0.3875,0.39812,1,1
2,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.00042807,0.38709,0.39981,1,1
2,GO ETHANOL CATABOLIC PROCESS,0.00017019,0.3862,0.41468,1,1
2,GO REGULATION OF BONE REMODELING,0.0010798,0.38608,0.36484,1,1
2,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,0.00332,0.38604,0.42696,1,1
2,GO PODOSOME ASSEMBLY,0.00045436,0.38602,0.43875,1,1
2,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.0013481,0.38574,0.39104,1,1
2,GO REGULATION OF LIPASE ACTIVITY,1.4947e-05,0.38556,0.41645,1,1
2,GO REGULATION OF HEMOPOIESIS,6.4139e-05,0.38543,0.38529,1,1
2,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.00017019,0.38528,0.46334,1,1
2,GO CHONDROCYTE PROLIFERATION,0.0038653,0.38509,0.35434,1,1
2,GO NEGATIVE REGULATION OF HEMOPOIESIS,3.7287e-05,0.38484,0.42966,1,1
2,GO REGULATION OF PODOSOME ASSEMBLY,0.00054254,0.38455,0.42192,1,1
2,GO REGULATION OF COAGULATION,0.00021879,0.38438,0.4502,1,1
2,GO COLLAGEN BIOSYNTHETIC PROCESS,0.00035748,0.3838,0.46897,1,1
2,GO PLATELET DEGRANULATION,0.00020554,0.38373,0.45276,1,1
2,GO COLLAGEN METABOLIC PROCESS,0.00026348,0.38316,0.45905,1,1
2,GO NEGATIVE REGULATION OF COAGULATION,0.00029789,0.38286,0.47658,1,1
2,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,0.00010866,0.38218,0.4444,1,1
2,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00026348,0.382,0.32691,1,1
2,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,2.4576e-05,0.3815,0.4431,1,1
2,GO STEROL HOMEOSTASIS,3.248e-05,0.3805,0.3983,1,1
2,GO REGULATION OF PLATELET AGGREGATION,0.0025648,0.38023,0.38472,1,1
2,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.00040321,0.38002,0.3017,1,1
2,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.0034935,0.37938,0.31014,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION,0.0003797,0.3792,0.34681,1,1
2,GO OSTEOBLAST DEVELOPMENT,0.0029965,0.379,0.30779,1,1
2,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,3.9936e-05,0.37863,0.42332,1,1
2,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,0.0010209,0.37853,0.40023,1,1
2,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.00040321,0.37805,0.41589,1,1
2,GO RESPONSE TO INTERLEUKIN 7,0.00019306,0.37791,0.38616,1,1
2,GO PLATELET AGGREGATION,0.0012071,0.37778,0.38801,1,1
2,GO INTERFERON BETA PRODUCTION,0.00033648,0.37732,0.38043,1,1
2,GO CELLULAR RESPONSE TO VIRUS,0.0003797,0.37719,0.3729,1,1
2,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,2.8267e-05,0.37636,0.41638,1,1
2,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.0025648,0.37621,0.35582,1,1
2,GO NIK NF KAPPAB SIGNALING,3.4805e-05,0.37614,0.35308,1,1
2,GO METANEPHRIC GLOMERULUS DEVELOPMENT,0.0024341,0.37604,0.53149,1,1
2,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,1.3909e-05,0.37545,0.44605,1,1
2,GO REGULATION OF TISSUE REMODELING,0.00081392,0.37476,0.36558,1,1
2,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,2.636e-05,0.3747,0.48167,1,1
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,6.8565e-05,0.37463,0.43234,1,1
2,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.0042727,0.37427,0.35736,1,1
2,GO PLATELET ACTIVATION,0.0015882,0.37396,0.35793,1,1
2,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.00026348,0.37369,0.40196,1,1
2,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.008797,0.37361,0.37169,1,1
2,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,0.00060992,0.37319,0.4425,1,1
2,GO POSITIVE REGULATION OF LIPID STORAGE,0.0010209,0.37271,0.38821,1,1
2,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,4.8997e-05,0.37237,0.40201,1,1
2,GO FATTY ACID DERIVATIVE TRANSPORT,8.9327e-05,0.37203,0.35954,1,1
2,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,7.8298e-05,0.37148,0.35641,1,1
2,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.00010181,0.37099,0.38734,1,1
2,GO REGULATION OF RECEPTOR BINDING,0.00054254,0.37078,0.37673,1,1
2,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,3.7287e-05,0.37077,0.38062,1,1
2,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.00033648,0.37067,0.36992,1,1
2,GO VAGINA DEVELOPMENT,0.0019699,0.36992,0.36644,1,1
2,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,0.0029965,0.3699,0.41923,1,1
2,GO MORPHOGENESIS OF AN ENDOTHELIUM,0.00033648,0.36964,0.39603,1,1
2,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.00048214,0.36953,0.43107,1,1
2,GO REGULATION OF CELL ADHESION,0.00014062,0.36924,0.41025,1,1
2,GO RIBONUCLEOSIDE CATABOLIC PROCESS,0.00014062,0.36922,0.35307,1,1
2,GO REGULATION OF COLLAGEN METABOLIC PROCESS,0.00024771,0.36833,0.46724,1,1
2,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,1.4947e-05,0.36804,0.43513,1,1
2,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,3.4805e-05,0.36738,0.36099,1,1
2,GO SERTOLI CELL DEVELOPMENT,0.00060992,0.36718,0.34437,1,1
2,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.00010181,0.36706,0.4874,1,1
2,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.00054254,0.36687,0.39156,1,1
2,GO RENAL ABSORPTION,5.2428e-05,0.3662,0.51471,1,1
2,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.00031664,0.36611,0.43466,1,1
2,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,9.6689e-06,0.36601,0.42174,1,1
2,GO RESPONSE TO FLUID SHEAR STRESS,0.00011593,0.3659,0.46504,1,1
2,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,3.7287e-05,0.36557,0.43218,1,1
2,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.00040321,0.3651,0.3626,1,1
2,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,8.9327e-05,0.36477,0.38567,1,1
2,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,0.0016767,0.36452,0.35764,1,1
2,GO MODULATION BY HOST OF SYMBIONT PROCESS,3.9936e-05,0.3645,0.37139,1,1
2,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.0027019,0.36407,0.33605,1,1
2,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.00018128,0.36288,0.38427,1,1
2,GO REGULATION OF MYOTUBE DIFFERENTIATION,0.00035748,0.36271,0.38478,1,1
2,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.00064645,0.3613,0.38347,1,1
2,GO I KAPPAB KINASE NF KAPPAB SIGNALING,5.6086e-05,0.36074,0.38299,1,1
2,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,8.3641e-05,0.36059,0.40507,1,1
2,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.00051151,0.36017,0.43928,1,1
2,GO MOVEMENT IN HOST ENVIRONMENT,6.4139e-05,0.35982,0.37444,1,1
2,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,2.2907e-05,0.35971,0.43984,1,1
2,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,0.0052065,0.3594,0.40967,1,1
2,GO P38MAPK CASCADE,2.8267e-05,0.3592,0.41471,1,1
2,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.00023283,0.35918,0.43261,1,1
2,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.00019306,0.35886,0.38149,1,1
2,GO AMINOGLYCAN CATABOLIC PROCESS,0.00024771,0.35868,0.40215,1,1
2,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.00021879,0.35814,0.36487,1,1
2,GO RESPONSE TO MINERALOCORTICOID,0.0003797,0.35798,0.32801,1,1
2,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.00024771,0.35782,0.40323,1,1
2,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.00081392,0.35656,0.39377,1,1
2,GO SEQUESTERING OF METAL ION,0.00091199,0.35591,0.35187,1,1
2,GO INTERACTION WITH SYMBIONT,1.9888e-05,0.35537,0.36391,1,1
2,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.0024341,0.35509,0.39363,1,1
2,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.0076456,0.35429,0.36359,1,1
2,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.00023283,0.35396,0.42023,1,1
2,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,0.00035748,0.35368,0.33222,1,1
2,GO REGULATION OF VASCULATURE DEVELOPMENT,0.00012367,0.35338,0.41413,1,1
2,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,0.00035748,0.35338,0.40861,1,1
2,GO RESPONSE TO MANGANESE ION,5.6086e-05,0.35314,0.36867,1,1
2,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.00021879,0.35231,0.3692,1,1
2,GO SUPEROXIDE METABOLIC PROCESS,0.00010866,0.35225,0.3632,1,1
2,GO POSITIVE REGULATION OF LIPASE ACTIVITY,4.5779e-05,0.35187,0.39557,1,1
2,GO COPPER ION TRANSPORT,0.00064645,0.35173,0.32378,1,1
2,GO ARACHIDONIC ACID METABOLIC PROCESS,7.3279e-05,0.3516,0.37977,1,1
2,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0018673,0.35143,0.29114,1,1
2,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.0010798,0.35131,0.39909,1,1
2,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.0042727,0.35098,0.33182,1,1
2,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,0.0027019,0.35014,0.49176,1,1
2,GO CALCIUM MEDIATED SIGNALING,0.00028019,0.35008,0.34381,1,1
2,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.00017019,0.34978,0.36298,1,1
2,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,6.4139e-05,0.34954,0.39305,1,1
2,GO RESPONSE TO ANGIOTENSIN,0.00011593,0.34947,0.35725,1,1
2,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,0.0016767,0.34831,0.38237,1,1
2,GO ETHER BIOSYNTHETIC PROCESS,0.00048214,0.34829,0.35318,1,1
2,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.00015974,0.34822,0.34632,1,1
2,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.00010181,0.34804,0.40706,1,1
2,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,3.9936e-05,0.34769,0.36839,1,1
2,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.0025648,0.34766,0.33798,1,1
2,GO SALIVA SECRETION,0.0040644,0.34744,0.3199,1,1
2,GO TYPE I INTERFERON PRODUCTION,0.00035748,0.34742,0.33843,1,1
2,GO RESPONSE TO THYROID HORMONE,0.0014241,0.3469,0.30554,1,1
2,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.00021879,0.34653,0.36244,1,1
2,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,6.4139e-05,0.34641,0.39855,1,1
2,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.00012367,0.34616,0.43436,1,1
2,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.00026348,0.34557,0.35427,1,1
2,GO BONE REMODELING,0.00042807,0.34539,0.38279,1,1
2,GO 3 UTR MEDIATED MRNA DESTABILIZATION,0.0010798,0.34534,0.33918,1,1
2,GO PHOSPHOLIPID HOMEOSTASIS,6.8565e-05,0.34487,0.3815,1,1
2,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.00048214,0.3447,0.341,1,1
2,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.0010209,0.34457,0.37838,1,1
2,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0096484,0.34455,0.29828,1,1
2,GO MAMMARY GLAND DUCT MORPHOGENESIS,0.0028457,0.34434,0.32957,1,1
2,GO TRANSEPITHELIAL TRANSPORT,0.0023095,0.34434,0.32668,1,1
2,GO SKELETAL MUSCLE TISSUE REGENERATION,0.00012367,0.34423,0.34914,1,1
2,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,7.3279e-05,0.34277,0.38336,1,1
2,GO MYELOID CELL DEVELOPMENT,0.00014989,0.34276,0.38404,1,1
2,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.00021879,0.34255,0.35329,1,1
2,GO LIPOPROTEIN CATABOLIC PROCESS,6.8565e-05,0.34224,0.35108,1,1
2,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.00081392,0.34216,0.39525,1,1
2,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.00014989,0.34178,0.29604,1,1
2,GO RESPONSE TO VITAMIN D,0.0028457,0.34165,0.31425,1,1
2,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.0025648,0.34152,0.4363,1,1
2,GO TONIC SMOOTH MUSCLE CONTRACTION,0.00086166,0.34151,0.3433,1,1
2,GO VASCULAR WOUND HEALING,0.0010209,0.34141,0.42804,1,1
2,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,0.00068502,0.34095,0.34551,1,1
2,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.0014241,0.34017,0.39846,1,1
2,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.011063,0.33962,0.34777,1,1
2,GO RETINAL METABOLIC PROCESS,0.00015974,0.33901,0.45358,1,1
2,GO SMOOTH MUSCLE CELL PROLIFERATION,8.9327e-05,0.33764,0.39082,1,1
2,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.00051151,0.33693,0.38143,1,1
2,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.0057394,0.33587,0.31458,1,1
2,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,3.7287e-05,0.33482,0.39076,1,1
2,GO TISSUE REMODELING,0.0003797,0.33472,0.39661,1,1
2,GO BARBED END ACTIN FILAMENT CAPPING,0.00029789,0.33446,0.32731,1,1
2,GO DECIDUALIZATION,0.00076864,0.33415,0.38602,1,1
2,GO TRIGLYCERIDE METABOLIC PROCESS,2.4576e-05,0.33321,0.31905,1,1
2,GO REGULATION OF LYSOSOMAL LUMEN PH,8.3641e-05,0.33285,0.36073,1,1
2,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.00031664,0.33274,0.43134,1,1
2,GO NEGATIVE REGULATION OF CELL ADHESION,0.00015974,0.33224,0.3847,1,1
2,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.00015974,0.33212,0.41229,1,1
2,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.0023095,0.33201,0.35066,1,1
2,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,7.3279e-05,0.3311,0.35411,1,1
2,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,0.0027019,0.33097,0.33335,1,1
2,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.00033648,0.33083,0.38633,1,1
2,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,0.012106,0.33079,0.30795,1,1
2,GO STEROID ESTERIFICATION,0.00014989,0.33046,0.33691,1,1
2,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,0.00054254,0.32904,0.30583,1,1
2,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.00081392,0.32774,0.40142,1,1
2,GO IMMUNE SYSTEM DEVELOPMENT,0.00018128,0.32681,0.34202,1,1
2,GO MODULATION BY HOST OF VIRAL PROCESS,8.9327e-05,0.32642,0.33927,1,1
2,GO KILLING OF CELLS OF OTHER ORGANISM,0.00023283,0.32589,0.37416,1,1
2,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,8.9327e-05,0.32585,0.34736,1,1
2,GO REGULATION OF VIRAL LIFE CYCLE,0.00026348,0.32567,0.34592,1,1
2,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,0.00068502,0.32525,0.34974,1,1
2,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.00020554,0.32481,0.33204,1,1
2,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.0012758,0.32455,0.32618,1,1
2,GO PULMONARY VALVE DEVELOPMENT,0.0027019,0.32452,0.3879,1,1
2,GO PHOSPHOLIPID CATABOLIC PROCESS,5.2428e-05,0.32376,0.36363,1,1
2,GO POSITIVE REGULATION OF LIPID LOCALIZATION,0.00054254,0.32331,0.3214,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,0.00057531,0.3232,0.30106,1,1
2,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00040321,0.32278,0.31314,1,1
2,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.0063209,0.32244,0.36253,1,1
2,GO PRIMARY ALCOHOL METABOLIC PROCESS,6.4139e-05,0.32227,0.34609,1,1
2,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.00068502,0.32225,0.30215,1,1
2,GO LABYRINTHINE LAYER MORPHOGENESIS,0.007293,0.32214,0.30677,1,1
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.00045436,0.32199,0.33569,1,1
2,GO RETINOIC ACID METABOLIC PROCESS,0.00026348,0.32191,0.35998,1,1
2,GO REGULATION OF KERATINOCYTE MIGRATION,0.0038653,0.32181,0.33426,1,1
2,GO REGULATION OF LIPID STORAGE,0.00045436,0.32139,0.33468,1,1
2,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.0060238,0.32138,0.28644,1,1
2,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,0.0034935,0.32107,0.28569,1,1
2,GO BILE ACID AND BILE SALT TRANSPORT,0.00024771,0.31984,0.32507,1,1
2,GO PROSTAGLANDIN TRANSPORT,0.00051151,0.3198,0.38018,1,1
2,GO CHOLESTEROL EFFLUX,0.00086166,0.31977,0.31795,1,1
2,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,9.5377e-05,0.31973,0.41545,1,1
2,GO NEGATIVE REGULATION OF WOUND HEALING,0.00042807,0.31933,0.39416,1,1
2,GO RESPONSE TO DEXAMETHASONE,0.00019306,0.31923,0.27978,1,1
2,GO REGULATION OF CALCIUM ION IMPORT,0.00033648,0.31882,0.36333,1,1
2,GO RESPONSE TO CORTICOSTERONE,0.0080134,0.31828,0.29046,1,1
2,GO ENTRY OF BACTERIUM INTO HOST CELL,0.015776,0.3181,0.26165,1,1
2,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.013834,0.31775,0.26777,1,1
2,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.00028019,0.3177,0.38497,1,1
2,GO CELLULAR RESPONSE TO DSRNA,0.0013481,0.31751,0.3412,1,1
2,GO MEMBRANE PROTEIN PROTEOLYSIS,8.3641e-05,0.31742,0.39717,1,1
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,0.00019306,0.31718,0.41492,1,1
2,GO NECROTIC CELL DEATH,0.00010181,0.31713,0.33335,1,1
2,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.00076864,0.31712,0.32963,1,1
2,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,0.00029789,0.31707,0.37237,1,1
2,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.00029789,0.31699,0.36615,1,1
2,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.00068502,0.3168,0.37181,1,1
2,GO RECEPTOR BIOSYNTHETIC PROCESS,0.00019306,0.3168,0.3138,1,1
2,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.0044907,0.31661,0.31755,1,1
2,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,0.00014989,0.31633,0.29927,1,1
2,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.0010209,0.31631,0.36959,1,1
2,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.00054254,0.31562,0.35688,1,1
2,GO RESPONSE TO NITRIC OXIDE,0.0024341,0.31519,0.26118,1,1
2,GO EPOXYGENASE P450 PATHWAY,0.0010209,0.31515,0.30715,1,1
2,GO REGULATION OF ISOTYPE SWITCHING,0.00060992,0.31514,0.3622,1,1
2,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.00060992,0.31505,0.37721,1,1
2,GO GLIAL CELL PROLIFERATION,0.00057531,0.31398,0.34606,1,1
2,GO B CELL APOPTOTIC PROCESS,0.00035748,0.31392,0.33664,1,1
2,GO SEQUESTERING OF CALCIUM ION,0.00057531,0.31391,0.33313,1,1
2,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.013235,0.3135,0.25459,1,1
2,GO REGULATION OF METANEPHROS DEVELOPMENT,0.00072571,0.31261,0.41799,1,1
2,GO REGULATION OF WOUND HEALING,0.0003797,0.31244,0.37007,1,1
2,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.00010866,0.31215,0.36017,1,1
2,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.00096503,0.31208,0.37191,1,1
2,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.0012071,0.31113,0.35355,1,1
2,GO RESPONSE TO DSRNA,0.00048214,0.31096,0.30062,1,1
2,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.00028019,0.31092,0.35146,1,1
2,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.0013481,0.30952,0.34087,1,1
2,GO RESPONSE TO AMYLOID BETA,0.0012758,0.30943,0.34479,1,1
2,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,3.4805e-05,0.30933,0.36089,1,1
2,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.0018673,0.30881,0.38997,1,1
2,GO REGULATION OF PROTEIN MATURATION,6.8565e-05,0.30872,0.35365,1,1
2,GO BLOOD VESSEL REMODELING,0.0028457,0.3081,0.39557,1,1
2,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,0.00096503,0.3078,0.29354,1,1
2,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,0.00086166,0.30754,0.37264,1,1
2,GO HYALURONAN METABOLIC PROCESS,0.0012758,0.3075,0.36196,1,1
2,GO SEMI LUNAR VALVE DEVELOPMENT,0.0029965,0.30734,0.38477,1,1
2,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.00013188,0.30718,0.33875,1,1
2,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,7.8298e-05,0.3063,0.32992,1,1
2,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,6.4139e-05,0.30629,0.34347,1,1
2,GO CELLULAR RESPONSE TO AMYLOID BETA,0.0027019,0.30559,0.33705,1,1
2,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,0.0019699,0.30546,0.34373,1,1
2,GO SKELETAL MUSCLE CELL PROLIFERATION,0.0028457,0.30531,0.31674,1,1
2,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,0.0027019,0.30523,0.30543,1,1
2,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.00033648,0.30504,0.33556,1,1
2,GO REGULATION OF VIRAL GENOME REPLICATION,0.0011418,0.30436,0.31717,1,1
2,GO CELL CELL RECOGNITION,9.5377e-05,0.30341,0.2954,1,1
2,GO POSITIVE CHEMOTAXIS,0.00064645,0.30327,0.36632,1,1
2,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.0040644,0.30306,0.25819,1,1
2,GO DETERMINATION OF ADULT LIFESPAN,0.060677,0.30252,0.17882,1,1
2,GO OVULATION,0.00015974,0.30218,0.39424,1,1
2,GO ARACHIDONIC ACID SECRETION,0.00045436,0.302,0.29135,1,1
2,GO CERAMIDE TRANSPORT,0.0023095,0.30195,0.29471,1,1
2,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,5.2428e-05,0.30188,0.33367,1,1
2,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.0003797,0.30154,0.40975,1,1
2,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,0.00017019,0.30145,0.42172,1,1
2,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,0.00091199,0.30116,0.41697,1,1
2,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,0.013834,0.30115,0.27261,1,1
2,GO POSITIVE REGULATION OF VASOCONSTRICTION,0.0020776,0.30041,0.36147,1,1
2,GO TRABECULA MORPHOGENESIS,0.01266,0.30016,0.28333,1,1
2,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,0.0029965,0.29987,0.32616,1,1
2,GO REGULATION OF SYMBIOTIC PROCESS,0.00031664,0.29982,0.30423,1,1
2,GO LYMPH VESSEL DEVELOPMENT,0.0044907,0.29967,0.38999,1,1
2,GO GLYCEROLIPID CATABOLIC PROCESS,0.00072571,0.29965,0.26446,1,1
2,GO POSITIVE REGULATION OF JNK CASCADE,0.00064645,0.29887,0.32513,1,1
2,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.0076456,0.29885,0.28434,1,1
2,GO REGULATION OF BONE MINERALIZATION,0.0016767,0.29827,0.33865,1,1
2,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.00020554,0.29815,0.3846,1,1
2,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,0.0036751,0.29812,0.34367,1,1
2,GO ANGIOTENSIN ACTIVATED SIGNALING PATHWAY,0.00054254,0.29802,0.36199,1,1
2,GO NUCLEOSIDE CATABOLIC PROCESS,9.5377e-05,0.29787,0.31804,1,1
2,GO RESPONSE TO PROGESTERONE,0.0016767,0.29776,0.31174,1,1
2,GO REGULATION OF PINOCYTOSIS,0.008797,0.29755,0.26637,1,1
2,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.0015041,0.2972,0.36669,1,1
2,GO HOMOTYPIC CELL CELL ADHESION,0.0024341,0.29716,0.32162,1,1
2,GO REGULATION OF LIPID CATABOLIC PROCESS,0.00033648,0.29702,0.32378,1,1
2,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.0017696,0.29701,0.24231,1,1
2,GO MATERNAL PLACENTA DEVELOPMENT,0.0010209,0.29673,0.31552,1,1
2,GO ARGININE METABOLIC PROCESS,0.00011593,0.29657,0.32805,1,1
2,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.00060992,0.29618,0.36109,1,1
2,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.01266,0.29612,0.25752,1,1
2,GO CELL REDOX HOMEOSTASIS,0.00020554,0.2961,0.29673,1,1
2,GO PROSTATE GLAND GROWTH,0.0017696,0.29567,0.3016,1,1
2,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,0.00015974,0.29551,0.36797,1,1
2,GO SUBSTRATE DEPENDENT CELL MIGRATION,0.0012071,0.29535,0.3934,1,1
2,GO ICOSANOID METABOLIC PROCESS,9.5377e-05,0.2951,0.35286,1,1
2,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,0.0023095,0.29506,0.37215,1,1
2,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.00031664,0.29484,0.30447,1,1
2,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.00072571,0.29469,0.27864,1,1
2,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.0010798,0.29425,0.31584,1,1
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.0076456,0.29421,0.35001,1,1
2,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.00054254,0.29418,0.2656,1,1
2,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,0.00042807,0.29405,0.26231,1,1
2,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,0.0020776,0.29389,0.29381,1,1
2,GO POSITIVE REGULATION OF ENDOCYTOSIS,0.0015882,0.29363,0.30682,1,1
2,GO NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.0027019,0.29354,0.33521,1,1
2,GO HYPOTONIC RESPONSE,0.0036751,0.29323,0.32765,1,1
2,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.00028019,0.29316,0.34527,1,1
2,GO LYMPHANGIOGENESIS,0.0025648,0.29308,0.4061,1,1
2,GO INTERACTION WITH HOST,0.00013188,0.29302,0.2985,1,1
2,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,0.00091199,0.29267,0.36507,1,1
2,GO POSITIVE REGULATION OF WOUND HEALING,0.00045436,0.29261,0.35874,1,1
2,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.0027019,0.2926,0.2205,1,1
2,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.00068502,0.29253,0.28056,1,1
2,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.00029789,0.29243,0.31916,1,1
2,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.0010798,0.29196,0.32967,1,1
2,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.0015041,0.29186,0.31242,1,1
2,GO REGULATION OF BIOMINERALIZATION,0.0034935,0.29179,0.30098,1,1
2,GO PROTEIN DEGLYCOSYLATION,0.0019699,0.29177,0.3135,1,1
2,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.0013481,0.29145,0.32777,1,1
2,GO HEPATOCYTE APOPTOTIC PROCESS,0.00096503,0.29136,0.30937,1,1
2,GO PEPTIDE CATABOLIC PROCESS,0.0003797,0.2913,0.36344,1,1
2,GO THYROID HORMONE METABOLIC PROCESS,0.0042727,0.29124,0.26869,1,1
2,GO RESPONSE TO INACTIVITY,0.010572,0.29121,0.24556,1,1
2,GO MYELOID CELL DIFFERENTIATION,0.00014062,0.29081,0.33417,1,1
2,GO STEROID CATABOLIC PROCESS,0.0054671,0.29052,0.26218,1,1
2,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.0016767,0.29046,0.28704,1,1
2,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0015041,0.29045,0.2841,1,1
2,GO RESPONSE TO INTERLEUKIN 12,0.00068502,0.28949,0.27185,1,1
2,GO POSITIVE REGULATION OF GLIOGENESIS,0.0010798,0.28932,0.28379,1,1
2,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.00051151,0.28919,0.29501,1,1
2,GO COAGULATION,0.00086166,0.28837,0.32334,1,1
2,GO HOMOCYSTEINE METABOLIC PROCESS,0.007293,0.28826,0.20911,1,1
2,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.0054671,0.28816,0.28421,1,1
2,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.00051151,0.288,0.29387,1,1
2,GO FC RECEPTOR SIGNALING PATHWAY,0.00042807,0.28735,0.28503,1,1
2,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.00060992,0.28721,0.34023,1,1
2,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,0.00033648,0.28682,0.31574,1,1
2,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,0.0040644,0.28673,0.29977,1,1
2,GO CELLULAR RESPONSE TO SALT STRESS,0.00026348,0.2867,0.34834,1,1
2,GO HYALURONAN BIOSYNTHETIC PROCESS,0.026142,0.28608,0.30199,1,1
2,GO KERATINOCYTE MIGRATION,0.0047188,0.28576,0.28854,1,1
2,GO REGULATION OF EPITHELIAL CELL MIGRATION,0.00040321,0.28568,0.34036,1,1
2,GO POSITIVE REGULATION OF MYELINATION,0.0054671,0.28548,0.29481,1,1
2,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,0.0052065,0.28481,0.26053,1,1
2,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.00023283,0.28475,0.34862,1,1
2,GO HEAT GENERATION,0.0010209,0.28408,0.30233,1,1
2,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,0.0060238,0.28364,0.2585,1,1
2,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.0092139,0.28362,0.27846,1,1
2,GO MODULATION OF PROCESS OF OTHER ORGANISM,0.00017019,0.28285,0.2971,1,1
2,GO SERTOLI CELL DIFFERENTIATION,0.0024341,0.28283,0.29935,1,1
2,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,5.9985e-05,0.28266,0.36275,1,1
2,GO URETER DEVELOPMENT,0.033245,0.28225,0.20758,1,1
2,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.00024771,0.28205,0.30091,1,1
2,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.0021907,0.28202,0.28139,1,1
2,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.0010798,0.28191,0.33978,1,1
2,GO PROSTAGLANDIN SECRETION,0.0023095,0.28151,0.34211,1,1
2,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.00081392,0.28116,0.36849,1,1
2,GO RUFFLE ORGANIZATION,0.00031664,0.28096,0.32532,1,1
2,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,0.015104,0.28091,0.31071,1,1
2,GO POSITIVE REGULATION OF MEMBRANE DEPOLARIZATION,0.0036751,0.28072,0.26844,1,1
2,GO REGULATION OF RESPONSE TO WOUNDING,0.00033648,0.28057,0.32876,1,1
2,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,8.9327e-05,0.28031,0.33727,1,1
2,GO RAP PROTEIN SIGNAL TRANSDUCTION,0.012106,0.28001,0.24676,1,1
2,GO TISSUE MIGRATION,0.00072571,0.27993,0.32108,1,1
2,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0040644,0.27981,0.26246,1,1
2,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.00060992,0.27968,0.32624,1,1
2,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,0.007293,0.27946,0.30294,1,1
2,GO RESPONSE TO STEROL,0.0013481,0.27939,0.29642,1,1
2,GO TRIGLYCERIDE CATABOLIC PROCESS,0.0027019,0.27912,0.25019,1,1
2,GO EPITHELIAL CELL APOPTOTIC PROCESS,0.00048214,0.27891,0.34403,1,1
2,GO ENDOTHELIAL CELL MIGRATION,0.00054254,0.27885,0.34672,1,1
2,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.0016767,0.2788,0.29792,1,1
2,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.00076864,0.27832,0.33066,1,1
2,GO METANEPHRIC NEPHRON DEVELOPMENT,0.00332,0.27822,0.3152,1,1
2,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.010572,0.27822,0.24227,1,1
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.0003797,0.27808,0.39107,1,1
2,GO REGULATION OF SPROUTING ANGIOGENESIS,0.00028019,0.27797,0.37756,1,1
2,GO KERATINOCYTE PROLIFERATION,0.0040644,0.2778,0.28537,1,1
2,GO HEPATOCYTE DIFFERENTIATION,0.031957,0.27739,0.2071,1,1
2,GO POSITIVE REGULATION OF HAIR CYCLE,0.018736,0.27738,0.24685,1,1
2,GO PULMONARY VALVE MORPHOGENESIS,0.010572,0.27738,0.34932,1,1
2,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.00054254,0.27732,0.29589,1,1
2,GO TERPENOID METABOLIC PROCESS,0.00011593,0.27719,0.27369,1,1
2,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.00010866,0.27712,0.31903,1,1
2,GO HOMEOSTASIS OF NUMBER OF CELLS,0.00029789,0.27674,0.30919,1,1
2,GO CELL SUBSTRATE ADHESION,0.0038653,0.27672,0.32786,1,1
2,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,6.8565e-05,0.27664,0.32019,1,1
2,GO ENAMEL MINERALIZATION,0.00026348,0.27637,0.4056,1,1
2,GO ASTROCYTE DIFFERENTIATION,0.0018673,0.27634,0.28602,1,1
2,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,0.019548,0.27599,0.24552,1,1
2,GO RESPONSE TO ATP,0.00011593,0.27584,0.32838,1,1
2,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.0021907,0.27582,0.3417,1,1
2,GO REGULATION OF AMYLOID BETA FORMATION,0.00068502,0.27488,0.30409,1,1
2,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.00081392,0.27479,0.2841,1,1
2,GO POSITIVE REGULATION OF URINE VOLUME,0.0076456,0.27474,0.3211,1,1
2,GO MUSCLE CELL PROLIFERATION,0.00026348,0.27419,0.33218,1,1
2,GO GLOMERULUS DEVELOPMENT,0.0063209,0.27405,0.34345,1,1
2,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.0028457,0.27358,0.28097,1,1
2,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.0028457,0.27329,0.39053,1,1
2,GO GLIAL CELL MIGRATION,0.0057394,0.27273,0.2767,1,1
2,GO LAMELLIPODIUM MORPHOGENESIS,0.0021907,0.27273,0.30296,1,1
2,GO INTRACELLULAR STEROL TRANSPORT,0.0014241,0.2726,0.27157,1,1
2,GO REGULATION OF CELL SUBSTRATE ADHESION,0.0021907,0.27259,0.32682,1,1
2,GO CELL MATRIX ADHESION,0.0044907,0.2725,0.31866,1,1
2,GO MUSCLE CELL FATE COMMITMENT,0.00096503,0.27236,0.31329,1,1
2,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,3.4805e-05,0.27207,0.31596,1,1
2,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.019548,0.272,0.3245,1,1
2,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.00040321,0.27191,0.30775,1,1
2,GO IRON ION HOMEOSTASIS,0.00045436,0.27188,0.2749,1,1
2,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.0018673,0.27176,0.3232,1,1
2,GO FUSION OF SPERM TO EGG PLASMA MEMBRANE INVOLVED IN SINGLE FERTILIZATION,0.012106,0.27162,0.25334,1,1
2,GO GLYCOPROTEIN CATABOLIC PROCESS,0.00064645,0.27137,0.31394,1,1
2,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.00076864,0.27085,0.27065,1,1
2,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.00076864,0.27077,0.39679,1,1
2,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.00010866,0.26983,0.37194,1,1
2,GO POSITIVE REGULATION OF TISSUE REMODELING,0.0057394,0.26975,0.26847,1,1
2,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.00072571,0.26945,0.30701,1,1
2,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.031957,0.26914,0.21025,1,1
2,GO POSITIVE REGULATION OF MAPK CASCADE,0.00033648,0.26831,0.31276,1,1
2,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.011574,0.26826,0.25817,1,1
2,GO CELLULAR RESPONSE TO LIPID,0.00023283,0.2677,0.2848,1,1
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.0036751,0.26751,0.28679,1,1
2,GO VIRAL GENOME REPLICATION,0.0014241,0.26695,0.28298,1,1
2,GO AORTIC VALVE DEVELOPMENT,0.0054671,0.26689,0.37204,1,1
2,GO WOUND HEALING,0.0011418,0.26682,0.31405,1,1
2,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,0.0019699,0.26647,0.31382,1,1
2,GO POSITIVE REGULATION OF PEPTIDE SECRETION,0.0042727,0.26629,0.23556,1,1
2,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.00010181,0.26623,0.32688,1,1
2,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00021879,0.26599,0.29834,1,1
2,GO RIG I SIGNALING PATHWAY,0.00081392,0.26592,0.27596,1,1
2,GO PROTEIN KINASE B SIGNALING,0.00024771,0.26587,0.31727,1,1
2,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.0020776,0.26564,0.25186,1,1
2,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.00031664,0.2654,0.26777,1,1
2,GO RESPONSE TO CORTICOSTEROID,0.00051151,0.26532,0.28705,1,1
2,GO SULFATION,0.0083971,0.26492,0.27034,1,1
2,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,0.00076864,0.26492,0.34475,1,1
2,GO PYRIMIDINE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORT,0.006955,0.26487,0.25314,1,1
2,GO POSITIVE REGULATION OF VASCULOGENESIS,0.0044907,0.2645,0.36226,1,1
2,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.0020776,0.26429,0.26623,1,1
2,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.0019699,0.26395,0.30473,1,1
2,GO MEMBRANE LIPID CATABOLIC PROCESS,0.0031545,0.26394,0.30151,1,1
2,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.00013188,0.2637,0.27899,1,1
2,GO RESPONSE TO LIPID,0.00031664,0.26366,0.27459,1,1
2,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.00042807,0.26351,0.30267,1,1
2,GO AMINO SUGAR METABOLIC PROCESS,4.8997e-05,0.26333,0.36175,1,1
2,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.00064645,0.26286,0.2926,1,1
2,GO REGULATION OF CELL SHAPE,0.00048214,0.26202,0.31994,1,1
2,GO PEPTIDYL TYROSINE MODIFICATION,0.00033648,0.26173,0.31778,1,1
2,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,0.00091199,0.26173,0.32914,1,1
2,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.0028457,0.26169,0.26986,1,1
2,GO MYOTUBE DIFFERENTIATION,0.0014241,0.26136,0.27377,1,1
2,GO SEQUESTERING OF TRIGLYCERIDE,0.0047188,0.26126,0.2779,1,1
2,GO WHITE FAT CELL DIFFERENTIATION,0.0015882,0.2612,0.30415,1,1
2,GO INOSITOL LIPID MEDIATED SIGNALING,0.00081392,0.26106,0.30253,1,1
2,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00045436,0.26083,0.28699,1,1
2,GO PROTEIN NITROSYLATION,0.00064645,0.26065,0.31931,1,1
2,GO MAMMARY GLAND MORPHOGENESIS,0.0021907,0.26034,0.34044,1,1
2,GO REGULATION OF AUTOPHAGOSOME MATURATION,0.0052065,0.26005,0.27928,1,1
2,GO POSITIVE REGULATION OF OSSIFICATION,0.011574,0.25995,0.26094,1,1
2,GO PANCREATIC JUICE SECRETION,0.014457,0.25993,0.25762,1,1
2,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.010101,0.25985,0.24846,1,1
2,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.00332,0.25938,0.3645,1,1
2,GO CELLULAR OXIDANT DETOXIFICATION,3.248e-05,0.25935,0.29131,1,1
2,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00015974,0.25903,0.28359,1,1
2,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,0.0012758,0.25883,0.27953,1,1
2,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,0.00011593,0.25843,0.29421,1,1
2,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.0023095,0.25792,0.24145,1,1
2,GO EXOCYTOSIS,0.00072571,0.25751,0.26235,1,1
2,GO CELLULAR COPPER ION HOMEOSTASIS,0.00051151,0.2574,0.27905,1,1
2,GO CELLULAR RESPONSE TO NUTRIENT,0.035953,0.25694,0.21534,1,1
2,GO REGULATION OF TRANSPOSITION,0.025096,0.25693,0.19572,1,1
2,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.052482,0.25661,0.29346,1,1
2,GO REGULATION OF CHOLESTEROL EFFLUX,0.0054671,0.25631,0.30059,1,1
2,GO REGULATION OF LIPID LOCALIZATION,0.00086166,0.25619,0.26158,1,1
2,GO CERAMIDE CATABOLIC PROCESS,0.0023095,0.25617,0.32139,1,1
2,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.0025648,0.25603,0.24003,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.013834,0.25592,0.22714,1,1
2,GO POSITIVE REGULATION OF BONE MINERALIZATION,0.021265,0.25551,0.29315,1,1
2,GO VIRAL LIFE CYCLE,0.00031664,0.25543,0.28042,1,1
2,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.011063,0.25534,0.24548,1,1
2,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,0.016475,0.25519,0.23622,1,1
2,GO PROTEIN DEMANNOSYLATION,0.0083971,0.25485,0.26944,1,1
2,GO CELLULAR IRON ION HOMEOSTASIS,0.0012758,0.25477,0.2318,1,1
2,GO BONE MATURATION,0.0096484,0.25452,0.2696,1,1
2,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.0034935,0.25422,0.2984,1,1
2,GO ARTERY MORPHOGENESIS,0.0021907,0.25402,0.32724,1,1
2,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,0.018736,0.25399,0.31195,1,1
2,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,0.0014241,0.2539,0.26475,1,1
2,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.00033648,0.25326,0.3063,1,1
2,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.0031545,0.25296,0.27001,1,1
2,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.0023095,0.25265,0.30934,1,1
2,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,0.0034935,0.2523,0.27527,1,1
2,GO BEHAVIORAL RESPONSE TO PAIN,0.0044907,0.25223,0.2903,1,1
2,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.0012758,0.25222,0.32372,1,1
2,GO NEGATIVE REGULATION OF HIPPO SIGNALING,0.046961,0.2522,0.23999,1,1
2,GO NEGATIVE REGULATION OF GENE SILENCING,0.00081392,0.25191,0.27472,1,1
2,GO ACYLGLYCEROL HOMEOSTASIS,0.0003797,0.2519,0.30685,1,1
2,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,0.00091199,0.2515,0.23036,1,1
2,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.0010209,0.25109,0.28292,1,1
2,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.0042727,0.25078,0.30081,1,1
2,GO PHAGOLYSOSOME ASSEMBLY,0.026142,0.25041,0.235,1,1
2,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,0.0025648,0.25039,0.22183,1,1
2,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00057531,0.25028,0.32456,1,1
2,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,0.0013481,0.25027,0.32033,1,1
2,GO ARTERY DEVELOPMENT,0.0038653,0.25021,0.3164,1,1
2,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0010209,0.24982,0.29034,1,1
2,GO FATTY ACID BIOSYNTHETIC PROCESS,4.2763e-05,0.24944,0.2729,1,1
2,GO CORNIFICATION,0.060677,0.24928,0.17093,1,1
2,GO BRONCHUS DEVELOPMENT,0.012106,0.24894,0.32423,1,1
2,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.0036751,0.24811,0.25941,1,1
2,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,5.6086e-05,0.24809,0.27756,1,1
2,GO EMBRYO IMPLANTATION,0.00081392,0.24809,0.31883,1,1
2,GO ISOPRENOID METABOLIC PROCESS,0.00012367,0.24773,0.2372,1,1
2,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.0024341,0.24728,0.27412,1,1
2,GO CORTICAL CYTOSKELETON ORGANIZATION,0.0028457,0.24694,0.23343,1,1
2,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.00060992,0.24658,0.30235,1,1
2,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.00021879,0.24655,0.25183,1,1
2,GO TISSUE REGENERATION,0.00072571,0.24637,0.24679,1,1
2,GO REPLACEMENT OSSIFICATION,0.0063209,0.24622,0.29878,1,1
2,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00023283,0.24557,0.28475,1,1
2,GO MANGANESE ION TRANSPORT,0.0057394,0.24556,0.2283,1,1
2,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.026142,0.24549,0.27679,1,1
2,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.00051151,0.24522,0.26557,1,1
2,GO POSITIVE REGULATION OF HEAT GENERATION,0.008797,0.2451,0.2664,1,1
2,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.0034935,0.24477,0.27445,1,1
2,GO RESPONSE TO VITAMIN,0.0044907,0.24452,0.23186,1,1
2,GO POSITIVE REGULATION OF BIOMINERALIZATION,0.018736,0.24438,0.261,1,1
2,GO HEART VALVE DEVELOPMENT,0.0066311,0.24433,0.31772,1,1
2,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00045436,0.24422,0.28756,1,1
2,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.00020554,0.24399,0.25631,1,1
2,GO TRANSITION METAL ION HOMEOSTASIS,0.00024771,0.24381,0.24815,1,1
2,GO RESPONSE TO HYPEROXIA,0.00081392,0.24298,0.30201,1,1
2,GO FIBROBLAST ACTIVATION,0.0054671,0.24284,0.27957,1,1
2,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.0080134,0.24283,0.26913,1,1
2,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.00072571,0.24264,0.25588,1,1
2,GO SECRETION BY TISSUE,0.00091199,0.24205,0.251,1,1
2,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,0.0012071,0.24203,0.24003,1,1
2,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.0020776,0.24191,0.28484,1,1
2,GO RESPONSE TO GROWTH HORMONE,0.00048214,0.24182,0.26862,1,1
2,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.016475,0.24148,0.23259,1,1
2,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.00042807,0.24116,0.24613,1,1
2,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.013834,0.24109,0.2148,1,1
2,GO LUNG MORPHOGENESIS,0.0057394,0.24104,0.28881,1,1
2,GO REGULATION OF KIDNEY DEVELOPMENT,0.0020776,0.24102,0.2567,1,1
2,GO RESPONSE TO RETINOIC ACID,0.0016767,0.24101,0.26534,1,1
2,GO BIOMINERALIZATION,0.0038653,0.24098,0.25479,1,1
2,GO TAXIS,0.0017696,0.24081,0.26859,1,1
2,GO BONE DEVELOPMENT,0.0016767,0.24072,0.2848,1,1
2,GO RESPONSE TO FATTY ACID,0.00060992,0.23988,0.25358,1,1
2,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,0.0066311,0.23937,0.33092,1,1
2,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.013235,0.23917,0.29556,1,1
2,GO REGULATION OF RUFFLE ASSEMBLY,0.0028457,0.23823,0.2478,1,1
2,GO FEMALE GENITALIA DEVELOPMENT,0.0076456,0.23781,0.20977,1,1
2,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,0.007293,0.23778,0.28126,1,1
2,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.0018673,0.23719,0.25357,1,1
2,GO RESPONSE TO WOUNDING,0.0018673,0.23688,0.28097,1,1
2,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.043559,0.23655,0.26193,1,1
2,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.00042807,0.23649,0.27202,1,1
2,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.0044907,0.23634,0.24985,1,1
2,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.0040644,0.23614,0.28814,1,1
2,GO PLASMA MEMBRANE FUSION,0.0042727,0.23613,0.28137,1,1
2,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.00054254,0.23608,0.25555,1,1
2,GO RESPONSE TO ISCHEMIA,0.0012758,0.23601,0.29126,1,1
2,GO ENGULFMENT OF APOPTOTIC CELL,0.013235,0.23582,0.25388,1,1
2,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.00060992,0.23565,0.25155,1,1
2,GO UNSATURATED FATTY ACID METABOLIC PROCESS,0.00019306,0.23564,0.27268,1,1
2,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,0.027226,0.23535,0.30662,1,1
2,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.0044907,0.23513,0.24334,1,1
2,GO HEMATOPOIETIC STEM CELL PROLIFERATION,0.0080134,0.23507,0.26233,1,1
2,GO AMINOGLYCAN METABOLIC PROCESS,0.0029965,0.2349,0.27362,1,1
2,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.026142,0.23459,0.21304,1,1
2,GO CELLULAR RESPONSE TO ANTIBIOTIC,0.0063209,0.23447,0.22055,1,1
2,GO TRANSPOSITION,0.034576,0.23429,0.17236,1,1
2,GO REGULATION OF BODY FLUID LEVELS,0.0028457,0.23404,0.25775,1,1
2,GO REGULATION OF PEPTIDASE ACTIVITY,0.00031664,0.23398,0.26658,1,1
2,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00023283,0.23383,0.25636,1,1
2,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.0021907,0.23378,0.24619,1,1
2,GO RESPONSE TO ESTROGEN,0.0015041,0.23364,0.2643,1,1
2,GO NEUTRAL LIPID METABOLIC PROCESS,0.00023283,0.23362,0.25156,1,1
2,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.014457,0.23343,0.2944,1,1
2,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.006955,0.23292,0.26901,1,1
2,GO CELLULAR RESPONSE TO RETINOIC ACID,0.0019699,0.23281,0.28428,1,1
2,GO CELL CELL ADHESION,0.00096503,0.23278,0.2875,1,1
2,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.0014241,0.23258,0.30319,1,1
2,GO MEGAKARYOCYTE DEVELOPMENT,0.0060238,0.23252,0.26171,1,1
2,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.00064645,0.23251,0.25609,1,1
2,GO ODONTOGENESIS,0.0031545,0.2325,0.25694,1,1
2,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.0018673,0.23236,0.2586,1,1
2,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.050584,0.23231,0.18445,1,1
2,GO DRUG METABOLIC PROCESS,0.0020776,0.2323,0.27827,1,1
2,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.016475,0.23168,0.23567,1,1
2,GO COPPER ION HOMEOSTASIS,0.0010209,0.23166,0.232,1,1
2,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,0.040368,0.23123,0.20467,1,1
2,GO DETOXIFICATION,0.00011593,0.23119,0.24179,1,1
2,GO ENDODERMAL CELL FATE COMMITMENT,0.046961,0.23105,0.18464,1,1
2,GO CELL SUBSTRATE JUNCTION ORGANIZATION,0.022172,0.23105,0.27442,1,1
2,GO STEROL TRANSPORT,0.00054254,0.23077,0.28312,1,1
2,GO LYMPH VESSEL MORPHOGENESIS,0.011574,0.23063,0.34537,1,1
2,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.0027019,0.23063,0.25974,1,1
2,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.0057394,0.23056,0.26782,1,1
2,GO CELLULAR RESPONSE TO OSMOTIC STRESS,0.00072571,0.23053,0.24965,1,1
2,GO AMEBOIDAL TYPE CELL MIGRATION,0.0047188,0.22942,0.26175,1,1
2,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.0038653,0.2292,0.2408,1,1
2,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.01266,0.2292,0.2996,1,1
2,GO AMYLOID BETA FORMATION,0.0013481,0.22913,0.25967,1,1
2,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.0057394,0.22843,0.26093,1,1
2,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.0010209,0.22834,0.28426,1,1
2,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.0036751,0.22816,0.25999,1,1
2,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,0.018736,0.22804,0.19545,1,1
2,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.016475,0.22791,0.24218,1,1
2,GO BROWN FAT CELL DIFFERENTIATION,0.0027019,0.22759,0.23499,1,1
2,GO REGULATION OF ERBB SIGNALING PATHWAY,0.00081392,0.2271,0.2601,1,1
2,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.007293,0.22698,0.2419,1,1
2,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,0.0020776,0.22687,0.23905,1,1
2,GO REGULATION OF RECEPTOR RECYCLING,0.0014241,0.22666,0.24661,1,1
2,GO ENDOCARDIAL CUSHION FORMATION,0.040368,0.22666,0.27338,1,1
2,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.0044907,0.22654,0.24697,1,1
2,GO ACTIN CYTOSKELETON REORGANIZATION,0.00081392,0.22608,0.28529,1,1
2,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.0021907,0.22607,0.20785,1,1
2,GO NEGATIVE REGULATION OF LIPID TRANSPORT,0.0013481,0.22583,0.3094,1,1
2,GO FACE DEVELOPMENT,0.035953,0.22561,0.23418,1,1
2,GO RESPONSE TO ANTIBIOTIC,0.00045436,0.22498,0.241,1,1
2,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,3.4805e-05,0.22478,0.25642,1,1
2,GO MRNA TRANSCRIPTION,0.011063,0.22473,0.26167,1,1
2,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,0.0083971,0.22468,0.28929,1,1
2,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.01266,0.22455,0.29252,1,1
2,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.031957,0.22451,0.22314,1,1
2,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,0.00045436,0.22431,0.25306,1,1
2,GO EPIBOLY,0.0028457,0.22383,0.29942,1,1
2,GO LIPID STORAGE,0.00076864,0.22378,0.27083,1,1
2,GO TERPENOID BIOSYNTHETIC PROCESS,0.00019306,0.22362,0.25813,1,1
2,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.00072571,0.22361,0.26314,1,1
2,GO DIVALENT INORGANIC CATION HOMEOSTASIS,0.0027019,0.22348,0.23706,1,1
2,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.0063209,0.22336,0.32088,1,1
2,GO REGULATION OF OSSIFICATION,0.006955,0.22332,0.25383,1,1
2,GO FATTY ACID TRANSPORT,0.00017019,0.22311,0.27545,1,1
2,GO BONE MINERALIZATION,0.008797,0.22224,0.2653,1,1
2,GO LIPID HOMEOSTASIS,0.00031664,0.22219,0.25917,1,1
2,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00045436,0.22209,0.24362,1,1
2,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.0012758,0.22168,0.25462,1,1
2,GO SENSORY PERCEPTION OF TASTE,0.040368,0.22153,0.28033,1,1
2,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.00014062,0.2215,0.25658,1,1
2,GO BIOLOGICAL ADHESION,0.0015882,0.22108,0.28469,1,1
2,GO RESPONSE TO GAMMA RADIATION,0.0017696,0.22101,0.24034,1,1
2,GO REGULATION OF LIPID TRANSPORT,0.0012071,0.22071,0.24299,1,1
2,GO AMELOGENESIS,0.00096503,0.22042,0.31601,1,1
2,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.0019699,0.22027,0.23875,1,1
2,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.0076456,0.21988,0.23615,1,1
2,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0011418,0.2195,0.21929,1,1
2,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.00064645,0.2195,0.24704,1,1
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.00096503,0.21872,0.29102,1,1
2,GO VITAMIN TRANSMEMBRANE TRANSPORT,0.0063209,0.21845,0.28551,1,1
2,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,0.022172,0.21814,0.22855,1,1
2,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0013481,0.21781,0.25332,1,1
2,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.00048214,0.21762,0.29284,1,1
2,GO RESPONSE TO OSMOTIC STRESS,0.0021907,0.21725,0.21504,1,1
2,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.00081392,0.21716,0.33714,1,1
2,GO SULFUR COMPOUND CATABOLIC PROCESS,0.0024341,0.21681,0.27776,1,1
2,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.0036751,0.21652,0.2601,1,1
2,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.0012758,0.21622,0.26454,1,1
2,GO TRACHEA MORPHOGENESIS,0.033245,0.2161,0.30768,1,1
2,GO C21 STEROID HORMONE METABOLIC PROCESS,0.0049572,0.21599,0.23402,1,1
2,GO REGULATION OF HORMONE METABOLIC PROCESS,0.0012758,0.21595,0.3085,1,1
2,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.020391,0.21581,0.23793,1,1
2,GO RECEPTOR MEDIATED ENDOCYTOSIS,0.0016767,0.2158,0.25501,1,1
2,GO REGULATION OF MAPK CASCADE,0.00086166,0.21569,0.26657,1,1
2,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,0.016475,0.21537,0.29124,1,1
2,GO RESPONSE TO ORGANOPHOSPHORUS,0.0003797,0.21534,0.2784,1,1
2,GO INTESTINAL ABSORPTION,0.0172,0.21531,0.26531,1,1
2,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,0.00096503,0.21526,0.2711,1,1
2,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.0023095,0.21517,0.28311,1,1
2,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.0018673,0.21499,0.29173,1,1
2,GO NEPHRON TUBULE FORMATION,0.0083971,0.21384,0.24798,1,1
2,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.0017696,0.21365,0.2049,1,1
2,GO BILE ACID METABOLIC PROCESS,0.00086166,0.21358,0.21879,1,1
2,GO REGULATION OF LIPID METABOLIC PROCESS,0.00031664,0.21354,0.2406,1,1
2,GO AORTA DEVELOPMENT,0.0047188,0.21344,0.2957,1,1
2,GO HEPARIN METABOLIC PROCESS,0.015776,0.21292,0.26666,1,1
2,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.0012071,0.21292,0.27104,1,1
2,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.050584,0.2123,0.22272,1,1
2,GO ANIMAL ORGAN REGENERATION,0.00029789,0.21203,0.24756,1,1
2,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.0172,0.21199,0.23122,1,1
2,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.0031545,0.21197,0.24184,1,1
2,GO PROTEIN AUTOPROCESSING,0.015104,0.21191,0.19025,1,1
2,GO BICARBONATE TRANSPORT,0.037377,0.21173,0.18123,1,1
2,GO POSITIVE REGULATION OF ERAD PATHWAY,0.0024341,0.21164,0.23053,1,1
2,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.0027019,0.21138,0.22482,1,1
2,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.0054671,0.21131,0.24625,1,1
2,GO ACTIVATION OF MAPK ACTIVITY,0.0025648,0.21109,0.22604,1,1
2,GO REGULATION OF CALCIUM ION TRANSPORT,0.0010798,0.21108,0.25699,1,1
2,GO CELLULAR HYPEROSMOTIC RESPONSE,0.008797,0.21065,0.20894,1,1
2,GO RESPONSE TO NUTRIENT,0.0019699,0.2105,0.22512,1,1
2,GO PRIMARY MIRNA PROCESSING,0.01266,0.21029,0.26462,1,1
2,GO TISSUE HOMEOSTASIS,0.00054254,0.21011,0.25297,1,1
2,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.025096,0.21002,0.20394,1,1
2,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.0172,0.2098,0.1899,1,1
2,GO METAL ION HOMEOSTASIS,0.0031545,0.20977,0.22939,1,1
2,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,0.0016767,0.20971,0.24646,1,1
2,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.0019699,0.2091,0.31626,1,1
2,GO RESPONSE TO SALT STRESS,0.030713,0.20906,0.20227,1,1
2,GO CELLULAR RESPONSE TO ALCOHOL,0.0024341,0.20878,0.24626,1,1
2,GO ERBB SIGNALING PATHWAY,0.0017696,0.20877,0.23921,1,1
2,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.0020776,0.2085,0.24588,1,1
2,GO ETHER METABOLIC PROCESS,0.0014241,0.20833,0.22429,1,1
2,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.0080134,0.20832,0.29422,1,1
2,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.0083971,0.20828,0.20336,1,1
2,GO RESPONSE TO HYDROGEN PEROXIDE,0.00014989,0.20827,0.26128,1,1
2,GO MYELOID CELL HOMEOSTASIS,0.00060992,0.20803,0.24909,1,1
2,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.018736,0.20801,0.22195,1,1
2,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.0066311,0.20789,0.21745,1,1
2,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.0036751,0.20766,0.23843,1,1
2,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.008797,0.20693,0.23526,1,1
2,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,0.007293,0.20684,0.25432,1,1
2,GO INTRACELLULAR LIPID TRANSPORT,0.0054671,0.20675,0.20745,1,1
2,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.011063,0.20668,0.20603,1,1
2,GO PROGESTERONE METABOLIC PROCESS,0.013834,0.20664,0.28608,1,1
2,GO FAT CELL DIFFERENTIATION,0.00332,0.20651,0.23882,1,1
2,GO RESPONSE TO XENOBIOTIC STIMULUS,0.0010798,0.20635,0.20929,1,1
2,GO REGULATION OF RESPONSE TO STRESS,0.00060992,0.20622,0.23695,1,1
2,GO REGULATION OF NECROTIC CELL DEATH,0.0015041,0.20584,0.24966,1,1
2,GO PLATELET MORPHOGENESIS,0.0034935,0.20573,0.28931,1,1
2,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.0016767,0.20541,0.24312,1,1
2,GO POLYSACCHARIDE CATABOLIC PROCESS,0.0016767,0.2053,0.22311,1,1
2,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,0.00057531,0.2051,0.34747,1,1
2,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.0049572,0.20501,0.26142,1,1
2,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.0063209,0.20479,0.28398,1,1
2,GO CELLULAR RESPONSE TO CAMP,0.00081392,0.20464,0.24316,1,1
2,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.041938,0.20462,0.23663,1,1
2,GO INTERMEMBRANE LIPID TRANSFER,0.00096503,0.20456,0.27517,1,1
2,GO CELL MOTILITY,0.0028457,0.20445,0.2398,1,1
2,GO LONG CHAIN FATTY ACID TRANSPORT,0.00081392,0.20438,0.22801,1,1
2,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.011063,0.2043,0.32159,1,1
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.0016767,0.20424,0.22119,1,1
2,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.0021907,0.20414,0.24185,1,1
2,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.0047188,0.20337,0.2078,1,1
2,GO MAINTENANCE OF LOCATION IN CELL,0.0012071,0.20272,0.23877,1,1
2,GO CELLULAR RESPONSE TO ATP,0.0025648,0.20268,0.26105,1,1
2,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.0020776,0.20258,0.27722,1,1
2,GO KERATINOCYTE DIFFERENTIATION,0.012106,0.20232,0.19129,1,1
2,GO CELLULAR ION HOMEOSTASIS,0.0038653,0.20197,0.21215,1,1
2,GO HEMOGLOBIN METABOLIC PROCESS,0.0012758,0.20173,0.25992,1,1
2,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.00024771,0.20171,0.25072,1,1
2,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.008797,0.20168,0.24574,1,1
2,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0025648,0.20161,0.23664,1,1
2,GO ERYTHROCYTE DEVELOPMENT,0.0038653,0.20103,0.2348,1,1
2,GO RESPONSE TO CAMP,0.0016767,0.20059,0.26263,1,1
2,GO FIBROBLAST APOPTOTIC PROCESS,0.006955,0.20022,0.23724,1,1
2,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.0010209,0.19912,0.24119,1,1
2,GO PHOSPHOLIPID METABOLIC PROCESS,0.0044907,0.19902,0.19242,1,1
2,GO CELLULAR RESPONSE TO STEROL,0.038848,0.19897,0.19983,1,1
2,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.0015882,0.19894,0.23299,1,1
2,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.0018673,0.19883,0.23778,1,1
2,GO PHOSPHATE ION TRANSPORT,0.0044907,0.1988,0.28249,1,1
2,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.0038653,0.19871,0.22247,1,1
2,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.0096484,0.19829,0.22705,1,1
2,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.045233,0.19799,0.18601,1,1
2,GO ACTIN FILAMENT BASED TRANSPORT,0.037377,0.19785,0.24066,1,1
2,GO PROTEIN PROCESSING,0.00060992,0.19772,0.26149,1,1
2,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.0060238,0.19755,0.2318,1,1
2,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.0057394,0.19688,0.22109,1,1
2,GO XENOBIOTIC TRANSPORT,0.060677,0.19673,0.18217,1,1
2,GO LIPID CATABOLIC PROCESS,0.00057531,0.19667,0.21502,1,1
2,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,0.0063209,0.19656,0.22864,1,1
2,GO REGULATION OF CELL POPULATION PROLIFERATION,0.00086166,0.19651,0.23304,1,1
2,GO PERICARDIUM DEVELOPMENT,0.0038653,0.19624,0.29346,1,1
2,GO PROTEIN ADP RIBOSYLATION,0.007293,0.19612,0.22203,1,1
2,GO RESPONSE TO KETONE,0.0016767,0.19608,0.2255,1,1
2,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.015776,0.19599,0.22469,1,1
2,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.00091199,0.19597,0.25638,1,1
2,GO ANIMAL ORGAN MATURATION,0.0172,0.19596,0.23317,1,1
2,GO OSTEOBLAST PROLIFERATION,0.028348,0.19497,0.23738,1,1
2,GO PHOSPHOLIPID TRANSPORT,0.013235,0.19493,0.20896,1,1
2,GO RNA DECAPPING,0.0096484,0.19462,0.21173,1,1
2,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.0054671,0.19449,0.21279,1,1
2,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.0012758,0.19378,0.24599,1,1
2,GO MIDDLE EAR MORPHOGENESIS,0.027226,0.19363,0.14794,1,1
2,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.021265,0.19361,0.19107,1,1
2,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00096503,0.19321,0.24951,1,1
2,GO EPITHELIAL CELL PROLIFERATION,0.011063,0.19321,0.21832,1,1
2,GO REGULATION OF PROTEOLYSIS,0.00064645,0.19294,0.21982,1,1
2,GO NUCLEOTIDE SALVAGE,0.0057394,0.19288,0.20091,1,1
2,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.0027019,0.19232,0.23127,1,1
2,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.0011418,0.19209,0.2308,1,1
2,GO POSITIVE REGULATION OF PROTEOLYSIS,0.0003797,0.19187,0.23161,1,1
2,GO REGULATION OF MAP KINASE ACTIVITY,0.0060238,0.19179,0.21348,1,1
2,GO MYOBLAST PROLIFERATION,0.0060238,0.19163,0.2893,1,1
2,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.0024341,0.1916,0.22109,1,1
2,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.031957,0.19141,0.20434,1,1
2,GO RESPONSE TO MECHANICAL STIMULUS,0.016475,0.19129,0.20382,1,1
2,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.0092139,0.19112,0.2287,1,1
2,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,0.0029965,0.19094,0.2038,1,1
2,GO REGULATION OF STEM CELL DIFFERENTIATION,0.0031545,0.1906,0.18304,1,1
2,GO REGULATION OF FAT CELL DIFFERENTIATION,0.0054671,0.19032,0.24166,1,1
2,GO NEGATIVE REGULATION OF HEART CONTRACTION,0.0044907,0.19011,0.25678,1,1
2,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,0.02951,0.18994,0.19157,1,1
2,GO MAINTENANCE OF LOCATION,0.0016767,0.18982,0.22096,1,1
2,GO ERBB2 SIGNALING PATHWAY,0.0040644,0.18982,0.22377,1,1
2,GO CELLULAR RESPONSE TO FATTY ACID,0.0076456,0.18963,0.20069,1,1
2,GO ZINC ION HOMEOSTASIS,0.019548,0.18956,0.21552,1,1
2,GO NEGATIVE REGULATION OF AUTOPHAGY,0.013235,0.18946,0.18978,1,1
2,GO FATTY ACID METABOLIC PROCESS,0.00096503,0.18941,0.19204,1,1
2,GO GLUTATHIONE METABOLIC PROCESS,0.0031545,0.18936,0.17994,1,1
2,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.015104,0.18902,0.25425,1,1
2,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.0010209,0.18892,0.23973,1,1
2,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,0.00064645,0.18889,0.23644,1,1
2,GO RESPONSE TO OXIDATIVE STRESS,0.00028019,0.18841,0.2215,1,1
2,GO ION HOMEOSTASIS,0.0031545,0.18809,0.20936,1,1
2,GO GLYCOSIDE METABOLIC PROCESS,0.0003797,0.18799,0.21216,1,1
2,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,0.0010798,0.18781,0.18158,1,1
2,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.0014241,0.18773,0.2144,1,1
2,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.0010798,0.18741,0.21572,1,1
2,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,0.015104,0.18716,0.21094,1,1
2,GO LIPID LOCALIZATION,0.0028457,0.18709,0.2239,1,1
2,GO POSITIVE REGULATION OF BONE RESORPTION,0.048745,0.18681,0.21198,1,1
2,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.0020776,0.18639,0.22357,1,1
2,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0025648,0.18607,0.22625,1,1
2,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.0096484,0.18584,0.20779,1,1
2,GO ER NUCLEUS SIGNALING PATHWAY,0.017954,0.18541,0.17372,1,1
2,GO REGULATION OF HEAT GENERATION,0.0096484,0.18536,0.25061,1,1
2,GO PROTEIN HOMOTETRAMERIZATION,0.0036751,0.18496,0.21822,1,1
2,GO LAMELLIPODIUM ORGANIZATION,0.0025648,0.18492,0.22817,1,1
2,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.011063,0.18482,0.20856,1,1
2,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.0015882,0.18473,0.26509,1,1
2,GO REGULATION OF ENDOCYTIC RECYCLING,0.015104,0.18456,0.24497,1,1
2,GO NEGATIVE REGULATION OF CELL DEATH,0.00064645,0.18433,0.20811,1,1
2,GO GLYCEROLIPID METABOLIC PROCESS,0.0044907,0.18402,0.18167,1,1
2,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.0040644,0.18367,0.23551,1,1
2,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.030713,0.1836,0.16699,1,1
2,GO JNK CASCADE,0.0036751,0.18319,0.2265,1,1
2,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.018736,0.18305,0.14488,1,1
2,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.0029965,0.18304,0.18583,1,1
2,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.021265,0.18296,0.18923,1,1
2,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.017954,0.18262,0.17684,1,1
2,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.018736,0.18261,0.20523,1,1
2,GO AUTOPHAGOSOME MATURATION,0.0057394,0.18165,0.17464,1,1
2,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.050584,0.18137,0.18234,1,1
2,GO SECRETION,0.0044907,0.18136,0.20594,1,1
2,GO DIGESTION,0.013235,0.18122,0.18015,1,1
2,GO LINOLEIC ACID METABOLIC PROCESS,0.011574,0.18116,0.21221,1,1
2,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.0057394,0.18115,0.20203,1,1
2,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,0.00040321,0.18112,0.20204,1,1
2,GO CELLULAR HORMONE METABOLIC PROCESS,0.00014062,0.18085,0.23544,1,1
2,GO ERYTHROCYTE HOMEOSTASIS,0.0014241,0.18055,0.21658,1,1
2,GO BILE ACID BIOSYNTHETIC PROCESS,0.00076864,0.18046,0.23429,1,1
2,GO PLACENTA DEVELOPMENT,0.0083971,0.18006,0.19899,1,1
2,GO EMBRYONIC PLACENTA DEVELOPMENT,0.013235,0.17987,0.19886,1,1
2,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.0021907,0.17952,0.20955,1,1
2,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0066311,0.17929,0.27593,1,1
2,GO RESPONSE TO INCREASED OXYGEN LEVELS,0.0015882,0.17927,0.21445,1,1
2,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.0025648,0.1792,0.22742,1,1
2,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.00091199,0.17894,0.20947,1,1
2,GO POSITIVE REGULATION OF VIRAL PROCESS,0.0092139,0.17866,0.1662,1,1
2,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,0.00045436,0.17863,0.23766,1,1
2,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.0017696,0.1784,0.27442,1,1
2,GO RESPONSE TO UV B,0.0063209,0.17801,0.21168,1,1
2,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.0063209,0.17746,0.19929,1,1
2,GO ENDOCYTOSIS,0.0052065,0.17716,0.22264,1,1
2,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.0016767,0.17706,0.22756,1,1
2,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.0040644,0.17694,0.26611,1,1
2,GO CELLULAR RESPONSE TO CHOLESTEROL,0.034576,0.17682,0.24013,1,1
2,GO REGULATION OF PROTEIN DEUBIQUITINATION,0.0031545,0.17675,0.23227,1,1
2,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.021265,0.17669,0.21212,1,1
2,GO SECOND MESSENGER MEDIATED SIGNALING,0.023112,0.17646,0.17721,1,1
2,GO CELLULAR RESPONSE TO KETONE,0.0076456,0.17644,0.18478,1,1
2,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,0.0020776,0.17616,0.21891,1,1
2,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.00068502,0.17576,0.21269,1,1
2,GO POSITIVE REGULATION OF DNA RECOMBINATION,0.060677,0.17574,0.16397,1,1
2,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,0.0003797,0.17561,0.22352,1,1
2,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.017954,0.17553,0.21043,1,1
2,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.031957,0.17525,0.10757,1,1
2,GO CELLULAR LIPID METABOLIC PROCESS,0.0012071,0.17524,0.1877,1,1
2,GO DIGESTIVE SYSTEM PROCESS,0.0096484,0.1749,0.18754,1,1
2,GO STEROL METABOLIC PROCESS,0.0016767,0.17451,0.20963,1,1
2,GO LIPID OXIDATION,0.013834,0.17438,0.14819,1,1
2,GO ACTIVATION OF JUN KINASE ACTIVITY,0.010101,0.17435,0.24586,1,1
2,GO REGULATION OF PROTEIN IMPORT,0.0021907,0.17428,0.20652,1,1
2,GO RESPONSE TO ALCOHOL,0.00332,0.17424,0.20627,1,1
2,GO HEME METABOLIC PROCESS,0.00045436,0.17395,0.20355,1,1
2,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.0057394,0.17349,0.19002,1,1
2,GO REGULATION OF STEROID METABOLIC PROCESS,0.0010798,0.17347,0.20514,1,1
2,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,0.031957,0.17202,0.17598,1,1
2,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.0036751,0.17164,0.19676,1,1
2,GO GENITALIA MORPHOGENESIS,0.043559,0.17151,0.23448,1,1
2,GO GLUCOCORTICOID METABOLIC PROCESS,0.017954,0.17139,0.21222,1,1
2,GO GLYCEROL ETHER METABOLIC PROCESS,0.015104,0.17071,0.17909,1,1
2,GO VITAMIN METABOLIC PROCESS,0.00029789,0.17055,0.20616,1,1
2,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.040368,0.17043,0.20496,1,1
2,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,0.030713,0.16985,0.25386,1,1
2,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.0083971,0.1697,0.21419,1,1
2,GO STEROID METABOLIC PROCESS,0.0012758,0.16949,0.18661,1,1
2,GO REGULATION OF JUN KINASE ACTIVITY,0.016475,0.16949,0.21129,1,1
2,GO CELLULAR RESPONSE TO MANGANESE ION,0.006955,0.16915,0.18632,1,1
2,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,0.034576,0.16878,0.22973,1,1
2,GO SKIN DEVELOPMENT,0.035953,0.16855,0.15132,1,1
2,GO POSITIVE REGULATION OF SIGNALING,0.0076456,0.16819,0.18121,1,1
2,GO AMYLOID BETA METABOLIC PROCESS,0.0080134,0.16815,0.2104,1,1
2,GO RESPONSE TO MUSCLE STRETCH,0.052482,0.16813,0.22936,1,1
2,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.013235,0.168,0.18096,1,1
2,GO NEGATIVE REGULATION OF MAPK CASCADE,0.0049572,0.16757,0.21672,1,1
2,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.0066311,0.16706,0.21318,1,1
2,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.0034935,0.16703,0.19826,1,1
2,GO RUFFLE ASSEMBLY,0.0054671,0.16699,0.21498,1,1
2,GO CELL RECOGNITION,0.008797,0.16668,0.19679,1,1
2,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.013834,0.16654,0.19114,1,1
2,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.0025648,0.16601,0.22942,1,1
2,GO LIVER REGENERATION,0.00096503,0.16595,0.23025,1,1
2,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,0.0066311,0.16523,0.20186,1,1
2,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.026142,0.16463,0.17692,1,1
2,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.021265,0.16446,0.18228,1,1
2,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,0.016475,0.16432,0.18718,1,1
2,GO MONOCARBOXYLIC ACID TRANSPORT,0.00096503,0.1642,0.23737,1,1
2,GO REGENERATION,0.0029965,0.1639,0.20035,1,1
2,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.0038653,0.16363,0.19517,1,1
2,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,0.034576,0.16348,0.20927,1,1
2,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.028348,0.16338,0.14458,1,1
2,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.016475,0.16333,0.16257,1,1
2,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.026142,0.1631,0.15925,1,1
2,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.0017696,0.1631,0.21741,1,1
2,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,0.011063,0.16307,0.17935,1,1
2,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.041938,0.16299,0.20889,1,1
2,GO ACTIVATION OF MAPKK ACTIVITY,0.060677,0.16299,0.1737,1,1
2,GO LIPID EXPORT FROM CELL,0.015104,0.16298,0.20696,1,1
2,GO CELLULAR LIPID CATABOLIC PROCESS,0.0042727,0.16258,0.18342,1,1
2,GO RESPONSE TO IONIZING RADIATION,0.031957,0.16246,0.1594,1,1
2,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.043559,0.1623,0.19603,1,1
2,GO SYMBIOTIC PROCESS,0.0015882,0.16208,0.17607,1,1
2,GO EMBRYONIC HEMOPOIESIS,0.013235,0.16206,0.24727,1,1
2,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.021265,0.16177,0.21864,1,1
2,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,0.025096,0.16154,0.22142,1,1
2,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.008797,0.16115,0.24584,1,1
2,GO ALCOHOL METABOLIC PROCESS,0.0010798,0.16111,0.20169,1,1
2,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,0.01266,0.16099,0.23758,1,1
2,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.0016767,0.1609,0.21662,1,1
2,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.011574,0.16026,0.19314,1,1
2,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.0016767,0.16015,0.19598,1,1
2,GO POSITIVE REGULATION OF CELL DEATH,0.0014241,0.15997,0.21235,1,1
2,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.0047188,0.15987,0.18884,1,1
2,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.0012071,0.15952,0.19792,1,1
2,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,0.0063209,0.15936,0.18928,1,1
2,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.0040644,0.15903,0.21218,1,1
2,GO REGULATION OF CELL DEATH,0.0012071,0.15894,0.19895,1,1
2,GO GDP METABOLIC PROCESS,0.021265,0.15878,0.21218,1,1
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.01266,0.15822,0.17297,1,1
2,GO POSITIVE REGULATION OF AUTOPHAGY,0.018736,0.15795,0.18417,1,1
2,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,0.0023095,0.15788,0.23289,1,1
2,GO VACUOLAR ACIDIFICATION,0.0031545,0.15787,0.20136,1,1
2,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,0.008797,0.15768,0.18313,1,1
2,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,0.00068502,0.15766,0.22667,1,1
2,GO RNA DESTABILIZATION,0.058535,0.15739,0.19834,1,1
2,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.010101,0.15736,0.17654,1,1
2,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.058535,0.15695,0.1368,1,1
2,GO PROTEIN MATURATION,0.0015041,0.1566,0.20201,1,1
2,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.0049572,0.15651,0.22523,1,1
2,GO LIPID IMPORT INTO CELL,0.045233,0.15632,0.17001,1,1
2,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.046961,0.1563,0.16238,1,1
2,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0049572,0.15598,0.19441,1,1
2,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.0038653,0.15576,0.19572,1,1
2,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.043559,0.15548,0.16026,1,1
2,GO LAMELLIPODIUM ASSEMBLY,0.013834,0.15515,0.19399,1,1
2,GO BLASTODERM SEGMENTATION,0.0028457,0.15502,0.23719,1,1
2,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.010101,0.15474,0.1696,1,1
2,GO LYTIC VACUOLE ORGANIZATION,0.033245,0.15459,0.1645,1,1
2,GO PROTEIN AUTOPHOSPHORYLATION,0.01266,0.15434,0.20851,1,1
2,GO REGULATION OF CELLULAR PH,0.041938,0.1543,0.13649,1,1
2,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.00018128,0.15395,0.20271,1,1
2,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.010572,0.15373,0.17563,1,1
2,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.0076456,0.15367,0.15757,1,1
2,GO ESTROGEN METABOLIC PROCESS,0.0060238,0.15367,0.16515,1,1
2,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.0047188,0.15322,0.17004,1,1
2,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.0028457,0.15288,0.2018,1,1
2,GO REGULATION OF DNA CATABOLIC PROCESS,0.012106,0.15272,0.15655,1,1
2,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.02951,0.15221,0.22781,1,1
2,GO ACTIN FILAMENT ORGANIZATION,0.0083971,0.15171,0.19989,1,1
2,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.0021907,0.15168,0.16611,1,1
2,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0014241,0.15131,0.22407,1,1
2,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,0.011574,0.1509,0.16571,1,1
2,GO LIPID METABOLIC PROCESS,0.0024341,0.15051,0.17737,1,1
2,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.006955,0.15034,0.19027,1,1
2,GO CELLULAR RESPONSE TO CHEMICAL STRESS,0.00064645,0.15021,0.20972,1,1
2,GO EPIDERMIS DEVELOPMENT,0.045233,0.14989,0.14595,1,1
2,GO DNA DEMETHYLATION,0.060677,0.14983,0.15102,1,1
2,GO CARDIOLIPIN METABOLIC PROCESS,0.013834,0.14959,0.14929,1,1
2,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.0042727,0.14933,0.19037,1,1
2,GO VITAMIN TRANSPORT,0.0092139,0.14924,0.19893,1,1
2,GO BODY FLUID SECRETION,0.030713,0.14922,0.14711,1,1
2,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.010572,0.14919,0.19488,1,1
2,GO REGULATION OF ACTIN NUCLEATION,0.041938,0.14908,0.1515,1,1
2,GO APOPTOTIC SIGNALING PATHWAY,0.0018673,0.14848,0.18686,1,1
2,GO ANION HOMEOSTASIS,0.0049572,0.14835,0.21925,1,1
2,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,0.022172,0.14832,0.18155,1,1
2,GO IRON ION TRANSPORT,0.0076456,0.14832,0.17846,1,1
2,GO FOLIC ACID METABOLIC PROCESS,0.0092139,0.1483,0.16137,1,1
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.027226,0.14788,0.18316,1,1
2,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.037377,0.14773,0.14525,1,1
2,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.027226,0.14747,0.19142,1,1
2,GO POSITIVE REGULATION OF PROTEIN IMPORT,0.011063,0.14704,0.22153,1,1
2,GO REGULATION OF ACTIN FILAMENT LENGTH,0.0049572,0.14627,0.20597,1,1
2,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.010101,0.14611,0.29829,1,1
2,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.0049572,0.14583,0.16445,1,1
2,GO NEGATIVE REGULATION OF SECRETION,0.0057394,0.14559,0.19636,1,1
2,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0096484,0.14536,0.14494,1,1
2,GO DIVALENT INORGANIC CATION TRANSPORT,0.0049572,0.1452,0.19107,1,1
2,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.023112,0.14503,0.17643,1,1
2,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.0013481,0.14496,0.17461,1,1
2,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,0.007293,0.14358,0.16298,1,1
2,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.010101,0.1435,0.17784,1,1
2,GO REGULATION OF PEPTIDE SECRETION,0.038848,0.14324,0.15808,1,1
2,GO VESICLE BUDDING FROM MEMBRANE,0.025096,0.14299,0.13627,1,1
2,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.034576,0.14292,0.1737,1,1
2,GO ACTIN FILAMENT DEPOLYMERIZATION,0.027226,0.14289,0.20394,1,1
2,GO CHEMICAL HOMEOSTASIS,0.010572,0.14273,0.17977,1,1
2,GO RESPONSE TO HORMONE,0.011574,0.14272,0.17318,1,1
2,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.012106,0.14263,0.1864,1,1
2,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.0023095,0.14255,0.19243,1,1
2,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.0080134,0.14233,0.18604,1,1
2,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.0027019,0.14205,0.155,1,1
2,GO REGULATION OF GTPASE ACTIVITY,0.019548,0.14182,0.19328,1,1
2,GO REGULATION OF VIRAL TRANSCRIPTION,0.0060238,0.14173,0.18287,1,1
2,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.0014241,0.14164,0.23145,1,1
2,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.0012758,0.14161,0.15522,1,1
2,GO POSITIVE REGULATION OF NEURON DEATH,0.0092139,0.14155,0.19801,1,1
2,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,0.0012758,0.14146,0.16547,1,1
2,GO REGULATION OF RIBOSOME BIOGENESIS,0.040368,0.14135,0.14975,1,1
2,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.025096,0.14085,0.15806,1,1
2,GO SLEEP,0.013235,0.14078,0.16598,1,1
2,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.0019699,0.14019,0.1924,1,1
2,GO NADP METABOLIC PROCESS,0.019548,0.13978,0.15327,1,1
2,GO MUSCLE ADAPTATION,0.021265,0.13932,0.18609,1,1
2,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,0.024086,0.13919,0.19457,1,1
2,GO POSITIVE REGULATION OF TRANSPORT,0.015776,0.13915,0.16352,1,1
2,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.013834,0.13889,0.17017,1,1
2,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.016475,0.13883,0.19253,1,1
2,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.007293,0.13877,0.16864,1,1
2,GO REGULATION OF PHOSPHORYLATION,0.010101,0.13853,0.16999,1,1
2,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.007293,0.13846,0.18417,1,1
2,GO RESPONSE TO OXYGEN RADICAL,0.019548,0.13803,0.15023,1,1
2,GO APOPTOTIC PROCESS,0.0029965,0.13709,0.17587,1,1
2,GO CELLULAR KETONE METABOLIC PROCESS,0.0023095,0.13703,0.14863,1,1
2,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.023112,0.13679,0.16692,1,1
2,GO NEUTRAL LIPID CATABOLIC PROCESS,0.040368,0.13667,0.16503,1,1
2,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.015776,0.13648,0.16491,1,1
2,GO ADAPTIVE THERMOGENESIS,0.050584,0.13641,0.14585,1,1
2,GO REGULATION OF METAL ION TRANSPORT,0.007293,0.136,0.18578,1,1
2,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.030713,0.13584,0.20174,1,1
2,GO NEGATIVE REGULATION OF TRANSPORT,0.0092139,0.13572,0.17151,1,1
2,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.033245,0.13532,0.193,1,1
2,GO TRANSITION METAL ION TRANSPORT,0.0076456,0.1353,0.16074,1,1
2,GO REGULATION OF HYDROLASE ACTIVITY,0.0036751,0.13528,0.1921,1,1
2,GO CELLULAR HOMEOSTASIS,0.0066311,0.1351,0.16891,1,1
2,GO VESICLE CARGO LOADING,0.038848,0.13506,0.14853,1,1
2,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.014457,0.134,0.20231,1,1
2,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,0.0096484,0.13399,0.17121,1,1
2,GO TEMPERATURE HOMEOSTASIS,0.024086,0.1338,0.16178,1,1
2,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.0076456,0.13296,0.23313,1,1
2,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.0034935,0.13286,0.17054,1,1
2,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,0.037377,0.13278,0.1346,1,1
2,GO RESPONSE TO TOXIC SUBSTANCE,0.0036751,0.1327,0.16046,1,1
2,GO SULFUR COMPOUND METABOLIC PROCESS,0.0047188,0.13239,0.15648,1,1
2,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.037377,0.13203,0.14797,1,1
2,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.050584,0.13202,0.14119,1,1
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0028457,0.13177,0.19269,1,1
2,GO BLASTOCYST FORMATION,0.0049572,0.13167,0.15671,1,1
2,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.0044907,0.13154,0.17804,1,1
2,GO ACTIN FILAMENT BASED PROCESS,0.033245,0.13122,0.17589,1,1
2,GO MUSCLE CELL CELLULAR HOMEOSTASIS,0.0029965,0.13052,0.20732,1,1
2,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.0036751,0.1304,0.15694,1,1
2,GO GTP METABOLIC PROCESS,0.0049572,0.13002,0.16085,1,1
2,GO HOMEOSTATIC PROCESS,0.0076456,0.12997,0.16994,1,1
2,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,0.027226,0.12902,0.16251,1,1
2,GO LIPID BIOSYNTHETIC PROCESS,0.007293,0.12892,0.15402,1,1
2,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.0066311,0.12888,0.21114,1,1
2,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,0.048745,0.12871,0.15236,1,1
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.013834,0.12851,0.15296,1,1
2,GO TRIPARTITE REGIONAL SUBDIVISION,0.020391,0.1285,0.16382,1,1
2,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.024086,0.1284,0.15907,1,1
2,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.010572,0.1269,0.16845,1,1
2,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.040368,0.12683,0.1292,1,1
2,GO REGULATION OF ENDOCYTOSIS,0.041938,0.12681,0.15975,1,1
2,GO URONIC ACID METABOLIC PROCESS,0.0049572,0.1267,0.13856,1,1
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0031545,0.12649,0.15778,1,1
2,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.045233,0.1263,0.12161,1,1
2,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.02951,0.12613,0.18184,1,1
2,GO INTERMEDIATE FILAMENT ORGANIZATION,0.054439,0.12589,0.15581,1,1
2,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.0038653,0.12581,0.19369,1,1
2,GO GALACTOSE METABOLIC PROCESS,0.058535,0.12525,0.17716,1,1
2,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.045233,0.12517,0.14448,1,1
2,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.018736,0.12494,0.14215,1,1
2,GO STRIATED MUSCLE CELL DIFFERENTIATION,0.046961,0.12476,0.15389,1,1
2,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.048745,0.12459,0.11576,1,1
2,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.020391,0.12443,0.17422,1,1
2,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.020391,0.12355,0.15415,1,1
2,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.040368,0.12317,0.14028,1,1
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0047188,0.12312,0.17789,1,1
2,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.015104,0.12289,0.1716,1,1
2,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.019548,0.12261,0.14918,1,1
2,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.023112,0.12215,0.15931,1,1
2,GO RESPONSE TO PEPTIDE,0.016475,0.12209,0.1642,1,1
2,GO EXTRACELLULAR VESICLE BIOGENESIS,0.019548,0.12203,0.14226,1,1
2,GO RIBONUCLEOSIDE METABOLIC PROCESS,0.00054254,0.12189,0.18677,1,1
2,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.00332,0.12187,0.13905,1,1
2,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,0.0023095,0.12036,0.17556,1,1
2,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.013834,0.12006,0.15902,1,1
2,GO NEGATIVE REGULATION OF SIGNALING,0.030713,0.12,0.15028,1,1
2,GO PROTEIN TETRAMERIZATION,0.014457,0.11985,0.16726,1,1
2,GO REGULATION OF MUSCLE ADAPTATION,0.046961,0.11848,0.16358,1,1
2,GO TETRAPYRROLE METABOLIC PROCESS,0.0066311,0.11793,0.16155,1,1
2,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.008797,0.11773,0.16526,1,1
2,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.016475,0.11772,0.15845,1,1
2,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.024086,0.11699,0.15576,1,1
2,GO PEPTIDYL ASPARAGINE MODIFICATION,0.040368,0.11691,0.14727,1,1
2,GO RESPIRATORY SYSTEM DEVELOPMENT,0.040368,0.11679,0.19309,1,1
2,GO REGULATION OF PH,0.056456,0.11634,0.12065,1,1
2,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.037377,0.11633,0.14174,1,1
2,GO ACTIN NUCLEATION,0.008797,0.11631,0.1665,1,1
2,GO CELLULAR RESPONSE TO PEPTIDE,0.041938,0.11622,0.15417,1,1
2,GO PROTEIN LOCALIZATION TO CELL SURFACE,0.040368,0.1158,0.1903,1,1
2,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,0.0096484,0.1156,0.16357,1,1
2,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.025096,0.11498,0.15848,1,1
2,GO POSITIVE REGULATION OF CATABOLIC PROCESS,0.012106,0.11441,0.17008,1,1
2,GO RESPONSE TO ISOQUINOLINE ALKALOID,0.016475,0.11427,0.1532,1,1
2,GO ACTIN FILAMENT BASED MOVEMENT,0.043559,0.11382,0.16907,1,1
2,GO AMP METABOLIC PROCESS,0.031957,0.11323,0.14036,1,1
2,GO COPII COATED VESICLE BUDDING,0.045233,0.11321,0.13396,1,1
2,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.0063209,0.11263,0.16026,1,1
2,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,0.054439,0.11249,0.1393,1,1
2,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.010572,0.11145,0.18523,1,1
2,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0076456,0.11137,0.14967,1,1
2,GO STEROID BIOSYNTHETIC PROCESS,0.0052065,0.11121,0.1398,1,1
2,GO RESPONSE TO INORGANIC SUBSTANCE,0.040368,0.11118,0.13985,1,1
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.020391,0.11108,0.13341,1,1
2,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.006955,0.10961,0.16748,1,1
2,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,0.0023095,0.1091,0.16023,1,1
2,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.020391,0.10868,0.15832,1,1
2,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.033245,0.10832,0.15388,1,1
2,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.041938,0.1082,0.14964,1,1
2,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.052482,0.10817,0.12793,1,1
2,GO UBIQUITIN DEPENDENT ERAD PATHWAY,0.060677,0.108,0.14003,1,1
2,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.025096,0.10768,0.14239,1,1
2,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.046961,0.10748,0.14394,1,1
2,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.045233,0.10745,0.15314,1,1
2,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,0.011063,0.10715,0.18851,1,1
2,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.023112,0.10661,0.16078,1,1
2,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.030713,0.1058,0.11251,1,1
2,GO POSITIVE REGULATION OF PROTEIN BINDING,0.034576,0.10577,0.1595,1,1
2,GO CELLULAR RESPONSE TO DRUG,0.0042727,0.10528,0.17317,1,1
2,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,0.015776,0.10512,0.15628,1,1
2,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.048745,0.10417,0.15712,1,1
2,GO RESPONSE TO ENDOGENOUS STIMULUS,0.043559,0.10409,0.14708,1,1
2,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.017954,0.10406,0.15425,1,1
2,GO RESPONSE TO OXYGEN LEVELS,0.0092139,0.10337,0.14854,1,1
2,GO AGING,0.013235,0.10326,0.16689,1,1
2,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.0044907,0.10245,0.16865,1,1
2,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.052482,0.10205,0.11893,1,1
2,GO RESPONSE TO DRUG,0.021265,0.10196,0.15452,1,1
2,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.052482,0.10157,0.12552,1,1
2,GO GOLGI VESICLE BUDDING,0.045233,0.10131,0.13343,1,1
2,GO GLYCOSYL COMPOUND METABOLIC PROCESS,0.0036751,0.10059,0.13939,1,1
2,GO PROTEOLYSIS,0.017954,0.099867,0.14489,1,1
2,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.02951,0.099651,0.15568,1,1
2,GO ANDROGEN METABOLIC PROCESS,0.033245,0.09963,0.12366,1,1
2,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.045233,0.097961,0.10889,1,1
2,GO ORGANIC ACID METABOLIC PROCESS,0.0096484,0.097728,0.14244,1,1
2,GO REGULATION OF LIGASE ACTIVITY,0.038848,0.097268,0.12944,1,1
2,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.030713,0.096838,0.16911,1,1
2,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.027226,0.096266,0.1481,1,1
2,GO NUCLEOSIDE METABOLIC PROCESS,0.010101,0.096158,0.1299,1,1
2,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,0.030713,0.095326,0.11028,1,1
2,GO MUSCLE CELL APOPTOTIC PROCESS,0.02951,0.094703,0.16224,1,1
2,GO PROTEIN DESTABILIZATION,0.022172,0.094451,0.15496,1,1
2,GO ALCOHOL BIOSYNTHETIC PROCESS,0.026142,0.092702,0.13864,1,1
2,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.037377,0.091185,0.12504,1,1
2,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.022172,0.090526,0.15532,1,1
2,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.056456,0.089673,0.13851,1,1
2,GO REGULATION OF ERAD PATHWAY,0.048745,0.089587,0.15544,1,1
2,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.010101,0.089322,0.13575,1,1
2,GO POSITIVE REGULATION OF TRANSLATION,0.034576,0.089208,0.12162,1,1
2,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.035953,0.08771,0.12959,1,1
2,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.0092139,0.087023,0.13624,1,1
2,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.050584,0.082346,0.1422,1,1
2,GO SOMATIC STEM CELL POPULATION MAINTENANCE,0.026142,0.081596,0.16617,1,1
2,GO RESPONSE TO NITROGEN COMPOUND,0.054439,0.080045,0.13147,1,1
2,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.023112,0.079362,0.13129,1,1
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.050584,0.076029,0.13864,1,1
2,GO RESPONSE TO ACID CHEMICAL,0.052482,0.075897,0.12982,1,1
2,GO ENDODERMAL CELL DIFFERENTIATION,0.0021907,0.38177,0.4319,1,0
2,GO ENDODERM FORMATION,0.00072571,0.33248,0.4231,1,0
2,GO EXTRACELLULAR STRUCTURE ORGANIZATION,0.0014241,0.3157,0.42055,1,0
2,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.0042727,0.29251,0.33367,1,0
2,GO EXTRACELLULAR MATRIX ASSEMBLY,0.0172,0.28764,0.37537,1,0
2,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.0042727,0.28408,0.34455,1,0
2,GO BLOOD VESSEL MORPHOGENESIS,0.00086166,0.28248,0.35326,1,0
2,GO VASCULATURE DEVELOPMENT,0.00068502,0.27969,0.34106,1,0
2,GO REGULATION OF RESPIRATORY BURST,0.015776,0.27585,0.23672,1,0
2,GO ENDODERM DEVELOPMENT,0.0060238,0.27126,0.29955,1,0
2,GO LYSOSOME LOCALIZATION,0.012106,0.25536,0.23941,1,0
2,GO VASCULOGENESIS,0.006955,0.25015,0.31251,1,0
2,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,0.0025648,0.24954,0.40485,1,0
2,GO MIDGUT DEVELOPMENT,0.027226,0.24603,0.25065,1,0
2,GO REGULATION OF GASTRULATION,0.0012758,0.24288,0.28876,1,0
2,GO REGULATION OF POSITIVE CHEMOTAXIS,0.018736,0.22845,0.29499,1,0
2,GO TUBE MORPHOGENESIS,0.0031545,0.21913,0.26634,1,0
2,GO KERATAN SULFATE METABOLIC PROCESS,0.0015882,0.21822,0.33123,1,0
2,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.0092139,0.21789,0.24245,1,0
2,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.020391,0.21737,0.27162,1,0
2,GO MUSCLE CELL MIGRATION,0.0044907,0.21656,0.27042,1,0
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,0.0057394,0.21585,0.29124,1,0
2,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.011574,0.21447,0.3093,1,0
2,GO REGULATION OF CELL MATRIX ADHESION,0.008797,0.21382,0.27888,1,0
2,GO O GLYCAN PROCESSING,0.037377,0.21331,0.19383,1,0
2,GO TOOTH MINERALIZATION,0.010101,0.21091,0.29473,1,0
2,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.017954,0.21011,0.25261,1,0
2,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.019548,0.20897,0.21466,1,0
2,GO SMOOTH MUSCLE CELL MIGRATION,0.0063209,0.20538,0.28837,1,0
2,GO CARDIOBLAST DIFFERENTIATION,0.050584,0.2048,0.21266,1,0
2,GO FOREGUT MORPHOGENESIS,0.024086,0.2016,0.24546,1,0
2,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.056456,0.20067,0.2466,1,0
2,GO RECEPTOR RECYCLING,0.019548,0.20065,0.18013,1,0
2,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.011063,0.19864,0.27372,1,0
2,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.034576,0.19582,0.19878,1,0
2,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.019548,0.19552,0.22697,1,0
2,GO BASEMENT MEMBRANE ORGANIZATION,0.018736,0.19413,0.29066,1,0
2,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.0011418,0.19386,0.34689,1,0
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.013235,0.19367,0.29845,1,0
2,GO FORMATION OF PRIMARY GERM LAYER,0.0054671,0.1935,0.28151,1,0
2,GO AORTA MORPHOGENESIS,0.019548,0.1926,0.26768,1,0
2,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.035953,0.19104,0.24248,1,0
2,GO OSSIFICATION,0.015776,0.19095,0.21163,1,0
2,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,0.0066311,0.19053,0.23354,1,0
2,GO MESENCHYMAL CELL DIFFERENTIATION,0.058535,0.19,0.18907,1,0
2,GO REGULATION OF MYELINATION,0.015776,0.18969,0.21228,1,0
2,GO CIRCULATORY SYSTEM DEVELOPMENT,0.007293,0.18954,0.24445,1,0
2,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.016475,0.1888,0.26547,1,0
2,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.046961,0.18705,0.19167,1,0
2,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.0044907,0.18623,0.23682,1,0
2,GO KIDNEY MESENCHYME DEVELOPMENT,0.0096484,0.18542,0.25215,1,0
2,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.016475,0.18484,0.24898,1,0
2,GO ENDOTHELIAL CELL PROLIFERATION,0.0052065,0.18191,0.28048,1,0
2,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.014457,0.18124,0.30679,1,0
2,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.020391,0.17908,0.24736,1,0
2,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,0.028348,0.17798,0.15328,1,0
2,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,0.034576,0.17725,0.1815,1,0
2,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.037377,0.17607,0.20762,1,0
2,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.043559,0.17499,0.26865,1,0
2,GO NEURON REMODELING,0.031957,0.17484,0.26148,1,0
2,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.023112,0.17434,0.20579,1,0
2,GO ENDOCRINE PROCESS,0.0076456,0.17423,0.23571,1,0
2,GO TUBE DEVELOPMENT,0.010572,0.1721,0.2213,1,0
2,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.056456,0.17105,0.23406,1,0
2,GO INACTIVATION OF MAPK ACTIVITY,0.011574,0.16758,0.23073,1,0
2,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.043559,0.16556,0.22803,1,0
2,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.030713,0.16526,0.21402,1,0
2,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.023112,0.16524,0.2608,1,0
2,GO RESPONSE TO STEROID HORMONE,0.007293,0.16319,0.1949,1,0
2,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.0096484,0.16293,0.27389,1,0
2,GO CELL VOLUME HOMEOSTASIS,0.0038653,0.16231,0.26424,1,0
2,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.0052065,0.16148,0.28217,1,0
2,GO EPIDERMAL CELL DIFFERENTIATION,0.046961,0.158,0.14271,1,0
2,GO STRIATED MUSCLE CELL PROLIFERATION,0.021265,0.15447,0.19549,1,0
2,GO CARDIAC SEPTUM DEVELOPMENT,0.056456,0.15428,0.1944,1,0
2,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,0.013834,0.15383,0.18359,1,0
2,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.0096484,0.15119,0.2032,1,0
2,GO OLIGOPEPTIDE TRANSPORT,0.026142,0.15069,0.21124,1,0
2,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,0.0172,0.147,0.20246,1,0
2,GO REGULATION OF MUSCLE HYPERTROPHY,0.048745,0.14622,0.16526,1,0
2,GO DISACCHARIDE METABOLIC PROCESS,0.017954,0.14607,0.24247,1,0
2,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.02951,0.14568,0.18394,1,0
2,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.024086,0.14479,0.19141,1,0
2,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.020391,0.14342,0.25735,1,0
2,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.023112,0.14339,0.23281,1,0
2,GO RECEPTOR CATABOLIC PROCESS,0.026142,0.14295,0.20421,1,0
2,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.0057394,0.14218,0.2802,1,0
2,GO PIGMENT GRANULE LOCALIZATION,0.037377,0.14201,0.15222,1,0
2,GO MITOCHONDRIAL DEPOLARIZATION,0.016475,0.14197,0.21947,1,0
2,GO GASTRULATION,0.011063,0.14084,0.21996,1,0
2,GO ERYTHROCYTE MATURATION,0.045233,0.13943,0.21843,1,0
2,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.052482,0.13894,0.2535,1,0
2,GO REGULATION OF FATTY ACID OXIDATION,0.031957,0.13885,0.18325,1,0
2,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.023112,0.13862,0.16599,1,0
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.048745,0.13766,0.22409,1,0
2,GO PROTEOGLYCAN METABOLIC PROCESS,0.052482,0.13761,0.17771,1,0
2,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.043559,0.13535,0.16353,1,0
2,GO CORONARY VASCULATURE DEVELOPMENT,0.037377,0.13469,0.24967,1,0
2,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.015104,0.13358,0.19023,1,0
2,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.043559,0.13052,0.20324,1,0
2,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.056456,0.12971,0.15235,1,0
2,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,0.046961,0.12757,0.26835,1,0
2,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.043559,0.12678,0.19022,1,0
2,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.046961,0.12564,0.16808,1,0
2,GO FOCAL ADHESION ASSEMBLY,0.050584,0.12504,0.23285,1,0
2,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,0.050584,0.12156,0.14745,1,0
2,GO HORMONE METABOLIC PROCESS,0.013834,0.12123,0.16434,1,0
2,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.054439,0.12066,0.13346,1,0
2,GO SELECTIVE AUTOPHAGY,0.054439,0.11952,0.14229,1,0
2,GO RESPONSE TO ESTRADIOL,0.024086,0.1167,0.17086,1,0
2,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.027226,0.11597,0.21322,1,0
2,GO LIPID MODIFICATION,0.050584,0.11549,0.13415,1,0
2,GO PHAGOSOME MATURATION,0.060677,0.11502,0.16322,1,0
2,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.033245,0.11459,0.18028,1,0
2,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.027226,0.10984,0.15056,1,0
2,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.028348,0.10957,0.18622,1,0
2,GO REGULATION OF ORGAN GROWTH,0.016475,0.10855,0.19057,1,0
2,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.058535,0.10827,0.16389,1,0
2,GO CELLULAR PIGMENTATION,0.025096,0.10755,0.15675,1,0
2,GO MUSCLE STRUCTURE DEVELOPMENT,0.045233,0.10704,0.15733,1,0
2,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.0096484,0.10677,0.14299,1,0
2,GO RECEPTOR METABOLIC PROCESS,0.034576,0.10613,0.14984,1,0
2,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.058535,0.10518,0.16526,1,0
2,GO REGULATION OF MEMBRANE DEPOLARIZATION,0.023112,0.10287,0.18076,1,0
2,GO GLYCOPROTEIN METABOLIC PROCESS,0.031957,0.10268,0.15378,1,0
2,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.056456,0.10242,0.18265,1,0
2,GO ORGANIC ACID CATABOLIC PROCESS,0.031957,0.10203,0.12599,1,0
2,GO CELLULAR AMINO ACID CATABOLIC PROCESS,0.046961,0.10075,0.11615,1,0
2,GO SMOOTH MUSCLE CELL DIFFERENTIATION,0.040368,0.099397,0.21546,1,0
2,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,0.028348,0.098073,0.16519,1,0
2,GO CALCINEURIN MEDIATED SIGNALING,0.056456,0.096663,0.16178,1,0
2,GO REGULATION OF BLOOD PRESSURE,0.023112,0.096326,0.18133,1,0
2,GO RESPONSE TO ETHANOL,0.043559,0.094994,0.12681,1,0
2,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.046961,0.094746,0.16896,1,0
2,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.050584,0.092188,0.18168,1,0
2,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.045233,0.090256,0.19343,1,0
2,GO SMALL MOLECULE CATABOLIC PROCESS,0.054439,0.089787,0.11758,1,0
2,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.034576,0.08882,0.14199,1,0
2,GO PIGMENT GRANULE ORGANIZATION,0.027226,0.084525,0.21217,1,0
2,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.058535,0.083149,0.16188,1,0
2,GO NEGATIVE REGULATION OF ION TRANSPORT,0.050584,0.081995,0.13628,1,0
2,GO ALPHA AMINO ACID CATABOLIC PROCESS,0.058535,0.081062,0.11521,1,0
2,GO KETONE BIOSYNTHETIC PROCESS,0.048745,0.07895,0.13464,1,0
2,GO OXIDATION REDUCTION PROCESS,0.025096,0.078367,0.10793,1,0
2,GO MEGAKARYOCYTE DIFFERENTIATION,0.050584,0.077561,0.16008,1,0
2,GO VACUOLE ORGANIZATION,0.058535,0.077297,0.12723,1,0
2,GO HORMONE BIOSYNTHETIC PROCESS,0.024086,0.076028,0.14059,1,0
2,GO POLYOL BIOSYNTHETIC PROCESS,0.041938,0.075346,0.13635,1,0
2,GO PEROXISOMAL TRANSPORT,0.038848,0.072743,0.10222,1,0
2,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.038848,0.072567,0.13438,1,0
2,GO PEROXISOME ORGANIZATION,0.025096,0.070894,0.10291,1,0
2,GO REGULATION OF CHROMOSOME SEPARATION,0.060677,-0.077592,-0.21596,1,0
2,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.052482,-0.080884,-0.25731,1,0
2,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.01266,-0.088829,-0.11853,1,0
2,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,0.050584,-0.098028,-0.10914,1,0
2,GO SUBSTANTIA NIGRA DEVELOPMENT,0.056456,-0.099206,-0.092329,1,0
2,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.038848,-0.099637,-0.088062,1,0
2,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.0044907,-0.10769,-0.13778,1,0
2,GO RESPONSE TO DOPAMINE,0.037377,-0.11115,-0.09942,1,0
2,GO REGULATION OF CYTOKINESIS,0.048745,-0.11489,-0.15314,1,0
2,GO GAMMA AMINOBUTYRIC ACID SECRETION,0.045233,-0.11589,-0.21056,1,0
2,GO CHROMOSOME SEGREGATION,0.060677,-0.11684,-0.195,1,0
2,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,0.046961,-0.11932,-0.11552,1,0
2,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.038848,-0.11955,-0.12697,1,0
2,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.058535,-0.12506,-0.10719,1,0
2,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.038848,-0.12517,-0.16681,1,0
2,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,0.050584,-0.12525,-0.15773,1,0
2,GO REGULATION OF EXIT FROM MITOSIS,0.045233,-0.12583,-0.21939,1,0
2,GO TUBULIN DEACETYLATION,0.060677,-0.12651,-0.1255,1,0
2,GO SISTER CHROMATID SEGREGATION,0.046961,-0.12922,-0.22082,1,0
2,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,0.027226,-0.13006,-0.28229,1,0
2,GO NUCLEAR CHROMOSOME SEGREGATION,0.050584,-0.13014,-0.20814,1,0
2,GO MICROTUBULE BASED MOVEMENT,0.043559,-0.13299,-0.1566,1,0
2,GO METENCEPHALON DEVELOPMENT,0.048745,-0.13639,-0.14791,1,0
2,GO ENDOCRINE SYSTEM DEVELOPMENT,0.058535,-0.13658,-0.10737,1,0
2,GO MEMBRANE DOCKING,0.018736,-0.13673,-0.14742,1,0
2,GO MITOCHONDRION LOCALIZATION,0.02951,-0.1376,-0.15571,1,0
2,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.0042727,-0.14007,-0.20139,1,0
2,GO PHOTORECEPTOR CELL DEVELOPMENT,0.017954,-0.14106,-0.1463,1,0
2,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.01266,-0.14118,-0.30351,1,0
2,GO REGULATION OF MEIOTIC CELL CYCLE,0.006955,-0.14167,-0.19127,1,0
2,GO REGULATION OF MICROTUBULE BASED PROCESS,0.018736,-0.1417,-0.15934,1,0
2,GO CEREBELLAR CORTEX DEVELOPMENT,0.052482,-0.142,-0.15021,1,0
2,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,0.048745,-0.14325,-0.10166,1,0
2,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,0.054439,-0.14417,-0.15097,1,0
2,GO POSITIVE REGULATION OF MRNA PROCESSING,0.013834,-0.14752,-0.16771,1,0
2,GO MICROTUBULE BASED PROCESS,0.037377,-0.15069,-0.1529,1,0
2,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,0.010572,-0.15213,-0.15981,1,0
2,GO HISTONE H2A ACETYLATION,0.054439,-0.15219,-0.16595,1,0
2,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,0.045233,-0.15232,-0.15085,1,0
2,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.027226,-0.15237,-0.16719,1,0
2,GO DENDRITE MORPHOGENESIS,0.046961,-0.15417,-0.14909,1,0
2,GO PHOTORECEPTOR CELL DIFFERENTIATION,0.037377,-0.15765,-0.13383,1,0
2,GO MEIOTIC CHROMOSOME SEGREGATION,0.018736,-0.15819,-0.27934,1,0
2,GO MITOTIC SISTER CHROMATID SEGREGATION,0.035953,-0.15869,-0.22973,1,0
2,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.035953,-0.15992,-0.14565,1,0
2,GO RAB PROTEIN SIGNAL TRANSDUCTION,0.02951,-0.16055,-0.15384,1,0
2,GO REGULATION OF DENDRITE MORPHOGENESIS,0.048745,-0.16249,-0.13992,1,0
2,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,0.0052065,-0.16252,-0.19684,1,0
2,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,0.024086,-0.16318,-0.17719,1,0
2,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.038848,-0.1635,-0.13922,1,0
2,GO MICROTUBULE CYTOSKELETON ORGANIZATION,0.023112,-0.16532,-0.1737,1,0
2,GO LOCOMOTORY BEHAVIOR,0.060677,-0.16592,-0.12841,1,0
2,GO MICROTUBULE BASED TRANSPORT,0.040368,-0.16834,-0.14816,1,0
2,GO DNA PACKAGING,0.048745,-0.17066,-0.19449,1,0
2,GO SPERMATID NUCLEUS DIFFERENTIATION,0.026142,-0.17109,-0.21163,1,0
2,GO MITOTIC SPINDLE ASSEMBLY,0.011063,-0.17264,-0.25235,1,0
2,GO NUCLEOSOME ORGANIZATION,0.056456,-0.1741,-0.1761,1,0
2,GO DICARBOXYLIC ACID TRANSPORT,0.048745,-0.17455,-0.11601,1,0
2,GO KINETOCHORE ASSEMBLY,0.028348,-0.17534,-0.34519,1,0
2,GO TRANSPORT ALONG MICROTUBULE,0.019548,-0.17548,-0.16691,1,0
2,GO FEEDING BEHAVIOR,0.01266,-0.17677,-0.16027,1,0
2,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,0.033245,-0.17793,-0.14984,1,0
2,GO CELL CYCLE DNA REPLICATION,0.058535,-0.17873,-0.22717,1,0
2,GO REGULATION OF SYNAPSE ASSEMBLY,0.045233,-0.1788,-0.16332,1,0
2,GO ATP DEPENDENT CHROMATIN REMODELING,0.017954,-0.17919,-0.24173,1,0
2,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,0.0172,-0.18019,-0.14825,1,0
2,GO REGULATION OF SYNAPSE MATURATION,0.038848,-0.18048,-0.28514,1,0
2,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.045233,-0.18069,-0.23275,1,0
2,GO CILIUM ORGANIZATION,0.060677,-0.18115,-0.14752,1,0
2,GO NEGATIVE REGULATION OF HISTONE METHYLATION,0.048745,-0.18175,-0.17089,1,0
2,GO HOMOLOGOUS RECOMBINATION,0.02951,-0.18181,-0.22299,1,0
2,GO REGULATION OF SISTER CHROMATID COHESION,0.033245,-0.18253,-0.21678,1,0
2,GO MEIOSIS I CELL CYCLE PROCESS,0.011574,-0.18272,-0.25034,1,0
2,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.060677,-0.18348,-0.28963,1,0
2,GO PROTEIN LOCALIZATION TO MICROTUBULE,0.035953,-0.1846,-0.14207,1,0
2,GO REGULATION OF MEMBRANE POTENTIAL,0.028348,-0.18712,-0.12156,1,0
2,GO NEUROEPITHELIAL CELL DIFFERENTIATION,0.011063,-0.18859,-0.20772,1,0
2,GO MITOTIC SISTER CHROMATID COHESION,0.050584,-0.18863,-0.21343,1,0
2,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,0.035953,-0.18894,-0.17228,1,0
2,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,0.037377,-0.18897,-0.24336,1,0
2,GO SISTER CHROMATID COHESION,0.056456,-0.18941,-0.21886,1,0
2,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.046961,-0.18955,-0.15056,1,0
2,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.035953,-0.19026,-0.24113,1,0
2,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,0.052482,-0.19082,-0.1605,1,0
2,GO PEPTIDE HORMONE SECRETION,0.048745,-0.19162,-0.09951,1,0
2,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.018736,-0.19202,-0.29492,1,0
2,GO SECRETORY GRANULE LOCALIZATION,0.027226,-0.19383,-0.23387,1,0
2,GO EMBRYONIC BRAIN DEVELOPMENT,0.034576,-0.19452,-0.20163,1,0
2,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.0083971,-0.19557,-0.18573,1,0
2,GO FEMALE MEIOTIC NUCLEAR DIVISION,0.0052065,-0.19811,-0.30073,1,0
2,GO AXO DENDRITIC PROTEIN TRANSPORT,0.016475,-0.19845,-0.22429,1,0
2,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.025096,-0.19893,-0.245,1,0
2,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,0.027226,-0.19937,-0.18293,1,0
2,GO REGULATION OF TRANS SYNAPTIC SIGNALING,0.046961,-0.19961,-0.14623,1,0
2,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,0.0092139,-0.2,-0.24331,1,0
2,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.022172,-0.20027,-0.21473,1,0
2,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,0.0057394,-0.20104,-0.26612,1,0
2,GO VESICLE DOCKING,0.027226,-0.20121,-0.1197,1,0
2,GO CENTROMERE COMPLEX ASSEMBLY,0.0092139,-0.20427,-0.33316,1,0
2,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.037377,-0.20486,-0.18677,1,0
2,GO SYNAPTIC SIGNALING,0.023112,-0.20571,-0.16362,1,0
2,GO NEURAL RETINA DEVELOPMENT,0.015776,-0.20599,-0.19725,1,0
2,GO NUCLEOSOME ASSEMBLY,0.018736,-0.20633,-0.23611,1,0
2,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,0.0060238,-0.20797,-0.24285,1,0
2,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.0080134,-0.20856,-0.27492,1,0
2,GO RETROGRADE AXONAL TRANSPORT,0.054439,-0.20863,-0.20089,1,0
2,GO MICROTUBULE NUCLEATION,0.030713,-0.20927,-0.16758,1,0
2,GO MICROTUBULE SEVERING,0.02951,-0.21045,-0.19255,1,0
2,GO DNA REPLICATION INITIATION,0.031957,-0.2108,-0.2637,1,0
2,GO PRESYNAPSE ORGANIZATION,0.025096,-0.21181,-0.17803,1,0
2,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,0.021265,-0.21223,-0.22029,1,0
2,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.030713,-0.21224,-0.17338,1,0
2,GO CELL DIFFERENTIATION IN SPINAL CORD,0.019548,-0.21308,-0.19585,1,0
2,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.0083971,-0.21339,-0.22229,1,0
2,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.01266,-0.21383,-0.22487,1,0
2,GO MICROTUBULE POLYMERIZATION,0.0040644,-0.21519,-0.22794,1,0
2,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.028348,-0.2156,-0.18005,1,0
2,GO SYNAPTIC VESICLE RECYCLING,0.010572,-0.21594,-0.16424,1,0
2,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,0.033245,-0.21627,-0.16841,1,0
2,GO NEURONAL ACTION POTENTIAL,0.022172,-0.21684,-0.19033,1,0
2,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,0.0057394,-0.21983,-0.29715,1,0
2,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,0.033245,-0.22064,-0.18786,1,0
2,GO SPLICEOSOMAL COMPLEX ASSEMBLY,0.021265,-0.22101,-0.20223,1,0
2,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.028348,-0.22125,-0.2193,1,0
2,GO REGULATION OF AMINO ACID TRANSPORT,0.045233,-0.22262,-0.15164,1,0
2,GO SPINAL CORD DEVELOPMENT,0.030713,-0.22377,-0.1947,1,0
2,GO ANTEROGRADE AXONAL TRANSPORT,0.010572,-0.22415,-0.2146,1,0
2,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.0049572,-0.22459,-0.32292,1,0
2,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,0.040368,-0.22515,-0.17868,1,0
2,GO PROTEIN LOCALIZATION TO CELL JUNCTION,0.0049572,-0.22616,-0.1918,1,0
2,GO REGULATION OF RESPONSE TO FOOD,0.034576,-0.22671,-0.21801,1,0
2,GO FOREBRAIN NEURON DEVELOPMENT,0.058535,-0.22727,-0.15692,1,0
2,GO HISTONE EXCHANGE,0.006955,-0.22999,-0.29414,1,0
2,GO LAYER FORMATION IN CEREBRAL CORTEX,0.016475,-0.23064,-0.23739,1,0
2,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,0.015104,-0.23155,-0.23105,1,0
2,GO ACIDIC AMINO ACID TRANSPORT,0.020391,-0.23308,-0.15159,1,0
2,GO CELL JUNCTION MAINTENANCE,0.020391,-0.23326,-0.20822,1,0
2,GO PROTEIN LOCALIZATION TO SYNAPSE,0.0017696,-0.23382,-0.25249,1,0
2,GO MICROTUBULE BUNDLE FORMATION,0.033245,-0.23393,-0.19738,1,0
2,GO AXO DENDRITIC TRANSPORT,0.0076456,-0.23452,-0.21401,1,0
2,GO RESPONSE TO COCAINE,0.013235,-0.23536,-0.20729,1,0
2,GO AXONAL TRANSPORT,0.0054671,-0.23705,-0.2254,1,0
2,GO ADULT LOCOMOTORY BEHAVIOR,0.0063209,-0.23715,-0.20226,1,0
2,GO SYNAPTIC VESICLE TRANSPORT,0.0080134,-0.23751,-0.19378,1,0
2,GO EXOCYTIC PROCESS,0.030713,-0.24074,-0.14352,1,0
2,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,0.0060238,-0.24078,-0.22426,1,0
2,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,0.031957,-0.24087,-0.21087,1,0
2,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.0012758,-0.24105,-0.26317,1,0
2,GO PRESYNAPTIC ENDOCYTOSIS,0.0092139,-0.24126,-0.17619,1,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,0.050584,-0.24188,-0.18481,1,0
2,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.026142,-0.24332,-0.2091,1,0
2,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.0019699,-0.24381,-0.24657,1,0
2,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,0.023112,-0.24382,-0.1951,1,0
2,GO DORSAL SPINAL CORD DEVELOPMENT,0.050584,-0.24537,-0.20875,1,0
2,GO VENTRAL SPINAL CORD DEVELOPMENT,0.0057394,-0.24666,-0.21966,1,0
2,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,0.00332,-0.24702,-0.25594,1,0
2,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,0.0036751,-0.24888,-0.26367,1,0
2,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,0.011063,-0.25018,-0.28779,1,0
2,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.013235,-0.25232,-0.2293,1,0
2,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,0.016475,-0.25305,-0.21584,1,0
2,GO PROTEIN TRANSPORT ALONG MICROTUBULE,0.011063,-0.25371,-0.24744,1,0
2,GO PROTEIN LOCALIZATION TO PRESYNAPSE,0.027226,-0.2544,-0.1936,1,0
2,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,0.035953,-0.25506,-0.25448,1,0
2,GO RECEPTOR LOCALIZATION TO SYNAPSE,0.0015041,-0.25678,-0.27993,1,0
2,GO REGULATION OF MICROTUBULE POLYMERIZATION,0.0015041,-0.25768,-0.26481,1,0
2,GO NEGATIVE REGULATION OF AMINE TRANSPORT,0.014457,-0.25896,-0.20486,1,0
2,GO CHROMATIN SILENCING AT TELOMERE,0.012106,-0.26338,-0.26069,1,0
2,GO MICROTUBULE DEPOLYMERIZATION,0.0036751,-0.2643,-0.33191,1,0
2,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.050584,-0.26994,-0.27537,1,0
2,GO RETINA LAYER FORMATION,0.0172,-0.27013,-0.28377,1,0
2,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.056456,-0.27056,-0.25841,1,0
2,GO INTRACILIARY TRANSPORT,0.018736,-0.27097,-0.23421,1,0
2,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,0.037377,-0.27327,-0.22715,1,0
2,GO CHROMATIN REMODELING AT CENTROMERE,0.0023095,-0.27336,-0.39302,1,0
2,GO FOREBRAIN REGIONALIZATION,0.058535,-0.27697,-0.19143,1,0
2,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,0.0083971,-0.27717,-0.247,1,0
2,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,0.027226,-0.27753,-0.29927,1,0
2,GO DETECTION OF CALCIUM ION,0.006955,-0.27884,-0.23087,1,0
2,GO SYNAPSE ASSEMBLY,0.022172,-0.27901,-0.20333,1,0
2,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,0.0018673,-0.28035,-0.28349,1,0
2,GO SYNAPTIC MEMBRANE ADHESION,0.02951,-0.28047,-0.28279,1,0
2,GO KINETOCHORE ORGANIZATION,0.0080134,-0.28145,-0.4304,1,0
2,GO REGULATION OF PRESYNAPSE ORGANIZATION,0.0080134,-0.28449,-0.26391,1,0
2,GO MRNA SPLICE SITE SELECTION,0.023112,-0.28899,-0.24141,1,0
2,GO TRANSMISSION OF NERVE IMPULSE,0.016475,-0.28957,-0.21912,1,0
2,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,0.016475,-0.29024,-0.20963,1,0
2,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,0.015776,-0.29241,-0.24707,1,0
2,GO NEURAL NUCLEUS DEVELOPMENT,0.0015882,-0.29251,-0.26604,1,0
2,GO DIENCEPHALON DEVELOPMENT,0.021265,-0.29314,-0.19597,1,0
2,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.038848,-0.29338,-0.23531,1,0
2,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,0.040368,-0.29346,-0.21183,1,0
2,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,0.040368,-0.29484,-0.19535,1,0
2,GO SYNAPSE MATURATION,0.050584,-0.29632,-0.27936,1,0
2,GO RESPONSE TO ACETYLCHOLINE,0.020391,-0.29736,-0.24499,1,0
2,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.021265,-0.29823,-0.38822,1,0
2,GO INTRACILIARY RETROGRADE TRANSPORT,0.016475,-0.2998,-0.26939,1,0
2,GO PARENTAL BEHAVIOR,0.060677,-0.30092,-0.26541,1,0
2,GO THALAMUS DEVELOPMENT,0.006955,-0.30399,-0.2996,1,0
2,GO REFLEX,0.043559,-0.30692,-0.2127,1,0
2,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,0.0031545,-0.31033,-0.28078,1,0
2,GO GLUTAMATE SECRETION,0.0054671,-0.31067,-0.25615,1,0
2,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,0.0019699,-0.31124,-0.27854,1,0
2,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,0.0012071,-0.31177,-0.29502,1,0
2,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,0.007293,-0.3121,-0.19066,1,0
2,GO TELENCEPHALON REGIONALIZATION,0.033245,-0.31226,-0.24327,1,0
2,GO VOCALIZATION BEHAVIOR,0.034576,-0.31403,-0.2586,1,0
2,GO SPONTANEOUS SYNAPTIC TRANSMISSION,0.010572,-0.31427,-0.3119,1,0
2,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,0.0080134,-0.31835,-0.26663,1,0
2,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,0.015104,-0.31986,-0.30309,1,0
2,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.023112,-0.32247,-0.27847,1,0
2,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,0.017954,-0.32325,-0.26125,1,0
2,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,0.0034935,-0.32333,-0.27649,1,0
2,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.008797,-0.32396,-0.31567,1,0
2,GO RESPONSE TO AUDITORY STIMULUS,0.038848,-0.32474,-0.22023,1,0
2,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,0.021265,-0.32487,-0.26711,1,0
2,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,0.046961,-0.33103,-0.22243,1,0
2,GO ADULT BEHAVIOR,0.0036751,-0.33138,-0.24971,1,0
2,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.00081392,-0.33264,-0.28938,1,0
2,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,0.0096484,-0.33364,-0.33715,1,0
2,GO MONOAMINE TRANSPORT,0.023112,-0.33396,-0.22738,1,0
2,GO DOPAMINE BIOSYNTHETIC PROCESS,0.010572,-0.33486,-0.27112,1,0
2,GO CGMP METABOLIC PROCESS,0.016475,-0.33616,-0.25672,1,0
2,GO REGULATION OF VESICLE FUSION,0.0027019,-0.33653,-0.27841,1,0
2,GO SYNAPTIC VESICLE LOCALIZATION,0.0024341,-0.33708,-0.26552,1,0
2,GO REGULATION OF CGMP MEDIATED SIGNALING,0.016475,-0.34167,-0.25319,1,0
2,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.054439,-0.34272,-0.26847,1,0
2,GO REGULATION OF NEUROTRANSMITTER LEVELS,0.0057394,-0.34553,-0.23174,1,0
2,GO NEURONAL ION CHANNEL CLUSTERING,0.007293,-0.35024,-0.32264,1,0
2,GO REGULATION OF MICROTUBULE BINDING,0.0019699,-0.35074,-0.30581,1,0
2,GO OPIOID RECEPTOR SIGNALING PATHWAY,0.01266,-0.3511,-0.26507,1,0
2,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.0020776,-0.3562,-0.32553,1,0
2,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,0.0024341,-0.36002,-0.28087,1,0
2,GO NEUROPEPTIDE SIGNALING PATHWAY,0.0038653,-0.36032,-0.25811,1,0
2,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.006955,-0.36242,-0.39279,1,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,0.0031545,-0.36387,-0.2986,1,0
2,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,0.021265,-0.36399,-0.25409,1,0
2,GO NEUROTRANSMITTER TRANSPORT,0.0019699,-0.36505,-0.27569,1,0
2,GO SPINAL CORD PATTERNING,0.00332,-0.36758,-0.3523,1,0
2,GO REGULATION OF SYNAPTIC VESICLE CYCLE,0.0011418,-0.3706,-0.32967,1,0
2,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,0.0014241,-0.37062,-0.35652,1,0
2,GO CATECHOLAMINE UPTAKE,0.011063,-0.37271,-0.29133,1,0
2,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.0011418,-0.38122,-0.35273,1,0
2,GO DENDRITE EXTENSION,0.0015041,-0.38128,-0.33658,1,0
2,GO AMINE TRANSPORT,0.0036751,-0.38731,-0.27264,1,0
2,GO SYNAPTIC VESICLE EXOCYTOSIS,0.0012071,-0.38802,-0.33579,1,0
2,GO DENDRITIC TRANSPORT,0.0011418,-0.38882,-0.43782,1,0
2,GO PROTEIN POLYGLUTAMYLATION,0.0011418,-0.38907,-0.3423,1,0
2,GO POSTSYNAPSE ASSEMBLY,0.0066311,-0.3899,-0.31458,1,0
2,GO PREPULSE INHIBITION,0.010572,-0.40054,-0.35916,1,0
2,GO RESPONSE TO INSECTICIDE,0.00012367,-0.40062,-0.39977,1,0
2,GO GLIAL CELL FATE COMMITMENT,0.0092139,-0.40471,-0.37256,1,0
2,GO MECHANOSENSORY BEHAVIOR,0.016475,-0.40709,-0.32374,1,0
2,GO PRESYNAPTIC MEMBRANE ORGANIZATION,0.02951,-0.40842,-0.30659,1,0
2,GO NEUROTRANSMITTER SECRETION,0.0012071,-0.41015,-0.31856,1,0
2,GO REGULATION OF ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0076456,-0.41156,-0.32078,1,0
2,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,0.0028457,-0.41372,-0.39733,1,0
2,GO GROWTH HORMONE SECRETION,0.010101,-0.41456,-0.3205,1,0
2,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.013235,-0.415,-0.40287,1,0
2,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,0.035953,-0.41604,-0.25678,1,0
2,GO PROTEIN LOCALIZATION TO AXON,0.020391,-0.41669,-0.29462,1,0
2,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,0.007293,-0.41814,-0.41789,1,0
2,GO REGULATION OF DENDRITE EXTENSION,0.0019699,-0.45263,-0.36828,1,0
2,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,0.012106,-0.46264,-0.32269,1,0
2,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.0052065,-0.46785,-0.41913,1,0
2,GO STARTLE RESPONSE,0.0060238,-0.46843,-0.34469,1,0
2,GO SYNAPTIC VESICLE PRIMING,0.00064645,-0.4708,-0.39381,1,0
2,GO VESICLE FUSION TO PLASMA MEMBRANE,0.0011418,-0.47871,-0.40866,1,0
2,GO DOPAMINE TRANSPORT,0.00054254,-0.48571,-0.40516,1,0
2,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,0.0015882,-0.49053,-0.40909,1,0
2,GO CATECHOLAMINE SECRETION,0.0015041,-0.49994,-0.35919,1,0
2,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,0.0047188,-0.50335,-0.36594,1,0
2,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,0.0023095,-0.50848,-0.36042,1,0
2,GO REGULATION OF DOPAMINE SECRETION,0.0003797,-0.51401,-0.44244,1,0
2,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0018673,-0.51507,-0.45479,1,0
2,GO NEURON CELL CELL ADHESION,0.0017696,-0.51855,-0.43565,1,0
2,GO INHIBITORY POSTSYNAPTIC POTENTIAL,0.0019699,-0.52536,-0.44152,1,0
2,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.0054671,-0.53109,-0.44011,1,0
2,GO REGULATION OF GROWTH HORMONE SECRETION,0.0080134,-0.53324,-0.45822,1,0
2,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.0012758,-0.53641,-0.45269,1,0
2,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,0.0060238,-0.53878,-0.44326,1,0
2,GO DENSE CORE GRANULE TRANSPORT,0.00040321,-0.55399,-0.56797,1,0
2,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,0.0021907,-0.55628,-0.44008,1,0
2,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.00086166,-0.56348,-0.44021,1,0
2,GO NEURON FATE SPECIFICATION,0.0003797,-0.5689,-0.5203,1,0
2,GO CALCIUM ION REGULATED EXOCYTOSIS,0.00096503,-0.57641,-0.42491,1,0
2,GO SYNAPTIC VESICLE MATURATION,0.00023283,-0.58106,-0.53142,1,0
2,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.00091199,-0.58497,-0.44591,1,0
2,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.00031664,-0.59279,-0.55943,1,0
2,GO SYNAPTIC VESICLE CLUSTERING,0.0010798,-0.61728,-0.49429,1,0
2,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,0.00332,-0.62938,-0.44517,1,0
2,GO SYNAPTIC VESICLE DOCKING,0.00031664,-0.63695,-0.58735,1,0
2,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,0.00023283,-0.68102,-0.65115,1,0
2,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.00029789,-0.77525,-0.6715,1,0
2,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,0.00035748,-0.77549,-0.61207,1,0
2,GO PONS DEVELOPMENT,0.0017696,-0.78513,-0.67904,1,0
2,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,0.0003797,-0.84042,-0.63936,1,0
2,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,0.00029789,-0.93279,-0.76532,1,0
2,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.065157,0.2854,0.19406,0,1
2,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.11894,0.24403,0.2641,0,1
2,GO HEAD MORPHOGENESIS,0.072385,0.24242,0.21092,0,1
2,GO RESPONSE TO PARATHYROID HORMONE,0.080256,0.23942,0.16448,0,1
2,GO REGULATION OF GASTRIC ACID SECRETION,0.077559,0.22755,0.22888,0,1
2,GO MYELIN MAINTENANCE,0.10134,0.21104,0.18671,0,1
2,GO NOTOCHORD DEVELOPMENT,0.077559,0.20561,0.18551,0,1
2,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.34626,0.20276,0.068409,0,1
2,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.16123,0.1987,0.13598,0,1
2,GO SENSORY PERCEPTION OF BITTER TASTE,0.17591,0.19538,0.26166,0,1
2,GO REGULATION OF VASCULOGENESIS,0.072385,0.18786,0.25223,0,1
2,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.11524,0.185,0.15758,0,1
2,GO CELL CELL JUNCTION MAINTENANCE,0.074935,0.18389,0.20934,0,1
2,GO MYOBLAST MIGRATION,0.08588,0.18183,0.18066,0,1
2,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.074935,0.18139,0.19067,0,1
2,GO IMP BIOSYNTHETIC PROCESS,0.062884,0.18124,0.10971,0,1
2,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.080256,0.17938,0.16641,0,1
2,GO REGULATION OF EPITHELIAL TUBE FORMATION,0.20256,0.17321,0.12699,0,1
2,GO ALDEHYDE BIOSYNTHETIC PROCESS,0.077559,0.1713,0.23821,0,1
2,GO REGULATION OF DNA METHYLATION,0.11524,0.16838,0.13695,0,1
2,GO SMAD PROTEIN COMPLEX ASSEMBLY,0.069906,0.16793,0.15082,0,1
2,GO RESPONSE TO UV C,0.077559,0.16634,0.16564,0,1
2,GO PROTEIN AUTO ADP RIBOSYLATION,0.08588,0.1645,0.19032,0,1
2,GO POSITIVE REGULATION OF CELL AGING,0.1306,0.16422,0.097578,0,1
2,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.21989,0.15969,0.09192,0,1
2,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.065157,0.15951,0.15945,0,1
2,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.062884,0.15822,0.15613,0,1
2,GO RESPONSE TO SALT,0.065157,0.15766,0.12642,0,1
2,GO PSEUDOURIDINE SYNTHESIS,0.11524,0.15725,0.083831,0,1
2,GO PROTEIN TARGETING TO LYSOSOME,0.13467,0.14883,0.14008,0,1
2,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.08588,0.14781,0.12782,0,1
2,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,0.074935,0.1476,0.1351,0,1
2,GO REGULATION OF HIPPO SIGNALING,0.51122,0.14543,0.089217,0,1
2,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.062884,0.14457,0.18205,0,1
2,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.13467,0.14,0.10414,0,1
2,GO GASTRIC ACID SECRETION,0.069906,0.13875,0.1331,0,1
2,GO FILOPODIUM ASSEMBLY,0.08588,0.13797,0.15543,0,1
2,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.10811,0.13611,0.12534,0,1
2,GO ACTIVATION OF MAPKKK ACTIVITY,0.08588,0.13413,0.17828,0,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.067497,0.12992,0.14629,0,1
2,GO PARTURITION,0.1306,0.12917,0.15797,0,1
2,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,0.069906,0.12902,0.1556,0,1
2,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.094909,0.12832,0.13009,0,1
2,GO MUSCLE FILAMENT SLIDING,0.10468,0.12818,0.1407,0,1
2,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.10811,0.12736,0.14475,0,1
2,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.067497,0.12677,0.11694,0,1
2,GO RESPONSE TO EPINEPHRINE,0.10468,0.12578,0.18124,0,1
2,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.13885,0.12423,0.13027,0,1
2,GO MICROVILLUS ORGANIZATION,0.067497,0.12332,0.13847,0,1
2,GO REGULATION OF PROTEIN BINDING,0.069906,0.12188,0.14895,0,1
2,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,0.11894,0.12064,0.087711,0,1
2,GO VIRAL RNA GENOME REPLICATION,0.18624,0.12053,0.098137,0,1
2,GO IMP METABOLIC PROCESS,0.098083,0.11934,0.10042,0,1
2,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.11894,0.11873,0.15882,0,1
2,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.08588,0.1187,0.14539,0,1
2,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.11163,0.1187,0.11226,0,1
2,GO V D J RECOMBINATION,0.20822,0.11828,0.1084,0,1
2,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.29248,0.11639,0.091828,0,1
2,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,0.17591,0.116,0.081078,0,1
2,GO DEFINITIVE HEMOPOIESIS,0.10468,0.11591,0.20692,0,1
2,GO DNA DEALKYLATION,0.067497,0.11482,0.13824,0,1
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.15655,0.11402,0.08142,0,1
2,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.074935,0.11373,0.21584,0,1
2,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.15655,0.11311,0.095234,0,1
2,GO NEGATIVE REGULATION OF ERAD PATHWAY,0.098083,0.11279,0.15307,0,1
2,GO POSITIVE REGULATION OF FILOPODIUM ASSEMBLY,0.197,0.11195,0.13885,0,1
2,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.1306,0.11065,0.069191,0,1
2,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.42405,0.11016,0.017072,0,1
2,GO PORE COMPLEX ASSEMBLY,0.13467,0.10946,0.12232,0,1
2,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.1475,0.10921,0.13271,0,1
2,GO TOXIN TRANSPORT,0.18624,0.1092,0.11303,0,1
2,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.12662,0.10914,0.1438,0,1
2,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,0.20822,0.10846,0.082397,0,1
2,GO POSITIVE REGULATION OF ION TRANSPORT,0.065157,0.10667,0.14404,0,1
2,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.072385,0.10652,0.1361,0,1
2,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,0.47137,0.10537,0.084318,0,1
2,GO COPII COATED VESICLE CARGO LOADING,0.10468,0.10377,0.13057,0,1
2,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.2577,0.10376,0.082758,0,1
2,GO SMAD PROTEIN SIGNAL TRANSDUCTION,0.072385,0.10263,0.18077,0,1
2,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.42405,0.10181,0.048056,0,1
2,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.069906,0.10148,0.10944,0,1
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.074935,0.10125,0.14596,0,1
2,GO PROTEIN LOCALIZATION TO NUCLEUS,0.24463,0.1008,0.095062,0,1
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.80618,0.098924,-0.019968,0,1
2,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.069906,0.097302,0.1251,0,1
2,GO REGULATION OF CELLULAR CATABOLIC PROCESS,0.065157,0.096585,0.11586,0,1
2,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,0.12662,0.09463,0.13276,0,1
2,GO REGULATION OF TRANSFERASE ACTIVITY,0.069906,0.094323,0.13466,0,1
2,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.23827,0.094055,0.11986,0,1
2,GO DENDRITIC SPINE MAINTENANCE,0.16123,0.093374,0.16522,0,1
2,GO PH REDUCTION,0.27126,0.09295,0.071002,0,1
2,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.17091,0.092645,0.11007,0,1
2,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.065157,0.092602,0.14306,0,1
2,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.15655,0.092148,0.10011,0,1
2,GO PROTEIN IMPORT,0.37111,0.092046,0.079864,0,1
2,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.08588,0.091501,0.12561,0,1
2,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.072385,0.090051,0.16076,0,1
2,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.069906,0.089526,0.13352,0,1
2,GO CELLULAR METABOLIC COMPOUND SALVAGE,0.08588,0.088578,0.1027,0,1
2,GO MULTIVESICULAR BODY SORTING PATHWAY,0.15197,0.088441,0.081304,0,1
2,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.10468,0.08804,0.14182,0,1
2,GO RESPONSE TO EXTRACELLULAR STIMULUS,0.094909,0.087941,0.11147,0,1
2,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.065157,0.086843,0.12299,0,1
2,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.12273,0.085693,0.12502,0,1
2,GO SPLEEN DEVELOPMENT,0.091819,0.085646,0.12716,0,1
2,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.12273,0.085212,0.12174,0,1
2,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,0.067497,0.08391,0.14237,0,1
2,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.069906,0.082938,0.13855,0,1
2,GO ACETYL COA METABOLIC PROCESS,0.094909,0.082606,0.15471,0,1
2,GO REGULATION OF CYTOPLASMIC TRANSPORT,0.17091,0.081937,0.12058,0,1
2,GO POLYAMINE BIOSYNTHETIC PROCESS,0.14312,0.081218,0.064917,0,1
2,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.23203,0.080783,0.075337,0,1
2,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.12662,0.080668,0.11524,0,1
2,GO CELLULAR RESPONSE TO OXYGEN LEVELS,0.091819,0.080447,0.099848,0,1
2,GO RESPONSE TO TESTOSTERONE,0.33821,0.080357,0.077683,0,1
2,GO POLYAMINE METABOLIC PROCESS,0.30724,0.079741,0.046656,0,1
2,GO MULTI ORGANISM LOCALIZATION,0.43329,0.079531,0.045705,0,1
2,GO REGULATION OF MRNA CATABOLIC PROCESS,0.2577,0.079077,0.068225,0,1
2,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.074935,0.078987,0.11848,0,1
2,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.16123,0.077517,0.081481,0,1
2,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.18102,0.076859,0.098487,0,1
2,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.27126,0.076846,0.099387,0,1
2,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.11524,0.076568,0.11915,0,1
2,GO RNA STABILIZATION,0.4521,0.075739,0.052514,0,1
2,GO RESPONSE TO PEPTIDE HORMONE,0.077559,0.074924,0.1327,0,1
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.42405,0.074239,0.055903,0,1
2,GO THYMUS DEVELOPMENT,0.23827,0.073459,0.095848,0,1
2,GO NUCLEOBASE METABOLIC PROCESS,0.12662,0.072555,0.089171,0,1
2,GO REGULATION OF CATABOLIC PROCESS,0.12273,0.071864,0.10578,0,1
2,GO REGULATION OF PROTEIN CATABOLIC PROCESS,0.091819,0.069288,0.11953,0,1
2,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,0.4521,0.069021,0.047036,0,1
2,GO REGULATION OF VACUOLE ORGANIZATION,0.077559,0.068845,0.12558,0,1
2,GO POST TRANSLATIONAL PROTEIN MODIFICATION,0.17091,0.066936,0.094736,0,1
2,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,0.23203,0.066302,0.093643,0,1
2,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,0.214,0.062877,0.070151,0,1
2,GO PROTEIN N LINKED GLYCOSYLATION,0.062884,0.062229,0.13878,0,1
2,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.098083,0.061714,0.13777,0,1
2,GO RESPONSE TO ABIOTIC STIMULUS,0.15655,0.060717,0.098236,0,1
2,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.074935,0.059409,0.12701,0,1
2,GO RRNA MODIFICATION,0.23827,0.056916,0.054129,0,1
2,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.098083,0.056828,0.11252,0,1
2,GO REGULATION OF TRANSLATIONAL INITIATION,0.18102,0.054124,0.088626,0,1
2,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.1475,0.052866,0.078793,0,1
2,GO VIRAL GENE EXPRESSION,0.38829,0.049592,0.030258,0,1
2,GO VIRION ASSEMBLY,0.11524,0.046176,0.073587,0,1
2,GO PURINE NUCLEOSIDE METABOLIC PROCESS,0.065157,0.043468,0.1066,0,1
2,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,0.54223,0.041892,0.040652,0,1
2,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.75756,0.036733,-0.016416,0,1
2,GO RNA CATABOLIC PROCESS,0.46168,0.019383,0.030286,0,1
2,GO EOSINOPHIL MIGRATION,0.00014989,0.81034,0.84504,0,0
2,GO EOSINOPHIL CHEMOTAXIS,0.00010866,0.76681,0.81943,0,0
2,GO NEGATIVE REGULATION OF MAST CELL ACTIVATION,7.8298e-05,0.61927,0.68209,0,0
2,GO NK T CELL DIFFERENTIATION,0.0017696,0.49942,0.4964,0,0
2,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.00096503,0.45989,0.57964,0,0
2,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.00029789,0.39937,0.44721,0,0
2,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.0014241,0.38074,0.35616,0,0
2,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.00040321,0.37766,0.46013,0,0
2,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.0027019,0.37571,0.45207,0,0
2,GO TRABECULA FORMATION,0.0038653,0.37335,0.3447,0,0
2,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,0.0031545,0.37219,0.34995,0,0
2,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,7.3279e-05,0.34959,0.43512,0,0
2,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.00013188,0.34953,0.48344,0,0
2,GO DEFENSE RESPONSE TO FUNGUS,0.00332,0.34831,0.36288,0,0
2,GO COLLAGEN FIBRIL ORGANIZATION,0.0049572,0.3481,0.46554,0,0
2,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,0.0028457,0.32,0.42461,0,0
2,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.062884,0.30942,0.25797,0,0
2,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.0172,0.30612,0.30887,0,0
2,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,0.0044907,0.30459,0.38612,0,0
2,GO CELLULAR RESPONSE TO VITAMIN,0.034576,0.30349,0.24444,0,0
2,GO REGULATION OF GLOMERULAR FILTRATION,0.0028457,0.30329,0.42366,0,0
2,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.0010798,0.30156,0.33054,0,0
2,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.019548,0.29846,0.35795,0,0
2,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.0021907,0.29459,0.36386,0,0
2,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.015104,0.28896,0.27592,0,0
2,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,0.013834,0.28642,0.30702,0,0
2,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,0.024086,0.28586,0.27878,0,0
2,GO STEM CELL DIVISION,0.014457,0.28467,0.25853,0,0
2,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,0.031957,0.28366,0.21692,0,0
2,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.030713,0.28175,0.30802,0,0
2,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.072385,0.27791,0.22153,0,0
2,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,0.025096,0.27503,0.24112,0,0
2,GO HISTAMINE SECRETION,0.098083,0.27014,0.21162,0,0
2,GO POLYOL TRANSPORT,0.052482,0.26509,0.20764,0,0
2,GO PROSTATIC BUD FORMATION,0.0080134,0.26385,0.34914,0,0
2,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,0.00021879,0.26384,0.33597,0,0
2,GO GLAND MORPHOGENESIS,0.0038653,0.26234,0.30928,0,0
2,GO BRANCH ELONGATION OF AN EPITHELIUM,0.0057394,0.26228,0.25409,0,0
2,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.008797,0.25912,0.30616,0,0
2,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,0.0057394,0.25787,0.37326,0,0
2,GO SPROUTING ANGIOGENESIS,0.00091199,0.25425,0.34489,0,0
2,GO SALIVARY GLAND DEVELOPMENT,0.010101,0.25148,0.30805,0,0
2,GO CELLULAR RESPONSE TO X RAY,0.015776,0.25094,0.26763,0,0
2,GO REGULATION OF CELL FATE COMMITMENT,0.0080134,0.25031,0.25817,0,0
2,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.022172,0.24854,0.23918,0,0
2,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,0.058535,0.24778,0.27072,0,0
2,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,0.013235,0.24771,0.24393,0,0
2,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,0.0080134,0.2475,0.24194,0,0
2,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.013834,0.2432,0.23755,0,0
2,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,0.0076456,0.24168,0.31178,0,0
2,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.025096,0.24079,0.2713,0,0
2,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.023112,0.2405,0.22032,0,0
2,GO PROSTATE GLAND DEVELOPMENT,0.0076456,0.24026,0.27216,0,0
2,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,0.035953,0.23931,0.39079,0,0
2,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,0.067497,0.23786,0.29326,0,0
2,GO RENAL VESICLE DEVELOPMENT,0.017954,0.23781,0.23748,0,0
2,GO CELLULAR RESPONSE TO CADMIUM ION,0.0076456,0.23276,0.25795,0,0
2,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,0.072385,0.23051,0.20156,0,0
2,GO MYOBLAST DIFFERENTIATION,0.0012071,0.22815,0.27492,0,0
2,GO BIOLOGICAL PHASE,0.094909,0.2279,0.19224,0,0
2,GO TRACHEA DEVELOPMENT,0.0028457,0.22406,0.33474,0,0
2,GO EPIDERMIS MORPHOGENESIS,0.013834,0.22347,0.27676,0,0
2,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.0018673,0.22113,0.33376,0,0
2,GO TROPHOBLAST CELL MIGRATION,0.00332,0.21996,0.26482,0,0
2,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,0.024086,0.21976,0.22969,0,0
2,GO DRUG CATABOLIC PROCESS,0.015104,0.21863,0.20754,0,0
2,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.08588,0.21821,0.15597,0,0
2,GO REGULATION OF ODONTOGENESIS,0.006955,0.21776,0.31564,0,0
2,GO FIBROBLAST PROLIFERATION,0.00064645,0.21692,0.27209,0,0
2,GO LABYRINTHINE LAYER DEVELOPMENT,0.031957,0.21512,0.17801,0,0
2,GO DETOXIFICATION OF INORGANIC COMPOUND,0.5959,0.21506,0.076694,0,0
2,GO RELAXATION OF CARDIAC MUSCLE,0.15655,0.21433,0.15079,0,0
2,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.0034935,0.21403,0.31541,0,0
2,GO CELLULAR RESPONSE TO VITAMIN D,0.23827,0.2103,0.13907,0,0
2,GO ESTROUS CYCLE,0.031957,0.20934,0.24928,0,0
2,GO RENAL FILTRATION,0.045233,0.20869,0.29603,0,0
2,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,0.080256,0.20771,0.23431,0,0
2,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,0.0060238,0.20594,0.25819,0,0
2,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.0057394,0.20478,0.23846,0,0
2,GO REGULATION OF PROSTAGLANDIN SECRETION,0.019548,0.20409,0.28598,0,0
2,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,0.014457,0.20314,0.30063,0,0
2,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.0031545,0.20276,0.27973,0,0
2,GO PEPTIDYL PROLINE HYDROXYLATION,0.091819,0.2019,0.13584,0,0
2,GO MESODERMAL CELL DIFFERENTIATION,0.0052065,0.20185,0.27357,0,0
2,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.028348,0.20184,0.21065,0,0
2,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.18624,0.20065,0.17524,0,0
2,GO EMBRYONIC PLACENTA MORPHOGENESIS,0.067497,0.19847,0.19916,0,0
2,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.006955,0.19527,0.20637,0,0
2,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.0060238,0.19387,0.25014,0,0
2,GO ENDOTHELIUM DEVELOPMENT,0.025096,0.19065,0.25862,0,0
2,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.016475,0.18838,0.20741,0,0
2,GO CORONARY VASCULATURE MORPHOGENESIS,0.10134,0.18733,0.21591,0,0
2,GO HIPPO SIGNALING,0.26442,0.18694,0.14401,0,0
2,GO INTESTINAL LIPID ABSORPTION,0.072385,0.18693,0.19868,0,0
2,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.041938,0.18613,0.23635,0,0
2,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.27126,0.18562,0.19406,0,0
2,GO GENITALIA DEVELOPMENT,0.035953,0.18316,0.18489,0,0
2,GO CELL PROLIFERATION IN HINDBRAIN,0.091819,0.18303,0.15292,0,0
2,GO REGULATION OF CELL FATE SPECIFICATION,0.08588,0.18267,0.22965,0,0
2,GO OSTEOBLAST DIFFERENTIATION,0.010101,0.18252,0.20793,0,0
2,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,0.08881,0.18145,0.19637,0,0
2,GO CHONDROCYTE DIFFERENTIATION,0.045233,0.18033,0.22426,0,0
2,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.013834,0.17966,0.23375,0,0
2,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.1475,0.17888,0.19468,0,0
2,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.098083,0.17812,0.18112,0,0
2,GO NEGATIVE REGULATION OF ANOIKIS,0.10468,0.17763,0.21615,0,0
2,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.0076456,0.1769,0.23565,0,0
2,GO CELLULAR RESPONSE TO COPPER ION,0.27821,0.17678,0.12372,0,0
2,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.022172,0.17513,0.2624,0,0
2,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.034576,0.17408,0.18315,0,0
2,GO REGULATION OF NUCLEASE ACTIVITY,0.043559,0.17363,0.15795,0,0
2,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.035953,0.17353,0.2206,0,0
2,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.08881,0.17337,0.21153,0,0
2,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,0.094909,0.17307,0.17774,0,0
2,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.021265,0.17237,0.26927,0,0
2,GO BONE MORPHOGENESIS,0.011574,0.17115,0.25669,0,0
2,GO CHONDROCYTE DEVELOPMENT,0.048745,0.16988,0.24805,0,0
2,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,0.11524,0.16934,0.22751,0,0
2,GO CARDIAC CHAMBER MORPHOGENESIS,0.077559,0.16896,0.18145,0,0
2,GO CELLULAR RESPONSE TO IRON ION,0.15655,0.16824,0.18396,0,0
2,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.048745,0.16609,0.29201,0,0
2,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,0.080256,0.16535,0.19081,0,0
2,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.045233,0.16519,0.18314,0,0
2,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.13467,0.16415,0.17355,0,0
2,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.067497,0.16388,0.22451,0,0
2,GO HISTAMINE TRANSPORT,0.17591,0.16375,0.17054,0,0
2,GO REGULATION OF ANOIKIS,0.054439,0.16321,0.21106,0,0
2,GO RELAXATION OF MUSCLE,0.15197,0.1627,0.12553,0,0
2,GO REGULATION OF WATER LOSS VIA SKIN,0.2259,0.16236,0.079091,0,0
2,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.060677,0.1623,0.14595,0,0
2,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.077559,0.16164,0.21973,0,0
2,GO CARTILAGE DEVELOPMENT,0.011574,0.16156,0.23392,0,0
2,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,0.08303,0.16147,0.24486,0,0
2,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.016475,0.16126,0.17905,0,0
2,GO LATERAL VENTRICLE DEVELOPMENT,0.20822,0.16101,0.18209,0,0
2,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.031957,0.16096,0.24704,0,0
2,GO NEGATIVE REGULATION OF OSSIFICATION,0.014457,0.16073,0.22556,0,0
2,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,0.013235,0.16068,0.16896,0,0
2,GO MALE GENITALIA DEVELOPMENT,0.072385,0.16065,0.16197,0,0
2,GO CELLULAR RESPONSE TO ZINC ION,0.40594,0.16011,0.084135,0,0
2,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.10468,0.15984,0.15122,0,0
2,GO CARDIAC SEPTUM MORPHOGENESIS,0.11163,0.15955,0.18322,0,0
2,GO REGULATION OF FATTY ACID TRANSPORT,0.013834,0.15916,0.2295,0,0
2,GO COCHLEA MORPHOGENESIS,0.074935,0.15867,0.15745,0,0
2,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS,0.2259,0.15757,0.18296,0,0
2,GO CHLORIDE ION HOMEOSTASIS,0.10811,0.15743,0.16127,0,0
2,GO DORSAL AORTA DEVELOPMENT,0.058535,0.15737,0.24405,0,0
2,GO REGULATION OF URINE VOLUME,0.043559,0.15687,0.22988,0,0
2,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.033245,0.15672,0.1971,0,0
2,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.13885,0.15664,0.21268,0,0
2,GO ENDOCARDIAL CUSHION DEVELOPMENT,0.062884,0.15625,0.22486,0,0
2,GO POSITIVE REGULATION OF ORGAN GROWTH,0.015104,0.15622,0.21695,0,0
2,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.10134,0.15621,0.17895,0,0
2,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.058535,0.15575,0.13825,0,0
2,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,0.10134,0.154,0.12387,0,0
2,GO LIPID DIGESTION,0.15197,0.15353,0.15901,0,0
2,GO METANEPHROS DEVELOPMENT,0.022172,0.1532,0.21627,0,0
2,GO BODY MORPHOGENESIS,0.1475,0.15315,0.15426,0,0
2,GO MESENCHYME MORPHOGENESIS,0.041938,0.15259,0.241,0,0
2,GO RESPONSE TO CADMIUM ION,0.013834,0.15226,0.1879,0,0
2,GO ECTODERM DEVELOPMENT,0.33821,0.15223,0.066064,0,0
2,GO EPITHELIAL TO MESENCHYMAL TRANSITION,0.074935,0.15194,0.17867,0,0
2,GO PARAXIAL MESODERM MORPHOGENESIS,0.15655,0.15187,0.14369,0,0
2,GO RESPONSE TO X RAY,0.037377,0.15125,0.19309,0,0
2,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,0.022172,0.15034,0.24119,0,0
2,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.048745,0.15001,0.14445,0,0
2,GO EPITHELIAL CELL CELL ADHESION,0.19156,0.14979,0.1753,0,0
2,GO GLIAL CELL APOPTOTIC PROCESS,0.022172,0.14906,0.19846,0,0
2,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,0.197,0.1477,0.09242,0,0
2,GO CELL AGGREGATION,0.065157,0.14715,0.19035,0,0
2,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.056456,0.14688,0.18917,0,0
2,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.17091,0.1467,0.16044,0,0
2,GO MESODERMAL CELL FATE COMMITMENT,0.026142,0.14643,0.13692,0,0
2,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,0.0040644,0.14635,0.25823,0,0
2,GO ENDOCARDIAL CUSHION MORPHOGENESIS,0.1306,0.1462,0.1929,0,0
2,GO PROTEIN O LINKED GLYCOSYLATION,0.11894,0.14556,0.12118,0,0
2,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.18102,0.14539,0.14423,0,0
2,GO AZOLE TRANSMEMBRANE TRANSPORT,0.49108,0.14503,0.099263,0,0
2,GO SKELETAL MUSCLE CELL DIFFERENTIATION,0.011574,0.14498,0.18337,0,0
2,GO POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION,0.27821,0.1449,0.091773,0,0
2,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.010572,0.14476,0.19869,0,0
2,GO CYSTEINE METABOLIC PROCESS,0.098083,0.14476,0.15272,0,0
2,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.47137,0.14445,0.058117,0,0
2,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.11894,0.14436,0.15572,0,0
2,GO L GLUTAMATE IMPORT,0.15655,0.14406,0.12519,0,0
2,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.072385,0.14399,0.21217,0,0
2,GO REGULATION OF CELL PROJECTION SIZE,0.68646,0.14393,0.021458,0,0
2,GO REGULATION OF GLIAL CELL PROLIFERATION,0.038848,0.14388,0.2062,0,0
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.067497,0.14381,0.13391,0,0
2,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.11163,0.14367,0.25598,0,0
2,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.17091,0.14337,0.18527,0,0
2,GO SIGNAL PEPTIDE PROCESSING,0.214,0.14329,0.11632,0,0
2,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.024086,0.14325,0.18631,0,0
2,GO RESPONSE TO ZINC ION,0.028348,0.14262,0.15028,0,0
2,GO TONGUE DEVELOPMENT,0.072385,0.14244,0.15575,0,0
2,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.045233,0.14226,0.1769,0,0
2,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,0.64051,0.14187,0.062809,0,0
2,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.074935,0.14176,0.13786,0,0
2,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.10134,0.13978,0.26299,0,0
2,GO ANIMAL ORGAN FORMATION,0.054439,0.13877,0.18493,0,0
2,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.27821,0.13865,0.11152,0,0
2,GO CARDIAC ATRIUM MORPHOGENESIS,0.23203,0.13862,0.14059,0,0
2,GO MESONEPHRIC TUBULE MORPHOGENESIS,0.1475,0.13859,0.13009,0,0
2,GO MAST CELL MIGRATION,0.16602,0.13853,0.17866,0,0
2,GO AUTOPHAGIC CELL DEATH,0.0096484,0.13837,0.18336,0,0
2,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,0.18624,0.13833,0.1584,0,0
2,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.035953,0.13813,0.18761,0,0
2,GO OUTFLOW TRACT MORPHOGENESIS,0.091819,0.13791,0.21068,0,0
2,GO AMINO ACID IMPORT,0.077559,0.13786,0.16461,0,0
2,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.045233,0.13775,0.17842,0,0
2,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.037377,0.13774,0.19835,0,0
2,GO REGULATION OF ASTROCYTE DIFFERENTIATION,0.23827,0.13631,0.11436,0,0
2,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,0.013235,0.13623,0.21478,0,0
2,GO HEART TRABECULA MORPHOGENESIS,0.1306,0.13521,0.1947,0,0
2,GO OVULATION CYCLE PROCESS,0.11524,0.13515,0.14885,0,0
2,GO RESPONSE TO COPPER ION,0.15197,0.13513,0.1241,0,0
2,GO RADIAL GLIAL CELL DIFFERENTIATION,0.040368,0.13472,0.18986,0,0
2,GO DERMATAN SULFATE METABOLIC PROCESS,0.13885,0.13468,0.23055,0,0
2,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,0.072385,0.13378,0.21991,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.10134,0.13339,0.16479,0,0
2,GO REGULATION OF HAIR CYCLE,0.080256,0.13306,0.17213,0,0
2,GO MESENCHYME DEVELOPMENT,0.091819,0.13264,0.16118,0,0
2,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,0.067497,0.13261,0.22302,0,0
2,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.08881,0.13249,0.21167,0,0
2,GO REGULATION OF RENAL SYSTEM PROCESS,0.052482,0.13238,0.22119,0,0
2,GO WATER HOMEOSTASIS,0.16602,0.13192,0.12117,0,0
2,GO REGULATION OF AXON GUIDANCE,0.2577,0.13185,0.13361,0,0
2,GO CONNECTIVE TISSUE DEVELOPMENT,0.020391,0.13168,0.20961,0,0
2,GO L SERINE METABOLIC PROCESS,0.69814,0.13102,-0.0052295,0,0
2,GO RENAL SYSTEM PROCESS,0.050584,0.13101,0.19774,0,0
2,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.13885,0.13015,0.15176,0,0
2,GO MITOTIC CELL CYCLE ARREST,0.046961,0.13005,0.17687,0,0
2,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.197,0.12959,0.1505,0,0
2,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.11894,0.12919,0.17092,0,0
2,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.39705,0.12918,0.074203,0,0
2,GO PROTEIN KINASE A SIGNALING,0.10811,0.1291,0.12961,0,0
2,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.037377,0.12905,0.16029,0,0
2,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.030713,0.129,0.17922,0,0
2,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.052482,0.12873,0.22879,0,0
2,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.065157,0.12843,0.23178,0,0
2,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.080256,0.12823,0.24273,0,0
2,GO POSITIVE REGULATION OF SECRETION,0.11524,0.12806,0.12213,0,0
2,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,0.17091,0.12776,0.18387,0,0
2,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.21989,0.1273,0.1298,0,0
2,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.17091,0.1265,0.17367,0,0
2,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,0.24463,0.1264,0.1087,0,0
2,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.026142,0.12629,0.16317,0,0
2,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,0.052482,0.12601,0.2185,0,0
2,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.62923,0.12586,0.026337,0,0
2,GO POSITIVE REGULATION OF HEART GROWTH,0.022172,0.12541,0.1995,0,0
2,GO GLYCINE TRANSPORT,0.2577,0.12533,0.12817,0,0
2,GO BASEMENT MEMBRANE ASSEMBLY,0.15197,0.12512,0.22855,0,0
2,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.197,0.12494,0.11927,0,0
2,GO NADPH REGENERATION,0.15655,0.12466,0.1023,0,0
2,GO GLIAL CELL DEVELOPMENT,0.16123,0.12448,0.12575,0,0
2,GO ENDOTHELIAL CELL CHEMOTAXIS,0.019548,0.12413,0.27723,0,0
2,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,0.12662,0.12399,0.21017,0,0
2,GO STEM CELL DIFFERENTIATION,0.024086,0.12388,0.14752,0,0
2,GO NEGATIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.14312,0.12327,0.11972,0,0
2,GO LUNG ALVEOLUS DEVELOPMENT,0.1475,0.12292,0.18971,0,0
2,GO REGULATION OF VASOCONSTRICTION,0.022172,0.12276,0.26501,0,0
2,GO OVULATION CYCLE,0.072385,0.12261,0.17593,0,0
2,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.17091,0.12229,0.15575,0,0
2,GO REGULATION OF SECONDARY METABOLIC PROCESS,0.14312,0.12212,0.11276,0,0
2,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.29248,0.12183,0.1222,0,0
2,GO MOTOR NEURON AXON GUIDANCE,0.4521,0.12157,0.10638,0,0
2,GO METANEPHRIC EPITHELIUM DEVELOPMENT,0.10468,0.12153,0.18229,0,0
2,GO REGULATION OF CILIUM MOVEMENT,0.90549,0.12055,-0.0047188,0,0
2,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,0.091819,0.1202,0.19448,0,0
2,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.060677,0.12012,0.19922,0,0
2,GO ENDOTHELIAL CELL DEVELOPMENT,0.054439,0.11988,0.24067,0,0
2,GO GLYCINE METABOLIC PROCESS,0.29248,0.11976,0.08351,0,0
2,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.12662,0.11966,0.22752,0,0
2,GO EPITHELIAL STRUCTURE MAINTENANCE,0.19156,0.11947,0.11915,0,0
2,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,0.074935,0.11945,0.20105,0,0
2,GO MAINTENANCE OF BLOOD BRAIN BARRIER,0.12662,0.11912,0.1744,0,0
2,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,0.16602,0.11849,0.11609,0,0
2,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,0.08303,0.11793,0.10427,0,0
2,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.065157,0.1178,0.1783,0,0
2,GO NEPHRIC DUCT MORPHOGENESIS,0.11163,0.11774,0.1835,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.031957,0.11735,0.17222,0,0
2,GO POST GOLGI VESICLE MEDIATED TRANSPORT,0.054439,0.11694,0.15209,0,0
2,GO NEURAL CREST CELL DIFFERENTIATION,0.15655,0.11684,0.14178,0,0
2,GO RESPONSE TO VITAMIN A,0.080256,0.11661,0.15645,0,0
2,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.16602,0.11656,0.18704,0,0
2,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,0.10134,0.11631,0.15467,0,0
2,GO VENTRICULAR SEPTUM DEVELOPMENT,0.098083,0.11596,0.17071,0,0
2,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.37111,0.11564,0.026186,0,0
2,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,0.50109,0.11554,0.081247,0,0
2,GO PROTEIN OXIDATION,0.094909,0.11546,0.12606,0,0
2,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.11163,0.1153,0.19031,0,0
2,GO ACTIVATION OF JNKK ACTIVITY,0.08881,0.11504,0.17595,0,0
2,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.062884,0.11453,0.17073,0,0
2,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,0.072385,0.11398,0.19588,0,0
2,GO SKELETAL SYSTEM MORPHOGENESIS,0.12662,0.11382,0.15541,0,0
2,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.08588,0.11343,0.12706,0,0
2,GO BASIC AMINO ACID TRANSPORT,0.62923,0.11333,0.074705,0,0
2,GO CALCIUM ION IMPORT INTO CYTOSOL,0.46168,0.11327,0.099405,0,0
2,GO REPLICATIVE SENESCENCE,0.28529,0.11303,0.091193,0,0
2,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.074935,0.1127,0.14631,0,0
2,GO SKELETAL SYSTEM DEVELOPMENT,0.02951,0.1124,0.19034,0,0
2,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.197,0.11219,0.17969,0,0
2,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.25111,0.11216,0.096995,0,0
2,GO NEPHRON DEVELOPMENT,0.08588,0.11203,0.17668,0,0
2,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.18624,0.11143,0.12491,0,0
2,GO MUSCLE HYPERTROPHY,0.17591,0.11141,0.13186,0,0
2,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,0.13885,0.1114,0.15426,0,0
2,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.36271,0.11136,0.13428,0,0
2,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,0.065157,0.11123,0.12075,0,0
2,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,0.065157,0.11119,0.13035,0,0
2,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.13467,0.11074,0.083109,0,0
2,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.067497,0.11019,0.24009,0,0
2,GO ALCOHOL CATABOLIC PROCESS,0.038848,0.11001,0.13811,0,0
2,GO CARDIAC CHAMBER DEVELOPMENT,0.077559,0.10973,0.16991,0,0
2,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.021265,0.10961,0.15616,0,0
2,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.1306,0.10906,0.14924,0,0
2,GO ENDOCHONDRAL BONE MORPHOGENESIS,0.062884,0.109,0.19815,0,0
2,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.10134,0.10873,0.11743,0,0
2,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.091819,0.10869,0.12961,0,0
2,GO REGULATION OF ICOSANOID SECRETION,0.035953,0.10863,0.19189,0,0
2,GO REGULATION OF EXOSOMAL SECRETION,0.27126,0.10845,0.088447,0,0
2,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,0.38829,0.10839,0.063068,0,0
2,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.091819,0.10839,0.12594,0,0
2,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.11163,0.10809,0.14231,0,0
2,GO IRON COORDINATION ENTITY TRANSPORT,0.2577,0.10807,0.11951,0,0
2,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,0.026142,0.10802,0.15833,0,0
2,GO REGULATION OF HEART GROWTH,0.028348,0.10778,0.17036,0,0
2,GO HEART MORPHOGENESIS,0.091819,0.10755,0.16495,0,0
2,GO HORMONE CATABOLIC PROCESS,0.15197,0.10732,0.12636,0,0
2,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.12273,0.10648,0.12199,0,0
2,GO LIPID PHOSPHORYLATION,0.067497,0.10643,0.16034,0,0
2,GO PROSTATE GLAND MORPHOGENESIS,0.27126,0.10627,0.14939,0,0
2,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.098083,0.10625,0.23199,0,0
2,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.13467,0.10595,0.12342,0,0
2,GO KERATINIZATION,0.2259,0.10584,0.085643,0,0
2,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.017954,0.10576,0.13956,0,0
2,GO REGULATION OF MIRNA METABOLIC PROCESS,0.13467,0.10564,0.16734,0,0
2,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.1306,0.10531,0.15621,0,0
2,GO EMBRYONIC HEART TUBE MORPHOGENESIS,0.27126,0.10523,0.11611,0,0
2,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.072385,0.10502,0.16894,0,0
2,GO UV PROTECTION,0.098083,0.10491,0.16811,0,0
2,GO REPRODUCTIVE SYSTEM DEVELOPMENT,0.077559,0.10486,0.13712,0,0
2,GO RESPONSE TO IRON ION,0.47137,0.1048,0.087897,0,0
2,GO REGULATION OF CARTILAGE DEVELOPMENT,0.1475,0.1047,0.15622,0,0
2,GO CARDIAC MUSCLE CELL CONTRACTION,0.14312,0.10449,0.12134,0,0
2,GO EPITHELIAL CELL DIFFERENTIATION,0.098083,0.10429,0.12359,0,0
2,GO BASE EXCISION REPAIR AP SITE FORMATION,0.51122,0.10402,0.0083551,0,0
2,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.24463,0.10346,0.12499,0,0
2,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,0.29248,0.1033,0.13285,0,0
2,GO NEGATIVE REGULATION OF GROWTH,0.08303,0.10327,0.14352,0,0
2,GO MICROVILLUS ASSEMBLY,0.26442,0.103,0.10151,0,0
2,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.091819,0.10275,0.12018,0,0
2,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.069906,0.10268,0.14303,0,0
2,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.32248,0.10248,0.1008,0,0
2,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.18102,0.10224,0.099402,0,0
2,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,0.49108,0.10184,0.090241,0,0
2,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.098083,0.10183,0.11949,0,0
2,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.14312,0.10139,0.11301,0,0
2,GO SEROTONIN TRANSPORT,0.15197,0.10119,0.18214,0,0
2,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.10134,0.10117,0.2358,0,0
2,GO ENDOCYTIC RECYCLING,0.15655,0.101,0.14692,0,0
2,GO REGULATION OF ANION TRANSPORT,0.11163,0.1009,0.13788,0,0
2,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,0.33821,0.10088,0.094396,0,0
2,GO AXIS ELONGATION,0.12662,0.10063,0.15911,0,0
2,GO REGULATION OF NEURON PROJECTION REGENERATION,0.214,0.1002,0.14279,0,0
2,GO REGULATION OF FILOPODIUM ASSEMBLY,0.28529,0.099709,0.11971,0,0
2,GO REGULATION OF HISTONE DEACETYLATION,0.18624,0.099539,0.12481,0,0
2,GO DENDRITE SELF AVOIDANCE,0.27821,0.099214,0.11478,0,0
2,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.23203,0.098872,0.095485,0,0
2,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.197,0.098865,0.16329,0,0
2,GO INDOLALKYLAMINE METABOLIC PROCESS,0.25111,0.098651,0.12393,0,0
2,GO EMBRYONIC HEART TUBE DEVELOPMENT,0.17091,0.098559,0.14188,0,0
2,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.16602,0.098003,0.17514,0,0
2,GO MUSCLE ORGAN DEVELOPMENT,0.080256,0.097909,0.13907,0,0
2,GO CARDIAC MUSCLE CELL PROLIFERATION,0.11163,0.097643,0.16701,0,0
2,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.17091,0.097488,0.14325,0,0
2,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,0.15197,0.09746,0.12558,0,0
2,GO INOSITOL PHOSPHATE METABOLIC PROCESS,0.20256,0.096875,0.10823,0,0
2,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,0.098083,0.096761,0.12416,0,0
2,GO ACTIN MEDIATED CELL CONTRACTION,0.098083,0.096711,0.13756,0,0
2,GO POSITIVE REGULATION OF MACROAUTOPHAGY,0.10134,0.096711,0.1388,0,0
2,GO NEGATIVE REGULATION OF TORC1 SIGNALING,0.64051,0.096706,0.0758,0,0
2,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.10468,0.096562,0.18706,0,0
2,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,0.094909,0.096517,0.11607,0,0
2,GO MESENCHYMAL CELL PROLIFERATION,0.21989,0.096376,0.15795,0,0
2,GO CARDIAC VENTRICLE DEVELOPMENT,0.25111,0.095982,0.10932,0,0
2,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.25111,0.095751,0.085576,0,0
2,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.11894,0.095744,0.11082,0,0
2,GO UROGENITAL SYSTEM DEVELOPMENT,0.08588,0.095659,0.16294,0,0
2,GO RESPONSE TO GROWTH FACTOR,0.11524,0.095552,0.14872,0,0
2,GO MUSCLE TISSUE DEVELOPMENT,0.098083,0.095504,0.13226,0,0
2,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.1306,0.095474,0.11214,0,0
2,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.1306,0.09547,0.17125,0,0
2,GO RESPONSE TO WATER,0.17591,0.095237,0.14599,0,0
2,GO MODIFIED AMINO ACID TRANSPORT,0.056456,0.095201,0.1572,0,0
2,GO MAMMARY GLAND DEVELOPMENT,0.13467,0.095127,0.15645,0,0
2,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.23827,0.095018,0.13725,0,0
2,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.57414,0.095007,0.02349,0,0
2,GO NEGATIVE REGULATION OF CELL DIVISION,0.42405,0.09486,0.053805,0,0
2,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.7336,0.094718,0.045445,0,0
2,GO SPHINGOSINE 1 PHOSPHATE RECEPTOR SIGNALING PATHWAY,0.08303,0.094571,0.23155,0,0
2,GO NEGATIVE CHEMOTAXIS,0.29248,0.094563,0.14121,0,0
2,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.20822,0.09429,0.12112,0,0
2,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.89296,0.094288,0.014182,0,0
2,GO REGULATION OF PEPTIDE TRANSPORT,0.098083,0.094108,0.12143,0,0
2,GO CARBOHYDRATE TRANSPORT,0.12662,0.093841,0.12406,0,0
2,GO FIBROBLAST MIGRATION,0.056456,0.093812,0.18951,0,0
2,GO CARDIOCYTE DIFFERENTIATION,0.072385,0.093731,0.14503,0,0
2,GO STRESS FIBER ASSEMBLY,0.094909,0.093678,0.18347,0,0
2,GO MUSCLE CELL DIFFERENTIATION,0.067497,0.093617,0.14167,0,0
2,GO DENTATE GYRUS DEVELOPMENT,0.75756,0.093366,-0.0084595,0,0
2,GO REGULATION OF CELL DIFFERENTIATION,0.069906,0.093329,0.13903,0,0
2,GO AMINO SUGAR BIOSYNTHETIC PROCESS,0.069906,0.093178,0.15234,0,0
2,GO PHOSPHATIDYLGLYCEROL BIOSYNTHETIC PROCESS,0.24463,0.093014,0.090317,0,0
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.02951,0.092984,0.19222,0,0
2,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.29248,0.092784,0.11338,0,0
2,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.15197,0.092622,0.15729,0,0
2,GO CARDIAC VENTRICLE MORPHOGENESIS,0.7336,0.092563,0.062972,0,0
2,GO HAIR FOLLICLE MATURATION,0.2998,0.092557,0.11187,0,0
2,GO FACIAL NERVE MORPHOGENESIS,0.39705,0.092329,0.12926,0,0
2,GO NEURAL CREST CELL MIGRATION,0.20256,0.092157,0.11765,0,0
2,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.23203,0.09208,0.13217,0,0
2,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.14312,0.091967,0.14961,0,0
2,GO ENSHEATHMENT OF NEURONS,0.2998,0.091644,0.10837,0,0
2,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,0.36271,0.091527,0.11132,0,0
2,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.12273,0.091487,0.11181,0,0
2,GO PIGMENT CELL DIFFERENTIATION,0.2577,0.091312,0.10917,0,0
2,GO RESPONSE TO GONADOTROPIN,0.18624,0.090849,0.12446,0,0
2,GO HEART TRABECULA FORMATION,0.25111,0.090698,0.14687,0,0
2,GO THIOESTER METABOLIC PROCESS,0.038848,0.090659,0.13636,0,0
2,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.015776,0.090298,0.15858,0,0
2,GO MUSCLE ORGAN MORPHOGENESIS,0.214,0.090276,0.11362,0,0
2,GO DNA METHYLATION OR DEMETHYLATION,0.27126,0.090269,0.076021,0,0
2,GO NEGATIVE REGULATION OF JNK CASCADE,0.11894,0.090103,0.12551,0,0
2,GO MELANOCYTE DIFFERENTIATION,0.46168,0.090103,0.061385,0,0
2,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.36271,0.089981,0.056094,0,0
2,GO CRANIAL NERVE STRUCTURAL ORGANIZATION,0.27821,0.089941,0.16356,0,0
2,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.33029,0.089725,0.078469,0,0
2,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.12662,0.089714,0.12717,0,0
2,GO REGULATION OF MULTI ORGANISM PROCESS,0.013834,0.089033,0.14057,0,0
2,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.36271,0.088985,0.10756,0,0
2,GO EXOCRINE SYSTEM DEVELOPMENT,0.13467,0.08842,0.18128,0,0
2,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,0.08881,0.088274,0.14174,0,0
2,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.15197,0.088263,0.11879,0,0
2,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,0.30724,0.088159,0.11299,0,0
2,GO INDUCTION OF POSITIVE CHEMOTAXIS,0.15655,0.08805,0.21983,0,0
2,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.15655,0.088014,0.17107,0,0
2,GO FATTY ACID BETA OXIDATION,0.27126,0.087835,0.089231,0,0
2,GO ALANINE TRANSPORT,0.56341,0.087598,0.10088,0,0
2,GO HINDLIMB MORPHOGENESIS,0.62923,0.087548,0.077815,0,0
2,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.08881,0.087498,0.15276,0,0
2,GO ORGANOPHOSPHATE ESTER TRANSPORT,0.10811,0.087323,0.13273,0,0
2,GO LENS FIBER CELL DEVELOPMENT,0.54223,0.087194,0.074421,0,0
2,GO VIRAL RELEASE FROM HOST CELL,0.091819,0.086993,0.10692,0,0
2,GO VASODILATION,0.12662,0.086814,0.13473,0,0
2,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,0.33029,0.086718,0.090882,0,0
2,GO SEGMENTATION,0.28529,0.086613,0.1096,0,0
2,GO REGULATION OF TUBE SIZE,0.11524,0.086531,0.16206,0,0
2,GO MORPHOGENESIS OF AN EPITHELIUM,0.098083,0.086432,0.14106,0,0
2,GO ASYMMETRIC CELL DIVISION,0.23203,0.086359,0.10282,0,0
2,GO RESPONSE TO ACTIVITY,0.11163,0.086259,0.12149,0,0
2,GO NEGATIVE REGULATION OF BINDING,0.2259,0.086135,0.096854,0,0
2,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.1306,0.086114,0.12258,0,0
2,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.2577,0.085906,0.15065,0,0
2,GO NEGATIVE REGULATION OF PROTEIN IMPORT,0.19156,0.085709,0.1669,0,0
2,GO COBALAMIN METABOLIC PROCESS,0.062884,0.08553,0.16419,0,0
2,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.10811,0.08547,0.12376,0,0
2,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,0.41494,0.085373,0.09897,0,0
2,GO AUTOPHAGOSOME ORGANIZATION,0.10811,0.085333,0.12225,0,0
2,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.018736,0.085333,0.13742,0,0
2,GO PIRNA METABOLIC PROCESS,0.56341,0.085194,0.043168,0,0
2,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.26442,0.084901,0.092556,0,0
2,GO LONG TERM MEMORY,0.85555,0.084816,0.038935,0,0
2,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.067497,0.084637,0.15338,0,0
2,GO PLASMA MEMBRANE ORGANIZATION,0.18102,0.084367,0.14196,0,0
2,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.17591,0.083928,0.12526,0,0
2,GO NEUROBLAST DIVISION,0.14312,0.083661,0.14889,0,0
2,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,0.17591,0.083628,0.12229,0,0
2,GO KIDNEY EPITHELIUM DEVELOPMENT,0.33029,0.083558,0.11945,0,0
2,GO STEROID HORMONE SECRETION,0.35442,0.083419,0.11152,0,0
2,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.050584,0.083242,0.17092,0,0
2,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.27126,0.083201,0.07477,0,0
2,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.098083,0.082984,0.19063,0,0
2,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.39705,0.082947,0.066068,0,0
2,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,0.28529,0.082914,0.091349,0,0
2,GO HEART GROWTH,0.12662,0.082584,0.13938,0,0
2,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,0.57414,0.082561,0.065527,0,0
2,GO EPITHELIAL TUBE MORPHOGENESIS,0.11894,0.082393,0.14528,0,0
2,GO APICAL JUNCTION ASSEMBLY,0.32248,0.082339,0.10389,0,0
2,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.12273,0.082323,0.14511,0,0
2,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.33821,0.082287,0.085942,0,0
2,GO REGULATION OF MESODERM DEVELOPMENT,0.66333,0.082129,0.047069,0,0
2,GO MAGNESIUM ION HOMEOSTASIS,0.67486,0.081957,0.032301,0,0
2,GO ORGANOPHOSPHATE CATABOLIC PROCESS,0.065157,0.081928,0.10899,0,0
2,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,0.10134,0.081922,0.1062,0,0
2,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.32248,0.081777,0.11611,0,0
2,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.080256,0.081673,0.12957,0,0
2,GO REGULATION OF GLIOGENESIS,0.031957,0.081396,0.16359,0,0
2,GO REGULATION OF HISTONE H4 ACETYLATION,0.29248,0.081394,0.087184,0,0
2,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.062884,0.081342,0.13808,0,0
2,GO REGULATION OF SENSORY PERCEPTION,0.197,0.081253,0.096387,0,0
2,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,0.57414,0.081221,0.074154,0,0
2,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,0.48117,0.081141,0.0917,0,0
2,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.2259,0.081001,0.13005,0,0
2,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.12662,0.080957,0.14238,0,0
2,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.2259,0.080955,0.12169,0,0
2,GO PIGMENT ACCUMULATION,0.16602,0.080863,0.22147,0,0
2,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,0.12273,0.080719,0.2114,0,0
2,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,0.56341,0.080673,0.067176,0,0
2,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.1475,0.080545,0.11355,0,0
2,GO RECEPTOR INTERNALIZATION,0.25111,0.0802,0.11789,0,0
2,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.23827,0.080174,0.1096,0,0
2,GO XENOBIOTIC CATABOLIC PROCESS,0.24463,0.080054,0.11889,0,0
2,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.20256,0.080034,0.12886,0,0
2,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.60692,0.079985,0.11891,0,0
2,GO RENAL WATER HOMEOSTASIS,0.20256,0.079807,0.15374,0,0
2,GO GLIOGENESIS,0.197,0.079537,0.11548,0,0
2,GO REGULATION OF THE FORCE OF HEART CONTRACTION,0.50109,0.079434,0.074967,0,0
2,GO FUCOSE METABOLIC PROCESS,0.29248,0.079376,0.083798,0,0
2,GO MESODERM MORPHOGENESIS,0.08588,0.079117,0.16384,0,0
2,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,0.15197,0.078983,0.16102,0,0
2,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.1306,0.078891,0.12113,0,0
2,GO CIRCULATORY SYSTEM PROCESS,0.08881,0.078816,0.14933,0,0
2,GO PRO B CELL DIFFERENTIATION,0.62923,0.078778,0.066437,0,0
2,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.85555,0.078754,0.018408,0,0
2,GO CALCIUM ION IMPORT,0.18102,0.078257,0.10697,0,0
2,GO MYOFIBRIL ASSEMBLY,0.14312,0.078216,0.15689,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.11524,0.078116,0.11286,0,0
2,GO REGULATION OF FIBROBLAST MIGRATION,0.11894,0.077986,0.17047,0,0
2,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.23203,0.077844,0.095526,0,0
2,GO SKELETAL MUSCLE CONTRACTION,0.33821,0.077716,0.074252,0,0
2,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.072385,0.077696,0.13836,0,0
2,GO GOLGI RIBBON FORMATION,0.30724,0.077692,0.11784,0,0
2,GO ORGANIC ANION TRANSPORT,0.12662,0.077586,0.11695,0,0
2,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.25111,0.077571,0.10921,0,0
2,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.08881,0.077394,0.14402,0,0
2,GO NEGATIVE REGULATION OF NEURON DEATH,0.39705,0.07739,0.081271,0,0
2,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.14312,0.077381,0.18046,0,0
2,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.20822,0.077172,0.1246,0,0
2,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.14312,0.077133,0.17291,0,0
2,GO CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.23827,0.076917,0.098552,0,0
2,GO DIGESTIVE TRACT MORPHOGENESIS,0.36271,0.076767,0.1058,0,0
2,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.197,0.076664,0.14323,0,0
2,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.4521,0.076554,0.11565,0,0
2,GO CELL CELL JUNCTION ASSEMBLY,0.37964,0.076553,0.10347,0,0
2,GO PEPTIDE SECRETION,0.12273,0.076332,0.12904,0,0
2,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,0.098083,0.076318,0.16792,0,0
2,GO MOLTING CYCLE,0.36271,0.076301,0.089554,0,0
2,GO ACTIVATION OF GTPASE ACTIVITY,0.091819,0.076202,0.16952,0,0
2,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.1475,0.076133,0.16851,0,0
2,GO REGULATION OF STRIATED MUSCLE CONTRACTION,0.37964,0.076105,0.076178,0,0
2,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.30724,0.076077,0.096815,0,0
2,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.17591,0.076044,0.11717,0,0
2,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.098083,0.076035,0.13453,0,0
2,GO L ASCORBIC ACID METABOLIC PROCESS,0.098083,0.07591,0.16674,0,0
2,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.11163,0.075706,0.12149,0,0
2,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,0.41494,0.075503,0.099312,0,0
2,GO DNA MODIFICATION,0.28529,0.075491,0.069071,0,0
2,GO CELLULAR RESPONSE TO UV,0.16602,0.075407,0.10244,0,0
2,GO EXPLORATION BEHAVIOR,0.53179,0.07534,0.074499,0,0
2,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.067497,0.075261,0.13256,0,0
2,GO TISSUE MORPHOGENESIS,0.11894,0.075152,0.13456,0,0
2,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,0.080256,0.075137,0.12769,0,0
2,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,0.038848,0.074964,0.13851,0,0
2,GO NEURON DEATH,0.26442,0.074876,0.10012,0,0
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.23203,0.074823,0.0992,0,0
2,GO ALPHA AMINO ACID METABOLIC PROCESS,0.10468,0.074762,0.088444,0,0
2,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.094909,0.074732,0.10472,0,0
2,GO RESPONSE TO CALCIUM ION,0.1475,0.074625,0.11253,0,0
2,GO RESPONSE TO PH,0.20256,0.074598,0.13626,0,0
2,GO ALDITOL METABOLIC PROCESS,0.34626,0.074442,0.033993,0,0
2,GO SIALYLATION,0.39705,0.074427,0.1055,0,0
2,GO NEPHRON MORPHOGENESIS,0.11894,0.074254,0.1365,0,0
2,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.24463,0.074158,0.052388,0,0
2,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.35442,0.074094,0.049159,0,0
2,GO BONE GROWTH,0.091819,0.074046,0.20611,0,0
2,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.3148,0.073878,0.096648,0,0
2,GO IMPORT INTO NUCLEUS,0.50109,0.073794,0.061783,0,0
2,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.13467,0.073407,0.16564,0,0
2,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.1475,0.073292,0.097934,0,0
2,GO MESODERM DEVELOPMENT,0.197,0.073157,0.10727,0,0
2,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,0.56341,0.073092,0.054456,0,0
2,GO REGULATION OF TRANSPORT,0.24463,0.072975,0.10247,0,0
2,GO REGULATION OF BINDING,0.3148,0.07277,0.095649,0,0
2,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.11524,0.072672,0.13108,0,0
2,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,0.5959,0.072542,0.035705,0,0
2,GO ROOF OF MOUTH DEVELOPMENT,0.40594,0.072402,0.088732,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.36271,0.072306,0.15549,0,0
2,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,0.33029,0.071764,0.10288,0,0
2,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.20256,0.071128,0.14789,0,0
2,GO POSITIVE REGULATION OF BINDING,0.68646,0.071016,0.070242,0,0
2,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.64051,0.070508,0.076239,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION,0.23827,0.070412,0.10722,0,0
2,GO RESPONSE TO NITROSATIVE STRESS,0.18624,0.070299,0.07841,0,0
2,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.24463,0.070242,0.12174,0,0
2,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,0.79394,0.070187,0.030776,0,0
2,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.52145,0.070123,0.069001,0,0
2,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.18102,0.070089,0.15257,0,0
2,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.10134,0.070081,0.12666,0,0
2,GO GLUTAMINE METABOLIC PROCESS,0.35442,0.070044,0.067157,0,0
2,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.80618,0.069789,-0.00021991,0,0
2,GO REGULATION OF FATTY ACID BETA OXIDATION,0.35442,0.069402,0.12014,0,0
2,GO SARCOMERE ORGANIZATION,0.12273,0.069219,0.12521,0,0
2,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.27821,0.06893,0.078051,0,0
2,GO QUINONE METABOLIC PROCESS,0.27821,0.068911,0.049175,0,0
2,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.34626,0.068883,0.078673,0,0
2,GO FATTY ACID CATABOLIC PROCESS,0.44264,0.068847,0.072398,0,0
2,GO LIPID TRANSLOCATION,0.54223,0.06878,0.092903,0,0
2,GO GROWTH PLATE CARTILAGE DEVELOPMENT,0.27821,0.068693,0.12197,0,0
2,GO VESICLE TARGETING,0.20256,0.068451,0.096794,0,0
2,GO RESPONSE TO METAL ION,0.18102,0.068438,0.10649,0,0
2,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,0.077559,0.06823,0.091091,0,0
2,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.50109,0.068079,0.1175,0,0
2,GO EPITHELIUM DEVELOPMENT,0.16123,0.068049,0.10867,0,0
2,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.18102,0.06797,0.11157,0,0
2,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,0.34626,0.067894,0.081707,0,0
2,GO NEUROTROPHIN SIGNALING PATHWAY,0.26442,0.067703,0.10105,0,0
2,GO GMP METABOLIC PROCESS,0.17591,0.067671,0.099192,0,0
2,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.052482,0.067619,0.13719,0,0
2,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.50109,0.067436,0.076793,0,0
2,GO ANION TRANSPORT,0.15655,0.067436,0.10432,0,0
2,GO PENTOSE METABOLIC PROCESS,0.10134,0.06741,0.13546,0,0
2,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.49108,0.067402,0.095596,0,0
2,GO MUSCLE SYSTEM PROCESS,0.16602,0.067252,0.12588,0,0
2,GO LIPOSACCHARIDE METABOLIC PROCESS,0.28529,0.067029,0.084763,0,0
2,GO REGULATION OF HEART MORPHOGENESIS,0.214,0.066908,0.14342,0,0
2,GO NCRNA CATABOLIC PROCESS,0.49108,0.066895,0.048197,0,0
2,GO LENS FIBER CELL DIFFERENTIATION,0.51122,0.066878,0.078724,0,0
2,GO CARBOHYDRATE DERIVATIVE TRANSPORT,0.2577,0.066723,0.092706,0,0
2,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.08881,0.066518,0.16374,0,0
2,GO REGULATION OF ENDOCRINE PROCESS,0.26442,0.06602,0.12774,0,0
2,GO ORGAN GROWTH,0.072385,0.065873,0.16502,0,0
2,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.197,0.065833,0.11179,0,0
2,GO CANONICAL WNT SIGNALING PATHWAY,0.39705,0.065826,0.099381,0,0
2,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.56341,0.06582,0.055047,0,0
2,GO REGULATION OF HISTONE PHOSPHORYLATION,0.74555,0.065787,0.063746,0,0
2,GO REGULATION OF MUSCLE SYSTEM PROCESS,0.17591,0.065604,0.11459,0,0
2,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.27126,0.06554,0.11218,0,0
2,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.23203,0.065409,0.10905,0,0
2,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.24463,0.065151,0.1302,0,0
2,GO ERAD PATHWAY,0.13885,0.064849,0.1142,0,0
2,GO BLASTOCYST GROWTH,0.85555,0.064754,0.020998,0,0
2,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.3148,0.06466,0.083121,0,0
2,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,0.33029,0.064589,0.096888,0,0
2,GO CELL CELL JUNCTION ORGANIZATION,0.51122,0.064467,0.10364,0,0
2,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.96843,0.064406,-0.037396,0,0
2,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,0.52145,0.064357,0.067206,0,0
2,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,0.34626,0.064191,0.095676,0,0
2,GO LOCOMOTOR RHYTHM,0.34626,0.063777,0.11003,0,0
2,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.17591,0.063737,0.10811,0,0
2,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.3148,0.06369,0.072732,0,0
2,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.57414,0.063532,0.074417,0,0
2,GO PROTEIN HYDROXYLATION,0.23827,0.063486,0.10549,0,0
2,GO NEURON PROJECTION ARBORIZATION,1,0.06346,0.064929,0,0
2,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,0.25111,0.063453,0.24643,0,0
2,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.074935,0.063417,0.1385,0,0
2,GO SPINDLE MIDZONE ASSEMBLY,0.83078,0.063263,-0.068326,0,0
2,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,0.41494,0.063231,0.10908,0,0
2,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,0.70989,0.06279,0.054853,0,0
2,GO CARBOHYDRATE CATABOLIC PROCESS,0.29248,0.062662,0.090612,0,0
2,GO EPITHELIAL CELL DEVELOPMENT,0.214,0.062475,0.13298,0,0
2,GO PHAGOSOME ACIDIFICATION,0.30724,0.062132,0.080319,0,0
2,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,0.16123,0.062004,0.10297,0,0
2,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.53179,0.061972,0.090568,0,0
2,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,0.21989,0.061837,0.081972,0,0
2,GO SKIN EPIDERMIS DEVELOPMENT,0.41494,0.06182,0.087116,0,0
2,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,0.38829,0.061673,0.085931,0,0
2,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.4521,0.061544,0.096783,0,0
2,GO INTRACELLULAR MRNA LOCALIZATION,0.197,0.06153,0.12647,0,0
2,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.1475,0.061424,0.12275,0,0
2,GO SULFUR AMINO ACID METABOLIC PROCESS,0.29248,0.061177,0.065221,0,0
2,GO ACTIN FILAMENT NETWORK FORMATION,0.49108,0.061147,0.092695,0,0
2,GO DICARBOXYLIC ACID CATABOLIC PROCESS,0.16602,0.061066,0.10109,0,0
2,GO SPHINGOLIPID METABOLIC PROCESS,0.29248,0.060917,0.097843,0,0
2,GO SNORNA METABOLIC PROCESS,0.84314,0.060841,-0.022194,0,0
2,GO CARDIAC MUSCLE CELL DIFFERENTIATION,0.12273,0.06056,0.12081,0,0
2,GO REGULATION OF DNA RECOMBINATION,0.47137,0.060526,0.062581,0,0
2,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.60692,0.06051,0.052962,0,0
2,GO MEMBRANE ORGANIZATION,0.25111,0.060328,0.092494,0,0
2,GO REGULATION OF MUSCLE CONTRACTION,0.2577,0.060312,0.10231,0,0
2,GO BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS,0.50109,0.060295,0.094077,0,0
2,GO ANIMAL ORGAN MORPHOGENESIS,0.27126,0.060245,0.11451,0,0
2,GO MITOCHONDRIAL RNA PROCESSING,0.89296,0.06004,0.013774,0,0
2,GO SPHINGOID METABOLIC PROCESS,0.40594,0.060017,0.10795,0,0
2,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,0.1475,0.059821,0.11035,0,0
2,GO RESPONSE TO MUSCLE ACTIVITY,0.20822,0.059749,0.087741,0,0
2,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.2577,0.059644,0.12127,0,0
2,GO TUBE FORMATION,0.53179,0.059116,0.069412,0,0
2,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,0.50109,0.058932,0.093609,0,0
2,GO RESPONSE TO COLD,0.35442,0.05892,0.079962,0,0
2,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.30724,0.058774,0.10535,0,0
2,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,0.99368,0.058747,-0.0024146,0,0
2,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,0.46168,0.05869,0.076216,0,0
2,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,0.094909,0.058605,0.10164,0,0
2,GO RESPONSE TO BMP,0.34626,0.058542,0.1279,0,0
2,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,0.50109,0.058366,0.077718,0,0
2,GO PLASMA MEMBRANE TUBULATION,0.37111,0.058247,0.12833,0,0
2,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.58498,0.05821,0.051015,0,0
2,GO ENDOCRINE HORMONE SECRETION,0.23203,0.058144,0.11343,0,0
2,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.81845,0.057857,0.07332,0,0
2,GO REGULATION OF PROTEIN COMPLEX STABILITY,0.33029,0.05774,0.09146,0,0
2,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,0.2577,0.057667,0.098992,0,0
2,GO MESONEPHROS DEVELOPMENT,0.33821,0.057602,0.099257,0,0
2,GO TRICARBOXYLIC ACID METABOLIC PROCESS,0.18102,0.057578,0.12702,0,0
2,GO REGULATION OF FERTILIZATION,0.2577,0.057546,0.06165,0,0
2,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.13885,0.057502,0.097939,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.60692,0.057499,0.073722,0,0
2,GO REGULATION OF CELLULAR LOCALIZATION,0.41494,0.057474,0.082568,0,0
2,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.3148,0.056563,0.088734,0,0
2,GO PHARYNGEAL SYSTEM DEVELOPMENT,0.5959,0.056397,0.067355,0,0
2,GO ER OVERLOAD RESPONSE,0.36271,0.056277,0.086468,0,0
2,GO INORGANIC ANION TRANSPORT,0.37111,0.056259,0.07902,0,0
2,GO LEFT RIGHT AXIS SPECIFICATION,0.57414,0.05624,0.079076,0,0
2,GO PEROXISOMAL MEMBRANE TRANSPORT,0.35442,0.056225,0.065675,0,0
2,GO SNORNA 3 END PROCESSING,0.90549,0.056161,-0.051339,0,0
2,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.26442,0.056124,0.13882,0,0
2,GO EPITHELIAL TUBE FORMATION,0.65188,0.056043,0.058933,0,0
2,GO NEGATIVE REGULATION OF CELL GROWTH,0.40594,0.055958,0.09437,0,0
2,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,0.40594,0.05593,0.047433,0,0
2,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.52145,0.055925,0.084807,0,0
2,GO NEURON APOPTOTIC PROCESS,0.69814,0.055781,0.054334,0,0
2,GO PIGMENTATION,0.38829,0.055731,0.067828,0,0
2,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,0.27821,0.055587,0.12527,0,0
2,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,0.10134,0.055579,0.11424,0,0
2,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,0.72171,0.055537,0.036421,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.84314,0.055455,0.040598,0,0
2,GO PROTEIN LOCALIZATION TO ENDOSOME,0.42405,0.055351,0.13247,0,0
2,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.30724,0.055323,0.119,0,0
2,GO REGULATION OF SODIUM ION TRANSPORT,0.5959,0.055262,0.060396,0,0
2,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.37964,0.05513,0.085145,0,0
2,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.15197,0.055098,0.15736,0,0
2,GO DNA METHYLATION,0.57414,0.055095,0.039852,0,0
2,GO LYSOSOMAL TRANSPORT,0.40594,0.055041,0.088795,0,0
2,GO SMOOTH MUSCLE CONTRACTION,0.1475,0.054882,0.14536,0,0
2,GO CARDIAC ATRIUM DEVELOPMENT,0.78176,0.054682,0.063364,0,0
2,GO RESPONSE TO INSULIN,0.1475,0.054596,0.11949,0,0
2,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,0.16123,0.054503,0.097552,0,0
2,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.23827,0.05448,0.13838,0,0
2,GO REGULATION OF REPRODUCTIVE PROCESS,0.29248,0.054421,0.079109,0,0
2,GO INSEMINATION,0.35442,0.054379,0.13033,0,0
2,GO SPERM EGG RECOGNITION,0.197,0.054285,0.081553,0,0
2,GO REGULATION OF PROTEIN SUMOYLATION,0.27821,0.054285,0.10475,0,0
2,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,0.47137,0.054214,0.072917,0,0
2,GO HEART DEVELOPMENT,0.1475,0.054159,0.13755,0,0
2,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.23827,0.054021,0.15567,0,0
2,GO REGULATION OF WNT SIGNALING PATHWAY,0.42405,0.053997,0.089976,0,0
2,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.25111,0.053778,0.11497,0,0
2,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.79394,0.05372,0.017594,0,0
2,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.3148,0.053662,0.175,0,0
2,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,0.11894,0.0536,0.10364,0,0
2,GO MACROMOLECULE CATABOLIC PROCESS,0.30724,0.053596,0.077518,0,0
2,GO NEPHRON EPITHELIUM DEVELOPMENT,0.26442,0.053512,0.12785,0,0
2,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.98106,0.053338,0.011252,0,0
2,GO LACTATE METABOLIC PROCESS,0.67486,0.053302,0.04443,0,0
2,GO EMBRYONIC FORELIMB MORPHOGENESIS,0.91805,0.053276,0.018658,0,0
2,GO AUTOPHAGY OF NUCLEUS,0.24463,0.053247,0.10387,0,0
2,GO KIDNEY MORPHOGENESIS,0.2259,0.053201,0.11824,0,0
2,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.32248,0.053048,0.089984,0,0
2,GO MALE SEX DIFFERENTIATION,0.21989,0.052898,0.10985,0,0
2,GO RETINA HOMEOSTASIS,0.15197,0.052876,0.078372,0,0
2,GO CELLULAR GLUCAN METABOLIC PROCESS,0.83078,0.052874,0.0090043,0,0
2,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,0.57414,0.052688,0.048578,0,0
2,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.23203,0.052617,0.088491,0,0
2,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,0.85555,0.052611,0.020624,0,0
2,GO REGULATION OF BEHAVIOR,0.51122,0.052448,0.046493,0,0
2,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,0.27126,0.052106,0.096376,0,0
2,GO NEGATIVE REGULATION OF AXON EXTENSION,0.91805,0.051964,0.036979,0,0
2,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,0.33821,0.051944,0.043256,0,0
2,GO CERAMIDE METABOLIC PROCESS,0.17091,0.051851,0.11456,0,0
2,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.33029,0.051787,0.099985,0,0
2,GO CELLULAR RESPONSE TO RADIATION,0.214,0.051753,0.094911,0,0
2,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,0.44264,0.051741,0.041177,0,0
2,GO PROTEIN K48 LINKED UBIQUITINATION,0.74555,0.051715,0.048408,0,0
2,GO GOLGI TO ENDOSOME TRANSPORT,0.197,0.051643,0.1253,0,0
2,GO RESPONSE TO ETHER,0.197,0.051603,0.12154,0,0
2,GO MATURATION OF SSU RRNA,0.64051,0.051444,0.010572,0,0
2,GO ORGANIC ACID TRANSPORT,0.32248,0.051326,0.094149,0,0
2,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.96843,0.051264,-0.006674,0,0
2,GO HEART VALVE FORMATION,0.52145,0.051136,0.091165,0,0
2,GO ORGAN INDUCTION,0.42405,0.051062,0.10483,0,0
2,GO REGULATION OF SECRETION,0.37964,0.051007,0.086203,0,0
2,GO ANOIKIS,0.24463,0.050804,0.13373,0,0
2,GO NAD METABOLIC PROCESS,0.33029,0.050788,0.095611,0,0
2,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.36271,0.050693,0.10462,0,0
2,GO POSITIVE REGULATION OF FERTILIZATION,0.56341,0.050637,0.04734,0,0
2,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,0.60692,0.05062,0.036857,0,0
2,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.13467,0.050566,0.18361,0,0
2,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.23203,0.050551,0.08732,0,0
2,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,0.44264,0.050534,0.065436,0,0
2,GO REGULATION OF PROTEIN DEACETYLATION,0.53179,0.050476,0.067016,0,0
2,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,0.70989,0.050386,0.061281,0,0
2,GO RESPONSE TO ACIDIC PH,0.42405,0.050254,0.096027,0,0
2,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.33821,0.050188,0.10454,0,0
2,GO REGULATION OF TELOMERASE ACTIVITY,0.4521,0.050064,0.046264,0,0
2,GO LIPOPROTEIN METABOLIC PROCESS,0.3148,0.049887,0.080409,0,0
2,GO ACETYL COA BIOSYNTHETIC PROCESS,0.21989,0.049887,0.10754,0,0
2,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.28529,0.049542,0.1403,0,0
2,GO HISTONE H3 ACETYLATION,0.47137,0.04953,0.070147,0,0
2,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.25111,0.049526,0.083935,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.29248,0.049445,0.095647,0,0
2,GO REGULATION OF INTRACELLULAR TRANSPORT,0.27821,0.049312,0.090133,0,0
2,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.050584,0.049264,0.1146,0,0
2,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.60692,0.049091,0.070504,0,0
2,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.37111,0.048997,0.09105,0,0
2,GO DEVELOPMENTAL PIGMENTATION,0.37964,0.048957,0.088501,0,0
2,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.21989,0.04874,0.11705,0,0
2,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.16123,0.048669,0.086698,0,0
2,GO CELLULAR COMPONENT DISASSEMBLY,0.197,0.048627,0.087104,0,0
2,GO RHYTHMIC BEHAVIOR,0.57414,0.04859,0.06175,0,0
2,GO FRUCTOSE METABOLIC PROCESS,0.214,0.048584,0.12097,0,0
2,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.61803,0.048558,0.01079,0,0
2,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.28529,0.048475,0.10257,0,0
2,GO AMINE METABOLIC PROCESS,0.1475,0.048441,0.083391,0,0
2,GO MEMBRANE LIPID METABOLIC PROCESS,0.26442,0.04843,0.089956,0,0
2,GO REGULATION OF LYASE ACTIVITY,0.43329,0.048387,0.046365,0,0
2,GO DIGESTIVE SYSTEM DEVELOPMENT,0.81845,0.047882,0.056661,0,0
2,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,0.16602,0.047842,0.098916,0,0
2,GO RAC PROTEIN SIGNAL TRANSDUCTION,0.24463,0.047837,0.1149,0,0
2,GO SEGMENT SPECIFICATION,0.42405,0.047836,0.096366,0,0
2,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,0.13885,0.047814,0.060703,0,0
2,GO TRNA 5 LEADER REMOVAL,0.69814,0.047721,0.0033016,0,0
2,GO ION TRANSPORT,0.35442,0.047638,0.082955,0,0
2,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,0.69814,0.047631,0.085521,0,0
2,GO GOLGI LOCALIZATION,0.30724,0.047189,0.065708,0,0
2,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.11524,0.047064,0.095652,0,0
2,GO GLIAL CELL DIFFERENTIATION,0.7336,0.046991,0.072346,0,0
2,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.197,0.046948,0.1087,0,0
2,GO CARNITINE SHUTTLE,0.66333,0.046906,0.035513,0,0
2,GO DICARBOXYLIC ACID METABOLIC PROCESS,0.23827,0.046886,0.074116,0,0
2,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.53179,0.046833,0.047548,0,0
2,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.60692,0.046803,0.070372,0,0
2,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.49108,0.046712,0.084949,0,0
2,GO POLYOL METABOLIC PROCESS,0.38829,0.046278,0.082657,0,0
2,GO REGULATION OF DEACETYLASE ACTIVITY,0.7336,0.046274,0.086118,0,0
2,GO REGULATION OF AUTOPHAGY,0.2259,0.046272,0.097324,0,0
2,GO REGULATION OF CELLULAR COMPONENT SIZE,0.2998,0.046258,0.11526,0,0
2,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.33821,0.046235,0.11627,0,0
2,GO RESPONSE TO UV,0.69814,0.046149,0.052499,0,0
2,GO POSITIVE REGULATION OF DNA BINDING,0.52145,0.046142,0.04747,0,0
2,GO POSITIVE REGULATION OF CELL DIVISION,0.54223,0.046035,0.073436,0,0
2,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.41494,0.045795,0.044527,0,0
2,GO POSITIVE REGULATION OF ACTIN NUCLEATION,0.20256,0.045793,0.11901,0,0
2,GO LATERAL MESODERM DEVELOPMENT,0.37964,0.045726,0.11422,0,0
2,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,0.47137,0.045701,0.12898,0,0
2,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.70989,0.045635,0.019995,0,0
2,GO CARDIAC MUSCLE CONTRACTION,0.30724,0.045564,0.081095,0,0
2,GO REGULATION OF ANIMAL ORGAN FORMATION,0.29248,0.045529,0.10719,0,0
2,GO POLYSACCHARIDE METABOLIC PROCESS,1,0.045448,0.041542,0,0
2,GO INNER CELL MASS CELL PROLIFERATION,0.79394,0.045437,-0.060741,0,0
2,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,0.38829,0.045289,0.091005,0,0
2,GO REGULATION OF CELL MORPHOGENESIS,0.83078,0.045271,0.072348,0,0
2,GO ATP BIOSYNTHETIC PROCESS,0.20822,0.045139,0.10311,0,0
2,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,0.52145,0.044751,-0.033509,0,0
2,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,0.4521,0.044716,0.065647,0,0
2,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.54223,0.044436,0.061347,0,0
2,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.66333,0.044379,0.061318,0,0
2,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.62923,0.044348,0.014466,0,0
2,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,0.85555,0.044288,-0.0020265,0,0
2,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.74555,0.044207,0.017208,0,0
2,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.78176,0.044031,0.00047052,0,0
2,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,0.28529,0.043937,0.088638,0,0
2,GO VITAMIN CATABOLIC PROCESS,0.69814,0.043895,0.045245,0,0
2,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.94321,0.043839,0.06073,0,0
2,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,0.21989,0.043666,0.06433,0,0
2,GO HISTONE H3 K9 ACETYLATION,0.5959,0.043538,0.059994,0,0
2,GO GOLGI TO VACUOLE TRANSPORT,0.49108,0.043434,0.10552,0,0
2,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.42405,0.043425,0.080326,0,0
2,GO REGULATION OF BMP SIGNALING PATHWAY,0.24463,0.043131,0.16407,0,0
2,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,0.93062,0.042927,0.021565,0,0
2,GO NOTCH SIGNALING PATHWAY,0.79394,0.04291,0.048917,0,0
2,GO REGULATION OF ION TRANSPORT,0.33029,0.042905,0.083624,0,0
2,GO MAINTENANCE OF CELL NUMBER,0.60692,0.042857,0.082449,0,0
2,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.41494,0.042845,0.085391,0,0
2,GO PROTEIN LOCALIZATION TO VACUOLE,0.62923,0.042799,0.074636,0,0
2,GO RESPONSE TO AXON INJURY,0.84314,0.042684,0.052909,0,0
2,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.3148,0.042681,0.090458,0,0
2,GO GLUCOSE IMPORT,0.57414,0.042634,0.060972,0,0
2,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.52145,0.042634,0.074032,0,0
2,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.34626,0.042412,0.084916,0,0
2,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.32248,0.042403,0.055457,0,0
2,GO ORGANIC HYDROXY COMPOUND TRANSPORT,0.42405,0.04237,0.086106,0,0
2,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.57414,0.04231,0.048453,0,0
2,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,0.41494,0.042226,0.0577,0,0
2,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.44264,0.042142,0.075724,0,0
2,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,0.33029,0.042122,0.02442,0,0
2,GO GOLGI VESICLE TRANSPORT,0.47137,0.042103,0.063498,0,0
2,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.56341,0.042074,0.070031,0,0
2,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.23827,0.042064,0.11143,0,0
2,GO IMPORT ACROSS PLASMA MEMBRANE,0.40594,0.042017,0.080316,0,0
2,GO RNA 5 END PROCESSING,0.62923,0.041999,0.018864,0,0
2,GO REGULATION OF PROTEIN STABILITY,0.29248,0.041819,0.079472,0,0
2,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.91805,0.041625,0.027579,0,0
2,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.90549,0.041541,0.025738,0,0
2,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.28529,0.041474,0.084288,0,0
2,GO ATRIAL SEPTUM MORPHOGENESIS,0.99368,0.041412,0.0095503,0,0
2,GO STEROL BIOSYNTHETIC PROCESS,0.51122,0.041411,0.073054,0,0
2,GO REGULATION OF TRANSLATIONAL TERMINATION,0.2259,0.041394,0.10131,0,0
2,GO ONE CARBON METABOLIC PROCESS,0.49108,0.041362,0.03563,0,0
2,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.33821,0.041279,0.087593,0,0
2,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.44264,0.040995,0.10866,0,0
2,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.37111,0.040953,0.072507,0,0
2,GO REGULATION OF EXCRETION,0.2577,0.040948,0.13606,0,0
2,GO DISTAL TUBULE DEVELOPMENT,0.89296,0.040942,0.0014682,0,0
2,GO MAINTENANCE OF PROTEIN LOCATION,0.34626,0.040749,0.084299,0,0
2,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,0.90549,0.040638,0.030802,0,0
2,GO PROTEIN COMPLEX OLIGOMERIZATION,0.26442,0.040597,0.08142,0,0
2,GO MULTICELLULAR ORGANISM AGING,0.81845,0.040434,0.044738,0,0
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.57414,0.040199,0.052093,0,0
2,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,0.23827,0.040123,0.084078,0,0
2,GO PROTEIN K63 LINKED UBIQUITINATION,0.39705,0.040108,0.07409,0,0
2,GO RENAL TUBULE DEVELOPMENT,0.3148,0.039858,0.11306,0,0
2,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.17591,0.039842,0.10195,0,0
2,GO PROTEIN POLYUBIQUITINATION,0.68646,0.039839,0.04741,0,0
2,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,0.094909,0.039806,0.067784,0,0
2,GO DETECTION OF STIMULUS,0.4521,0.039792,0.058554,0,0
2,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.39705,0.039726,0.11679,0,0
2,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.58498,0.039683,0.063785,0,0
2,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,0.14312,0.039581,0.12972,0,0
2,GO CELLULAR PROTEIN CATABOLIC PROCESS,0.61803,0.039507,0.058689,0,0
2,GO ENDOSOME TO LYSOSOME TRANSPORT,0.49108,0.039282,0.055666,0,0
2,GO METAL ION TRANSPORT,0.23203,0.039192,0.095418,0,0
2,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.64051,0.039164,0.065139,0,0
2,GO NUCLEOSIDE SALVAGE,0.37964,0.039048,0.044726,0,0
2,GO ADAPTATION OF SIGNALING PATHWAY,0.51122,0.038857,0.056225,0,0
2,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.55277,0.038787,0.06688,0,0
2,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.64051,0.038765,0.05398,0,0
2,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.81845,0.038527,0.043146,0,0
2,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,0.93062,0.038467,0.012412,0,0
2,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.30724,0.038438,0.079925,0,0
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.29248,0.038308,0.10465,0,0
2,GO RRNA METHYLATION,0.39705,0.038269,0.055377,0,0
2,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.23203,0.038184,0.10113,0,0
2,GO TRANSMEMBRANE TRANSPORT,0.43329,0.038178,0.068158,0,0
2,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.32248,0.038177,0.087465,0,0
2,GO CYTOPLASM ORGANIZATION,0.37964,0.038058,0.14502,0,0
2,GO HISTONE H2B UBIQUITINATION,0.67486,0.038049,0.038047,0,0
2,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.60692,0.038029,0.056693,0,0
2,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.95582,0.037946,-0.012856,0,0
2,GO POST ANAL TAIL MORPHOGENESIS,0.93062,0.037891,0.030612,0,0
2,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,0.67486,0.037559,0.041826,0,0
2,GO PARAXIAL MESODERM DEVELOPMENT,0.58498,0.037268,0.057334,0,0
2,GO PROTEIN CATABOLIC PROCESS,0.44264,0.037253,0.073676,0,0
2,GO REGULATION OF ACROSOME REACTION,0.94321,0.036961,0.0098928,0,0
2,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.54223,0.036926,0.035733,0,0
2,GO CARBOHYDRATE METABOLIC PROCESS,0.18102,0.036923,0.10125,0,0
2,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.49108,0.036745,0.084035,0,0
2,GO GLYCOSYLATION,0.49108,0.036666,0.072937,0,0
2,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.38829,0.036584,0.076629,0,0
2,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.80618,0.036551,-0.0098665,0,0
2,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.54223,0.03638,0.039512,0,0
2,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.56341,0.036364,0.068735,0,0
2,GO PURINE CONTAINING COMPOUND SALVAGE,0.3148,0.03633,0.074873,0,0
2,GO CONVERGENT EXTENSION,0.72171,0.03622,0.07368,0,0
2,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.94321,0.036043,-0.084605,0,0
2,GO SENSORY PERCEPTION,0.80618,0.035859,0.036805,0,0
2,GO REGULATION OF DNA BINDING,0.79394,0.035796,0.023872,0,0
2,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.25111,0.035751,0.059799,0,0
2,GO CELLULAR SENESCENCE,0.46168,0.035729,0.062483,0,0
2,GO METANEPHROS MORPHOGENESIS,0.70989,0.035712,0.081473,0,0
2,GO REGULATION OF TRANSMEMBRANE TRANSPORT,0.44264,0.035709,0.074925,0,0
2,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.42405,0.035601,0.1148,0,0
2,GO MONOSACCHARIDE METABOLIC PROCESS,0.29248,0.035509,0.087327,0,0
2,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.4521,0.035482,0.095031,0,0
2,GO NEGATIVE REGULATION OF NEURON MIGRATION,0.66333,0.035476,0.060898,0,0
2,GO STRIATED MUSCLE CONTRACTION,0.54223,0.035449,0.056779,0,0
2,GO TRNA 5 END PROCESSING,0.90549,0.035423,-0.018224,0,0
2,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.20256,0.035114,0.11452,0,0
2,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.33821,0.035029,0.10008,0,0
2,GO REGULATION OF RELAXATION OF MUSCLE,0.83078,0.034939,-0.041422,0,0
2,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.96843,0.034705,-0.0049786,0,0
2,GO NUCLEAR PORE ORGANIZATION,0.91805,0.034672,-0.031196,0,0
2,GO CELL CELL SIGNALING BY WNT,0.69814,0.034572,0.074319,0,0
2,GO VACUOLAR TRANSPORT,0.40594,0.034525,0.080234,0,0
2,GO RESPONSE TO TEMPERATURE STIMULUS,0.60692,0.034421,0.058284,0,0
2,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,0.61803,0.034074,0.074441,0,0
2,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.89296,0.033922,0.016584,0,0
2,GO GTP BIOSYNTHETIC PROCESS,0.42405,0.033731,0.055137,0,0
2,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.23203,0.03349,0.10473,0,0
2,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.79394,0.033365,0.057145,0,0
2,GO CERAMIDE BIOSYNTHETIC PROCESS,0.3148,0.033352,0.09272,0,0
2,GO LATE ENDOSOME TO VACUOLE TRANSPORT,0.50109,0.033319,0.038319,0,0
2,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.47137,0.033291,0.050728,0,0
2,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.56341,0.033154,0.074325,0,0
2,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.15655,0.033016,0.10689,0,0
2,GO MESODERMAL CELL FATE SPECIFICATION,0.99368,0.033001,-0.0069169,0,0
2,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,0.46168,0.032863,0.08124,0,0
2,GO RESPONSE TO STEROL DEPLETION,0.11894,0.032849,0.16199,0,0
2,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,0.61803,0.032812,0.054724,0,0
2,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.67486,0.032502,0.058081,0,0
2,GO PROTEIN POLYMERIZATION,0.55277,0.032485,0.075421,0,0
2,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.83078,0.03236,0.074452,0,0
2,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.78176,0.032287,0.032728,0,0
2,GO MACROMOLECULE DEPALMITOYLATION,0.43329,0.032284,0.041932,0,0
2,GO IN UTERO EMBRYONIC DEVELOPMENT,0.2998,0.032253,0.097648,0,0
2,GO CELLULAR RESPONSE TO HEAT,0.72171,0.032202,0.043892,0,0
2,GO ANATOMICAL STRUCTURE MATURATION,0.35442,0.032114,0.080712,0,0
2,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.38829,0.032008,0.064095,0,0
2,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,0.94321,0.031972,0.059166,0,0
2,GO SULFUR COMPOUND TRANSPORT,0.43329,0.031847,0.076416,0,0
2,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,0.96843,0.031747,0.048848,0,0
2,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.40594,0.031685,0.080894,0,0
2,GO NEGATIVE REGULATION OF LYASE ACTIVITY,0.68646,0.031635,-0.04507,0,0
2,GO EMBRYONIC MORPHOGENESIS,0.52145,0.031402,0.089753,0,0
2,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.56341,0.031293,0.070128,0,0
2,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.35442,0.030959,0.083921,0,0
2,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,0.50109,0.030869,0.052405,0,0
2,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.55277,0.030856,0.055982,0,0
2,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.79394,0.030819,0.050456,0,0
2,GO RESPONSE TO MAGNESIUM ION,0.5959,0.030583,0.091408,0,0
2,GO LACTATION,0.96843,0.030486,0.045834,0,0
2,GO PEPTIDYL AMINO ACID MODIFICATION,0.39705,0.030111,0.088014,0,0
2,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,0.93062,0.030083,0.00022097,0,0
2,GO MITOCHONDRIAL PROTEIN PROCESSING,0.094909,0.029777,0.11057,0,0
2,GO ANION TRANSMEMBRANE TRANSPORT,0.67486,0.029745,0.060866,0,0
2,GO PIGMENT METABOLIC PROCESS,0.29248,0.029356,0.076979,0,0
2,GO EMBRYONIC ORGAN DEVELOPMENT,0.48117,0.029272,0.086659,0,0
2,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.80618,0.028998,0.035632,0,0
2,GO FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS,0.50109,0.028954,0.021166,0,0
2,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.52145,0.028917,0.09399,0,0
2,GO ENDOCARDIUM DEVELOPMENT,0.58498,0.02888,0.092236,0,0
2,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.3148,0.028726,0.13897,0,0
2,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.57414,0.028601,0.084847,0,0
2,GO CELLULAR RESPONSE TO PH,0.89296,0.028582,0.031401,0,0
2,GO CELL CYCLE G1 S PHASE TRANSITION,0.91805,0.028556,0.019978,0,0
2,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,0.98106,0.028359,-0.020814,0,0
2,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,0.81845,0.028351,0.043236,0,0
2,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.57414,0.028043,0.067826,0,0
2,GO REGULATION OF MITOCHONDRIAL FISSION,0.83078,0.028007,0.044902,0,0
2,GO REGULATION OF PROTON TRANSPORT,0.48117,0.027955,0.059285,0,0
2,GO RNA INTERFERENCE,0.81845,0.027937,-0.016197,0,0
2,GO REGULATION OF VASCULAR PERMEABILITY,0.33029,0.027655,0.15588,0,0
2,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,0.44264,0.027612,0.087469,0,0
2,GO REGULATION OF GENE SILENCING,0.5959,0.027521,0.054783,0,0
2,GO CELLULAR RESPONSE TO STARVATION,0.61803,0.027135,0.059453,0,0
2,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.53179,0.027024,0.082071,0,0
2,GO DNA RECOMBINATION,0.83078,0.026852,-0.037922,0,0
2,GO CELLULAR RESPONSE TO CALCIUM ION,0.90549,0.026847,0.037845,0,0
2,GO SENSORY PERCEPTION OF SMELL,0.64051,0.026833,-0.033693,0,0
2,GO ENERGY RESERVE METABOLIC PROCESS,0.85555,0.026799,0.0063028,0,0
2,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,0.33821,0.026611,0.14041,0,0
2,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,0.95582,0.026606,-0.011622,0,0
2,GO NUCLEAR TRANSPORT,0.94321,0.026366,0.017023,0,0
2,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,0.37111,0.026293,0.078367,0,0
2,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.54223,0.026266,0.059296,0,0
2,GO GROWTH,0.75756,0.026184,0.074037,0,0
2,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.76963,0.026132,0.056258,0,0
2,GO ENDOSOMAL TRANSPORT,0.50109,0.026114,0.069916,0,0
2,GO NEURONAL STEM CELL POPULATION MAINTENANCE,0.78176,0.026021,-0.033049,0,0
2,GO RNA MODIFICATION,0.25111,0.025947,0.072813,0,0
2,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.93062,0.025921,0.036282,0,0
2,GO RNA SURVEILLANCE,0.84314,0.025854,-0.031052,0,0
2,GO ELECTRON TRANSPORT CHAIN,0.42405,0.025801,0.034766,0,0
2,GO FUCOSYLATION,0.91805,0.025789,0.015404,0,0
2,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.29248,0.025778,0.078831,0,0
2,GO PROTEIN HOMOOLIGOMERIZATION,0.38829,0.025738,0.069907,0,0
2,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.19156,0.025734,0.12396,0,0
2,GO POST EMBRYONIC DEVELOPMENT,0.46168,0.025709,0.092408,0,0
2,GO MEMBRANE FUSION,0.79394,0.025692,0.048972,0,0
2,GO REGULATION OF ATP METABOLIC PROCESS,0.74555,0.0255,0.041815,0,0
2,GO RESPONSE TO HEAT,0.46168,0.025196,0.066286,0,0
2,GO SYNAPTIC VESICLE BUDDING,0.55277,0.025182,0.078835,0,0
2,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.5959,0.025151,0.039815,0,0
2,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.49108,0.024899,0.083173,0,0
2,GO HISTONE H3 K4 TRIMETHYLATION,0.65188,0.024893,0.084506,0,0
2,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.58498,0.024839,0.088841,0,0
2,GO RESPONSE TO LEPTIN,0.89296,0.024802,0.065093,0,0
2,GO ENDOSOME ORGANIZATION,0.29248,0.024786,0.079172,0,0
2,GO MULTIVESICULAR BODY ORGANIZATION,0.70989,0.024735,0.030318,0,0
2,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.95582,0.02473,0.020243,0,0
2,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.69814,0.024677,0.029034,0,0
2,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.51122,0.024592,0.045038,0,0
2,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.79394,0.024402,0.049414,0,0
2,GO POSITIVE REGULATION OF AXON EXTENSION,0.79394,0.024363,0.044816,0,0
2,GO KETONE BODY METABOLIC PROCESS,0.43329,0.024149,0.047016,0,0
2,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.62923,0.023923,0.025436,0,0
2,GO ADIPOSE TISSUE DEVELOPMENT,0.85555,0.023828,0.020867,0,0
2,GO VESICLE ORGANIZATION,0.52145,0.02375,0.06762,0,0
2,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.99368,0.023742,0.019195,0,0
2,GO MRNA MODIFICATION,0.70989,0.023685,0.051767,0,0
2,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.42405,0.023642,0.071382,0,0
2,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,0.26442,0.023536,0.095537,0,0
2,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.96843,0.023484,-0.01502,0,0
2,GO POSITIVE REGULATION OF INSULIN SECRETION,0.89296,0.023447,0.021321,0,0
2,GO SPHINGOMYELIN METABOLIC PROCESS,0.90549,0.023433,0.03163,0,0
2,GO EXCRETION,0.52145,0.023422,0.071945,0,0
2,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.64051,0.023331,0.058453,0,0
2,GO MUSCLE CONTRACTION,0.3148,0.023233,0.10318,0,0
2,GO DEPHOSPHORYLATION,0.50109,0.022889,0.068294,0,0
2,GO 3 UTR MEDIATED MRNA STABILIZATION,0.61803,0.022868,0.082728,0,0
2,GO PENILE ERECTION,0.83078,0.022776,-0.0022164,0,0
2,GO REGULATION OF GLUCOSE IMPORT,0.64051,0.022719,0.049327,0,0
2,GO REPRODUCTION,0.96843,0.022585,0.028894,0,0
2,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.42405,0.022539,0.094459,0,0
2,GO REGULATION OF GROWTH,0.57414,0.022398,0.082728,0,0
2,GO SODIUM ION HOMEOSTASIS,0.44264,0.022366,0.087028,0,0
2,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.83078,0.022274,0.0507,0,0
2,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.41494,0.022113,0.095816,0,0
2,GO RENAL SODIUM EXCRETION,0.30724,0.022112,0.12367,0,0
2,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.72171,0.022026,0.056735,0,0
2,GO INTERMEDIATE FILAMENT BASED PROCESS,0.57414,0.021864,0.054736,0,0
2,GO REGULATION OF RECEPTOR CLUSTERING,0.88046,0.021779,0.012996,0,0
2,GO SEX DIFFERENTIATION,0.67486,0.021695,0.063724,0,0
2,GO GOLGI ORGANIZATION,0.5959,0.021568,0.068648,0,0
2,GO REGULATION OF PROTEIN TARGETING,0.40594,0.021536,0.076689,0,0
2,GO MITOTIC CYTOKINETIC PROCESS,0.89296,0.021407,-0.0091137,0,0
2,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.89296,0.021351,0.033168,0,0
2,GO NEGATIVE REGULATION OF CELL CYCLE,0.95582,0.021343,0.0087483,0,0
2,GO CELL JUNCTION ASSEMBLY,0.75756,0.021291,0.030172,0,0
2,GO REGULATION OF PROTEIN POLYMERIZATION,0.69814,0.021081,0.068794,0,0
2,GO VIRAL TRANSLATION,0.43329,0.021057,0.052323,0,0
2,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.49108,0.020966,0.078121,0,0
2,GO RETINAL ROD CELL DIFFERENTIATION,0.98106,0.02091,-0.013017,0,0
2,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.74555,0.020881,0.055741,0,0
2,GO POSITIVE REGULATION OF CELL GROWTH,0.80618,0.020879,0.058493,0,0
2,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,0.84314,0.020797,0.048225,0,0
2,GO REGULATION OF PHOSPHATASE ACTIVITY,0.68646,0.020722,0.068654,0,0
2,GO PEPTIDYL PROLINE MODIFICATION,0.44264,0.020708,0.055776,0,0
2,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.86799,0.020612,0.024285,0,0
2,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,0.99368,0.020424,0.017478,0,0
2,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.67486,0.020308,0.027882,0,0
2,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,0.84314,0.020275,0.015379,0,0
2,GO CELL AGING,0.2998,0.020222,0.08833,0,0
2,GO REGULATION OF TELOMERE MAINTENANCE,0.93062,0.020051,-0.0065372,0,0
2,GO REGULATION OF CELL DIVISION,0.86799,0.019966,0.02441,0,0
2,GO DOPAMINERGIC NEURON DIFFERENTIATION,0.79394,0.019876,0.036975,0,0
2,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.26442,0.019873,0.12339,0,0
2,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.75756,0.019779,0.033063,0,0
2,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.27821,0.019779,0.06565,0,0
2,GO SECONDARY METABOLIC PROCESS,0.96843,0.01973,0.021612,0,0
2,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.65188,0.019675,0.066586,0,0
2,GO EMBRYONIC DIGIT MORPHOGENESIS,0.86799,0.019638,0.045517,0,0
2,GO REGULATION OF CELL AGING,0.74555,0.019516,0.016818,0,0
2,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.56341,0.019475,0.067758,0,0
2,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.67486,0.01945,-0.086751,0,0
2,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.49108,0.019029,0.061242,0,0
2,GO STRIATED MUSCLE ADAPTATION,0.7336,0.019012,0.056646,0,0
2,GO CRANIAL NERVE MORPHOGENESIS,0.70989,0.018769,0.073634,0,0
2,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.56341,0.018678,0.019452,0,0
2,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.86799,0.018497,0.014402,0,0
2,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.84314,0.018398,-0.010237,0,0
2,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,1,0.018362,0.0057322,0,0
2,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.88046,0.018351,0.026526,0,0
2,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.95582,0.018249,0.032478,0,0
2,GO EAR MORPHOGENESIS,0.94321,0.018198,0.016815,0,0
2,GO SOMITOGENESIS,0.7336,0.018096,0.048468,0,0
2,GO ACTIN CROSSLINK FORMATION,0.98106,0.017948,0.039873,0,0
2,GO UTERUS DEVELOPMENT,0.64051,0.017622,0.039914,0,0
2,GO RESPONSE TO LITHIUM ION,0.79394,0.017593,0.054614,0,0
2,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.65188,0.017589,0.058831,0,0
2,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,0.89296,0.017346,0.04179,0,0
2,GO EAR DEVELOPMENT,0.98106,0.017301,0.025504,0,0
2,GO REGULATION OF MACROAUTOPHAGY,0.64051,0.017102,0.057548,0,0
2,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.39705,0.016963,0.045225,0,0
2,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.80618,0.016918,-0.020481,0,0
2,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.93062,0.016725,0.028035,0,0
2,GO METHYLATION,0.99368,0.016685,0.0092117,0,0
2,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.46168,0.016669,0.14177,0,0
2,GO SECRETORY GRANULE ORGANIZATION,0.64051,0.016603,-0.022321,0,0
2,GO PROTEIN STABILIZATION,0.64051,0.016562,0.058347,0,0
2,GO CARTILAGE MORPHOGENESIS,0.54223,0.016525,0.10217,0,0
2,GO CATION TRANSPORT,0.48117,0.016437,0.06914,0,0
2,GO STEM CELL PROLIFERATION,0.84314,0.016376,0.026788,0,0
2,GO SENSORY ORGAN MORPHOGENESIS,0.95582,0.016202,0.030789,0,0
2,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.43329,0.016163,0.078532,0,0
2,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,0.44264,0.016119,0.088521,0,0
2,GO NEURAL TUBE FORMATION,0.68646,0.016105,0.059084,0,0
2,GO NON CANONICAL WNT SIGNALING PATHWAY,0.64051,0.015942,0.054407,0,0
2,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,0.99368,0.015937,0.024769,0,0
2,GO HISTONE H4 DEACETYLATION,0.84314,0.015935,-0.010604,0,0
2,GO REGULATION OF STEM CELL PROLIFERATION,0.90549,0.01588,0.0090961,0,0
2,GO REGULATION OF FEEDING BEHAVIOR,0.65188,0.015732,0.012451,0,0
2,GO RESPONSE TO RADIATION,0.65188,0.015655,0.057012,0,0
2,GO MEMBRANE DISASSEMBLY,0.56341,0.015509,-0.071563,0,0
2,GO AUTOPHAGY OF MITOCHONDRION,0.81845,0.015352,0.044854,0,0
2,GO POSITIVE REGULATION OF GROWTH,0.79394,0.015265,0.072832,0,0
2,GO FEMALE GAMETE GENERATION,0.67486,0.015072,-0.02217,0,0
2,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.74555,0.014845,0.0046358,0,0
2,GO INNER EAR MORPHOGENESIS,0.94321,0.014791,0.0025337,0,0
2,GO LUNG EPITHELIUM DEVELOPMENT,0.64051,0.014771,0.048584,0,0
2,GO NEURON CELLULAR HOMEOSTASIS,0.84314,0.014476,-0.022966,0,0
2,GO PROXIMAL DISTAL PATTERN FORMATION,0.94321,0.014471,0.030166,0,0
2,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.65188,0.014421,0.0068804,0,0
2,GO REGULATION OF DEPHOSPHORYLATION,0.65188,0.014394,0.071835,0,0
2,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.66333,0.0142,0.051534,0,0
2,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.56341,0.014179,-0.030484,0,0
2,GO CARBOHYDRATE PHOSPHORYLATION,0.75756,0.014173,0.064136,0,0
2,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.83078,0.014038,0.037971,0,0
2,GO MODULATION BY VIRUS OF HOST PROCESS,0.72171,0.013704,0.065332,0,0
2,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.93062,0.013657,0.014678,0,0
2,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,0.52145,0.013629,0.039699,0,0
2,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,0.93062,0.013406,0.023695,0,0
2,GO CELLULAR AMIDE METABOLIC PROCESS,0.197,0.013375,0.064597,0,0
2,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.84314,0.013366,0.067488,0,0
2,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.65188,0.013329,0.067058,0,0
2,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.96843,0.013314,0.023851,0,0
2,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.46168,0.013312,0.09033,0,0
2,GO PHASIC SMOOTH MUSCLE CONTRACTION,0.39705,0.01322,0.046078,0,0
2,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.95582,0.013045,0.0082259,0,0
2,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.91805,0.013017,-0.012214,0,0
2,GO ORGANIC CATION TRANSPORT,0.44264,0.012972,0.095883,0,0
2,GO MACROAUTOPHAGY,0.48117,0.012876,0.058985,0,0
2,GO CYTOKINETIC PROCESS,0.83078,0.012842,-0.035635,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.94321,0.012813,-0.011126,0,0
2,GO PROTON TRANSMEMBRANE TRANSPORT,0.80618,0.012737,0.0061097,0,0
2,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,0.81845,0.012723,0.051385,0,0
2,GO MANNOSYLATION,1,0.012638,0.0036713,0,0
2,GO DEVELOPMENTAL INDUCTION,0.96843,0.012629,0.0051289,0,0
2,GO PEPTIDYL SERINE MODIFICATION,0.90549,0.012619,0.056466,0,0
2,GO PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.89296,0.012562,0.0043244,0,0
2,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.93062,0.012446,0.029796,0,0
2,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.33821,0.012401,0.079957,0,0
2,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,0.62923,0.012342,-0.0058674,0,0
2,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.99368,0.012242,0.019553,0,0
2,GO HISTONE PHOSPHORYLATION,0.76963,0.012232,-0.023933,0,0
2,GO CIRCADIAN SLEEP WAKE CYCLE,1,0.012152,0.0058156,0,0
2,GO CAMP METABOLIC PROCESS,0.65188,0.012086,0.079974,0,0
2,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,0.42405,0.01207,0.06504,0,0
2,GO HISTONE DEACETYLATION,0.81845,0.011987,0.035794,0,0
2,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.98106,0.011873,0.03579,0,0
2,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.94321,0.011785,0.0064616,0,0
2,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,0.58498,0.011717,0.084843,0,0
2,GO NEURON PROJECTION REGENERATION,0.80618,0.011583,0.055824,0,0
2,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.70989,0.011475,0.073121,0,0
2,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.64051,0.011354,0.020932,0,0
2,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.81845,0.011345,0.029309,0,0
2,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.48117,0.011128,0.091483,0,0
2,GO APOPTOTIC MITOCHONDRIAL CHANGES,1,0.010983,0.01438,0,0
2,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,0.60692,0.010917,0.067156,0,0
2,GO TETRAHYDROFOLATE INTERCONVERSION,1,0.010878,-0.069262,0,0
2,GO KERATINOCYTE DEVELOPMENT,0.38829,0.010773,0.15548,0,0
2,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,0.60692,0.010727,-0.0019213,0,0
2,GO MONOSACCHARIDE CATABOLIC PROCESS,0.84314,0.010576,0.048667,0,0
2,GO CAVEOLIN MEDIATED ENDOCYTOSIS,0.33029,0.010561,0.11793,0,0
2,GO MATURATION OF 5 8S RRNA,0.93062,0.010478,-0.018329,0,0
2,GO PHOSPHOLIPID DEPHOSPHORYLATION,0.57414,0.010427,0.055429,0,0
2,GO EXECUTION PHASE OF APOPTOSIS,0.88046,0.010416,0.039998,0,0
2,GO DEMETHYLATION,0.78176,0.01021,0.042568,0,0
2,GO POSITIVE REGULATION OF HEART RATE,0.4521,0.010207,0.070668,0,0
2,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.68646,0.010143,0.008808,0,0
2,GO FATTY ACID HOMEOSTASIS,0.38829,0.010094,0.081386,0,0
2,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.70989,0.010093,0.071796,0,0
2,GO FEMALE SEX DIFFERENTIATION,0.54223,0.009885,0.074026,0,0
2,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.62923,0.0096574,0.07176,0,0
2,GO EMBRYONIC EYE MORPHOGENESIS,0.79394,0.0095054,0.089264,0,0
2,GO ESTABLISHMENT OF TISSUE POLARITY,0.85555,0.0094541,0.028754,0,0
2,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.96843,0.0092669,0.014179,0,0
2,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.83078,0.0092113,0.029457,0,0
2,GO MULTI ORGANISM PROCESS,0.80618,0.0091667,0.012768,0,0
2,GO HISTONE H3 K14 ACETYLATION,0.85555,0.0090835,0.036074,0,0
2,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.98106,0.0088686,0.0021365,0,0
2,GO GLAND DEVELOPMENT,0.46168,0.0087407,0.10232,0,0
2,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.88046,0.0087198,0.036953,0,0
2,GO EMBRYONIC PATTERN SPECIFICATION,0.99368,0.0085595,0.021693,0,0
2,GO REGULATION OF DNA METABOLIC PROCESS,0.96843,0.0085367,0.023206,0,0
2,GO CELL MATURATION,0.83078,0.008351,0.053039,0,0
2,GO ESTABLISHMENT OF CELL POLARITY,0.50109,0.0083121,0.090719,0,0
2,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.93062,0.0081283,0.040641,0,0
2,GO PROTEIN DEPHOSPHORYLATION,0.67486,0.0080522,0.059959,0,0
2,GO DETECTION OF MECHANICAL STIMULUS,0.94321,0.0079856,0.057276,0,0
2,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,0.61803,0.0079655,0.049812,0,0
2,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,0.91805,0.0078901,0.031022,0,0
2,GO RESPONSE TO CARBOHYDRATE,0.78176,0.0077944,0.057705,0,0
2,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.67486,0.0076379,0.063611,0,0
2,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.69814,0.0075962,0.064032,0,0
2,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.86799,0.0075846,-0.002056,0,0
2,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.53179,0.0074109,0.067433,0,0
2,GO ZINC ION TRANSPORT,0.60692,0.0071117,0.05679,0,0
2,GO REGULATION OF CYCLASE ACTIVITY,0.78176,0.0070167,0.026046,0,0
2,GO NODAL SIGNALING PATHWAY,0.84314,0.0068925,0.011277,0,0
2,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.85555,0.0067772,0.05932,0,0
2,GO HYPEROSMOTIC RESPONSE,0.76963,0.0067053,0.06351,0,0
2,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.81845,0.0066853,0.054275,0,0
2,GO LUTEINIZATION,0.50109,0.0066776,0.094642,0,0
2,GO POSITIVE REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.99368,0.0066554,0.00089418,0,0
2,GO REGULATION OF DEOXYRIBONUCLEASE ACTIVITY,0.7336,0.0065283,0.036238,0,0
2,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,0.90549,0.0064778,0.022306,0,0
2,GO NCRNA EXPORT FROM NUCLEUS,0.80618,0.0064553,-0.04234,0,0
2,GO RESPIRATORY SYSTEM PROCESS,0.57414,0.0063429,0.081634,0,0
2,GO REGULATION OF MICROVILLUS ORGANIZATION,0.34626,0.0063393,0.11138,0,0
2,GO BLASTOCYST DEVELOPMENT,0.70989,0.0063307,-0.010363,0,0
2,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,0.89296,0.0062806,-0.0095952,0,0
2,GO AMINO ACID TRANSMEMBRANE TRANSPORT,0.54223,0.0062052,0.068752,0,0
2,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.67486,0.0061887,0.071237,0,0
2,GO ECTODERMAL PLACODE DEVELOPMENT,0.80618,0.0058965,0.017369,0,0
2,GO RESPONSE TO CAFFEINE,0.95582,0.0058097,0.014742,0,0
2,GO COLLECTING DUCT DEVELOPMENT,0.90549,0.0057676,-0.01508,0,0
2,GO REGULATION OF GLUCONEOGENESIS,0.65188,0.0057498,0.061065,0,0
2,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.86799,0.0057447,0.014619,0,0
2,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.57414,0.0056449,-0.062517,0,0
2,GO REGULATION OF TRANSPORTER ACTIVITY,0.58498,0.0053723,0.060596,0,0
2,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.68646,0.0053312,0.058482,0,0
2,GO COPULATION,0.48117,0.0052742,0.096051,0,0
2,GO VIRAL BUDDING,0.78176,0.0052723,-0.00091562,0,0
2,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.70989,0.0052519,-0.0025144,0,0
2,GO CELL FATE COMMITMENT,0.88046,0.0051194,0.051646,0,0
2,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.95582,0.0051047,0.053903,0,0
2,GO MUSCLE CELL DEVELOPMENT,0.72171,0.0050627,0.07158,0,0
2,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,0.64051,0.0049661,0.061058,0,0
2,GO GLYCOGEN BIOSYNTHETIC PROCESS,0.41494,0.0044424,-0.03633,0,0
2,GO PROTEIN TARGETING TO VACUOLE,0.62923,0.0042612,0.081162,0,0
2,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.65188,0.0041508,0.0020671,0,0
2,GO PYRUVATE METABOLIC PROCESS,0.99368,0.0041037,0.027047,0,0
2,GO REGULATION OF NMDA RECEPTOR ACTIVITY,0.96843,0.0040417,-0.0025231,0,0
2,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,0.83078,0.0039871,0.054719,0,0
2,GO MATURATION OF LSU RRNA,0.96843,0.0038883,-0.0075197,0,0
2,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.81845,0.0037592,0.098744,0,0
2,GO NEUTRAL AMINO ACID TRANSPORT,0.39705,0.0036781,0.10227,0,0
2,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.94321,0.0036348,0.042011,0,0
2,GO ADHERENS JUNCTION ASSEMBLY,0.7336,0.0035209,0.018639,0,0
2,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.74555,0.0034562,0.02536,0,0
2,GO GENE SILENCING,0.89296,0.0033911,0.017141,0,0
2,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.75756,0.0033125,0.047135,0,0
2,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,0.7336,0.0032772,0.02358,0,0
2,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,0.84314,0.0031724,0.035696,0,0
2,GO TRANSLATIONAL INITIATION,0.91805,0.0031652,0.0013434,0,0
2,GO REGULATION OF GONAD DEVELOPMENT,0.44264,0.0031065,0.069448,0,0
2,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.7336,0.0030196,0.070405,0,0
2,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.99368,0.0028506,0.027706,0,0
2,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.84314,0.0028439,0.043038,0,0
2,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.99368,0.0028079,0.025328,0,0
2,GO VESICLE LOCALIZATION,0.80618,0.0027754,0.023064,0,0
2,GO RHYTHMIC PROCESS,0.99368,0.0027038,0.036643,0,0
2,GO CELL JUNCTION ORGANIZATION,0.60692,0.0025335,0.0090153,0,0
2,GO SERINE PHOSPHORYLATION OF STAT PROTEIN,0.52145,0.0024948,-0.040814,0,0
2,GO REGULATION OF HORMONE LEVELS,1,0.0022174,0.034376,0,0
2,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.66333,0.0021931,0.073776,0,0
2,GO CELL GROWTH,0.99368,0.002118,0.053657,0,0
2,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.57414,0.0018515,0.00059654,0,0
2,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.79394,0.0016753,0.069519,0,0
2,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.93062,0.0015356,0.036043,0,0
2,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,0.75756,0.0015133,0.047034,0,0
2,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.54223,0.0014539,0.058906,0,0
2,GO POSITIVE REGULATION OF HEART CONTRACTION,0.66333,0.0014021,-0.020504,0,0
2,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.83078,0.0013982,0.0033219,0,0
2,GO L AMINO ACID TRANSPORT,0.57414,0.0013743,0.067696,0,0
2,GO MIRNA METABOLIC PROCESS,0.74555,0.0010347,0.059932,0,0
2,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.78176,0.00083036,0.0098031,0,0
2,GO POSITIVE REGULATION OF MITOPHAGY,0.99368,0.00068971,0.040238,0,0
2,GO RNA METHYLATION,0.70989,0.00063353,0.035923,0,0
2,GO PEPTIDYL METHIONINE MODIFICATION,0.83078,0.00062056,-0.0011876,0,0
2,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,0.74555,0.00059501,0.031104,0,0
2,GO REGULATION OF CATION CHANNEL ACTIVITY,0.98106,0.00057977,0.024365,0,0
2,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.53179,0.0005632,0.069304,0,0
2,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.5959,0.00048886,0.071648,0,0
2,GO PROTEIN K63 LINKED DEUBIQUITINATION,0.88046,0.00040796,0.013903,0,0
2,GO CARBOHYDRATE HOMEOSTASIS,0.84314,0.00036583,0.026261,0,0
2,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,0.55277,0.00018991,0.089176,0,0
2,GO POSITIVE REGULATION OF NEURON MIGRATION,0.94321,0.00010713,0.045539,0,0
2,GO RIBOSOME ASSEMBLY,0.70989,-3.4812e-06,-0.017305,0,0
2,GO PROTEIN K48 LINKED DEUBIQUITINATION,0.90549,-9.9081e-05,0.0034136,0,0
2,GO TRNA PROCESSING,0.79394,-0.00010649,0.021736,0,0
2,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.90549,-0.00011692,-0.010912,0,0
2,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.91805,-0.00030647,-0.054194,0,0
2,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.69814,-0.00051843,-0.0039036,0,0
2,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.93062,-0.00053085,0.011624,0,0
2,GO PROTEIN TRANSMEMBRANE TRANSPORT,0.54223,-0.00060188,0.043864,0,0
2,GO REGULATION OF CELL SIZE,0.99368,-0.00098979,0.059159,0,0
2,GO IMPORT INTO CELL,0.75756,-0.001017,0.050971,0,0
2,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.84314,-0.0010862,0.0052988,0,0
2,GO DEVELOPMENTAL GROWTH,0.88046,-0.0012455,0.043027,0,0
2,GO TRNA MODIFICATION,0.66333,-0.0013283,0.031809,0,0
2,GO DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.84314,-0.0013553,-0.00043825,0,0
2,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,0.60692,-0.0016128,0.072349,0,0
2,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.96843,-0.0016451,-0.019985,0,0
2,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.61803,-0.0016797,0.061381,0,0
2,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,0.76963,-0.002007,0.053745,0,0
2,GO MITOCHONDRIAL TRANSLATION,0.50109,-0.0020882,-0.049057,0,0
2,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.83078,-0.0021948,0.015586,0,0
2,GO ION TRANSMEMBRANE TRANSPORT,0.75756,-0.0022085,0.048754,0,0
2,GO RESPONSE TO AMINO ACID STARVATION,0.48117,-0.002256,-0.009588,0,0
2,GO TRNA TRANSPORT,0.78176,-0.0027113,-0.049808,0,0
2,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.86799,-0.0027966,0.026855,0,0
2,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.85555,-0.0028925,-0.0040708,0,0
2,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.96843,-0.002943,0.036477,0,0
2,GO OVARIAN FOLLICLE DEVELOPMENT,0.65188,-0.0029634,-0.015471,0,0
2,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.70989,-0.0029674,-0.044662,0,0
2,GO MIDBODY ABSCISSION,0.58498,-0.0029748,-0.039679,0,0
2,GO RESPONSE TO STARVATION,0.94321,-0.0030046,0.03759,0,0
2,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.80618,-0.0030051,0.053245,0,0
2,GO CARDIAC MYOFIBRIL ASSEMBLY,0.72171,-0.0030848,-0.029379,0,0
2,GO EPITHELIAL CELL MORPHOGENESIS,0.95582,-0.0030931,0.044708,0,0
2,GO GLUCOSE METABOLIC PROCESS,0.94321,-0.0032218,0.043904,0,0
2,GO SENSORY PERCEPTION OF LIGHT STIMULUS,0.99368,-0.0032744,0.011609,0,0
2,GO POSITIVE REGULATION OF CELL DEVELOPMENT,0.88046,-0.0035098,0.042975,0,0
2,GO RRNA METABOLIC PROCESS,0.86799,-0.0035118,0.0021025,0,0
2,GO SODIUM ION TRANSMEMBRANE TRANSPORT,0.78176,-0.0036913,0.0039353,0,0
2,GO HORMONE MEDIATED SIGNALING PATHWAY,0.99368,-0.0038227,0.039758,0,0
2,GO NCRNA METABOLIC PROCESS,0.83078,-0.0039225,0.012712,0,0
2,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,0.80618,-0.0039544,0.011942,0,0
2,GO HEXOSE CATABOLIC PROCESS,1,-0.0040233,0.037904,0,0
2,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.61803,-0.0041687,-0.020469,0,0
2,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.51122,-0.0042059,0.059191,0,0
2,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,0.72171,-0.0042139,0.0089809,0,0
2,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.79394,-0.0042234,0.023245,0,0
2,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.84314,-0.0042743,-0.01708,0,0
2,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.89296,-0.0042955,0.019805,0,0
2,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,0.90549,-0.0043777,0.011015,0,0
2,GO REGULATION OF CELL JUNCTION ASSEMBLY,0.86799,-0.0043922,0.050894,0,0
2,GO NUCLEAR ENVELOPE ORGANIZATION,0.64051,-0.0044851,-0.016823,0,0
2,GO SPERM CAPACITATION,0.95582,-0.0045132,0.022089,0,0
2,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.66333,-0.0046111,-0.037028,0,0
2,GO DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.74555,-0.004673,-0.031471,0,0
2,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.60692,-0.0048711,-0.034041,0,0
2,GO RIBOSOME BIOGENESIS,0.74555,-0.0050709,0.0050221,0,0
2,GO PROTEIN DNA COMPLEX DISASSEMBLY,0.61803,-0.0051035,0.057122,0,0
2,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.90549,-0.0051046,0.017874,0,0
2,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,0.51122,-0.0051211,-0.0063163,0,0
2,GO EMBRYO DEVELOPMENT,0.76963,-0.0051955,0.067422,0,0
2,GO TRNA WOBBLE URIDINE MODIFICATION,0.89296,-0.0054896,0.0067753,0,0
2,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,0.96843,-0.0056622,0.031312,0,0
2,GO CATION TRANSMEMBRANE TRANSPORT,0.79394,-0.005905,0.050419,0,0
2,GO MULTICELLULAR ORGANISM REPRODUCTION,0.70989,-0.006064,0.0020909,0,0
2,GO POSITIVE REGULATION OF ANION TRANSPORT,0.56341,-0.006126,0.07072,0,0
2,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.53179,-0.0061322,0.062347,0,0
2,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.86799,-0.0062058,0.050384,0,0
2,GO P BODY ASSEMBLY,0.88046,-0.0065269,0.028668,0,0
2,GO AMIDE BIOSYNTHETIC PROCESS,0.70989,-0.0065682,0.02624,0,0
2,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.91805,-0.0068221,-0.012558,0,0
2,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.98106,-0.0068811,0.030744,0,0
2,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,0.86799,-0.0069332,0.040963,0,0
2,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.95582,-0.0070219,0.024306,0,0
2,GO NCRNA PROCESSING,0.66333,-0.0071141,0.02026,0,0
2,GO MITOCHONDRIAL GENE EXPRESSION,0.54223,-0.0072054,-0.044052,0,0
2,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,0.46168,-0.0072316,-0.018162,0,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.93062,-0.0073024,0.03768,0,0
2,GO MITOTIC G1 S TRANSITION CHECKPOINT,0.98106,-0.0073369,-1.2579e-05,0,0
2,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.85555,-0.0074026,0.032388,0,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,0.99368,-0.0074847,0.019692,0,0
2,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,0.55277,-0.0076492,0.069968,0,0
2,GO PROTEIN SUMOYLATION,0.90549,-0.0077179,0.018267,0,0
2,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.84314,-0.0078929,0.020866,0,0
2,GO CORTICOSTEROID HORMONE SECRETION,1,-0.0078938,-0.00035706,0,0
2,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,0.80618,-0.0079011,0.029986,0,0
2,GO REGULATION OF RECEPTOR INTERNALIZATION,0.75756,-0.0079317,0.035398,0,0
2,GO REGULATION OF DEVELOPMENTAL GROWTH,0.78176,-0.0079416,0.029748,0,0
2,GO PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS,0.98106,-0.0079633,-0.048984,0,0
2,GO PROTEIN LOCALIZATION TO LYSOSOME,0.93062,-0.008131,0.032561,0,0
2,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.80618,-0.0082411,-0.020666,0,0
2,GO COGNITION,0.78176,-0.0082962,-0.0017928,0,0
2,GO CYTOSKELETON ORGANIZATION,0.88046,-0.008301,0.039064,0,0
2,GO NEURAL TUBE DEVELOPMENT,0.84314,-0.0083531,0.046891,0,0
2,GO REGULATION OF PROTEIN ACETYLATION,0.98106,-0.0083976,0.034778,0,0
2,GO TRANSCRIPTION BY RNA POLYMERASE I,0.86799,-0.0084422,-0.0023569,0,0
2,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,0.95582,-0.0088511,0.039904,0,0
2,GO PEPTIDE BIOSYNTHETIC PROCESS,0.75756,-0.0090078,0.019481,0,0
2,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.27821,-0.0090776,-0.11715,0,0
2,GO REGULATION OF HEART RATE,0.80618,-0.0091438,0.025829,0,0
2,GO REGULATION OF MRNA METABOLIC PROCESS,0.76963,-0.0093924,-0.007431,0,0
2,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.89296,-0.009604,0.020104,0,0
2,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,0.93062,-0.0099216,0.019632,0,0
2,GO CARDIAC CELL DEVELOPMENT,0.65188,-0.010056,0.063469,0,0
2,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,0.90549,-0.010256,0.025317,0,0
2,GO AEROBIC RESPIRATION,0.16602,-0.01042,-0.046341,0,0
2,GO FORELIMB MORPHOGENESIS,0.60692,-0.010443,-0.027459,0,0
2,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,0.78176,-0.01054,0.028798,0,0
2,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,0.74555,-0.010864,0.015482,0,0
2,GO DNA TEMPLATED TRANSCRIPTION INITIATION,0.67486,-0.01097,0.0095525,0,0
2,GO UTP METABOLIC PROCESS,0.88046,-0.011026,-0.0013785,0,0
2,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.84314,-0.011205,0.00012257,0,0
2,GO LUNG CELL DIFFERENTIATION,0.84314,-0.011248,-0.040406,0,0
2,GO EMBRYONIC CAMERA TYPE EYE FORMATION,0.93062,-0.011251,-0.0042385,0,0
2,GO C4 DICARBOXYLATE TRANSPORT,0.85555,-0.011507,0.029674,0,0
2,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.69814,-0.011516,0.048449,0,0
2,GO SPECIFICATION OF SYMMETRY,0.89296,-0.011634,0.033862,0,0
2,GO CELL CYCLE ARREST,0.89296,-0.011802,0.0099434,0,0
2,GO LONG TERM SYNAPTIC POTENTIATION,0.58498,-0.011906,-0.021269,0,0
2,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.2998,-0.011931,-0.080938,0,0
2,GO HISTONE H3 K4 METHYLATION,0.62923,-0.012034,-0.052751,0,0
2,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,0.72171,-0.012089,0.028115,0,0
2,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.37111,-0.012281,-0.054948,0,0
2,GO SHORT TERM MEMORY,0.95582,-0.012307,0.025245,0,0
2,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,0.56341,-0.012348,0.065585,0,0
2,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.55277,-0.012619,0.012339,0,0
2,GO TOXIN METABOLIC PROCESS,0.79394,-0.012691,0.015265,0,0
2,GO TOR SIGNALING,0.94321,-0.012729,0.040618,0,0
2,GO ACID SECRETION,1,-0.012854,0.013857,0,0
2,GO ESTABLISHMENT OF RNA LOCALIZATION,0.7336,-0.012916,-0.0077142,0,0
2,GO CYTOPLASMIC TRANSLATION,0.46168,-0.013085,-0.031363,0,0
2,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.49108,-0.013144,-0.025447,0,0
2,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.70989,-0.013192,0.024054,0,0
2,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.62923,-0.013452,-0.039173,0,0
2,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.61803,-0.013523,-0.026344,0,0
2,GO LIPID DROPLET ORGANIZATION,0.90549,-0.013775,0.0089563,0,0
2,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.91805,-0.01379,0.032924,0,0
2,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.7336,-0.013795,0.058396,0,0
2,GO RESPONSE TO DIETARY EXCESS,0.98106,-0.013811,0.012494,0,0
2,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.83078,-0.013882,0.013209,0,0
2,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.88046,-0.013883,0.029942,0,0
2,GO HISTONE SERINE PHOSPHORYLATION,0.67486,-0.014024,-0.08518,0,0
2,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.60692,-0.01409,0.037555,0,0
2,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.85555,-0.014123,0.0098713,0,0
2,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.86799,-0.014123,0.045598,0,0
2,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.61803,-0.014138,-0.03751,0,0
2,GO EMBRYONIC APPENDAGE MORPHOGENESIS,0.93062,-0.014187,0.038678,0,0
2,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.89296,-0.014296,0.018654,0,0
2,GO REGULATION OF TORC1 SIGNALING,0.62923,-0.014366,-0.011116,0,0
2,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.4521,-0.014472,-0.030794,0,0
2,GO PEPTIDE METABOLIC PROCESS,0.40594,-0.014498,0.04478,0,0
2,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.68646,-0.014742,0.047847,0,0
2,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.83078,-0.0148,0.005394,0,0
2,GO RNA LOCALIZATION,0.65188,-0.014843,-0.022649,0,0
2,GO PIGMENT BIOSYNTHETIC PROCESS,0.69814,-0.014852,0.043583,0,0
2,GO CELLULAR MACROMOLECULE LOCALIZATION,0.75756,-0.014889,0.019453,0,0
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.76963,-0.014919,-0.014189,0,0
2,GO CELL MORPHOGENESIS,0.69814,-0.015182,0.030728,0,0
2,GO REGULATION OF BLOOD CIRCULATION,0.66333,-0.01522,0.060159,0,0
2,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.72171,-0.015266,0.01238,0,0
2,GO RESPONSE TO AMPHETAMINE,0.86799,-0.015426,-0.0044132,0,0
2,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.94321,-0.015794,0.016727,0,0
2,GO MEMBRANE REPOLARIZATION,0.99368,-0.015885,0.03834,0,0
2,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,0.33821,-0.015957,-0.049925,0,0
2,GO PROTEIN AUTOUBIQUITINATION,0.80618,-0.016052,-0.00058078,0,0
2,GO DNA CATABOLIC PROCESS,0.88046,-0.016109,0.021585,0,0
2,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.98106,-0.016195,0.020881,0,0
2,GO UV DAMAGE EXCISION REPAIR,0.91805,-0.01623,0.0072051,0,0
2,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,0.76963,-0.016383,-0.004291,0,0
2,GO PHOTOTRANSDUCTION,0.96843,-0.016397,0.0014553,0,0
2,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.98106,-0.01646,0.037467,0,0
2,GO APPENDAGE MORPHOGENESIS,0.95582,-0.016529,0.0445,0,0
2,GO REGULATION OF CELLULAR RESPIRATION,0.64051,-0.016547,0.0042648,0,0
2,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,0.44264,-0.016571,-0.026026,0,0
2,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,0.96843,-0.016741,0.013498,0,0
2,GO MALE MEIOTIC NUCLEAR DIVISION,0.33029,-0.016948,-0.1135,0,0
2,GO NEGATIVE REGULATION OF AXONOGENESIS,0.76963,-0.017108,-0.0043441,0,0
2,GO APPENDAGE DEVELOPMENT,0.86799,-0.017202,0.041585,0,0
2,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.47137,-0.017597,0.0021093,0,0
2,GO REGULATION OF NOTCH SIGNALING PATHWAY,0.57414,-0.017625,0.009496,0,0
2,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.52145,-0.017773,-0.034693,0,0
2,GO REGULATION OF CELL DEVELOPMENT,0.69814,-0.017997,0.025737,0,0
2,GO REGULATION OF TRANSLATIONAL ELONGATION,0.33821,-0.018077,-0.043932,0,0
2,GO PROTEASOME ASSEMBLY,0.81845,-0.018088,-0.024295,0,0
2,GO HISTONE H3 K9 MODIFICATION,0.79394,-0.018125,-0.013812,0,0
2,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,0.78176,-0.01813,-0.0075292,0,0
2,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,0.76963,-0.018212,0.014541,0,0
2,GO REGULATION OF NEUROBLAST PROLIFERATION,0.70989,-0.018302,-0.026389,0,0
2,GO REGULATION OF MITOTIC CELL CYCLE,0.43329,-0.018344,-0.041988,0,0
2,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,0.93062,-0.018377,-0.0081621,0,0
2,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.66333,-0.018401,-0.012834,0,0
2,GO OXIDATIVE DEMETHYLATION,0.51122,-0.018528,-0.042692,0,0
2,GO REGULATION OF ORGANELLE ORGANIZATION,0.7336,-0.018649,0.020178,0,0
2,GO TRNA WOBBLE BASE MODIFICATION,0.80618,-0.018676,-0.0012073,0,0
2,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.89296,-0.018697,0.0052753,0,0
2,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.83078,-0.018731,0.05248,0,0
2,GO LIPID GLYCOSYLATION,0.49108,-0.018738,-0.031903,0,0
2,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.64051,-0.018789,-0.01469,0,0
2,GO MUSCLE FIBER DEVELOPMENT,0.61803,-0.018879,-0.013845,0,0
2,GO MAGNESIUM ION TRANSPORT,0.81845,-0.018889,-0.024442,0,0
2,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,0.72171,-0.018897,0.014866,0,0
2,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,0.94321,-0.018906,0.028428,0,0
2,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,0.58498,-0.018909,-0.025083,0,0
2,GO DNA BIOSYNTHETIC PROCESS,0.78176,-0.018985,0.0078251,0,0
2,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.33029,-0.019059,0.12524,0,0
2,GO CELLULAR SODIUM ION HOMEOSTASIS,0.86799,-0.019201,0.028029,0,0
2,GO REGULATION OF CELL CYCLE,0.4521,-0.019246,-0.029662,0,0
2,GO RESPONSE TO MONOSACCHARIDE,0.80618,-0.019271,0.028885,0,0
2,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,0.56341,-0.019528,0.12935,0,0
2,GO MACROMOLECULE DEACYLATION,0.89296,-0.019547,0.031372,0,0
2,GO NEGATIVE REGULATION OF DNA BINDING,0.68646,-0.01961,-0.035777,0,0
2,GO SENSORY ORGAN DEVELOPMENT,0.84314,-0.019735,0.032193,0,0
2,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,0.62923,-0.019875,-0.042099,0,0
2,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,0.69814,-0.020072,0.0042553,0,0
2,GO MITOPHAGY,0.94321,-0.020184,0.028012,0,0
2,GO REGULATION OF CHROMATIN ASSEMBLY,0.99368,-0.020208,0.020168,0,0
2,GO RIBONUCLEOTIDE CATABOLIC PROCESS,0.62923,-0.02024,0.048717,0,0
2,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.7336,-0.020358,0.055773,0,0
2,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,0.67486,-0.020455,-0.017071,0,0
2,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.94321,-0.020465,0.032584,0,0
2,GO REGULATION OF HISTONE MODIFICATION,0.85555,-0.02077,0.014065,0,0
2,GO NEPHRIC DUCT DEVELOPMENT,0.95582,-0.020897,0.033336,0,0
2,GO ESCRT COMPLEX DISASSEMBLY,0.75756,-0.020955,-0.024254,0,0
2,GO REGULATION OF PROTEIN DEPOLYMERIZATION,0.64051,-0.021011,0.033515,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.3148,-0.021106,-0.1339,0,0
2,GO THYROID GLAND DEVELOPMENT,0.54223,-0.021138,-0.0094445,0,0
2,GO ATRIAL SEPTUM DEVELOPMENT,0.47137,-0.02118,-0.040351,0,0
2,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.54223,-0.021298,-0.042886,0,0
2,GO CELL CELL SIGNALING,0.79394,-0.021396,0.026454,0,0
2,GO MITOCHONDRION ORGANIZATION,0.72171,-0.021435,0.011117,0,0
2,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.29248,-0.02161,-0.09655,0,0
2,GO SODIUM ION TRANSPORT,0.72171,-0.021768,-0.0020917,0,0
2,GO POSITIVE REGULATION OF ACROSOME REACTION,0.83078,-0.021794,-0.021907,0,0
2,GO REGULATION OF TOR SIGNALING,0.88046,-0.021877,0.030634,0,0
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.80618,-0.021889,0.036177,0,0
2,GO GANGLIOSIDE METABOLIC PROCESS,0.46168,-0.021978,0.11451,0,0
2,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.69814,-0.021981,-0.028549,0,0
2,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.84314,-0.022196,0.045109,0,0
2,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,0.72171,-0.022249,-0.051501,0,0
2,GO REGULATION OF CHROMATIN ORGANIZATION,0.79394,-0.022286,0.0093588,0,0
2,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.7336,-0.022385,0.020682,0,0
2,GO GONADOTROPIN SECRETION,0.7336,-0.022401,0.01347,0,0
2,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,0.57414,-0.022665,-0.017742,0,0
2,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.94321,-0.022716,0.0013209,0,0
2,GO POSITIVE REGULATION OF HORMONE SECRETION,0.4521,-0.022746,-0.023624,0,0
2,GO BINDING OF SPERM TO ZONA PELLUCIDA,0.53179,-0.022913,-0.049248,0,0
2,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.4521,-0.022983,-0.016248,0,0
2,GO DE NOVO PROTEIN FOLDING,0.53179,-0.02335,-0.013542,0,0
2,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,0.86799,-0.023505,0.056737,0,0
2,GO TRNA METABOLIC PROCESS,0.96843,-0.023562,-0.00076865,0,0
2,GO ESTABLISHMENT OF SPINDLE ORIENTATION,0.27126,-0.023642,-0.060149,0,0
2,GO TRANSLATIONAL TERMINATION,0.40594,-0.023679,-0.048214,0,0
2,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.5959,-0.023683,-0.048354,0,0
2,GO PROTEIN LOCALIZATION TO ORGANELLE,0.64051,-0.023915,0.0076259,0,0
2,GO SPERM MOTILITY,0.54223,-0.024,-0.047704,0,0
2,GO CELL PROLIFERATION IN FOREBRAIN,0.70989,-0.024141,-0.030735,0,0
2,GO PEPTIDYL THREONINE MODIFICATION,0.81845,-0.024384,0.029854,0,0
2,GO EPHRIN RECEPTOR SIGNALING PATHWAY,0.58498,-0.02443,0.015157,0,0
2,GO MEMORY,0.64051,-0.024593,-0.010227,0,0
2,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,1,-0.024603,0.08511,0,0
2,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.99368,-0.024708,0.027503,0,0
2,GO INTRACELLULAR TRANSPORT,0.84314,-0.024727,0.023214,0,0
2,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.52145,-0.024758,-0.026605,0,0
2,GO NEGATIVE REGULATION OF HORMONE SECRETION,0.83078,-0.024871,0.0071723,0,0
2,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.65188,-0.024998,0.019513,0,0
2,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.79394,-0.024999,-0.0088151,0,0
2,GO PHOTOPERIODISM,0.98106,-0.025236,0.013261,0,0
2,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.96843,-0.025294,-0.012002,0,0
2,GO HEART PROCESS,0.75756,-0.0253,0.042192,0,0
2,GO MRNA TRANSPORT,0.58498,-0.025453,-0.034256,0,0
2,GO CHAPERONE MEDIATED PROTEIN FOLDING,0.89296,-0.026301,0.037178,0,0
2,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.62923,-0.026312,-0.0057328,0,0
2,GO MYELIN ASSEMBLY,0.66333,-0.026417,0.02732,0,0
2,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,0.74555,-0.026578,-0.00071964,0,0
2,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.55277,-0.026591,-0.038148,0,0
2,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,0.66333,-0.026884,0.080246,0,0
2,GO NUCLEAR EXPORT,0.67486,-0.0269,-0.018641,0,0
2,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,0.89296,-0.027014,0.0084923,0,0
2,GO REGULATION OF ORGANELLE ASSEMBLY,0.51122,-0.02704,-0.012269,0,0
2,GO RESPONSE TO AMINE,0.80618,-0.027224,-0.0062582,0,0
2,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.80618,-0.0273,0.037971,0,0
2,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.7336,-0.027499,0.028132,0,0
2,GO NUCLEOTIDE PHOSPHORYLATION,0.79394,-0.027544,0.012531,0,0
2,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.90549,-0.027645,0.014192,0,0
2,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,0.40594,-0.027723,-0.087612,0,0
2,GO CGMP MEDIATED SIGNALING,0.99368,-0.027857,0.020022,0,0
2,GO PROTEIN LOCALIZATION TO MEMBRANE,0.58498,-0.027905,0.013765,0,0
2,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,0.56341,-0.027966,-0.023324,0,0
2,GO REGULATION OF CELL CYCLE PROCESS,0.33821,-0.027983,-0.053843,0,0
2,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.65188,-0.028031,0.013262,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.65188,-0.028125,0.022469,0,0
2,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.98106,-0.028273,-0.0031806,0,0
2,GO TRANSFERRIN TRANSPORT,0.72171,-0.028357,0.0057658,0,0
2,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,0.99368,-0.028361,0.044406,0,0
2,GO TORC1 SIGNALING,0.83078,-0.028482,0.016915,0,0
2,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.68646,-0.028709,0.044226,0,0
2,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.98106,-0.028718,0.02756,0,0
2,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.90549,-0.028752,0.027912,0,0
2,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.75756,-0.02902,-0.037997,0,0
2,GO NEGATIVE REGULATION OF AMINO ACID TRANSPORT,0.86799,-0.029176,0.0013645,0,0
2,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.52145,-0.029257,-0.037032,0,0
2,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.50109,-0.029324,-0.045642,0,0
2,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.62923,-0.029373,-0.022524,0,0
2,GO CELL CYCLE PHASE TRANSITION,0.50109,-0.029473,-0.050226,0,0
2,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.81845,-0.029479,0.033787,0,0
2,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.72171,-0.029678,-0.022626,0,0
2,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,0.88046,-0.029889,0.00069233,0,0
2,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,0.47137,-0.029923,-0.038124,0,0
2,GO INTRACELLULAR PROTEIN TRANSPORT,0.7336,-0.029954,0.015219,0,0
2,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.81845,-0.030145,0.0039778,0,0
2,GO CHLORIDE TRANSPORT,0.95582,-0.03023,0.027348,0,0
2,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.42405,-0.030354,0.0035524,0,0
2,GO APOPTOTIC DNA FRAGMENTATION,0.58498,-0.03037,-0.006636,0,0
2,GO PROTEIN TARGETING,0.56341,-0.03039,0.0049379,0,0
2,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,0.37964,-0.030406,-0.040571,0,0
2,GO PEPTIDYL SERINE DEPHOSPHORYLATION,0.64051,-0.030594,0.0021363,0,0
2,GO WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.84314,-0.030608,0.042054,0,0
2,GO CELLULAR RESPONSE TO ALKALOID,0.74555,-0.030609,0.0030831,0,0
2,GO TRICARBOXYLIC ACID CYCLE,0.57414,-0.030638,-0.011771,0,0
2,GO SENSORY SYSTEM DEVELOPMENT,0.7336,-0.030641,0.029431,0,0
2,GO DNA METABOLIC PROCESS,0.52145,-0.030794,-0.039891,0,0
2,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.62923,-0.031028,-0.0023576,0,0
2,GO CELLULAR RESPIRATION,0.12273,-0.031145,-0.045951,0,0
2,GO TELOMERE ORGANIZATION,0.54223,-0.031211,-0.061185,0,0
2,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,0.70989,-0.031284,-0.033425,0,0
2,GO REGULATION OF MEMBRANE PERMEABILITY,0.33821,-0.031319,-0.038619,0,0
2,GO MITOCHONDRIAL FISSION,0.85555,-0.031465,0.040058,0,0
2,GO EMBRYONIC ORGAN MORPHOGENESIS,0.99368,-0.031606,0.035724,0,0
2,GO REGULATION OF GTP BINDING,0.94321,-0.031673,0.019991,0,0
2,GO CELLULAR GLUCOSE HOMEOSTASIS,0.42405,-0.031906,-0.0037929,0,0
2,GO PROTEIN MONOUBIQUITINATION,0.39705,-0.031971,-0.056379,0,0
2,GO FATTY ACYL COA METABOLIC PROCESS,0.98106,-0.03201,0.044256,0,0
2,GO MITOCHONDRIAL TRANSPORT,0.50109,-0.032026,-0.012679,0,0
2,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,0.72171,-0.03224,0.070304,0,0
2,GO REGULATION OF TELOMERE CAPPING,0.55277,-0.032662,-0.040047,0,0
2,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.58498,-0.032879,-0.030338,0,0
2,GO MRNA METHYLATION,0.65188,-0.032922,-0.018887,0,0
2,GO NCRNA 3 END PROCESSING,0.44264,-0.033095,-0.054398,0,0
2,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.39705,-0.033173,-0.078936,0,0
2,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.43329,-0.033257,-0.00897,0,0
2,GO TONGUE MORPHOGENESIS,0.83078,-0.033399,-0.028199,0,0
2,GO REGULATION OF SYSTEM PROCESS,0.88046,-0.033419,0.043579,0,0
2,GO REGULATION OF GLIAL CELL DIFFERENTIATION,0.76963,-0.033739,0.055336,0,0
2,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.96843,-0.033895,0.021631,0,0
2,GO REGULATION OF SULFUR METABOLIC PROCESS,0.99368,-0.033971,0.035435,0,0
2,GO MITOCHONDRION MORPHOGENESIS,0.42405,-0.033988,-0.023959,0,0
2,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,0.95582,-0.034245,0.054807,0,0
2,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.81845,-0.034289,0.012406,0,0
2,GO HEART FORMATION,0.84314,-0.034303,0.016969,0,0
2,GO RRNA CATABOLIC PROCESS,0.53179,-0.034424,-0.046094,0,0
2,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,0.46168,-0.034457,-0.063802,0,0
2,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.65188,-0.034497,0.045694,0,0
2,GO CYTOSOLIC TRANSPORT,0.99368,-0.034589,0.030667,0,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.5959,-0.034616,-0.028482,0,0
2,GO SNRNA PROCESSING,0.88046,-0.0347,-0.012778,0,0
2,GO ORGANELLE DISASSEMBLY,0.93062,-0.034856,0.02068,0,0
2,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,0.58498,-0.03488,0.011469,0,0
2,GO NUCLEAR ENVELOPE REASSEMBLY,0.62923,-0.034887,-0.014605,0,0
2,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.49108,-0.035286,-0.055767,0,0
2,GO REGULATION OF APPETITE,0.5959,-0.035366,-0.048706,0,0
2,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.78176,-0.03567,-0.0030065,0,0
2,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.44264,-0.03586,-0.02949,0,0
2,GO GPI ANCHOR METABOLIC PROCESS,0.69814,-0.035906,-0.013458,0,0
2,GO POSITIVE REGULATION OF AXONOGENESIS,0.42405,-0.035924,-0.00762,0,0
2,GO NEGATIVE REGULATION OF CELL AGING,0.5959,-0.035943,-0.033857,0,0
2,GO SPHINGOLIPID MEDIATED SIGNALING PATHWAY,0.90549,-0.036035,0.013633,0,0
2,GO CYTOCHROME COMPLEX ASSEMBLY,0.80618,-0.036056,0.02579,0,0
2,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,0.90549,-0.036075,0.017693,0,0
2,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,0.33821,-0.036076,-0.030761,0,0
2,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.49108,-0.036084,-0.011966,0,0
2,GO CLATHRIN COAT ASSEMBLY,0.36271,-0.036149,-0.015788,0,0
2,GO MYOTUBE CELL DEVELOPMENT,0.96843,-0.036162,0.0089606,0,0
2,GO DNA DOUBLE STRAND BREAK PROCESSING,0.51122,-0.03618,-0.093453,0,0
2,GO TRNA METHYLATION,0.69814,-0.036181,0.033052,0,0
2,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.42405,-0.036186,-0.03185,0,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.20822,-0.036374,-0.13213,0,0
2,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,0.48117,-0.036463,0.0025687,0,0
2,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.38829,-0.036543,-0.01056,0,0
2,GO DIOL METABOLIC PROCESS,0.66333,-0.036605,-0.010323,0,0
2,GO TRANSCRIPTION BY RNA POLYMERASE III,0.61803,-0.036748,-0.029321,0,0
2,GO CARDIAC CELL FATE COMMITMENT,0.54223,-0.03677,-0.066328,0,0
2,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,0.5959,-0.036819,-0.036551,0,0
2,GO MALE GAMETE GENERATION,0.30724,-0.036976,-0.056672,0,0
2,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.55277,-0.037017,0.073362,0,0
2,GO REGULATION OF ORGANIC ACID TRANSPORT,0.78176,-0.03703,0.036966,0,0
2,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.74555,-0.03724,0.02251,0,0
2,GO MITOTIC CELL CYCLE CHECKPOINT,0.36271,-0.037379,-0.089989,0,0
2,GO REGULATION OF CELL CYCLE ARREST,0.32248,-0.037415,-0.053733,0,0
2,GO TRANSLATIONAL ELONGATION,0.10468,-0.037426,-0.068281,0,0
2,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.90549,-0.037536,0.063504,0,0
2,GO MITOTIC DNA INTEGRITY CHECKPOINT,0.57414,-0.03765,-0.045819,0,0
2,GO NEGATIVE REGULATION OF DNA REPLICATION,0.46168,-0.037711,-0.070059,0,0
2,GO EYE MORPHOGENESIS,0.88046,-0.038004,0.041948,0,0
2,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.99368,-0.038119,0.035011,0,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.08303,-0.038284,-0.14161,0,0
2,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.65188,-0.038327,0.048436,0,0
2,GO TYPE B PANCREATIC CELL PROLIFERATION,0.78176,-0.038398,0.015527,0,0
2,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.26442,-0.038456,-0.16524,0,0
2,GO APICAL PROTEIN LOCALIZATION,0.51122,-0.03849,-0.037396,0,0
2,GO REGULATION OF ACTION POTENTIAL,0.95582,-0.038622,0.02185,0,0
2,GO REGULATION OF GLUCOSE METABOLIC PROCESS,0.48117,-0.039,-0.0059001,0,0
2,GO PEPTIDYL LYSINE TRIMETHYLATION,0.81845,-0.03933,-0.0031282,0,0
2,GO SECONDARY PALATE DEVELOPMENT,0.91805,-0.039386,-0.0049459,0,0
2,GO NEURAL TUBE PATTERNING,0.88046,-0.039567,-0.0087919,0,0
2,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.96843,-0.039607,0.029732,0,0
2,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.50109,-0.039702,-0.046723,0,0
2,GO ENTRAINMENT OF CIRCADIAN CLOCK,0.37964,-0.040009,-0.024985,0,0
2,GO MITOCHONDRIAL DNA REPLICATION,0.88046,-0.040092,-0.026722,0,0
2,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.56341,-0.040176,-0.035705,0,0
2,GO MULTICELLULAR ORGANISM GROWTH,0.36271,-0.040196,-0.00068931,0,0
2,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.52145,-0.040321,-0.002617,0,0
2,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,0.95582,-0.040327,0.094121,0,0
2,GO HISTONE MRNA METABOLIC PROCESS,0.62923,-0.040597,-0.048896,0,0
2,GO REGULATION OF CHROMOSOME ORGANIZATION,0.37964,-0.040683,-0.052731,0,0
2,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.88046,-0.040695,0.00038264,0,0
2,GO SOMITE DEVELOPMENT,0.72171,-0.040834,0.0053196,0,0
2,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,0.72171,-0.040944,0.02255,0,0
2,GO THIOESTER BIOSYNTHETIC PROCESS,0.75756,-0.041011,0.058866,0,0
2,GO RESPONSE TO LIGHT STIMULUS,0.74555,-0.041057,0.0072857,0,0
2,GO HISTONE DEUBIQUITINATION,0.91805,-0.041078,0.012159,0,0
2,GO MRNA CLEAVAGE,0.90549,-0.041225,0.020898,0,0
2,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.61803,-0.041343,-0.026041,0,0
2,GO SEXUAL REPRODUCTION,0.28529,-0.041428,-0.043225,0,0
2,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.51122,-0.04161,-0.036052,0,0
2,GO PROTEIN TARGETING TO MEMBRANE,0.15197,-0.041666,-0.039281,0,0
2,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,0.30724,-0.04175,-0.051296,0,0
2,GO CAMERA TYPE EYE DEVELOPMENT,0.66333,-0.041796,0.021758,0,0
2,GO CIRCADIAN RHYTHM,0.49108,-0.04203,-0.0031005,0,0
2,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.51122,-0.042376,-0.014008,0,0
2,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.28529,-0.04242,-0.0652,0,0
2,GO ALDEHYDE CATABOLIC PROCESS,0.41494,-0.042453,-0.045516,0,0
2,GO GAMETE GENERATION,0.28529,-0.042612,-0.048714,0,0
2,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,0.84314,-0.042671,0.056999,0,0
2,GO REGULATION OF CELL PROJECTION ORGANIZATION,0.54223,-0.042699,0.0070881,0,0
2,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.53179,-0.043063,-0.0069017,0,0
2,GO ORGANELLE MEMBRANE FUSION,0.36271,-0.043078,-0.0076313,0,0
2,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.40594,-0.043103,-0.010167,0,0
2,GO REGULATION OF CENTROSOME DUPLICATION,0.20256,-0.043459,-0.11238,0,0
2,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,0.11163,-0.043558,-0.12161,0,0
2,GO RESPONSE TO HYDROXYUREA,0.18102,-0.043643,-0.11905,0,0
2,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.56341,-0.043684,-0.040788,0,0
2,GO POSITIVE REGULATION OF TOR SIGNALING,0.54223,-0.043988,-0.014085,0,0
2,GO NUCLEUS ORGANIZATION,0.40594,-0.043993,-0.045685,0,0
2,GO AMINO ACID BETAINE METABOLIC PROCESS,0.54223,-0.044024,-0.026902,0,0
2,GO VESICLE CYTOSKELETAL TRAFFICKING,0.214,-0.044252,-0.046315,0,0
2,GO GENETIC IMPRINTING,0.51122,-0.044452,-0.036666,0,0
2,GO DETECTION OF LIGHT STIMULUS,0.35442,-0.044459,-0.046008,0,0
2,GO REGULATION OF EXTENT OF CELL GROWTH,0.52145,-0.044466,-0.026524,0,0
2,GO REGULATION OF NEURON MATURATION,0.46168,-0.044636,0.0071825,0,0
2,GO NOREPINEPHRINE METABOLIC PROCESS,0.50109,-0.044774,-0.040326,0,0
2,GO REGULATION OF GOLGI ORGANIZATION,0.86799,-0.044802,0.032599,0,0
2,GO AXON EXTENSION,0.4521,-0.044972,-0.012269,0,0
2,GO NEGATIVE REGULATION OF TOR SIGNALING,0.80618,-0.044972,0.02307,0,0
2,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.65188,-0.045088,-0.0013812,0,0
2,GO CELL CYCLE,0.32248,-0.045145,-0.048403,0,0
2,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.4521,-0.045325,-0.032558,0,0
2,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,0.81845,-0.045545,0.023177,0,0
2,GO TELOMERASE RNA LOCALIZATION,0.23827,-0.045754,-0.1097,0,0
2,GO RNA PROCESSING,0.49108,-0.045781,-0.027474,0,0
2,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.23203,-0.046095,-0.066569,0,0
2,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.90549,-0.046103,-0.0039825,0,0
2,GO NEGATIVE REGULATION OF BEHAVIOR,0.58498,-0.046128,-0.041887,0,0
2,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.62923,-0.046271,0.015201,0,0
2,GO G2 DNA DAMAGE CHECKPOINT,0.32248,-0.046325,-0.11168,0,0
2,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.43329,-0.046405,-0.0095557,0,0
2,GO REGULATION OF GENE EXPRESSION EPIGENETIC,0.70989,-0.046479,-0.020927,0,0
2,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.28529,-0.046631,-0.078807,0,0
2,GO LOCALIZATION WITHIN MEMBRANE,0.75756,-0.046645,0.012749,0,0
2,GO ENDOTHELIAL CELL MORPHOGENESIS,0.85555,-0.046692,0.049405,0,0
2,GO PROTEIN TARGETING TO MITOCHONDRION,0.197,-0.047596,-0.019948,0,0
2,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.54223,-0.047852,-0.025886,0,0
2,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.62923,-0.047906,-0.033171,0,0
2,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.79394,-0.048146,0.030853,0,0
2,GO DNA INTEGRITY CHECKPOINT,0.46168,-0.048426,-0.069408,0,0
2,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.37111,-0.048474,-0.053201,0,0
2,GO CELL FATE DETERMINATION,0.90549,-0.048478,0.0041193,0,0
2,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.35442,-0.048711,-0.082965,0,0
2,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.52145,-0.048734,-0.091624,0,0
2,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,0.28529,-0.048793,-0.045136,0,0
2,GO RRNA TRANSCRIPTION,0.68646,-0.048974,-0.025189,0,0
2,GO POSITIVE REGULATION OF CELL CYCLE,0.214,-0.048988,-0.054473,0,0
2,GO REGULATION OF HISTONE METHYLATION,0.39705,-0.048994,-0.044336,0,0
2,GO OOGENESIS,0.17091,-0.049119,-0.097207,0,0
2,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.18102,-0.049163,-0.025505,0,0
2,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.37964,-0.049347,-0.070166,0,0
2,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.69814,-0.049396,-0.027379,0,0
2,GO PEPTIDYL LYSINE MODIFICATION,0.51122,-0.049406,-0.021584,0,0
2,GO LONG TERM SYNAPTIC DEPRESSION,0.65188,-0.049409,-0.03098,0,0
2,GO REGULATION OF CELL MATURATION,0.70989,-0.049617,-0.012072,0,0
2,GO MATING,0.81845,-0.049809,0.007725,0,0
2,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.33029,-0.049994,-0.071618,0,0
2,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.86799,-0.050023,-0.028422,0,0
2,GO CELL CYCLE PROCESS,0.214,-0.050066,-0.067728,0,0
2,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,0.28529,-0.050177,-0.10004,0,0
2,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.79394,-0.050198,0.03287,0,0
2,GO AXONAL FASCICULATION,0.49108,-0.050238,-0.07392,0,0
2,GO DETECTION OF ABIOTIC STIMULUS,0.08303,-0.050399,-0.058423,0,0
2,GO EMBRYONIC BODY MORPHOGENESIS,0.96843,-0.050494,0.011796,0,0
2,GO RNA EXPORT FROM NUCLEUS,0.39705,-0.05051,-0.058202,0,0
2,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.2259,-0.050597,-0.1118,0,0
2,GO CELL CYCLE CHECKPOINT,0.34626,-0.051091,-0.09622,0,0
2,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,0.2998,-0.051235,-0.053161,0,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.11163,-0.051295,-0.02929,0,0
2,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.30724,-0.051324,-0.022366,0,0
2,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,0.89296,-0.051746,0.035929,0,0
2,GO DIVALENT METAL ION EXPORT,0.54223,-0.051804,-0.054022,0,0
2,GO EPITHELIAL CELL FATE COMMITMENT,0.64051,-0.052267,-0.0020553,0,0
2,GO HISTONE H3 K9 METHYLATION,0.4521,-0.052335,-0.055066,0,0
2,GO ORGANELLE LOCALIZATION,0.17091,-0.052866,-0.056057,0,0
2,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.4521,-0.052905,-0.0061447,0,0
2,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.40594,-0.053003,-0.036478,0,0
2,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,0.47137,-0.05302,-0.041345,0,0
2,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.49108,-0.053111,-0.057111,0,0
2,GO SPERMATID DIFFERENTIATION,0.37111,-0.053324,-0.062177,0,0
2,GO DIOL BIOSYNTHETIC PROCESS,0.47137,-0.053368,-0.018773,0,0
2,GO FOREBRAIN CELL MIGRATION,0.33821,-0.053529,-0.054722,0,0
2,GO POSITIVE REGULATION OF CHROMATIN BINDING,0.43329,-0.053537,-0.082448,0,0
2,GO ADHERENS JUNCTION ORGANIZATION,0.67486,-0.053693,0.026478,0,0
2,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.68646,-0.053752,-0.0028645,0,0
2,GO GERM CELL DEVELOPMENT,0.18624,-0.053767,-0.076388,0,0
2,GO PROTEIN DEMETHYLATION,0.37964,-0.053846,-0.045442,0,0
2,GO HETEROCHROMATIN ORGANIZATION,0.52145,-0.053876,-0.040069,0,0
2,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.17091,-0.053958,-0.17171,0,0
2,GO CILIUM MOVEMENT,0.4521,-0.054051,-0.073108,0,0
2,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,0.60692,-0.054187,-0.1187,0,0
2,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.61803,-0.054266,-0.014575,0,0
2,GO AROMATIC AMINO ACID TRANSPORT,0.61803,-0.054506,-0.0093452,0,0
2,GO AMINO ACID ACTIVATION,0.66333,-0.054547,-0.030571,0,0
2,GO PROTEIN HETEROOLIGOMERIZATION,0.20822,-0.054576,-0.054934,0,0
2,GO SCHWANN CELL DIFFERENTIATION,0.88046,-0.05465,0.045854,0,0
2,GO CELL CELL ADHESION MEDIATED BY CADHERIN,0.55277,-0.054661,0.0063279,0,0
2,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.2998,-0.054669,-0.13156,0,0
2,GO TRNA CATABOLIC PROCESS,0.85555,-0.054814,-0.019574,0,0
2,GO REGULATION OF CHROMATIN BINDING,0.46168,-0.055083,-0.047654,0,0
2,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,0.25111,-0.055084,-0.10595,0,0
2,GO FERTILIZATION,0.2259,-0.055449,-0.049552,0,0
2,GO ATP METABOLIC PROCESS,0.2577,-0.055474,-0.028792,0,0
2,GO MRNA METABOLIC PROCESS,0.4521,-0.055572,-0.030804,0,0
2,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.94321,-0.055577,0.014417,0,0
2,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.54223,-0.055687,0.095514,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,0.32248,-0.055715,-0.06741,0,0
2,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.37111,-0.056223,-0.019258,0,0
2,GO EXTRACELLULAR TRANSPORT,0.95582,-0.056329,-0.016346,0,0
2,GO MEMBRANE BIOGENESIS,0.57414,-0.056516,-0.011236,0,0
2,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.37964,-0.056557,-0.094711,0,0
2,GO PATTERN SPECIFICATION PROCESS,0.36271,-0.056615,-0.02004,0,0
2,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.20822,-0.056734,-0.11434,0,0
2,GO RESPONSE TO IMMOBILIZATION STRESS,0.69814,-0.056968,-0.016372,0,0
2,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,0.90549,-0.057146,0.025219,0,0
2,GO PROTEIN METHYLATION,0.3148,-0.057517,-0.072979,0,0
2,GO MIDBRAIN DEVELOPMENT,0.33029,-0.057567,-0.0099913,0,0
2,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.51122,-0.057707,-0.034258,0,0
2,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.7336,-0.057718,-0.019556,0,0
2,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.91805,-0.057861,0.026789,0,0
2,GO REGULATION OF MITOCHONDRIAL FUSION,0.46168,-0.057903,-0.016524,0,0
2,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,0.43329,-0.057904,-0.04846,0,0
2,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.34626,-0.057971,-0.059464,0,0
2,GO CORPUS CALLOSUM DEVELOPMENT,1,-0.058095,0.054108,0,0
2,GO NERVOUS SYSTEM PROCESS,0.52145,-0.058165,-0.004095,0,0
2,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,0.70989,-0.058425,-0.0043812,0,0
2,GO MITOTIC CELL CYCLE,0.20822,-0.058481,-0.074462,0,0
2,GO LEFT RIGHT PATTERN FORMATION,0.61803,-0.058563,-0.024388,0,0
2,GO SIGNAL RELEASE,0.56341,-0.058714,0.0016328,0,0
2,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,0.42405,-0.058839,-0.013751,0,0
2,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.88046,-0.058968,0.013299,0,0
2,GO POSITIVE REGULATION OF NUCLEAR DIVISION,0.18102,-0.05908,-0.070002,0,0
2,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.34626,-0.059198,-0.052563,0,0
2,GO REGULATION OF MEMBRANE REPOLARIZATION,0.66333,-0.059306,-0.00079871,0,0
2,GO ORGANELLE FUSION,0.13467,-0.059335,-0.031818,0,0
2,GO MITOTIC CYTOKINESIS,0.12662,-0.059452,-0.11168,0,0
2,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,0.40594,-0.059467,-0.027517,0,0
2,GO NEURON PROJECTION GUIDANCE,0.37111,-0.059776,-0.02347,0,0
2,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.80618,-0.059839,0.00094729,0,0
2,GO ENERGY HOMEOSTASIS,0.50109,-0.060092,-0.0081625,0,0
2,GO ASSOCIATIVE LEARNING,0.20822,-0.060158,-0.064496,0,0
2,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.91805,-0.06017,0.013706,0,0
2,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,0.65188,-0.060173,-0.015727,0,0
2,GO RESPONSE TO LEAD ION,0.60692,-0.060572,0.00012847,0,0
2,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,0.93062,-0.060653,0.042065,0,0
2,GO METHIONINE METABOLIC PROCESS,0.74555,-0.060763,-0.010388,0,0
2,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,0.72171,-0.060881,0.0030541,0,0
2,GO MEMBRANE DEPOLARIZATION,0.50109,-0.060884,-0.02791,0,0
2,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.41494,-0.060887,-0.014696,0,0
2,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.067497,-0.061051,-0.11059,0,0
2,GO PROTEIN INSERTION INTO MEMBRANE,0.23827,-0.061113,-0.029401,0,0
2,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,0.69814,-0.06129,-0.041469,0,0
2,GO RESPONSE TO ELECTRICAL STIMULUS,0.81845,-0.061302,-0.010093,0,0
2,GO PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.17591,-0.061345,-0.11963,0,0
2,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,0.29248,-0.06137,-0.037327,0,0
2,GO REGULATION OF CENTROSOME CYCLE,0.1475,-0.06139,-0.13879,0,0
2,GO REGULATION OF SPINDLE CHECKPOINT,0.13885,-0.061476,-0.19455,0,0
2,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,0.54223,-0.061512,0.004097,0,0
2,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.3148,-0.061636,-0.038137,0,0
2,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,0.2259,-0.061727,-0.053456,0,0
2,GO OTIC VESICLE DEVELOPMENT,0.79394,-0.061806,0.02433,0,0
2,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,0.13885,-0.061889,-0.066034,0,0
2,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,0.61803,-0.062001,-0.0078238,0,0
2,GO REGULATION OF MITOPHAGY,0.55277,-0.06212,-0.012666,0,0
2,GO REGULATION OF PROTEIN FOLDING,0.094909,-0.062312,-0.058688,0,0
2,GO HISTONE MONOUBIQUITINATION,0.57414,-0.062755,-0.048169,0,0
2,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.26442,-0.062818,-0.070745,0,0
2,GO POTASSIUM ION HOMEOSTASIS,0.52145,-0.062833,-0.02971,0,0
2,GO FAT CELL PROLIFERATION,0.23827,-0.062958,-0.07995,0,0
2,GO PROTEIN FOLDING,0.13885,-0.063161,-0.028778,0,0
2,GO POSITIVE REGULATION OF CELL MATURATION,0.75756,-0.063501,0.0049811,0,0
2,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.15655,-0.063616,-0.074152,0,0
2,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.51122,-0.063921,0.0018864,0,0
2,GO PEPTIDYL LYSINE METHYLATION,0.34626,-0.06403,-0.070435,0,0
2,GO RESPONSE TO LEUCINE,0.18624,-0.064084,-0.12695,0,0
2,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,0.3148,-0.064373,-0.084679,0,0
2,GO HISTONE H2A UBIQUITINATION,0.42405,-0.064562,-0.057406,0,0
2,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,0.52145,-0.064722,-0.067636,0,0
2,GO OOCYTE DIFFERENTIATION,0.08588,-0.064792,-0.10876,0,0
2,GO CELL DIVISION,0.1306,-0.064937,-0.098611,0,0
2,GO TELOMERE CAPPING,0.4521,-0.065137,-0.045944,0,0
2,GO CELL CYCLE G2 M PHASE TRANSITION,0.11163,-0.065257,-0.10997,0,0
2,GO PROTEIN REFOLDING,0.33821,-0.065303,-0.060242,0,0
2,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.47137,-0.0654,-0.05039,0,0
2,GO NEUROGENESIS,0.27126,-0.065469,-0.02375,0,0
2,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.49108,-0.065697,-0.034833,0,0
2,GO METHIONINE BIOSYNTHETIC PROCESS,0.83078,-0.065722,0.011617,0,0
2,GO POSITIVE REGULATION OF EXOCYTOSIS,0.44264,-0.065753,-0.022105,0,0
2,GO TELENCEPHALON DEVELOPMENT,0.214,-0.065892,-0.057265,0,0
2,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.10468,-0.065989,-0.15881,0,0
2,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.74555,-0.066078,0.072221,0,0
2,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.54223,-0.066101,-0.017082,0,0
2,GO REGULATION OF ATPASE ACTIVITY,0.17091,-0.066385,-0.023273,0,0
2,GO RESPONSE TO ALKALOID,0.214,-0.066518,-0.037843,0,0
2,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.66333,-0.066573,-0.011342,0,0
2,GO IRON SULFUR CLUSTER ASSEMBLY,0.47137,-0.066722,-0.01878,0,0
2,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.85555,-0.066784,0.010871,0,0
2,GO VIRAL LATENCY,0.49108,-0.066847,-0.071243,0,0
2,GO REGIONALIZATION,0.34626,-0.067018,-0.021164,0,0
2,GO CARNITINE METABOLIC PROCESS,0.69814,-0.067154,0.0076838,0,0
2,GO COVALENT CHROMATIN MODIFICATION,0.46168,-0.0674,-0.036824,0,0
2,GO NEUROBLAST PROLIFERATION,0.197,-0.06744,-0.094011,0,0
2,GO REGULATION OF CELLULAR RESPONSE TO HEAT,0.2998,-0.067458,-0.047387,0,0
2,GO CELL PROJECTION ASSEMBLY,0.56341,-0.067551,-0.0039306,0,0
2,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.17091,-0.067651,-0.078422,0,0
2,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.33821,-0.067706,-0.088574,0,0
2,GO MRNA EXPORT FROM NUCLEUS,0.33821,-0.068436,-0.06669,0,0
2,GO RESPONSE TO MISFOLDED PROTEIN,0.34626,-0.068592,0.0011479,0,0
2,GO MITOTIC G2 M TRANSITION CHECKPOINT,0.33029,-0.068639,-0.097804,0,0
2,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,0.86799,-0.068747,0.017664,0,0
2,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.85555,-0.068774,0.013341,0,0
2,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.36271,-0.068809,-0.032042,0,0
2,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.98106,-0.068964,0.016372,0,0
2,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.80618,-0.068971,-0.0083622,0,0
2,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.20822,-0.069194,-0.081462,0,0
2,GO ORGANELLE INHERITANCE,0.7336,-0.069261,-0.0077462,0,0
2,GO CARDIAC CHAMBER FORMATION,0.55277,-0.069308,-0.066444,0,0
2,GO NCRNA TRANSCRIPTION,0.37964,-0.069343,-0.046447,0,0
2,GO ACTION POTENTIAL,0.27126,-0.069527,-0.039556,0,0
2,GO DNA LIGATION,0.16602,-0.069532,-0.12506,0,0
2,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.10134,-0.069566,-0.042241,0,0
2,GO TETRAHYDROFOLATE METABOLIC PROCESS,0.54223,-0.069922,-0.092414,0,0
2,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.32248,-0.069937,-0.082004,0,0
2,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.43329,-0.070238,-0.084834,0,0
2,GO SENSORY PERCEPTION OF PAIN,0.99368,-0.070257,0.03794,0,0
2,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,0.36271,-0.070511,-0.13265,0,0
2,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,0.29248,-0.070531,-0.070742,0,0
2,GO G0 TO G1 TRANSITION,0.35442,-0.070536,-0.10492,0,0
2,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.58498,-0.070576,-0.030808,0,0
2,GO REGULATION OF NEURON MIGRATION,0.29248,-0.070876,-0.090253,0,0
2,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.062884,-0.070943,-0.17917,0,0
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.33029,-0.071065,-0.056903,0,0
2,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.15655,-0.071065,-0.05497,0,0
2,GO ATP TRANSPORT,0.25111,-0.071092,-0.032033,0,0
2,GO AXON DEVELOPMENT,0.2577,-0.071118,-0.047241,0,0
2,GO PURINE NUCLEOTIDE TRANSPORT,0.17591,-0.071189,-0.035634,0,0
2,GO REPLICATION FORK PROCESSING,0.39705,-0.071227,-0.11867,0,0
2,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,0.50109,-0.071243,-0.013523,0,0
2,GO SKELETAL MUSCLE ADAPTATION,0.62923,-0.071463,-0.015097,0,0
2,GO SINGLE FERTILIZATION,0.10811,-0.071476,-0.062437,0,0
2,GO DEVELOPMENTAL MATURATION,0.57414,-0.071618,-0.0051961,0,0
2,GO DIACYLGLYCEROL METABOLIC PROCESS,0.93062,-0.071637,0.046673,0,0
2,GO SCHWANN CELL DEVELOPMENT,0.66333,-0.07167,-0.011783,0,0
2,GO HISTONE METHYLATION,0.29248,-0.071697,-0.075237,0,0
2,GO BRAIN MORPHOGENESIS,0.39705,-0.071802,-0.062851,0,0
2,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,1,-0.071948,0.024425,0,0
2,GO HISTONE UBIQUITINATION,0.34626,-0.071955,-0.071411,0,0
2,GO MITOCHONDRIAL TRANSCRIPTION,0.41494,-0.072296,-0.057545,0,0
2,GO NEUROTRANSMITTER REUPTAKE,0.36271,-0.072402,-0.062196,0,0
2,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.49108,-0.072706,-0.070848,0,0
2,GO REGULATION OF CYTOPLASMIC TRANSLATION,0.56341,-0.072908,-0.0096926,0,0
2,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.41494,-0.07303,0.010009,0,0
2,GO POSITIVE REGULATION OF TORC1 SIGNALING,0.2259,-0.073038,-0.10718,0,0
2,GO CHROMOSOME ORGANIZATION,0.18624,-0.073118,-0.092648,0,0
2,GO DOSAGE COMPENSATION,0.30724,-0.073153,-0.078346,0,0
2,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.39705,-0.073402,-0.020998,0,0
2,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,0.42405,-0.073462,-0.045562,0,0
2,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.72171,-0.073736,0.011868,0,0
2,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.2998,-0.073907,-0.056203,0,0
2,GO DETECTION OF VISIBLE LIGHT,0.1306,-0.074212,-0.076249,0,0
2,GO GLYCOLIPID BIOSYNTHETIC PROCESS,0.43329,-0.074222,-0.010171,0,0
2,GO REGULATION OF MRNA 3 END PROCESSING,0.27126,-0.074587,-0.059992,0,0
2,GO SNRNA TRANSCRIPTION,0.52145,-0.074623,-0.031723,0,0
2,GO COENZYME A METABOLIC PROCESS,0.17091,-0.074697,-0.05632,0,0
2,GO RECOMBINATIONAL REPAIR,0.19156,-0.074699,-0.13086,0,0
2,GO HISTONE H3 DEACETYLATION,0.51122,-0.074849,-0.027595,0,0
2,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,0.15655,-0.074938,-0.07344,0,0
2,GO REGULATION OF NEURON DIFFERENTIATION,0.19156,-0.075196,-0.051029,0,0
2,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,0.37111,-0.075234,-0.07869,0,0
2,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,0.18102,-0.075279,-0.059997,0,0
2,GO POSITIVE REGULATION OF VESICLE FUSION,0.35442,-0.075469,-0.045351,0,0
2,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.18624,-0.07624,-0.14406,0,0
2,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.50109,-0.076275,-0.015349,0,0
2,GO POSITIVE REGULATION OF CYTOKINESIS,0.18102,-0.076393,-0.13629,0,0
2,GO PROTEIN ACETYLATION,0.30724,-0.076533,-0.045229,0,0
2,GO POSITIVE REGULATION OF BEHAVIOR,0.60692,-0.076533,-0.030006,0,0
2,GO CIRCADIAN REGULATION OF GENE EXPRESSION,0.80618,-0.076645,0.038274,0,0
2,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,0.15655,-0.076782,-0.12759,0,0
2,GO POSITIVE REGULATION OF HISTONE METHYLATION,0.28529,-0.076849,-0.093976,0,0
2,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.5959,-0.076875,-0.068052,0,0
2,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,0.33029,-0.076878,-0.031468,0,0
2,GO PROTEIN HETEROTETRAMERIZATION,0.32248,-0.077133,-0.0576,0,0
2,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.08303,-0.077585,-0.21078,0,0
2,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.83078,-0.077642,-0.020811,0,0
2,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.11894,-0.077752,-0.12289,0,0
2,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,0.4521,-0.077907,-0.053029,0,0
2,GO CLATHRIN DEPENDENT ENDOCYTOSIS,0.30724,-0.078212,-0.0088546,0,0
2,GO HEART INDUCTION,0.62923,-0.078506,0.0016105,0,0
2,GO NON RECOMBINATIONAL REPAIR,0.3148,-0.078724,-0.060132,0,0
2,GO OXIDATIVE PHOSPHORYLATION,0.021265,-0.078811,-0.092112,0,0
2,GO EMBRYONIC AXIS SPECIFICATION,0.21989,-0.078929,-0.078659,0,0
2,GO CHROMATIN ORGANIZATION,0.27126,-0.078988,-0.066834,0,0
2,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,0.10468,-0.07903,-0.15963,0,0
2,GO RESPONSE TO PAIN,0.60692,-0.079402,-0.024772,0,0
2,GO NADH METABOLIC PROCESS,0.26442,-0.079459,-0.050643,0,0
2,GO RECEPTOR CLUSTERING,0.58498,-0.07963,-0.013497,0,0
2,GO VENTRICULAR SYSTEM DEVELOPMENT,0.21989,-0.079679,-0.056763,0,0
2,GO NUCLEOTIDE TRANSPORT,0.43329,-0.079849,-0.008359,0,0
2,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,0.17091,-0.080608,-0.053774,0,0
2,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,0.43329,-0.08063,-0.039637,0,0
2,GO INTRA S DNA DAMAGE CHECKPOINT,0.23203,-0.080968,-0.10254,0,0
2,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.23203,-0.080969,-0.087919,0,0
2,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.25111,-0.081133,-0.051432,0,0
2,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.2577,-0.081223,-0.10859,0,0
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.20822,-0.081256,-0.06412,0,0
2,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.41494,-0.081317,-0.035627,0,0
2,GO MONOVALENT INORGANIC CATION TRANSPORT,0.32248,-0.081324,-0.032132,0,0
2,GO NEURAL PRECURSOR CELL PROLIFERATION,0.2259,-0.081703,-0.055431,0,0
2,GO EXPORT ACROSS PLASMA MEMBRANE,0.50109,-0.081754,-0.012133,0,0
2,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.38829,-0.081793,-0.076203,0,0
2,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.49108,-0.081818,0.00052364,0,0
2,GO LIMBIC SYSTEM DEVELOPMENT,0.13885,-0.081995,-0.06994,0,0
2,GO SULFATE TRANSPORT,0.17091,-0.082011,-0.096933,0,0
2,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,0.33821,-0.082033,-0.053692,0,0
2,GO REGULATION OF HISTONE UBIQUITINATION,0.24463,-0.082178,-0.067656,0,0
2,GO CRISTAE FORMATION,0.26442,-0.082244,-0.050591,0,0
2,GO PEPTIDYL ARGININE MODIFICATION,0.86799,-0.082261,0.012464,0,0
2,GO DOUBLE STRAND BREAK REPAIR,0.23203,-0.082427,-0.11174,0,0
2,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,0.86799,-0.082493,0.026442,0,0
2,GO RNA 3 END PROCESSING,0.34626,-0.082663,-0.068474,0,0
2,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.17591,-0.083252,-0.12051,0,0
2,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.072385,-0.083297,-0.081546,0,0
2,GO RNA POLYADENYLATION,0.43329,-0.083909,-0.036023,0,0
2,GO PEPTIDYL LYSINE ACETYLATION,0.3148,-0.083929,-0.043562,0,0
2,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.015776,-0.083975,-0.093313,0,0
2,GO CHROMATIN REMODELING,0.214,-0.084006,-0.10845,0,0
2,GO LEYDIG CELL DIFFERENTIATION,0.85555,-0.084168,-0.0050893,0,0
2,GO DENDRITIC SPINE DEVELOPMENT,0.24463,-0.084218,-0.076117,0,0
2,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.32248,-0.084898,-0.044184,0,0
2,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.034576,-0.085031,-0.058161,0,0
2,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.3148,-0.08508,-0.034502,0,0
2,GO RESPONSE TO REDOX STATE,0.39705,-0.085405,-0.04594,0,0
2,GO MRNA 3 END PROCESSING,0.28529,-0.085507,-0.076361,0,0
2,GO REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT,0.16123,-0.085582,-0.11623,0,0
2,GO REGULATION OF HISTONE H3 K9 METHYLATION,0.25111,-0.08584,-0.085339,0,0
2,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.2577,-0.085947,-0.05251,0,0
2,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,0.14312,-0.086104,-0.073117,0,0
2,GO PROTEIN ACYLATION,0.20822,-0.086128,-0.067168,0,0
2,GO POSITIVE REGULATION OF TELOMERE CAPPING,0.26442,-0.086227,-0.10551,0,0
2,GO STRIATUM DEVELOPMENT,0.93062,-0.086244,0.029692,0,0
2,GO CELL PROJECTION ORGANIZATION,0.3148,-0.086556,-0.023734,0,0
2,GO PROTEIN NEDDYLATION,0.11163,-0.086572,-0.071404,0,0
2,GO CEREBRAL CORTEX CELL MIGRATION,0.17091,-0.086785,-0.11246,0,0
2,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,0.39705,-0.08684,-0.046695,0,0
2,GO ANATOMICAL STRUCTURE REGRESSION,0.68646,-0.087072,-0.012547,0,0
2,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,0.091819,-0.087102,-0.064726,0,0
2,GO NUCLEUS LOCALIZATION,0.43329,-0.087229,-0.046195,0,0
2,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,0.41494,-0.087417,-0.020624,0,0
2,GO PROTEIN O LINKED MANNOSYLATION,0.57414,-0.087938,-0.049365,0,0
2,GO REGULATION OF SISTER CHROMATID SEGREGATION,0.072385,-0.08796,-0.20996,0,0
2,GO DNA DEPENDENT DNA REPLICATION,0.14312,-0.088024,-0.16993,0,0
2,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.4521,-0.088114,-0.037092,0,0
2,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.43329,-0.088251,-0.062723,0,0
2,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,0.18624,-0.08826,-0.06311,0,0
2,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.20256,-0.088263,-0.09595,0,0
2,GO N GLYCAN PROCESSING,0.85555,-0.088426,0.058484,0,0
2,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.28529,-0.0885,-0.092194,0,0
2,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.33029,-0.088512,-0.046358,0,0
2,GO POSITIVE REGULATION OF CELL CYCLE ARREST,0.34626,-0.088558,-0.059693,0,0
2,GO SNARE COMPLEX ASSEMBLY,0.17591,-0.0889,-0.059702,0,0
2,GO CELL PART MORPHOGENESIS,0.1306,-0.089253,-0.073354,0,0
2,GO RESPONSE TO NERVE GROWTH FACTOR,0.091819,-0.089259,-0.088676,0,0
2,GO DNA GEOMETRIC CHANGE,0.17091,-0.089374,-0.1313,0,0
2,GO HINDBRAIN MORPHOGENESIS,0.197,-0.089395,-0.066899,0,0
2,GO CAMERA TYPE EYE MORPHOGENESIS,0.65188,-0.089433,0.0090486,0,0
2,GO REGULATION OF TRANSLATIONAL FIDELITY,0.34626,-0.089526,-0.077238,0,0
2,GO HIPPOCAMPUS DEVELOPMENT,0.18624,-0.089708,-0.077688,0,0
2,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.022172,-0.089799,-0.066644,0,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,0.15197,-0.089828,-0.066277,0,0
2,GO SYNAPTIC VESICLE ENDOSOMAL PROCESSING,0.3148,-0.090024,-0.064778,0,0
2,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,0.43329,-0.09031,-0.039346,0,0
2,GO RESPONSE TO GLUCAGON,0.30724,-0.090342,-0.064221,0,0
2,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.14312,-0.090371,-0.059608,0,0
2,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.11163,-0.090453,-0.14675,0,0
2,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.197,-0.090988,-0.053114,0,0
2,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,0.21989,-0.091113,-0.046377,0,0
2,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.84314,-0.091124,0.0056592,0,0
2,GO REGULATION OF AXONOGENESIS,0.30724,-0.091236,-0.052754,0,0
2,GO CRANIAL NERVE DEVELOPMENT,0.42405,-0.091292,-0.073958,0,0
2,GO BEHAVIOR,0.214,-0.091459,-0.056653,0,0
2,GO MECHANORECEPTOR DIFFERENTIATION,0.17091,-0.091526,-0.059277,0,0
2,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.32248,-0.0917,-0.04783,0,0
2,GO REGULATION OF POTASSIUM ION TRANSPORT,0.20256,-0.09177,-0.050627,0,0
2,GO NUCLEAR MIGRATION,0.37111,-0.091818,-0.04942,0,0
2,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.17091,-0.091835,-0.15678,0,0
2,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,0.2259,-0.091945,-0.07624,0,0
2,GO GLUCOSE CATABOLIC PROCESS,0.35442,-0.092131,-0.044824,0,0
2,GO CELLULAR COMPONENT MORPHOGENESIS,0.18102,-0.092422,-0.056136,0,0
2,GO CHROMATIN SILENCING,0.11524,-0.092557,-0.12826,0,0
2,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,0.24463,-0.092562,-0.0629,0,0
2,GO REGULATION OF MRNA BINDING,0.12662,-0.092711,-0.076232,0,0
2,GO CHROMOSOME SEPARATION,0.074935,-0.092725,-0.21307,0,0
2,GO NEURON DIFFERENTIATION,0.18102,-0.092728,-0.053598,0,0
2,GO LEARNING,0.1475,-0.092859,-0.10885,0,0
2,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.1475,-0.093045,-0.10542,0,0
2,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,0.2577,-0.09323,-0.04303,0,0
2,GO UBIQUINONE METABOLIC PROCESS,0.38829,-0.093251,-0.043426,0,0
2,GO CENTROSOME DUPLICATION,0.074935,-0.093336,-0.1659,0,0
2,GO DNA REPLICATION,0.1475,-0.093404,-0.13482,0,0
2,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,0.3148,-0.093419,-0.07853,0,0
2,GO MALE SEX DETERMINATION,0.2259,-0.09347,-0.14686,0,0
2,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,0.2577,-0.093655,-0.085756,0,0
2,GO SMOOTHENED SIGNALING PATHWAY,0.35442,-0.093716,-0.036659,0,0
2,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,0.42405,-0.093996,-0.039008,0,0
2,GO OLIGODENDROCYTE DIFFERENTIATION,0.33821,-0.094007,-0.039192,0,0
2,GO POLYOL CATABOLIC PROCESS,0.10468,-0.094301,-0.09741,0,0
2,GO POSTREPLICATION REPAIR,0.12662,-0.094359,-0.095323,0,0
2,GO DNA REPAIR,0.18102,-0.094585,-0.10468,0,0
2,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.40594,-0.094596,-0.0044785,0,0
2,GO HEAD DEVELOPMENT,0.13885,-0.094942,-0.065426,0,0
2,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.25111,-0.095494,-0.105,0,0
2,GO SEX DETERMINATION,0.36271,-0.095732,-0.080591,0,0
2,GO RESPONSE TO CATECHOLAMINE,0.08303,-0.096317,-0.074183,0,0
2,GO NUCLEAR BODY ORGANIZATION,0.080256,-0.096352,-0.096045,0,0
2,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.27126,-0.096434,-0.1228,0,0
2,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,0.66333,-0.096627,-0.007192,0,0
2,GO REGULATION OF CHROMOSOME SEGREGATION,0.065157,-0.096854,-0.21808,0,0
2,GO PROTEIN K11 LINKED UBIQUITINATION,0.10134,-0.096876,-0.09051,0,0
2,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.93062,-0.096911,-0.00093234,0,0
2,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.045233,-0.096951,-0.068372,0,0
2,GO REGULATION OF CARDIAC CONDUCTION,0.68646,-0.097131,0.0032482,0,0
2,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.10134,-0.097432,-0.11273,0,0
2,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,0.33029,-0.097959,-0.045114,0,0
2,GO WALKING BEHAVIOR,0.074935,-0.098016,-0.12641,0,0
2,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.08303,-0.098112,-0.17979,0,0
2,GO MOTILE CILIUM ASSEMBLY,0.18102,-0.098141,-0.16428,0,0
2,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.23203,-0.098268,-0.068191,0,0
2,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.42405,-0.098341,-0.069285,0,0
2,GO POSITIVE REGULATION OF DNA REPAIR,0.11163,-0.098367,-0.097389,0,0
2,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.08303,-0.098499,-0.11457,0,0
2,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,0.15655,-0.098601,-0.048128,0,0
2,GO EXIT FROM MITOSIS,0.065157,-0.098947,-0.16532,0,0
2,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,0.15197,-0.099142,-0.22071,0,0
2,GO STRESS GRANULE ASSEMBLY,0.25111,-0.099451,-0.058703,0,0
2,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,0.21989,-0.099588,-0.097103,0,0
2,GO HISTONE H4 K16 ACETYLATION,0.2259,-0.099643,-0.10488,0,0
2,GO NEGATIVE REGULATION OF DNA RECOMBINATION,0.3148,-0.099806,-0.084239,0,0
2,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.15197,-0.099818,-0.098043,0,0
2,GO SNRNA METABOLIC PROCESS,0.52145,-0.099903,-0.037266,0,0
2,GO NEURON DEVELOPMENT,0.14312,-0.099943,-0.059639,0,0
2,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.52145,-0.10014,-0.058933,0,0
2,GO REGULATION OF DNA REPLICATION,0.1475,-0.10059,-0.11389,0,0
2,GO HISTONE H3 K9 TRIMETHYLATION,0.35442,-0.10073,-0.071588,0,0
2,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.30724,-0.10099,-0.04994,0,0
2,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.24463,-0.101,-0.029641,0,0
2,GO CYTOKINESIS,0.048745,-0.10105,-0.13154,0,0
2,GO POSTSYNAPSE ORGANIZATION,0.080256,-0.10107,-0.10794,0,0
2,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.040368,-0.10145,-0.090707,0,0
2,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.1306,-0.10183,-0.12414,0,0
2,GO REGULATION OF NUCLEAR DIVISION,0.040368,-0.10209,-0.12638,0,0
2,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.0057394,-0.10216,-0.13169,0,0
2,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.197,-0.10237,-0.070632,0,0
2,GO NEURON PROJECTION ORGANIZATION,0.16602,-0.10257,-0.070004,0,0
2,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,0.21989,-0.10269,-0.1562,0,0
2,GO ACROSOME REACTION,0.14312,-0.10348,-0.07893,0,0
2,GO SPINDLE LOCALIZATION,0.077559,-0.10363,-0.14571,0,0
2,GO ENDOCRINE PANCREAS DEVELOPMENT,0.1475,-0.10381,-0.069325,0,0
2,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,0.19156,-0.10397,-0.062789,0,0
2,GO NEUROTRANSMITTER UPTAKE,0.35442,-0.10409,-0.043411,0,0
2,GO REGULATION OF EXOCYTOSIS,0.34626,-0.10416,-0.031001,0,0
2,GO BRANCHING MORPHOGENESIS OF A NERVE,0.34626,-0.10437,-0.080781,0,0
2,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.025096,-0.10518,-0.10657,0,0
2,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,0.1306,-0.1053,-0.12331,0,0
2,GO CARDIAC CONDUCTION,0.3148,-0.10534,-0.046311,0,0
2,GO RESPONSE TO FOOD,0.10468,-0.10545,-0.13115,0,0
2,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,0.48117,-0.10551,-0.03685,0,0
2,GO PROTEIN DEPOLYMERIZATION,0.074935,-0.10552,-0.063085,0,0
2,GO CELL DIFFERENTIATION IN HINDBRAIN,0.23203,-0.10572,-0.093801,0,0
2,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,0.24463,-0.10601,-0.058909,0,0
2,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.12273,-0.10613,-0.093616,0,0
2,GO CHAPERONE MEDIATED AUTOPHAGY,0.70989,-0.10623,-0.0043994,0,0
2,GO REGULATION OF HORMONE SECRETION,0.24463,-0.1064,-0.040541,0,0
2,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,0.11894,-0.10644,-0.11207,0,0
2,GO OOCYTE MATURATION,0.13467,-0.10647,-0.13465,0,0
2,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.021265,-0.10675,-0.12962,0,0
2,GO MALE MEIOSIS I,0.10134,-0.10698,-0.14901,0,0
2,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.20822,-0.10736,-0.04974,0,0
2,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,0.18624,-0.10744,-0.066924,0,0
2,GO FOREBRAIN DEVELOPMENT,0.11894,-0.10815,-0.083288,0,0
2,GO MITOTIC RECOMBINATION,0.43329,-0.1083,-0.057615,0,0
2,GO PEPTIDYL CYSTEINE MODIFICATION,0.16123,-0.10833,-0.073885,0,0
2,GO AXIS SPECIFICATION,0.14312,-0.10873,-0.08007,0,0
2,GO FEAR RESPONSE,0.1306,-0.10876,-0.10564,0,0
2,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.069906,-0.10885,-0.19187,0,0
2,GO REGULATION OF MRNA POLYADENYLATION,0.17091,-0.10887,-0.075609,0,0
2,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.24463,-0.10918,-0.10401,0,0
2,GO REGULATION OF RNA BINDING,0.17091,-0.10942,-0.091046,0,0
2,GO HISTONE H3 K36 METHYLATION,0.16602,-0.10963,-0.13028,0,0
2,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.12662,-0.1097,-0.12117,0,0
2,GO LOOP OF HENLE DEVELOPMENT,0.61803,-0.1097,-0.073048,0,0
2,GO COENZYME A BIOSYNTHETIC PROCESS,0.045233,-0.1097,-0.10123,0,0
2,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,0.18624,-0.10971,-0.05478,0,0
2,GO REGULATION OF DNA REPAIR,0.13467,-0.10988,-0.097752,0,0
2,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.045233,-0.10996,-0.1842,0,0
2,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.019548,-0.10999,-0.15955,0,0
2,GO PALLIUM DEVELOPMENT,0.091819,-0.11029,-0.10766,0,0
2,GO PROTEIN KINASE C SIGNALING,0.81845,-0.11034,0.079503,0,0
2,GO HORMONE TRANSPORT,0.19156,-0.11059,-0.047424,0,0
2,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,0.32248,-0.11064,-0.08197,0,0
2,GO ORGANELLE ASSEMBLY,0.18102,-0.11064,-0.057659,0,0
2,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.1475,-0.11073,-0.098533,0,0
2,GO DNA CONFORMATION CHANGE,0.10468,-0.1111,-0.15041,0,0
2,GO MEIOTIC CELL CYCLE,0.030713,-0.11127,-0.18773,0,0
2,GO CENTRIOLE ASSEMBLY,0.12273,-0.11198,-0.15059,0,0
2,GO REGULATION OF CENTRIOLE REPLICATION,0.1475,-0.1121,-0.14937,0,0
2,GO REGULATION OF CIRCADIAN RHYTHM,0.17091,-0.11246,-0.074625,0,0
2,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.18624,-0.1127,-0.075544,0,0
2,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.080256,-0.11298,-0.087552,0,0
2,GO HYPEROSMOTIC SALINITY RESPONSE,0.62923,-0.11326,-0.027536,0,0
2,GO RNA CAPPING,0.14312,-0.11333,-0.079698,0,0
2,GO MITOCHONDRION DISTRIBUTION,0.23203,-0.11343,-0.061412,0,0
2,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,0.50109,-0.11379,-0.024662,0,0
2,GO DENDRITE DEVELOPMENT,0.098083,-0.11381,-0.10722,0,0
2,GO PROTEIN LOCALIZATION TO CHROMATIN,0.16123,-0.11388,-0.15632,0,0
2,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,0.65188,-0.1139,-0.021628,0,0
2,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.37111,-0.114,-0.027283,0,0
2,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.14312,-0.11407,-0.08711,0,0
2,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,0.17091,-0.11411,-0.074736,0,0
2,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.55277,-0.11423,-0.027091,0,0
2,GO NUCLEOTIDE EXCISION REPAIR,0.067497,-0.11445,-0.095025,0,0
2,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.11894,-0.1149,-0.11951,0,0
2,GO CHROMATIN DISASSEMBLY,0.81845,-0.11492,-0.0070947,0,0
2,GO HISTONE H4 ACETYLATION,0.18102,-0.11534,-0.078367,0,0
2,GO COCHLEA DEVELOPMENT,0.23827,-0.11541,-0.071511,0,0
2,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.14312,-0.11618,-0.14221,0,0
2,GO MITOTIC METAPHASE PLATE CONGRESSION,0.016475,-0.1162,-0.21651,0,0
2,GO ORGANELLE FISSION,0.052482,-0.11642,-0.15097,0,0
2,GO REGULATION OF POSTSYNAPSE ORGANIZATION,0.069906,-0.11659,-0.11452,0,0
2,GO ACROSOME ASSEMBLY,0.24463,-0.11698,-0.12773,0,0
2,GO PEPTIDYL LYSINE DIMETHYLATION,0.28529,-0.11722,-0.072477,0,0
2,GO SINGLE STRAND BREAK REPAIR,0.11894,-0.11729,-0.10873,0,0
2,GO HISTONE H2A MONOUBIQUITINATION,0.197,-0.11754,-0.10504,0,0
2,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.16602,-0.11769,-0.083392,0,0
2,GO MRNA PROCESSING,0.17591,-0.11773,-0.08299,0,0
2,GO LYSINE METABOLIC PROCESS,0.50109,-0.11782,-0.064316,0,0
2,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.16602,-0.11808,-0.052574,0,0
2,GO SYNAPTIC TRANSMISSION GABAERGIC,0.08588,-0.11824,-0.10916,0,0
2,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.4521,-0.11845,-0.066716,0,0
2,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,0.48117,-0.11856,-0.076653,0,0
2,GO RESPONSE TO NICOTINE,0.33029,-0.11883,-0.074036,0,0
2,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,0.3148,-0.11936,-0.05152,0,0
2,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,0.10468,-0.11946,-0.1081,0,0
2,GO EPITHELIAL CELL MATURATION,0.10811,-0.11948,-0.1769,0,0
2,GO NEURAL CREST FORMATION,0.99368,-0.11974,0.033356,0,0
2,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.11163,-0.11998,-0.1026,0,0
2,GO COMMISSURAL NEURON AXON GUIDANCE,0.26442,-0.12003,-0.12728,0,0
2,GO NEUROTRANSMITTER METABOLIC PROCESS,0.55277,-0.12039,-0.042898,0,0
2,GO DEVELOPMENTAL CELL GROWTH,0.23203,-0.12044,-0.053739,0,0
2,GO VISUAL BEHAVIOR,0.12662,-0.12052,-0.080586,0,0
2,GO MAINTENANCE OF ORGANELLE LOCATION,0.3148,-0.12055,-0.09407,0,0
2,GO BASE EXCISION REPAIR,0.16123,-0.12066,-0.1274,0,0
2,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.14312,-0.12072,-0.10742,0,0
2,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.20822,-0.12082,-0.11896,0,0
2,GO CELLULAR COMPONENT MAINTENANCE,0.18102,-0.121,-0.071064,0,0
2,GO CHROMOSOME LOCALIZATION,0.034576,-0.12142,-0.18888,0,0
2,GO TRANSLESION SYNTHESIS,0.1475,-0.12184,-0.091626,0,0
2,GO CENTROSOME SEPARATION,0.13885,-0.12192,-0.20075,0,0
2,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.27126,-0.12194,-0.092641,0,0
2,GO REGULATION OF DENDRITE DEVELOPMENT,0.08303,-0.12195,-0.10519,0,0
2,GO CATECHOLAMINE METABOLIC PROCESS,0.27821,-0.12195,-0.055597,0,0
2,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,0.20256,-0.12205,-0.069989,0,0
2,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,0.15197,-0.12269,-0.13337,0,0
2,GO EXCITATORY SYNAPSE ASSEMBLY,0.13467,-0.12278,-0.15716,0,0
2,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.13467,-0.12296,-0.099773,0,0
2,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,0.069906,-0.12327,-0.10761,0,0
2,GO CELL FATE SPECIFICATION,0.094909,-0.12386,-0.12611,0,0
2,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.4521,-0.12423,-0.013382,0,0
2,GO REGULATION OF MICROTUBULE BASED MOVEMENT,0.43329,-0.1245,-0.046785,0,0
2,GO NEGATIVE REGULATION OF DNA REPAIR,0.13885,-0.12462,-0.10096,0,0
2,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.19156,-0.12495,-0.098704,0,0
2,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.02951,-0.12515,-0.14773,0,0
2,GO SPERM AXONEME ASSEMBLY,0.29248,-0.12521,-0.08969,0,0
2,GO CEREBRAL CORTEX DEVELOPMENT,0.069906,-0.12549,-0.1354,0,0
2,GO RNA SPLICING,0.16123,-0.12563,-0.08485,0,0
2,GO REGULATION OF INSULIN SECRETION,0.1475,-0.12592,-0.052638,0,0
2,GO SUBPALLIUM DEVELOPMENT,0.18624,-0.12609,-0.11695,0,0
2,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.033245,-0.12623,-0.13834,0,0
2,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.014457,-0.12626,-0.13794,0,0
2,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.043559,-0.12696,-0.23661,0,0
2,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,0.20256,-0.12697,-0.13912,0,0
2,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.214,-0.12814,-0.067482,0,0
2,GO REGULATION OF PROTEIN GLYCOSYLATION,0.23827,-0.12837,-0.098507,0,0
2,GO OLFACTORY LOBE DEVELOPMENT,0.75756,-0.1284,-0.0015728,0,0
2,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.18624,-0.12881,-0.062292,0,0
2,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,0.37111,-0.12912,-0.066071,0,0
2,GO TELENCEPHALON GLIAL CELL MIGRATION,0.094909,-0.1299,-0.14008,0,0
2,GO RESPONSE TO L GLUTAMATE,0.26442,-0.13035,-0.091748,0,0
2,GO OPTIC NERVE DEVELOPMENT,0.17091,-0.13043,-0.2077,0,0
2,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,0.08303,-0.13075,-0.15229,0,0
2,GO HISTONE H3 K9 DEMETHYLATION,0.23827,-0.1311,-0.098963,0,0
2,GO MITOCHONDRIAL FUSION,0.069906,-0.13112,-0.078796,0,0
2,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.067497,-0.13137,-0.14722,0,0
2,GO PROTEIN MANNOSYLATION,0.28529,-0.13181,-0.081887,0,0
2,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.17091,-0.13181,-0.084603,0,0
2,GO MEMBRANE FISSION,0.046961,-0.13243,-0.10936,0,0
2,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,0.2259,-0.13269,-0.081123,0,0
2,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.0172,-0.13286,-0.18909,0,0
2,GO BEHAVIORAL RESPONSE TO COCAINE,0.17091,-0.13289,-0.15655,0,0
2,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,0.12273,-0.13307,-0.097965,0,0
2,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.48117,-0.13348,-0.052059,0,0
2,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,0.12662,-0.13368,-0.10357,0,0
2,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,0.14312,-0.13388,-0.16744,0,0
2,GO CHEMOSENSORY BEHAVIOR,0.35442,-0.13412,-0.082507,0,0
2,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,0.069906,-0.13414,-0.15506,0,0
2,GO CARDIAC VENTRICLE FORMATION,0.30724,-0.13425,-0.13443,0,0
2,GO MITOTIC NUCLEAR DIVISION,0.048745,-0.13428,-0.17405,0,0
2,GO REGULATION OF TUBULIN DEACETYLATION,0.038848,-0.13436,-0.14311,0,0
2,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.1306,-0.13447,-0.10976,0,0
2,GO MISMATCH REPAIR,0.10811,-0.13533,-0.12761,0,0
2,GO POSITIVE REGULATION OF RNA SPLICING,0.077559,-0.13553,-0.11672,0,0
2,GO HAIR CELL DIFFERENTIATION,0.2577,-0.13589,-0.050942,0,0
2,GO METAPHASE PLATE CONGRESSION,0.033245,-0.13592,-0.21055,0,0
2,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,0.25111,-0.13603,-0.072345,0,0
2,GO CENTRIOLE CENTRIOLE COHESION,0.11524,-0.13615,-0.19746,0,0
2,GO NEURON PROJECTION EXTENSION,0.18102,-0.13616,-0.068864,0,0
2,GO REGULATION OF SPINDLE ASSEMBLY,0.065157,-0.13638,-0.16122,0,0
2,GO REGULATION OF RNA SPLICING,0.15197,-0.13688,-0.078902,0,0
2,GO HISTONE H3 K27 METHYLATION,0.2577,-0.13725,-0.1279,0,0
2,GO TYPE B PANCREATIC CELL DEVELOPMENT,0.11894,-0.13774,-0.11988,0,0
2,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,0.091819,-0.13797,-0.13043,0,0
2,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.094909,-0.1383,-0.11534,0,0
2,GO NEURON RECOGNITION,0.214,-0.13909,-0.10217,0,0
2,GO HINDBRAIN DEVELOPMENT,0.15655,-0.1393,-0.080659,0,0
2,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,0.13885,-0.13936,-0.09615,0,0
2,GO REGULATION OF MITOTIC SPINDLE ASSEMBLY,0.02951,-0.13976,-0.15919,0,0
2,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.15655,-0.14035,-0.098279,0,0
2,GO DENDRITIC SPINE MORPHOGENESIS,0.10134,-0.14052,-0.13639,0,0
2,GO GASTRULATION WITH MOUTH FORMING SECOND,0.39705,-0.14052,-0.051678,0,0
2,GO CEREBELLAR CORTEX MORPHOGENESIS,0.10134,-0.14055,-0.12852,0,0
2,GO MULTICELLULAR ORGANISMAL SIGNALING,0.1306,-0.14123,-0.080151,0,0
2,GO MODIFICATION OF SYNAPTIC STRUCTURE,0.13885,-0.14152,-0.076855,0,0
2,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,0.15655,-0.14251,-0.13958,0,0
2,GO REGULATION OF CELL CYCLE CHECKPOINT,0.27821,-0.1426,-0.13528,0,0
2,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.10811,-0.14268,-0.10742,0,0
2,GO REGULATION OF MRNA PROCESSING,0.067497,-0.14276,-0.11194,0,0
2,GO PROTEIN DENEDDYLATION,0.0172,-0.14279,-0.11086,0,0
2,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.13885,-0.143,-0.16204,0,0
2,GO AMINE BIOSYNTHETIC PROCESS,0.46168,-0.14329,-0.035612,0,0
2,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,0.074935,-0.14336,-0.1699,0,0
2,GO REGULATION OF CAMP MEDIATED SIGNALING,0.19156,-0.1438,-0.071983,0,0
2,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,0.18624,-0.14404,-0.12795,0,0
2,GO INCLUSION BODY ASSEMBLY,0.074935,-0.1444,-0.04478,0,0
2,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.20822,-0.1459,-0.13393,0,0
2,GO INTERSTRAND CROSS LINK REPAIR,0.13885,-0.14633,-0.16833,0,0
2,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.062884,-0.14667,-0.098503,0,0
2,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,0.10134,-0.14672,-0.11759,0,0
2,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,0.18102,-0.14729,-0.12307,0,0
2,GO REGULATION OF HELICASE ACTIVITY,0.15197,-0.14764,-0.12549,0,0
2,GO PANCREAS DEVELOPMENT,0.10811,-0.14845,-0.085958,0,0
2,GO SEMINIFEROUS TUBULE DEVELOPMENT,0.10811,-0.1501,-0.22699,0,0
2,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,0.050584,-0.15017,-0.22911,0,0
2,GO REGULATION OF CILIUM ASSEMBLY,0.11524,-0.1502,-0.12922,0,0
2,GO AMINO ACID TRANSPORT,0.17091,-0.15034,-0.055506,0,0
2,GO MICROTUBULE ANCHORING AT CENTROSOME,0.19156,-0.15068,-0.13822,0,0
2,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.10134,-0.15137,-0.10873,0,0
2,GO MITOCHONDRIAL GENOME MAINTENANCE,0.25111,-0.15243,-0.070048,0,0
2,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,0.17091,-0.15317,-0.063374,0,0
2,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.08303,-0.15327,-0.10674,0,0
2,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.014457,-0.15425,-0.17862,0,0
2,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.25111,-0.15426,-0.13335,0,0
2,GO SYNAPSE ORGANIZATION,0.069906,-0.15432,-0.11279,0,0
2,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,0.39705,-0.15435,-0.044613,0,0
2,GO SPINDLE ASSEMBLY,0.056456,-0.15476,-0.18681,0,0
2,GO PEPTIDYL ARGININE METHYLATION,0.098083,-0.1549,-0.11386,0,0
2,GO OLIGODENDROCYTE DEVELOPMENT,0.08303,-0.15525,-0.10537,0,0
2,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,0.13467,-0.15606,-0.13644,0,0
2,GO ENTEROENDOCRINE CELL DIFFERENTIATION,0.067497,-0.15632,-0.13286,0,0
2,GO MEIOTIC CELL CYCLE PROCESS,0.0172,-0.15697,-0.22098,0,0
2,GO NEGATIVE REGULATION OF GLIOGENESIS,0.24463,-0.15702,-0.071632,0,0
2,GO RESPONSE TO POTASSIUM ION,0.077559,-0.15705,-0.22523,0,0
2,GO INNER DYNEIN ARM ASSEMBLY,0.197,-0.15855,-0.2036,0,0
2,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.41494,-0.15888,-0.0883,0,0
2,GO POTASSIUM ION TRANSPORT,0.1306,-0.15954,-0.081639,0,0
2,GO REGULATION OF COLLATERAL SPROUTING,0.15655,-0.15968,-0.14165,0,0
2,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,0.15197,-0.1611,-0.085974,0,0
2,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.023112,-0.16119,-0.25754,0,0
2,GO MICROTUBULE ANCHORING,0.1475,-0.16164,-0.114,0,0
2,GO REGULATION OF OOGENESIS,0.080256,-0.16207,-0.10627,0,0
2,GO GLUTAMATE METABOLIC PROCESS,0.13467,-0.16219,-0.075995,0,0
2,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,0.014457,-0.16223,-0.19202,0,0
2,GO RRNA 3 END PROCESSING,0.041938,-0.16258,-0.15563,0,0
2,GO INOSITOL METABOLIC PROCESS,0.062884,-0.16286,-0.1538,0,0
2,GO PHOTORECEPTOR CELL MAINTENANCE,0.11524,-0.16418,-0.12676,0,0
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.68646,-0.16455,0.034537,0,0
2,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,0.11894,-0.16461,-0.10639,0,0
2,GO DORSAL VENTRAL AXIS SPECIFICATION,0.3148,-0.16463,-0.07786,0,0
2,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.054439,-0.16531,-0.12757,0,0
2,GO HYPOTHALAMUS DEVELOPMENT,0.12273,-0.16553,-0.11154,0,0
2,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,0.214,-0.16609,-0.061768,0,0
2,GO PROTEIN LOCALIZATION TO CYTOSKELETON,0.058535,-0.1665,-0.14039,0,0
2,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,0.058535,-0.16765,-0.15476,0,0
2,GO REGULATION OF REGULATED SECRETORY PATHWAY,0.18102,-0.16781,-0.073374,0,0
2,GO VESICLE TRANSPORT ALONG MICROTUBULE,0.077559,-0.16865,-0.1278,0,0
2,GO SEQUESTERING OF ACTIN MONOMERS,0.023112,-0.16979,-0.18707,0,0
2,GO MAINTENANCE OF CELL POLARITY,0.08881,-0.16991,-0.12465,0,0
2,GO ERROR FREE TRANSLESION SYNTHESIS,0.015104,-0.17028,-0.17483,0,0
2,GO NEURON MIGRATION,0.069906,-0.17039,-0.13849,0,0
2,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.15655,-0.17047,-0.16512,0,0
2,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,0.19156,-0.17175,-0.12273,0,0
2,GO INNER EAR RECEPTOR CELL DEVELOPMENT,0.02951,-0.17176,-0.13093,0,0
2,GO CEREBELLAR CORTEX FORMATION,0.067497,-0.17227,-0.14401,0,0
2,GO NOTCH RECEPTOR PROCESSING,0.11163,-0.17307,-0.13411,0,0
2,GO HEART FIELD SPECIFICATION,0.33821,-0.17319,-0.11514,0,0
2,GO NON MOTILE CILIUM ASSEMBLY,0.098083,-0.17324,-0.13983,0,0
2,GO MEMBRANE HYPERPOLARIZATION,0.20256,-0.17426,-0.10811,0,0
2,GO DORSAL VENTRAL PATTERN FORMATION,0.014457,-0.17431,-0.18765,0,0
2,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,0.2577,-0.17459,-0.11824,0,0
2,GO RETINAL CONE CELL DIFFERENTIATION,0.38829,-0.17465,-0.073241,0,0
2,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,0.28529,-0.1747,-0.11411,0,0
2,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,0.44264,-0.17538,-0.071341,0,0
2,GO REGULATION OF PEPTIDE HORMONE SECRETION,0.08881,-0.17546,-0.085261,0,0
2,GO AXONEME ASSEMBLY,0.091819,-0.17621,-0.19723,0,0
2,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.065157,-0.17639,-0.16275,0,0
2,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.072385,-0.17651,-0.1296,0,0
2,GO NERVE DEVELOPMENT,0.094909,-0.17661,-0.14512,0,0
2,GO FOREBRAIN GENERATION OF NEURONS,0.13467,-0.17693,-0.09652,0,0
2,GO ASTRAL MICROTUBULE ORGANIZATION,0.20822,-0.17725,-0.13465,0,0
2,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.062884,-0.17858,-0.175,0,0
2,GO REGULATION OF SYNAPTIC PLASTICITY,0.065157,-0.17873,-0.12983,0,0
2,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,0.080256,-0.17899,-0.18678,0,0
2,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.0047188,-0.17977,-0.2025,0,0
2,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,0.27821,-0.18113,-0.11544,0,0
2,GO MATING BEHAVIOR,0.21989,-0.18123,-0.11484,0,0
2,GO NEURON MATURATION,0.08881,-0.18166,-0.11449,0,0
2,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.031957,-0.18178,-0.23494,0,0
2,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.015104,-0.18264,-0.23176,0,0
2,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.2577,-0.18279,-0.098432,0,0
2,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.08303,-0.18381,-0.19479,0,0
2,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.013235,-0.18462,-0.21377,0,0
2,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.010101,-0.1853,-0.36763,0,0
2,GO RDNA HETEROCHROMATIN ASSEMBLY,0.12662,-0.18565,-0.14559,0,0
2,GO PROTEIN LOCALIZATION TO CILIUM,0.08588,-0.18582,-0.14057,0,0
2,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.074935,-0.18603,-0.16606,0,0
2,GO INSULIN SECRETION,0.074935,-0.18661,-0.083976,0,0
2,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,0.077559,-0.18762,-0.24182,0,0
2,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,0.10811,-0.18838,-0.13415,0,0
2,GO COLLATERAL SPROUTING,0.15655,-0.18955,-0.11581,0,0
2,GO DOPAMINE METABOLIC PROCESS,0.1306,-0.19022,-0.096095,0,0
2,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.36271,-0.19093,-0.03555,0,0
2,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,0.12662,-0.1912,-0.18122,0,0
2,GO HISTONE H4 K5 ACETYLATION,0.11894,-0.19351,-0.13569,0,0
2,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,0.098083,-0.19515,-0.18317,0,0
2,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.069906,-0.19543,-0.27295,0,0
2,GO SPINDLE ORGANIZATION,0.026142,-0.19559,-0.20983,0,0
2,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.046961,-0.19584,-0.2909,0,0
2,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,0.041938,-0.19635,-0.18046,0,0
2,GO DETECTION OF TEMPERATURE STIMULUS,0.026142,-0.19661,-0.1614,0,0
2,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,0.12662,-0.19725,-0.17536,0,0
2,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,0.025096,-0.20053,-0.15559,0,0
2,GO REGULATION OF NERVOUS SYSTEM PROCESS,0.11894,-0.20096,-0.1036,0,0
2,GO NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING,0.023112,-0.20152,-0.17151,0,0
2,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.10134,-0.20179,-0.18743,0,0
2,GO POSITIVE REGULATION OF DNA REPLICATION,0.050584,-0.20283,-0.15128,0,0
2,GO AMMONIUM ION METABOLIC PROCESS,0.094909,-0.20317,-0.15228,0,0
2,GO NOREPINEPHRINE SECRETION,0.36271,-0.2034,-0.091259,0,0
2,GO DNA REPLICATION CHECKPOINT,0.056456,-0.20371,-0.26454,0,0
2,GO ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.10468,-0.20507,-0.15072,0,0
2,GO ERROR PRONE TRANSLESION SYNTHESIS,0.0031545,-0.2093,-0.23481,0,0
2,GO MITOTIC DNA REPLICATION,0.067497,-0.20977,-0.25058,0,0
2,GO MITOTIC SPINDLE ORGANIZATION,0.0092139,-0.21039,-0.26885,0,0
2,GO LIMB BUD FORMATION,0.86799,-0.21197,0.015914,0,0
2,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.013235,-0.21264,-0.19162,0,0
2,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,0.11163,-0.21481,-0.13949,0,0
2,GO NEUROMUSCULAR PROCESS,0.067497,-0.21507,-0.13606,0,0
2,GO CHROMOSOME CONDENSATION,0.010101,-0.21755,-0.32393,0,0
2,GO NEGATIVE REGULATION OF MRNA PROCESSING,0.021265,-0.22166,-0.19136,0,0
2,GO ADRENAL GLAND DEVELOPMENT,0.17091,-0.22184,-0.11159,0,0
2,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,0.12273,-0.22614,-0.14569,0,0
2,GO MEIOTIC SPINDLE ORGANIZATION,0.08881,-0.22747,-0.23345,0,0
2,GO SUCKLING BEHAVIOR,0.010572,-0.22812,-0.27314,0,0
2,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,0.37964,-0.22839,-0.058369,0,0
2,GO REGULATION OF PROTEIN KINASE C SIGNALING,0.10134,-0.22846,-0.12474,0,0
2,GO REGULATION OF SPINDLE ORGANIZATION,0.007293,-0.22887,-0.23059,0,0
2,GO TRIGEMINAL NERVE DEVELOPMENT,0.098083,-0.22889,-0.25603,0,0
2,GO REPRODUCTIVE BEHAVIOR,0.08303,-0.22903,-0.15374,0,0
2,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,0.13885,-0.22926,-0.15415,0,0
2,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,0.067497,-0.23146,-0.14978,0,0
2,GO NEGATIVE REGULATION OF RNA SPLICING,0.016475,-0.23213,-0.19846,0,0
2,GO REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.14312,-0.23317,-0.16288,0,0
2,GO CELL MIGRATION IN HINDBRAIN,0.12273,-0.23527,-0.10213,0,0
2,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.072385,-0.23534,-0.16367,0,0
2,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,0.031957,-0.23557,-0.25265,0,0
2,GO DNA STRAND ELONGATION,0.022172,-0.23605,-0.30252,0,0
2,GO MEIOTIC CHROMOSOME SEPARATION,0.074935,-0.24104,-0.28721,0,0
2,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.11894,-0.24172,-0.14687,0,0
2,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.091819,-0.24247,-0.15382,0,0
2,GO AXONAL TRANSPORT OF MITOCHONDRION,0.0057394,-0.24373,-0.25847,0,0
2,GO CELLULAR POTASSIUM ION HOMEOSTASIS,0.040368,-0.25334,-0.16426,0,0
2,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,0.11524,-0.25369,-0.12386,0,0
2,GO GROOMING BEHAVIOR,0.013834,-0.25385,-0.25769,0,0
2,GO SECONDARY HEART FIELD SPECIFICATION,0.031957,-0.25407,-0.25116,0,0
2,GO PROTEIN PALMITOYLATION,0.016475,-0.25989,-0.21336,0,0
2,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,0.043559,-0.2615,-0.14488,0,0
2,GO FOREBRAIN NEURON DIFFERENTIATION,0.067497,-0.26263,-0.14573,0,0
2,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.0076456,-0.26794,-0.22885,0,0
2,GO RESPONSE TO FORSKOLIN,0.067497,-0.27233,-0.18467,0,0
2,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,0.012106,-0.27435,-0.21503,0,0
2,GO EATING BEHAVIOR,0.0040644,-0.27518,-0.22463,0,0
2,GO NOREPINEPHRINE TRANSPORT,0.24463,-0.28147,-0.12403,0,0
2,GO OUTER DYNEIN ARM ASSEMBLY,0.067497,-0.28418,-0.28503,0,0
2,GO INHIBITORY SYNAPSE ASSEMBLY,0.1306,-0.29026,-0.17294,0,0
2,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.024086,-0.29113,-0.37628,0,0
2,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,0.028348,-0.30677,-0.25282,0,0
2,GO OLFACTORY BULB INTERNEURON DIFFERENTIATION,0.17591,-0.31267,-0.15065,0,0
2,GO MITOTIC CHROMOSOME CONDENSATION,0.018736,-0.31522,-0.36641,0,0
2,GO GANGLION DEVELOPMENT,0.0096484,-0.3346,-0.33281,0,0
2,GO RETINAL GANGLION CELL AXON GUIDANCE,0.0052065,-0.33726,-0.30528,0,0
2,GO PITUITARY GLAND DEVELOPMENT,0.013834,-0.33837,-0.26627,0,0
2,GO STABILIZATION OF MEMBRANE POTENTIAL,0.10468,-0.34222,-0.24731,0,0
2,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,0.13885,-0.347,-0.19917,0,0
2,GO NEURON FATE COMMITMENT,0.0038653,-0.35368,-0.30273,0,0
2,GO REGULATION OF GLUTAMATE SECRETION,0.011574,-0.35652,-0.32535,0,0
2,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.0092139,-0.36062,-0.27025,0,0
2,GO NOSE DEVELOPMENT,0.060677,-0.36441,-0.34345,0,0
2,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.023112,-0.39899,-0.28929,0,0
2,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,0.017954,-0.42036,-0.35394,0,0
2,GO MAINTENANCE OF SYNAPSE STRUCTURE,0.00081392,-0.48073,-0.48695,0,0
2,GO FOREBRAIN NEURON FATE COMMITMENT,0.041938,-0.48615,-0.38402,0,0
2,GO POSITIVE REGULATION OF AMINE TRANSPORT,0.00332,-0.49754,-0.36537,0,0
2,GO INNERVATION,0.0047188,-0.51472,-0.39722,0,0
2,GO GABAERGIC NEURON DIFFERENTIATION,0.0028457,-0.66296,-0.4833,0,0
2,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,0.0014241,-0.85385,-0.68228,0,0
3,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,0.00011593,0.66771,0.66494,1,1
3,GO COMMISSURAL NEURON AXON GUIDANCE,3.4805e-05,0.65709,0.5884,1,1
3,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0066311,0.65483,0.48233,1,1
3,GO RESPONSE TO POTASSIUM ION,0.00081392,0.64682,0.47754,1,1
3,GO OPTIC NERVE DEVELOPMENT,0.0023095,0.63923,0.51753,1,1
3,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,0.0015041,0.63061,0.48695,1,1
3,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.00072571,0.61198,0.51373,1,1
3,GO SYNAPTIC MEMBRANE ADHESION,0.00023283,0.60825,0.54678,1,1
3,GO REGULATION OF SYNAPSE MATURATION,0.00024771,0.60697,0.57369,1,1
3,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,0.00051151,0.59893,0.51692,1,1
3,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,1.4947e-05,0.59795,0.67878,1,1
3,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,0.00031664,0.58419,0.47663,1,1
3,GO PREPULSE INHIBITION,0.00010181,0.57503,0.57284,1,1
3,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.00048214,0.55783,0.45449,1,1
3,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,0.00096503,0.55217,0.43922,1,1
3,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,0.00031664,0.53498,0.48049,1,1
3,GO CENTRIOLE CENTRIOLE COHESION,2.4576e-05,0.53217,0.54824,1,1
3,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,0.0018673,0.52575,0.48088,1,1
3,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,0.0013481,0.5227,0.43851,1,1
3,GO MEIOTIC CHROMOSOME SEPARATION,0.00024771,0.51632,0.46043,1,1
3,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,0.00026348,0.50494,0.48753,1,1
3,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.00332,0.50008,0.47835,1,1
3,GO POSITIVE REGULATION OF NEURON MIGRATION,0.00014989,0.49886,0.57002,1,1
3,GO DISTAL TUBULE DEVELOPMENT,0.0063209,0.49814,0.42514,1,1
3,GO SEMINIFEROUS TUBULE DEVELOPMENT,0.0011418,0.49626,0.43254,1,1
3,GO POSTSYNAPSE ASSEMBLY,0.00033648,0.49027,0.47313,1,1
3,GO MICROTUBULE DEPOLYMERIZATION,0.00018128,0.47855,0.44339,1,1
3,GO TRIGEMINAL NERVE DEVELOPMENT,0.0063209,0.47279,0.44135,1,1
3,GO SYNAPSE MATURATION,0.00064645,0.46501,0.49857,1,1
3,GO REGULATION OF NEURON MIGRATION,0.00019306,0.45598,0.49733,1,1
3,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.00033648,0.45544,0.39666,1,1
3,GO DORSAL SPINAL CORD DEVELOPMENT,0.00072571,0.45436,0.42975,1,1
3,GO FOREBRAIN REGIONALIZATION,0.00019306,0.45136,0.50593,1,1
3,GO PRESYNAPTIC MEMBRANE ORGANIZATION,0.0040644,0.44818,0.40388,1,1
3,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.026142,0.44699,0.3961,1,1
3,GO DENDRITIC TRANSPORT,0.0011418,0.44437,0.44479,1,1
3,GO PROTEIN LOCALIZATION TO AXON,0.00068502,0.44268,0.44515,1,1
3,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.0017696,0.4401,0.37002,1,1
3,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,0.00035748,0.43943,0.41621,1,1
3,GO CARDIAC VENTRICLE FORMATION,0.0015882,0.43512,0.39532,1,1
3,GO HISTONE H3 K36 METHYLATION,0.00033648,0.42971,0.44396,1,1
3,GO SPINAL CORD PATTERNING,0.0012758,0.42597,0.44615,1,1
3,GO DENTATE GYRUS DEVELOPMENT,0.00033648,0.42533,0.51043,1,1
3,GO CELL PROLIFERATION IN HINDBRAIN,0.0057394,0.41946,0.32448,1,1
3,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.00072571,0.41781,0.38256,1,1
3,GO REGULATION OF PRESYNAPSE ORGANIZATION,0.0020776,0.4164,0.35161,1,1
3,GO KINETOCHORE ORGANIZATION,0.00033648,0.41565,0.4183,1,1
3,GO SYNAPTIC VESICLE CLUSTERING,0.00096503,0.41548,0.44561,1,1
3,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,0.00057531,0.41375,0.45555,1,1
3,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,0.00028019,0.41273,0.38043,1,1
3,GO BEHAVIORAL RESPONSE TO COCAINE,0.0025648,0.40982,0.37726,1,1
3,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,0.00060992,0.40885,0.40134,1,1
3,GO HISTONE H3 K9 DEMETHYLATION,0.00013188,0.40693,0.41871,1,1
3,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,0.00045436,0.40543,0.38458,1,1
3,GO CELL DIFFERENTIATION IN HINDBRAIN,0.00072571,0.40495,0.35811,1,1
3,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,0.0040644,0.39872,0.34086,1,1
3,GO REPLICATION FORK PROCESSING,0.00064645,0.39861,0.40228,1,1
3,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,0.00021879,0.39842,0.42227,1,1
3,GO ANATOMICAL STRUCTURE REGRESSION,0.0013481,0.3972,0.4014,1,1
3,GO NEURONAL ION CHANNEL CLUSTERING,0.00026348,0.3959,0.44236,1,1
3,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,0.0015882,0.39374,0.34409,1,1
3,GO HISTONE H3 K9 METHYLATION,0.00028019,0.39349,0.39548,1,1
3,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.0011418,0.39278,0.39023,1,1
3,GO GROWTH HORMONE SECRETION,0.00035748,0.39209,0.42689,1,1
3,GO REGULATION OF HISTONE H3 K9 METHYLATION,0.00031664,0.392,0.3778,1,1
3,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,0.00054254,0.39089,0.39745,1,1
3,GO CEREBELLAR CORTEX DEVELOPMENT,0.00011593,0.38898,0.36659,1,1
3,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0028457,0.38759,0.34284,1,1
3,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,0.0023095,0.38679,0.31593,1,1
3,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.00081392,0.38619,0.35083,1,1
3,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0016767,0.38615,0.3247,1,1
3,GO MICROTUBULE ANCHORING AT CENTROSOME,0.00076864,0.38596,0.41259,1,1
3,GO MRNA SPLICE SITE SELECTION,0.00010866,0.38582,0.4212,1,1
3,GO KINETOCHORE ASSEMBLY,0.0015041,0.38506,0.36876,1,1
3,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,8.9327e-05,0.38113,0.49063,1,1
3,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.00057531,0.37459,0.38124,1,1
3,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,0.00057531,0.37284,0.38557,1,1
3,GO REGULATION OF GROWTH HORMONE SECRETION,0.00028019,0.37117,0.51755,1,1
3,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.00076864,0.36962,0.3765,1,1
3,GO REGULATION OF COLLATERAL SPROUTING,0.006955,0.36818,0.3033,1,1
3,GO DNA DOUBLE STRAND BREAK PROCESSING,0.0019699,0.36817,0.3205,1,1
3,GO CELL DIFFERENTIATION IN SPINAL CORD,0.00035748,0.36793,0.34146,1,1
3,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,0.00011593,0.36607,0.44716,1,1
3,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,0.0012758,0.36508,0.34201,1,1
3,GO REGULATION OF SPINDLE CHECKPOINT,0.00011593,0.36459,0.3747,1,1
3,GO STARTLE RESPONSE,0.00021879,0.36335,0.4142,1,1
3,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,0.00072571,0.36284,0.37002,1,1
3,GO TELENCEPHALON REGIONALIZATION,0.0012071,0.36238,0.43152,1,1
3,GO CEREBELLAR CORTEX MORPHOGENESIS,0.00024771,0.36006,0.37565,1,1
3,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,0.0031545,0.35895,0.32791,1,1
3,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.00042807,0.35773,0.36346,1,1
3,GO CENTRIOLE ASSEMBLY,0.0003797,0.35663,0.35357,1,1
3,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.00017019,0.35638,0.42923,1,1
3,GO NEGATIVE REGULATION OF LYASE ACTIVITY,0.0012758,0.35599,0.32576,1,1
3,GO CRANIAL NERVE MORPHOGENESIS,0.01266,0.35568,0.29645,1,1
3,GO DENSE CORE GRANULE TRANSPORT,0.0044907,0.35542,0.40703,1,1
3,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,0.0028457,0.35423,0.34115,1,1
3,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,0.00064645,0.35349,0.27504,1,1
3,GO METENCEPHALON DEVELOPMENT,8.9327e-05,0.35324,0.34532,1,1
3,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.014457,0.35222,0.29615,1,1
3,GO BRANCHING MORPHOGENESIS OF A NERVE,0.0060238,0.35114,0.32543,1,1
3,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.00040321,0.35062,0.331,1,1
3,GO RESPONSE TO COCAINE,0.00019306,0.34764,0.36926,1,1
3,GO REGULATION OF CELL CYCLE CHECKPOINT,0.00031664,0.34752,0.3485,1,1
3,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.00019306,0.34625,0.36058,1,1
3,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.0080134,0.34623,0.27991,1,1
3,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.00072571,0.34583,0.38934,1,1
3,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.0012758,0.34509,0.28804,1,1
3,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,0.00013188,0.34434,0.36193,1,1
3,GO RESPONSE TO L GLUTAMATE,0.00023283,0.3439,0.34031,1,1
3,GO ASTRAL MICROTUBULE ORGANIZATION,0.00096503,0.34373,0.41151,1,1
3,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.00033648,0.34331,0.33764,1,1
3,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.0042727,0.34172,0.29584,1,1
3,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,0.00028019,0.34001,0.3359,1,1
3,GO EPITHELIAL CELL MATURATION,0.011063,0.337,0.26149,1,1
3,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.0015882,0.33477,0.31678,1,1
3,GO VENTRAL SPINAL CORD DEVELOPMENT,0.00064645,0.33471,0.32842,1,1
3,GO PROTEIN POLYGLUTAMYLATION,0.00332,0.33441,0.33054,1,1
3,GO CELL PROLIFERATION IN FOREBRAIN,0.0054671,0.33336,0.32903,1,1
3,GO PHASIC SMOOTH MUSCLE CONTRACTION,0.00081392,0.33316,0.30277,1,1
3,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.015776,0.33266,0.37581,1,1
3,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.0034935,0.33202,0.30443,1,1
3,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.0021907,0.33131,0.32884,1,1
3,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.00068502,0.33078,0.32455,1,1
3,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.016475,0.33064,0.27062,1,1
3,GO CEREBELLAR CORTEX FORMATION,0.00054254,0.33043,0.35005,1,1
3,GO MITOTIC SISTER CHROMATID COHESION,0.00020554,0.32849,0.34655,1,1
3,GO AXONAL FASCICULATION,0.0034935,0.32773,0.31403,1,1
3,GO POSITIVE REGULATION OF CHROMATIN BINDING,0.0014241,0.32734,0.31344,1,1
3,GO HOMOLOGOUS RECOMBINATION,0.00051151,0.32669,0.32497,1,1
3,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,0.0044907,0.3265,0.42983,1,1
3,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.00086166,0.32638,0.28829,1,1
3,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,0.00096503,0.32637,0.44989,1,1
3,GO TELENCEPHALON GLIAL CELL MIGRATION,0.0021907,0.32612,0.33137,1,1
3,GO INTERSTRAND CROSS LINK REPAIR,0.00042807,0.32566,0.32271,1,1
3,GO REGULATION OF NEUROBLAST PROLIFERATION,0.0015882,0.32472,0.31158,1,1
3,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,0.00023283,0.32451,0.32601,1,1
3,GO REGULATION OF FEEDING BEHAVIOR,0.00017019,0.32395,0.29018,1,1
3,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.00091199,0.32289,0.32434,1,1
3,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.013235,0.32287,0.28782,1,1
3,GO METHIONINE BIOSYNTHETIC PROCESS,0.011063,0.32221,0.25969,1,1
3,GO SPERMATID NUCLEUS DIFFERENTIATION,0.00028019,0.32195,0.33196,1,1
3,GO FACIAL NERVE MORPHOGENESIS,0.048745,0.32191,0.26184,1,1
3,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.0016767,0.32128,0.30414,1,1
3,GO DENDRITE MORPHOGENESIS,0.00072571,0.32096,0.31387,1,1
3,GO EMBRYONIC BRAIN DEVELOPMENT,0.0040644,0.32075,0.28897,1,1
3,GO AXO DENDRITIC PROTEIN TRANSPORT,0.0021907,0.31946,0.36857,1,1
3,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.0038653,0.3184,0.33378,1,1
3,GO PEPTIDYL LYSINE DIMETHYLATION,0.0012071,0.31752,0.31855,1,1
3,GO FOREBRAIN NEURON DEVELOPMENT,0.0034935,0.31663,0.29678,1,1
3,GO HISTONE H3 K9 MODIFICATION,0.00064645,0.31612,0.33348,1,1
3,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.01266,0.31543,0.2613,1,1
3,GO RESPONSE TO INSECTICIDE,0.0076456,0.31469,0.28282,1,1
3,GO RAB PROTEIN SIGNAL TRANSDUCTION,0.0083971,0.31427,0.26155,1,1
3,GO DENDRITIC SPINE MORPHOGENESIS,0.00096503,0.31418,0.31153,1,1
3,GO CATECHOLAMINE UPTAKE,0.0010798,0.31404,0.35752,1,1
3,GO REGULATION OF SISTER CHROMATID COHESION,0.00026348,0.31391,0.36528,1,1
3,GO SECRETORY GRANULE LOCALIZATION,0.0023095,0.31377,0.35306,1,1
3,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.0020776,0.31361,0.32658,1,1
3,GO CENTROMERE COMPLEX ASSEMBLY,0.00051151,0.31238,0.35987,1,1
3,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.00060992,0.31058,0.32091,1,1
3,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.0017696,0.31029,0.30146,1,1
3,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.0028457,0.31026,0.36679,1,1
3,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,0.0017696,0.30967,0.37064,1,1
3,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.027226,0.30934,0.30156,1,1
3,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,0.00042807,0.30817,0.33606,1,1
3,GO NEGATIVE REGULATION OF HISTONE METHYLATION,0.00020554,0.30602,0.36447,1,1
3,GO CHROMATIN SILENCING AT TELOMERE,0.00015974,0.30584,0.3265,1,1
3,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,0.0019699,0.30538,0.30174,1,1
3,GO PROTEIN LOCALIZATION TO PRESYNAPSE,0.0042727,0.30511,0.35568,1,1
3,GO SPINAL CORD DEVELOPMENT,0.00014989,0.30481,0.38724,1,1
3,GO EMBRYONIC FORELIMB MORPHOGENESIS,0.0016767,0.30471,0.29438,1,1
3,GO HISTONE EXCHANGE,0.0003797,0.30445,0.31065,1,1
3,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.00011593,0.30418,0.34698,1,1
3,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.00026348,0.30409,0.34049,1,1
3,GO CARNITINE SHUTTLE,0.00091199,0.3034,0.30249,1,1
3,GO ADULT BEHAVIOR,0.00045436,0.3022,0.3121,1,1
3,GO UTERUS DEVELOPMENT,0.0036751,0.29975,0.35534,1,1
3,GO G0 TO G1 TRANSITION,0.00048214,0.29974,0.32932,1,1
3,GO NEURON FATE SPECIFICATION,0.0024341,0.299,0.39055,1,1
3,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.0011418,0.29879,0.29252,1,1
3,GO REGULATION OF CHROMOSOME SEGREGATION,7.3279e-05,0.29798,0.3231,1,1
3,GO MEIOTIC CHROMOSOME SEGREGATION,0.00054254,0.29796,0.31102,1,1
3,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,0.0011418,0.29774,0.29936,1,1
3,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.007293,0.29744,0.28756,1,1
3,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.00051151,0.29727,0.32248,1,1
3,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.00091199,0.29658,0.31644,1,1
3,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.0016767,0.2959,0.2713,1,1
3,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.00064645,0.29496,0.34732,1,1
3,GO CORONARY VASCULATURE MORPHOGENESIS,0.0060238,0.29496,0.31181,1,1
3,GO RESPONSE TO ACETYLCHOLINE,0.00096503,0.29479,0.36183,1,1
3,GO NEUROTRANSMITTER SECRETION,0.0010798,0.29435,0.30328,1,1
3,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,0.0060238,0.29388,0.2856,1,1
3,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.0016767,0.29384,0.27746,1,1
3,GO MITOTIC RECOMBINATION,0.0018673,0.29366,0.29876,1,1
3,GO SYNAPTIC VESICLE PRIMING,0.027226,0.29291,0.23604,1,1
3,GO PROXIMAL DISTAL PATTERN FORMATION,0.010572,0.29217,0.2946,1,1
3,GO REGULATION OF CHROMATIN BINDING,0.00076864,0.2916,0.3304,1,1
3,GO NEURON MIGRATION,0.00013188,0.29136,0.36993,1,1
3,GO ANTEROGRADE AXONAL TRANSPORT,0.0013481,0.29122,0.2857,1,1
3,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,8.9327e-05,0.29014,0.35661,1,1
3,GO NUCLEAR PORE ORGANIZATION,0.0042727,0.2891,0.31153,1,1
3,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,0.00040321,0.28896,0.29685,1,1
3,GO P BODY ASSEMBLY,0.0023095,0.2889,0.31919,1,1
3,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.008797,0.28884,0.28639,1,1
3,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.0020776,0.2878,0.31925,1,1
3,GO CHROMOSOME SEPARATION,0.00018128,0.28778,0.33085,1,1
3,GO GOLGI RIBBON FORMATION,0.00091199,0.28761,0.34267,1,1
3,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,0.0092139,0.28759,0.25689,1,1
3,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.00057531,0.28756,0.31329,1,1
3,GO REGULATION OF MICROTUBULE BINDING,0.0015882,0.28744,0.34764,1,1
3,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.00033648,0.28693,0.3334,1,1
3,GO NEGATIVE REGULATION OF DNA RECOMBINATION,0.00332,0.28678,0.27202,1,1
3,GO HISTONE H3 K4 TRIMETHYLATION,0.011063,0.28642,0.3187,1,1
3,GO GLIAL CELL FATE COMMITMENT,0.0052065,0.28602,0.30384,1,1
3,GO STRESS GRANULE ASSEMBLY,0.00028019,0.2853,0.31205,1,1
3,GO DENDRITE DEVELOPMENT,0.00081392,0.28488,0.29366,1,1
3,GO CHROMATIN REMODELING AT CENTROMERE,0.00081392,0.28427,0.35219,1,1
3,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,0.0010209,0.28406,0.30325,1,1
3,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,0.0011418,0.28406,0.28435,1,1
3,GO REGULATION OF SISTER CHROMATID SEGREGATION,7.3279e-05,0.28339,0.31914,1,1
3,GO THALAMUS DEVELOPMENT,0.011063,0.28279,0.26197,1,1
3,GO NUCLEAR MIGRATION,0.0013481,0.2826,0.3914,1,1
3,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.00091199,0.28216,0.34805,1,1
3,GO PEPTIDYL LYSINE METHYLATION,0.00051151,0.28139,0.32248,1,1
3,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.0021907,0.28126,0.28663,1,1
3,GO GASTRULATION WITH MOUTH FORMING SECOND,0.0092139,0.28069,0.30029,1,1
3,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.0015041,0.28047,0.32038,1,1
3,GO REGULATION OF DENDRITE MORPHOGENESIS,0.00028019,0.27997,0.31495,1,1
3,GO ATP DEPENDENT CHROMATIN REMODELING,0.00012367,0.2796,0.32925,1,1
3,GO SPLICEOSOMAL COMPLEX ASSEMBLY,7.8298e-05,0.27934,0.31953,1,1
3,GO REGULATION OF CHROMATIN ASSEMBLY,0.0021907,0.27902,0.29187,1,1
3,GO RESPONSE TO NICOTINE,0.0021907,0.27875,0.27849,1,1
3,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.0028457,0.27829,0.30246,1,1
3,GO RECOMBINATIONAL REPAIR,0.00054254,0.27811,0.29992,1,1
3,GO MICROTUBULE CYTOSKELETON ORGANIZATION,0.00035748,0.27774,0.28845,1,1
3,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.0012758,0.27747,0.28448,1,1
3,GO SYNAPTIC VESICLE ENDOSOMAL PROCESSING,0.0052065,0.27744,0.27899,1,1
3,GO RESPONSE TO HYDROXYUREA,0.0025648,0.27706,0.27102,1,1
3,GO REGULATION OF NMDA RECEPTOR ACTIVITY,0.038848,0.27665,0.21657,1,1
3,GO HISTONE H2A UBIQUITINATION,0.0020776,0.27659,0.27126,1,1
3,GO REGULATION OF DENDRITE DEVELOPMENT,0.00051151,0.27547,0.29323,1,1
3,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,0.0080134,0.27523,0.27804,1,1
3,GO NEGATIVE REGULATION OF TORC1 SIGNALING,0.0018673,0.27518,0.31367,1,1
3,GO MEIOSIS I CELL CYCLE PROCESS,0.00040321,0.27494,0.28482,1,1
3,GO HISTONE METHYLATION,0.00045436,0.27464,0.31801,1,1
3,GO MISMATCH REPAIR,0.00014989,0.27366,0.29031,1,1
3,GO FEMALE MEIOTIC NUCLEAR DIVISION,0.0040644,0.27362,0.25859,1,1
3,GO LEARNING,0.00068502,0.27227,0.28858,1,1
3,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,0.0011418,0.27197,0.31691,1,1
3,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,0.0024341,0.27177,0.29238,1,1
3,GO POSTSYNAPSE ORGANIZATION,0.0010209,0.27167,0.28356,1,1
3,GO POSITIVE REGULATION OF HISTONE METHYLATION,0.00010181,0.27077,0.35146,1,1
3,GO PROTEIN METHYLATION,0.0003797,0.27071,0.2995,1,1
3,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,0.0011418,0.27059,0.29661,1,1
3,GO MALE MEIOTIC NUCLEAR DIVISION,0.00091199,0.2702,0.31276,1,1
3,GO NUCLEAR CHROMOSOME SEGREGATION,0.00045436,0.27016,0.282,1,1
3,GO DENDRITIC SPINE DEVELOPMENT,0.00072571,0.2697,0.29537,1,1
3,GO RESPONSE TO ELECTRICAL STIMULUS,0.0042727,0.26959,0.25679,1,1
3,GO SYNAPTIC VESICLE LOCALIZATION,0.0060238,0.26934,0.254,1,1
3,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,0.017954,0.26838,0.2964,1,1
3,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.00068502,0.26782,0.29093,1,1
3,GO NEUROBLAST PROLIFERATION,0.0013481,0.2671,0.29694,1,1
3,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.015776,0.26692,0.24362,1,1
3,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,0.0044907,0.26685,0.2865,1,1
3,GO ENTEROENDOCRINE CELL DIFFERENTIATION,0.0028457,0.26624,0.33072,1,1
3,GO SMOOTHENED SIGNALING PATHWAY,0.00064645,0.26621,0.27409,1,1
3,GO MICROTUBULE BASED PROCESS,0.00045436,0.26614,0.26843,1,1
3,GO CHROMOSOME SEGREGATION,0.00064645,0.2658,0.27877,1,1
3,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.0017696,0.2643,0.30178,1,1
3,GO LATERAL VENTRICLE DEVELOPMENT,0.021265,0.26413,0.2739,1,1
3,GO SISTER CHROMATID COHESION,0.00045436,0.26353,0.3185,1,1
3,GO DNA GEOMETRIC CHANGE,0.00086166,0.26259,0.28273,1,1
3,GO GENITALIA MORPHOGENESIS,0.030713,0.26242,0.26073,1,1
3,GO CORPUS CALLOSUM DEVELOPMENT,0.0017696,0.26152,0.33538,1,1
3,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.0028457,0.26024,0.26208,1,1
3,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.0038653,0.25994,0.29086,1,1
3,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.00051151,0.25947,0.25756,1,1
3,GO NEUROPEPTIDE SIGNALING PATHWAY,0.015776,0.25832,0.20467,1,1
3,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.00040321,0.25832,0.29879,1,1
3,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.025096,0.25814,0.196,1,1
3,GO REGULATION OF AXONOGENESIS,0.00332,0.25814,0.29078,1,1
3,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.0031545,0.25783,0.24676,1,1
3,GO SINGLE STRAND BREAK REPAIR,0.0025648,0.25747,0.26372,1,1
3,GO MICROTUBULE NUCLEATION,0.0038653,0.25715,0.30377,1,1
3,GO REGULATION OF CHROMOSOME SEPARATION,7.3279e-05,0.2562,0.30263,1,1
3,GO POSITIVE REGULATION OF CYTOKINESIS,0.0013481,0.25576,0.25823,1,1
3,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,0.010572,0.2557,0.28935,1,1
3,GO RESPONSE TO LEUCINE,0.0042727,0.25533,0.31002,1,1
3,GO HIPPOCAMPUS DEVELOPMENT,0.00017019,0.25512,0.29057,1,1
3,GO NEUROTRANSMITTER TRANSPORT,0.0015041,0.25466,0.2782,1,1
3,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.0016767,0.25395,0.27864,1,1
3,GO DNA DEPENDENT DNA REPLICATION,0.00081392,0.2537,0.28542,1,1
3,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.00076864,0.25317,0.34712,1,1
3,GO PHOTORECEPTOR CELL MAINTENANCE,0.00045436,0.25308,0.24195,1,1
3,GO REGULATION OF TRANS SYNAPTIC SIGNALING,0.0017696,0.25307,0.25866,1,1
3,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.00024771,0.25264,0.29023,1,1
3,GO FEEDING BEHAVIOR,0.006955,0.2525,0.20778,1,1
3,GO SYNAPTIC SIGNALING,0.0017696,0.25238,0.24737,1,1
3,GO HISTONE H4 K16 ACETYLATION,0.0012758,0.25209,0.28824,1,1
3,GO AXONAL TRANSPORT,0.0015041,0.25176,0.28836,1,1
3,GO MITOTIC SPINDLE ASSEMBLY,0.0011418,0.25101,0.26836,1,1
3,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.00019306,0.25045,0.27059,1,1
3,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.0021907,0.2503,0.28079,1,1
3,GO RESPONSE TO FOOD,0.0017696,0.24986,0.27212,1,1
3,GO HISTONE H3 K4 METHYLATION,0.00051151,0.2498,0.29901,1,1
3,GO HISTONE H3 K9 TRIMETHYLATION,0.0012758,0.24917,0.30892,1,1
3,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,9.5377e-05,0.24869,0.29854,1,1
3,GO CHROMATIN REMODELING,0.00048214,0.24849,0.28388,1,1
3,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.00035748,0.24836,0.30298,1,1
3,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.00026348,0.24814,0.27471,1,1
3,GO DNA RECOMBINATION,0.0038653,0.24783,0.22274,1,1
3,GO REGULATION OF MRNA POLYADENYLATION,0.0017696,0.24762,0.2634,1,1
3,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,0.0013481,0.24724,0.30397,1,1
3,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,9.5377e-05,0.24669,0.30855,1,1
3,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.0031545,0.24662,0.27568,1,1
3,GO HINDBRAIN MORPHOGENESIS,0.00068502,0.24598,0.27634,1,1
3,GO HINDBRAIN DEVELOPMENT,0.00048214,0.24539,0.27107,1,1
3,GO PEPTIDYL METHIONINE MODIFICATION,0.031957,0.24459,0.1746,1,1
3,GO SISTER CHROMATID SEGREGATION,0.0003797,0.24445,0.28425,1,1
3,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,0.0014241,0.24408,0.36138,1,1
3,GO TYPE B PANCREATIC CELL DEVELOPMENT,0.013834,0.24343,0.30326,1,1
3,GO METHIONINE METABOLIC PROCESS,0.020391,0.24323,0.20539,1,1
3,GO APICAL PROTEIN LOCALIZATION,0.011574,0.24313,0.27084,1,1
3,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.00033648,0.24262,0.27848,1,1
3,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.0083971,0.24156,0.36615,1,1
3,GO REGULATION OF CYTOKINESIS,0.0014241,0.24095,0.26557,1,1
3,GO ECTODERM DEVELOPMENT,0.00332,0.2389,0.23661,1,1
3,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.018736,0.23881,0.2102,1,1
3,GO NEUROTRANSMITTER REUPTAKE,0.0047188,0.23863,0.24847,1,1
3,GO HIPPO SIGNALING,0.013834,0.23826,0.25346,1,1
3,GO HISTONE H4 DEACETYLATION,0.0066311,0.23774,0.20177,1,1
3,GO NUCLEOSOME ORGANIZATION,0.00060992,0.2366,0.27492,1,1
3,GO PROTEIN K48 LINKED DEUBIQUITINATION,0.017954,0.23602,0.2305,1,1
3,GO NON RECOMBINATIONAL REPAIR,0.0012758,0.23583,0.23662,1,1
3,GO CELL CYCLE DNA REPLICATION,0.0013481,0.2354,0.29628,1,1
3,GO REGULATION OF CIRCADIAN RHYTHM,0.00072571,0.23536,0.25608,1,1
3,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.00086166,0.23475,0.26257,1,1
3,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,0.010101,0.23464,0.286,1,1
3,GO REGULATION OF HISTONE METHYLATION,0.00048214,0.23423,0.31172,1,1
3,GO NEGATIVE REGULATION OF DNA REPAIR,0.0019699,0.23404,0.23445,1,1
3,GO DNA REPLICATION,0.00051151,0.23364,0.28281,1,1
3,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.0027019,0.23339,0.31036,1,1
3,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.0040644,0.23274,0.23018,1,1
3,GO SIALYLATION,0.006955,0.23269,0.26879,1,1
3,GO LOCOMOTORY BEHAVIOR,0.0015041,0.23226,0.26933,1,1
3,GO NEGATIVE REGULATION OF NEURON MIGRATION,0.0057394,0.2321,0.26686,1,1
3,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.00096503,0.23193,0.28117,1,1
3,GO SPINDLE LOCALIZATION,0.0028457,0.23181,0.25157,1,1
3,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,0.010101,0.23145,0.22069,1,1
3,GO VESICLE TRANSPORT ALONG MICROTUBULE,0.0017696,0.23061,0.25551,1,1
3,GO MITOTIC SISTER CHROMATID SEGREGATION,0.00048214,0.23021,0.27874,1,1
3,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.00081392,0.23009,0.25966,1,1
3,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,0.0054671,0.22998,0.28372,1,1
3,GO REGULATION OF NERVOUS SYSTEM PROCESS,0.0027019,0.22952,0.26056,1,1
3,GO PEPTIDYL LYSINE TRIMETHYLATION,0.0042727,0.22909,0.29126,1,1
3,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,0.0029965,0.22831,0.2395,1,1
3,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,0.0024341,0.22821,0.2807,1,1
3,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.00057531,0.2281,0.27389,1,1
3,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,0.00035748,0.22762,0.26977,1,1
3,GO RDNA HETEROCHROMATIN ASSEMBLY,0.0083971,0.22748,0.29221,1,1
3,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.012106,0.22748,0.20665,1,1
3,GO NEGATIVE REGULATION OF AXON EXTENSION,0.0044907,0.22703,0.25708,1,1
3,GO REGULATION OF NEUROTRANSMITTER LEVELS,0.0027019,0.2264,0.25074,1,1
3,GO PANCREAS DEVELOPMENT,0.0027019,0.22567,0.28631,1,1
3,GO MRNA 3 END PROCESSING,0.0013481,0.22543,0.2331,1,1
3,GO DNA CONFORMATION CHANGE,0.00072571,0.2254,0.28844,1,1
3,GO HISTONE UBIQUITINATION,0.0025648,0.22528,0.24662,1,1
3,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,0.031957,0.22488,0.21682,1,1
3,GO RNA POLYADENYLATION,0.0029965,0.22427,0.23186,1,1
3,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.00091199,0.22324,0.25206,1,1
3,GO DNA REPLICATION INITIATION,0.0047188,0.22304,0.24613,1,1
3,GO EPITHELIAL CELL FATE COMMITMENT,0.0076456,0.22287,0.27248,1,1
3,GO POSITIVE REGULATION OF RNA SPLICING,0.0017696,0.22274,0.23846,1,1
3,GO MRNA METHYLATION,0.0031545,0.22273,0.26552,1,1
3,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.00086166,0.2222,0.22311,1,1
3,GO REGULATION OF NEURON DIFFERENTIATION,0.0019699,0.22125,0.25132,1,1
3,GO REGULATION OF MRNA 3 END PROCESSING,0.0025648,0.22009,0.23403,1,1
3,GO HISTONE MONOUBIQUITINATION,0.0057394,0.21953,0.24411,1,1
3,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,0.0031545,0.21945,0.24419,1,1
3,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.0020776,0.21936,0.28386,1,1
3,GO NUCLEOSOME ASSEMBLY,0.0012071,0.21929,0.29292,1,1
3,GO ENDOCRINE PANCREAS DEVELOPMENT,0.0028457,0.21911,0.28156,1,1
3,GO REGULATION OF EXIT FROM MITOSIS,0.0029965,0.21842,0.29166,1,1
3,GO PALLIUM DEVELOPMENT,0.00072571,0.21792,0.25722,1,1
3,GO ACTIVATION OF JNKK ACTIVITY,0.054439,0.21726,0.20486,1,1
3,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.0057394,0.21621,0.27361,1,1
3,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,0.0052065,0.21615,0.29622,1,1
3,GO POSITIVE REGULATION OF MRNA PROCESSING,0.00076864,0.21583,0.22593,1,1
3,GO POSITIVE REGULATION OF DNA REPAIR,0.0012758,0.21561,0.23808,1,1
3,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.008797,0.21555,0.22469,1,1
3,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.0060238,0.21527,0.26704,1,1
3,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,0.0024341,0.21518,0.28386,1,1
3,GO NEGATIVE REGULATION OF DNA BINDING,0.0012071,0.21326,0.23228,1,1
3,GO REGULATION OF CYCLASE ACTIVITY,0.007293,0.21232,0.22315,1,1
3,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,0.0036751,0.21185,0.26014,1,1
3,GO DNA PACKAGING,0.00051151,0.21178,0.29906,1,1
3,GO NEGATIVE REGULATION OF BEHAVIOR,0.011574,0.21086,0.1948,1,1
3,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.006955,0.21083,0.2483,1,1
3,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.013834,0.21059,0.24614,1,1
3,GO MALE MEIOSIS I,0.0052065,0.21054,0.26788,1,1
3,GO METANEPHROS MORPHOGENESIS,0.02951,0.21034,0.21882,1,1
3,GO NCRNA EXPORT FROM NUCLEUS,0.0031545,0.21019,0.23279,1,1
3,GO TORC1 SIGNALING,0.0023095,0.20995,0.26766,1,1
3,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,0.00091199,0.20985,0.27084,1,1
3,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.006955,0.20958,0.22409,1,1
3,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,0.00060992,0.20954,0.23421,1,1
3,GO RRNA CATABOLIC PROCESS,0.030713,0.20844,0.16046,1,1
3,GO MEMBRANE DOCKING,0.00332,0.20784,0.22494,1,1
3,GO NEGATIVE REGULATION OF DNA REPLICATION,0.0054671,0.20747,0.22811,1,1
3,GO DOUBLE STRAND BREAK REPAIR,0.0010798,0.2069,0.26544,1,1
3,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.0066311,0.20624,0.19419,1,1
3,GO RNA INTERFERENCE,0.0044907,0.20441,0.22248,1,1
3,GO DNA INTEGRITY CHECKPOINT,0.0024341,0.2036,0.26577,1,1
3,GO RNA EXPORT FROM NUCLEUS,0.0019699,0.20351,0.21993,1,1
3,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.00086166,0.20293,0.21376,1,1
3,GO PROTEIN AUTOUBIQUITINATION,0.0025648,0.20284,0.20867,1,1
3,GO HISTONE H2A ACETYLATION,0.0016767,0.20256,0.22774,1,1
3,GO ASSOCIATIVE LEARNING,0.0010209,0.20046,0.23583,1,1
3,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.0010209,0.20029,0.1832,1,1
3,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.00081392,0.19995,0.23373,1,1
3,GO METHYLATION,0.00081392,0.19933,0.21449,1,1
3,GO REGULATION OF FATTY ACID BETA OXIDATION,0.008797,0.19678,0.2474,1,1
3,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,0.027226,0.19668,0.1957,1,1
3,GO CELL CYCLE CHECKPOINT,0.0019699,0.19656,0.26668,1,1
3,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.010572,0.19629,0.23685,1,1
3,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.0024341,0.19629,0.21929,1,1
3,GO AMINO ACID BETAINE METABOLIC PROCESS,0.058535,0.19623,0.19976,1,1
3,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,0.033245,0.19622,0.20216,1,1
3,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.0017696,0.19494,0.24932,1,1
3,GO REGULATION OF DNA REPLICATION,0.0010209,0.19444,0.24692,1,1
3,GO POSITIVE REGULATION OF FERTILIZATION,0.052482,0.19394,0.13203,1,1
3,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.0040644,0.19354,0.20992,1,1
3,GO NEURAL PRECURSOR CELL PROLIFERATION,0.00332,0.19285,0.22751,1,1
3,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,0.0021907,0.19259,0.27385,1,1
3,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.0038653,0.19251,0.25747,1,1
3,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,0.052482,0.1909,0.28154,1,1
3,GO FOREBRAIN DEVELOPMENT,0.00076864,0.18971,0.25174,1,1
3,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.0044907,0.18912,0.17838,1,1
3,GO REGULATION OF BEHAVIOR,0.007293,0.18852,0.19594,1,1
3,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.00086166,0.18818,0.31308,1,1
3,GO PROTEIN MONOUBIQUITINATION,0.00332,0.18808,0.235,1,1
3,GO RNA METHYLATION,0.0096484,0.18799,0.16775,1,1
3,GO RESPONSE TO VITAMIN A,0.052482,0.18753,0.1429,1,1
3,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.0013481,0.18742,0.23158,1,1
3,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.010101,0.18702,0.21858,1,1
3,GO TRNA TRANSPORT,0.0038653,0.18624,0.21212,1,1
3,GO INCLUSION BODY ASSEMBLY,0.0096484,0.18536,0.24321,1,1
3,GO TELENCEPHALON DEVELOPMENT,0.0010798,0.18529,0.24601,1,1
3,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,0.0042727,0.18396,0.23158,1,1
3,GO MITOTIC G1 S TRANSITION CHECKPOINT,0.0042727,0.18391,0.24483,1,1
3,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,0.0012071,0.1836,0.1876,1,1
3,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.0027019,0.18359,0.22908,1,1
3,GO PRIMARY MIRNA PROCESSING,0.011063,0.18312,0.21312,1,1
3,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,0.0057394,0.18305,0.18644,1,1
3,GO REGULATION OF MEIOTIC CELL CYCLE,0.006955,0.18279,0.20218,1,1
3,GO ATP TRANSPORT,0.026142,0.18275,0.17209,1,1
3,GO NEGATIVE REGULATION OF CELL AGING,0.0038653,0.18248,0.2377,1,1
3,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.0083971,0.18219,0.20312,1,1
3,GO CELL CYCLE G2 M PHASE TRANSITION,0.0010798,0.18179,0.20596,1,1
3,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,0.0057394,0.18173,0.21696,1,1
3,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,0.0027019,0.1812,0.22084,1,1
3,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.0025648,0.18058,0.17625,1,1
3,GO 3 UTR MEDIATED MRNA STABILIZATION,0.016475,0.18054,0.25633,1,1
3,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,0.0029965,0.18051,0.24163,1,1
3,GO DNA METABOLIC PROCESS,0.0031545,0.17884,0.18687,1,1
3,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,0.00332,0.17664,0.16222,1,1
3,GO VESICLE CYTOSKELETAL TRAFFICKING,0.008797,0.17643,0.2193,1,1
3,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.0028457,0.17443,0.20994,1,1
3,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,0.0023095,0.1743,0.21513,1,1
3,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.0034935,0.17386,0.21688,1,1
3,GO ESTABLISHMENT OF SPINDLE ORIENTATION,0.0054671,0.17374,0.20533,1,1
3,GO SYNAPTIC VESICLE RECYCLING,0.0096484,0.17369,0.20547,1,1
3,GO REGULATION OF DNA RECOMBINATION,0.02951,0.17356,0.17384,1,1
3,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.0063209,0.1731,0.20087,1,1
3,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,0.0011418,0.17283,0.23783,1,1
3,GO NCRNA TRANSCRIPTION,0.0019699,0.17273,0.18456,1,1
3,GO NUCLEAR BODY ORGANIZATION,0.0047188,0.17159,0.19374,1,1
3,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.0054671,0.17156,0.17983,1,1
3,GO MOTOR NEURON AXON GUIDANCE,0.030713,0.17102,0.22988,1,1
3,GO REGULATION OF CELL CYCLE PROCESS,0.00096503,0.17014,0.216,1,1
3,GO TELOMERE ORGANIZATION,0.0028457,0.16975,0.19895,1,1
3,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.0096484,0.16955,0.15627,1,1
3,GO TRNA METHYLATION,0.010572,0.16873,0.16442,1,1
3,GO CARTILAGE MORPHOGENESIS,0.048745,0.16853,0.24361,1,1
3,GO NUCLEAR EXPORT,0.0021907,0.16788,0.20242,1,1
3,GO ORGANELLE LOCALIZATION,0.011063,0.16726,0.17504,1,1
3,GO DETECTION OF VISIBLE LIGHT,0.0017696,0.16678,0.15586,1,1
3,GO RNA SURVEILLANCE,0.0057394,0.16629,0.13955,1,1
3,GO MITOCHONDRIAL TRANSCRIPTION,0.050584,0.16466,0.13277,1,1
3,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,0.0029965,0.16403,0.20645,1,1
3,GO RNA DESTABILIZATION,0.023112,0.16399,0.20591,1,1
3,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.00051151,0.16365,0.16367,1,1
3,GO ESTABLISHMENT OF RNA LOCALIZATION,0.0052065,0.16358,0.18107,1,1
3,GO PROTEIN SUMOYLATION,0.0038653,0.16312,0.20896,1,1
3,GO DEMETHYLATION,0.0040644,0.16218,0.21576,1,1
3,GO RRNA TRANSCRIPTION,0.0040644,0.16213,0.17589,1,1
3,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.027226,0.1616,0.17639,1,1
3,GO SNRNA TRANSCRIPTION,0.0034935,0.16158,0.17606,1,1
3,GO MITOCHONDRION DISTRIBUTION,0.0076456,0.16089,0.26086,1,1
3,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.017954,0.16062,0.18601,1,1
3,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.017954,0.16019,0.15264,1,1
3,GO REGULATION OF CELL CYCLE ARREST,0.00051151,0.15788,0.23211,1,1
3,GO REGULATION OF PROTEIN SUMOYLATION,0.034576,0.15781,0.16656,1,1
3,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.021265,0.15777,0.21078,1,1
3,GO MRNA CLEAVAGE,0.013235,0.15715,0.21346,1,1
3,GO RNA STABILIZATION,0.0047188,0.15677,0.2062,1,1
3,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.035953,0.15588,0.21736,1,1
3,GO DNA METHYLATION OR DEMETHYLATION,0.0080134,0.15528,0.16754,1,1
3,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.023112,0.1552,0.17103,1,1
3,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.0080134,0.15474,0.13721,1,1
3,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.0016767,0.15328,0.19623,1,1
3,GO FOREBRAIN NEURON DIFFERENTIATION,0.038848,0.15322,0.20207,1,1
3,GO NUCLEAR TRANSPORT,0.0040644,0.15174,0.17717,1,1
3,GO DNA METHYLATION,0.008797,0.15149,0.17709,1,1
3,GO REGULATION OF GENE EXPRESSION EPIGENETIC,0.0027019,0.15145,0.22411,1,1
3,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.0038653,0.15042,0.15891,1,1
3,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.045233,0.1502,0.20681,1,1
3,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.048745,0.14852,0.20585,1,1
3,GO DETECTION OF LIGHT STIMULUS,0.0083971,0.14815,0.11569,1,1
3,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.040368,0.14812,0.15144,1,1
3,GO REGULATION OF SENSORY PERCEPTION,0.019548,0.14764,0.18413,1,1
3,GO TRANSCRIPTION BY RNA POLYMERASE III,0.007293,0.14683,0.15415,1,1
3,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.058535,0.14677,0.15095,1,1
3,GO RNA LOCALIZATION,0.0049572,0.14633,0.1699,1,1
3,GO RNA MODIFICATION,0.025096,0.14619,0.11543,1,1
3,GO OLIGODENDROCYTE DEVELOPMENT,0.0083971,0.14588,0.21572,1,1
3,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.0080134,0.1456,0.1537,1,1
3,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.0017696,0.14488,0.16039,1,1
3,GO REGULATION OF CELLULAR RESPONSE TO HEAT,0.0044907,0.14428,0.19468,1,1
3,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.0096484,0.14418,0.1649,1,1
3,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.024086,0.14351,0.10288,1,1
3,GO INTRACELLULAR LIPID TRANSPORT,0.033245,0.14259,0.17685,1,1
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.023112,0.14244,0.15834,1,1
3,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,0.0034935,0.14229,0.19549,1,1
3,GO MRNA METABOLIC PROCESS,0.0014241,0.141,0.1686,1,1
3,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,0.0060238,0.13895,0.22262,1,1
3,GO PROTEIN REFOLDING,0.038848,0.1382,0.16872,1,1
3,GO SENSORY PERCEPTION OF SMELL,0.006955,0.13798,0.12678,1,1
3,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.026142,0.13759,0.27582,1,1
3,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,0.01266,0.13735,0.24283,1,1
3,GO IMPORT INTO NUCLEUS,0.018736,0.13589,0.14896,1,1
3,GO MAINTENANCE OF CELL NUMBER,0.01266,0.13571,0.17406,1,1
3,GO REGULATION OF MRNA METABOLIC PROCESS,0.0040644,0.13571,0.17469,1,1
3,GO INTRACELLULAR MRNA LOCALIZATION,0.012106,0.13484,0.19204,1,1
3,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.007293,0.13388,0.12455,1,1
3,GO RESPONSE TO AMINO ACID STARVATION,0.0096484,0.13326,0.18551,1,1
3,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.010572,0.13318,0.15188,1,1
3,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,0.0060238,0.13311,0.17213,1,1
3,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,0.0066311,0.1311,0.12726,1,1
3,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.0028457,0.13054,0.20466,1,1
3,GO PROTEIN POLYUBIQUITINATION,0.034576,0.12975,0.1309,1,1
3,GO TRNA MODIFICATION,0.023112,0.12844,0.13235,1,1
3,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.020391,0.12783,0.13715,1,1
3,GO PHOTOTRANSDUCTION,0.014457,0.1277,0.10206,1,1
3,GO MITOCHONDRIAL DNA REPLICATION,0.018736,0.12695,0.15686,1,1
3,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.019548,0.12687,0.16837,1,1
3,GO CELLULAR RESPONSE TO CHOLESTEROL,0.058535,0.12637,0.19542,1,1
3,GO APOPTOTIC DNA FRAGMENTATION,0.019548,0.12587,0.15922,1,1
3,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.054439,0.12466,0.11602,1,1
3,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.015104,0.12343,0.14401,1,1
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.037377,0.12342,0.1965,1,1
3,GO MULTI ORGANISM LOCALIZATION,0.019548,0.12252,0.13372,1,1
3,GO SNRNA METABOLIC PROCESS,0.01266,0.12179,0.13065,1,1
3,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.010572,0.1209,0.17505,1,1
3,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,0.050584,0.12031,0.12493,1,1
3,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,0.0066311,0.1197,0.12633,1,1
3,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.023112,0.11842,0.13876,1,1
3,GO DNA MODIFICATION,0.018736,0.1181,0.1393,1,1
3,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.030713,0.11735,0.11621,1,1
3,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.028348,0.11717,0.20015,1,1
3,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.026142,0.11703,0.13229,1,1
3,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.0049572,0.11682,0.28201,1,1
3,GO MATURATION OF SSU RRNA,0.043559,0.11522,0.10675,1,1
3,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.0060238,0.11414,0.16639,1,1
3,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,0.024086,0.11345,0.099375,1,1
3,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.027226,0.11331,0.09312,1,1
3,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.038848,0.11322,0.13368,1,1
3,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.030713,0.11241,0.15969,1,1
3,GO PROTEIN LOCALIZATION TO ORGANELLE,0.011574,0.11229,0.11894,1,1
3,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.037377,0.11055,0.17886,1,1
3,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.0066311,0.10993,0.20458,1,1
3,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.058535,0.10828,0.10414,1,1
3,GO REGULATION OF MRNA CATABOLIC PROCESS,0.034576,0.10717,0.11938,1,1
3,GO NCRNA PROCESSING,0.024086,0.10695,0.10384,1,1
3,GO RRNA METABOLIC PROCESS,0.034576,0.10415,0.095757,1,1
3,GO ESTABLISHMENT OF CELL POLARITY,0.028348,0.10277,0.18762,1,1
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.030713,0.10174,0.091875,1,1
3,GO HISTONE MRNA METABOLIC PROCESS,0.0080134,0.10102,0.13322,1,1
3,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.025096,0.099082,0.13217,1,1
3,GO RHYTHMIC BEHAVIOR,0.048745,0.099042,0.14539,1,1
3,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.060677,0.096103,0.1257,1,1
3,GO NCRNA METABOLIC PROCESS,0.025096,0.093731,0.10247,1,1
3,GO RIBOSOME BIOGENESIS,0.040368,0.093478,0.088074,1,1
3,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.024086,0.093436,0.11718,1,1
3,GO RESPONSE TO STARVATION,0.040368,0.091299,0.15271,1,1
3,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.025096,0.088764,0.10758,1,1
3,GO IRON SULFUR CLUSTER ASSEMBLY,0.043559,0.075273,0.089819,1,1
3,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,0.02951,0.073024,0.081987,1,1
3,GO RNA CATABOLIC PROCESS,0.013834,0.067469,0.09184,1,1
3,GO AMIDE BIOSYNTHETIC PROCESS,0.056456,0.066618,0.064114,1,1
3,GO PEPTIDE BIOSYNTHETIC PROCESS,0.052482,0.056709,0.06305,1,1
3,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.00086166,0.63976,0.53771,1,0
3,GO INHIBITORY POSTSYNAPTIC POTENTIAL,0.0020776,0.44874,0.49143,1,0
3,GO SYNAPTIC VESICLE DOCKING,0.015776,0.43395,0.33425,1,0
3,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,0.0017696,0.4302,0.37776,1,0
3,GO VOCALIZATION BEHAVIOR,0.0018673,0.42102,0.39964,1,0
3,GO REGULATION OF ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0011418,0.39611,0.41695,1,0
3,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,0.00086166,0.38846,0.36575,1,0
3,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.010101,0.38625,0.37176,1,0
3,GO LOOP OF HENLE DEVELOPMENT,0.0066311,0.38482,0.38653,1,0
3,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,0.0076456,0.37915,0.5036,1,0
3,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,0.0029965,0.37311,0.37745,1,0
3,GO CARDIAC CHAMBER FORMATION,0.0080134,0.3593,0.31126,1,0
3,GO NEURON CELL CELL ADHESION,0.0027019,0.34118,0.37199,1,0
3,GO RETROGRADE AXONAL TRANSPORT,0.0010209,0.33901,0.38745,1,0
3,GO REGULATION OF MICROTUBULE POLYMERIZATION,0.00064645,0.32375,0.3329,1,0
3,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,0.0042727,0.32164,0.37733,1,0
3,GO INHIBITORY SYNAPSE ASSEMBLY,0.0012071,0.31782,0.45371,1,0
3,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.00068502,0.31434,0.33496,1,0
3,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,0.01266,0.31421,0.28985,1,0
3,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.00096503,0.31233,0.33583,1,0
3,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,0.0031545,0.31154,0.31207,1,0
3,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,0.015776,0.31071,0.2895,1,0
3,GO REPRODUCTIVE BEHAVIOR,0.0019699,0.30949,0.28801,1,0
3,GO RECEPTOR LOCALIZATION TO SYNAPSE,0.0031545,0.3068,0.29178,1,0
3,GO PROTEIN TRANSPORT ALONG MICROTUBULE,0.00064645,0.30391,0.32859,1,0
3,GO PRESYNAPSE ORGANIZATION,0.0018673,0.30301,0.29648,1,0
3,GO PROTEIN LOCALIZATION TO SYNAPSE,0.00332,0.30107,0.27795,1,0
3,GO MICROTUBULE ANCHORING,0.00028019,0.30028,0.35863,1,0
3,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,0.0025648,0.29464,0.32449,1,0
3,GO PROTEIN LOCALIZATION TO CILIUM,0.0024341,0.29387,0.29365,1,0
3,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,0.0031545,0.29255,0.31566,1,0
3,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,0.0080134,0.29228,0.29038,1,0
3,GO RETINA LAYER FORMATION,0.0024341,0.29087,0.36917,1,0
3,GO NUCLEUS LOCALIZATION,0.00081392,0.29075,0.39344,1,0
3,GO NOREPINEPHRINE TRANSPORT,0.011574,0.28789,0.29732,1,0
3,GO REGULATION OF CILIUM ASSEMBLY,0.0027019,0.28774,0.27838,1,0
3,GO NEURON CELLULAR HOMEOSTASIS,0.016475,0.28717,0.27687,1,0
3,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,0.034576,0.28659,0.31371,1,0
3,GO LONG TERM SYNAPTIC DEPRESSION,0.023112,0.28615,0.23281,1,0
3,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.013834,0.28558,0.254,1,0
3,GO NEURAL RETINA DEVELOPMENT,0.0010209,0.28484,0.30006,1,0
3,GO MICROTUBULE POLYMERIZATION,0.00086166,0.28403,0.30716,1,0
3,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,0.0049572,0.28367,0.27722,1,0
3,GO SYNAPTIC VESICLE EXOCYTOSIS,0.0015882,0.2832,0.30544,1,0
3,GO MICROTUBULE BUNDLE FORMATION,0.0063209,0.28268,0.24535,1,0
3,GO SYNAPSE ASSEMBLY,0.0017696,0.28215,0.29991,1,0
3,GO NEGATIVE REGULATION OF AXONOGENESIS,0.0028457,0.2793,0.27856,1,0
3,GO MICROTUBULE SEVERING,0.00332,0.27924,0.29865,1,0
3,GO PROTEIN LOCALIZATION TO CELL JUNCTION,0.0044907,0.2762,0.25035,1,0
3,GO REGULATION OF SYNAPTIC VESICLE CYCLE,0.0020776,0.27503,0.31103,1,0
3,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.012106,0.27483,0.22889,1,0
3,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.014457,0.27393,0.26165,1,0
3,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,0.0014241,0.2735,0.28789,1,0
3,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.060677,0.2728,0.18846,1,0
3,GO REGULATION OF SYNAPSE ASSEMBLY,0.0023095,0.27178,0.28765,1,0
3,GO BRAIN MORPHOGENESIS,0.0010798,0.27091,0.30054,1,0
3,GO INOSITOL METABOLIC PROCESS,0.021265,0.26923,0.2274,1,0
3,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,0.0012071,0.26708,0.29575,1,0
3,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,0.0027019,0.26674,0.31059,1,0
3,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0096484,0.26524,0.25737,1,0
3,GO NON MOTILE CILIUM ASSEMBLY,0.0027019,0.26485,0.26856,1,0
3,GO FEAR RESPONSE,0.0038653,0.26317,0.24138,1,0
3,GO TRANSPORT ALONG MICROTUBULE,0.00076864,0.26304,0.26935,1,0
3,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,0.0057394,0.26259,0.25858,1,0
3,GO INTRACILIARY RETROGRADE TRANSPORT,0.0036751,0.2608,0.34005,1,0
3,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.0040644,0.25889,0.28405,1,0
3,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.0052065,0.2586,0.24896,1,0
3,GO EXCITATORY SYNAPSE ASSEMBLY,0.0044907,0.25777,0.2831,1,0
3,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.0083971,0.25743,0.34838,1,0
3,GO MICROTUBULE BASED MOVEMENT,0.0011418,0.25702,0.26126,1,0
3,GO PROTEIN DEMETHYLATION,0.0016767,0.25571,0.31283,1,0
3,GO SEX DETERMINATION,0.041938,0.25568,0.19792,1,0
3,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.040368,0.25565,0.21619,1,0
3,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,0.0028457,0.25541,0.29961,1,0
3,GO COLLATERAL SPROUTING,0.014457,0.25519,0.26453,1,0
3,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,0.050584,0.25365,0.20317,1,0
3,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,0.01266,0.25317,0.27392,1,0
3,GO REGULATION OF MICROTUBULE BASED PROCESS,0.00054254,0.25311,0.26669,1,0
3,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,0.0052065,0.25309,0.40238,1,0
3,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,0.0010798,0.25291,0.30361,1,0
3,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,0.0038653,0.25277,0.27239,1,0
3,GO SYNAPSE ORGANIZATION,0.0028457,0.25187,0.25348,1,0
3,GO PROTEIN LOCALIZATION TO MICROTUBULE,0.00072571,0.24907,0.29979,1,0
3,GO REGULATION OF RESPONSE TO FOOD,0.0040644,0.24843,0.32854,1,0
3,GO TUBULIN DEACETYLATION,0.026142,0.24825,0.22912,1,0
3,GO POSITIVE REGULATION OF TORC1 SIGNALING,0.008797,0.24773,0.27739,1,0
3,GO CILIUM ORGANIZATION,0.0018673,0.24729,0.25742,1,0
3,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.0096484,0.24254,0.32548,1,0
3,GO NEURAL TUBE PATTERNING,0.0052065,0.24158,0.25477,1,0
3,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,0.0012758,0.24049,0.26733,1,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,0.006955,0.24022,0.26235,1,0
3,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.0063209,0.23957,0.27377,1,0
3,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,0.0028457,0.23906,0.28821,1,0
3,GO MICROTUBULE BASED TRANSPORT,0.0019699,0.23873,0.25964,1,0
3,GO CEREBRAL CORTEX CELL MIGRATION,0.0054671,0.23811,0.28103,1,0
3,GO NEURON PROJECTION GUIDANCE,0.0054671,0.23797,0.27826,1,0
3,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,0.028348,0.23714,0.29345,1,0
3,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,0.0092139,0.23673,0.27175,1,0
3,GO NEURON PROJECTION ARBORIZATION,0.024086,0.23546,0.26692,1,0
3,GO HISTONE H4 K5 ACETYLATION,0.0054671,0.23501,0.24297,1,0
3,GO CELL PART MORPHOGENESIS,0.00332,0.23409,0.26343,1,0
3,GO NEURON RECOGNITION,0.01266,0.23404,0.24943,1,0
3,GO REGULATION OF EXTENT OF CELL GROWTH,0.0057394,0.23297,0.26712,1,0
3,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.0054671,0.23239,0.30745,1,0
3,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,0.0038653,0.22881,0.23948,1,0
3,GO AXON DEVELOPMENT,0.0036751,0.2285,0.26528,1,0
3,GO MITOCHONDRION LOCALIZATION,0.0016767,0.22825,0.26549,1,0
3,GO AXO DENDRITIC TRANSPORT,0.0044907,0.22813,0.26713,1,0
3,GO INTRACILIARY TRANSPORT,0.0018673,0.22797,0.29959,1,0
3,GO CELL JUNCTION MAINTENANCE,0.040368,0.22575,0.23081,1,0
3,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,0.027226,0.22556,0.18302,1,0
3,GO POSITIVE REGULATION OF AXONOGENESIS,0.0063209,0.22478,0.27584,1,0
3,GO REGULATION OF APPETITE,0.031957,0.22392,0.20895,1,0
3,GO RESPONSE TO GLUCAGON,0.056456,0.22297,0.18336,1,0
3,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,0.0027019,0.22155,0.30474,1,0
3,GO UV DAMAGE EXCISION REPAIR,0.0083971,0.22093,0.2335,1,0
3,GO HISTONE DEUBIQUITINATION,0.0083971,0.21999,0.26528,1,0
3,GO AXONEME ASSEMBLY,0.052482,0.21981,0.19636,1,0
3,GO NEURON MATURATION,0.007293,0.21895,0.25467,1,0
3,GO MUSCLE FIBER DEVELOPMENT,0.018736,0.2183,0.20233,1,0
3,GO MODIFICATION OF SYNAPTIC STRUCTURE,0.010572,0.2154,0.23497,1,0
3,GO LAYER FORMATION IN CEREBRAL CORTEX,0.015104,0.21498,0.26487,1,0
3,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,0.050584,0.2138,0.25657,1,0
3,GO EMBRYONIC AXIS SPECIFICATION,0.0010209,0.21371,0.24886,1,0
3,GO BEHAVIOR,0.0040644,0.21366,0.22095,1,0
3,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,0.0018673,0.21357,0.25868,1,0
3,GO MYOTUBE CELL DEVELOPMENT,0.034576,0.2135,0.16144,1,0
3,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,0.018736,0.21348,0.26849,1,0
3,GO RESPONSE TO NERVE GROWTH FACTOR,0.0063209,0.2129,0.21043,1,0
3,GO HETEROCHROMATIN ORGANIZATION,0.0018673,0.21213,0.26938,1,0
3,GO CELLULAR COMPONENT MORPHOGENESIS,0.0044907,0.21143,0.24461,1,0
3,GO REGULATION OF TORC1 SIGNALING,0.0025648,0.211,0.26527,1,0
3,GO NEUROMUSCULAR PROCESS,0.007293,0.21026,0.23175,1,0
3,GO DIVALENT METAL ION EXPORT,0.026142,0.20949,0.23713,1,0
3,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,0.0063209,0.20878,0.25012,1,0
3,GO CALCIUM ION REGULATED EXOCYTOSIS,0.02951,0.20785,0.25513,1,0
3,GO CELL MIGRATION IN HINDBRAIN,0.040368,0.20779,0.23983,1,0
3,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,0.0015041,0.207,0.27714,1,0
3,GO VENTRICULAR SYSTEM DEVELOPMENT,0.0010798,0.20696,0.2769,1,0
3,GO REGULATION OF POSTSYNAPSE ORGANIZATION,0.0040644,0.20679,0.25313,1,0
3,GO SYNAPTIC TRANSMISSION GABAERGIC,0.00332,0.20642,0.29071,1,0
3,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,0.0096484,0.20513,0.21349,1,0
3,GO AXON EXTENSION,0.010101,0.2041,0.24073,1,0
3,GO NEURON PROJECTION EXTENSION,0.007293,0.20383,0.23716,1,0
3,GO REGULATION OF DNA REPAIR,0.0015882,0.20313,0.24258,1,0
3,GO REGULATION OF SYNAPTIC PLASTICITY,0.010101,0.20164,0.22039,1,0
3,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.0054671,0.20143,0.24884,1,0
3,GO NEURON PROJECTION ORGANIZATION,0.0057394,0.20049,0.24688,1,0
3,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,0.0076456,0.19955,0.13845,1,0
3,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,0.0034935,0.19892,0.24994,1,0
3,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,0.031957,0.19836,0.22491,1,0
3,GO NEURON DIFFERENTIATION,0.0020776,0.19791,0.23911,1,0
3,GO LENS FIBER CELL DIFFERENTIATION,0.028348,0.19775,0.18669,1,0
3,GO SYNAPTIC VESICLE TRANSPORT,0.054439,0.19769,0.16273,1,0
3,GO NEURON DEVELOPMENT,0.0025648,0.19677,0.23821,1,0
3,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,0.0066311,0.19565,0.22575,1,0
3,GO HEART VALVE FORMATION,0.015776,0.19558,0.30409,1,0
3,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.026142,0.19496,0.26332,1,0
3,GO EMBRYONIC BODY MORPHOGENESIS,0.016475,0.19483,0.25901,1,0
3,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.052482,0.19439,0.21921,1,0
3,GO PROTEIN HETEROOLIGOMERIZATION,0.022172,0.19397,0.16395,1,0
3,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,0.056456,0.19347,0.32505,1,0
3,GO REGULATION OF DOPAMINE SECRETION,0.040368,0.1931,0.24574,1,0
3,GO OVARIAN FOLLICLE DEVELOPMENT,0.0066311,0.19269,0.2359,1,0
3,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.0038653,0.19249,0.21988,1,0
3,GO SPERMATID DIFFERENTIATION,0.0042727,0.19242,0.17867,1,0
3,GO POSITIVE REGULATION OF AXON EXTENSION,0.026142,0.19235,0.22693,1,0
3,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.018736,0.19228,0.20133,1,0
3,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.028348,0.19214,0.22299,1,0
3,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,0.021265,0.19128,0.2079,1,0
3,GO COLLECTING DUCT DEVELOPMENT,0.014457,0.1912,0.2567,1,0
3,GO REGULATION OF RNA SPLICING,0.0017696,0.19091,0.23676,1,0
3,GO REGULATION OF ORGANELLE ASSEMBLY,0.0054671,0.19091,0.20868,1,0
3,GO PROTEIN ACYLATION,0.0044907,0.19058,0.22243,1,0
3,GO DOPAMINE TRANSPORT,0.016475,0.19056,0.27554,1,0
3,GO RESPONSE TO AUDITORY STIMULUS,0.031957,0.19028,0.27853,1,0
3,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.006955,0.1881,0.21756,1,0
3,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,0.041938,0.18788,0.33478,1,0
3,GO REGULATION OF CAMP MEDIATED SIGNALING,0.0076456,0.18733,0.19974,1,0
3,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.056456,0.18694,0.20873,1,0
3,GO CELL PROJECTION ORGANIZATION,0.0052065,0.18596,0.2061,1,0
3,GO COVALENT CHROMATIN MODIFICATION,0.0014241,0.18576,0.25491,1,0
3,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.048745,0.18524,0.22983,1,0
3,GO POTASSIUM ION HOMEOSTASIS,0.034576,0.18468,0.15698,1,0
3,GO DEVELOPMENTAL CELL GROWTH,0.016475,0.18445,0.20564,1,0
3,GO HEAD DEVELOPMENT,0.0023095,0.1839,0.22822,1,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.060677,0.18355,0.25475,1,0
3,GO REGULATION OF MITOPHAGY,0.017954,0.18326,0.22021,1,0
3,GO ACTIN CROSSLINK FORMATION,0.011063,0.18173,0.28633,1,0
3,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,0.018736,0.18154,0.19436,1,0
3,GO CHEMOSENSORY BEHAVIOR,0.015776,0.18137,0.18474,1,0
3,GO REGULATION OF PROTEIN GLYCOSYLATION,0.030713,0.18116,0.24223,1,0
3,GO POSITIVE REGULATION OF TOR SIGNALING,0.015104,0.18058,0.19457,1,0
3,GO CHROMATIN ORGANIZATION,0.0011418,0.18018,0.26073,1,0
3,GO FUCOSYLATION,0.040368,0.18013,0.16292,1,0
3,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,0.007293,0.17957,0.22341,1,0
3,GO RECEPTOR CLUSTERING,0.021265,0.17941,0.23476,1,0
3,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,0.0083971,0.17923,0.24735,1,0
3,GO ADULT LOCOMOTORY BEHAVIOR,0.027226,0.1785,0.18997,1,0
3,GO NEUROGENESIS,0.0034935,0.17617,0.21603,1,0
3,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,0.017954,0.17576,0.19756,1,0
3,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.013834,0.17545,0.19143,1,0
3,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.017954,0.17481,0.20672,1,0
3,GO SPERM MOTILITY,0.011574,0.17314,0.17546,1,0
3,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.030713,0.17306,0.20291,1,0
3,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.0096484,0.17291,0.22641,1,0
3,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,0.006955,0.17288,0.2778,1,0
3,GO ORGANELLE ASSEMBLY,0.0049572,0.17285,0.18672,1,0
3,GO COGNITION,0.0096484,0.1727,0.1795,1,0
3,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.012106,0.17231,0.21573,1,0
3,GO ADIPOSE TISSUE DEVELOPMENT,0.020391,0.17202,0.21645,1,0
3,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,0.027226,0.17171,0.19234,1,0
3,GO PROTEIN ACETYLATION,0.0042727,0.17159,0.21444,1,0
3,GO NEUROTRANSMITTER UPTAKE,0.01266,0.17123,0.20085,1,0
3,GO NEGATIVE REGULATION OF HORMONE SECRETION,0.006955,0.17104,0.20289,1,0
3,GO ADHERENS JUNCTION ASSEMBLY,0.054439,0.17026,0.23836,1,0
3,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.0034935,0.17023,0.23634,1,0
3,GO VESICLE FUSION TO PLASMA MEMBRANE,0.040368,0.17011,0.26727,1,0
3,GO CELLULAR RESPONSE TO STEROL,0.023112,0.17004,0.22672,1,0
3,GO REGULATION OF CELL SIZE,0.035953,0.16995,0.19591,1,0
3,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,0.0096484,0.16987,0.20481,1,0
3,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.033245,0.16913,0.16365,1,0
3,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,0.00332,0.1688,0.21886,1,0
3,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,0.010101,0.16822,0.22094,1,0
3,GO REGULATION OF ACTION POTENTIAL,0.027226,0.16736,0.17821,1,0
3,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,0.016475,0.16721,0.19079,1,0
3,GO PEPTIDYL LYSINE MODIFICATION,0.0023095,0.16687,0.2236,1,0
3,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.031957,0.16677,0.15946,1,0
3,GO OXIDATIVE DEMETHYLATION,0.021265,0.16593,0.19651,1,0
3,GO DIENCEPHALON DEVELOPMENT,0.008797,0.16473,0.24296,1,0
3,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.041938,0.16469,0.25138,1,0
3,GO REGULATION OF NEURON MATURATION,0.026142,0.1642,0.23438,1,0
3,GO DENDRITE EXTENSION,0.010572,0.16409,0.24407,1,0
3,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,0.021265,0.16359,0.21006,1,0
3,GO SOMITE DEVELOPMENT,0.0096484,0.16247,0.20789,1,0
3,GO PROTEIN LOCALIZATION TO LYSOSOME,0.033245,0.16222,0.20694,1,0
3,GO REGULATION OF CELL PROJECTION ORGANIZATION,0.011574,0.16146,0.19938,1,0
3,GO PEPTIDYL LYSINE ACETYLATION,0.0054671,0.16144,0.21954,1,0
3,GO TRANSMISSION OF NERVE IMPULSE,0.0092139,0.16132,0.22073,1,0
3,GO SHORT TERM MEMORY,0.058535,0.16103,0.18479,1,0
3,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.010101,0.16101,0.19824,1,0
3,GO POST EMBRYONIC DEVELOPMENT,0.030713,0.15983,0.19256,1,0
3,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,0.0044907,0.15909,0.19602,1,0
3,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.018736,0.159,0.21894,1,0
3,GO SEXUAL REPRODUCTION,0.0028457,0.15857,0.17551,1,0
3,GO MULTICELLULAR ORGANISM GROWTH,0.0096484,0.15847,0.21044,1,0
3,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,0.0042727,0.15846,0.17846,1,0
3,GO SCHWANN CELL DIFFERENTIATION,0.058535,0.15839,0.18232,1,0
3,GO NEGATIVE REGULATION OF TOR SIGNALING,0.017954,0.15831,0.2036,1,0
3,GO EMBRYONIC PATTERN SPECIFICATION,0.00076864,0.15782,0.21,1,0
3,GO MATING,0.010101,0.15762,0.19999,1,0
3,GO REGULATION OF TOR SIGNALING,0.021265,0.15758,0.18428,1,0
3,GO TELOMERE CAPPING,0.038848,0.15732,0.18046,1,0
3,GO GERM CELL DEVELOPMENT,0.0025648,0.15717,0.19209,1,0
3,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,0.045233,0.15711,0.17364,1,0
3,GO ADHERENS JUNCTION ORGANIZATION,0.027226,0.15692,0.20644,1,0
3,GO DIACYLGLYCEROL METABOLIC PROCESS,0.035953,0.15643,0.177,1,0
3,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.035953,0.15548,0.099033,1,0
3,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,0.0063209,0.15533,0.20754,1,0
3,GO REGULATION OF CHROMATIN ORGANIZATION,0.0029965,0.15512,0.21586,1,0
3,GO LATERAL MESODERM DEVELOPMENT,0.040368,0.15487,0.18537,1,0
3,GO PRESYNAPTIC ENDOCYTOSIS,0.0083971,0.15471,0.21263,1,0
3,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,0.035953,0.15419,0.18865,1,0
3,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,0.01266,0.15416,0.17037,1,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.054439,0.15401,0.17015,1,0
3,GO CAMERA TYPE EYE MORPHOGENESIS,0.031957,0.15375,0.19196,1,0
3,GO PHOTORECEPTOR CELL DEVELOPMENT,0.019548,0.15312,0.13772,1,0
3,GO GAMETE GENERATION,0.0018673,0.15299,0.18932,1,0
3,GO CAMERA TYPE EYE DEVELOPMENT,0.0096484,0.15279,0.20674,1,0
3,GO FUCOSE METABOLIC PROCESS,0.016475,0.15208,0.16968,1,0
3,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,0.02951,0.15207,0.18415,1,0
3,GO MEMORY,0.030713,0.15187,0.16458,1,0
3,GO OLIGODENDROCYTE DIFFERENTIATION,0.041938,0.15159,0.15048,1,0
3,GO EPITHELIAL TUBE FORMATION,0.050584,0.1515,0.16427,1,0
3,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,0.035953,0.15077,0.16813,1,0
3,GO CIRCADIAN RHYTHM,0.0076456,0.15071,0.19797,1,0
3,GO OOGENESIS,0.0047188,0.14979,0.18738,1,0
3,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,0.033245,0.14963,0.17533,1,0
3,GO HISTONE DEACETYLATION,0.016475,0.14921,0.21512,1,0
3,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.028348,0.14903,0.13409,1,0
3,GO REGULATION OF MEMBRANE POTENTIAL,0.014457,0.1489,0.17348,1,0
3,GO SOMITOGENESIS,0.022172,0.14881,0.19058,1,0
3,GO NEGATIVE CHEMOTAXIS,0.045233,0.14859,0.2199,1,0
3,GO CILIUM MOVEMENT,0.025096,0.1472,0.17681,1,0
3,GO REGULATION OF LYASE ACTIVITY,0.011063,0.14713,0.18526,1,0
3,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.020391,0.14638,0.19978,1,0
3,GO SCHWANN CELL DEVELOPMENT,0.052482,0.14632,0.18344,1,0
3,GO TOR SIGNALING,0.025096,0.1456,0.17307,1,0
3,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.037377,0.14452,0.14213,1,0
3,GO CELL JUNCTION ORGANIZATION,0.030713,0.14443,0.17888,1,0
3,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,0.031957,0.14389,0.2485,1,0
3,GO REGULATION OF CELL DEVELOPMENT,0.01266,0.14332,0.18901,1,0
3,GO OOCYTE DIFFERENTIATION,0.038848,0.14321,0.13681,1,0
3,GO REGULATION OF MICROTUBULE BASED MOVEMENT,0.0172,0.14258,0.14379,1,0
3,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.043559,0.14205,0.1743,1,0
3,GO PHOTORECEPTOR CELL DIFFERENTIATION,0.026142,0.14174,0.146,1,0
3,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,0.031957,0.14156,0.20471,1,0
3,GO REGULATION OF DEVELOPMENTAL GROWTH,0.0172,0.14122,0.18285,1,0
3,GO CATECHOLAMINE SECRETION,0.010101,0.1411,0.26985,1,0
3,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,0.023112,0.14078,0.16142,1,0
3,GO CELL MORPHOGENESIS,0.023112,0.1406,0.1921,1,0
3,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.02951,0.14058,0.19866,1,0
3,GO RESPONSE TO DOPAMINE,0.033245,0.14053,0.15276,1,0
3,GO SEGMENTATION,0.018736,0.14001,0.19106,1,0
3,GO ENDOCRINE SYSTEM DEVELOPMENT,0.024086,0.13961,0.20667,1,0
3,GO HISTONE H3 K14 ACETYLATION,0.0172,0.13913,0.20804,1,0
3,GO POSITIVE REGULATION OF MITOPHAGY,0.043559,0.13888,0.20761,1,0
3,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.0172,0.13887,0.21936,1,0
3,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,0.010101,0.13846,0.16595,1,0
3,GO MONOAMINE TRANSPORT,0.025096,0.13804,0.21633,1,0
3,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,0.0044907,0.13675,0.1954,1,0
3,GO MULTICELLULAR ORGANISM REPRODUCTION,0.013235,0.13635,0.15469,1,0
3,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.037377,0.1353,0.14504,1,0
3,GO PEPTIDE HORMONE SECRETION,0.0057394,0.13515,0.19452,1,0
3,GO LOCALIZATION WITHIN MEMBRANE,0.052482,0.13515,0.18032,1,0
3,GO PEPTIDYL SERINE MODIFICATION,0.028348,0.13499,0.16905,1,0
3,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.0092139,0.13461,0.20124,1,0
3,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.046961,0.13427,0.19156,1,0
3,GO REGULATION OF HISTONE MODIFICATION,0.0080134,0.13405,0.19963,1,0
3,GO NERVOUS SYSTEM PROCESS,0.037377,0.134,0.13614,1,0
3,GO REGULATION OF CELL MATURATION,0.0034935,0.13396,0.16881,1,0
3,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.015776,0.13384,0.16666,1,0
3,GO ACIDIC AMINO ACID TRANSPORT,0.023112,0.1336,0.18691,1,0
3,GO REGULATION OF CYTOPLASMIC TRANSLATION,0.013834,0.13305,0.16834,1,0
3,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.052482,0.13223,0.19121,1,0
3,GO REGULATION OF CELL MORPHOGENESIS,0.037377,0.13198,0.1814,1,0
3,GO FERTILIZATION,0.008797,0.13161,0.14745,1,0
3,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,0.035953,0.13127,0.15394,1,0
3,GO AXIS SPECIFICATION,0.0047188,0.13114,0.19205,1,0
3,GO DEVELOPMENTAL GROWTH,0.041938,0.13093,0.1673,1,0
3,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,0.034576,0.13092,0.17918,1,0
3,GO VISUAL BEHAVIOR,0.012106,0.13023,0.18043,1,0
3,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.016475,0.12964,0.1887,1,0
3,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.058535,0.12942,0.23339,1,0
3,GO PROTEIN TARGETING TO VACUOLE,0.058535,0.12829,0.16381,1,0
3,GO POSITIVE REGULATION OF CELL DEVELOPMENT,0.027226,0.12739,0.16864,1,0
3,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.026142,0.12728,0.17959,1,0
3,GO REGULATION OF RECEPTOR INTERNALIZATION,0.0076456,0.12725,0.17874,1,0
3,GO CELL PROJECTION ASSEMBLY,0.027226,0.12711,0.16806,1,0
3,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,0.060677,0.1269,0.16853,1,0
3,GO MACROMOLECULE DEACYLATION,0.020391,0.12642,0.18568,1,0
3,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.017954,0.1262,0.15412,1,0
3,GO NEURAL NUCLEUS DEVELOPMENT,0.052482,0.12551,0.18414,1,0
3,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.013235,0.12545,0.15679,1,0
3,GO AMINE TRANSPORT,0.015776,0.12362,0.21431,1,0
3,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.0054671,0.1236,0.19061,1,0
3,GO MITOPHAGY,0.048745,0.12341,0.17471,1,0
3,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.038848,0.12245,0.18472,1,0
3,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,0.048745,0.12125,0.15031,1,0
3,GO HAIR CELL DIFFERENTIATION,0.034576,0.12077,0.16971,1,0
3,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.034576,0.12066,0.18211,1,0
3,GO RHYTHMIC PROCESS,0.0096484,0.11897,0.18822,1,0
3,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.0057394,0.11875,0.22405,1,0
3,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.048745,0.11849,0.15049,1,0
3,GO RESPONSE TO LIGHT STIMULUS,0.011574,0.11838,0.15485,1,0
3,GO REGULATION OF PHOSPHATASE ACTIVITY,0.040368,0.11617,0.15178,1,0
3,GO RESPONSE TO ALKALOID,0.040368,0.11603,0.14877,1,0
3,GO SENSORY SYSTEM DEVELOPMENT,0.034576,0.11568,0.18113,1,0
3,GO SPECIFICATION OF SYMMETRY,0.027226,0.11485,0.15678,1,0
3,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.0066311,0.11457,0.1893,1,0
3,GO FEMALE SEX DIFFERENTIATION,0.017954,0.11427,0.19152,1,0
3,GO DNA DEMETHYLATION,0.034576,0.11354,0.16503,1,0
3,GO REGULATION OF HISTONE UBIQUITINATION,0.0083971,0.11288,0.19387,1,0
3,GO REGULATION OF PEPTIDE HORMONE SECRETION,0.010101,0.11128,0.19711,1,0
3,GO FEMALE GAMETE GENERATION,0.0096484,0.11119,0.17037,1,0
3,GO HISTONE H3 ACETYLATION,0.056456,0.11015,0.15461,1,0
3,GO CLATHRIN DEPENDENT ENDOCYTOSIS,0.045233,0.11006,0.17434,1,0
3,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.013834,0.10946,0.18453,1,0
3,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.040368,0.10908,0.15362,1,0
3,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.048745,0.10878,0.13479,1,0
3,GO DNA TEMPLATED TRANSCRIPTION INITIATION,0.023112,0.10849,0.13748,1,0
3,GO PEPTIDYL THREONINE MODIFICATION,0.060677,0.10804,0.16853,1,0
3,GO MULTI ORGANISM PROCESS,0.025096,0.10687,0.13644,1,0
3,GO SEGMENT SPECIFICATION,0.054439,0.10656,0.17286,1,0
3,GO INTRACELLULAR TRANSPORT,0.038848,0.10643,0.11352,1,0
3,GO INNER EAR MORPHOGENESIS,0.02951,0.10554,0.19911,1,0
3,GO CYTOSKELETON ORGANIZATION,0.031957,0.1044,0.16303,1,0
3,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,0.058535,0.10376,0.12,1,0
3,GO CELLULAR MACROMOLECULE LOCALIZATION,0.035953,0.10355,0.12354,1,0
3,GO REGULATION OF GONAD DEVELOPMENT,0.048745,0.1035,0.17441,1,0
3,GO POTASSIUM ION TRANSPORT,0.035953,0.10228,0.15528,1,0
3,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.060677,0.10178,0.13567,1,0
3,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.037377,0.10122,0.12653,1,0
3,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.0096484,0.10044,0.17475,1,0
3,GO SENSORY ORGAN DEVELOPMENT,0.025096,0.10024,0.16893,1,0
3,GO REGULATION OF ORGANELLE ORGANIZATION,0.035953,0.099279,0.14244,1,0
3,GO REGULATION OF HORMONE SECRETION,0.054439,0.098791,0.14493,1,0
3,GO ACTION POTENTIAL,0.045233,0.098497,0.14121,1,0
3,GO INTRACELLULAR PROTEIN TRANSPORT,0.045233,0.098452,0.10182,1,0
3,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.012106,0.097543,0.18344,1,0
3,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.045233,0.096569,0.17518,1,0
3,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,0.045233,0.095529,0.13576,1,0
3,GO INSULIN SECRETION,0.014457,0.095316,0.1792,1,0
3,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,0.056456,0.095028,0.13522,1,0
3,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.038848,0.094902,0.158,1,0
3,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.048745,0.094462,0.12123,1,0
3,GO SENSORY PERCEPTION OF LIGHT STIMULUS,0.056456,0.093916,0.10002,1,0
3,GO RESPONSE TO RADIATION,0.040368,0.093678,0.12914,1,0
3,GO LIPID DROPLET ORGANIZATION,0.035953,0.093553,0.13881,1,0
3,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,0.054439,0.092694,0.138,1,0
3,GO HORMONE MEDIATED SIGNALING PATHWAY,0.035953,0.091601,0.15776,1,0
3,GO REPRODUCTION,0.041938,0.0902,0.13754,1,0
3,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.041938,0.090198,0.1731,1,0
3,GO STRIATED MUSCLE ADAPTATION,0.054439,0.089818,0.17544,1,0
3,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.058535,0.08532,0.12689,1,0
3,GO REGULATION OF INSULIN SECRETION,0.015776,0.08431,0.17573,1,0
3,GO REGULATION OF DENDRITE EXTENSION,0.043559,0.080249,0.21132,1,0
3,GO TRANSPOSITION,0.045233,0.078739,0.14914,1,0
3,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.050584,0.076789,0.15603,1,0
3,GO MULTICELLULAR ORGANISMAL SIGNALING,0.048745,0.069286,0.1427,1,0
3,GO PROTEIN LOCALIZATION TO MEMBRANE,0.020391,0.067231,0.10867,1,0
3,GO CELLULAR GLUCOSE HOMEOSTASIS,0.058535,0.065263,0.13804,1,0
3,GO VITAMIN METABOLIC PROCESS,0.052482,-0.077912,-0.068088,1,0
3,GO URONIC ACID METABOLIC PROCESS,0.007293,-0.089128,-0.12036,1,0
3,GO RESPONSE TO XENOBIOTIC STIMULUS,0.046961,-0.09774,-0.10938,1,0
3,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.02951,-0.097756,-0.084695,1,0
3,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.041938,-0.098243,-0.092092,1,0
3,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,0.046961,-0.10417,-0.093448,1,0
3,GO GLUTATHIONE METABOLIC PROCESS,0.033245,-0.10503,-0.11571,1,0
3,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.017954,-0.10541,-0.090675,1,0
3,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.050584,-0.11091,-0.070075,1,0
3,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.056456,-0.11564,-0.065556,1,0
3,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.052482,-0.11659,-0.088981,1,0
3,GO PROTEIN PROCESSING,0.060677,-0.11978,-0.074381,1,0
3,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.02951,-0.12346,-0.1546,1,0
3,GO LIPID IMPORT INTO CELL,0.040368,-0.12618,-0.088394,1,0
3,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.041938,-0.12726,-0.13971,1,0
3,GO RESPONSE TO TUMOR NECROSIS FACTOR,0.058535,-0.1318,-0.14308,1,0
3,GO HEMOGLOBIN METABOLIC PROCESS,0.052482,-0.13451,-0.083625,1,0
3,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,0.024086,-0.1359,-0.10538,1,0
3,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.056456,-0.13764,-0.13344,1,0
3,GO POSITIVE REGULATION OF HEART CONTRACTION,0.043559,-0.13863,-0.12994,1,0
3,GO ARACHIDONIC ACID SECRETION,0.046961,-0.13916,-0.10889,1,0
3,GO CELL REDOX HOMEOSTASIS,0.043559,-0.13927,-0.14646,1,0
3,GO TRANSITION METAL ION HOMEOSTASIS,0.050584,-0.13976,-0.081281,1,0
3,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,0.043559,-0.14496,-0.16029,1,0
3,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.045233,-0.14553,-0.099892,1,0
3,GO POSITIVE REGULATION OF HEART RATE,0.037377,-0.14613,-0.18335,1,0
3,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.041938,-0.15082,-0.09375,1,0
3,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.034576,-0.15383,-0.12793,1,0
3,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,0.040368,-0.15984,-0.13734,1,0
3,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.041938,-0.16632,-0.1372,1,0
3,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,0.056456,-0.16796,-0.15992,1,0
3,GO VACUOLAR ACIDIFICATION,0.052482,-0.17019,-0.093832,1,0
3,GO INDUCTION OF POSITIVE CHEMOTAXIS,0.046961,-0.17055,-0.1398,1,0
3,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,0.027226,-0.17101,-0.18837,1,0
3,GO ETHER METABOLIC PROCESS,0.015104,-0.17155,-0.13783,1,0
3,GO UNSATURATED FATTY ACID METABOLIC PROCESS,0.033245,-0.17289,-0.13329,1,0
3,GO PHOSPHOLIPID CATABOLIC PROCESS,0.054439,-0.17738,-0.1357,1,0
3,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.050584,-0.18071,-0.15057,1,0
3,GO B CELL APOPTOTIC PROCESS,0.023112,-0.18829,-0.15884,1,0
3,GO RESPONSE TO INCREASED OXYGEN LEVELS,0.037377,-0.18878,-0.094398,1,0
3,GO MYELOID LEUKOCYTE ACTIVATION,0.056456,-0.19045,-0.18906,1,0
3,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.038848,-0.19188,-0.18142,1,0
3,GO REGULATION OF CALCIUM ION IMPORT,0.058535,-0.19271,-0.13647,1,0
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.020391,-0.19342,-0.10038,1,0
3,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,0.02951,-0.19377,-0.14438,1,0
3,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.050584,-0.1947,-0.091737,1,0
3,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.041938,-0.19494,-0.23322,1,0
3,GO GLYCEROL ETHER METABOLIC PROCESS,0.0080134,-0.19742,-0.15497,1,0
3,GO GAP JUNCTION ASSEMBLY,0.030713,-0.19881,-0.26902,1,0
3,GO LEUKOCYTE MEDIATED IMMUNITY,0.058535,-0.19994,-0.19498,1,0
3,GO PROTEIN CONTAINING COMPLEX REMODELING,0.045233,-0.20322,-0.20265,1,0
3,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.034576,-0.20432,-0.11344,1,0
3,GO ETHER BIOSYNTHETIC PROCESS,0.021265,-0.20627,-0.19933,1,0
3,GO STEROID CATABOLIC PROCESS,0.043559,-0.20673,-0.19413,1,0
3,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.054439,-0.20831,-0.15483,1,0
3,GO RESPONSE TO BACTERIUM,0.043559,-0.20847,-0.20066,1,0
3,GO RESPONSE TO EPINEPHRINE,0.058535,-0.20861,-0.1527,1,0
3,GO POSITIVE REGULATION OF CHEMOTAXIS,0.038848,-0.20885,-0.20995,1,0
3,GO CELLULAR COPPER ION HOMEOSTASIS,0.019548,-0.20903,-0.14601,1,0
3,GO RETINAL CONE CELL DIFFERENTIATION,0.045233,-0.20919,-0.16235,1,0
3,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.030713,-0.21078,-0.21238,1,0
3,GO AMINO SUGAR CATABOLIC PROCESS,0.045233,-0.2113,-0.29404,1,0
3,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,0.030713,-0.21172,-0.21246,1,0
3,GO LYMPHOCYTE APOPTOTIC PROCESS,0.060677,-0.21178,-0.21025,1,0
3,GO LIPOPROTEIN CATABOLIC PROCESS,0.040368,-0.21189,-0.17504,1,0
3,GO PROSTANOID METABOLIC PROCESS,0.007293,-0.21384,-0.24706,1,0
3,GO REGULATION OF PHAGOCYTOSIS,0.060677,-0.21419,-0.2337,1,0
3,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,0.023112,-0.2145,-0.22206,1,0
3,GO GERMINAL CENTER FORMATION,0.048745,-0.21463,-0.31003,1,0
3,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.043559,-0.21513,-0.19192,1,0
3,GO CELL CELL RECOGNITION,0.024086,-0.21618,-0.13438,1,0
3,GO LEUKOCYTE APOPTOTIC PROCESS,0.054439,-0.21663,-0.23429,1,0
3,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.054439,-0.21812,-0.19646,1,0
3,GO IRON ION TRANSMEMBRANE TRANSPORT,0.028348,-0.21869,-0.17819,1,0
3,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.050584,-0.22184,-0.22749,1,0
3,GO ETHANOL METABOLIC PROCESS,0.030713,-0.22278,-0.25041,1,0
3,GO REGULATION OF BONE REMODELING,0.056456,-0.22412,-0.14901,1,0
3,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,0.013834,-0.22451,-0.26173,1,0
3,GO CD40 SIGNALING PATHWAY,0.030713,-0.22453,-0.27214,1,0
3,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.046961,-0.22468,-0.17113,1,0
3,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,0.020391,-0.22481,-0.24227,1,0
3,GO LIPID DIGESTION,0.054439,-0.22651,-0.22035,1,0
3,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,0.048745,-0.22727,-0.20779,1,0
3,GO ACTIVATED T CELL PROLIFERATION,0.043559,-0.22938,-0.20897,1,0
3,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.050584,-0.22967,-0.22496,1,0
3,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.02951,-0.23117,-0.27895,1,0
3,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.030713,-0.23163,-0.22401,1,0
3,GO REGULATION OF LYSOSOMAL LUMEN PH,0.0021907,-0.23176,-0.23573,1,0
3,GO RESPIRATORY BURST INVOLVED IN DEFENSE RESPONSE,0.033245,-0.2318,-0.26106,1,0
3,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.035953,-0.23299,-0.27292,1,0
3,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.056456,-0.23323,-0.1633,1,0
3,GO LEUKOCYTE MIGRATION,0.050584,-0.23324,-0.21276,1,0
3,GO REGULATION OF B CELL APOPTOTIC PROCESS,0.018736,-0.23389,-0.20433,1,0
3,GO BONE RESORPTION,0.037377,-0.23493,-0.18262,1,0
3,GO ICOSANOID METABOLIC PROCESS,0.014457,-0.23504,-0.19334,1,0
3,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,0.018736,-0.23572,-0.21348,1,0
3,GO PLASMA MEMBRANE FUSION,0.012106,-0.23623,-0.25737,1,0
3,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.0052065,-0.23711,-0.20205,1,0
3,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.006955,-0.23753,-0.18414,1,0
3,GO VITAMIN TRANSPORT,0.017954,-0.23759,-0.13452,1,0
3,GO GALACTOSE METABOLIC PROCESS,0.0080134,-0.23857,-0.20215,1,0
3,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.011063,-0.24013,-0.21161,1,0
3,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.052482,-0.2404,-0.22759,1,0
3,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.037377,-0.24106,-0.19481,1,0
3,GO ACUTE INFLAMMATORY RESPONSE,0.035953,-0.24189,-0.21798,1,0
3,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.025096,-0.24216,-0.28334,1,0
3,GO CELL CHEMOTAXIS,0.043559,-0.24234,-0.22095,1,0
3,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,0.013235,-0.2427,-0.20099,1,0
3,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.02951,-0.24305,-0.20437,1,0
3,GO REGULATION OF HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.025096,-0.24315,-0.35596,1,0
3,GO ACUTE PHASE RESPONSE,0.031957,-0.24361,-0.2092,1,0
3,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,0.027226,-0.24463,-0.19276,1,0
3,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.046961,-0.24464,-0.21967,1,0
3,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,0.0057394,-0.2453,-0.1746,1,0
3,GO INTERLEUKIN 8 PRODUCTION,0.038848,-0.24564,-0.24339,1,0
3,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.037377,-0.24566,-0.26949,1,0
3,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.052482,-0.24781,-0.2721,1,0
3,GO TONIC SMOOTH MUSCLE CONTRACTION,0.046961,-0.24958,-0.19087,1,0
3,GO GLYCOLIPID CATABOLIC PROCESS,0.058535,-0.25253,-0.18656,1,0
3,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.021265,-0.25321,-0.22536,1,0
3,GO VITAMIN TRANSMEMBRANE TRANSPORT,0.015776,-0.2535,-0.20121,1,0
3,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,0.0066311,-0.25429,-0.25271,1,0
3,GO NEGATIVE REGULATION OF PROTEIN MATURATION,0.017954,-0.25727,-0.2355,1,0
3,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.060677,-0.25728,-0.17042,1,0
3,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.033245,-0.25793,-0.25957,1,0
3,GO FUSION OF SPERM TO EGG PLASMA MEMBRANE INVOLVED IN SINGLE FERTILIZATION,0.014457,-0.25916,-0.26202,1,0
3,GO REGULATION OF T CELL APOPTOTIC PROCESS,0.038848,-0.25939,-0.31506,1,0
3,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,0.021265,-0.26077,-0.26847,1,0
3,GO NEGATIVE REGULATION OF TISSUE REMODELING,0.050584,-0.26108,-0.25278,1,0
3,GO ARACHIDONIC ACID METABOLIC PROCESS,0.0096484,-0.26114,-0.2168,1,0
3,GO ACTIN FILAMENT SEVERING,0.02951,-0.26123,-0.20521,1,0
3,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.058535,-0.26169,-0.23465,1,0
3,GO PROTEIN TRIMERIZATION,0.031957,-0.26238,-0.21183,1,0
3,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.0018673,-0.26298,-0.27563,1,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.048745,-0.26318,-0.25112,1,0
3,GO EMBRYO IMPLANTATION,0.037377,-0.26324,-0.16634,1,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.041938,-0.26397,-0.29638,1,0
3,GO REGULATION OF LEUKOCYTE MIGRATION,0.028348,-0.26454,-0.25495,1,0
3,GO POSITIVE REGULATION OF COAGULATION,0.020391,-0.26573,-0.22316,1,0
3,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.041938,-0.26705,-0.28068,1,0
3,GO REGULATION OF T CELL CYTOKINE PRODUCTION,0.043559,-0.26859,-0.30803,1,0
3,GO T CELL PROLIFERATION,0.058535,-0.26991,-0.24543,1,0
3,GO RESPIRATORY BURST,0.021265,-0.27,-0.31673,1,0
3,GO VITAMIN BIOSYNTHETIC PROCESS,0.022172,-0.27153,-0.21922,1,0
3,GO NEGATIVE REGULATION OF B CELL ACTIVATION,0.033245,-0.27276,-0.29806,1,0
3,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.02951,-0.27292,-0.24594,1,0
3,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.041938,-0.27319,-0.2674,1,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.040368,-0.27403,-0.27748,1,0
3,GO NEUROINFLAMMATORY RESPONSE,0.060677,-0.27438,-0.25813,1,0
3,GO ZYMOGEN INHIBITION,0.043559,-0.27448,-0.23741,1,0
3,GO PLASMINOGEN ACTIVATION,0.0076456,-0.27465,-0.30966,1,0
3,GO CHEMOKINE PRODUCTION,0.037377,-0.27482,-0.22527,1,0
3,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.018736,-0.27582,-0.23033,1,0
3,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,0.030713,-0.27623,-0.23939,1,0
3,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.045233,-0.27697,-0.2845,1,0
3,GO POSITIVE REGULATION OF PHAGOCYTOSIS,0.052482,-0.27716,-0.26846,1,0
3,GO INTERLEUKIN 2 PRODUCTION,0.040368,-0.27756,-0.28257,1,0
3,GO REGULATION OF T CELL MEDIATED IMMUNITY,0.024086,-0.27818,-0.31131,1,0
3,GO IMMUNOGLOBULIN SECRETION,0.037377,-0.27878,-0.264,1,0
3,GO NEGATIVE REGULATION OF BONE REMODELING,0.060677,-0.27928,-0.2764,1,0
3,GO OLIGOSACCHARIDE CATABOLIC PROCESS,0.020391,-0.27946,-0.21725,1,0
3,GO PROSTANOID BIOSYNTHETIC PROCESS,0.0047188,-0.28026,-0.34968,1,0
3,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.018736,-0.28197,-0.28675,1,0
3,GO ZYMOGEN ACTIVATION,0.017954,-0.28248,-0.22806,1,0
3,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,0.056456,-0.28285,-0.26645,1,0
3,GO EPOXYGENASE P450 PATHWAY,0.023112,-0.28357,-0.2337,1,0
3,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,0.024086,-0.28442,-0.19935,1,0
3,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.050584,-0.2848,-0.26394,1,0
3,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.050584,-0.28583,-0.25602,1,0
3,GO INTERLEUKIN 1 PRODUCTION,0.026142,-0.28615,-0.28245,1,0
3,GO T CELL MEDIATED IMMUNITY,0.024086,-0.28668,-0.30191,1,0
3,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,0.013834,-0.28675,-0.26388,1,0
3,GO REGULATION OF B CELL PROLIFERATION,0.037377,-0.28731,-0.31309,1,0
3,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,0.060677,-0.28773,-0.26495,1,0
3,GO INTERLEUKIN 1 BETA PRODUCTION,0.048745,-0.28876,-0.27607,1,0
3,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,0.050584,-0.28922,-0.1803,1,0
3,GO LEUKOCYTE CHEMOTAXIS,0.024086,-0.28942,-0.27634,1,0
3,GO MYELOID LEUKOCYTE MIGRATION,0.012106,-0.29062,-0.29006,1,0
3,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,0.015104,-0.29188,-0.34219,1,0
3,GO SEQUESTERING OF METAL ION,0.0034935,-0.29194,-0.27948,1,0
3,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,0.052482,-0.29202,-0.25552,1,0
3,GO REGULATION OF NEUTROPHIL MIGRATION,0.028348,-0.29215,-0.32597,1,0
3,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,0.050584,-0.29248,-0.35009,1,0
3,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.043559,-0.29253,-0.26624,1,0
3,GO T HELPER 1 CELL DIFFERENTIATION,0.054439,-0.29499,-0.30593,1,0
3,GO REGULATION OF COAGULATION,0.01266,-0.29526,-0.26139,1,0
3,GO MACROPHAGE MIGRATION,0.021265,-0.29564,-0.282,1,0
3,GO GLIAL CELL ACTIVATION,0.052482,-0.2957,-0.27926,1,0
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,0.018736,-0.2957,-0.23227,1,0
3,GO VITAMIN D BIOSYNTHETIC PROCESS,0.054439,-0.2965,-0.27341,1,0
3,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,0.015104,-0.29804,-0.29541,1,0
3,GO REGULATION OF T CELL CHEMOTAXIS,0.031957,-0.29868,-0.36162,1,0
3,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.0054671,-0.29985,-0.34263,1,0
3,GO ICOSANOID BIOSYNTHETIC PROCESS,0.0052065,-0.30038,-0.29536,1,0
3,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.031957,-0.30076,-0.20566,1,0
3,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.033245,-0.30079,-0.259,1,0
3,GO PLATELET DEGRANULATION,0.030713,-0.30089,-0.20626,1,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.017954,-0.30092,-0.29964,1,0
3,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.035953,-0.30093,-0.30328,1,0
3,GO RESPONSE TO INTERFERON GAMMA,0.043559,-0.30093,-0.30149,1,0
3,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,0.015104,-0.30357,-0.28598,1,0
3,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.023112,-0.30437,-0.27046,1,0
3,GO CELL KILLING,0.020391,-0.30443,-0.29117,1,0
3,GO KILLING OF CELLS OF OTHER ORGANISM,0.012106,-0.30502,-0.21846,1,0
3,GO B CELL PROLIFERATION,0.054439,-0.30535,-0.29283,1,0
3,GO REGULATION OF CELLULAR EXTRAVASATION,0.030713,-0.3058,-0.26095,1,0
3,GO LEUKOTRIENE METABOLIC PROCESS,0.027226,-0.30608,-0.21791,1,0
3,GO POSITIVE REGULATION OF CELL KILLING,0.060677,-0.30643,-0.28786,1,0
3,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,0.01266,-0.30655,-0.31701,1,0
3,GO LEUKOCYTE MEDIATED CYTOTOXICITY,0.043559,-0.30816,-0.29373,1,0
3,GO ADAPTIVE IMMUNE RESPONSE,0.060677,-0.30904,-0.29087,1,0
3,GO SUPEROXIDE ANION GENERATION,0.050584,-0.30963,-0.23569,1,0
3,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.021265,-0.31079,-0.25853,1,0
3,GO INTEGRIN ACTIVATION,0.033245,-0.31268,-0.28564,1,0
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.015104,-0.31311,-0.23605,1,0
3,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,0.027226,-0.31335,-0.26687,1,0
3,GO VITAMIN D METABOLIC PROCESS,0.034576,-0.31355,-0.24237,1,0
3,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.015776,-0.31382,-0.30577,1,0
3,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.056456,-0.31436,-0.2943,1,0
3,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,0.025096,-0.31454,-0.29019,1,0
3,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.054439,-0.3165,-0.3083,1,0
3,GO REGULATION OF PLASMINOGEN ACTIVATION,0.007293,-0.31695,-0.34832,1,0
3,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.052482,-0.31794,-0.32953,1,0
3,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.037377,-0.31804,-0.28332,1,0
3,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.037377,-0.3181,-0.33624,1,0
3,GO MACROPHAGE CHEMOTAXIS,0.015776,-0.31866,-0.27917,1,0
3,GO B CELL MEDIATED IMMUNITY,0.050584,-0.31981,-0.27009,1,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.034576,-0.31982,-0.28469,1,0
3,GO ANTIBACTERIAL HUMORAL RESPONSE,0.0172,-0.32081,-0.32138,1,0
3,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,0.02951,-0.32141,-0.27902,1,0
3,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.046961,-0.32413,-0.32862,1,0
3,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.026142,-0.32486,-0.26723,1,0
3,GO REGULATION OF LEUKOCYTE PROLIFERATION,0.033245,-0.32488,-0.28398,1,0
3,GO INTERLEUKIN 17 PRODUCTION,0.0052065,-0.325,-0.37512,1,0
3,GO REGULATION OF CELL KILLING,0.037377,-0.32618,-0.29751,1,0
3,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.0017696,-0.3268,-0.29515,1,0
3,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.046961,-0.32771,-0.26691,1,0
3,GO RESPONSE TO FUNGUS,0.0083971,-0.32812,-0.2816,1,0
3,GO REGULATION OF LYMPHOCYTE MIGRATION,0.037377,-0.32824,-0.27814,1,0
3,GO NEUTROPHIL MIGRATION,0.015776,-0.3283,-0.34287,1,0
3,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.050584,-0.32966,-0.28643,1,0
3,GO REGULATION OF BONE DEVELOPMENT,0.018736,-0.33039,-0.26584,1,0
3,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.033245,-0.33155,-0.29341,1,0
3,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.041938,-0.33215,-0.40138,1,0
3,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.010101,-0.33244,-0.33523,1,0
3,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.013235,-0.33245,-0.25781,1,0
3,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,0.048745,-0.33256,-0.25781,1,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.030713,-0.33523,-0.32367,1,0
3,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.050584,-0.33613,-0.27437,1,0
3,GO RESPONSE TO PROTOZOAN,0.052482,-0.3363,-0.32014,1,0
3,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.02951,-0.33668,-0.30501,1,0
3,GO REGULATION OF MACROPHAGE MIGRATION,0.016475,-0.33676,-0.2966,1,0
3,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,0.022172,-0.33747,-0.30144,1,0
3,GO INTERFERON GAMMA PRODUCTION,0.037377,-0.33822,-0.29882,1,0
3,GO LYMPHOCYTE MIGRATION,0.027226,-0.33838,-0.33169,1,0
3,GO INFLAMMATORY RESPONSE TO WOUNDING,0.014457,-0.33838,-0.35072,1,0
3,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.016475,-0.33851,-0.30899,1,0
3,GO DEFENSE RESPONSE TO BACTERIUM,0.0092139,-0.33932,-0.27253,1,0
3,GO FIBRINOLYSIS,0.013834,-0.33935,-0.31643,1,0
3,GO PROTEIN ACTIVATION CASCADE,0.033245,-0.33937,-0.24726,1,0
3,GO REGULATION OF T CELL MIGRATION,0.016475,-0.33947,-0.32401,1,0
3,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.031957,-0.33982,-0.35627,1,0
3,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.037377,-0.34002,-0.3246,1,0
3,GO NEGATIVE REGULATION OF CELL KILLING,0.031957,-0.3425,-0.39181,1,0
3,GO GRANULOCYTE CHEMOTAXIS,0.008797,-0.34255,-0.35284,1,0
3,GO DECIDUALIZATION,0.041938,-0.34283,-0.21106,1,0
3,GO GRANULOCYTE MIGRATION,0.010101,-0.34306,-0.34089,1,0
3,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.033245,-0.34593,-0.30528,1,0
3,GO TYPE 2 IMMUNE RESPONSE,0.027226,-0.34635,-0.34656,1,0
3,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.034576,-0.34663,-0.28761,1,0
3,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,0.016475,-0.3467,-0.23733,1,0
3,GO RESPONSE TO CHEMOKINE,0.022172,-0.34745,-0.34179,1,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.056456,-0.34768,-0.26047,1,0
3,GO T CELL CHEMOTAXIS,0.033245,-0.34785,-0.38364,1,0
3,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,0.018736,-0.34873,-0.3346,1,0
3,GO RESPONSE TO INTERFERON ALPHA,0.028348,-0.35001,-0.29265,1,0
3,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,0.033245,-0.35015,-0.37185,1,0
3,GO ANTIMICROBIAL HUMORAL RESPONSE,0.013235,-0.35017,-0.26424,1,0
3,GO CELL ADHESION MEDIATED BY INTEGRIN,0.031957,-0.35052,-0.28168,1,0
3,GO RESPONSE TO INTERFERON BETA,0.023112,-0.35061,-0.31754,1,0
3,GO PEPTIDE CROSS LINKING,0.0052065,-0.35229,-0.35333,1,0
3,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.050584,-0.35383,-0.32016,1,0
3,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.046961,-0.3542,-0.28012,1,0
3,GO REGULATION OF MYOBLAST FUSION,0.035953,-0.35446,-0.30645,1,0
3,GO NEGATIVE REGULATION OF COAGULATION,0.013834,-0.35461,-0.27782,1,0
3,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,0.022172,-0.35652,-0.35664,1,0
3,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.037377,-0.35688,-0.36616,1,0
3,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,0.025096,-0.35689,-0.27904,1,0
3,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.02951,-0.35725,-0.30533,1,0
3,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.019548,-0.35865,-0.35226,1,0
3,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,0.02951,-0.35887,-0.32405,1,0
3,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.008797,-0.35952,-0.28983,1,0
3,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,0.01266,-0.35969,-0.36214,1,0
3,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.013834,-0.36132,-0.3245,1,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.0092139,-0.36158,-0.31925,1,0
3,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.054439,-0.36229,-0.37752,1,0
3,GO B CELL RECEPTOR SIGNALING PATHWAY,0.052482,-0.36233,-0.31626,1,0
3,GO NEUTROPHIL CHEMOTAXIS,0.01266,-0.36261,-0.36489,1,0
3,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,0.027226,-0.36271,-0.31713,1,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.048745,-0.36637,-0.32798,1,0
3,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.027226,-0.36651,-0.37299,1,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.043559,-0.36769,-0.36018,1,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.046961,-0.36789,-0.40399,1,0
3,GO T CELL MIGRATION,0.021265,-0.36811,-0.33959,1,0
3,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.02951,-0.36915,-0.27978,1,0
3,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.026142,-0.36938,-0.28728,1,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.0172,-0.36939,-0.37358,1,0
3,GO POSITIVE REGULATION OF T CELL MIGRATION,0.01266,-0.3706,-0.38194,1,0
3,GO COLLAGEN CATABOLIC PROCESS,0.054439,-0.37083,-0.21572,1,0
3,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,0.02951,-0.37098,-0.354,1,0
3,GO DENDRITIC CELL MIGRATION,0.023112,-0.37229,-0.4027,1,0
3,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.040368,-0.37576,-0.30859,1,0
3,GO CELL JUNCTION DISASSEMBLY,0.028348,-0.37621,-0.32766,1,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.013834,-0.37769,-0.3548,1,0
3,GO HUMORAL IMMUNE RESPONSE,0.0096484,-0.3794,-0.3197,1,0
3,GO REGULATION OF MONONUCLEAR CELL MIGRATION,0.010572,-0.38099,-0.33555,1,0
3,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.050584,-0.38283,-0.31221,1,0
3,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.030713,-0.38313,-0.24063,1,0
3,GO REGULATION OF FIBRINOLYSIS,0.0063209,-0.3835,-0.34277,1,0
3,GO POSITIVE REGULATION OF T CELL PROLIFERATION,0.015776,-0.38406,-0.37253,1,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,0.021265,-0.38698,-0.28033,1,0
3,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.013834,-0.38757,-0.40137,1,0
3,GO CHEMOKINE BIOSYNTHETIC PROCESS,0.014457,-0.38977,-0.37785,1,0
3,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.026142,-0.39014,-0.35721,1,0
3,GO APOPTOTIC CELL CLEARANCE,0.030713,-0.40007,-0.29552,1,0
3,GO INTERLEUKIN 12 PRODUCTION,0.043559,-0.4001,-0.33652,1,0
3,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.010101,-0.40326,-0.42547,1,0
3,GO T CELL MEDIATED CYTOTOXICITY,0.011063,-0.40535,-0.42249,1,0
3,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,0.025096,-0.40589,-0.35673,1,0
3,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,0.015776,-0.40764,-0.36167,1,0
3,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,0.046961,-0.40786,-0.3484,1,0
3,GO INTERLEUKIN 10 PRODUCTION,0.011574,-0.40807,-0.39595,1,0
3,GO DENDRITIC CELL DIFFERENTIATION,0.020391,-0.40902,-0.40083,1,0
3,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,0.030713,-0.41171,-0.35564,1,0
3,GO LIPOXYGENASE PATHWAY,0.0020776,-0.41284,-0.38428,1,0
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,0.0038653,-0.4146,-0.38472,1,0
3,GO T HELPER 1 TYPE IMMUNE RESPONSE,0.014457,-0.4154,-0.40785,1,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.0060238,-0.41758,-0.35187,1,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,0.015104,-0.41994,-0.40147,1,0
3,GO ETHANOL OXIDATION,0.0038653,-0.42087,-0.41409,1,0
3,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,0.012106,-0.42144,-0.41827,1,0
3,GO REGULATION OF PLATELET ACTIVATION,0.0076456,-0.42529,-0.35855,1,0
3,GO REGULATION OF MEMBRANE INVAGINATION,0.0172,-0.42614,-0.34066,1,0
3,GO MONONUCLEAR CELL MIGRATION,0.0044907,-0.42631,-0.42205,1,0
3,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,0.0060238,-0.42738,-0.39369,1,0
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,0.0047188,-0.42911,-0.39731,1,0
3,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,0.018736,-0.43025,-0.42405,1,0
3,GO CELLULAR DEFENSE RESPONSE,0.025096,-0.43046,-0.37844,1,0
3,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.020391,-0.4345,-0.40185,1,0
3,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.0096484,-0.43688,-0.31275,1,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.010572,-0.43957,-0.40695,1,0
3,GO DENDRITIC CELL CHEMOTAXIS,0.0172,-0.44158,-0.4363,1,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.015776,-0.44747,-0.48644,1,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,0.015104,-0.45219,-0.3903,1,0
3,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.007293,-0.45254,-0.44598,1,0
3,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.011574,-0.45281,-0.37109,1,0
3,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.018736,-0.45557,-0.41395,1,0
3,GO REGULATION OF ANGIOTENSIN LEVELS IN BLOOD,0.0036751,-0.45837,-0.43267,1,0
3,GO KERATAN SULFATE CATABOLIC PROCESS,0.015104,-0.463,-0.35825,1,0
3,GO RESPONSE TO LIPOTEICHOIC ACID,0.015104,-0.4653,-0.36378,1,0
3,GO HYPERSENSITIVITY,0.0066311,-0.46998,-0.5323,1,0
3,GO CHEMOKINE SECRETION,0.0049572,-0.47743,-0.44485,1,0
3,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.040368,-0.47964,-0.39248,1,0
3,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,0.017954,-0.4842,-0.36857,1,0
3,GO MACROPHAGE PROLIFERATION,0.02951,-0.48439,-0.35617,1,0
3,GO ADHESION OF SYMBIONT TO HOST,0.019548,-0.49288,-0.4006,1,0
3,GO REGULATION OF HUMORAL IMMUNE RESPONSE,0.0054671,-0.4939,-0.45524,1,0
3,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,0.033245,-0.49542,-0.44965,1,0
3,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.011574,-0.49625,-0.4552,1,0
3,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.043559,-0.49633,-0.34564,1,0
3,GO TOLERANCE INDUCTION,0.027226,-0.49787,-0.47572,1,0
3,GO POSITIVE REGULATION OF CHEMOKINE SECRETION,0.0038653,-0.49815,-0.49086,1,0
3,GO INTERLEUKIN 4 PRODUCTION,0.0080134,-0.50196,-0.40572,1,0
3,GO INTERLEUKIN 5 PRODUCTION,0.0034935,-0.50538,-0.41976,1,0
3,GO LYMPHOCYTE CHEMOTAXIS,0.013235,-0.50575,-0.42266,1,0
3,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.02951,-0.50584,-0.44695,1,0
3,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.016475,-0.51669,-0.5276,1,0
3,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,0.0057394,-0.52414,-0.51954,1,0
3,GO MONOCYTE CHEMOTAXIS,0.0027019,-0.53439,-0.50638,1,0
3,GO COMPLEMENT ACTIVATION,0.0060238,-0.53561,-0.44032,1,0
3,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.011063,-0.53646,-0.43153,1,0
3,GO NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.0063209,-0.53755,-0.44022,1,0
3,GO INTERLEUKIN 13 PRODUCTION,0.0028457,-0.54071,-0.48592,1,0
3,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.0076456,-0.54273,-0.4326,1,0
3,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.013834,-0.54366,-0.52615,1,0
3,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,0.00332,-0.54444,-0.45453,1,0
3,GO REGULATION OF TOLERANCE INDUCTION,0.038848,-0.54617,-0.45715,1,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.0172,-0.54689,-0.48229,1,0
3,GO MUCUS SECRETION,0.0014241,-0.55501,-0.39499,1,0
3,GO CYTOLYSIS,0.023112,-0.55532,-0.43479,1,0
3,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.0066311,-0.56105,-0.43215,1,0
3,GO CYCLOOXYGENASE PATHWAY,0.0047188,-0.56221,-0.45377,1,0
3,GO RESPONSE TO PEPTIDOGLYCAN,0.00076864,-0.5631,-0.52519,1,0
3,GO COMPLEMENT RECEPTOR MEDIATED SIGNALING PATHWAY,0.008797,-0.57283,-0.49057,1,0
3,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.017954,-0.59255,-0.51884,1,0
3,GO COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY,0.0060238,-0.59363,-0.59602,1,0
3,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.0054671,-0.59807,-0.56121,1,0
3,GO CHRONIC INFLAMMATORY RESPONSE,0.011063,-0.60624,-0.52275,1,0
3,GO REGULATION OF NEUTROPHIL ACTIVATION,0.017954,-0.62363,-0.43207,1,0
3,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,0.0060238,-0.64005,-0.53244,1,0
3,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.0038653,-0.66633,-0.58337,1,0
3,GO DENDRITIC CELL APOPTOTIC PROCESS,0.0015882,-0.70106,-0.72618,1,0
3,GO SYNAPSE PRUNING,0.0038653,-0.72429,-0.66724,1,0
3,GO DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION,0.0066311,-0.74316,-0.73651,1,0
3,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,0.0060238,-0.76982,-0.72468,1,0
3,GO T CELL ACTIVATION VIA T CELL RECEPTOR CONTACT WITH ANTIGEN BOUND TO MHC MOLECULE ON ANTIGEN PRESENTING CELL,0.023112,-0.79417,-0.63729,1,0
3,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.098083,0.43079,0.25329,0,1
3,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.08588,0.27614,0.18383,0,1
3,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,0.080256,0.27278,0.24234,0,1
3,GO CRANIAL NERVE STRUCTURAL ORGANIZATION,0.08881,0.25188,0.25762,0,1
3,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,0.065157,0.24783,0.15418,0,1
3,GO ACTIVATION OF MAPKKK ACTIVITY,0.062884,0.22017,0.20025,0,1
3,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.17091,0.21923,0.13717,0,1
3,GO SKELETAL MUSCLE ADAPTATION,0.098083,0.21592,0.14926,0,1
3,GO MIDGUT DEVELOPMENT,0.08588,0.20908,0.16665,0,1
3,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,0.065157,0.19804,0.22153,0,1
3,GO HISTONE H2B UBIQUITINATION,0.08303,0.19193,0.14282,0,1
3,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.077559,0.18894,0.16491,0,1
3,GO SKELETAL MUSCLE CELL PROLIFERATION,0.30724,0.18298,0.095557,0,1
3,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.15655,0.17092,0.13899,0,1
3,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.15197,0.16039,0.10863,0,1
3,GO CYSTEINE METABOLIC PROCESS,0.12273,0.15473,0.17031,0,1
3,GO SERINE PHOSPHORYLATION OF STAT PROTEIN,0.1306,0.15378,0.15899,0,1
3,GO MITOCHONDRIAL RNA PROCESSING,0.13467,0.15203,0.1048,0,1
3,GO PORE COMPLEX ASSEMBLY,0.14312,0.14728,0.098453,0,1
3,GO RIBONUCLEOTIDE CATABOLIC PROCESS,0.094909,0.14656,0.098498,0,1
3,GO AMMONIUM ION METABOLIC PROCESS,0.27126,0.14568,0.13799,0,1
3,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.067497,0.14505,0.15167,0,1
3,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.1306,0.14097,0.11135,0,1
3,GO THIOESTER BIOSYNTHETIC PROCESS,0.11894,0.14065,0.095598,0,1
3,GO REGULATION OF SULFUR METABOLIC PROCESS,0.18624,0.13651,0.23637,0,1
3,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.11163,0.13615,0.16079,0,1
3,GO SULFUR AMINO ACID METABOLIC PROCESS,0.091819,0.13533,0.13204,0,1
3,GO CIRCADIAN SLEEP WAKE CYCLE,0.15655,0.12879,0.10284,0,1
3,GO PROSTATE GLAND GROWTH,0.11163,0.12826,0.12481,0,1
3,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.091819,0.12672,0.13954,0,1
3,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.11894,0.12579,0.097383,0,1
3,GO REGULATION OF RECEPTOR RECYCLING,0.43329,0.12303,0.085964,0,1
3,GO RRNA MODIFICATION,0.21989,0.1216,0.070877,0,1
3,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.074935,0.1213,0.11364,0,1
3,GO ENAMEL MINERALIZATION,0.1306,0.12005,0.14964,0,1
3,GO IMP METABOLIC PROCESS,0.69814,0.11923,0.042258,0,1
3,GO ACETYL COA METABOLIC PROCESS,0.16123,0.11922,0.07878,0,1
3,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.072385,0.11581,0.16478,0,1
3,GO BILE ACID METABOLIC PROCESS,0.37964,0.11514,0.066314,0,1
3,GO NCRNA CATABOLIC PROCESS,0.10468,0.11445,0.10855,0,1
3,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.1306,0.11428,0.10477,0,1
3,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.077559,0.11311,0.11532,0,1
3,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,0.1306,0.11286,0.1072,0,1
3,GO PYRUVATE METABOLIC PROCESS,0.065157,0.11197,0.13363,0,1
3,GO SNORNA 3 END PROCESSING,0.12273,0.11184,0.094591,0,1
3,GO PROTEIN IMPORT,0.074935,0.11153,0.10899,0,1
3,GO NUCLEOTIDE TRANSPORT,0.26442,0.11094,0.09109,0,1
3,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.08588,0.10706,0.21056,0,1
3,GO REGULATION OF DEACETYLASE ACTIVITY,0.08881,0.1069,0.17639,0,1
3,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.08303,0.10635,0.11241,0,1
3,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.21989,0.10403,0.088119,0,1
3,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.08303,0.10384,0.12654,0,1
3,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.1306,0.10053,0.10871,0,1
3,GO SNORNA METABOLIC PROCESS,0.08588,0.099066,0.086418,0,1
3,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.094909,0.097045,0.088476,0,1
3,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,0.30724,0.096679,0.092687,0,1
3,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.18102,0.096582,0.066462,0,1
3,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.12662,0.095788,0.10104,0,1
3,GO RRNA METHYLATION,0.3148,0.095714,0.058438,0,1
3,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,0.15197,0.095608,0.088524,0,1
3,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.13885,0.093287,0.069612,0,1
3,GO MATURATION OF LSU RRNA,0.098083,0.092975,0.086075,0,1
3,GO UBIQUINONE METABOLIC PROCESS,0.13885,0.092063,0.065828,0,1
3,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,0.19156,0.084074,0.051015,0,1
3,GO CLATHRIN COAT ASSEMBLY,0.12273,0.079936,0.12717,0,1
3,GO REGULATION OF PROTON TRANSPORT,0.12662,0.078421,0.10116,0,1
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.62923,0.077343,0.039106,0,1
3,GO IMP BIOSYNTHETIC PROCESS,0.79394,0.07531,0.014074,0,1
3,GO FATTY ACID HOMEOSTASIS,0.197,0.074956,0.12382,0,1
3,GO CYTOPLASMIC TRANSLATION,0.17591,0.073716,0.060071,0,1
3,GO REGULATION OF ERAD PATHWAY,0.42405,0.068621,0.059158,0,1
3,GO RESPONSE TO ETHER,0.42405,0.068517,0.089826,0,1
3,GO ALDITOL METABOLIC PROCESS,0.52145,0.067796,0.075233,0,1
3,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.091819,0.066937,0.13977,0,1
3,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.30724,0.063378,0.089266,0,1
3,GO REGULATION OF MIRNA METABOLIC PROCESS,0.56341,0.060747,0.070674,0,1
3,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.20822,0.058425,0.049425,0,1
3,GO PROTEIN TARGETING TO MEMBRANE,0.13885,0.056292,0.039084,0,1
3,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.30724,0.045162,0.087354,0,1
3,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,0.10134,0.043935,0.063444,0,1
3,GO TRANSLATIONAL INITIATION,0.43329,0.041811,0.040222,0,1
3,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.93062,0.026644,0.014744,0,1
3,GO MAINTENANCE OF SYNAPSE STRUCTURE,0.0012758,0.50596,0.48348,0,0
3,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.0016767,0.43671,0.37007,0,0
3,GO LIMB BUD FORMATION,0.0047188,0.38874,0.37081,0,0
3,GO HISTONE H3 K27 METHYLATION,0.0019699,0.38474,0.35711,0,0
3,GO REGULATION OF CENTRIOLE REPLICATION,0.00064645,0.3787,0.34472,0,0
3,GO MALE SEX DETERMINATION,0.0092139,0.37015,0.32618,0,0
3,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,0.012106,0.36522,0.26947,0,0
3,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.0083971,0.35435,0.33969,0,0
3,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,0.023112,0.34374,0.30776,0,0
3,GO NOSE DEVELOPMENT,0.0083971,0.34204,0.34821,0,0
3,GO MATING BEHAVIOR,0.0010798,0.33657,0.32139,0,0
3,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,0.0049572,0.33432,0.27338,0,0
3,GO FORELIMB MORPHOGENESIS,0.0013481,0.3238,0.3541,0,0
3,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,0.0054671,0.32094,0.27904,0,0
3,GO POSITIVE REGULATION OF BEHAVIOR,0.0038653,0.31418,0.28178,0,0
3,GO INNERVATION,0.0076456,0.31359,0.41355,0,0
3,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,0.0096484,0.30711,0.29902,0,0
3,GO SUCKLING BEHAVIOR,0.0057394,0.29927,0.32379,0,0
3,GO CENTROSOME DUPLICATION,0.00068502,0.2952,0.3033,0,0
3,GO GAMMA AMINOBUTYRIC ACID SECRETION,0.065157,0.29186,0.20912,0,0
3,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,0.0038653,0.29185,0.30898,0,0
3,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.0031545,0.29129,0.31073,0,0
3,GO NOREPINEPHRINE SECRETION,0.017954,0.2906,0.25299,0,0
3,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,0.0017696,0.29011,0.25367,0,0
3,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,0.00081392,0.28938,0.28585,0,0
3,GO MITOTIC CHROMOSOME CONDENSATION,0.00057531,0.28385,0.43004,0,0
3,GO NERVE DEVELOPMENT,0.0047188,0.28342,0.32431,0,0
3,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,0.00060992,0.27756,0.31825,0,0
3,GO DNA STRAND ELONGATION,0.0023095,0.27708,0.26874,0,0
3,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,0.0063209,0.27489,0.25737,0,0
3,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,0.008797,0.27016,0.30305,0,0
3,GO PROTEIN LOCALIZATION TO CYTOSKELETON,0.00048214,0.26767,0.29742,0,0
3,GO DOSAGE COMPENSATION,0.0024341,0.26741,0.30907,0,0
3,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,0.041938,0.26577,0.22711,0,0
3,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,0.00021879,0.26467,0.31263,0,0
3,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,0.0028457,0.26398,0.26339,0,0
3,GO MAINTENANCE OF ORGANELLE LOCATION,0.0021907,0.26292,0.32979,0,0
3,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,0.17091,0.26014,0.25869,0,0
3,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.0042727,0.25829,0.25468,0,0
3,GO URETER DEVELOPMENT,0.065157,0.25533,0.35794,0,0
3,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,0.0028457,0.25509,0.23757,0,0
3,GO OTIC VESICLE DEVELOPMENT,0.024086,0.25471,0.24323,0,0
3,GO EMBRYONIC CAMERA TYPE EYE FORMATION,0.025096,0.25259,0.25361,0,0
3,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,0.0023095,0.25252,0.32696,0,0
3,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.026142,0.25238,0.25337,0,0
3,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.0024341,0.25176,0.24774,0,0
3,GO PENILE ERECTION,0.067497,0.25094,0.19518,0,0
3,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,0.0023095,0.24907,0.27442,0,0
3,GO DNA REPLICATION CHECKPOINT,0.0019699,0.24906,0.32469,0,0
3,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,0.021265,0.24858,0.23324,0,0
3,GO MAGNESIUM ION HOMEOSTASIS,0.0092139,0.24838,0.32021,0,0
3,GO REGULATION OF MRNA PROCESSING,0.0011418,0.24813,0.25459,0,0
3,GO MITOTIC SPINDLE ORGANIZATION,0.00042807,0.24788,0.29662,0,0
3,GO HISTONE H2A MONOUBIQUITINATION,0.0013481,0.24667,0.31771,0,0
3,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.00060992,0.246,0.29479,0,0
3,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,0.046961,0.24588,0.18215,0,0
3,GO REGULATION OF CENTROSOME CYCLE,0.0015041,0.24526,0.24906,0,0
3,GO CHROMATIN SILENCING,0.00072571,0.24317,0.27557,0,0
3,GO PARENTAL BEHAVIOR,0.10134,0.24299,0.20391,0,0
3,GO REGULATION OF RECEPTOR CLUSTERING,0.25111,0.24268,0.16436,0,0
3,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.034576,0.24232,0.25601,0,0
3,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.0017696,0.24206,0.25068,0,0
3,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.0031545,0.24053,0.29566,0,0
3,GO AXONAL TRANSPORT OF MITOCHONDRION,0.0049572,0.23982,0.27648,0,0
3,GO RETINAL ROD CELL DIFFERENTIATION,0.18102,0.23964,0.12079,0,0
3,GO MYOBLAST MIGRATION,0.062884,0.23964,0.20204,0,0
3,GO REGULATION OF SPINDLE ASSEMBLY,0.0047188,0.23733,0.22601,0,0
3,GO REGULATION OF CENTROSOME DUPLICATION,0.0023095,0.23678,0.23375,0,0
3,GO PROTEIN PALMITOYLATION,0.0066311,0.2348,0.26852,0,0
3,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.0063209,0.23437,0.25825,0,0
3,GO SPINDLE ORGANIZATION,0.00064645,0.23311,0.28449,0,0
3,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,0.1475,0.23164,0.14021,0,0
3,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.080256,0.23118,0.21677,0,0
3,GO EXPLORATION BEHAVIOR,0.08588,0.22983,0.16121,0,0
3,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.00096503,0.22972,0.2777,0,0
3,GO PROTEIN HETEROTETRAMERIZATION,0.010572,0.22927,0.22604,0,0
3,GO REGULATION OF CELL PROJECTION SIZE,0.08588,0.22911,0.20343,0,0
3,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0028457,0.2284,0.28056,0,0
3,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.0063209,0.22831,0.22485,0,0
3,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.0172,0.227,0.24676,0,0
3,GO POSITIVE REGULATION OF AMINE TRANSPORT,0.011574,0.22592,0.28035,0,0
3,GO REGULATION OF GLUTAMATE SECRETION,0.11524,0.2252,0.22202,0,0
3,GO SPINDLE ASSEMBLY,0.0013481,0.22449,0.27015,0,0
3,GO MITOTIC G2 M TRANSITION CHECKPOINT,0.0083971,0.22383,0.2491,0,0
3,GO GROOMING BEHAVIOR,0.048745,0.22354,0.16746,0,0
3,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0024341,0.22204,0.28062,0,0
3,GO CHROMOSOME CONDENSATION,0.00086166,0.22004,0.34894,0,0
3,GO MEIOTIC CELL CYCLE,0.0003797,0.2194,0.27726,0,0
3,GO LEFT RIGHT AXIS SPECIFICATION,0.016475,0.21933,0.24289,0,0
3,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,0.091819,0.21775,0.20289,0,0
3,GO MEIOTIC CELL CYCLE PROCESS,0.0003797,0.21714,0.27194,0,0
3,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0040644,0.21679,0.2611,0,0
3,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,0.00096503,0.21659,0.28918,0,0
3,GO REGULATION OF SPINDLE ORGANIZATION,0.0015882,0.21622,0.2479,0,0
3,GO RETINAL GANGLION CELL AXON GUIDANCE,0.074935,0.21601,0.21153,0,0
3,GO MEMBRANE DISASSEMBLY,0.024086,0.21525,0.2187,0,0
3,GO CHROMOSOME LOCALIZATION,0.0010209,0.2134,0.23388,0,0
3,GO NEURONAL STEM CELL POPULATION MAINTENANCE,0.0054671,0.2134,0.27697,0,0
3,GO EPITHELIAL CELL CELL ADHESION,0.10811,0.21279,0.20227,0,0
3,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.0083971,0.21276,0.29683,0,0
3,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.18624,0.21218,0.18611,0,0
3,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.0047188,0.21121,0.19727,0,0
3,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,0.040368,0.21093,0.22883,0,0
3,GO CEREBRAL CORTEX DEVELOPMENT,0.0015882,0.21016,0.26623,0,0
3,GO CGMP METABOLIC PROCESS,0.14312,0.21006,0.14386,0,0
3,GO G2 DNA DAMAGE CHECKPOINT,0.0057394,0.21003,0.26619,0,0
3,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.045233,0.21001,0.23749,0,0
3,GO MITOTIC NUCLEAR DIVISION,0.00054254,0.20979,0.25512,0,0
3,GO CRANIAL NERVE DEVELOPMENT,0.014457,0.20953,0.29168,0,0
3,GO CARDIAC MYOFIBRIL ASSEMBLY,0.091819,0.20952,0.17492,0,0
3,GO MITOTIC DNA REPLICATION,0.023112,0.20867,0.22272,0,0
3,GO REGULATION OF HELICASE ACTIVITY,0.013834,0.20837,0.18403,0,0
3,GO CELL FATE SPECIFICATION,0.012106,0.20741,0.22022,0,0
3,GO REGULATION OF TUBULIN DEACETYLATION,0.022172,0.20738,0.22947,0,0
3,GO ERROR PRONE TRANSLESION SYNTHESIS,0.0011418,0.20618,0.22175,0,0
3,GO NEURON FATE COMMITMENT,0.0052065,0.20545,0.28553,0,0
3,GO ORGANELLE FISSION,0.00072571,0.20486,0.23072,0,0
3,GO MEIOTIC SPINDLE ORGANIZATION,0.0040644,0.204,0.327,0,0
3,GO REGULATION OF PROTEIN KINASE C SIGNALING,0.091819,0.20301,0.21617,0,0
3,GO PRO B CELL DIFFERENTIATION,0.0083971,0.2028,0.31095,0,0
3,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.0060238,0.20258,0.23237,0,0
3,GO HISTONE H3 DEACETYLATION,0.006955,0.20248,0.23776,0,0
3,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,0.0092139,0.20223,0.29198,0,0
3,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.0029965,0.20136,0.25313,0,0
3,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.11163,0.20057,0.15402,0,0
3,GO NEURAL CREST FORMATION,0.043559,0.20047,0.26741,0,0
3,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,0.013834,0.20038,0.24924,0,0
3,GO ASYMMETRIC CELL DIVISION,0.018736,0.20034,0.21797,0,0
3,GO REGULATION OF EPITHELIAL TUBE FORMATION,0.074935,0.19893,0.22024,0,0
3,GO INTRA S DNA DAMAGE CHECKPOINT,0.007293,0.19892,0.27028,0,0
3,GO PROTEIN LOCALIZATION TO CHROMATIN,0.00081392,0.1979,0.28076,0,0
3,GO FOREBRAIN CELL MIGRATION,0.0021907,0.19705,0.26893,0,0
3,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,0.01266,0.19656,0.20061,0,0
3,GO DORSAL VENTRAL PATTERN FORMATION,0.0027019,0.1963,0.2685,0,0
3,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,0.0011418,0.19626,0.26504,0,0
3,GO TRNA CATABOLIC PROCESS,0.016475,0.19602,0.22402,0,0
3,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.091819,0.19573,0.22057,0,0
3,GO METAPHASE PLATE CONGRESSION,0.00081392,0.19554,0.2384,0,0
3,GO ACROSOME ASSEMBLY,0.015776,0.19518,0.24457,0,0
3,GO CYTOKINESIS,0.0017696,0.19443,0.21874,0,0
3,GO HINDLIMB MORPHOGENESIS,0.040368,0.19415,0.19592,0,0
3,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.031957,0.19381,0.2026,0,0
3,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.17091,0.19228,0.1791,0,0
3,GO MITOTIC DNA INTEGRITY CHECKPOINT,0.0029965,0.19222,0.25354,0,0
3,GO CHROMOSOME ORGANIZATION,0.00091199,0.19083,0.24885,0,0
3,GO CELLULAR POTASSIUM ION HOMEOSTASIS,0.024086,0.19035,0.20145,0,0
3,GO ESTROUS CYCLE,0.10134,0.1903,0.18727,0,0
3,GO CELLULAR COMPONENT MAINTENANCE,0.028348,0.18991,0.20855,0,0
3,GO MRNA PROCESSING,0.0013481,0.18979,0.22182,0,0
3,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.0013481,0.18963,0.23979,0,0
3,GO OOCYTE MATURATION,0.0096484,0.18876,0.26379,0,0
3,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,0.17091,0.18841,0.29399,0,0
3,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,0.0025648,0.18837,0.23005,0,0
3,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,0.008797,0.18727,0.21954,0,0
3,GO NEGATIVE REGULATION OF MRNA PROCESSING,0.0024341,0.18714,0.23894,0,0
3,GO REGULATION OF HIPPO SIGNALING,0.035953,0.18666,0.23384,0,0
3,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,0.067497,0.18621,0.20008,0,0
3,GO MECHANOSENSORY BEHAVIOR,0.074935,0.18518,0.33113,0,0
3,GO CENTROSOME SEPARATION,0.0028457,0.18498,0.25431,0,0
3,GO RNA 3 END PROCESSING,0.0019699,0.18456,0.19034,0,0
3,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.060677,0.18439,0.22807,0,0
3,GO REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT,0.08588,0.18424,0.20396,0,0
3,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.067497,0.18351,0.17976,0,0
3,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.094909,0.18311,0.13835,0,0
3,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,0.00332,0.18278,0.24925,0,0
3,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.0083971,0.18277,0.21414,0,0
3,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,0.034576,0.18235,0.20412,0,0
3,GO MRNA EXPORT FROM NUCLEUS,0.0015882,0.18192,0.22931,0,0
3,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.08588,0.18177,0.17978,0,0
3,GO HISTONE H4 ACETYLATION,0.006955,0.18051,0.21695,0,0
3,GO DNA REPAIR,0.0010798,0.18031,0.23366,0,0
3,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,0.20822,0.18022,0.1379,0,0
3,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,0.041938,0.17999,0.24317,0,0
3,GO CELL DIVISION,0.0010209,0.17945,0.22074,0,0
3,GO LACTATION,0.045233,0.17933,0.18595,0,0
3,GO GANGLION DEVELOPMENT,0.16123,0.17908,0.14837,0,0
3,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.011063,0.1789,0.22329,0,0
3,GO HISTONE SERINE PHOSPHORYLATION,0.0038653,0.17878,0.20904,0,0
3,GO STABILIZATION OF MEMBRANE POTENTIAL,0.13885,0.17869,0.21616,0,0
3,GO BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS,0.197,0.17845,0.15373,0,0
3,GO REGULATION OF AXON GUIDANCE,0.074935,0.17823,0.19416,0,0
3,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,0.027226,0.17821,0.22412,0,0
3,GO NEGATIVE REGULATION OF CELL DIVISION,0.077559,0.17813,0.19163,0,0
3,GO LIMBIC SYSTEM DEVELOPMENT,0.0012758,0.17789,0.22866,0,0
3,GO DORSAL VENTRAL AXIS SPECIFICATION,0.0172,0.17767,0.24958,0,0
3,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.11524,0.17754,0.16011,0,0
3,GO MAMMARY GLAND DUCT MORPHOGENESIS,0.27126,0.17697,0.14945,0,0
3,GO NEURAL TUBE DEVELOPMENT,0.027226,0.17643,0.19509,0,0
3,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.034576,0.17608,0.15828,0,0
3,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,0.016475,0.17515,0.16642,0,0
3,GO RNA SPLICING,0.0011418,0.17463,0.21815,0,0
3,GO MITOTIC CELL CYCLE CHECKPOINT,0.0020776,0.17447,0.2563,0,0
3,GO MRNA TRANSPORT,0.0020776,0.17428,0.2094,0,0
3,GO LONG TERM MEMORY,0.080256,0.17372,0.17433,0,0
3,GO POST ANAL TAIL MORPHOGENESIS,0.0172,0.17275,0.2505,0,0
3,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,0.46168,0.17266,0.091344,0,0
3,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.0015041,0.17263,0.21908,0,0
3,GO EXIT FROM MITOSIS,0.0021907,0.17209,0.22842,0,0
3,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,0.0083971,0.17207,0.21708,0,0
3,GO SOMATIC STEM CELL DIVISION,0.29248,0.17205,0.1704,0,0
3,GO PROSTATE GLAND MORPHOGENESIS,0.1306,0.17195,0.18332,0,0
3,GO RRNA 3 END PROCESSING,0.0047188,0.17194,0.16672,0,0
3,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.11524,0.17189,0.15439,0,0
3,GO EMBRYONIC DIGIT MORPHOGENESIS,0.025096,0.17107,0.18895,0,0
3,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.058535,0.17096,0.18355,0,0
3,GO REGULATION OF NUCLEAR DIVISION,0.00072571,0.17077,0.21992,0,0
3,GO PATTERN SPECIFICATION PROCESS,0.0083971,0.17067,0.19602,0,0
3,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.12273,0.17063,0.19365,0,0
3,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,0.067497,0.17034,0.24043,0,0
3,GO OLFACTORY BULB INTERNEURON DIFFERENTIATION,0.08588,0.17017,0.22142,0,0
3,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.012106,0.17014,0.20817,0,0
3,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.013834,0.16969,0.1853,0,0
3,GO INNER CELL MASS CELL PROLIFERATION,0.10811,0.16925,0.15503,0,0
3,GO MITOTIC METAPHASE PLATE CONGRESSION,0.0044907,0.16923,0.18308,0,0
3,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,0.15655,0.16906,0.189,0,0
3,GO MRNA MODIFICATION,0.008797,0.16879,0.18047,0,0
3,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.022172,0.16805,0.1983,0,0
3,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,0.0013481,0.16788,0.21711,0,0
3,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.015776,0.16766,0.20429,0,0
3,GO STEM CELL DIVISION,0.29248,0.16678,0.13865,0,0
3,GO POSITIVE REGULATION OF DNA REPLICATION,0.00091199,0.16676,0.25425,0,0
3,GO REGULATION OF CHROMOSOME ORGANIZATION,0.00096503,0.16654,0.22703,0,0
3,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,0.014457,0.16645,0.18131,0,0
3,GO ACTIN FILAMENT BASED TRANSPORT,0.10134,0.16623,0.19958,0,0
3,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.25111,0.16569,0.16641,0,0
3,GO FAT CELL PROLIFERATION,0.23203,0.16538,0.10393,0,0
3,GO REGULATION OF STEM CELL PROLIFERATION,0.028348,0.165,0.19661,0,0
3,GO EXTRACELLULAR TRANSPORT,0.074935,0.16482,0.17907,0,0
3,GO DNA LIGATION,0.011063,0.16348,0.16895,0,0
3,GO REGULATION OF CELL CYCLE,0.0018673,0.16324,0.20188,0,0
3,GO INNER DYNEIN ARM ASSEMBLY,0.34626,0.16287,0.21522,0,0
3,GO MALE GAMETE GENERATION,0.0017696,0.16268,0.18812,0,0
3,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.0031545,0.16264,0.17918,0,0
3,GO REGULATION OF CELL DIVISION,0.026142,0.16261,0.16333,0,0
3,GO REGULATION OF OOGENESIS,0.048745,0.16164,0.14046,0,0
3,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,0.008797,0.16118,0.18336,0,0
3,GO TONGUE MORPHOGENESIS,0.20822,0.16085,0.12134,0,0
3,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.013235,0.16044,0.17808,0,0
3,GO POSITIVE REGULATION OF CELL CYCLE ARREST,0.0012071,0.16002,0.24846,0,0
3,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.013235,0.16002,0.20347,0,0
3,GO CELL CYCLE PROCESS,0.0013481,0.15991,0.21806,0,0
3,GO EMBRYONIC HEART TUBE MORPHOGENESIS,0.10468,0.15976,0.17032,0,0
3,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,0.038848,0.15943,0.20897,0,0
3,GO WALKING BEHAVIOR,0.072385,0.15935,0.15183,0,0
3,GO REGULATION OF TELOMERE MAINTENANCE,0.011574,0.15883,0.19358,0,0
3,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.008797,0.15875,0.12937,0,0
3,GO ECTODERMAL PLACODE DEVELOPMENT,0.12273,0.15821,0.14105,0,0
3,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.045233,0.15809,0.15791,0,0
3,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,0.062884,0.15764,0.21689,0,0
3,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.14312,0.15741,0.11732,0,0
3,GO AZOLE TRANSMEMBRANE TRANSPORT,0.43329,0.1574,0.11374,0,0
3,GO TUBE FORMATION,0.033245,0.15662,0.1735,0,0
3,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,0.17091,0.15631,0.17896,0,0
3,GO HISTONE PHOSPHORYLATION,0.0083971,0.15601,0.18806,0,0
3,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.067497,0.15587,0.17714,0,0
3,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.15655,0.15584,0.13933,0,0
3,GO CELL CYCLE,0.0021907,0.15567,0.20275,0,0
3,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,0.0047188,0.15549,0.18577,0,0
3,GO CALCIUM ION IMPORT INTO CYTOSOL,0.17091,0.15522,0.15021,0,0
3,GO NEURONAL ACTION POTENTIAL,0.077559,0.15504,0.14859,0,0
3,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.091819,0.15469,0.18366,0,0
3,GO MAINTENANCE OF CELL POLARITY,0.072385,0.15412,0.17178,0,0
3,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,0.2577,0.15364,0.13162,0,0
3,GO CHROMATIN DISASSEMBLY,0.11524,0.15351,0.15756,0,0
3,GO GENE SILENCING,0.007293,0.15295,0.19353,0,0
3,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.020391,0.15284,0.21191,0,0
3,GO MITOTIC CELL CYCLE,0.0015882,0.15253,0.20573,0,0
3,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.016475,0.15245,0.20327,0,0
3,GO TONGUE DEVELOPMENT,0.065157,0.1514,0.15334,0,0
3,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.038848,0.15138,0.20905,0,0
3,GO PROTEIN K48 LINKED UBIQUITINATION,0.15655,0.15105,0.11295,0,0
3,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.16123,0.1509,0.17168,0,0
3,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.0054671,0.1506,0.16626,0,0
3,GO INNER EAR RECEPTOR CELL DEVELOPMENT,0.019548,0.15046,0.17724,0,0
3,GO POSITIVE REGULATION OF CELL CYCLE,0.0034935,0.15032,0.1884,0,0
3,GO MITOTIC CYTOKINESIS,0.0057394,0.15005,0.19057,0,0
3,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.056456,0.15005,0.15574,0,0
3,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.091819,0.14992,0.14862,0,0
3,GO APPENDAGE MORPHOGENESIS,0.016475,0.14975,0.21873,0,0
3,GO V D J RECOMBINATION,0.014457,0.14824,0.22485,0,0
3,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.0076456,0.14821,0.16875,0,0
3,GO MOTILE CILIUM ASSEMBLY,0.1306,0.14813,0.17015,0,0
3,GO PROTEIN TARGETING TO LYSOSOME,0.12273,0.14783,0.14939,0,0
3,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.020391,0.14762,0.17319,0,0
3,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,0.052482,0.14747,0.19463,0,0
3,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,0.0012071,0.147,0.22116,0,0
3,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.006955,0.1468,0.18761,0,0
3,GO CELL CYCLE ARREST,0.0027019,0.14667,0.19637,0,0
3,GO REGIONALIZATION,0.01266,0.14641,0.19165,0,0
3,GO NEURAL TUBE FORMATION,0.080256,0.14637,0.15909,0,0
3,GO ORGANIC CATION TRANSPORT,0.080256,0.14629,0.16712,0,0
3,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.29248,0.14613,0.12336,0,0
3,GO CELL AGGREGATION,0.20256,0.146,0.11027,0,0
3,GO POSITIVE REGULATION OF NUCLEAR DIVISION,0.0172,0.14549,0.16235,0,0
3,GO SEX DIFFERENTIATION,0.018736,0.14539,0.16823,0,0
3,GO RENAL VESICLE DEVELOPMENT,0.11894,0.14504,0.18042,0,0
3,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.0042727,0.1445,0.19209,0,0
3,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.14312,0.14442,0.17244,0,0
3,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.20822,0.14423,0.16291,0,0
3,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.019548,0.14411,0.18799,0,0
3,GO NEGATIVE REGULATION OF CELL CYCLE,0.0027019,0.14384,0.18391,0,0
3,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,0.0080134,0.14374,0.17984,0,0
3,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.13467,0.14373,0.10073,0,0
3,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,0.214,0.14349,0.22367,0,0
3,GO PROTEIN DEPOLYMERIZATION,0.007293,0.1429,0.21948,0,0
3,GO STEM CELL PROLIFERATION,0.037377,0.14275,0.18587,0,0
3,GO MANNOSYLATION,0.041938,0.14239,0.14868,0,0
3,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.0024341,0.1418,0.19555,0,0
3,GO NOTOCHORD DEVELOPMENT,0.11163,0.14159,0.1775,0,0
3,GO SNRNA PROCESSING,0.033245,0.14121,0.10331,0,0
3,GO LENS FIBER CELL DEVELOPMENT,0.080256,0.1412,0.17917,0,0
3,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,0.056456,0.14108,0.15956,0,0
3,GO EMBRYONIC APPENDAGE MORPHOGENESIS,0.023112,0.1409,0.1979,0,0
3,GO PARTURITION,0.18624,0.14088,0.12415,0,0
3,GO CELL CYCLE PHASE TRANSITION,0.0017696,0.14074,0.19647,0,0
3,GO RNA PROCESSING,0.0031545,0.14072,0.16912,0,0
3,GO ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.17591,0.14041,0.15604,0,0
3,GO REGULATION OF MITOTIC CELL CYCLE,0.0020776,0.13999,0.1877,0,0
3,GO RESPONSE TO UV,0.014457,0.13955,0.17254,0,0
3,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,0.13467,0.13945,0.2005,0,0
3,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.20822,0.13936,0.17481,0,0
3,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,0.27126,0.13926,0.14862,0,0
3,GO DNA CATABOLIC PROCESS,0.012106,0.13913,0.15993,0,0
3,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,0.0092139,0.13889,0.26005,0,0
3,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.034576,0.13856,0.2416,0,0
3,GO SYNAPTIC VESICLE MATURATION,0.094909,0.13851,0.23382,0,0
3,GO THYROID HORMONE METABOLIC PROCESS,0.23203,0.1383,0.13845,0,0
3,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.21989,0.13815,0.1541,0,0
3,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,0.23827,0.1375,0.11398,0,0
3,GO MYELIN MAINTENANCE,0.11894,0.13736,0.17591,0,0
3,GO CARNITINE METABOLIC PROCESS,0.18624,0.13724,0.10542,0,0
3,GO TRANSCRIPTION BY RNA POLYMERASE I,0.040368,0.1372,0.13415,0,0
3,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.013235,0.13638,0.15645,0,0
3,GO POSTREPLICATION REPAIR,0.010101,0.13589,0.14591,0,0
3,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.094909,0.13574,0.15508,0,0
3,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.0096484,0.13572,0.15484,0,0
3,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.08303,0.1357,0.15309,0,0
3,GO NUCLEUS ORGANIZATION,0.010572,0.13529,0.16556,0,0
3,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,0.0038653,0.13522,0.17437,0,0
3,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0042727,0.13502,0.1807,0,0
3,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.0015041,0.13476,0.20847,0,0
3,GO IRON COORDINATION ENTITY TRANSPORT,0.12662,0.13452,0.15632,0,0
3,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,0.074935,0.1345,0.16529,0,0
3,GO LONG TERM SYNAPTIC POTENTIATION,0.091819,0.13417,0.14584,0,0
3,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,0.11524,0.13408,0.15192,0,0
3,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.023112,0.13381,0.16257,0,0
3,GO EATING BEHAVIOR,0.025096,0.13365,0.19417,0,0
3,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.08588,0.13364,0.10595,0,0
3,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.011574,0.13334,0.18949,0,0
3,GO GOLGI LOCALIZATION,0.072385,0.13297,0.10909,0,0
3,GO POSITIVE REGULATION OF ACROSOME REACTION,0.098083,0.1329,0.11532,0,0
3,GO ACTIVATION OF MAPKK ACTIVITY,0.12662,0.13274,0.16584,0,0
3,GO FATTY ACID BETA OXIDATION,0.077559,0.13268,0.1123,0,0
3,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,0.08303,0.13212,0.16041,0,0
3,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,0.006955,0.1321,0.17637,0,0
3,GO LYSOSOMAL TRANSPORT,0.069906,0.13204,0.15521,0,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.065157,0.13198,0.16905,0,0
3,GO REGULATION OF CELL AGING,0.040368,0.13083,0.16441,0,0
3,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.0036751,0.1308,0.2023,0,0
3,GO REGULATION OF RNA BINDING,0.041938,0.13071,0.12974,0,0
3,GO SPINDLE MIDZONE ASSEMBLY,0.11524,0.13059,0.18035,0,0
3,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.12273,0.13039,0.16145,0,0
3,GO REGULATION OF GTP BINDING,0.37111,0.13027,0.094124,0,0
3,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.065157,0.13011,0.12023,0,0
3,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.028348,0.12967,0.19802,0,0
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.031957,0.12956,0.11221,0,0
3,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,0.47137,0.12907,0.081527,0,0
3,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.0080134,0.12884,0.18045,0,0
3,GO NUCLEOTIDE EXCISION REPAIR,0.0052065,0.12882,0.15228,0,0
3,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.35442,0.12856,0.077644,0,0
3,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,0.13467,0.12852,0.18974,0,0
3,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,0.024086,0.12843,0.15019,0,0
3,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.16123,0.12817,0.11656,0,0
3,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.067497,0.12809,0.13197,0,0
3,GO RESPONSE TO INACTIVITY,0.40594,0.128,0.095559,0,0
3,GO ATRIAL SEPTUM DEVELOPMENT,0.08303,0.12732,0.19274,0,0
3,GO TOXIN TRANSPORT,0.1475,0.12728,0.11215,0,0
3,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.041938,0.12719,0.13109,0,0
3,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,0.28529,0.12711,0.10979,0,0
3,GO CELL JUNCTION ASSEMBLY,0.08588,0.12669,0.16101,0,0
3,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.0042727,0.12666,0.22308,0,0
3,GO REGULATION OF HISTONE PHOSPHORYLATION,0.040368,0.12613,0.18082,0,0
3,GO GANGLIOSIDE METABOLIC PROCESS,0.041938,0.12611,0.19629,0,0
3,GO RESPONSE TO PARATHYROID HORMONE,0.2259,0.12606,0.12816,0,0
3,GO FIBROBLAST APOPTOTIC PROCESS,0.072385,0.12598,0.15601,0,0
3,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.013235,0.12594,0.1605,0,0
3,GO ERROR FREE TRANSLESION SYNTHESIS,0.018736,0.12571,0.13249,0,0
3,GO TRANSLESION SYNTHESIS,0.016475,0.12564,0.13187,0,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,0.0096484,0.12548,0.23349,0,0
3,GO COCHLEA MORPHOGENESIS,0.16123,0.12537,0.16704,0,0
3,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,0.054439,0.12531,0.1818,0,0
3,GO NEUROEPITHELIAL CELL DIFFERENTIATION,0.069906,0.12509,0.1851,0,0
3,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,0.077559,0.12475,0.14911,0,0
3,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.16123,0.12475,0.13729,0,0
3,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.0096484,0.1243,0.15738,0,0
3,GO OVULATION CYCLE PROCESS,0.10468,0.1238,0.14791,0,0
3,GO PROSTATIC BUD FORMATION,0.30724,0.12376,0.09441,0,0
3,GO BICARBONATE TRANSPORT,0.42405,0.12325,0.091929,0,0
3,GO MEMBRANE HYPERPOLARIZATION,0.08303,0.12284,0.21357,0,0
3,GO EMBRYONIC HEART TUBE DEVELOPMENT,0.16123,0.12275,0.15398,0,0
3,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.20822,0.12257,0.17641,0,0
3,GO DORSAL AORTA DEVELOPMENT,0.54223,0.12227,0.10541,0,0
3,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,0.13885,0.12187,0.16173,0,0
3,GO RADIAL GLIAL CELL DIFFERENTIATION,0.1306,0.12164,0.13964,0,0
3,GO REGULATION OF TRANSLATIONAL INITIATION,0.019548,0.12122,0.12359,0,0
3,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.033245,0.12115,0.1402,0,0
3,GO REGULATION OF DNA BINDING,0.010572,0.12103,0.17454,0,0
3,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.214,0.12062,0.12184,0,0
3,GO SNARE COMPLEX ASSEMBLY,0.13467,0.12051,0.1194,0,0
3,GO POSITIVE REGULATION OF CELL MATURATION,0.197,0.12035,0.10515,0,0
3,GO KERATINOCYTE DEVELOPMENT,0.080256,0.12029,0.24148,0,0
3,GO PROTEIN LOCALIZATION TO VACUOLE,0.08881,0.12009,0.15146,0,0
3,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,0.10468,0.12004,0.19214,0,0
3,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.060677,0.11983,0.17514,0,0
3,GO MEMBRANE FISSION,0.050584,0.11964,0.17011,0,0
3,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.072385,0.11938,0.12443,0,0
3,GO POSITIVE REGULATION OF DNA BINDING,0.034576,0.11919,0.14638,0,0
3,GO ACROSOME REACTION,0.11524,0.11907,0.12497,0,0
3,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.072385,0.11901,0.12074,0,0
3,GO REGULATION OF MRNA BINDING,0.1306,0.11889,0.093535,0,0
3,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,0.080256,0.11884,0.14255,0,0
3,GO POLYOL CATABOLIC PROCESS,0.015776,0.11868,0.17653,0,0
3,GO CIRCADIAN REGULATION OF GENE EXPRESSION,0.028348,0.11831,0.21451,0,0
3,GO NUCLEAR ENVELOPE ORGANIZATION,0.14312,0.11824,0.12544,0,0
3,GO SINGLE FERTILIZATION,0.0080134,0.11817,0.14621,0,0
3,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.052482,0.11797,0.12257,0,0
3,GO PROTEIN K63 LINKED DEUBIQUITINATION,0.058535,0.11788,0.16729,0,0
3,GO FOREBRAIN GENERATION OF NEURONS,0.058535,0.11787,0.17021,0,0
3,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.14312,0.11778,0.12574,0,0
3,GO MIRNA METABOLIC PROCESS,0.069906,0.11776,0.14647,0,0
3,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.0092139,0.11772,0.15175,0,0
3,GO REGULATION OF FATTY ACID OXIDATION,0.094909,0.11768,0.16991,0,0
3,GO CELL CYCLE G1 S PHASE TRANSITION,0.010101,0.11763,0.17898,0,0
3,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.66333,0.11756,0.062239,0,0
3,GO DEFINITIVE HEMOPOIESIS,0.11894,0.11754,0.19469,0,0
3,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.30724,0.11752,0.084718,0,0
3,GO DNA DEALKYLATION,0.067497,0.11738,0.13347,0,0
3,GO BASIC AMINO ACID TRANSPORT,0.34626,0.11724,0.10773,0,0
3,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.39705,0.11713,0.06994,0,0
3,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,0.34626,0.11699,0.087419,0,0
3,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.13467,0.11676,0.20167,0,0
3,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.074935,0.11662,0.12528,0,0
3,GO NEGATIVE REGULATION OF GLIOGENESIS,0.091819,0.11655,0.13071,0,0
3,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.10134,0.11611,0.11004,0,0
3,GO DETERMINATION OF ADULT LIFESPAN,0.29248,0.11597,0.11845,0,0
3,GO UV PROTECTION,0.10811,0.11595,0.17074,0,0
3,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.1306,0.11593,0.12217,0,0
3,GO BASE EXCISION REPAIR,0.0018673,0.11592,0.20113,0,0
3,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.67486,0.11589,0.04523,0,0
3,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.013834,0.11564,0.19947,0,0
3,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,0.25111,0.11555,0.17394,0,0
3,GO EYE MORPHOGENESIS,0.10134,0.11524,0.16032,0,0
3,GO MECHANORECEPTOR DIFFERENTIATION,0.0063209,0.11474,0.16143,0,0
3,GO PROTEIN LOCALIZATION TO NUCLEUS,0.074935,0.11473,0.1276,0,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.074935,0.11466,0.12096,0,0
3,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,0.056456,0.11464,0.17128,0,0
3,GO ENDOSOME TO LYSOSOME TRANSPORT,0.072385,0.1143,0.14129,0,0
3,GO MELANOCYTE DIFFERENTIATION,0.11524,0.11427,0.14137,0,0
3,GO OVULATION CYCLE,0.11524,0.11426,0.15918,0,0
3,GO ENTRAINMENT OF CIRCADIAN CLOCK,0.069906,0.11393,0.15011,0,0
3,GO REGULATION OF PROTEIN DEPOLYMERIZATION,0.08881,0.1139,0.15271,0,0
3,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.19156,0.11364,0.17551,0,0
3,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.12662,0.11362,0.12704,0,0
3,GO RAP PROTEIN SIGNAL TRANSDUCTION,0.27126,0.11348,0.13174,0,0
3,GO CARDIAC ATRIUM DEVELOPMENT,0.33029,0.11341,0.13793,0,0
3,GO TRNA PROCESSING,0.050584,0.11336,0.10244,0,0
3,GO APPENDAGE DEVELOPMENT,0.035953,0.11334,0.18698,0,0
3,GO OUTER DYNEIN ARM ASSEMBLY,0.29248,0.11323,0.15787,0,0
3,GO CELLULAR RESPONSE TO PH,0.15197,0.11319,0.13794,0,0
3,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.50109,0.11311,0.072372,0,0
3,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.10134,0.11297,0.12004,0,0
3,GO LACTATE METABOLIC PROCESS,0.062884,0.11292,0.1241,0,0
3,GO REGULATION OF TELOMERE CAPPING,0.091819,0.11205,0.16371,0,0
3,GO PITUITARY GLAND DEVELOPMENT,0.027226,0.11201,0.26334,0,0
3,GO MATURATION OF 5 8S RRNA,0.15655,0.11198,0.08619,0,0
3,GO SPERM AXONEME ASSEMBLY,0.14312,0.11197,0.15449,0,0
3,GO VIRAL LATENCY,0.02951,0.11191,0.15548,0,0
3,GO COCHLEA DEVELOPMENT,0.056456,0.11169,0.19338,0,0
3,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.091819,0.11164,0.12372,0,0
3,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.025096,0.11157,0.11925,0,0
3,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.14312,0.11138,0.14306,0,0
3,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.10811,0.11109,0.11519,0,0
3,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.08588,0.11104,0.13389,0,0
3,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.13467,0.11089,0.11475,0,0
3,GO MYOBLAST PROLIFERATION,0.11894,0.11085,0.10414,0,0
3,GO REGULATION OF RIBOSOME BIOGENESIS,0.1306,0.11072,0.11471,0,0
3,GO PERICARDIUM DEVELOPMENT,0.13885,0.11067,0.15877,0,0
3,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,0.1306,0.11064,0.19149,0,0
3,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.074935,0.1106,0.18178,0,0
3,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.035953,0.11026,0.12881,0,0
3,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.046961,0.11017,0.17792,0,0
3,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,0.11524,0.11004,0.12055,0,0
3,GO CELLULAR RESPONSE TO UV,0.034576,0.10946,0.14723,0,0
3,GO RNA DECAPPING,0.2577,0.10941,0.11768,0,0
3,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.12273,0.10923,0.13331,0,0
3,GO LIPID PHOSPHORYLATION,0.13467,0.1092,0.14718,0,0
3,GO NEURAL CREST CELL MIGRATION,0.11163,0.10909,0.14865,0,0
3,GO SKELETAL MUSCLE CELL DIFFERENTIATION,0.08303,0.10888,0.12704,0,0
3,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.12662,0.10873,0.15959,0,0
3,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.017954,0.10872,0.15257,0,0
3,GO OSTEOBLAST DEVELOPMENT,0.2259,0.1087,0.11227,0,0
3,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.1475,0.10866,0.10903,0,0
3,GO REGULATION OF EXOCYTOSIS,0.098083,0.10845,0.13498,0,0
3,GO RESPONSE TO SALT,0.14312,0.10842,0.11139,0,0
3,GO PONS DEVELOPMENT,0.14312,0.10841,0.31825,0,0
3,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,0.56341,0.10832,0.058727,0,0
3,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.2577,0.10792,0.17962,0,0
3,GO OPIOID RECEPTOR SIGNALING PATHWAY,0.21989,0.1078,0.14557,0,0
3,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.64051,0.10724,0.062693,0,0
3,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.32248,0.10702,0.11834,0,0
3,GO REGULATION OF REGULATED SECRETORY PATHWAY,0.077559,0.10696,0.15384,0,0
3,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.1306,0.10668,0.18013,0,0
3,GO ONE CARBON METABOLIC PROCESS,0.10468,0.10661,0.12424,0,0
3,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.18102,0.10657,0.11701,0,0
3,GO GOLGI ORGANIZATION,0.08303,0.10615,0.13092,0,0
3,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.062884,0.10597,0.11339,0,0
3,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.52145,0.10578,0.10514,0,0
3,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.062884,0.1053,0.19059,0,0
3,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,0.16602,0.10525,0.11897,0,0
3,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,0.16602,0.10517,0.098675,0,0
3,GO INTRACELLULAR STEROL TRANSPORT,0.20822,0.10502,0.13798,0,0
3,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.3148,0.10477,0.10216,0,0
3,GO MITOCHONDRIAL GENOME MAINTENANCE,0.054439,0.10473,0.16408,0,0
3,GO REFLEX,0.95582,0.10457,0.0061609,0,0
3,GO PLASMA MEMBRANE TUBULATION,0.26442,0.10427,0.1357,0,0
3,GO GLYCOGEN BIOSYNTHETIC PROCESS,0.10468,0.10413,0.14936,0,0
3,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,0.08303,0.10387,0.14491,0,0
3,GO VIRAL TRANSLATION,0.034576,0.10366,0.11013,0,0
3,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.041938,0.10356,0.14265,0,0
3,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.15197,0.10348,0.083107,0,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.12273,0.10333,0.1533,0,0
3,GO ENDOCYTIC RECYCLING,0.21989,0.10319,0.13392,0,0
3,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.050584,0.10308,0.12,0,0
3,GO POSITIVE REGULATION OF BINDING,0.10134,0.10308,0.11285,0,0
3,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.021265,0.10277,0.15815,0,0
3,GO AROMATIC AMINO ACID TRANSPORT,0.2259,0.10274,0.17519,0,0
3,GO EMBRYONIC ORGAN MORPHOGENESIS,0.024086,0.1026,0.20329,0,0
3,GO POSITIVE REGULATION OF CELL DIVISION,0.12662,0.10248,0.1202,0,0
3,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.2998,0.10229,0.14694,0,0
3,GO GMP METABOLIC PROCESS,0.060677,0.10199,0.1261,0,0
3,GO TRNA METABOLIC PROCESS,0.065157,0.10195,0.10027,0,0
3,GO ERYTHROCYTE MATURATION,0.24463,0.10194,0.10882,0,0
3,GO LEFT RIGHT PATTERN FORMATION,0.17091,0.1018,0.13207,0,0
3,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.10468,0.10176,0.14446,0,0
3,GO REGULATION OF DNA METABOLIC PROCESS,0.015104,0.10151,0.15731,0,0
3,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.018736,0.10119,0.11547,0,0
3,GO PROTEIN DNA COMPLEX DISASSEMBLY,0.15655,0.10072,0.11878,0,0
3,GO POSITIVE REGULATION OF TELOMERE CAPPING,0.2998,0.10053,0.11803,0,0
3,GO SENSORY ORGAN MORPHOGENESIS,0.069906,0.10037,0.15223,0,0
3,GO GENETIC IMPRINTING,0.098083,0.1002,0.17419,0,0
3,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,0.13467,0.099929,0.12166,0,0
3,GO COENZYME A METABOLIC PROCESS,0.15655,0.099866,0.11223,0,0
3,GO ENERGY HOMEOSTASIS,0.11163,0.099812,0.16014,0,0
3,GO REGULATION OF CELL JUNCTION ASSEMBLY,0.10811,0.099724,0.15389,0,0
3,GO REGULATION OF MITOTIC SPINDLE ASSEMBLY,0.054439,0.099655,0.14297,0,0
3,GO HYPEROSMOTIC SALINITY RESPONSE,0.2577,0.099617,0.0848,0,0
3,GO LIPID OXIDATION,0.5959,0.099507,0.056892,0,0
3,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,0.072385,0.099305,0.15484,0,0
3,GO NCRNA 3 END PROCESSING,0.040368,0.099161,0.095826,0,0
3,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.40594,0.099097,0.082816,0,0
3,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.197,0.09898,0.088057,0,0
3,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.15197,0.098823,0.15263,0,0
3,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.20256,0.098736,0.1861,0,0
3,GO PURINE NUCLEOTIDE TRANSPORT,0.197,0.098708,0.10287,0,0
3,GO REGULATION OF PROTEIN ACETYLATION,0.072385,0.098582,0.12849,0,0
3,GO NEGATIVE REGULATION OF RNA SPLICING,0.0052065,0.098511,0.20324,0,0
3,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,0.062884,0.098263,0.20559,0,0
3,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,0.18102,0.098219,0.078796,0,0
3,GO THYROID GLAND DEVELOPMENT,0.11524,0.098202,0.15691,0,0
3,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.091819,0.098018,0.12741,0,0
3,GO PROTEIN NEDDYLATION,0.058535,0.098009,0.093111,0,0
3,GO POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION,0.51122,0.097821,0.061781,0,0
3,GO BLASTOCYST GROWTH,0.27126,0.097771,0.09336,0,0
3,GO FATTY ACID CATABOLIC PROCESS,0.2259,0.097617,0.086049,0,0
3,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.37111,0.097535,0.066268,0,0
3,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.10468,0.09733,0.12347,0,0
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.17591,0.097219,0.10159,0,0
3,GO PROTEIN MANNOSYLATION,0.074935,0.096971,0.14691,0,0
3,GO 3 UTR MEDIATED MRNA DESTABILIZATION,0.27821,0.096781,0.14156,0,0
3,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,0.17591,0.096239,0.11565,0,0
3,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.17091,0.096228,0.12458,0,0
3,GO MULTICELLULAR ORGANISM AGING,0.62923,0.09609,0.060804,0,0
3,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.35442,0.096062,0.097512,0,0
3,GO REGULATION OF ATP METABOLIC PROCESS,0.069906,0.096058,0.12009,0,0
3,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.39705,0.096031,0.052618,0,0
3,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.14312,0.096011,0.16436,0,0
3,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.080256,0.095974,0.17786,0,0
3,GO SMAD PROTEIN COMPLEX ASSEMBLY,0.21989,0.095659,0.12302,0,0
3,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.077559,0.095531,0.13034,0,0
3,GO REGULATION OF POTASSIUM ION TRANSPORT,0.062884,0.09546,0.12651,0,0
3,GO REGULATION OF CILIUM MOVEMENT,0.214,0.095411,0.083919,0,0
3,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.12273,0.095375,0.12625,0,0
3,GO VIRAL RNA GENOME REPLICATION,0.12273,0.095351,0.1322,0,0
3,GO ACETYL COA BIOSYNTHETIC PROCESS,0.32248,0.095321,0.076534,0,0
3,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.021265,0.095314,0.14483,0,0
3,GO OXYGEN TRANSPORT,0.69814,0.09515,0.091379,0,0
3,GO LIPOPROTEIN METABOLIC PROCESS,0.2577,0.09506,0.081367,0,0
3,GO REGULATION OF DNA METHYLATION,0.2998,0.094933,0.082614,0,0
3,GO TETRAHYDROFOLATE METABOLIC PROCESS,0.20822,0.094685,0.081167,0,0
3,GO VACUOLAR TRANSPORT,0.15197,0.094585,0.1171,0,0
3,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.12662,0.094502,0.12388,0,0
3,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.062884,0.094456,0.1518,0,0
3,GO REGULATION OF TRANSPOSITION,0.08303,0.094327,0.1455,0,0
3,GO GOLGI TO VACUOLE TRANSPORT,0.44264,0.094119,0.11194,0,0
3,GO CELLULAR PROTEIN CATABOLIC PROCESS,0.10468,0.093925,0.10331,0,0
3,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,0.2998,0.093925,0.11843,0,0
3,GO BLASTOCYST DEVELOPMENT,0.026142,0.093821,0.11426,0,0
3,GO REGULATION OF PROTEIN DEACETYLATION,0.11163,0.09356,0.14359,0,0
3,GO SODIUM ION TRANSMEMBRANE TRANSPORT,0.098083,0.09353,0.12295,0,0
3,GO COPII COATED VESICLE CARGO LOADING,0.15655,0.093448,0.15033,0,0
3,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.3148,0.093199,0.070829,0,0
3,GO INTERMEDIATE FILAMENT BASED PROCESS,0.1475,0.093083,0.13375,0,0
3,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.25111,0.092982,0.10013,0,0
3,GO SPONTANEOUS SYNAPTIC TRANSMISSION,0.12273,0.092956,0.22375,0,0
3,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,0.10468,0.092849,0.11909,0,0
3,GO REGULATION OF RELAXATION OF MUSCLE,0.60692,0.092726,0.020987,0,0
3,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,0.052482,0.092706,0.1577,0,0
3,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.34626,0.092552,0.067384,0,0
3,GO POSITIVE REGULATION OF MACROAUTOPHAGY,0.15655,0.092509,0.14096,0,0
3,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,0.91805,0.09215,0.015834,0,0
3,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.17591,0.091972,0.12579,0,0
3,GO GENITALIA DEVELOPMENT,0.37111,0.091844,0.09742,0,0
3,GO ESTABLISHMENT OF TISSUE POLARITY,0.1475,0.091506,0.10286,0,0
3,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.02951,0.09117,0.14226,0,0
3,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.72171,0.090831,0.016243,0,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.067497,0.090826,0.11036,0,0
3,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.41494,0.090787,0.075918,0,0
3,GO NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING,0.017954,0.090686,0.13609,0,0
3,GO NEPHRON TUBULE FORMATION,0.48117,0.090662,0.071017,0,0
3,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.040368,0.090636,0.094329,0,0
3,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.2998,0.090617,0.066172,0,0
3,GO CELLULAR RESPONSE TO RADIATION,0.043559,0.090551,0.12317,0,0
3,GO MOLTING CYCLE,0.17591,0.09017,0.12794,0,0
3,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,0.052482,0.090083,0.11363,0,0
3,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.094909,0.089959,0.15679,0,0
3,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.038848,0.08979,0.15144,0,0
3,GO THIOESTER METABOLIC PROCESS,0.27821,0.08957,0.05473,0,0
3,GO EAR MORPHOGENESIS,0.065157,0.089557,0.16399,0,0
3,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.18102,0.089473,0.089695,0,0
3,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.14312,0.089149,0.16759,0,0
3,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.89296,0.089144,0.020224,0,0
3,GO PIRNA METABOLIC PROCESS,0.26442,0.089144,0.056498,0,0
3,GO HISTONE H3 K9 ACETYLATION,0.069906,0.089092,0.13281,0,0
3,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.08588,0.08905,0.1516,0,0
3,GO NEURAL CREST CELL DIFFERENTIATION,0.25111,0.088893,0.12471,0,0
3,GO SKIN EPIDERMIS DEVELOPMENT,0.14312,0.088629,0.13826,0,0
3,GO REGULATION OF LIGASE ACTIVITY,0.077559,0.08856,0.10537,0,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.33029,0.088496,0.063463,0,0
3,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.13885,0.088436,0.12283,0,0
3,GO CELLULAR GLUCAN METABOLIC PROCESS,0.16123,0.088193,0.11838,0,0
3,GO RESPIRATORY SYSTEM PROCESS,0.11163,0.088022,0.14835,0,0
3,GO RAC PROTEIN SIGNAL TRANSDUCTION,0.214,0.087991,0.12083,0,0
3,GO TETRAHYDROFOLATE INTERCONVERSION,0.26442,0.087529,0.090282,0,0
3,GO REGULATION OF DEOXYRIBONUCLEASE ACTIVITY,0.58498,0.087293,0.054961,0,0
3,GO SMOOTH MUSCLE CONTRACTION,0.1475,0.087225,0.12615,0,0
3,GO VESICLE LOCALIZATION,0.098083,0.087157,0.12258,0,0
3,GO REGULATION OF ENDOCYTIC RECYCLING,0.1475,0.087125,0.17603,0,0
3,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.12662,0.087029,0.10868,0,0
3,GO C4 DICARBOXYLATE TRANSPORT,0.13885,0.086965,0.10542,0,0
3,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,0.38829,0.086791,0.16022,0,0
3,GO LYMPH VESSEL MORPHOGENESIS,0.52145,0.086606,0.10861,0,0
3,GO CRISTAE FORMATION,0.18624,0.086569,0.10702,0,0
3,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.2577,0.086494,0.12703,0,0
3,GO VESICLE DOCKING,0.077559,0.086485,0.14514,0,0
3,GO DEVELOPMENTAL MATURATION,0.10811,0.086485,0.14078,0,0
3,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,0.12273,0.086377,0.15906,0,0
3,GO HORMONE TRANSPORT,0.065157,0.086356,0.14072,0,0
3,GO MIDBRAIN DEVELOPMENT,0.080256,0.08629,0.12148,0,0
3,GO CELL CELL SIGNALING,0.10134,0.086188,0.12076,0,0
3,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.2259,0.085804,0.085295,0,0
3,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,0.1475,0.085704,0.11596,0,0
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.4521,0.085545,0.046107,0,0
3,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,0.51122,0.085527,0.12789,0,0
3,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,0.043559,0.085427,0.11699,0,0
3,GO REGULATION OF CATION CHANNEL ACTIVITY,0.094909,0.085193,0.11291,0,0
3,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,0.091819,0.084945,0.12219,0,0
3,GO SULFATION,0.36271,0.084853,0.1034,0,0
3,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.48117,0.084209,0.10917,0,0
3,GO BILE ACID BIOSYNTHETIC PROCESS,0.69814,0.08403,0.033709,0,0
3,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.75756,0.08396,0.022006,0,0
3,GO CELLULAR RESPONSE TO STARVATION,0.048745,0.083801,0.15511,0,0
3,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,0.040368,0.08371,0.10583,0,0
3,GO CELL CELL ADHESION MEDIATED BY CADHERIN,0.37111,0.0837,0.13307,0,0
3,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.13885,0.083659,0.13423,0,0
3,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.10811,0.083541,0.1045,0,0
3,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.12662,0.08345,0.11844,0,0
3,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.2998,0.083424,0.11347,0,0
3,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.61803,0.083412,0.1098,0,0
3,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.33821,0.083189,0.14294,0,0
3,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,0.23827,0.083124,0.12659,0,0
3,GO GLUTAMATE SECRETION,0.15655,0.083092,0.15958,0,0
3,GO SENSORY PERCEPTION,0.094909,0.082948,0.098109,0,0
3,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,0.91805,0.082898,-0.020936,0,0
3,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.17591,0.082898,0.099835,0,0
3,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.2577,0.082533,0.12345,0,0
3,GO PROTEIN LOCALIZATION TO ENDOSOME,0.19156,0.082532,0.18028,0,0
3,GO RESPONSE TO MISFOLDED PROTEIN,0.1475,0.082394,0.12594,0,0
3,GO REGULATION OF MUSCLE HYPERTROPHY,0.41494,0.082218,0.11247,0,0
3,GO CELL CELL SIGNALING BY WNT,0.18624,0.082073,0.12568,0,0
3,GO MITOCHONDRIAL TRANSPORT,0.08881,0.081993,0.090043,0,0
3,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.42405,0.081989,0.075927,0,0
3,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,0.20256,0.081981,0.17094,0,0
3,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.33821,0.081602,0.089186,0,0
3,GO EMBRYONIC EYE MORPHOGENESIS,0.091819,0.081565,0.17909,0,0
3,GO NEGATIVE REGULATION OF HIPPO SIGNALING,0.51122,0.081516,0.098047,0,0
3,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.48117,0.081435,0.11409,0,0
3,GO RESPONSE TO IRON ION,0.85555,0.081381,0.034965,0,0
3,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,0.2998,0.081368,0.063778,0,0
3,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.062884,0.081089,0.10983,0,0
3,GO RESPONSE TO CATECHOLAMINE,0.15655,0.080949,0.10691,0,0
3,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.094909,0.08088,0.157,0,0
3,GO DNA BIOSYNTHETIC PROCESS,0.023112,0.080793,0.12783,0,0
3,GO TRNA WOBBLE BASE MODIFICATION,0.077559,0.080726,0.11626,0,0
3,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.14312,0.080725,0.12953,0,0
3,GO MAGNESIUM ION TRANSPORT,0.046961,0.080627,0.14287,0,0
3,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.42405,0.080547,0.081272,0,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,0.072385,0.080509,0.089314,0,0
3,GO RESPONSE TO ISOQUINOLINE ALKALOID,0.18624,0.080414,0.089839,0,0
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.75756,0.080387,0.047299,0,0
3,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,0.19156,0.080256,0.10957,0,0
3,GO CYTOSOLIC TRANSPORT,0.16123,0.080252,0.12931,0,0
3,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.29248,0.079849,0.14659,0,0
3,GO NADH METABOLIC PROCESS,0.197,0.07971,0.1083,0,0
3,GO REGULATION OF GTPASE ACTIVITY,0.55277,0.079504,0.11306,0,0
3,GO POSITIVE REGULATION OF HEART GROWTH,0.5959,0.0795,0.077305,0,0
3,GO PROTEIN KINASE C SIGNALING,0.61803,0.079442,0.11037,0,0
3,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.15655,0.07934,0.11765,0,0
3,GO PEPTIDYL SERINE DEPHOSPHORYLATION,0.2259,0.079251,0.10286,0,0
3,GO N GLYCAN PROCESSING,0.2577,0.078796,0.17193,0,0
3,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,0.43329,0.078789,0.13801,0,0
3,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.50109,0.07869,0.049531,0,0
3,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.11524,0.078668,0.13293,0,0
3,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,0.16123,0.078628,0.15144,0,0
3,GO MYELIN ASSEMBLY,0.15197,0.07854,0.17682,0,0
3,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.42405,0.078492,0.088338,0,0
3,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.25111,0.078173,0.13131,0,0
3,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.043559,0.078071,0.14363,0,0
3,GO NUCLEOTIDE PHOSPHORYLATION,0.065157,0.077857,0.13407,0,0
3,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.27821,0.077798,0.065773,0,0
3,GO PROTEIN K11 LINKED UBIQUITINATION,0.17091,0.077741,0.085352,0,0
3,GO CELLULAR RESPONSE TO CALCIUM ION,0.18624,0.077601,0.11286,0,0
3,GO REGULATION OF HEAT GENERATION,0.197,0.077562,0.15506,0,0
3,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,0.10134,0.077523,0.087043,0,0
3,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,0.052482,0.077465,0.10999,0,0
3,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.197,0.077266,0.10003,0,0
3,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.25111,0.077245,0.17549,0,0
3,GO SUBSTANTIA NIGRA DEVELOPMENT,0.08588,0.077242,0.11679,0,0
3,GO NEGATIVE REGULATION OF NEURON DEATH,0.2577,0.077224,0.10369,0,0
3,GO REGULATION OF INTRACELLULAR TRANSPORT,0.197,0.077219,0.10326,0,0
3,GO SODIUM ION TRANSPORT,0.080256,0.077134,0.12646,0,0
3,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.13467,0.077128,0.14934,0,0
3,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.038848,0.077085,0.15391,0,0
3,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.3148,0.077058,0.12463,0,0
3,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,0.054439,0.076813,0.11257,0,0
3,GO NOREPINEPHRINE METABOLIC PROCESS,0.24463,0.076681,0.16561,0,0
3,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,0.44264,0.076594,0.092017,0,0
3,GO REGULATION OF GENE SILENCING,0.045233,0.076491,0.14504,0,0
3,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.52145,0.076487,0.06268,0,0
3,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.36271,0.076225,0.079661,0,0
3,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.3148,0.07618,0.094408,0,0
3,GO POSITIVE REGULATION OF HEAT GENERATION,0.20822,0.076123,0.164,0,0
3,GO REGULATION OF TRANSLATIONAL FIDELITY,0.15197,0.075947,0.09156,0,0
3,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.062884,0.075877,0.19035,0,0
3,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.2998,0.075836,0.088122,0,0
3,GO INOSITOL PHOSPHATE METABOLIC PROCESS,0.23827,0.075796,0.10829,0,0
3,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,0.15197,0.075746,0.091844,0,0
3,GO DE NOVO PROTEIN FOLDING,0.16602,0.075648,0.10984,0,0
3,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.32248,0.075517,0.084052,0,0
3,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,0.33821,0.075487,0.11408,0,0
3,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.016475,0.075385,0.1245,0,0
3,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,0.072385,0.075188,0.1531,0,0
3,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,0.11163,0.0751,0.1164,0,0
3,GO REGULATION OF CELLULAR CATABOLIC PROCESS,0.28529,0.074928,0.087529,0,0
3,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.29248,0.074665,0.15371,0,0
3,GO REGULATION OF DEPHOSPHORYLATION,0.10811,0.074664,0.13504,0,0
3,GO GLYCOLIPID BIOSYNTHETIC PROCESS,0.1475,0.074639,0.09991,0,0
3,GO RESPONSE TO CAFFEINE,0.27126,0.074562,0.085262,0,0
3,GO PROTEIN CATABOLIC PROCESS,0.18624,0.074535,0.096078,0,0
3,GO RESPONSE TO NITROSATIVE STRESS,0.2577,0.074481,0.056695,0,0
3,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.069906,0.074348,0.14045,0,0
3,GO EXECUTION PHASE OF APOPTOSIS,0.18102,0.074281,0.097149,0,0
3,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.054439,0.074174,0.084352,0,0
3,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,0.18624,0.074162,0.11815,0,0
3,GO REGULATION OF HEART GROWTH,0.37111,0.074081,0.082142,0,0
3,GO CARDIAC CELL DEVELOPMENT,0.14312,0.07405,0.12152,0,0
3,GO DEPHOSPHORYLATION,0.1306,0.073715,0.10914,0,0
3,GO DETECTION OF ABIOTIC STIMULUS,0.062884,0.073713,0.11587,0,0
3,GO TRACHEA DEVELOPMENT,0.72171,0.073688,0.078043,0,0
3,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.93062,0.073486,0.006892,0,0
3,GO PROTEIN DEPHOSPHORYLATION,0.074935,0.073454,0.11625,0,0
3,GO GOLGI VESICLE TRANSPORT,0.23203,0.073435,0.094464,0,0
3,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.37964,0.073322,0.049601,0,0
3,GO ENDOSOMAL TRANSPORT,0.16602,0.073182,0.10503,0,0
3,GO MODULATION BY VIRUS OF HOST PROCESS,0.13885,0.073162,0.10287,0,0
3,GO INTERMEDIATE FILAMENT ORGANIZATION,0.19156,0.073159,0.11589,0,0
3,GO GLIAL CELL DIFFERENTIATION,0.36271,0.072932,0.11817,0,0
3,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.29248,0.07289,0.1299,0,0
3,GO POLYOL METABOLIC PROCESS,0.2998,0.072754,0.087727,0,0
3,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.23827,0.072634,0.12189,0,0
3,GO MACROMOLECULE CATABOLIC PROCESS,0.14312,0.072556,0.091107,0,0
3,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.13885,0.072548,0.076082,0,0
3,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.077559,0.072356,0.15277,0,0
3,GO GABAERGIC NEURON DIFFERENTIATION,0.42405,0.072278,0.15059,0,0
3,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.13885,0.071879,0.11343,0,0
3,GO CARDIAC MUSCLE CELL PROLIFERATION,0.34626,0.071718,0.10192,0,0
3,GO REGULATION OF GLUCOSE IMPORT,0.16123,0.071644,0.1063,0,0
3,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.19156,0.071634,0.11266,0,0
3,GO REGULATION OF SYSTEM PROCESS,0.11524,0.071632,0.12556,0,0
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.2259,0.071598,0.09138,0,0
3,GO CARDIAC CONDUCTION,0.10134,0.071549,0.12616,0,0
3,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.197,0.071485,0.16182,0,0
3,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.37964,0.071432,0.087898,0,0
3,GO EPHRIN RECEPTOR SIGNALING PATHWAY,0.12273,0.07138,0.13456,0,0
3,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.2259,0.071366,0.11493,0,0
3,GO CELL FATE COMMITMENT,0.048745,0.071319,0.15586,0,0
3,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.3148,0.071268,0.10463,0,0
3,GO CANONICAL WNT SIGNALING PATHWAY,0.24463,0.071102,0.12232,0,0
3,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.39705,0.071069,0.11844,0,0
3,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.214,0.071038,0.12773,0,0
3,GO REGULATION OF MEMBRANE PERMEABILITY,0.08303,0.070972,0.11221,0,0
3,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.36271,0.070969,0.091916,0,0
3,GO PEPTIDYL AMINO ACID MODIFICATION,0.10468,0.070958,0.11913,0,0
3,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,0.55277,0.070812,0.048619,0,0
3,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,0.060677,0.070729,0.10597,0,0
3,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.2259,0.070677,0.059474,0,0
3,GO METANEPHRIC EPITHELIUM DEVELOPMENT,0.42405,0.07064,0.11583,0,0
3,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.15197,0.070432,0.10403,0,0
3,GO RECEPTOR RECYCLING,0.38829,0.070404,0.094485,0,0
3,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.21989,0.070305,0.11197,0,0
3,GO PEPTIDYL CYSTEINE MODIFICATION,0.1306,0.069871,0.12304,0,0
3,GO POSITIVE REGULATION OF ORGAN GROWTH,0.47137,0.069864,0.098381,0,0
3,GO NEUROBLAST DIVISION,0.10134,0.069605,0.16661,0,0
3,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.34626,0.069266,0.14826,0,0
3,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,0.048745,0.069194,0.1062,0,0
3,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,0.18102,0.06913,0.12121,0,0
3,GO COENZYME A BIOSYNTHETIC PROCESS,0.36271,0.069101,0.078243,0,0
3,GO SIGNAL RELEASE,0.15197,0.069097,0.10895,0,0
3,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,0.21989,0.069054,0.12001,0,0
3,GO CARBOHYDRATE CATABOLIC PROCESS,0.32248,0.068967,0.091186,0,0
3,GO MEMBRANE BIOGENESIS,0.20256,0.068909,0.12332,0,0
3,GO VITAMIN CATABOLIC PROCESS,0.35442,0.068718,0.13913,0,0
3,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.58498,0.068595,0.02134,0,0
3,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,0.69814,0.068464,0.025068,0,0
3,GO REGULATION OF NOTCH SIGNALING PATHWAY,0.11163,0.068441,0.15432,0,0
3,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.37111,0.068393,0.11705,0,0
3,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,0.17591,0.068337,0.11811,0,0
3,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.2998,0.068299,0.089352,0,0
3,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.40594,0.068178,0.091673,0,0
3,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.17091,0.068118,0.11938,0,0
3,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.25111,0.067961,0.16129,0,0
3,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.098083,0.0679,0.094337,0,0
3,GO REGULATION OF BINDING,0.38829,0.067797,0.10065,0,0
3,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.41494,0.06761,0.092865,0,0
3,GO REGULATION OF ATPASE ACTIVITY,0.11524,0.067589,0.082911,0,0
3,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,0.19156,0.067555,0.1226,0,0
3,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.27821,0.067321,0.11222,0,0
3,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,0.46168,0.067282,0.13206,0,0
3,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.7336,0.066946,0.041763,0,0
3,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.35442,0.066857,0.082597,0,0
3,GO RNA CAPPING,0.13467,0.066831,0.074137,0,0
3,GO SKELETAL SYSTEM MORPHOGENESIS,0.12662,0.06653,0.1669,0,0
3,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.61803,0.066506,0.068239,0,0
3,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,0.11524,0.066384,0.098899,0,0
3,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.13885,0.066273,0.13479,0,0
3,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.16602,0.066156,0.10904,0,0
3,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.27821,0.06615,0.093974,0,0
3,GO NEUROTRANSMITTER METABOLIC PROCESS,0.41494,0.066107,0.099681,0,0
3,GO GLUTAMATE METABOLIC PROCESS,0.13885,0.066076,0.11946,0,0
3,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,0.32248,0.066029,0.12383,0,0
3,GO REGULATION OF TRANSPORTER ACTIVITY,0.16602,0.066019,0.10345,0,0
3,GO TRNA WOBBLE URIDINE MODIFICATION,0.15197,0.065729,0.077203,0,0
3,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.17591,0.065658,0.12079,0,0
3,GO AXIS ELONGATION,0.61803,0.065581,0.076108,0,0
3,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.39705,0.065555,0.085298,0,0
3,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,0.37111,0.065494,0.11886,0,0
3,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,1,0.065477,-0.014681,0,0
3,GO SERTOLI CELL DEVELOPMENT,0.30724,0.06544,0.13072,0,0
3,GO MESENCHYMAL CELL PROLIFERATION,0.53179,0.065413,0.10325,0,0
3,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,0.20822,0.06531,0.094772,0,0
3,GO RESPONSE TO IMMOBILIZATION STRESS,0.51122,0.065287,0.059869,0,0
3,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.23203,0.065064,0.10223,0,0
3,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,0.40594,0.06494,0.098892,0,0
3,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.21989,0.06489,0.049009,0,0
3,GO REGULATION OF NUCLEASE ACTIVITY,0.99368,0.06486,0.015876,0,0
3,GO HEAT GENERATION,0.50109,0.064854,0.079993,0,0
3,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,0.35442,0.064826,0.076146,0,0
3,GO PROTEIN STABILIZATION,0.17091,0.064731,0.09451,0,0
3,GO BLASTOCYST FORMATION,0.1306,0.064706,0.087139,0,0
3,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.33821,0.064669,0.085944,0,0
3,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,0.36271,0.064607,0.12756,0,0
3,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.16123,0.064606,0.07435,0,0
3,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.46168,0.064559,0.054661,0,0
3,GO ORGANIC ACID CATABOLIC PROCESS,0.66333,0.064488,0.046462,0,0
3,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.14312,0.064164,0.12543,0,0
3,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,0.43329,0.064128,0.08404,0,0
3,GO CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.56341,0.063981,0.032306,0,0
3,GO CELLULAR RESPONSE TO HEAT,0.098083,0.063915,0.11296,0,0
3,GO RESPONSE TO ACTIVITY,0.27821,0.063898,0.086318,0,0
3,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.53179,0.063896,0.069034,0,0
3,GO RESPONSE TO IONIZING RADIATION,0.197,0.063776,0.10082,0,0
3,GO EPITHELIAL TUBE MORPHOGENESIS,0.26442,0.063699,0.12358,0,0
3,GO REGULATION OF MACROAUTOPHAGY,0.214,0.063383,0.1049,0,0
3,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.10134,0.063316,0.10637,0,0
3,GO CELL FATE DETERMINATION,0.3148,0.063267,0.10654,0,0
3,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.38829,0.06325,0.065386,0,0
3,GO POSITIVE REGULATION OF PROTEIN IMPORT,0.56341,0.063246,0.067542,0,0
3,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.16123,0.063231,0.16546,0,0
3,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.20256,0.063229,0.14969,0,0
3,GO LYSINE METABOLIC PROCESS,0.1306,0.063215,0.1701,0,0
3,GO POST GOLGI VESICLE MEDIATED TRANSPORT,0.51122,0.063214,0.08247,0,0
3,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.1306,0.06315,0.10192,0,0
3,GO REGULATION OF HISTONE H4 ACETYLATION,0.49108,0.063031,0.067731,0,0
3,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.50109,0.063006,0.086713,0,0
3,GO MALE SEX DIFFERENTIATION,0.214,0.062949,0.12497,0,0
3,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,0.23827,0.062871,0.12302,0,0
3,GO NEGATIVE REGULATION OF ERAD PATHWAY,0.47137,0.062647,0.066255,0,0
3,GO RESPONSE TO OXYGEN RADICAL,0.72171,0.062609,0.040172,0,0
3,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.1306,0.062584,0.11576,0,0
3,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.34626,0.062512,0.12033,0,0
3,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.65188,0.062223,0.10023,0,0
3,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,0.069906,0.062186,0.10718,0,0
3,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,0.18102,0.062149,0.090068,0,0
3,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.080256,0.062114,0.11089,0,0
3,GO POSITIVE REGULATION OF DNA RECOMBINATION,0.2998,0.062054,0.10076,0,0
3,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.19156,0.062049,0.10303,0,0
3,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,0.11524,0.062016,0.17208,0,0
3,GO NEGATIVE REGULATION OF AMINE TRANSPORT,0.15655,0.062004,0.13564,0,0
3,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.20256,0.061969,0.090397,0,0
3,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,0.54223,0.061923,0.11013,0,0
3,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,0.214,0.061779,0.081434,0,0
3,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,0.30724,0.061766,0.10033,0,0
3,GO MACROAUTOPHAGY,0.2259,0.061764,0.0935,0,0
3,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.51122,0.06172,0.11213,0,0
3,GO CELLULAR RESPONSE TO VITAMIN D,0.4521,0.061698,0.090907,0,0
3,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.074935,0.061674,0.13395,0,0
3,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.96843,0.061586,0.0071057,0,0
3,GO POSITIVE REGULATION OF AUTOPHAGY,0.42405,0.061392,0.10259,0,0
3,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.10134,0.061375,0.11953,0,0
3,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.61803,0.061229,0.12371,0,0
3,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.23203,0.061189,0.15196,0,0
3,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,0.2577,0.061187,0.087549,0,0
3,GO REGULATION OF CATABOLIC PROCESS,0.27126,0.06116,0.090785,0,0
3,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.32248,0.061158,0.10313,0,0
3,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.14312,0.061083,0.11171,0,0
3,GO PROTEIN AUTO ADP RIBOSYLATION,0.65188,0.06098,0.08082,0,0
3,GO REGULATION OF CELLULAR LOCALIZATION,0.32248,0.060756,0.093472,0,0
3,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.30724,0.060544,0.10581,0,0
3,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.15655,0.060505,0.14368,0,0
3,GO REGULATION OF GLIAL CELL DIFFERENTIATION,0.52145,0.060461,0.076238,0,0
3,GO REGULATION OF AMINO ACID TRANSPORT,0.25111,0.060156,0.1281,0,0
3,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,0.10468,0.060052,0.16973,0,0
3,GO DOPAMINE METABOLIC PROCESS,0.68646,0.060049,0.058394,0,0
3,GO PROTEIN ADP RIBOSYLATION,0.84314,0.059726,0.0019212,0,0
3,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,0.26442,0.05944,0.094866,0,0
3,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,0.46168,0.05934,0.10279,0,0
3,GO MANGANESE ION TRANSPORT,0.76963,0.059275,0.039975,0,0
3,GO GROWTH PLATE CARTILAGE DEVELOPMENT,0.60692,0.05926,0.070496,0,0
3,GO NEGATIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.62923,0.059234,0.05064,0,0
3,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.214,0.059232,0.099188,0,0
3,GO PROTEIN INSERTION INTO MEMBRANE,0.10134,0.059187,0.082581,0,0
3,GO REGULATION OF TRANSLATIONAL ELONGATION,0.61803,0.05913,0.033042,0,0
3,GO SENSORY PERCEPTION OF PAIN,0.214,0.059078,0.1108,0,0
3,GO RESPONSE TO AMINE,0.19156,0.059045,0.11603,0,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.074935,0.058979,0.15078,0,0
3,GO POSITIVE REGULATION OF CATABOLIC PROCESS,0.40594,0.058953,0.099099,0,0
3,GO CARDIAC VENTRICLE MORPHOGENESIS,0.57414,0.058914,0.09037,0,0
3,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.36271,0.058818,0.066428,0,0
3,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,0.2577,0.058767,0.083848,0,0
3,GO EPITHELIAL STRUCTURE MAINTENANCE,0.28529,0.058616,0.08586,0,0
3,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.14312,0.058527,0.11865,0,0
3,GO EXOCYTIC PROCESS,0.27821,0.058409,0.10838,0,0
3,GO NEURON APOPTOTIC PROCESS,0.27821,0.058374,0.09423,0,0
3,GO LOCOMOTOR RHYTHM,0.3148,0.058307,0.12052,0,0
3,GO REGULATION OF FIBROBLAST MIGRATION,0.48117,0.058262,0.10901,0,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.54223,0.0579,0.074754,0,0
3,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.13467,0.05787,0.080192,0,0
3,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,0.35442,0.057842,0.063667,0,0
3,GO ENSHEATHMENT OF NEURONS,0.37111,0.057831,0.10448,0,0
3,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.32248,0.057738,0.058137,0,0
3,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.19156,0.057648,0.12257,0,0
3,GO ENERGY RESERVE METABOLIC PROCESS,0.21989,0.057606,0.10412,0,0
3,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.39705,0.057453,0.11857,0,0
3,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.74555,0.057431,0.028065,0,0
3,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.17091,0.057429,0.14947,0,0
3,GO CELLULAR SENESCENCE,0.19156,0.057117,0.10358,0,0
3,GO PIGMENT ACCUMULATION,0.90549,0.057115,0.022435,0,0
3,GO NEGATIVE REGULATION OF BINDING,0.29248,0.057076,0.10807,0,0
3,GO LIPID MODIFICATION,0.39705,0.056902,0.081896,0,0
3,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.38829,0.056657,0.11099,0,0
3,GO GROWTH,0.18624,0.056528,0.12235,0,0
3,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.85555,0.056517,0.087253,0,0
3,GO EXCRETION,0.2577,0.056448,0.11909,0,0
3,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.16123,0.056359,0.068955,0,0
3,GO VESICLE CARGO LOADING,0.36271,0.056166,0.088676,0,0
3,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.84314,0.056115,0.011407,0,0
3,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.2998,0.056081,0.11086,0,0
3,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,0.20256,0.055948,0.18972,0,0
3,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.15655,0.055881,0.12093,0,0
3,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,0.23827,0.055803,0.094397,0,0
3,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,0.52145,0.055788,0.10611,0,0
3,GO DICARBOXYLIC ACID TRANSPORT,0.214,0.055752,0.11835,0,0
3,GO FATTY ACYL COA METABOLIC PROCESS,0.2998,0.055725,0.076983,0,0
3,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,0.39705,0.055721,0.088324,0,0
3,GO SELECTIVE AUTOPHAGY,0.32248,0.05569,0.10232,0,0
3,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.18624,0.055607,0.12253,0,0
3,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.14312,0.055601,0.14035,0,0
3,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,0.23827,0.055592,0.16698,0,0
3,GO NODAL SIGNALING PATHWAY,0.15197,0.055529,0.15199,0,0
3,GO ORGANELLE DISASSEMBLY,0.15197,0.055527,0.10063,0,0
3,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.56341,0.055487,0.077102,0,0
3,GO REGULATION OF CELLULAR RESPIRATION,0.30724,0.055463,0.066018,0,0
3,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.24463,0.055392,0.078994,0,0
3,GO RESPONSE TO BMP,0.61803,0.055279,0.11194,0,0
3,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.10134,0.055101,0.12914,0,0
3,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.34626,0.055079,0.058705,0,0
3,GO CHAPERONE MEDIATED AUTOPHAGY,0.2259,0.054776,0.10921,0,0
3,GO CELLULAR RESPONSE TO ALKALOID,0.16123,0.05472,0.11843,0,0
3,GO HEART MORPHOGENESIS,0.47137,0.054711,0.11852,0,0
3,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.17591,0.05469,0.094187,0,0
3,GO TRIPARTITE REGIONAL SUBDIVISION,0.27821,0.05463,0.089829,0,0
3,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.33821,0.054542,0.093812,0,0
3,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.99368,0.054462,0.045943,0,0
3,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.1475,0.054421,0.21761,0,0
3,GO DETECTION OF CALCIUM ION,0.52145,0.054344,0.046506,0,0
3,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.32248,0.054234,0.084536,0,0
3,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,0.30724,0.054041,0.070361,0,0
3,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.33821,0.053889,0.08511,0,0
3,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.33029,0.053827,0.11674,0,0
3,GO OLFACTORY LOBE DEVELOPMENT,0.18102,0.053744,0.14742,0,0
3,GO AUTOPHAGY OF MITOCHONDRION,0.26442,0.053714,0.099415,0,0
3,GO REGULATION OF WNT SIGNALING PATHWAY,0.30724,0.053263,0.1083,0,0
3,GO CELLULAR AMINO ACID CATABOLIC PROCESS,0.68646,0.053214,0.043248,0,0
3,GO MONOVALENT INORGANIC CATION TRANSPORT,0.15197,0.053198,0.10368,0,0
3,GO REGULATION OF SODIUM ION TRANSPORT,0.20256,0.053066,0.1098,0,0
3,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,0.68646,0.053055,0.15101,0,0
3,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.42405,0.052951,0.08455,0,0
3,GO BASEMENT MEMBRANE ASSEMBLY,0.37111,0.052932,0.12849,0,0
3,GO REGULATION OF FILOPODIUM ASSEMBLY,0.51122,0.05293,0.083663,0,0
3,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.65188,0.052834,0.06408,0,0
3,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,0.21989,0.052826,0.13508,0,0
3,GO REGULATION OF GLUCONEOGENESIS,0.16123,0.052759,0.13187,0,0
3,GO PROTEIN K63 LINKED UBIQUITINATION,0.24463,0.05269,0.087766,0,0
3,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.52145,0.052605,0.05269,0,0
3,GO REGULATION OF GLUCOSE METABOLIC PROCESS,0.14312,0.052537,0.13612,0,0
3,GO REGULATION OF STEM CELL DIFFERENTIATION,0.52145,0.052506,0.043895,0,0
3,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.3148,0.052442,0.095725,0,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,0.067497,0.052249,0.074579,0,0
3,GO RETINA HOMEOSTASIS,0.20256,0.05208,0.068465,0,0
3,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.56341,0.052069,0.09672,0,0
3,GO ENDOCARDIAL CUSHION MORPHOGENESIS,0.80618,0.051963,0.059515,0,0
3,GO EMBRYO DEVELOPMENT,0.080256,0.051907,0.14409,0,0
3,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.37964,0.051862,0.064586,0,0
3,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.7336,0.051832,0.022927,0,0
3,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.17091,0.051813,0.11934,0,0
3,GO NON CANONICAL WNT SIGNALING PATHWAY,0.21989,0.051789,0.096662,0,0
3,GO LIVER REGENERATION,0.80618,0.051712,0.038122,0,0
3,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.20256,0.051676,0.131,0,0
3,GO REGULATION OF CELL DIFFERENTIATION,0.4521,0.051385,0.11185,0,0
3,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.49108,0.051149,0.04992,0,0
3,GO EAR DEVELOPMENT,0.067497,0.051053,0.14633,0,0
3,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.76963,0.051046,0.033736,0,0
3,GO REGULATION OF HORMONE LEVELS,0.2577,0.051034,0.08795,0,0
3,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,0.27821,0.050906,0.093602,0,0
3,GO ESCRT COMPLEX DISASSEMBLY,0.60692,0.050905,0.019998,0,0
3,GO AMINO ACID TRANSMEMBRANE TRANSPORT,0.42405,0.050791,0.080042,0,0
3,GO CELLULAR RESPONSE TO IRON ION,0.99368,0.050711,0.0054484,0,0
3,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.197,0.050647,0.087718,0,0
3,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.33821,0.050524,0.11594,0,0
3,GO STRIATED MUSCLE CELL PROLIFERATION,0.38829,0.050417,0.096846,0,0
3,GO ROOF OF MOUTH DEVELOPMENT,0.28529,0.050238,0.12506,0,0
3,GO METANEPHRIC NEPHRON DEVELOPMENT,0.51122,0.050139,0.12463,0,0
3,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,0.5959,0.050132,0.063838,0,0
3,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,0.29248,0.050063,0.14063,0,0
3,GO REGULATION OF AUTOPHAGY,0.3148,0.050061,0.09026,0,0
3,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.17091,0.049734,0.12006,0,0
3,GO STEM CELL DIFFERENTIATION,0.67486,0.049668,0.073974,0,0
3,GO PYROPTOSIS,0.37111,0.049568,0.097561,0,0
3,GO HEMIDESMOSOME ASSEMBLY,0.7336,0.049568,0.056164,0,0
3,GO DENDRITIC SPINE MAINTENANCE,0.5959,0.049337,0.076991,0,0
3,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.57414,0.049297,0.071822,0,0
3,GO NUCLEOBASE METABOLIC PROCESS,0.68646,0.049223,0.019821,0,0
3,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.35442,0.049089,0.088367,0,0
3,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.49108,0.049062,0.080317,0,0
3,GO ANIMAL ORGAN MATURATION,0.55277,0.048822,0.10242,0,0
3,GO CHLORIDE TRANSPORT,0.33029,0.048786,0.074719,0,0
3,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.26442,0.048759,0.076127,0,0
3,GO MUSCLE ORGAN MORPHOGENESIS,0.58498,0.048706,0.08604,0,0
3,GO DEVELOPMENTAL INDUCTION,0.72171,0.048579,0.058099,0,0
3,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.37111,0.048492,0.092969,0,0
3,GO REGULATION OF BMP SIGNALING PATHWAY,0.5959,0.048433,0.12042,0,0
3,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.28529,0.048429,0.10021,0,0
3,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.84314,0.048311,0.042482,0,0
3,GO PIGMENTATION,0.3148,0.048156,0.085655,0,0
3,GO NEUROTROPHIN SIGNALING PATHWAY,0.19156,0.048068,0.11329,0,0
3,GO MAMMARY GLAND DEVELOPMENT,0.30724,0.048064,0.13347,0,0
3,GO EMBRYONIC ORGAN DEVELOPMENT,0.11894,0.047905,0.15539,0,0
3,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,0.18624,0.047885,0.10996,0,0
3,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,0.39705,0.04784,0.081562,0,0
3,GO ENDOTHELIAL CELL MORPHOGENESIS,0.95582,0.047813,0.065227,0,0
3,GO REGULATION OF PROTEIN LOCALIZATION,0.40594,0.0477,0.082362,0,0
3,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,0.11894,0.047638,0.15319,0,0
3,GO PURINE CONTAINING COMPOUND SALVAGE,0.98106,0.047581,-0.004406,0,0
3,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.74555,0.047538,0.10664,0,0
3,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.52145,0.047442,0.085419,0,0
3,GO ER OVERLOAD RESPONSE,0.39705,0.047432,0.076915,0,0
3,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.79394,0.047392,0.022487,0,0
3,GO SMALL MOLECULE CATABOLIC PROCESS,0.85555,0.047342,0.039791,0,0
3,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.57414,0.047211,0.043766,0,0
3,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.2259,0.047117,0.1206,0,0
3,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.3148,0.047047,0.092461,0,0
3,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.23203,0.046982,0.142,0,0
3,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,0.2998,0.046976,0.093698,0,0
3,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,0.33029,0.046954,0.099172,0,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.36271,0.046923,0.085624,0,0
3,GO PHOTOPERIODISM,0.08303,0.046877,0.13165,0,0
3,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,0.51122,0.046841,0.076528,0,0
3,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.30724,0.046838,0.092294,0,0
3,GO RESPONSE TO MONOSACCHARIDE,0.20822,0.046834,0.1054,0,0
3,GO AUTOPHAGY OF NUCLEUS,0.47137,0.046796,0.076225,0,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.028348,0.046788,0.062836,0,0
3,GO IN UTERO EMBRYONIC DEVELOPMENT,0.25111,0.046743,0.10447,0,0
3,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,0.89296,0.04668,0.011274,0,0
3,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.48117,0.046669,0.10781,0,0
3,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.40594,0.046642,0.11122,0,0
3,GO PROTEIN FOLDING,0.36271,0.046607,0.057719,0,0
3,GO REGULATION OF ASTROCYTE DIFFERENTIATION,0.60692,0.046588,0.06845,0,0
3,GO REGULATION OF CELLULAR COMPONENT SIZE,0.33821,0.046455,0.10895,0,0
3,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.23203,0.046315,0.11282,0,0
3,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.43329,0.046098,0.086904,0,0
3,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.64051,0.046088,0.077787,0,0
3,GO MALE GENITALIA DEVELOPMENT,0.95582,0.046016,0.0029558,0,0
3,GO NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.44264,0.045985,0.079016,0,0
3,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.62923,0.045594,0.045946,0,0
3,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.57414,0.04557,0.068205,0,0
3,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.43329,0.045565,0.08911,0,0
3,GO MAMMARY GLAND MORPHOGENESIS,0.96843,0.045534,0.058449,0,0
3,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,0.56341,0.045492,0.10934,0,0
3,GO THYMUS DEVELOPMENT,0.11163,0.045415,0.13702,0,0
3,GO CELL GROWTH,0.35442,0.045361,0.10562,0,0
3,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,0.90549,0.045358,0.048277,0,0
3,GO NEURON DEATH,0.39705,0.045258,0.089372,0,0
3,GO LYMPHANGIOGENESIS,0.99368,0.045216,0.02318,0,0
3,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.66333,0.04507,0.077095,0,0
3,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,0.72171,0.044933,0.047182,0,0
3,GO PEPTIDYL ARGININE METHYLATION,0.60692,0.044804,0.055181,0,0
3,GO POSITIVE REGULATION OF GROWTH,0.34626,0.044799,0.11578,0,0
3,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.57414,0.044797,0.024723,0,0
3,GO EMBRYONIC MORPHOGENESIS,0.18624,0.044757,0.13749,0,0
3,GO GOLGI TO ENDOSOME TRANSPORT,0.54223,0.044751,0.081026,0,0
3,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.16602,0.044502,0.080657,0,0
3,GO REGULATION OF REPRODUCTIVE PROCESS,0.50109,0.044474,0.06828,0,0
3,GO RESPONSE TO STEROL,0.44264,0.044473,0.11952,0,0
3,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.56341,0.044167,0.057513,0,0
3,GO CARBOHYDRATE HOMEOSTASIS,0.16602,0.044108,0.10408,0,0
3,GO MEMBRANE DEPOLARIZATION,0.43329,0.044013,0.092844,0,0
3,GO SALIVA SECRETION,0.51122,0.044003,0.078893,0,0
3,GO PURINE NUCLEOSIDE METABOLIC PROCESS,0.51122,0.043774,0.031577,0,0
3,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.20256,0.043746,0.11325,0,0
3,GO REGULATION OF CGMP MEDIATED SIGNALING,0.99368,0.043654,0.011848,0,0
3,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.64051,0.043653,0.063374,0,0
3,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.24463,0.043624,0.13671,0,0
3,GO REGULATION OF CYTOPLASMIC TRANSPORT,0.30724,0.04354,0.11236,0,0
3,GO MAINTENANCE OF PROTEIN LOCATION,0.35442,0.043523,0.090812,0,0
3,GO ACTIVATION OF GTPASE ACTIVITY,0.30724,0.043499,0.12859,0,0
3,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.48117,0.043353,0.056824,0,0
3,GO NEURON PROJECTION REGENERATION,0.28529,0.043309,0.14437,0,0
3,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS,0.83078,0.043298,0.0067265,0,0
3,GO REGULATION OF SECONDARY METABOLIC PROCESS,0.75756,0.043179,0.037028,0,0
3,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.40594,0.043159,0.11804,0,0
3,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.65188,0.043049,0.071454,0,0
3,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,0.26442,0.043028,0.043892,0,0
3,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.90549,0.042978,0.073554,0,0
3,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.27821,0.042917,0.097279,0,0
3,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.38829,0.042784,0.059539,0,0
3,GO DIGESTIVE TRACT MORPHOGENESIS,0.2998,0.042746,0.1291,0,0
3,GO AMINO ACID TRANSPORT,0.25111,0.042624,0.11336,0,0
3,GO DETECTION OF MECHANICAL STIMULUS,0.55277,0.042552,0.089798,0,0
3,GO MUSCLE HYPERTROPHY,0.44264,0.042541,0.10694,0,0
3,GO DENDRITE SELF AVOIDANCE,0.36271,0.042389,0.098417,0,0
3,GO PROTEIN HOMOOLIGOMERIZATION,0.37111,0.04233,0.075805,0,0
3,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.48117,0.042328,0.063829,0,0
3,GO PROTEIN COMPLEX OLIGOMERIZATION,0.42405,0.0423,0.077488,0,0
3,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,0.17591,0.042285,0.068067,0,0
3,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.49108,0.042247,0.077869,0,0
3,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.17091,0.042246,0.1146,0,0
3,GO REGULATION OF MITOCHONDRIAL FISSION,0.86799,0.042232,0.053765,0,0
3,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,0.35442,0.042107,0.05271,0,0
3,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.24463,0.041898,0.050854,0,0
3,GO VIRAL GENE EXPRESSION,0.33821,0.041705,0.038507,0,0
3,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.80618,0.041642,0.046904,0,0
3,GO ORGANELLE FUSION,0.47137,0.041601,0.075012,0,0
3,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.48117,0.041575,0.097695,0,0
3,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.86799,0.041563,0.074982,0,0
3,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.58498,0.041416,0.091738,0,0
3,GO LUNG CELL DIFFERENTIATION,0.33821,0.041378,0.12971,0,0
3,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.26442,0.041368,0.096455,0,0
3,GO ENDOSOME ORGANIZATION,0.51122,0.041352,0.049408,0,0
3,GO INSEMINATION,0.90549,0.041217,-0.0060235,0,0
3,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.25111,0.04121,0.10846,0,0
3,GO REGULATION OF HISTONE DEACETYLATION,0.51122,0.041203,0.10265,0,0
3,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.37964,0.041165,0.11079,0,0
3,GO RESPONSE TO CALCIUM ION,0.69814,0.040926,0.061759,0,0
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.91805,0.040873,0.0067884,0,0
3,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.40594,0.0408,0.049035,0,0
3,GO REGULATION OF GOLGI ORGANIZATION,0.48117,0.040785,0.085521,0,0
3,GO DETECTION OF TEMPERATURE STIMULUS,0.41494,0.040775,0.15458,0,0
3,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.2998,0.040769,0.093083,0,0
3,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,0.38829,0.040765,0.077019,0,0
3,GO POSITIVE REGULATION OF CELL AGING,0.94321,0.040733,-0.0046417,0,0
3,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.72171,0.040678,0.059731,0,0
3,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,0.197,0.040627,0.11042,0,0
3,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.2998,0.040422,0.095561,0,0
3,GO MESODERM DEVELOPMENT,0.4521,0.040372,0.079011,0,0
3,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.2998,0.040056,0.053493,0,0
3,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.36271,0.040031,0.1031,0,0
3,GO COPULATION,0.58498,0.03998,0.076425,0,0
3,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.35442,0.039874,0.044096,0,0
3,GO GLIAL CELL DEVELOPMENT,0.61803,0.039503,0.092086,0,0
3,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.88046,0.039492,0.041784,0,0
3,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.60692,0.039449,0.10088,0,0
3,GO GDP METABOLIC PROCESS,0.42405,0.039171,0.09392,0,0
3,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.25111,0.039137,0.15116,0,0
3,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.52145,0.039123,0.088539,0,0
3,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.4521,0.039044,0.062536,0,0
3,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.18624,0.038957,0.11914,0,0
3,GO AUTOPHAGOSOME ORGANIZATION,0.51122,0.038899,0.077841,0,0
3,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,0.48117,0.038887,0.089953,0,0
3,GO REGULATION OF HAIR CYCLE,0.4521,0.038879,0.084057,0,0
3,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.46168,0.038801,0.089542,0,0
3,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.55277,0.038742,0.075897,0,0
3,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.69814,0.038216,0.05787,0,0
3,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.75756,0.038204,0.050807,0,0
3,GO REGULATION OF PROTEIN IMPORT,0.76963,0.038104,0.053905,0,0
3,GO HEART FORMATION,0.80618,0.037976,0.040476,0,0
3,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,0.39705,0.037748,0.14049,0,0
3,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.17091,0.037744,0.074782,0,0
3,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,0.18102,0.037576,0.13593,0,0
3,GO L AMINO ACID TRANSPORT,0.80618,0.037472,0.049022,0,0
3,GO FEVER GENERATION,0.76963,0.037458,0.044536,0,0
3,GO CELLULAR RESPONSE TO ALCOHOL,0.84314,0.037456,0.076189,0,0
3,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,0.56341,0.037268,0.097869,0,0
3,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.20256,0.037178,0.090972,0,0
3,GO ANOIKIS,0.58498,0.037039,0.095433,0,0
3,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.17591,0.036836,0.11854,0,0
3,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.37111,0.036817,0.11771,0,0
3,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.7336,0.036806,0.040042,0,0
3,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.27821,0.036758,0.10753,0,0
3,GO REGULATION OF NEURON PROJECTION REGENERATION,0.47137,0.036758,0.10793,0,0
3,GO REGULATION OF VESICLE FUSION,0.21989,0.036653,0.15058,0,0
3,GO REGULATION OF DNA CATABOLIC PROCESS,0.27126,0.036545,0.098315,0,0
3,GO LUNG MORPHOGENESIS,0.81845,0.036395,0.070862,0,0
3,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.3148,0.036352,0.11298,0,0
3,GO REGULATION OF NATURAL KILLER CELL DIFFERENTIATION,0.66333,0.036348,0.075875,0,0
3,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.93062,0.036271,0.029261,0,0
3,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,0.5959,0.036087,0.060882,0,0
3,GO GLIOGENESIS,0.70989,0.036077,0.089914,0,0
3,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,0.70989,0.035944,0.08389,0,0
3,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.4521,0.035871,0.082932,0,0
3,GO VENTRICULAR SEPTUM DEVELOPMENT,0.67486,0.035815,0.087325,0,0
3,GO RESPONSE TO UV C,0.3148,0.035759,0.099813,0,0
3,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.68646,0.035758,0.052136,0,0
3,GO CHLORIDE ION HOMEOSTASIS,0.44264,0.035642,0.10443,0,0
3,GO DRUG CATABOLIC PROCESS,0.75756,0.035632,0.0072221,0,0
3,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,0.50109,0.035613,0.092311,0,0
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.46168,0.035569,0.089338,0,0
3,GO ATRIAL SEPTUM MORPHOGENESIS,0.47137,0.035562,0.1104,0,0
3,GO SPLEEN DEVELOPMENT,0.72171,0.03543,0.043621,0,0
3,GO NEPHRIC DUCT DEVELOPMENT,0.38829,0.035282,0.12141,0,0
3,GO GLAND DEVELOPMENT,0.28529,0.035179,0.11635,0,0
3,GO AMELOGENESIS,0.76963,0.035122,0.07298,0,0
3,GO CELL SUBSTRATE JUNCTION ORGANIZATION,0.83078,0.035106,0.089591,0,0
3,GO ENDOCHONDRAL BONE MORPHOGENESIS,0.90549,0.034905,0.066215,0,0
3,GO CARDIAC VENTRICLE DEVELOPMENT,0.70989,0.034768,0.0893,0,0
3,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,0.58498,0.034756,0.066867,0,0
3,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.79394,0.034697,0.06903,0,0
3,GO ION TRANSMEMBRANE TRANSPORT,0.35442,0.034624,0.081599,0,0
3,GO CELL AGING,0.25111,0.034545,0.092237,0,0
3,GO PIGMENT GRANULE ORGANIZATION,0.72171,0.03446,0.047323,0,0
3,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,0.4521,0.034373,0.073041,0,0
3,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,0.53179,0.034319,0.12282,0,0
3,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.53179,0.034242,0.051058,0,0
3,GO RECEPTOR INTERNALIZATION,0.56341,0.034227,0.085646,0,0
3,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,0.83078,0.034223,0.035957,0,0
3,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.48117,0.034151,0.078404,0,0
3,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.57414,0.034055,0.057598,0,0
3,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.46168,0.03403,0.074964,0,0
3,GO IMPORT INTO CELL,0.37964,0.033885,0.085048,0,0
3,GO RESPONSE TO HEAT,0.2577,0.033846,0.090823,0,0
3,GO REGULATION OF AUTOPHAGOSOME MATURATION,0.91805,0.033813,0.051424,0,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.79394,0.03376,-0.025411,0,0
3,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.41494,0.033756,0.073017,0,0
3,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.51122,0.033738,0.074962,0,0
3,GO PEROXISOME ORGANIZATION,0.78176,0.033732,0.01442,0,0
3,GO LIPID TRANSLOCATION,0.60692,0.033678,0.088678,0,0
3,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.14312,0.033632,0.10466,0,0
3,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.47137,0.033572,0.069287,0,0
3,GO RESPONSE TO AXON INJURY,0.66333,0.033333,0.09183,0,0
3,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.74555,0.033329,0.066471,0,0
3,GO HYPEROSMOTIC RESPONSE,0.36271,0.033204,0.12039,0,0
3,GO CYTOKINETIC PROCESS,0.3148,0.033189,0.09765,0,0
3,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.58498,0.033062,0.093801,0,0
3,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.64051,0.033034,0.042075,0,0
3,GO REGULATION OF PROTEIN STABILITY,0.44264,0.033011,0.070364,0,0
3,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.53179,0.032949,0.11447,0,0
3,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.79394,0.032949,0.0097715,0,0
3,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.46168,0.032828,0.086036,0,0
3,GO COBALAMIN METABOLIC PROCESS,0.90549,0.032752,0.0090014,0,0
3,GO MUSCLE ORGAN DEVELOPMENT,0.34626,0.032741,0.10793,0,0
3,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,0.75756,0.032697,0.031594,0,0
3,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,0.74555,0.032556,0.08998,0,0
3,GO LAMELLIPODIUM ASSEMBLY,0.69814,0.032481,0.074621,0,0
3,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,0.85555,0.032468,0.062624,0,0
3,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,0.40594,0.03241,0.1002,0,0
3,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.52145,0.032358,0.05202,0,0
3,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.75756,0.032321,0.076554,0,0
3,GO HEART DEVELOPMENT,0.37964,0.032318,0.11731,0,0
3,GO MORPHOGENESIS OF AN EPITHELIUM,0.46168,0.032264,0.1034,0,0
3,GO MYOBLAST DIFFERENTIATION,0.69814,0.032221,0.065861,0,0
3,GO REGULATION OF MITOCHONDRIAL FUSION,0.57414,0.032109,0.064727,0,0
3,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.70989,0.032068,0.048829,0,0
3,GO REGULATION OF TRANSFERASE ACTIVITY,0.78176,0.032063,0.078676,0,0
3,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.90549,0.032031,-0.018616,0,0
3,GO PSEUDOURIDINE SYNTHESIS,0.55277,0.032001,0.030561,0,0
3,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.86799,0.031917,0.049519,0,0
3,GO SODIUM ION HOMEOSTASIS,0.72171,0.031914,0.050102,0,0
3,GO EPITHELIAL CELL MORPHOGENESIS,0.69814,0.031722,0.096534,0,0
3,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.80618,0.031698,0.067515,0,0
3,GO WHITE FAT CELL DIFFERENTIATION,0.32248,0.031684,0.10132,0,0
3,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.2577,0.031661,0.21013,0,0
3,GO PROTEIN KINASE A SIGNALING,0.81845,0.031615,0.032941,0,0
3,GO REGULATION OF PROTEIN TARGETING,0.55277,0.031589,0.070866,0,0
3,GO ALPHA AMINO ACID METABOLIC PROCESS,0.66333,0.031324,0.047691,0,0
3,GO ODONTOGENESIS,0.81845,0.031323,0.070704,0,0
3,GO MITRAL VALVE DEVELOPMENT,0.4521,0.031319,0.10699,0,0
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.76963,0.031107,0.05864,0,0
3,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.94321,0.03108,0.069746,0,0
3,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,0.89296,0.031026,0.098502,0,0
3,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.29248,0.030861,0.089297,0,0
3,GO MUSCLE CELL DEVELOPMENT,0.42405,0.030696,0.089958,0,0
3,GO NEPHRIC DUCT MORPHOGENESIS,0.68646,0.030639,0.06184,0,0
3,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,1,0.030471,0.043685,0,0
3,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,0.51122,0.030454,0.075187,0,0
3,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,0.44264,0.03045,0.083069,0,0
3,GO RIBOSOME ASSEMBLY,0.34626,0.030398,0.038213,0,0
3,GO GLYCOSYLATION,0.72171,0.030308,0.056032,0,0
3,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.84314,0.030303,0.062193,0,0
3,GO CARDIAC SEPTUM DEVELOPMENT,0.74555,0.0303,0.097662,0,0
3,GO TOOTH MINERALIZATION,0.50109,0.030269,0.12432,0,0
3,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.83078,0.030143,0.048498,0,0
3,GO POSITIVE REGULATION OF PROTEIN BINDING,0.74555,0.030124,0.078367,0,0
3,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.56341,0.030121,0.072741,0,0
3,GO GLUCOSE IMPORT,0.55277,0.030097,0.062018,0,0
3,GO HOMOCYSTEINE METABOLIC PROCESS,0.72171,0.030094,0.071717,0,0
3,GO HEART GROWTH,0.70989,0.029869,0.067188,0,0
3,GO REGULATION OF PEPTIDE TRANSPORT,0.89296,0.02974,0.060216,0,0
3,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.30724,0.029556,0.053235,0,0
3,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.7336,0.029531,0.017497,0,0
3,GO KERATINOCYTE PROLIFERATION,0.93062,0.029463,0.051876,0,0
3,GO ERYTHROCYTE HOMEOSTASIS,0.75756,0.029206,0.067672,0,0
3,GO REPLACEMENT OSSIFICATION,0.76963,0.029067,0.016776,0,0
3,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,0.79394,0.029053,-0.0070914,0,0
3,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.32248,0.029047,0.066053,0,0
3,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.65188,0.029005,0.092715,0,0
3,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,0.69814,0.028933,0.052078,0,0
3,GO CORONARY VASCULATURE DEVELOPMENT,0.32248,0.028841,0.14753,0,0
3,GO RESPONSE TO TEMPERATURE STIMULUS,0.39705,0.028808,0.080792,0,0
3,GO PROTEIN TARGETING,0.094909,0.028805,0.051041,0,0
3,GO REGULATION OF PROTEIN CATABOLIC PROCESS,0.50109,0.028751,0.078443,0,0
3,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,0.85555,0.028696,0.0089847,0,0
3,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.41494,0.028641,0.052433,0,0
3,GO ERYTHROCYTE DEVELOPMENT,0.85555,0.02858,0.055513,0,0
3,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.40594,0.028551,0.079772,0,0
3,GO POSITIVE REGULATION OF FILOPODIUM ASSEMBLY,0.80618,0.028479,0.075581,0,0
3,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.40594,0.028436,0.10178,0,0
3,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.90549,0.028402,0.017669,0,0
3,GO DIGESTIVE SYSTEM DEVELOPMENT,0.36271,0.028277,0.11435,0,0
3,GO PROTEIN POLYMERIZATION,0.44264,0.02826,0.087809,0,0
3,GO EMBRYONIC HEMOPOIESIS,0.33029,0.028198,0.12731,0,0
3,GO SPHINGOLIPID MEDIATED SIGNALING PATHWAY,0.69814,0.028075,0.071651,0,0
3,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.38829,0.028016,0.07954,0,0
3,GO CELL CELL JUNCTION ORGANIZATION,0.57414,0.027959,0.094344,0,0
3,GO ANION TRANSMEMBRANE TRANSPORT,0.41494,0.027875,0.07605,0,0
3,GO RIBONUCLEOSIDE METABOLIC PROCESS,0.74555,0.027687,0.021308,0,0
3,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,0.62923,0.027671,0.062166,0,0
3,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,0.39705,0.027591,0.076417,0,0
3,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,0.57414,0.027587,0.095405,0,0
3,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.42405,0.027554,0.093771,0,0
3,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.74555,0.027522,0.051683,0,0
3,GO GLUCOSE CATABOLIC PROCESS,0.32248,0.02735,0.10636,0,0
3,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.36271,0.027302,0.041551,0,0
3,GO REPRODUCTIVE SYSTEM DEVELOPMENT,0.54223,0.027195,0.091957,0,0
3,GO SYNAPTIC VESICLE BUDDING,0.7336,0.027061,0.036458,0,0
3,GO AMINO ACID ACTIVATION,0.38829,0.026909,0.053742,0,0
3,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.78176,0.026904,0.03686,0,0
3,GO NEGATIVE REGULATION OF OSSIFICATION,0.78176,0.026881,0.070511,0,0
3,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.43329,0.026359,0.08507,0,0
3,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.53179,0.026347,0.044382,0,0
3,GO SARCOMERE ORGANIZATION,0.39705,0.026311,0.066315,0,0
3,GO REGULATION OF MESODERM DEVELOPMENT,0.29248,0.026298,0.096592,0,0
3,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.89296,0.026163,0.055102,0,0
3,GO BONE GROWTH,0.83078,0.026115,0.071627,0,0
3,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.62923,0.025977,0.05648,0,0
3,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.58498,0.025945,0.059085,0,0
3,GO PROTEOGLYCAN METABOLIC PROCESS,0.75756,0.025939,0.070872,0,0
3,GO REGULATION OF JUN KINASE ACTIVITY,0.85555,0.025817,0.085923,0,0
3,GO CELLULAR AMIDE METABOLIC PROCESS,0.4521,0.025804,0.039266,0,0
3,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.69814,0.025789,0.10769,0,0
3,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.76963,0.025786,0.07477,0,0
3,GO CELL MATURATION,0.36271,0.025781,0.10069,0,0
3,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.96843,0.025741,0.08109,0,0
3,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.99368,0.025738,0.068533,0,0
3,GO SEROTONIN TRANSPORT,0.37111,0.025724,0.099932,0,0
3,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.30724,0.025547,0.095092,0,0
3,GO POSITIVE REGULATION OF EXOCYTOSIS,0.67486,0.02529,0.058956,0,0
3,GO PROTEIN TETRAMERIZATION,0.79394,0.025278,0.033465,0,0
3,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,0.91805,0.025267,0.049118,0,0
3,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.74555,0.025236,0.060937,0,0
3,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,0.38829,0.025175,0.052276,0,0
3,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.93062,0.025171,0.041867,0,0
3,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.57414,0.024964,0.10708,0,0
3,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.7336,0.024923,0.080072,0,0
3,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.91805,0.024807,0.032397,0,0
3,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.5959,0.024674,0.070054,0,0
3,GO MESENCHYME DEVELOPMENT,0.69814,0.024443,0.073284,0,0
3,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.60692,0.024422,0.059035,0,0
3,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.81845,0.024412,0.039958,0,0
3,GO PROTEIN DEGLYCOSYLATION,0.53179,0.02439,-0.0089161,0,0
3,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.68646,0.024217,0.064379,0,0
3,GO SECRETORY GRANULE ORGANIZATION,0.51122,0.024055,0.086493,0,0
3,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.57414,0.02393,0.053952,0,0
3,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.40594,0.023884,0.062427,0,0
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.7336,0.023774,0.0691,0,0
3,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.28529,0.023744,0.10525,0,0
3,GO RESPONSE TO TESTOSTERONE,0.89296,0.023535,0.038667,0,0
3,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.88046,0.023379,0.049713,0,0
3,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.46168,0.023366,0.063967,0,0
3,GO VESICLE ORGANIZATION,0.81845,0.023344,0.055675,0,0
3,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.65188,0.023255,0.068863,0,0
3,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.81845,0.023193,0.02751,0,0
3,GO REGULATION OF ORGAN GROWTH,0.46168,0.023152,0.086037,0,0
3,GO ORGANELLE MEMBRANE FUSION,0.61803,0.022993,0.067479,0,0
3,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.80618,0.022921,0.069351,0,0
3,GO REGULATION OF TRANSPORT,0.72171,0.022912,0.064448,0,0
3,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,0.81845,0.022801,0.0051487,0,0
3,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.78176,0.022787,0.060103,0,0
3,GO TELOMERASE RNA LOCALIZATION,0.23203,0.022692,0.060156,0,0
3,GO HEART PROCESS,0.28529,0.022627,0.078231,0,0
3,GO RESPONSE TO CARBOHYDRATE,0.34626,0.022547,0.090512,0,0
3,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.64051,0.022516,0.10169,0,0
3,GO MITOTIC CELL CYCLE ARREST,0.40594,0.022488,0.092295,0,0
3,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.72171,0.022303,0.03295,0,0
3,GO PROTEIN AUTOPHOSPHORYLATION,0.5959,0.022229,0.10072,0,0
3,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.4521,0.022132,0.062556,0,0
3,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.66333,0.022131,0.042048,0,0
3,GO VESICLE TARGETING,0.86799,0.022111,0.043941,0,0
3,GO SECONDARY PALATE DEVELOPMENT,0.62923,0.022036,0.078871,0,0
3,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,0.72171,0.021966,0.070934,0,0
3,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.86799,0.021932,0.042821,0,0
3,GO ALPHA AMINO ACID CATABOLIC PROCESS,0.69814,0.021865,0.043753,0,0
3,GO RENAL TUBULE DEVELOPMENT,0.46168,0.021798,0.092896,0,0
3,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.91805,0.021726,0.060086,0,0
3,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,0.19156,0.021687,0.10474,0,0
3,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.3148,0.021527,0.086568,0,0
3,GO NUCLEAR ENVELOPE REASSEMBLY,0.94321,0.021325,0.032657,0,0
3,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.89296,0.021319,0.058075,0,0
3,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.65188,0.02122,0.06032,0,0
3,GO PIGMENT CELL DIFFERENTIATION,0.41494,0.021131,0.097803,0,0
3,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.95582,0.021063,-0.0058408,0,0
3,GO NUCLEOSIDE METABOLIC PROCESS,0.74555,0.020947,0.017003,0,0
3,GO KIDNEY MORPHOGENESIS,0.17091,0.020935,0.14717,0,0
3,GO REGULATION OF TRANSMEMBRANE TRANSPORT,0.37964,0.020933,0.081,0,0
3,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,0.4521,0.020877,0.076286,0,0
3,GO LAMELLIPODIUM ORGANIZATION,0.94321,0.020834,0.061542,0,0
3,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.94321,0.020801,0.032082,0,0
3,GO REGULATION OF BLOOD CIRCULATION,0.44264,0.02078,0.073184,0,0
3,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.64051,0.020594,0.028204,0,0
3,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.84314,0.020536,0.075724,0,0
3,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.91805,0.020465,0.073756,0,0
3,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.58498,0.020396,0.083035,0,0
3,GO PEPTIDE METABOLIC PROCESS,0.33029,0.020391,0.040441,0,0
3,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,0.81845,0.020381,0.019969,0,0
3,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.70989,0.020364,0.084357,0,0
3,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.98106,0.020316,0.044212,0,0
3,GO ENDOCARDIAL CUSHION DEVELOPMENT,0.86799,0.020299,0.047946,0,0
3,GO CALCINEURIN MEDIATED SIGNALING,0.26442,0.020292,0.11832,0,0
3,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.33821,0.020257,0.10478,0,0
3,GO GLUTAMINE METABOLIC PROCESS,0.47137,0.020113,0.071542,0,0
3,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.94321,0.020085,0.0069375,0,0
3,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.83078,0.020065,0.044412,0,0
3,GO TRANSMEMBRANE TRANSPORT,0.57414,0.020024,0.059844,0,0
3,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.36271,0.020008,0.067023,0,0
3,GO EXPORT ACROSS PLASMA MEMBRANE,0.54223,0.019946,0.076737,0,0
3,GO ATP METABOLIC PROCESS,0.41494,0.019938,0.053179,0,0
3,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.38829,0.019834,0.07478,0,0
3,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.58498,0.019823,0.070691,0,0
3,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.24463,0.019726,0.22868,0,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.65188,0.01971,0.063678,0,0
3,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.69814,0.019505,0.082806,0,0
3,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.91805,0.019501,0.024528,0,0
3,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,0.69814,0.01948,0.059039,0,0
3,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.65188,0.019372,0.096326,0,0
3,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.51122,0.019248,0.0603,0,0
3,GO ENDOCRINE HORMONE SECRETION,0.94321,0.019151,0.031418,0,0
3,GO LIPOSACCHARIDE METABOLIC PROCESS,0.81845,0.019123,0.048931,0,0
3,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.76963,0.018997,0.052406,0,0
3,GO STRIATUM DEVELOPMENT,0.53179,0.018994,0.081029,0,0
3,GO CATION TRANSMEMBRANE TRANSPORT,0.36271,0.018965,0.08145,0,0
3,GO SKELETAL MUSCLE CONTRACTION,0.41494,0.018933,0.064819,0,0
3,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.50109,0.018671,0.08578,0,0
3,GO CELLULAR RESPONSE TO X RAY,0.88046,0.018671,0.069726,0,0
3,GO REGULATION OF VASCULAR PERMEABILITY,0.86799,0.018593,0.078807,0,0
3,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,0.17091,0.018545,0.13869,0,0
3,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,0.78176,0.018513,0.10916,0,0
3,GO DEVELOPMENTAL PIGMENTATION,0.49108,0.018435,0.082574,0,0
3,GO REGULATION OF PROTEIN BINDING,0.98106,0.018289,0.060164,0,0
3,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,0.80618,0.018288,-0.0015365,0,0
3,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.46168,0.018155,0.066921,0,0
3,GO POLYSACCHARIDE METABOLIC PROCESS,0.47137,0.01806,0.083591,0,0
3,GO MEGAKARYOCYTE DIFFERENTIATION,0.57414,0.018022,0.084599,0,0
3,GO PEROXISOMAL TRANSPORT,0.96843,0.017945,0.0038053,0,0
3,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.34626,0.017921,0.059321,0,0
3,GO FOREGUT MORPHOGENESIS,0.23203,0.017755,0.135,0,0
3,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.65188,0.01774,0.06638,0,0
3,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,0.67486,0.017709,0.098282,0,0
3,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.57414,0.017647,0.080238,0,0
3,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.98106,0.017595,0.029944,0,0
3,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.80618,0.01756,0.072266,0,0
3,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.84314,0.017505,0.079734,0,0
3,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.89296,0.01736,-0.012466,0,0
3,GO NEGATIVE REGULATION OF SIGNALING,0.75756,0.017265,0.074403,0,0
3,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.83078,0.017244,0.041214,0,0
3,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.56341,0.017197,0.10236,0,0
3,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.88046,0.017195,0.088038,0,0
3,GO POSITIVE REGULATION OF CELL GROWTH,0.46168,0.017169,0.08678,0,0
3,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,0.99368,0.016809,0.031998,0,0
3,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,0.80618,0.016799,0.054141,0,0
3,GO GLUCOSE METABOLIC PROCESS,0.61803,0.016731,0.073166,0,0
3,GO GOLGI VESICLE BUDDING,0.89296,0.016687,0.037961,0,0
3,GO CORTICAL CYTOSKELETON ORGANIZATION,0.81845,0.016534,0.037129,0,0
3,GO NOTCH SIGNALING PATHWAY,0.38829,0.016438,0.098074,0,0
3,GO ANIMAL ORGAN MORPHOGENESIS,0.34626,0.016352,0.12217,0,0
3,GO BONE MATURATION,0.56341,0.016249,0.10108,0,0
3,GO CARBOHYDRATE METABOLIC PROCESS,0.76963,0.01618,0.052047,0,0
3,GO ALANINE TRANSPORT,0.48117,0.015975,0.10529,0,0
3,GO MESODERMAL CELL FATE SPECIFICATION,0.53179,0.015929,0.057074,0,0
3,GO PROTEIN DESTABILIZATION,0.81845,0.015742,0.059253,0,0
3,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.64051,0.015602,0.065243,0,0
3,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.88046,0.015596,0.034801,0,0
3,GO LIPID HOMEOSTASIS,0.98106,0.015522,0.034101,0,0
3,GO NUCLEOSIDE SALVAGE,0.34626,0.015349,0.078727,0,0
3,GO NEGATIVE REGULATION OF CELL GROWTH,0.84314,0.015281,0.074234,0,0
3,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,0.20256,0.015187,0.11974,0,0
3,GO NEPHRON MORPHOGENESIS,0.197,0.015109,0.1346,0,0
3,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.64051,0.015047,0.058208,0,0
3,GO MITOCHONDRIAL FUSION,0.43329,0.015011,0.074406,0,0
3,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.62923,0.014991,-0.017662,0,0
3,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,0.99368,0.014857,0.0385,0,0
3,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.80618,0.014816,0.039128,0,0
3,GO PHOSPHATIDYLGLYCEROL BIOSYNTHETIC PROCESS,0.93062,0.014783,0.019706,0,0
3,GO TYPE B PANCREATIC CELL PROLIFERATION,0.93062,0.014727,0.040871,0,0
3,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.3148,0.014522,0.11503,0,0
3,GO RESPONSE TO MUSCLE ACTIVITY,0.94321,0.014291,0.027918,0,0
3,GO EXOCRINE SYSTEM DEVELOPMENT,0.5959,0.014168,0.10213,0,0
3,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.98106,0.014096,0.027595,0,0
3,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.78176,0.013888,0.023516,0,0
3,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,0.96843,0.013735,0.048158,0,0
3,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.80618,0.013693,0.083763,0,0
3,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.39705,0.01369,0.083448,0,0
3,GO RESPONSE TO EXTRACELLULAR STIMULUS,0.72171,0.013496,0.062476,0,0
3,GO INORGANIC ANION TRANSPORT,0.93062,0.013496,0.051128,0,0
3,GO MEMBRANE ORGANIZATION,0.76963,0.013477,0.058375,0,0
3,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.94321,0.013468,0.032772,0,0
3,GO PROTEIN TARGETING TO MITOCHONDRION,0.36271,0.013335,0.047286,0,0
3,GO MITOCHONDRIAL PROTEIN PROCESSING,0.43329,0.013185,0.048124,0,0
3,GO REGULATION OF MUSCLE ADAPTATION,0.7336,0.013014,0.093107,0,0
3,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.5959,0.012962,0.081508,0,0
3,GO MUSCLE TISSUE DEVELOPMENT,0.62923,0.012838,0.086873,0,0
3,GO REGULATION OF MUSCLE CONTRACTION,0.79394,0.012789,0.049375,0,0
3,GO PEROXISOMAL MEMBRANE TRANSPORT,0.64051,0.012718,0.052534,0,0
3,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.89296,0.012709,0.066445,0,0
3,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.5959,0.012502,0.084482,0,0
3,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.93062,0.012439,0.018563,0,0
3,GO BINDING OF SPERM TO ZONA PELLUCIDA,0.40594,0.012392,0.034519,0,0
3,GO STEROL METABOLIC PROCESS,0.68646,0.012358,0.00077774,0,0
3,GO MITOCHONDRION ORGANIZATION,0.47137,0.012356,0.055391,0,0
3,GO CARDIAC MUSCLE CELL DIFFERENTIATION,0.43329,0.012267,0.092703,0,0
3,GO HYPOTHALAMUS DEVELOPMENT,0.57414,0.012235,0.077587,0,0
3,GO BODY FLUID SECRETION,0.80618,0.012229,0.055895,0,0
3,GO TISSUE MORPHOGENESIS,0.55277,0.012172,0.098364,0,0
3,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.84314,0.012061,0.072054,0,0
3,GO ERBB SIGNALING PATHWAY,0.91805,0.012036,0.041691,0,0
3,GO CAMP METABOLIC PROCESS,0.55277,0.01203,0.10731,0,0
3,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.51122,0.011832,0.083161,0,0
3,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.90549,0.011819,0.043335,0,0
3,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,0.80618,0.011421,0.049088,0,0
3,GO POLYSACCHARIDE CATABOLIC PROCESS,0.66333,0.011207,0.058653,0,0
3,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,0.79394,0.011112,0.065355,0,0
3,GO EPITHELIAL CELL DEVELOPMENT,0.54223,0.011084,0.11204,0,0
3,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.96843,0.011018,0.038121,0,0
3,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,0.68646,0.010883,0.0017917,0,0
3,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.96843,0.010209,0.040276,0,0
3,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.80618,0.010106,0.063479,0,0
3,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,0.75756,0.010009,-0.016906,0,0
3,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.95582,0.0099644,0.039111,0,0
3,GO POSITIVE REGULATION OF HORMONE SECRETION,0.68646,0.009939,0.050739,0,0
3,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.88046,0.009862,-0.0071275,0,0
3,GO LYMPH VESSEL DEVELOPMENT,0.91805,0.0098215,0.056441,0,0
3,GO RESPONSE TO STEROL DEPLETION,0.93062,0.0097057,0.029793,0,0
3,GO LIPOPROTEIN LOCALIZATION,0.81845,0.0096543,0.035761,0,0
3,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.48117,0.0095624,0.075728,0,0
3,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.75756,0.0095459,0.081306,0,0
3,GO PIGMENT BIOSYNTHETIC PROCESS,0.83078,0.0094813,0.025894,0,0
3,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.81845,0.0094429,0.088637,0,0
3,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,0.99368,0.0094061,0.061622,0,0
3,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,0.95582,0.0093961,0.048437,0,0
3,GO REGULATION OF ACROSOME REACTION,0.61803,0.0091627,0.056586,0,0
3,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.51122,0.009145,0.059762,0,0
3,GO REGULATION OF PROTEIN POLYMERIZATION,0.41494,0.0091272,0.092425,0,0
3,GO PHOSPHOLIPID DEPHOSPHORYLATION,0.34626,0.0089683,0.12347,0,0
3,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.98106,0.0089472,0.031667,0,0
3,GO MICROVILLUS ASSEMBLY,0.78176,0.0089202,0.058159,0,0
3,GO POSITIVE REGULATION OF INSULIN SECRETION,0.48117,0.0089044,0.075192,0,0
3,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.66333,0.0088858,0.069428,0,0
3,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.75756,0.0087538,-0.00014619,0,0
3,GO REGULATION OF GROWTH,0.51122,0.0087333,0.10185,0,0
3,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.94321,0.0086945,0.057886,0,0
3,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,0.61803,0.0086266,0.080282,0,0
3,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,0.94321,0.0085804,0.023992,0,0
3,GO MAST CELL MIGRATION,0.47137,0.0085302,0.093121,0,0
3,GO BLASTODERM SEGMENTATION,0.33821,0.0085108,0.099615,0,0
3,GO RESPONSE TO INSULIN,0.60692,0.0084783,0.07617,0,0
3,GO FOCAL ADHESION ASSEMBLY,0.65188,0.0084315,0.11366,0,0
3,GO VIRAL RELEASE FROM HOST CELL,0.83078,0.0083826,0.016187,0,0
3,GO REGULATION OF PHOSPHORYLATION,0.90549,0.0083182,0.05934,0,0
3,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.78176,0.0082982,0.085258,0,0
3,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.4521,0.0081894,0.095661,0,0
3,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.67486,0.0081352,0.07659,0,0
3,GO BROWN FAT CELL DIFFERENTIATION,0.88046,0.0080317,0.021703,0,0
3,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.81845,0.0080026,0.027708,0,0
3,GO HEART VALVE DEVELOPMENT,0.89296,0.007946,0.090229,0,0
3,GO ACTIVATION OF JUN KINASE ACTIVITY,0.98106,0.0078421,0.055254,0,0
3,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.86799,0.007735,0.042399,0,0
3,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.90549,0.0076942,0.051931,0,0
3,GO REGULATION OF PROTEIN FOLDING,0.81845,0.0076908,0.047071,0,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.89296,0.0076557,0.04063,0,0
3,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.39705,0.0076184,0.14478,0,0
3,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,0.49108,0.0075634,0.090955,0,0
3,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.94321,0.0075091,0.053571,0,0
3,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,0.74555,0.0073815,0.066345,0,0
3,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,0.66333,0.0072872,0.080045,0,0
3,GO FIBROBLAST MIGRATION,0.84314,0.0071777,0.086394,0,0
3,GO SENSORY PERCEPTION OF BITTER TASTE,0.68646,0.006933,0.063566,0,0
3,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.69814,0.0068795,0.079899,0,0
3,GO POSITIVE REGULATION OF TRANSLATION,0.83078,0.0068775,0.03045,0,0
3,GO CARDIOCYTE DIFFERENTIATION,0.90549,0.0068264,0.068145,0,0
3,GO CARDIAC CHAMBER DEVELOPMENT,0.85555,0.0067769,0.080168,0,0
3,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,0.33821,0.0067607,0.13029,0,0
3,GO ERAD PATHWAY,0.94321,0.006716,0.045269,0,0
3,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.86799,0.0067041,0.05185,0,0
3,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.75756,0.0066966,0.069604,0,0
3,GO SKIN MORPHOGENESIS,0.91805,0.006672,0.047767,0,0
3,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.83078,0.0066287,0.051843,0,0
3,GO FILOPODIUM ASSEMBLY,0.76963,0.0066026,0.079434,0,0
3,GO GLYCOSYL COMPOUND METABOLIC PROCESS,0.96843,0.0065957,0.016649,0,0
3,GO REGULATION OF HYDROLASE ACTIVITY,0.76963,0.0065643,0.038347,0,0
3,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.86799,0.0065352,0.047094,0,0
3,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.79394,0.0064277,0.059524,0,0
3,GO VACUOLE ORGANIZATION,0.95582,0.0061852,0.048722,0,0
3,GO LUNG EPITHELIUM DEVELOPMENT,1,0.0061024,0.069195,0,0
3,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.76963,0.0060769,0.030559,0,0
3,GO REGULATION OF GLIAL CELL PROLIFERATION,0.40594,0.0059871,0.099704,0,0
3,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,1,0.0059579,0.039539,0,0
3,GO POST TRANSLATIONAL PROTEIN MODIFICATION,0.7336,0.0059028,0.02697,0,0
3,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.96843,0.0057564,0.057287,0,0
3,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.83078,0.0056364,0.064206,0,0
3,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.4521,0.005568,0.070144,0,0
3,GO STEROL HOMEOSTASIS,0.81845,0.0055437,-0.011587,0,0
3,GO RESPONSE TO ACID CHEMICAL,0.89296,0.005485,0.056863,0,0
3,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.91805,0.0053842,0.036885,0,0
3,GO SLEEP,0.98106,0.0053209,-0.0039381,0,0
3,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.84314,0.0051256,0.01573,0,0
3,GO ADAPTATION OF SIGNALING PATHWAY,0.55277,0.0051054,0.069272,0,0
3,GO DNA DEAMINATION,0.46168,0.0050851,-0.078684,0,0
3,GO RESPONSE TO GAMMA RADIATION,0.90549,0.0049241,0.034824,0,0
3,GO ACTIN FILAMENT BASED MOVEMENT,0.67486,0.0047868,0.082707,0,0
3,GO MESONEPHROS DEVELOPMENT,0.29248,0.0047827,0.10673,0,0
3,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.58498,0.0047027,0.065546,0,0
3,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.90549,0.004678,0.054584,0,0
3,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.80618,0.004615,-0.0097204,0,0
3,GO NEPHRON EPITHELIUM DEVELOPMENT,0.41494,0.0045267,0.093902,0,0
3,GO ERBB2 SIGNALING PATHWAY,0.90549,0.0044532,0.052788,0,0
3,GO SOMATIC STEM CELL POPULATION MAINTENANCE,0.60692,0.0043988,0.068801,0,0
3,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.80618,0.004389,0.012121,0,0
3,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.64051,0.0043796,-0.077028,0,0
3,GO VASCULOGENESIS,0.79394,0.0043289,0.080005,0,0
3,GO RECEPTOR CATABOLIC PROCESS,0.66333,0.0042255,0.015413,0,0
3,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.75756,0.0041426,0.045405,0,0
3,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.34626,0.0039651,0.064286,0,0
3,GO NATURAL KILLER CELL DIFFERENTIATION,0.96843,0.0038995,0.012763,0,0
3,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.33029,0.0038864,0.11996,0,0
3,GO MONOSACCHARIDE METABOLIC PROCESS,0.98106,0.0038612,0.03958,0,0
3,GO CELLULAR LIPID CATABOLIC PROCESS,0.67486,0.0037837,0.0038387,0,0
3,GO RESPONSE TO PEPTIDE HORMONE,0.68646,0.0037832,0.078391,0,0
3,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.89296,0.0037512,0.0026933,0,0
3,GO REGULATION OF SECRETION,0.80618,0.0037137,0.065808,0,0
3,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.36271,0.0036922,0.10163,0,0
3,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.84314,0.0036576,0.068763,0,0
3,GO EPIDERMIS DEVELOPMENT,0.99368,0.0036284,0.02953,0,0
3,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.99368,0.0035959,0.033944,0,0
3,GO CATECHOLAMINE METABOLIC PROCESS,0.83078,0.0035215,0.046157,0,0
3,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,0.65188,0.0034015,0.078118,0,0
3,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.89296,0.00327,0.046932,0,0
3,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.75756,0.0032657,0.041362,0,0
3,GO ENDOCARDIUM DEVELOPMENT,0.65188,0.0032013,0.081943,0,0
3,GO ENTRY OF BACTERIUM INTO HOST CELL,0.70989,0.0031411,-0.014387,0,0
3,GO BRANCH ELONGATION OF AN EPITHELIUM,0.96843,0.0030531,-0.0078021,0,0
3,GO CELLULAR RESPONSE TO ANTIBIOTIC,0.95582,0.0029752,0.023462,0,0
3,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,0.61803,0.0028488,0.081493,0,0
3,GO RECEPTOR METABOLIC PROCESS,0.72171,0.0027737,0.069021,0,0
3,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.93062,0.0025378,0.055886,0,0
3,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.90549,0.0025148,0.06483,0,0
3,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.61803,0.0024748,0.066977,0,0
3,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.57414,0.0024029,0.12211,0,0
3,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.91805,0.0023677,0.0044384,0,0
3,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.57414,0.0023618,0.058842,0,0
3,GO POSITIVE REGULATION OF ERAD PATHWAY,0.52145,0.0023465,-0.01719,0,0
3,GO INTERMEMBRANE LIPID TRANSFER,0.95582,0.0022427,0.040292,0,0
3,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.65188,0.0021278,0.019316,0,0
3,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,1,0.0020647,0.020387,0,0
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.91805,0.0020129,0.058436,0,0
3,GO CARDIAC MUSCLE CONTRACTION,0.70989,0.0018509,0.053297,0,0
3,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.68646,0.0017673,0.046401,0,0
3,GO MITOCHONDRION MORPHOGENESIS,0.70989,0.001732,0.056664,0,0
3,GO REPLICATIVE SENESCENCE,0.88046,0.0016884,0.0056201,0,0
3,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.88046,0.0016588,0.0097732,0,0
3,GO POSITIVE REGULATION OF ANION TRANSPORT,0.90549,0.0016292,0.035524,0,0
3,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.81845,0.0015536,0.025454,0,0
3,GO FEMALE GENITALIA DEVELOPMENT,0.66333,0.0014674,0.060736,0,0
3,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.88046,0.0013896,0.014588,0,0
3,GO DIOL BIOSYNTHETIC PROCESS,0.84314,0.0013774,0.06186,0,0
3,GO CELLULAR RESPONSE TO PEPTIDE,0.52145,0.001346,0.088563,0,0
3,GO CARDIOLIPIN METABOLIC PROCESS,0.38829,0.0013254,-0.036284,0,0
3,GO ORGAN GROWTH,0.83078,0.0012891,0.08102,0,0
3,GO TERPENOID BIOSYNTHETIC PROCESS,0.86799,0.0012463,0.0020529,0,0
3,GO UBIQUITIN DEPENDENT ERAD PATHWAY,0.89296,0.0011802,0.03363,0,0
3,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.86799,0.0011619,0.081477,0,0
3,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,0.50109,0.0011265,0.091633,0,0
3,GO CHAPERONE MEDIATED PROTEIN FOLDING,0.62923,0.00106,0.0533,0,0
3,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,0.70989,0.0010278,0.059186,0,0
3,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,0.72171,0.00095471,0.11945,0,0
3,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.34626,0.0009111,0.097542,0,0
3,GO MYELOID CELL HOMEOSTASIS,0.93062,0.00082089,0.040142,0,0
3,GO SULFUR COMPOUND METABOLIC PROCESS,0.7336,0.00079577,0.013336,0,0
3,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.96843,0.00071912,0.043944,0,0
3,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.90549,0.00065158,0.02834,0,0
3,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.85555,0.00055561,0.005353,0,0
3,GO MESONEPHRIC TUBULE MORPHOGENESIS,0.38829,0.00024531,0.093827,0,0
3,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.84314,0.00017883,0.073976,0,0
3,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,0.51122,6.617e-05,0.082442,0,0
3,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.75756,-6.5107e-05,0.082806,0,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.56341,-9.825e-05,0.0046333,0,0
3,GO RESPONSE TO ABIOTIC STIMULUS,0.89296,-0.00010496,0.054836,0,0
3,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,0.65188,-0.00012366,0.07467,0,0
3,GO NEGATIVE REGULATION OF GENE SILENCING,0.7336,-0.00025142,0.04777,0,0
3,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.78176,-0.00032354,0.076318,0,0
3,GO CELL VOLUME HOMEOSTASIS,0.46168,-0.00060176,0.10281,0,0
3,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.90549,-0.00069708,0.047492,0,0
3,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.79394,-0.0007003,0.097085,0,0
3,GO COPII COATED VESICLE BUDDING,0.91805,-0.00080993,0.032028,0,0
3,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.47137,-0.00082709,-0.036902,0,0
3,GO JNK CASCADE,0.80618,-0.00088155,0.042636,0,0
3,GO NEGATIVE REGULATION OF ION TRANSPORT,0.75756,-0.00090345,0.059317,0,0
3,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.93062,-0.0009087,0.023596,0,0
3,GO LIPID BIOSYNTHETIC PROCESS,0.70989,-0.00095912,0.018418,0,0
3,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.74555,-0.0010744,0.089549,0,0
3,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.57414,-0.0011685,0.064379,0,0
3,GO DOPAMINERGIC NEURON DIFFERENTIATION,0.48117,-0.0012024,0.10699,0,0
3,GO ENDOCARDIAL CUSHION FORMATION,0.67486,-0.0012028,0.010738,0,0
3,GO MIDBODY ABSCISSION,0.78176,-0.0012863,-0.010262,0,0
3,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.57414,-0.0013445,0.10631,0,0
3,GO REGULATION OF FERTILIZATION,0.42405,-0.0013656,0.065893,0,0
3,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,1,-0.0013772,0.041778,0,0
3,GO INOSITOL LIPID MEDIATED SIGNALING,0.99368,-0.0015241,0.064622,0,0
3,GO NEGATIVE REGULATION OF JNK CASCADE,0.7336,-0.0015572,0.07389,0,0
3,GO DOPAMINE BIOSYNTHETIC PROCESS,0.37111,-0.0015881,0.11165,0,0
3,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.95582,-0.0016025,0.039923,0,0
3,GO MESENCHYMAL CELL DIFFERENTIATION,0.95582,-0.0017639,0.06606,0,0
3,GO STEROL BIOSYNTHETIC PROCESS,0.81845,-0.0019492,0.050279,0,0
3,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.86799,-0.0021614,0.094709,0,0
3,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,0.85555,-0.0022444,0.025764,0,0
3,GO CELLULAR RESPONSE TO VITAMIN,0.64051,-0.0025081,-0.00099085,0,0
3,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.75756,-0.0025214,0.083775,0,0
3,GO CELLULAR PIGMENTATION,0.81845,-0.0025737,0.025178,0,0
3,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.90549,-0.0026671,0.034897,0,0
3,GO DICARBOXYLIC ACID METABOLIC PROCESS,0.72171,-0.0027935,0.044876,0,0
3,GO ALCOHOL METABOLIC PROCESS,0.64051,-0.0028802,0.0073796,0,0
3,GO NEGATIVE REGULATION OF AUTOPHAGY,0.81845,-0.0028984,0.061012,0,0
3,GO AORTA DEVELOPMENT,0.96843,-0.0029452,0.078337,0,0
3,GO REGULATION OF MYELINATION,0.84314,-0.0030138,0.039002,0,0
3,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.65188,-0.0031556,0.10715,0,0
3,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.64051,-0.0032244,0.065951,0,0
3,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.74555,-0.0032416,0.03991,0,0
3,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,0.99368,-0.0032643,0.011156,0,0
3,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,0.46168,-0.0032792,0.092411,0,0
3,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.78176,-0.0033029,0.056239,0,0
3,GO UROGENITAL SYSTEM DEVELOPMENT,0.64051,-0.0033154,0.083487,0,0
3,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.58498,-0.0034001,-0.031559,0,0
3,GO SULFATE TRANSPORT,0.52145,-0.0034132,0.070596,0,0
3,GO OSTEOBLAST DIFFERENTIATION,0.81845,-0.003519,0.039439,0,0
3,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.61803,-0.0035889,0.058569,0,0
3,GO ACID SECRETION,0.51122,-0.0036153,0.049239,0,0
3,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.67486,-0.003634,-0.0013882,0,0
3,GO ESTROGEN METABOLIC PROCESS,0.67486,-0.0036486,-0.035446,0,0
3,GO CARDIAC ATRIUM MORPHOGENESIS,0.86799,-0.0037304,0.068301,0,0
3,GO HEMATOPOIETIC STEM CELL PROLIFERATION,0.70989,-0.0038457,0.036636,0,0
3,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.98106,-0.0041416,0.034861,0,0
3,GO ION TRANSPORT,0.76963,-0.0041628,0.053188,0,0
3,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.95582,-0.0041849,-0.0023374,0,0
3,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.89296,-0.0042087,0.030984,0,0
3,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,0.23203,-0.004329,0.11039,0,0
3,GO REGULATION OF GLIOGENESIS,0.98106,-0.0044473,0.047724,0,0
3,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.95582,-0.0045049,0.02064,0,0
3,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.84314,-0.0045675,0.03726,0,0
3,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.52145,-0.0045731,-0.058601,0,0
3,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.57414,-0.0046853,0.041785,0,0
3,GO HOMEOSTASIS OF NUMBER OF CELLS,0.85555,-0.0046938,0.02028,0,0
3,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,0.96843,-0.0047238,0.037247,0,0
3,GO KIDNEY MESENCHYME DEVELOPMENT,0.68646,-0.0047472,0.0029275,0,0
3,GO CYTOPLASM ORGANIZATION,0.57414,-0.0047848,0.087716,0,0
3,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.67486,-0.0047856,0.037257,0,0
3,GO GPI ANCHOR METABOLIC PROCESS,0.93062,-0.0048089,0.013579,0,0
3,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.88046,-0.0049193,0.062224,0,0
3,GO REGULATION OF PEPTIDE SECRETION,0.80618,-0.0049291,0.034079,0,0
3,GO KIDNEY EPITHELIUM DEVELOPMENT,0.39705,-0.0049981,0.097127,0,0
3,GO SYMBIOTIC PROCESS,0.79394,-0.0050518,0.018214,0,0
3,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.98106,-0.0050907,0.017786,0,0
3,GO FOREBRAIN NEURON FATE COMMITMENT,0.42405,-0.0050982,0.19962,0,0
3,GO DETECTION OF STIMULUS,0.68646,-0.0052609,0.046443,0,0
3,GO MITOCHONDRIAL GENE EXPRESSION,0.64051,-0.0053829,-0.010064,0,0
3,GO RNA 5 END PROCESSING,0.94321,-0.0054084,0.0078571,0,0
3,GO MITOCHONDRIAL FISSION,0.93062,-0.0055276,0.037533,0,0
3,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.65188,-0.0056632,0.085058,0,0
3,GO RESPIRATORY SYSTEM DEVELOPMENT,1,-0.0057723,0.081866,0,0
3,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.53179,-0.0058035,0.12137,0,0
3,GO MUSCLE CELL MIGRATION,0.74555,-0.0058246,0.033837,0,0
3,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,0.76963,-0.0059235,0.021268,0,0
3,GO RESPONSE TO WATER,0.68646,-0.0059336,-0.0055796,0,0
3,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.88046,-0.0059912,0.034059,0,0
3,GO MEMBRANE LIPID METABOLIC PROCESS,0.85555,-0.0060865,0.029264,0,0
3,GO TRICARBOXYLIC ACID METABOLIC PROCESS,0.90549,-0.006213,0.03548,0,0
3,GO ACTIN FILAMENT DEPOLYMERIZATION,0.75756,-0.0062816,0.035361,0,0
3,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.76963,-0.0063613,0.035692,0,0
3,GO SECONDARY HEART FIELD SPECIFICATION,1,-0.0063672,0.065454,0,0
3,GO SEQUESTERING OF ACTIN MONOMERS,0.91805,-0.0064598,0.010796,0,0
3,GO SMAD PROTEIN SIGNAL TRANSDUCTION,0.84314,-0.0065112,0.073545,0,0
3,GO CELLULAR COMPONENT DISASSEMBLY,0.96843,-0.0066278,0.043653,0,0
3,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.84314,-0.0067529,-0.0018182,0,0
3,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,0.99368,-0.0068615,0.06745,0,0
3,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.96843,-0.0070256,0.058177,0,0
3,GO CARBOHYDRATE PHOSPHORYLATION,0.7336,-0.0071583,0.076232,0,0
3,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.80618,-0.0072133,0.028609,0,0
3,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.44264,-0.0072608,-0.066211,0,0
3,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.74555,-0.0074009,0.096981,0,0
3,GO IMPORT ACROSS PLASMA MEMBRANE,0.76963,-0.0074177,0.04823,0,0
3,GO NEGATIVE REGULATION OF GROWTH,0.95582,-0.007467,0.058737,0,0
3,GO CELLULAR RESPONSE TO VIRUS,0.48117,-0.0074838,-0.047976,0,0
3,GO PIGMENT GRANULE LOCALIZATION,0.69814,-0.0075097,0.054695,0,0
3,GO PENTOSE METABOLIC PROCESS,0.95582,-0.0076142,0.029417,0,0
3,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,0.69814,-0.0076436,0.025631,0,0
3,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.99368,-0.0076789,0.0081908,0,0
3,GO REGULATION OF MUSCLE SYSTEM PROCESS,0.66333,-0.0077427,0.069646,0,0
3,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.78176,-0.007916,0.045706,0,0
3,GO PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.60692,-0.0079221,-0.011331,0,0
3,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,0.65188,-0.007988,0.015727,0,0
3,GO REGULATION OF GASTRIC ACID SECRETION,0.95582,-0.008077,0.0090137,0,0
3,GO CAVEOLIN MEDIATED ENDOCYTOSIS,0.76963,-0.0081364,0.064612,0,0
3,GO MYOFIBRIL ASSEMBLY,0.7336,-0.0082173,0.019057,0,0
3,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.81845,-0.0082274,0.088844,0,0
3,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,0.80618,-0.0083515,0.071958,0,0
3,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.60692,-0.0084361,0.0066393,0,0
3,GO RESPONSE TO ESTRADIOL,0.74555,-0.008534,0.059224,0,0
3,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.80618,-0.0086658,-0.017743,0,0
3,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,0.70989,-0.0086703,-0.019154,0,0
3,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.96843,-0.0087523,0.046647,0,0
3,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.38829,-0.0088838,-0.089069,0,0
3,GO SPHINGOID METABOLIC PROCESS,0.85555,-0.0089273,0.066913,0,0
3,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,0.51122,-0.0090166,-0.02984,0,0
3,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.75756,-0.0090632,0.026107,0,0
3,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,0.57414,-0.0090912,-0.041447,0,0
3,GO PROSTATE GLAND DEVELOPMENT,0.72171,-0.0091234,0.059852,0,0
3,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.7336,-0.0092297,0.026238,0,0
3,GO REGULATION OF KIDNEY DEVELOPMENT,0.94321,-0.0093318,0.041622,0,0
3,GO LIPID METABOLIC PROCESS,0.54223,-0.0094006,0.012118,0,0
3,GO NEPHRON DEVELOPMENT,0.85555,-0.0094933,0.069521,0,0
3,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,0.48117,-0.0095438,0.06551,0,0
3,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.80618,-0.0097661,0.01351,0,0
3,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.94321,-0.0098108,0.034093,0,0
3,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.91805,-0.0098162,0.025675,0,0
3,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.96843,-0.0098392,0.076017,0,0
3,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.80618,-0.0098584,0.059771,0,0
3,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,0.90549,-0.010123,0.04755,0,0
3,GO MITOTIC CYTOKINETIC PROCESS,0.90549,-0.010142,0.0080779,0,0
3,GO EPITHELIAL CELL PROLIFERATION,0.85555,-0.010194,0.044706,0,0
3,GO EPITHELIUM DEVELOPMENT,0.67486,-0.010294,0.075928,0,0
3,GO INDOLALKYLAMINE METABOLIC PROCESS,0.84314,-0.010305,0.0081317,0,0
3,GO L GLUTAMATE IMPORT,0.5959,-0.010318,0.070055,0,0
3,GO STRIATED MUSCLE CONTRACTION,0.62923,-0.010334,0.05431,0,0
3,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.78176,-0.010362,0.038221,0,0
3,GO METANEPHROS DEVELOPMENT,0.91805,-0.010366,0.063273,0,0
3,GO NAD METABOLIC PROCESS,0.80618,-0.010436,0.062464,0,0
3,GO REGULATION OF VASCULOGENESIS,0.83078,-0.010451,0.052594,0,0
3,GO RESPONSE TO NITROGEN COMPOUND,0.95582,-0.010727,0.050448,0,0
3,GO RESPONSE TO DRUG,0.70989,-0.010729,0.036734,0,0
3,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,1,-0.01082,0.014727,0,0
3,GO REGULATION OF ENDOCYTOSIS,0.7336,-0.011127,0.039,0,0
3,GO EPITHELIAL CELL DIFFERENTIATION,0.98106,-0.011239,0.048581,0,0
3,GO EPITHELIAL TO MESENCHYMAL TRANSITION,0.89296,-0.011442,0.058413,0,0
3,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.70989,-0.011578,0.014257,0,0
3,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.94321,-0.011643,0.047445,0,0
3,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.76963,-0.011735,0.030465,0,0
3,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.52145,-0.011929,0.012166,0,0
3,GO AUTOPHAGOSOME MATURATION,0.96843,-0.011985,0.027156,0,0
3,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.70989,-0.012013,0.016881,0,0
3,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.67486,-0.012017,0.034173,0,0
3,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.76963,-0.012219,0.055033,0,0
3,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,0.65188,-0.012233,-0.015287,0,0
3,GO HEXOSE CATABOLIC PROCESS,0.94321,-0.012499,0.032983,0,0
3,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.79394,-0.012552,0.092248,0,0
3,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.98106,-0.012592,0.066288,0,0
3,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.84314,-0.012624,0.052745,0,0
3,GO CELLULAR LIPID METABOLIC PROCESS,0.48117,-0.012728,0.0050528,0,0
3,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.47137,-0.012752,-0.024117,0,0
3,GO CERAMIDE BIOSYNTHETIC PROCESS,0.85555,-0.012775,0.058512,0,0
3,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.84314,-0.012775,0.047338,0,0
3,GO CELLULAR METABOLIC COMPOUND SALVAGE,0.93062,-0.012886,0.022713,0,0
3,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.78176,-0.012929,0.05466,0,0
3,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.93062,-0.012938,0.038073,0,0
3,GO CATION TRANSPORT,0.65188,-0.013037,0.063527,0,0
3,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.65188,-0.0131,0.057132,0,0
3,GO POSITIVE REGULATION OF SIGNALING,0.69814,-0.013121,0.034664,0,0
3,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.91805,-0.013382,0.027888,0,0
3,GO CELL CELL JUNCTION ASSEMBLY,0.90549,-0.013392,0.066662,0,0
3,GO SPERM CAPACITATION,0.83078,-0.013425,0.031215,0,0
3,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.88046,-0.013448,0.012106,0,0
3,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,0.37964,-0.013537,-0.02488,0,0
3,GO ANATOMICAL STRUCTURE MATURATION,0.5959,-0.013672,0.093949,0,0
3,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.64051,-0.013735,0.089227,0,0
3,GO HOMEOSTATIC PROCESS,0.67486,-0.013764,0.02817,0,0
3,GO PEPTIDYL PROLINE MODIFICATION,0.4521,-0.013857,-0.0048611,0,0
3,GO LIPID CATABOLIC PROCESS,0.50109,-0.013889,-0.0073092,0,0
3,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.65188,-0.013933,0.03686,0,0
3,GO MUSCLE CELL CELLULAR HOMEOSTASIS,0.79394,-0.013978,0.051379,0,0
3,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.80618,-0.014003,0.0017433,0,0
3,GO MUSCLE SYSTEM PROCESS,0.95582,-0.014006,0.046219,0,0
3,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.61803,-0.01402,0.072659,0,0
3,GO GLYCEROLIPID METABOLIC PROCESS,0.61803,-0.014068,0.016322,0,0
3,GO TRNA 5 LEADER REMOVAL,0.48117,-0.014426,-0.02655,0,0
3,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.46168,-0.014432,-0.018867,0,0
3,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.76963,-0.014519,0.069151,0,0
3,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.70989,-0.01464,0.053427,0,0
3,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.69814,-0.014706,0.027428,0,0
3,GO ACYLGLYCEROL HOMEOSTASIS,0.54223,-0.01474,-0.060972,0,0
3,GO BONE MORPHOGENESIS,0.69814,-0.014856,0.083522,0,0
3,GO TRICARBOXYLIC ACID CYCLE,0.60692,-0.014917,-0.0077858,0,0
3,GO EPIDERMAL CELL DIFFERENTIATION,0.83078,-0.014942,-0.0027562,0,0
3,GO APOPTOTIC PROCESS,0.69814,-0.015054,0.029775,0,0
3,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.68646,-0.015167,-0.0079775,0,0
3,GO AMINE CATABOLIC PROCESS,0.75756,-0.015177,-0.027251,0,0
3,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.90549,-0.015178,0.058919,0,0
3,GO POSITIVE REGULATION OF PROTEOLYSIS,0.49108,-0.015181,0.0082034,0,0
3,GO POSITIVE REGULATION OF JNK CASCADE,0.5959,-0.015201,0.012132,0,0
3,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.88046,-0.015259,0.072287,0,0
3,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,0.84314,-0.015334,0.08585,0,0
3,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.84314,-0.015547,0.018238,0,0
3,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.67486,-0.015605,0.091194,0,0
3,GO POSITIVE REGULATION OF VIRAL PROCESS,0.55277,-0.015647,0.0035904,0,0
3,GO CARDIAC MUSCLE CELL CONTRACTION,0.69814,-0.015699,0.069129,0,0
3,GO CERAMIDE METABOLIC PROCESS,1,-0.016077,0.053904,0,0
3,GO SKELETAL SYSTEM DEVELOPMENT,0.70989,-0.016117,0.080847,0,0
3,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.64051,-0.01619,0.090112,0,0
3,GO POSITIVE REGULATION OF VESICLE FUSION,0.89296,-0.016296,-0.030482,0,0
3,GO FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS,0.50109,-0.016366,-0.020688,0,0
3,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.74555,-0.016367,0.047873,0,0
3,GO ORGANOPHOSPHATE CATABOLIC PROCESS,0.70989,-0.016374,0.012941,0,0
3,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.93062,-0.01638,0.073755,0,0
3,GO QUINONE METABOLIC PROCESS,0.95582,-0.016648,0.055274,0,0
3,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.76963,-0.016796,0.027701,0,0
3,GO ORGANIC ACID METABOLIC PROCESS,0.60692,-0.01696,0.0097686,0,0
3,GO STRESS FIBER ASSEMBLY,0.99368,-0.017038,0.083468,0,0
3,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.66333,-0.017072,0.026406,0,0
3,GO PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS,0.90549,-0.017122,0.02352,0,0
3,GO ORGANOPHOSPHATE ESTER TRANSPORT,0.84314,-0.017191,0.03006,0,0
3,GO APICAL JUNCTION ASSEMBLY,0.81845,-0.017207,0.067248,0,0
3,GO NUCLEOTIDE SALVAGE,0.36271,-0.017222,-0.039011,0,0
3,GO KERATINOCYTE MIGRATION,0.98106,-0.017243,0.050222,0,0
3,GO REGULATION OF TELOMERASE ACTIVITY,0.94321,-0.0174,0.051341,0,0
3,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.96843,-0.017438,0.015155,0,0
3,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.95582,-0.017589,0.03342,0,0
3,GO REGULATION OF MEMBRANE REPOLARIZATION,0.95582,-0.017662,0.029845,0,0
3,GO REGULATION OF PROTEIN DEUBIQUITINATION,0.81845,-0.017697,0.061061,0,0
3,GO CELLULAR RESPONSE TO RETINOIC ACID,0.66333,-0.017701,0.015096,0,0
3,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.42405,-0.017902,-0.084475,0,0
3,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.86799,-0.017904,0.034793,0,0
3,GO METAL ION TRANSPORT,0.72171,-0.018054,0.058542,0,0
3,GO SMOOTH MUSCLE CELL DIFFERENTIATION,0.85555,-0.018128,0.069028,0,0
3,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.86799,-0.018142,0.048065,0,0
3,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,0.64051,-0.018303,0.00077707,0,0
3,GO REGULATION OF CARDIAC CONDUCTION,0.75756,-0.018507,0.039325,0,0
3,GO PODOSOME ASSEMBLY,0.91805,-0.018581,0.038748,0,0
3,GO SUBPALLIUM DEVELOPMENT,0.98106,-0.018649,0.034763,0,0
3,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,1,-0.018771,0.065117,0,0
3,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,0.83078,-0.018778,0.01305,0,0
3,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,0.89296,-0.018957,0.037921,0,0
3,GO PROTEOLYSIS,0.69814,-0.018962,0.033578,0,0
3,GO CONVERGENT EXTENSION,0.93062,-0.01917,0.058898,0,0
3,GO CARDIOBLAST DIFFERENTIATION,0.83078,-0.019293,-0.0056257,0,0
3,GO METANEPHRIC GLOMERULUS DEVELOPMENT,0.78176,-0.019377,0.022016,0,0
3,GO DICARBOXYLIC ACID CATABOLIC PROCESS,0.69814,-0.019391,0.0524,0,0
3,GO PROTEIN TRANSMEMBRANE TRANSPORT,0.5959,-0.019399,-0.0024864,0,0
3,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.7336,-0.019475,0.019475,0,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.83078,-0.019496,0.029997,0,0
3,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.76963,-0.019594,0.081768,0,0
3,GO RESPONSE TO GROWTH FACTOR,0.86799,-0.019624,0.076831,0,0
3,GO RELAXATION OF MUSCLE,0.68646,-0.019636,-0.017847,0,0
3,GO SECONDARY METABOLIC PROCESS,0.81845,-0.019917,0.054697,0,0
3,GO REGULATION OF GASTRULATION,0.74555,-0.019995,0.0086637,0,0
3,GO REGULATION OF ION TRANSPORT,0.74555,-0.02003,0.05798,0,0
3,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.61803,-0.020138,0.061957,0,0
3,GO ANION HOMEOSTASIS,0.84314,-0.020142,0.045308,0,0
3,GO REGULATION OF PROTEIN COMPLEX STABILITY,0.76963,-0.020194,-4.7858e-06,0,0
3,GO STEROID METABOLIC PROCESS,0.43329,-0.020276,-0.010592,0,0
3,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,0.69814,-0.020368,-3.3603e-06,0,0
3,GO DIOL METABOLIC PROCESS,0.94321,-0.020424,0.047554,0,0
3,GO GLYCOPROTEIN METABOLIC PROCESS,0.69814,-0.020434,0.024982,0,0
3,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,0.62923,-0.020675,0.094484,0,0
3,GO HORMONE BIOSYNTHETIC PROCESS,0.74555,-0.02069,0.012343,0,0
3,GO ORGANELLE INHERITANCE,0.51122,-0.020789,0.086538,0,0
3,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.70989,-0.020801,0.014903,0,0
3,GO MUSCLE CONTRACTION,0.93062,-0.020878,0.044167,0,0
3,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,0.7336,-0.021075,0.011034,0,0
3,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.60692,-0.021151,0.01869,0,0
3,GO INTERFERON BETA PRODUCTION,0.62923,-0.02119,-0.0068154,0,0
3,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.70989,-0.021204,-0.0096812,0,0
3,GO AMINO SUGAR BIOSYNTHETIC PROCESS,0.75756,-0.021288,0.029978,0,0
3,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,1,-0.021352,0.0072005,0,0
3,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.78176,-0.021413,0.059655,0,0
3,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.67486,-0.021414,0.019619,0,0
3,GO PHOSPHOLIPID METABOLIC PROCESS,0.57414,-0.021464,0.012672,0,0
3,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.41494,-0.021834,-0.076578,0,0
3,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.46168,-0.021924,-0.0077747,0,0
3,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.98106,-0.022176,0.046873,0,0
3,GO VIRAL BUDDING,0.36271,-0.022181,-0.039809,0,0
3,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,0.85555,-0.022292,0.039709,0,0
3,GO RIBONUCLEOSIDE CATABOLIC PROCESS,0.54223,-0.022496,-0.042914,0,0
3,GO SPHINGOLIPID METABOLIC PROCESS,0.93062,-0.02256,0.052455,0,0
3,GO GLAND MORPHOGENESIS,0.93062,-0.02262,0.052115,0,0
3,GO PROTEIN DEMANNOSYLATION,0.78176,-0.022814,0.019857,0,0
3,GO REGULATION OF ENDOCRINE PROCESS,0.78176,-0.022834,0.003986,0,0
3,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,0.46168,-0.022888,-0.020365,0,0
3,GO REGULATION OF ORGANIC ACID TRANSPORT,0.95582,-0.023204,0.050322,0,0
3,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.90549,-0.023276,0.048148,0,0
3,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.7336,-0.023384,0.075013,0,0
3,GO SUBSTRATE DEPENDENT CELL MIGRATION,0.70989,-0.023521,0.021887,0,0
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.4521,-0.023523,-0.021121,0,0
3,GO RESPONSE TO AMPHETAMINE,0.40594,-0.023586,0.096638,0,0
3,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.91805,-0.023595,0.063583,0,0
3,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,0.79394,-0.0237,0.034257,0,0
3,GO RESPONSE TO ACIDIC PH,0.80618,-0.023702,0.0081826,0,0
3,GO AMYLOID BETA METABOLIC PROCESS,0.50109,-0.023758,0.0044069,0,0
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.53179,-0.023778,0.0132,0,0
3,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.89296,-0.023874,0.04196,0,0
3,GO RESPONSE TO OSMOTIC STRESS,0.66333,-0.023891,0.021429,0,0
3,GO REGULATION OF LIPID METABOLIC PROCESS,0.42405,-0.024046,0.0052388,0,0
3,GO PROTEIN N LINKED GLYCOSYLATION,0.2998,-0.024096,-0.022495,0,0
3,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.46168,-0.02411,-0.0024917,0,0
3,GO RESPONSE TO PAIN,0.90549,-0.024257,0.030738,0,0
3,GO ANION TRANSPORT,0.90549,-0.024274,0.041015,0,0
3,GO RETINOIC ACID METABOLIC PROCESS,0.85555,-0.024308,0.0031723,0,0
3,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.64051,-0.024309,-0.010676,0,0
3,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.7336,-0.024315,0.065044,0,0
3,GO SECOND MESSENGER MEDIATED SIGNALING,0.94321,-0.024485,0.023437,0,0
3,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.42405,-0.024488,-0.025835,0,0
3,GO RESPONSE TO INTERLEUKIN 12,0.33029,-0.024635,-0.05959,0,0
3,GO BASE EXCISION REPAIR AP SITE FORMATION,0.83078,-0.025224,0.010301,0,0
3,GO REGULATION OF HEART RATE,0.96843,-0.025425,0.025978,0,0
3,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.4521,-0.025615,-0.031991,0,0
3,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.93062,-0.025847,0.030561,0,0
3,GO ASTROCYTE DIFFERENTIATION,0.78176,-0.025907,0.019811,0,0
3,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.83078,-0.025945,0.032392,0,0
3,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.79394,-0.026053,0.022112,0,0
3,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,0.52145,-0.026063,0.001836,0,0
3,GO POLYOL BIOSYNTHETIC PROCESS,0.90549,-0.026066,0.027695,0,0
3,GO AORTA MORPHOGENESIS,0.84314,-0.026152,0.029053,0,0
3,GO REGULATION OF VIRAL TRANSCRIPTION,0.5959,-0.026239,0.0095016,0,0
3,GO CARDIAC SEPTUM MORPHOGENESIS,0.95582,-0.026302,0.068742,0,0
3,GO MUSCLE ADAPTATION,0.95582,-0.026321,0.062389,0,0
3,GO TRACHEA MORPHOGENESIS,0.89296,-0.026508,0.080537,0,0
3,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.78176,-0.026515,0.016291,0,0
3,GO CELLULAR RESPONSE TO OXYGEN LEVELS,0.85555,-0.026564,0.028093,0,0
3,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.83078,-0.026603,0.041998,0,0
3,GO TRANSLATIONAL ELONGATION,0.66333,-0.026606,-0.0066967,0,0
3,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.68646,-0.026639,0.017112,0,0
3,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.65188,-0.026644,0.013855,0,0
3,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,0.85555,-0.026829,0.021105,0,0
3,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.66333,-0.026893,0.031477,0,0
3,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,0.52145,-0.02692,-0.008129,0,0
3,GO ENDODERMAL CELL FATE COMMITMENT,0.72171,-0.027012,-0.021566,0,0
3,GO CELLULAR HOMEOSTASIS,0.36271,-0.0273,0.0019403,0,0
3,GO MEMBRANE FUSION,0.66333,-0.027313,0.022005,0,0
3,GO KETONE BIOSYNTHETIC PROCESS,0.84314,-0.027336,0.0078906,0,0
3,GO MULTIVESICULAR BODY ORGANIZATION,0.55277,-0.027413,-0.026512,0,0
3,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.61803,-0.027509,0.020741,0,0
3,GO MODULATION OF PROCESS OF OTHER ORGANISM,0.44264,-0.027584,-0.021827,0,0
3,GO FAT CELL DIFFERENTIATION,0.84314,-0.027589,0.048828,0,0
3,GO TEMPERATURE HOMEOSTASIS,0.68646,-0.027605,0.043501,0,0
3,GO CONNECTIVE TISSUE DEVELOPMENT,0.67486,-0.027629,0.046543,0,0
3,GO MESODERM MORPHOGENESIS,0.69814,-0.027703,0.027695,0,0
3,GO PLASMA MEMBRANE ORGANIZATION,0.80618,-0.027761,0.046593,0,0
3,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,0.69814,-0.028166,0.02316,0,0
3,GO PROTEIN HOMOTETRAMERIZATION,0.47137,-0.028297,-0.01454,0,0
3,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.61803,-0.028327,0.029504,0,0
3,GO CELLULAR KETONE METABOLIC PROCESS,0.98106,-0.028356,0.022818,0,0
3,GO MEMBRANE REPOLARIZATION,0.91805,-0.028497,0.029254,0,0
3,GO ZINC ION TRANSPORT,0.55277,-0.028591,-0.0028724,0,0
3,GO RESPONSE TO UV B,0.53179,-0.028617,-0.00059253,0,0
3,GO ORGANIC HYDROXY COMPOUND TRANSPORT,0.94321,-0.028763,0.049989,0,0
3,GO BODY MORPHOGENESIS,0.85555,-0.028799,0.050456,0,0
3,GO LABYRINTHINE LAYER DEVELOPMENT,0.80618,-0.02885,0.017947,0,0
3,GO MUSCLE STRUCTURE DEVELOPMENT,0.83078,-0.028875,0.077254,0,0
3,GO RESPONSE TO ENDOGENOUS STIMULUS,0.93062,-0.02888,0.055309,0,0
3,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.7336,-0.028904,0.047106,0,0
3,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.47137,-0.02895,-0.018113,0,0
3,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.86799,-0.02898,0.0080754,0,0
3,GO DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.79394,-0.029039,0.0078951,0,0
3,GO REGULATION OF CELL DEATH,0.54223,-0.029113,0.021927,0,0
3,GO VIRAL GENOME REPLICATION,0.66333,-0.029172,-0.00685,0,0
3,GO GASTRIC ACID SECRETION,0.79394,-0.029342,0.029304,0,0
3,GO OXIDATION REDUCTION PROCESS,0.44264,-0.029362,-0.0041246,0,0
3,GO MESODERMAL CELL FATE COMMITMENT,0.94321,-0.029391,0.0068382,0,0
3,GO PIGMENT METABOLIC PROCESS,0.79394,-0.029408,0.010084,0,0
3,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,0.86799,-0.029505,0.023694,0,0
3,GO PHARYNGEAL SYSTEM DEVELOPMENT,0.56341,-0.029569,-0.0079944,0,0
3,GO EMBRYONIC PLACENTA DEVELOPMENT,0.90549,-0.029622,0.056248,0,0
3,GO PROTEIN O LINKED MANNOSYLATION,0.95582,-0.02975,0.043489,0,0
3,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,0.5959,-0.029815,0.011297,0,0
3,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.90549,-0.029856,0.02193,0,0
3,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.53179,-0.029896,0.0043351,0,0
3,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.85555,-0.029909,0.019319,0,0
3,GO CIRCULATORY SYSTEM PROCESS,0.88046,-0.030091,0.040949,0,0
3,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.68646,-0.030276,-0.011335,0,0
3,GO RESPONSE TO COLD,0.68646,-0.030412,0.005358,0,0
3,GO ALDEHYDE CATABOLIC PROCESS,0.66333,-0.030433,-0.023662,0,0
3,GO REGULATION OF AMYLOID BETA FORMATION,0.53179,-0.030442,-0.0017342,0,0
3,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.95582,-0.030562,0.058957,0,0
3,GO CELLULAR RESPONSE TO MANGANESE ION,0.78176,-0.03065,0.024338,0,0
3,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.60692,-0.030688,-0.0040575,0,0
3,GO REGULATION OF RESPONSE TO STRESS,0.46168,-0.030775,0.00075864,0,0
3,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.95582,-0.030817,0.071906,0,0
3,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.69814,-0.030907,0.030728,0,0
3,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,0.86799,-0.030923,0.037651,0,0
3,GO REGULATION OF STEROID METABOLIC PROCESS,0.46168,-0.030953,0.0016571,0,0
3,GO MUSCLE CELL DIFFERENTIATION,0.89296,-0.031035,0.07459,0,0
3,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.91805,-0.031067,0.032124,0,0
3,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,0.48117,-0.03107,-0.04075,0,0
3,GO NEGATIVE REGULATION OF CELL DEATH,0.54223,-0.031103,0.012207,0,0
3,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,0.57414,-0.031215,0.017714,0,0
3,GO PEPTIDE SECRETION,0.93062,-0.031266,0.042409,0,0
3,GO ACTIN FILAMENT BASED PROCESS,0.94321,-0.031622,0.076833,0,0
3,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.94321,-0.03165,0.045083,0,0
3,GO CELLULAR RESPONSE TO DRUG,0.53179,-0.031692,0.016569,0,0
3,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.72171,-0.031725,0.002698,0,0
3,GO RESPONSE TO PH,0.94321,-0.031821,0.049726,0,0
3,GO FATTY ACID METABOLIC PROCESS,0.33029,-0.031999,-0.018118,0,0
3,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.68646,-0.032026,0.03256,0,0
3,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,0.28529,-0.032207,-0.039096,0,0
3,GO NADPH REGENERATION,0.91805,-0.032294,0.0098258,0,0
3,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.88046,-0.032325,0.021549,0,0
3,GO POSITIVE REGULATION OF GLIOGENESIS,0.60692,-0.032346,-0.0077373,0,0
3,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.65188,-0.032379,-0.015567,0,0
3,GO RESPONSE TO PEPTIDE,0.89296,-0.032389,0.055855,0,0
3,GO REGULATION OF CARTILAGE DEVELOPMENT,0.74555,-0.032451,0.012382,0,0
3,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.5959,-0.032522,-0.0001107,0,0
3,GO NEGATIVE REGULATION BY HOST OF VIRAL PROCESS,0.80618,-0.032603,-0.010737,0,0
3,GO CELLULAR RESPIRATION,0.50109,-0.032657,-0.018423,0,0
3,GO MONOSACCHARIDE CATABOLIC PROCESS,0.70989,-0.032755,0.017162,0,0
3,GO PHOSPHOLIPID TRANSPORT,0.51122,-0.032791,0.0017338,0,0
3,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.84314,-0.032993,0.066981,0,0
3,GO VAGINA DEVELOPMENT,0.56341,-0.033024,0.10275,0,0
3,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.81845,-0.033093,-0.032724,0,0
3,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.70989,-0.03315,0.057917,0,0
3,GO LAMELLIPODIUM MORPHOGENESIS,0.94321,-0.033337,0.06951,0,0
3,GO STEROID BIOSYNTHETIC PROCESS,0.48117,-0.033437,-0.0014815,0,0
3,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,0.64051,-0.033699,-0.017989,0,0
3,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.60692,-0.033961,0.018542,0,0
3,GO PROTEIN AUTOPROCESSING,0.94321,-0.033985,0.018933,0,0
3,GO CORTICOSTEROID HORMONE SECRETION,0.83078,-0.034156,-0.014854,0,0
3,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,0.85555,-0.034274,0.01973,0,0
3,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,0.26442,-0.034336,-0.061183,0,0
3,GO MODIFIED AMINO ACID TRANSPORT,0.43329,-0.034419,-0.019143,0,0
3,GO POSITIVE REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.58498,-0.034431,-0.015116,0,0
3,GO ALCOHOL BIOSYNTHETIC PROCESS,0.90549,-0.034511,0.027379,0,0
3,GO MUSCLE FILAMENT SLIDING,0.53179,-0.034785,-0.029876,0,0
3,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.46168,-0.034953,-0.017276,0,0
3,GO STRIATED MUSCLE CELL DIFFERENTIATION,0.81845,-0.034974,0.045422,0,0
3,GO RESPONSE TO DIETARY EXCESS,0.48117,-0.034979,-0.034275,0,0
3,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.39705,-0.035014,0.0058348,0,0
3,GO RESPONSE TO FORSKOLIN,0.4521,-0.035167,0.15534,0,0
3,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,0.68646,-0.035485,0.045513,0,0
3,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,0.41494,-0.03555,-0.0966,0,0
3,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.96843,-0.035599,0.079333,0,0
3,GO CELLULAR SODIUM ION HOMEOSTASIS,0.85555,-0.035656,0.054436,0,0
3,GO UTP METABOLIC PROCESS,0.70989,-0.035744,-0.025714,0,0
3,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,0.75756,-0.035823,0.04574,0,0
3,GO MYELOID CELL DIFFERENTIATION,0.46168,-0.035844,-0.0053282,0,0
3,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.66333,-0.035884,-0.016237,0,0
3,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,0.93062,-0.035894,0.10253,0,0
3,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.75756,-0.036165,0.038153,0,0
3,GO CELL MOTILITY,0.50109,-0.036192,0.023473,0,0
3,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.67486,-0.036311,0.019098,0,0
3,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.27821,-0.036347,0.012707,0,0
3,GO HEPATOCYTE DIFFERENTIATION,0.90549,-0.036499,-0.016737,0,0
3,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.43329,-0.036603,-0.021907,0,0
3,GO MITOCHONDRIAL TRANSLATION,0.2259,-0.036637,-0.035333,0,0
3,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.39705,-0.03671,-0.054701,0,0
3,GO RESPONSE TO METAL ION,0.54223,-0.036785,0.014098,0,0
3,GO ENDOTHELIUM DEVELOPMENT,0.57414,-0.036788,0.017184,0,0
3,GO SKIN DEVELOPMENT,0.81845,-0.036874,0.013874,0,0
3,GO REGULATION OF CELL SHAPE,0.74555,-0.036978,0.038358,0,0
3,GO NEUTRAL LIPID CATABOLIC PROCESS,0.48117,-0.037013,-0.034274,0,0
3,GO RESPONSE TO X RAY,0.76963,-0.037033,0.05746,0,0
3,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.85555,-0.037249,-0.0015131,0,0
3,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.98106,-0.037255,0.039194,0,0
3,GO REGULATION OF MAP KINASE ACTIVITY,0.66333,-0.037459,0.036496,0,0
3,GO RENAL SYSTEM PROCESS,0.68646,-0.037675,0.037588,0,0
3,GO DIVALENT INORGANIC CATION TRANSPORT,0.60692,-0.037865,0.01237,0,0
3,GO CELLULAR RESPONSE TO ATP,0.41494,-0.03787,-0.035448,0,0
3,GO CALCIUM ION IMPORT,0.98106,-0.038024,0.036092,0,0
3,GO CHONDROCYTE DEVELOPMENT,0.81845,-0.038066,0.028754,0,0
3,GO ACTIN FILAMENT ORGANIZATION,0.75756,-0.038088,0.047606,0,0
3,GO AMYLOID BETA FORMATION,0.64051,-0.038283,0.0095053,0,0
3,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,0.5959,-0.03848,0.03504,0,0
3,GO NEGATIVE REGULATION OF TRANSPORT,0.60692,-0.038551,0.023398,0,0
3,GO WATER HOMEOSTASIS,0.84314,-0.038708,0.015288,0,0
3,GO REGULATION OF MEMBRANE DEPOLARIZATION,0.84314,-0.038815,0.013168,0,0
3,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.86799,-0.038823,0.049987,0,0
3,GO ACTIN MEDIATED CELL CONTRACTION,0.88046,-0.038916,0.04613,0,0
3,GO LIPID GLYCOSYLATION,0.90549,-0.038955,0.073955,0,0
3,GO GAS TRANSPORT,0.83078,-0.038966,-0.0010083,0,0
3,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,0.58498,-0.038992,0.023368,0,0
3,GO REGULATION OF KERATINOCYTE MIGRATION,0.89296,-0.039024,0.04836,0,0
3,GO SENSORY PERCEPTION OF TASTE,0.94321,-0.039038,0.0095884,0,0
3,GO TRNA 5 END PROCESSING,0.33029,-0.03924,-0.022535,0,0
3,GO RENAL SODIUM EXCRETION,0.81845,-0.039331,0.0042593,0,0
3,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.43329,-0.039347,-0.014628,0,0
3,GO GONADOTROPIN SECRETION,0.80618,-0.039479,0.016764,0,0
3,GO CIRCULATORY SYSTEM DEVELOPMENT,0.78176,-0.039481,0.052065,0,0
3,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,0.84314,-0.039638,0.022863,0,0
3,GO MEGAKARYOCYTE DEVELOPMENT,0.90549,-0.039679,0.072646,0,0
3,GO PROTON TRANSMEMBRANE TRANSPORT,0.64051,-0.039719,-0.0069168,0,0
3,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.57414,-0.039745,0.027429,0,0
3,GO ER NUCLEUS SIGNALING PATHWAY,0.4521,-0.039788,-0.0016041,0,0
3,GO CELLULAR RESPONSE TO NUTRIENT,0.51122,-0.039853,-0.017011,0,0
3,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.41494,-0.039878,0.0083874,0,0
3,GO ORGANIC ANION TRANSPORT,0.76963,-0.039916,0.031189,0,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.58498,-0.039942,0.0093928,0,0
3,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.47137,-0.039946,0.014491,0,0
3,GO T CELL DIFFERENTIATION IN THYMUS,0.70989,-0.040045,-0.013466,0,0
3,GO LYTIC VACUOLE ORGANIZATION,0.38829,-0.040411,-0.0010334,0,0
3,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,0.64051,-0.040534,-0.0021826,0,0
3,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.2998,-0.040585,-0.032649,0,0
3,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.84314,-0.040609,-0.0072609,0,0
3,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.65188,-0.040673,0.12462,0,0
3,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.58498,-0.040785,-0.031636,0,0
3,GO AGING,0.53179,-0.040789,0.017534,0,0
3,GO CYTOCHROME COMPLEX ASSEMBLY,0.39705,-0.040793,-0.032836,0,0
3,GO OVULATION,0.54223,-0.041038,-0.03217,0,0
3,GO RESPONSE TO STEROID HORMONE,0.79394,-0.041231,0.038468,0,0
3,GO REGULATION OF LIPID CATABOLIC PROCESS,0.70989,-0.041254,0.0069872,0,0
3,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.67486,-0.041307,0.036607,0,0
3,GO IMMUNE SYSTEM DEVELOPMENT,0.47137,-0.041321,-0.018307,0,0
3,GO ACTIVATION OF MAPK ACTIVITY,0.68646,-0.04136,0.04414,0,0
3,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.61803,-0.041446,-0.038751,0,0
3,GO REGULATION OF PH,0.29248,-0.041615,-0.0097941,0,0
3,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.84314,-0.041623,0.049889,0,0
3,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.96843,-0.041787,0.0083668,0,0
3,GO HEPARIN METABOLIC PROCESS,0.68646,-0.041908,0.054106,0,0
3,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,0.52145,-0.041972,-0.029374,0,0
3,GO NIK NF KAPPAB SIGNALING,0.27126,-0.041983,-0.065203,0,0
3,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.91805,-0.042,0.0572,0,0
3,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,0.55277,-0.042147,0.015416,0,0
3,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.33821,-0.04255,-0.042368,0,0
3,GO REGULATION OF PODOSOME ASSEMBLY,0.76963,-0.04265,0.014018,0,0
3,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.62923,-0.042691,0.002172,0,0
3,GO HEART TRABECULA MORPHOGENESIS,0.80618,-0.042793,0.023563,0,0
3,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.61803,-0.042796,-0.0088474,0,0
3,GO RESPONSE TO DEXAMETHASONE,0.37964,-0.043012,-0.025418,0,0
3,GO TETRAPYRROLE METABOLIC PROCESS,0.37964,-0.043196,-0.021156,0,0
3,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.78176,-0.043258,0.070368,0,0
3,GO PROTEIN MATURATION,0.27821,-0.043268,-0.019891,0,0
3,GO MRNA TRANSCRIPTION,0.67486,-0.043601,0.084756,0,0
3,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,0.78176,-0.043726,0.037833,0,0
3,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.48117,-0.043835,0.0023558,0,0
3,GO NEGATIVE REGULATION OF MAPK CASCADE,0.60692,-0.044054,0.030925,0,0
3,GO NEGATIVE REGULATION OF SECRETION,0.66333,-0.044073,0.022714,0,0
3,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.34626,-0.044181,-0.047239,0,0
3,GO PLACENTA DEVELOPMENT,0.66333,-0.044207,0.028053,0,0
3,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.91805,-0.044221,0.041797,0,0
3,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.62923,-0.044549,0.098891,0,0
3,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.35442,-0.04461,-0.088998,0,0
3,GO GASTRULATION,0.66333,-0.044625,0.030031,0,0
3,GO NOTCH RECEPTOR PROCESSING,1,-0.044649,0.024598,0,0
3,GO POLYAMINE BIOSYNTHETIC PROCESS,0.094909,-0.04468,-0.068302,0,0
3,GO REGULATION OF HEART MORPHOGENESIS,0.84314,-0.044704,0.030913,0,0
3,GO GLIAL CELL MIGRATION,0.54223,-0.044704,-0.012122,0,0
3,GO REGULATION OF EXCRETION,0.72171,-0.044771,-0.014574,0,0
3,GO STEROL TRANSPORT,0.56341,-0.044782,-0.0051241,0,0
3,GO ACTIN CYTOSKELETON REORGANIZATION,0.64051,-0.044784,0.029545,0,0
3,GO REGULATION OF HORMONE METABOLIC PROCESS,0.67486,-0.044787,-0.0011815,0,0
3,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,0.54223,-0.044913,-0.02404,0,0
3,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.72171,-0.044975,0.0038938,0,0
3,GO ENDOTHELIAL CELL DEVELOPMENT,0.65188,-0.045076,0.046031,0,0
3,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,0.61803,-0.045244,-0.066186,0,0
3,GO RESPONSE TO SALT STRESS,0.93062,-0.045312,0.019772,0,0
3,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.96843,-0.045505,0.065226,0,0
3,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.33821,-0.045531,-0.0092523,0,0
3,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.85555,-0.045611,0.01536,0,0
3,GO REGULATION OF VIRAL GENOME REPLICATION,0.49108,-0.045692,-0.036178,0,0
3,GO REGULATION OF PROTEOLYSIS,0.29248,-0.045835,-0.013099,0,0
3,GO ANGIOTENSIN ACTIVATED SIGNALING PATHWAY,0.76963,-0.04627,0.00091801,0,0
3,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.53179,-0.046384,-0.062459,0,0
3,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.49108,-0.046497,0.0093794,0,0
3,GO MAINTENANCE OF LOCATION,0.30724,-0.046577,-0.010203,0,0
3,GO RESPONSE TO ESTROGEN,0.41494,-0.046623,-0.014647,0,0
3,GO I KAPPAB KINASE NF KAPPAB SIGNALING,0.23827,-0.046632,-0.06054,0,0
3,GO HORMONE METABOLIC PROCESS,0.66333,-0.046708,0.00057569,0,0
3,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,0.64051,-0.046982,-0.027879,0,0
3,GO CHONDROCYTE DIFFERENTIATION,0.67486,-0.046985,0.036409,0,0
3,GO POSITIVE REGULATION OF NEURON DEATH,0.81845,-0.04701,0.04734,0,0
3,GO VIRAL LIFE CYCLE,0.2998,-0.047013,-0.029926,0,0
3,GO PEPTIDYL ASPARAGINE MODIFICATION,0.23203,-0.047216,-0.074277,0,0
3,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.68646,-0.047297,-0.0056254,0,0
3,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.43329,-0.047555,-0.0078579,0,0
3,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.48117,-0.04758,0.006113,0,0
3,GO LUNG ALVEOLUS DEVELOPMENT,0.68646,-0.047613,0.051275,0,0
3,GO REGULATION OF ACTIN FILAMENT LENGTH,0.51122,-0.047616,0.0095535,0,0
3,GO RESPONSE TO CORTICOSTERONE,0.66333,-0.047645,0.0039287,0,0
3,GO CHOLESTEROL STORAGE,0.52145,-0.047746,-0.038654,0,0
3,GO REGULATION OF CELL POPULATION PROLIFERATION,0.49108,-0.047747,0.010372,0,0
3,GO TYPE I INTERFERON PRODUCTION,0.43329,-0.047765,-0.041508,0,0
3,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,0.94321,-0.047952,0.0604,0,0
3,GO RESPONSE TO TOXIC SUBSTANCE,0.34626,-0.047966,-0.012229,0,0
3,GO CELLULAR RESPONSE TO KETONE,0.80618,-0.048027,0.059354,0,0
3,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.54223,-0.048074,0.0066392,0,0
3,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.43329,-0.048217,0.013648,0,0
3,GO POSITIVE REGULATION OF TRANSPORT,0.55277,-0.048237,0.014,0,0
3,GO HEART FIELD SPECIFICATION,0.80618,-0.048326,0.045658,0,0
3,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.42405,-0.048375,-0.072969,0,0
3,GO MODULATION BY HOST OF VIRAL PROCESS,0.26442,-0.04839,-0.059064,0,0
3,GO SULFUR COMPOUND TRANSPORT,0.95582,-0.048935,0.061323,0,0
3,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.65188,-0.04909,0.04334,0,0
3,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.36271,-0.049143,-0.02974,0,0
3,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.52145,-0.049372,-0.003275,0,0
3,GO FC RECEPTOR SIGNALING PATHWAY,0.30724,-0.04939,-0.048736,0,0
3,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,0.26442,-0.049655,-0.078897,0,0
3,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,0.65188,-0.049655,-0.028975,0,0
3,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,0.91805,-0.04979,0.037554,0,0
3,GO REGULATION OF ANION TRANSPORT,0.66333,-0.049829,0.0050462,0,0
3,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,0.44264,-0.050078,-0.057434,0,0
3,GO SECRETION BY TISSUE,0.2577,-0.050087,-0.065524,0,0
3,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.57414,-0.050203,-0.0067941,0,0
3,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.91805,-0.050242,-0.0030361,0,0
3,GO ADAPTIVE THERMOGENESIS,0.68646,-0.050267,0.037803,0,0
3,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.30724,-0.05028,-0.056203,0,0
3,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,0.85555,-0.050497,0.033831,0,0
3,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.1475,-0.050522,-0.054946,0,0
3,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.2259,-0.050677,-0.072365,0,0
3,GO REGULATION OF NIK NF KAPPAB SIGNALING,0.30724,-0.050859,-0.075435,0,0
3,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,0.48117,-0.050895,-0.025077,0,0
3,GO L ASCORBIC ACID METABOLIC PROCESS,0.29248,-0.050962,-0.10012,0,0
3,GO TOXIN METABOLIC PROCESS,0.69814,-0.050979,-0.010771,0,0
3,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.48117,-0.051227,-0.044607,0,0
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.43329,-0.051355,0.026597,0,0
3,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.56341,-0.051477,0.026466,0,0
3,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.91805,-0.05152,0.025588,0,0
3,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.78176,-0.051551,0.055019,0,0
3,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,0.81845,-0.051559,0.020744,0,0
3,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,0.51122,-0.051608,-0.070034,0,0
3,GO FOLIC ACID METABOLIC PROCESS,0.18624,-0.051741,-0.042038,0,0
3,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,0.46168,-0.051822,-0.08707,0,0
3,GO RESPONSE TO VIRUS,0.33029,-0.052148,-0.082612,0,0
3,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,0.41494,-0.052213,-0.04361,0,0
3,GO MULTIVESICULAR BODY SORTING PATHWAY,0.48117,-0.052363,-0.016462,0,0
3,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.25111,-0.052383,-0.077253,0,0
3,GO ARGININE METABOLIC PROCESS,0.5959,-0.052418,-0.0067708,0,0
3,GO ENDOCYTOSIS,0.4521,-0.052448,0.0084722,0,0
3,GO POSITIVE REGULATION OF CELL DEATH,0.50109,-0.052553,0.024755,0,0
3,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,0.58498,-0.052561,-0.016994,0,0
3,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.74555,-0.052569,0.014454,0,0
3,GO BONE DEVELOPMENT,0.7336,-0.05257,0.048542,0,0
3,GO EMBRYONIC PLACENTA MORPHOGENESIS,0.61803,-0.052591,-0.0087689,0,0
3,GO CHEMICAL HOMEOSTASIS,0.43329,-0.052628,0.0046619,0,0
3,GO REGULATION OF FAT CELL DIFFERENTIATION,0.79394,-0.052633,0.06676,0,0
3,GO MUSCLE CELL APOPTOTIC PROCESS,0.93062,-0.052668,0.053463,0,0
3,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.67486,-0.052728,0.02276,0,0
3,GO TUBE DEVELOPMENT,0.74555,-0.052778,0.047505,0,0
3,GO NEUTRAL LIPID METABOLIC PROCESS,0.29248,-0.052854,-0.032089,0,0
3,GO ALDEHYDE BIOSYNTHETIC PROCESS,0.55277,-0.052948,-0.024739,0,0
3,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.39705,-0.052969,-0.011381,0,0
3,GO REGULATION OF CELLULAR PH,0.29248,-0.053009,-0.009468,0,0
3,GO CELLULAR RESPONSE TO FATTY ACID,0.88046,-0.053015,0.030647,0,0
3,GO RESPONSE TO HORMONE,0.7336,-0.053113,0.040406,0,0
3,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.5959,-0.053206,0.0082006,0,0
3,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.40594,-0.05323,-0.0046356,0,0
3,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.44264,-0.053328,-0.035853,0,0
3,GO PROTEIN O LINKED GLYCOSYLATION,0.54223,-0.053392,-0.017089,0,0
3,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.55277,-0.053428,0.016487,0,0
3,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.68646,-0.053456,0.0051487,0,0
3,GO RESPONSE TO ETHANOL,0.5959,-0.053526,0.021811,0,0
3,GO REGULATION OF SPROUTING ANGIOGENESIS,0.76963,-0.053549,0.040347,0,0
3,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.54223,-0.053709,-0.010735,0,0
3,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,0.76963,-0.053903,0.016115,0,0
3,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.41494,-0.053919,-0.011817,0,0
3,GO ANIMAL ORGAN FORMATION,0.75756,-0.054018,0.01389,0,0
3,GO MODULATION BY HOST OF SYMBIONT PROCESS,0.49108,-0.054229,-0.030839,0,0
3,GO RECEPTOR BIOSYNTHETIC PROCESS,0.79394,-0.054263,0.0083244,0,0
3,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.49108,-0.054401,-0.0081856,0,0
3,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.91805,-0.054434,0.028974,0,0
3,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.64051,-0.054575,0.032953,0,0
3,GO REGULATION OF ANIMAL ORGAN FORMATION,0.55277,-0.054857,-0.0051586,0,0
3,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.51122,-0.054908,-0.0045192,0,0
3,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.37964,-0.055102,-0.015681,0,0
3,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.72171,-0.055131,-0.00095568,0,0
3,GO TUBE MORPHOGENESIS,0.70989,-0.055148,0.04416,0,0
3,GO VESICLE BUDDING FROM MEMBRANE,0.52145,-0.055169,0.0018582,0,0
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.40594,-0.055269,-0.003482,0,0
3,GO REGULATION OF METAL ION TRANSPORT,0.50109,-0.055295,0.0055954,0,0
3,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,0.26442,-0.05532,-0.13315,0,0
3,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.49108,-0.055441,-0.023762,0,0
3,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.32248,-0.055558,-0.02618,0,0
3,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.7336,-0.055835,0.016077,0,0
3,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.37111,-0.05586,-0.028218,0,0
3,GO PEPTIDE CATABOLIC PROCESS,0.53179,-0.056372,-0.0304,0,0
3,GO REGULATION OF MAPK CASCADE,0.34626,-0.056494,-0.0019713,0,0
3,GO AMINO SUGAR METABOLIC PROCESS,0.26442,-0.056503,-0.047219,0,0
3,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.13467,-0.056608,-0.03,0,0
3,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.55277,-0.056749,-0.038292,0,0
3,GO REGULATION OF MULTI ORGANISM PROCESS,0.27126,-0.056914,-0.010328,0,0
3,GO REGULATION OF VASOCONSTRICTION,0.4521,-0.057015,0.0095397,0,0
3,GO RESPONSE TO GONADOTROPIN,0.35442,-0.057141,-0.048086,0,0
3,GO REGULATION OF ERBB SIGNALING PATHWAY,0.51122,-0.057181,-0.0075302,0,0
3,GO INACTIVATION OF MAPK ACTIVITY,0.34626,-0.057195,-0.022269,0,0
3,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.62923,-0.057335,0.030386,0,0
3,GO REGULATION OF EXOSOMAL SECRETION,0.53179,-0.057627,-0.0083692,0,0
3,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.27821,-0.057704,-0.060471,0,0
3,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.39705,-0.057882,0.0041458,0,0
3,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.76963,-0.058082,0.040637,0,0
3,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.50109,-0.058084,0.019981,0,0
3,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.38829,-0.058152,-0.036104,0,0
3,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.93062,-0.058495,0.027025,0,0
3,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.78176,-0.058825,0.041398,0,0
3,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.26442,-0.058874,-0.087664,0,0
3,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.4521,-0.058912,-0.083314,0,0
3,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,1,-0.059088,0.017492,0,0
3,GO CARDIAC CHAMBER MORPHOGENESIS,0.69814,-0.059144,0.041926,0,0
3,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,0.75756,-0.059339,0.028787,0,0
3,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,0.37964,-0.059434,-0.047631,0,0
3,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.24463,-0.059597,-0.0067834,0,0
3,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.54223,-0.05983,-0.031642,0,0
3,GO REGULATION OF CELL MATRIX ADHESION,0.4521,-0.060093,0.029553,0,0
3,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.21989,-0.060239,-0.07283,0,0
3,GO NEGATIVE REGULATION OF LIPID STORAGE,0.83078,-0.060318,0.0085703,0,0
3,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.84314,-0.060328,0.047979,0,0
3,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.7336,-0.060437,-0.0024205,0,0
3,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.29248,-0.060458,-0.01657,0,0
3,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.56341,-0.060515,0.006303,0,0
3,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.69814,-0.060551,0.0017401,0,0
3,GO HAIR FOLLICLE MATURATION,0.54223,-0.060646,0.072187,0,0
3,GO ACTIN NUCLEATION,0.20822,-0.060718,-0.035624,0,0
3,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.62923,-0.060752,0.025091,0,0
3,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.17591,-0.06076,-0.069514,0,0
3,GO TRABECULA MORPHOGENESIS,0.54223,-0.060844,-0.013944,0,0
3,GO PSEUDOPODIUM ORGANIZATION,0.69814,-0.060891,-0.012221,0,0
3,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.40594,-0.061192,-0.017069,0,0
3,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.33821,-0.061261,-0.081485,0,0
3,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,0.42405,-0.061385,-0.048787,0,0
3,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.65188,-0.061391,0.014788,0,0
3,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.57414,-0.061525,-0.049872,0,0
3,GO RESPONSE TO INORGANIC SUBSTANCE,0.36271,-0.061711,0.0013669,0,0
3,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,0.66333,-0.061757,0.020318,0,0
3,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.13885,-0.061784,-0.037011,0,0
3,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.83078,-0.06192,0.012247,0,0
3,GO THYMOCYTE APOPTOTIC PROCESS,0.40594,-0.061965,-0.072326,0,0
3,GO CELLULAR RESPONSE TO CHEMICAL STRESS,0.24463,-0.061974,-0.0048863,0,0
3,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.14312,-0.062084,-0.047556,0,0
3,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.86799,-0.062233,0.022944,0,0
3,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.26442,-0.062452,-0.062883,0,0
3,GO SEROTONIN SECRETION,0.94321,-0.062473,-0.011504,0,0
3,GO CELLULAR RESPONSE TO LIPID,0.38829,-0.062811,-0.0090961,0,0
3,GO RESPONSE TO CADMIUM ION,0.67486,-0.062863,-0.0042182,0,0
3,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.83078,-0.062938,0.050196,0,0
3,GO RESPONSE TO ANTIBIOTIC,0.32248,-0.063192,-0.016571,0,0
3,GO HYPOTONIC RESPONSE,0.67486,-0.063204,0.014806,0,0
3,GO ORGANIC ACID TRANSPORT,0.78176,-0.063302,0.026067,0,0
3,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,0.29248,-0.06335,-0.032124,0,0
3,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.84314,-0.063356,0.012254,0,0
3,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,0.51122,-0.063366,-0.012905,0,0
3,GO APOPTOTIC SIGNALING PATHWAY,0.18102,-0.063402,-0.02054,0,0
3,GO HEAD MORPHOGENESIS,0.48117,-0.063411,0.0049474,0,0
3,GO RESPONSE TO MUSCLE STRETCH,0.50109,-0.063707,-0.033311,0,0
3,GO RIG I SIGNALING PATHWAY,0.42405,-0.063796,-0.042653,0,0
3,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.46168,-0.063825,-0.06522,0,0
3,GO STEROID ESTERIFICATION,0.17091,-0.063851,-0.11707,0,0
3,GO ION HOMEOSTASIS,0.33029,-0.063895,-0.017496,0,0
3,GO REGULATION OF WATER LOSS VIA SKIN,0.36271,-0.06392,-0.048589,0,0
3,GO NATURAL KILLER CELL ACTIVATION,0.214,-0.063922,-0.15278,0,0
3,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.44264,-0.063948,-0.031546,0,0
3,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,0.41494,-0.063986,-0.032532,0,0
3,GO EPIDERMIS MORPHOGENESIS,0.50109,-0.064036,-0.030691,0,0
3,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.33029,-0.064382,-0.0073272,0,0
3,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.25111,-0.064429,-0.028454,0,0
3,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.60692,-0.064458,0.019123,0,0
3,GO RENAL WATER HOMEOSTASIS,0.99368,-0.064484,0.061269,0,0
3,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,0.15655,-0.064499,-0.090347,0,0
3,GO REGULATION OF TUBE SIZE,0.47137,-0.064592,-0.0096335,0,0
3,GO REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.75756,-0.064617,-0.037246,0,0
3,GO REGULATION OF HEMOPOIESIS,0.42405,-0.064618,-0.034565,0,0
3,GO PULMONARY VALVE MORPHOGENESIS,0.51122,-0.064738,-0.0217,0,0
3,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.74555,-0.064743,-0.0019796,0,0
3,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.80618,-0.065008,0.061315,0,0
3,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.49108,-0.06507,0.0078084,0,0
3,GO CELL MATRIX ADHESION,0.40594,-0.065301,0.0077211,0,0
3,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,0.51122,-0.065379,0.0063718,0,0
3,GO KERATINOCYTE DIFFERENTIATION,0.56341,-0.065435,-0.042372,0,0
3,GO REGULATION OF LIPID STORAGE,0.56341,-0.065439,-0.011075,0,0
3,GO POSITIVE REGULATION OF ACTIN NUCLEATION,0.55277,-0.065602,0.0023212,0,0
3,GO RESPONSE TO LEAD ION,0.93062,-0.066142,0.031867,0,0
3,GO MACROMOLECULE DEPALMITOYLATION,0.18624,-0.0662,-0.06428,0,0
3,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,0.26442,-0.066284,-0.036234,0,0
3,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.33029,-0.066433,-0.089817,0,0
3,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.61803,-0.066505,-0.020133,0,0
3,GO RENAL FILTRATION,0.75756,-0.066527,0.048489,0,0
3,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.25111,-0.066589,0.0083332,0,0
3,GO GTP METABOLIC PROCESS,0.37111,-0.066651,-0.025014,0,0
3,GO REGENERATION,0.46168,-0.066685,0.012345,0,0
3,GO RESPONSE TO OXIDATIVE STRESS,0.20256,-0.06684,-0.021353,0,0
3,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.10134,-0.0669,-0.074486,0,0
3,GO RESPONSE TO ALCOHOL,0.56341,-0.067044,0.018953,0,0
3,GO TRANSLATIONAL TERMINATION,0.10134,-0.067047,-0.054076,0,0
3,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.79394,-0.067075,0.088345,0,0
3,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.17591,-0.067124,-0.030406,0,0
3,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.36271,-0.067126,-0.033228,0,0
3,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.34626,-0.067374,0.016305,0,0
3,GO OPSONIZATION,0.37964,-0.067529,-0.16411,0,0
3,GO REGULATION OF EPITHELIAL CELL MIGRATION,0.27821,-0.067551,-0.031728,0,0
3,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.26442,-0.067691,-0.042647,0,0
3,GO OLIGOPEPTIDE TRANSPORT,0.65188,-0.067694,0.010819,0,0
3,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.43329,-0.067714,-0.075225,0,0
3,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,0.69814,-0.067729,-0.014729,0,0
3,GO KERATINIZATION,0.20256,-0.067747,-0.098654,0,0
3,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,0.34626,-0.067757,-0.052348,0,0
3,GO REGULATION OF BLOOD PRESSURE,0.41494,-0.067797,-0.0055571,0,0
3,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.42405,-0.067862,-0.054887,0,0
3,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.94321,-0.067865,0.063527,0,0
3,GO LIPID STORAGE,0.53179,-0.067881,0.00079342,0,0
3,GO DIET INDUCED THERMOGENESIS,0.33821,-0.068,-0.07811,0,0
3,GO HEPATOCYTE APOPTOTIC PROCESS,0.24463,-0.06812,-0.071902,0,0
3,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.40594,-0.068162,0.0044627,0,0
3,GO PROTEIN LOCALIZATION TO CELL SURFACE,0.49108,-0.068172,0.0054646,0,0
3,GO REGULATION OF RESPIRATORY BURST,0.35442,-0.068219,-0.056014,0,0
3,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.43329,-0.068262,-0.022962,0,0
3,GO REGULATION OF MONOCYTE DIFFERENTIATION,0.68646,-0.068281,-0.020361,0,0
3,GO POSITIVE REGULATION OF PEPTIDE SECRETION,0.33821,-0.068344,-0.033127,0,0
3,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.75756,-0.068394,0.0067125,0,0
3,GO REGULATION OF ACTIN NUCLEATION,0.43329,-0.068543,-0.027192,0,0
3,GO AMINO ACID IMPORT,0.58498,-0.068602,-0.0019565,0,0
3,GO ENDOTHELIAL CELL PROLIFERATION,0.52145,-0.068613,0.020698,0,0
3,GO PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.66333,-0.068782,0.0049018,0,0
3,GO REGULATION OF AMYLOID BETA CLEARANCE,0.44264,-0.068895,-0.080313,0,0
3,GO REGULATION OF PINOCYTOSIS,0.60692,-0.069015,0.0087756,0,0
3,GO CARTILAGE DEVELOPMENT,0.47137,-0.069162,0.019395,0,0
3,GO TRIGLYCERIDE CATABOLIC PROCESS,0.46168,-0.069169,-0.049463,0,0
3,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.35442,-0.069243,-0.0030254,0,0
3,GO TISSUE HOMEOSTASIS,0.32248,-0.069371,-0.012547,0,0
3,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,0.27821,-0.069456,-0.0059971,0,0
3,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.27821,-0.069575,-0.073368,0,0
3,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.57414,-0.069779,-0.021662,0,0
3,GO NEGATIVE REGULATION OF ANOIKIS,0.47137,-0.069798,-0.035954,0,0
3,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,0.90549,-0.069803,-0.022518,0,0
3,GO SEQUESTERING OF TRIGLYCERIDE,0.94321,-0.069806,0.019567,0,0
3,GO VIRION ASSEMBLY,0.11163,-0.069959,-0.042196,0,0
3,GO CELLULAR HYPEROSMOTIC RESPONSE,0.61803,-0.069963,-0.0059845,0,0
3,GO ALCOHOL CATABOLIC PROCESS,0.80618,-0.069994,0.0095314,0,0
3,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.91805,-0.070256,0.038445,0,0
3,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.16123,-0.070266,-0.018118,0,0
3,GO REGULATION OF VACUOLE ORGANIZATION,0.27126,-0.07034,-0.00023197,0,0
3,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.20256,-0.07037,-0.015349,0,0
3,GO REGULATION OF SYMBIOTIC PROCESS,0.19156,-0.070408,-0.058777,0,0
3,GO CELL SUBSTRATE ADHESION,0.38829,-0.070575,0.0041077,0,0
3,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.41494,-0.070605,-0.026927,0,0
3,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.14312,-0.070692,-0.045141,0,0
3,GO GLIAL CELL APOPTOTIC PROCESS,0.36271,-0.070776,-0.036068,0,0
3,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.34626,-0.070797,-0.056618,0,0
3,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.20256,-0.070829,-0.029636,0,0
3,GO CELLULAR HORMONE METABOLIC PROCESS,0.24463,-0.070934,-0.050162,0,0
3,GO AMP METABOLIC PROCESS,0.20256,-0.070947,-0.05974,0,0
3,GO PEPTIDYL ARGININE MODIFICATION,0.5959,-0.071119,-0.02274,0,0
3,GO REGULATION OF URINE VOLUME,0.70989,-0.071187,-0.0084516,0,0
3,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.33821,-0.071286,-0.056628,0,0
3,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.52145,-0.071305,-0.032999,0,0
3,GO REGULATION OF LIPID KINASE ACTIVITY,0.39705,-0.071348,-0.05041,0,0
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.42405,-0.071446,0.0026595,0,0
3,GO RESPONSE TO ANGIOTENSIN,0.3148,-0.071497,-0.054258,0,0
3,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.28529,-0.071847,-0.021097,0,0
3,GO SKELETAL MUSCLE TISSUE REGENERATION,0.44264,-0.072086,-0.038546,0,0
3,GO NEURON REMODELING,0.36271,-0.072268,-0.090628,0,0
3,GO SPERM EGG RECOGNITION,0.48117,-0.0723,-0.022328,0,0
3,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.27821,-0.072409,-0.021933,0,0
3,GO XENOBIOTIC TRANSPORT,0.70989,-0.072482,0.071782,0,0
3,GO AEROBIC RESPIRATION,0.13467,-0.0725,-0.035372,0,0
3,GO RESPONSE TO NUTRIENT,0.17591,-0.072535,-0.034196,0,0
3,GO GAMMA DELTA T CELL ACTIVATION,0.27126,-0.072679,-0.13844,0,0
3,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.37111,-0.072708,-0.037758,0,0
3,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.62923,-0.072847,-0.018496,0,0
3,GO GLUCOCORTICOID METABOLIC PROCESS,0.27821,-0.072878,-0.047799,0,0
3,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.81845,-0.072965,0.054767,0,0
3,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.40594,-0.073032,-0.024971,0,0
3,GO AMEBOIDAL TYPE CELL MIGRATION,0.51122,-0.073094,0.0092781,0,0
3,GO REGULATION OF STRIATED MUSCLE CONTRACTION,0.37111,-0.073151,-0.023377,0,0
3,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.53179,-0.073206,-0.0014365,0,0
3,GO CELLULAR RESPONSE TO OSMOTIC STRESS,0.38829,-0.073435,-0.016803,0,0
3,GO SECRETION,0.29248,-0.073515,-0.020631,0,0
3,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.43329,-0.073612,-0.0077718,0,0
3,GO METAL ION HOMEOSTASIS,0.26442,-0.073672,-0.035422,0,0
3,GO RESPONSE TO OXYGEN LEVELS,0.2577,-0.073695,-0.0094797,0,0
3,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,0.197,-0.073856,-0.041234,0,0
3,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,0.54223,-0.074414,-0.0049732,0,0
3,GO DEFENSE RESPONSE TO VIRUS,0.3148,-0.074441,-0.085459,0,0
3,GO REGULATION OF ANOIKIS,0.42405,-0.074878,-0.01321,0,0
3,GO FIBROBLAST PROLIFERATION,0.62923,-0.074915,0.032938,0,0
3,GO MITOCHONDRIAL DEPOLARIZATION,0.37964,-0.075139,-0.055529,0,0
3,GO EPIBOLY,0.50109,-0.075165,0.026342,0,0
3,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.080256,-0.075396,-0.064117,0,0
3,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.39705,-0.075652,0.002373,0,0
3,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,0.197,-0.075711,-0.046932,0,0
3,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.34626,-0.075773,-0.013103,0,0
3,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.62923,-0.075938,0.017596,0,0
3,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.24463,-0.075974,-0.054446,0,0
3,GO RELAXATION OF CARDIAC MUSCLE,0.20256,-0.076041,-0.091658,0,0
3,GO PROTEIN OXIDATION,0.1475,-0.076095,-0.10645,0,0
3,GO REGULATION OF TRANSLATIONAL TERMINATION,0.47137,-0.076207,-0.023679,0,0
3,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.78176,-0.076233,0.0058395,0,0
3,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.48117,-0.076238,-0.011856,0,0
3,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,0.27821,-0.076496,-0.10591,0,0
3,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.37111,-0.076516,-0.0088239,0,0
3,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,0.17591,-0.076539,-0.057626,0,0
3,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.2998,-0.076564,-0.034868,0,0
3,GO CELLULAR RESPONSE TO DSRNA,0.43329,-0.076675,-0.046389,0,0
3,GO CARBOHYDRATE TRANSPORT,0.34626,-0.07671,-0.0046191,0,0
3,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.57414,-0.076717,-0.049578,0,0
3,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.3148,-0.076775,-0.041278,0,0
3,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.20822,-0.076804,-0.038299,0,0
3,GO B CELL DIFFERENTIATION,0.41494,-0.077116,-0.060586,0,0
3,GO SALIVARY GLAND DEVELOPMENT,0.66333,-0.077156,0.028857,0,0
3,GO C21 STEROID HORMONE METABOLIC PROCESS,0.21989,-0.077172,-0.054413,0,0
3,GO TISSUE REGENERATION,0.37964,-0.077538,-0.027835,0,0
3,GO FATTY ACID TRANSPORT,0.20256,-0.077783,-0.0476,0,0
3,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.072385,-0.077878,-0.059361,0,0
3,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.61803,-0.077985,0.032708,0,0
3,GO CELL RECOGNITION,0.50109,-0.078062,0.0015061,0,0
3,GO ARTERY DEVELOPMENT,0.95582,-0.078116,0.055808,0,0
3,GO SPROUTING ANGIOGENESIS,0.7336,-0.078146,0.034978,0,0
3,GO INTERACTION WITH HOST,0.21989,-0.078296,-0.050795,0,0
3,GO GLIAL CELL PROLIFERATION,0.64051,-0.078385,-0.021169,0,0
3,GO POSITIVE REGULATION OF SECRETION,0.49108,-0.078472,0.00052723,0,0
3,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.36271,-0.07882,-0.029805,0,0
3,GO ISOPRENOID METABOLIC PROCESS,0.58498,-0.07902,-0.017232,0,0
3,GO HEME METABOLIC PROCESS,0.16602,-0.079061,-0.053096,0,0
3,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,0.27126,-0.079522,-0.023299,0,0
3,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.1475,-0.079692,-0.033391,0,0
3,GO PARAXIAL MESODERM DEVELOPMENT,0.49108,-0.079699,-0.037245,0,0
3,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,0.20822,-0.079734,-0.082262,0,0
3,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.08588,-0.079831,-0.078583,0,0
3,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.47137,-0.079928,-0.0081601,0,0
3,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.70989,-0.080046,0.0048372,0,0
3,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.33821,-0.080106,-0.0023031,0,0
3,GO BASEMENT MEMBRANE ORGANIZATION,0.83078,-0.080109,0.035313,0,0
3,GO OSSIFICATION,0.41494,-0.080348,0.010243,0,0
3,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.62923,-0.080596,0.0046514,0,0
3,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,0.17091,-0.080734,-0.040614,0,0
3,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.21989,-0.080882,-0.07303,0,0
3,GO TERPENOID METABOLIC PROCESS,0.5959,-0.080981,-0.022656,0,0
3,GO ACTIN FILAMENT NETWORK FORMATION,0.75756,-0.080987,0.019553,0,0
3,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,0.30724,-0.080987,-0.030432,0,0
3,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.23203,-0.081133,-0.023173,0,0
3,GO AMINOGLYCAN METABOLIC PROCESS,0.37111,-0.081227,-0.0255,0,0
3,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,0.14312,-0.081428,-0.030198,0,0
3,GO SMOOTH MUSCLE CELL MIGRATION,0.39705,-0.081475,0.00019676,0,0
3,GO TRANSFERRIN TRANSPORT,0.40594,-0.08159,-0.006959,0,0
3,GO ANDROGEN METABOLIC PROCESS,0.10134,-0.08178,-0.063908,0,0
3,GO SERTOLI CELL DIFFERENTIATION,0.72171,-0.082002,0.016654,0,0
3,GO RETINOL METABOLIC PROCESS,0.13885,-0.082115,-0.12194,0,0
3,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.2998,-0.082271,-0.012578,0,0
3,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.35442,-0.082403,-0.017103,0,0
3,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,0.89296,-0.08255,0.034453,0,0
3,GO LONG CHAIN FATTY ACID TRANSPORT,0.20822,-0.082641,-0.042013,0,0
3,GO POSITIVE REGULATION OF VASCULOGENESIS,0.46168,-0.082649,-0.048219,0,0
3,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.40594,-0.082657,-0.04692,0,0
3,GO NEGATIVE REGULATION OF HEART CONTRACTION,0.29248,-0.082674,-0.044749,0,0
3,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.27126,-0.083255,-0.070418,0,0
3,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.67486,-0.083316,0.028007,0,0
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.17591,-0.083371,-0.013211,0,0
3,GO RESPONSE TO DSRNA,0.24463,-0.083494,-0.063923,0,0
3,GO TRIGLYCERIDE METABOLIC PROCESS,0.16123,-0.083676,-0.067504,0,0
3,GO MIDDLE EAR MORPHOGENESIS,0.48117,-0.083742,-0.056522,0,0
3,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,0.51122,-0.08387,-0.030968,0,0
3,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.41494,-0.083987,-0.080113,0,0
3,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.37964,-0.084048,-0.067759,0,0
3,GO AMINE METABOLIC PROCESS,0.26442,-0.08416,-0.027537,0,0
3,GO NEGATIVE REGULATION OF PROTEIN IMPORT,0.69814,-0.084179,-0.029401,0,0
3,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.11524,-0.084226,-0.094599,0,0
3,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.20256,-0.08425,-0.059469,0,0
3,GO PEPTIDYL TYROSINE MODIFICATION,0.30724,-0.084351,-0.018232,0,0
3,GO POSITIVE REGULATION OF URINE VOLUME,0.34626,-0.084467,-0.06444,0,0
3,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.96843,-0.084565,0.033934,0,0
3,GO BIOMINERALIZATION,0.30724,-0.084597,-0.017126,0,0
3,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.41494,-0.084703,-0.031516,0,0
3,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,0.4521,-0.084713,-0.025257,0,0
3,GO ATP BIOSYNTHETIC PROCESS,0.14312,-0.084713,-0.090291,0,0
3,GO PROTEASOME ASSEMBLY,0.08303,-0.084744,-0.079683,0,0
3,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.1306,-0.084773,-0.045207,0,0
3,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.24463,-0.084785,-0.07661,0,0
3,GO DIGESTION,0.46168,-0.084951,-0.024752,0,0
3,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.1475,-0.084956,-0.077672,0,0
3,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.80618,-0.085195,0.044135,0,0
3,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.4521,-0.085303,-0.10212,0,0
3,GO DRUG METABOLIC PROCESS,0.20822,-0.085412,-0.10251,0,0
3,GO P38MAPK CASCADE,0.5959,-0.085521,0.021854,0,0
3,GO FIBROBLAST ACTIVATION,0.27821,-0.08571,-0.051604,0,0
3,GO MESODERMAL CELL DIFFERENTIATION,0.54223,-0.086199,-0.0098609,0,0
3,GO BIOLOGICAL ADHESION,0.36271,-0.086252,0.00072543,0,0
3,GO MESENCHYME MORPHOGENESIS,0.38829,-0.086487,-0.027824,0,0
3,GO REGULATION OF OSSIFICATION,0.46168,-0.086513,0.0099693,0,0
3,GO RESPONSE TO MECHANICAL STIMULUS,0.2577,-0.086717,-0.016432,0,0
3,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.12662,-0.086874,-0.060254,0,0
3,GO PHOSPHOLIPID HOMEOSTASIS,0.57414,-0.086996,-0.014165,0,0
3,GO TAXIS,0.46168,-0.087038,0.012961,0,0
3,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.5959,-0.087112,0.028605,0,0
3,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.51122,-0.087207,-0.018882,0,0
3,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,0.32248,-0.087333,-0.050776,0,0
3,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.27126,-0.087377,-0.045132,0,0
3,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.23827,-0.087456,-0.074411,0,0
3,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.27821,-0.08762,-0.050201,0,0
3,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,0.55277,-0.087772,-0.027734,0,0
3,GO CELLULAR RESPONSE TO CAMP,0.33821,-0.087844,-0.026166,0,0
3,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,0.50109,-0.087959,-0.052727,0,0
3,GO GLYCINE METABOLIC PROCESS,0.2998,-0.088083,-0.068694,0,0
3,GO RESPONSE TO THYROID HORMONE,0.26442,-0.088132,-0.07472,0,0
3,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,0.51122,-0.088156,-0.055312,0,0
3,GO KETONE BODY METABOLIC PROCESS,0.41494,-0.088181,-0.051221,0,0
3,GO CELL CELL ADHESION,0.47137,-0.088214,0.00012329,0,0
3,GO HYALURONAN BIOSYNTHETIC PROCESS,0.15197,-0.088495,-0.10644,0,0
3,GO OXIDATIVE PHOSPHORYLATION,0.054439,-0.088612,-0.061494,0,0
3,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.072385,-0.08873,-0.091435,0,0
3,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.52145,-0.088976,0.0080362,0,0
3,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.16123,-0.089083,-0.024551,0,0
3,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.2998,-0.089214,-0.037074,0,0
3,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,0.95582,-0.089295,0.034248,0,0
3,GO INTERFERON ALPHA PRODUCTION,0.48117,-0.089307,-0.0804,0,0
3,GO MYOTUBE DIFFERENTIATION,0.47137,-0.089411,-0.016451,0,0
3,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.58498,-0.089473,0.023658,0,0
3,GO POSITIVE REGULATION OF ION TRANSPORT,0.56341,-0.089713,0.001649,0,0
3,GO PROTEIN HYDROXYLATION,0.062884,-0.089951,-0.10347,0,0
3,GO DIGESTIVE SYSTEM PROCESS,0.3148,-0.090126,-0.030968,0,0
3,GO RESPONSE TO MURAMYL DIPEPTIDE,0.40594,-0.090244,-0.046818,0,0
3,GO LUTEINIZATION,0.99368,-0.090361,0.041596,0,0
3,GO NUCLEOSIDE CATABOLIC PROCESS,0.18624,-0.090395,-0.092082,0,0
3,GO WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.2259,-0.090425,-0.06735,0,0
3,GO NEGATIVE REGULATION OF HEMOPOIESIS,0.3148,-0.090461,-0.038984,0,0
3,GO CELLULAR OXIDANT DETOXIFICATION,0.2259,-0.090744,-0.067626,0,0
3,GO REGULATION OF VIRAL LIFE CYCLE,0.197,-0.090802,-0.073917,0,0
3,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.1475,-0.090894,-0.067044,0,0
3,GO LYSOSOME LOCALIZATION,0.37964,-0.091015,-0.04436,0,0
3,GO MAINTENANCE OF BLOOD BRAIN BARRIER,0.61803,-0.091249,0.02052,0,0
3,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.4521,-0.091339,-0.072281,0,0
3,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.08881,-0.09137,-0.048747,0,0
3,GO CELLULAR ION HOMEOSTASIS,0.23827,-0.091384,-0.036214,0,0
3,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,0.91805,-0.09168,0.028705,0,0
3,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.197,-0.091994,-0.053099,0,0
3,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.37111,-0.092041,-0.064614,0,0
3,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.29248,-0.092054,-0.12974,0,0
3,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.68646,-0.092085,0.0051881,0,0
3,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,0.30724,-0.092278,-0.034477,0,0
3,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.33029,-0.092284,-0.13411,0,0
3,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.76963,-0.092328,0.012916,0,0
3,GO LIPID LOCALIZATION,0.37964,-0.092405,-0.017333,0,0
3,GO EXOCYTOSIS,0.17091,-0.092471,-0.064388,0,0
3,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,0.33029,-0.092539,-0.04281,0,0
3,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.89296,-0.092782,0.040286,0,0
3,GO AUTOPHAGIC CELL DEATH,0.15655,-0.092836,-0.055019,0,0
3,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.23827,-0.092875,-0.069556,0,0
3,GO VASCULATURE DEVELOPMENT,0.33029,-0.092918,-0.0031487,0,0
3,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.18624,-0.093537,-0.099505,0,0
3,GO RESPONSE TO KETONE,0.29248,-0.093555,-0.0023034,0,0
3,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.66333,-0.093572,0.0071392,0,0
3,GO RESPONSE TO LIPID,0.25111,-0.093598,-0.030208,0,0
3,GO DERMATAN SULFATE METABOLIC PROCESS,0.66333,-0.093691,0.001497,0,0
3,GO RESPONSE TO WOUNDING,0.27126,-0.093995,-0.028051,0,0
3,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.62923,-0.094146,-0.014875,0,0
3,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.32248,-0.094221,0.0033963,0,0
3,GO FATTY ACID BIOSYNTHETIC PROCESS,0.11894,-0.094365,-0.061132,0,0
3,GO REGULATION OF FATTY ACID TRANSPORT,0.38829,-0.094383,-0.040859,0,0
3,GO TISSUE MIGRATION,0.32248,-0.09443,-0.023685,0,0
3,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.80618,-0.094565,0.013235,0,0
3,GO NEGATIVE REGULATION OF LIPID TRANSPORT,0.48117,-0.094568,-0.017327,0,0
3,GO MAINTENANCE OF LOCATION IN CELL,0.18624,-0.094661,-0.050558,0,0
3,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.30724,-0.094829,-0.031722,0,0
3,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.197,-0.094954,-0.088349,0,0
3,GO TRANSITION METAL ION TRANSPORT,0.21989,-0.095049,-0.036673,0,0
3,GO BONE MINERALIZATION,0.15655,-0.095168,-0.044274,0,0
3,GO OUTFLOW TRACT MORPHOGENESIS,0.52145,-0.095454,0.0056747,0,0
3,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.17091,-0.095503,-0.058476,0,0
3,GO GRANULOCYTE DIFFERENTIATION,0.18102,-0.095654,-0.12393,0,0
3,GO TRANSEPITHELIAL TRANSPORT,0.39705,-0.095699,-0.054862,0,0
3,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.10811,-0.095753,-0.064076,0,0
3,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.17091,-0.09579,-0.052035,0,0
3,GO L SERINE METABOLIC PROCESS,0.85555,-0.095831,-0.00059366,0,0
3,GO ANIMAL ORGAN REGENERATION,0.17591,-0.096066,-0.040716,0,0
3,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.3148,-0.096208,-0.13058,0,0
3,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.13885,-0.09623,-0.0077231,0,0
3,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,0.67486,-0.096395,-0.062274,0,0
3,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.20822,-0.096509,-0.07216,0,0
3,GO RESPONSE TO GROWTH HORMONE,0.24463,-0.096677,-0.031516,0,0
3,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.038848,-0.097285,-0.08682,0,0
3,GO EXTRACELLULAR VESICLE BIOGENESIS,0.15197,-0.097419,-0.058629,0,0
3,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,0.34626,-0.097431,-0.067054,0,0
3,GO POSITIVE REGULATION OF MAPK CASCADE,0.29248,-0.09753,-0.023942,0,0
3,GO PYRIMIDINE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORT,0.66333,-0.098389,-0.043868,0,0
3,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.21989,-0.098709,-0.048879,0,0
3,GO FACE DEVELOPMENT,0.33029,-0.098897,-0.0063853,0,0
3,GO POSITIVE REGULATION OF VASOCONSTRICTION,0.28529,-0.099141,-0.080322,0,0
3,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.41494,-0.099182,-0.050911,0,0
3,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.32248,-0.0992,-0.029924,0,0
3,GO RESPONSE TO MINERALOCORTICOID,0.39705,-0.099398,-0.028207,0,0
3,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.55277,-0.099671,-0.016956,0,0
3,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,0.14312,-0.09968,-0.065447,0,0
3,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.20822,-0.099709,-0.090325,0,0
3,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,0.66333,-0.09972,-0.018233,0,0
3,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,0.34626,-0.099804,-0.040861,0,0
3,GO ENGULFMENT OF APOPTOTIC CELL,0.39705,-0.099897,-0.061892,0,0
3,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,0.24463,-0.1,-0.049001,0,0
3,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.2577,-0.1,-0.050433,0,0
3,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.36271,-0.10001,-0.029992,0,0
3,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,0.077559,-0.10005,-0.088629,0,0
3,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.28529,-0.10007,-0.017137,0,0
3,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.35442,-0.10013,-0.048233,0,0
3,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.26442,-0.10029,-0.060331,0,0
3,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.41494,-0.10031,-0.00074809,0,0
3,GO RESPONSE TO VITAMIN,0.17091,-0.10063,-0.057136,0,0
3,GO RESPONSE TO ATP,0.48117,-0.10087,-0.038609,0,0
3,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.41494,-0.10103,-0.048301,0,0
3,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.40594,-0.10131,-0.03536,0,0
3,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.08588,-0.10139,-0.060196,0,0
3,GO RESPONSE TO FATTY ACID,0.28529,-0.10154,-0.02722,0,0
3,GO LINOLEIC ACID METABOLIC PROCESS,0.077559,-0.1016,-0.10513,0,0
3,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.15655,-0.10171,-0.054262,0,0
3,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.15197,-0.10183,-0.077686,0,0
3,GO REGULATION OF CELL SUBSTRATE ADHESION,0.2998,-0.10219,-0.014652,0,0
3,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,0.94321,-0.10222,0.039627,0,0
3,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.33029,-0.10246,-0.077874,0,0
3,GO REGULATION OF CALCIUM ION TRANSPORT,0.27126,-0.10246,-0.043529,0,0
3,GO DIVALENT INORGANIC CATION HOMEOSTASIS,0.24463,-0.10254,-0.043443,0,0
3,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.24463,-0.10263,-0.039433,0,0
3,GO RESPONSE TO CORTICOSTEROID,0.37964,-0.10274,-0.014172,0,0
3,GO POSITIVE REGULATION OF OSSIFICATION,0.32248,-0.10283,-0.012572,0,0
3,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.065157,-0.10287,-0.042266,0,0
3,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.2998,-0.10293,-0.049604,0,0
3,GO STEROID HORMONE SECRETION,0.44264,-0.10318,-0.033877,0,0
3,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.67486,-0.10325,0.0020102,0,0
3,GO CORNIFICATION,0.2259,-0.10327,-0.11571,0,0
3,GO REGULATION OF ICOSANOID SECRETION,0.30724,-0.10341,-0.057926,0,0
3,GO REGULATION OF ISOTYPE SWITCHING,0.57414,-0.1035,-0.018733,0,0
3,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.34626,-0.10353,-0.0077428,0,0
3,GO BEHAVIORAL RESPONSE TO PAIN,0.78176,-0.10376,0.027368,0,0
3,GO AMINE BIOSYNTHETIC PROCESS,0.42405,-0.10382,-0.052494,0,0
3,GO CHOLESTEROL EFFLUX,0.33029,-0.10441,-0.06,0,0
3,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.30724,-0.10457,-0.099736,0,0
3,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.29248,-0.10458,-0.067777,0,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.17591,-0.10464,-0.018669,0,0
3,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.197,-0.10467,-0.11622,0,0
3,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.28529,-0.1049,-0.036111,0,0
3,GO RESPONSE TO RETINOIC ACID,0.28529,-0.10503,-0.031735,0,0
3,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,0.33821,-0.10511,-0.05262,0,0
3,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.11894,-0.10511,-0.10395,0,0
3,GO CELLULAR RESPONSE TO INTERFERON BETA,0.2577,-0.10517,-0.11992,0,0
3,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.197,-0.10518,-0.02805,0,0
3,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.20256,-0.1053,-0.025944,0,0
3,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.70989,-0.10534,0.046328,0,0
3,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.197,-0.10536,-0.093663,0,0
3,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.15655,-0.10558,-0.10445,0,0
3,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.10134,-0.10559,-0.071906,0,0
3,GO ENDODERM DEVELOPMENT,0.57414,-0.10578,0.017389,0,0
3,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,0.51122,-0.10581,-0.0039019,0,0
3,GO MICROVILLUS ORGANIZATION,0.34626,-0.10583,-0.033897,0,0
3,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.3148,-0.10584,-0.0042305,0,0
3,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.12662,-0.10609,-0.094492,0,0
3,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.54223,-0.1063,-0.016341,0,0
3,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.33029,-0.10638,-0.072536,0,0
3,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.86799,-0.10639,0.012278,0,0
3,GO CHONDROCYTE PROLIFERATION,0.66333,-0.10642,-0.01795,0,0
3,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.15197,-0.10646,-0.13912,0,0
3,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.15197,-0.10655,-0.047944,0,0
3,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.34626,-0.10664,-0.022889,0,0
3,GO REGULATION OF RUFFLE ASSEMBLY,0.10468,-0.10681,-0.070199,0,0
3,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.17591,-0.10687,-0.080695,0,0
3,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,0.55277,-0.10702,-0.034816,0,0
3,GO CELLULAR RESPONSE TO SALT STRESS,0.43329,-0.10712,-0.03742,0,0
3,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.37111,-0.10729,-0.02464,0,0
3,GO PROTEIN NITROSYLATION,0.15655,-0.10762,-0.12294,0,0
3,GO RESPONSE TO FLUID SHEAR STRESS,0.33821,-0.10772,-0.034542,0,0
3,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.2577,-0.10781,-0.057402,0,0
3,GO FORMATION OF PRIMARY GERM LAYER,0.27126,-0.10781,-0.018549,0,0
3,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.27126,-0.1079,-0.071058,0,0
3,GO HEART TRABECULA FORMATION,0.197,-0.108,-0.11322,0,0
3,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.214,-0.10825,-0.040261,0,0
3,GO RESPONSE TO NITRIC OXIDE,0.197,-0.10836,-0.076674,0,0
3,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.14312,-0.1085,-0.089974,0,0
3,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.42405,-0.10876,-0.059278,0,0
3,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.4521,-0.10893,-0.054667,0,0
3,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.29248,-0.10901,-0.045404,0,0
3,GO LIVER MORPHOGENESIS,0.41494,-0.10918,-0.043243,0,0
3,GO BRONCHUS DEVELOPMENT,0.68646,-0.10922,0.014674,0,0
3,GO RESPONSE TO VITAMIN D,0.37964,-0.10925,-0.050636,0,0
3,GO POSITIVE REGULATION OF BIOMINERALIZATION,0.26442,-0.10931,-0.03438,0,0
3,GO IRON ION TRANSPORT,0.17591,-0.10932,-0.04366,0,0
3,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.40594,-0.1096,-0.066944,0,0
3,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.15655,-0.10999,-0.087394,0,0
3,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.64051,-0.11006,-0.02681,0,0
3,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.20256,-0.1102,-0.10933,0,0
3,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,0.33029,-0.11025,-0.037639,0,0
3,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.67486,-0.11066,-0.015982,0,0
3,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.84314,-0.11084,0.027223,0,0
3,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,0.33029,-0.11084,-0.075152,0,0
3,GO NK T CELL DIFFERENTIATION,0.35442,-0.11087,-0.12873,0,0
3,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.35442,-0.1109,-0.059672,0,0
3,GO POSITIVE REGULATION OF BONE MINERALIZATION,0.35442,-0.1112,-0.030997,0,0
3,GO POLYAMINE METABOLIC PROCESS,0.033245,-0.11123,-0.064329,0,0
3,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.26442,-0.11134,-0.043792,0,0
3,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,0.19156,-0.1114,-0.11352,0,0
3,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,0.69814,-0.11141,-0.0034789,0,0
3,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.23203,-0.11159,-0.1883,0,0
3,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,0.15197,-0.11174,-0.081216,0,0
3,GO REGULATION OF RENAL SYSTEM PROCESS,0.23203,-0.11201,-0.05319,0,0
3,GO PH REDUCTION,0.10468,-0.11234,-0.053623,0,0
3,GO REGULATION OF INNATE IMMUNE RESPONSE,0.17591,-0.11237,-0.10858,0,0
3,GO HORMONE CATABOLIC PROCESS,0.74555,-0.11238,-0.023775,0,0
3,GO RECEPTOR MEDIATED ENDOCYTOSIS,0.34626,-0.11251,-0.01761,0,0
3,GO PARAXIAL MESODERM MORPHOGENESIS,0.27821,-0.11277,-0.081186,0,0
3,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.37111,-0.11287,-0.049268,0,0
3,GO MONONUCLEAR CELL DIFFERENTIATION,0.4521,-0.11295,-0.040581,0,0
3,GO RESPONSE TO PROGESTERONE,0.32248,-0.11304,-0.02815,0,0
3,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.51122,-0.11304,-0.0048357,0,0
3,GO CELL CELL JUNCTION MAINTENANCE,0.25111,-0.11306,-0.065049,0,0
3,GO POSITIVE REGULATION OF MYELINATION,0.42405,-0.11322,-0.066283,0,0
3,GO INTERACTION WITH SYMBIONT,0.19156,-0.11329,-0.069613,0,0
3,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.1475,-0.1134,-0.067064,0,0
3,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.26442,-0.11347,-0.06116,0,0
3,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.33821,-0.1139,-0.058185,0,0
3,GO RESPONSE TO CAMP,0.26442,-0.11413,-0.016426,0,0
3,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.2259,-0.11432,-0.040632,0,0
3,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.40594,-0.11438,-0.02613,0,0
3,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,0.34626,-0.1144,-0.029513,0,0
3,GO T CELL HOMEOSTASIS,0.44264,-0.11483,-0.061358,0,0
3,GO NADP METABOLIC PROCESS,0.19156,-0.115,-0.057984,0,0
3,GO SPHINGOMYELIN METABOLIC PROCESS,0.56341,-0.11506,-0.022534,0,0
3,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.16602,-0.11517,-0.18114,0,0
3,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.080256,-0.11523,-0.16895,0,0
3,GO WOUND HEALING,0.26442,-0.11546,-0.042888,0,0
3,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.214,-0.11555,-0.069121,0,0
3,GO POSITIVE REGULATION OF HAIR CYCLE,0.10811,-0.11564,-0.12055,0,0
3,GO PLATELET MORPHOGENESIS,0.27821,-0.11622,-0.04394,0,0
3,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.2998,-0.11684,-0.039325,0,0
3,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.25111,-0.11696,-0.082657,0,0
3,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.39705,-0.11698,-0.097506,0,0
3,GO RESPONSE TO CYTOKINE,0.098083,-0.11712,-0.11351,0,0
3,GO MORPHOGENESIS OF AN ENDOTHELIUM,0.23203,-0.11718,-0.096986,0,0
3,GO NEGATIVE REGULATION OF VIRAL PROCESS,0.15197,-0.11731,-0.1133,0,0
3,GO REGULATION OF THE FORCE OF HEART CONTRACTION,0.2259,-0.11747,-0.080019,0,0
3,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.21989,-0.11764,-0.039738,0,0
3,GO HYALURONAN METABOLIC PROCESS,0.2577,-0.11783,-0.052651,0,0
3,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,0.197,-0.11791,-0.058564,0,0
3,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.23203,-0.11807,-0.054746,0,0
3,GO REGULATION OF RESPONSE TO WOUNDING,0.1475,-0.11819,-0.07602,0,0
3,GO REGULATION OF VASCULATURE DEVELOPMENT,0.27821,-0.11822,-0.033859,0,0
3,GO MYELOID CELL DEVELOPMENT,0.26442,-0.11833,-0.040421,0,0
3,GO NECROTIC CELL DEATH,0.091819,-0.11841,-0.084943,0,0
3,GO REGULATION OF NECROTIC CELL DEATH,0.098083,-0.11849,-0.081813,0,0
3,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.78176,-0.11855,0.011266,0,0
3,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.43329,-0.11883,-0.072411,0,0
3,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.24463,-0.1189,-0.10458,0,0
3,GO BLOOD VESSEL MORPHOGENESIS,0.28529,-0.11939,-0.014325,0,0
3,GO PROGRAMMED NECROTIC CELL DEATH,0.11894,-0.1195,-0.086872,0,0
3,GO CYTIDINE TO URIDINE EDITING,0.27821,-0.12017,-0.11963,0,0
3,GO ARTERY MORPHOGENESIS,0.64051,-0.12029,0.0082589,0,0
3,GO ETHANOL CATABOLIC PROCESS,0.51122,-0.12032,-0.098556,0,0
3,GO OSTEOBLAST PROLIFERATION,0.33821,-0.12036,-0.013337,0,0
3,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.55277,-0.12053,-0.039134,0,0
3,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.37964,-0.12056,-0.083461,0,0
3,GO RUFFLE ASSEMBLY,0.18624,-0.12096,-0.032499,0,0
3,GO REGULATION OF CELL FATE COMMITMENT,0.11163,-0.12116,-0.095801,0,0
3,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.2998,-0.12134,-0.087456,0,0
3,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,0.25111,-0.12137,-0.054254,0,0
3,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.37964,-0.12166,-0.084907,0,0
3,GO CGMP MEDIATED SIGNALING,0.18624,-0.12197,-0.09695,0,0
3,GO RESPONSE TO PROSTAGLANDIN,0.38829,-0.12217,-0.077972,0,0
3,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,0.2577,-0.12227,-0.033771,0,0
3,GO REGULATION OF CHOLESTEROL EFFLUX,0.49108,-0.12239,-0.038735,0,0
3,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,0.29248,-0.12242,-0.12179,0,0
3,GO REGULATION OF LIPID LOCALIZATION,0.38829,-0.12244,-0.03298,0,0
3,GO POSITIVE REGULATION OF HEMOPOIESIS,0.26442,-0.12251,-0.089329,0,0
3,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,0.214,-0.12253,-0.066337,0,0
3,GO RESPONSE TO TUMOR CELL,0.21989,-0.12271,-0.14156,0,0
3,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.33029,-0.12279,-0.063944,0,0
3,GO POSITIVE REGULATION OF LIPASE ACTIVITY,0.197,-0.12283,-0.090749,0,0
3,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.4521,-0.12304,-0.039256,0,0
3,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,0.5959,-0.12329,-0.049796,0,0
3,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.2577,-0.12338,-0.081588,0,0
3,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,0.040368,-0.12344,-0.10141,0,0
3,GO DETOXIFICATION,0.21989,-0.12348,-0.060124,0,0
3,GO T CELL RECEPTOR SIGNALING PATHWAY,0.1306,-0.12357,-0.1321,0,0
3,GO IRON ION HOMEOSTASIS,0.15197,-0.12374,-0.071888,0,0
3,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.18624,-0.12391,-0.093953,0,0
3,GO ELECTRON TRANSPORT CHAIN,0.0080134,-0.12399,-0.10118,0,0
3,GO POSITIVE REGULATION OF LIPID STORAGE,0.15655,-0.12405,-0.11941,0,0
3,GO CELLULAR RESPONSE TO ZINC ION,0.81845,-0.12417,-0.016366,0,0
3,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,0.23203,-0.12418,-0.051146,0,0
3,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.2577,-0.1242,-0.099285,0,0
3,GO TUMOR NECROSIS FACTOR SECRETION,0.197,-0.12442,-0.10759,0,0
3,GO CARDIAC CELL FATE COMMITMENT,0.29248,-0.12459,-0.088986,0,0
3,GO COPPER ION HOMEOSTASIS,0.11524,-0.12466,-0.06944,0,0
3,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.13885,-0.12481,-0.11645,0,0
3,GO REGULATION OF DEFENSE RESPONSE,0.14312,-0.12487,-0.11404,0,0
3,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,0.19156,-0.12498,-0.10122,0,0
3,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.27821,-0.12503,-0.10943,0,0
3,GO REGULATION OF METANEPHROS DEVELOPMENT,0.40594,-0.1255,-0.057489,0,0
3,GO REGULATION OF STEROL TRANSPORT,0.21989,-0.12578,-0.075673,0,0
3,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.98106,-0.1261,0.042675,0,0
3,GO MUSCLE CELL PROLIFERATION,0.23203,-0.12638,-0.035971,0,0
3,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.35442,-0.12641,-0.068296,0,0
3,GO REGULATION OF BODY FLUID LEVELS,0.23827,-0.12643,-0.040258,0,0
3,GO B CELL HOMEOSTASIS,0.21989,-0.12753,-0.10795,0,0
3,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.96843,-0.1276,0.079895,0,0
3,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.1306,-0.12771,-0.082549,0,0
3,GO PROGESTERONE METABOLIC PROCESS,0.23827,-0.12803,-0.014657,0,0
3,GO CELLULAR RESPONSE TO LITHIUM ION,0.17591,-0.12806,-0.078652,0,0
3,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.15655,-0.12806,-0.041837,0,0
3,GO CELLULAR IRON ION HOMEOSTASIS,0.11894,-0.12814,-0.081421,0,0
3,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.40594,-0.12818,-0.040158,0,0
3,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.28529,-0.12818,-0.10848,0,0
3,GO CARBOHYDRATE DERIVATIVE TRANSPORT,0.12662,-0.12823,-0.05684,0,0
3,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.26442,-0.12832,-0.044605,0,0
3,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.44264,-0.12851,-0.050899,0,0
3,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,0.15655,-0.12859,-0.1704,0,0
3,GO REGULATION OF PEPTIDASE ACTIVITY,0.072385,-0.12879,-0.084985,0,0
3,GO LYMPHOCYTE HOMEOSTASIS,0.23827,-0.12882,-0.11287,0,0
3,GO EPITHELIAL CELL APOPTOTIC PROCESS,0.25111,-0.12894,-0.031647,0,0
3,GO RESPONSE TO ZINC ION,0.30724,-0.12917,-0.070677,0,0
3,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,0.11524,-0.12942,-0.086315,0,0
3,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.23827,-0.12951,-0.058409,0,0
3,GO BILE ACID AND BILE SALT TRANSPORT,0.15655,-0.12964,-0.11482,0,0
3,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.11894,-0.12974,-0.048988,0,0
3,GO MONOCARBOXYLIC ACID TRANSPORT,0.37111,-0.13009,-0.021767,0,0
3,GO LATE ENDOSOME TO VACUOLE TRANSPORT,0.16602,-0.13026,-0.076297,0,0
3,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.33029,-0.13045,-0.067602,0,0
3,GO NEGATIVE REGULATION OF CHEMOTAXIS,0.33821,-0.1309,-0.045416,0,0
3,GO ENDOTHELIAL CELL MIGRATION,0.18102,-0.13094,-0.05708,0,0
3,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.11524,-0.13101,-0.15578,0,0
3,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.14312,-0.13116,-0.14464,0,0
3,GO CELLULAR RESPONSE TO ETHANOL,0.27821,-0.13143,-0.10711,0,0
3,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.20256,-0.1315,-0.13588,0,0
3,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.2259,-0.13169,-0.039587,0,0
3,GO REGULATION OF RECEPTOR BINDING,0.18102,-0.13171,-0.076878,0,0
3,GO RESPONSE TO ORGANOPHOSPHORUS,0.32248,-0.13174,-0.021424,0,0
3,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,0.2998,-0.13177,-0.013548,0,0
3,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.20256,-0.13205,-0.12665,0,0
3,GO REGULATION OF STEM CELL DIVISION,0.197,-0.13226,-0.12265,0,0
3,GO EXTRACELLULAR MATRIX ASSEMBLY,0.60692,-0.13241,0.016285,0,0
3,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.24463,-0.13257,-0.078625,0,0
3,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.11894,-0.13268,-0.048986,0,0
3,GO PROTEIN KINASE B SIGNALING,0.33029,-0.13281,-0.029056,0,0
3,GO GLYCOSIDE METABOLIC PROCESS,0.13467,-0.13299,-0.013228,0,0
3,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.32248,-0.13319,-0.076044,0,0
3,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.21989,-0.13324,-0.063432,0,0
3,GO SULFUR COMPOUND CATABOLIC PROCESS,0.19156,-0.13331,-0.068088,0,0
3,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.33029,-0.13356,-0.019663,0,0
3,GO POSITIVE REGULATION OF MEMBRANE DEPOLARIZATION,0.48117,-0.13357,-0.033727,0,0
3,GO REVERSE CHOLESTEROL TRANSPORT,0.35442,-0.13419,-0.083174,0,0
3,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,0.1475,-0.13442,-0.11007,0,0
3,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,0.23827,-0.13453,-0.091323,0,0
3,GO MYELOID LEUKOCYTE DIFFERENTIATION,0.20822,-0.13468,-0.10559,0,0
3,GO T CELL DIFFERENTIATION,0.37111,-0.13511,-0.10705,0,0
3,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.33029,-0.13523,-0.074998,0,0
3,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,0.25111,-0.13523,-0.065317,0,0
3,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.18102,-0.13552,-0.07073,0,0
3,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.2259,-0.13557,-0.10031,0,0
3,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.23203,-0.13585,-0.12845,0,0
3,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.214,-0.13589,-0.12196,0,0
3,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,0.74555,-0.13593,-0.014584,0,0
3,GO REGULATION OF LIPID TRANSPORT,0.35442,-0.13642,-0.038796,0,0
3,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,0.16602,-0.13685,-0.098785,0,0
3,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,0.26442,-0.13688,-0.047497,0,0
3,GO REGULATION OF B CELL DIFFERENTIATION,0.2259,-0.13736,-0.181,0,0
3,GO PULMONARY VALVE DEVELOPMENT,0.37111,-0.13748,-0.045894,0,0
3,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,0.33029,-0.13749,-0.081443,0,0
3,GO REGULATION OF RESPONSE TO TUMOR CELL,0.17091,-0.13749,-0.15251,0,0
3,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.47137,-0.13786,-0.001738,0,0
3,GO CERAMIDE TRANSPORT,0.20256,-0.13788,-0.10105,0,0
3,GO MULTI ORGANISM CELLULAR PROCESS,0.28529,-0.13793,-0.078003,0,0
3,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.37111,-0.13796,-0.17897,0,0
3,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.3148,-0.13796,-0.060767,0,0
3,GO DISACCHARIDE METABOLIC PROCESS,0.080256,-0.1381,-0.07798,0,0
3,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.17591,-0.13823,-0.069499,0,0
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,0.25111,-0.13838,-0.045042,0,0
3,GO RESPONSE TO MANGANESE ION,0.21989,-0.13841,-0.054145,0,0
3,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.12662,-0.13854,-0.10683,0,0
3,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.17091,-0.13858,-0.0916,0,0
3,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.2998,-0.13863,-0.051229,0,0
3,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,0.27126,-0.13863,-0.07613,0,0
3,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.11894,-0.13867,-0.091324,0,0
3,GO CYTOKINE PRODUCTION,0.1306,-0.13881,-0.13905,0,0
3,GO I KAPPAB PHOSPHORYLATION,0.20822,-0.13893,-0.11252,0,0
3,GO COAGULATION,0.1475,-0.139,-0.084236,0,0
3,GO AORTIC VALVE DEVELOPMENT,0.54223,-0.13942,-0.019233,0,0
3,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,0.12273,-0.13978,-0.10582,0,0
3,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.33821,-0.13979,-0.057082,0,0
3,GO REGULATION OF PROTEIN MATURATION,0.15197,-0.14011,-0.057618,0,0
3,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.13467,-0.14028,-0.084958,0,0
3,GO LEUKOCYTE DIFFERENTIATION,0.33821,-0.14031,-0.091467,0,0
3,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.14312,-0.14047,-0.11715,0,0
3,GO PINOCYTOSIS,0.28529,-0.14125,-0.063123,0,0
3,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.20822,-0.14134,-0.061747,0,0
3,GO ZINC ION HOMEOSTASIS,0.17091,-0.1415,-0.11546,0,0
3,GO BIOLOGICAL PHASE,0.81845,-0.14162,-0.030072,0,0
3,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,0.79394,-0.14165,-0.0028638,0,0
3,GO ORGAN INDUCTION,0.3148,-0.14191,-0.054829,0,0
3,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,0.25111,-0.14194,-0.031669,0,0
3,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,0.12662,-0.14202,-0.0943,0,0
3,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.2577,-0.14212,-0.10795,0,0
3,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,0.61803,-0.14217,-0.051569,0,0
3,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,0.091819,-0.1424,-0.118,0,0
3,GO MACROPHAGE DIFFERENTIATION,0.25111,-0.14267,-0.12797,0,0
3,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,0.30724,-0.14272,-0.086947,0,0
3,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.51122,-0.14272,-0.029677,0,0
3,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.2259,-0.14301,-0.074986,0,0
3,GO RESPONSE TO COPPER ION,0.214,-0.14336,-0.079499,0,0
3,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,0.067497,-0.1436,-0.08723,0,0
3,GO POSITIVE REGULATION OF WOUND HEALING,0.18102,-0.1437,-0.092696,0,0
3,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.18102,-0.1438,-0.14254,0,0
3,GO POSITIVE CHEMOTAXIS,0.197,-0.14381,-0.084251,0,0
3,GO SEQUESTERING OF CALCIUM ION,0.10811,-0.144,-0.11233,0,0
3,GO PHAGOSOME ACIDIFICATION,0.11524,-0.14423,-0.077369,0,0
3,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,0.18624,-0.14426,-0.031936,0,0
3,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.21989,-0.14445,-0.10828,0,0
3,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.23827,-0.14447,-0.12257,0,0
3,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.13467,-0.14486,-0.1295,0,0
3,GO BONE CELL DEVELOPMENT,0.20822,-0.14488,-0.07329,0,0
3,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.38829,-0.14523,-0.039864,0,0
3,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,0.3148,-0.14529,-0.067609,0,0
3,GO RESPONSE TO ISCHEMIA,0.23827,-0.14538,-0.046644,0,0
3,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.214,-0.1454,-0.073249,0,0
3,GO CELLULAR RESPONSE TO CADMIUM ION,0.50109,-0.14547,-0.048156,0,0
3,GO LYMPHOCYTE DIFFERENTIATION,0.37964,-0.14576,-0.09038,0,0
3,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.11524,-0.1458,-0.088138,0,0
3,GO REGULATION OF ODONTOGENESIS,0.23203,-0.14592,-0.094775,0,0
3,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.20822,-0.14593,-0.087625,0,0
3,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,0.12273,-0.14595,-0.097549,0,0
3,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.26442,-0.1461,-0.040303,0,0
3,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,0.24463,-0.14625,-0.2015,0,0
3,GO HOMOTYPIC CELL CELL ADHESION,0.18102,-0.14631,-0.071236,0,0
3,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.16602,-0.14642,-0.075325,0,0
3,GO ENDOCRINE PROCESS,0.13467,-0.14661,-0.083392,0,0
3,GO PHAGOSOME MATURATION,0.08303,-0.14671,-0.077114,0,0
3,GO DEFENSE RESPONSE,0.11524,-0.14713,-0.14133,0,0
3,GO CALCIUM MEDIATED SIGNALING,0.36271,-0.14719,-0.065928,0,0
3,GO RESPONSE TO MAGNESIUM ION,0.197,-0.14721,-0.10574,0,0
3,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.17091,-0.14735,-0.10082,0,0
3,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,0.35442,-0.14741,-0.029168,0,0
3,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.56341,-0.14749,-0.0052337,0,0
3,GO IMMUNE RESPONSE TO TUMOR CELL,0.08588,-0.14766,-0.21286,0,0
3,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.35442,-0.148,-0.091846,0,0
3,GO GLOMERULUS DEVELOPMENT,0.39705,-0.1482,-0.031622,0,0
3,GO RESPONSE TO REDOX STATE,0.214,-0.14828,-0.1015,0,0
3,GO IMMUNOLOGICAL MEMORY PROCESS,0.2577,-0.14835,-0.12518,0,0
3,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.1306,-0.14836,-0.083321,0,0
3,GO PROTEIN DENEDDYLATION,0.08588,-0.14857,-0.077274,0,0
3,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.23827,-0.1486,-0.047337,0,0
3,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,0.15197,-0.14861,-0.09033,0,0
3,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.10468,-0.14885,-0.097651,0,0
3,GO RESPONSE TO PROSTAGLANDIN E,0.30724,-0.14896,-0.080617,0,0
3,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.18102,-0.14904,-0.051366,0,0
3,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.10468,-0.14913,-0.14234,0,0
3,GO REGULATION OF CELL FATE SPECIFICATION,0.20822,-0.14931,-0.10369,0,0
3,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,0.1475,-0.14933,-0.1029,0,0
3,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,0.13467,-0.14977,-0.12518,0,0
3,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.15197,-0.14978,-0.10852,0,0
3,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,0.13885,-0.1498,-0.14434,0,0
3,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.20822,-0.15015,-0.073287,0,0
3,GO GLYCEROLIPID CATABOLIC PROCESS,0.13885,-0.15029,-0.081462,0,0
3,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.17091,-0.15048,-0.1341,0,0
3,GO CELLULAR RESPONSE TO AMYLOID BETA,0.46168,-0.15076,-0.016698,0,0
3,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.067497,-0.15102,-0.15336,0,0
3,GO MUSCLE CELL FATE COMMITMENT,0.072385,-0.15123,-0.1624,0,0
3,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.23827,-0.15127,-0.089448,0,0
3,GO REGULATION OF GLOMERULAR FILTRATION,0.33029,-0.15146,-0.081416,0,0
3,GO RESPONSE TO HYPEROXIA,0.1306,-0.15164,-0.07147,0,0
3,GO T CELL APOPTOTIC PROCESS,0.074935,-0.15176,-0.2176,0,0
3,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.29248,-0.15208,-0.052475,0,0
3,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,0.062884,-0.15234,-0.19472,0,0
3,GO POSITIVE REGULATION OF DEFENSE RESPONSE,0.10134,-0.15235,-0.13569,0,0
3,GO PANCREATIC JUICE SECRETION,0.1306,-0.15249,-0.11524,0,0
3,GO LEUKOCYTE TETHERING OR ROLLING,0.15655,-0.15257,-0.19989,0,0
3,GO RESPONSE TO AMYLOID BETA,0.33821,-0.1526,-0.029099,0,0
3,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.27821,-0.15281,-0.08783,0,0
3,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,0.41494,-0.15297,-0.037277,0,0
3,GO REGULATION OF BIOMINERALIZATION,0.15655,-0.15315,-0.060452,0,0
3,GO POSITIVE REGULATION OF TISSUE REMODELING,0.1475,-0.15329,-0.090428,0,0
3,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,0.11524,-0.15329,-0.11666,0,0
3,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.23203,-0.15378,-0.077705,0,0
3,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.33821,-0.15389,-0.11028,0,0
3,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.29248,-0.15428,-0.067854,0,0
3,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.080256,-0.15428,-0.11042,0,0
3,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,0.12662,-0.15444,-0.1998,0,0
3,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,0.11163,-0.15448,-0.13511,0,0
3,GO POSITIVE REGULATION OF BONE RESORPTION,0.091819,-0.15463,-0.090385,0,0
3,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.19156,-0.15491,-0.090563,0,0
3,GO REGULATION OF IMMUNE SYSTEM PROCESS,0.19156,-0.15516,-0.11231,0,0
3,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.197,-0.15551,-0.080819,0,0
3,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.15655,-0.15558,-0.085865,0,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.197,-0.15573,-0.10933,0,0
3,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.18102,-0.1558,-0.15588,0,0
3,GO IMMUNOGLOBULIN PRODUCTION,0.20822,-0.15585,-0.13141,0,0
3,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.077559,-0.15601,-0.22714,0,0
3,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.16602,-0.15653,-0.076692,0,0
3,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.15197,-0.15667,-0.13731,0,0
3,GO RESPONSE TO INTERLEUKIN 1,0.080256,-0.15672,-0.1375,0,0
3,GO POSITIVE REGULATION OF STEROL TRANSPORT,0.13885,-0.15682,-0.1127,0,0
3,GO NEGATIVE REGULATION OF CELL ADHESION,0.27126,-0.15714,-0.047846,0,0
3,GO REGULATION OF CELL ADHESION,0.20822,-0.15715,-0.075957,0,0
3,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.24463,-0.15741,-0.11041,0,0
3,GO SMOOTH MUSCLE CELL PROLIFERATION,0.12662,-0.15786,-0.078467,0,0
3,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.17091,-0.15802,-0.096522,0,0
3,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,0.098083,-0.15802,-0.13799,0,0
3,GO O GLYCAN PROCESSING,0.13467,-0.15837,-0.10075,0,0
3,GO POLYOL TRANSPORT,0.1475,-0.15837,-0.11599,0,0
3,GO TRANSCYTOSIS,0.19156,-0.15843,-0.11795,0,0
3,GO DETOXIFICATION OF INORGANIC COMPOUND,0.81845,-0.1585,-0.016399,0,0
3,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.21989,-0.15877,-0.15627,0,0
3,GO NEGATIVE REGULATION OF AMINO ACID TRANSPORT,0.15655,-0.15886,-0.091535,0,0
3,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.39705,-0.15887,-0.081488,0,0
3,GO NEUTRAL AMINO ACID TRANSPORT,0.15655,-0.15936,-0.060209,0,0
3,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.37964,-0.15984,-0.032666,0,0
3,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.0076456,-0.15988,-0.16813,0,0
3,GO CYTOKINE MEDIATED SIGNALING PATHWAY,0.072385,-0.15997,-0.16673,0,0
3,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.2259,-0.16005,-0.084888,0,0
3,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.14312,-0.16024,-0.083744,0,0
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.08303,-0.16039,-0.12693,0,0
3,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.16123,-0.16039,-0.12134,0,0
3,GO HYALURONAN CATABOLIC PROCESS,0.38829,-0.16046,-0.071539,0,0
3,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.17591,-0.16074,-0.17967,0,0
3,GO MOVEMENT IN HOST ENVIRONMENT,0.098083,-0.1608,-0.10866,0,0
3,GO B CELL ACTIVATION,0.25111,-0.16082,-0.12466,0,0
3,GO POSITIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.55277,-0.16089,-0.068116,0,0
3,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,0.11163,-0.16103,-0.25978,0,0
3,GO POSITIVE REGULATION OF ENDOCYTOSIS,0.11894,-0.16131,-0.076986,0,0
3,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.23827,-0.16178,-0.12921,0,0
3,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.2259,-0.16197,-0.16396,0,0
3,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.3148,-0.16218,-0.12747,0,0
3,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.37111,-0.16221,-0.061981,0,0
3,GO RESPONSE TO INTERLEUKIN 7,0.08588,-0.16239,-0.13154,0,0
3,GO GTP BIOSYNTHETIC PROCESS,0.214,-0.1625,-0.10671,0,0
3,GO IMMUNE EFFECTOR PROCESS,0.10468,-0.16268,-0.15334,0,0
3,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,0.24463,-0.16273,-0.11747,0,0
3,GO ENDOTHELIAL CELL CHEMOTAXIS,0.10811,-0.16283,-0.08786,0,0
3,GO CELLULAR RESPONSE TO COPPER ION,0.4521,-0.16291,-0.066978,0,0
3,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,0.069906,-0.16293,-0.1304,0,0
3,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.50109,-0.16299,-0.066867,0,0
3,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.067497,-0.16323,-0.1736,0,0
3,GO CELL ACTIVATION,0.14312,-0.16332,-0.12869,0,0
3,GO STORE OPERATED CALCIUM ENTRY,0.25111,-0.16359,-0.087024,0,0
3,GO RESPONSE TO LEPTIN,0.12273,-0.16388,-0.080006,0,0
3,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.11524,-0.16394,-0.24339,0,0
3,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,0.17091,-0.16401,-0.077682,0,0
3,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.17591,-0.16402,-0.11692,0,0
3,GO DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.020391,-0.16409,-0.11487,0,0
3,GO RESPONSE TO BIOTIC STIMULUS,0.098083,-0.1641,-0.14268,0,0
3,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.28529,-0.1643,-0.12466,0,0
3,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.197,-0.16447,-0.094458,0,0
3,GO POSITIVE REGULATION OF LIPID LOCALIZATION,0.15197,-0.1652,-0.094074,0,0
3,GO INNATE IMMUNE RESPONSE IN MUCOSA,0.21989,-0.16527,-0.21888,0,0
3,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,0.08881,-0.16556,-0.097167,0,0
3,GO REGULATION OF MYOTUBE DIFFERENTIATION,0.27821,-0.16601,-0.07607,0,0
3,GO REGULATION OF PLATELET AGGREGATION,0.1475,-0.16623,-0.14597,0,0
3,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.10468,-0.1663,-0.16213,0,0
3,GO MEMBRANE PROTEIN PROTEOLYSIS,0.1475,-0.16724,-0.09706,0,0
3,GO RESPONSE TO INTERLEUKIN 4,0.067497,-0.16738,-0.16368,0,0
3,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.2577,-0.16738,-0.073677,0,0
3,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.18624,-0.16769,-0.13086,0,0
3,GO RUFFLE ORGANIZATION,0.065157,-0.16771,-0.097835,0,0
3,GO FLUID TRANSPORT,0.077559,-0.16772,-0.17932,0,0
3,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.15197,-0.16777,-0.20499,0,0
3,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.18624,-0.16785,-0.10714,0,0
3,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.23827,-0.16789,-0.113,0,0
3,GO COPPER ION TRANSPORT,0.08303,-0.16802,-0.137,0,0
3,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,0.08881,-0.1681,-0.14585,0,0
3,GO POSITIVE REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.2259,-0.16816,-0.1246,0,0
3,GO RESPONSE TO LITHIUM ION,0.21989,-0.16836,-0.04706,0,0
3,GO HETEROTYPIC CELL CELL ADHESION,0.16123,-0.16868,-0.11977,0,0
3,GO HEART INDUCTION,0.21989,-0.16891,-0.090384,0,0
3,GO KERATAN SULFATE METABOLIC PROCESS,0.072385,-0.16891,-0.11072,0,0
3,GO ALPHA BETA T CELL ACTIVATION,0.214,-0.16916,-0.17865,0,0
3,GO RESPONSE TO HYDROGEN PEROXIDE,0.12273,-0.16924,-0.059507,0,0
3,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.10468,-0.16937,-0.18892,0,0
3,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.10134,-0.1708,-0.092099,0,0
3,GO INTERLEUKIN 6 PRODUCTION,0.080256,-0.1718,-0.19011,0,0
3,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.11894,-0.17193,-0.19487,0,0
3,GO REGULATION OF WOUND HEALING,0.08303,-0.17193,-0.12112,0,0
3,GO VASCULAR WOUND HEALING,0.14312,-0.17218,-0.090236,0,0
3,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.033245,-0.17235,-0.12982,0,0
3,GO MAST CELL MEDIATED IMMUNITY,0.13467,-0.17236,-0.16635,0,0
3,GO REGULATION OF T CELL DIFFERENTIATION,0.27126,-0.17302,-0.12875,0,0
3,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.33029,-0.17305,-0.024086,0,0
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.12662,-0.17308,-0.072402,0,0
3,GO LYMPHOCYTE ACTIVATION,0.23203,-0.1737,-0.12766,0,0
3,GO LIPID EXPORT FROM CELL,0.20256,-0.17413,-0.074469,0,0
3,GO NEGATIVE REGULATION OF CELL CELL ADHESION,0.197,-0.1742,-0.12731,0,0
3,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.19156,-0.17497,-0.076741,0,0
3,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,0.25111,-0.17498,-0.062561,0,0
3,GO T CELL LINEAGE COMMITMENT,0.26442,-0.1755,-0.13602,0,0
3,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,0.11524,-0.17578,-0.16063,0,0
3,GO T CELL ACTIVATION,0.21989,-0.17598,-0.15423,0,0
3,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.26442,-0.17599,-0.090256,0,0
3,GO INFLAMMATORY RESPONSE,0.08588,-0.1762,-0.17325,0,0
3,GO NEGATIVE REGULATION OF MACROPHAGE MIGRATION,0.072385,-0.17624,-0.18949,0,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.08881,-0.17625,-0.19685,0,0
3,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.10811,-0.17677,-0.092652,0,0
3,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.19156,-0.17684,-0.14951,0,0
3,GO LEUKOCYTE HOMEOSTASIS,0.20256,-0.17777,-0.12301,0,0
3,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.16602,-0.17782,-0.14861,0,0
3,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,0.08303,-0.17789,-0.16821,0,0
3,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.10468,-0.17794,-0.19665,0,0
3,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,0.062884,-0.178,-0.11575,0,0
3,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,0.17091,-0.17803,-0.088738,0,0
3,GO GLYCINE TRANSPORT,0.33821,-0.17837,-0.080541,0,0
3,GO ANTIGEN PROCESSING AND PRESENTATION,0.08881,-0.17861,-0.14756,0,0
3,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.15655,-0.17866,-0.10021,0,0
3,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.11894,-0.17909,-0.12563,0,0
3,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.35442,-0.17931,-0.13449,0,0
3,GO ERK1 AND ERK2 CASCADE,0.17591,-0.17939,-0.10267,0,0
3,GO GAMMA DELTA T CELL DIFFERENTIATION,0.34626,-0.17956,-0.1135,0,0
3,GO BONE TRABECULA MORPHOGENESIS,0.4521,-0.18024,-0.054402,0,0
3,GO LABYRINTHINE LAYER MORPHOGENESIS,0.2577,-0.18055,-0.098261,0,0
3,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.12662,-0.18089,-0.14466,0,0
3,GO MEMBRANE LIPID CATABOLIC PROCESS,0.08303,-0.18128,-0.11914,0,0
3,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.1475,-0.18142,-0.14942,0,0
3,GO ASTROCYTE DEVELOPMENT,0.40594,-0.18191,-0.06532,0,0
3,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.18102,-0.18244,-0.095525,0,0
3,GO BARBED END ACTIN FILAMENT CAPPING,0.072385,-0.18259,-0.12301,0,0
3,GO TISSUE REMODELING,0.13885,-0.18268,-0.099306,0,0
3,GO GLYCOPROTEIN CATABOLIC PROCESS,0.14312,-0.18272,-0.082455,0,0
3,GO BONE REMODELING,0.15197,-0.18275,-0.08086,0,0
3,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.11894,-0.18289,-0.13143,0,0
3,GO RESPONSE TO HYDROPEROXIDE,0.17591,-0.18328,-0.13671,0,0
3,GO REGULATION OF TISSUE REMODELING,0.08881,-0.18415,-0.11289,0,0
3,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.10811,-0.18425,-0.18389,0,0
3,GO PHOSPHATE ION TRANSPORT,0.074935,-0.18515,-0.11354,0,0
3,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.25111,-0.18544,-0.15719,0,0
3,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.027226,-0.18567,-0.18226,0,0
3,GO REGULATION OF POSITIVE CHEMOTAXIS,0.18624,-0.18576,-0.096765,0,0
3,GO SEMI LUNAR VALVE DEVELOPMENT,0.37111,-0.18585,-0.061645,0,0
3,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,0.098083,-0.18589,-0.21996,0,0
3,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.25111,-0.18609,-0.13654,0,0
3,GO FOAM CELL DIFFERENTIATION,0.10134,-0.18617,-0.1413,0,0
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.72171,-0.18623,-0.011933,0,0
3,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.16123,-0.18646,-0.20712,0,0
3,GO MATERNAL PLACENTA DEVELOPMENT,0.08588,-0.18646,-0.093223,0,0
3,GO OSTEOCLAST DIFFERENTIATION,0.21989,-0.1868,-0.094525,0,0
3,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.35442,-0.18686,-0.051457,0,0
3,GO ALPHA BETA T CELL DIFFERENTIATION,0.214,-0.18741,-0.1759,0,0
3,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.094909,-0.18743,-0.15081,0,0
3,GO RESPONSE TO INTERLEUKIN 6,0.13885,-0.18768,-0.11381,0,0
3,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.069906,-0.18774,-0.10914,0,0
3,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.08881,-0.18796,-0.12722,0,0
3,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.14312,-0.18818,-0.10945,0,0
3,GO POSITIVE REGULATION OF GLIAL CELL MIGRATION,0.20256,-0.18829,-0.19215,0,0
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.10811,-0.18832,-0.11177,0,0
3,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.21989,-0.18877,-0.17171,0,0
3,GO REGULATORY T CELL DIFFERENTIATION,0.21989,-0.18878,-0.19919,0,0
3,GO INNATE IMMUNE RESPONSE,0.069906,-0.18884,-0.18914,0,0
3,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.11894,-0.18885,-0.18492,0,0
3,GO REGULATION OF BONE MINERALIZATION,0.12273,-0.18887,-0.088833,0,0
3,GO T CELL CYTOKINE PRODUCTION,0.065157,-0.18893,-0.26519,0,0
3,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,0.34626,-0.18912,-0.10802,0,0
3,GO REGULATION OF MACROPHAGE DIFFERENTIATION,0.17591,-0.18917,-0.11477,0,0
3,GO POSITIVE REGULATION OF B CELL ACTIVATION,0.11163,-0.18919,-0.197,0,0
3,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,0.50109,-0.19027,-0.045526,0,0
3,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.091819,-0.19031,-0.26264,0,0
3,GO ENDODERM FORMATION,0.27126,-0.19036,-0.063528,0,0
3,GO NAD BIOSYNTHETIC PROCESS,0.24463,-0.19246,-0.1138,0,0
3,GO SUPEROXIDE METABOLIC PROCESS,0.12273,-0.19257,-0.09503,0,0
3,GO ENTRY INTO HOST,0.10134,-0.19262,-0.13336,0,0
3,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.13467,-0.19287,-0.21415,0,0
3,GO PEPTIDYL PROLINE HYDROXYLATION,0.012106,-0.19287,-0.19328,0,0
3,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.10134,-0.19339,-0.12583,0,0
3,GO REGULATION OF CELL CELL ADHESION,0.19156,-0.19348,-0.14096,0,0
3,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,0.17091,-0.19387,-0.09089,0,0
3,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.062884,-0.19525,-0.18799,0,0
3,GO FATTY ACID DERIVATIVE TRANSPORT,0.1306,-0.19556,-0.10764,0,0
3,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.11894,-0.1959,-0.17055,0,0
3,GO MAST CELL ACTIVATION,0.16602,-0.19612,-0.15798,0,0
3,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,0.2259,-0.19652,-0.11404,0,0
3,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.20822,-0.19659,-0.11317,0,0
3,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.16123,-0.19674,-0.10982,0,0
3,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,0.020391,-0.19696,-0.18121,0,0
3,GO DEFENSE RESPONSE TO OTHER ORGANISM,0.080256,-0.19779,-0.17767,0,0
3,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.17591,-0.19817,-0.098065,0,0
3,GO SPHINGOSINE 1 PHOSPHATE RECEPTOR SIGNALING PATHWAY,0.2998,-0.19871,-0.087043,0,0
3,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,0.214,-0.19877,-0.091211,0,0
3,GO MEMBRANE RAFT ORGANIZATION,0.10134,-0.19966,-0.18533,0,0
3,GO FRUCTOSE METABOLIC PROCESS,0.072385,-0.20023,-0.10519,0,0
3,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.074935,-0.20043,-0.17921,0,0
3,GO POSITIVE REGULATION OF CELL ADHESION,0.13467,-0.20053,-0.15495,0,0
3,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.12273,-0.20073,-0.1558,0,0
3,GO RETINAL METABOLIC PROCESS,0.15655,-0.20093,-0.14012,0,0
3,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.27821,-0.2013,-0.081613,0,0
3,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.08588,-0.20211,-0.25393,0,0
3,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.38829,-0.2026,-0.059216,0,0
3,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.10468,-0.20266,-0.112,0,0
3,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.080256,-0.20305,-0.2101,0,0
3,GO NEUTROPHIL EXTRAVASATION,0.14312,-0.20429,-0.18296,0,0
3,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.08881,-0.20466,-0.21936,0,0
3,GO CERAMIDE CATABOLIC PROCESS,0.08303,-0.20478,-0.10484,0,0
3,GO REGULATION OF LEUKOCYTE TETHERING OR ROLLING,0.065157,-0.20524,-0.27222,0,0
3,GO TRABECULA FORMATION,0.10468,-0.20561,-0.139,0,0
3,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.1475,-0.20648,-0.10453,0,0
3,GO RESPONSE TO INTERLEUKIN 18,0.094909,-0.20676,-0.22453,0,0
3,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,0.08881,-0.20676,-0.17258,0,0
3,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.17591,-0.20681,-0.20201,0,0
3,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,0.21989,-0.20696,-0.10566,0,0
3,GO REGULATION OF LIPASE ACTIVITY,0.077559,-0.20868,-0.1322,0,0
3,GO NEGATIVE REGULATION OF WOUND HEALING,0.094909,-0.20911,-0.13756,0,0
3,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.11894,-0.20933,-0.20304,0,0
3,GO NEUTROPHIL HOMEOSTASIS,0.098083,-0.20942,-0.16455,0,0
3,GO PLATELET ACTIVATION,0.10468,-0.20959,-0.1111,0,0
3,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.094909,-0.20963,-0.097062,0,0
3,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.11163,-0.21015,-0.12997,0,0
3,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,0.069906,-0.21096,-0.1215,0,0
3,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.13885,-0.21098,-0.17966,0,0
3,GO SYNCYTIUM FORMATION,0.11894,-0.21136,-0.13614,0,0
3,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.34626,-0.21141,-0.16711,0,0
3,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.15197,-0.21152,-0.18278,0,0
3,GO CYTOKINE METABOLIC PROCESS,0.08303,-0.21226,-0.21597,0,0
3,GO AMYLOID BETA CLEARANCE,0.074935,-0.2123,-0.18945,0,0
3,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.1475,-0.21245,-0.12951,0,0
3,GO REGULATION OF INFLAMMATORY RESPONSE,0.074935,-0.21269,-0.17638,0,0
3,GO MYELOID CELL APOPTOTIC PROCESS,0.11524,-0.21279,-0.13987,0,0
3,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.062884,-0.21347,-0.23446,0,0
3,GO LEUKOCYTE AGGREGATION,0.18624,-0.21389,-0.25459,0,0
3,GO REGULATION OF MAST CELL ACTIVATION,0.074935,-0.21436,-0.21053,0,0
3,GO EXTRACELLULAR STRUCTURE ORGANIZATION,0.16123,-0.21493,-0.086605,0,0
3,GO REGULATION OF IMMUNE RESPONSE,0.11163,-0.21584,-0.17319,0,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.067497,-0.21598,-0.22105,0,0
3,GO REGULATION OF T HELPER CELL DIFFERENTIATION,0.1306,-0.21654,-0.20749,0,0
3,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.10134,-0.2166,-0.20315,0,0
3,GO LEYDIG CELL DIFFERENTIATION,0.60692,-0.21711,-0.045207,0,0
3,GO POSITIVE REGULATION OF IMMUNE RESPONSE,0.10134,-0.21878,-0.17025,0,0
3,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.14312,-0.21888,-0.21698,0,0
3,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.074935,-0.21903,-0.17866,0,0
3,GO CELLULAR EXTRAVASATION,0.08881,-0.22007,-0.21036,0,0
3,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.11163,-0.2206,-0.18807,0,0
3,GO RENAL ABSORPTION,0.23827,-0.22128,-0.10479,0,0
3,GO TROPHOBLAST CELL MIGRATION,0.094909,-0.22134,-0.099414,0,0
3,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.44264,-0.22264,-0.089724,0,0
3,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.072385,-0.22281,-0.14281,0,0
3,GO POSITIVE T CELL SELECTION,0.24463,-0.2232,-0.21499,0,0
3,GO ADRENAL GLAND DEVELOPMENT,0.37111,-0.22397,-0.045911,0,0
3,GO T CELL SELECTION,0.2259,-0.22407,-0.21341,0,0
3,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.18102,-0.22407,-0.20988,0,0
3,GO REGULATION OF GLIAL CELL MIGRATION,0.08588,-0.2244,-0.2265,0,0
3,GO MYOBLAST FUSION,0.13885,-0.22449,-0.14749,0,0
3,GO REGULATION OF CHEMOTAXIS,0.077559,-0.22506,-0.15074,0,0
3,GO ENDODERMAL CELL DIFFERENTIATION,0.13885,-0.22527,-0.12372,0,0
3,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,0.23203,-0.22545,-0.18146,0,0
3,GO ASTROCYTE ACTIVATION,0.1306,-0.22639,-0.17876,0,0
3,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.11524,-0.22681,-0.1973,0,0
3,GO REGULATION OF MICROVILLUS ORGANIZATION,0.17091,-0.22755,-0.09966,0,0
3,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.13467,-0.22763,-0.14815,0,0
3,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.098083,-0.22772,-0.12728,0,0
3,GO AMINOGLYCAN CATABOLIC PROCESS,0.10134,-0.22788,-0.10517,0,0
3,GO REGULATION OF CELL ACTIVATION,0.13467,-0.22789,-0.18176,0,0
3,GO WATER TRANSPORT,0.12273,-0.22803,-0.20385,0,0
3,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,0.11524,-0.22882,-0.13607,0,0
3,GO AMYLOID FIBRIL FORMATION,0.08303,-0.22893,-0.13786,0,0
3,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.08881,-0.22925,-0.18778,0,0
3,GO PHAGOLYSOSOME ASSEMBLY,0.08881,-0.22931,-0.10231,0,0
3,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.08588,-0.2294,-0.21088,0,0
3,GO NEGATIVE REGULATION OF MAST CELL ACTIVATION,0.15197,-0.22944,-0.20214,0,0
3,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.08881,-0.2296,-0.12403,0,0
3,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.10134,-0.23039,-0.17618,0,0
3,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.14312,-0.23053,-0.20226,0,0
3,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.10134,-0.23095,-0.14706,0,0
3,GO ACTIVATION OF IMMUNE RESPONSE,0.098083,-0.23101,-0.1654,0,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.13467,-0.23126,-0.19411,0,0
3,GO T HELPER CELL LINEAGE COMMITMENT,0.13885,-0.23272,-0.26137,0,0
3,GO REGULATION OF B CELL ACTIVATION,0.074935,-0.23275,-0.23989,0,0
3,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.23827,-0.23294,-0.21917,0,0
3,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,0.16602,-0.23336,-0.20615,0,0
3,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.098083,-0.23346,-0.20951,0,0
3,GO RESPONSE TO INTERLEUKIN 2,0.16602,-0.23494,-0.19234,0,0
3,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.21989,-0.23671,-0.13417,0,0
3,GO PLATELET AGGREGATION,0.069906,-0.23682,-0.14045,0,0
3,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.16602,-0.23693,-0.17617,0,0
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.36271,-0.23699,-0.11378,0,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.013834,-0.2376,-0.1722,0,0
3,GO REGULATION OF COLLAGEN METABOLIC PROCESS,0.10134,-0.2382,-0.15117,0,0
3,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.074935,-0.23858,-0.21741,0,0
3,GO POSITIVE REGULATION OF CYTOKINE SECRETION,0.08881,-0.23875,-0.1692,0,0
3,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.091819,-0.23904,-0.2185,0,0
3,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,0.20822,-0.23994,-0.18963,0,0
3,GO CYTOKINE SECRETION,0.074935,-0.24164,-0.1927,0,0
3,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.10468,-0.24207,-0.15821,0,0
3,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,0.062884,-0.24228,-0.19457,0,0
3,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,0.24463,-0.2423,-0.085993,0,0
3,GO REGULATION OF T CELL ACTIVATION,0.14312,-0.24255,-0.19069,0,0
3,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.12662,-0.24294,-0.13401,0,0
3,GO REGULATION OF MACROPHAGE ACTIVATION,0.08881,-0.24418,-0.23088,0,0
3,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.072385,-0.24446,-0.21862,0,0
3,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.072385,-0.24499,-0.28768,0,0
3,GO REGULATION OF PROSTAGLANDIN SECRETION,0.069906,-0.24586,-0.17006,0,0
3,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.12273,-0.24591,-0.23599,0,0
3,GO LEUKOCYTE CELL CELL ADHESION,0.11894,-0.24726,-0.20836,0,0
3,GO REGULATION OF IMMUNE EFFECTOR PROCESS,0.074935,-0.24799,-0.21154,0,0
3,GO NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.074935,-0.24818,-0.20852,0,0
3,GO NEGATIVE REGULATION OF CELL ACTIVATION,0.10468,-0.24887,-0.1958,0,0
3,GO INTEGRIN MEDIATED SIGNALING PATHWAY,0.08588,-0.24891,-0.16858,0,0
3,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.062884,-0.24893,-0.15948,0,0
3,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.1475,-0.24898,-0.22138,0,0
3,GO POSITIVE REGULATION OF B CELL PROLIFERATION,0.094909,-0.2495,-0.22851,0,0
3,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.08588,-0.25052,-0.21738,0,0
3,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,0.065157,-0.25135,-0.19512,0,0
3,GO PHAGOCYTOSIS RECOGNITION,0.1475,-0.25151,-0.18142,0,0
3,GO PHAGOCYTOSIS,0.067497,-0.25153,-0.18368,0,0
3,GO CELL ADHESION MOLECULE PRODUCTION,0.16123,-0.2529,-0.14846,0,0
3,GO MACROPHAGE APOPTOTIC PROCESS,0.15655,-0.25299,-0.16821,0,0
3,GO PROSTAGLANDIN SECRETION,0.17091,-0.25303,-0.13757,0,0
3,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.20256,-0.25359,-0.08919,0,0
3,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.12273,-0.25373,-0.12847,0,0
3,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.074935,-0.25375,-0.24906,0,0
3,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.069906,-0.25409,-0.18563,0,0
3,GO ALPHA BETA T CELL PROLIFERATION,0.11524,-0.25419,-0.24662,0,0
3,GO POSITIVE REGULATION OF CELL ACTIVATION,0.08881,-0.25524,-0.22216,0,0
3,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.074935,-0.25573,-0.23441,0,0
3,GO MACROPHAGE CYTOKINE PRODUCTION,0.15197,-0.25607,-0.19464,0,0
3,GO REGULATION OF INTEGRIN ACTIVATION,0.072385,-0.25668,-0.2051,0,0
3,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.08881,-0.2569,-0.21753,0,0
3,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.069906,-0.25723,-0.22167,0,0
3,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,0.12662,-0.25765,-0.14724,0,0
3,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.08588,-0.25804,-0.17522,0,0
3,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.062884,-0.25826,-0.15608,0,0
3,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.065157,-0.2592,-0.25203,0,0
3,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,0.18102,-0.26016,-0.20793,0,0
3,GO HISTAMINE TRANSPORT,0.074935,-0.2605,-0.20132,0,0
3,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,0.10134,-0.26068,-0.11356,0,0
3,GO PROSTAGLANDIN TRANSPORT,0.10811,-0.26123,-0.14475,0,0
3,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,0.19156,-0.26123,-0.17538,0,0
3,GO INFLAMMATORY CELL APOPTOTIC PROCESS,0.10134,-0.26127,-0.19879,0,0
3,GO REGULATION OF B CELL MEDIATED IMMUNITY,0.12273,-0.26159,-0.18552,0,0
3,GO MEMBRANE INVAGINATION,0.080256,-0.26208,-0.17903,0,0
3,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.074935,-0.2622,-0.2057,0,0
3,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.12662,-0.26285,-0.18854,0,0
3,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.074935,-0.26286,-0.25365,0,0
3,GO COLLAGEN BIOSYNTHETIC PROCESS,0.098083,-0.26422,-0.14834,0,0
3,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.15197,-0.26497,-0.11753,0,0
3,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,0.074935,-0.26521,-0.22391,0,0
3,GO INTESTINAL ABSORPTION,0.069906,-0.26647,-0.19293,0,0
3,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.062884,-0.26673,-0.23197,0,0
3,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.098083,-0.26676,-0.20325,0,0
3,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.08303,-0.26768,-0.22156,0,0
3,GO DETECTION OF BIOTIC STIMULUS,0.080256,-0.26793,-0.22259,0,0
3,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.08588,-0.2688,-0.24537,0,0
3,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.11163,-0.26933,-0.20872,0,0
3,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.08881,-0.27013,-0.25696,0,0
3,GO OSTEOCLAST DEVELOPMENT,0.080256,-0.27088,-0.20301,0,0
3,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.2259,-0.27216,-0.22975,0,0
3,GO BLOOD VESSEL REMODELING,0.11163,-0.27331,-0.1362,0,0
3,GO RESPONSE TO TYPE I INTERFERON,0.08303,-0.2734,-0.22742,0,0
3,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.26442,-0.27386,-0.2024,0,0
3,GO NEGATIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.24463,-0.27475,-0.16753,0,0
3,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.08881,-0.27519,-0.25732,0,0
3,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.030713,-0.27646,-0.26345,0,0
3,GO MATURE B CELL DIFFERENTIATION,0.15197,-0.27683,-0.20956,0,0
3,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.072385,-0.2775,-0.22769,0,0
3,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,0.074935,-0.27816,-0.31724,0,0
3,GO SIGNAL PEPTIDE PROCESSING,0.0042727,-0.27825,-0.23206,0,0
3,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.13467,-0.27903,-0.20793,0,0
3,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,0.08303,-0.27958,-0.24696,0,0
3,GO BLEB ASSEMBLY,0.17591,-0.2797,-0.12713,0,0
3,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,0.069906,-0.28086,-0.1948,0,0
3,GO LYMPHOCYTE MEDIATED IMMUNITY,0.065157,-0.28096,-0.25718,0,0
3,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.11163,-0.28131,-0.15784,0,0
3,GO ELASTIC FIBER ASSEMBLY,0.1306,-0.28133,-0.22968,0,0
3,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.072385,-0.28224,-0.17743,0,0
3,GO MYELOID DENDRITIC CELL ACTIVATION,0.072385,-0.28234,-0.30676,0,0
3,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.077559,-0.28343,-0.24097,0,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.08303,-0.28404,-0.21626,0,0
3,GO T CELL EXTRAVASATION,0.098083,-0.28421,-0.23791,0,0
3,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.10811,-0.28451,-0.2523,0,0
3,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.067497,-0.2849,-0.20483,0,0
3,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.069906,-0.28715,-0.29868,0,0
3,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.062884,-0.28764,-0.25294,0,0
3,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.067497,-0.28788,-0.26371,0,0
3,GO THYMIC T CELL SELECTION,0.18624,-0.28995,-0.243,0,0
3,GO VASODILATION,0.028348,-0.29311,-0.17527,0,0
3,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.08588,-0.29329,-0.23445,0,0
3,GO COLLAGEN METABOLIC PROCESS,0.074935,-0.29379,-0.15609,0,0
3,GO LEUKOCYTE PROLIFERATION,0.062884,-0.29638,-0.23698,0,0
3,GO LYMPH NODE DEVELOPMENT,0.08588,-0.29809,-0.21584,0,0
3,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.08303,-0.2986,-0.24114,0,0
3,GO POSITIVE REGULATION OF REGULATORY T CELL DIFFERENTIATION,0.1306,-0.29926,-0.28538,0,0
3,GO XENOBIOTIC CATABOLIC PROCESS,0.0083971,-0.30072,-0.29995,0,0
3,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,0.067497,-0.30084,-0.23913,0,0
3,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.065157,-0.30299,-0.22758,0,0
3,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.17591,-0.3051,-0.19731,0,0
3,GO MACROPHAGE ACTIVATION,0.062884,-0.30553,-0.26174,0,0
3,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.065157,-0.31232,-0.28723,0,0
3,GO COLLAGEN FIBRIL ORGANIZATION,0.077559,-0.31397,-0.22281,0,0
3,GO EXTRACELLULAR MATRIX DISASSEMBLY,0.067497,-0.31644,-0.18118,0,0
3,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.048745,-0.31689,-0.24357,0,0
3,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,0.16123,-0.31824,-0.18292,0,0
3,GO LYMPHOCYTE COSTIMULATION,0.10134,-0.31858,-0.24022,0,0
3,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,0.15197,-0.32029,-0.18946,0,0
3,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.077559,-0.32035,-0.22916,0,0
3,GO GLOMERULAR MESANGIUM DEVELOPMENT,0.20256,-0.32358,-0.13624,0,0
3,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.0054671,-0.32582,-0.28239,0,0
3,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.062884,-0.32815,-0.21993,0,0
3,GO DETECTION OF OTHER ORGANISM,0.072385,-0.33366,-0.2837,0,0
3,GO POSITIVE THYMIC T CELL SELECTION,0.197,-0.34628,-0.28646,0,0
3,GO INTESTINAL LIPID ABSORPTION,0.08303,-0.35463,-0.21813,0,0
3,GO DEFENSE RESPONSE TO FUNGUS,0.00076864,-0.35469,-0.37107,0,0
3,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.10134,-0.36714,-0.25923,0,0
3,GO RESPONSE TO INTERLEUKIN 15,0.074935,-0.37423,-0.30544,0,0
3,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.065157,-0.38726,-0.27614,0,0
3,GO NEGATIVE T CELL SELECTION,0.14312,-0.39105,-0.32001,0,0
3,GO HISTAMINE SECRETION,0.016475,-0.39173,-0.29922,0,0
3,GO T HELPER 2 CELL DIFFERENTIATION,0.072385,-0.40544,-0.28849,0,0
3,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.072385,-0.4117,-0.31483,0,0
3,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,0.067497,-0.42444,-0.1894,0,0
3,GO T CELL TOLERANCE INDUCTION,0.067497,-0.43957,-0.4241,0,0
3,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,0.077559,-0.48148,-0.34783,0,0
3,GO REGULATION OF T CELL TOLERANCE INDUCTION,0.067497,-0.48447,-0.49341,0,0
3,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.0172,-0.53127,-0.40625,0,0
3,GO EOSINOPHIL MIGRATION,0.0040644,-0.63813,-0.57216,0,0
3,GO EOSINOPHIL CHEMOTAXIS,0.0044907,-0.69189,-0.56454,0,0
3,GO NATURAL KILLER CELL CHEMOTAXIS,0.072385,-0.7335,-0.47235,0,0
4,GO OUTER DYNEIN ARM ASSEMBLY,7.8298e-05,0.74089,0.66843,1,1
4,GO INNER DYNEIN ARM ASSEMBLY,0.00029789,0.64477,0.60731,1,1
4,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,0.00012367,0.64095,0.58737,1,1
4,GO ADHESION OF SYMBIONT TO HOST,0.0011418,0.59833,0.59521,1,1
4,GO LOOP OF HENLE DEVELOPMENT,0.00096503,0.56502,0.49584,1,1
4,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,4.8997e-05,0.55906,0.6318,1,1
4,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.00020554,0.55535,0.52814,1,1
4,GO REGULATION OF CGMP MEDIATED SIGNALING,4.8997e-05,0.54079,0.56593,1,1
4,GO DENSE CORE GRANULE TRANSPORT,0.00028019,0.53825,0.60671,1,1
4,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.041938,0.53519,0.33995,1,1
4,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.007293,0.53035,0.4769,1,1
4,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,0.00029789,0.52327,0.46019,1,1
4,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.00015974,0.5215,0.52004,1,1
4,GO PONS DEVELOPMENT,0.00019306,0.51956,0.57388,1,1
4,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.0031545,0.49926,0.50975,1,1
4,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00035748,0.49031,0.63092,1,1
4,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.00015974,0.48895,0.71166,1,1
4,GO NEURON REMODELING,3.7287e-05,0.48408,0.54782,1,1
4,GO VOCALIZATION BEHAVIOR,0.0003797,0.4826,0.4906,1,1
4,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,0.00031664,0.48173,0.40524,1,1
4,GO REGULATION OF PROTEIN KINASE C SIGNALING,0.00033648,0.48159,0.48977,1,1
4,GO GAMMA AMINOBUTYRIC ACID SECRETION,0.0017696,0.47815,0.45996,1,1
4,GO AXONEME ASSEMBLY,0.00011593,0.47527,0.49149,1,1
4,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,0.0172,0.47266,0.34989,1,1
4,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.012106,0.47255,0.45701,1,1
4,GO LAYER FORMATION IN CEREBRAL CORTEX,0.00028019,0.4678,0.46472,1,1
4,GO DISTAL TUBULE DEVELOPMENT,0.015776,0.46603,0.36091,1,1
4,GO SENSORY PERCEPTION OF BITTER TASTE,0.00010866,0.46491,0.38958,1,1
4,GO MICROTUBULE BUNDLE FORMATION,0.00012367,0.46353,0.43278,1,1
4,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,2.2907e-05,0.46347,0.61123,1,1
4,GO EXTRACELLULAR TRANSPORT,0.00026348,0.46198,0.45644,1,1
4,GO DENDRITIC TRANSPORT,0.0054671,0.4608,0.38071,1,1
4,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,0.00096503,0.45915,0.46725,1,1
4,GO SYNAPTIC VESICLE DOCKING,0.0014241,0.45664,0.62294,1,1
4,GO ELASTIC FIBER ASSEMBLY,0.020391,0.45292,0.43337,1,1
4,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,0.00076864,0.45075,0.44683,1,1
4,GO MOTILE CILIUM ASSEMBLY,0.00051151,0.44903,0.40296,1,1
4,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00064645,0.44852,0.49467,1,1
4,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.00017019,0.44568,0.52873,1,1
4,GO INTERLEUKIN 13 PRODUCTION,0.030713,0.44285,0.31269,1,1
4,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.019548,0.44279,0.38053,1,1
4,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,0.011063,0.44273,0.35732,1,1
4,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0076456,0.44197,0.41319,1,1
4,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.00014062,0.43807,0.45119,1,1
4,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,0.0066311,0.43502,0.46091,1,1
4,GO RECEPTOR CLUSTERING,0.00035748,0.43125,0.3925,1,1
4,GO INTERLEUKIN 5 PRODUCTION,0.0054671,0.42967,0.39555,1,1
4,GO RESPONSE TO PAIN,4.5779e-05,0.42854,0.451,1,1
4,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,0.00029789,0.42728,0.46231,1,1
4,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,0.0012071,0.42592,0.37893,1,1
4,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,0.0092139,0.4247,0.36406,1,1
4,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00060992,0.4247,0.41802,1,1
4,GO SECRETORY GRANULE LOCALIZATION,0.00033648,0.42463,0.46749,1,1
4,GO ADRENAL GLAND DEVELOPMENT,7.3279e-05,0.42423,0.44035,1,1
4,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.0028457,0.42352,0.44054,1,1
4,GO BRANCHED CHAIN AMINO ACID TRANSPORT,7.8298e-05,0.42336,0.44818,1,1
4,GO AXO DENDRITIC PROTEIN TRANSPORT,0.0014241,0.42275,0.44086,1,1
4,GO LUTEINIZATION,0.0010798,0.4222,0.43504,1,1
4,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,0.00076864,0.42155,0.66127,1,1
4,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,4.8997e-05,0.42105,0.43891,1,1
4,GO IRON COORDINATION ENTITY TRANSPORT,0.00068502,0.41659,0.39648,1,1
4,GO LONG TERM SYNAPTIC DEPRESSION,0.0038653,0.41547,0.34052,1,1
4,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,0.00332,0.41537,0.56475,1,1
4,GO SYNAPSE MATURATION,0.006955,0.41524,0.36734,1,1
4,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.0027019,0.41399,0.37671,1,1
4,GO TYPE B PANCREATIC CELL PROLIFERATION,0.00013188,0.4129,0.40884,1,1
4,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.0015041,0.41231,0.39951,1,1
4,GO PARENTAL BEHAVIOR,0.028348,0.41186,0.29041,1,1
4,GO DERMATAN SULFATE METABOLIC PROCESS,0.00076864,0.41143,0.47254,1,1
4,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.0036751,0.41031,0.34161,1,1
4,GO RESPONSE TO POTASSIUM ION,0.0021907,0.4101,0.43513,1,1
4,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.0025648,0.4091,0.38477,1,1
4,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,0.0034935,0.40892,0.46203,1,1
4,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,0.00031664,0.40816,0.57271,1,1
4,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.007293,0.40751,0.36124,1,1
4,GO COLLECTING DUCT DEVELOPMENT,0.0063209,0.40487,0.37976,1,1
4,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,0.00057531,0.40341,0.38876,1,1
4,GO PROTEIN LOCALIZATION TO SYNAPSE,0.00029789,0.40326,0.41446,1,1
4,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.0054671,0.40278,0.38971,1,1
4,GO CALCIUM ION IMPORT INTO CYTOSOL,0.0083971,0.40114,0.36772,1,1
4,GO RESPONSE TO FORSKOLIN,0.00064645,0.40074,0.41279,1,1
4,GO NEURON CELLULAR HOMEOSTASIS,0.022172,0.3993,0.27823,1,1
4,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,0.00068502,0.39898,0.38617,1,1
4,GO REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.00040321,0.39815,0.63061,1,1
4,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,0.00019306,0.39743,0.62283,1,1
4,GO DOPAMINE BIOSYNTHETIC PROCESS,0.0019699,0.3955,0.36674,1,1
4,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,4.8997e-05,0.39418,0.43335,1,1
4,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.0014241,0.39392,0.40837,1,1
4,GO DIVALENT METAL ION EXPORT,0.0092139,0.39309,0.29333,1,1
4,GO HYALURONAN BIOSYNTHETIC PROCESS,0.00028019,0.39265,0.44708,1,1
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.00042807,0.39164,0.40964,1,1
4,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.00028019,0.39089,0.55625,1,1
4,GO INTESTINAL LIPID ABSORPTION,0.0042727,0.39043,0.40269,1,1
4,GO PROTEIN LOCALIZATION TO CELL JUNCTION,0.00023283,0.39007,0.38574,1,1
4,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.0016767,0.38769,0.3862,1,1
4,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,0.00045436,0.3876,0.41917,1,1
4,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,2.8267e-05,0.38743,0.56262,1,1
4,GO MICROTUBULE ANCHORING AT CENTROSOME,0.010101,0.38672,0.36864,1,1
4,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,0.0060238,0.38595,0.38647,1,1
4,GO NEURON MATURATION,9.5377e-05,0.38582,0.39117,1,1
4,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0016767,0.38543,0.37385,1,1
4,GO REFLEX,0.00068502,0.38451,0.43046,1,1
4,GO REGULATION OF NEURON MIGRATION,0.0034935,0.38437,0.38592,1,1
4,GO INHIBITORY POSTSYNAPTIC POTENTIAL,0.0036751,0.38403,0.52903,1,1
4,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,0.0018673,0.38194,0.38451,1,1
4,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,0.00072571,0.38004,0.38322,1,1
4,GO LIPOXYGENASE PATHWAY,0.015104,0.37795,0.26384,1,1
4,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,0.00332,0.37771,0.39012,1,1
4,GO MEMBRANE DEPOLARIZATION,8.3641e-05,0.37604,0.41137,1,1
4,GO INHIBITORY SYNAPSE ASSEMBLY,0.021265,0.37577,0.38542,1,1
4,GO OPIOID RECEPTOR SIGNALING PATHWAY,0.0012071,0.37526,0.37718,1,1
4,GO LEYDIG CELL DIFFERENTIATION,0.00076864,0.37372,0.47113,1,1
4,GO CRANIAL NERVE STRUCTURAL ORGANIZATION,0.025096,0.37311,0.30845,1,1
4,GO COLLATERAL SPROUTING,0.00017019,0.37305,0.44204,1,1
4,GO INSEMINATION,0.0021907,0.37271,0.38655,1,1
4,GO FEAR RESPONSE,0.0036751,0.37214,0.26827,1,1
4,GO PROTEIN LOCALIZATION TO PRESYNAPSE,0.00048214,0.37204,0.50935,1,1
4,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,0.011063,0.37175,0.35629,1,1
4,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.00021879,0.37131,0.33001,1,1
4,GO SYNAPTIC MEMBRANE ADHESION,0.0080134,0.37032,0.37265,1,1
4,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,0.0023095,0.36962,0.39746,1,1
4,GO CALCIUM ION REGULATED EXOCYTOSIS,3.4805e-05,0.3689,0.55708,1,1
4,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.0016767,0.36888,0.29507,1,1
4,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,0.00091199,0.36857,0.4248,1,1
4,GO LYMPH NODE DEVELOPMENT,0.010101,0.36818,0.34607,1,1
4,GO REGULATION OF COLLATERAL SPROUTING,0.00091199,0.36785,0.41976,1,1
4,GO REGULATION OF CHOLESTEROL EFFLUX,0.00051151,0.3675,0.36613,1,1
4,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.0040644,0.36715,0.35257,1,1
4,GO SYNAPTIC VESICLE BUDDING,0.00045436,0.36625,0.38344,1,1
4,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,0.0028457,0.36615,0.4426,1,1
4,GO CILIUM MOVEMENT,0.00054254,0.36582,0.37553,1,1
4,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,0.00072571,0.36543,0.41544,1,1
4,GO RESPONSE TO MAGNESIUM ION,0.0016767,0.36496,0.37451,1,1
4,GO CGMP MEDIATED SIGNALING,0.00029789,0.36494,0.38969,1,1
4,GO ENGULFMENT OF APOPTOTIC CELL,0.0052065,0.36434,0.35412,1,1
4,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,0.012106,0.36427,0.35647,1,1
4,GO MEMBRANE HYPERPOLARIZATION,0.0010798,0.3641,0.33009,1,1
4,GO AMMONIUM ION METABOLIC PROCESS,0.0023095,0.36296,0.32523,1,1
4,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,0.00033648,0.36141,0.52927,1,1
4,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,0.00033648,0.36132,0.42924,1,1
4,GO PANCREATIC JUICE SECRETION,0.0014241,0.36028,0.32745,1,1
4,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,0.0034935,0.36,0.32901,1,1
4,GO EXCITATORY SYNAPSE ASSEMBLY,0.00086166,0.35915,0.48935,1,1
4,GO REGULATION OF SYNAPSE MATURATION,0.0092139,0.3587,0.3629,1,1
4,GO RESPONSE TO AUDITORY STIMULUS,0.00048214,0.35787,0.38058,1,1
4,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,0.00028019,0.35757,0.48299,1,1
4,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.00026348,0.35734,0.53205,1,1
4,GO EXTRACELLULAR MATRIX ASSEMBLY,0.0036751,0.35676,0.40901,1,1
4,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.00031664,0.35647,0.3493,1,1
4,GO RECEPTOR LOCALIZATION TO SYNAPSE,0.0019699,0.35618,0.34912,1,1
4,GO PREPULSE INHIBITION,0.0172,0.35598,0.34503,1,1
4,GO CHEMOSENSORY BEHAVIOR,0.00051151,0.35492,0.39004,1,1
4,GO LIPID DIGESTION,0.0076456,0.35473,0.34204,1,1
4,GO REGULATION OF MICROTUBULE POLYMERIZATION,0.0012758,0.35469,0.34,1,1
4,GO SYNAPTIC VESICLE PRIMING,0.00086166,0.3538,0.51576,1,1
4,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,0.00076864,0.3533,0.33794,1,1
4,GO RESPONSE TO DIETARY EXCESS,8.3641e-05,0.35324,0.38986,1,1
4,GO ACTIVATION OF JNKK ACTIVITY,0.0019699,0.35234,0.32077,1,1
4,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.0019699,0.35234,0.41948,1,1
4,GO NEURON CELL CELL ADHESION,0.00076864,0.35142,0.52666,1,1
4,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,4.2763e-05,0.35084,0.36426,1,1
4,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.00042807,0.35075,0.42215,1,1
4,GO LATERAL VENTRICLE DEVELOPMENT,0.0025648,0.35075,0.35973,1,1
4,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,0.00057531,0.35068,0.37585,1,1
4,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,0.006955,0.35041,0.36443,1,1
4,GO LIPID TRANSLOCATION,0.00035748,0.34966,0.36417,1,1
4,GO SPONTANEOUS SYNAPTIC TRANSMISSION,0.0016767,0.34777,0.57511,1,1
4,GO LOCALIZATION WITHIN MEMBRANE,0.00096503,0.34758,0.32582,1,1
4,GO CARDIAC MYOFIBRIL ASSEMBLY,0.00021879,0.34756,0.39938,1,1
4,GO LEARNING,0.0014241,0.3474,0.31579,1,1
4,GO SYNAPTIC VESICLE LOCALIZATION,0.00033648,0.34668,0.38084,1,1
4,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.00010866,0.34651,0.38294,1,1
4,GO ATRIAL SEPTUM DEVELOPMENT,0.0013481,0.34573,0.36075,1,1
4,GO REGULATION OF REGULATED SECRETORY PATHWAY,0.00031664,0.3455,0.37126,1,1
4,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.01266,0.34533,0.34972,1,1
4,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.0034935,0.34451,0.352,1,1
4,GO POSTSYNAPSE ASSEMBLY,0.0049572,0.34376,0.42516,1,1
4,GO REGULATION OF SYNAPTIC PLASTICITY,0.00017019,0.34228,0.39153,1,1
4,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,0.0042727,0.3413,0.2836,1,1
4,GO SYNAPSE ORGANIZATION,0.00057531,0.34123,0.35052,1,1
4,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.01266,0.34084,0.294,1,1
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,0.0010798,0.34039,0.39408,1,1
4,GO CARDIAC CHAMBER FORMATION,0.056456,0.34006,0.21338,1,1
4,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,0.021265,0.3388,0.28294,1,1
4,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.00054254,0.33865,0.39906,1,1
4,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,0.0015882,0.33809,0.48087,1,1
4,GO NEPHRIC DUCT DEVELOPMENT,0.011063,0.33739,0.29155,1,1
4,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.0017696,0.33702,0.36109,1,1
4,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,0.0016767,0.33648,0.40977,1,1
4,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,0.00020554,0.33645,0.36121,1,1
4,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.019548,0.33555,0.30364,1,1
4,GO PROTEIN TRANSPORT ALONG MICROTUBULE,0.0042727,0.3354,0.28523,1,1
4,GO REGULATION OF TRANS SYNAPTIC SIGNALING,0.0003797,0.33397,0.36677,1,1
4,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,0.0015041,0.33362,0.36479,1,1
4,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.0028457,0.33353,0.37796,1,1
4,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.018736,0.33349,0.25124,1,1
4,GO ASSOCIATIVE LEARNING,0.0017696,0.33315,0.32186,1,1
4,GO LONG TERM MEMORY,0.0042727,0.33284,0.32665,1,1
4,GO SENSORY PERCEPTION OF TASTE,8.9327e-05,0.33266,0.33282,1,1
4,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.00018128,0.33257,0.43481,1,1
4,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.00060992,0.33251,0.38833,1,1
4,GO EXPLORATION BEHAVIOR,0.0080134,0.33212,0.30966,1,1
4,GO REGULATION OF NERVOUS SYSTEM PROCESS,0.00076864,0.33202,0.3224,1,1
4,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,0.00042807,0.33188,0.36877,1,1
4,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.0010798,0.33157,0.3457,1,1
4,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.00081392,0.33143,0.37624,1,1
4,GO DOPAMINE TRANSPORT,0.00011593,0.3312,0.43143,1,1
4,GO CELL AGGREGATION,0.0040644,0.33114,0.32318,1,1
4,GO ASTROCYTE ACTIVATION,0.052482,0.33108,0.27485,1,1
4,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.011063,0.33099,0.29014,1,1
4,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,0.00026348,0.33093,0.33323,1,1
4,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.0011418,0.33068,0.3278,1,1
4,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.0021907,0.33042,0.30899,1,1
4,GO MYOTUBE CELL DEVELOPMENT,0.0010798,0.33029,0.27375,1,1
4,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.00033648,0.33016,0.38654,1,1
4,GO TELENCEPHALON GLIAL CELL MIGRATION,0.0038653,0.32905,0.32545,1,1
4,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.00060992,0.32892,0.39957,1,1
4,GO DOPAMINE METABOLIC PROCESS,0.00045436,0.32891,0.34058,1,1
4,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.0017696,0.32877,0.37132,1,1
4,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0049572,0.32852,0.30184,1,1
4,GO MEMORY,0.00048214,0.32851,0.33122,1,1
4,GO SYNAPSE ASSEMBLY,0.00051151,0.32837,0.39524,1,1
4,GO POSTSYNAPSE ORGANIZATION,0.0014241,0.32826,0.30227,1,1
4,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,0.00060992,0.3277,0.3996,1,1
4,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.00091199,0.32714,0.38289,1,1
4,GO CARDIOBLAST DIFFERENTIATION,0.0034935,0.32699,0.30353,1,1
4,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,0.011063,0.32696,0.29693,1,1
4,GO NEUROMUSCULAR PROCESS,0.0018673,0.32627,0.3058,1,1
4,GO CHOLESTEROL EFFLUX,0.0028457,0.32593,0.2803,1,1
4,GO REGULATION OF NMDA RECEPTOR ACTIVITY,0.0016767,0.32588,0.33711,1,1
4,GO PROTEIN POLYGLUTAMYLATION,0.00086166,0.32588,0.34795,1,1
4,GO MECHANOSENSORY BEHAVIOR,0.0024341,0.32585,0.37337,1,1
4,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.00076864,0.32494,0.39861,1,1
4,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.0049572,0.32457,0.28297,1,1
4,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.0014241,0.32422,0.31504,1,1
4,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,0.00048214,0.32328,0.36111,1,1
4,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.00024771,0.32266,0.39098,1,1
4,GO REGULATION OF SYNAPSE ASSEMBLY,0.00068502,0.32193,0.37194,1,1
4,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,0.0011418,0.32147,0.30495,1,1
4,GO TYPE B PANCREATIC CELL DEVELOPMENT,0.00072571,0.32134,0.33781,1,1
4,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,0.00081392,0.32122,0.31289,1,1
4,GO DIOL METABOLIC PROCESS,0.00018128,0.32108,0.31774,1,1
4,GO NEURONAL ACTION POTENTIAL,0.00048214,0.32103,0.42556,1,1
4,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,6.4139e-05,0.32081,0.37504,1,1
4,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,0.00048214,0.32017,0.39357,1,1
4,GO COLLAGEN CATABOLIC PROCESS,0.011063,0.32001,0.35388,1,1
4,GO LONG TERM SYNAPTIC POTENTIATION,0.00040321,0.31953,0.36411,1,1
4,GO EPITHELIAL CELL MORPHOGENESIS,0.00024771,0.31945,0.36617,1,1
4,GO SYNAPTIC VESICLE CLUSTERING,0.0016767,0.3182,0.48396,1,1
4,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,3.9936e-05,0.3182,0.35216,1,1
4,GO SECONDARY PALATE DEVELOPMENT,0.00064645,0.31812,0.41314,1,1
4,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.00021879,0.31782,0.39785,1,1
4,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.00021879,0.31779,0.35707,1,1
4,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.0054671,0.31724,0.30842,1,1
4,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.024086,0.31716,0.2651,1,1
4,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.00023283,0.31699,0.35298,1,1
4,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.0044907,0.31691,0.293,1,1
4,GO REGULATION OF MICROTUBULE BINDING,0.00035748,0.3161,0.37525,1,1
4,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,0.0018673,0.31544,0.40321,1,1
4,GO REGULATION OF ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.054439,0.31536,0.2578,1,1
4,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.00076864,0.31508,0.38317,1,1
4,GO MUSCLE FIBER DEVELOPMENT,0.00031664,0.31504,0.30518,1,1
4,GO SYNAPTIC VESICLE MATURATION,0.00076864,0.31454,0.49508,1,1
4,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.022172,0.31447,0.27865,1,1
4,GO SYNAPTIC SIGNALING,0.00042807,0.31434,0.34399,1,1
4,GO REGULATION OF RESPIRATORY BURST,0.0031545,0.31421,0.30568,1,1
4,GO MACROPHAGE CYTOKINE PRODUCTION,0.014457,0.31391,0.40088,1,1
4,GO RETINA LAYER FORMATION,0.007293,0.31345,0.38702,1,1
4,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,0.0066311,0.31336,0.37654,1,1
4,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,0.016475,0.31326,0.26898,1,1
4,GO CEREBRAL CORTEX CELL MIGRATION,0.0020776,0.31265,0.32202,1,1
4,GO SYNAPTIC VESICLE TRANSPORT,0.00019306,0.31257,0.35837,1,1
4,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,0.00076864,0.31247,0.39171,1,1
4,GO EPITHELIAL CELL CELL ADHESION,0.023112,0.31236,0.26802,1,1
4,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.0076456,0.31195,0.30122,1,1
4,GO ENTRY OF BACTERIUM INTO HOST CELL,0.0096484,0.31183,0.26348,1,1
4,GO NEGATIVE REGULATION OF NEURON MIGRATION,0.0013481,0.31183,0.42862,1,1
4,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,0.0010209,0.31167,0.28569,1,1
4,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,4.5779e-05,0.31118,0.37935,1,1
4,GO CELL JUNCTION MAINTENANCE,0.0023095,0.31073,0.33234,1,1
4,GO POSITIVE REGULATION OF EXOCYTOSIS,2.4576e-05,0.31071,0.35772,1,1
4,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,0.00064645,0.3104,0.33717,1,1
4,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,0.00051151,0.31036,0.35302,1,1
4,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,0.0015882,0.31029,0.39085,1,1
4,GO ALANINE TRANSPORT,0.0052065,0.30983,0.3289,1,1
4,GO STARTLE RESPONSE,0.007293,0.30964,0.3114,1,1
4,GO TRANSCYTOSIS,0.0044907,0.30944,0.31521,1,1
4,GO ACTIVATION OF JUN KINASE ACTIVITY,0.00042807,0.30941,0.38249,1,1
4,GO NOTCH RECEPTOR PROCESSING,0.0010798,0.30925,0.38714,1,1
4,GO REGULATION OF SYNAPTIC VESICLE CYCLE,0.00081392,0.3092,0.42288,1,1
4,GO POSITIVE REGULATION OF LIPID STORAGE,0.0063209,0.30895,0.31079,1,1
4,GO POSITIVE REGULATION OF AXONOGENESIS,0.00054254,0.30882,0.3453,1,1
4,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.0029965,0.30843,0.32393,1,1
4,GO ENDODERMAL CELL DIFFERENTIATION,0.007293,0.30839,0.38461,1,1
4,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.0060238,0.30823,0.38318,1,1
4,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.015776,0.30785,0.25255,1,1
4,GO REGULATION OF VESICLE FUSION,0.00045436,0.30779,0.38634,1,1
4,GO AXON EXTENSION,0.0012758,0.30772,0.33107,1,1
4,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,0.00015974,0.30742,0.41541,1,1
4,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,0.0017696,0.30658,0.36401,1,1
4,GO NEURONAL ION CHANNEL CLUSTERING,0.0034935,0.30635,0.37996,1,1
4,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,0.00014989,0.30631,0.31607,1,1
4,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,0.00060992,0.30629,0.37909,1,1
4,GO POSITIVE REGULATION OF AXON EXTENSION,0.00076864,0.30625,0.34354,1,1
4,GO WATER HOMEOSTASIS,0.0018673,0.30613,0.27878,1,1
4,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.00017019,0.30611,0.38838,1,1
4,GO NEURON PROJECTION GUIDANCE,0.0015041,0.30594,0.31079,1,1
4,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,0.013834,0.30573,0.25096,1,1
4,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.0034935,0.30547,0.50284,1,1
4,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,0.015104,0.30537,0.29273,1,1
4,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,0.0080134,0.30531,0.25506,1,1
4,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.0020776,0.30526,0.28639,1,1
4,GO SKELETAL MUSCLE ADAPTATION,0.0003797,0.30488,0.36444,1,1
4,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.0012758,0.3043,0.30668,1,1
4,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,0.015104,0.30409,0.37352,1,1
4,GO SEX DETERMINATION,0.0052065,0.30393,0.28241,1,1
4,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.0015882,0.3037,0.28194,1,1
4,GO GLOMERULAR MESANGIUM DEVELOPMENT,0.052482,0.30366,0.30161,1,1
4,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,4.5779e-05,0.30322,0.3621,1,1
4,GO POSITIVE REGULATION OF MYELINATION,0.0049572,0.30266,0.33128,1,1
4,GO REGULATION OF CILIUM ASSEMBLY,0.0049572,0.30256,0.27799,1,1
4,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.0012758,0.3025,0.39704,1,1
4,GO O GLYCAN PROCESSING,0.0049572,0.30213,0.26941,1,1
4,GO SPINAL CORD PATTERNING,0.031957,0.30194,0.28064,1,1
4,GO CELL CELL ADHESION MEDIATED BY CADHERIN,0.00072571,0.30152,0.34995,1,1
4,GO SYNAPTIC VESICLE EXOCYTOSIS,0.00091199,0.30111,0.4258,1,1
4,GO KERATINOCYTE DEVELOPMENT,0.010572,0.30099,0.29465,1,1
4,GO BLOOD VESSEL REMODELING,0.0023095,0.30091,0.35042,1,1
4,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.00057531,0.30088,0.34031,1,1
4,GO LYMPH VESSEL DEVELOPMENT,0.015104,0.30016,0.32239,1,1
4,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.0031545,0.30014,0.28295,1,1
4,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,0.0083971,0.2993,0.3572,1,1
4,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.0020776,0.29918,0.35697,1,1
4,GO REGULATION OF PROTEIN GLYCOSYLATION,0.00028019,0.29914,0.4262,1,1
4,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.0014241,0.29887,0.33622,1,1
4,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.00060992,0.29877,0.31914,1,1
4,GO NEUROTRANSMITTER TRANSPORT,0.00060992,0.29877,0.37018,1,1
4,GO GOLGI TO VACUOLE TRANSPORT,0.00014062,0.29852,0.37139,1,1
4,GO REGULATION OF PRESYNAPSE ORGANIZATION,0.0040644,0.29789,0.33058,1,1
4,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,0.025096,0.29787,0.26258,1,1
4,GO CARDIAC ATRIUM DEVELOPMENT,0.0027019,0.29781,0.31718,1,1
4,GO REGULATION OF PINOCYTOSIS,0.0066311,0.29772,0.30802,1,1
4,GO RAB PROTEIN SIGNAL TRANSDUCTION,0.0027019,0.2976,0.30562,1,1
4,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,0.00081392,0.29736,0.29788,1,1
4,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,7.3279e-05,0.2972,0.34402,1,1
4,GO BEHAVIOR,0.00096503,0.29702,0.27858,1,1
4,GO REGULATION OF AXON GUIDANCE,0.0080134,0.29671,0.33147,1,1
4,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.00076864,0.29659,0.38836,1,1
4,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.0015041,0.29653,0.32735,1,1
4,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,0.00057531,0.2963,0.31495,1,1
4,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.00028019,0.2958,0.32113,1,1
4,GO PHOSPHOLIPID CATABOLIC PROCESS,0.00332,0.2957,0.27129,1,1
4,GO RESPONSE TO GLUCAGON,0.0044907,0.29564,0.24933,1,1
4,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.00014989,0.29537,0.32638,1,1
4,GO REGULATION OF AXONOGENESIS,0.0012758,0.29516,0.32923,1,1
4,GO MICROTUBULE BASED MOVEMENT,0.0015041,0.29491,0.28102,1,1
4,GO REGULATION OF STEM CELL DIVISION,0.021265,0.29487,0.30099,1,1
4,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,0.00014989,0.29478,0.34138,1,1
4,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,0.00076864,0.29458,0.28382,1,1
4,GO MICROTUBULE SEVERING,0.0083971,0.29453,0.26612,1,1
4,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,0.017954,0.29425,0.23747,1,1
4,GO COPULATION,0.020391,0.29415,0.24276,1,1
4,GO NEURON PROJECTION EXTENSION,0.00057531,0.29411,0.33978,1,1
4,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.0040644,0.29321,0.52376,1,1
4,GO POSITIVE REGULATION OF TELOMERE CAPPING,0.013235,0.293,0.22833,1,1
4,GO CELLULAR HYPEROSMOTIC RESPONSE,0.0019699,0.2929,0.26301,1,1
4,GO DIOL BIOSYNTHETIC PROCESS,0.00013188,0.29272,0.30249,1,1
4,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.00045436,0.29264,0.33709,1,1
4,GO PROTEIN ACTIVATION CASCADE,0.027226,0.29254,0.25454,1,1
4,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.0023095,0.29173,0.23389,1,1
4,GO NEUROTRANSMITTER SECRETION,0.00096503,0.29171,0.39112,1,1
4,GO DIACYLGLYCEROL METABOLIC PROCESS,0.00081392,0.29127,0.3384,1,1
4,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.013235,0.29124,0.29057,1,1
4,GO INTRACILIARY RETROGRADE TRANSPORT,0.0060238,0.29122,0.3065,1,1
4,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0044907,0.2912,0.28977,1,1
4,GO SPECIFICATION OF SYMMETRY,0.00045436,0.29118,0.29699,1,1
4,GO NEURON PROJECTION ARBORIZATION,0.0024341,0.29084,0.32759,1,1
4,GO REGULATION OF DEACETYLASE ACTIVITY,3.7287e-05,0.29083,0.35923,1,1
4,GO CELL PART MORPHOGENESIS,0.00076864,0.29081,0.29315,1,1
4,GO DETECTION OF CALCIUM ION,0.0063209,0.29046,0.34269,1,1
4,GO REGULATION OF FATTY ACID BETA OXIDATION,0.0019699,0.29045,0.34684,1,1
4,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.0034935,0.29007,0.25673,1,1
4,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,0.00033648,0.28993,0.32349,1,1
4,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,0.0036751,0.28986,0.30251,1,1
4,GO REGULATION OF EXTENT OF CELL GROWTH,0.0014241,0.28986,0.3315,1,1
4,GO NEURAL RETINA DEVELOPMENT,0.0083971,0.2898,0.23064,1,1
4,GO DIET INDUCED THERMOGENESIS,0.0066311,0.28944,0.27887,1,1
4,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,0.056456,0.28939,0.38007,1,1
4,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.00057531,0.28915,0.30652,1,1
4,GO ADULT BEHAVIOR,0.0021907,0.28891,0.29809,1,1
4,GO AXO DENDRITIC TRANSPORT,0.0012071,0.28878,0.30726,1,1
4,GO ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.024086,0.28862,0.23734,1,1
4,GO CELLULAR COMPONENT MORPHOGENESIS,0.00060992,0.28852,0.2909,1,1
4,GO INTRACILIARY TRANSPORT,0.015104,0.28834,0.235,1,1
4,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,0.00048214,0.28817,0.38922,1,1
4,GO SEQUESTERING OF CALCIUM ION,0.0083971,0.28801,0.26486,1,1
4,GO CELL JUNCTION ORGANIZATION,0.00048214,0.28709,0.31699,1,1
4,GO ANTEROGRADE AXONAL TRANSPORT,0.0029965,0.28674,0.2969,1,1
4,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.006955,0.28664,0.25852,1,1
4,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,0.0040644,0.28641,0.26774,1,1
4,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.0060238,0.28624,0.3121,1,1
4,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00045436,0.28594,0.31372,1,1
4,GO SPERM MOTILITY,0.0021907,0.28534,0.28733,1,1
4,GO RESPONSE TO EPINEPHRINE,0.0017696,0.28512,0.35439,1,1
4,GO AXON DEVELOPMENT,0.00086166,0.28462,0.29016,1,1
4,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.0021907,0.28443,0.33588,1,1
4,GO NOREPINEPHRINE METABOLIC PROCESS,0.0172,0.28417,0.27936,1,1
4,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,0.00057531,0.28413,0.28737,1,1
4,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.0024341,0.28392,0.32176,1,1
4,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.0047188,0.28385,0.2629,1,1
4,GO NEUROPEPTIDE SIGNALING PATHWAY,0.00054254,0.28382,0.32268,1,1
4,GO ATRIAL SEPTUM MORPHOGENESIS,0.008797,0.28381,0.32239,1,1
4,GO GLUTAMATE SECRETION,0.0021907,0.28349,0.32963,1,1
4,GO REGULATION OF MITOPHAGY,8.3641e-05,0.2834,0.40713,1,1
4,GO RETROGRADE AXONAL TRANSPORT,0.013235,0.2834,0.31828,1,1
4,GO OLFACTORY BULB INTERNEURON DIFFERENTIATION,0.00332,0.28308,0.3744,1,1
4,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.0021907,0.28293,0.41424,1,1
4,GO REGULATION OF DOPAMINE SECRETION,0.00023283,0.28291,0.46241,1,1
4,GO VESICLE FUSION TO PLASMA MEMBRANE,0.0013481,0.28287,0.44715,1,1
4,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.008797,0.28275,0.29184,1,1
4,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.0018673,0.28274,0.37253,1,1
4,GO LOCOMOTOR RHYTHM,0.00054254,0.2827,0.40088,1,1
4,GO NEGATIVE CHEMOTAXIS,0.0023095,0.28264,0.35393,1,1
4,GO DEVELOPMENTAL CELL GROWTH,0.00029789,0.28254,0.32879,1,1
4,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.0080134,0.28245,0.29283,1,1
4,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.01266,0.28242,0.27063,1,1
4,GO POTASSIUM ION TRANSPORT,0.00045436,0.28238,0.31615,1,1
4,GO WALKING BEHAVIOR,0.00081392,0.28226,0.30981,1,1
4,GO NEURON RECOGNITION,0.0096484,0.28197,0.30001,1,1
4,GO AZOLE TRANSMEMBRANE TRANSPORT,0.023112,0.28189,0.259,1,1
4,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00068502,0.28185,0.30768,1,1
4,GO MICROTUBULE POLYMERIZATION,0.0036751,0.28176,0.27743,1,1
4,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.00086166,0.28167,0.33269,1,1
4,GO CAMP METABOLIC PROCESS,0.0019699,0.28143,0.33605,1,1
4,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.00051151,0.28131,0.35003,1,1
4,GO PROTEIN O LINKED GLYCOSYLATION,0.0018673,0.2813,0.27146,1,1
4,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,0.00017019,0.28086,0.31976,1,1
4,GO PEPTIDE HORMONE SECRETION,0.00010866,0.28062,0.30627,1,1
4,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0031545,0.28059,0.26934,1,1
4,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,0.0015041,0.28038,0.2954,1,1
4,GO DENDRITE SELF AVOIDANCE,0.045233,0.28027,0.2523,1,1
4,GO GLOMERULUS DEVELOPMENT,0.011574,0.28024,0.31769,1,1
4,GO COGNITION,0.0017696,0.27983,0.27465,1,1
4,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.0013481,0.27965,0.26913,1,1
4,GO MICROTUBULE BASED TRANSPORT,0.00091199,0.27948,0.2792,1,1
4,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.0017696,0.27948,0.27844,1,1
4,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.00086166,0.2792,0.32581,1,1
4,GO REGULATION OF CAMP MEDIATED SIGNALING,0.0023095,0.27868,0.31225,1,1
4,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.0014241,0.27863,0.37071,1,1
4,GO REGULATION OF JUN KINASE ACTIVITY,0.00054254,0.27863,0.32081,1,1
4,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.0023095,0.27862,0.26641,1,1
4,GO SYNAPTIC VESICLE RECYCLING,9.5377e-05,0.27842,0.39943,1,1
4,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.00081392,0.27822,0.32254,1,1
4,GO SULFUR COMPOUND CATABOLIC PROCESS,0.0012758,0.27795,0.27961,1,1
4,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,0.027226,0.2778,0.24454,1,1
4,GO MONOAMINE TRANSPORT,0.00021879,0.27778,0.36307,1,1
4,GO ENDOTHELIAL CELL MORPHOGENESIS,0.0060238,0.27759,0.3367,1,1
4,GO DEVELOPMENTAL MATURATION,0.00011593,0.27732,0.2986,1,1
4,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.0060238,0.27723,0.37361,1,1
4,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.0012758,0.2772,0.35979,1,1
4,GO AORTIC VALVE DEVELOPMENT,0.0096484,0.27717,0.29953,1,1
4,GO CELL JUNCTION ASSEMBLY,0.00031664,0.27715,0.3163,1,1
4,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.0020776,0.27673,0.40212,1,1
4,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.0012071,0.27665,0.33493,1,1
4,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00014989,0.27665,0.45764,1,1
4,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,0.0054671,0.27634,0.23171,1,1
4,GO NEGATIVE REGULATION OF LYASE ACTIVITY,0.019548,0.27621,0.238,1,1
4,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,0.00068502,0.27616,0.30519,1,1
4,GO REGULATION OF METANEPHROS DEVELOPMENT,0.0066311,0.27586,0.31564,1,1
4,GO MACROPHAGE PROLIFERATION,0.054439,0.27543,0.33419,1,1
4,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,0.00076864,0.27538,0.35269,1,1
4,GO THYROID HORMONE METABOLIC PROCESS,0.0060238,0.27496,0.26769,1,1
4,GO REGULATION OF EXOCYTOSIS,0.00019306,0.27491,0.32661,1,1
4,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.011063,0.27456,0.25023,1,1
4,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,0.019548,0.27441,0.27605,1,1
4,GO REGULATION OF NEUROTRANSMITTER LEVELS,0.00045436,0.27437,0.36912,1,1
4,GO METANEPHRIC EPITHELIUM DEVELOPMENT,0.0052065,0.27428,0.28656,1,1
4,GO IMPORT ACROSS PLASMA MEMBRANE,0.0010798,0.27419,0.26214,1,1
4,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.052482,0.27408,0.23688,1,1
4,GO GLUCOCORTICOID METABOLIC PROCESS,0.00060992,0.27382,0.29118,1,1
4,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,0.0083971,0.27369,0.35751,1,1
4,GO BASEMENT MEMBRANE ASSEMBLY,0.0016767,0.2733,0.43582,1,1
4,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.00024771,0.27323,0.32094,1,1
4,GO ADULT LOCOMOTORY BEHAVIOR,0.0013481,0.27316,0.28196,1,1
4,GO REGULATION OF POSTSYNAPSE ORGANIZATION,0.0024341,0.27314,0.28785,1,1
4,GO ACTIN CROSSLINK FORMATION,0.0063209,0.27311,0.28455,1,1
4,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,0.00010866,0.27306,0.30841,1,1
4,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.060677,0.27306,0.21188,1,1
4,GO ADHERENS JUNCTION ASSEMBLY,0.00031664,0.273,0.36507,1,1
4,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.00051151,0.27284,0.33156,1,1
4,GO REPRODUCTIVE BEHAVIOR,0.010101,0.27279,0.25201,1,1
4,GO CILIUM ORGANIZATION,0.0042727,0.27248,0.26676,1,1
4,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.00096503,0.27248,0.37263,1,1
4,GO REGULATION OF MEMBRANE POTENTIAL,0.00035748,0.27219,0.32564,1,1
4,GO CENTRIOLE CENTRIOLE COHESION,0.045233,0.272,0.26899,1,1
4,GO SECOND MESSENGER MEDIATED SIGNALING,0.0024341,0.27188,0.25615,1,1
4,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.00042807,0.27156,0.30558,1,1
4,GO RESPONSE TO AMYLOID BETA,0.0092139,0.2714,0.29202,1,1
4,GO PLATELET MORPHOGENESIS,0.00031664,0.27125,0.3451,1,1
4,GO FUCOSYLATION,0.00028019,0.27113,0.33452,1,1
4,GO NEUROEPITHELIAL CELL DIFFERENTIATION,0.00072571,0.271,0.32594,1,1
4,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.00028019,0.2707,0.29248,1,1
4,GO CELL VOLUME HOMEOSTASIS,0.0017696,0.27023,0.28249,1,1
4,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.017954,0.27015,0.29582,1,1
4,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,0.00096503,0.27003,0.31666,1,1
4,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.0060238,0.26992,0.27085,1,1
4,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,0.01266,0.26977,0.28003,1,1
4,GO REGULATION OF AMINO ACID TRANSPORT,0.0083971,0.26976,0.25953,1,1
4,GO SEMI LUNAR VALVE DEVELOPMENT,0.021265,0.26966,0.28011,1,1
4,GO NEGATIVE REGULATION OF TORC1 SIGNALING,0.018736,0.26958,0.29465,1,1
4,GO AMINOGLYCAN METABOLIC PROCESS,0.0015882,0.26957,0.28972,1,1
4,GO NEURON DEVELOPMENT,0.00076864,0.2694,0.28715,1,1
4,GO PRESYNAPTIC ENDOCYTOSIS,0.00014989,0.26905,0.39135,1,1
4,GO PROTEIN KINASE C SIGNALING,0.00060992,0.26892,0.37341,1,1
4,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.02951,0.26884,0.32625,1,1
4,GO NERVOUS SYSTEM PROCESS,0.00040321,0.26861,0.26553,1,1
4,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.00332,0.26861,0.37504,1,1
4,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.054439,0.26851,0.22429,1,1
4,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,0.0028457,0.26842,0.33048,1,1
4,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00332,0.26825,0.32768,1,1
4,GO GLYCOPROTEIN CATABOLIC PROCESS,0.0076456,0.26825,0.33363,1,1
4,GO DENDRITE DEVELOPMENT,0.0017696,0.2682,0.28312,1,1
4,GO RESPONSE TO AMPHETAMINE,0.0019699,0.26796,0.23801,1,1
4,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.0015882,0.26795,0.28834,1,1
4,GO CELLULAR RESPONSE TO AMYLOID BETA,0.012106,0.26775,0.27522,1,1
4,GO INSULIN SECRETION,7.8298e-05,0.2675,0.31047,1,1
4,GO RESPONSE TO ISCHEMIA,0.00081392,0.26737,0.297,1,1
4,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.0012071,0.26731,0.25758,1,1
4,GO OSTEOCLAST DEVELOPMENT,0.014457,0.26718,0.30766,1,1
4,GO LYSOSOME LOCALIZATION,0.0052065,0.26697,0.26379,1,1
4,GO RESPONSE TO IMMOBILIZATION STRESS,0.00048214,0.26696,0.30299,1,1
4,GO POSITIVE REGULATION OF HORMONE SECRETION,0.0003797,0.26694,0.26744,1,1
4,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.0020776,0.26659,0.30135,1,1
4,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.00054254,0.26655,0.27532,1,1
4,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,0.0060238,0.26654,0.33613,1,1
4,GO NEURON PROJECTION ORGANIZATION,0.0014241,0.26637,0.31345,1,1
4,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,0.00068502,0.26617,0.28892,1,1
4,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.050584,0.26593,0.26649,1,1
4,GO POSITIVE REGULATION OF BONE RESORPTION,0.0015882,0.26567,0.32808,1,1
4,GO SIGNAL RELEASE,0.00031664,0.26525,0.28347,1,1
4,GO ENDOCYTIC RECYCLING,0.00024771,0.26517,0.31998,1,1
4,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,0.035953,0.26507,0.32155,1,1
4,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.00081392,0.26502,0.25802,1,1
4,GO DENDRITE MORPHOGENESIS,0.0028457,0.26501,0.30218,1,1
4,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,0.0003797,0.26497,0.3038,1,1
4,GO AXONAL TRANSPORT,0.0024341,0.26463,0.29186,1,1
4,GO IMPORT INTO CELL,0.00060992,0.26456,0.27147,1,1
4,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0019699,0.26448,0.28707,1,1
4,GO INOSITOL METABOLIC PROCESS,0.019548,0.26433,0.235,1,1
4,GO COLLAGEN METABOLIC PROCESS,0.0172,0.26431,0.33229,1,1
4,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,0.020391,0.2642,0.22966,1,1
4,GO REGULATION OF HORMONE SECRETION,0.00023283,0.26416,0.27515,1,1
4,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,0.0020776,0.26416,0.32129,1,1
4,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.0027019,0.26402,0.27392,1,1
4,GO GLYCEROLIPID CATABOLIC PROCESS,0.0019699,0.26402,0.25089,1,1
4,GO PHOSPHOLIPID TRANSPORT,0.0025648,0.26371,0.24446,1,1
4,GO REGULATION OF BONE REMODELING,0.025096,0.26349,0.2667,1,1
4,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,1.6059e-05,0.26343,0.35438,1,1
4,GO LIPID GLYCOSYLATION,0.00086166,0.26342,0.33875,1,1
4,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.0063209,0.26337,0.31843,1,1
4,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.00064645,0.26316,0.2888,1,1
4,GO SUBSTRATE DEPENDENT CELL MIGRATION,0.0083971,0.26291,0.32014,1,1
4,GO TRANSPORT ALONG MICROTUBULE,0.0028457,0.26289,0.247,1,1
4,GO POSITIVE REGULATION OF MITOPHAGY,0.00011593,0.26285,0.44191,1,1
4,GO ADHERENS JUNCTION ORGANIZATION,0.00064645,0.26264,0.32014,1,1
4,GO PHOTORECEPTOR CELL DIFFERENTIATION,0.0028457,0.26255,0.26701,1,1
4,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.0172,0.26241,0.26998,1,1
4,GO OLIGODENDROCYTE DEVELOPMENT,0.00040321,0.26239,0.27565,1,1
4,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.00091199,0.26238,0.28596,1,1
4,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,0.0012071,0.26236,0.30834,1,1
4,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.015776,0.26235,0.27973,1,1
4,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,0.025096,0.2623,0.22562,1,1
4,GO CATECHOLAMINE METABOLIC PROCESS,0.00033648,0.26228,0.31592,1,1
4,GO REGULATION OF CELL SIZE,0.00076864,0.26227,0.30291,1,1
4,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.006955,0.26222,0.23564,1,1
4,GO HORMONE TRANSPORT,0.00019306,0.26159,0.27784,1,1
4,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,0.028348,0.26154,0.24481,1,1
4,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.037377,0.26141,0.21266,1,1
4,GO PHOTORECEPTOR CELL DEVELOPMENT,0.00096503,0.26136,0.29727,1,1
4,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.00054254,0.26123,0.2865,1,1
4,GO POSITIVE REGULATION OF STEROL TRANSPORT,0.034576,0.26119,0.23369,1,1
4,GO SPHINGOSINE BIOSYNTHETIC PROCESS,6.4139e-05,0.26117,0.3483,1,1
4,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,0.00019306,0.2611,0.3029,1,1
4,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,0.016475,0.261,0.25998,1,1
4,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.00060992,0.2609,0.29032,1,1
4,GO DENDRITIC SPINE MORPHOGENESIS,0.00332,0.26086,0.3234,1,1
4,GO REGULATION OF PEPTIDE HORMONE SECRETION,0.00017019,0.26064,0.30429,1,1
4,GO CALCIUM ION IMPORT,0.0024341,0.26055,0.30989,1,1
4,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.0027019,0.26029,0.37667,1,1
4,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.00081392,0.26028,0.29442,1,1
4,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,0.030713,0.26017,0.25842,1,1
4,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,0.0063209,0.25998,0.30525,1,1
4,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.018736,0.25998,0.27956,1,1
4,GO GASTRULATION WITH MOUTH FORMING SECOND,0.00026348,0.25967,0.37262,1,1
4,GO PROTEIN LOCALIZATION TO CILIUM,0.011574,0.25939,0.25736,1,1
4,GO CATION TRANSMEMBRANE TRANSPORT,0.00031664,0.25935,0.27749,1,1
4,GO CELL MIGRATION IN HINDBRAIN,0.0036751,0.25921,0.31834,1,1
4,GO NODAL SIGNALING PATHWAY,0.00035748,0.25915,0.30828,1,1
4,GO RESPONSE TO MURAMYL DIPEPTIDE,0.056456,0.25904,0.23018,1,1
4,GO BASEMENT MEMBRANE ORGANIZATION,0.00096503,0.25897,0.37416,1,1
4,GO OVARIAN FOLLICLE DEVELOPMENT,0.0044907,0.25893,0.2267,1,1
4,GO ACROSOME REACTION,0.00031664,0.25888,0.27029,1,1
4,GO POSITIVE REGULATION OF JNK CASCADE,0.0076456,0.25883,0.25522,1,1
4,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,0.0034935,0.25862,0.28506,1,1
4,GO RESPONSE TO REDOX STATE,0.00045436,0.25831,0.35994,1,1
4,GO REGULATION OF DENDRITE MORPHOGENESIS,0.0024341,0.25827,0.28986,1,1
4,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.017954,0.25799,0.22191,1,1
4,GO REGULATION OF NEURON DIFFERENTIATION,0.0011418,0.25778,0.26851,1,1
4,GO PROTEIN KINASE A SIGNALING,0.0028457,0.25771,0.24515,1,1
4,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,0.0029965,0.25758,0.30617,1,1
4,GO MYOTUBE DIFFERENTIATION,0.0024341,0.25727,0.26658,1,1
4,GO CERAMIDE TRANSPORT,0.0031545,0.25727,0.34453,1,1
4,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.00023283,0.25718,0.30636,1,1
4,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.00014062,0.25715,0.3123,1,1
4,GO ACTIVATION OF MAPKKK ACTIVITY,0.011063,0.25704,0.29158,1,1
4,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.00021879,0.25697,0.29839,1,1
4,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.00020554,0.25693,0.30909,1,1
4,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.00021879,0.25689,0.36174,1,1
4,GO SPHINGOID METABOLIC PROCESS,0.00023283,0.2567,0.33522,1,1
4,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.00045436,0.25666,0.2598,1,1
4,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.031957,0.25665,0.25914,1,1
4,GO CELL PROJECTION ORGANIZATION,0.00091199,0.25665,0.27123,1,1
4,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.010572,0.25635,0.24481,1,1
4,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.0042727,0.25594,0.3172,1,1
4,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.0049572,0.25578,0.27435,1,1
4,GO FOREGUT MORPHOGENESIS,0.012106,0.25575,0.24652,1,1
4,GO CELL CELL SIGNALING,0.00045436,0.25571,0.26487,1,1
4,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.00051151,0.2557,0.29021,1,1
4,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.0012758,0.25568,0.29723,1,1
4,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,8.3641e-05,0.25567,0.33283,1,1
4,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,0.015776,0.25564,0.25077,1,1
4,GO REGULATION OF TRANSMEMBRANE TRANSPORT,0.00051151,0.25558,0.28342,1,1
4,GO LEFT RIGHT PATTERN FORMATION,0.0063209,0.25523,0.26359,1,1
4,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.0010209,0.25498,0.32424,1,1
4,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,0.0020776,0.25471,0.37051,1,1
4,GO SECRETORY GRANULE ORGANIZATION,0.00024771,0.2547,0.30324,1,1
4,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0014241,0.2547,0.44497,1,1
4,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.020391,0.25466,0.22635,1,1
4,GO NEUROGENESIS,0.00072571,0.25457,0.2614,1,1
4,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.0010209,0.25456,0.27894,1,1
4,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.008797,0.25448,0.27258,1,1
4,GO PLATELET ACTIVATION,0.014457,0.2544,0.2769,1,1
4,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,0.00019306,0.25429,0.26709,1,1
4,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.0049572,0.25398,0.34364,1,1
4,GO CALCIUM MEDIATED SIGNALING,0.013834,0.25396,0.2371,1,1
4,GO REGULATION OF ION TRANSPORT,0.00054254,0.25386,0.28514,1,1
4,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.0057394,0.25376,0.2339,1,1
4,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,0.00033648,0.25352,0.26863,1,1
4,GO NEURON DIFFERENTIATION,0.00091199,0.25325,0.2691,1,1
4,GO CELL MORPHOGENESIS,0.00076864,0.25308,0.27866,1,1
4,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,0.00021879,0.25293,0.318,1,1
4,GO TRANSMISSION OF NERVE IMPULSE,0.0014241,0.25292,0.34417,1,1
4,GO CELLULAR RESPONSE TO ATP,0.016475,0.25292,0.20688,1,1
4,GO ACIDIC AMINO ACID TRANSPORT,0.0018673,0.2529,0.29169,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.0083971,0.2525,0.21581,1,1
4,GO THALAMUS DEVELOPMENT,0.008797,0.25237,0.27533,1,1
4,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.0049572,0.25223,0.36405,1,1
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.0063209,0.25204,0.25954,1,1
4,GO MYELOID CELL DEVELOPMENT,0.0057394,0.25203,0.25749,1,1
4,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0013481,0.25181,0.30796,1,1
4,GO INTEGRIN MEDIATED SIGNALING PATHWAY,0.035953,0.25181,0.26572,1,1
4,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.00051151,0.2518,0.32413,1,1
4,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.020391,0.25168,0.21715,1,1
4,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.0057394,0.25142,0.24165,1,1
4,GO PHOSPHATE ION TRANSPORT,0.0021907,0.25132,0.27388,1,1
4,GO LOCOMOTORY BEHAVIOR,0.0023095,0.25122,0.2973,1,1
4,GO AMINE BIOSYNTHETIC PROCESS,0.0017696,0.25113,0.25008,1,1
4,GO BONE RESORPTION,0.031957,0.2509,0.25537,1,1
4,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,0.012106,0.25087,0.42089,1,1
4,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.025096,0.25068,0.32515,1,1
4,GO BONE MATURATION,0.0066311,0.2504,0.26422,1,1
4,GO REGULATION OF INSULIN SECRETION,0.00014062,0.25014,0.30244,1,1
4,GO NEGATIVE REGULATION OF WOUND HEALING,0.010101,0.25012,0.26373,1,1
4,GO REGULATION OF BLOOD CIRCULATION,0.0015882,0.25004,0.27292,1,1
4,GO TORC1 SIGNALING,0.00076864,0.24963,0.3186,1,1
4,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.0029965,0.24957,0.30218,1,1
4,GO REGULATION OF LYASE ACTIVITY,0.019548,0.24944,0.19736,1,1
4,GO CARDIAC ATRIUM MORPHOGENESIS,0.0092139,0.24941,0.29295,1,1
4,GO REGULATION OF MEMBRANE DEPOLARIZATION,0.00064645,0.24911,0.27068,1,1
4,GO VESICLE TRANSPORT ALONG MICROTUBULE,0.0010209,0.24907,0.29447,1,1
4,GO PRESYNAPSE ORGANIZATION,0.0025648,0.24884,0.3451,1,1
4,GO REGULATION OF KERATINOCYTE MIGRATION,0.0044907,0.24873,0.33531,1,1
4,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.0063209,0.24871,0.28104,1,1
4,GO BONE CELL DEVELOPMENT,0.0021907,0.24843,0.30941,1,1
4,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.008797,0.2484,0.3543,1,1
4,GO PANCREAS DEVELOPMENT,0.00064645,0.24812,0.28785,1,1
4,GO BODY MORPHOGENESIS,0.0031545,0.24799,0.29658,1,1
4,GO NEGATIVE REGULATION OF HORMONE SECRETION,0.00054254,0.2478,0.27633,1,1
4,GO REGULATION OF DENDRITE DEVELOPMENT,0.0015041,0.24768,0.28388,1,1
4,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,0.0020776,0.24751,0.27275,1,1
4,GO EXTRACELLULAR MATRIX DISASSEMBLY,0.01266,0.24733,0.30861,1,1
4,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.0028457,0.24729,0.24475,1,1
4,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.0010798,0.2472,0.28633,1,1
4,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.0042727,0.24718,0.32666,1,1
4,GO ENDODERM DEVELOPMENT,0.0034935,0.24715,0.30905,1,1
4,GO CHAPERONE MEDIATED AUTOPHAGY,0.0031545,0.2471,0.26282,1,1
4,GO CHROMATIN SILENCING AT TELOMERE,0.025096,0.24705,0.208,1,1
4,GO ENDOTHELIAL CELL MIGRATION,0.013834,0.24704,0.24328,1,1
4,GO REGULATION OF CARDIAC CONDUCTION,0.0021907,0.24686,0.30213,1,1
4,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,0.0012758,0.24664,0.27004,1,1
4,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.0018673,0.24663,0.32203,1,1
4,GO POSITIVE REGULATION OF SECRETION,0.00081392,0.24659,0.25089,1,1
4,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.017954,0.24633,0.26523,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.013235,0.24628,0.23219,1,1
4,GO CELLULAR ION HOMEOSTASIS,0.00332,0.24618,0.21957,1,1
4,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,0.02951,0.24617,0.26082,1,1
4,GO NEGATIVE REGULATION OF AXON EXTENSION,0.0092139,0.24605,0.31402,1,1
4,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.0036751,0.24603,0.28636,1,1
4,GO REGULATION OF VASCULAR PERMEABILITY,0.0018673,0.24602,0.27668,1,1
4,GO FIBROBLAST ACTIVATION,0.0083971,0.246,0.2343,1,1
4,GO DENDRITE EXTENSION,0.00018128,0.24584,0.4149,1,1
4,GO ALDEHYDE BIOSYNTHETIC PROCESS,0.006955,0.24554,0.31063,1,1
4,GO MONOVALENT INORGANIC CATION TRANSPORT,0.00014989,0.24553,0.29346,1,1
4,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.0063209,0.24549,0.25583,1,1
4,GO REGULATION OF POSITIVE CHEMOTAXIS,0.043559,0.24537,0.18929,1,1
4,GO REGULATION OF MYOTUBE DIFFERENTIATION,0.011574,0.24532,0.26734,1,1
4,GO THYROID GLAND DEVELOPMENT,0.0024341,0.24528,0.25944,1,1
4,GO REGULATION OF TELOMERE CAPPING,0.012106,0.24523,0.23289,1,1
4,GO REGULATION OF DENDRITE EXTENSION,0.00017019,0.24519,0.51076,1,1
4,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.011574,0.24505,0.2249,1,1
4,GO ENTEROENDOCRINE CELL DIFFERENTIATION,0.0044907,0.24503,0.25125,1,1
4,GO CELL CELL JUNCTION MAINTENANCE,0.0052065,0.245,0.32905,1,1
4,GO MODIFICATION OF SYNAPTIC STRUCTURE,0.0096484,0.24493,0.25359,1,1
4,GO REGULATION OF HORMONE LEVELS,0.00019306,0.24483,0.25016,1,1
4,GO REGULATION OF TUBE SIZE,0.0013481,0.2448,0.24324,1,1
4,GO EMBRYONIC HEART TUBE MORPHOGENESIS,0.0060238,0.24473,0.24311,1,1
4,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,0.0049572,0.24464,0.26678,1,1
4,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,0.014457,0.24447,0.23604,1,1
4,GO SKELETAL MUSCLE CONTRACTION,0.00081392,0.2444,0.33123,1,1
4,GO LUNG ALVEOLUS DEVELOPMENT,0.00035748,0.24438,0.36612,1,1
4,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,0.00072571,0.24424,0.26381,1,1
4,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.00054254,0.24414,0.31081,1,1
4,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.0021907,0.24382,0.28533,1,1
4,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,0.0060238,0.24372,0.29033,1,1
4,GO MEMBRANE BIOGENESIS,0.00015974,0.24363,0.36397,1,1
4,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,0.006955,0.24345,0.24079,1,1
4,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.00072571,0.24336,0.32449,1,1
4,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.0015882,0.24335,0.24727,1,1
4,GO ORGANIC CATION TRANSPORT,0.0060238,0.24318,0.23737,1,1
4,GO INTERMEDIATE FILAMENT BASED PROCESS,0.0027019,0.24309,0.23509,1,1
4,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.0015041,0.24309,0.25761,1,1
4,GO OLFACTORY LOBE DEVELOPMENT,0.0054671,0.24309,0.28043,1,1
4,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,0.0023095,0.24295,0.29521,1,1
4,GO RESPONSE TO NICOTINE,0.048745,0.24295,0.17547,1,1
4,GO CARDIAC CHAMBER MORPHOGENESIS,0.0020776,0.24279,0.25486,1,1
4,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.0031545,0.24241,0.3358,1,1
4,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0015041,0.24225,0.35345,1,1
4,GO PINOCYTOSIS,0.028348,0.24211,0.23674,1,1
4,GO KERATINOCYTE MIGRATION,0.0052065,0.24202,0.27343,1,1
4,GO REGULATION OF NECROTIC CELL DEATH,0.0023095,0.24182,0.23728,1,1
4,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.040368,0.24165,0.22318,1,1
4,GO CATECHOLAMINE SECRETION,0.00018128,0.24152,0.39571,1,1
4,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.0060238,0.24147,0.23644,1,1
4,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,0.008797,0.24135,0.26854,1,1
4,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0024341,0.24131,0.23791,1,1
4,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.00014062,0.2413,0.31094,1,1
4,GO SCHWANN CELL DEVELOPMENT,0.0011418,0.24129,0.30905,1,1
4,GO REGULATION OF ASTROCYTE DIFFERENTIATION,0.008797,0.24119,0.22128,1,1
4,GO CELL SUBSTRATE JUNCTION ORGANIZATION,0.008797,0.24099,0.29504,1,1
4,GO NUCLEUS LOCALIZATION,0.0034935,0.24079,0.37537,1,1
4,GO POSITIVE REGULATION OF INSULIN SECRETION,0.00023283,0.24078,0.30587,1,1
4,GO REGULATION OF BODY FLUID LEVELS,0.0038653,0.24075,0.23627,1,1
4,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,0.023112,0.24073,0.26756,1,1
4,GO AMINOGLYCAN CATABOLIC PROCESS,0.0076456,0.24058,0.27029,1,1
4,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,0.021265,0.24054,0.26561,1,1
4,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,0.0027019,0.2405,0.30359,1,1
4,GO MITOPHAGY,0.00026348,0.24049,0.31338,1,1
4,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.0042727,0.24048,0.26903,1,1
4,GO SODIUM ION TRANSMEMBRANE TRANSPORT,0.00017019,0.24021,0.33782,1,1
4,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,0.0010798,0.23982,0.24746,1,1
4,GO REGULATION OF DEVELOPMENTAL GROWTH,0.00033648,0.23972,0.27711,1,1
4,GO REGULATION OF TISSUE REMODELING,0.017954,0.2397,0.26488,1,1
4,GO POSITIVE REGULATION OF TORC1 SIGNALING,0.0015041,0.23968,0.26302,1,1
4,GO HEAD MORPHOGENESIS,0.007293,0.23968,0.31014,1,1
4,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.017954,0.2396,0.25448,1,1
4,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.0092139,0.2396,0.21286,1,1
4,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,0.0027019,0.23935,0.23426,1,1
4,GO SENSORY PERCEPTION,0.00064645,0.23923,0.22678,1,1
4,GO AORTA MORPHOGENESIS,0.0044907,0.23918,0.33241,1,1
4,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.0027019,0.23916,0.2311,1,1
4,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.00060992,0.23912,0.26009,1,1
4,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.019548,0.23896,0.27905,1,1
4,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.0029965,0.23894,0.29224,1,1
4,GO REGULATION OF EPITHELIAL CELL MIGRATION,0.014457,0.23894,0.2357,1,1
4,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.0060238,0.23892,0.26871,1,1
4,GO RESPONSE TO INACTIVITY,0.020391,0.2387,0.23082,1,1
4,GO CALCINEURIN MEDIATED SIGNALING,0.0019699,0.23862,0.25975,1,1
4,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,0.00018128,0.23862,0.27359,1,1
4,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.0040644,0.2386,0.31217,1,1
4,GO KERATAN SULFATE METABOLIC PROCESS,0.010101,0.23859,0.27303,1,1
4,GO REGULATION OF CELL JUNCTION ASSEMBLY,0.00076864,0.23857,0.31437,1,1
4,GO POSITIVE REGULATION OF ION TRANSPORT,0.0027019,0.23856,0.22942,1,1
4,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.0016767,0.23854,0.30131,1,1
4,GO REGULATION OF GONAD DEVELOPMENT,0.022172,0.23848,0.20764,1,1
4,GO CHONDROCYTE PROLIFERATION,0.014457,0.23847,0.30014,1,1
4,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,0.045233,0.23832,0.26991,1,1
4,GO REGULATION OF PROTEIN DEACETYLATION,0.00019306,0.2383,0.30416,1,1
4,GO REGULATION OF ENDOCYTOSIS,0.0011418,0.23823,0.26991,1,1
4,GO REGULATION OF TORC1 SIGNALING,0.0012071,0.23818,0.28699,1,1
4,GO AORTA DEVELOPMENT,0.0049572,0.23787,0.30084,1,1
4,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.00332,0.2378,0.23065,1,1
4,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,0.0052065,0.23772,0.29148,1,1
4,GO TISSUE MIGRATION,0.015776,0.23757,0.23666,1,1
4,GO ACTIN FILAMENT BASED PROCESS,0.0012758,0.23747,0.25589,1,1
4,GO BONE GROWTH,0.010101,0.2374,0.27432,1,1
4,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,9.5377e-05,0.23736,0.39314,1,1
4,GO CATION TRANSPORT,0.00031664,0.23735,0.26324,1,1
4,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.007293,0.23721,0.23176,1,1
4,GO GENETIC IMPRINTING,0.00072571,0.23708,0.32121,1,1
4,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.043559,0.23703,0.19587,1,1
4,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.0021907,0.23687,0.30442,1,1
4,GO TRANSFERRIN TRANSPORT,6.8565e-05,0.23666,0.28704,1,1
4,GO SENSORY SYSTEM DEVELOPMENT,0.00081392,0.23652,0.25605,1,1
4,GO METAL ION TRANSPORT,0.00060992,0.23651,0.26721,1,1
4,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.0017696,0.23635,0.32768,1,1
4,GO PLASMA MEMBRANE ORGANIZATION,0.00024771,0.23627,0.32802,1,1
4,GO NEURON MIGRATION,0.0083971,0.23625,0.25844,1,1
4,GO RESPONSE TO CATECHOLAMINE,0.00013188,0.23615,0.2831,1,1
4,GO GROWTH PLATE CARTILAGE DEVELOPMENT,0.022172,0.23603,0.22601,1,1
4,GO EPITHELIAL STRUCTURE MAINTENANCE,0.006955,0.236,0.25662,1,1
4,GO PEPTIDE SECRETION,0.00086166,0.23588,0.25572,1,1
4,GO REGULATION OF LIPID KINASE ACTIVITY,0.040368,0.23573,0.22105,1,1
4,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.010572,0.23568,0.28274,1,1
4,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.0028457,0.23556,0.25351,1,1
4,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.015104,0.23551,0.22624,1,1
4,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.00086166,0.23544,0.39671,1,1
4,GO REGULATION OF TRANSPORT,0.00072571,0.23543,0.24242,1,1
4,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.0060238,0.2354,0.24609,1,1
4,GO PLASMA MEMBRANE TUBULATION,0.0014241,0.23527,0.30088,1,1
4,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.0023095,0.23526,0.28175,1,1
4,GO TUBULIN DEACETYLATION,0.0012071,0.23523,0.3629,1,1
4,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.022172,0.23522,0.26372,1,1
4,GO REGULATION OF CELL PROJECTION ORGANIZATION,0.00064645,0.23515,0.27862,1,1
4,GO ION TRANSMEMBRANE TRANSPORT,0.00033648,0.23506,0.27104,1,1
4,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.0019699,0.23503,0.26975,1,1
4,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,0.0024341,0.23498,0.23953,1,1
4,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,0.0018673,0.23494,0.27425,1,1
4,GO SODIUM ION TRANSPORT,0.00014062,0.23483,0.33025,1,1
4,GO POSITIVE REGULATION OF TISSUE REMODELING,0.0023095,0.23464,0.30131,1,1
4,GO CGMP METABOLIC PROCESS,0.0052065,0.23458,0.32156,1,1
4,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0038653,0.23428,0.27926,1,1
4,GO REGULATION OF HORMONE METABOLIC PROCESS,0.0031545,0.23397,0.25703,1,1
4,GO POSITIVE REGULATION OF CELL GROWTH,7.3279e-05,0.2338,0.29425,1,1
4,GO REGULATION OF NEURON MATURATION,0.0011418,0.23373,0.31729,1,1
4,GO MICROTUBULE ANCHORING,0.010101,0.23358,0.31123,1,1
4,GO REGULATION OF CELL MORPHOGENESIS,0.0010798,0.23353,0.27351,1,1
4,GO EXPORT ACROSS PLASMA MEMBRANE,0.00054254,0.2335,0.31511,1,1
4,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.0021907,0.23349,0.27631,1,1
4,GO PROTEIN LOCALIZATION TO LYSOSOME,0.008797,0.23345,0.24491,1,1
4,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.0063209,0.23316,0.30683,1,1
4,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.0054671,0.23307,0.27494,1,1
4,GO RESPONSE TO INSECTICIDE,0.033245,0.23289,0.22616,1,1
4,GO SPHINGOMYELIN METABOLIC PROCESS,0.00020554,0.2328,0.30344,1,1
4,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,0.050584,0.2327,0.17358,1,1
4,GO SENSORY PERCEPTION OF LIGHT STIMULUS,0.00072571,0.23266,0.2282,1,1
4,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,0.00031664,0.23265,0.27728,1,1
4,GO REGULATION OF HISTONE DEACETYLATION,0.00014989,0.23263,0.30191,1,1
4,GO RDNA HETEROCHROMATIN ASSEMBLY,0.0172,0.23262,0.275,1,1
4,GO BRAIN MORPHOGENESIS,0.0049572,0.23233,0.28016,1,1
4,GO NEURAL NUCLEUS DEVELOPMENT,0.00035748,0.23227,0.27143,1,1
4,GO CELL MATRIX ADHESION,0.00332,0.23222,0.30471,1,1
4,GO CELL SUBSTRATE ADHESION,0.0036751,0.23209,0.29486,1,1
4,GO NEGATIVE REGULATION OF JNK CASCADE,0.00048214,0.23208,0.26638,1,1
4,GO NEURAL TUBE PATTERNING,0.046961,0.23204,0.1932,1,1
4,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,0.025096,0.23193,0.36164,1,1
4,GO LENS FIBER CELL DIFFERENTIATION,0.011063,0.23173,0.2047,1,1
4,GO EXTRACELLULAR STRUCTURE ORGANIZATION,0.0049572,0.23172,0.33794,1,1
4,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.0031545,0.23157,0.28136,1,1
4,GO RESPONSE TO MUSCLE STRETCH,0.006955,0.2315,0.34543,1,1
4,GO SCHWANN CELL DIFFERENTIATION,0.0015041,0.23136,0.26471,1,1
4,GO NEGATIVE REGULATION OF HIPPO SIGNALING,0.0021907,0.23131,0.33354,1,1
4,GO CHROMATIN DISASSEMBLY,0.018736,0.23126,0.22345,1,1
4,GO NEGATIVE REGULATION OF COAGULATION,0.034576,0.23124,0.24912,1,1
4,GO METENCEPHALON DEVELOPMENT,0.0016767,0.2312,0.26219,1,1
4,GO SEGMENT SPECIFICATION,0.015104,0.23115,0.29459,1,1
4,GO REGULATION OF ENDOCYTIC RECYCLING,0.0029965,0.23115,0.31109,1,1
4,GO ACTIVATION OF GTPASE ACTIVITY,0.0014241,0.23094,0.31697,1,1
4,GO CELL PROJECTION ASSEMBLY,0.0028457,0.23087,0.24366,1,1
4,GO PROTEIN TRIMERIZATION,0.030713,0.23086,0.24374,1,1
4,GO PARTURITION,0.0015882,0.23084,0.28402,1,1
4,GO VENTRAL SPINAL CORD DEVELOPMENT,0.02951,0.23074,0.18488,1,1
4,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.0023095,0.23071,0.25908,1,1
4,GO REGULATION OF CYCLASE ACTIVITY,0.020391,0.2307,0.19941,1,1
4,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.010572,0.23049,0.23249,1,1
4,GO RESPONSE TO DOPAMINE,0.00045436,0.23047,0.25296,1,1
4,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.021265,0.23044,0.26489,1,1
4,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.0044907,0.23036,0.27147,1,1
4,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.021265,0.2303,0.21897,1,1
4,GO REGULATION OF MRNA POLYADENYLATION,0.0036751,0.23024,0.28507,1,1
4,GO ACTIVATED T CELL PROLIFERATION,0.043559,0.23015,0.23377,1,1
4,GO LYMPH VESSEL MORPHOGENESIS,0.02951,0.23004,0.27186,1,1
4,GO ENERGY HOMEOSTASIS,0.00076864,0.23003,0.29285,1,1
4,GO CARDIAC CONDUCTION,0.0023095,0.23003,0.30619,1,1
4,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.033245,0.22991,0.20654,1,1
4,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,0.0092139,0.22991,0.30971,1,1
4,GO CARDIAC SEPTUM MORPHOGENESIS,0.0052065,0.2298,0.25845,1,1
4,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.0015882,0.22978,0.2359,1,1
4,GO NUCLEAR MIGRATION,0.0036751,0.22977,0.37693,1,1
4,GO REGULATION OF PEPTIDE SECRETION,0.0012071,0.22964,0.24696,1,1
4,GO RESPONSE TO PROGESTERONE,0.013235,0.22964,0.24506,1,1
4,GO REGULATION OF SYSTEM PROCESS,0.00091199,0.22957,0.26461,1,1
4,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,0.0012071,0.22954,0.21414,1,1
4,GO ANATOMICAL STRUCTURE MATURATION,0.00033648,0.22949,0.25931,1,1
4,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.0034935,0.22947,0.23023,1,1
4,GO REGULATION OF CELL DEVELOPMENT,0.0010209,0.22944,0.24596,1,1
4,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,0.019548,0.22944,0.23448,1,1
4,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.0013481,0.2294,0.272,1,1
4,GO DIVALENT INORGANIC CATION HOMEOSTASIS,0.0047188,0.22925,0.22462,1,1
4,GO AMEBOIDAL TYPE CELL MIGRATION,0.0060238,0.2289,0.23657,1,1
4,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.0010209,0.22882,0.23002,1,1
4,GO AMINO ACID BETAINE METABOLIC PROCESS,0.0015041,0.22862,0.28058,1,1
4,GO INACTIVATION OF MAPK ACTIVITY,0.0036751,0.22852,0.25645,1,1
4,GO ARACHIDONIC ACID SECRETION,0.01266,0.22832,0.18106,1,1
4,GO VESICLE CYTOSKELETAL TRAFFICKING,0.0003797,0.22826,0.30144,1,1
4,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,8.9327e-05,0.22822,0.26313,1,1
4,GO REGULATION OF SECRETION,0.00072571,0.22813,0.25417,1,1
4,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.017954,0.22777,0.22695,1,1
4,GO MYOBLAST FUSION,0.018736,0.22739,0.28031,1,1
4,GO TELOMERE CAPPING,0.010101,0.22734,0.22184,1,1
4,GO POSITIVE REGULATION OF GROWTH,0.00029789,0.22727,0.27467,1,1
4,GO EPIDERMAL CELL DIFFERENTIATION,0.0080134,0.22717,0.18954,1,1
4,GO POSITIVE REGULATION OF ENDOCYTOSIS,0.006955,0.22709,0.26738,1,1
4,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.00014062,0.227,0.31911,1,1
4,GO CARDIAC CHAMBER DEVELOPMENT,0.0023095,0.22696,0.25946,1,1
4,GO ENDODERM FORMATION,0.0092139,0.22687,0.33279,1,1
4,GO METAL ION HOMEOSTASIS,0.0042727,0.22685,0.21896,1,1
4,GO ACTIN FILAMENT SEVERING,0.027226,0.22675,0.26931,1,1
4,GO BIOLOGICAL ADHESION,0.0023095,0.22665,0.2753,1,1
4,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.0038653,0.22659,0.27561,1,1
4,GO RECEPTOR RECYCLING,0.0028457,0.22654,0.23852,1,1
4,GO ACTION POTENTIAL,0.0012071,0.22646,0.3365,1,1
4,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.056456,0.22646,0.25255,1,1
4,GO SMOOTHENED SIGNALING PATHWAY,0.0040644,0.22646,0.24053,1,1
4,GO ARTERY MORPHOGENESIS,0.0049572,0.22643,0.27969,1,1
4,GO HISTONE H3 K14 ACETYLATION,0.0038653,0.22637,0.30534,1,1
4,GO OVULATION CYCLE PROCESS,0.012106,0.22629,0.25252,1,1
4,GO STRIATED MUSCLE ADAPTATION,0.00024771,0.22629,0.34772,1,1
4,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,0.006955,0.22621,0.23523,1,1
4,GO INDUCTION OF POSITIVE CHEMOTAXIS,0.041938,0.22594,0.18983,1,1
4,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0034935,0.22592,0.24364,1,1
4,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.00028019,0.22585,0.27776,1,1
4,GO SPLEEN DEVELOPMENT,0.0024341,0.22574,0.2478,1,1
4,GO CELLULAR RESPONSE TO PH,0.0017696,0.2254,0.28733,1,1
4,GO STRIATED MUSCLE CELL DIFFERENTIATION,0.00057531,0.22538,0.25027,1,1
4,GO RESPONSE TO IRON ION,0.0054671,0.22522,0.23349,1,1
4,GO ORGANIC HYDROXY COMPOUND TRANSPORT,0.00051151,0.22494,0.25979,1,1
4,GO POSITIVE REGULATION OF TOR SIGNALING,0.00086166,0.22487,0.24917,1,1
4,GO STRIATED MUSCLE CONTRACTION,0.0012758,0.2248,0.2918,1,1
4,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.00068502,0.22477,0.28951,1,1
4,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,0.0047188,0.22469,0.30754,1,1
4,GO RESPONSE TO STEROL,0.0049572,0.22456,0.2906,1,1
4,GO MYELIN ASSEMBLY,0.00064645,0.22453,0.34982,1,1
4,GO BEHAVIORAL RESPONSE TO PAIN,0.0028457,0.22447,0.32427,1,1
4,GO REGULATION OF ACTIN NUCLEATION,0.0036751,0.22435,0.22966,1,1
4,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.0038653,0.22429,0.26018,1,1
4,GO METANEPHROS MORPHOGENESIS,0.0060238,0.22417,0.25738,1,1
4,GO RESPONSE TO ELECTRICAL STIMULUS,0.015104,0.22409,0.21914,1,1
4,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.00064645,0.22407,0.28765,1,1
4,GO REGULATION OF POTASSIUM ION TRANSPORT,0.0021907,0.22389,0.27698,1,1
4,GO CARDIAC SEPTUM DEVELOPMENT,0.0049572,0.22386,0.27165,1,1
4,GO DIGESTIVE SYSTEM DEVELOPMENT,0.0044907,0.2236,0.25251,1,1
4,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.0029965,0.22352,0.2561,1,1
4,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,0.0060238,0.2235,0.23231,1,1
4,GO MATING,0.006955,0.22316,0.23666,1,1
4,GO CEREBELLAR CORTEX DEVELOPMENT,0.0057394,0.22308,0.24627,1,1
4,GO ION HOMEOSTASIS,0.00332,0.223,0.22111,1,1
4,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.007293,0.22245,0.26298,1,1
4,GO SPERM AXONEME ASSEMBLY,0.015104,0.22244,0.22261,1,1
4,GO PROTEIN O LINKED MANNOSYLATION,0.0010209,0.22243,0.26542,1,1
4,GO RESPONSE TO GONADOTROPIN,0.00054254,0.22233,0.26247,1,1
4,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,0.007293,0.22228,0.21332,1,1
4,GO POSITIVE REGULATION OF BONE MINERALIZATION,0.010572,0.22226,0.25237,1,1
4,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,0.0031545,0.22222,0.26529,1,1
4,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,0.0024341,0.22208,0.23832,1,1
4,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.00040321,0.22172,0.25927,1,1
4,GO VISUAL BEHAVIOR,0.00031664,0.22157,0.3047,1,1
4,GO HAIR CELL DIFFERENTIATION,0.00091199,0.22147,0.30663,1,1
4,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,0.00081392,0.22138,0.24698,1,1
4,GO RELAXATION OF CARDIAC MUSCLE,0.008797,0.22131,0.33841,1,1
4,GO REGULATION OF WOUND HEALING,0.011574,0.22129,0.23173,1,1
4,GO ANIMAL ORGAN MATURATION,0.007293,0.22119,0.26656,1,1
4,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.0054671,0.22118,0.28246,1,1
4,GO PHAGOSOME MATURATION,0.00026348,0.22102,0.27218,1,1
4,GO MESENCHYMAL CELL DIFFERENTIATION,0.0047188,0.22081,0.23976,1,1
4,GO NEGATIVE REGULATION OF HISTONE METHYLATION,0.008797,0.22078,0.26006,1,1
4,GO REGULATION OF NATURAL KILLER CELL DIFFERENTIATION,0.023112,0.22077,0.28655,1,1
4,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,0.00031664,0.22066,0.36631,1,1
4,GO RESPONSE TO XENOBIOTIC STIMULUS,0.0044907,0.22053,0.20313,1,1
4,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0076456,0.2204,0.29314,1,1
4,GO SENSORY ORGAN MORPHOGENESIS,0.0040644,0.22039,0.22203,1,1
4,GO HISTONE H3 K9 DEMETHYLATION,0.027226,0.22034,0.25779,1,1
4,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.007293,0.22009,0.25039,1,1
4,GO COAGULATION,0.011063,0.22001,0.24022,1,1
4,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,0.0018673,0.21981,0.21975,1,1
4,GO REGULATION OF STEROL TRANSPORT,0.025096,0.21972,0.19792,1,1
4,GO LUNG CELL DIFFERENTIATION,0.035953,0.21962,0.24717,1,1
4,GO BILE ACID AND BILE SALT TRANSPORT,0.0052065,0.21959,0.24176,1,1
4,GO REGULATION OF CATION CHANNEL ACTIVITY,0.0018673,0.21943,0.30576,1,1
4,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,0.0060238,0.2194,0.20177,1,1
4,GO CELLULAR GLUCOSE HOMEOSTASIS,6.4139e-05,0.21928,0.27221,1,1
4,GO DEVELOPMENTAL GROWTH,0.00076864,0.21921,0.25479,1,1
4,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.0016767,0.21918,0.2928,1,1
4,GO CORNIFICATION,0.054439,0.21909,0.14961,1,1
4,GO PEPTIDYL ARGININE METHYLATION,0.0020776,0.219,0.25555,1,1
4,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.031957,0.21895,0.1927,1,1
4,GO CIRCULATORY SYSTEM PROCESS,0.0017696,0.21883,0.24501,1,1
4,GO PLATELET DEGRANULATION,0.020391,0.21869,0.25924,1,1
4,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,0.0027019,0.21863,0.26892,1,1
4,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.019548,0.21856,0.27045,1,1
4,GO POSITIVE REGULATION OF PEPTIDE SECRETION,0.007293,0.21851,0.2214,1,1
4,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.0010798,0.21849,0.27432,1,1
4,GO NEGATIVE REGULATION OF AUTOPHAGY,0.0020776,0.21824,0.24017,1,1
4,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.054439,0.21807,0.20861,1,1
4,GO POSITIVE REGULATION OF TRANSPORT,0.0020776,0.21795,0.22053,1,1
4,GO EYE MORPHOGENESIS,0.0017696,0.21782,0.26822,1,1
4,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.0017696,0.2178,0.20505,1,1
4,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.0034935,0.21767,0.27947,1,1
4,GO AMINE TRANSPORT,0.00051151,0.21716,0.31718,1,1
4,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,0.050584,0.2171,0.23807,1,1
4,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.0027019,0.21704,0.31086,1,1
4,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.010572,0.21701,0.2509,1,1
4,GO REGULATION OF CELLULAR COMPONENT SIZE,0.00076864,0.21682,0.2636,1,1
4,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,0.013834,0.21661,0.21868,1,1
4,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.019548,0.2166,0.24631,1,1
4,GO NEUROTRANSMITTER REUPTAKE,0.0028457,0.21659,0.28977,1,1
4,GO MULTICELLULAR ORGANISMAL SIGNALING,0.0012758,0.21639,0.31144,1,1
4,GO GLIAL CELL FATE COMMITMENT,0.043559,0.21635,0.24435,1,1
4,GO ENDOCYTOSIS,0.0015882,0.21635,0.26038,1,1
4,GO ARTERY DEVELOPMENT,0.0060238,0.21633,0.27682,1,1
4,GO MEGAKARYOCYTE DEVELOPMENT,0.0012071,0.21625,0.31137,1,1
4,GO RESPONSE TO ATP,0.027226,0.21624,0.19454,1,1
4,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.011063,0.21624,0.26417,1,1
4,GO EMBRYONIC HEART TUBE DEVELOPMENT,0.0054671,0.21614,0.24303,1,1
4,GO CIRCULATORY SYSTEM DEVELOPMENT,0.0057394,0.21592,0.23231,1,1
4,GO RESPONSE TO CORTICOSTERONE,0.016475,0.21588,0.23572,1,1
4,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.0025648,0.21576,0.23067,1,1
4,GO CELLULAR RESPONSE TO CHOLESTEROL,0.0012071,0.21558,0.34183,1,1
4,GO SYNAPTIC TRANSMISSION GABAERGIC,0.0063209,0.21527,0.29208,1,1
4,GO RESPONSE TO AXON INJURY,0.00035748,0.2151,0.26009,1,1
4,GO EPIBOLY,0.008797,0.21508,0.26455,1,1
4,GO MULTICELLULAR ORGANISM GROWTH,0.00064645,0.21504,0.27281,1,1
4,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,0.01266,0.21501,0.20678,1,1
4,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00072571,0.215,0.28382,1,1
4,GO HEART PROCESS,0.0029965,0.21496,0.25518,1,1
4,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,0.024086,0.21493,0.28747,1,1
4,GO MESENCHYME DEVELOPMENT,0.0031545,0.21489,0.2403,1,1
4,GO REGULATION OF FILOPODIUM ASSEMBLY,0.012106,0.21473,0.21912,1,1
4,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.060677,0.21472,0.20699,1,1
4,GO HINDBRAIN DEVELOPMENT,0.0019699,0.21457,0.24486,1,1
4,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.0024341,0.21447,0.23478,1,1
4,GO REGULATION OF FATTY ACID OXIDATION,0.0172,0.21436,0.21235,1,1
4,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,0.0052065,0.21422,0.24439,1,1
4,GO REGULATION OF PROTEIN POLYMERIZATION,0.00018128,0.21409,0.27063,1,1
4,GO DIGESTION,0.0024341,0.21406,0.2142,1,1
4,GO SMOOTH MUSCLE CELL DIFFERENTIATION,0.0036751,0.21387,0.24963,1,1
4,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.0092139,0.21377,0.26605,1,1
4,GO ARACHIDONIC ACID METABOLIC PROCESS,0.006955,0.21375,0.23648,1,1
4,GO SOMITE DEVELOPMENT,0.0038653,0.21351,0.22768,1,1
4,GO DIVALENT INORGANIC CATION TRANSPORT,0.00332,0.21343,0.2384,1,1
4,GO CARDIAC VENTRICLE MORPHOGENESIS,0.00060992,0.21334,0.26038,1,1
4,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.00081392,0.21334,0.26794,1,1
4,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,0.048745,0.21331,0.18592,1,1
4,GO DENDRITIC SPINE DEVELOPMENT,0.0049572,0.21326,0.27715,1,1
4,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.00057531,0.21319,0.26762,1,1
4,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.0036751,0.21318,0.29993,1,1
4,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.035953,0.21308,0.22627,1,1
4,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,0.0027019,0.21298,0.30044,1,1
4,GO POSITIVE REGULATION OF ACROSOME REACTION,0.008797,0.21297,0.21092,1,1
4,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0092139,0.21296,0.24098,1,1
4,GO LYMPHANGIOGENESIS,0.050584,0.21289,0.24071,1,1
4,GO CAMERA TYPE EYE DEVELOPMENT,0.0027019,0.21279,0.23754,1,1
4,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.013834,0.21273,0.22617,1,1
4,GO LYTIC VACUOLE ORGANIZATION,0.00045436,0.21261,0.25948,1,1
4,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.0020776,0.2126,0.24276,1,1
4,GO WOUND HEALING,0.008797,0.21235,0.25037,1,1
4,GO PROTEIN AUTOPHOSPHORYLATION,0.0052065,0.21227,0.24681,1,1
4,GO ION TRANSPORT,0.0003797,0.21205,0.25177,1,1
4,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.037377,0.212,0.22818,1,1
4,GO CAVEOLIN MEDIATED ENDOCYTOSIS,0.011574,0.21188,0.24305,1,1
4,GO CHEMICAL HOMEOSTASIS,0.00076864,0.21183,0.22934,1,1
4,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.00091199,0.21178,0.28595,1,1
4,GO LIPID PHOSPHORYLATION,0.0040644,0.21176,0.23314,1,1
4,GO AMINO ACID TRANSPORT,0.00068502,0.21171,0.24969,1,1
4,GO HEART MORPHOGENESIS,0.0040644,0.21165,0.23181,1,1
4,GO RESPONSE TO AMINE,0.0031545,0.21163,0.20794,1,1
4,GO NEGATIVE REGULATION OF HEART CONTRACTION,0.006955,0.21161,0.29327,1,1
4,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.00026348,0.21151,0.25335,1,1
4,GO SENSORY ORGAN DEVELOPMENT,0.0038653,0.2115,0.21972,1,1
4,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,4.5779e-05,0.21142,0.2759,1,1
4,GO REGULATION OF MYELINATION,0.025096,0.21138,0.20993,1,1
4,GO REGULATION OF METAL ION TRANSPORT,0.0029965,0.21137,0.25638,1,1
4,GO DETECTION OF VISIBLE LIGHT,0.00051151,0.21131,0.20492,1,1
4,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,0.00060992,0.21123,0.24991,1,1
4,GO FOCAL ADHESION ASSEMBLY,0.0076456,0.21116,0.27992,1,1
4,GO CELLULAR RESPONSE TO STEROL,0.0057394,0.21109,0.29244,1,1
4,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00086166,0.21101,0.34853,1,1
4,GO REGULATION OF PROTEIN TARGETING,0.00011593,0.21094,0.25718,1,1
4,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.0010209,0.21093,0.24595,1,1
4,GO EXOCYTIC PROCESS,0.00017019,0.2109,0.32829,1,1
4,GO NOREPINEPHRINE TRANSPORT,0.054439,0.21084,0.24197,1,1
4,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.0066311,0.21084,0.23019,1,1
4,GO FUCOSE METABOLIC PROCESS,0.0036751,0.21082,0.23183,1,1
4,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.0019699,0.21065,0.29346,1,1
4,GO LIPID LOCALIZATION,0.0015882,0.2106,0.22766,1,1
4,GO ACTIN FILAMENT ORGANIZATION,0.00096503,0.2105,0.24818,1,1
4,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.0172,0.21045,0.23845,1,1
4,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,0.00076864,0.21023,0.2211,1,1
4,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.0015041,0.21014,0.25138,1,1
4,GO HEAD DEVELOPMENT,0.0015041,0.21001,0.24034,1,1
4,GO NEGATIVE REGULATION OF AMINE TRANSPORT,0.0063209,0.21,0.25971,1,1
4,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.037377,0.20997,0.2043,1,1
4,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,0.0036751,0.2099,0.29085,1,1
4,GO CELL GROWTH,0.00019306,0.20988,0.26136,1,1
4,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.00054254,0.20977,0.26642,1,1
4,GO MAINTENANCE OF CELL POLARITY,0.012106,0.20977,0.24129,1,1
4,GO ENTRY INTO HOST,0.048745,0.20957,0.20196,1,1
4,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.0080134,0.20953,0.29573,1,1
4,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.00060992,0.20937,0.25648,1,1
4,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.0083971,0.20919,0.27328,1,1
4,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,0.006955,0.20898,0.30931,1,1
4,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,0.014457,0.20894,0.28274,1,1
4,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,0.0014241,0.20888,0.25874,1,1
4,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.0003797,0.20874,0.26165,1,1
4,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.0076456,0.20861,0.24821,1,1
4,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,0.0003797,0.20854,0.33815,1,1
4,GO ACTIVATION OF MAPKK ACTIVITY,0.0044907,0.20834,0.29431,1,1
4,GO RESPONSE TO LEPTIN,0.00014989,0.20816,0.31428,1,1
4,GO OLIGODENDROCYTE DIFFERENTIATION,0.0010209,0.20816,0.2194,1,1
4,GO CARBOHYDRATE HOMEOSTASIS,3.7287e-05,0.20814,0.24922,1,1
4,GO PROTEIN HOMOOLIGOMERIZATION,0.0018673,0.2081,0.23364,1,1
4,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,0.0040644,0.20795,0.28881,1,1
4,GO FATTY ACID BETA OXIDATION,0.0010798,0.20791,0.23646,1,1
4,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,0.037377,0.20766,0.24709,1,1
4,GO NEUROTRANSMITTER UPTAKE,0.0021907,0.20764,0.23593,1,1
4,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,0.0014241,0.20763,0.28736,1,1
4,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,0.0054671,0.20758,0.26832,1,1
4,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.00091199,0.20741,0.2562,1,1
4,GO MEMBRANE PROTEIN PROTEOLYSIS,0.014457,0.20734,0.27429,1,1
4,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.00048214,0.20733,0.25581,1,1
4,GO POLYSACCHARIDE METABOLIC PROCESS,0.00010181,0.2073,0.27112,1,1
4,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.0012071,0.20725,0.26528,1,1
4,GO EMBRYONIC BODY MORPHOGENESIS,0.0092139,0.20708,0.28008,1,1
4,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.037377,0.20693,0.20857,1,1
4,GO SYNAPTIC VESICLE ENDOSOMAL PROCESSING,0.006955,0.20674,0.30235,1,1
4,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,0.00045436,0.20673,0.29635,1,1
4,GO MICROTUBULE BASED PROCESS,0.01266,0.20672,0.20589,1,1
4,GO HYALURONAN METABOLIC PROCESS,0.0080134,0.20672,0.28645,1,1
4,GO TRANSEPITHELIAL TRANSPORT,0.031957,0.20669,0.20586,1,1
4,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.017954,0.20668,0.30425,1,1
4,GO JNK CASCADE,0.0021907,0.20651,0.25306,1,1
4,GO GOLGI RIBBON FORMATION,0.023112,0.20649,0.27957,1,1
4,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.00096503,0.20649,0.25526,1,1
4,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.0044907,0.20647,0.20178,1,1
4,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.0018673,0.20616,0.26683,1,1
4,GO REGULATION OF RESPONSE TO FOOD,0.017954,0.2061,0.27161,1,1
4,GO RESPONSE TO ENDOGENOUS STIMULUS,0.00076864,0.20595,0.22362,1,1
4,GO CELL MATURATION,0.00028019,0.20592,0.24749,1,1
4,GO HEMATOPOIETIC STEM CELL PROLIFERATION,0.0028457,0.20586,0.29712,1,1
4,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.0020776,0.20578,0.2348,1,1
4,GO HISTONE H4 K5 ACETYLATION,0.013834,0.2056,0.23661,1,1
4,GO NEGATIVE REGULATION OF MAPK CASCADE,0.0016767,0.20541,0.25117,1,1
4,GO RESPONSE TO ESTROGEN,0.0060238,0.2053,0.22087,1,1
4,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.006955,0.20525,0.2265,1,1
4,GO REGULATION OF THE FORCE OF HEART CONTRACTION,0.0083971,0.20521,0.32952,1,1
4,GO PROTEIN LOCALIZATION TO CELL SURFACE,0.0012071,0.2052,0.25694,1,1
4,GO ERYTHROCYTE MATURATION,0.019548,0.20517,0.26008,1,1
4,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.0029965,0.20511,0.26158,1,1
4,GO SMAD PROTEIN SIGNAL TRANSDUCTION,0.00068502,0.20502,0.25891,1,1
4,GO MUSCLE CELL FATE COMMITMENT,0.052482,0.20501,0.21027,1,1
4,GO DOPAMINERGIC NEURON DIFFERENTIATION,0.0047188,0.20499,0.22943,1,1
4,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.024086,0.20499,0.17977,1,1
4,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.0036751,0.20494,0.26311,1,1
4,GO ICOSANOID METABOLIC PROCESS,0.014457,0.20492,0.20647,1,1
4,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.010101,0.20484,0.23214,1,1
4,GO MYOFIBRIL ASSEMBLY,0.00076864,0.20474,0.27351,1,1
4,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.0054671,0.20457,0.27492,1,1
4,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.021265,0.20456,0.21296,1,1
4,GO SOMITOGENESIS,0.0066311,0.20454,0.22531,1,1
4,GO DISACCHARIDE METABOLIC PROCESS,0.0012071,0.20454,0.3794,1,1
4,GO NEUTRAL LIPID CATABOLIC PROCESS,0.0011418,0.20436,0.2519,1,1
4,GO PROTEIN DEMETHYLATION,0.0060238,0.20434,0.32723,1,1
4,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.0060238,0.20415,0.27743,1,1
4,GO ENDOCRINE PANCREAS DEVELOPMENT,0.0096484,0.2041,0.242,1,1
4,GO GLIAL CELL DEVELOPMENT,0.0010798,0.20404,0.24819,1,1
4,GO REGULATION OF CELLULAR LOCALIZATION,0.0010209,0.204,0.23241,1,1
4,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.0020776,0.20399,0.26,1,1
4,GO REGULATION OF NOTCH SIGNALING PATHWAY,0.00033648,0.20373,0.31986,1,1
4,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.018736,0.20366,0.22963,1,1
4,GO LEUKOTRIENE METABOLIC PROCESS,0.056456,0.20343,0.1878,1,1
4,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.0036751,0.20339,0.2823,1,1
4,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.00028019,0.20334,0.21308,1,1
4,GO SECRETION,0.0021907,0.20323,0.21904,1,1
4,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,0.006955,0.20316,0.2126,1,1
4,GO REGULATION OF LIPID STORAGE,0.01266,0.20315,0.23806,1,1
4,GO MAINTENANCE OF LOCATION IN CELL,0.0054671,0.20308,0.21185,1,1
4,GO TRANSMEMBRANE TRANSPORT,0.00035748,0.20294,0.23877,1,1
4,GO PEPTIDYL THREONINE MODIFICATION,0.00024771,0.2029,0.29233,1,1
4,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.0054671,0.20286,0.25039,1,1
4,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,0.0024341,0.20283,0.2378,1,1
4,GO POSITIVE REGULATION OF HEART CONTRACTION,0.0011418,0.20279,0.33956,1,1
4,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.00081392,0.20279,0.25419,1,1
4,GO RESPONSE TO MECHANICAL STIMULUS,0.0025648,0.20276,0.25007,1,1
4,GO MUSCLE CONTRACTION,0.0014241,0.20268,0.25177,1,1
4,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,0.013834,0.20263,0.22728,1,1
4,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.0010798,0.20262,0.28419,1,1
4,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.0024341,0.20248,0.27031,1,1
4,GO FORMATION OF PRIMARY GERM LAYER,0.0049572,0.20231,0.26981,1,1
4,GO CARDIAC VENTRICLE DEVELOPMENT,0.00091199,0.20228,0.26059,1,1
4,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.010101,0.20226,0.22633,1,1
4,GO PEPTIDE CATABOLIC PROCESS,0.006955,0.20212,0.24895,1,1
4,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.008797,0.202,0.2432,1,1
4,GO RECEPTOR INTERNALIZATION,0.010572,0.20188,0.22198,1,1
4,GO RESPONSE TO MONOSACCHARIDE,4.5779e-05,0.2018,0.26717,1,1
4,GO MIRNA METABOLIC PROCESS,0.00332,0.20175,0.24519,1,1
4,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.0014241,0.2017,0.20375,1,1
4,GO ORGANOPHOSPHATE ESTER TRANSPORT,0.00086166,0.20161,0.22963,1,1
4,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.0021907,0.20159,0.28335,1,1
4,GO POSITIVE REGULATION OF CELL DEVELOPMENT,0.0012758,0.20153,0.23929,1,1
4,GO ADAPTIVE THERMOGENESIS,0.0016767,0.20148,0.21367,1,1
4,GO CELLULAR RESPONSE TO SALT STRESS,0.011574,0.20147,0.22445,1,1
4,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.0034935,0.20132,0.22906,1,1
4,GO EMBRYO IMPLANTATION,0.012106,0.2013,0.26129,1,1
4,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.0044907,0.20128,0.20248,1,1
4,GO OOGENESIS,0.008797,0.20125,0.1845,1,1
4,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.00051151,0.20114,0.29797,1,1
4,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.00332,0.20108,0.27417,1,1
4,GO MUSCLE CELL DIFFERENTIATION,0.00081392,0.20083,0.24923,1,1
4,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.0010798,0.20074,0.25505,1,1
4,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.031957,0.20066,0.21175,1,1
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.0066311,0.20057,0.22066,1,1
4,GO ADAPTATION OF SIGNALING PATHWAY,0.041938,0.20044,0.26209,1,1
4,GO PROTEOGLYCAN METABOLIC PROCESS,0.0025648,0.20034,0.27901,1,1
4,GO PROTEIN LOCALIZATION TO VACUOLE,0.0023095,0.20029,0.23696,1,1
4,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.0057394,0.20026,0.20658,1,1
4,GO BASE EXCISION REPAIR AP SITE FORMATION,0.048745,0.20022,0.17106,1,1
4,GO DIGESTIVE SYSTEM PROCESS,0.0060238,0.20004,0.19735,1,1
4,GO RESPONSE TO HORMONE,0.0027019,0.2,0.20776,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,0.0019699,0.19986,0.21606,1,1
4,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,0.0023095,0.19978,0.21724,1,1
4,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.006955,0.19967,0.26299,1,1
4,GO INTESTINAL ABSORPTION,0.043559,0.19966,0.23333,1,1
4,GO REGULATION OF AUTOPHAGOSOME MATURATION,0.014457,0.19961,0.27657,1,1
4,GO EXOCYTOSIS,0.0080134,0.19956,0.21362,1,1
4,GO REGULATION OF GTPASE ACTIVITY,0.0040644,0.19947,0.24942,1,1
4,GO MAINTENANCE OF LOCATION,0.0047188,0.19944,0.21396,1,1
4,GO OVULATION CYCLE,0.016475,0.19939,0.24873,1,1
4,GO INOSITOL PHOSPHATE METABOLIC PROCESS,0.0015041,0.19937,0.28154,1,1
4,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.0060238,0.19933,0.22949,1,1
4,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.0049572,0.19931,0.27449,1,1
4,GO DICARBOXYLIC ACID TRANSPORT,0.00081392,0.1993,0.25857,1,1
4,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.021265,0.19919,0.2039,1,1
4,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.00064645,0.19914,0.27303,1,1
4,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.00010181,0.19908,0.29882,1,1
4,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,0.0019699,0.19899,0.23579,1,1
4,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.01266,0.19895,0.22394,1,1
4,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.040368,0.19893,0.20581,1,1
4,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.038848,0.19888,0.19699,1,1
4,GO RESPONSE TO WOUNDING,0.0080134,0.19885,0.24305,1,1
4,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.00057531,0.19862,0.24572,1,1
4,GO VENTRICULAR SEPTUM DEVELOPMENT,0.0027019,0.19842,0.27218,1,1
4,GO REGULATION OF CALCIUM ION TRANSPORT,0.0063209,0.19833,0.25875,1,1
4,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,0.013235,0.19832,0.23083,1,1
4,GO REGULATION OF RESPONSE TO WOUNDING,0.014457,0.19831,0.22624,1,1
4,GO REGULATION OF RECEPTOR INTERNALIZATION,0.007293,0.19822,0.23347,1,1
4,GO RESPONSE TO CARBOHYDRATE,6.4139e-05,0.19819,0.25292,1,1
4,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.0024341,0.19816,0.35063,1,1
4,GO HISTONE H4 DEACETYLATION,0.0172,0.19809,0.17866,1,1
4,GO REGULATION OF TRANSPORTER ACTIVITY,0.0025648,0.19808,0.27768,1,1
4,GO MEMBRANE DOCKING,0.0042727,0.19802,0.22649,1,1
4,GO REGULATION OF CELL MATRIX ADHESION,0.013834,0.19764,0.26012,1,1
4,GO FACE DEVELOPMENT,0.0063209,0.19746,0.28597,1,1
4,GO KERATINIZATION,0.021265,0.19738,0.17104,1,1
4,GO NEGATIVE REGULATION OF SIGNALING,0.0011418,0.19722,0.22767,1,1
4,GO RESPONSE TO CALCIUM ION,0.00048214,0.1972,0.28786,1,1
4,GO MATERNAL PLACENTA DEVELOPMENT,0.025096,0.19711,0.22862,1,1
4,GO STRESS FIBER ASSEMBLY,0.0011418,0.19708,0.27148,1,1
4,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0025648,0.19691,0.33462,1,1
4,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,0.0080134,0.19687,0.27151,1,1
4,GO REGULATION OF STRIATED MUSCLE CONTRACTION,0.0021907,0.19675,0.28808,1,1
4,GO NEURAL CREST CELL DIFFERENTIATION,0.035953,0.19674,0.19478,1,1
4,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,0.0052065,0.19674,0.23363,1,1
4,GO SHORT TERM MEMORY,0.035953,0.19669,0.27604,1,1
4,GO OSTEOBLAST PROLIFERATION,0.058535,0.19667,0.20904,1,1
4,GO MUSCLE STRUCTURE DEVELOPMENT,0.0015882,0.19658,0.23169,1,1
4,GO TISSUE REGENERATION,0.0080134,0.19653,0.21214,1,1
4,GO NEGATIVE REGULATION OF NEURON DEATH,0.0021907,0.19651,0.22481,1,1
4,GO NEUTRAL LIPID METABOLIC PROCESS,0.0027019,0.19644,0.22245,1,1
4,GO SERINE PHOSPHORYLATION OF STAT PROTEIN,0.0096484,0.19643,0.20582,1,1
4,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.00064645,0.19637,0.26265,1,1
4,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.012106,0.1963,0.1929,1,1
4,GO REGULATION OF ENDOCRINE PROCESS,0.012106,0.19612,0.20477,1,1
4,GO PROGESTERONE METABOLIC PROCESS,0.014457,0.19609,0.20627,1,1
4,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.0015882,0.19606,0.22587,1,1
4,GO REGULATION OF CELL SUBSTRATE ADHESION,0.015776,0.196,0.26472,1,1
4,GO REGULATION OF ACTION POTENTIAL,0.0057394,0.19591,0.31937,1,1
4,GO REGULATION OF GLUCOSE METABOLIC PROCESS,0.00064645,0.19583,0.26764,1,1
4,GO CAMERA TYPE EYE MORPHOGENESIS,0.00332,0.19578,0.25799,1,1
4,GO ENDOCRINE SYSTEM DEVELOPMENT,0.0012071,0.19578,0.26338,1,1
4,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,0.035953,0.19547,0.22019,1,1
4,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,0.0029965,0.1953,0.26036,1,1
4,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,0.011063,0.19524,0.1952,1,1
4,GO REGULATION OF TOR SIGNALING,0.00091199,0.1952,0.23475,1,1
4,GO CARDIAC CELL DEVELOPMENT,0.0020776,0.19511,0.23391,1,1
4,GO POSITIVE REGULATION OF HEART RATE,0.01266,0.19509,0.23767,1,1
4,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.0042727,0.19506,0.2585,1,1
4,GO PHOSPHATIDYLGLYCEROL BIOSYNTHETIC PROCESS,0.0063209,0.19506,0.20845,1,1
4,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,0.0025648,0.19506,0.30374,1,1
4,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.011574,0.19498,0.22438,1,1
4,GO MUSCLE SYSTEM PROCESS,0.0017696,0.19496,0.23964,1,1
4,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.0096484,0.19494,0.21121,1,1
4,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.0042727,0.19494,0.24258,1,1
4,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,0.00024771,0.19494,0.24887,1,1
4,GO FILOPODIUM ASSEMBLY,0.017954,0.19479,0.21616,1,1
4,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,0.0029965,0.19477,0.27371,1,1
4,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.0014241,0.19469,0.228,1,1
4,GO REGULATION OF PEPTIDE TRANSPORT,0.0010209,0.19462,0.21109,1,1
4,GO CARDIAC MUSCLE CONTRACTION,0.0047188,0.19442,0.26681,1,1
4,GO REGULATION OF MIRNA METABOLIC PROCESS,0.0096484,0.19435,0.26507,1,1
4,GO NEGATIVE REGULATION OF AXONOGENESIS,0.010101,0.19419,0.3156,1,1
4,GO REGULATION OF CELLULAR PH,0.00057531,0.19417,0.22835,1,1
4,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.0021907,0.19407,0.26643,1,1
4,GO RECEPTOR CATABOLIC PROCESS,0.00054254,0.19392,0.26603,1,1
4,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,0.007293,0.1939,0.25729,1,1
4,GO POST EMBRYONIC DEVELOPMENT,0.00096503,0.19385,0.26541,1,1
4,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.0036751,0.19371,0.21714,1,1
4,GO SPINAL CORD DEVELOPMENT,0.012106,0.19364,0.23907,1,1
4,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.013235,0.19354,0.302,1,1
4,GO LIPID DROPLET ORGANIZATION,0.0010209,0.19344,0.21561,1,1
4,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,0.00057531,0.19341,0.28754,1,1
4,GO NEURON DEATH,0.0019699,0.19341,0.21765,1,1
4,GO GROWTH,0.00057531,0.19306,0.22593,1,1
4,GO EPOXYGENASE P450 PATHWAY,0.033245,0.19292,0.22055,1,1
4,GO VITAMIN TRANSMEMBRANE TRANSPORT,0.023112,0.19281,0.21774,1,1
4,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.0018673,0.19276,0.25028,1,1
4,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.0047188,0.19269,0.29266,1,1
4,GO LIPID CATABOLIC PROCESS,0.0019699,0.19265,0.19981,1,1
4,GO DETECTION OF MECHANICAL STIMULUS,0.0027019,0.19262,0.25488,1,1
4,GO CELLULAR RESPONSE TO ALCOHOL,0.0044907,0.19262,0.24857,1,1
4,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,0.017954,0.19257,0.19298,1,1
4,GO ZYMOGEN ACTIVATION,0.050584,0.19253,0.1987,1,1
4,GO EPHRIN RECEPTOR SIGNALING PATHWAY,0.0014241,0.19245,0.22351,1,1
4,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.00091199,0.19242,0.26412,1,1
4,GO RESPONSE TO NITROGEN COMPOUND,0.00096503,0.19209,0.21247,1,1
4,GO HISTONE H3 K9 ACETYLATION,0.010572,0.192,0.21516,1,1
4,GO PROTEIN LOCALIZATION TO MICROTUBULE,0.014457,0.19191,0.2561,1,1
4,GO HEART DEVELOPMENT,0.0020776,0.19184,0.23638,1,1
4,GO REGULATION OF PROTEIN BINDING,0.00045436,0.19167,0.23903,1,1
4,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.035953,0.19155,0.21799,1,1
4,GO NADH METABOLIC PROCESS,0.0014241,0.19147,0.22628,1,1
4,GO EPITHELIAL CELL DIFFERENTIATION,0.0015882,0.19142,0.21248,1,1
4,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.00072571,0.19138,0.22861,1,1
4,GO DETECTION OF LIGHT STIMULUS,0.00024771,0.1913,0.20635,1,1
4,GO AMYLOID FIBRIL FORMATION,0.056456,0.1912,0.20807,1,1
4,GO SENSORY PERCEPTION OF SMELL,0.0063209,0.19115,0.19504,1,1
4,GO CERAMIDE BIOSYNTHETIC PROCESS,0.00014989,0.19114,0.26563,1,1
4,GO SEGMENTATION,0.014457,0.19092,0.19429,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,0.0057394,0.19091,0.25868,1,1
4,GO ACTIVATION OF MAPK ACTIVITY,0.0031545,0.1908,0.24713,1,1
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.0047188,0.19073,0.23763,1,1
4,GO MIDGUT DEVELOPMENT,0.025096,0.19068,0.29259,1,1
4,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.00332,0.19054,0.3025,1,1
4,GO REGULATION OF MAP KINASE ACTIVITY,0.0019699,0.19051,0.2472,1,1
4,GO MUSCLE HYPERTROPHY,0.00064645,0.19048,0.25742,1,1
4,GO BROWN FAT CELL DIFFERENTIATION,0.0172,0.19046,0.17885,1,1
4,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.014457,0.19045,0.21009,1,1
4,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,0.052482,0.19025,0.17056,1,1
4,GO REGULATION OF CILIUM MOVEMENT,0.025096,0.19022,0.19711,1,1
4,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.011063,0.19012,0.25192,1,1
4,GO FEEDING BEHAVIOR,0.0080134,0.1901,0.20279,1,1
4,GO RESPONSE TO ESTRADIOL,0.0057394,0.19009,0.19947,1,1
4,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.0076456,0.1899,0.26944,1,1
4,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.0023095,0.18985,0.23522,1,1
4,GO MUSCLE CELL DEVELOPMENT,0.00035748,0.18983,0.2554,1,1
4,GO VENTRICULAR SYSTEM DEVELOPMENT,0.0057394,0.1898,0.25923,1,1
4,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.0036751,0.1898,0.2088,1,1
4,GO LIPID MODIFICATION,0.0015882,0.18956,0.23425,1,1
4,GO REGULATION OF PEPTIDASE ACTIVITY,0.0096484,0.18937,0.1971,1,1
4,GO PROTEIN COMPLEX OLIGOMERIZATION,0.0012758,0.18931,0.23021,1,1
4,GO MITOCHONDRION LOCALIZATION,0.013235,0.1893,0.23692,1,1
4,GO ORGANIC ACID TRANSPORT,0.00081392,0.18927,0.21975,1,1
4,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.0015041,0.1889,0.24238,1,1
4,GO PROTEIN PROCESSING,0.0023095,0.18889,0.2176,1,1
4,GO HOMEOSTATIC PROCESS,0.0016767,0.18879,0.20243,1,1
4,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,0.00023283,0.18875,0.29472,1,1
4,GO ACTIN FILAMENT BASED MOVEMENT,0.0040644,0.18874,0.25546,1,1
4,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.0076456,0.1887,0.23918,1,1
4,GO NEURAL CREST CELL MIGRATION,0.019548,0.18849,0.23145,1,1
4,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,0.0024341,0.18848,0.25332,1,1
4,GO REGULATION OF GROWTH,0.00033648,0.18846,0.2259,1,1
4,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.0052065,0.18839,0.20428,1,1
4,GO MUSCLE ORGAN MORPHOGENESIS,0.007293,0.18834,0.24359,1,1
4,GO COBALAMIN METABOLIC PROCESS,0.0092139,0.1883,0.2066,1,1
4,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.0044907,0.18827,0.28813,1,1
4,GO REGULATION OF PROTEIN FOLDING,0.0054671,0.18822,0.20336,1,1
4,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.0076456,0.18817,0.22393,1,1
4,GO CELL MOTILITY,0.0047188,0.18809,0.23377,1,1
4,GO CELLULAR HOMEOSTASIS,0.0024341,0.188,0.20139,1,1
4,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,0.043559,0.18787,0.21516,1,1
4,GO PHOSPHOLIPID METABOLIC PROCESS,0.0018673,0.18777,0.22155,1,1
4,GO RESPONSE TO OSMOTIC STRESS,0.0076456,0.18775,0.21121,1,1
4,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.025096,0.18766,0.20358,1,1
4,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,0.00091199,0.18748,0.23539,1,1
4,GO RESPONSE TO STEROL DEPLETION,0.00086166,0.18745,0.27101,1,1
4,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.00332,0.18738,0.22421,1,1
4,GO REGULATION OF SODIUM ION TRANSPORT,0.00054254,0.18738,0.29775,1,1
4,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.0017696,0.18737,0.2549,1,1
4,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.0025648,0.18736,0.23258,1,1
4,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,0.0034935,0.18734,0.25873,1,1
4,GO SNARE COMPLEX ASSEMBLY,0.0029965,0.18727,0.3174,1,1
4,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.0042727,0.18727,0.22382,1,1
4,GO MUSCLE ORGAN DEVELOPMENT,0.0040644,0.18709,0.20988,1,1
4,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.0049572,0.18701,0.28438,1,1
4,GO MELANOCYTE DIFFERENTIATION,0.02951,0.18697,0.20553,1,1
4,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,0.018736,0.18693,0.24412,1,1
4,GO ENSHEATHMENT OF NEURONS,0.0029965,0.1869,0.22206,1,1
4,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,0.023112,0.18661,0.19679,1,1
4,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.035953,0.18642,0.25486,1,1
4,GO RECEPTOR METABOLIC PROCESS,0.0049572,0.1864,0.2184,1,1
4,GO BONE REMODELING,0.025096,0.18632,0.26247,1,1
4,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,0.041938,0.18629,0.17539,1,1
4,GO DETECTION OF ABIOTIC STIMULUS,8.3641e-05,0.18621,0.23642,1,1
4,GO NEPHRON DEVELOPMENT,0.008797,0.18609,0.24738,1,1
4,GO RESPONSE TO GROWTH FACTOR,0.0010798,0.18609,0.24368,1,1
4,GO REGULATION OF CHROMATIN ASSEMBLY,0.0172,0.18602,0.23446,1,1
4,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.007293,0.18599,0.18936,1,1
4,GO RESPONSE TO PH,0.0012758,0.18594,0.32915,1,1
4,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.02951,0.18583,0.13694,1,1
4,GO TISSUE REMODELING,0.015104,0.1858,0.27536,1,1
4,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.00076864,0.1858,0.26741,1,1
4,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,0.060677,0.18574,0.21209,1,1
4,GO ENTRAINMENT OF CIRCADIAN CLOCK,0.00031664,0.18561,0.26854,1,1
4,GO CELLULAR LIPID CATABOLIC PROCESS,0.00096503,0.18552,0.21134,1,1
4,GO ENDOCARDIUM DEVELOPMENT,0.023112,0.18546,0.19339,1,1
4,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,0.00054254,0.18516,0.2667,1,1
4,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.0042727,0.18515,0.25221,1,1
4,GO ORGANOPHOSPHATE CATABOLIC PROCESS,0.0017696,0.18496,0.22426,1,1
4,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.0034935,0.1849,0.34491,1,1
4,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.00091199,0.18487,0.25916,1,1
4,GO RESPONSE TO NERVE GROWTH FACTOR,0.0018673,0.18487,0.26457,1,1
4,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,0.013834,0.18482,0.28033,1,1
4,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.00076864,0.18478,0.24117,1,1
4,GO VASCULOGENESIS,0.058535,0.18476,0.20685,1,1
4,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.050584,0.18471,0.21216,1,1
4,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0060238,0.18468,0.23446,1,1
4,GO PROTEIN HETEROOLIGOMERIZATION,0.0054671,0.18467,0.23522,1,1
4,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,0.0017696,0.18463,0.2545,1,1
4,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,0.0080134,0.18458,0.24138,1,1
4,GO HISTONE DEUBIQUITINATION,0.027226,0.18456,0.22715,1,1
4,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.054439,0.18455,0.20853,1,1
4,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.0010798,0.18453,0.23399,1,1
4,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.014457,0.18434,0.18449,1,1
4,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.0029965,0.18421,0.22983,1,1
4,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.027226,0.18406,0.20904,1,1
4,GO CELLULAR RESPONSE TO NUTRIENT,0.021265,0.18404,0.23849,1,1
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,0.0083971,0.18393,0.25556,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,0.026142,0.1839,0.20909,1,1
4,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.045233,0.18386,0.20965,1,1
4,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.0092139,0.18377,0.22819,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.024086,0.18376,0.18048,1,1
4,GO KERATINOCYTE PROLIFERATION,0.024086,0.18376,0.20969,1,1
4,GO REGULATION OF APPETITE,0.030713,0.18372,0.26506,1,1
4,GO NEGATIVE REGULATION OF CELL GROWTH,0.00060992,0.18369,0.24342,1,1
4,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,0.0012071,0.18364,0.32081,1,1
4,GO POSITIVE REGULATION OF MEMBRANE DEPOLARIZATION,0.027226,0.18363,0.21798,1,1
4,GO POSITIVE REGULATION OF WOUND HEALING,0.048745,0.18362,0.19055,1,1
4,GO CHLORIDE TRANSPORT,0.0031545,0.18351,0.2734,1,1
4,GO CELL CELL ADHESION,0.0063209,0.18347,0.25255,1,1
4,GO NEURON APOPTOTIC PROCESS,0.0021907,0.18344,0.21133,1,1
4,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.0028457,0.18327,0.20283,1,1
4,GO LIPOPROTEIN LOCALIZATION,0.046961,0.18324,0.21369,1,1
4,GO ACTIN MEDIATED CELL CONTRACTION,0.006955,0.18322,0.24032,1,1
4,GO POSITIVE REGULATION OF VESICLE FUSION,0.0063209,0.18317,0.28074,1,1
4,GO TAXIS,0.0172,0.18316,0.22608,1,1
4,GO POTASSIUM ION HOMEOSTASIS,0.0044907,0.1831,0.25578,1,1
4,GO RESPONSE TO MISFOLDED PROTEIN,0.0011418,0.18301,0.26279,1,1
4,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.00045436,0.18297,0.21799,1,1
4,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.0031545,0.18279,0.22387,1,1
4,GO STEROL TRANSPORT,0.0066311,0.18273,0.23144,1,1
4,GO RESPONSE TO FLUID SHEAR STRESS,0.028348,0.18259,0.23526,1,1
4,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.010572,0.18253,0.20381,1,1
4,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.0015041,0.18251,0.20482,1,1
4,GO CRISTAE FORMATION,0.0040644,0.18248,0.20581,1,1
4,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0054671,0.18242,0.20457,1,1
4,GO AUTOPHAGY OF MITOCHONDRION,0.00014989,0.18235,0.25215,1,1
4,GO REGULATION OF PH,0.00060992,0.18228,0.21975,1,1
4,GO TUBE MORPHOGENESIS,0.016475,0.18227,0.22288,1,1
4,GO RESPONSE TO COLD,0.00091199,0.1821,0.26467,1,1
4,GO ORGANELLE MEMBRANE FUSION,0.00081392,0.18208,0.27528,1,1
4,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.018736,0.18206,0.16971,1,1
4,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.0012758,0.18206,0.22859,1,1
4,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.0012758,0.18203,0.22346,1,1
4,GO CEREBELLAR CORTEX MORPHOGENESIS,0.014457,0.18196,0.25238,1,1
4,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.0038653,0.18195,0.22264,1,1
4,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.012106,0.18194,0.19245,1,1
4,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,0.0038653,0.18192,0.22285,1,1
4,GO OOCYTE DIFFERENTIATION,0.00332,0.18161,0.22389,1,1
4,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.018736,0.18142,0.23445,1,1
4,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.008797,0.18138,0.17471,1,1
4,GO GLYCOPROTEIN METABOLIC PROCESS,0.0011418,0.18138,0.22994,1,1
4,GO GLIAL CELL DIFFERENTIATION,0.00068502,0.18136,0.23545,1,1
4,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.0052065,0.18132,0.21839,1,1
4,GO OLIGOPEPTIDE TRANSPORT,0.048745,0.18131,0.19614,1,1
4,GO EAR MORPHOGENESIS,0.021265,0.18125,0.1774,1,1
4,GO CERAMIDE METABOLIC PROCESS,0.00010866,0.18124,0.25557,1,1
4,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.013235,0.1811,0.22493,1,1
4,GO EPITHELIAL TUBE FORMATION,0.0066311,0.18105,0.21299,1,1
4,GO POSITIVE REGULATION OF SIGNALING,0.0025648,0.18095,0.20985,1,1
4,GO SYNCYTIUM FORMATION,0.030713,0.1807,0.2436,1,1
4,GO PROTEIN KINASE B SIGNALING,0.013235,0.18064,0.22436,1,1
4,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.021265,0.18061,0.20124,1,1
4,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0011418,0.18028,0.20517,1,1
4,GO VESICLE BUDDING FROM MEMBRANE,0.0010209,0.18027,0.21753,1,1
4,GO RAC PROTEIN SIGNAL TRANSDUCTION,0.0054671,0.18022,0.22261,1,1
4,GO NEURAL TUBE FORMATION,0.0063209,0.1798,0.22548,1,1
4,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.00076864,0.17977,0.24043,1,1
4,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.045233,0.17975,0.20154,1,1
4,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.0044907,0.17966,0.21098,1,1
4,GO LATERAL MESODERM DEVELOPMENT,0.013834,0.17965,0.22113,1,1
4,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.0028457,0.1796,0.31348,1,1
4,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.017954,0.1795,0.20036,1,1
4,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.0052065,0.17947,0.21871,1,1
4,GO HEMOGLOBIN METABOLIC PROCESS,0.00072571,0.17939,0.24172,1,1
4,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.00076864,0.17938,0.24283,1,1
4,GO REGULATION OF BLOOD PRESSURE,0.0044907,0.17927,0.22164,1,1
4,GO RESPONSE TO ORGANOPHOSPHORUS,0.014457,0.17925,0.18099,1,1
4,GO REGULATION OF LIPASE ACTIVITY,0.056456,0.17916,0.1773,1,1
4,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.011063,0.17914,0.20011,1,1
4,GO PURINE NUCLEOTIDE TRANSPORT,0.0083971,0.17907,0.17635,1,1
4,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,0.020391,0.1788,0.21224,1,1
4,GO REGULATION OF LIPID METABOLIC PROCESS,0.007293,0.17871,0.1908,1,1
4,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,0.00020554,0.17863,0.25293,1,1
4,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,0.015776,0.17855,0.26271,1,1
4,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.0040644,0.17848,0.22717,1,1
4,GO CARBOHYDRATE PHOSPHORYLATION,0.0010798,0.17846,0.25064,1,1
4,GO RESPONSE TO PEPTIDE,0.0015882,0.17844,0.21218,1,1
4,GO TISSUE HOMEOSTASIS,0.0044907,0.17841,0.22682,1,1
4,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.0060238,0.17833,0.23195,1,1
4,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.027226,0.17829,0.23505,1,1
4,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,0.015776,0.17828,0.24446,1,1
4,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.0020776,0.1782,0.25222,1,1
4,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.010572,0.17794,0.19911,1,1
4,GO HEART VALVE FORMATION,0.050584,0.17791,0.23396,1,1
4,GO CELLULAR RESPONSE TO CALCIUM ION,0.00010181,0.17768,0.30371,1,1
4,GO REGULATION OF MICROTUBULE BASED PROCESS,0.018736,0.17768,0.18848,1,1
4,GO POSITIVE REGULATION OF PROTEIN BINDING,0.00072571,0.17762,0.23306,1,1
4,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,0.01266,0.17749,0.20054,1,1
4,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.0016767,0.17746,0.31117,1,1
4,GO RESPONSE TO ACID CHEMICAL,0.0023095,0.17742,0.21784,1,1
4,GO NEUTRAL AMINO ACID TRANSPORT,0.0060238,0.17734,0.21362,1,1
4,GO CELL CELL SIGNALING BY WNT,0.00091199,0.1772,0.22116,1,1
4,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,0.00021879,0.17709,0.21519,1,1
4,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.0019699,0.17694,0.35205,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.020391,0.17689,0.21699,1,1
4,GO CYTOSKELETON ORGANIZATION,0.0027019,0.17686,0.22963,1,1
4,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.00076864,0.17675,0.27887,1,1
4,GO HORMONE METABOLIC PROCESS,0.0020776,0.17668,0.19553,1,1
4,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.0057394,0.17664,0.18476,1,1
4,GO PHAGOSOME ACIDIFICATION,0.00018128,0.17663,0.23143,1,1
4,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.0012758,0.17656,0.23539,1,1
4,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0049572,0.17648,0.21983,1,1
4,GO RESPONSE TO STEROID HORMONE,0.010101,0.17639,0.19523,1,1
4,GO PEPTIDYL TYROSINE MODIFICATION,0.0172,0.17633,0.23238,1,1
4,GO REGULATION OF PROTEIN LOCALIZATION,0.0015041,0.17631,0.20495,1,1
4,GO LYSOSOMAL TRANSPORT,0.0017696,0.17625,0.28457,1,1
4,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.0076456,0.17624,0.21035,1,1
4,GO RESPONSE TO ALKALOID,0.0025648,0.17624,0.21253,1,1
4,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.0092139,0.1762,0.25234,1,1
4,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.00072571,0.17609,0.22809,1,1
4,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.00033648,0.17606,0.27677,1,1
4,GO MOVEMENT IN HOST ENVIRONMENT,0.035953,0.17603,0.194,1,1
4,GO AMYLOID BETA METABOLIC PROCESS,0.0027019,0.17602,0.25456,1,1
4,GO NON MOTILE CILIUM ASSEMBLY,0.030713,0.17584,0.1894,1,1
4,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.0172,0.17583,0.34335,1,1
4,GO CIRCADIAN RHYTHM,0.0024341,0.17574,0.19776,1,1
4,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,0.0015882,0.17566,0.24686,1,1
4,GO HEPARIN METABOLIC PROCESS,0.043559,0.17566,0.27534,1,1
4,GO DETECTION OF STIMULUS,0.00010866,0.17561,0.20262,1,1
4,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,0.052482,0.17557,0.20542,1,1
4,GO POSITIVE REGULATION OF ACTIN NUCLEATION,0.0057394,0.17554,0.25555,1,1
4,GO PHOTOPERIODISM,0.0010798,0.17537,0.22242,1,1
4,GO VASCULATURE DEVELOPMENT,0.020391,0.17535,0.22777,1,1
4,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.0076456,0.17533,0.20951,1,1
4,GO VITAMIN TRANSPORT,0.0036751,0.17528,0.21143,1,1
4,GO MACROMOLECULE DEACYLATION,0.0013481,0.17509,0.24698,1,1
4,GO PROGRAMMED NECROTIC CELL DEATH,0.043559,0.17505,0.17961,1,1
4,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0092139,0.17501,0.1752,1,1
4,GO ANIMAL ORGAN MORPHOGENESIS,0.0038653,0.17496,0.21825,1,1
4,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.0044907,0.17494,0.24134,1,1
4,GO BLOOD VESSEL MORPHOGENESIS,0.024086,0.17489,0.22493,1,1
4,GO CELLULAR RESPONSE TO ALKALOID,0.0029965,0.17479,0.20567,1,1
4,GO MICROTUBULE CYTOSKELETON ORGANIZATION,0.026142,0.17479,0.1899,1,1
4,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,0.031957,0.17477,0.26859,1,1
4,GO POSITIVE REGULATION OF AUTOPHAGY,0.018736,0.17459,0.20559,1,1
4,GO GOLGI TO ENDOSOME TRANSPORT,0.0038653,0.17457,0.31316,1,1
4,GO INOSITOL LIPID MEDIATED SIGNALING,0.023112,0.17455,0.21824,1,1
4,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.0080134,0.17452,0.22899,1,1
4,GO NEGATIVE REGULATION OF TOR SIGNALING,0.006955,0.1745,0.21607,1,1
4,GO SPHINGOLIPID METABOLIC PROCESS,7.8298e-05,0.17447,0.24752,1,1
4,GO MEMBRANE FUSION,0.00072571,0.17441,0.25107,1,1
4,GO REGULATION OF GLUCONEOGENESIS,0.0016767,0.17439,0.27668,1,1
4,GO ORGANELLE LOCALIZATION,0.0029965,0.17439,0.20712,1,1
4,GO AXIS SPECIFICATION,0.0066311,0.17425,0.1852,1,1
4,GO REGULATION OF PROTEIN COMPLEX STABILITY,0.00091199,0.17399,0.21573,1,1
4,GO PHOTOTRANSDUCTION,0.00024771,0.17396,0.18242,1,1
4,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.0038653,0.1738,0.22785,1,1
4,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.0011418,0.17378,0.20478,1,1
4,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.034576,0.17378,0.14123,1,1
4,GO TRIGLYCERIDE CATABOLIC PROCESS,0.048745,0.17369,0.17311,1,1
4,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.020391,0.17363,0.19559,1,1
4,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.0020776,0.17361,0.26479,1,1
4,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.011063,0.17358,0.22277,1,1
4,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,0.014457,0.1734,0.23565,1,1
4,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.0015882,0.17334,0.2175,1,1
4,GO INORGANIC ANION TRANSPORT,0.0013481,0.17333,0.25109,1,1
4,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.0080134,0.17316,0.22754,1,1
4,GO LIPID OXIDATION,0.0027019,0.17299,0.21147,1,1
4,GO CORONARY VASCULATURE DEVELOPMENT,0.006955,0.17298,0.26509,1,1
4,GO RNA DESTABILIZATION,0.013834,0.17294,0.24959,1,1
4,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.0018673,0.17286,0.22701,1,1
4,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.0044907,0.17284,0.22638,1,1
4,GO LAMELLIPODIUM ASSEMBLY,0.033245,0.17273,0.19141,1,1
4,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.0034935,0.1727,0.27972,1,1
4,GO PROTEIN MATURATION,0.0017696,0.17267,0.18685,1,1
4,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.0020776,0.17251,0.2489,1,1
4,GO ECTODERM DEVELOPMENT,0.02951,0.17243,0.17435,1,1
4,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.023112,0.17232,0.202,1,1
4,GO UV DAMAGE EXCISION REPAIR,0.030713,0.17232,0.21417,1,1
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00023283,0.17231,0.23786,1,1
4,GO TOR SIGNALING,0.00081392,0.17214,0.22166,1,1
4,GO CELL CELL RECOGNITION,0.040368,0.17184,0.14595,1,1
4,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.0017696,0.17183,0.22693,1,1
4,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.0028457,0.17182,0.25368,1,1
4,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.0057394,0.17173,0.2445,1,1
4,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,0.00091199,0.17145,0.20309,1,1
4,GO MIDBRAIN DEVELOPMENT,0.0015041,0.17138,0.18074,1,1
4,GO CARDIOCYTE DIFFERENTIATION,0.0023095,0.17125,0.23976,1,1
4,GO ACTIN CYTOSKELETON REORGANIZATION,0.0076456,0.17124,0.24362,1,1
4,GO HISTONE DEACETYLATION,0.00332,0.17117,0.2485,1,1
4,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.038848,0.17112,0.19117,1,1
4,GO SELECTIVE AUTOPHAGY,0.0017696,0.17103,0.24772,1,1
4,GO PIGMENT CELL DIFFERENTIATION,0.013834,0.17074,0.21599,1,1
4,GO RESPONSE TO METAL ION,0.00033648,0.1707,0.21755,1,1
4,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.011063,0.17067,0.20287,1,1
4,GO MEMBRANE ORGANIZATION,0.0010209,0.17066,0.2196,1,1
4,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,0.0044907,0.17063,0.27731,1,1
4,GO MITOCHONDRIAL DEPOLARIZATION,0.0034935,0.1706,0.26904,1,1
4,GO INNER EAR MORPHOGENESIS,0.025096,0.17043,0.1859,1,1
4,GO REGULATION OF ACTIN FILAMENT LENGTH,0.0025648,0.1704,0.22657,1,1
4,GO ANION TRANSMEMBRANE TRANSPORT,0.00081392,0.17028,0.23806,1,1
4,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.00086166,0.17028,0.22496,1,1
4,GO RESPONSE TO INORGANIC SUBSTANCE,0.00064645,0.17013,0.20574,1,1
4,GO GASTRULATION,0.0031545,0.17004,0.24822,1,1
4,GO UNSATURATED FATTY ACID METABOLIC PROCESS,0.018736,0.16996,0.17239,1,1
4,GO HISTONE H3 ACETYLATION,0.0172,0.16975,0.18449,1,1
4,GO MUSCLE ADAPTATION,0.0016767,0.16963,0.23636,1,1
4,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.010572,0.16958,0.2631,1,1
4,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.0023095,0.16946,0.19412,1,1
4,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.0038653,0.16942,0.2337,1,1
4,GO VACUOLAR TRANSPORT,0.00068502,0.16941,0.26499,1,1
4,GO ALDEHYDE CATABOLIC PROCESS,0.0023095,0.1694,0.1893,1,1
4,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.0040644,0.16931,0.23539,1,1
4,GO LONG CHAIN FATTY ACID TRANSPORT,0.0076456,0.16922,0.18088,1,1
4,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.0096484,0.16911,0.19793,1,1
4,GO RIBONUCLEOTIDE CATABOLIC PROCESS,0.010572,0.16908,0.18881,1,1
4,GO EXCRETION,0.008797,0.16906,0.2414,1,1
4,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.035953,0.16902,0.21628,1,1
4,GO HISTONE METHYLATION,0.0063209,0.16897,0.24168,1,1
4,GO MULTICELLULAR ORGANISM REPRODUCTION,0.0057394,0.16884,0.19538,1,1
4,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.0012071,0.16866,0.22482,1,1
4,GO ORGANIC ANION TRANSPORT,0.00091199,0.16858,0.21271,1,1
4,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.045233,0.16853,0.20556,1,1
4,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.019548,0.16824,0.18069,1,1
4,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,0.0047188,0.16815,0.21981,1,1
4,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.056456,0.16814,0.218,1,1
4,GO REGULATION OF CELL DIFFERENTIATION,0.00332,0.16807,0.21711,1,1
4,GO TRANSCRIPTION BY RNA POLYMERASE III,0.0038653,0.16796,0.187,1,1
4,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,0.0096484,0.16796,0.20732,1,1
4,GO GLUTAMATE METABOLIC PROCESS,0.0014241,0.16784,0.22078,1,1
4,GO REGULATION OF WNT SIGNALING PATHWAY,0.0025648,0.16783,0.20851,1,1
4,GO REGULATION OF GLIAL CELL DIFFERENTIATION,0.0092139,0.16779,0.18189,1,1
4,GO REGULATION OF MAPK CASCADE,0.0092139,0.16773,0.21849,1,1
4,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.00064645,0.16772,0.22603,1,1
4,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.056456,0.1676,0.20065,1,1
4,GO TUBE DEVELOPMENT,0.0080134,0.16757,0.22542,1,1
4,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.0060238,0.16749,0.19682,1,1
4,GO PEPTIDYL ARGININE MODIFICATION,0.018736,0.16747,0.13318,1,1
4,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.0060238,0.16743,0.18909,1,1
4,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.01266,0.16725,0.21483,1,1
4,GO TOOTH MINERALIZATION,0.0052065,0.1672,0.34895,1,1
4,GO RESPONSE TO WATER,0.011063,0.16719,0.21344,1,1
4,GO VESICLE LOCALIZATION,0.00054254,0.16715,0.26697,1,1
4,GO POSITIVE REGULATION OF LIPID LOCALIZATION,0.033245,0.16714,0.20055,1,1
4,GO PEPTIDYL SERINE MODIFICATION,0.0019699,0.16709,0.23623,1,1
4,GO VESICLE DOCKING,0.00028019,0.16703,0.31834,1,1
4,GO ADIPOSE TISSUE DEVELOPMENT,0.013235,0.16695,0.19727,1,1
4,GO CANONICAL WNT SIGNALING PATHWAY,0.0015882,0.16685,0.21869,1,1
4,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.00091199,0.16685,0.21397,1,1
4,GO NEGATIVE REGULATION OF GROWTH,0.0010209,0.16672,0.21631,1,1
4,GO CARDIAC MUSCLE CELL DIFFERENTIATION,0.0015041,0.16665,0.24444,1,1
4,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,0.045233,0.16659,0.16984,1,1
4,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.011063,0.16655,0.16481,1,1
4,GO REGULATION OF PHOSPHORYLATION,0.0025648,0.16642,0.20557,1,1
4,GO CLATHRIN COAT ASSEMBLY,0.012106,0.16638,0.2896,1,1
4,GO REGULATION OF MUSCLE CONTRACTION,0.0031545,0.16638,0.22125,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.00040321,0.16629,0.19816,1,1
4,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.0021907,0.16624,0.20998,1,1
4,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,0.033245,0.16622,0.24793,1,1
4,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.0044907,0.16622,0.22053,1,1
4,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.010572,0.16606,0.16425,1,1
4,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.017954,0.16602,0.23303,1,1
4,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.021265,0.16593,0.2242,1,1
4,GO NECROTIC CELL DEATH,0.038848,0.16592,0.16422,1,1
4,GO GLYCEROLIPID METABOLIC PROCESS,0.0031545,0.16592,0.2212,1,1
4,GO ANION TRANSPORT,0.00064645,0.16583,0.22985,1,1
4,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.013834,0.16569,0.23796,1,1
4,GO ACTIN NUCLEATION,0.0034935,0.16563,0.20712,1,1
4,GO PROTEIN POLYMERIZATION,0.00081392,0.16552,0.23566,1,1
4,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.00076864,0.16543,0.22733,1,1
4,GO ERBB SIGNALING PATHWAY,0.0096484,0.16541,0.2166,1,1
4,GO REGULATION OF MEIOTIC CELL CYCLE,0.027226,0.16541,0.16044,1,1
4,GO IRON ION TRANSPORT,0.00064645,0.16538,0.21725,1,1
4,GO FAT CELL DIFFERENTIATION,0.0063209,0.16531,0.20919,1,1
4,GO ERBB2 SIGNALING PATHWAY,0.0049572,0.16527,0.24392,1,1
4,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,0.0080134,0.16525,0.26538,1,1
4,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,0.0023095,0.1651,0.30139,1,1
4,GO POSITIVE REGULATION OF MAPK CASCADE,0.017954,0.16506,0.21462,1,1
4,GO RESPONSE TO CAMP,0.007293,0.16495,0.20095,1,1
4,GO LIPID HOMEOSTASIS,0.011574,0.16475,0.18478,1,1
4,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.0083971,0.16466,0.21635,1,1
4,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.00057531,0.16464,0.18852,1,1
4,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,0.013235,0.16456,0.21548,1,1
4,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.022172,0.16455,0.18143,1,1
4,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.0018673,0.16443,0.23034,1,1
4,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.008797,0.16441,0.20078,1,1
4,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.010572,0.16429,0.20945,1,1
4,GO FATTY ACID CATABOLIC PROCESS,0.0017696,0.16414,0.21834,1,1
4,GO PIGMENT GRANULE ORGANIZATION,0.0047188,0.16409,0.19934,1,1
4,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.0096484,0.16404,0.20267,1,1
4,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,0.014457,0.16402,0.1877,1,1
4,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.026142,0.16399,0.21657,1,1
4,GO HYPOTHALAMUS DEVELOPMENT,0.01266,0.16394,0.20354,1,1
4,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,0.00096503,0.16385,0.21643,1,1
4,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,0.0092139,0.16379,0.23698,1,1
4,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,0.0040644,0.16369,0.26864,1,1
4,GO OXIDATIVE DEMETHYLATION,0.017954,0.16356,0.23279,1,1
4,GO MEGAKARYOCYTE DIFFERENTIATION,0.0018673,0.16335,0.24542,1,1
4,GO OSSIFICATION,0.0057394,0.16334,0.22061,1,1
4,GO FEMALE SEX DIFFERENTIATION,0.010572,0.16327,0.18808,1,1
4,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.0047188,0.16308,0.20399,1,1
4,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.0040644,0.16303,0.24593,1,1
4,GO POSITIVE REGULATION OF HISTONE METHYLATION,0.046961,0.16291,0.18486,1,1
4,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.0011418,0.16285,0.26527,1,1
4,GO REGULATION OF ERBB SIGNALING PATHWAY,0.026142,0.16284,0.19621,1,1
4,GO CELL RECOGNITION,0.013235,0.16265,0.20446,1,1
4,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.0092139,0.16258,0.26936,1,1
4,GO MUSCLE TISSUE DEVELOPMENT,0.0052065,0.16252,0.20924,1,1
4,GO PEPTIDYL LYSINE ACETYLATION,0.0080134,0.16248,0.20943,1,1
4,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0096484,0.16242,0.30572,1,1
4,GO CARBOHYDRATE DERIVATIVE TRANSPORT,0.00076864,0.16242,0.21007,1,1
4,GO RHYTHMIC PROCESS,0.0042727,0.16219,0.20187,1,1
4,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.0096484,0.16212,0.21377,1,1
4,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.006955,0.162,0.2112,1,1
4,GO ENDOCRINE PROCESS,0.050584,0.16198,0.1655,1,1
4,GO AMINO SUGAR METABOLIC PROCESS,0.060677,0.16182,0.15693,1,1
4,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.0172,0.16178,0.2129,1,1
4,GO ORGANELLE FUSION,0.0012758,0.16169,0.24355,1,1
4,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.0080134,0.16145,0.20804,1,1
4,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.0028457,0.16136,0.22394,1,1
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.0096484,0.16116,0.22602,1,1
4,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.045233,0.16101,0.18457,1,1
4,GO REGULATION OF MUSCLE SYSTEM PROCESS,0.0044907,0.16081,0.21104,1,1
4,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.0031545,0.16077,0.20153,1,1
4,GO DNA DEALKYLATION,0.0040644,0.16069,0.17873,1,1
4,GO NUCLEOTIDE PHOSPHORYLATION,0.0010798,0.16058,0.19679,1,1
4,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,0.034576,0.16046,0.18975,1,1
4,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,0.027226,0.16045,0.20306,1,1
4,GO GASTRIC ACID SECRETION,0.040368,0.16045,0.1464,1,1
4,GO GPI ANCHOR METABOLIC PROCESS,0.025096,0.16041,0.15741,1,1
4,GO EMBRYO DEVELOPMENT,0.0066311,0.16038,0.19905,1,1
4,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.016475,0.16026,0.2015,1,1
4,GO PEPTIDYL LYSINE MODIFICATION,0.015104,0.16021,0.19571,1,1
4,GO HETEROCHROMATIN ORGANIZATION,0.041938,0.1602,0.19024,1,1
4,GO UBIQUITIN DEPENDENT ERAD PATHWAY,0.0031545,0.16018,0.22396,1,1
4,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.0025648,0.16013,0.20734,1,1
4,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,0.0015882,0.16008,0.22662,1,1
4,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.052482,0.16003,0.16126,1,1
4,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.0044907,0.15989,0.18893,1,1
4,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.013834,0.15984,0.20432,1,1
4,GO CARDIAC MUSCLE CELL CONTRACTION,0.018736,0.15984,0.2777,1,1
4,GO PROTEIN K48 LINKED DEUBIQUITINATION,0.0172,0.15979,0.22402,1,1
4,GO ERYTHROCYTE DEVELOPMENT,0.025096,0.15957,0.21077,1,1
4,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.008797,0.15944,0.26263,1,1
4,GO C21 STEROID HORMONE METABOLIC PROCESS,0.017954,0.15933,0.17615,1,1
4,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,0.00091199,0.15927,0.20009,1,1
4,GO POSITIVE REGULATION OF DNA RECOMBINATION,0.030713,0.15912,0.19429,1,1
4,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.046961,0.1591,0.18957,1,1
4,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.050584,0.15908,0.13372,1,1
4,GO MAMMARY GLAND DEVELOPMENT,0.0038653,0.15901,0.24342,1,1
4,GO REGULATION OF MICROTUBULE BASED MOVEMENT,0.018736,0.159,0.17304,1,1
4,GO GLYCEROL ETHER METABOLIC PROCESS,0.026142,0.1589,0.20463,1,1
4,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.0036751,0.15887,0.19972,1,1
4,GO P38MAPK CASCADE,0.045233,0.15882,0.21248,1,1
4,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.0044907,0.15873,0.18894,1,1
4,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.00096503,0.15871,0.23109,1,1
4,GO STEROL METABOLIC PROCESS,0.0057394,0.15868,0.1906,1,1
4,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.0042727,0.15846,0.23048,1,1
4,GO SENSORY PERCEPTION OF PAIN,0.013834,0.15838,0.20213,1,1
4,GO RESPONSE TO PEPTIDE HORMONE,0.0013481,0.15836,0.20692,1,1
4,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.0038653,0.15835,0.19695,1,1
4,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.0012071,0.15829,0.22312,1,1
4,GO POSITIVE REGULATION OF PROTEOLYSIS,0.0052065,0.15826,0.18724,1,1
4,GO REGULATION OF AMYLOID BETA FORMATION,0.026142,0.15815,0.20977,1,1
4,GO ORGAN GROWTH,0.0031545,0.15786,0.2248,1,1
4,GO CARNITINE SHUTTLE,0.0096484,0.15782,0.25232,1,1
4,GO RESPONSE TO ALCOHOL,0.0083971,0.15781,0.19623,1,1
4,GO POSITIVE REGULATION OF CATABOLIC PROCESS,0.0060238,0.15773,0.20246,1,1
4,GO RESPONSE TO ACIDIC PH,0.011063,0.15771,0.31503,1,1
4,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0040644,0.15768,0.24468,1,1
4,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.0080134,0.15753,0.20476,1,1
4,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.054439,0.15736,0.18389,1,1
4,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.0012071,0.15729,0.20498,1,1
4,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,0.0057394,0.15724,0.20453,1,1
4,GO CELLULAR PIGMENTATION,0.0029965,0.15721,0.22171,1,1
4,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.0063209,0.15716,0.18206,1,1
4,GO POLYOL METABOLIC PROCESS,0.00048214,0.15696,0.2334,1,1
4,GO PROTEIN HOMOTETRAMERIZATION,0.013834,0.15683,0.17946,1,1
4,GO REGULATION OF HISTONE MODIFICATION,0.0020776,0.15671,0.22046,1,1
4,GO CARBOHYDRATE CATABOLIC PROCESS,0.0025648,0.15668,0.18391,1,1
4,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.035953,0.15663,0.18931,1,1
4,GO COPII COATED VESICLE BUDDING,0.0038653,0.1566,0.20942,1,1
4,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,0.0038653,0.1566,0.18705,1,1
4,GO RESPONSE TO MANGANESE ION,0.027226,0.15645,0.18043,1,1
4,GO DEVELOPMENTAL PIGMENTATION,0.01266,0.15643,0.21461,1,1
4,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.00054254,0.15642,0.24874,1,1
4,GO RESPONSE TO INSULIN,0.0010209,0.15641,0.20898,1,1
4,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,0.0034935,0.15637,0.19181,1,1
4,GO TISSUE MORPHOGENESIS,0.0042727,0.15628,0.21002,1,1
4,GO REGULATION OF PROTEIN ACETYLATION,0.0063209,0.15627,0.19414,1,1
4,GO CELLULAR GLUCAN METABOLIC PROCESS,0.0003797,0.1562,0.24215,1,1
4,GO REGULATION OF LIPID CATABOLIC PROCESS,0.007293,0.15617,0.21361,1,1
4,GO GLYCOSYLATION,0.0016767,0.15612,0.21753,1,1
4,GO MUSCLE CELL PROLIFERATION,0.043559,0.15608,0.18487,1,1
4,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.00054254,0.15598,0.19281,1,1
4,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.0040644,0.15572,0.19593,1,1
4,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.015104,0.15558,0.22567,1,1
4,GO HAIR FOLLICLE MATURATION,0.020391,0.15558,0.23154,1,1
4,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.035953,0.15548,0.21116,1,1
4,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.0080134,0.15546,0.18173,1,1
4,GO LIPID STORAGE,0.0092139,0.1554,0.21755,1,1
4,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.0034935,0.15538,0.19853,1,1
4,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,0.0016767,0.15537,0.20854,1,1
4,GO PROTEIN ACYLATION,0.0063209,0.15534,0.20702,1,1
4,GO TRIGLYCERIDE METABOLIC PROCESS,0.021265,0.15524,0.17447,1,1
4,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.0040644,0.1552,0.2037,1,1
4,GO HORMONE BIOSYNTHETIC PROCESS,0.00072571,0.15515,0.19825,1,1
4,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.00332,0.15496,0.20718,1,1
4,GO EAR DEVELOPMENT,0.015776,0.15475,0.18164,1,1
4,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.00332,0.15474,0.20425,1,1
4,GO DEMETHYLATION,0.0011418,0.15469,0.26391,1,1
4,GO EMBRYONIC MORPHOGENESIS,0.011063,0.15463,0.20479,1,1
4,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.00332,0.15446,0.19355,1,1
4,GO DIENCEPHALON DEVELOPMENT,0.0060238,0.15432,0.23256,1,1
4,GO PROTEIN AUTOUBIQUITINATION,0.0057394,0.15416,0.2023,1,1
4,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,0.027226,0.15401,0.16246,1,1
4,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,0.0057394,0.15388,0.17374,1,1
4,GO BODY FLUID SECRETION,0.0052065,0.15379,0.19425,1,1
4,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0023095,0.15373,0.21786,1,1
4,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.015776,0.15366,0.2027,1,1
4,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.0063209,0.15365,0.18438,1,1
4,GO CELLULAR RESPONSE TO PEPTIDE,0.0014241,0.15353,0.21397,1,1
4,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.034576,0.15347,0.19933,1,1
4,GO ZINC ION TRANSPORT,0.00086166,0.15336,0.16878,1,1
4,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.006955,0.15334,0.21911,1,1
4,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.0060238,0.1532,0.24948,1,1
4,GO TERPENOID METABOLIC PROCESS,0.056456,0.15312,0.1239,1,1
4,GO RESPONSE TO LIPID,0.026142,0.153,0.17757,1,1
4,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.008797,0.15295,0.23534,1,1
4,GO SPERM CAPACITATION,0.0083971,0.1529,0.22443,1,1
4,GO MESODERM DEVELOPMENT,0.0029965,0.15285,0.19916,1,1
4,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,0.0044907,0.15284,0.21425,1,1
4,GO GERM CELL DEVELOPMENT,0.0076456,0.15279,0.18759,1,1
4,GO UV PROTECTION,0.040368,0.15276,0.19501,1,1
4,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.0076456,0.15261,0.20084,1,1
4,GO PROTEIN METHYLATION,0.01266,0.15252,0.21086,1,1
4,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.010572,0.15245,0.24437,1,1
4,GO GLUCOSE METABOLIC PROCESS,0.00060992,0.15238,0.21124,1,1
4,GO REGULATION OF PROTEOLYSIS,0.0066311,0.15228,0.18496,1,1
4,GO EMBRYONIC EYE MORPHOGENESIS,0.010101,0.15222,0.26393,1,1
4,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.0012071,0.15199,0.22475,1,1
4,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.0014241,0.15193,0.21138,1,1
4,GO ERAD PATHWAY,0.0044907,0.15179,0.20997,1,1
4,GO NEGATIVE REGULATION OF SECRETION,0.0092139,0.15174,0.20143,1,1
4,GO PEPTIDYL LYSINE TRIMETHYLATION,0.024086,0.15165,0.25313,1,1
4,GO ISOPRENOID METABOLIC PROCESS,0.041938,0.15162,0.11983,1,1
4,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.0054671,0.15158,0.20403,1,1
4,GO RESPONSE TO MINERALOCORTICOID,0.02951,0.15158,0.16518,1,1
4,GO DNA DEMETHYLATION,0.011574,0.15154,0.1741,1,1
4,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.012106,0.15152,0.22538,1,1
4,GO RETINAL CONE CELL DIFFERENTIATION,0.015776,0.15148,0.18609,1,1
4,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,0.0047188,0.15147,0.22183,1,1
4,GO SEXUAL REPRODUCTION,0.0063209,0.15144,0.1841,1,1
4,GO RESPIRATORY SYSTEM PROCESS,0.011063,0.15136,0.27227,1,1
4,GO POST TRANSLATIONAL PROTEIN MODIFICATION,0.00015974,0.15135,0.20741,1,1
4,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,0.00091199,0.15131,0.21317,1,1
4,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.011063,0.15126,0.19201,1,1
4,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.0054671,0.15094,0.19852,1,1
4,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.00072571,0.15088,0.22637,1,1
4,GO REGULATION OF HISTONE METHYLATION,0.0083971,0.15068,0.21872,1,1
4,GO TOXIN METABOLIC PROCESS,0.037377,0.15063,0.18813,1,1
4,GO PROTEOLYSIS,0.0010798,0.15032,0.19886,1,1
4,GO TEMPERATURE HOMEOSTASIS,0.0047188,0.1502,0.19331,1,1
4,GO RECEPTOR MEDIATED ENDOCYTOSIS,0.0080134,0.15015,0.22506,1,1
4,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,0.021265,0.15013,0.24749,1,1
4,GO MACROMOLECULE DEPALMITOYLATION,0.0080134,0.15011,0.15989,1,1
4,GO GLYCOGEN BIOSYNTHETIC PROCESS,0.0013481,0.14998,0.24287,1,1
4,GO MONOCARBOXYLIC ACID TRANSPORT,0.011574,0.14976,0.19173,1,1
4,GO NUCLEAR BODY ORGANIZATION,0.012106,0.14972,0.21897,1,1
4,GO INTERACTION WITH HOST,0.028348,0.14971,0.18081,1,1
4,GO SECRETION BY TISSUE,0.020391,0.14958,0.16769,1,1
4,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,0.00068502,0.14947,0.26512,1,1
4,GO POSITIVE REGULATION OF RNA SPLICING,0.033245,0.14942,0.16476,1,1
4,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.022172,0.14938,0.15628,1,1
4,GO LAMELLIPODIUM ORGANIZATION,0.035953,0.14938,0.18186,1,1
4,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.00332,0.14917,0.25019,1,1
4,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.015776,0.14901,0.19243,1,1
4,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.0012071,0.14894,0.20898,1,1
4,GO REGULATION OF RNA SPLICING,0.054439,0.14888,0.16134,1,1
4,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.02951,0.14885,0.1727,1,1
4,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.015776,0.14884,0.2172,1,1
4,GO PEPTIDYL AMINO ACID MODIFICATION,0.0038653,0.14878,0.20584,1,1
4,GO PROTEIN HYDROXYLATION,0.010101,0.14871,0.22273,1,1
4,GO LIPOPROTEIN METABOLIC PROCESS,0.0023095,0.14851,0.18345,1,1
4,GO HEART GROWTH,0.00332,0.14842,0.21659,1,1
4,GO REGULATION OF DEPHOSPHORYLATION,0.0060238,0.14836,0.21128,1,1
4,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.016475,0.14829,0.20963,1,1
4,GO NEGATIVE REGULATION OF TRANSPORT,0.0096484,0.14812,0.17838,1,1
4,GO RETINA HOMEOSTASIS,0.0017696,0.14784,0.22764,1,1
4,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.0023095,0.14774,0.18041,1,1
4,GO RESPONSE TO EXTRACELLULAR STIMULUS,0.00081392,0.14763,0.19451,1,1
4,GO RESPIRATORY SYSTEM DEVELOPMENT,0.0019699,0.14754,0.25306,1,1
4,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.0016767,0.14751,0.20387,1,1
4,GO VESICLE ORGANIZATION,0.00051151,0.14746,0.23985,1,1
4,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,0.0031545,0.14741,0.16424,1,1
4,GO ENDOCRINE HORMONE SECRETION,0.024086,0.14738,0.17516,1,1
4,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.0018673,0.14713,0.20502,1,1
4,GO DEPHOSPHORYLATION,0.0027019,0.14713,0.22431,1,1
4,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.021265,0.14701,0.16448,1,1
4,GO MORPHOGENESIS OF AN EPITHELIUM,0.0076456,0.14689,0.20465,1,1
4,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.0027019,0.1467,0.17509,1,1
4,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.0015041,0.14665,0.23022,1,1
4,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.0040644,0.1466,0.19229,1,1
4,GO CLATHRIN DEPENDENT ENDOCYTOSIS,0.0023095,0.14658,0.27749,1,1
4,GO RESPONSE TO DRUG,0.0023095,0.14656,0.19261,1,1
4,GO COVALENT CHROMATIN MODIFICATION,0.019548,0.14648,0.20972,1,1
4,GO PROTEIN TARGETING TO VACUOLE,0.0076456,0.14635,0.2258,1,1
4,GO ORGANELLE ASSEMBLY,0.0047188,0.14633,0.19309,1,1
4,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,0.025096,0.14619,0.14916,1,1
4,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,0.0023095,0.14583,0.22017,1,1
4,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,0.0011418,0.14578,0.22409,1,1
4,GO NEGATIVE REGULATION OF CELL ADHESION,0.023112,0.14574,0.24321,1,1
4,GO RESPONSE TO NUTRIENT,0.014457,0.14572,0.19215,1,1
4,GO CARNITINE METABOLIC PROCESS,0.0044907,0.14565,0.2448,1,1
4,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.043559,0.14554,0.19385,1,1
4,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.024086,0.14546,0.16961,1,1
4,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00054254,0.14544,0.2174,1,1
4,GO REGULATION OF HYDROLASE ACTIVITY,0.0052065,0.14529,0.20579,1,1
4,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.0020776,0.14526,0.19434,1,1
4,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.0063209,0.14515,0.25265,1,1
4,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.0060238,0.14501,0.18933,1,1
4,GO BONE DEVELOPMENT,0.0172,0.14488,0.22781,1,1
4,GO PH REDUCTION,0.0028457,0.14487,0.17679,1,1
4,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,0.007293,0.14483,0.17236,1,1
4,GO REGULATION OF ORGANELLE ASSEMBLY,0.0092139,0.14475,0.19242,1,1
4,GO REGULATION OF PHOSPHATASE ACTIVITY,0.0076456,0.14457,0.20775,1,1
4,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.008797,0.14453,0.22826,1,1
4,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.0016767,0.14452,0.22371,1,1
4,GO PLACENTA DEVELOPMENT,0.026142,0.14444,0.18079,1,1
4,GO REGULATION OF CHROMATIN ORGANIZATION,0.007293,0.14429,0.20333,1,1
4,GO KIDNEY MESENCHYME DEVELOPMENT,0.052482,0.14424,0.17551,1,1
4,GO VIRAL BUDDING,0.0025648,0.14416,0.16438,1,1
4,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.056456,0.14407,0.14157,1,1
4,GO ENDOTHELIAL CELL PROLIFERATION,0.034576,0.14388,0.19889,1,1
4,GO CELLULAR RESPONSE TO OSMOTIC STRESS,0.01266,0.14379,0.17747,1,1
4,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,0.0066311,0.14377,0.18439,1,1
4,GO SMALL MOLECULE CATABOLIC PROCESS,0.0012071,0.14375,0.17846,1,1
4,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.056456,0.14369,0.20685,1,1
4,GO VACUOLE ORGANIZATION,0.00091199,0.14368,0.2352,1,1
4,GO REGULATION OF AUTOPHAGY,0.00068502,0.14362,0.2294,1,1
4,GO PROTEIN POLYUBIQUITINATION,0.0076456,0.14359,0.17693,1,1
4,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.025096,0.14359,0.23132,1,1
4,GO ESTABLISHMENT OF TISSUE POLARITY,0.0066311,0.14348,0.15645,1,1
4,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.00051151,0.14345,0.18366,1,1
4,GO NEGATIVE REGULATION OF BINDING,0.011063,0.14341,0.17449,1,1
4,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.0172,0.14317,0.1834,1,1
4,GO EPITHELIAL CELL DEVELOPMENT,0.00048214,0.14309,0.25977,1,1
4,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.0010209,0.14307,0.22725,1,1
4,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.0096484,0.1428,0.17385,1,1
4,GO KETONE BIOSYNTHETIC PROCESS,0.0025648,0.14273,0.21917,1,1
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.0031545,0.14271,0.19046,1,1
4,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.00068502,0.14269,0.19182,1,1
4,GO VIRAL RELEASE FROM HOST CELL,0.0020776,0.14265,0.17517,1,1
4,GO GLIOGENESIS,0.0031545,0.14254,0.22365,1,1
4,GO REGULATION OF ORGANELLE ORGANIZATION,0.0031545,0.14254,0.19748,1,1
4,GO LIPOSACCHARIDE METABOLIC PROCESS,0.00029789,0.14243,0.20835,1,1
4,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.0020776,0.14239,0.18037,1,1
4,GO SUPEROXIDE METABOLIC PROCESS,0.045233,0.14233,0.17824,1,1
4,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.0092139,0.14232,0.16824,1,1
4,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,0.00068502,0.14231,0.2005,1,1
4,GO REGULATION OF MUSCLE ADAPTATION,0.0038653,0.14219,0.21416,1,1
4,GO GOLGI ORGANIZATION,0.0080134,0.14218,0.23732,1,1
4,GO SPERMATID DIFFERENTIATION,0.013834,0.14217,0.18832,1,1
4,GO RESPONSE TO ABIOTIC STIMULUS,0.0013481,0.14205,0.17463,1,1
4,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.0042727,0.14204,0.18468,1,1
4,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.0029965,0.14203,0.20515,1,1
4,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.0092139,0.142,0.18379,1,1
4,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.0063209,0.14192,0.1879,1,1
4,GO PROTEIN ACETYLATION,0.01266,0.14192,0.19473,1,1
4,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.019548,0.14182,0.23034,1,1
4,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,0.0092139,0.14166,0.19692,1,1
4,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.02951,0.14165,0.18827,1,1
4,GO REGULATION OF CELL MATURATION,0.0066311,0.14162,0.1752,1,1
4,GO ALCOHOL METABOLIC PROCESS,0.00332,0.14161,0.1974,1,1
4,GO SMOOTH MUSCLE CELL MIGRATION,0.013834,0.1416,0.25204,1,1
4,GO ENERGY RESERVE METABOLIC PROCESS,0.00064645,0.14159,0.23777,1,1
4,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.007293,0.14135,0.18262,1,1
4,GO REGULATION OF CELL ADHESION,0.041938,0.14118,0.23323,1,1
4,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.00086166,0.14112,0.20701,1,1
4,GO REGULATION OF MUSCLE HYPERTROPHY,0.022172,0.14101,0.18456,1,1
4,GO CELLULAR LIPID METABOLIC PROCESS,0.0023095,0.14096,0.19753,1,1
4,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.041938,0.14092,0.18592,1,1
4,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.0015882,0.14091,0.21153,1,1
4,GO HISTONE H3 K4 METHYLATION,0.041938,0.14067,0.19779,1,1
4,GO MULTI ORGANISM PROCESS,0.0031545,0.14048,0.18538,1,1
4,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.017954,0.14047,0.18488,1,1
4,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,0.0036751,0.14019,0.1874,1,1
4,GO ALCOHOL BIOSYNTHETIC PROCESS,0.0014241,0.14016,0.18171,1,1
4,GO CELLULAR RESPONSE TO KETONE,0.021265,0.14014,0.1677,1,1
4,GO DNA TEMPLATED TRANSCRIPTION INITIATION,0.0080134,0.14012,0.16054,1,1
4,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.056456,0.14006,0.20495,1,1
4,GO PROTON TRANSMEMBRANE TRANSPORT,0.00024771,0.1399,0.20737,1,1
4,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.0038653,0.13966,0.19816,1,1
4,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,0.016475,0.13945,0.17303,1,1
4,GO MONOSACCHARIDE METABOLIC PROCESS,0.00091199,0.1394,0.1912,1,1
4,GO NON CANONICAL WNT SIGNALING PATHWAY,0.0019699,0.13937,0.19629,1,1
4,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.010572,0.13922,0.23075,1,1
4,GO PROTEIN DEPHOSPHORYLATION,0.0027019,0.1392,0.2097,1,1
4,GO PROTEIN TETRAMERIZATION,0.0049572,0.13901,0.18465,1,1
4,GO ESTABLISHMENT OF CELL POLARITY,0.0025648,0.13891,0.23768,1,1
4,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.0047188,0.13874,0.19397,1,1
4,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.050584,0.13874,0.15126,1,1
4,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,0.00096503,0.13872,0.20237,1,1
4,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,0.0040644,0.13867,0.24833,1,1
4,GO RESPONSE TO OXIDATIVE STRESS,0.0040644,0.13846,0.17951,1,1
4,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.011574,0.13846,0.15176,1,1
4,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.01266,0.13814,0.20066,1,1
4,GO SARCOMERE ORGANIZATION,0.0083971,0.13812,0.18367,1,1
4,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.0083971,0.13802,0.19041,1,1
4,GO CARBOHYDRATE METABOLIC PROCESS,0.00060992,0.13797,0.1982,1,1
4,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,0.0029965,0.13795,0.27987,1,1
4,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,0.058535,0.1375,0.13824,1,1
4,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.017954,0.13749,0.19677,1,1
4,GO CELLULAR RESPONSE TO MANGANESE ION,0.011574,0.13741,0.20209,1,1
4,GO POLYOL BIOSYNTHETIC PROCESS,0.00064645,0.13715,0.20331,1,1
4,GO LUNG EPITHELIUM DEVELOPMENT,0.015104,0.13705,0.22904,1,1
4,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.0066311,0.1366,0.20176,1,1
4,GO EXECUTION PHASE OF APOPTOSIS,0.00096503,0.13645,0.1955,1,1
4,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,0.00076864,0.13637,0.19178,1,1
4,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.038848,0.13635,0.23814,1,1
4,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.015104,0.13634,0.21802,1,1
4,GO REGULATION OF FAT CELL DIFFERENTIATION,0.022172,0.13619,0.21009,1,1
4,GO GOLGI VESICLE BUDDING,0.0054671,0.13611,0.21073,1,1
4,GO SULFUR COMPOUND TRANSPORT,0.0028457,0.13566,0.21998,1,1
4,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.0027019,0.13561,0.21691,1,1
4,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.00048214,0.13558,0.1788,1,1
4,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,0.0080134,0.13554,0.2194,1,1
4,GO MITOCHONDRION DISTRIBUTION,0.034576,0.13552,0.24178,1,1
4,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.0040644,0.13535,0.18691,1,1
4,GO CELLULAR RESPONSE TO LIPID,0.058535,0.13521,0.16297,1,1
4,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.0013481,0.13521,0.18169,1,1
4,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.00051151,0.13495,0.21498,1,1
4,GO POSITIVE REGULATION OF DNA REPAIR,0.019548,0.13485,0.19861,1,1
4,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,0.016475,0.13483,0.21476,1,1
4,GO ALPHA AMINO ACID CATABOLIC PROCESS,0.0031545,0.13479,0.16146,1,1
4,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.00031664,0.13445,0.21118,1,1
4,GO REGULATION OF CATABOLIC PROCESS,0.0038653,0.13434,0.185,1,1
4,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.030713,0.13427,0.18535,1,1
4,GO GAMETE GENERATION,0.0096484,0.13423,0.18021,1,1
4,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,0.0018673,0.1342,0.18822,1,1
4,GO RESPONSE TO CAFFEINE,0.023112,0.13419,0.23876,1,1
4,GO VESICLE TARGETING,0.0040644,0.13417,0.2148,1,1
4,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.010572,0.13416,0.16756,1,1
4,GO MUSCLE CELL CELLULAR HOMEOSTASIS,0.058535,0.13403,0.14714,1,1
4,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.010101,0.13395,0.23287,1,1
4,GO INTERMEMBRANE LIPID TRANSFER,0.015104,0.13378,0.20919,1,1
4,GO HORMONE MEDIATED SIGNALING PATHWAY,0.011063,0.13369,0.20051,1,1
4,GO REGULATION OF GASTRULATION,0.056456,0.13334,0.17815,1,1
4,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.014457,0.13322,0.18161,1,1
4,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.008797,0.13305,0.17801,1,1
4,GO CELLULAR AMINO ACID CATABOLIC PROCESS,0.0023095,0.13277,0.16725,1,1
4,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.008797,0.13277,0.18131,1,1
4,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.0012758,0.13275,0.18916,1,1
4,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.043559,0.13266,0.143,1,1
4,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.0020776,0.13253,0.18627,1,1
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.013834,0.13248,0.15075,1,1
4,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.031957,0.13246,0.14375,1,1
4,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.054439,0.13241,0.14685,1,1
4,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.030713,0.13229,0.17885,1,1
4,GO LIPID METABOLIC PROCESS,0.0021907,0.13216,0.19595,1,1
4,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.0023095,0.1321,0.16002,1,1
4,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,0.0066311,0.132,0.18035,1,1
4,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.028348,0.132,0.16362,1,1
4,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.0047188,0.13199,0.14526,1,1
4,GO REGULATION OF RESPONSE TO STRESS,0.018736,0.13193,0.17072,1,1
4,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,0.0060238,0.13181,0.20159,1,1
4,GO ORGANIC ACID CATABOLIC PROCESS,0.0017696,0.13177,0.18258,1,1
4,GO REGULATION OF PROTEIN CATABOLIC PROCESS,0.0029965,0.13157,0.19167,1,1
4,GO MAINTENANCE OF PROTEIN LOCATION,0.0012071,0.13151,0.17924,1,1
4,GO PROTEIN CATABOLIC PROCESS,0.0052065,0.13146,0.17954,1,1
4,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.0029965,0.13125,0.19442,1,1
4,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.00017019,0.13122,0.21949,1,1
4,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.0052065,0.13112,0.1892,1,1
4,GO RESPONSE TO GROWTH HORMONE,0.014457,0.13104,0.18725,1,1
4,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,0.0047188,0.13072,0.18809,1,1
4,GO PEPTIDYL SERINE DEPHOSPHORYLATION,0.017954,0.1307,0.1575,1,1
4,GO CYTOSOLIC TRANSPORT,0.0011418,0.13069,0.27209,1,1
4,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,0.0021907,0.13061,0.2293,1,1
4,GO GOLGI VESICLE TRANSPORT,0.0047188,0.1306,0.21358,1,1
4,GO SECONDARY METABOLIC PROCESS,0.0013481,0.13016,0.21848,1,1
4,GO POSITIVE REGULATION OF NEURON DEATH,0.020391,0.12999,0.1847,1,1
4,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.033245,0.12997,0.28523,1,1
4,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.052482,0.12983,0.13281,1,1
4,GO MODULATION BY VIRUS OF HOST PROCESS,0.0076456,0.1296,0.17579,1,1
4,GO SUBSTANTIA NIGRA DEVELOPMENT,0.013834,0.12954,0.15641,1,1
4,GO VACUOLAR ACIDIFICATION,0.014457,0.12949,0.17451,1,1
4,GO RNA POLYADENYLATION,0.038848,0.12947,0.19443,1,1
4,GO MEMBRANE LIPID METABOLIC PROCESS,0.00014062,0.12926,0.22721,1,1
4,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.0047188,0.12921,0.18502,1,1
4,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,0.027226,0.1292,0.19482,1,1
4,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,0.0049572,0.12902,0.19363,1,1
4,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.0047188,0.12898,0.20085,1,1
4,GO ORGANELLE DISASSEMBLY,0.00096503,0.12845,0.21443,1,1
4,GO CELLULAR COMPONENT DISASSEMBLY,0.00064645,0.12836,0.18044,1,1
4,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.034576,0.12819,0.25196,1,1
4,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.01266,0.128,0.16697,1,1
4,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.011574,0.12799,0.17234,1,1
4,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.0036751,0.12794,0.19233,1,1
4,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,0.00072571,0.12791,0.21832,1,1
4,GO NEGATIVE REGULATION OF ION TRANSPORT,0.015104,0.12775,0.19554,1,1
4,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.034576,0.12746,0.1626,1,1
4,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.037377,0.12741,0.15452,1,1
4,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.014457,0.12732,0.1829,1,1
4,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.00086166,0.12719,0.21799,1,1
4,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.0038653,0.12707,0.19433,1,1
4,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.0017696,0.12694,0.18919,1,1
4,GO EMBRYONIC PATTERN SPECIFICATION,0.028348,0.1264,0.19753,1,1
4,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.025096,0.12605,0.17691,1,1
4,GO AUTOPHAGOSOME ORGANIZATION,0.0036751,0.12575,0.22591,1,1
4,GO PROTEIN LOCALIZATION TO MEMBRANE,0.00081392,0.12563,0.16264,1,1
4,GO CHROMATIN ORGANIZATION,0.030713,0.12557,0.18922,1,1
4,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.0172,0.12537,0.22721,1,1
4,GO REPRODUCTION,0.0036751,0.12526,0.18683,1,1
4,GO PIGMENTATION,0.008797,0.12518,0.22087,1,1
4,GO REGULATION OF CELLULAR CATABOLIC PROCESS,0.0060238,0.12494,0.18042,1,1
4,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.0023095,0.12486,0.18834,1,1
4,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.018736,0.12484,0.12648,1,1
4,GO CELLULAR HORMONE METABOLIC PROCESS,0.058535,0.12458,0.12498,1,1
4,GO MESODERM MORPHOGENESIS,0.0049572,0.12456,0.21308,1,1
4,GO REGULATION OF MACROAUTOPHAGY,0.00096503,0.1245,0.22273,1,1
4,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.026142,0.12442,0.20389,1,1
4,GO SULFUR COMPOUND METABOLIC PROCESS,0.0024341,0.12397,0.17107,1,1
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.011063,0.12393,0.22516,1,1
4,GO REGULATION OF DNA REPAIR,0.054439,0.12391,0.15422,1,1
4,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.043559,0.12351,0.15056,1,1
4,GO RESPONSE TO LIGHT STIMULUS,0.0060238,0.12339,0.18458,1,1
4,GO SPERM EGG RECOGNITION,0.0049572,0.12338,0.13141,1,1
4,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.0027019,0.12336,0.18178,1,1
4,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.011063,0.12324,0.16245,1,1
4,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.01266,0.12319,0.16984,1,1
4,GO IRON ION HOMEOSTASIS,0.038848,0.12316,0.15887,1,1
4,GO METHYLATION,0.033245,0.12301,0.15859,1,1
4,GO REGULATION OF MRNA 3 END PROCESSING,0.058535,0.12276,0.16704,1,1
4,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,0.01266,0.12252,0.15615,1,1
4,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,0.013235,0.12233,0.15858,1,1
4,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.020391,0.12223,0.22816,1,1
4,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.011574,0.12215,0.14411,1,1
4,GO DENDRITIC SPINE MAINTENANCE,0.037377,0.12186,0.21437,1,1
4,GO REGULATION OF STEROID METABOLIC PROCESS,0.0083971,0.12178,0.16802,1,1
4,GO ENDOSOMAL TRANSPORT,0.0018673,0.12132,0.23131,1,1
4,GO RESPONSE TO STARVATION,0.0023095,0.12098,0.18041,1,1
4,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.0066311,0.12081,0.18412,1,1
4,GO STEROID METABOLIC PROCESS,0.0029965,0.12074,0.18298,1,1
4,GO CELLULAR PROTEIN CATABOLIC PROCESS,0.0076456,0.12062,0.16902,1,1
4,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.0025648,0.12047,0.19623,1,1
4,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.0036751,0.12037,0.18513,1,1
4,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,0.041938,0.12032,0.14106,1,1
4,GO REGULATION OF TRANSFERASE ACTIVITY,0.0054671,0.12024,0.18923,1,1
4,GO FEMALE GAMETE GENERATION,0.02951,0.12005,0.16212,1,1
4,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.028348,0.11958,0.17365,1,1
4,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0018673,0.11932,0.16313,1,1
4,GO FATTY ACID METABOLIC PROCESS,0.0038653,0.11926,0.1778,1,1
4,GO PHOSPHOLIPID HOMEOSTASIS,0.050584,0.11911,0.19316,1,1
4,GO PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.01266,0.11906,0.13161,1,1
4,GO EPITHELIAL CELL PROLIFERATION,0.028348,0.11896,0.19312,1,1
4,GO REGULATION OF GENE EXPRESSION EPIGENETIC,0.024086,0.11876,0.17729,1,1
4,GO GLUCOSE IMPORT,0.0096484,0.11857,0.18831,1,1
4,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.052482,0.11855,0.15131,1,1
4,GO REGULATION OF HISTONE UBIQUITINATION,0.023112,0.11845,0.16241,1,1
4,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.038848,0.11824,0.14936,1,1
4,GO AUTOPHAGY OF NUCLEUS,0.043559,0.11823,0.15557,1,1
4,GO RESPONSE TO ETHANOL,0.0076456,0.11759,0.1762,1,1
4,GO MRNA CLEAVAGE,0.028348,0.11726,0.15196,1,1
4,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.012106,0.11653,0.14859,1,1
4,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.0076456,0.11644,0.14609,1,1
4,GO ETHER METABOLIC PROCESS,0.011574,0.11639,0.22629,1,1
4,GO TETRAPYRROLE METABOLIC PROCESS,0.016475,0.11609,0.12948,1,1
4,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.008797,0.11557,0.16349,1,1
4,GO CELLULAR MACROMOLECULE LOCALIZATION,0.0025648,0.11554,0.17768,1,1
4,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.0060238,0.11422,0.16929,1,1
4,GO FERTILIZATION,0.011063,0.11392,0.14834,1,1
4,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.0083971,0.11362,0.17777,1,1
4,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.050584,0.11362,0.1511,1,1
4,GO B CELL APOPTOTIC PROCESS,0.048745,0.1135,0.15807,1,1
4,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.0076456,0.11302,0.1701,1,1
4,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,0.019548,0.11245,0.15401,1,1
4,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,0.056456,0.11237,0.15969,1,1
4,GO EMBRYONIC AXIS SPECIFICATION,0.0066311,0.11216,0.18891,1,1
4,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.035953,0.11196,0.18574,1,1
4,GO MUSCLE CELL APOPTOTIC PROCESS,0.0083971,0.11145,0.18328,1,1
4,GO APOPTOTIC PROCESS,0.014457,0.11024,0.16893,1,1
4,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,0.011574,0.11023,0.1774,1,1
4,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.0021907,0.1102,0.21692,1,1
4,GO CELLULAR RESPONSE TO DRUG,0.026142,0.11009,0.14585,1,1
4,GO MUSCLE CELL MIGRATION,0.037377,0.11,0.20085,1,1
4,GO REGULATION OF INTRACELLULAR TRANSPORT,0.007293,0.10996,0.17412,1,1
4,GO MACROAUTOPHAGY,0.0020776,0.10905,0.20122,1,1
4,GO PROTEIN DESTABILIZATION,0.0057394,0.109,0.18007,1,1
4,GO REGULATION OF VACUOLE ORGANIZATION,0.0044907,0.10878,0.22219,1,1
4,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.0080134,0.10874,0.17012,1,1
4,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.0172,0.10858,0.15673,1,1
4,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.011063,0.10838,0.1702,1,1
4,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.034576,0.10836,0.15522,1,1
4,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,0.050584,0.10822,0.11128,1,1
4,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.0028457,0.10808,0.15605,1,1
4,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.031957,0.10806,0.12297,1,1
4,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.0028457,0.10798,0.16352,1,1
4,GO STEROID BIOSYNTHETIC PROCESS,0.0052065,0.10761,0.14715,1,1
4,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.046961,0.10739,0.17298,1,1
4,GO LIPID BIOSYNTHETIC PROCESS,0.0018673,0.10717,0.18727,1,1
4,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.037377,0.10695,0.16073,1,1
4,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,0.021265,0.10674,0.15546,1,1
4,GO REGULATION OF CELL POPULATION PROLIFERATION,0.021265,0.10667,0.18416,1,1
4,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,0.040368,0.10659,0.24495,1,1
4,GO REGULATION OF CELL DEATH,0.021265,0.10608,0.1644,1,1
4,GO RESPONSE TO OXYGEN LEVELS,0.007293,0.10602,0.15582,1,1
4,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.0080134,0.10596,0.17751,1,1
4,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.0047188,0.10557,0.2,1,1
4,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.041938,0.10513,0.17166,1,1
4,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.007293,0.10508,0.13578,1,1
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.021265,0.10496,0.16122,1,1
4,GO STRIATED MUSCLE CELL PROLIFERATION,0.050584,0.10479,0.1692,1,1
4,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.060677,0.10462,0.12132,1,1
4,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,0.045233,0.10431,0.15855,1,1
4,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.020391,0.1042,0.17983,1,1
4,GO PROTEIN FOLDING,0.0034935,0.1042,0.13867,1,1
4,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.0083971,0.10396,0.12127,1,1
4,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.0057394,0.10392,0.15405,1,1
4,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.0054671,0.1039,0.22325,1,1
4,GO REGULATION OF ORGAN GROWTH,0.031957,0.10366,0.1798,1,1
4,GO REGULATION OF CYTOPLASMIC TRANSLATION,0.027226,0.10331,0.17926,1,1
4,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.012106,0.10326,0.16478,1,1
4,GO INTRACELLULAR TRANSPORT,0.0054671,0.10309,0.16555,1,1
4,GO ENDOSOME ORGANIZATION,0.0049572,0.10253,0.177,1,1
4,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.014457,0.10243,0.1677,1,1
4,GO RESPONSE TO TEMPERATURE STIMULUS,0.0027019,0.10232,0.17119,1,1
4,GO APOPTOTIC SIGNALING PATHWAY,0.016475,0.1018,0.15619,1,1
4,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.035953,0.10135,0.166,1,1
4,GO ORGANIC ACID METABOLIC PROCESS,0.0024341,0.1013,0.16349,1,1
4,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.0011418,0.10121,0.12709,1,1
4,GO PIGMENT GRANULE LOCALIZATION,0.060677,0.099716,0.19861,1,1
4,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.037377,0.099414,0.21436,1,1
4,GO RESPONSE TO RADIATION,0.014457,0.09936,0.15418,1,1
4,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.026142,0.099224,0.10101,1,1
4,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,0.058535,0.09877,0.13326,1,1
4,GO NEGATIVE REGULATION OF CELL DEATH,0.046961,0.098464,0.14569,1,1
4,GO REGENERATION,0.014457,0.098172,0.18635,1,1
4,GO THYMUS DEVELOPMENT,0.028348,0.098028,0.14979,1,1
4,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.0020776,0.098009,0.17515,1,1
4,GO POSITIVE REGULATION OF CELL DEATH,0.020391,0.097429,0.17954,1,1
4,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,0.0042727,0.097117,0.22429,1,1
4,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00057531,0.096944,0.16438,1,1
4,GO MULTIVESICULAR BODY ORGANIZATION,0.024086,0.096176,0.12466,1,1
4,GO PEROXISOMAL MEMBRANE TRANSPORT,0.0063209,0.093815,0.2047,1,1
4,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,0.034576,0.093511,0.14471,1,1
4,GO INTRACELLULAR PROTEIN TRANSPORT,0.0080134,0.092978,0.14541,1,1
4,GO ALPHA AMINO ACID METABOLIC PROCESS,0.0076456,0.092961,0.14021,1,1
4,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.01266,0.092649,0.16643,1,1
4,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.0060238,0.090013,0.17336,1,1
4,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.0019699,0.089846,0.16169,1,1
4,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.012106,0.088546,0.13859,1,1
4,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.056456,0.088451,0.14996,1,1
4,GO RESPONSE TO HEAT,0.034576,0.087938,0.13596,1,1
4,GO PROTEIN TARGETING TO MITOCHONDRION,0.022172,0.087683,0.10579,1,1
4,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.024086,0.087456,0.144,1,1
4,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.021265,0.086631,0.14357,1,1
4,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.022172,0.085971,0.16155,1,1
4,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.007293,0.085643,0.14346,1,1
4,GO FATTY ACYL COA METABOLIC PROCESS,0.048745,0.08525,0.13116,1,1
4,GO PEROXISOMAL TRANSPORT,0.012106,0.08452,0.14354,1,1
4,GO PIGMENT METABOLIC PROCESS,0.024086,0.08428,0.1189,1,1
4,GO OXIDATION REDUCTION PROCESS,0.0013481,0.083907,0.14868,1,1
4,GO PROTEIN SUMOYLATION,0.048745,0.083235,0.14974,1,1
4,GO CELLULAR RESPONSE TO CHEMICAL STRESS,0.011574,0.08288,0.16219,1,1
4,GO PIGMENT BIOSYNTHETIC PROCESS,0.048745,0.082398,0.10771,1,1
4,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.052482,0.082386,0.21052,1,1
4,GO CELLULAR RESPONSE TO OXYGEN LEVELS,0.041938,0.082168,0.11535,1,1
4,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.024086,0.081199,0.17566,1,1
4,GO PEROXISOME ORGANIZATION,0.014457,0.08005,0.15867,1,1
4,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.054439,0.079453,0.21072,1,1
4,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.0054671,0.077443,0.12457,1,1
4,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.020391,0.076993,0.16641,1,1
4,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.0076456,0.07548,0.12133,1,1
4,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.0092139,0.072951,0.12648,1,1
4,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.037377,0.071667,0.16732,1,1
4,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.033245,0.071523,0.12977,1,1
4,GO REGULATION OF CELLULAR RESPIRATION,0.058535,0.068558,0.099202,1,1
4,GO VIRION ASSEMBLY,0.0096484,0.064163,0.11798,1,1
4,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,0.019548,0.36627,0.33427,1,0
4,GO REVERSE CHOLESTEROL TRANSPORT,0.038848,0.33478,0.2886,1,0
4,GO NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.033245,0.32084,0.29113,1,0
4,GO PROTEIN LOCALIZATION TO AXON,0.058535,0.31324,0.26741,1,0
4,GO PRESYNAPTIC MEMBRANE ORGANIZATION,0.026142,0.30852,0.34836,1,0
4,GO MICROTUBULE DEPOLYMERIZATION,0.020391,0.30124,0.29139,1,0
4,GO FOREBRAIN NEURON DEVELOPMENT,0.0080134,0.29213,0.2885,1,0
4,GO CELL JUNCTION DISASSEMBLY,0.043559,0.29205,0.30369,1,0
4,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.031957,0.2891,0.41613,1,0
4,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,0.050584,0.28812,0.30597,1,0
4,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.017954,0.28193,0.27583,1,0
4,GO POSITIVE REGULATION OF HAIR CYCLE,0.0036751,0.28169,0.34177,1,0
4,GO SKIN MORPHOGENESIS,0.034576,0.27546,0.28272,1,0
4,GO FACIAL NERVE MORPHOGENESIS,0.050584,0.2739,0.27174,1,0
4,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,0.058535,0.27216,0.35764,1,0
4,GO RESPONSE TO ACETYLCHOLINE,0.008797,0.26762,0.2949,1,0
4,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.028348,0.26584,0.24627,1,0
4,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.050584,0.25874,0.41912,1,0
4,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.046961,0.25839,0.21859,1,0
4,GO MAST CELL MEDIATED IMMUNITY,0.060677,0.25457,0.25009,1,0
4,GO RESPONSE TO LEUCINE,0.017954,0.25428,0.26785,1,0
4,GO 3 UTR MEDIATED MRNA DESTABILIZATION,0.022172,0.25413,0.25378,1,0
4,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.056456,0.25213,0.27122,1,0
4,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.0054671,0.25191,0.25996,1,0
4,GO METANEPHRIC GLOMERULUS DEVELOPMENT,0.045233,0.24846,0.302,1,0
4,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,0.0031545,0.24804,0.27398,1,0
4,GO REGULATION OF MACROPHAGE DIFFERENTIATION,0.040368,0.24754,0.256,1,0
4,GO REGULATION OF BONE DEVELOPMENT,0.033245,0.24692,0.26421,1,0
4,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.024086,0.24571,0.2617,1,0
4,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.033245,0.24371,0.23953,1,0
4,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,0.026142,0.2435,0.33337,1,0
4,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.024086,0.23957,0.26857,1,0
4,GO GAMMA DELTA T CELL DIFFERENTIATION,0.054439,0.23811,0.28431,1,0
4,GO PEPTIDE CROSS LINKING,0.028348,0.23485,0.28392,1,0
4,GO BEHAVIORAL RESPONSE TO COCAINE,0.041938,0.23175,0.21353,1,0
4,GO STORE OPERATED CALCIUM ENTRY,0.034576,0.22809,0.22537,1,0
4,GO PULMONARY VALVE DEVELOPMENT,0.046961,0.22724,0.26496,1,0
4,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,0.050584,0.22716,0.31112,1,0
4,GO CATECHOLAMINE UPTAKE,0.0042727,0.22385,0.33775,1,0
4,GO PHAGOLYSOSOME ASSEMBLY,0.011063,0.22352,0.30246,1,0
4,GO RESPONSE TO INTERLEUKIN 2,0.046961,0.22254,0.33266,1,0
4,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,0.011574,0.22118,0.26107,1,0
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.043559,0.22084,0.2451,1,0
4,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.058535,0.21874,0.26412,1,0
4,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.054439,0.21748,0.29752,1,0
4,GO AXONAL FASCICULATION,0.026142,0.21519,0.28644,1,0
4,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.048745,0.21389,0.20847,1,0
4,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.016475,0.21198,0.27657,1,0
4,GO BONE TRABECULA MORPHOGENESIS,0.058535,0.21101,0.33179,1,0
4,GO MRNA TRANSCRIPTION,0.010101,0.21055,0.24717,1,0
4,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.058535,0.20953,0.18727,1,0
4,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.040368,0.20839,0.26252,1,0
4,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,0.017954,0.20795,0.21813,1,0
4,GO TRABECULA MORPHOGENESIS,0.023112,0.20675,0.24332,1,0
4,GO MAMMARY GLAND DUCT MORPHOGENESIS,0.037377,0.20675,0.23997,1,0
4,GO RESPONSE TO COCAINE,0.0083971,0.20633,0.22789,1,0
4,GO EPIDERMIS DEVELOPMENT,0.012106,0.20605,0.1862,1,0
4,GO PULMONARY VALVE MORPHOGENESIS,0.041938,0.20358,0.25473,1,0
4,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.038848,0.20187,0.31163,1,0
4,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.054439,0.20153,0.24689,1,0
4,GO ACTIN FILAMENT BASED TRANSPORT,0.031957,0.20109,0.25294,1,0
4,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.015776,0.20072,0.25634,1,0
4,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.018736,0.2,0.20218,1,0
4,GO PEPTIDYL LYSINE DIMETHYLATION,0.019548,0.1982,0.22219,1,0
4,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.0057394,0.19789,0.25065,1,0
4,GO POSITIVE REGULATION OF BIOMINERALIZATION,0.012106,0.19776,0.22713,1,0
4,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.013834,0.19693,0.21731,1,0
4,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.035953,0.19662,0.22867,1,0
4,GO MOTOR NEURON AXON GUIDANCE,0.015776,0.19646,0.2462,1,0
4,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,0.02951,0.19428,0.22474,1,0
4,GO HEART VALVE DEVELOPMENT,0.016475,0.19191,0.2657,1,0
4,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.058535,0.1892,0.2145,1,0
4,GO SKIN DEVELOPMENT,0.0057394,0.1891,0.20542,1,0
4,GO GLIAL CELL MIGRATION,0.021265,0.18804,0.24116,1,0
4,GO MAMMARY GLAND MORPHOGENESIS,0.010101,0.188,0.27979,1,0
4,GO HISTONE H3 K9 METHYLATION,0.014457,0.18798,0.24601,1,0
4,GO SULFATION,0.038848,0.18776,0.21399,1,0
4,GO REGULATION OF HISTONE H3 K9 METHYLATION,0.026142,0.18764,0.19462,1,0
4,GO HISTONE H3 K9 MODIFICATION,0.0096484,0.18653,0.24028,1,0
4,GO CELL DIFFERENTIATION IN HINDBRAIN,0.017954,0.18615,0.2222,1,0
4,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.034576,0.18601,0.24963,1,0
4,GO NEGATIVE REGULATION OF LIPID TRANSPORT,0.0066311,0.18516,0.24075,1,0
4,GO POSITIVE REGULATION OF OSSIFICATION,0.017954,0.18281,0.22276,1,0
4,GO SERTOLI CELL DIFFERENTIATION,0.052482,0.18176,0.20531,1,0
4,GO REGULATION OF RECEPTOR RECYCLING,0.01266,0.18174,0.22754,1,0
4,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.060677,0.17873,0.16398,1,0
4,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.028348,0.17865,0.254,1,0
4,GO BONE MINERALIZATION,0.0172,0.17846,0.21183,1,0
4,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.018736,0.17737,0.20597,1,0
4,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.007293,0.17706,0.28027,1,0
4,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.058535,0.17682,0.17315,1,0
4,GO POSITIVE REGULATION OF VASOCONSTRICTION,0.02951,0.17669,0.23601,1,0
4,GO COLLAGEN BIOSYNTHETIC PROCESS,0.048745,0.17524,0.28919,1,0
4,GO ASTRAL MICROTUBULE ORGANIZATION,0.058535,0.17523,0.25651,1,0
4,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.033245,0.1751,0.19433,1,0
4,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.027226,0.17407,0.21153,1,0
4,GO HINDBRAIN MORPHOGENESIS,0.01266,0.17396,0.24203,1,0
4,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,0.037377,0.17378,0.22557,1,0
4,GO ACTIN FILAMENT DEPOLYMERIZATION,0.0034935,0.17364,0.25447,1,0
4,GO MEMBRANE LIPID CATABOLIC PROCESS,0.023112,0.17225,0.24496,1,0
4,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,0.020391,0.17176,0.21235,1,0
4,GO PLATELET AGGREGATION,0.040368,0.17095,0.24024,1,0
4,GO FOREBRAIN NEURON DIFFERENTIATION,0.0083971,0.16981,0.23709,1,0
4,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,0.024086,0.16921,0.24255,1,0
4,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.0038653,0.16903,0.24963,1,0
4,GO CEREBELLAR CORTEX FORMATION,0.008797,0.16885,0.2652,1,0
4,GO LIPID IMPORT INTO CELL,0.0029965,0.16802,0.232,1,0
4,GO BIOMINERALIZATION,0.013235,0.16714,0.21834,1,0
4,GO HISTONE H3 K4 TRIMETHYLATION,0.025096,0.16673,0.28509,1,0
4,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,0.050584,0.16646,0.19657,1,0
4,GO XENOBIOTIC TRANSPORT,0.02951,0.16609,0.23922,1,0
4,GO INTERFERON BETA PRODUCTION,0.045233,0.16442,0.21534,1,0
4,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.028348,0.16415,0.23014,1,0
4,GO FOREBRAIN DEVELOPMENT,0.0080134,0.16409,0.21408,1,0
4,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.041938,0.16395,0.17997,1,0
4,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.012106,0.16332,0.22495,1,0
4,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.030713,0.16048,0.20144,1,0
4,GO OLIGOSACCHARIDE CATABOLIC PROCESS,0.034576,0.15999,0.24099,1,0
4,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,0.016475,0.15957,0.27681,1,0
4,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.0066311,0.15865,0.22442,1,0
4,GO ENDOCARDIAL CUSHION FORMATION,0.0172,0.15855,0.22149,1,0
4,GO REPLACEMENT OSSIFICATION,0.058535,0.15822,0.21195,1,0
4,GO KERATINOCYTE DIFFERENTIATION,0.027226,0.15715,0.15224,1,0
4,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,0.023112,0.15713,0.205,1,0
4,GO PEPTIDYL LYSINE METHYLATION,0.013235,0.15708,0.22933,1,0
4,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.045233,0.15638,0.1816,1,0
4,GO PALLIUM DEVELOPMENT,0.023112,0.15537,0.18394,1,0
4,GO POSITIVE REGULATION OF FERTILIZATION,0.028348,0.15531,0.17407,1,0
4,GO RESPONSE TO VITAMIN,0.038848,0.15484,0.18334,1,0
4,GO REGULATION OF CIRCADIAN RHYTHM,0.0083971,0.15467,0.19156,1,0
4,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.014457,0.15463,0.19733,1,0
4,GO TYPE I INTERFERON PRODUCTION,0.033245,0.15429,0.19548,1,0
4,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.019548,0.1541,0.25313,1,0
4,GO PHOTORECEPTOR CELL MAINTENANCE,0.0083971,0.15362,0.24245,1,0
4,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,0.0060238,0.15347,0.18844,1,0
4,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,0.0042727,0.15274,0.25407,1,0
4,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.048745,0.15217,0.21869,1,0
4,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.040368,0.1517,0.2076,1,0
4,GO FATTY ACID DERIVATIVE TRANSPORT,0.056456,0.15121,0.16908,1,0
4,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,0.056456,0.15103,0.19723,1,0
4,GO RESPONSE TO RETINOIC ACID,0.030713,0.15066,0.19634,1,0
4,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.014457,0.14901,0.21883,1,0
4,GO TELENCEPHALON DEVELOPMENT,0.022172,0.1478,0.19238,1,0
4,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.017954,0.14765,0.20375,1,0
4,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.034576,0.14723,0.23377,1,0
4,GO EPITHELIAL CELL APOPTOTIC PROCESS,0.025096,0.14706,0.22321,1,0
4,GO CERAMIDE CATABOLIC PROCESS,0.022172,0.14681,0.24751,1,0
4,GO DNA METHYLATION,0.027226,0.14371,0.17968,1,0
4,GO SMOOTH MUSCLE CELL PROLIFERATION,0.052482,0.14366,0.1955,1,0
4,GO CELLULAR RESPONSE TO RETINOIC ACID,0.046961,0.1436,0.18155,1,0
4,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.034576,0.1433,0.15922,1,0
4,GO ANION HOMEOSTASIS,0.0080134,0.14316,0.20551,1,0
4,GO HISTONE H3 K9 TRIMETHYLATION,0.010101,0.14217,0.24738,1,0
4,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.045233,0.14201,0.20099,1,0
4,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.052482,0.14159,0.17052,1,0
4,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,0.048745,0.14144,0.22914,1,0
4,GO RESPONSE TO OXYGEN RADICAL,0.007293,0.1412,0.17291,1,0
4,GO ENDODERMAL CELL FATE COMMITMENT,0.030713,0.14079,0.18096,1,0
4,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,0.022172,0.14065,0.23255,1,0
4,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.045233,0.13999,0.19358,1,0
4,GO HOMOTYPIC CELL CELL ADHESION,0.052482,0.13984,0.20963,1,0
4,GO MICROTUBULE NUCLEATION,0.052482,0.13979,0.21142,1,0
4,GO ATP TRANSPORT,0.045233,0.13892,0.1377,1,0
4,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.014457,0.13876,0.20332,1,0
4,GO REGULATION OF RUFFLE ASSEMBLY,0.018736,0.13873,0.20739,1,0
4,GO SOMATIC STEM CELL POPULATION MAINTENANCE,0.0092139,0.13857,0.18666,1,0
4,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.023112,0.13687,0.1761,1,0
4,GO DNA MODIFICATION,0.0047188,0.13662,0.17513,1,0
4,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,0.0060238,0.13548,0.25455,1,0
4,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.02951,0.13458,0.21551,1,0
4,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.037377,0.13457,0.17551,1,0
4,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.040368,0.13378,0.24267,1,0
4,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.048745,0.13256,0.21241,1,0
4,GO ENAMEL MINERALIZATION,0.015776,0.13163,0.31659,1,0
4,GO FATTY ACID TRANSPORT,0.023112,0.13136,0.16783,1,0
4,GO HISTONE H2A UBIQUITINATION,0.054439,0.13114,0.15409,1,0
4,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,0.038848,0.13107,0.20869,1,0
4,GO REGULATION OF BONE MINERALIZATION,0.037377,0.13085,0.2269,1,0
4,GO RIG I SIGNALING PATHWAY,0.041938,0.12898,0.17059,1,0
4,GO AMYLOID BETA FORMATION,0.027226,0.12882,0.20053,1,0
4,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.022172,0.12819,0.21245,1,0
4,GO ERYTHROCYTE HOMEOSTASIS,0.023112,0.1279,0.17051,1,0
4,GO GLUTATHIONE METABOLIC PROCESS,0.023112,0.12682,0.15016,1,0
4,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.060677,0.12674,0.16527,1,0
4,GO RUFFLE ORGANIZATION,0.060677,0.12592,0.19267,1,0
4,GO AMELOGENESIS,0.010101,0.12528,0.22551,1,0
4,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.052482,0.12511,0.17204,1,0
4,GO RESPONSE TO AMINO ACID STARVATION,0.0057394,0.12489,0.18675,1,0
4,GO METHIONINE METABOLIC PROCESS,0.046961,0.12475,0.15667,1,0
4,GO NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.021265,0.1245,0.21321,1,0
4,GO METHIONINE BIOSYNTHETIC PROCESS,0.037377,0.12109,0.1385,1,0
4,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.056456,0.12083,0.17145,1,0
4,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.017954,0.12064,0.20772,1,0
4,GO REGULATION OF BIOMINERALIZATION,0.035953,0.11975,0.21515,1,0
4,GO AUTOPHAGOSOME MATURATION,0.0076456,0.11908,0.24155,1,0
4,GO CELLULAR IRON ION HOMEOSTASIS,0.056456,0.11854,0.1524,1,0
4,GO REGULATION OF OSSIFICATION,0.028348,0.11853,0.21307,1,0
4,GO LINOLEIC ACID METABOLIC PROCESS,0.019548,0.11785,0.2171,1,0
4,GO REGULATION OF BEHAVIOR,0.033245,0.11784,0.15721,1,0
4,GO TRANSITION METAL ION TRANSPORT,0.0010209,0.11778,0.18847,1,0
4,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,0.046961,0.11732,0.18497,1,0
4,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,0.041938,0.11702,0.1359,1,0
4,GO TRANSPOSITION,0.045233,0.11647,0.13758,1,0
4,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.050584,0.11562,0.18009,1,0
4,GO RESPONSE TO CORTICOSTEROID,0.056456,0.11468,0.15045,1,0
4,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.034576,0.11443,0.1335,1,0
4,GO NADP METABOLIC PROCESS,0.056456,0.11409,0.12455,1,0
4,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.027226,0.11305,0.15023,1,0
4,GO RESPONSE TO KETONE,0.043559,0.11297,0.16724,1,0
4,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.043559,0.11275,0.14904,1,0
4,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,0.027226,0.11243,0.14288,1,0
4,GO NEURAL PRECURSOR CELL PROLIFERATION,0.025096,0.11207,0.19207,1,0
4,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.030713,0.11199,0.17536,1,0
4,GO REGULATION OF PROTEIN SUMOYLATION,0.024086,0.11078,0.21404,1,0
4,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.056456,0.10992,0.17022,1,0
4,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.060677,0.10975,0.16297,1,0
4,GO CELLULAR RESPONSE TO CAMP,0.027226,0.10865,0.17365,1,0
4,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.054439,0.10804,0.13531,1,0
4,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.025096,0.10752,0.20487,1,0
4,GO REGULATION OF LIPID LOCALIZATION,0.02951,0.1066,0.18441,1,0
4,GO MAINTENANCE OF CELL NUMBER,0.022172,0.10599,0.17247,1,0
4,GO DNA METHYLATION OR DEMETHYLATION,0.011063,0.10576,0.1753,1,0
4,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.045233,0.10472,0.20822,1,0
4,GO REGULATION OF LIPID TRANSPORT,0.058535,0.10343,0.16421,1,0
4,GO MYELOID CELL HOMEOSTASIS,0.038848,0.10304,0.16275,1,0
4,GO CARDIOLIPIN METABOLIC PROCESS,0.058535,0.10244,0.11793,1,0
4,GO VIRAL LIFE CYCLE,0.060677,0.102,0.15323,1,0
4,GO RUFFLE ASSEMBLY,0.030713,0.1008,0.198,1,0
4,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.014457,0.10014,0.13739,1,0
4,GO PROTEIN AUTOPROCESSING,0.054439,0.10013,0.18644,1,0
4,GO RHYTHMIC BEHAVIOR,0.01266,0.10011,0.20665,1,0
4,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,0.024086,0.099705,0.21904,1,0
4,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.033245,0.097915,0.1143,1,0
4,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.034576,0.097198,0.19916,1,0
4,GO INTRACELLULAR LIPID TRANSPORT,0.058535,0.09714,0.17045,1,0
4,GO CELLULAR COPPER ION HOMEOSTASIS,0.060677,0.096596,0.15964,1,0
4,GO HIPPOCAMPUS DEVELOPMENT,0.052482,0.093354,0.15383,1,0
4,GO RESPONSE TO TOXIC SUBSTANCE,0.010572,0.091065,0.14738,1,0
4,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.021265,0.090715,0.16803,1,0
4,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.054439,0.086849,0.19385,1,0
4,GO AGING,0.027226,0.085304,0.16078,1,0
4,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.014457,0.080859,0.19744,1,0
4,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.052482,0.080508,0.17379,1,0
4,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,0.034576,0.0786,0.16458,1,0
4,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.010572,0.076842,0.15456,1,0
4,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.037377,0.074489,0.17169,1,0
4,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.048745,0.074192,0.13785,1,0
4,GO EXTRACELLULAR VESICLE BIOGENESIS,0.060677,0.073882,0.15217,1,0
4,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.060677,0.073708,0.13186,1,0
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.012106,0.071723,0.14302,1,0
4,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.058535,0.069569,0.14772,1,0
4,GO REGULATION OF VIRAL TRANSCRIPTION,0.041938,0.068947,0.12021,1,0
4,GO PROTEIN LOCALIZATION TO ORGANELLE,0.054439,0.05931,0.1102,1,0
4,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.056456,0.058916,0.15662,1,0
4,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.028348,-0.078606,-0.097082,1,0
4,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.043559,-0.12953,-0.12292,1,0
4,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.060677,-0.13752,-0.085622,1,0
4,GO CHROMATIN REMODELING AT CENTROMERE,0.041938,-0.19269,-0.2053,1,0
4,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.058535,-0.21272,-0.17544,1,0
4,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.0049572,-0.21857,-0.16588,1,0
4,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.0027019,-0.23398,-0.22294,1,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.0015882,-0.30958,-0.25957,1,0
4,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.00091199,-0.33661,-0.31663,1,0
4,GO OPSONIZATION,0.15655,0.47756,0.19541,0,1
4,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,0.08881,0.40663,0.30599,0,1
4,GO NK T CELL DIFFERENTIATION,0.10811,0.39129,0.25634,0,1
4,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.077559,0.34532,0.24377,0,1
4,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,0.065157,0.31346,0.30005,0,1
4,GO REGULATION OF MYOBLAST FUSION,0.067497,0.29027,0.27382,0,1
4,GO CELLULAR RESPONSE TO ETHANOL,0.11894,0.28999,0.2398,0,1
4,GO TRABECULA FORMATION,0.11894,0.27438,0.18611,0,1
4,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.08303,0.27338,0.19286,0,1
4,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,0.44264,0.27275,0.10183,0,1
4,GO T CELL LINEAGE COMMITMENT,0.08303,0.26984,0.25004,0,1
4,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.098083,0.26161,0.17588,0,1
4,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,0.11894,0.25435,0.20409,0,1
4,GO XENOBIOTIC CATABOLIC PROCESS,0.12662,0.25353,0.17176,0,1
4,GO IMMUNOLOGICAL MEMORY PROCESS,0.10468,0.25094,0.19954,0,1
4,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.077559,0.24233,0.19152,0,1
4,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.11524,0.23088,0.18334,0,1
4,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,0.08588,0.23009,0.17631,0,1
4,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.067497,0.22922,0.19178,0,1
4,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,0.074935,0.22908,0.27171,0,1
4,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.197,0.22838,0.19349,0,1
4,GO B CELL HOMEOSTASIS,0.094909,0.22826,0.19054,0,1
4,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.16123,0.22793,0.17362,0,1
4,GO LYSINE METABOLIC PROCESS,0.065157,0.22627,0.15808,0,1
4,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.080256,0.22221,0.18466,0,1
4,GO MATING BEHAVIOR,0.062884,0.22083,0.18411,0,1
4,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,0.072385,0.21964,0.18484,0,1
4,GO POSITIVE REGULATION OF BEHAVIOR,0.062884,0.21637,0.17921,0,1
4,GO CELL DIFFERENTIATION IN SPINAL CORD,0.08303,0.21574,0.16227,0,1
4,GO REGULATION OF FIBRINOLYSIS,0.065157,0.21261,0.22501,0,1
4,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.15197,0.20697,0.17735,0,1
4,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,0.18624,0.20653,0.12619,0,1
4,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.1306,0.20616,0.18511,0,1
4,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.062884,0.20509,0.23025,0,1
4,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.098083,0.19981,0.2108,0,1
4,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.17091,0.19942,0.16751,0,1
4,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,0.10134,0.19247,0.2054,0,1
4,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,0.11163,0.19247,0.14251,0,1
4,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,0.069906,0.18738,0.20052,0,1
4,GO CELLULAR RESPONSE TO VITAMIN D,0.11524,0.18715,0.17695,0,1
4,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.08881,0.18714,0.20001,0,1
4,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.072385,0.18681,0.18326,0,1
4,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,0.10468,0.18656,0.1516,0,1
4,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,0.15655,0.18387,0.17326,0,1
4,GO POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION,0.10468,0.18376,0.16931,0,1
4,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,0.11894,0.18266,0.16047,0,1
4,GO REGULATION OF GASTRIC ACID SECRETION,0.1306,0.18207,0.12598,0,1
4,GO REGULATION OF CHEMOTAXIS,0.1306,0.18053,0.1767,0,1
4,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,0.14312,0.17762,0.15622,0,1
4,GO PROTEIN HETEROTETRAMERIZATION,0.074935,0.17657,0.1441,0,1
4,GO POSITIVE CHEMOTAXIS,0.10468,0.17604,0.16326,0,1
4,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.065157,0.1753,0.21096,0,1
4,GO OSTEOBLAST DEVELOPMENT,0.13467,0.1749,0.15886,0,1
4,GO RENAL VESICLE DEVELOPMENT,0.12273,0.17488,0.17057,0,1
4,GO ACYLGLYCEROL HOMEOSTASIS,0.18102,0.17374,0.11712,0,1
4,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.065157,0.17184,0.17688,0,1
4,GO REGULATION OF CALCIUM ION IMPORT,0.067497,0.16923,0.18451,0,1
4,GO MIDDLE EAR MORPHOGENESIS,0.214,0.1667,0.10433,0,1
4,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.08588,0.1648,0.1983,0,1
4,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,0.14312,0.16434,0.17932,0,1
4,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.072385,0.16412,0.1867,0,1
4,GO NEGATIVE REGULATION OF CHEMOTAXIS,0.08303,0.16265,0.20661,0,1
4,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,0.098083,0.16235,0.17526,0,1
4,GO P BODY ASSEMBLY,0.08303,0.1615,0.18262,0,1
4,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.080256,0.15848,0.1648,0,1
4,GO RESPONSE TO FOOD,0.067497,0.15831,0.15885,0,1
4,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.10468,0.1557,0.18853,0,1
4,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.080256,0.15557,0.17672,0,1
4,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.10134,0.15505,0.14574,0,1
4,GO DNA DEAMINATION,0.20822,0.15243,0.11791,0,1
4,GO MYOBLAST DIFFERENTIATION,0.11163,0.15174,0.14669,0,1
4,GO PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS,0.197,0.15026,0.13101,0,1
4,GO RENAL ABSORPTION,0.1475,0.1443,0.17879,0,1
4,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.12273,0.13854,0.12785,0,1
4,GO CORPUS CALLOSUM DEVELOPMENT,0.14312,0.13479,0.17661,0,1
4,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.08881,0.13461,0.1362,0,1
4,GO REGULATION OF FEEDING BEHAVIOR,0.062884,0.13367,0.14729,0,1
4,GO MITOTIC RECOMBINATION,0.23203,0.13314,0.11546,0,1
4,GO L ASCORBIC ACID METABOLIC PROCESS,0.11524,0.13057,0.1155,0,1
4,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.077559,0.13037,0.20469,0,1
4,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,0.077559,0.12936,0.15477,0,1
4,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.21989,0.12833,0.087587,0,1
4,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.27821,0.12629,0.14139,0,1
4,GO HISTONE UBIQUITINATION,0.08303,0.12552,0.1526,0,1
4,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.067497,0.12477,0.15221,0,1
4,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.074935,0.12417,0.17883,0,1
4,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,0.14312,0.12368,0.14881,0,1
4,GO HISTONE MONOUBIQUITINATION,0.062884,0.12363,0.15146,0,1
4,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,0.15197,0.12359,0.11789,0,1
4,GO ER NUCLEUS SIGNALING PATHWAY,0.074935,0.12221,0.13173,0,1
4,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.10134,0.12082,0.099574,0,1
4,GO QUINONE METABOLIC PROCESS,0.10468,0.12055,0.071214,0,1
4,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,0.069906,0.11996,0.14842,0,1
4,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.15655,0.11948,0.15497,0,1
4,GO REGULATION OF TELOMERE MAINTENANCE,0.1306,0.11749,0.13382,0,1
4,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,0.08303,0.11717,0.16358,0,1
4,GO SKELETAL MUSCLE CELL DIFFERENTIATION,0.11894,0.11708,0.12838,0,1
4,GO STRESS GRANULE ASSEMBLY,0.08303,0.11423,0.16139,0,1
4,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.080256,0.11347,0.20735,0,1
4,GO POSITIVE REGULATION OF MRNA PROCESSING,0.35442,0.11336,0.080558,0,1
4,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.11163,0.11238,0.12831,0,1
4,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,0.39705,0.11154,0.086281,0,1
4,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.091819,0.11139,0.10892,0,1
4,GO HEME METABOLIC PROCESS,0.098083,0.10953,0.099926,0,1
4,GO TRANSITION METAL ION HOMEOSTASIS,0.067497,0.10867,0.12406,0,1
4,GO FATTY ACID BIOSYNTHETIC PROCESS,0.08303,0.10656,0.10953,0,1
4,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.077559,0.10654,0.12266,0,1
4,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.12273,0.10095,0.17786,0,1
4,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.16602,0.10086,0.13566,0,1
4,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.33029,0.10082,0.063477,0,1
4,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.11894,0.099969,0.12389,0,1
4,GO HISTONE H2A ACETYLATION,0.067497,0.0996,0.18001,0,1
4,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.20256,0.099205,0.10369,0,1
4,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.20256,0.098559,0.078307,0,1
4,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.18624,0.098391,0.11337,0,1
4,GO NEGATIVE REGULATION OF DNA REPAIR,0.08881,0.097954,0.13519,0,1
4,GO REGULATION OF ATPASE ACTIVITY,0.067497,0.096183,0.097139,0,1
4,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.065157,0.092935,0.1061,0,1
4,GO MRNA 3 END PROCESSING,0.20822,0.090661,0.10384,0,1
4,GO REGULATION OF DNA CATABOLIC PROCESS,0.08303,0.09039,0.12586,0,1
4,GO MYELOID CELL DIFFERENTIATION,0.072385,0.089725,0.1695,0,1
4,GO NCRNA TRANSCRIPTION,0.14312,0.089298,0.10799,0,1
4,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.094909,0.089167,0.1261,0,1
4,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.10134,0.089047,0.12807,0,1
4,GO UBIQUINONE METABOLIC PROCESS,0.072385,0.088807,0.098783,0,1
4,GO CHAPERONE MEDIATED PROTEIN FOLDING,0.080256,0.086866,0.109,0,1
4,GO RRNA TRANSCRIPTION,0.08303,0.085803,0.14095,0,1
4,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.36271,0.084397,0.10878,0,1
4,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.17091,0.08411,0.077525,0,1
4,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.11163,0.082601,0.11236,0,1
4,GO BINDING OF SPERM TO ZONA PELLUCIDA,0.077559,0.079953,0.08443,0,1
4,GO REGULATION OF TRANSLATIONAL FIDELITY,0.21989,0.078213,0.093525,0,1
4,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.2259,0.077666,0.098069,0,1
4,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,0.13885,0.077192,0.171,0,1
4,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.11524,0.077098,0.11975,0,1
4,GO PIRNA METABOLIC PROCESS,0.41494,0.074453,0.062782,0,1
4,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,0.18624,0.072252,0.10342,0,1
4,GO MITOCHONDRIAL PROTEIN PROCESSING,0.25111,0.068735,0.10014,0,1
4,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,0.08588,0.068445,0.1567,0,1
4,GO PENTOSE METABOLIC PROCESS,0.51122,0.067438,0.030611,0,1
4,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.10134,0.062189,0.1097,0,1
4,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,0.12273,0.059959,0.090911,0,1
4,GO AMINO ACID ACTIVATION,0.35442,0.05168,0.059452,0,1
4,GO SNORNA 3 END PROCESSING,0.2577,0.049679,0.082385,0,1
4,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.32248,0.049378,0.067926,0,1
4,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.2998,0.43415,0.22938,0,0
4,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,0.16123,0.4219,0.3049,0,0
4,GO COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY,0.11894,0.38421,0.31701,0,0
4,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.1306,0.38297,0.31578,0,0
4,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.007293,0.38273,0.36942,0,0
4,GO RESPONSE TO TYPE I INTERFERON,0.08303,0.37149,0.25875,0,0
4,GO MAINTENANCE OF SYNAPSE STRUCTURE,0.021265,0.36436,0.35318,0,0
4,GO POSITIVE REGULATION OF REGULATORY T CELL DIFFERENTIATION,0.17591,0.36113,0.24171,0,0
4,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,0.0012071,0.34803,0.41409,0,0
4,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.25111,0.34674,0.19967,0,0
4,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.197,0.34387,0.21978,0,0
4,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.094909,0.34303,0.23825,0,0
4,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.12273,0.33639,0.23977,0,0
4,GO INNERVATION,0.013834,0.33517,0.34256,0,0
4,GO SYNAPSE PRUNING,0.21989,0.33084,0.27291,0,0
4,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,0.17591,0.33029,0.26331,0,0
4,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,0.27126,0.32923,0.16478,0,0
4,GO NEGATIVE REGULATION OF CELL KILLING,0.27821,0.32718,0.20708,0,0
4,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.3148,0.327,0.21821,0,0
4,GO GLYCINE TRANSPORT,0.067497,0.3258,0.21231,0,0
4,GO SPHINGOLIPID MEDIATED SIGNALING PATHWAY,0.0024341,0.32484,0.40825,0,0
4,GO REGULATION OF RECEPTOR CLUSTERING,0.017954,0.3229,0.29818,0,0
4,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.00042807,0.31777,0.34696,0,0
4,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,0.02951,0.31625,0.3152,0,0
4,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,0.1306,0.31566,0.30792,0,0
4,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,0.27126,0.31504,0.17836,0,0
4,GO HEMIDESMOSOME ASSEMBLY,0.077559,0.31434,0.25991,0,0
4,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.18624,0.31351,0.22788,0,0
4,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.00040321,0.31296,0.44192,0,0
4,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.08881,0.31159,0.24162,0,0
4,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,0.0057394,0.31138,0.32054,0,0
4,GO RETINAL GANGLION CELL AXON GUIDANCE,0.0023095,0.31101,0.33305,0,0
4,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,0.0092139,0.30917,0.27683,0,0
4,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,0.0036751,0.30912,0.39744,0,0
4,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.11894,0.30876,0.2821,0,0
4,GO SECONDARY HEART FIELD SPECIFICATION,0.0015882,0.3082,0.40486,0,0
4,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,0.2259,0.30805,0.23497,0,0
4,GO T HELPER CELL LINEAGE COMMITMENT,0.17591,0.30441,0.24431,0,0
4,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.2998,0.30138,0.18119,0,0
4,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.15197,0.30046,0.23594,0,0
4,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.12662,0.29916,0.22678,0,0
4,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,0.197,0.29894,0.22263,0,0
4,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.18624,0.29576,0.19924,0,0
4,GO REGULATION OF T CELL TOLERANCE INDUCTION,0.20822,0.2945,0.33301,0,0
4,GO REGULATION OF HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.069906,0.29361,0.26745,0,0
4,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.20822,0.29319,0.19407,0,0
4,GO CARDIAC VENTRICLE FORMATION,0.13885,0.29315,0.16495,0,0
4,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.214,0.29173,0.15277,0,0
4,GO PIGMENT ACCUMULATION,0.008797,0.29166,0.26717,0,0
4,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.00048214,0.28854,0.42651,0,0
4,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,0.19156,0.28831,0.1978,0,0
4,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,0.020391,0.28807,0.29431,0,0
4,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.0025648,0.28677,0.40251,0,0
4,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.094909,0.28611,0.21932,0,0
4,GO COMPLEMENT ACTIVATION,0.21989,0.28435,0.18975,0,0
4,GO NEUTROPHIL EXTRAVASATION,0.1475,0.28195,0.23153,0,0
4,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,0.10134,0.28023,0.23699,0,0
4,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.08303,0.28009,0.23228,0,0
4,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.0060238,0.27966,0.32023,0,0
4,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.08303,0.27966,0.24426,0,0
4,GO CORTICOSTEROID HORMONE SECRETION,0.11163,0.27881,0.17761,0,0
4,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,0.197,0.27702,0.1496,0,0
4,GO REGULATION OF NEUTROPHIL MIGRATION,0.2577,0.27676,0.1662,0,0
4,GO HISTONE H3 K27 METHYLATION,0.010101,0.27529,0.34194,0,0
4,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,0.028348,0.27475,0.25617,0,0
4,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,0.098083,0.27426,0.21673,0,0
4,GO REGULATION OF TOLERANCE INDUCTION,0.24463,0.27211,0.24607,0,0
4,GO POSITIVE THYMIC T CELL SELECTION,0.2577,0.27202,0.25273,0,0
4,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.12662,0.27184,0.23563,0,0
4,GO POSITIVE REGULATION OF AMINE TRANSPORT,0.0052065,0.27139,0.31849,0,0
4,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.19156,0.27113,0.18254,0,0
4,GO REGULATION OF CELLULAR EXTRAVASATION,0.16602,0.27051,0.20151,0,0
4,GO REGULATION OF HUMORAL IMMUNE RESPONSE,0.20256,0.26935,0.20413,0,0
4,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,0.33821,0.26876,0.12916,0,0
4,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,0.00091199,0.26767,0.30489,0,0
4,GO HEART FIELD SPECIFICATION,0.0013481,0.26561,0.32788,0,0
4,GO PROTEIN PALMITOYLATION,0.00086166,0.26461,0.28189,0,0
4,GO HYPERSENSITIVITY,0.33821,0.26458,0.1797,0,0
4,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,0.0021907,0.26361,0.27985,0,0
4,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0057394,0.26247,0.2864,0,0
4,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.17591,0.26193,0.18806,0,0
4,GO DENDRITIC CELL APOPTOTIC PROCESS,0.44264,0.26169,0.16044,0,0
4,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.031957,0.2606,0.2698,0,0
4,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,0.27821,0.25981,0.16355,0,0
4,GO THYMOCYTE APOPTOTIC PROCESS,0.08881,0.2596,0.17101,0,0
4,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.214,0.25956,0.15493,0,0
4,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.10811,0.25843,0.20442,0,0
4,GO DETECTION OF OTHER ORGANISM,0.11163,0.25828,0.25433,0,0
4,GO REGULATION OF B CELL MEDIATED IMMUNITY,0.069906,0.25687,0.22303,0,0
4,GO NEUROTRANSMITTER METABOLIC PROCESS,0.00064645,0.25671,0.36747,0,0
4,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,0.12662,0.25664,0.26567,0,0
4,GO EPIDERMIS MORPHOGENESIS,0.0052065,0.25605,0.28947,0,0
4,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.025096,0.25574,0.27835,0,0
4,GO HEART INDUCTION,0.014457,0.25493,0.2622,0,0
4,GO GERMINAL CENTER FORMATION,0.080256,0.2538,0.26713,0,0
4,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,0.031957,0.25365,0.23586,0,0
4,GO COLLAGEN FIBRIL ORGANIZATION,0.025096,0.2535,0.35298,0,0
4,GO SEROTONIN TRANSPORT,0.020391,0.2527,0.24199,0,0
4,GO HYPEROSMOTIC RESPONSE,0.00332,0.25211,0.29081,0,0
4,GO INTERLEUKIN 4 PRODUCTION,0.16123,0.25009,0.22102,0,0
4,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.20256,0.24997,0.19894,0,0
4,GO POSITIVE T CELL SELECTION,0.17591,0.24891,0.2456,0,0
4,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.08588,0.24889,0.17391,0,0
4,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.0025648,0.2482,0.36112,0,0
4,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,0.0057394,0.24759,0.30001,0,0
4,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.12662,0.24715,0.19669,0,0
4,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.0012071,0.24532,0.30017,0,0
4,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.094909,0.24527,0.24402,0,0
4,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.11524,0.24376,0.19191,0,0
4,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,0.012106,0.24364,0.26632,0,0
4,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.27126,0.2418,0.15663,0,0
4,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.072385,0.24096,0.2027,0,0
4,GO MITRAL VALVE DEVELOPMENT,0.077559,0.23942,0.22555,0,0
4,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,0.2577,0.23725,0.22841,0,0
4,GO MEMBRANE RAFT ORGANIZATION,0.094909,0.23621,0.22407,0,0
4,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,0.0080134,0.23608,0.28657,0,0
4,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,0.17091,0.23579,0.18418,0,0
4,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.1475,0.23492,0.24241,0,0
4,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.15197,0.23457,0.1691,0,0
4,GO SPHINGOSINE 1 PHOSPHATE RECEPTOR SIGNALING PATHWAY,0.0034935,0.23422,0.3499,0,0
4,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,0.012106,0.2338,0.24395,0,0
4,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,0.11894,0.23361,0.21036,0,0
4,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.17091,0.23332,0.18432,0,0
4,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.12273,0.23316,0.20042,0,0
4,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,0.072385,0.23282,0.194,0,0
4,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.17591,0.23281,0.17984,0,0
4,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.21989,0.2328,0.249,0,0
4,GO ACTIN FILAMENT NETWORK FORMATION,0.0036751,0.23255,0.30471,0,0
4,GO DETECTION OF BIOTIC STIMULUS,0.23203,0.23192,0.16255,0,0
4,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.10811,0.2315,0.27168,0,0
4,GO ENDOCARDIAL CUSHION DEVELOPMENT,0.013834,0.23121,0.22987,0,0
4,GO RESPONSE TO INTERLEUKIN 6,0.069906,0.23071,0.24094,0,0
4,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.031957,0.22946,0.27508,0,0
4,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,0.1475,0.2294,0.19299,0,0
4,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,0.0023095,0.22924,0.2873,0,0
4,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.29248,0.22846,0.15879,0,0
4,GO LIMB BUD FORMATION,0.34626,0.22829,0.1247,0,0
4,GO POLYOL TRANSPORT,0.060677,0.22756,0.21216,0,0
4,GO REGULATION OF PLATELET ACTIVATION,0.080256,0.22699,0.23988,0,0
4,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.094909,0.22683,0.21373,0,0
4,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.08881,0.22671,0.26197,0,0
4,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,0.011574,0.22631,0.25103,0,0
4,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.013235,0.22598,0.33767,0,0
4,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.0080134,0.22574,0.27516,0,0
4,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.10134,0.22552,0.22048,0,0
4,GO REGULATION OF T CELL MEDIATED IMMUNITY,0.18624,0.22535,0.17033,0,0
4,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,0.13885,0.22504,0.24287,0,0
4,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.17091,0.22467,0.18489,0,0
4,GO REGULATION OF MEMBRANE REPOLARIZATION,0.0014241,0.22433,0.36047,0,0
4,GO POSITIVE REGULATION OF NEURON MIGRATION,0.094909,0.22427,0.26058,0,0
4,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.14312,0.22334,0.18531,0,0
4,GO REGULATION OF T CELL MIGRATION,0.16602,0.22254,0.18927,0,0
4,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.074935,0.22251,0.23025,0,0
4,GO RESPONSE TO PROSTAGLANDIN E,0.3148,0.22243,0.14453,0,0
4,GO CHLORIDE ION HOMEOSTASIS,0.0038653,0.22211,0.27659,0,0
4,GO CELLULAR COMPONENT MAINTENANCE,0.0016767,0.22203,0.27991,0,0
4,GO PLASMINOGEN ACTIVATION,0.08303,0.22196,0.18313,0,0
4,GO CHEMOKINE BIOSYNTHETIC PROCESS,0.36271,0.22155,0.11231,0,0
4,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,0.060677,0.22147,0.3423,0,0
4,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.062884,0.22143,0.20937,0,0
4,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,0.0047188,0.22121,0.26887,0,0
4,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,0.0038653,0.22098,0.35982,0,0
4,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,0.0014241,0.22059,0.35184,0,0
4,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,0.19156,0.22041,0.20803,0,0
4,GO OPTIC NERVE DEVELOPMENT,0.08303,0.22011,0.21899,0,0
4,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.18102,0.21953,0.18084,0,0
4,GO DETECTION OF TEMPERATURE STIMULUS,0.025096,0.21951,0.24857,0,0
4,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.1475,0.21937,0.2302,0,0
4,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,0.11894,0.21933,0.22026,0,0
4,GO ENDOCARDIAL CUSHION MORPHOGENESIS,0.022172,0.21827,0.22352,0,0
4,GO GLIAL CELL ACTIVATION,0.18624,0.21825,0.189,0,0
4,GO SUBPALLIUM DEVELOPMENT,0.014457,0.21822,0.25139,0,0
4,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.35442,0.21795,0.15689,0,0
4,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.15655,0.21768,0.20048,0,0
4,GO NEGATIVE REGULATION OF TISSUE REMODELING,0.25111,0.21687,0.20632,0,0
4,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,0.030713,0.21677,0.28041,0,0
4,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.30724,0.21672,0.187,0,0
4,GO T CELL MEDIATED IMMUNITY,0.20256,0.21658,0.16172,0,0
4,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,0.038848,0.21646,0.35637,0,0
4,GO LYMPHOCYTE COSTIMULATION,0.15197,0.21623,0.18839,0,0
4,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.10811,0.21562,0.19537,0,0
4,GO CELL ADHESION MEDIATED BY INTEGRIN,0.074935,0.21514,0.26866,0,0
4,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.10134,0.21471,0.18851,0,0
4,GO PHARYNGEAL SYSTEM DEVELOPMENT,0.0029965,0.21445,0.23845,0,0
4,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,0.2998,0.21424,0.16759,0,0
4,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,0.56341,0.21397,0.16973,0,0
4,GO T CELL TOLERANCE INDUCTION,0.2259,0.21386,0.28053,0,0
4,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,0.008797,0.21374,0.35427,0,0
4,GO DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION,0.72171,0.21341,0.1086,0,0
4,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,0.01266,0.21321,0.27305,0,0
4,GO METANEPHRIC NEPHRON DEVELOPMENT,0.072385,0.21285,0.21426,0,0
4,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.015776,0.21223,0.25571,0,0
4,GO RESPONSE TO PROTOZOAN,0.27126,0.21222,0.18836,0,0
4,GO MACROPHAGE CHEMOTAXIS,0.12662,0.21172,0.21102,0,0
4,GO OUTFLOW TRACT MORPHOGENESIS,0.0083971,0.21162,0.23386,0,0
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.18102,0.2115,0.18219,0,0
4,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.10468,0.2115,0.20417,0,0
4,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,0.1475,0.2114,0.17334,0,0
4,GO STEROID HORMONE SECRETION,0.058535,0.21126,0.1806,0,0
4,GO CELLULAR RESPONSE TO VITAMIN,0.077559,0.21116,0.19582,0,0
4,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.11163,0.21099,0.1718,0,0
4,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS,0.025096,0.21078,0.3292,0,0
4,GO APOPTOTIC CELL CLEARANCE,0.10811,0.21043,0.22889,0,0
4,GO MATURE B CELL DIFFERENTIATION,0.2259,0.21036,0.18878,0,0
4,GO RESPONSE TO INTERFERON ALPHA,0.11894,0.20983,0.23598,0,0
4,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.25111,0.2097,0.19052,0,0
4,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.41494,0.20955,0.12533,0,0
4,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.007293,0.20926,0.25633,0,0
4,GO TOLERANCE INDUCTION,0.32248,0.20903,0.19285,0,0
4,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.10811,0.20872,0.2104,0,0
4,GO NEUROINFLAMMATORY RESPONSE,0.21989,0.20858,0.17718,0,0
4,GO FIBRINOLYSIS,0.12273,0.20856,0.19885,0,0
4,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.0052065,0.20812,0.23851,0,0
4,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.031957,0.20788,0.19669,0,0
4,GO CYTIDINE TO URIDINE EDITING,0.26442,0.20739,0.1494,0,0
4,GO ETHANOL CATABOLIC PROCESS,0.18624,0.20738,0.10947,0,0
4,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.020391,0.20716,0.23459,0,0
4,GO ANTIBACTERIAL HUMORAL RESPONSE,0.08588,0.20686,0.2411,0,0
4,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.11163,0.20686,0.20009,0,0
4,GO REGULATION OF COAGULATION,0.062884,0.20646,0.21747,0,0
4,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.0021907,0.20619,0.26873,0,0
4,GO ALPHA BETA T CELL PROLIFERATION,0.27821,0.20619,0.18714,0,0
4,GO REGULATION OF WATER LOSS VIA SKIN,0.007293,0.20597,0.2142,0,0
4,GO REGULATION OF PHAGOCYTOSIS,0.20822,0.20554,0.16101,0,0
4,GO REGULATORY T CELL DIFFERENTIATION,0.1306,0.20547,0.2361,0,0
4,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,0.10468,0.20459,0.16844,0,0
4,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.16602,0.20323,0.17697,0,0
4,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.022172,0.2032,0.22144,0,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.32248,0.2031,0.11683,0,0
4,GO BRONCHUS DEVELOPMENT,0.069906,0.20298,0.23686,0,0
4,GO BASIC AMINO ACID TRANSPORT,0.10468,0.20294,0.19976,0,0
4,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.12662,0.20287,0.27958,0,0
4,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.20822,0.20275,0.17474,0,0
4,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,0.098083,0.20268,0.19608,0,0
4,GO REGULATION OF CARTILAGE DEVELOPMENT,0.0080134,0.2022,0.26479,0,0
4,GO T CELL CYTOKINE PRODUCTION,0.17591,0.20118,0.17869,0,0
4,GO FOREBRAIN CELL MIGRATION,0.0047188,0.20063,0.25385,0,0
4,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.23203,0.20042,0.13714,0,0
4,GO POST ANAL TAIL MORPHOGENESIS,0.008797,0.2001,0.26697,0,0
4,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.056456,0.20006,0.25629,0,0
4,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,0.013834,0.19929,0.26325,0,0
4,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,0.0172,0.19922,0.20549,0,0
4,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.00042807,0.19899,0.34601,0,0
4,GO RESPIRATORY BURST,0.23827,0.19824,0.16981,0,0
4,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.17091,0.19744,0.16076,0,0
4,GO RESPONSE TO PEPTIDOGLYCAN,0.37964,0.19699,0.1186,0,0
4,GO POSITIVE REGULATION OF IMMUNE RESPONSE,0.1475,0.19683,0.15911,0,0
4,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.1306,0.19654,0.18333,0,0
4,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.214,0.19616,0.18785,0,0
4,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.074935,0.196,0.1962,0,0
4,GO NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.17091,0.1953,0.23108,0,0
4,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.0028457,0.19503,0.33475,0,0
4,GO REGULATION OF PLASMINOGEN ACTIVATION,0.19156,0.19478,0.1925,0,0
4,GO NEGATIVE REGULATION OF BONE REMODELING,0.47137,0.19439,0.15377,0,0
4,GO REGULATION OF HAIR CYCLE,0.0060238,0.19436,0.23495,0,0
4,GO CONVERGENT EXTENSION,0.007293,0.19433,0.2848,0,0
4,GO HEART TRABECULA MORPHOGENESIS,0.022172,0.19426,0.21775,0,0
4,GO REGULATION OF IMMUNE EFFECTOR PROCESS,0.1306,0.19418,0.18514,0,0
4,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.33029,0.19358,0.11653,0,0
4,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.12273,0.19358,0.2641,0,0
4,GO REGULATION OF HIPPO SIGNALING,0.072385,0.19347,0.21423,0,0
4,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.56341,0.19344,0.12858,0,0
4,GO MAST CELL ACTIVATION,0.08303,0.19287,0.21794,0,0
4,GO ENDOTHELIAL CELL CHEMOTAXIS,0.0040644,0.19267,0.29308,0,0
4,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.072385,0.19222,0.30158,0,0
4,GO REGULATION OF MAST CELL ACTIVATION,0.11163,0.19221,0.19829,0,0
4,GO INFLAMMATORY RESPONSE TO WOUNDING,0.15655,0.1922,0.22849,0,0
4,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,0.0054671,0.19212,0.21287,0,0
4,GO NEURON PROJECTION REGENERATION,0.0010209,0.19193,0.28076,0,0
4,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.031957,0.19157,0.24853,0,0
4,GO TRIGEMINAL NERVE DEVELOPMENT,0.34626,0.1911,0.17823,0,0
4,GO MESENCHYMAL CELL PROLIFERATION,0.026142,0.19102,0.22968,0,0
4,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.11163,0.19097,0.17628,0,0
4,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.026142,0.19089,0.22988,0,0
4,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.08588,0.19078,0.22085,0,0
4,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.080256,0.1902,0.28249,0,0
4,GO REGULATION OF PROTEIN DEPOLYMERIZATION,0.0016767,0.19004,0.26819,0,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.33029,0.18991,0.15712,0,0
4,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.18102,0.18976,0.17589,0,0
4,GO GANGLION DEVELOPMENT,0.019548,0.18928,0.26622,0,0
4,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,0.33821,0.18923,0.10858,0,0
4,GO MACROPHAGE DIFFERENTIATION,0.11524,0.18917,0.20423,0,0
4,GO MRNA SPLICE SITE SELECTION,0.094909,0.18913,0.18986,0,0
4,GO POLYOL CATABOLIC PROCESS,0.028348,0.18907,0.19914,0,0
4,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.10811,0.18897,0.23433,0,0
4,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.08881,0.18891,0.2297,0,0
4,GO REGULATION OF CELL PROJECTION SIZE,0.18624,0.18885,0.17735,0,0
4,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.067497,0.18878,0.23738,0,0
4,GO POSITIVE REGULATION OF FILOPODIUM ASSEMBLY,0.028348,0.18874,0.20562,0,0
4,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,0.197,0.18869,0.12921,0,0
4,GO NEURON FATE SPECIFICATION,0.37111,0.18864,0.11743,0,0
4,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.4521,0.18826,0.12393,0,0
4,GO T CELL RECEPTOR SIGNALING PATHWAY,0.12273,0.1882,0.15685,0,0
4,GO VITAMIN D METABOLIC PROCESS,0.23203,0.18793,0.15518,0,0
4,GO I KAPPAB PHOSPHORYLATION,0.074935,0.18784,0.22334,0,0
4,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.74555,0.18772,0.11392,0,0
4,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.20256,0.18772,0.16477,0,0
4,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,0.048745,0.18766,0.27784,0,0
4,GO MEMBRANE REPOLARIZATION,0.0016767,0.18761,0.33349,0,0
4,GO INTERFERON GAMMA PRODUCTION,0.15197,0.1875,0.18965,0,0
4,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.02951,0.187,0.21777,0,0
4,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.065157,0.18673,0.22374,0,0
4,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,0.08588,0.18651,0.18755,0,0
4,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,0.14312,0.18609,0.19337,0,0
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.0015882,0.18575,0.28678,0,0
4,GO NEURAL TUBE DEVELOPMENT,0.013834,0.18571,0.21463,0,0
4,GO REGULATION OF IMMUNE RESPONSE,0.15197,0.18565,0.16076,0,0
4,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,0.020391,0.18565,0.23504,0,0
4,GO T CELL MEDIATED CYTOTOXICITY,0.39705,0.18522,0.12714,0,0
4,GO RENAL WATER HOMEOSTASIS,0.015104,0.185,0.24228,0,0
4,GO REGULATION OF CELL KILLING,0.2998,0.18486,0.13648,0,0
4,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.11163,0.18482,0.15215,0,0
4,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.13467,0.18469,0.2232,0,0
4,GO REGULATION OF INFLAMMATORY RESPONSE,0.11163,0.18444,0.17909,0,0
4,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,0.0010209,0.18436,0.26791,0,0
4,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,0.080256,0.18429,0.17578,0,0
4,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,0.074935,0.18422,0.20299,0,0
4,GO CELL CELL JUNCTION ORGANIZATION,0.00064645,0.18384,0.26435,0,0
4,GO COCHLEA DEVELOPMENT,0.022172,0.1838,0.18361,0,0
4,GO CELL FATE SPECIFICATION,0.033245,0.18357,0.18357,0,0
4,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.12273,0.18347,0.16139,0,0
4,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.15197,0.18342,0.18131,0,0
4,GO VASODILATION,0.0036751,0.18328,0.24203,0,0
4,GO VASCULAR WOUND HEALING,0.069906,0.18318,0.22734,0,0
4,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,0.0080134,0.18309,0.21913,0,0
4,GO ENDOTHELIUM DEVELOPMENT,0.011063,0.18298,0.24846,0,0
4,GO ANIMAL ORGAN FORMATION,0.019548,0.18264,0.18003,0,0
4,GO HEART FORMATION,0.0031545,0.18258,0.24765,0,0
4,GO INNER EAR RECEPTOR CELL DEVELOPMENT,0.0076456,0.18227,0.26231,0,0
4,GO CELLULAR EXTRAVASATION,0.197,0.18217,0.18597,0,0
4,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.022172,0.18204,0.2898,0,0
4,GO REGULATION OF PLATELET AGGREGATION,0.10134,0.18193,0.19422,0,0
4,GO EXOCRINE SYSTEM DEVELOPMENT,0.021265,0.18174,0.25869,0,0
4,GO SALIVARY GLAND DEVELOPMENT,0.023112,0.18167,0.24688,0,0
4,GO REGULATION OF LYMPHOCYTE MIGRATION,0.30724,0.18151,0.14164,0,0
4,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.0013481,0.18123,0.26315,0,0
4,GO METANEPHROS DEVELOPMENT,0.018736,0.18123,0.2144,0,0
4,GO CEREBRAL CORTEX DEVELOPMENT,0.012106,0.18117,0.21836,0,0
4,GO EATING BEHAVIOR,0.0031545,0.18103,0.25231,0,0
4,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.0016767,0.18095,0.30027,0,0
4,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,0.16602,0.18083,0.16618,0,0
4,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.15197,0.18078,0.1561,0,0
4,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,0.0083971,0.18053,0.20903,0,0
4,GO STEM CELL DIVISION,0.1306,0.18049,0.16229,0,0
4,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.35442,0.18002,0.16722,0,0
4,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.019548,0.17988,0.21351,0,0
4,GO RESPONSE TO INTERLEUKIN 15,0.15655,0.17981,0.24703,0,0
4,GO PROTEIN DEPOLYMERIZATION,0.0019699,0.1798,0.27261,0,0
4,GO RESPONSE TO LITHIUM ION,0.0066311,0.17979,0.23053,0,0
4,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.14312,0.17941,0.21312,0,0
4,GO FAT CELL PROLIFERATION,0.028348,0.17935,0.20108,0,0
4,GO MEMBRANE INVAGINATION,0.094909,0.17929,0.21623,0,0
4,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.33821,0.17878,0.1508,0,0
4,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.069906,0.1784,0.24819,0,0
4,GO ACUTE INFLAMMATORY RESPONSE,0.16123,0.17834,0.16641,0,0
4,GO MORPHOGENESIS OF AN ENDOTHELIUM,0.067497,0.17833,0.2167,0,0
4,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,0.060677,0.17803,0.19632,0,0
4,GO CELL CELL JUNCTION ASSEMBLY,0.00076864,0.17803,0.25555,0,0
4,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,0.00023283,0.17796,0.24844,0,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.23203,0.17784,0.15565,0,0
4,GO THYMIC T CELL SELECTION,0.15655,0.17765,0.24548,0,0
4,GO REGULATION OF TUBULIN DEACETYLATION,0.0023095,0.17765,0.33824,0,0
4,GO ACTIVATION OF IMMUNE RESPONSE,0.13467,0.17757,0.16364,0,0
4,GO FLUID TRANSPORT,0.11524,0.17749,0.15846,0,0
4,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.016475,0.17726,0.27574,0,0
4,GO PARAXIAL MESODERM DEVELOPMENT,0.041938,0.17721,0.19076,0,0
4,GO SPROUTING ANGIOGENESIS,0.062884,0.17716,0.20071,0,0
4,GO HISTONE H3 K36 METHYLATION,0.072385,0.17703,0.22701,0,0
4,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.12662,0.177,0.22683,0,0
4,GO HINDLIMB MORPHOGENESIS,0.015776,0.17681,0.22789,0,0
4,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.10134,0.17635,0.19076,0,0
4,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.33029,0.17622,0.10501,0,0
4,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,0.025096,0.17619,0.19137,0,0
4,GO REGULATION OF T CELL CYTOKINE PRODUCTION,0.16123,0.17614,0.21202,0,0
4,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.026142,0.17601,0.26069,0,0
4,GO SUCKLING BEHAVIOR,0.10468,0.17555,0.16847,0,0
4,GO NERVE DEVELOPMENT,0.031957,0.17554,0.23404,0,0
4,GO REGULATION OF HISTONE H4 ACETYLATION,0.007293,0.17546,0.19343,0,0
4,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.08303,0.17516,0.2015,0,0
4,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.3148,0.17506,0.20764,0,0
4,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.13885,0.17502,0.16925,0,0
4,GO REGULATION OF RECEPTOR BINDING,0.10134,0.17429,0.19761,0,0
4,GO REGULATION OF ANION TRANSPORT,0.0036751,0.17417,0.2257,0,0
4,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.15655,0.17415,0.15231,0,0
4,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.13467,0.17399,0.17034,0,0
4,GO FOREBRAIN REGIONALIZATION,0.44264,0.17398,0.088641,0,0
4,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.067497,0.17388,0.20332,0,0
4,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.20822,0.17383,0.16039,0,0
4,GO RESPONSE TO BMP,0.0040644,0.17369,0.25848,0,0
4,GO MACROPHAGE MIGRATION,0.13467,0.17366,0.18511,0,0
4,GO DEVELOPMENTAL INDUCTION,0.00332,0.17355,0.22713,0,0
4,GO RESPONSE TO INTERFERON GAMMA,0.23827,0.17344,0.17088,0,0
4,GO ESTROUS CYCLE,0.074935,0.17342,0.21362,0,0
4,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.67486,0.17342,0.060527,0,0
4,GO STEROID CATABOLIC PROCESS,0.098083,0.17326,0.17326,0,0
4,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.069906,0.17309,0.2122,0,0
4,GO CYTOKINE MEDIATED SIGNALING PATHWAY,0.10134,0.17296,0.16849,0,0
4,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.018736,0.17289,0.23426,0,0
4,GO REGULATION OF VASOCONSTRICTION,0.040368,0.17266,0.20334,0,0
4,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.0019699,0.17253,0.1952,0,0
4,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,0.0054671,0.17246,0.21976,0,0
4,GO REGULATION OF HEART MORPHOGENESIS,0.022172,0.17237,0.20442,0,0
4,GO IMMUNOGLOBULIN SECRETION,0.37111,0.17224,0.10954,0,0
4,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.19156,0.17199,0.1273,0,0
4,GO REGULATION OF ACROSOME REACTION,0.006955,0.17158,0.20031,0,0
4,GO CELLULAR SODIUM ION HOMEOSTASIS,0.026142,0.17145,0.19853,0,0
4,GO RENAL SYSTEM PROCESS,0.010101,0.17144,0.2318,0,0
4,GO CYTOKINE PRODUCTION,0.091819,0.17123,0.18471,0,0
4,GO T CELL SELECTION,0.1475,0.17122,0.23384,0,0
4,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.012106,0.17117,0.33242,0,0
4,GO ASTROCYTE DEVELOPMENT,0.13885,0.17108,0.19919,0,0
4,GO REGULATION OF PROSTAGLANDIN SECRETION,0.077559,0.17104,0.19153,0,0
4,GO NOSE DEVELOPMENT,0.2998,0.17102,0.17392,0,0
4,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.15197,0.17096,0.1926,0,0
4,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,0.19156,0.17092,0.17675,0,0
4,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.15655,0.17089,0.17482,0,0
4,GO REGULATION OF ORGANIC ACID TRANSPORT,0.0040644,0.17067,0.22795,0,0
4,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,0.008797,0.17024,0.25554,0,0
4,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,0.027226,0.17019,0.30005,0,0
4,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.045233,0.17009,0.21803,0,0
4,GO GROWTH HORMONE SECRETION,0.065157,0.16988,0.25607,0,0
4,GO NUCLEOTIDE TRANSPORT,0.0096484,0.16962,0.17009,0,0
4,GO AMINO ACID IMPORT,0.024086,0.16953,0.17797,0,0
4,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.0092139,0.16944,0.25366,0,0
4,GO PROTEIN LOCALIZATION TO ENDOSOME,0.0054671,0.16941,0.26957,0,0
4,GO EPITHELIAL TUBE MORPHOGENESIS,0.010101,0.16931,0.21592,0,0
4,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.01266,0.16929,0.28343,0,0
4,GO B CELL MEDIATED IMMUNITY,0.16123,0.169,0.208,0,0
4,GO SKIN EPIDERMIS DEVELOPMENT,0.0057394,0.16894,0.22734,0,0
4,GO NOTCH SIGNALING PATHWAY,0.00051151,0.16891,0.28308,0,0
4,GO APICAL JUNCTION ASSEMBLY,0.0076456,0.1689,0.21381,0,0
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.0092139,0.1685,0.19863,0,0
4,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.060677,0.16845,0.17858,0,0
4,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0060238,0.16835,0.31652,0,0
4,GO REGULATION OF MACROPHAGE ACTIVATION,0.2577,0.1682,0.16098,0,0
4,GO LACTATION,0.0080134,0.168,0.21636,0,0
4,GO REGULATION OF COLLAGEN METABOLIC PROCESS,0.067497,0.16789,0.25077,0,0
4,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.23827,0.16783,0.16427,0,0
4,GO POSITIVE REGULATION OF CELL ADHESION,0.094909,0.16772,0.20919,0,0
4,GO REGULATION OF LEUKOCYTE TETHERING OR ROLLING,0.46168,0.16767,0.11016,0,0
4,GO NEGATIVE REGULATION OF GLIOGENESIS,0.01266,0.16757,0.19173,0,0
4,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,0.013235,0.1675,0.28618,0,0
4,GO REGULATION OF MACROPHAGE MIGRATION,0.11524,0.16749,0.22108,0,0
4,GO MANNOSYLATION,0.060677,0.16735,0.13649,0,0
4,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,0.094909,0.16722,0.19349,0,0
4,GO DORSAL AORTA DEVELOPMENT,0.094909,0.16717,0.21373,0,0
4,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,0.13885,0.16706,0.16261,0,0
4,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,0.025096,0.16704,0.22234,0,0
4,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,0.08588,0.16694,0.17938,0,0
4,GO MACROPHAGE ACTIVATION,0.2577,0.16674,0.1699,0,0
4,GO RENAL FILTRATION,0.050584,0.16661,0.28772,0,0
4,GO ACID SECRETION,0.00054254,0.16655,0.24523,0,0
4,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.0031545,0.16651,0.27861,0,0
4,GO CELL PROLIFERATION IN FOREBRAIN,0.1475,0.16645,0.17467,0,0
4,GO GLUCOSE CATABOLIC PROCESS,0.015104,0.16636,0.20487,0,0
4,GO DRUG CATABOLIC PROCESS,0.069906,0.16636,0.18919,0,0
4,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,0.1306,0.16624,0.16007,0,0
4,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,0.024086,0.1662,0.24538,0,0
4,GO MOLTING CYCLE,0.0049572,0.16601,0.22611,0,0
4,GO KERATAN SULFATE CATABOLIC PROCESS,0.074935,0.166,0.30267,0,0
4,GO PATTERN SPECIFICATION PROCESS,0.0092139,0.16554,0.1943,0,0
4,GO INTERFERON ALPHA PRODUCTION,0.14312,0.16542,0.16056,0,0
4,GO CRANIAL NERVE MORPHOGENESIS,0.08588,0.16534,0.20548,0,0
4,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.077559,0.1653,0.17901,0,0
4,GO HUMORAL IMMUNE RESPONSE,0.17591,0.16501,0.16199,0,0
4,GO LYMPHOCYTE APOPTOTIC PROCESS,0.19156,0.16484,0.14275,0,0
4,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.0036751,0.16481,0.23537,0,0
4,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.080256,0.16466,0.25845,0,0
4,GO REGULATION OF MEMBRANE INVAGINATION,0.16602,0.16434,0.22467,0,0
4,GO POSITIVE REGULATION OF B CELL PROLIFERATION,0.20822,0.1643,0.17482,0,0
4,GO INTERLEUKIN 6 PRODUCTION,0.20256,0.16402,0.16532,0,0
4,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.15197,0.164,0.18393,0,0
4,GO TYPE 2 IMMUNE RESPONSE,0.27821,0.16385,0.15945,0,0
4,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.0028457,0.16373,0.28453,0,0
4,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.041938,0.16372,0.20574,0,0
4,GO TONGUE DEVELOPMENT,0.23203,0.16364,0.094234,0,0
4,GO T CELL ACTIVATION VIA T CELL RECEPTOR CONTACT WITH ANTIGEN BOUND TO MHC MOLECULE ON ANTIGEN PRESENTING CELL,0.70989,0.16356,0.1076,0,0
4,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.027226,0.16354,0.1933,0,0
4,GO NEPHRON EPITHELIUM DEVELOPMENT,0.007293,0.16337,0.22152,0,0
4,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.18102,0.16328,0.18294,0,0
4,GO DOSAGE COMPENSATION,0.040368,0.16326,0.22206,0,0
4,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.0012758,0.16319,0.2344,0,0
4,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.11524,0.16288,0.2245,0,0
4,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,0.34626,0.16287,0.10114,0,0
4,GO LENS FIBER CELL DEVELOPMENT,0.026142,0.16282,0.19887,0,0
4,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.021265,0.16272,0.20473,0,0
4,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.10134,0.16268,0.21952,0,0
4,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,0.010572,0.16247,0.20136,0,0
4,GO GALACTOSE METABOLIC PROCESS,0.11524,0.16232,0.15359,0,0
4,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,0.0096484,0.16216,0.29712,0,0
4,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.15655,0.16216,0.15057,0,0
4,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.16123,0.16202,0.17311,0,0
4,GO REGULATION OF MONOCYTE DIFFERENTIATION,0.13467,0.16201,0.25477,0,0
4,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.10811,0.16197,0.1891,0,0
4,GO LYMPHOCYTE MEDIATED IMMUNITY,0.19156,0.16195,0.16881,0,0
4,GO POSITIVE REGULATION OF T CELL MIGRATION,0.36271,0.16178,0.13269,0,0
4,GO MALE SEX DETERMINATION,0.072385,0.16171,0.21444,0,0
4,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.0052065,0.16168,0.22889,0,0
4,GO DEFENSE RESPONSE TO VIRUS,0.12273,0.16147,0.17066,0,0
4,GO EPITHELIAL TO MESENCHYMAL TRANSITION,0.0063209,0.16142,0.24194,0,0
4,GO CIRCADIAN REGULATION OF GENE EXPRESSION,0.0060238,0.16129,0.24667,0,0
4,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.42405,0.16124,0.12028,0,0
4,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,0.034576,0.16121,0.27882,0,0
4,GO HISTONE H3 DEACETYLATION,0.0031545,0.16114,0.26618,0,0
4,GO NEGATIVE REGULATION OF CELL CELL ADHESION,0.08303,0.16111,0.208,0,0
4,GO AROMATIC AMINO ACID TRANSPORT,0.077559,0.16104,0.22386,0,0
4,GO INTERLEUKIN 1 BETA PRODUCTION,0.36271,0.16103,0.12254,0,0
4,GO INTERLEUKIN 2 PRODUCTION,0.35442,0.16095,0.11233,0,0
4,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.197,0.16068,0.15674,0,0
4,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,0.2259,0.16043,0.12989,0,0
4,GO DEFENSE RESPONSE TO OTHER ORGANISM,0.12662,0.16041,0.15899,0,0
4,GO BIOLOGICAL PHASE,0.15655,0.16039,0.17547,0,0
4,GO INNATE IMMUNE RESPONSE,0.14312,0.16038,0.15512,0,0
4,GO NAD BIOSYNTHETIC PROCESS,0.39705,0.16035,0.09835,0,0
4,GO RESPONSE TO LEAD ION,0.0019699,0.16034,0.25785,0,0
4,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0063209,0.16026,0.31452,0,0
4,GO CELL PROLIFERATION IN HINDBRAIN,0.11894,0.16023,0.16867,0,0
4,GO POSITIVE REGULATION OF CHEMOTAXIS,0.24463,0.16012,0.15835,0,0
4,GO REGULATION OF GOLGI ORGANIZATION,0.0011418,0.16005,0.31886,0,0
4,GO STRIATUM DEVELOPMENT,0.008797,0.15997,0.25304,0,0
4,GO REGULATION OF DEFENSE RESPONSE,0.10468,0.15991,0.16113,0,0
4,GO ALCOHOL CATABOLIC PROCESS,0.013235,0.15955,0.17453,0,0
4,GO ERK1 AND ERK2 CASCADE,0.098083,0.15948,0.18203,0,0
4,GO TUMOR NECROSIS FACTOR SECRETION,0.23827,0.15919,0.12731,0,0
4,GO POSITIVE REGULATION OF ANION TRANSPORT,0.025096,0.15903,0.20147,0,0
4,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,0.2998,0.15891,0.12248,0,0
4,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.08303,0.15887,0.15854,0,0
4,GO TUBE FORMATION,0.010101,0.15864,0.20621,0,0
4,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.16123,0.15846,0.18043,0,0
4,GO MESONEPHROS DEVELOPMENT,0.065157,0.15844,0.15495,0,0
4,GO MESENCHYME MORPHOGENESIS,0.013834,0.15843,0.22654,0,0
4,GO CD40 SIGNALING PATHWAY,0.35442,0.15833,0.12336,0,0
4,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.069906,0.15824,0.15942,0,0
4,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.11524,0.15822,0.1646,0,0
4,GO LEUKOCYTE CHEMOTAXIS,0.32248,0.15822,0.12574,0,0
4,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.2577,0.1582,0.12618,0,0
4,GO PROTEIN DEGLYCOSYLATION,0.069906,0.15805,0.19268,0,0
4,GO SODIUM ION HOMEOSTASIS,0.027226,0.15797,0.21267,0,0
4,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,0.21989,0.15781,0.18443,0,0
4,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,0.072385,0.15742,0.19183,0,0
4,GO SUPEROXIDE ANION GENERATION,0.17591,0.15733,0.19444,0,0
4,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,0.0060238,0.15707,0.27317,0,0
4,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,0.080256,0.15685,0.18831,0,0
4,GO RESPONSE TO L GLUTAMATE,0.069906,0.1567,0.15522,0,0
4,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.32248,0.15661,0.12336,0,0
4,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.011574,0.15656,0.22862,0,0
4,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.022172,0.15655,0.24421,0,0
4,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.23827,0.15653,0.14524,0,0
4,GO MYELIN MAINTENANCE,0.13467,0.15649,0.17609,0,0
4,GO RESPONSE TO BACTERIUM,0.11163,0.15644,0.16249,0,0
4,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.0049572,0.15636,0.23922,0,0
4,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.43329,0.1563,0.1099,0,0
4,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.11524,0.15621,0.22382,0,0
4,GO MECHANORECEPTOR DIFFERENTIATION,0.0047188,0.15595,0.26311,0,0
4,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.040368,0.15584,0.14249,0,0
4,GO ACUTE PHASE RESPONSE,0.12662,0.15573,0.15293,0,0
4,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.0080134,0.1557,0.19344,0,0
4,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.26442,0.15568,0.16883,0,0
4,GO SEQUESTERING OF METAL ION,0.42405,0.15565,0.054594,0,0
4,GO KIDNEY EPITHELIUM DEVELOPMENT,0.013235,0.15563,0.20458,0,0
4,GO NEGATIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.37111,0.15556,0.16592,0,0
4,GO NEGATIVE REGULATION OF CELL ACTIVATION,0.10134,0.15546,0.21266,0,0
4,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,0.27126,0.15536,0.21046,0,0
4,GO GAP JUNCTION ASSEMBLY,0.16602,0.15536,0.19173,0,0
4,GO HEXOSE CATABOLIC PROCESS,0.0016767,0.15521,0.2101,0,0
4,GO REGULATION OF EPITHELIAL TUBE FORMATION,0.18624,0.15518,0.17641,0,0
4,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,0.12662,0.15508,0.17213,0,0
4,GO PROTEIN MANNOSYLATION,0.022172,0.15507,0.18787,0,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.023112,0.15495,0.1825,0,0
4,GO NOREPINEPHRINE SECRETION,0.080256,0.15482,0.22322,0,0
4,GO REGULATION OF MESODERM DEVELOPMENT,0.013235,0.15465,0.20137,0,0
4,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,0.074935,0.1545,0.20299,0,0
4,GO MYELOID LEUKOCYTE MIGRATION,0.34626,0.15444,0.11482,0,0
4,GO INTERLEUKIN 10 PRODUCTION,0.36271,0.15429,0.12717,0,0
4,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.022172,0.15415,0.18606,0,0
4,GO IMMUNE EFFECTOR PROCESS,0.11894,0.15414,0.16207,0,0
4,GO EPITHELIUM DEVELOPMENT,0.0016767,0.15409,0.21012,0,0
4,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.1306,0.15407,0.17288,0,0
4,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.020391,0.15399,0.26838,0,0
4,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.11524,0.15384,0.17515,0,0
4,GO DEFENSE RESPONSE,0.091819,0.15374,0.1782,0,0
4,GO LYMPHOCYTE MIGRATION,0.25111,0.15364,0.15651,0,0
4,GO REGULATION OF AMYLOID BETA CLEARANCE,0.10811,0.15343,0.19675,0,0
4,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.4521,0.15331,0.10305,0,0
4,GO B CELL RECEPTOR SIGNALING PATHWAY,0.197,0.15325,0.19091,0,0
4,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.010101,0.15312,0.15155,0,0
4,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,0.08588,0.15308,0.18592,0,0
4,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.43329,0.15307,0.085956,0,0
4,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,0.20256,0.15292,0.2215,0,0
4,GO GDP METABOLIC PROCESS,0.074935,0.15291,0.17391,0,0
4,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.054439,0.15277,0.19478,0,0
4,GO INTERLEUKIN 12 PRODUCTION,0.39705,0.15272,0.13338,0,0
4,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.2577,0.15272,0.14814,0,0
4,GO POSITIVE REGULATION OF PHAGOCYTOSIS,0.27126,0.15264,0.1568,0,0
4,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.10468,0.15253,0.17807,0,0
4,GO GONADOTROPIN SECRETION,0.043559,0.15248,0.18391,0,0
4,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.50109,0.15244,0.11056,0,0
4,GO CELLULAR POTASSIUM ION HOMEOSTASIS,0.022172,0.15202,0.23919,0,0
4,GO RESPONSE TO INTERFERON BETA,0.27821,0.15187,0.15542,0,0
4,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.13885,0.15185,0.15515,0,0
4,GO TRACHEA DEVELOPMENT,0.18624,0.15182,0.15229,0,0
4,GO GLAND MORPHOGENESIS,0.040368,0.15178,0.22118,0,0
4,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.16123,0.1517,0.14128,0,0
4,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,0.14312,0.15169,0.18237,0,0
4,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,0.065157,0.15157,0.18224,0,0
4,GO STEROL HOMEOSTASIS,0.08588,0.1513,0.1377,0,0
4,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.28529,0.15129,0.14969,0,0
4,GO CORONARY VASCULATURE MORPHOGENESIS,0.091819,0.15123,0.24378,0,0
4,GO GRANULOCYTE MIGRATION,0.43329,0.15116,0.10181,0,0
4,GO HEART TRABECULA FORMATION,0.1475,0.15114,0.1275,0,0
4,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,0.35442,0.15104,0.12214,0,0
4,GO DORSAL SPINAL CORD DEVELOPMENT,0.20256,0.15095,0.15052,0,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,0.30724,0.15091,0.13799,0,0
4,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.030713,0.15084,0.18439,0,0
4,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.214,0.15071,0.15026,0,0
4,GO VITAMIN D BIOSYNTHETIC PROCESS,0.37111,0.15071,0.10453,0,0
4,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.023112,0.15054,0.2026,0,0
4,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,0.037377,0.15048,0.25475,0,0
4,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.14312,0.15045,0.16833,0,0
4,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.046961,0.15036,0.25194,0,0
4,GO MONONUCLEAR CELL DIFFERENTIATION,0.17091,0.15032,0.17695,0,0
4,GO WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.12273,0.15018,0.14201,0,0
4,GO REGULATION OF B CELL PROLIFERATION,0.29248,0.15003,0.15328,0,0
4,GO PHAGOCYTOSIS,0.11163,0.14999,0.19735,0,0
4,GO CARDIAC CELL FATE COMMITMENT,0.10468,0.14987,0.16387,0,0
4,GO HISTONE H4 ACETYLATION,0.012106,0.14974,0.22118,0,0
4,GO LYMPHOCYTE HOMEOSTASIS,0.214,0.14972,0.133,0,0
4,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,0.197,0.14967,0.23437,0,0
4,GO ASTROCYTE DIFFERENTIATION,0.08303,0.14953,0.17756,0,0
4,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.11163,0.14953,0.13041,0,0
4,GO NEGATIVE REGULATION OF MAST CELL ACTIVATION,0.38829,0.14952,0.11661,0,0
4,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.10134,0.14946,0.15936,0,0
4,GO RESPONSE TO INTERLEUKIN 7,0.12662,0.14945,0.16445,0,0
4,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.42405,0.14944,0.11773,0,0
4,GO POSITIVE REGULATION OF MACROAUTOPHAGY,0.0060238,0.14933,0.23437,0,0
4,GO STEROID ESTERIFICATION,0.2998,0.14932,0.12978,0,0
4,GO REGULATION OF FATTY ACID TRANSPORT,0.035953,0.14926,0.1997,0,0
4,GO DRUG METABOLIC PROCESS,0.091819,0.1492,0.15455,0,0
4,GO RESPONSE TO PARATHYROID HORMONE,0.23203,0.14914,0.12838,0,0
4,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.11894,0.14901,0.13608,0,0
4,GO REGULATION OF CELL ACTIVATION,0.15655,0.1488,0.17664,0,0
4,GO B CELL ACTIVATION,0.15655,0.14863,0.17354,0,0
4,GO REGULATION OF MICROVILLUS ORGANIZATION,0.074935,0.14856,0.23228,0,0
4,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0034935,0.14855,0.26527,0,0
4,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.11524,0.14846,0.16758,0,0
4,GO B CELL PROLIFERATION,0.34626,0.14832,0.12681,0,0
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.21989,0.14829,0.1409,0,0
4,GO REGULATION OF CELL CELL ADHESION,0.12662,0.1482,0.19105,0,0
4,GO REGULATION OF VASCULOGENESIS,0.10811,0.14814,0.16692,0,0
4,GO RESPONSE TO INTERLEUKIN 4,0.067497,0.14808,0.19393,0,0
4,GO FOREBRAIN GENERATION OF NEURONS,0.015104,0.148,0.20291,0,0
4,GO MONOSACCHARIDE CATABOLIC PROCESS,0.0018673,0.14796,0.18877,0,0
4,GO DEFENSE RESPONSE TO BACTERIUM,0.10811,0.14792,0.17159,0,0
4,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.08588,0.1478,0.21877,0,0
4,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,0.1475,0.14772,0.19022,0,0
4,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.17591,0.14736,0.14065,0,0
4,GO CYTOPLASM ORGANIZATION,0.094909,0.14705,0.18987,0,0
4,GO RESPONSE TO CYTOKINE,0.074935,0.14687,0.17139,0,0
4,GO RESPONSE TO HYDROPEROXIDE,0.20256,0.14681,0.15634,0,0
4,GO APICAL PROTEIN LOCALIZATION,0.10134,0.14677,0.1533,0,0
4,GO T CELL DIFFERENTIATION IN THYMUS,0.11894,0.14652,0.1857,0,0
4,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.037377,0.14633,0.14436,0,0
4,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.10134,0.14628,0.2433,0,0
4,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,0.02951,0.14615,0.16807,0,0
4,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.008797,0.14604,0.27627,0,0
4,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,0.054439,0.14584,0.17111,0,0
4,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.10811,0.14573,0.2045,0,0
4,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,0.065157,0.14568,0.18557,0,0
4,GO ENDOTHELIAL CELL DEVELOPMENT,0.0092139,0.14567,0.26284,0,0
4,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.25111,0.14565,0.18216,0,0
4,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.062884,0.14563,0.18873,0,0
4,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.10468,0.14513,0.12603,0,0
4,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.4521,0.14488,0.10701,0,0
4,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.0060238,0.14479,0.16923,0,0
4,GO INFLAMMATORY RESPONSE,0.15655,0.14473,0.17191,0,0
4,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.1475,0.14455,0.16923,0,0
4,GO RESPONSE TO BIOTIC STIMULUS,0.11894,0.14446,0.15787,0,0
4,GO PROTEIN AUTO ADP RIBOSYLATION,0.043559,0.14439,0.21002,0,0
4,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.027226,0.14435,0.2802,0,0
4,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.58498,0.14431,0.068437,0,0
4,GO REGULATION OF BMP SIGNALING PATHWAY,0.0052065,0.14419,0.27049,0,0
4,GO CARBOHYDRATE TRANSPORT,0.00332,0.14409,0.22218,0,0
4,GO ADAPTIVE IMMUNE RESPONSE,0.20256,0.14407,0.18199,0,0
4,GO REGULATION OF EXOSOMAL SECRETION,0.052482,0.14394,0.15667,0,0
4,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.11163,0.14388,0.22741,0,0
4,GO T CELL APOPTOTIC PROCESS,0.2998,0.14387,0.11957,0,0
4,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.010572,0.14382,0.21799,0,0
4,GO POSITIVE REGULATION OF CELL KILLING,0.36271,0.14373,0.12684,0,0
4,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,0.048745,0.14342,0.20476,0,0
4,GO REGULATION OF MRNA PROCESSING,0.077559,0.1434,0.15777,0,0
4,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.10811,0.14318,0.17936,0,0
4,GO TRIPARTITE REGIONAL SUBDIVISION,0.08303,0.14305,0.15312,0,0
4,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,0.074935,0.14292,0.16273,0,0
4,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.1306,0.14286,0.15007,0,0
4,GO N GLYCAN PROCESSING,0.035953,0.1427,0.24971,0,0
4,GO REGULATION OF VASCULATURE DEVELOPMENT,0.065157,0.14264,0.20932,0,0
4,GO KETONE BODY METABOLIC PROCESS,0.021265,0.14244,0.19099,0,0
4,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.080256,0.14233,0.21848,0,0
4,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.21989,0.14222,0.16051,0,0
4,GO HISTONE H2A MONOUBIQUITINATION,0.045233,0.14213,0.18111,0,0
4,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,0.033245,0.14203,0.26576,0,0
4,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.34626,0.14141,0.14314,0,0
4,GO REGULATION OF GROWTH HORMONE SECRETION,0.12662,0.14135,0.24845,0,0
4,GO EMBRYONIC CAMERA TYPE EYE FORMATION,0.2259,0.14123,0.17734,0,0
4,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,0.013834,0.14119,0.29307,0,0
4,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,0.57414,0.14119,0.1019,0,0
4,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.0018673,0.14107,0.1869,0,0
4,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,0.20256,0.14078,0.1811,0,0
4,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.46168,0.14071,0.079727,0,0
4,GO CELL CHEMOTAXIS,0.23203,0.14051,0.14878,0,0
4,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,0.015104,0.1405,0.19855,0,0
4,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,0.065157,0.14039,0.16912,0,0
4,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.11894,0.1403,0.22512,0,0
4,GO INNATE IMMUNE RESPONSE IN MUCOSA,0.60692,0.1402,0.1065,0,0
4,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.030713,0.14016,0.19458,0,0
4,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,0.12273,0.14012,0.14033,0,0
4,GO REGULATION OF HEART RATE,0.0025648,0.14007,0.28094,0,0
4,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.18102,0.13998,0.15199,0,0
4,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.08303,0.13986,0.15184,0,0
4,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.21989,0.13973,0.11612,0,0
4,GO CYSTEINE METABOLIC PROCESS,0.16123,0.13969,0.15885,0,0
4,GO GLYCINE METABOLIC PROCESS,0.27821,0.13963,0.030293,0,0
4,GO POSITIVE REGULATION OF CHROMATIN BINDING,0.20822,0.13952,0.11144,0,0
4,GO LEUKOCYTE MEDIATED IMMUNITY,0.13885,0.13946,0.15218,0,0
4,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,0.20256,0.13915,0.14663,0,0
4,GO REGULATION OF SPINDLE ORGANIZATION,0.069906,0.13904,0.15355,0,0
4,GO INTEGRIN ACTIVATION,0.13467,0.13897,0.21089,0,0
4,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.21989,0.13897,0.15295,0,0
4,GO NEGATIVE REGULATION OF ANOIKIS,0.12273,0.13876,0.21496,0,0
4,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.2998,0.13875,0.13552,0,0
4,GO SPINDLE LOCALIZATION,0.098083,0.13875,0.15673,0,0
4,GO POSITIVE REGULATION OF LIPASE ACTIVITY,0.098083,0.1382,0.16884,0,0
4,GO EPITHELIAL CELL MATURATION,0.10468,0.1382,0.19605,0,0
4,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.16123,0.13815,0.20376,0,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.62923,0.13792,0.063467,0,0
4,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,0.091819,0.13758,0.26079,0,0
4,GO DIGESTIVE TRACT MORPHOGENESIS,0.069906,0.13752,0.20405,0,0
4,GO NEGATIVE REGULATION OF MACROPHAGE MIGRATION,0.197,0.13752,0.1307,0,0
4,GO COMPLEMENT RECEPTOR MEDIATED SIGNALING PATHWAY,0.44264,0.13721,0.15644,0,0
4,GO BARBED END ACTIN FILAMENT CAPPING,0.098083,0.13711,0.17959,0,0
4,GO T CELL ACTIVATION,0.19156,0.1371,0.16804,0,0
4,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.15197,0.13704,0.16004,0,0
4,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,0.37964,0.13694,0.09518,0,0
4,GO NEGATIVE T CELL SELECTION,0.37964,0.13669,0.18307,0,0
4,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.040368,0.13638,0.1879,0,0
4,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,0.00091199,0.13638,0.19492,0,0
4,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.2577,0.13635,0.14044,0,0
4,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.058535,0.13614,0.1663,0,0
4,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.11163,0.13612,0.17321,0,0
4,GO EMBRYONIC PLACENTA MORPHOGENESIS,0.077559,0.13582,0.18266,0,0
4,GO STABILIZATION OF MEMBRANE POTENTIAL,0.054439,0.13578,0.28874,0,0
4,GO NEGATIVE REGULATION OF PROTEIN MATURATION,0.2259,0.1357,0.1397,0,0
4,GO ETHANOL METABOLIC PROCESS,0.33821,0.13553,0.032069,0,0
4,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.056456,0.13551,0.18779,0,0
4,GO RESPONSE TO VITAMIN D,0.26442,0.13535,0.11466,0,0
4,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.08303,0.13522,0.12318,0,0
4,GO PLASMA MEMBRANE FUSION,0.074935,0.13522,0.18256,0,0
4,GO MULTICELLULAR ORGANISM AGING,0.052482,0.13512,0.1672,0,0
4,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,0.25111,0.13509,0.12952,0,0
4,GO PEPTIDYL CYSTEINE MODIFICATION,0.0063209,0.13507,0.17957,0,0
4,GO NEPHRIC DUCT MORPHOGENESIS,0.040368,0.13496,0.20737,0,0
4,GO RADIAL GLIAL CELL DIFFERENTIATION,0.054439,0.13485,0.19341,0,0
4,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.79394,0.1348,0.03627,0,0
4,GO POSITIVE REGULATION OF DEFENSE RESPONSE,0.15197,0.13464,0.12543,0,0
4,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.26442,0.13462,0.1654,0,0
4,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,0.38829,0.13462,0.1656,0,0
4,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.054439,0.13459,0.17772,0,0
4,GO MAGNESIUM ION HOMEOSTASIS,0.23203,0.13445,0.18676,0,0
4,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.21989,0.13439,0.10321,0,0
4,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.20256,0.13438,0.13416,0,0
4,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.043559,0.13435,0.16879,0,0
4,GO REGULATION OF IMMUNE SYSTEM PROCESS,0.11524,0.13425,0.16671,0,0
4,GO MAST CELL MIGRATION,0.11524,0.13415,0.22703,0,0
4,GO ANATOMICAL STRUCTURE REGRESSION,0.065157,0.13414,0.23859,0,0
4,GO REGULATION OF ODONTOGENESIS,0.16123,0.13413,0.12682,0,0
4,GO ENDOCHONDRAL BONE MORPHOGENESIS,0.040368,0.1341,0.20909,0,0
4,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,0.091819,0.13407,0.13511,0,0
4,GO POST GOLGI VESICLE MEDIATED TRANSPORT,0.011063,0.13387,0.24116,0,0
4,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.15655,0.13387,0.21688,0,0
4,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,0.12273,0.13366,0.20066,0,0
4,GO CELL ACTIVATION,0.10468,0.13358,0.17292,0,0
4,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.19156,0.13356,0.16532,0,0
4,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.08881,0.13352,0.22721,0,0
4,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.08588,0.13344,0.1881,0,0
4,GO REGULATION OF T CELL APOPTOTIC PROCESS,0.56341,0.13343,0.079864,0,0
4,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.23203,0.13341,0.18514,0,0
4,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.13467,0.13339,0.16811,0,0
4,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.20256,0.13334,0.18964,0,0
4,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.12273,0.13325,0.14976,0,0
4,GO REGULATION OF LYSOSOMAL LUMEN PH,0.098083,0.1332,0.1287,0,0
4,GO TONGUE MORPHOGENESIS,0.2998,0.13308,0.1029,0,0
4,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.0063209,0.13298,0.20253,0,0
4,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.53179,0.13295,0.080001,0,0
4,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.23203,0.13288,0.13737,0,0
4,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.0034935,0.13284,0.16344,0,0
4,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,0.022172,0.13271,0.2205,0,0
4,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.24463,0.13266,0.12696,0,0
4,GO SKELETAL MUSCLE TISSUE REGENERATION,0.11524,0.13265,0.12046,0,0
4,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.13885,0.13254,0.13818,0,0
4,GO GRANULOCYTE CHEMOTAXIS,0.51122,0.13251,0.093483,0,0
4,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.1306,0.1323,0.17592,0,0
4,GO T CELL MIGRATION,0.29248,0.13225,0.16231,0,0
4,GO REGULATION OF NEUTROPHIL ACTIVATION,0.26442,0.13218,0.21374,0,0
4,GO ANTIGEN PROCESSING AND PRESENTATION,0.18624,0.13215,0.14068,0,0
4,GO PARAXIAL MESODERM MORPHOGENESIS,0.13467,0.13214,0.16875,0,0
4,GO INTERLEUKIN 8 PRODUCTION,0.41494,0.13214,0.10147,0,0
4,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.08303,0.13209,0.18201,0,0
4,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,0.13467,0.13208,0.16939,0,0
4,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.013834,0.13195,0.21275,0,0
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,0.33821,0.13189,0.12299,0,0
4,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.214,0.13188,0.10874,0,0
4,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.091819,0.13188,0.19767,0,0
4,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,0.040368,0.13186,0.17957,0,0
4,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.10134,0.13179,0.15942,0,0
4,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.25111,0.13172,0.072492,0,0
4,GO NEURONAL STEM CELL POPULATION MAINTENANCE,0.035953,0.13119,0.22506,0,0
4,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.57414,0.13097,0.090516,0,0
4,GO FUSION OF SPERM TO EGG PLASMA MEMBRANE INVOLVED IN SINGLE FERTILIZATION,0.17091,0.13071,0.13963,0,0
4,GO WATER TRANSPORT,0.18102,0.13062,0.16679,0,0
4,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.013834,0.13054,0.22346,0,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.3148,0.13051,0.11675,0,0
4,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.10134,0.13044,0.18005,0,0
4,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,0.10134,0.13043,0.222,0,0
4,GO CHONDROCYTE DIFFERENTIATION,0.0172,0.13037,0.25149,0,0
4,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,0.08881,0.13032,0.12644,0,0
4,GO RESPONSE TO TUMOR NECROSIS FACTOR,0.15197,0.13029,0.13562,0,0
4,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,0.2577,0.13028,0.14191,0,0
4,GO CARTILAGE DEVELOPMENT,0.015104,0.13013,0.22193,0,0
4,GO PROTEIN LOCALIZATION TO CYTOSKELETON,0.11524,0.13004,0.16469,0,0
4,GO ROOF OF MOUTH DEVELOPMENT,0.015104,0.12992,0.22994,0,0
4,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,0.10811,0.12979,0.20303,0,0
4,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.44264,0.12977,0.10759,0,0
4,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.069906,0.12971,0.2634,0,0
4,GO REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT,0.65188,0.12966,0.0469,0,0
4,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.23827,0.12965,0.11329,0,0
4,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.27126,0.12963,0.11749,0,0
4,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,0.33029,0.12956,0.12976,0,0
4,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.60692,0.12955,0.091459,0,0
4,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.021265,0.12948,0.20321,0,0
4,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.080256,0.12933,0.12793,0,0
4,GO LEUKOCYTE TETHERING OR ROLLING,0.214,0.12928,0.18009,0,0
4,GO REGULATION OF EXCRETION,0.18102,0.12928,0.13374,0,0
4,GO RESPONSE TO UV B,0.13885,0.12919,0.12286,0,0
4,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,0.10134,0.12908,0.19625,0,0
4,GO ICOSANOID BIOSYNTHETIC PROCESS,0.29248,0.129,0.098334,0,0
4,GO POSITIVE REGULATION OF CYTOKINE SECRETION,0.28529,0.129,0.12686,0,0
4,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.32248,0.12899,0.13964,0,0
4,GO LUNG MORPHOGENESIS,0.11524,0.12894,0.17611,0,0
4,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.014457,0.1289,0.16853,0,0
4,GO REGULATION OF ANIMAL ORGAN FORMATION,0.074935,0.1286,0.14621,0,0
4,GO GLYCOLIPID CATABOLIC PROCESS,0.18624,0.1286,0.18277,0,0
4,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.062884,0.12853,0.22684,0,0
4,GO PITUITARY GLAND DEVELOPMENT,0.034576,0.12837,0.23307,0,0
4,GO GAMMA DELTA T CELL ACTIVATION,0.2259,0.12831,0.19381,0,0
4,GO POSITIVE REGULATION OF CELL AGING,0.33029,0.12828,0.069588,0,0
4,GO COMMISSURAL NEURON AXON GUIDANCE,0.32248,0.12816,0.13419,0,0
4,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.32248,0.12797,0.1264,0,0
4,GO PYRUVATE METABOLIC PROCESS,0.0066311,0.12785,0.17386,0,0
4,GO BRANCHING MORPHOGENESIS OF A NERVE,0.11163,0.1278,0.18214,0,0
4,GO HOMOCYSTEINE METABOLIC PROCESS,0.2998,0.12778,0.10292,0,0
4,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.065157,0.12774,0.10843,0,0
4,GO RESPONSE TO CHEMOKINE,0.60692,0.1277,0.057729,0,0
4,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.48117,0.1277,0.10065,0,0
4,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.17091,0.12763,0.14853,0,0
4,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,0.11163,0.12758,0.12834,0,0
4,GO SULFATE TRANSPORT,0.091819,0.12744,0.16237,0,0
4,GO T CELL PROLIFERATION,0.197,0.12738,0.17672,0,0
4,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.11524,0.12736,0.16907,0,0
4,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.197,0.12732,0.13983,0,0
4,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.11524,0.12727,0.085424,0,0
4,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,0.10134,0.12719,0.18922,0,0
4,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.15197,0.1271,0.13763,0,0
4,GO STEM CELL DIFFERENTIATION,0.023112,0.12707,0.1552,0,0
4,GO INTERLEUKIN 1 PRODUCTION,0.39705,0.12704,0.10887,0,0
4,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,0.065157,0.12702,0.17048,0,0
4,GO VITAMIN BIOSYNTHETIC PROCESS,0.24463,0.12686,0.12427,0,0
4,GO DORSAL VENTRAL PATTERN FORMATION,0.027226,0.12675,0.18024,0,0
4,GO POSITIVE REGULATION OF URINE VOLUME,0.10468,0.12674,0.19173,0,0
4,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,0.18102,0.12638,0.17842,0,0
4,GO PROTEIN DEMANNOSYLATION,0.072385,0.12616,0.18573,0,0
4,GO TELENCEPHALON REGIONALIZATION,0.76963,0.12608,0.014773,0,0
4,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.29248,0.12599,0.13728,0,0
4,GO REGULATION OF SECONDARY METABOLIC PROCESS,0.016475,0.12589,0.25446,0,0
4,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.0172,0.1257,0.17044,0,0
4,GO HIPPO SIGNALING,0.11163,0.12557,0.18806,0,0
4,GO T CELL EXTRAVASATION,0.25111,0.12552,0.1752,0,0
4,GO MESONEPHRIC TUBULE MORPHOGENESIS,0.10468,0.12551,0.13359,0,0
4,GO CHROMATIN SILENCING,0.19156,0.12551,0.10933,0,0
4,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,0.16602,0.12545,0.14112,0,0
4,GO LYMPHOCYTE ACTIVATION,0.16123,0.1254,0.17006,0,0
4,GO POSITIVE REGULATION OF CELL MATURATION,0.031957,0.12529,0.1976,0,0
4,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,0.2577,0.12503,0.12467,0,0
4,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,0.020391,0.12496,0.23629,0,0
4,GO MACROPHAGE APOPTOTIC PROCESS,0.68646,0.12471,0.052306,0,0
4,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,0.57414,0.1247,0.10827,0,0
4,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.2259,0.1247,0.15645,0,0
4,GO ANTIMICROBIAL HUMORAL RESPONSE,0.25111,0.12465,0.13569,0,0
4,GO DEFENSE RESPONSE TO FUNGUS,0.2577,0.1246,0.12223,0,0
4,GO LEUKOCYTE CELL CELL ADHESION,0.21989,0.12448,0.14859,0,0
4,GO T CELL DIFFERENTIATION,0.15197,0.12441,0.18274,0,0
4,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.17091,0.12435,0.16882,0,0
4,GO PROTEIN DNA COMPLEX DISASSEMBLY,0.043559,0.12429,0.15602,0,0
4,GO REGULATION OF GLIAL CELL MIGRATION,0.23827,0.12417,0.16872,0,0
4,GO FC RECEPTOR SIGNALING PATHWAY,0.11524,0.1241,0.12503,0,0
4,GO REGULATION OF MEMBRANE PERMEABILITY,0.040368,0.12406,0.12481,0,0
4,GO ETHER BIOSYNTHETIC PROCESS,0.2998,0.12403,0.097331,0,0
4,GO SEROTONIN SECRETION,0.21989,0.12386,0.15003,0,0
4,GO PEPTIDYL METHIONINE MODIFICATION,0.46168,0.12384,0.071727,0,0
4,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,0.067497,0.12373,0.16941,0,0
4,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,0.34626,0.12368,0.1418,0,0
4,GO SKELETAL SYSTEM DEVELOPMENT,0.023112,0.12345,0.20689,0,0
4,GO SEQUESTERING OF TRIGLYCERIDE,0.18102,0.12339,0.16177,0,0
4,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,0.0092139,0.12337,0.17207,0,0
4,GO RETINOL METABOLIC PROCESS,0.15197,0.12326,0.1028,0,0
4,GO POSITIVE REGULATION OF CELL ACTIVATION,0.2259,0.12324,0.15483,0,0
4,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.17091,0.12297,0.14167,0,0
4,GO FOAM CELL DIFFERENTIATION,0.16123,0.12288,0.1541,0,0
4,GO LABYRINTHINE LAYER DEVELOPMENT,0.080256,0.12272,0.14887,0,0
4,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.060677,0.12258,0.16836,0,0
4,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.44264,0.12254,0.14574,0,0
4,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.28529,0.12247,0.15097,0,0
4,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.033245,0.12238,0.16107,0,0
4,GO REGULATION OF NEURON PROJECTION REGENERATION,0.018736,0.12232,0.25129,0,0
4,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.2998,0.12226,0.14366,0,0
4,GO MODIFIED AMINO ACID TRANSPORT,0.0057394,0.12222,0.19955,0,0
4,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,0.29248,0.12218,0.11941,0,0
4,GO ENDOSOME TO LYSOSOME TRANSPORT,0.0047188,0.12216,0.27269,0,0
4,GO LEFT RIGHT AXIS SPECIFICATION,0.30724,0.1221,0.13103,0,0
4,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.19156,0.12207,0.16278,0,0
4,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.17591,0.12194,0.14114,0,0
4,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,0.10134,0.12193,0.11837,0,0
4,GO MYELOID LEUKOCYTE ACTIVATION,0.17591,0.12188,0.13932,0,0
4,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.094909,0.12182,0.17275,0,0
4,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.016475,0.12177,0.24173,0,0
4,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,0.78176,0.12154,0.022025,0,0
4,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.11524,0.12144,0.15467,0,0
4,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,0.038848,0.12139,0.2652,0,0
4,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,0.017954,0.121,0.17939,0,0
4,GO ATP BIOSYNTHETIC PROCESS,0.014457,0.1209,0.15065,0,0
4,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,0.28529,0.12087,0.12863,0,0
4,GO CARDIAC MUSCLE CELL PROLIFERATION,0.037377,0.12073,0.18738,0,0
4,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.056456,0.12066,0.16324,0,0
4,GO CYTOKINE SECRETION,0.2577,0.12049,0.12963,0,0
4,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.23827,0.12047,0.12523,0,0
4,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.0052065,0.12047,0.17469,0,0
4,GO POSITIVE REGULATION OF ORGAN GROWTH,0.08303,0.1204,0.16446,0,0
4,GO OVULATION,0.14312,0.12027,0.15279,0,0
4,GO MALE GAMETE GENERATION,0.010101,0.12013,0.17569,0,0
4,GO EMBRYONIC PLACENTA DEVELOPMENT,0.067497,0.12011,0.17949,0,0
4,GO REGULATION OF KIDNEY DEVELOPMENT,0.10468,0.12,0.15673,0,0
4,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,0.57414,0.11998,0.072957,0,0
4,GO MICROVILLUS ASSEMBLY,0.10468,0.11987,0.13058,0,0
4,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.30724,0.11985,0.11102,0,0
4,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.12273,0.11984,0.14076,0,0
4,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,0.15197,0.11979,0.12422,0,0
4,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.21989,0.11976,0.14089,0,0
4,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,0.197,0.1196,0.21437,0,0
4,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.15655,0.1196,0.15661,0,0
4,GO RESPONSE TO PROSTAGLANDIN,0.30724,0.11959,0.11752,0,0
4,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.067497,0.11945,0.17796,0,0
4,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.2259,0.11917,0.14308,0,0
4,GO PSEUDOPODIUM ORGANIZATION,0.28529,0.11911,0.13608,0,0
4,GO POSITIVE REGULATION OF B CELL ACTIVATION,0.17591,0.11908,0.18115,0,0
4,GO PHOSPHOLIPID DEPHOSPHORYLATION,0.020391,0.11892,0.27436,0,0
4,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.29248,0.11885,0.10726,0,0
4,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.38829,0.11866,0.14386,0,0
4,GO FIBROBLAST MIGRATION,0.052482,0.11861,0.18738,0,0
4,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,0.18624,0.11855,0.1694,0,0
4,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,0.08303,0.11848,0.15044,0,0
4,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.16602,0.11844,0.11584,0,0
4,GO VAGINA DEVELOPMENT,0.38829,0.11843,0.076888,0,0
4,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,0.23203,0.11826,0.16976,0,0
4,GO PROTEIN ADP RIBOSYLATION,0.062884,0.11824,0.13701,0,0
4,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,0.38829,0.11822,0.090631,0,0
4,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.18102,0.11822,0.1611,0,0
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,0.39705,0.11814,0.1116,0,0
4,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,0.1306,0.1181,0.15462,0,0
4,GO REGULATION OF FERTILIZATION,0.022172,0.11808,0.14539,0,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.55277,0.11806,0.072729,0,0
4,GO STEROL BIOSYNTHETIC PROCESS,0.072385,0.11805,0.1156,0,0
4,GO HYPOTONIC RESPONSE,0.16602,0.11805,0.14095,0,0
4,GO REGULATION OF LEUKOCYTE MIGRATION,0.33029,0.11802,0.13328,0,0
4,GO NEUTROPHIL HOMEOSTASIS,0.39705,0.11801,0.13373,0,0
4,GO OSTEOCLAST DIFFERENTIATION,0.16602,0.11799,0.15777,0,0
4,GO INTERLEUKIN 17 PRODUCTION,0.36271,0.11794,0.10797,0,0
4,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.44264,0.11793,0.11802,0,0
4,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.019548,0.11784,0.25272,0,0
4,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.52145,0.11783,0.094707,0,0
4,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.42405,0.11776,0.10856,0,0
4,GO L AMINO ACID TRANSPORT,0.045233,0.11774,0.15994,0,0
4,GO REGULATION OF SPINDLE ASSEMBLY,0.16602,0.11756,0.1202,0,0
4,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.011063,0.11746,0.16345,0,0
4,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.011063,0.11739,0.17303,0,0
4,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.17091,0.11724,0.16297,0,0
4,GO CELL ADHESION MOLECULE PRODUCTION,0.10468,0.1172,0.22744,0,0
4,GO EMBRYONIC ORGAN DEVELOPMENT,0.023112,0.11716,0.18752,0,0
4,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.08588,0.11712,0.21557,0,0
4,GO REGULATION OF B CELL ACTIVATION,0.24463,0.1171,0.17759,0,0
4,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.011574,0.11688,0.2131,0,0
4,GO RESPIRATORY BURST INVOLVED IN DEFENSE RESPONSE,0.20256,0.11685,0.16775,0,0
4,GO SMOOTH MUSCLE CONTRACTION,0.033245,0.11681,0.19019,0,0
4,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,0.050584,0.11636,0.1845,0,0
4,GO LEUKOCYTE APOPTOTIC PROCESS,0.34626,0.11634,0.12483,0,0
4,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,0.015104,0.1163,0.16163,0,0
4,GO FRUCTOSE METABOLIC PROCESS,0.062884,0.1163,0.14863,0,0
4,GO REGIONALIZATION,0.030713,0.11624,0.16508,0,0
4,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,0.060677,0.1162,0.13632,0,0
4,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,0.080256,0.11616,0.10401,0,0
4,GO NEUTROPHIL CHEMOTAXIS,0.69814,0.1161,0.050989,0,0
4,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.014457,0.11605,0.15395,0,0
4,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,0.27126,0.11603,0.06302,0,0
4,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.17591,0.11603,0.11655,0,0
4,GO REGULATION OF ATP METABOLIC PROCESS,0.0063209,0.11601,0.16584,0,0
4,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,0.035953,0.11594,0.16717,0,0
4,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.214,0.11592,0.18456,0,0
4,GO REGULATION OF ICOSANOID SECRETION,0.043559,0.11585,0.19233,0,0
4,GO PROSTATIC BUD FORMATION,0.23827,0.1157,0.1586,0,0
4,GO I KAPPAB KINASE NF KAPPAB SIGNALING,0.08303,0.11561,0.16887,0,0
4,GO AMYLOID BETA CLEARANCE,0.197,0.11554,0.16466,0,0
4,GO REGULATION OF T CELL ACTIVATION,0.23203,0.11534,0.15145,0,0
4,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.27821,0.11523,0.16783,0,0
4,GO REGULATION OF MULTI ORGANISM PROCESS,0.027226,0.11517,0.14257,0,0
4,GO POSITIVE REGULATION OF GLIOGENESIS,0.11524,0.11517,0.15672,0,0
4,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.056456,0.11512,0.14384,0,0
4,GO VIRAL RNA GENOME REPLICATION,0.043559,0.115,0.16112,0,0
4,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.26442,0.115,0.13405,0,0
4,GO RENAL TUBULE DEVELOPMENT,0.011063,0.11494,0.20068,0,0
4,GO REGULATION OF B CELL DIFFERENTIATION,0.2259,0.11494,0.1692,0,0
4,GO FIBROBLAST PROLIFERATION,0.094909,0.11492,0.16174,0,0
4,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.010572,0.1149,0.21309,0,0
4,GO REGULATION OF FIBROBLAST MIGRATION,0.065157,0.11487,0.17481,0,0
4,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.39705,0.11483,0.12365,0,0
4,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.42405,0.11476,0.099133,0,0
4,GO PEPTIDYL PROLINE HYDROXYLATION,0.072385,0.11472,0.14934,0,0
4,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.23203,0.11458,0.12568,0,0
4,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,0.34626,0.1145,0.13568,0,0
4,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.13885,0.11447,0.19659,0,0
4,GO TOXIN TRANSPORT,0.0080134,0.11436,0.22213,0,0
4,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.074935,0.11421,0.17411,0,0
4,GO REGULATION OF TRANSPOSITION,0.098083,0.11417,0.1334,0,0
4,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.17591,0.11407,0.17438,0,0
4,GO REGULATION OF GLUTAMATE SECRETION,0.091819,0.11407,0.22483,0,0
4,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.24463,0.11395,0.12382,0,0
4,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,0.050584,0.11394,0.15605,0,0
4,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,0.069906,0.11392,0.15955,0,0
4,GO LIMBIC SYSTEM DEVELOPMENT,0.0172,0.11385,0.17785,0,0
4,GO PROTEIN K63 LINKED DEUBIQUITINATION,0.054439,0.1138,0.15885,0,0
4,GO UTP METABOLIC PROCESS,0.024086,0.11378,0.1879,0,0
4,GO REGULATION OF MITOCHONDRIAL FISSION,0.0060238,0.11362,0.2295,0,0
4,GO REGULATION OF INNATE IMMUNE RESPONSE,0.17591,0.11358,0.12,0,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.24463,0.11333,0.13605,0,0
4,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,0.080256,0.11331,0.17502,0,0
4,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,0.069906,0.1132,0.12256,0,0
4,GO NATURAL KILLER CELL DIFFERENTIATION,0.11163,0.11319,0.18799,0,0
4,GO LEUKOCYTE MIGRATION,0.214,0.11318,0.16301,0,0
4,GO ALPHA BETA T CELL ACTIVATION,0.21989,0.11316,0.16797,0,0
4,GO BONE MORPHOGENESIS,0.052482,0.11313,0.21839,0,0
4,GO REGULATION OF BINDING,0.010572,0.11306,0.16987,0,0
4,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.10134,0.11274,0.16452,0,0
4,GO PROSTATE GLAND MORPHOGENESIS,0.30724,0.11272,0.13794,0,0
4,GO CELL FATE DETERMINATION,0.026142,0.11258,0.19576,0,0
4,GO ALPHA BETA T CELL DIFFERENTIATION,0.27126,0.11247,0.17556,0,0
4,GO LEUKOCYTE DIFFERENTIATION,0.13885,0.11229,0.17157,0,0
4,GO NEGATIVE REGULATION OF B CELL ACTIVATION,0.28529,0.11227,0.14811,0,0
4,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.26442,0.11223,0.15565,0,0
4,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,0.058535,0.11202,0.22694,0,0
4,GO NATURAL KILLER CELL ACTIVATION,0.32248,0.11188,0.12484,0,0
4,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.1475,0.11175,0.17394,0,0
4,GO OSTEOBLAST DIFFERENTIATION,0.033245,0.11174,0.17839,0,0
4,GO CRANIAL NERVE DEVELOPMENT,0.10468,0.11167,0.19312,0,0
4,GO CELL FATE COMMITMENT,0.013834,0.11164,0.19184,0,0
4,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.072385,0.11158,0.19203,0,0
4,GO CHONDROCYTE DEVELOPMENT,0.033245,0.11139,0.25296,0,0
4,GO NAD METABOLIC PROCESS,0.035953,0.11133,0.16255,0,0
4,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.08881,0.11133,0.18474,0,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.32248,0.11123,0.11532,0,0
4,GO AXONAL TRANSPORT OF MITOCHONDRION,0.16602,0.11119,0.13347,0,0
4,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,0.065157,0.11108,0.16503,0,0
4,GO GLIAL CELL PROLIFERATION,0.16123,0.11096,0.15542,0,0
4,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.067497,0.11095,0.16265,0,0
4,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,0.15655,0.11094,0.166,0,0
4,GO CELLULAR RESPONSE TO DSRNA,0.2259,0.11052,0.1306,0,0
4,GO REGULATION OF INTEGRIN ACTIVATION,0.197,0.11049,0.17427,0,0
4,GO POSITIVE REGULATION OF GLIAL CELL MIGRATION,0.23203,0.11046,0.20513,0,0
4,GO OXYGEN TRANSPORT,0.49108,0.11045,0.045344,0,0
4,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.33029,0.11037,0.13808,0,0
4,GO POSITIVE REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.011063,0.11035,0.17416,0,0
4,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,0.21989,0.11023,0.15857,0,0
4,GO HEPATOCYTE APOPTOTIC PROCESS,0.29248,0.10977,0.10451,0,0
4,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.38829,0.10963,0.10337,0,0
4,GO NON RECOMBINATIONAL REPAIR,0.10468,0.10955,0.12791,0,0
4,GO RELAXATION OF MUSCLE,0.025096,0.10943,0.25464,0,0
4,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.14312,0.10941,0.19054,0,0
4,GO RESPONSE TO VITAMIN A,0.38829,0.1094,0.069495,0,0
4,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.072385,0.10925,0.1195,0,0
4,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.13885,0.10914,0.096652,0,0
4,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.197,0.10913,0.13903,0,0
4,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,0.23827,0.1091,0.12176,0,0
4,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.077559,0.109,0.14663,0,0
4,GO NEPHRON MORPHOGENESIS,0.048745,0.10888,0.17448,0,0
4,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.30724,0.10884,0.1289,0,0
4,GO NEUTROPHIL MIGRATION,0.61803,0.10881,0.066635,0,0
4,GO SINGLE STRAND BREAK REPAIR,0.12662,0.10879,0.15811,0,0
4,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.074935,0.10879,0.25307,0,0
4,GO ANGIOTENSIN ACTIVATED SIGNALING PATHWAY,0.11524,0.10863,0.13164,0,0
4,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.19156,0.1086,0.15074,0,0
4,GO UROGENITAL SYSTEM DEVELOPMENT,0.043559,0.1085,0.18678,0,0
4,GO MUSCLE FILAMENT SLIDING,0.052482,0.1085,0.16121,0,0
4,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.062884,0.1085,0.18281,0,0
4,GO IN UTERO EMBRYONIC DEVELOPMENT,0.0060238,0.10846,0.1862,0,0
4,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.28529,0.10844,0.1461,0,0
4,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,0.18102,0.10835,0.12944,0,0
4,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.1475,0.1083,0.1154,0,0
4,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.11894,0.10829,0.14537,0,0
4,GO ESCRT COMPLEX DISASSEMBLY,0.024086,0.10826,0.15878,0,0
4,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.48117,0.10814,0.10886,0,0
4,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,0.098083,0.10811,0.12267,0,0
4,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.81845,0.10806,-0.024905,0,0
4,GO REGULATION OF T CELL CHEMOTAXIS,0.78176,0.10795,0.0609,0,0
4,GO MRNA PROCESSING,0.1306,0.10782,0.11072,0,0
4,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.18624,0.10778,0.16285,0,0
4,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.13885,0.10778,0.11658,0,0
4,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.27821,0.10772,0.13845,0,0
4,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.18102,0.1077,0.17024,0,0
4,GO FEMALE GENITALIA DEVELOPMENT,0.2998,0.10767,0.084829,0,0
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,0.15655,0.10763,0.15012,0,0
4,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.37964,0.10721,0.091043,0,0
4,GO DECIDUALIZATION,0.12662,0.10701,0.21153,0,0
4,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.76963,0.10696,0.038517,0,0
4,GO CORTICAL CYTOSKELETON ORGANIZATION,0.08881,0.10691,0.15698,0,0
4,GO T HELPER 2 CELL DIFFERENTIATION,0.33029,0.10686,0.16626,0,0
4,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,0.14312,0.10673,0.19986,0,0
4,GO PROTEIN STABILIZATION,0.021265,0.10671,0.1372,0,0
4,GO REGULATION OF OOGENESIS,0.10811,0.10661,0.12086,0,0
4,GO GROOMING BEHAVIOR,0.2998,0.1066,0.13226,0,0
4,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.050584,0.10648,0.12115,0,0
4,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.2577,0.10642,0.12303,0,0
4,GO POLYSACCHARIDE CATABOLIC PROCESS,0.214,0.1063,0.10754,0,0
4,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.065157,0.10628,0.1809,0,0
4,GO ORGAN INDUCTION,0.11524,0.10616,0.11185,0,0
4,GO REGULATION OF PROTON TRANSPORT,0.008797,0.10606,0.1569,0,0
4,GO CELLULAR RESPONSE TO LITHIUM ION,0.39705,0.10604,0.056726,0,0
4,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.10468,0.10599,0.11338,0,0
4,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.11163,0.10597,0.15172,0,0
4,GO T HELPER 1 TYPE IMMUNE RESPONSE,0.4521,0.10596,0.12016,0,0
4,GO CONNECTIVE TISSUE DEVELOPMENT,0.010572,0.10594,0.22363,0,0
4,GO LEUKOCYTE MEDIATED CYTOTOXICITY,0.37111,0.10593,0.11203,0,0
4,GO COCHLEA MORPHOGENESIS,0.27821,0.10585,0.12752,0,0
4,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.50109,0.10576,0.10656,0,0
4,GO NEURON FATE COMMITMENT,0.28529,0.10572,0.12484,0,0
4,GO BLEB ASSEMBLY,0.37964,0.1055,0.10411,0,0
4,GO POSITIVE REGULATION OF NUCLEAR DIVISION,0.062884,0.1054,0.13892,0,0
4,GO MULTI ORGANISM CELLULAR PROCESS,0.197,0.10512,0.16694,0,0
4,GO REGULATION OF URINE VOLUME,0.08303,0.10505,0.17649,0,0
4,GO REGULATION OF CHROMATIN BINDING,0.10811,0.105,0.14896,0,0
4,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,0.046961,0.10497,0.13775,0,0
4,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.077559,0.10487,0.1313,0,0
4,GO MEIOTIC SPINDLE ORGANIZATION,0.12662,0.10482,0.18875,0,0
4,GO REGULATION OF ISOTYPE SWITCHING,0.067497,0.10476,0.20572,0,0
4,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.33029,0.1046,0.079335,0,0
4,GO MEMBRANE FISSION,0.080256,0.1046,0.21301,0,0
4,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.2259,0.10432,0.14382,0,0
4,GO REGULATION OF RENAL SYSTEM PROCESS,0.1475,0.10408,0.16042,0,0
4,GO PROTEIN OXIDATION,0.10468,0.10404,0.15758,0,0
4,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.058535,0.10402,0.15971,0,0
4,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,0.56341,0.1038,0.065462,0,0
4,GO CYTOKINE METABOLIC PROCESS,0.20822,0.10374,0.13721,0,0
4,GO RESPONSE TO VIRUS,0.13885,0.10374,0.146,0,0
4,GO MESODERMAL CELL DIFFERENTIATION,0.072385,0.10373,0.19008,0,0
4,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.47137,0.10367,0.1134,0,0
4,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,0.08881,0.10358,0.1809,0,0
4,GO REPRODUCTIVE SYSTEM DEVELOPMENT,0.022172,0.10352,0.17211,0,0
4,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,0.019548,0.10345,0.16704,0,0
4,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.0083971,0.10341,0.16151,0,0
4,GO POSITIVE REGULATION OF BINDING,0.02951,0.10306,0.14356,0,0
4,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.23203,0.10305,0.15667,0,0
4,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.18624,0.10304,0.15443,0,0
4,GO NEGATIVE REGULATION OF OSSIFICATION,0.062884,0.10283,0.20565,0,0
4,GO LYMPHOCYTE DIFFERENTIATION,0.1306,0.10279,0.18261,0,0
4,GO MYOBLAST PROLIFERATION,0.1306,0.10277,0.19864,0,0
4,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.27126,0.10268,0.14881,0,0
4,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.08881,0.10266,0.13283,0,0
4,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,0.16123,0.10262,0.15601,0,0
4,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.23827,0.10254,0.21403,0,0
4,GO PODOSOME ASSEMBLY,0.13885,0.10226,0.19854,0,0
4,GO LEUKOCYTE PROLIFERATION,0.23203,0.10218,0.15995,0,0
4,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,0.16123,0.10202,0.15276,0,0
4,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.39705,0.10189,0.12434,0,0
4,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.028348,0.1018,0.20721,0,0
4,GO RENAL SODIUM EXCRETION,0.091819,0.10178,0.17337,0,0
4,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.2998,0.10176,0.15239,0,0
4,GO IMMUNE SYSTEM DEVELOPMENT,0.080256,0.10171,0.16731,0,0
4,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.1475,0.10154,0.18543,0,0
4,GO LEUKOCYTE HOMEOSTASIS,0.28529,0.10146,0.12176,0,0
4,GO ZYMOGEN INHIBITION,0.30724,0.10144,0.13684,0,0
4,GO REGULATION OF PROTEIN STABILITY,0.0080134,0.10129,0.15142,0,0
4,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.32248,0.10125,0.13602,0,0
4,GO POLYAMINE METABOLIC PROCESS,0.010101,0.1011,0.13486,0,0
4,GO REGULATION OF ANOIKIS,0.14312,0.1008,0.17949,0,0
4,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.4521,0.10074,0.12586,0,0
4,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.55277,0.10071,0.058185,0,0
4,GO GENE SILENCING,0.040368,0.1007,0.14925,0,0
4,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.0042727,0.10066,0.15049,0,0
4,GO GLYCOLIPID BIOSYNTHETIC PROCESS,0.00091199,0.10063,0.19609,0,0
4,GO CELL KILLING,0.37111,0.1006,0.10638,0,0
4,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.010572,0.10046,0.16216,0,0
4,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.0076456,0.10045,0.18556,0,0
4,GO BICARBONATE TRANSPORT,0.3148,0.10039,0.081279,0,0
4,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.39705,0.10034,0.090362,0,0
4,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.054439,0.10021,0.10924,0,0
4,GO PROSTAGLANDIN TRANSPORT,0.13467,0.10014,0.17296,0,0
4,GO HETEROTYPIC CELL CELL ADHESION,0.26442,0.10006,0.13505,0,0
4,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,0.0092139,0.10005,0.13522,0,0
4,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.077559,0.10001,0.14473,0,0
4,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,0.015104,0.099948,0.17684,0,0
4,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.040368,0.099896,0.17809,0,0
4,GO OOCYTE MATURATION,0.12662,0.099884,0.12765,0,0
4,GO AMINE CATABOLIC PROCESS,0.27126,0.099849,0.11094,0,0
4,GO CELLULAR RESPONSE TO IRON ION,0.44264,0.099824,0.10707,0,0
4,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.15655,0.099815,0.10005,0,0
4,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.27821,0.099715,0.12195,0,0
4,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,0.2998,0.099588,0.11031,0,0
4,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.28529,0.099559,0.11362,0,0
4,GO GABAERGIC NEURON DIFFERENTIATION,0.08881,0.099531,0.24402,0,0
4,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.35442,0.099496,0.11035,0,0
4,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,0.23203,0.09894,0.11543,0,0
4,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.015776,0.09879,0.12831,0,0
4,GO DEFINITIVE HEMOPOIESIS,0.091819,0.098789,0.22299,0,0
4,GO INTRACELLULAR STEROL TRANSPORT,0.16602,0.098694,0.15031,0,0
4,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.39705,0.098607,0.13062,0,0
4,GO EMBRYONIC BRAIN DEVELOPMENT,0.2259,0.098325,0.12247,0,0
4,GO SULFUR AMINO ACID METABOLIC PROCESS,0.037377,0.098228,0.14183,0,0
4,GO SIGNAL PEPTIDE PROCESSING,0.094909,0.097839,0.16667,0,0
4,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.214,0.097821,0.15686,0,0
4,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,0.17091,0.097805,0.15195,0,0
4,GO COPPER ION TRANSPORT,0.197,0.097782,0.11554,0,0
4,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.37111,0.097773,0.12537,0,0
4,GO SMAD PROTEIN COMPLEX ASSEMBLY,0.214,0.097763,0.11209,0,0
4,GO REGULATION OF CELL DIVISION,0.060677,0.097667,0.14283,0,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,0.43329,0.097553,0.1301,0,0
4,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.11163,0.09752,0.11833,0,0
4,GO INNER CELL MASS CELL PROLIFERATION,0.54223,0.097447,0.078137,0,0
4,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.10811,0.097351,0.20267,0,0
4,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.13467,0.097345,0.17837,0,0
4,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.47137,0.097196,0.082141,0,0
4,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.038848,0.097169,0.25833,0,0
4,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.024086,0.097167,0.14092,0,0
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.12273,0.096817,0.12667,0,0
4,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.30724,0.096705,0.078167,0,0
4,GO NUCLEAR ENVELOPE ORGANIZATION,0.072385,0.096592,0.14375,0,0
4,GO CELLULAR RESPONSE TO STARVATION,0.00332,0.096105,0.18213,0,0
4,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.15655,0.096038,0.16499,0,0
4,GO GLAND DEVELOPMENT,0.0047188,0.095996,0.20678,0,0
4,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,0.0040644,0.095924,0.16125,0,0
4,GO POSITIVE REGULATION OF CHEMOKINE SECRETION,0.49108,0.095717,0.11117,0,0
4,GO B CELL DIFFERENTIATION,0.1306,0.09565,0.17869,0,0
4,GO ODONTOGENESIS,0.072385,0.095602,0.17357,0,0
4,GO C4 DICARBOXYLATE TRANSPORT,0.067497,0.095463,0.12974,0,0
4,GO POSITIVE REGULATION OF HEART GROWTH,0.074935,0.095274,0.16247,0,0
4,GO REGULATION OF ANGIOTENSIN LEVELS IN BLOOD,0.50109,0.095052,0.069238,0,0
4,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.091819,0.095042,0.16957,0,0
4,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,0.2998,0.094988,0.073719,0,0
4,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.20256,0.094912,0.12767,0,0
4,GO POSITIVE REGULATION OF T CELL PROLIFERATION,0.41494,0.094867,0.12365,0,0
4,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.037377,0.094628,0.20669,0,0
4,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.069906,0.094594,0.20736,0,0
4,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.0042727,0.094558,0.14466,0,0
4,GO INDOLALKYLAMINE METABOLIC PROCESS,0.11163,0.094359,0.16533,0,0
4,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.041938,0.094304,0.16369,0,0
4,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,0.19156,0.09428,0.15533,0,0
4,GO SEX DIFFERENTIATION,0.035953,0.09424,0.15711,0,0
4,GO NOTOCHORD DEVELOPMENT,0.46168,0.094231,0.097939,0,0
4,GO ONE CARBON METABOLIC PROCESS,0.052482,0.094088,0.1109,0,0
4,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.020391,0.094076,0.24046,0,0
4,GO DICARBOXYLIC ACID CATABOLIC PROCESS,0.056456,0.094051,0.14968,0,0
4,GO MAINTENANCE OF BLOOD BRAIN BARRIER,0.056456,0.094016,0.18863,0,0
4,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.16123,0.093997,0.1083,0,0
4,GO PROTEIN TARGETING TO LYSOSOME,0.42405,0.09394,0.13114,0,0
4,GO RETINAL ROD CELL DIFFERENTIATION,0.37111,0.093913,0.071606,0,0
4,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.16602,0.093827,0.13804,0,0
4,GO MULTIVESICULAR BODY SORTING PATHWAY,0.013834,0.093794,0.14776,0,0
4,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.20256,0.093706,0.13549,0,0
4,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.2998,0.093685,0.11598,0,0
4,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.35442,0.093483,0.10883,0,0
4,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.197,0.093456,0.1919,0,0
4,GO NCRNA CATABOLIC PROCESS,0.10134,0.093373,0.12213,0,0
4,GO L GLUTAMATE IMPORT,0.16123,0.093293,0.11574,0,0
4,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.12662,0.093247,0.11591,0,0
4,GO SKELETAL SYSTEM MORPHOGENESIS,0.13467,0.09322,0.16241,0,0
4,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.36271,0.093037,0.12456,0,0
4,GO ANDROGEN METABOLIC PROCESS,0.098083,0.092958,0.092814,0,0
4,GO MYELOID LEUKOCYTE DIFFERENTIATION,0.18624,0.092921,0.14665,0,0
4,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.0092139,0.092846,0.14206,0,0
4,GO CYTOKINESIS,0.11524,0.092753,0.12725,0,0
4,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,0.046961,0.092722,0.27771,0,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,0.37964,0.092676,0.082307,0,0
4,GO POSITIVE REGULATION OF COAGULATION,0.2259,0.092497,0.13714,0,0
4,GO THIOESTER METABOLIC PROCESS,0.08303,0.092483,0.10113,0,0
4,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.20256,0.09242,0.11847,0,0
4,GO MITOCHONDRIAL FISSION,0.00332,0.092377,0.21041,0,0
4,GO GENITALIA DEVELOPMENT,0.28529,0.092292,0.11497,0,0
4,GO DICARBOXYLIC ACID METABOLIC PROCESS,0.010572,0.092287,0.13033,0,0
4,GO REGULATION OF B CELL APOPTOTIC PROCESS,0.2577,0.092168,0.11499,0,0
4,GO RECEPTOR BIOSYNTHETIC PROCESS,0.25111,0.092123,0.11339,0,0
4,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.37964,0.092067,0.086363,0,0
4,GO HISTONE H4 K16 ACETYLATION,0.16123,0.092051,0.14686,0,0
4,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.021265,0.091993,0.1621,0,0
4,GO RESPONSE TO DEXAMETHASONE,0.25111,0.091964,0.093111,0,0
4,GO REGULATION OF NEUROBLAST PROLIFERATION,0.26442,0.091894,0.11708,0,0
4,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,0.094909,0.091846,0.14426,0,0
4,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.37111,0.091834,0.11683,0,0
4,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.2259,0.091819,0.16645,0,0
4,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,0.0092139,0.091731,0.16862,0,0
4,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.43329,0.0917,0.1369,0,0
4,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.18102,0.091604,0.14606,0,0
4,GO RETINAL METABOLIC PROCESS,0.26442,0.091602,0.11289,0,0
4,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.13467,0.091457,0.14978,0,0
4,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.11524,0.091441,0.15828,0,0
4,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.11163,0.091392,0.13443,0,0
4,GO RESPONSE TO FATTY ACID,0.18102,0.091273,0.12313,0,0
4,GO PROTEIN CONTAINING COMPLEX REMODELING,0.37964,0.091244,0.091558,0,0
4,GO STEM CELL PROLIFERATION,0.052482,0.091233,0.18911,0,0
4,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.18102,0.091171,0.19974,0,0
4,GO PROTEIN K63 LINKED UBIQUITINATION,0.025096,0.091105,0.16069,0,0
4,GO REGULATION OF T CELL DIFFERENTIATION,0.2259,0.091085,0.15645,0,0
4,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,0.49108,0.090815,0.12987,0,0
4,GO EMBRYONIC HEMOPOIESIS,0.1475,0.090762,0.18017,0,0
4,GO PEPTIDYL PROLINE MODIFICATION,0.048745,0.090536,0.10602,0,0
4,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.37111,0.090464,0.069511,0,0
4,GO REGULATION OF CELL FATE COMMITMENT,0.18102,0.090346,0.13317,0,0
4,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.44264,0.090328,0.11653,0,0
4,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.35442,0.090271,0.10456,0,0
4,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.077559,0.090245,0.17068,0,0
4,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,0.30724,0.090089,0.11485,0,0
4,GO REGULATION OF SULFUR METABOLIC PROCESS,0.056456,0.090032,0.17003,0,0
4,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.33821,0.08987,0.12971,0,0
4,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.197,0.08983,0.14958,0,0
4,GO RESPONSE TO NITRIC OXIDE,0.17091,0.0897,0.12198,0,0
4,GO NEUROBLAST DIVISION,0.23827,0.089685,0.12977,0,0
4,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.2998,0.089601,0.10065,0,0
4,GO SLEEP,0.13885,0.089495,0.13846,0,0
4,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.27821,0.089461,0.11947,0,0
4,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.3148,0.08946,0.15419,0,0
4,GO LIPID EXPORT FROM CELL,0.11894,0.089355,0.12247,0,0
4,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.26442,0.089325,0.1375,0,0
4,GO POSITIVE REGULATION OF CELL DIVISION,0.094909,0.089304,0.1283,0,0
4,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,0.3148,0.089269,0.13907,0,0
4,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.094909,0.089243,0.11569,0,0
4,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.098083,0.089049,0.15782,0,0
4,GO LABYRINTHINE LAYER MORPHOGENESIS,0.34626,0.088939,0.099822,0,0
4,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,0.29248,0.088809,0.11849,0,0
4,GO REGULATION OF NIK NF KAPPAB SIGNALING,0.20256,0.088627,0.1365,0,0
4,GO RNA SPLICING,0.214,0.088584,0.089774,0,0
4,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.60692,0.088547,0.06773,0,0
4,GO GANGLIOSIDE METABOLIC PROCESS,0.08881,0.088494,0.16384,0,0
4,GO MYELOID CELL APOPTOTIC PROCESS,0.44264,0.088482,0.097336,0,0
4,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,0.23203,0.088384,0.16793,0,0
4,GO SINGLE FERTILIZATION,0.0172,0.088375,0.13024,0,0
4,GO EMBRYONIC DIGIT MORPHOGENESIS,0.060677,0.088374,0.16884,0,0
4,GO REGULATION OF LEUKOCYTE PROLIFERATION,0.2577,0.088292,0.15915,0,0
4,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.53179,0.088157,0.081,0,0
4,GO CHROMATIN REMODELING,0.10134,0.087783,0.14284,0,0
4,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.16602,0.087783,0.15712,0,0
4,GO GAS TRANSPORT,0.40594,0.087726,0.076027,0,0
4,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.10468,0.087534,0.20008,0,0
4,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.18624,0.087511,0.095379,0,0
4,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.10468,0.087457,0.11824,0,0
4,GO PROTEIN K48 LINKED UBIQUITINATION,0.20256,0.087421,0.10057,0,0
4,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,0.050584,0.087416,0.13289,0,0
4,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,0.13885,0.087363,0.094697,0,0
4,GO EMBRYONIC ORGAN MORPHOGENESIS,0.031957,0.087359,0.17994,0,0
4,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.47137,0.087328,0.099008,0,0
4,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.33029,0.087223,0.093101,0,0
4,GO CELLULAR OXIDANT DETOXIFICATION,0.2577,0.087121,0.07501,0,0
4,GO GLIAL CELL APOPTOTIC PROCESS,0.054439,0.087069,0.17646,0,0
4,GO REGULATION OF CELL SHAPE,0.074935,0.087041,0.20593,0,0
4,GO NEGATIVE REGULATION OF CELL AGING,0.10134,0.086923,0.12611,0,0
4,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.10134,0.086907,0.11459,0,0
4,GO CELLULAR RESPONSE TO INTERFERON BETA,0.46168,0.086584,0.10126,0,0
4,GO DORSAL VENTRAL AXIS SPECIFICATION,0.34626,0.086564,0.092988,0,0
4,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.08588,0.08655,0.14417,0,0
4,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.12273,0.086374,0.10597,0,0
4,GO KILLING OF CELLS OF OTHER ORGANISM,0.38829,0.086351,0.062466,0,0
4,GO REGULATION OF REPRODUCTIVE PROCESS,0.074935,0.086271,0.11943,0,0
4,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.33029,0.08619,0.12511,0,0
4,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.062884,0.086188,0.14496,0,0
4,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.1475,0.085859,0.19179,0,0
4,GO NEGATIVE REGULATION OF LIPID STORAGE,0.2577,0.085737,0.13962,0,0
4,GO REGULATION OF HEART GROWTH,0.048745,0.085733,0.16079,0,0
4,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.045233,0.085644,0.18431,0,0
4,GO RESPONSE TO HYDROGEN PEROXIDE,0.072385,0.085633,0.14351,0,0
4,GO REGULATION OF SPROUTING ANGIOGENESIS,0.19156,0.085591,0.1629,0,0
4,GO BILE ACID BIOSYNTHETIC PROCESS,0.069906,0.085539,0.13994,0,0
4,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,0.18102,0.085515,0.18517,0,0
4,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.48117,0.085349,0.091271,0,0
4,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.17591,0.085244,0.086555,0,0
4,GO KIDNEY MORPHOGENESIS,0.02951,0.085223,0.1827,0,0
4,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.33821,0.08521,0.10624,0,0
4,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.16602,0.085098,0.12618,0,0
4,GO MACROMOLECULE CATABOLIC PROCESS,0.014457,0.08505,0.13878,0,0
4,GO BLASTODERM SEGMENTATION,0.14312,0.084991,0.14256,0,0
4,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,0.20256,0.084899,0.13053,0,0
4,GO MODULATION OF PROCESS OF OTHER ORGANISM,0.23827,0.08485,0.10617,0,0
4,GO RESPONSE TO SALT STRESS,0.2259,0.084636,0.11648,0,0
4,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.37964,0.084587,0.13881,0,0
4,GO AMINO SUGAR BIOSYNTHETIC PROCESS,0.080256,0.084536,0.14226,0,0
4,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.094909,0.084279,0.14756,0,0
4,GO INTRA S DNA DAMAGE CHECKPOINT,0.2998,0.08424,0.12039,0,0
4,GO 3 UTR MEDIATED MRNA STABILIZATION,0.18624,0.084194,0.14075,0,0
4,GO DNA CATABOLIC PROCESS,0.048745,0.08418,0.12306,0,0
4,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,0.214,0.083967,0.099666,0,0
4,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.27126,0.083884,0.071278,0,0
4,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,0.66333,0.083863,0.040756,0,0
4,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.2998,0.083843,0.10114,0,0
4,GO AMINO ACID TRANSMEMBRANE TRANSPORT,0.091819,0.083805,0.14351,0,0
4,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.35442,0.083606,0.10913,0,0
4,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.46168,0.083598,0.085173,0,0
4,GO TRANSCRIPTION BY RNA POLYMERASE I,0.10811,0.083533,0.13196,0,0
4,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,0.3148,0.083363,0.16297,0,0
4,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.2259,0.083207,0.12436,0,0
4,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.091819,0.083178,0.14588,0,0
4,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,0.27821,0.083094,0.12135,0,0
4,GO RETINOIC ACID METABOLIC PROCESS,0.4521,0.083073,0.049323,0,0
4,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,0.13885,0.082926,0.1669,0,0
4,GO NUCLEUS ORGANIZATION,0.052482,0.082788,0.14365,0,0
4,GO MISMATCH REPAIR,0.18102,0.08278,0.11976,0,0
4,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.2259,0.082776,0.12202,0,0
4,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,0.62923,0.08266,0.074936,0,0
4,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,0.10134,0.082644,0.10154,0,0
4,GO DENDRITIC CELL DIFFERENTIATION,0.37964,0.082628,0.16909,0,0
4,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,0.40594,0.082624,0.096065,0,0
4,GO NEUROTROPHIN SIGNALING PATHWAY,0.046961,0.082594,0.18746,0,0
4,GO HORMONE CATABOLIC PROCESS,0.16123,0.082552,0.13902,0,0
4,GO BLASTOCYST DEVELOPMENT,0.038848,0.082502,0.11592,0,0
4,GO HISTONE H2B UBIQUITINATION,0.197,0.082435,0.10602,0,0
4,GO ATP METABOLIC PROCESS,0.0044907,0.082421,0.10681,0,0
4,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.098083,0.08206,0.14154,0,0
4,GO PROTEIN MONOUBIQUITINATION,0.11163,0.081999,0.11816,0,0
4,GO RESPONSE TO UV,0.10134,0.081748,0.12153,0,0
4,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.094909,0.081717,0.17155,0,0
4,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.031957,0.081516,0.15934,0,0
4,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.61803,0.081299,0.068332,0,0
4,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.214,0.081218,0.16123,0,0
4,GO FEVER GENERATION,0.33029,0.081118,0.086128,0,0
4,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.43329,0.080997,0.11376,0,0
4,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.08881,0.08097,0.10569,0,0
4,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.29248,0.080731,0.10502,0,0
4,GO G2 DNA DAMAGE CHECKPOINT,0.37964,0.080598,0.094491,0,0
4,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.36271,0.080303,0.082718,0,0
4,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,0.46168,0.080158,0.072779,0,0
4,GO RESPONSE TO HYDROXYUREA,0.48117,0.080139,0.1068,0,0
4,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.30724,0.080121,0.091587,0,0
4,GO HEAT GENERATION,0.30724,0.080024,0.10319,0,0
4,GO CELLULAR RESPONSE TO ZINC ION,0.76963,0.080009,0.044825,0,0
4,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.014457,0.079881,0.13465,0,0
4,GO REGULATION OF GLUCOSE IMPORT,0.094909,0.07958,0.14735,0,0
4,GO REGULATION OF GLIOGENESIS,0.041938,0.079564,0.15728,0,0
4,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,0.1306,0.079513,0.092777,0,0
4,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.20822,0.079433,0.077906,0,0
4,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.006955,0.079405,0.10322,0,0
4,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.17091,0.079309,0.20045,0,0
4,GO INCLUSION BODY ASSEMBLY,0.13885,0.079249,0.16978,0,0
4,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.045233,0.079189,0.13926,0,0
4,GO NEGATIVE REGULATION OF VIRAL PROCESS,0.28529,0.079187,0.12506,0,0
4,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.041938,0.079136,0.11725,0,0
4,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,0.47137,0.079125,0.11125,0,0
4,GO NEGATIVE REGULATION OF HEMOPOIESIS,0.12662,0.079096,0.17026,0,0
4,GO COENZYME A BIOSYNTHETIC PROCESS,0.214,0.079041,0.089181,0,0
4,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,0.23203,0.078992,0.11107,0,0
4,GO REGULATION OF SYMBIOTIC PROCESS,0.10811,0.078982,0.13975,0,0
4,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.15197,0.078755,0.10692,0,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.11894,0.078736,0.12115,0,0
4,GO RNA 3 END PROCESSING,0.27126,0.078643,0.082455,0,0
4,GO MANGANESE ION TRANSPORT,0.2577,0.078639,0.10309,0,0
4,GO VITAMIN METABOLIC PROCESS,0.067497,0.078461,0.11537,0,0
4,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.23203,0.078296,0.083952,0,0
4,GO LIVER MORPHOGENESIS,0.23827,0.078222,0.12009,0,0
4,GO BLASTOCYST FORMATION,0.074935,0.078197,0.10443,0,0
4,GO AMINO SUGAR CATABOLIC PROCESS,0.58498,0.078118,0.067671,0,0
4,GO RESPONSE TO ZINC ION,0.17591,0.078101,0.11011,0,0
4,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.2998,0.07807,0.11492,0,0
4,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,0.60692,0.078017,0.037698,0,0
4,GO NEGATIVE REGULATION OF AMINO ACID TRANSPORT,0.16123,0.078012,0.15194,0,0
4,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.1475,0.077972,0.076605,0,0
4,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.30724,0.077722,0.12338,0,0
4,GO BILE ACID METABOLIC PROCESS,0.08881,0.077681,0.13307,0,0
4,GO APPENDAGE DEVELOPMENT,0.072385,0.077569,0.18121,0,0
4,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.16602,0.077465,0.12223,0,0
4,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.10811,0.077427,0.11972,0,0
4,GO PROSTANOID METABOLIC PROCESS,0.17091,0.077415,0.12061,0,0
4,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,0.072385,0.077355,0.10627,0,0
4,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.32248,0.077288,0.14815,0,0
4,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,0.054439,0.07705,0.12837,0,0
4,GO REGULATION OF GENE SILENCING,0.045233,0.076682,0.14237,0,0
4,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,0.033245,0.076621,0.12028,0,0
4,GO REGULATION OF CYTOPLASMIC TRANSPORT,0.08588,0.07653,0.16065,0,0
4,GO MITOCHONDRIAL TRANSPORT,0.020391,0.076501,0.11497,0,0
4,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.074935,0.07644,0.10755,0,0
4,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.08881,0.076354,0.12442,0,0
4,GO SPERMATID NUCLEUS DIFFERENTIATION,0.47137,0.076292,0.065093,0,0
4,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,0.44264,0.076272,0.10002,0,0
4,GO MITOCHONDRION ORGANIZATION,0.0034935,0.076191,0.12349,0,0
4,GO EMBRYONIC FORELIMB MORPHOGENESIS,0.48117,0.076117,0.076661,0,0
4,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.90549,0.07597,0.0089817,0,0
4,GO ACROSOME ASSEMBLY,0.2259,0.075937,0.12614,0,0
4,GO POSITIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.52145,0.075835,0.096336,0,0
4,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,0.098083,0.075831,0.13871,0,0
4,GO POSITIVE REGULATION OF VASCULOGENESIS,0.15197,0.07578,0.14606,0,0
4,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,0.42405,0.07578,0.099119,0,0
4,GO CELLULAR DEFENSE RESPONSE,0.53179,0.075702,0.10586,0,0
4,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,0.17591,0.075692,0.1951,0,0
4,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.10134,0.075438,0.095947,0,0
4,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.25111,0.075422,0.099999,0,0
4,GO SOMATIC STEM CELL DIVISION,0.20256,0.07538,0.18701,0,0
4,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.26442,0.075256,0.1296,0,0
4,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.4521,0.075201,0.063503,0,0
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.065157,0.075055,0.11747,0,0
4,GO OTIC VESICLE DEVELOPMENT,0.69814,0.074965,0.041105,0,0
4,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.10468,0.074909,0.15616,0,0
4,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.18624,0.074727,0.14903,0,0
4,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.077559,0.074609,0.13505,0,0
4,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,0.36271,0.074555,0.1044,0,0
4,GO REGULATION OF CELL AGING,0.1475,0.074421,0.096213,0,0
4,GO REGULATION OF HISTONE PHOSPHORYLATION,0.29248,0.074332,0.10838,0,0
4,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.98106,0.074313,0.030737,0,0
4,GO REGULATION OF GTP BINDING,0.27821,0.074072,0.11865,0,0
4,GO REGULATION OF PROTEIN DEUBIQUITINATION,0.10468,0.074011,0.15432,0,0
4,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.50109,0.07394,0.070297,0,0
4,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.15655,0.073914,0.10503,0,0
4,GO CELLULAR RESPONSE TO VIRUS,0.10811,0.073871,0.15231,0,0
4,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,0.23827,0.07387,0.14074,0,0
4,GO CHOLESTEROL STORAGE,0.2259,0.073794,0.14855,0,0
4,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.18624,0.073752,0.099334,0,0
4,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.08588,0.073311,0.10817,0,0
4,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.40594,0.073279,0.097724,0,0
4,GO TROPHOBLAST CELL MIGRATION,0.13885,0.073268,0.17224,0,0
4,GO POSITIVE REGULATION OF VIRAL PROCESS,0.094909,0.073249,0.12018,0,0
4,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,0.25111,0.073037,0.11153,0,0
4,GO ORGANELLE INHERITANCE,0.094909,0.072948,0.11725,0,0
4,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.026142,0.072786,0.1138,0,0
4,GO REGULATION OF T HELPER CELL DIFFERENTIATION,0.2577,0.07276,0.17095,0,0
4,GO SKELETAL MUSCLE CELL PROLIFERATION,0.33029,0.072421,0.088507,0,0
4,GO COPII COATED VESICLE CARGO LOADING,0.054439,0.072399,0.19498,0,0
4,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,0.3148,0.072165,0.084998,0,0
4,GO APPENDAGE MORPHOGENESIS,0.12662,0.072057,0.17383,0,0
4,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,0.16602,0.072053,0.11196,0,0
4,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.069906,0.071983,0.157,0,0
4,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.098083,0.071832,0.10533,0,0
4,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.18624,0.071776,0.10916,0,0
4,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.90549,0.071695,0.038587,0,0
4,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.23827,0.071672,0.11705,0,0
4,GO RESPONSE TO ANTIBIOTIC,0.13885,0.071487,0.11502,0,0
4,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,0.72171,0.071477,0.050462,0,0
4,GO SNRNA TRANSCRIPTION,0.37111,0.071397,0.079318,0,0
4,GO REGULATION OF PROTEIN IMPORT,0.11524,0.071325,0.12038,0,0
4,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,0.17091,0.071198,0.16218,0,0
4,GO RESPONSE TO THYROID HORMONE,0.60692,0.071106,0.056714,0,0
4,GO T CELL HOMEOSTASIS,0.15655,0.070563,0.14801,0,0
4,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,0.78176,0.070385,0.029644,0,0
4,GO TRICARBOXYLIC ACID CYCLE,0.28529,0.070341,0.067362,0,0
4,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.11163,0.070312,0.079495,0,0
4,GO FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS,0.10468,0.070217,0.097746,0,0
4,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,0.080256,0.070118,0.11823,0,0
4,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.20256,0.070101,0.097356,0,0
4,GO SPLICEOSOMAL COMPLEX ASSEMBLY,0.26442,0.069953,0.11236,0,0
4,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,0.2577,0.069477,0.1138,0,0
4,GO REGULATION OF GLOMERULAR FILTRATION,0.17091,0.06943,0.20971,0,0
4,GO WHITE FAT CELL DIFFERENTIATION,0.1475,0.069421,0.12825,0,0
4,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.52145,0.069363,0.071559,0,0
4,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,0.17091,0.069259,0.08086,0,0
4,GO GTP BIOSYNTHETIC PROCESS,0.056456,0.069132,0.14283,0,0
4,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,0.2259,0.069081,0.083025,0,0
4,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.08303,0.069021,0.12668,0,0
4,GO RESPONSE TO SALT,0.48117,0.068916,0.045228,0,0
4,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.26442,0.068885,0.13258,0,0
4,GO RESPONSE TO ANGIOTENSIN,0.36271,0.068809,0.10684,0,0
4,GO RESPONSE TO INCREASED OXYGEN LEVELS,0.065157,0.068669,0.14386,0,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.11894,0.068481,0.10048,0,0
4,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.20822,0.068154,0.1158,0,0
4,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.094909,0.068005,0.23534,0,0
4,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,0.21989,0.067726,0.13338,0,0
4,GO REGULATION OF VIRAL LIFE CYCLE,0.10811,0.067574,0.14763,0,0
4,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.48117,0.067487,0.063037,0,0
4,GO AMINE METABOLIC PROCESS,0.0172,0.067363,0.13766,0,0
4,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.60692,0.06717,0.037213,0,0
4,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.42405,0.067097,0.13631,0,0
4,GO PROTEIN N LINKED GLYCOSYLATION,0.034576,0.067039,0.11647,0,0
4,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,0.3148,0.066997,0.07954,0,0
4,GO COPPER ION HOMEOSTASIS,0.08588,0.066994,0.13574,0,0
4,GO AXIS ELONGATION,0.21989,0.066959,0.14846,0,0
4,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,0.33029,0.06687,0.10426,0,0
4,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,0.18624,0.066856,0.1811,0,0
4,GO NEUROBLAST PROLIFERATION,0.1475,0.066852,0.16156,0,0
4,GO DETOXIFICATION,0.61803,0.066766,0.045203,0,0
4,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.48117,0.066535,0.13006,0,0
4,GO GRANULOCYTE DIFFERENTIATION,0.17091,0.066216,0.17279,0,0
4,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.040368,0.066185,0.16668,0,0
4,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,0.10468,0.066109,0.095765,0,0
4,GO MRNA METHYLATION,0.35442,0.066092,0.090245,0,0
4,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.20256,0.066086,0.1296,0,0
4,GO NIK NF KAPPAB SIGNALING,0.25111,0.066024,0.090124,0,0
4,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,0.53179,0.065829,0.052148,0,0
4,GO THIOESTER BIOSYNTHETIC PROCESS,0.08588,0.065755,0.12251,0,0
4,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,0.214,0.065667,0.14152,0,0
4,GO CELL CYCLE ARREST,0.038848,0.065572,0.14348,0,0
4,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,0.37111,0.065564,0.129,0,0
4,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.32248,0.065505,0.16993,0,0
4,GO BRANCH ELONGATION OF AN EPITHELIUM,0.7336,0.065489,0.032709,0,0
4,GO HISTAMINE TRANSPORT,0.27821,0.065413,0.13411,0,0
4,GO CELLULAR RESPONSE TO FATTY ACID,0.37111,0.065343,0.093093,0,0
4,GO MAINTENANCE OF ORGANELLE LOCATION,0.47137,0.065227,0.092858,0,0
4,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.34626,0.065173,0.12378,0,0
4,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,0.16123,0.065167,0.09347,0,0
4,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,0.20822,0.065148,0.093944,0,0
4,GO TRICARBOXYLIC ACID METABOLIC PROCESS,0.3148,0.064948,0.087132,0,0
4,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,0.10134,0.064537,0.15053,0,0
4,GO RESPONSE TO ACTIVITY,0.16123,0.064442,0.11473,0,0
4,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,0.20256,0.064339,0.092316,0,0
4,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,0.33821,0.064298,0.1542,0,0
4,GO COENZYME A METABOLIC PROCESS,0.16123,0.064184,0.092163,0,0
4,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.38829,0.063924,0.08622,0,0
4,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.26442,0.063679,0.07972,0,0
4,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,0.58498,0.06334,0.052304,0,0
4,GO PROTEIN DENEDDYLATION,0.34626,0.063202,0.053544,0,0
4,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.13885,0.063153,0.098526,0,0
4,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.094909,0.063105,0.14983,0,0
4,GO RNA PROCESSING,0.2259,0.063031,0.080408,0,0
4,GO NEGATIVE REGULATION OF DNA RECOMBINATION,0.32248,0.06292,0.10335,0,0
4,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,0.16123,0.062896,0.12852,0,0
4,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.10134,0.062848,0.12187,0,0
4,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,0.32248,0.062751,0.11253,0,0
4,GO PYROPTOSIS,0.4521,0.062653,0.074057,0,0
4,GO RESPONSE TO ISOQUINOLINE ALKALOID,0.25111,0.062619,0.10003,0,0
4,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.13467,0.062565,0.13243,0,0
4,GO NUCLEOSIDE CATABOLIC PROCESS,0.53179,0.062523,0.053112,0,0
4,GO ANIMAL ORGAN REGENERATION,0.17591,0.062328,0.11811,0,0
4,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,0.37964,0.062326,0.089278,0,0
4,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.2259,0.062299,0.096851,0,0
4,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.08881,0.062234,0.16632,0,0
4,GO SYMBIOTIC PROCESS,0.069906,0.062198,0.10874,0,0
4,GO NUCLEOTIDE SALVAGE,0.50109,0.062106,0.045263,0,0
4,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.16123,0.061931,0.11809,0,0
4,GO LYMPHOCYTE CHEMOTAXIS,0.67486,0.061883,0.054495,0,0
4,GO POSITIVE REGULATION OF TRANSLATION,0.067497,0.061865,0.097741,0,0
4,GO REGULATION OF CELL CYCLE,0.060677,0.061849,0.13178,0,0
4,GO REGULATION OF PROTEIN MATURATION,0.16602,0.06164,0.13763,0,0
4,GO RNA CAPPING,0.069906,0.061211,0.098306,0,0
4,GO CYTOCHROME COMPLEX ASSEMBLY,0.3148,0.061158,0.044121,0,0
4,GO POSITIVE REGULATION OF HEMOPOIESIS,0.214,0.06115,0.15531,0,0
4,GO CYCLOOXYGENASE PATHWAY,0.64051,0.061104,0.086364,0,0
4,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,0.11894,0.06104,0.11562,0,0
4,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,0.46168,0.061033,0.10659,0,0
4,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.2998,0.060898,0.14457,0,0
4,GO VITAMIN CATABOLIC PROCESS,0.42405,0.060404,0.038695,0,0
4,GO EMBRYONIC APPENDAGE MORPHOGENESIS,0.1306,0.060381,0.17187,0,0
4,GO CHROMOSOME ORGANIZATION,0.10134,0.060303,0.13328,0,0
4,GO CYTOKINETIC PROCESS,0.13467,0.060236,0.10641,0,0
4,GO RESPONSE TO ETHER,0.197,0.060118,0.093981,0,0
4,GO REGULATION OF HEMOPOIESIS,0.17091,0.060077,0.13925,0,0
4,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.043559,0.059945,0.10825,0,0
4,GO POSITIVE REGULATION OF ERAD PATHWAY,0.17591,0.059796,0.11886,0,0
4,GO FOLIC ACID METABOLIC PROCESS,0.10468,0.059585,0.11951,0,0
4,GO LAMELLIPODIUM MORPHOGENESIS,0.20822,0.059489,0.15239,0,0
4,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.037377,0.059433,0.129,0,0
4,GO REGULATION OF STEM CELL DIFFERENTIATION,0.3148,0.059401,0.053466,0,0
4,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.18102,0.059378,0.18941,0,0
4,GO IMMUNE RESPONSE TO TUMOR CELL,0.72171,0.059286,0.055745,0,0
4,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.58498,0.059277,0.065418,0,0
4,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.35442,0.05904,0.10414,0,0
4,GO TRACHEA MORPHOGENESIS,0.21989,0.058813,0.13865,0,0
4,GO REGULATION OF CELL CYCLE ARREST,0.17591,0.058751,0.11396,0,0
4,GO ESTROGEN METABOLIC PROCESS,0.16602,0.058706,0.15432,0,0
4,GO REGULATION OF DNA RECOMBINATION,0.16123,0.058659,0.12815,0,0
4,GO ASYMMETRIC CELL DIVISION,0.24463,0.058618,0.1191,0,0
4,GO RESPONSE TO TESTOSTERONE,0.56341,0.058591,0.060393,0,0
4,GO CELL AGING,0.052482,0.058531,0.12217,0,0
4,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.30724,0.058346,0.08422,0,0
4,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.37111,0.058311,0.082386,0,0
4,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,0.18624,0.057868,0.1168,0,0
4,GO RESPONSE TO LIPOTEICHOIC ACID,0.56341,0.057813,0.10388,0,0
4,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.4521,0.057678,0.054081,0,0
4,GO NUCLEOTIDE EXCISION REPAIR,0.18102,0.057576,0.081461,0,0
4,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.10468,0.057565,0.10574,0,0
4,GO REGULATION OF RELAXATION OF MUSCLE,0.13885,0.057564,0.33788,0,0
4,GO MRNA EXPORT FROM NUCLEUS,0.20822,0.057489,0.10882,0,0
4,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.23203,0.057282,0.1484,0,0
4,GO LEUKOCYTE AGGREGATION,0.88046,0.057179,0.01907,0,0
4,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.2577,0.056959,0.10167,0,0
4,GO ESTABLISHMENT OF SPINDLE ORIENTATION,0.35442,0.056786,0.10264,0,0
4,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.26442,0.056642,0.16603,0,0
4,GO PHAGOCYTOSIS RECOGNITION,0.47137,0.056564,0.11364,0,0
4,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.58498,0.056549,0.095914,0,0
4,GO PROTEIN TRANSMEMBRANE TRANSPORT,0.065157,0.056454,0.11061,0,0
4,GO POSITIVE REGULATION OF PROTEIN IMPORT,0.1306,0.056417,0.12393,0,0
4,GO NUCLEAR ENVELOPE REASSEMBLY,0.32248,0.056361,0.071034,0,0
4,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,0.28529,0.056282,0.11382,0,0
4,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.47137,0.05609,0.14191,0,0
4,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.11524,0.055951,0.12454,0,0
4,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,0.056456,0.055704,0.069386,0,0
4,GO PROTEIN REFOLDING,0.41494,0.055441,0.060572,0,0
4,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.054439,0.055292,0.17069,0,0
4,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.34626,0.055279,0.079044,0,0
4,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.52145,0.05525,0.072076,0,0
4,GO POSITIVE REGULATION OF DNA REPLICATION,0.34626,0.055056,0.10771,0,0
4,GO NEGATIVE REGULATION OF GENE SILENCING,0.1306,0.054861,0.12782,0,0
4,GO REGULATION OF CHROMOSOME ORGANIZATION,0.10811,0.054783,0.12898,0,0
4,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.93062,0.054709,-0.0039619,0,0
4,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,0.21989,0.054372,0.15987,0,0
4,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.20822,0.054307,0.084188,0,0
4,GO LATE ENDOSOME TO VACUOLE TRANSPORT,0.091819,0.054137,0.10494,0,0
4,GO EPITHELIAL CELL FATE COMMITMENT,0.15655,0.054126,0.17296,0,0
4,GO SPINDLE ORGANIZATION,0.76963,0.054055,0.06595,0,0
4,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.058535,0.053862,0.099171,0,0
4,GO REGULATION OF DNA METABOLIC PROCESS,0.11163,0.053831,0.1255,0,0
4,GO SNRNA PROCESSING,0.33029,0.053705,0.058871,0,0
4,GO MUCUS SECRETION,0.51122,0.053697,0.074042,0,0
4,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,0.21989,0.05363,0.090896,0,0
4,GO MALE MEIOSIS I,0.56341,0.053496,0.076842,0,0
4,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.32248,0.053305,0.081165,0,0
4,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.15655,0.053304,0.11119,0,0
4,GO IRON SULFUR CLUSTER ASSEMBLY,0.074935,0.052856,0.11234,0,0
4,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.10134,0.052761,0.11073,0,0
4,GO REGULATION OF STEM CELL PROLIFERATION,0.18624,0.052753,0.12953,0,0
4,GO INTERACTION WITH SYMBIONT,0.37964,0.052553,0.06481,0,0
4,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,0.37111,0.052539,0.10388,0,0
4,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.15655,0.052509,0.1038,0,0
4,GO RESPONSE TO TUMOR CELL,0.52145,0.052502,0.090333,0,0
4,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,0.32248,0.052276,0.090673,0,0
4,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,0.094909,0.052195,0.12171,0,0
4,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.55277,0.051737,0.074884,0,0
4,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.2577,0.051637,0.11514,0,0
4,GO REGULATION OF MRNA METABOLIC PROCESS,0.08303,0.051626,0.12077,0,0
4,GO REGULATION OF NUCLEAR DIVISION,0.33029,0.051606,0.079523,0,0
4,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.40594,0.051604,0.13397,0,0
4,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.39705,0.051427,0.068892,0,0
4,GO MONONUCLEAR CELL MIGRATION,0.7336,0.051408,0.032848,0,0
4,GO MITOTIC CYTOKINETIC PROCESS,0.080256,0.051358,0.10316,0,0
4,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.072385,0.051247,0.092757,0,0
4,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.65188,0.051223,0.036603,0,0
4,GO NEGATIVE REGULATION OF PROTEIN IMPORT,0.33029,0.051114,0.14627,0,0
4,GO PROTEIN LOCALIZATION TO NUCLEUS,0.1306,0.051059,0.12454,0,0
4,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,0.094909,0.050961,0.17767,0,0
4,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.17091,0.050718,0.083115,0,0
4,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.42405,0.05009,0.068698,0,0
4,GO IMMUNOGLOBULIN PRODUCTION,0.21989,0.049996,0.1353,0,0
4,GO AMP METABOLIC PROCESS,0.17091,0.049931,0.089242,0,0
4,GO SNRNA METABOLIC PROCESS,0.55277,0.049848,0.040633,0,0
4,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.32248,0.049842,0.083407,0,0
4,GO SIALYLATION,0.26442,0.049804,0.15267,0,0
4,GO PERICARDIUM DEVELOPMENT,0.26442,0.049615,0.14024,0,0
4,GO HOMEOSTASIS OF NUMBER OF CELLS,0.13467,0.049524,0.14326,0,0
4,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.28529,0.04949,0.15351,0,0
4,GO RESPONSE TO HYPEROXIA,0.2577,0.049482,0.11401,0,0
4,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.36271,0.049463,0.085338,0,0
4,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.52145,0.049356,0.081976,0,0
4,GO HYPEROSMOTIC SALINITY RESPONSE,0.26442,0.049324,0.10875,0,0
4,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.50109,0.049078,0.086611,0,0
4,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.15655,0.049032,0.13165,0,0
4,GO VIRAL GENOME REPLICATION,0.16602,0.048805,0.12908,0,0
4,GO ACETYL COA METABOLIC PROCESS,0.1475,0.048645,0.10905,0,0
4,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.43329,0.04859,0.093265,0,0
4,GO RESPONSE TO DSRNA,0.37964,0.048386,0.097193,0,0
4,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.14312,0.048382,0.10909,0,0
4,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.84314,0.048213,-0.018995,0,0
4,GO PROSTATE GLAND DEVELOPMENT,0.28529,0.04797,0.11027,0,0
4,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.2259,0.047906,0.10597,0,0
4,GO REGULATION OF MONONUCLEAR CELL MIGRATION,0.67486,0.047838,0.068686,0,0
4,GO MAGNESIUM ION TRANSPORT,0.27126,0.04776,0.17837,0,0
4,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,0.13885,0.047504,0.088437,0,0
4,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,0.40594,0.047461,0.09596,0,0
4,GO RNA DECAPPING,0.35442,0.047348,0.12548,0,0
4,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,0.32248,0.047298,0.10308,0,0
4,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.50109,0.047297,0.066984,0,0
4,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,0.10134,0.046927,0.14899,0,0
4,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.27821,0.046848,0.099929,0,0
4,GO CELL CYCLE G1 S PHASE TRANSITION,0.46168,0.046806,0.073594,0,0
4,GO CELLULAR KETONE METABOLIC PROCESS,0.08588,0.046714,0.090886,0,0
4,GO CHEMOKINE PRODUCTION,0.32248,0.046659,0.12169,0,0
4,GO AEROBIC RESPIRATION,0.44264,0.046607,0.030313,0,0
4,GO T CELL CHEMOTAXIS,0.67486,0.046525,0.051098,0,0
4,GO DOUBLE STRAND BREAK REPAIR,0.2577,0.046429,0.10192,0,0
4,GO PEPTIDYL ASPARAGINE MODIFICATION,0.50109,0.046261,0.033592,0,0
4,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.27821,0.046247,0.14307,0,0
4,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.4521,0.046185,0.087776,0,0
4,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,0.40594,0.046062,0.13177,0,0
4,GO REGULATION OF CELLULAR RESPONSE TO HEAT,0.214,0.046009,0.12101,0,0
4,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,0.43329,0.046001,0.045444,0,0
4,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.2577,0.045848,0.14321,0,0
4,GO REGULATION OF PODOSOME ASSEMBLY,0.41494,0.045622,0.11982,0,0
4,GO VESICLE CARGO LOADING,0.20822,0.045534,0.1535,0,0
4,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.48117,0.045508,0.069711,0,0
4,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,0.16123,0.045284,0.10012,0,0
4,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.37111,0.045205,0.11531,0,0
4,GO CELLULAR RESPONSE TO RADIATION,0.12273,0.045123,0.095963,0,0
4,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.29248,0.045022,0.070205,0,0
4,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.17591,0.045011,0.097197,0,0
4,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.49108,0.044956,0.062615,0,0
4,GO URONIC ACID METABOLIC PROCESS,0.72171,0.044954,0.011288,0,0
4,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,0.64051,0.044796,0.07216,0,0
4,GO GLYCOSIDE METABOLIC PROCESS,0.23203,0.044633,0.070642,0,0
4,GO RECOMBINATIONAL REPAIR,0.5959,0.044576,0.072336,0,0
4,GO TRANSLESION SYNTHESIS,0.7336,0.044527,0.034835,0,0
4,GO BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS,0.95582,0.04448,0.03354,0,0
4,GO MONOCYTE CHEMOTAXIS,0.99368,0.044465,-0.021616,0,0
4,GO PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.91805,0.044268,0.023496,0,0
4,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.47137,0.044227,0.058652,0,0
4,GO REGULATION OF HEAT GENERATION,0.64051,0.044194,0.068585,0,0
4,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.40594,0.044019,0.048254,0,0
4,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,0.20822,0.043865,0.12529,0,0
4,GO REGULATION OF MITOTIC SPINDLE ASSEMBLY,0.62923,0.043849,0.048701,0,0
4,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,0.197,0.04369,0.067614,0,0
4,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.35442,0.043643,0.080255,0,0
4,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.11524,0.043558,0.10581,0,0
4,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.57414,0.043547,0.075408,0,0
4,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.91805,0.043517,0.021043,0,0
4,GO POSITIVE REGULATION OF HEAT GENERATION,0.57414,0.043389,0.077189,0,0
4,GO CHEMOKINE SECRETION,0.50109,0.043309,0.1041,0,0
4,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.30724,0.043236,0.1076,0,0
4,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.16123,0.043224,0.084501,0,0
4,GO MALE SEX DIFFERENTIATION,0.074935,0.043102,0.15977,0,0
4,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.38829,0.043093,0.090016,0,0
4,GO TRNA WOBBLE BASE MODIFICATION,0.214,0.043043,0.097999,0,0
4,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.20822,0.043035,0.08553,0,0
4,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.067497,0.042917,0.14195,0,0
4,GO REGULATION OF DNA BINDING,0.34626,0.042896,0.092991,0,0
4,GO REGULATION OF VIRAL GENOME REPLICATION,0.23827,0.042332,0.12696,0,0
4,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.50109,0.042149,0.054641,0,0
4,GO NEGATIVE REGULATION OF DNA BINDING,0.50109,0.042122,0.06875,0,0
4,GO GMP METABOLIC PROCESS,0.58498,0.041824,0.045017,0,0
4,GO POSITIVE REGULATION OF CELL CYCLE,0.08881,0.041785,0.13443,0,0
4,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.33821,0.041722,0.12197,0,0
4,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,0.7336,0.041419,0.028331,0,0
4,GO INTERMEDIATE FILAMENT ORGANIZATION,0.4521,0.041411,0.062808,0,0
4,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.66333,0.041401,0.063109,0,0
4,GO HYALURONAN CATABOLIC PROCESS,0.47137,0.040793,0.10029,0,0
4,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.42405,0.040709,0.061944,0,0
4,GO PROSTATE GLAND GROWTH,0.60692,0.040589,0.037919,0,0
4,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.214,0.040574,0.085071,0,0
4,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.75756,0.040329,0.049964,0,0
4,GO MESODERMAL CELL FATE SPECIFICATION,0.65188,0.040318,0.053014,0,0
4,GO CENTROSOME DUPLICATION,0.58498,0.040178,0.064363,0,0
4,GO MICROVILLUS ORGANIZATION,0.18624,0.040139,0.13177,0,0
4,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.23203,0.040073,0.11158,0,0
4,GO POLYAMINE BIOSYNTHETIC PROCESS,0.39705,0.039986,0.049762,0,0
4,GO BASE EXCISION REPAIR,0.27821,0.039958,0.093129,0,0
4,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,0.57414,0.039806,0.17051,0,0
4,GO CENTRIOLE ASSEMBLY,0.64051,0.039595,0.055643,0,0
4,GO RESPONSE TO FUNGUS,0.44264,0.039496,0.080895,0,0
4,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,0.15655,0.039275,0.11433,0,0
4,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.35442,0.039046,0.095978,0,0
4,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,0.38829,0.039045,0.087089,0,0
4,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.20256,0.038863,0.074271,0,0
4,GO RNA STABILIZATION,0.214,0.038567,0.10992,0,0
4,GO BLASTOCYST GROWTH,0.54223,0.03843,0.05773,0,0
4,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.7336,0.038367,0.0571,0,0
4,GO DENTATE GYRUS DEVELOPMENT,0.90549,0.03829,-0.015176,0,0
4,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,0.26442,0.038146,0.10912,0,0
4,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.23827,0.038134,0.12681,0,0
4,GO CELLULAR AMIDE METABOLIC PROCESS,0.062884,0.037929,0.083219,0,0
4,GO ARGININE METABOLIC PROCESS,0.5959,0.037919,0.046281,0,0
4,GO CELLULAR RESPONSE TO UV,0.214,0.037866,0.095909,0,0
4,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,0.51122,0.037731,0.10664,0,0
4,GO REGULATION OF CELL FATE SPECIFICATION,0.48117,0.037575,0.10318,0,0
4,GO SALIVA SECRETION,0.5959,0.037274,0.069345,0,0
4,GO RESPONSE TO MUSCLE ACTIVITY,0.30724,0.036917,0.10067,0,0
4,GO CELL CYCLE,0.094909,0.03666,0.1226,0,0
4,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.43329,0.036623,0.077013,0,0
4,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.214,0.036608,0.10106,0,0
4,GO NEPHRON TUBULE FORMATION,0.32248,0.036485,0.081471,0,0
4,GO MALE GENITALIA DEVELOPMENT,0.41494,0.036279,0.096417,0,0
4,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.13885,0.036204,0.12754,0,0
4,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.12273,0.035937,0.14757,0,0
4,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,0.62923,0.035816,0.043485,0,0
4,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,0.4521,0.03577,0.081544,0,0
4,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.29248,0.035766,0.12482,0,0
4,GO RESPONSE TO INTERLEUKIN 1,0.62923,0.035575,0.053072,0,0
4,GO MITOTIC CYTOKINESIS,0.40594,0.035473,0.078247,0,0
4,GO NUCLEOSIDE SALVAGE,0.49108,0.035448,0.042764,0,0
4,GO RNA 5 END PROCESSING,0.60692,0.035422,0.017796,0,0
4,GO MITOCHONDRIAL FUSION,0.08881,0.035347,0.13963,0,0
4,GO NEGATIVE REGULATION OF MRNA PROCESSING,0.18624,0.035305,0.12314,0,0
4,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,0.48117,0.03494,0.063142,0,0
4,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,0.08303,0.034919,0.10495,0,0
4,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,0.5959,0.034863,0.093818,0,0
4,GO PROTEIN IMPORT,0.18624,0.03484,0.10101,0,0
4,GO POSITIVE REGULATION OF DNA BINDING,0.49108,0.034827,0.062725,0,0
4,GO PENILE ERECTION,0.85555,0.034724,0.018585,0,0
4,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.46168,0.034433,0.092587,0,0
4,GO IRON ION TRANSMEMBRANE TRANSPORT,0.46168,0.034212,0.069718,0,0
4,GO REGULATION OF MITOTIC CELL CYCLE,0.20256,0.034177,0.10176,0,0
4,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.44264,0.034112,0.090695,0,0
4,GO REGULATION OF TELOMERASE ACTIVITY,0.44264,0.03411,0.083798,0,0
4,GO DNA RECOMBINATION,0.50109,0.033968,0.075602,0,0
4,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.37964,0.033904,0.15116,0,0
4,GO RNA MODIFICATION,0.27126,0.033809,0.086261,0,0
4,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.38829,0.033777,0.096736,0,0
4,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.51122,0.03363,0.12178,0,0
4,GO ELECTRON TRANSPORT CHAIN,0.30724,0.033436,0.041619,0,0
4,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,0.197,0.033298,0.10937,0,0
4,GO ORGANELLE FISSION,0.42405,0.033191,0.081128,0,0
4,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.79394,0.032955,0.040053,0,0
4,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.53179,0.032663,0.038889,0,0
4,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.61803,0.032588,0.052537,0,0
4,GO DNA BIOSYNTHETIC PROCESS,0.23827,0.032443,0.097887,0,0
4,GO ANOIKIS,0.214,0.032383,0.14971,0,0
4,GO PROTEIN TARGETING,0.058535,0.032153,0.062629,0,0
4,GO RRNA CATABOLIC PROCESS,0.2998,0.032063,0.10699,0,0
4,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,0.61803,0.031988,0.0233,0,0
4,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.51122,0.03126,0.06678,0,0
4,GO REGULATION OF CENTROSOME DUPLICATION,0.52145,0.031184,0.062325,0,0
4,GO RAP PROTEIN SIGNAL TRANSDUCTION,0.83078,0.031166,0.06021,0,0
4,GO SNORNA METABOLIC PROCESS,0.37111,0.031089,0.075245,0,0
4,GO REGULATION OF CENTROSOME CYCLE,0.55277,0.031003,0.056606,0,0
4,GO DNA METABOLIC PROCESS,0.18102,0.030829,0.10482,0,0
4,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.34626,0.030619,0.091228,0,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.39705,0.030544,0.12939,0,0
4,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,0.54223,0.030533,0.075046,0,0
4,GO REGULATION OF CELL CYCLE PROCESS,0.17091,0.030374,0.10182,0,0
4,GO NUCLEAR EXPORT,0.21989,0.030332,0.09931,0,0
4,GO GOLGI LOCALIZATION,0.54223,0.029944,0.05286,0,0
4,GO CELLULAR RESPONSE TO HEAT,0.21989,0.029862,0.10817,0,0
4,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.5959,0.029547,0.062578,0,0
4,GO CELLULAR METABOLIC COMPOUND SALVAGE,0.38829,0.029396,0.04979,0,0
4,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.17591,0.029241,0.13245,0,0
4,GO DNA REPAIR,0.18102,0.029208,0.098265,0,0
4,GO RNA SURVEILLANCE,0.66333,0.028877,0.035666,0,0
4,GO REGULATION OF MRNA CATABOLIC PROCESS,0.11163,0.027851,0.096117,0,0
4,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.25111,0.027747,0.12841,0,0
4,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.37111,0.027684,0.07456,0,0
4,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.38829,0.027673,0.075131,0,0
4,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.4521,0.027627,0.078415,0,0
4,GO NCRNA METABOLIC PROCESS,0.65188,0.027607,0.040885,0,0
4,GO MESODERMAL CELL FATE COMMITMENT,0.75756,0.027603,0.056867,0,0
4,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.23203,0.027553,0.12515,0,0
4,GO PSEUDOURIDINE SYNTHESIS,0.90549,0.027349,0.0094819,0,0
4,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.70989,0.027208,0.054842,0,0
4,GO MITOCHONDRION MORPHOGENESIS,0.23827,0.027064,0.096316,0,0
4,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,0.68646,0.026905,0.043887,0,0
4,GO REGULATION OF CYTOKINESIS,0.27126,0.026703,0.10323,0,0
4,GO NUCLEOSOME ORGANIZATION,0.2998,0.02655,0.089828,0,0
4,GO DNA PACKAGING,0.50109,0.026491,0.074662,0,0
4,GO URETER DEVELOPMENT,0.5959,0.025803,0.036297,0,0
4,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,0.3148,0.025794,0.092706,0,0
4,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.48117,0.025759,0.041615,0,0
4,GO MEIOTIC CELL CYCLE,0.28529,0.025697,0.093044,0,0
4,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.65188,0.025682,0.03039,0,0
4,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.27821,0.025509,0.13064,0,0
4,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.51122,0.025365,0.026233,0,0
4,GO NEGATIVE REGULATION OF CELL CYCLE,0.17091,0.025283,0.10288,0,0
4,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,0.69814,0.025031,0.054271,0,0
4,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,0.38829,0.024934,0.08831,0,0
4,GO RNA EXPORT FROM NUCLEUS,0.41494,0.024666,0.077236,0,0
4,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.66333,0.024635,0.072211,0,0
4,GO PROTEIN INSERTION INTO MEMBRANE,0.098083,0.024343,0.085605,0,0
4,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.29248,0.023902,0.12512,0,0
4,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,0.30724,0.023851,0.096818,0,0
4,GO POSITIVE REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.91805,0.023769,-0.013321,0,0
4,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,0.33029,0.023672,0.067011,0,0
4,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.214,0.023659,0.12254,0,0
4,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,0.48117,0.023572,0.077046,0,0
4,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.96843,0.023466,0.0151,0,0
4,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.21989,0.023374,0.082408,0,0
4,GO MITOTIC CELL CYCLE ARREST,0.25111,0.023318,0.11686,0,0
4,GO MITOCHONDRIAL DNA REPLICATION,0.38829,0.023129,0.068289,0,0
4,GO MODULATION BY HOST OF SYMBIONT PROCESS,0.69814,0.023009,0.055861,0,0
4,GO PEPTIDE METABOLIC PROCESS,0.1475,0.022394,0.059756,0,0
4,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,0.43329,0.022246,0.091442,0,0
4,GO TRNA PROCESSING,0.62923,0.02221,0.049021,0,0
4,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,0.35442,0.021957,0.095508,0,0
4,GO FORELIMB MORPHOGENESIS,0.47137,0.021524,0.088809,0,0
4,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.57414,0.021299,0.039391,0,0
4,GO REGULATION OF ERAD PATHWAY,0.33029,0.021092,0.10063,0,0
4,GO RESPONSE TO INTERLEUKIN 18,0.51122,0.020893,0.11691,0,0
4,GO TRNA WOBBLE URIDINE MODIFICATION,0.2577,0.020632,0.087159,0,0
4,GO POSITIVE REGULATION OF CYTOKINESIS,0.56341,0.020568,0.064019,0,0
4,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.91805,0.020471,0.030122,0,0
4,GO ATP DEPENDENT CHROMATIN REMODELING,0.61803,0.020325,0.061749,0,0
4,GO IMP METABOLIC PROCESS,0.96843,0.020236,0.018653,0,0
4,GO GLUTAMINE METABOLIC PROCESS,0.54223,0.020144,0.071734,0,0
4,GO CELL CYCLE PROCESS,0.17091,0.020078,0.10548,0,0
4,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.49108,0.01994,0.11739,0,0
4,GO NUCLEOSIDE METABOLIC PROCESS,0.38829,0.019899,0.055476,0,0
4,GO REGULATION OF SENSORY PERCEPTION,0.18102,0.019617,0.14993,0,0
4,GO TRNA METABOLIC PROCESS,0.61803,0.019294,0.044778,0,0
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.28529,0.019256,0.091338,0,0
4,GO DETERMINATION OF ADULT LIFESPAN,0.47137,0.019042,0.11041,0,0
4,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.60692,0.01904,0.059044,0,0
4,GO POSTREPLICATION REPAIR,0.90549,0.01891,0.010127,0,0
4,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,0.26442,0.018124,0.10299,0,0
4,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.54223,0.018109,0.041205,0,0
4,GO MITOTIC G2 M TRANSITION CHECKPOINT,0.51122,0.01784,0.073146,0,0
4,GO GLYCOSYL COMPOUND METABOLIC PROCESS,0.3148,0.017415,0.062138,0,0
4,GO AMIDE BIOSYNTHETIC PROCESS,0.42405,0.017348,0.048478,0,0
4,GO RESPONSE TO IONIZING RADIATION,0.38829,0.01734,0.083001,0,0
4,GO FEMALE MEIOTIC NUCLEAR DIVISION,0.4521,0.017162,0.078997,0,0
4,GO RIBONUCLEOSIDE METABOLIC PROCESS,0.61803,0.017121,0.039065,0,0
4,GO PYRIMIDINE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORT,0.83078,0.016876,0.019473,0,0
4,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.61803,0.016815,-0.044478,0,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,0.28529,0.01674,0.062023,0,0
4,GO CELL DIVISION,0.40594,0.016455,0.084509,0,0
4,GO MITOCHONDRIAL RNA PROCESSING,0.65188,0.016401,0.069654,0,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.23827,0.016332,0.043449,0,0
4,GO POSITIVE REGULATION OF CELL CYCLE ARREST,0.44264,0.016305,0.089297,0,0
4,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.26442,0.016259,0.092605,0,0
4,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.64051,0.016071,0.037291,0,0
4,GO ACETYL COA BIOSYNTHETIC PROCESS,0.57414,0.016051,0.074124,0,0
4,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.44264,0.016037,0.084558,0,0
4,GO MRNA METABOLIC PROCESS,0.34626,0.015898,0.059186,0,0
4,GO CELLULAR SENESCENCE,0.16123,0.015801,0.10815,0,0
4,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.42405,0.015709,0.093429,0,0
4,GO KINETOCHORE ASSEMBLY,0.69814,0.015441,-0.025527,0,0
4,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,0.1306,0.015358,0.1885,0,0
4,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.42405,0.015172,0.085519,0,0
4,GO NUCLEAR TRANSPORT,0.27126,0.015103,0.092921,0,0
4,GO PROSTAGLANDIN SECRETION,0.26442,0.014926,0.12568,0,0
4,GO APOPTOTIC DNA FRAGMENTATION,0.51122,0.014653,0.060292,0,0
4,GO UTERUS DEVELOPMENT,0.68646,0.014567,0.048402,0,0
4,GO PRO B CELL DIFFERENTIATION,0.34626,0.014546,0.11587,0,0
4,GO NCRNA 3 END PROCESSING,0.68646,0.014326,0.025363,0,0
4,GO MULTI ORGANISM LOCALIZATION,0.56341,0.013917,0.079073,0,0
4,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.96843,0.013791,0.031245,0,0
4,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.33821,0.013763,0.095796,0,0
4,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.214,0.013688,0.097655,0,0
4,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.20256,0.013265,0.11103,0,0
4,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.42405,0.013233,0.066314,0,0
4,GO IMP BIOSYNTHETIC PROCESS,0.76963,0.013191,0.00038515,0,0
4,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.47137,0.012841,0.058439,0,0
4,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,0.44264,0.012775,0.11074,0,0
4,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.37964,0.012504,0.096139,0,0
4,GO MRNA MODIFICATION,0.86799,0.012379,0.030591,0,0
4,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.86799,0.012333,-0.0016688,0,0
4,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.21989,0.012289,0.10576,0,0
4,GO LIVER REGENERATION,0.43329,0.011873,0.080674,0,0
4,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.72171,0.011692,0.049341,0,0
4,GO SPINDLE ASSEMBLY,0.91805,0.011488,0.041844,0,0
4,GO PEPTIDE BIOSYNTHETIC PROCESS,0.86799,0.01145,0.021385,0,0
4,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.3148,0.011294,0.090773,0,0
4,GO MRNA TRANSPORT,0.33821,0.011083,0.093967,0,0
4,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.69814,0.011024,0.053381,0,0
4,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.56341,0.010895,0.073939,0,0
4,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.61803,0.01067,0.049466,0,0
4,GO SERTOLI CELL DEVELOPMENT,0.36271,0.010145,0.12443,0,0
4,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,0.74555,0.010081,-0.0024533,0,0
4,GO MATURATION OF SSU RRNA,0.68646,0.0098263,0.037954,0,0
4,GO REGULATION OF GLIAL CELL PROLIFERATION,0.47137,0.0095956,0.080137,0,0
4,GO CELL CYCLE PHASE TRANSITION,0.53179,0.0094588,0.066213,0,0
4,GO TELOMERE ORGANIZATION,0.67486,0.009219,0.059932,0,0
4,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.95582,0.0089802,0.041714,0,0
4,GO REGULATION OF RIBOSOME BIOGENESIS,0.49108,0.008684,0.086165,0,0
4,GO MEMBRANE DISASSEMBLY,0.67486,0.0086719,0.076099,0,0
4,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.37111,0.0086311,0.072101,0,0
4,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.95582,0.008592,0.0024387,0,0
4,GO MITOTIC CELL CYCLE,0.3148,0.0084969,0.086734,0,0
4,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.50109,0.0081283,0.069919,0,0
4,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,0.68646,0.0077803,0.066038,0,0
4,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.79394,0.0075771,0.019385,0,0
4,GO MIDBODY ABSCISSION,0.4521,0.0075308,0.065709,0,0
4,GO INFLAMMATORY CELL APOPTOTIC PROCESS,0.81845,0.007501,0.031951,0,0
4,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.61803,0.0074995,0.042114,0,0
4,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.91805,0.0073071,0.010258,0,0
4,GO RESPONSE TO UV C,0.35442,0.0068803,0.10572,0,0
4,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.69814,0.0068055,0.071177,0,0
4,GO CELLULAR RESPIRATION,0.33029,0.0065887,0.040025,0,0
4,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.39705,0.0062011,0.090945,0,0
4,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.32248,0.0061632,0.12525,0,0
4,GO REGULATION OF RESPONSE TO TUMOR CELL,0.91805,0.0059676,0.0098764,0,0
4,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.44264,0.0057238,0.08445,0,0
4,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.7336,0.0053372,0.042212,0,0
4,GO REGULATION OF DNA METHYLATION,0.56341,0.0050712,0.073879,0,0
4,GO DNA REPLICATION,0.91805,0.0047076,0.035289,0,0
4,GO MEIOTIC CELL CYCLE PROCESS,0.46168,0.0046396,0.080065,0,0
4,GO NCRNA PROCESSING,0.91805,0.0044784,0.026668,0,0
4,GO RESPONSE TO GAMMA RADIATION,0.55277,0.0043278,0.078506,0,0
4,GO EXIT FROM MITOSIS,0.48117,0.0042178,0.080408,0,0
4,GO PRIMARY MIRNA PROCESSING,0.55277,0.0042169,0.078557,0,0
4,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.7336,0.0041244,-0.010536,0,0
4,GO TRNA TRANSPORT,0.80618,0.0035235,0.062406,0,0
4,GO REGULATION OF RNA BINDING,0.93062,0.0030163,0.027071,0,0
4,GO DNA STRAND ELONGATION,0.66333,0.002949,-0.031819,0,0
4,GO TRNA MODIFICATION,0.7336,0.0028505,0.049417,0,0
4,GO CELL CYCLE G2 M PHASE TRANSITION,0.53179,0.0026572,0.058393,0,0
4,GO NCRNA EXPORT FROM NUCLEUS,0.72171,0.0020107,0.067141,0,0
4,GO IMPORT INTO NUCLEUS,0.37111,0.0018117,0.091259,0,0
4,GO RESPONSE TO INTERLEUKIN 12,0.74555,0.0014513,-0.023522,0,0
4,GO HEPATOCYTE DIFFERENTIATION,0.85555,0.0013912,-0.013797,0,0
4,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.7336,0.00090512,0.050435,0,0
4,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,0.61803,0.00085067,0.059794,0,0
4,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,0.65188,0.00084245,0.10495,0,0
4,GO RNA METHYLATION,0.72171,0.00068319,0.045574,0,0
4,GO REGULATION OF TRANSLATIONAL TERMINATION,0.53179,0.00041736,0.06903,0,0
4,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.54223,0.00040507,0.068128,0,0
4,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.54223,0.00034792,0.063144,0,0
4,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.99368,0.00029557,0.010446,0,0
4,GO RNA INTERFERENCE,0.66333,7.327e-05,0.05253,0,0
4,GO PROTEIN K11 LINKED UBIQUITINATION,0.80618,-4.7572e-05,0.0015183,0,0
4,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.38829,-0.000103,0.15942,0,0
4,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.93062,-0.00019172,0.0069356,0,0
4,GO GENITALIA MORPHOGENESIS,0.79394,-0.00056477,0.03182,0,0
4,GO MITOCHONDRIAL GENOME MAINTENANCE,0.78176,-0.00072713,0.062953,0,0
4,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.66333,-0.00088852,0.070407,0,0
4,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.80618,-0.0010806,0.0096201,0,0
4,GO RESPONSE TO X RAY,0.65188,-0.0011679,0.067574,0,0
4,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.75756,-0.001399,0.0098625,0,0
4,GO VIRAL TRANSLATION,0.96843,-0.0014263,0.013667,0,0
4,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.53179,-0.0019678,0.074615,0,0
4,GO MITOTIC SPINDLE ORGANIZATION,0.96843,-0.0023496,0.024352,0,0
4,GO NEURAL CREST FORMATION,0.95582,-0.002479,-0.011648,0,0
4,GO DNA CONFORMATION CHANGE,0.55277,-0.0025484,0.069165,0,0
4,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.37111,-0.0026591,0.06991,0,0
4,GO INTRACELLULAR MRNA LOCALIZATION,0.43329,-0.0029485,0.095748,0,0
4,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.68646,-0.0030537,-0.025885,0,0
4,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,0.96843,-0.0032663,0.01922,0,0
4,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.93062,-0.0033126,0.012787,0,0
4,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.69814,-0.0034274,0.047634,0,0
4,GO MITOTIC G1 S TRANSITION CHECKPOINT,0.65188,-0.0040191,0.068502,0,0
4,GO ESTABLISHMENT OF RNA LOCALIZATION,0.35442,-0.0045251,0.080039,0,0
4,GO G0 TO G1 TRANSITION,0.46168,-0.0045729,0.096745,0,0
4,GO MITOTIC DNA INTEGRITY CHECKPOINT,0.54223,-0.004618,0.079647,0,0
4,GO CIRCADIAN SLEEP WAKE CYCLE,0.2998,-0.0046275,0.12413,0,0
4,GO CELLULAR RESPONSE TO X RAY,0.69814,-0.0050703,0.087033,0,0
4,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,0.35442,-0.0052896,0.057854,0,0
4,GO DNA GEOMETRIC CHANGE,0.74555,-0.005488,0.050512,0,0
4,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.49108,-0.0055439,0.086961,0,0
4,GO ECTODERMAL PLACODE DEVELOPMENT,0.58498,-0.0059637,0.066383,0,0
4,GO NEGATIVE REGULATION OF ERAD PATHWAY,0.65188,-0.0065717,0.048875,0,0
4,GO RESPONSE TO NITROSATIVE STRESS,0.91805,-0.0065804,0.0077867,0,0
4,GO MEIOTIC CHROMOSOME SEPARATION,0.48117,-0.0070911,0.10027,0,0
4,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.98106,-0.0070978,0.02619,0,0
4,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.91805,-0.0071161,0.033874,0,0
4,GO LACTATE METABOLIC PROCESS,0.66333,-0.0074997,0.039181,0,0
4,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.61803,-0.0075283,0.078166,0,0
4,GO TERPENOID BIOSYNTHETIC PROCESS,0.96843,-0.00755,-0.0037949,0,0
4,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.98106,-0.0077659,0.070539,0,0
4,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.65188,-0.007979,0.070056,0,0
4,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.27821,-0.0079883,0.13068,0,0
4,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,0.89296,-0.0088181,-0.00056102,0,0
4,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.61803,-0.0088963,0.07571,0,0
4,GO REGULATION OF TRANSLATIONAL INITIATION,0.93062,-0.0090391,0.034712,0,0
4,GO REGULATION OF CENTRIOLE REPLICATION,0.83078,-0.0090443,-0.008574,0,0
4,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.34626,-0.0091175,0.058852,0,0
4,GO NEGATIVE REGULATION OF CELL DIVISION,0.49108,-0.0091359,0.10565,0,0
4,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.66333,-0.0093246,-0.015195,0,0
4,GO DNA INTEGRITY CHECKPOINT,0.57414,-0.0094314,0.075071,0,0
4,GO RNA CATABOLIC PROCESS,0.55277,-0.0094487,-0.0072656,0,0
4,GO MITOTIC NUCLEAR DIVISION,0.94321,-0.009834,0.046215,0,0
4,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.98106,-0.010132,0.018438,0,0
4,GO CELL REDOX HOMEOSTASIS,1,-0.010697,0.0094565,0,0
4,GO L SERINE METABOLIC PROCESS,0.86799,-0.010814,0.0028663,0,0
4,GO FIBROBLAST APOPTOTIC PROCESS,0.93062,-0.010975,0.032178,0,0
4,GO MATURATION OF 5 8S RRNA,0.85555,-0.010993,0.02256,0,0
4,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,0.5959,-0.011401,0.098714,0,0
4,GO HISTONE PHOSPHORYLATION,0.66333,-0.01149,0.054053,0,0
4,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,0.51122,-0.011783,0.039168,0,0
4,GO MEIOSIS I CELL CYCLE PROCESS,0.60692,-0.012192,0.059255,0,0
4,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,0.5959,-0.012439,0.042992,0,0
4,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.98106,-0.012565,0.053549,0,0
4,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.75756,-0.012574,0.041881,0,0
4,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.76963,-0.012834,-0.010563,0,0
4,GO TRANSLATIONAL ELONGATION,0.37964,-0.012971,-0.028916,0,0
4,GO RNA LOCALIZATION,0.47137,-0.013314,0.069792,0,0
4,GO MITOTIC CELL CYCLE CHECKPOINT,0.78176,-0.013324,0.058725,0,0
4,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.83078,-0.013581,0.028856,0,0
4,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,0.96843,-0.013813,0.039364,0,0
4,GO RRNA METABOLIC PROCESS,0.76963,-0.014031,0.0084273,0,0
4,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,0.84314,-0.014076,0.040212,0,0
4,GO ZINC ION HOMEOSTASIS,0.93062,-0.014221,0.03766,0,0
4,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.89296,-0.014223,0.014009,0,0
4,GO NADPH REGENERATION,0.91805,-0.0148,0.015612,0,0
4,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.80618,-0.015318,0.037138,0,0
4,GO PORE COMPLEX ASSEMBLY,0.68646,-0.015567,0.0086831,0,0
4,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.85555,-0.015832,0.032413,0,0
4,GO REGULATION OF MITOCHONDRIAL FUSION,0.50109,-0.016213,0.086211,0,0
4,GO PURINE NUCLEOSIDE METABOLIC PROCESS,0.81845,-0.016304,0.033568,0,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.98106,-0.016626,0.033688,0,0
4,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,0.79394,-0.016667,-0.014677,0,0
4,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.50109,-0.016769,0.08786,0,0
4,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.38829,-0.016845,-0.035439,0,0
4,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,1,-0.017223,0.0043546,0,0
4,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.57414,-0.017345,-0.029432,0,0
4,GO CELLULAR RESPONSE TO COPPER ION,0.95582,-0.017353,0.022236,0,0
4,GO MYELOID DENDRITIC CELL ACTIVATION,0.68646,-0.017748,0.06775,0,0
4,GO ER OVERLOAD RESPONSE,0.85555,-0.017929,0.053295,0,0
4,GO HOMOLOGOUS RECOMBINATION,0.53179,-0.018279,0.073664,0,0
4,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.91805,-0.018313,0.029143,0,0
4,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.214,-0.018542,0.16661,0,0
4,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.61803,-0.018799,0.096608,0,0
4,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.79394,-0.019147,0.043182,0,0
4,GO DE NOVO PROTEIN FOLDING,0.55277,-0.01959,0.066088,0,0
4,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.58498,-0.019626,-0.039049,0,0
4,GO NUCLEOBASE METABOLIC PROCESS,0.42405,-0.020552,-0.025875,0,0
4,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.86799,-0.020619,0.036588,0,0
4,GO CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.53179,-0.020663,0.11675,0,0
4,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.89296,-0.021119,0.0065158,0,0
4,GO NEGATIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.66333,-0.021627,0.0832,0,0
4,GO MEIOTIC CHROMOSOME SEGREGATION,0.79394,-0.021657,0.047889,0,0
4,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.4521,-0.02169,0.011057,0,0
4,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.84314,-0.021723,0.044684,0,0
4,GO TETRAHYDROFOLATE METABOLIC PROCESS,0.99368,-0.021927,0.023087,0,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,0.72171,-0.02222,0.035995,0,0
4,GO FATTY ACID HOMEOSTASIS,0.90549,-0.022363,0.013647,0,0
4,GO DNA REPLICATION INITIATION,0.58498,-0.02259,-0.052951,0,0
4,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,0.83078,-0.02277,0.089421,0,0
4,GO REGULATION OF MRNA BINDING,0.88046,-0.022839,0.028003,0,0
4,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.88046,-0.022926,0.017132,0,0
4,GO GTP METABOLIC PROCESS,0.90549,-0.023421,0.038545,0,0
4,GO TRNA METHYLATION,0.81845,-0.023762,0.0046939,0,0
4,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.58498,-0.023977,0.048812,0,0
4,GO REGULATION OF SISTER CHROMATID COHESION,0.84314,-0.02436,0.04763,0,0
4,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.67486,-0.024386,-0.011191,0,0
4,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.39705,-0.024399,-0.12162,0,0
4,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.75756,-0.024586,0.026093,0,0
4,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.68646,-0.024613,-0.036642,0,0
4,GO MITOCHONDRIAL GENE EXPRESSION,0.2998,-0.025074,-0.043782,0,0
4,GO REGULATION OF TRANSLATIONAL ELONGATION,0.81845,-0.025317,0.019038,0,0
4,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,0.75756,-0.025404,0.0080946,0,0
4,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,0.35442,-0.025442,0.10868,0,0
4,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.83078,-0.025946,0.010146,0,0
4,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.56341,-0.025961,-0.019575,0,0
4,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.99368,-0.026098,-0.021574,0,0
4,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.43329,-0.026417,0.10738,0,0
4,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.7336,-0.02652,-0.019617,0,0
4,GO OXIDATIVE PHOSPHORYLATION,0.78176,-0.026662,-0.0019869,0,0
4,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.98106,-0.026718,0.015091,0,0
4,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.40594,-0.026894,-0.017309,0,0
4,GO SEMINIFEROUS TUBULE DEVELOPMENT,0.83078,-0.026932,0.014946,0,0
4,GO ERROR FREE TRANSLESION SYNTHESIS,0.197,-0.027069,-0.055027,0,0
4,GO PROTEIN LOCALIZATION TO CHROMATIN,0.94321,-0.028084,0.057186,0,0
4,GO HISTAMINE SECRETION,0.5959,-0.028119,0.072242,0,0
4,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.66333,-0.028152,0.047967,0,0
4,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.65188,-0.028301,0.063813,0,0
4,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.4521,-0.028314,-0.015764,0,0
4,GO MITOCHONDRIAL TRANSLATION,0.19156,-0.028369,-0.053931,0,0
4,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,0.5959,-0.028405,0.084366,0,0
4,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.62923,-0.029083,-0.0029588,0,0
4,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,0.69814,-0.029879,0.047987,0,0
4,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.61803,-0.030182,0.065446,0,0
4,GO REGULATION OF DNA REPLICATION,0.90549,-0.030371,0.040687,0,0
4,GO CELLULAR RESPONSE TO CADMIUM ION,0.88046,-0.030684,0.024924,0,0
4,GO CELL CYCLE CHECKPOINT,0.75756,-0.031301,0.058771,0,0
4,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.80618,-0.032326,0.016706,0,0
4,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.38829,-0.032796,-0.06831,0,0
4,GO DENDRITIC CELL MIGRATION,0.96843,-0.032853,0.0018477,0,0
4,GO REGULATION OF SISTER CHROMATID SEGREGATION,0.56341,-0.033503,-0.024868,0,0
4,GO TRNA 5 LEADER REMOVAL,0.21989,-0.033524,-0.068839,0,0
4,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,0.98106,-0.033801,0.029496,0,0
4,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,0.031957,-0.033927,-0.092403,0,0
4,GO NEGATIVE REGULATION OF RNA SPLICING,0.99368,-0.034027,0.019935,0,0
4,GO CHROMOSOME SEGREGATION,0.79394,-0.034448,0.0048188,0,0
4,GO CHROMOSOME SEPARATION,0.74555,-0.034706,-0.0076229,0,0
4,GO ALDITOL METABOLIC PROCESS,0.32248,-0.034953,-0.047144,0,0
4,GO REGULATION OF HELICASE ACTIVITY,0.61803,-0.035285,-0.015704,0,0
4,GO REGULATION OF EXIT FROM MITOSIS,0.83078,-0.035488,0.0038009,0,0
4,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.78176,-0.035702,0.07692,0,0
4,GO T HELPER 1 CELL DIFFERENTIATION,0.62923,-0.03574,0.085508,0,0
4,GO CHROMOSOME LOCALIZATION,0.78176,-0.035908,0.01539,0,0
4,GO CENTROSOME SEPARATION,0.86799,-0.036165,0.030432,0,0
4,GO TRANSLATIONAL TERMINATION,0.11894,-0.037549,-0.063648,0,0
4,GO RESPONSE TO CADMIUM ION,0.79394,-0.037633,0.021401,0,0
4,GO DNA DEPENDENT DNA REPLICATION,0.60692,-0.037799,-0.010118,0,0
4,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.69814,-0.038089,-0.0080676,0,0
4,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.5959,-0.038131,0.0004997,0,0
4,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.19156,-0.038773,-0.079356,0,0
4,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.46168,-0.039007,-0.024828,0,0
4,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.76963,-0.039168,-0.035401,0,0
4,GO DENDRITIC CELL CHEMOTAXIS,0.93062,-0.039256,0.0013259,0,0
4,GO RIBONUCLEOSIDE CATABOLIC PROCESS,0.84314,-0.039327,-0.0017437,0,0
4,GO MODULATION BY HOST OF VIRAL PROCESS,0.78176,-0.039965,0.054668,0,0
4,GO CELLULAR RESPONSE TO ANTIBIOTIC,0.76963,-0.040428,0.042681,0,0
4,GO NEGATIVE REGULATION OF BEHAVIOR,0.81845,-0.04055,-0.0051048,0,0
4,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.80618,-0.040862,0.0092745,0,0
4,GO NUCLEOSOME ASSEMBLY,0.94321,-0.0409,0.014845,0,0
4,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.94321,-0.041141,-0.0073382,0,0
4,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.54223,-0.04208,-0.0031736,0,0
4,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.40594,-0.042832,-0.036898,0,0
4,GO NUCLEAR PORE ORGANIZATION,0.91805,-0.043144,0.019482,0,0
4,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.61803,-0.04451,-0.027921,0,0
4,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,0.64051,-0.044752,0.084053,0,0
4,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,0.20822,-0.044989,-0.098139,0,0
4,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.56341,-0.045027,-0.0089787,0,0
4,GO RESPONSE TO COPPER ION,0.90549,-0.04555,0.024485,0,0
4,GO MITOTIC SPINDLE ASSEMBLY,0.76963,-0.045742,-0.0025006,0,0
4,GO VIRAL LATENCY,0.35442,-0.046018,-0.054075,0,0
4,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.53179,-0.046671,-0.037921,0,0
4,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.40594,-0.047168,0.084624,0,0
4,GO SEQUESTERING OF ACTIN MONOMERS,0.80618,-0.047197,-0.040515,0,0
4,GO NUCLEAR CHROMOSOME SEGREGATION,0.89296,-0.047243,0.0087119,0,0
4,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,0.89296,-0.047243,0.021745,0,0
4,GO EOSINOPHIL MIGRATION,0.69814,-0.047409,-0.049674,0,0
4,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.93062,-0.047915,0.031961,0,0
4,GO NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING,0.38829,-0.048229,-0.032395,0,0
4,GO CYTOLYSIS,0.78176,-0.04854,0.036972,0,0
4,GO LIPOPROTEIN CATABOLIC PROCESS,0.90549,-0.049099,0.0038216,0,0
4,GO DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.38829,-0.0492,-0.024698,0,0
4,GO NEGATIVE REGULATION OF DNA REPLICATION,0.49108,-0.049379,-0.026573,0,0
4,GO TRNA 5 END PROCESSING,0.2259,-0.050253,-0.054538,0,0
4,GO INTERSTRAND CROSS LINK REPAIR,0.56341,-0.05028,-0.017432,0,0
4,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.47137,-0.050346,-0.033641,0,0
4,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.98106,-0.051019,0.037068,0,0
4,GO MITOTIC METAPHASE PLATE CONGRESSION,0.58498,-0.051739,-0.025198,0,0
4,GO RIBOSOME BIOGENESIS,0.39705,-0.051832,-0.024851,0,0
4,GO REGULATION OF CHROMOSOME SEPARATION,0.2577,-0.051898,-0.055259,0,0
4,GO ETHANOL OXIDATION,0.89296,-0.052166,-0.056675,0,0
4,GO REGULATION OF CHROMOSOME SEGREGATION,0.51122,-0.052456,-0.030608,0,0
4,GO PROSTANOID BIOSYNTHETIC PROCESS,0.83078,-0.05302,-0.012,0,0
4,GO REPLICATION FORK PROCESSING,1,-0.053191,0.030515,0,0
4,GO CHRONIC INFLAMMATORY RESPONSE,0.98106,-0.053491,-0.0095848,0,0
4,GO TELOMERASE RNA LOCALIZATION,0.4521,-0.053522,-0.017749,0,0
4,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.48117,-0.054752,-0.019255,0,0
4,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.80618,-0.055126,0.0057619,0,0
4,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.21989,-0.055425,-0.055142,0,0
4,GO ERROR PRONE TRANSLESION SYNTHESIS,0.18102,-0.056027,-0.083526,0,0
4,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.95582,-0.056156,0.0045127,0,0
4,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.50109,-0.056908,0.10206,0,0
4,GO MITOCHONDRIAL TRANSCRIPTION,0.29248,-0.058232,-0.048954,0,0
4,GO RRNA METHYLATION,0.96843,-0.058265,0.030703,0,0
4,GO MITOTIC CHROMOSOME CONDENSATION,0.75756,-0.058813,0.0023213,0,0
4,GO DNA DOUBLE STRAND BREAK PROCESSING,0.99368,-0.059579,0.019474,0,0
4,GO DNA REPLICATION CHECKPOINT,0.5959,-0.061069,-0.025216,0,0
4,GO AUTOPHAGIC CELL DEATH,0.50109,-0.061485,-0.024512,0,0
4,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.78176,-0.061934,0.031689,0,0
4,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.27821,-0.062079,-0.043085,0,0
4,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.89296,-0.063461,0.01846,0,0
4,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.045233,-0.064026,-0.075866,0,0
4,GO PROTEIN NEDDYLATION,0.074935,-0.064511,-0.084419,0,0
4,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.42405,-0.065439,-0.031406,0,0
4,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.16123,-0.066034,-0.080356,0,0
4,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.74555,-0.067375,-0.01297,0,0
4,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,0.7336,-0.06892,-0.0031014,0,0
4,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.52145,-0.069113,-0.026817,0,0
4,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.35442,-0.070373,-0.032681,0,0
4,GO SISTER CHROMATID COHESION,0.99368,-0.070562,0.022876,0,0
4,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,0.20256,-0.070573,-0.052656,0,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.79394,-0.070698,-0.006495,0,0
4,GO DNA LIGATION,0.60692,-0.070737,-0.022275,0,0
4,GO REPLICATIVE SENESCENCE,0.89296,-0.070887,0.037777,0,0
4,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.67486,-0.071139,0.0077781,0,0
4,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,0.89296,-0.071226,-0.011604,0,0
4,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.88046,-0.071238,0.020422,0,0
4,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.21989,-0.071444,-0.062602,0,0
4,GO NEGATIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.95582,-0.071523,0.016541,0,0
4,GO MITOTIC DNA REPLICATION,0.57414,-0.071719,-0.053216,0,0
4,GO SISTER CHROMATID SEGREGATION,0.5959,-0.071874,-0.013739,0,0
4,GO RRNA MODIFICATION,0.96843,-0.073299,0.017513,0,0
4,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.85555,-0.074006,0.036633,0,0
4,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.32248,-0.074054,-0.095852,0,0
4,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.17591,-0.074485,-0.067293,0,0
4,GO PROTEIN TARGETING TO MEMBRANE,0.045233,-0.074588,-0.061629,0,0
4,GO METAPHASE PLATE CONGRESSION,0.61803,-0.075258,-0.010543,0,0
4,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.065157,-0.075323,-0.088875,0,0
4,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.18102,-0.075659,-0.081552,0,0
4,GO MATURATION OF LSU RRNA,0.214,-0.075789,-0.069204,0,0
4,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.30724,-0.075945,-0.029537,0,0
4,GO RRNA 3 END PROCESSING,0.44264,-0.076101,-0.041392,0,0
4,GO TONIC SMOOTH MUSCLE CONTRACTION,0.79394,-0.077928,-0.020279,0,0
4,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.84314,-0.078765,0.10639,0,0
4,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.29248,-0.078854,-0.023059,0,0
4,GO CHROMOSOME CONDENSATION,0.72171,-0.080426,-0.0090856,0,0
4,GO REGULATION OF SPINDLE CHECKPOINT,0.33029,-0.080668,-0.069952,0,0
4,GO TETRAHYDROFOLATE INTERCONVERSION,0.49108,-0.082191,-0.01174,0,0
4,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.69814,-0.08227,-0.041371,0,0
4,GO MALE MEIOTIC NUCLEAR DIVISION,0.88046,-0.082541,0.056254,0,0
4,GO EOSINOPHIL CHEMOTAXIS,0.51122,-0.082846,-0.11051,0,0
4,GO CARTILAGE MORPHOGENESIS,0.49108,-0.083242,-0.032219,0,0
4,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.50109,-0.083499,-0.037083,0,0
4,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.094909,-0.084921,-0.11145,0,0
4,GO MITOTIC SISTER CHROMATID SEGREGATION,0.55277,-0.085877,-0.027021,0,0
4,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.61803,-0.087537,-0.056628,0,0
4,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.13467,-0.088222,-0.097521,0,0
4,GO PURINE CONTAINING COMPOUND SALVAGE,0.045233,-0.08974,-0.10284,0,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.23203,-0.09,-0.025347,0,0
4,GO NEGATIVE REGULATION BY HOST OF VIRAL PROCESS,0.66333,-0.090082,-0.038308,0,0
4,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.80618,-0.091237,-0.025356,0,0
4,GO CYTOPLASMIC TRANSLATION,0.014457,-0.091466,-0.11378,0,0
4,GO PROTEIN NITROSYLATION,0.75756,-0.09166,-0.024183,0,0
4,GO REGULATION OF LIGASE ACTIVITY,0.33821,-0.091956,-0.03513,0,0
4,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.16602,-0.09199,-0.075141,0,0
4,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,0.33029,-0.093015,-0.045888,0,0
4,GO VIRAL GENE EXPRESSION,0.017954,-0.095165,-0.10447,0,0
4,GO PHASIC SMOOTH MUSCLE CONTRACTION,0.60692,-0.097772,-0.020244,0,0
4,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.37111,-0.098272,-0.069048,0,0
4,GO HISTONE SERINE PHOSPHORYLATION,0.27126,-0.098884,-0.072016,0,0
4,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,0.76963,-0.099379,-0.013228,0,0
4,GO HISTONE EXCHANGE,0.19156,-0.10008,-0.107,0,0
4,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,0.214,-0.10071,-0.074716,0,0
4,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.62923,-0.10079,-0.0016599,0,0
4,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.098083,-0.10094,-0.099603,0,0
4,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.35442,-0.10098,-0.049604,0,0
4,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.21989,-0.10117,-0.082306,0,0
4,GO CELL CYCLE DNA REPLICATION,0.28529,-0.10363,-0.06132,0,0
4,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.0172,-0.10449,-0.13029,0,0
4,GO REGULATION OF NUCLEASE ACTIVITY,0.40594,-0.10662,-0.047912,0,0
4,GO RIBOSOME ASSEMBLY,0.031957,-0.10683,-0.11026,0,0
4,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.077559,-0.10761,-0.086279,0,0
4,GO CENTROMERE COMPLEX ASSEMBLY,0.15655,-0.10857,-0.12811,0,0
4,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.48117,-0.10946,-0.046118,0,0
4,GO HISTONE MRNA METABOLIC PROCESS,0.20822,-0.11061,-0.047858,0,0
4,GO KINETOCHORE ORGANIZATION,0.40594,-0.11217,-0.082143,0,0
4,GO TRNA CATABOLIC PROCESS,0.56341,-0.11313,-0.012401,0,0
4,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.27821,-0.11398,-0.049892,0,0
4,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.28529,-0.11409,-0.083462,0,0
4,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,0.0172,-0.11581,-0.13749,0,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.20822,-0.11714,-0.057791,0,0
4,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,0.008797,-0.11824,-0.13376,0,0
4,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.013235,-0.11893,-0.14775,0,0
4,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.18102,-0.12073,-0.12721,0,0
4,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.069906,-0.12348,-0.072881,0,0
4,GO FOREBRAIN NEURON FATE COMMITMENT,0.83078,-0.12356,0.075253,0,0
4,GO REGULATION OF DEOXYRIBONUCLEASE ACTIVITY,0.11894,-0.12412,-0.14036,0,0
4,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.18624,-0.12588,-0.12201,0,0
4,GO MYOBLAST MIGRATION,0.61803,-0.12601,-0.055102,0,0
4,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.094909,-0.12643,-0.10302,0,0
4,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.0031545,-0.12964,-0.15102,0,0
4,GO PROTEASOME ASSEMBLY,0.040368,-0.13131,-0.10425,0,0
4,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.11894,-0.13274,-0.10712,0,0
4,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.1475,-0.1353,-0.089109,0,0
4,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.056456,-0.13532,-0.13163,0,0
4,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.197,-0.13764,-0.094816,0,0
4,GO MITOTIC SISTER CHROMATID COHESION,0.74555,-0.1407,0.0055438,0,0
4,GO REGULATION OF CELL CYCLE CHECKPOINT,0.38829,-0.14192,-0.056998,0,0
4,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.2259,-0.14221,-0.073913,0,0
4,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.81845,-0.15126,-0.008698,0,0
4,GO PROXIMAL DISTAL PATTERN FORMATION,0.16602,-0.15315,-0.13005,0,0
4,GO DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.019548,-0.15697,-0.12839,0,0
4,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.010572,-0.15709,-0.23912,0,0
4,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.21989,-0.172,-0.12164,0,0
4,GO V D J RECOMBINATION,0.27821,-0.17938,-0.09867,0,0
4,GO TRANSLATIONAL INITIATION,0.0044907,-0.18389,-0.16394,0,0
4,GO SPINDLE MIDZONE ASSEMBLY,0.21989,-0.20823,-0.073944,0,0
4,GO DETOXIFICATION OF INORGANIC COMPOUND,0.17591,-0.37338,-0.20581,0,0
4,GO NATURAL KILLER CELL CHEMOTAXIS,0.27821,-0.46063,-0.25571,0,0
